PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zahedi, K; Barone, S; Wang, Y; Murray-Stewart, T; Roy-Chaudhury, P; Smith, RD; Casero, RA; Soleimani, M				Zahedi, Kamyar; Barone, Sharon; Wang, Yang; Murray-Stewart, Tracy; Roy-Chaudhury, Prabir; Smith, Roger D.; Casero, Robert A., Jr.; Soleimani, Manoocher			Proximal Tubule Epithelial Cell Specific Ablation of the Spermidine/Spermine N-1-Acetyltransferase Gene Reduces the Severity of Renal Ischemia/Reperfusion Injury	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ACUTE KIDNEY INJURY; POLYAMINE CATABOLISM; CEREBRAL-ISCHEMIA; METABOLIC FLUX; DNA-DAMAGE; LIVER; OVEREXPRESSION; ACTIVATION; GROWTH	Background: Expression and activity of spermidine/spermine N-1-acetyltransferase (SSAT) increases in kidneys subjected to ischemia/reperfusion (I/R) injury, while its ablation reduces the severity of such injuries. These results suggest that increased SSAT levels contribute to organ injury; however, the role of SSAT specifically expressed in proximal tubule epithelial cells, which are the primary targets of I/R injury, in the mediation of renal damage remains unresolved. Methods: Severity of I/R injury in wt and renal proximal tubule specific SSAT-ko mice (PT-SSAT-Cko) subjected to bilateral renal I/R injury was assessed using cellular and molecular biological approaches. Results: Severity of the loss of kidney function and tubular damage are reduced in PT-SSAT-Cko-compared to wt-mice after I/R injury. In addition, animals treated with MDL72527, an inhibitor of polyamine oxidases, had less severe renal damage than their vehicle treated counter-parts. The renal expression of HMGB 1 and Toll like receptors (TLR) 2 and 4 were also reduced in PT-SSAT-Cko-compared to wt mice after I/R injury. Furthermore, infiltration of neutrophils, as well as expression of tumor necrosis factor-alpha (TNF-alpha), monocyte chemoattractant protein-1 (MCP-1) and interleukin-6 (IL-6) transcripts were lower in the kidneys of PT-SSAT-Cko compared to wt mice after I/R injury. Finally, the activation of caspase3 was more pronounced in the wt compared to PT-SSAT-Cko animals. Conclusions: Enhanced SSAT expression by proximal tubule epithelial cells leads to tubular damage, and its deficiency reduces the severity of renal I/R injury through reduction of cellular damage and modulation of the innate immune response.	[Zahedi, Kamyar; Barone, Sharon; Wang, Yang; Roy-Chaudhury, Prabir; Soleimani, Manoocher] Univ Cincinnati, Coll Med, Dept Internal Med, Div Nephrol & Hypertens, Cincinnati, OH 45221 USA; [Murray-Stewart, Tracy; Casero, Robert A., Jr.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Smith, Roger D.] Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH USA; [Zahedi, Kamyar; Barone, Sharon; Soleimani, Manoocher] Vet Affair Med Ctr, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; Johns Hopkins University; Johns Hopkins Medicine; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Zahedi, K (corresponding author), Univ Cincinnati, Coll Med, Dept Internal Med, Div Nephrol & Hypertens, Cincinnati, OH 45221 USA.	zahedika@ucmail.uc.edu	Stewart, Tracy Murray/B-6137-2017; Zahedi, Kamyar/AAQ-3428-2021	Stewart, Tracy Murray/0000-0001-8679-6414; Casero, Robert/0000-0001-5653-3306	National Institutes of Health [CA051085, CA098454]; VA Merit Award; Center on Genetics of Transport and Epithelial Biology at the University of Cincinnati; DCI; US Renal Care Inc.; NATIONAL CANCER INSTITUTE [R01CA098454, R01CA051085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); Center on Genetics of Transport and Epithelial Biology at the University of Cincinnati; DCI; US Renal Care Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants CA051085 and CA098454 (RAC) from National Institutes of Health and VA Merit Award (MS). These studies were supported in part by funds from the Center on Genetics of Transport and Epithelial Biology at the University of Cincinnati, funds from DCI and US Renal Care Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhonen L, 2000, P NATL ACAD SCI USA, V97, P8290, DOI 10.1073/pnas.140122097; Barone S, 2005, AM J PHYSIOL-CELL PH, V289, pC826, DOI 10.1152/ajpcell.00629.2004; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Chen Y, 2001, CANCER RES, V61, P6437; Gao J, 2011, RENAL FAILURE, V33, P805, DOI 10.3109/0886022X.2011.601829; Grenz A, 2012, J IMMUNOL, V189, P4566, DOI 10.4049/jimmunol.1201651; Ha HC, 1997, P NATL ACAD SCI USA, V94, P11557, DOI 10.1073/pnas.94.21.11557; HASAN R, 1995, FEBS LETT, V368, P27, DOI 10.1016/0014-5793(95)00591-V; Hegardt C, 2002, EUR J BIOCHEM, V269, P1033, DOI 10.1046/j.0014-2956.2001.02744.x; Hong SKS, 2010, INFLAMM BOWEL DIS, V16, P1557, DOI 10.1002/ibd.21224; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Ivanova S, 2002, P NATL ACAD SCI USA, V99, P5579, DOI 10.1073/pnas.082609299; Ivanova S, 1998, J EXP MED, V188, P327, DOI 10.1084/jem.188.2.327; JANNE J, 1991, ANN MED, V23, P241, DOI 10.3109/07853899109148056; Kielar ML, 2005, J AM SOC NEPHROL, V16, P3315, DOI 10.1681/asn.2003090757; KRAMER D, 1995, BIOCHEM PHARMACOL, V50, P1433, DOI 10.1016/0006-2952(95)02037-3; Kramer DL, 2008, J BIOL CHEM, V283, P4241, DOI 10.1074/jbc.M706806200; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; MARTON LJ, 1995, ANNU REV PHARMACOL, V35, P55, DOI 10.1146/annurev.pa.35.040195.000415; Pietila M, 1997, J BIOL CHEM, V272, P18746, DOI 10.1074/jbc.272.30.18746; Pietila M, 2001, J INVEST DERMATOL, V116, P801, DOI 10.1046/j.1523-1747.2001.01330.x; Rusai K, 2010, PEDIATR NEPHROL, V25, P853, DOI 10.1007/s00467-009-1422-4; Shigeoka AA, 2007, J IMMUNOL, V178, P6252, DOI 10.4049/jimmunol.178.10.6252; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Vujcic S, 2000, J BIOL CHEM, V275, P38319, DOI 10.1074/jbc.M003270200; Wang ZH, 2004, J AM SOC NEPHROL, V15, P1844, DOI 10.1097/01.ASN.0000131525.77636.D5; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Wu HL, 2010, J AM SOC NEPHROL, V21, P1878, DOI 10.1681/ASN.2009101048; Xu HX, 2004, CANCER RES, V64, P8521, DOI 10.1158/0008-5472.CAN-04-3511; Zahedi K, 2004, AM J PHYSIOL-CELL PH, V286, pC1203, DOI 10.1152/ajpcell.00432.2003; Zahedi K, 2003, AM J PHYSIOL-RENAL, V284, pF1046, DOI 10.1152/ajprenal.00318.2002; Zahedi K, 2007, AM J PHYSIOL-CELL PH, V292, pC1204, DOI 10.1152/ajpcell.00451.2006; Zahedi K, 2012, AM J PHYSIOL-GASTR L, V303, pG546, DOI 10.1152/ajpgi.00431.2011; Zahedi K, 2010, AM J PHYSIOL-CELL PH, V299, pC164, DOI 10.1152/ajpcell.00512.2009; Zahedi K, 2010, J NEUROTRAUM, V27, P515, DOI 10.1089/neu.2009.1097; Zahedi K, 2009, AM J PHYSIOL-GASTR L, V296, pG899, DOI 10.1152/ajpgi.90507.2008; Zhang W, 2007, TRANSPL P, V39, P1332, DOI 10.1016/j.transproceed.2006.11.021	37	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e110161	10.1371/journal.pone.0110161	http://dx.doi.org/10.1371/journal.pone.0110161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390069	gold, Green Published, Green Submitted			2022-12-27	WOS:000349144400012
J	Gobet, N; Ketterer, S; Meier, M				Gobet, Nicolas; Ketterer, Simon; Meier, Matthias			Design and Validation of DNA Libraries for Multiplexing Proximity Ligation Assays	PLOS ONE			English	Article							NUCLEIC-ACID; PROTEIN-DETECTION; IN-SITU	Here, we present an in silico, analytical procedure for designing and testing orthogonal DNA templates for multiplexing of the proximity ligation assay (PLA). PLA is a technology for the detection of protein interactions, post-translational modifications, and protein concentrations. To enable multiplexing of the PLA, the target information of antibodies was encoded within the DNA template of a PLA, where each template comprised four single-stranded DNA molecules. Our DNA design procedure followed the principles of minimizing the free energy of DNA cross-hybridization. To validate the functionality, orthogonality, and efficiency of the constructed template libraries, we developed a high-throughput solid-phase rolling-circle amplification assay and solid-phase PLA on a microfluidic platform. Upon integration on a microfluidic chip, 640 miniaturized pull-down assays for oligonucleotides or antibodies could be performed in parallel together with steps of DNA ligation, isothermal amplification, and detection under controlled microenvironments. From a large computed PLA template library, we randomly selected 10 template sets and tested all DNA combinations for cross-reactivity in the presence and absence of antibodies. By using the microfluidic chip application, we determined rapidly the false-positive rate of the design procedure, which was less than 1%. The combined theoretical and experimental procedure is applicable for high-throughput PLA studies on a microfluidic chip.	[Gobet, Nicolas; Ketterer, Simon; Meier, Matthias] Univ Freiburg, Dept Microsyst Engn Microfluid & Biol Engn, IMTEK, D-79106 Freiburg, Germany; [Gobet, Nicolas; Ketterer, Simon; Meier, Matthias] Univ Freiburg, BIOSS Ctr Signalling Studies, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg	Meier, M (corresponding author), Univ Freiburg, Dept Microsyst Engn Microfluid & Biol Engn, IMTEK, Hugstetter Str 55, D-79106 Freiburg, Germany.	matthias.meier@imtek.de			German Excellence Initiative [EXE-294]; German Research Foundation [ME3823/1-1]	German Excellence Initiative; German Research Foundation(German Research Foundation (DFG))	This study was supported by the German Excellence Initiative (EXE-294) and by the German Research Foundation (Emmy-Noether Grant ME3823/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Blazek M, 2013, MOL CELL PROTEOMICS, V12, P3898, DOI 10.1074/mcp.M113.032821; Darmanis S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025583; Dirks RM, 2007, SIAM REV, V49, P65, DOI 10.1137/060651100; Ericsson O, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn106; FIRE A, 1995, P NATL ACAD SCI USA, V92, P4641, DOI 10.1073/pnas.92.10.4641; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Fredriksson S, 2007, NAT METHODS, V4, P327, DOI 10.1038/NMETH1020; Gustafsdottir SM, 2006, CLIN CHEM, V52, P1152, DOI 10.1373/clinchem.2005.065847; Han KN, 2013, ANNU REV ANAL CHEM, V6, P119, DOI 10.1146/annurev-anchem-062012-092616; Hofacker IL, 2011, VIENNARNA PACKAGE 2; Juncker D, 2014, CURR OPIN CHEM BIOL, V18, P29, DOI 10.1016/j.cbpa.2013.11.012; Kim J, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp827; Leuchowius K, 2013, MOL CELLULAR PROTEOM, P1; Lundberg M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004978; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Meier M, 2013, P NATL ACAD SCI USA, V110, P477, DOI 10.1073/pnas.1210634110; Nong RY, 2013, NAT PROTOC, V8, P1234, DOI 10.1038/nprot.2013.070; Schweitzer B, 2002, NATURE, DOI [10.1016/S0958-1669(02)00019-8, DOI 10.1016/S0958-1669(02)00019-8]; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tafer H, 2008, BIOINFORMATICS, V24, P2657, DOI 10.1093/bioinformatics/btn193; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; YALOW RS, 1960, J CLIN INVEST, V39, P1157, DOI 10.1172/JCI104130; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhang DY, 2012, NAT CHEM, V4, P208, DOI [10.1038/NCHEM.1246, 10.1038/nchem.1246]	28	1	1	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112629	10.1371/journal.pone.0112629	http://dx.doi.org/10.1371/journal.pone.0112629			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386748	Green Submitted, Green Published, gold			2022-12-27	WOS:000345250400074
J	Lin, R; Tao, YY; Yu, YB; Xu, ZD; Su, J; Liu, ZQ				Lin, Rong; Tao, Yiyi; Yu, Yibing; Xu, Zhendong; Su, Jing; Liu, Zhiqiang			Intravenous Remifentanil versus Epidural Ropivacaine with Sufentanil for Labour Analgesia: A Retrospective Study	PLOS ONE			English	Article							PATIENT-CONTROLLED ANALGESIA; PAIN RELIEF; OBSTETRIC ANALGESIA; ANESTHESIA; FENTANYL; BOLUS; MEPERIDINE; EFFICACY; DELIVERY; SAFETY	Remifentanil with appropriate pharmacological properties seems to be an ideal alternative to epidural analgesia during labour. A retrospective cohort study was undertaken to assess the efficacy and safety of remifentanil intravenous patient-controlled analgesia (IVPCA) compared with epidural analgesia. Medical records of 370 primiparas who received remifentanil IVPCA or epidural analgesia were reviewed. Pain and sedation scores, overall satisfaction, the extent of pain control, maternal side effects and neonatal outcome as primary observational indicators were collected. There was a significant decline of pain scores in both groups. Pain reduction was greater in the epidural group throughout the whole study period (0 similar to 180 min) (P<0.0001), and pain scores in the remifentanil group showed an increasing trend one hour later. The remifentanil group had a lower SpO(2) (P, 0.0001) and a higher sedation score (P<0.0001) within 30 min after treatment. The epidural group had a higher overall satisfaction score (3.8 +/- 0.4 vs. 3.7 +/- 0.6, P = 0.007) and pain relief score (2.9 +/- 0.3 vs. 2.8 +/- 0.4, P<0.0001) compared with the remifentanil group. There was no significant difference on side effects between the two groups, except that a higher rate of dizziness (1% vs. 21.8%, P<0.0001) was observed during remifentanil analgesia. And logistic regression analysis demonstrated that nausea, vomiting were associated with oxytocin usage and instrumental delivery, and dizziness was associated to the type and duration of analgesia. Neonatal outcomes such as Apgar scores and umbilical-cord blood gas analysis were within the normal range, but umbilical pH and base excess of neonatus in the remifentanil group were significantly lower. Remifentanil IVPCA provides poorer efficacy on labor analgesia than epidural analgesia, with more sedation on parturients and a trend of newborn acidosis. Despite these adverse effects, remifentanil IVPCA can still be an alternative option for labor analgesia under the condition of one-to-one bedside care, continuous monitoring, oxygen supply and preparation for neonatal resuscitation.	[Lin, Rong; Tao, Yiyi; Yu, Yibing; Xu, Zhendong; Su, Jing; Liu, Zhiqiang] Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Dept Anaesthesiol, Shanghai 200092, Peoples R China	Tongji University	Liu, ZQ (corresponding author), Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Dept Anaesthesiol, Shanghai 200092, Peoples R China.	drliuzhq@hotmail.com						Althaus J, 2005, OBSTET GYN CLIN N AM, V32, P231, DOI 10.1016/j.ogc.2005.01.002; [Anonymous], 2011, CHIN J PERINAT MED, V14, P415; Babenco HD, 2000, ANESTHESIOLOGY, V92, P393, DOI 10.1097/00000542-200002000-00020; Balcioglu O, 2007, EXPERT OPIN PHARMACO, V8, P3089, DOI 10.1517/14656566.8.18.3089; Balki M, 2007, CAN J ANAESTH, V54, P626, DOI 10.1007/BF03022956; Blair JM, 2005, ANAESTHESIA, V60, P22, DOI 10.1111/j.1365-2044.2004.03975.x; Blair JM, 2001, BRIT J ANAESTH, V87, P415, DOI 10.1093/bja/87.3.415; Bonner JC, 2012, ANAESTHESIA, V67, P538, DOI 10.1111/j.1365-2044.2011.06997.x; D'Onofrio P, 2009, ANESTH ANALG, V109, P1922, DOI 10.1213/ane.0b013e3181acc6fc; Dhileepan S, 2001, ANESTH ANALG, V92, P1358; Douma MR, 2011, INT J OBSTET ANESTH, V20, P118, DOI 10.1016/j.ijoa.2010.11.009; Douma MR, 2010, BRIT J ANAESTH, V104, P209, DOI 10.1093/bja/aep359; Egan T D, 2000, Curr Opin Anaesthesiol, V13, P449, DOI 10.1097/00001503-200008000-00009; Egan TD, 1998, ANESTHESIOLOGY, V89, P562, DOI 10.1097/00000542-199809000-00004; Egan TD, 2004, BRIT J ANAESTH, V92, P335, DOI 10.1093/bja/aeh075; Evron S, 2005, ANESTH ANALG, V100, P233, DOI 10.1213/01.ANE.0000143351.64538.BC; Evron S, 2008, J ANESTH, V22, P105, DOI 10.1007/s00540-007-0589-8; Hill D, 2008, CURR OPIN ANESTHESIO, V21, P270, DOI 10.1097/ACO.0b013e3282f8e26c; Ismail MT, 2012, ARCH GYNECOL OBSTET, V286, P1375, DOI 10.1007/s00404-012-2459-3; Kan RE, 1998, ANESTHESIOLOGY, V88, P1467, DOI 10.1097/00000542-199806000-00008; KAPILA A, 1995, ANESTHESIOLOGY, V83, P968, DOI 10.1097/00000542-199511000-00009; Kattwinkel J, 2010, PEDIATRICS, V126, pE1400, DOI 10.1542/peds.2010-2972E; Kee WDN, 2006, ANESTHESIOLOGY, V104, P14, DOI 10.1097/00000542-200601000-00004; Kee WDN, 2004, BRIT J ANAESTH, V92, P469, DOI 10.1093/bja/aeh088; Landau R, 2004, ANESTHESIOLOGY, V100, P1030, DOI 10.1097/00000542-200404000-00042; Liu ZQ, 2014, ANESTH ANALG, V118, P598, DOI 10.1213/ANE.0000000000000077; Marwah R, 2012, CAN J ANESTH, V59, P246, DOI 10.1007/s12630-011-9625-0; Miller R.D., 2010, MILLERS ANESTHESIA, P2827; Olufolabi AJ, 2000, ANESTH ANALG, V91, P606, DOI 10.1213/00000539-200009000-00020; Shahriari A, 2007, J MED SCI, V7, P635; Stourac P, 2014, BIOMED PAP, V158, P227, DOI 10.5507/bp.2012.073; Thurlow JA, 2002, BRIT J ANAESTH, V88, P374, DOI 10.1093/bja/88.3.374; Tveit TO, 2013, INT J OBSTET ANESTH, V22, P19, DOI 10.1016/j.ijoa.2012.09.003; Tveit TO, 2012, EUR J ANAESTH, V29, P129, DOI 10.1097/EJA.0b013e32834dfa98; Volikas I, 2005, BRIT J ANAESTH, V95, P504, DOI 10.1093/bja/aei219; Volmanen P, 2008, ACTA ANAESTH SCAND, V52, P249, DOI 10.1111/j.1399-6576.2007.01509.x; Volmanen P, 2005, ACTA ANAESTH SCAND, V49, P453, DOI 10.1111/j.1399-6576.2005.00639.x; Volmanen P, 2004, INT J OBSTET ANESTH, V13, P1, DOI 10.1016/j.ijoa.2003.10.002; Volmanen P, 2002, ANESTH ANALG, V94, P913, DOI 10.1097/00000539-200204000-00026; Volmanen PVE, 2011, ACTA ANAESTH SCAND, V55, P486, DOI 10.1111/j.1399-6576.2010.02390.x	40	14	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112283	10.1371/journal.pone.0112283	http://dx.doi.org/10.1371/journal.pone.0112283			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386749	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400053
J	van Dijk, JGB; Mateman, AC; Klaassen, M				van Dijk, Jacintha G. B.; Mateman, A. Christa; Klaassen, Marcel			Transfer of Maternal Antibodies against Avian Influenza Virus in Mallards (Anas platyrhynchos)	PLOS ONE			English	Article							EGG SIZE; HEMAGGLUTININ SUBTYPE; A VIRUS; YOLK; TRANSMISSION; PERSISTENCE; PATERNITY; IMMUNITY; PATTERNS; GROWTH	Maternal antibodies protect chicks from infection with pathogens early in life and may impact pathogen dynamics due to the alteration of the proportion of susceptible individuals in a population. We investigated the transfer of maternal antibodies against avian influenza virus (AIV) in a key AIV host species, the mallard (Anas platyrhynchos). Combining observations in both the field and in mallards kept in captivity, we connected maternal AIV antibody concentrations in eggs to (i) female body condition, (ii) female AIV antibody concentration, (iii) egg laying order, (iv) egg size and (v) embryo sex. We applied maternity analysis to the eggs collected in the field to account for intraspecific nest parasitism, which is reportedly high in Anseriformes, detecting parasitic eggs in one out of eight clutches. AIV antibody prevalence in free-living and captive females was respectively 48% and 56%, with 43% and 24% of the eggs receiving these antibodies maternally. In both field and captive study, maternal AIV antibody concentrations in egg yolk correlated positively with circulating AIV antibody concentrations in females. In the captive study, yolk AIV antibody concentrations correlated positively with egg laying order. Female body mass and egg size from the field and captive study, and embryos sex from the field study were not associated with maternal AIV antibody concentrations in eggs. Our study indicates that maternal AIV antibody transfer may potentially play an important role in shaping AIV infection dynamics in mallards.	[van Dijk, Jacintha G. B.; Mateman, A. Christa; Klaassen, Marcel] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands; [Klaassen, Marcel] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Geelong, Vic 3217, Australia	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Deakin University	van Dijk, JGB (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands.	jacintha.vandijk@gmail.com	Mateman, Christa/C-9380-2012; Klaassen, Marcel/B-4325-2008; KNAW, NIOO-KNAW/A-4320-2012	Mateman, Christa/0000-0002-9832-5780; Klaassen, Marcel/0000-0003-3907-9599; KNAW, NIOO-KNAW/0000-0002-3835-159X	Netherlands Organization for Scientific Research (NWO) [820.01.018]; National Institutes of Health (NIH) [NIAID HHSN266200700010C]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the Netherlands Organization for Scientific Research (NWO; grant 820.01.018) and the National Institutes of Health (NIH; contract NIAID HHSN266200700010C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Gomez JM, 2012, J AVIAN BIOL, V43, P491, DOI 10.1111/j.1600-048X.2012.05792.x; Al-Natour MQ, 2004, AVIAN DIS, V48, P177, DOI 10.1637/5319; Baker K, 1993, IDENTIFICATION GUIDE; Bates D., 2012, IME4 LINEAR MIXED EF; Boulinier T, 2008, TRENDS ECOL EVOL, V23, P282, DOI 10.1016/j.tree.2007.12.006; Boutette JB, 2002, J AVIAN MED SURG, V16, P198, DOI 10.1647/1082-6742(2002)016[0198:AIPCRR]2.0.CO;2; Boyd H., 1975, DUCK WINGS STUDY DUC; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; BYERS SM, 1991, J WILDLIFE MANAGE, V55, P580, DOI 10.2307/3809502; Cramp S, 1977, HDB BIRDS EUROPE MID, P1; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; Denk AG, 2004, MOL ECOL NOTES, V4, P506, DOI 10.1111/j.1471-8286.2004.00707.x; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Garnier R, 2012, P ROY SOC B-BIOL SCI, V279, P2033, DOI 10.1098/rspb.2011.2277; Gasparini J, 2007, J EVOLUTION BIOL, V20, P874, DOI 10.1111/j.1420-9101.2007.01315.x; Gasparini J, 2002, ECOL LETT, V5, P519, DOI 10.1046/j.1461-0248.2002.00345.x; Geffen E, 2001, ANIM BEHAV, V62, P1027, DOI 10.1006/anbe.2001.1855; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Grindstaff JL, 2010, J ORNITHOL, V151, P423, DOI 10.1007/s10336-009-0472-5; Grindstaff JL, 2006, P ROY SOC B-BIOL SCI, V273, P2551, DOI 10.1098/rspb.2006.3608; Grindstaff JL, 2005, J ANIM ECOL, V74, P1051, DOI 10.1111/j.1365-2656.2005.01002.x; Grindstaff JL, 2003, P ROY SOC B-BIOL SCI, V270, P2309, DOI 10.1098/rspb.2003.2485; Groothuis TGG, 2006, J EVOLUTION BIOL, V19, P1304, DOI 10.1111/j.1420-9101.2005.01072.x; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Gunnarsson G, 2008, ANN ZOOL FENN, V45, P483, DOI 10.5735/086.045.0603; Hammouda A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034966; Hammouda A, 2011, VECTOR-BORNE ZOONOT, V11, P1583, DOI 10.1089/vbz.2011.0639; Hargitai R, 2006, FUNCT ECOL, V20, P829, DOI 10.1111/j.1365-2435.2006.01171.x; Hasselquist D, 2009, PHILOS T R SOC B, V364, P51, DOI 10.1098/rstb.2008.0137; HINSHAW VS, 1982, J VIROL, V42, P865, DOI 10.1128/JVI.42.3.865-872.1982; Holveck MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050389; Hoye BJ, 2012, METHODS ECOL EVOL, V3, P162, DOI 10.1111/j.2041-210X.2011.00135.x; HOYT DF, 1979, AUK, V96, P73; Ismail A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079942; Jacobson RH, 1998, REV SCI TECH OIE, V17, P469, DOI 10.20506/rst.17.2.1119; Jacquin L, 2013, BIOL J LINN SOC, V108, P647, DOI 10.1111/bij.12001; Jeong OM, 2010, VET MICROBIOL, V144, P287, DOI 10.1016/j.vetmic.2010.01.022; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Karell P, 2008, FUNCT ECOL, V22, P682, DOI 10.1111/j.1365-2435.2008.01425.x; King MO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009639; KOWALCZYK K, 1985, IMMUNOLOGY, V54, P755; Kreisinger J, 2010, J AVIAN BIOL, V41, P551, DOI 10.1111/j.1600-048X.2010.05002.x; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; LIU SS, 1990, COMP BIOCHEM PHYS B, V97, P637, DOI 10.1016/0305-0491(90)90100-8; Maak S, 2003, MOL ECOL NOTES, V3, P224, DOI 10.1046/j.1471-8286.2003.00405.x; MacCluskie MC, 1997, CONDOR, V99, P224, DOI 10.2307/1370245; Martyka R, 2011, BIOL LETTERS, V7, P50, DOI 10.1098/rsbl.2010.0549; MOHAMMED HO, 1986, AVIAN DIS, V30, P398, DOI 10.2307/1590547; Morales J, 2006, BIOL LETTERS, V2, P334, DOI 10.1098/rsbl.2006.0471; Moreno J, 2008, OECOLOGIA, V156, P727, DOI 10.1007/s00442-008-1029-7; Muller W, 2004, FUNCT ECOL, V18, P719, DOI 10.1111/j.0269-8463.2004.00902.x; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; OTAKI Y, 1992, AVIAN PATHOL, V21, P147, DOI 10.1080/03079459208418828; Pearce-Duvet JMC, 2009, EMERG INFECT DIS, V15, P1147, DOI 10.3201/eid1507.090036; PEHRSSON O, 1991, CAN J ZOOL, V69, P156, DOI 10.1139/z91-024; Pihlaja M, 2006, J ANIM ECOL, V75, P1154, DOI 10.1111/j.1365-2656.2006.01136.x; R Development Core Team, 2012, R LANG ENV STAT COMP; RHYMER JM, 1988, OECOLOGIA, V75, P20, DOI 10.1007/BF00378809; Saino N, 2003, J EVOLUTION BIOL, V16, P516, DOI 10.1046/j.1420-9101.2003.00534.x; Saino N, 2002, P ROY SOC B-BIOL SCI, V269, P1005, DOI 10.1098/rspb.2002.1992; Schwabl H, 1997, NATURE, V386, P231, DOI 10.1038/386231a0; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Staszewski V, 2007, J ANIM ECOL, V76, P1215, DOI 10.1111/j.1365-2656.2007.01293.x; Stearns S.C., 1992, pi; Velarde R, 2010, AVIAN DIS, V54, P411, DOI 10.1637/8808-040109-Reg.1	65	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112595	10.1371/journal.pone.0112595	http://dx.doi.org/10.1371/journal.pone.0112595			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386907	Green Published, Green Submitted, gold			2022-12-27	WOS:000345250400069
J	Xiong, EH; Wu, XL; Yang, L; Gong, FP; Tai, FJ; Wang, W				Xiong, Erhui; Wu, Xiaolin; Yang, Le; Gong, Fangping; Tai, Fuju; Wang, Wei			Chloroform-Assisted Phenol Extraction Improving Proteome Profiling of Maize Embryos through Selective Depletion of High-Abundance Storage Proteins	PLOS ONE			English	Article							MEMBRANE-PROTEINS; GLOBULIN; PRECIPITATION; EXPRESSION; VICILINS; GENE	The presence of abundant storage proteins in plant embryos greatly impedes seed proteomics analysis. Vicilin (or globulin-1) is the most abundant storage protein in maize embryo. There is a need to deplete the vicilins from maize embryo extracts for enhanced proteomics analysis. We here reported a chloroform-assisted phenol extraction (CAPE) method for vicilin depletion. By CAPE, maize embryo proteins were first extracted in an aqueous buffer, denatured by chloroform and then subjected to phenol extraction. We found that CAPE can effectively deplete the vicilins from maize embryo extract, allowing the detection of low-abundance proteins that were masked by vicilins in 2-DE gel. The novelty of CAPE is that it selectively depletes abundant storage proteins from embryo extracts of both monocot (maize) and dicot (soybean and pea) seeds, whereas other embryo proteins were not depleted. CAPE can significantly improve proteome profiling of embryos and extends the application of chloroform and phenol extraction in plant proteomics. In addition, the rationale behind CAPE depletion of abundant storage proteins was explored.	[Xiong, Erhui; Wu, Xiaolin; Yang, Le; Gong, Fangping; Tai, Fuju; Wang, Wei] Henan Agr Univ, Coll Life Sci, Collaborat Innovat Ctr Henan Grain Crops, Zhengzhou 450002, Peoples R China	Henan Agricultural University	Wang, W (corresponding author), Henan Agr Univ, Coll Life Sci, Collaborat Innovat Ctr Henan Grain Crops, Zhengzhou 450002, Peoples R China.	wangwei@henau.edu.cn	Wang, Wei/R-7323-2016	Wang, Wei/0000-0002-3711-5181	National Natural Science Foundation of China [31371543]; Plan for Scientific Innovation Talent of Henan Province [144200510012]; State Key Laboratory of Crop Biology in Shandong Agricultural University [2012KF01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Plan for Scientific Innovation Talent of Henan Province; State Key Laboratory of Crop Biology in Shandong Agricultural University	This work was supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn/; grant no. 31371543, to WW), Plan for Scientific Innovation Talent of Henan Province (http://www.hnkjt.gov.cn/; grant no. 144200510012, to WW) and State Key Laboratory of Crop Biology in Shandong Agricultural University (http://klab.sdau.edu.cn/; grant no. 2012KF01, to WW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astwood JD, 2002, J ALLERGY CLIN IMMUN, V110, P26, DOI 10.1067/mai.2002.125690; BELANGER FC, 1991, GENETICS, V129, P863; BELANGER FC, 1989, PLANT PHYSIOL, V91, P636, DOI 10.1104/pp.91.2.636; Bellei E, 2011, AMINO ACIDS, V40, P145, DOI 10.1007/s00726-010-0628-x; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Colmsee C, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-245; Di Girolamo F, 2010, ANTICANCER RES, V30, P1121; Fasoli E, 2009, J PROTEOMICS, V72, P501, DOI 10.1016/j.jprot.2009.01.013; Fukuda T, 2007, J AGR FOOD CHEM, V55, P3667, DOI 10.1021/jf063205l; Gerlach JQ, 2009, J BOT, DOI [DOI 10.1155/2009/560394, 10.1155/2009/560394]; GIBBS PEM, 1989, MOL BIOL EVOL, V6, P614; HIGGINS TJV, 1988, PLANT MOL BIOL, V11, P683, DOI 10.1007/BF00017468; Kim YJ, 2013, PROTEOMICS, V13, P2176, DOI 10.1002/pmic.201200555; Krishnan HB, 2009, PROTEOMICS, V9, P3174, DOI 10.1002/pmic.200800875; KRIZ AR, 1990, PLANT PHYSIOL, V92, P538, DOI 10.1104/pp.92.2.538; Liu B, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-24; Mirza SP, 2007, PHYSIOL GENOMICS, V30, P89, DOI 10.1152/physiolgenomics.00279.2006; Reigada R, 2014, BBA-BIOMEMBRANES, V1838, P814, DOI 10.1016/j.bbamem.2013.10.008; Sambrook Joseph, 2006, CSH Protoc, V2006, DOI [10.1101/pdb.prot3966, 10.1101/pdb.prot4044, 10.1101/pdb.prot4085, 10.1101/pdb.prot4056, 10.1101/pdb.prot4027, 10.1101/pdb.prot4453, 10.1101/pdb.prot3825, 10.1101/pdb.prot4050, 10.1101/pdb.prot4022, 10.1101/pdb.prot3871, 10.1101/pdb.prot4455, 10.1101/pdb.prot3972, 10.1101/pdb.prot3723]; SHEWRY PR, 1995, PLANT CELL, V7, P945, DOI 10.1105/tpc.7.7.945; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; Wu XL, 2014, PROTEOMICS, V14, P645, DOI 10.1002/pmic.201300239; Wu XL, 2014, NAT PROTOC, V9, P362, DOI 10.1038/nprot.2014.022; Wu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050497	24	13	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112724	10.1371/journal.pone.0112724	http://dx.doi.org/10.1371/journal.pone.0112724			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386674	Green Submitted, Green Published, gold			2022-12-27	WOS:000345250400087
J	Duan, RY; Kong, XQ; Huang, MY; Fan, WY; Wang, ZG				Duan, Ren-Yan; Kong, Xiao-Quan; Huang, Min-Yi; Fan, Wei-Yi; Wang, Zhi-Gao			The Predictive Performance and Stability of Six Species Distribution Models	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; CLIMATE-CHANGE; UNCERTAINTY; NICHE; CLASSIFICATION; FORESTS; OAK; CONSERVATION; DISTURBANCE; VALIDATION	Background: Predicting species' potential geographical range by species distribution models (SDMs) is central to understand their ecological requirements. However, the effects of using different modeling techniques need further investigation. In order to improve the prediction effect, we need to assess the predictive performance and stability of different SDMs. Methodology: We collected the distribution data of five common tree species (Pinus massoniana, Betula platyphylla, Quercus wutaishanica, Quercus mongolica and Quercus variabilis) and simulated their potential distribution area using 13 environmental variables and six widely used SDMs: BIOCLIM, DOMAIN, MAHAL, RF, MAXENT, and SVM. Each model run was repeated 100 times (trials). We compared the predictive performance by testing the consistency between observations and simulated distributions and assessed the stability by the standard deviation, coefficient of variation, and the 99% confidence interval of Kappa and AUC values. Results: The mean values of AUC and Kappa from MAHAL, RF, MAXENT, and SVM trials were similar and significantly higher than those from BIOCLIM and DOMAIN trials (p<0.05), while the associated standard deviations and coefficients of variation were larger for BIOCLIM and DOMAIN trials (p<0.05), and the 99% confidence intervals for AUC and Kappa values were narrower for MAHAL, RF, MAXENT, and SVM. Compared to BIOCLIM and DOMAIN, other SDMs (MAHAL, RF, MAXENT, and SVM) had higher prediction accuracy, smaller confidence intervals, and were more stable and less affected by the random variable (randomly selected pseudo-absence points). Conclusions: According to the prediction performance and stability of SDMs, we can divide these six SDMs into two categories: a high performance and stability group including MAHAL, RF, MAXENT, and SVM, and a low performance and stability group consisting of BIOCLIM, and DOMAIN. We highlight that choosing appropriate SDMs to address a specific problem is an important part of the modeling process.	[Duan, Ren-Yan; Kong, Xiao-Quan; Huang, Min-Yi; Wang, Zhi-Gao] Anqing Normal Coll, Sch Life Sci, Anqing, Anhui, Peoples R China; [Fan, Wei-Yi] Shaanxi Normal Univ, Coll Life Sci, Xian, Shaanxi, Peoples R China	Anqing Normal University; Shaanxi Normal University	Huang, MY (corresponding author), Anqing Normal Coll, Sch Life Sci, Anqing, Anhui, Peoples R China.	huang.m.y@163.com	Kong, Xiaoquan/B-3571-2016	Kong, Xiaoquan/0000-0003-1039-494X	National Natural Science Foundation of China [NSFC 31100311]; excellent provincial young fund of Anhui [2012SQRL113ZD]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); excellent provincial young fund of Anhui	This study was jointly funded by the National Natural Science Foundation of China (NSFC 31100311) and the excellent provincial young fund of Anhui (2012SQRL113ZD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Beale CM, 2012, PHILOS T R SOC B, V367, P247, DOI 10.1098/rstb.2011.0178; Benito Garzon M, 2008, APPL VEG SCI, V11, P169, DOI 10.3170/2008-7-18348; Brotons L, 2004, ECOGRAPHY, V27, P437, DOI 10.1111/j.0906-7590.2004.03764.x; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Cantor SB, 1999, J CLIN EPIDEMIOL, V52, P885, DOI 10.1016/S0895-4356(99)00075-X; CARPENTER G, 1993, BIODIVERS CONSERV, V2, P667, DOI 10.1007/BF00051966; Cheaib A, 2012, ECOL LETT, V15, P533, DOI 10.1111/j.1461-0248.2012.01764.x; Drake JM, 2006, J APPL ECOL, V43, P424, DOI 10.1111/j.1365-2664.2006.01141.x; Elith J, 2002, ECOL MODEL, V157, P313, DOI 10.1016/S0304-3800(02)00202-8; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Farber O, 2003, ECOL MODEL, V160, P115, DOI 10.1016/S0304-3800(02)00327-7; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Franklin J, 2006, J VEG SCI, V17, P233, DOI 10.1111/j.1654-1103.2006.tb02442.x; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Giovanelli JGR, 2010, ECOL MODEL, V221, P215, DOI 10.1016/j.ecolmodel.2009.10.009; Gomez-Mendoza L, 2007, CONSERV BIOL, V21, P1545, DOI 10.1111/j.1523-1739.2007.00814.x; Gritti ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068823; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guo QH, 2005, ECOL MODEL, V182, P75, DOI 10.1016/j.ecolmodel.2004.07.012; Guyon I, 2010, J MACH LEARN RES, V11, P61; Hanberry BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044486; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hijmans R.J., SPECIES DISTRIBUTION; Hijmans R.J., 2013, DISMO SPECIES DISTRI, V0, P8; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Keenan T, 2011, GLOBAL CHANGE BIOL, V17, P565, DOI 10.1111/j.1365-2486.2010.02254.x; Lawton J.L., 2000, ECOLOGICAL CONSEQUEN, P401; Li GQ, 2012, ECOL RES, V27, P427, DOI 10.1007/s11284-011-0914-4; Moisen GG, 2002, ECOL MODEL, V157, P209, DOI 10.1016/S0304-3800(02)00197-7; MONSERUD RA, 1992, ECOL MODEL, V62, P275, DOI 10.1016/0304-3800(92)90003-W; Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1; Nix H.A., 1986, ATLAS ELAPID SNAKES, P4; Olden JD, 2002, T AM FISH SOC, V131, P329, DOI 10.1577/1548-8659(2002)131<0329:PMOFSD>2.0.CO;2; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Raxworthy CJ, 2003, NATURE, V426, P837, DOI 10.1038/nature02205; Reiss H, 2011, MAR ECOL PROG SER, V442, P71, DOI 10.3354/meps09391; Rosner B, 2010, FUNDAMENTALS BIOSTAT; Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Thuiller W, 2003, J VEG SCI, V14, P669, DOI 10.1111/j.1654-1103.2003.tb02199.x; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; Wang R, 2006, DIVERS DISTRIB, V12, P397, DOI 10.1111/j.1366-9516.2006.00250.x; Wang XP, 2006, J INTEGR PLANT BIOL, V48, P778, DOI 10.1111/j.1744-7909.2006.00294.x; Williams JN, 2009, DIVERS DISTRIB, V15, P565, DOI 10.1111/j.1472-4642.2009.00567.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Xu CG, 2004, ECOL MODEL, V180, P57, DOI 10.1016/j.ecolmodel.2004.01.018; Zhang MG, 2012, BIOL CONSERV, V153, P257, DOI 10.1016/j.biocon.2012.04.023; Zhu L, 2007, LANDSCAPE ECOL, V22, P1143, DOI 10.1007/s10980-007-9096-4	58	89	96	6	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112764	10.1371/journal.pone.0112764	http://dx.doi.org/10.1371/journal.pone.0112764			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383906	gold, Green Submitted, Green Published			2022-12-27	WOS:000344816700092
J	Guo, YT; Niu, K; Momma, H; Kobayashi, Y; Chujo, M; Otomo, A; Fukudo, S; Nagatomi, R				Guo, Yinting; Niu, Kaijun; Momma, Haruki; Kobayashi, Yoritoshi; Chujo, Masahiko; Otomo, Atsushi; Fukudo, Shin; Nagatomi, Ryoichi			Irritable Bowel Syndrome Is Positively Related to Metabolic Syndrome: A Population-Based Cross-Sectional Study	PLOS ONE			English	Article							DIETARY PATTERN-ANALYSIS; GASTROINTESTINAL SYMPTOMS; PREVALENCE; FOOD; METAANALYSIS; ASSOCIATION; CONSUMPTION; DEPRESSION; MANAGEMENT; EXERCISE	Irritable bowel syndrome is a common gastrointestinal disorder that may affect dietary pattern, food digestion, and nutrient absorption. The nutrition-related factors are closely related to metabolic syndrome, implying that irritable bowel syndrome may be a potential risk factor for metabolic syndrome. However, few epidemiological studies are available which are related to this potential link. The purpose of this study is to determine whether irritable bowel syndrome is related to metabolic syndrome among middle-aged people. We designed a cross-sectional study of 1,096 subjects to evaluate the relationship between irritable bowel syndrome and metabolic syndrome and its components. Diagnosis of irritable bowel syndrome was based on the Japanese version of the Rome III Questionnaire. Metabolic syndrome was defined according to the criteria of the American Heart Association scientific statements of 2009. Dietary consumption was assessed via a validated food frequency questionnaire. Principal-components analysis was used to derive 3 major dietary patterns: "Japanese", "sweetsfruits", and "Izakaya (Japanese Pub) "from 39 food groups. The prevalence of irritable bowel syndrome and metabolic syndrome were 19.4% and 14.6%, respectively. No significant relationship was found between the dietary pattern factor score tertiles and irritable bowel syndrome. After adjustment for potential confounders (including dietary pattern), the odds ratio (95% confidence interval) of having metabolic syndrome and elevated triglycerides for subjects with irritable bowel syndrome as compared with non-irritable bowel syndrome are 2.01(1.13-3.55) and 1.50(1.03-2.18), respectively. Irritable bowel syndrome is significantly related to metabolic syndrome and it components. This study is the first to show that irritable bowel syndrome was significantly related to a higher prevalence of metabolic syndrome and elevated triglycerides among an adult population. The findings suggest that the treatment of irritable bowel syndrome may be a potentially beneficial factor for the prevention of metabolic syndrome. Further study is needed to clarify this association.	[Guo, Yinting; Niu, Kaijun] Tianjin Med Univ, Nutr Epidemiol Inst, Tianjin, Peoples R China; [Guo, Yinting; Niu, Kaijun] Tianjin Med Univ, Sch Publ Hlth, Tianjin, Peoples R China; [Guo, Yinting; Fukudo, Shin] Tohoku Univ, Dept Behav Med, Grad Sch Med, Sendai, Miyagi 980, Japan; [Momma, Haruki; Kobayashi, Yoritoshi; Chujo, Masahiko; Otomo, Atsushi; Nagatomi, Ryoichi] Tohoku Univ, Div Biomed Engn Hlth & Welf, Grad Sch Biomed Engn, Sendai, Miyagi 980, Japan	Tianjin Medical University; Tianjin Medical University; Tohoku University; Tohoku University	Niu, K (corresponding author), Tianjin Med Univ, Nutr Epidemiol Inst, Tianjin, Peoples R China.	nkj0809@163.com	Fukudo, Shin/J-4813-2014; Nagatomi, Ryoichi/T-5296-2019; Nagatomi, Ryoichi/Q-8792-2016	Nagatomi, Ryoichi/0000-0003-3038-7202; Momma, Haruki/0000-0003-1134-0898; Niu, Kaijun/0000-0002-8772-2481	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid for "Knowledge Cluster Initiative" from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alkerwi A, 2009, ATHEROSCLEROSIS, V204, P624, DOI 10.1016/j.atherosclerosis.2008.10.036; Aller R, 2004, An Med Interna, V21, P577; BARRETT J, 1978, ARCH GEN PSYCHIAT, V35, P741; Bohn L, 2013, AM J GASTROENTEROL, V108, P634, DOI 10.1038/ajg.2013.105; Camilleri M, 2001, GASTROENTEROLOGY, V120, P652, DOI 10.1053/gast.2001.21908; Camilleri M, 2012, AM J PHYSIOL-GASTR L, V303, pG775, DOI 10.1152/ajpgi.00155.2012; Leao LSCD, 2011, ARQ BRAS CARDIOL, V97, P260, DOI 10.1590/S0066-782X2011001200012; Cena H, 2011, NUTR REV, V69, P745, DOI 10.1111/j.1753-4887.2011.00446.x; Chang L, 2004, ALIMENT PHARM THER, V20, P31, DOI 10.1111/j.1365-2036.2004.02183.x; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; D'Aversa F, 2013, INTERN EMERG MED, V8, pS11, DOI 10.1007/s11739-013-0916-z; Feinle-Bisset C, 2013, AM J GASTROENTEROL, V108, P737, DOI 10.1038/ajg.2013.76; Fukuda K, 1973, Seishin Shinkeigaku Zasshi, V75, P673; Fukudo S, 2008, JAPANESE VERSION ROM; Ghoshal UC, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/151085; Gulcan E, 2009, AM J MED SCI, V338, P116, DOI 10.1097/MAJ.0b013e31819f7587; Guo H, 2012, NUTR METAB CARDIOVAS, V22, P277, DOI 10.1016/j.numecd.2010.06.006; Hayes P, 2014, J HUM NUTR DIET, V27, P36, DOI 10.1111/jhn.12114; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Ishikawa-Takata K, 2007, J EPIDEMIOL, V17, P177; Josse AR, 2008, J NUTRIGENET NUTRIGE, V1, P109, DOI 10.1159/000112458; Jung HJ, 2011, J NEUROGASTROENTEROL, V17, P294, DOI 10.5056/jnm.2011.17.3.294; Keller J, 2009, BEST PRACT RES CL GA, V23, P407, DOI 10.1016/j.bpg.2009.02.012; Kim J, 1978, FACTOR ANAL STAT MET; Li YQ, 2013, SAUDI MED J, V34, P929; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Marciani L, 2010, GASTROENTEROLOGY, V138, P469, DOI 10.1053/j.gastro.2009.10.055; Morcos A, 2009, J DIGEST DIS, V10, P237, DOI 10.1111/j.1751-2980.2009.00392.x; Nestel P, 2004, ENDOCRIN METAB CLIN, V33, P483, DOI 10.1016/j.ecl.2004.03.010; Nikolopoulou A, 2012, EXPERT REV CARDIOVAS, V10, P933, DOI [10.1586/erc.12.74, 10.1586/ERC.12.74]; Niu K, 2013, INT J CARDIOL; Niu KJ, 2013, EUR J NUTR, V52, P771, DOI 10.1007/s00394-012-0383-8; Pan A, 2012, DIABETES CARE, V35, P1171, DOI 10.2337/dc11-2055; Park HJ, 2010, WESTERN J NURS RES, V32, P218, DOI 10.1177/0193945909349116; Saito YA, 2005, AM J GASTROENTEROL, V100, P2743, DOI 10.1111/j.1572-0241.2005.00288.x; SAKAI K, 1995, J LIPID NUTR, V4, P97; Sasaki S, 2005, SERUM BIOMARKER BASE, P10; Science and Technology Agency, 2000, STAND TABL FOOD COMP; Shimazu T, 2007, INT J EPIDEMIOL, V36, P600, DOI 10.1093/ije/dym005; Simren M, 2001, DIGESTION, V63, P108, DOI 10.1159/000051878; Simren M, 2007, CLIN GASTROENTEROL H, V5, P201, DOI 10.1016/j.cgh.2006.09.032; Willett WC, 2008, ASIA PAC J CLIN NUTR, V17, P75; Williams EA, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-9; Xiao SM, 2014, FEMS MICROBIOL ECOL, V87, P357, DOI 10.1111/1574-6941.12228; Yamaoka K, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-138; Yao CK, 2013, J HUM NUTR DIET	47	22	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112289	10.1371/journal.pone.0112289	http://dx.doi.org/10.1371/journal.pone.0112289			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383869	Green Published, gold, Green Submitted			2022-12-27	WOS:000344816700045
J	Liao, YJ; Yang, JR; Chen, SE; Wu, SJ; Huang, SY; Lin, JJ; Chen, LR; Tang, PC				Liao, Yu-Jing; Yang, Jenn-Rong; Chen, Shuen-Ei; Wu, Sing-Jhou; Huang, San-Yuan; Lin, Jiang-Jen; Chen, Lih-Ren; Tang, Pin-Chi			Inhibition of Fumonisin B-1 Cytotoxicity by Nanosilicate Platelets during Mouse Embryo Development	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; SPHINGOLIPID METABOLISM; SILVER NANOPARTICLES; RISK-FACTOR; MYCOTOXINS; CLAY; EXFOLIATION; SYNTHASE; LASS5	Nanosilicate platelets (NSP), the form of natural silicate clay that was exfoliated from montmorillonite (MMT), is widely used as a feed additive for its high non-specific binding capacity with mycotoxins such as fumonisin B-1 (FB1), and has been evaluated its safety for biomedical use including cytotoxicity, genotoxicity, and lethal dosage (LD). In the study, we further examined its toxicity on the development of CD1 mouse embryos and its capacity to prevent teratogenesis-induced by FB1. In vitro cultures, NSP did not disturb the development and the quality of intact pre-implantation mouse embryos. Further, newborn mice from females consumed with NSP showed no abnormalities. NSP had an unexpected high adsorption capacity in vitro. In contrast to female mice consumed with FB1 only, a very low residual level of FB1 in the circulation, reduced incidence of neutral tube defects and significantly increased fetal weight were observed in the females consumed with FB1 and NSP, suggesting a high alleviation effect of NSP on FB1 in vivo. Furthermore, FB1 treatment disturbed the gene expression of sphingolipid metabolism enzymes (longevity assurance homolog 5, LASS 5; sphingosine kinase 1, Sphk1; sphingosine kinase 2, Sphk2; sphingosine 1-phosphate lyase, Sgpl1; sphingosine 1- phosphate phosphatase, Sgpp1) in the maternal liver, uterus, fetus, and placenta, but NSP administration reversed the perturbations. Based on these findings, we conclude that NSP is a feasible and effective agent for supplementary use in reducing the toxicity of FB1 to animals.	[Liao, Yu-Jing; Yang, Jenn-Rong; Chen, Lih-Ren] Council Agr Execut Yuan, Livestock Res Inst, Div Physiol, Tainan, Taiwan; [Liao, Yu-Jing; Chen, Shuen-Ei; Wu, Sing-Jhou; Huang, San-Yuan; Tang, Pin-Chi] Natl Chung Hsing Univ, Dept Anim Sci, Taichung 40227, Taiwan; [Chen, Shuen-Ei; Huang, San-Yuan; Tang, Pin-Chi] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan; [Chen, Shuen-Ei; Huang, San-Yuan; Tang, Pin-Chi] Natl Chung Hsing Univ, Ctr Integrat & Evolutionary Galliformes Genom, Taichung 40227, Taiwan; [Huang, San-Yuan] Natl Chung Hsing Univ, Ctr Nanosci & Nanotechnol, Taichung 40227, Taiwan; [Lin, Jiang-Jen] Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 10764, Taiwan	Taiwan Livestock Research Institute; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Taiwan University	Tang, PC (corresponding author), Natl Chung Hsing Univ, Dept Anim Sci, Taichung 40227, Taiwan.	pctang@dragon.nchu.edu.tw	Chen, Shuen-Ei/AAE-3574-2019; Chen, Shuen-Ei/B-2341-2019	Chen, Shuen-Ei/0000-0003-1737-2591; LIN, JIANG-JEN/0000-0002-8704-9653; Liao, Yu Jing/0000-0003-0421-3268	National Science Council (NSC) [101-2313-B-005-006]; Ministry of Education, Taiwan, under the ATU (Aim for the Top University) plan; Ministry of Economic Affairs [101-EC-17-A-21-S1-229]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, under the ATU (Aim for the Top University) plan; Ministry of Economic Affairs	This study was supported, in part, by a grant from the National Science Council (NSC 101-2313-B-005-006), a grant from the Ministry of Education, Taiwan, under the ATU (Aim for the Top University) plan and also a grant from the Ministry of Economic Affairs (101-EC-17-A-21-S1-229). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boudergue C., 2009, EFSA SUPPORTING PUBL, V6; Cheng MC, 2008, THESIS NATL CHUNG H; Chiao SH, 2012, INT J NANOMED, V7, P2421, DOI 10.2147/IJN.S31594; Chu CC, 2005, MACROMOLECULES, V38, P6240, DOI 10.1021/ma0503716; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; GELDERBLOM WCA, 1988, APPL ENVIRON MICROB, V54, P1806, DOI 10.1128/AEM.54.7.1806-1811.1988; Gelineau-van Waes J, 2009, ADV FOOD NUTR RES, V56, P145, DOI 10.1016/S1043-4526(08)00605-0; Hansen DK, 2003, BIRTH DEFECTS RES A, V67, P475, DOI 10.1002/bdra.10072; Harrison L R, 1990, J Vet Diagn Invest, V2, P217; Hsu SH, 2009, ACS APPL MATER INTER, V1, P2556, DOI 10.1021/am900479q; Huwig A, 2001, TOXICOL LETT, V122, P179, DOI 10.1016/S0378-4274(01)00360-5; Jones FT, 2007, UNDERSTANDING COPING, P1; KELLERMAN TS, 1990, ONDERSTEPOORT J VET, V57, P269; Lahiri S, 2005, J BIOL CHEM, V280, P33735, DOI 10.1074/jbc.M506485200; Li PR, 2010, ACS APPL MATER INTER, V2, P1608, DOI 10.1021/am1001162; Lin JJ, 2006, J PHYS CHEM B, V110, P18115, DOI 10.1021/jp0636773; Lin JJ, 2013, ACS APPL MATER INTER, V5, P433, DOI 10.1021/am302534k; Marasas WFO, 2004, J NUTR, V134, P711, DOI 10.1093/jn/134.4.711; Merrill AH, 2001, ENVIRON HEALTH PERSP, V109, P283, DOI 10.2307/3435020; NELSON PE, 1993, ANNU REV PHYTOPATHOL, V31, P233, DOI 10.1146/annurev.py.31.090193.001313; Piedrahita JA, 1999, NAT GENET, V23, P228, DOI 10.1038/13861; Reddy RV, 1996, MYCOPATHOLOGIA, V134, P161, DOI 10.1007/BF00436724; Richard JL, 2007, INT J FOOD MICROBIOL, V119, P3, DOI 10.1016/j.ijfoodmicro.2007.07.019; Riley RT, 2001, ENVIRON HEALTH PERSP, V109, P301, DOI 10.2307/3435022; Rothenberg SP, 2004, OBSTET GYNECOL SURV, V59, P410; Saitsu H, 2003, DEV DYNAM, V226, P112, DOI 10.1002/dvdy.10203; Tao ZM, 2010, LANGMUIR, V26, P8914, DOI 10.1021/la904695a; Usuki A, 2001, NANO LETT, V1, P271, DOI 10.1021/nl010015a; Voss K A, 2006, Mycotoxin Res, V22, P61, DOI 10.1007/BF02954559; Voss KA, 2014, MOL NUTR FOOD RES, V58, P1190, DOI 10.1002/mnfr.201300720; Waes JG, 2005, BIRTH DEFECTS RES A, V73, P487, DOI 10.1002/bdra.20148; Wei JC, 2011, J PHYS CHEM C, V115, P18770, DOI 10.1021/jp2067233; Xu ZW, 2005, J LIPID RES, V46, P1229, DOI 10.1194/jlr.M500001-JLR200	33	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112290	10.1371/journal.pone.0112290	http://dx.doi.org/10.1371/journal.pone.0112290			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383881	Green Submitted, gold, Green Published			2022-12-27	WOS:000344816700046
J	Barton, SK; Moss, TJM; Hooper, SB; Crossley, KJ; Gill, AW; Kluckow, M; Zahra, V; Wong, FY; Pichler, G; Galinsky, R; Miller, SL; Tolcos, M; Polglase, GR				Barton, Samantha K.; Moss, Timothy J. M.; Hooper, Stuart B.; Crossley, Kelly J.; Gill, Andrew W.; Kluckow, Martin; Zahra, Valerie; Wong, Flora Y.; Pichler, Gerhard; Galinsky, Robert; Miller, Suzanne L.; Tolcos, Mary; Polglase, Graeme R.			Protective Ventilation of Preterm Lambs Exposed to Acute Chorioamnionitis Does Not Reduce Ventilation-Induced Lung or Brain Injury	PLOS ONE			English	Article							SPATIALLY-RESOLVED SPECTROSCOPY; END-EXPIRATORY PRESSURE; WHITE-MATTER INJURY; CEREBRAL-BLOOD-FLOW; BRONCHOPULMONARY DYSPLASIA; TIDAL VOLUME; INTRAAMNIOTIC ENDOTOXIN; SYSTEMIC INFLAMMATION; RISK-FACTOR; DELIVERY	Background: The onset of mechanical ventilation is a critical time for the initiation of cerebral white matter (WM) injury in preterm neonates, particularly if they are inadvertently exposed to high tidal volumes (V-T) in the delivery room. Protective ventilation strategies at birth reduce ventilation-induced lung and brain inflammation and injury, however its efficacy in a compromised newborn is not known. Chorioamnionitis is a common antecedent of preterm birth, and increases the risk and severity of WM injury. We investigated the effects of high V-T ventilation, after chorioamnionitis, on preterm lung and WM inflammation and injury, and whether a protective ventilation strategy could mitigate the response. Methods: Pregnant ewes (n = 18) received intra-amniotic lipopolysaccharide (LPS) 2 days before delivery, instrumentation and ventilation at 12 +/- 1 days gestation. Lambs were either immediately euthanased and used as unventilated controls (LPSUVC; n = 6), or were ventilated using an injurious high V-T strategy (LPSINJ; n = 5) or a protective ventilation strategy (LPSPROT; n = 7) for a total of 90 min. Mean arterial pressure, heart rate and cerebral haemodynamics and oxygenation were measured continuously. Lungs and brains underwent molecular and histological assessment of inflammation and injury. Results: LPSINJ lambs had poorer oxygenation than LPSPROT lambs. Ventilation requirements and cardiopulmonary and systemic haemodynamics were not different between ventilation strategies. Compared to unventilated lambs, LPSINJ and LPSPROT lambs had increases in pro-inflammatory cytokine expression within the lungs and brain, and increased astrogliosis (p<0.02) and cell death (p<0.05) in the WM, which were equivalent in magnitude between groups. Conclusions: Ventilation after acute chorioamnionitis, irrespective of strategy used, increases haemodynamic instability and lung and cerebral inflammation and injury. Mechanical ventilation is a potential contributor to WM injury in infants exposed to chorioamnionitis.	[Barton, Samantha K.; Moss, Timothy J. M.; Hooper, Stuart B.; Crossley, Kelly J.; Zahra, Valerie; Wong, Flora Y.; Galinsky, Robert; Miller, Suzanne L.; Tolcos, Mary; Polglase, Graeme R.] Monash Univ, Inst Med Res, MIMR PHI, Ritchie Ctr, Clayton, Vic 3168, Australia; [Moss, Timothy J. M.; Hooper, Stuart B.; Miller, Suzanne L.; Polglase, Graeme R.] Monash Univ, Dept Obstet & Gynecol, Clayton, Vic 3168, Australia; [Gill, Andrew W.] Univ Western Australia, Sch Womens & Infants Hlth, Nedlands, WA 6009, Australia; [Kluckow, Martin] Royal N Shore Hosp, Dept Neonatal Med, Sydney, NSW 2065, Australia; [Kluckow, Martin] Univ Sydney, Sydney, NSW 2065, Australia; [Pichler, Gerhard] Med Univ Graz, Dept Pediat, A-8036 Graz, Austria	Monash University; Prince Henry's Institute of Medical Research; University of Sydney; Westmead Institute for Medical Research; Monash University; University of Western Australia; Royal North Shore Hospital; University of Sydney; University of Sydney; Medical University of Graz	Polglase, GR (corresponding author), Monash Univ, Inst Med Res, MIMR PHI, Ritchie Ctr, Clayton, Vic 3168, Australia.	graeme.polglase@monash.edu	Moss, Timothy/A-6633-2008; Crossley, Kelly J/I-7407-2013	Moss, Timothy/0000-0002-9408-4027; Crossley, Kelly J/0000-0002-1580-1156; Hooper, Stuart/0000-0003-1676-4825; Pichler, Gerhard/0000-0003-2405-7143; Miller, Suzanne/0000-0002-0451-8304; Kluckow, Martin/0000-0003-1875-7530; Tolcos, Mary/0000-0001-6105-4553; Galinsky, Robert/0000-0002-6374-9372; Barton, Samantha/0000-0001-7601-0238; Polglase, Graeme/0000-0002-8906-614X	Avant Innovative Research Grant - Research Foundation of Cerebral Palsy Alliance; North Shore Heart Research Foundation; National Health and Medical Research Council Research Fellowship [1026890, APP1043294, 545921]; Rebecca L. Cooper Medical Research Foundation Fellowship; Victorian Government's Operational Infrastructure Support Program	Avant Innovative Research Grant - Research Foundation of Cerebral Palsy Alliance; North Shore Heart Research Foundation; National Health and Medical Research Council Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Rebecca L. Cooper Medical Research Foundation Fellowship; Victorian Government's Operational Infrastructure Support Program	This research was supported by an Avant Innovative Research Grant awarded by the Research Foundation of Cerebral Palsy Alliance, North Shore Heart Research Foundation, National Health and Medical Research Council Research Fellowship (GRP, 1026890: TJMM, APP1043294: SBH, 545921), Rebecca L. Cooper Medical Research Foundation Fellowship (GRP) and the Victorian Government's Operational Infrastructure Support Program. Chiesi Farmaceutica generously donated the surfactant used in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atik A, 2014, PEDIATR RES, V76, P54, DOI 10.1038/pr.2014.55; Bennet L, 2012, P AUSTR PHYSL SOC, V43, P81; Brown AS, 2006, SCHIZOPHRENIA BULL, V32, P200, DOI 10.1093/schbul/sbj052; Chiumello D, 1999, AM J RESP CRIT CARE, V160, P109, DOI 10.1164/ajrccm.160.1.9803046; Di Palma S, 2012, COMP IMMUNOL MICROB, V35, P429, DOI 10.1016/j.cimid.2012.03.009; DUNCAN A, 1995, PHYS MED BIOL, V40, P295, DOI 10.1088/0031-9155/40/2/007; Eklind S, 2005, PEDIATR RES, V58, P112, DOI 10.1203/01.PDR.0000163513.03619.8D; Quilez ME, 2011, CRIT CARE, V15, DOI 10.1186/cc10230; Fahey JO, 2008, J MIDWIFERY WOM HEAL, V53, P227, DOI 10.1016/j.jmwh.2008.01.001; Feng YS, 2008, AM J PHYSIOL-REG I, V296, pR640; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Fox WW, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.5.e5; Gagliardi L, 2009, PAEDIATR PERINAT EP, V23, P582, DOI 10.1111/j.1365-3016.2009.01069.x; Galinsky R, 2013, J PHYSL, V15, P2127; GLEASON CA, 1988, AM J PHYSIOL, V255, pR1049, DOI 10.1152/ajpregu.1988.255.6.R1049; Greisen G, 2005, EARLY HUM DEV, V81, P423, DOI 10.1016/j.earlhumdev.2005.03.005; Grether JK, 1997, JAMA-J AM MED ASSOC, V278, P207, DOI 10.1001/jama.278.3.207; Hagino K, 2005, J THORAC CARDIOV SUR, V130, P384, DOI 10.1016/j.jtcvs.2005.02.058; Hansen A, 1999, AM J OBSTET GYNECOL, V181, P997, DOI 10.1016/S0002-9378(99)70339-X; Herder V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062939; Hillman NH, 2007, AM J RESP CRIT CARE, V176, P575, DOI 10.1164/rccm.200701-051OC; Hillman NH, 2011, AM J PHYSIOL-LUNG C, V301, pL712, DOI 10.1152/ajplung.00157.2011; Hillman NH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-151; Hillman NH, 2010, PEDIATR RES, V67, P60, DOI 10.1203/PDR.0b013e3181c1b09e; Jobe AH, 2000, AM J RESP CRIT CARE, V162, P1656, DOI 10.1164/ajrccm.162.5.2003044; Jobe AH, 2008, NEONATOLOGY, V94, P190, DOI 10.1159/000143721; Kallapur SG, 2011, AM J PHYSIOL-LUNG C, V301, pL285, DOI 10.1152/ajplung.00446.2010; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; Kramer BW, 2002, AM J RESP CRIT CARE, V165, P463, DOI 10.1164/ajrccm.165.4.2011118; Kramer BW, 2002, AM J PHYSIOL-LUNG C, V283, pL452, DOI 10.1152/ajplung.00407.2001; Kramer BW, 2001, AM J RESP CRIT CARE, V164, P982, DOI 10.1164/ajrccm.164.6.2103061; Lahra MM, 2004, AM J OBSTET GYNECOL, V190, P147, DOI 10.1016/j.ajog.2003.07.012; McAdams RM, 2012, ROLE CYTOKINES INFLA; Moss TJM, 2002, AM J RESP CRIT CARE, V165, P805, DOI 10.1164/ajrccm.165.6.2108053; Newnham JP, 2001, AM J OBSTET GYNECOL, V185, P190, DOI 10.1067/mob.2001.114500; Nitsos I, 2006, J SOC GYNECOL INVEST, V13, P239, DOI 10.1016/j.jsgi.2006.02.011; O'Donnell CPF, 2005, ARCH DIS CHILD-FETAL, V90, pF392, DOI 10.1136/adc.2004.064691; Polglase GR, 2008, PEDIAT RES; Polglase GR, 2008, PEDIATR RES, V64, P517, DOI 10.1203/PDR.0b013e3181841363; Polglase GR, 2008, J APPL PHYSIOL, V105, P603, DOI 10.1152/japplphysiol.00041.2008; Polglase GR, 2014, PEDIATR RES, V75, P682, DOI 10.1038/pr.2014.40; Polglase GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039535; Polglase GR, 2012, J APPL PHYSIOL, V112, P481, DOI 10.1152/japplphysiol.00995.2011; Polglase GR, 2010, PEDIATR RES, V67, P630, DOI 10.1203/PDR.0b013e3181dbbd18; Polglase GR, 2009, PEDIATR RES, V65, P67, DOI 10.1203/PDR.0b013e318189487e; Poulton DA, 2011, RESUSCITATION, V82, P175, DOI 10.1016/j.resuscitation.2010.10.012; Roehr CC, 2010, RESUSCITATION, V81, P202, DOI 10.1016/j.resuscitation.2009.10.008; Schmolzer GM, 2010, ARCH DIS CHILD-FETAL, V95, pF393, DOI 10.1136/adc.2009.174003; Speer CP, 2006, SEMIN FETAL NEONAT M, V11, P354, DOI 10.1016/j.siny.2006.03.004; Stonestreet BS, 2000, J APPL PHYSIOL, V88, P1672, DOI 10.1152/jappl.2000.88.5.1672; van den Heuij LG, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-89; VANBEL F, 1994, PEDIATR RES, V35, P329; Vigneswaran R, 2000, J PAEDIATR CHILD H, V36, P293, DOI 10.1046/j.1440-1754.2000.00536.x; Viscardi RM, 2010, CLIN PERINATOL, V37, P393, DOI 10.1016/j.clp.2009.12.003; Volpe JJ, 2003, PEDIATRICS, V112, P176, DOI 10.1542/peds.112.1.176; Wallace MJ, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-19; Wang XY, 2006, SEMIN FETAL NEONAT M, V11, P343, DOI 10.1016/j.siny.2006.04.002; Wong FY, 2008, PEDIATRICS, V121, pE604, DOI 10.1542/peds.2007-1487; Wong FY, 2010, ANESTHESIOLOGY, V113, P1385, DOI 10.1097/ALN.0b013e3181fc5567; Wong FY, 2009, INTENS CARE MED, V35, P1464, DOI 10.1007/s00134-009-1486-4; Wu YW, 2000, JAMA-J AM MED ASSOC, V284, P1417, DOI 10.1001/jama.284.11.1417; Yanowitz TD, 2006, PEDIATR RES, V59, P299, DOI 10.1203/01.pdr.0000196738.03171.f1; Yanowitz TD, 2004, PEDIATR RES, V55, p524A; Yanowitz TD, 2002, PEDIATR RES, V51, P310, DOI 10.1203/00006450-200203000-00008; Yanowitz TD, 2004, J PERINATOLOGY, V24, P229	65	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112402	10.1371/journal.pone.0112402	http://dx.doi.org/10.1371/journal.pone.0112402			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379714	Green Published, gold, Green Submitted			2022-12-27	WOS:000344863100083
J	Elsherif, L; Ozler, M; Zayed, MA; Shen, JH; Chernoff, J; Faber, JE; Parise, LV				Elsherif, Laila; Ozler, Mehmet; Zayed, Mohamed A.; Shen, Jessica H.; Chernoff, Jonathan; Faber, James E.; Parise, Leslie V.			Potential Compensation among Group I PAK Members in Hindlimb Ischemia and Wound Healing	PLOS ONE			English	Article							SIGNAL-REGULATED-KINASE; P21-ACTIVATED KINASE; ENDOTHELIAL-CELL; ERK ACTIVATION; INFLAMMATORY RESPONSE; TARGETED DISRUPTION; UP-REGULATION; MICE LACKING; ANGIOGENESIS; GROWTH	PAKs are serine/threonine kinases that regulate cytoskeletal dynamics and cell migration. PAK1 is activated by binding to the small EF hand protein, CIB1, or to the Rho GTPases Rac1 or Cdc42. The role of PAK1 in angiogenesis was established based only on in vitro studies and its role in angiogenesis in vivo has never been examined. Here we tested the hypothesis that PAK1 is an essential regulator of ischemic neovascularization (arteriogenesis and angiogenesis) and wound healing using a global PAK1 knockout mouse. Neovascularization was assessed using unilateral hindlimb ischemia. We found that plantar perfusion, limb use and appearance were not significantly different between 6-8 week old PAK1(-/-) and PAK1(+/+) mice throughout the 21-day period following hindlimb ischemia; however a slightly delayed healing was observed in 16 week old PAK1(-/-) mice. In addition, the wound healing rate, as assessed with an ear punch assay, was unchanged in PAK1(-/-) mice. Surprisingly, however, we observed a notable increase in PAK2 expression and phosphorylation in ischemic gastrocnemius tissue from PAK1(-/-) but not PAK1(+/+) mice. Furthermore, we observed higher levels of activated ERK2, but not AKT, in ischemic and non-ischemic muscle of PAK1(-/-) mice upon hindlimb ischemic injury. A group I PAK inhibitor, IPA3, significantly inhibited endothelial cell sprouting from aortic rings in both PAK1(-/-) and PAK1(+/+) mice, implying that PAK2 is a potential contributor to this process. Taken together, our data indicate that while PAK1 has the potential to contribute to neovascularization and wound healing, PAK2 may functionally compensate when PAK1 is deficient.	[Elsherif, Laila; Ozler, Mehmet; Zayed, Mohamed A.; Shen, Jessica H.; Parise, Leslie V.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27514 USA; [Chernoff, Jonathan] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [Faber, James E.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Faber, James E.; Parise, Leslie V.] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA; [Parise, Leslie V.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; Fox Chase Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Parise, LV (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27514 USA.	parise@med.unc.edu	Chernoff, Jonathan/I-7631-2014; Elsherif, Laila/AAT-9307-2021	Chernoff, Jonathan/0000-0002-4803-7836; 	National Institute of Health [5R01HL092544, 01CA148805, 5R01HL111070]; NATIONAL CANCER INSTITUTE [R01CA148805] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111070, R01HL092544] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institute of Health grants 5R01HL092544 (LVP), 01CA148805 (JC) and 5R01HL111070 (JF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agah A, 2004, MATRIX BIOL, V22, P539, DOI 10.1016/j.matbio.2003.09.004; Allen JD, 2009, BLOOD, V113, P2695, DOI 10.1182/blood-2008-06-160861; Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Asrar S, 2009, NEUROPHARMACOLOGY, V56, P73, DOI 10.1016/j.neuropharm.2008.06.055; Bagheri-Yarmand R, 2000, J BIOL CHEM, V275, P39451, DOI 10.1074/jbc.M006150200; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Balasenthil S, 2004, J BIOL CHEM, V279, P1422, DOI 10.1074/jbc.M309937200; Beeser A, 2005, J BIOL CHEM, V280, P36609, DOI 10.1074/jbc.M502306200; Bienvenu T, 2000, AM J MED GENET, V93, P294, DOI 10.1002/1096-8628(20000814)93:4<294::AID-AJMG8>3.0.CO;2-F; Bokoch GM, 1998, J BIOL CHEM, V273, P8137, DOI 10.1074/jbc.273.14.8137; Bright MD, 2009, CELL SIGNAL, V21, P1738, DOI 10.1016/j.cellsig.2009.07.005; Chalothorn D, 2005, AM J PHYSIOL-HEART C, V289, pH947, DOI 10.1152/ajpheart.00952.2004; Chalothorn D, 2007, PHYSIOL GENOMICS, V30, P179, DOI 10.1152/physiolgenomics.00047.2007; Cho CH, 2006, P NATL ACAD SCI USA, V103, P4946, DOI 10.1073/pnas.0506352103; Chow HY, 2012, CANCER RES, V72, P5966, DOI 10.1158/0008-5472.CAN-12-2246; Coniglio SJ, 2008, MOL CELL BIOL, V28, P4162, DOI 10.1128/MCB.01532-07; Connolly JO, 2002, MOL BIOL CELL, V13, P2474, DOI 10.1091/mbc.E02-01-0006; Dharmawardhane S, 1997, J CELL BIOL, V138, P1265, DOI 10.1083/jcb.138.6.1265; Dono R, 1998, EMBO J, V17, P4213, DOI 10.1093/emboj/17.15.4213; Dorrance AM, 2013, BLOOD, V121, P2474, DOI 10.1182/blood-2012-10-460709; Du J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015940; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Faber JE, 2011, ARTERIOSCL THROM VAS, V31, P1748, DOI 10.1161/ATVBAHA.111.227314; Frost JA, 1998, J BIOL CHEM, V273, P28191, DOI 10.1074/jbc.273.43.28191; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Goc A, 2013, J BIOL CHEM, V288, P3025, DOI 10.1074/jbc.M112.424770; Higuchi M, 2008, NAT CELL BIOL, V10, P1356, DOI 10.1038/ncb1795; Hoffmann J, 2001, CIRC RES, V89, P709, DOI 10.1161/hh2001.097796; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Hood JD, 2003, J CELL BIOL, V162, P933, DOI 10.1083/jcb.200304105; Huang MT, 2005, BLOOD, V106, P1636, DOI 10.1182/blood-2004-12-4716; Huang WN, 2011, MOL CELL BIOL, V31, P388, DOI 10.1128/MCB.00969-10; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Kamiyama M, 2006, ONCOGENE, V25, P7019, DOI 10.1038/sj.onc.1209694; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Kelly Mollie L, 2012, Cell Logist, V2, P84; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Kiosses WB, 1999, J CELL BIOL, V147, P831, DOI 10.1083/jcb.147.4.831; Kiosses WB, 2002, CIRC RES, V90, P697, DOI 10.1161/01.RES.0000014227.76102.5D; Koike T, 2003, J GERONTOL A-BIOL, V58, P798; Kosoff R, 2013, J BIOL CHEM, V288, P974, DOI 10.1074/jbc.M112.422295; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Leisner TM, 2005, J CELL BIOL, V170, P465, DOI 10.1083/jcb.200502090; Li LH, 2010, INT J ONCOL, V37, P951, DOI 10.3892/ijo_00000746; Li XF, 2003, MOL CELL BIOL, V23, P7134, DOI 10.1128/MCB.23.20.7134-7142.2003; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Lu W, 2013, ONCOL REP, V29, P1547, DOI 10.3892/or.2013.2237; Ma YH, 2013, J CLIN ENDOCR METAB, V98, pE1314, DOI 10.1210/jc.2012-3937; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Master Z, 2001, EMBO J, V20, P5919, DOI 10.1093/emboj/20.21.5919; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; Meng JS, 2005, J NEUROSCI, V25, P6641, DOI 10.1523/JNEUROSCI.0028-05.2005; Menghini R, 2009, CIRCULATION, V120, P1524, DOI 10.1161/CIRCULATIONAHA.109.864629; Nekrasova T, 2008, DEV BIOL, V322, P95, DOI 10.1016/j.ydbio.2008.07.006; Park JH, 2014, HEAD NECK; Pascual G, 2007, J VASC RES, V44, P192, DOI 10.1159/000100375; Puolakkainen Pauli A., 1995, Wound Repair and Regeneration, V3, P330, DOI 10.1046/j.1524-475X.1995.t01-1-30314.x; Ramos E, 1997, RECEPT SIGNAL TRANS, V7, P99; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rivard A, 1999, CIRCULATION, V99, P111, DOI 10.1161/01.CIR.99.1.111; Roig J, 2000, P NATL ACAD SCI USA, V97, P14346, DOI 10.1073/pnas.97.26.14346; Sadoun E, 2003, J HISTOCHEM CYTOCHEM, V51, P1119, DOI 10.1177/002215540305100902; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Slack-Davis JK, 2003, J CELL BIOL, V162, P281, DOI 10.1083/jcb.200212141; Smith SD, 2008, J CELL SCI, V121, P3729, DOI 10.1242/jcs.027680; Stabile E, 2003, CIRCULATION, V108, P205, DOI 10.1161/01.CIR.0000079225.50817.71; Stockton R, 2007, MOL BIOL CELL, V18, P2346, DOI 10.1091/mbc.E06-07-0584; Sundberg-Smith LJ, 2005, J BIOL CHEM, V280, P2055, DOI 10.1074/jbc.M406013200; Suzuki K, 2007, CANCER RES, V67, P3673, DOI 10.1158/0008-5472.CAN-06-3211; Swift ME, 2001, J INVEST DERMATOL, V117, P1027, DOI 10.1046/j.0022-202x.2001.01539.x; Tang Y, 2000, J BIOL CHEM, V275, P9106, DOI 10.1074/jbc.275.13.9106; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; Vasa-Nicotera M, 2011, ATHEROSCLEROSIS, V217, P326, DOI 10.1016/j.atherosclerosis.2011.03.034; Wang HJ, 2014, AGING CELL, V13, P254, DOI 10.1111/acel.12169; Wang ZP, 2013, J BIOL CHEM, V288, P20093, DOI 10.1074/jbc.M112.426023; Zayed MA, 2007, CIRC RES, V101, P1185, DOI 10.1161/CIRCRESAHA.107.157586; Zayed MA, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-17; Zegers MMP, 2003, EMBO J, V22, P4155, DOI 10.1093/emboj/cdg398; Zhang XP, 2013, BIOCHEM BIOPH RES CO, V431, P404, DOI 10.1016/j.bbrc.2012.12.157	83	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112239	10.1371/journal.pone.0112239	http://dx.doi.org/10.1371/journal.pone.0112239			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379771	gold, Green Published, Green Submitted			2022-12-27	WOS:000344863100067
J	Lauer, A; Talamantes, J; Olivares, LRC; Medina, LJ; Baal, JDH; Casimiro, K; Shroff, N; Emery, KW				Lauer, Antje; Talamantes, Jorge; Castanon Olivares, Laura Rosio; Medina, Luis Jaime; Baal, Joe Daryl Hugo; Casimiro, Kayla; Shroff, Natasha; Emery, Kirt W.			Combining Forces - The Use of Landsat TM Satellite Imagery, Soil Parameter Information, and Multiplex PCR to Detect Coccidioides immitis Growth Sites in Kern County, California	PLOS ONE			English	Article							VALLEY FEVER; CLIMATE; POPULATION; DIVERSITY; POSADASII; ARIZONA	Coccidioidomycosis is a fungal disease acquired through the inhalation of spores of Coccidioides spp., which afflicts primarily humans and other mammals. It is endemic to areas in the southwestern United States, including the San Joaquin Valley portion of Kern County, California, our region of interest (ROI). Recently, incidence of coccidioidomycosis, also known as valley fever, has increased significantly, and several factors including climate change have been suggested as possible drivers for this observation. Up to date details about the ecological niche of C. immitis have escaped full characterization. In our project, we chose a three-step approach to investigate this niche: 1) We examined Landsat-5-Thematic-Mapper multispectral images of our ROI by using training pixels at a 750 mx750 m section of Sharktooth Hill, a site confirmed to be a C. immitis growth site, to implement a Maximum Likelihood Classification scheme to map out the locations that could be suitable to support the growth of the pathogen; 2) We used the websoilsurvey database of the US Department of Agriculture to obtain soil parameter data; and 3) We investigated soil samples from 23 sites around Bakersfield, California using a multiplex Polymerase Chain Reaction (PCR) based method to detect the pathogen. Our results indicated that a combination of satellite imagery, soil type information, and multiplex PCR are powerful tools to predict and identify growth sites of C. immitis. This approach can be used as a basis for systematic sampling and investigation of soils to detect Coccidioides spp.	[Lauer, Antje; Baal, Joe Daryl Hugo; Casimiro, Kayla; Shroff, Natasha] Calif State Univ, Dept Biol, Bakersfield, CA 93311 USA; [Talamantes, Jorge; Medina, Luis Jaime] Calif State Univ, Dept Phys & Engn, Bakersfield, CA USA; [Castanon Olivares, Laura Rosio] Univ Nacl Autonoma Mexico, Fac Med, Lab Micol Med, Mexico City 04510, DF, Mexico; [Emery, Kirt W.] Cty Kern Publ Hlth Serv Dept, Bakersfield, CA USA	California State University System; California State University Bakersfield; California State University System; California State University Bakersfield; Universidad Nacional Autonoma de Mexico	Lauer, A (corresponding author), Calif State Univ, Dept Biol, Bakersfield, CA 93311 USA.	alauer@csub.edu			National Science Foundation [HRD-0331537]; Chevron (Research Experience Vitalizing Science Undergraduate Program (REVS-UP) at CSUB	National Science Foundation(National Science Foundation (NSF)); Chevron (Research Experience Vitalizing Science Undergraduate Program (REVS-UP) at CSUB	The work was supported by National Science Foundation grant HRD-0331537, and support from Chevron (Research Experience Vitalizing Science Undergraduate Program (REVS-UP) at CSUB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baptista-Rosas RC, 2012, FUNGAL ECOL, V5, P177, DOI 10.1016/j.funeco.2011.08.004; Barker BM, 2012, FUNGAL ECOL, V5, P163, DOI 10.1016/j.funeco.2011.07.010; Cayan DR, 2008, CLIMATIC CHANGE, V87, pS21, DOI 10.1007/s10584-007-9377-6; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P109; Chander G, 2003, IEEE T GEOSCI REMOTE, V41, P2674, DOI 10.1109/TGRS.2003.818464; Comrie AC, 2005, ENVIRON HEALTH PERSP, V113, P688, DOI 10.1289/ehp.7786; Comrie AC, 2007, ANN NY ACAD SCI, V1111, P83, DOI 10.1196/annals.1406.024; Craglia M, 2008, INT J SPAT DATA INFR, V3, P146, DOI 10.2902/1725-0463.2008.03.art9; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; EGEBERG RO, 1956, AM J MED SCI, V231, P151, DOI 10.1097/00000441-195623120-00005; Fisher FS, 2007, ANN NY ACAD SCI, V1111, P47, DOI 10.1196/annals.1406.031; Fisher MC, 2002, MYCOLOGIA, V94, P73, DOI 10.2307/3761847; Fisher MC, 2001, P NATL ACAD SCI USA, V98, P4558, DOI 10.1073/pnas.071406098; Goetz SJ, 2000, ADV PARASIT, V47, P289, DOI 10.1016/S0065-308X(00)47012-0; Greene DR, 2000, MYCOLOGIA, V92, P406, DOI 10.2307/3761498; Greer A, 2008, CMAJ, V11, P178; Hector RF, 2011, INT J ENV RES PUB HE, V8, P1150, DOI 10.3390/ijerph8041150; Hugenholtz P., 1957, P S COCC, P136; Jinadu BA, 1994, MMWR-MORBID MORTAL W, V43, P421; Kemp R, 1974, THESIS CALIFORNIA ST; Kirkland TN, 1996, EMERG INFECT DIS, V2, P192, DOI 10.3201/eid0203.960305; Koelle K, 2005, NATURE, V436, P696, DOI 10.1038/nature03820; Kolivras KN, 2003, INT J BIOMETEOROL, V47, P87, DOI 10.1007/s00484-002-0155-x; Kolivras KN, 2001, AEROBIOLOGIA, V17, P31, DOI DOI 10.1023/A:1007619813435; Lauer A, 2012, MYCOLOGIA, V104, P62, DOI 10.3852/11-127; Lee Russel V., 1944, CALIFORNIA AND WEST MED, V61, P133; Maddy K., 1957, P S COCCIDIOIDOMYCOS, P144; MADDY K. T., 1959, Veterinary Medicine, V54, P233; MADDY K T, 1958, Ariz Med, V15, P178; Marsden-Haug N, 2013, BRIEFREPORT COCCIDIO, V2013, P56; Merriam CH, 1898, B 10 DIVISION BIOL S; MOSLEY D, 1996, MMWR-MORBID MORTAL W, V45, P1069; Nannipieri P, 2003, EUR J SOIL SCI, V54, P655, DOI 10.1046/j.1351-0754.2003.0556.x; Neafsey DE, 2010, GENOME RES, V20, P938, DOI 10.1101/gr.103911.109; Negroni R, 2008, REV ARGENT MICROBIOL, V40, P246; Nguyen C, 2013, CLIN MICROBIOL REV, V26, P505, DOI 10.1128/CMR.00005-13; Nuckols JR, 2004, ENVIRON HEALTH PERSP, V112, P1007, DOI 10.1289/ehp.6738; Pappagianis D, 1988, Curr Top Med Mycol, V2, P199; PAPPAGIANIS D, 1994, CLIN INFECT DIS, V19, pS14, DOI 10.1093/clinids/19.Supplement_1.14; PAPPAGIANIS D, 1978, WESTERN J MED, V129, P527; Richards J. A., 2006, REMOTE SENSING DIGIT; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Rogers DJ, 2000, ADV PARASIT, V47, P129, DOI 10.1016/S0065-308X(00)47008-9; Schneider E, 1997, JAMA-J AM MED ASSOC, V277, P904, DOI 10.1001/jama.277.11.904; Sharpton TJ, 2009, GENOME RES, V19, P1722, DOI 10.1101/gr.087551.108; SMITH CE, 1946, JAMA-J AM MED ASSOC, V132, P833, DOI 10.1001/jama.1946.02870490011003; SWATEK FE, 1970, MYCOPATH MYCOL APPL, V41, P3, DOI 10.1007/BF02051479; Talamantes J, 2007, ANN NY ACAD SCI, V1111, P73, DOI 10.1196/annals.1406.028; Talamantes J, 2007, INT J BIOMETEOROL, V51, P307, DOI 10.1007/s00484-006-0065-4; Tamerius JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021009; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433; Zender CS, 2006, INT J BIOMETEOROL, V50, P174, DOI 10.1007/s00484-005-0007-6	52	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111921	10.1371/journal.pone.0111921	http://dx.doi.org/10.1371/journal.pone.0111921			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380290	Green Submitted, Green Published, gold			2022-12-27	WOS:000344863100045
J	Tibana, RA; Nascimento, DD; de Sousa, NMF; de Souza, VC; Durigan, J; Vieira, A; Bottaro, M; Nobrega, OD; de Almeida, JA; Navalta, JW; Franco, OL; Prestes, J				Tibana, Ramires Alsamir; Nascimento, Dahan da Cunha; Frade de Sousa, Nuno Manuel; de Souza, Vinicius Carolino; Durigan, Joao; Vieira, Amilton; Bottaro, Martim; Nobrega, Otavio de Toledo; de Almeida, Jeeser Alves; Navalta, James Wilfred; Franco, Octavio Luiz; Prestes, Jonato			Enhancing of Women Functional Status with Metabolic Syndrome by Cardioprotective and Anti-Inflammatory Effects of Combined Aerobic and Resistance Training	PLOS ONE			English	Article							PLASMA NITRIC-OXIDE; QUALITY-OF-LIFE; EXERCISE; INFLAMMATION; RISK; OSTEOPROTEGERIN; HYPERTENSION; VALIDATION; OVERWEIGHT; CYTOKINES	These data describe the effects of combined aerobic plus resistance training (CT) with regards to risk factors of metabolic syndrome (MetS), quality of life, functional capacity, and pro-and anti-inflammatory cytokines in women with MetS. In this context, thirteen women (35.4 +/- 6.2 yr) completed 10 weeks of CT consisting of three weekly sessions of similar to 60 min aerobic training (treadmill at 65-70% of reserve heart rate, 30 min) and resistance training (3 sets of 8-12 repetitions maximum for main muscle groups). Dependent variables were maximum chest press strength; isometric hand-grip strength; 30 s chair stand test; six minute walk test; body mass; body mass index; body adiposity index; waist circumference; systolic (SBP), diastolic and mean blood pressure (MBP); blood glucose; HDL-C; triglycerides; interleukins (IL) 6, 10 and 12, osteoprotegerin (OPG) and serum nitric oxide metabolite (NOx); quality of life (SF-36) and Z-Score of MetS. There was an improvement in muscle strength on chest press (p = 0.009), isometric hand-grip strength (p = 0.03) and 30 s chair stand (p = 0.007). There was a decrease in SBP (p = 0.049), MBP (p = 0.041), Z-Score of MetS (p = 0.046), OPG (0.42 +/- 0.26 to 0.38 +/- 0.19 ng/mL, p, 0.05) and NOx (13.3 +/- 2.3 mu mol/L to 9.1 +/- 2.3 mu mol/L; p<0.0005). IL-10 displayed an increase (13.6 +/- 7.5 to 17.2 +/- 12.3 pg/mL, p<0.05) after 10 weeks of training. Combined training also increased the perception of physical capacity (p = 0.011). This study endorses CT as an efficient tool to improve blood pressure, functional capacity, quality of life and reduce blood markers of inflammation, which has a clinical relevance in the prevention and treatment of MetS.	[Tibana, Ramires Alsamir; Nascimento, Dahan da Cunha; de Souza, Vinicius Carolino; de Almeida, Jeeser Alves; Franco, Octavio Luiz; Prestes, Jonato] Univ Catolica Brasilia, Graduat Program Phys Educ, Brasilia, DF, Brazil; [Frade de Sousa, Nuno Manuel] Fac Estacio Vitoria, Exercise Physiol Lab, Espirito Santo, Brazil; [Durigan, Joao; Vieira, Amilton; Bottaro, Martim; Nobrega, Otavio de Toledo; de Almeida, Jeeser Alves] Univ Brasilia, Brasilia, DF, Brazil; [Navalta, James Wilfred] Univ Nevada, Dept Kinesiol & Nutr Sci, Las Vegas, NV 89154 USA; [Franco, Octavio Luiz] Univ Catolica Brasilia, Programa Posgrad Ciencias Genom & Biotecnol, Ctr Anal Proteom & Bioquim, Brasilia, DF, Brazil	Universidade Catolica de Brasilia; Universidade de Brasilia; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Universidade Catolica de Brasilia	Tibana, RA (corresponding author), Univ Catolica Brasilia, Graduat Program Phys Educ, Brasilia, DF, Brazil.	ramirestibana@gmail.com	Almeida, Jeeser A/O-2912-2014; Sousa, Nuno/H-8611-2013; Navalta, James/H-6626-2019; da Cunha Nascimento, Dahan/AAP-9675-2021; Tibana, Ramires A./G-2648-2013; Prestes, Jonato/H-2702-2012; Bottaro, Martim/X-1433-2019; Vieira, Amilton/A-7694-2018; Nobrega, Otavio T/J-7738-2012; Durigan, João Luiz Quagliotti/D-1110-2012; Bottaro, Martim/H-9593-2014; Franco, Octavio L/T-3020-2017	Almeida, Jeeser A/0000-0002-3409-8005; Sousa, Nuno/0000-0001-5854-616X; Navalta, James/0000-0002-4445-7614; da Cunha Nascimento, Dahan/0000-0002-6580-9404; Prestes, Jonato/0000-0003-0399-8817; Bottaro, Martim/0000-0002-4315-3176; Vieira, Amilton/0000-0002-6027-4367; Nobrega, Otavio T/0000-0003-1775-7176; Durigan, João Luiz Quagliotti/0000-0002-7511-5289; Franco, Octavio/0000-0001-9546-0525				Aoki A, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-11; Asl SZ, 2008, CLIN BIOCHEM, V41, P1342, DOI 10.1016/j.clinbiochem.2008.08.076; Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38; Bruunsgaard H, 2005, J LEUKOCYTE BIOL, V78, P819, DOI 10.1189/jlb.0505247; Ciconelli RM, 1999, REV BRAS REUMATOL, V39, P143, DOI DOI 10.1590/S0482-50042010000300005; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Dallaire P, 2004, CAN J DIABETES, V28, P59; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Ervin R Bethene, 2009, Natl Health Stat Report, P1; Esposito K, 2004, NUTR METAB CARDIOVAS, V14, P228, DOI 10.1016/S0939-4753(04)80048-6; Festa A, 2000, CIRCULATION, V102, P42, DOI 10.1161/01.CIR.102.1.42; Fyfe JJ, 2014, SPORTS MED, V44, P743, DOI 10.1007/s40279-014-0162-1; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Ho SS, 2013, INFLAMMATION, V36, P625, DOI 10.1007/s10753-012-9584-9; Imayama I, 2011, INT J BEHAV NUTR PHY, V25, P8; Imayama I, 2012, CANCER RES, V72, P2314, DOI 10.1158/0008-5472.CAN-11-3092; Kanbak G, 2011, DIABETES METAB SYND, V5, P7, DOI 10.1016/j.dsx.2010.05.006; Kang J, 2014, ACSMS HEALTH FIT J, V18, P9, DOI 10.1249/FIT.0000000000000004; Kim HM, 2007, DIABETES CARE, V30, P701, DOI 10.2337/dc06-1400; Maejima K, 2001, J DIABETES COMPLICAT, V15, P135, DOI 10.1016/S1056-8727(01)00144-1; Mathur N, 2008, MEDIATORS I IN PRESS; Morena M, 2006, J AM SOC NEPHROL, V17, P262, DOI 10.1681/ASN.2005030260; Okosun IS, 2013, DIABETES METAB SYND, V7, P154, DOI 10.1016/j.dsx.2013.06.007; Orozco LJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003054.pub3; Pedersen BK, 1997, INT J SPORTS MED, V18, pS2, DOI 10.1055/s-2007-972695; Pereira GB, 2013, CLIN PHYSIOL FUNCT I, V33, P122, DOI 10.1111/cpf.12004; Prestes J, 2013, REV ASSOC MED BRAS, V59, P308, DOI 10.1016/j.ramb.2013.01.009; Prestes J, 2009, J SPORT SCI, V27, P1607, DOI 10.1080/02640410903352923; Rikli RE, 1999, J AGING PHYS ACTIV, V7, P129, DOI 10.1123/japa.7.2.129; Robbie L, 2001, ANN NY ACAD SCI, V947, P167; Schwingshackl L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082853; Shaw K, 2006, COCHRANE DB SYST REV, V8; Stensvold D, 2012, METAB SYNDR RELAT D, V10, P267, DOI 10.1089/met.2011.0140; Tavel ME, 2001, CHEST, V119, P907, DOI 10.1378/chest.119.3.907; Tibana RA, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-11; Tibana RA, 2012, EINSTEIN-SAO PAULO, V10, P329, DOI 10.1590/S1679-45082012000300013; Topouchian JA, 2005, BLOOD PRESS MONIT, V10, P325, DOI 10.1097/00126097-200512000-00008; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.immunol.13.1.251; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; Williamson DA, 2009, ARCH INTERN MED, V169, P163, DOI 10.1001/archinternmed.2008.544; Yoon Y, 2000, CLIN CHEM, V46, P1626	44	14	15	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e110160	10.1371/journal.pone.0110160	http://dx.doi.org/10.1371/journal.pone.0110160			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379699	Green Published, Green Submitted, gold			2022-12-27	WOS:000344863100011
J	Girard, LC; Pingault, JB; Falissard, B; Boivin, M; Dionne, G; Tremblay, RE				Girard, Lisa-Christine; Pingault, Jean-Baptiste; Falissard, Bruno; Boivin, Michel; Dionne, Ginette; Tremblay, Richard E.			Physical Aggression and Language Ability from 17 to 72 Months: Cross-Lagged Effects in a Population Sample	PLOS ONE			English	Article							EARLY-CHILDHOOD; BEHAVIOR PROBLEMS; EXTERNALIZING BEHAVIOR; SOCIOECONOMIC-STATUS; ANGER EXPRESSION; ASSOCIATIONS; PARENT; SKILLS; SIZE; IMPAIRMENT	Background: Does poor language ability in early childhood increase the likelihood of physical aggression or is language ability delayed by frequent physical aggression? This study examined the longitudinal associations between physical aggression and language ability from toddlerhood to early childhood in a population sample while controlling for parenting behaviours, non-verbal intellectual functioning, and children's sex. Methods: Children enrolled in the Quebec Longitudinal Study of Child Development (QLSCD) (N = 2, 057) were assessed longitudinally from 17 to 72 months via parent reports and standardized assessments. Results: The cross-lagged models revealed modest reciprocal associations between physical aggression and language performance from 17 to 41 months but not thereafter. Conclusions: Significant associations between physical aggression and poor language ability are minimal and limited to the period when physical aggression and language performance are both substantially increasing. During that period parenting behaviours may play an important role in supporting language ability while reducing the frequency of physical aggression. Further studies are needed that utilize multiple assessments of physical aggression, assess multiple domains of language abilities, and that examine the potential mediating role of parenting behaviours between 12 and 48 months.	[Girard, Lisa-Christine; Tremblay, Richard E.] Univ Montreal, Res Unit Childrens Psychosocial Maladjustment GRI, Montreal, PQ, Canada; [Girard, Lisa-Christine; Falissard, Bruno] INSERM, Paris Sud Innovat Grp Adolescent Mental Hlth, U669, Paris, France; [Pingault, Jean-Baptiste] UCL, Div Psychol & Language Sci, London, England; [Falissard, Bruno] Univ Paris 11, Fac Med, Paris, France; [Falissard, Bruno] Univ Paris 05, Fac Med, Paris, France; [Boivin, Michel; Dionne, Ginette] Univ Laval, Sch Psychol, Montreal, PQ, Canada; [Boivin, Michel; Tremblay, Richard E.] Tomsk State Univ, Inst Genet Neurobiol & Social Fdn Child Dev, Tomsk 634050, Russia; [Tremblay, Richard E.] Univ Montreal, Dept Pediat & Psychol, Montreal, PQ, Canada; [Tremblay, Richard E.] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Dublin 2, Ireland	Universite de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; University of London; University College London; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Laval University; Tomsk State University; Universite de Montreal; University College Dublin	Girard, LC (corresponding author), Univ Montreal, Res Unit Childrens Psychosocial Maladjustment GRI, Montreal, PQ, Canada.	lisa.girard@alum.utoronto.ca	Tremblay, Richard E./O-1360-2014; Girard, Lisa-Christine/ABD-6846-2020	Girard, Lisa-Christine/0000-0003-3817-034X; Boivin, Michel/0000-0001-8621-9844; Pingault, Jean-Baptiste/0000-0003-2557-4716				Alink LRA, 2006, CHILD DEV, V77, P954, DOI 10.1111/j.1467-8624.2006.00912.x; [Anonymous], 1991, MANUAL CHILD BEHAV C; Asbury K, 2005, INTELLIGENCE, V33, P643, DOI 10.1016/j.intell.2005.03.008; Ayduk O, 2007, J RES PERS, V41, P374, DOI 10.1016/j.jrp.2006.04.008; Barnett MA, 2012, INFANT CHILD DEV, V21, P374, DOI 10.1002/icd.1750; BEHAR L, 1974, DEV PSYCHOL, V10, P601, DOI 10.1037/h0037058; Beitchman JH, 1996, J AM ACAD CHILD PSY, V35, P815, DOI 10.1097/00004583-199606000-00022; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Botting N, 2000, CHILD LANG TEACH THE, V16, P105, DOI DOI 10.1177/026565900001600201; Broidy LM, 2003, DEV PSYCHOL, V39, P222, DOI 10.1037/0012-1649.39.2.222; Browne M. W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; Brownlie EB, 2004, J ABNORM CHILD PSYCH, V32, P453, DOI 10.1023/B:JACP.0000030297.91759.74; Camp BW, 1997, J EDUC PSYCHOL, V69, P129; Cole PM, 2011, DEV PSYCHOL, V47, P1078, DOI 10.1037/a0023813; Conti-Ramsden G, 2004, J SPEECH LANG HEAR R, V47, P145, DOI 10.1044/1092-4388(2004/013); Derauf C, 2011, J DEV BEHAV PEDIATR, V32, P125, DOI 10.1097/DBP.0b013e31820839d7; Dionne G, 2003, DEV PSYCHOL, V39, P261, DOI 10.1037/0012-1649.39.2.261; Doctoroff GL, 2004, J CLIN CHILD ADOLESC, V33, P813, DOI 10.1207/s15374424jccp3304_16; Doyle O, 2009, ECON HUM BIOL, V7, P1, DOI 10.1016/j.ehb.2009.01.002; Dunn L.M., 1981, PEABODY PICTURE VOCA; Estrem TL, 2005, EARLY EDUC DEV, V16, P207, DOI DOI 10.1207/S15566935EED1602_6; Fan XT, 1999, STRUCT EQU MODELING, V6, P56, DOI 10.1080/10705519909540119; Fenson L, 2000, APPL PSYCHOLINGUIST, V21, P95, DOI 10.1017/S0142716400001053; Gardner F, 2007, J FAM PSYCHOL, V21, P398, DOI 10.1037/0893-3200.21.3.398; Giddan JJ, 1996, AM J ORTHOPSYCHIAT, V66, P85, DOI 10.1037/h0080158; Heckman JJ, 2010, J PUBLIC ECON, V94, P114, DOI 10.1016/j.jpubeco.2009.11.001; Hoff E, 2006, DEV REV, V26, P55, DOI 10.1016/j.dr.2005.11.002; Hooper D., 2008, EJBRM, V6, P53, DOI DOI 10.21427/D7CF7R; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jette M, 2000, LONGITUDINAL STUDY C, V1, P7; Lee J, 2011, APPL PSYCHOLINGUIST, V32, P69, DOI 10.1017/S0142716410000299; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Makin L, 2006, EARLY YEARS, V26, P267, DOI 10.1080/09575140600898449; McKee L, 2007, J FAM VIOLENCE, V22, P187, DOI 10.1007/s10896-007-9070-6; Meece D, 2010, EARLY CHILD DEV CARE, V180, P585, DOI 10.1080/03004430802181452; Menting B, 2011, J CHILD PSYCHOL PSYC, V52, P72, DOI 10.1111/j.1469-7610.2010.02279.x; Muthen L. K., 2017, MPLUS USERS GUIDE, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Naerde A, 2014, DEV PSYCHOL, V50, P1710, DOI 10.1037/a0036324; Nozadi SS, 2013, INFANT BEHAV DEV, V36, P650, DOI 10.1016/j.infbeh.2013.06.002; Oliver B, 2004, J CHILD LANG, V31, P609, DOI 10.1017/S0305000904006221; Park JH, 2005, EARLY EDUC DEV, V16, P233, DOI DOI 10.1080/10409289.2005.10472869; Paul R, 1996, CLIN IMPLICATIONS NA; Petrill SA, 2004, INTELLIGENCE, V32, P445, DOI 10.1016/j.intell.2004.06.010; Plomin R, 2002, J CHILD PSYCHOL PSYC, V43, P619, DOI 10.1111/1469-7610.00051; PROVOST MA, 1985, AGGRESSIVE BEHAV, V11, P283, DOI 10.1002/1098-2337(1985)11:4<283::AID-AB2480110403>3.0.CO;2-4; Pungello EP, 2009, DEV PSYCHOL, V45, P544, DOI 10.1037/a0013917; Qi CQC, 2004, J SPEECH LANG HEAR R, V47, P595, DOI 10.1044/1092-4388(2004/046); Raine A, 2002, DEV PSYCHOPATHOL, V14, P25, DOI 10.1017/S0954579402001025; Ripley K, 2005, BRIT J EDUC PSYCHOL, V75, P37, DOI 10.1348/000709905x27696; Roben CKP, 2013, CHILD DEV, V84, P891, DOI 10.1111/cdev.12027; Rose SA, 2009, CHILD DEV, V80, P134, DOI 10.1111/j.1467-8624.2008.01250.x; RUTTER M, 1967, J CHILD PSYCHOL PSYC, V8, P1, DOI 10.1111/j.1469-7610.1967.tb02175.x; Seguin JR, 2009, J CHILD PSYCHOL PSYC, V50, P679, DOI 10.1111/j.1469-7610.2008.02030.x; STRAYHORN JM, 1988, J AM ACAD CHILD PSY, V27, P613, DOI 10.1097/00004583-198809000-00016; Toppelberg CO, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200206000-00011; Tremblay R. E., 1999, CRIM BEHAV MENT HEAL, V9, P8, DOI [DOI 10.1002/CBM.288, 10.1002/CBM.288]; TREMBLAY RE, 1991, J ABNORM CHILD PSYCH, V19, P285, DOI 10.1007/BF00911232; Tremblay RE, 2004, PEDIATRICS, V114, pE43, DOI 10.1542/peds.114.1.e43; Tremblay RE, 2008, EARLY CHILDHOOD LEAR; Tremblay RE, 2010, J CHILD PSYCHOL PSYC, V51, P341, DOI 10.1111/j.1469-7610.2010.02211.x; van Daal J, 2007, J CHILD PSYCHOL PSYC, V48, P1139, DOI 10.1111/j.1469-7610.2007.01790.x; Vygotsky L. S., 1978, MIND SOC DEV HIGHER, P52; Waller R, 2012, J CHILD PSYCHOL PSYC, V53, P946, DOI 10.1111/j.1469-7610.2012.02550.x; Wechsler D., 2014, WECHSLER PRESCHOOL P	64	25	25	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112185	10.1371/journal.pone.0112185	http://dx.doi.org/10.1371/journal.pone.0112185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XM	25375971	Green Published, gold			2022-12-27	WOS:000344402600114
J	Al-Henhena, N; Ying, RPY; Ismail, S; Najm, W; Khalifa, SAM; El-Seedi, H; Abdulla, MA				Al-Henhena, Nawal; Ying, Rozaida Poh Yuen; Ismail, Salmah; Najm, Wala; Khalifa, Shaden A. M.; El-Seedi, Hesham; Abdulla, Mahmood Ameen			Chemopreventive Efficacy of Andrographis paniculata on Azoxymethane-Induced Aberrant Colon Crypt Foci In Vivo	PLOS ONE			English	Article							TOTAL PHENOLIC CONTENT; COLORECTAL-CANCER; OXIDATIVE STRESS; ANTIOXIDANT; PLANTS; EXTRACT; 5-FLUOROURACIL; CARCINOGENESIS; ABSORPTION; PREVENTION	Andrographis paniculata is a grass-shaped medicinal herb, traditionally used in Southeast Asia. The aim of this study was to evaluate the chemoprotective effects of A. paniculata on colorectal cancer. A. paniculata ethanol extract was tested on azoxymethane (AOM)-induced aberrant crypt foci (ACF) in vivo and in vitro. A. paniculata treated groups showed a significant reduction in the number of ACF of the treated rats. Microscopically, ACF showed remarkably elongated and stratified cells, and depletion of the submucosal glands of AOM group compared to the treated groups. Histologically, staining showed slightly elevated masses above the surrounding mucosa with oval or slit-like orifices. Immunohistochemically, expression of proliferating cell nuclear antigen (PCNA) and beta-catenin protein were down-regulated in the A. paniculata treated groups compared to the AOM group. When colon tissue was homogenized, malondialdehyde (MDA) and nitric oxide (NO) levels were significantly decreased, whereas superoxide dismutase (SOD) activity was increased in the treated groups compared to the AOM group. A. paniculata ethanol extract showed antioxidant and free radical scavenging activity, as elucidated by the measure of oxidative stress markers. Further, the active fractions were assessed against cell lines of CCD841 and HT29 colon cancer cells.	[Al-Henhena, Nawal; Ying, Rozaida Poh Yuen; Najm, Wala; Abdulla, Mahmood Ameen] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur 50603, Malaysia; [Khalifa, Shaden A. M.] Karolinska Univ Hosp, Dept Expt Hematol, SE-14186 Huddinge, Sweden; [El-Seedi, Hesham] Uppsala Univ, Dept Med Chem, Div Pharmacognosy, SE-75123 Uppsala, Sweden; [Ismail, Salmah] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Universiti Malaya	Abdulla, MA (corresponding author), Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur 50603, Malaysia.	ammeen@um.edu.my	ISMAIL, SALMAH/B-9680-2010; Ismail, Salmah/A-6504-2016; El-Seedi, Hesham R./C-8627-2018; POH, ROZAIDA Yuen Ying/B-9625-2010	ISMAIL, SALMAH/0000-0001-5595-8222; POH, ROZAIDA Yuen Ying/0000-0002-7893-9929	University of Malaya [PS246-2010B]; Ministry of Higher Education Malaysia [UM-MOHE UM.C/625/1/HIR/MOHE/SC/09]	University of Malaya(Universiti Malaya); Ministry of Higher Education Malaysia(Ministry of Education, Malaysia)	Funding provided by University of Malaya, Grant No. (PS246-2010B) and High Impact Research Grant UM-MOHE UM.C/625/1/HIR/MOHE/SC/09 from the Ministry of Higher Education Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhishek Niranjan, 2010, Indian Journal of Natural Products and Resources, V1, P125; Akowuah GA, 2009, FOOD CHEM TOXICOL, V47, P2321, DOI 10.1016/j.fct.2009.06.022; Al Batran R, 2013, BIOMED RES INT 2013, V2013; Al-Bayaty FH, 2012, NAT PROD RES, V26, P423, DOI 10.1080/14786419.2010.496114; Amaryan G, 2003, PHYTOMEDICINE, V10, P271, DOI 10.1078/094471103322004767; Bagchi D, 2000, TOXICOLOGY, V148, P187, DOI 10.1016/S0300-483X(00)00210-9; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; BIRD RP, 1987, CANCER LETT, V37, P147, DOI 10.1016/0304-3835(87)90157-1; Calabrese C, 2000, PHYTOTHER RES, V14, P333, DOI 10.1002/1099-1573(200008)14:5&lt;333::AID-PTR584&gt;3.0.CO;2-D; Chan AT, 2010, GASTROENTEROLOGY, V138, P2029, DOI 10.1053/j.gastro.2010.01.057; Cheah PL, 2014, ASIAN PAC J CANCER P, V15, P3287, DOI 10.7314/APJCP.2014.15.7.3287; El-Seedi HR, 2013, J ETHNOPHARMACOL, V145, P746, DOI 10.1016/j.jep.2012.12.007; FRAGA CG, 1987, BIOCHEM PHARMACOL, V36, P717, DOI 10.1016/0006-2952(87)90724-6; Gan RY, 2010, J MED PLANTS RES, V4, P2438; Hosono K, 2010, MOL CARCINOGEN, V49, P662, DOI 10.1002/mc.20637; Ikram EHK, 2009, J FOOD COMPOS ANAL, V22, P388, DOI 10.1016/j.jfca.2009.04.001; Jarukamjorn K, 2008, J HEALTH SCI, V54, P370, DOI 10.1248/jhs.54.370; Jubeh TT, 2006, J DRUG TARGET, V14, P155, DOI 10.1080/10611860600648429; Khalifa SAM, 2014, BIOCHEM BIOPH RES CO, V446, P681, DOI 10.1016/j.bbrc.2013.12.134; Ko HC, 2006, J ETHNOPHARMACOL, V107, P205, DOI 10.1016/j.jep.2006.03.004; Koukourakis M, 2009, COLORECTAL CANC; Lin FL, 2009, PHYTOTHER RES, V23, P958, DOI 10.1002/ptr.2701; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Marotta F, 2003, HEPATO-GASTROENTEROL, V50, P1914; Murthy NS, 2009, J POSTGRAD MED, V55, P45, DOI 10.4103/0022-3859.43549; Neelwarne B., 2012, RED BEET BIOTECHNOLO, DOI [10.1007/978-1-4614-3458-0, DOI 10.1007/978-1-4614-3458-0]; Norwati D, 2014, ASIAN PAC J CANCER P, V15, P2901, DOI 10.7314/APJCP.2014.15.6.2901; OECD, 2005, DOFO OECD GUID TEST; Ohishi T, 2002, CANCER LETT, V177, P49, DOI 10.1016/S0304-3835(01)00767-4; PINEDO HM, 1988, J CLIN ONCOL, V6, P1653, DOI 10.1200/JCO.1988.6.10.1653; Qader SW, 2011, MOLECULES, V16, P3433, DOI 10.3390/molecules16043433; RADERER M, 1995, EUR J CANCER, V31A, P1002, DOI 10.1016/0959-8049(95)00078-X; Rajagopal Sriram, 2003, J Exp Ther Oncol, V3, P147, DOI 10.1046/j.1359-4117.2003.01090.x; Rao NK., 2006, IRAN J PHARM THERAP, V5, P47; Roy S, 2010, WORLD J MICROB BIOT, V26, P85, DOI 10.1007/s11274-009-0146-8; Saha K, 2004, J ETHNOPHARMACOL, V92, P263, DOI [10.1016/j.jep.2004.03.007, 10.1016/j/jep.2004.03.007]; Samy RP, 2008, J ETHNOPHARMACOL, V115, P302, DOI 10.1016/j.jep.2007.10.006; Sathuvan Malairaj, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, pS741; Segui J, 2005, INFLAMM BOWEL DIS, V11, P872, DOI 10.1097/01.MIB.0000183420.25186.7a; Seril DN, 2003, CARCINOGENESIS, V24, P353, DOI 10.1093/carcin/24.3.353; Shafie NH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/681027; Sharma OP, 2009, FOOD CHEM, V113, P1202, DOI 10.1016/j.foodchem.2008.08.008; Sheeja K, 2007, IMMUNOPHARM IMMUNOT, V29, P81, DOI 10.1080/08923970701282726; Sheeja K, 2006, IMMUNOPHARM IMMUNOT, V28, P129, DOI 10.1080/08923970600626007; Singha PK, 2003, FITOTERAPIA, V74, P692, DOI [10.1016/S0367-326X(03)00159-X, 10.1016/s0367-326X(03)00159-X]; Skrovankova S, 2012, ADV FOOD NUTR RES; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tomimatsu T, 2005, CHEM-BIOL INTERACT, V155, P129, DOI 10.1016/j.cbi.2005.04.001; Traverso G, 2002, LANCET, V359, P403, DOI 10.1016/S0140-6736(02)07591-8; Violette S, 2002, INT J CANCER, V98, P498, DOI 10.1002/ijc.10146; Wasman SQ, 2011, INDIAN J EXP BIOL, V49, P767; Yamaguchi H, 2003, CANCER RES, V63, P1483; Yen GC, 2001, FOOD CHEM, V74, P471, DOI 10.1016/S0308-8146(01)00165-0; Yoopan N, 2007, PLANTA MED, V73, P503, DOI 10.1055/s-2007-967181; Yu CC, 2005, J PLANT PHYSIOL, V162, P1319, DOI 10.1016/j.jplph.2005.02.003; Zhao F, 2008, J ASIAN NAT PROD RES, V10, P473, DOI [10.1080/10286020801948334, 10.1080/10286020801948599]	56	19	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111118	10.1371/journal.pone.0111118	http://dx.doi.org/10.1371/journal.pone.0111118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390042	Green Published, gold			2022-12-27	WOS:000349144400018
J	Schutkowski, A; Wege, N; Stangl, GI; Konig, B				Schutkowski, Alexandra; Wege, Nicole; Stangl, Gabriele I.; Koenig, Bettina			Tissue-Specific Expression of Monocarboxylate Transporters during Fasting in Mice	PLOS ONE			English	Article							THYROID-HORMONE TRANSPORTER; AMINO-ACID TRANSPORTER; ALPHA PPAR-ALPHA; XENOPUS-LAEVIS OOCYTES; PSYCHOMOTOR RETARDATION; TRANSLATIONAL ACTIVATION; ANCILLARY PROTEIN; SKELETAL-MUSCLES; TAT1 SLC16A10; NULL MOUSE	Monocarboxylates such as pyruvate, lactate and ketone bodies are crucial for energy supply of all tissues, especially during energy restriction. The transport of monocarboxylates across the plasma membrane of cells is mediated by monocarboxylate transporters (MCTs). Out of 14 known mammalian MCTs, six isoforms have been functionally characterized to transport monocarboxylates and short chain fatty acids (MCT1-4), thyroid hormones (MCT8, -10) and aromatic amino acids (MCT10). Knowledge on the regulation of the different MCT isoforms is rare. In an attempt to get more insights in regulation of MCT expression upon energy deprivation, we carried out a comprehensive analysis of tissue specific expression of five MCT isoforms upon 48 h of fasting in mice. Due to the crucial role of peroxisome proliferator-activated receptor (PPAR)-alpha as a central regulator of energy metabolism and as known regulator of MCT1 expression, we included both wildtype (WT) and PPAR alpha knockout (KO) mice in our study. Liver, kidney, heart, small intestine, hypothalamus, pituitary gland and thyroid gland of the mice were analyzed. Here we show that the expression of all examined MCT isoforms was markedly altered by fasting compared to feeding. Expression of MCT1, MCT2 and MCT10 was either increased or decreased by fasting dependent on the analyzed tissue. MCT4 and MCT8 were down-regulated by fasting in all examined tissues. However, PPARa appeared to have a minor impact on MCT isoform regulation. Due to the fundamental role of MCTs in transport of energy providing metabolites and hormones involved in the regulation of energy homeostasis, we assumed that the observed fasting-induced adaptations of MCT expression seem to ensure an adequate energy supply of tissues during the fasting state. Since, MCT isoforms 1-4 are also necessary for the cellular uptake of drugs, the fasting-induced modifications of MCT expression have to be considered in future clinical care algorithms.	[Schutkowski, Alexandra; Wege, Nicole; Stangl, Gabriele I.; Koenig, Bettina] Univ Halle Wittenberg, Inst Agr & Nutr Sci, D-06108 Halle, Germany	Martin Luther University Halle Wittenberg	Konig, B (corresponding author), Univ Halle Wittenberg, Inst Agr & Nutr Sci, D-06108 Halle, Germany.	bettina.koenig@landw.uni-halle.de		Schutkowski, Alexandra/0000-0002-9387-7869				Abe S, 2012, ENDOCRINOLOGY, V153, P4049, DOI 10.1210/en.2011-1713; Alkemade A, 2005, J CLIN ENDOCR METAB, V90, P4322, DOI 10.1210/jc.2004-2567; Becker HM, 2010, AM J PHYSIOL-RENAL, V299, pF141, DOI 10.1152/ajprenal.00488.2009; Bettzieche A, 2009, MOL NUTR FOOD RES, V53, P1134, DOI 10.1002/mnfr.200800393; Borthakur A, 2008, J CELL BIOCHEM, V103, P1452, DOI 10.1002/jcb.21532; Borthakur A, 2012, AM J PHYSIOL-GASTR L, V303, pG1126, DOI 10.1152/ajpgi.00308.2012; Broer S, 1999, BIOCHEM J, V341, P529, DOI 10.1042/0264-6021:3410529; Broer S, 1998, BIOCHEM J, V333, P167, DOI 10.1042/bj3330167; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; Campbell FM, 2002, J BIOL CHEM, V277, P4098, DOI 10.1074/jbc.M106054200; Chenal J, 2008, EUR J NEUROSCI, V27, P53, DOI 10.1111/j.1460-9568.2007.05981.x; Chenal J, 2007, J NEUROCHEM, V102, P389, DOI 10.1111/j.1471-4159.2007.04495.x; Cortes-Campos C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062532; DEHOFF JL, 1978, CLIN CHEM, V24, P433; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Enoki T, 2003, J APPL PHYSIOL, V94, P2433, DOI 10.1152/japplphysiol.01155.2002; Friesema ECH, 2004, LANCET, V364, P1435, DOI 10.1016/S0140-6736(04)17226-7; Friesema ECH, 2003, J BIOL CHEM, V278, P40128, DOI 10.1074/jbc.M300909200; Friesema ECH, 2006, NAT CLIN PRACT ENDOC, V2, P512, DOI 10.1038/ncpendmet0262; Gelinas R, 2008, AM J PHYSIOL-HEART C, V294, pH1571, DOI 10.1152/ajpheart.01340.2007; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Halestrap AP, 2012, IUBMB LIFE, V64, P1, DOI 10.1002/iub.573; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Hashimoto T, 2000, J BIOL CHEM, V275, P28918, DOI 10.1074/jbc.M910350199; Heuer H, 2005, ENDOCRINOLOGY, V146, P1701, DOI 10.1210/en.2004-1179; Iwanaga T, 2006, BIOMED RES-TOKYO, V27, P243, DOI 10.2220/biomedres.27.243; Kekuda R, 2013, DIGEST DIS SCI, V58, P660, DOI 10.1007/s10620-012-2407-x; Kersten S, 2001, FASEB J, V15, P1971, DOI 10.1096/fj.01-0147com; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kim DK, 2001, J BIOL CHEM, V276, P17221, DOI 10.1074/jbc.M009462200; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Konig B, 2008, BBA-GEN SUBJECTS, V1780, P899, DOI 10.1016/j.bbagen.2008.03.002; Konig B, 2010, MOL NUTR FOOD RES, V54, P1248, DOI 10.1002/mnfr.200900432; Lee SST, 2004, J LIPID RES, V45, P2025, DOI 10.1194/jlr.M400078-JLR200; Leino RL, 2001, NEUROCHEM INT, V38, P519, DOI 10.1016/S0197-0186(00)00102-9; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Liepinsh E, 2014, METABOLISM, V63, P127, DOI 10.1016/j.metabol.2013.09.014; Mariotta L, 2012, J PHYSIOL-LONDON, V590, P6413, DOI 10.1113/jphysiol.2012.239574; Matsuyama S, 2009, J REPROD DEVELOP, V55, P256, DOI 10.1262/jrd.20214; Morris ME, 2008, AAPS J, V10, P311, DOI 10.1208/s12248-008-9035-6; Moschen I, 2012, NEUROCHEM RES, V37, P2562, DOI 10.1007/s11064-012-0857-3; Murray CM, 2005, NAT CHEM BIOL, V1, P371, DOI 10.1038/nchembio744; Ovens MJ, 2010, BIOCHEM J, V431, P217, DOI 10.1042/BJ20100890; Pellerin L, 2012, J CEREBR BLOOD F MET, V32, P1152, DOI 10.1038/jcbfm.2011.149; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Pinheiro C, 2012, J BIOENERG BIOMEMBR, V44, P127, DOI 10.1007/s10863-012-9428-1; Ramadan T, 2006, J CELL PHYSIOL, V206, P771, DOI 10.1002/jcp.20531; Rinholm JE, 2012, NATURE, V487, P435, DOI 10.1038/487435a; Ritzhaupt A, 1998, J PHYSIOL-LONDON, V513, P719, DOI 10.1111/j.1469-7793.1998.719ba.x; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Thomas C, 2012, AM J PHYSIOL-REG I, V302, pR1, DOI 10.1152/ajpregu.00250.2011; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Vijay N, 2014, CURR PHARM DESIGN, V20, P1487, DOI 10.2174/13816128113199990462; Visser W, 2007, BEST PRACT RES CL EN, V21, P223, DOI 10.1016/j.beem.2007.03.008; Visser WE, 2011, MOL ENDOCRINOL, V25, P1, DOI 10.1210/me.2010-0095; Wege N, 2013, MOL NUTR FOOD RES, V57, P376, DOI 10.1002/mnfr.201200409; Wilson MC, 2005, J BIOL CHEM, V280, P27213, DOI 10.1074/jbc.M411950200; Xu J, 2002, J BIOL CHEM, V277, P50237, DOI 10.1074/jbc.M201208200	60	31	31	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112118	10.1371/journal.pone.0112118	http://dx.doi.org/10.1371/journal.pone.0112118			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390336	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400055
J	Shimamoto, A; Kagawa, H; Zensho, K; Sera, Y; Kazuki, Y; Osaki, M; Oshimura, M; Ishigaki, Y; Hamasaki, K; Kodama, Y; Yuasa, S; Fukuda, K; Hirashima, K; Seimiya, H; Koyama, H; Shimizu, T; Takemoto, M; Yokote, K; Goto, M; Tahara, H				Shimamoto, Akira; Kagawa, Harunobu; Zensho, Kazumasa; Sera, Yukihiro; Kazuki, Yasuhiro; Osaki, Mitsuhiko; Oshimura, Mitsuo; Ishigaki, Yasuhito; Hamasaki, Kanya; Kodama, Yoshiaki; Yuasa, Shinsuke; Fukuda, Keiichi; Hirashima, Kyotaro; Seimiya, Hiroyuki; Koyama, Hirofumi; Shimizu, Takahiko; Takemoto, Minoru; Yokote, Koutaro; Goto, Makoto; Tahara, Hidetoshi			Reprogramming Suppresses Premature Senescence Phenotypes of Werner Syndrome Cells and Maintains Chromosomal Stability over Long-Term Culture	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; INFLAMMATION; INDUCTION; GENE; ABNORMALITIES; OPPORTUNITIES; FIBROBLASTS; EXPRESSION; MUTATIONS; PREVENTS	Werner syndrome (WS) is a premature aging disorder characterized by chromosomal instability and cancer predisposition. Mutations in WRN are responsible for the disease and cause telomere dysfunction, resulting in accelerated aging. Recent studies have revealed that cells from WS patients can be successfully reprogrammed into induced pluripotent stem cells (iPSCs). In the present study, we describe the effects of long-term culture on WS iPSCs, which acquired and maintained infinite proliferative potential for self-renewal over 2 years. After long-term cultures, WS iPSCs exhibited stable undifferentiated states and differentiation capacity, and premature upregulation of senescence-associated genes in WS cells was completely suppressed in WS iPSCs despite WRN deficiency. WS iPSCs also showed recapitulation of the phenotypes during differentiation. Furthermore, karyotype analysis indicated that WS iPSCs were stable, and half of the descendant clones had chromosomal profiles that were similar to those of parental cells. These unexpected properties might be achieved by induced expression of endogenous telomerase gene during reprogramming, which trigger telomerase reactivation leading to suppression of both replicative senescence and telomere dysfunction in WS cells. These findings demonstrated that reprogramming suppressed premature senescence phenotypes in WS cells and WS iPSCs could lead to chromosomal stability over the long term. WS iPSCs will provide opportunities to identify affected lineages in WS and to develop a new strategy for the treatment of WS.	[Shimamoto, Akira; Kagawa, Harunobu; Zensho, Kazumasa; Sera, Yukihiro; Tahara, Hidetoshi] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cellular & Mol Biol, Hiroshima, Japan; [Kazuki, Yasuhiro; Osaki, Mitsuhiko; Oshimura, Mitsuo] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Dept Biomed Sci, Yonago, Tottori, Japan; [Osaki, Mitsuhiko] Tottori Univ, Fac Med, Div Pathol Biochem, Yonago, Tottori 683, Japan; [Ishigaki, Yasuhito] Kanazawa Med Univ, Med Res Inst, Kahoku, Ishikawa 92002, Japan; [Hamasaki, Kanya; Kodama, Yoshiaki] Radiat Effects Res Fdn, Dept Genet, Hiroshima, Japan; [Yuasa, Shinsuke; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Hirashima, Kyotaro; Seimiya, Hiroyuki] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Div Mol Biotherapy, Tokyo 170, Japan; [Koyama, Hirofumi; Shimizu, Takahiko] Chiba Univ, Grad Sch Med, Dept Adv Aging Med, Chiba, Japan; [Takemoto, Minoru; Yokote, Koutaro] Chiba Univ, Grad Sch Med, Dept Clin Cell Biol & Med, Chiba, Japan; [Goto, Makoto] Tokyo Womens Med Univ, Med Ctr East, Div Orthoped Surg & Rheumatol, Tokyo, Japan	Hiroshima University; Tottori University; Tottori University; Kanazawa Medical University; Radiation Effects Research Foundation - Japan; Keio University; Japanese Foundation for Cancer Research; Chiba University; Chiba University	Shimamoto, A (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cellular & Mol Biol, Hiroshima, Japan.	shim@hiroshima-u.ac.jp; toshi@hiroshima-u.ac.jp	Tahara, Hidetoshi/G-7697-2019; Fukuda, Keiichi/L-3777-2013	Seimiya, Hiroyuki/0000-0003-3314-9736; Kagawa, Harunobu/0000-0003-0436-3805; Yuasa, Shinsuke/0000-0001-5593-7552	Ministry of Education, Culture, Sports, Science and Technology of Japan [25670030, 20014015, 24590902]; Ministry of Health Labor and Welfare of Japan; Grants-in-Aid for Scientific Research [24590902, 221S0001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Challenging Exploratory Research No. 25670030 (to A.S) and for Scientific Research No. 20014015 (to H.T) and No. 24590902 (to M.G) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. This work was also supported by a Health and Labor Sciences Research Grant from the Ministry of Health Labor and Welfare of Japan (to A.S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Batista LFZ, 2011, NATURE, V474, P399, DOI 10.1038/nature10084; Cheung HH, 2014, STEM CELL REP, V2, P534, DOI 10.1016/j.stemcr.2014.02.006; Choi DH, 2001, FASEB J, V15, P1014, DOI 10.1096/fj.00-0104com; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Crabbe L, 2007, P NATL ACAD SCI USA, V104, P2205, DOI 10.1073/pnas.0609410104; Davis T, 2006, REJUV RES, V9, P402, DOI 10.1089/rej.2006.9.402; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Goto M, 1997, HUM GENET, V99, P191, DOI 10.1007/s004390050336; Goto M, 2000, CLIN EXP RHEUMATOL, V18, P760; Goto M, 1996, CANCER EPIDEM BIOMAR, V5, P239; Goto M, 2013, BIOSCI TRENDS; Goto M, 2012, EXP GERONTOL, V47, P936, DOI 10.1016/j.exger.2012.08.010; Goto M, 2008, BIOSCI TRENDS, V2, P218; Kojima H, 2012, CELL CYCLE, V11, P730, DOI 10.4161/cc.11.4.19172; KUMAR S, 1993, EXP GERONTOL, V28, P505, DOI 10.1016/0531-5565(93)90039-G; Martins-Taylor K, 2011, NAT BIOTECHNOL, V29, P488, DOI 10.1038/nbt.1890; Mathew R, 2010, FASEB J, V24, P2702, DOI 10.1096/fj.09-148973; Matsumoto T, 1997, HUM GENET, V100, P123, DOI 10.1007/s004390050477; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Murano S, 1997, GERONTOLOGY, V43, P43; OHTAKI K, 1994, MUTAT RES, V316, P49, DOI 10.1016/0921-8734(94)90007-8; Okita K, 2011, PHILOS T R SOC B, V366, P2198, DOI 10.1098/rstb.2011.0016; Oshima J, 1996, HUM MOL GENET, V5, P1909, DOI 10.1093/hmg/5.12.1909; Rossi ML, 2010, DNA REPAIR, V9, P331, DOI 10.1016/j.dnarep.2009.12.011; RUBIN CD, 1992, J AM GERIATR SOC, V40, P1161, DOI 10.1111/j.1532-5415.1992.tb01808.x; Salama R, 2014, GENE DEV, V28, P99, DOI 10.1101/gad.235184.113; SALK D, 1981, CYTOGENET CELL GENET, V30, P108, DOI 10.1159/000131597; SALK D, 1981, HUM GENET, V57, P269; Shimamoto Akira, 2004, Int J Clin Oncol, V9, P288, DOI 10.1007/s10147-004-0426-0; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Taapken SM, 2011, NAT BIOTECHNOL, V29, P313, DOI 10.1038/nbt.1835; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vaziri H, 2010, REGEN MED, V5, P345, DOI 10.2217/RME.10.21; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wyllie FS, 2000, NAT GENET, V24, P16, DOI 10.1038/71630; Yokote K, 2004, DIABETES CARE, V27, P2562, DOI 10.2337/diacare.27.10.2562; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	44	41	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112900	10.1371/journal.pone.0112900	http://dx.doi.org/10.1371/journal.pone.0112900			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390333	gold, Green Submitted, Green Published			2022-12-27	WOS:000349144400139
J	Wada, Y; Iyoda, M; Matsumoto, K; Shindo-Hirai, Y; Kuno, Y; Yamamoto, Y; Suzuki, T; Saito, T; Iseri, K; Shibata, T				Wada, Yukihiro; Iyoda, Masayuki; Matsumoto, Kei; Shindo-Hirai, Yuki; Kuno, Yoshihiro; Yamamoto, Yasutaka; Suzuki, Taihei; Saito, Tomohiro; Iseri, Ken; Shibata, Takanori			Epidermal Growth Factor Receptor Inhibition with Erlotinib Partially Prevents Cisplatin-Induced Nephrotoxicity in Rats	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; TUBULAR EPITHELIAL-CELLS; PHASE-II TRIAL; RENAL INJURY; INDUCED APOPTOSIS; ERK ACTIVATION; CANCER; DEDIFFERENTIATION; PROLIFERATION; CHEMOTHERAPY	The effects of blocking the epidermal growth factor receptor (EGFR) in acute kidney injury (AKI) are controversial. Here we investigated the renoprotective effect of erlotinib, a selective tyrosine kinase inhibitor that can block EGFR activity, on cisplatin (CP)-induced AKI. Groups of animals were given either erlotinib or vehicle from one day before up to Day 3 following induction of CP-nephrotoxicity (CP-N). In addition, we analyzed the effects of erlotinib on signaling pathways involved in CP-N by using human renal proximal tubular cells (HK-2). Compared to controls, rats treated with erlotinib exhibited significant improvement of renal function and attenuation of tubulointerstitial injury, and reduced the number of apoptotic and proliferating cells. Erlotinib-treated rats had a significant reduction of renal cortical mRNA for profibrogenic genes. The Bax/Bcl-2 mRNA and protein ratios were significantly reduced by erlotinib treatment. In vitro, we observed that erlotinib significantly reduced the phosphorylation of MEK1 and Akt, processes that were induced by CP in HK-2. Taken together, these data indicate that erlotinib has renoprotective properties that are likely mediated through decreases in the apoptosis and proliferation of tubular cells, effects that reflect inhibition of downstream signaling pathways of EGFR. These results suggest that erlotinib may be useful for preventing AKI in patients receiving CP chemotherapy.	[Wada, Yukihiro; Iyoda, Masayuki; Matsumoto, Kei; Shindo-Hirai, Yuki; Kuno, Yoshihiro; Yamamoto, Yasutaka; Suzuki, Taihei; Saito, Tomohiro; Iseri, Ken; Shibata, Takanori] Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo 142, Japan	Showa University	Iyoda, M (corresponding author), Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo 142, Japan.	iyoda@med.showa-u.ac.jp	Saito, Tomohiro/AAD-6724-2021; Iseri, Ken/K-6376-2019	Iseri, Ken/0000-0002-6610-2451	Showa University; Showa University Medical Foundation	Showa University; Showa University Medical Foundation	YW and YK were supported by a Showa University Research Grant for Young Researchers. MI was supported by the Showa University Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ali BH, 2006, FOOD CHEM TOXICOL, V44, P1173, DOI 10.1016/j.fct.2006.01.013; Ali BH, 2011, BASIC CLIN PHARMACOL, V109, P300, DOI 10.1111/j.1742-7843.2011.00724.x; Arany I, 2004, AM J PHYSIOL-RENAL, V287, pF543, DOI 10.1152/ajprenal.00112.2004; Benhar M, 2002, ONCOGENE, V21, P8723, DOI 10.1038/sj.onc.1205980; Bollee G, 2011, NAT MED, V17, P1242, DOI 10.1038/nm.2491; BREYER MD, 1990, AM J PHYSIOL, V259, pF553, DOI 10.1152/ajprenal.1990.259.4.F553; Chen JC, 2012, KIDNEY INT, V82, P45, DOI 10.1038/ki.2012.43; Coaxum SD, 2009, BIOCHIM BIOPHYS ACTA, V1973, P1174; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; de Jonge MJA, 2006, SEMIN ONCOL, V33, P68, DOI 10.1053/j.seminoncol.2005.11.011; Flamant M, 2012, NEPHROL DIAL TRANSPL, V27, P1297, DOI 10.1093/ndt/gfs030; Gao S, 2013, CANCER LETT, V333, P36, DOI 10.1016/j.canlet.2012.12.029; Hanigan Marie H, 2003, Cancer Ther, V1, P47; He S, 2013, AM J PHYSIOL-RENAL, V304, pF356, DOI 10.1152/ajprenal.00553.2012; Hirai Y, 2012, AM J PHYSIOL-RENAL, V302, pF244, DOI 10.1152/ajprenal.00113.2011; Hise MK, 2001, NEPHRON, V88, P71, DOI 10.1159/000045962; HOMMA T, 1995, J CLIN INVEST, V96, P1018, DOI 10.1172/JCI118087; Humanes B, 2012, KIDNEY INT, V82, P652, DOI 10.1038/ki.2012.199; Hwang IG, 2012, INVEST NEW DRUG, V30, P2371, DOI 10.1007/s10637-012-9792-z; Iyoda M, 2011, J AM SOC NEPHROL, V22, P1486, DOI 10.1681/ASN.2010111158; Jiang M, 2006, ONCOGENE, V25, P4056, DOI 10.1038/sj.onc.1209440; Jo SK, 2005, KIDNEY INT, V67, P458, DOI 10.1111/j.1523-1755.2005.67102.x; Kaushal GP, 2001, KIDNEY INT, V60, P1726, DOI 10.1046/j.1523-1755.2001.00026.x; Kim YK, 2005, J APPL TOXICOL, V25, P374, DOI 10.1002/jat.1081; Kuwana H, 2008, KIDNEY INT, V73, P430, DOI 10.1038/sj.ki.5002702; Lee JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048532; Maeda Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058775; Martins RG, 2013, J CLIN ONCOL, V31, P1415, DOI 10.1200/JCO.2012.46.3299; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Morigi M, 2010, STEM CELLS, V28, P513, DOI 10.1002/stem.293; Nakagawa T, 1997, KIDNEY INT, V51, P1774, DOI 10.1038/ki.1997.244; Nowak G, 2002, J BIOL CHEM, V277, P43377, DOI 10.1074/jbc.M206373200; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Perol M, 2012, J CLIN ONCOL, V30, P3516, DOI 10.1200/JCO.2011.39.9782; Sakai M, 1997, J CLIN INVEST, V99, P2128, DOI 10.1172/JCI119386; Santarpia L, 2012, EXPERT OPIN THER TAR, V16, P103, DOI 10.1517/14728222.2011.645805; Schrier RW, 2002, J CLIN INVEST, V110, P743, DOI 10.1172/JCI200216568; Singh AB, 2005, CELL SIGNAL, V17, P1183, DOI 10.1016/j.cellsig.2005.03.026; Sorensen OE, 2006, J CLIN INVEST, V116, P1878, DOI 10.1172/JCI28422; Tang JH, 2013, AM J PATHOL, V183, P160, DOI 10.1016/j.ajpath.2013.04.005; Tang JH, 2013, KIDNEY INT, V83, P804, DOI 10.1038/ki.2012.435; Terada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080850; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Zhuang SG, 2004, AM J PHYSIOL-RENAL, V287, pF365, DOI 10.1152/ajprenal.00035.2004; Zhuang SG, 2012, J CELL PHYSIOL, V227, P2138, DOI 10.1002/jcp.22946	46	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111728	10.1371/journal.pone.0111728	http://dx.doi.org/10.1371/journal.pone.0111728			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390346	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400031
J	Bennmann, D; Horstkorte, R; Hofmann, B; Jacobs, K; Navarrete-Santos, A; Simm, A; Bork, K; Gnanapragassam, VS				Bennmann, Dorit; Horstkorte, Ruediger; Hofmann, Britt; Jacobs, Kathleen; Navarrete-Santos, Alexander; Simm, Andreas; Bork, Kaya; Gnanapragassam, Vinayaga S.			Advanced Glycation Endproducts Interfere with Adhesion and Neurite Outgrowth	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; ALZHEIMERS-DISEASE; END-PRODUCTS; PC12 CELLS; MAILLARD REACTION; PHOSPHORYLATION; IDENTIFICATION; GERONTOTOXINS; ACTIVATION; BIOMARKERS	Advanced glycation endproducts (AGEs) represent a non-enzymatic posttranslational protein modification. AGEs are generated by a series of chemical reactions of free reducing monosaccharides, such as glucose, fructose or metabolites of the monosaccharide metabolism with amino groups of proteins. After oxidation, dehydration and condensation, stable AGE-modifications are formed. AGE-modified proteins accumulate in all cells and tissues as a normal feature of ageing and correlate with the glucose concentration in the blood. AGEs are increased in diabetic patients and play a significant role in the pathogenesis of most age-related neural disorders, such as Alzheimer's disease. We examined the role of AGEs on neurite outgrowth of PC12 cells. We induced the formation of AGEs using the reactive carbonyl compound methylglyoxal (MGO) as a physiological metabolite of glucose. We found that AGE-modification of laminin or collagen interfered with adhesion but not with neurite outgrowth of PC12 cells. Furthermore, the AGE-modification of PC12 cell proteins reduced NGF-induced neurite outgrowth. In conclusion, our data show that AGEs negatively influence neural plasticity.	[Bennmann, Dorit; Horstkorte, Ruediger; Bork, Kaya; Gnanapragassam, Vinayaga S.] Univ Halle Wittenberg, Inst Physiol Chem, D-06108 Halle, Saale, Germany; [Hofmann, Britt; Jacobs, Kathleen; Navarrete-Santos, Alexander; Simm, Andreas] Univ Hosp, Dept Cardiothorac Surg, Halle, Saale, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Gnanapragassam, VS (corresponding author), Univ Halle Wittenberg, Inst Physiol Chem, D-06108 Halle, Saale, Germany.	vinayaga.gnanapragassam@medizin.uni-halle.de			Medical Faculty of the Martin-Luther-University (Roux-TIF)	Medical Faculty of the Martin-Luther-University (Roux-TIF)	The authors received funding by the Medical Faculty of the Martin-Luther-University (Roux-TIF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari NA, 2011, DIS MARKERS, V30, P317, DOI [10.3233/DMA-2011-0791, 10.1155/2011/718694]; Colaco CALS, 1996, NEPHROL DIAL TRANSPL, V11, P7; Gasser A, 2008, PROTEIN PEPTIDE LETT, V15, P385, DOI 10.2174/092986608784246515; Gems D, 2005, MECH AGEING DEV, V126, P381, DOI 10.1016/j.mad.2004.09.001; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Heidland A, 1998, Przegl Lek, V55 Suppl 1, P29; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; KAPLAN DR, 1994, J NEUROBIOL, V25, P1404, DOI 10.1002/neu.480251108; KIM UH, 1991, J BIOL CHEM, V266, P1359; Kontou M, 2008, NEUROREPORT, V19, P1239, DOI 10.1097/WNR.0b013e32830b368a; Kovacic U, 2009, INT REV NEUROBIOL, V87, P465, DOI 10.1016/S0074-7742(09)87026-8; Krautwald M, 2010, EXP GERONTOL, V45, P744, DOI 10.1016/j.exger.2010.03.001; LABATROBERT J, 1988, EXP GERONTOL, V23, P5, DOI 10.1016/0531-5565(88)90015-0; Loske C, 1998, J NEURAL TRANSM, V105, P1005, DOI 10.1007/s007020050108; Monnier V.M., 1989, Progress in Clinical and Biological Research, V304, P1; MONNIER VM, 1981, SCIENCE, V211, P491, DOI 10.1126/science.6779377; Munch G, 2012, AMINO ACIDS, V42, P1221, DOI 10.1007/s00726-010-0777-y; Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016; Plantman S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/981695; Pollscheit J, 2012, J NEUROSCI RES, V90, P1577, DOI 10.1002/jnr.23038; Rahmadi A, 2011, CLIN CHEM LAB MED, V49, P385, DOI 10.1515/CCLM.2011.079; Requena V, 1996, MECH AGEING DEV, V89, P185, DOI 10.1016/0047-6374(96)01752-6; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; SMITH MA, 1995, NATURE, V374, P316, DOI 10.1038/374316b0; Srikanth V, 2011, NEUROBIOL AGING, V32, P763, DOI 10.1016/j.neurobiolaging.2009.04.016; Tan J, 2007, AM J CLIN NUTR, V86, P1502; Thorpe SR, 1996, DRUG AGING, V9, P69, DOI 10.2165/00002512-199609020-00001; TOMASELLI KJ, 1987, J CELL BIOL, V105, P2347, DOI 10.1083/jcb.105.5.2347; Yamagishi S, 2002, BIOCHEM BIOPH RES CO, V290, P973, DOI 10.1006/bbrc.2001.6312	29	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112115	10.1371/journal.pone.0112115	http://dx.doi.org/10.1371/journal.pone.0112115			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386903	gold, Green Published, Green Submitted			2022-12-27	WOS:000345250400041
J	Malik, P; Zuleger, N; de las Heras, JI; Saiz-Ros, N; Makarov, AA; Lazou, V; Meinke, P; Waterfall, M; Kelly, DA; Schirmer, EC				Malik, Poonam; Zuleger, Nikolaj; de las Heras, Jose I.; Saiz-Ros, Natalia; Makarov, Alexandr A.; Lazou, Vassiliki; Meinke, Peter; Waterfall, Martin; Kelly, David A.; Schirmer, Eric C.			NET23/STING Promotes Chromatin Compaction from the Nuclear Envelope	PLOS ONE			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; HUTCHINSON-GILFORD-PROGERIA; LAMIN-B RECEPTOR; DEACETYLASE 3 HDAC3; TRANSCRIPTIONAL REPRESSOR; TAIL DOMAIN; PROTEIN; MEMBRANE; BINDING; EMERIN	Changes in the peripheral distribution and amount of condensed chromatin are observed in a number of diseases linked to mutations in the lamin A protein of the nuclear envelope. We postulated that lamin A interactions with nuclear envelope transmembrane proteins (NETs) that affect chromatin structure might be altered in these diseases and so screened thirty-one NETs for those that promote chromatin compaction as determined by an increase in the number of chromatin clusters of high pixel intensity. One of these, NET23 (also called STING, MITA, MPYS, ERIS, Tmem173), strongly promoted chromatin compaction. A correlation between chromatin compaction and endogenous levels of NET23/STING was observed for a number of human cell lines, suggesting that NET23/STING may contribute generally to chromatin condensation. NET23/STING has separately been found to be involved in innate immune response signaling. Upon infection cells make a choice to either apoptose or to alter chromatin architecture to support focused expression of interferon genes and other response factors. We postulate that the chromatin compaction induced by NET23/STING may contribute to this choice because the cells expressing NET23/STING eventually apoptose, but the chromatin compaction effect is separate from this as the condensation was still observed when cells were treated with Z-VAD to block apoptosis. NET23/STING-induced compacted chromatin revealed changes in epigenetic marks including changes in histone methylation and acetylation. This indicates a previously uncharacterized nuclear role for NET23/STING potentially in both innate immune signaling and general chromatin architecture.	[Malik, Poonam; Zuleger, Nikolaj; de las Heras, Jose I.; Saiz-Ros, Natalia; Makarov, Alexandr A.; Lazou, Vassiliki; Meinke, Peter; Kelly, David A.; Schirmer, Eric C.] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland; [Malik, Poonam; Zuleger, Nikolaj; de las Heras, Jose I.; Saiz-Ros, Natalia; Makarov, Alexandr A.; Lazou, Vassiliki; Meinke, Peter; Kelly, David A.; Schirmer, Eric C.] Univ Edinburgh, Inst Cell Biol, Edinburgh, Midlothian, Scotland; [Waterfall, Martin] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh	Schirmer, EC (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland.	e.schirmer@ed.ac.uk	Meinke, Peter/AAS-9231-2021; Malik, Poonam/A-1756-2008	Meinke, Peter/0000-0003-3359-3837; Malik, Poonam/0000-0002-1733-722X; Schirmer, Eric/0000-0003-2635-1338	Wellcome Trust Senior Research Fellowship [076616, 095209, 077707]; Royal Society Research Fellowship [DH051766]; Royal Society Research Grant [RG090330]	Wellcome Trust Senior Research Fellowship(Wellcome Trust); Royal Society Research Fellowship(Royal Society of London); Royal Society Research Grant(Royal Society of London)	This work was supported by Wellcome Trust Senior Research Fellowship (076616 and 095209) to E.C.S., core funding to the Wellcome Trust Centre for Cell Biology (077707), and a Royal Society Research Fellowship (DH051766) and a Royal Society Research Grant (RG090330) to P.M. The funders had no role in the study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Abe T, 2013, MOL CELL, V50, P5, DOI 10.1016/j.molcel.2013.01.039; Andrulis ED, 2002, MOL CELL BIOL, V22, P8292, DOI 10.1128/MCB.22.23.8292-8301.2002; Berghe W.V., 2006, BIOCHEM PHARMACOL, V72, P1114, DOI DOI 10.1016/j.bcp.2006.07.012; Brown CR, 2008, GENE DEV, V22, P627, DOI 10.1101/gad.1632708; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; BURKE B, 1990, EXP CELL RES, V186, P169, DOI 10.1016/0014-4827(90)90223-W; Clements L, 2000, BIOCHEM BIOPH RES CO, V267, P709, DOI 10.1006/bbrc.1999.2023; Columbaro M, 2005, CELL MOL LIFE SCI, V62, P2669, DOI 10.1007/s00018-005-5318-6; de las Heras JI, 2013, NUCLEUS-PHILA, V4, P460, DOI 10.4161/nucl.26872; De Sandre-Giovannoli A, 2003, SCIENCE, DOI DOI 10.1126; Demmerle J, 2013, CHROMOSOME RES, V21, P765, DOI 10.1007/s10577-013-9381-9; Demmerle J, 2012, J BIOL CHEM, V287, P22080, DOI 10.1074/jbc.M111.325308; Ding B, 2012, PLANT CELL, V24, P3783, DOI 10.1105/tpc.112.101972; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fang TC, 2012, J EXP MED, V209, P661, DOI 10.1084/jem.20112343; Fidzianska A, 1998, J NEUROL SCI, V159, P88, DOI 10.1016/S0022-510X(98)00130-0; Filesi I, 2005, PHYSIOL GENOMICS, V23, P150, DOI 10.1152/physiolgenomics.00060.2005; Furukawa K, 1997, BIOCHEM BIOPH RES CO, V238, P240, DOI 10.1006/bbrc.1997.7235; Goldberg M, 1999, P NATL ACAD SCI USA, V96, P2852, DOI 10.1073/pnas.96.6.2852; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Guarda A, 2009, EXP CELL RES, V315, P1895, DOI 10.1016/j.yexcr.2009.01.019; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Haraguchi T, 2004, EUR J BIOCHEM, V271, P1035, DOI 10.1111/j.1432-1033.2004.04007.x; Hartel S, 2003, CYTOM PART A, V55A, P15, DOI 10.1002/cyto.a.10068; HIRSCHHORN R, 1971, CELL IMMUNOL, V2, P696, DOI 10.1016/0008-8749(71)90016-5; HOGER TH, 1991, EXP CELL RES, V197, P280, DOI 10.1016/0014-4827(91)90434-V; Holaska JM, 2003, J BIOL CHEM, V278, P6969, DOI 10.1074/jbc.M208811200; Huang L, 2013, J IMMUNOL, V191, P3509, DOI 10.4049/jimmunol.1301419; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kind J, 2013, CELL, V153, P178, DOI 10.1016/j.cell.2013.02.028; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Lattanzi G, 2007, J CELL BIOCHEM, V102, P1149, DOI 10.1002/jcb.21467; Lemos H, 2014, J IMMUNOL; Makatsori D, 2004, J BIOL CHEM, V279, P25567, DOI 10.1074/jbc.M313606200; Malik P, 2012, J BIOL CHEM, V287, P12277, DOI 10.1074/jbc.M111.331777; Malik P, 2010, CELL MOL LIFE SCI, V67, P1353, DOI 10.1007/s00018-010-0257-2; Maraldi NM, 2006, ADV ENZYME REGUL, V46, P33, DOI 10.1016/j.advenzreg.2006.01.001; Maraldi NM, 2011, J CELL BIOCHEM, V112, P979, DOI 10.1002/jcb.22992; Maraldi NM, 2002, ADV ENZYME REGUL, V42, P1, DOI 10.1016/S0065-2571(01)00022-X; Melcon G, 2006, HUM MOL GENET, V15, P637, DOI 10.1093/hmg/ddi479; MIRSKY AE, 1960, DIS NERV SYST, V21, P23; Ognibene A, 1999, MUSCLE NERVE, V22, P864, DOI 10.1002/(SICI)1097-4598(199907)22:7<864::AID-MUS8>3.3.CO;2-7; Ohba T, 2004, J CELL BIOL, V167, P1051, DOI 10.1083/jcb.200409149; Ohzeki J, 2012, EMBO J, V31, P2391, DOI 10.1038/emboj.2012.82; Patel DJ, 2013, ANNU REV BIOCHEM, V82, P81, DOI 10.1146/annurev-biochem-072711-165700; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Pindyurin AV, 2007, J CELL SCI, V120, P2344, DOI 10.1242/jcs.006007; Polioudaki H, 2001, EMBO REP, V2, P920, DOI 10.1093/embo-reports/kve199; Roger T, 2011, BLOOD, V117, P1205, DOI 10.1182/blood-2010-05-284711; Sabbattini P, 2014, MOL BIOL CELL, V25, P904, DOI 10.1091/mbc.E13-10-0628; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Schirmer EC, 2001, J CELL BIOL, V153, P479, DOI 10.1083/jcb.153.3.479; Sewry CA, 2001, NEUROPATH APPL NEURO, V27, P281, DOI 10.1046/j.0305-1846.2001.00323.x; Shimizu N, 1998, J CELL BIOL, V140, P1307, DOI 10.1083/jcb.140.6.1307; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Somech R, 2005, J CELL SCI, V118, P4017, DOI 10.1242/jcs.02521; SOULLAM B, 1993, J CELL BIOL, V120, P1093, DOI 10.1083/jcb.120.5.1093; SOULLAM B, 1995, J CELL BIOL, V130, P15, DOI 10.1083/jcb.130.1.15; Stender JD, 2013, CURR OPIN PHARMACOL, V13, P582, DOI 10.1016/j.coph.2013.06.002; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; TANIURA H, 1995, J CELL BIOL, V131, P33, DOI 10.1083/jcb.131.1.33; Toth KF, 2004, J CELL SCI, V117, P4277, DOI 10.1242/jcs.01293; Tsukahara T, 2002, MUSCLE NERVE, V25, P898, DOI 10.1002/mus.10085; Verga L, 2003, VIRCHOWS ARCH, V443, P664, DOI 10.1007/s00428-003-0865-4; Wang YX, 2006, HUM MOL GENET, V15, P2479, DOI 10.1093/hmg/ddl170; Williams RRE, 2006, J CELL SCI, V119, P132, DOI 10.1242/jcs.02727; Ye Q, 1996, J BIOL CHEM, V271, P14653, DOI 10.1074/jbc.271.25.14653; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zink D, 2004, J CELL BIOL, V166, P815, DOI 10.1083/jcb.200404107; Zuleger N, 2011, J CELL BIOL, V193, P109, DOI 10.1083/jcb.201009068; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035	75	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111851	10.1371/journal.pone.0111851	http://dx.doi.org/10.1371/journal.pone.0111851			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386906	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000345250400027
J	Park, JI; Frantz, MG; Kast, RJ; Chapman, KS; Dorton, HM; Stephany, CE; Arnett, MT; Herman, DH; McGee, AW				Park, Jennifer I.; Frantz, Michael G.; Kast, Ryan J.; Chapman, Katherine S.; Dorton, Hilary M.; Stephany, Celeste-Elise; Arnett, Megan T.; Herman, David H.; McGee, Aaron W.			Nogo Receptor 1 Limits Tactile Task Performance Independent of Basal Anatomical Plasticity	PLOS ONE			English	Article							LONG-TERM; STRUCTURAL PLASTICITY; SYNAPTIC PLASTICITY; NEURONAL CIRCUITS; REGENERATION; RECOVERY; CORTEX; MYELIN; NEOCORTEX; PROTEINS	The genes that govern how experience refines neural circuitry and alters synaptic structural plasticity are poorly understood. The nogo-66 receptor 1 gene (ngr1) is one candidate that may restrict the rate of learning as well as basal anatomical plasticity in adult cerebral cortex. To investigate if ngr1 limits the rate of learning we tested adult ngr1 null mice on a tactile learning task. Ngr1 mutants display greater overall performance despite a normal rate of improvement on the gap-cross assay, a whisker-dependent learning paradigm. To determine if ngr1 restricts basal anatomical plasticity in the associated sensory cortex, we repeatedly imaged dendritic spines and axonal varicosities of both constitutive and conditional adult ngr1 mutant mice in somatosensory barrel cortex for two weeks through cranial windows with two-photon chronic in vivo imaging. Neither constant nor acute deletion of ngr1 affected turnover or stability of dendritic spines or axonal boutons. The improved performance on the gap-cross task is not attributable to greater motor coordination, as ngr1 mutant mice possess a mild deficit in overall performance and a normal learning rate on the rotarod, a motor task. Mice lacking ngr1 also exhibit normal induction of tone-associated fear conditioning yet accelerated fear extinction and impaired consolidation. Thus, ngr1 alters tactile and motor task performance but does not appear to limit the rate of tactile or motor learning, nor determine the low set point for synaptic turnover in sensory cortex.	[Park, Jennifer I.; Frantz, Michael G.; Kast, Ryan J.; Chapman, Katherine S.; Dorton, Hilary M.; Stephany, Celeste-Elise; Arnett, Megan T.; McGee, Aaron W.] Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles, Dev Neurosci Program,Saban Res Inst,Dept Pediat, Los Angeles, CA 90027 USA; [Herman, David H.] Univ So Calif, Dept Biol Sci, Neurobiol Sect, Los Angeles, CA 90089 USA	Children's Hospital Los Angeles; University of Southern California; University of Southern California	McGee, AW (corresponding author), Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles, Dev Neurosci Program,Saban Res Inst,Dept Pediat, Los Angeles, CA 90027 USA.	amcgee@usc.edu		Stephany, Celeste-Elise/0000-0001-9997-5745	National Eye Institute [1R01EY021580]; National Institute of Neurological Disorder and Stroke [5R21NS077288]; Research Development Career Award from Children's Hospital Los Angeles; Biological Sciences (CABS) from the Burroughs Wellcome Fund; NATIONAL EYE INSTITUTE [R01EY021580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS077288] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Neurological Disorder and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Research Development Career Award from Children's Hospital Los Angeles; Biological Sciences (CABS) from the Burroughs Wellcome Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research is supported by the National Eye Institute (1R01EY021580), the National Institute of Neurological Disorder and Stroke (5R21NS077288) and a Research Development Career Award from Children's Hospital Los Angeles. AWM is the recipient of a Career Award in the Biological Sciences (CABS) from the Burroughs Wellcome Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbik F, 2012, EXP NEUROL, V235, P43, DOI 10.1016/j.expneurol.2011.06.006; Akbik FV, 2013, NEURON, V77, P859, DOI 10.1016/j.neuron.2012.12.027; Barrette B, 2007, MOL CELL NEUROSCI, V34, P519, DOI 10.1016/j.mcn.2006.12.004; Bridge KE, 2009, NEUROBIOL AGING, V30, P309, DOI 10.1016/j.neurobiolaging.2007.06.002; Celikel T, 2007, P NATL ACAD SCI USA, V104, P1395, DOI 10.1073/pnas.0610267104; Chong SYC, 2012, P NATL ACAD SCI USA, V109, P1299, DOI 10.1073/pnas.1113540109; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Dodd DA, 2005, J BIOL CHEM, V280, P12494, DOI 10.1074/jbc.M411827200; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Harris JA, 1999, P NATL ACAD SCI USA, V96, P7587, DOI 10.1073/pnas.96.13.7587; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; He ZG, 2004, ANNU REV NEUROSCI, V27, P341, DOI 10.1146/annurev.neuro.27.070203.144340; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196, DOI 10.1152/jn.1986.56.4.1196; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Keck T, 2008, NAT NEUROSCI, V11, P1162, DOI 10.1038/nn.2181; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Kuhlman SJ, 2014, J NEUROSCI, V34, P6078, DOI 10.1523/JNEUROSCI.4919-12.2014; Lai CSW, 2012, NATURE, V483, P87, DOI 10.1038/nature10792; Lebron-Milad K, 2012, BIOL MOOD ANXIETY DI, V2, DOI [10.1186/2045-5380-2-7, 10.1186/2045-5380-2-3]; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Milad MR, 2009, NEUROSCIENCE, V164, P887, DOI 10.1016/j.neuroscience.2009.09.011; Mostany R, 2013, J NEUROSCI, V33, P4094, DOI 10.1523/JNEUROSCI.4825-12.2013; Padmashri R, 2013, J NEUROSCI, V33, P19715, DOI 10.1523/JNEUROSCI.2514-13.2013; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Sato M, 2008, J NEUROSCI, V28, P10278, DOI 10.1523/JNEUROSCI.2451-08.2008; Smith SL, 2007, NAT NEUROSCI, V10, P370, DOI 10.1038/nn1844; Stephany CE, 2014, J NEUROSCI, V34, P11631, DOI 10.1523/JNEUROSCI.0545-14.2014; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Voigts J, 2008, J NEUROPHYSIOL, V100, P504, DOI 10.1152/jn.00012.2008; Voikar V, 2001, PHYSIOL BEHAV, V72, P271, DOI 10.1016/S0031-9384(00)00405-4; Wang XX, 2011, ANN NEUROL, V70, P805, DOI 10.1002/ana.22527; Wang XX, 2002, J NEUROSCI, V22, P5505; Wilbrecht L, 2010, J NEUROSCI, V30, P4927, DOI 10.1523/JNEUROSCI.6403-09.2010; Wills ZP, 2012, NEURON, V73, P466, DOI 10.1016/j.neuron.2011.11.029; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2010, NAT PROTOC, V5, P201, DOI 10.1038/nprot.2009.222; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	51	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112678	10.1371/journal.pone.0112678	http://dx.doi.org/10.1371/journal.pone.0112678			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386856	Green Submitted, Green Published, gold			2022-12-27	WOS:000345250400082
J	Zhao, W; Shi, XZ; Li, JN; Guo, W; Liu, CB; Chen, X				Zhao, Wei; Shi, Xiaozheng; Li, Jiangnan; Guo, Wei; Liu, Chengbai; Chen, Xia			Genetic, Epigenetic, and HPLC Fingerprint Differentiation between Natural and Ex Situ Populations of Rhodiola sachalinensis from Changbai Mountain, China	PLOS ONE			English	Article							DNA METHYLATION; PLANT; ADAPTATION; DIVERSITY; FLOW; CHROMATOGRAPHY; CONSERVATION; EXTINCTION; PATTERNS; RISK	Rhodiola sachalinensis is an endangered species with important medicinal value. We used inter-simple sequence repeat (ISSR) and methylation-sensitive amplified polymorphism (MSAP) markers to analyze genetic and epigenetic differentiation in different populations of R. sachalinensis, including three natural populations and an ex situ population. Chromatographic fingerprint was used to reveal HPLC fingerprint differentiation. According to our results, the ex situ population of R. sachalinensis has higher level genetic diversity and greater HPLC fingerprint variation than natural populations, but shows lower epigenetic diversity. Most genetic variation (54.88%) was found to be distributed within populations, and epigenetic variation was primarily distributed among populations (63.87%). UPGMA cluster analysis of ISSR and MSAP data showed identical results, with individuals from each given population grouping together. The results of UPGMA cluster analysis of HPLC fingerprint patterns was significantly different from results obtained from ISSR and MSAP data. Correlation analysis revealed close relationships among altitude, genetic structure, epigenetic structure, and HPLC fingerprint patterns (R-2 = 0.98 for genetic and epigenetic distance; R-2 = 0.90 for DNA methylation level and altitude; R-2 = -0.95 for HPLC fingerprint and altitude). Taken together, our results indicate that ex situ population of R. sachalinensis show significantly different genetic and epigenetic population structures and HPLC fingerprint patterns. Along with other potential explanations, these findings suggest that the ex situ environmental factors caused by different altitude play an important role in keeping hereditary characteristic of R. sachalinensis.	[Zhao, Wei; Li, Jiangnan; Guo, Wei; Liu, Chengbai; Chen, Xia] Jilin Univ, Sch Life Sci, Natl & Local United Engn Lab Chinese Herbal Med B, Changchun 130023, Jilin, Peoples R China; [Shi, Xiaozheng] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130023, Jilin, Peoples R China; [Zhao, Wei; Shi, Xiaozheng; Li, Jiangnan; Guo, Wei; Liu, Chengbai; Chen, Xia] Jilin Univ, Sch Life Sci, Changchun 130023, Jilin, Peoples R China; [Zhao, Wei; Guo, Wei] Changbai Mt Acad Sci, Inst Bot, Erdao, Jilin, Peoples R China	Jilin University; Jilin University; Jilin University	Chen, X (corresponding author), Jilin Univ, Sch Life Sci, Natl & Local United Engn Lab Chinese Herbal Med B, Changchun 130023, Jilin, Peoples R China.	chenxiajlu@163.com	chen, xia/GXM-5435-2022		Project for Wildlife Conservation and Management of the National Forestry Bureau of China; Program for Science and Technology Support of Jilin; National Special Research Foundation for the Earthquake Industry of China [201208005]	Project for Wildlife Conservation and Management of the National Forestry Bureau of China; Program for Science and Technology Support of Jilin; National Special Research Foundation for the Earthquake Industry of China	This study was supported by the Project for Wildlife Conservation and Management of the National Forestry Bureau of China (No relevent grant number was provided when we applied for this fund.), the Program for Science and Technology Support of Jilin, and the National Special Research Foundation for the Earthquake Industry of China (Grant number: 201208005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, MOL BIOL BIOTECHNOLO; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Bijlsma R, 2000, J EVOLUTION BIOL, V13, P502, DOI 10.1046/j.1420-9101.2000.00177.x; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; Boyko A, 2008, ENVIRON MOL MUTAGEN, V49, P61, DOI 10.1002/em.20347; Cervera MT, 2002, MOL GENET GENOMICS, V268, P543, DOI 10.1007/s00438-002-0772-4; [段传人 Duan Chuanren], 2003, [重庆大学学报. 自然科学版, Journal of Chongqing University(Natural Science Edition)], V26, P67; Dyachenko OV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P461, DOI 10.1134/S000629790604016X; EXCOFFIER L, 1992, GENETICS, V131, P479; Falconer D. S., 1996, INTRO QUANTITATIVE G; Falk DA, 1991, GENETICS CONSERVATIO; Frankham R, 2008, MOL ECOL, V17, P325, DOI 10.1111/j.1365-294X.2007.03399.x; FU LG, 1992, RED BOOK CHINESE PLA; Gao LX, 2010, PLANT CELL ENVIRON, V33, P1820, DOI 10.1111/j.1365-3040.2010.02186.x; Gu M, 2004, J CHROMATOGR A, V1022, P139, DOI 10.1016/j.chroma.2003.09.038; Hamrick J.L., 1989, PLANT POPULATION GEN; Herrera CM, 2011, MOL ECOL, V20, P1675, DOI 10.1111/j.1365-294X.2011.05026.x; Hou Y, 2014, J HERED, V105, P101, DOI 10.1093/jhered/est072; Huang S, 2000, CHINESE BIODIVERSITY, V4, P359; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Kalisz S, 2004, TRENDS ECOL EVOL, V19, P309, DOI 10.1016/j.tree.2004.03.034; Labra M, 2002, PLANT BIOLOGY, V4, P694, DOI 10.1055/s-2002-37398; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Li QM, 2002, BIOL CONSERV, V106, P151, DOI 10.1016/S0006-3207(01)00240-3; Li TL, 2007, PHYTOMEDICINE, V14, P601, DOI 10.1016/j.phymed.2006.12.016; Liang YZ, 2004, J CHROMATOGR B, V812, P53, DOI 10.1016/j.jchromb.2004.08.041; Lin MJ, 2005, J BIOL CHEM, V280, P861, DOI 10.1074/jbc.C400477200; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; Ma XC, 2014, PHARM CROPS, V5, P1, DOI DOI 10.2174/2210290601405010001; Maxted N., 1997, PLANT GENETIC CONSER; MCDERMOTT JM, 1993, ANNU REV PHYTOPATHOL, V31, P353, DOI 10.1146/annurev.py.31.090193.002033; Mirouze M, 2011, CURR OPIN PLANT BIOL, V14, P267, DOI 10.1016/j.pbi.2011.03.004; Nakamura S, 2007, CHEM PHARM BULL, V55, P1505, DOI 10.1248/cpb.55.1505; Navascues M, 2007, FOREST ECOL MANAG, V244, P122, DOI 10.1016/j.foreco.2007.04.009; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NEI M, 1978, GENETICS, V89, P583; Nybom Hilde, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P93, DOI 10.1078/1433-8319-00006; Paun O, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-113; Paun O, 2010, MOL BIOL EVOL, V27, P2465, DOI 10.1093/molbev/msq150; Pichersky E, 2000, TRENDS PLANT SCI, V5, P439, DOI 10.1016/S1360-1385(00)01741-6; Rafii ZA, 1998, BIOCHEM SYST ECOL, V26, P441, DOI 10.1016/S0305-1978(97)00125-7; Rapp RA, 2005, NEW PHYTOL, V168, P81, DOI 10.1111/j.1469-8137.2005.01491.x; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Rohlf FJ, 1997, NTSYS PC VERSION 2 0; Sakthivel K, 2010, EUPHYTICA, V175, P303, DOI 10.1007/s10681-010-0167-2; Schellenbaum P, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-78; SFDA. State Drug Administration of China, 2000, CHIN TRADIT PAT MED, V22, P671; Shepherdson D., 1994, P167; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; van Beek TA, 2002, J CHROMATOGR A, V967, P21, DOI 10.1016/S0021-9673(02)00172-3; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang Yang, 2003, Journal of Plant Physiology and Molecular Biology, V29, P357; Wolf DE, 2001, CONSERV BIOL, V15, P1039, DOI 10.1046/j.1523-1739.2001.0150041039.x; Wu WC, 1987, CHANGBAI MOUNTAIN RA; Yan TF, 2003, CONSERV GENET, V4, P213, DOI 10.1023/A:1023342723814; [阎秀峰 Yan Xiufeng], 2004, [生态学报, Acta Ecologica Sinica], V24, P674; Zhang XY, 2008, SCIENCE, V320, P489, DOI 10.1126/science.1153996; Zhang ZQ, 2011, FLORA, V206, P567, DOI 10.1016/j.flora.2011.01.008; Zhou GB, 2007, J CHROMATOGR A, V1142, P236, DOI 10.1016/j.chroma.2006.12.093; Zhu XF, 2010, BIOL LETTERS, V6, P785, DOI 10.1098/rsbl.2010.0345	60	15	15	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112869	10.1371/journal.pone.0112869	http://dx.doi.org/10.1371/journal.pone.0112869			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386983	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400098
J	Zhao, YJ; Kang, BW; Liu, YW; Li, YC; Shi, GQ; Shen, T; Jiang, Y; Zhang, M; Zhou, MG; Wang, LM				Zhao, Yinjun; Kang, Bowei; Liu, Yawen; Li, Yichong; Shi, Guoqing; Shen, Tao; Jiang, Yong; Zhang, Mei; Zhou, Maigeng; Wang, Limin			Health Insurance Coverage and Its Impact on Medical Cost: Observations from the Floating Population in China	PLOS ONE			English	Article							OUT-OF-POCKET; MIGRANT WORKERS; CARE	Background: China has the world's largest floating (migrant) population, which has characteristics largely different from the rest of the population. Our goal is to study health insurance coverage and its impact on medical cost for this population. Methods: A telephone survey was conducted in 2012. 644 subjects were surveyed. Univariate and multivariate analysis were conducted on insurance coverage and medical cost. Results: 82.2% of the surveyed subjects were covered by basic insurance at hometowns with hukou or at residences. Subjects' characteristics including age, education, occupation, and presence of chronic diseases were associated with insurance coverage. After controlling for confounders, insurance coverage was not significantly associated with gross or out-of-pocket medical cost. Conclusion: For the floating population, health insurance coverage needs to be improved. Policy interventions are needed so that health insurance can have a more effective protective effect on cost.	[Zhao, Yinjun; Li, Yichong; Jiang, Yong; Zhang, Mei; Zhou, Maigeng; Wang, Limin] Natl Ctr Chron & Noncommunicable Dis Control & Pr, Dept Risk Factor Surveillance, Beijing, Peoples R China; [Kang, Bowei] China Life Insurance Co Ltd, Actuarial Dept, Beijing, Peoples R China; [Liu, Yawen] Univ Int Business & Econ, Sch Stat, Beijing, Peoples R China; [Shi, Guoqing; Shen, Tao] Chinese Ctr Dis Control & Prevent, Dept Educ & Training, Chinese Field Epidemiol Training Program, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; China Life Insurance; University of International Business & Economics; Chinese Center for Disease Control & Prevention	Zhou, MG (corresponding author), Natl Ctr Chron & Noncommunicable Dis Control & Pr, Dept Risk Factor Surveillance, Beijing, Peoples R China.	maigengzhou@126.com; wlm65@126.com	Li, Yichong/A-3559-2019; Zhou, Maigeng/HCH-7703-2022; JIANG, Yong/GYU-9887-2022	Li, Yichong/0000-0003-3842-475X; JIANG, Yong/0000-0001-7700-6054; Kang, Bowei/0000-0001-9093-359X	Special Funding for Public Health of China Medical Reform Project	Special Funding for Public Health of China Medical Reform Project	This study was funded by Special Funding for Public Health of China Medical Reform Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao Q, 2012, INT J HEALTH SERV, V42, P177, DOI 10.2190/HS.42.2.b; Dou C, 2009, CHINA OCCUPATIONAL M, V4, P28; Du P., 2007, POPULATION J, P3; Fang KN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039157; Giles J, 2013, RES LABOR ECON, V37, P123, DOI 10.1108/S0147-9121(2013)0000037009; Gong P, 2012, LANCET, V379, P843, DOI 10.1016/S0140-6736(11)61878-3; Gu CL, 2006, PROG PLANN, V66, P249, DOI 10.1016/j.progress.2006.10.001; Hesketh T, 2008, PUBLIC HEALTH REP, V123, P189, DOI 10.1177/003335490812300211; Hong Yan, 2006, World Health Popul, V8, P22; Nguyen KT, 2012, AM J PUBLIC HEALTH, V102, P1450, DOI 10.2105/AJPH.2011.300618; Nguyen KT, 2012, SOC SCI MED, V74, P724, DOI 10.1016/j.socscimed.2011.10.027; Li L, 2007, SOC PSYCH PSYCH EPID, V42, P716, DOI 10.1007/s00127-007-0221-0; Liang Z, 2013, CONTEMP SOCIOL, V42, P860; Lin L, 2009, MULTILEVEL ANAL DETE; Liu YL, 2004, HEALTH POLICY PLANN, V19, P159, DOI 10.1093/heapol/czh019; Lu CL, 2009, B WORLD HEALTH ORGAN, V87, P238, DOI 10.2471/BLT.08.054379; Ma LJC, 1998, CHINA QUART, P546, DOI 10.1017/S0305741000049997; Mou J, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-214; National Bureau of Statistics of China, 2001, CHIN STAT YB; Nielsen I, 2005, GLOB SOC POLICY, V5, P353, DOI 10.1177/1468018105057416; Roger JP, 2007, AM J PUBLIC HEALTH, V97, P804, DOI 10.2105/AJPH.2005.080184; Wang H, 2005, HEALTH POLICY PLANN, V20, P366, DOI 10.1093/heapol/czi045; WANG Y, 2013, PLOS ONE, V2013; You X, 2011, APPL HEALTH ECON HEA, V9, P39, DOI 10.2165/11530730-000000000-00000	24	41	41	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111555	10.1371/journal.pone.0111555	http://dx.doi.org/10.1371/journal.pone.0111555			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT9MC	25386914	Green Submitted, gold, Green Published			2022-12-27	WOS:000345250400020
J	Maggioni, E; Arrubla, J; Warbrick, T; Dammers, J; Bianchi, AM; Reni, G; Tosetti, M; Neuner, I; Shah, NJ				Maggioni, Eleonora; Arrubla, Jorge; Warbrick, Tracy; Dammers, Juergen; Bianchi, Anna M.; Reni, Gianluigi; Tosetti, Michela; Neuner, Irene; Shah, N. Jon			Removal of Pulse Artefact from EEG Data Recorded in MR Environment at 3T. Setting of ICA Parameters for Marking Artefactual Components: Application to Resting-State Data	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; BALLISTOCARDIOGRAM ARTIFACTS; TASK DEMANDS; HUMAN BRAIN; FMRI DATA; NETWORKS; DYNAMICS; SCANNER; OSCILLATIONS; INTEGRATION	Simultaneous electroencephalography (EEG) and functional magnetic resonance imaging (fMRI) allow for a non-invasive investigation of cerebral functions with high temporal and spatial resolution. The main challenge of such integration is the removal of the pulse artefact (PA) that affects EEG signals recorded in the magnetic resonance (MR) scanner. Often applied techniques for this purpose are Optimal Basis Set (OBS) and Independent Component Analysis (ICA). The combination of OBS and ICA is increasingly used, since it can potentially improve the correction performed by each technique separately. The present study is focused on the OBS-ICA combination and is aimed at providing the optimal ICA parameters for PA correction in resting-state EEG data, where the information of interest is not specified in latency and amplitude as in, for example, evoked potential. A comparison between two intervals for ICA calculation and four methods for marking artefactual components was performed. The performance of the methods was discussed in terms of their capability to 1) remove the artefact and 2) preserve the information of interest. The analysis included 12 subjects and two resting-state datasets for each of them. The results showed that none of the signal lengths for the ICA calculation was highly preferable to the other. Among the methods for the identification of PA-related components, the one based on the wavelets transform of each component emerged as the best compromise between the effectiveness in removing PA and the conservation of the physiological neuronal content.	[Maggioni, Eleonora; Arrubla, Jorge; Warbrick, Tracy; Dammers, Juergen; Neuner, Irene; Shah, N. Jon] Forschungszentrum Julich, Inst Neurosci & Med 4, D-52425 Julich, Germany; [Maggioni, Eleonora; Bianchi, Anna M.] Politecn Milan, Dept Elect Informat & Bioengn, I-20133 Milan, Italy; [Maggioni, Eleonora; Reni, Gianluigi] Sci Inst IRCCS E Medea, Bioengn Lab, Bosisio Parini, Italy; [Arrubla, Jorge; Neuner, Irene] Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Tosetti, Michela] IRCCS Fdn Stella Maris, Lab Med Phys & Magnet Resonance Technol, Pisa, Italy; [Neuner, Irene; Shah, N. Jon] Rhein Westfal TH Aachen, JARA BRAIN Translat Med, Aachen, Germany; [Shah, N. Jon] Rhein Westfal TH Aachen, JARA, Fac Med, Dept Neurol, Aachen, Germany	Helmholtz Association; Research Center Julich; Polytechnic University of Milan; IRCCS Eugenio Medea; RWTH Aachen University; IRCCS Fondazione Stella Maris; RWTH Aachen University; RWTH Aachen University	Maggioni, E (corresponding author), Forschungszentrum Julich, Inst Neurosci & Med 4, D-52425 Julich, Germany.	e.maggioni@fz-juelich.de	Tosetti, Michela/K-5749-2016; Bianchi, Anna M./AAA-4258-2020; Reni, Gianluigi/L-7781-2015; Shah, N. Jon/H-5849-2013; Dammers, Jürgen/I-1485-2013; Maggioni, Eleonora/AAC-6040-2019	Tosetti, Michela/0000-0002-2515-7560; Reni, Gianluigi/0000-0003-0822-3287; Shah, N. Jon/0000-0002-8151-6169; Dammers, Jürgen/0000-0003-1526-6592; Maggioni, Eleonora/0000-0003-4331-4029; Bianchi, Anna M./0000-0002-8290-7460; Neuner, Irene/0000-0002-5164-8873	Fondazione Cariplo [2010-0344]; EU FP7 project TRIMAGE [602621]	Fondazione Cariplo(Fondazione Cariplo); EU FP7 project TRIMAGE	Grant support of EM was provided by Fondazione Cariplo (project #2010-0344, ''Spider@Lecco''). JA, IN and NJS are also funded in part through the EU FP7 project TRIMAGE (Grant no. 602621). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; Babiloni F, 2005, NEUROIMAGE, V24, P118, DOI 10.1016/j.neuroimage.2004.09.036; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Briselli E, 2006, MAGN RESON IMAGING, V24, P393, DOI 10.1016/j.mri.2006.01.008; Britz J, 2010, NEUROIMAGE, V52, P1162, DOI 10.1016/j.neuroimage.2010.02.052; Comon P., 1992, Higher Order Statistics. Proceedings of the International Signal Processing Workshop, P29; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; Debener S, 2008, INT J PSYCHOPHYSIOL, V67, P189, DOI 10.1016/j.ijpsycho.2007.05.015; Debener S, 2007, NEUROIMAGE, V34, P587, DOI 10.1016/j.neuroimage.2006.09.031; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Grech R, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-25; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Grouiller F, 2007, NEUROIMAGE, V38, P124, DOI 10.1016/j.neuroimage.2007.07.025; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Huiskamp G, 2006, C P IEEE ENG MED BIO, V4, P3691; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Laufs H, 2006, NEUROIMAGE, V31, P1408, DOI 10.1016/j.neuroimage.2006.02.002; Laufs H, 2008, HUM BRAIN MAPP, V29, P762, DOI 10.1002/hbm.20600; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Lei X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024642; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; Mullinger KJ, 2013, NEUROIMAGE, V71, P75, DOI 10.1016/j.neuroimage.2012.12.070; Nakamura W, 2006, IEEE T BIO-MED ENG, V53, P1294, DOI 10.1109/TBME.2006.875718; Neuner I, 2013, NEUROIMAGE IN PRESS; Neuner I, 2013, NEUROIMAGE, V68, P214, DOI 10.1016/j.neuroimage.2012.11.064; Niazy RK, 2005, NEUROIMAGE, V28, P720, DOI 10.1016/j.neuroimage.2005.06.067; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P91; Raichle ME, 2006, SCIENCE, V314, P1249, DOI 10.1126/science.1134405; Rosa MJ, 2010, NEUROIMAGE, V49, P1496, DOI 10.1016/j.neuroimage.2009.09.011; Srivastava G, 2005, NEUROIMAGE, V24, P50, DOI 10.1016/j.neuroimage.2004.09.041; Vanderperren K., 2007, INT J BIOELECTROMAGN, V9, P146; Vanderperren K, 2010, NEUROIMAGE, V50, P920, DOI 10.1016/j.neuroimage.2010.01.010; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Warbrick T, 2014, J COGNITIVE NEUROSCI, V26, P529, DOI 10.1162/jocn_a_00490; Warbrick T, 2013, NEUROIMAGE, V77, P177, DOI 10.1016/j.neuroimage.2013.03.026; Zijlmans M, 2007, BRAIN, V130, P2343, DOI 10.1093/brain/awm141	40	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112147	10.1371/journal.pone.0112147	http://dx.doi.org/10.1371/journal.pone.0112147			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383625	gold, Green Published, Green Submitted			2022-12-27	WOS:000344816700034
J	Markovetz, MR; Corcoran, TE; Locke, LW; Myerburg, MM; Pilewski, JM; Parker, RS				Markovetz, Matthew R.; Corcoran, Timothy E.; Locke, Landon W.; Myerburg, Michael M.; Pilewski, Joseph M.; Parker, Robert S.			A Physiologically-Motivated Compartment-Based Model of the Effect of Inhaled Hypertonic Saline on Mucociliary Clearance and Liquid Transport in Cystic Fibrosis	PLOS ONE			English	Article							IN-VITRO; BRONCHIAL-MUCOSA; AIRWAY; TC-99M-DTPA; DISPOSITION; ABSORPTION; IVACAFTOR; DELIVERY; CHANNEL; DISEASE	Background: Cystic Fibrosis (CF) lung disease is characterized by liquid hyperabsorption, airway surface dehydration, and impaired mucociliary clearance (MCC). Herein, we present a compartment-based mathematical model of the airway that extends the resolution of functional imaging data. Methods: Using functional imaging data to inform our model, we developed a system of mechanism-motivated ordinary differential equations to describe the mucociliary clearance and absorption of aerosolized radiolabeled particle and small molecules probes from human subjects with and without CF. We also utilized a novel imaging metric in vitro to gauge the fraction of airway epithelial cells that have functional ciliary activity. Results: This model, and its incorporated kinetic rate parameters, captures the MCC and liquid dynamics of the hyperabsorptive state in CF airways and the mitigation of that state by hypertonic saline treatment. Conclusions: We postulate, based on the model structure and its ability to capture clinical patient data, that patients with CF have regions of airway with diminished MCC function that can be recruited with hypertonic saline treatment. In so doing, this model structure not only makes a case for durable osmotic agents used in lung-region specific treatments, but also may provide a possible clinical endpoint, the fraction of functional ciliated airway.	[Markovetz, Matthew R.; Corcoran, Timothy E.; Parker, Robert S.] Univ Pittsburgh, Swanson Sch Engn, Dept Chem & Petr Engn, Pittsburgh, PA 15260 USA; [Corcoran, Timothy E.; Locke, Landon W.; Myerburg, Michael M.; Pilewski, Joseph M.] Univ Pittsburgh, Pittsburgh, PA USA; [Parker, Robert S.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Parker, Robert S.] Univ Pittsburgh, Clin Res Invest & Syst Modeling Acute Illness CRI, Pittsburgh, PA USA; [Parker, Robert S.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Corcoran, Timothy E.] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Parker, RS (corresponding author), Univ Pittsburgh, Swanson Sch Engn, Dept Chem & Petr Engn, Pittsburgh, PA 15260 USA.	rparker@pitt.edu	Pilewski, Joseph/AAF-5149-2021	Corcoran, Tim/0000-0003-1069-095X	Graduate Assistantships in Areas of National Need (GAANN) fellowship (U.S. Department of Education) [P200A120195]; National Institutes of Health [R01HL108929, RO1HL112862]; B.P. America Faculty Fellowship in the Swanson School of Engineering; NIH [P30DK072506]; Cystic Fibrosis Foundation Research Development Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112863, T32HL007563, R01HL108929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072506] Funding Source: NIH RePORTER	Graduate Assistantships in Areas of National Need (GAANN) fellowship (U.S. Department of Education); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); B.P. America Faculty Fellowship in the Swanson School of Engineering; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation Research Development Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	MRM is supported by a Graduate Assistantships in Areas of National Need (GAANN) fellowship (U.S. Department of Education (www.ed.gov), P200A120195). The functional imaging project in [6] and TEC were supported by National Institutes of Health (www.nih.gov) R01HL108929. RSP acknowledges support of the B.P. America Faculty Fellowship in the Swanson School of Engineering. MMM acknowledges support from National Institutes of Health (www.nih.gov) RO1HL112862. Work performed in HBE cell cultures was supported by the NIH (www.nih.gov) P30DK072506 and the Cystic Fibrosis Foundation (www.cff.org) Research Development Program. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BENNETT WD, 1989, AM REV RESPIR DIS, V139, P1132, DOI 10.1164/ajrccm/139.5.1132; Biddiscombe MF, 2011, J AEROSOL MED PULM D, V24, P165, DOI 10.1089/jamp.2010.0845; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Boucher RC, 2007, TRENDS MOL MED, V13, P231, DOI 10.1016/j.molmed.2007.05.001; BYRON PR, 1994, J AEROSOL MED, V7, P49, DOI 10.1089/jam.1994.7.49; Corcoran TE, 2010, EUR RESPIR J, V35, P781, DOI 10.1183/09031936.00059009; Corcoran TE, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-14; Donaldson Scott H, 2007, Proc Am Thorac Soc, V4, P399, DOI 10.1513/pats.200703-042BR; Donaldson SH, 2006, NEW ENGL J MED, V354, P241, DOI 10.1056/NEJMoa043891; Eckford PDW, 2012, J BIOL CHEM, V287, P36639, DOI 10.1074/jbc.M112.393637; Elkins MR, 2006, NEW ENGL J MED, V354, P229, DOI 10.1056/NEJMoa043900; Hoegger MJ, 2014, SCIENCE, V345, P818, DOI 10.1126/science.1255825; ILOWITE JS, 1989, AM REV RESPIR DIS, V139, P1139, DOI 10.1164/ajrccm/139.5.1139; Locke L, 2014, EUROPEAN RE IN PRESS; Myerburg MM, 2010, AM J RESP CELL MOL, V43, P712, DOI 10.1165/rcmb.2009-0348OC; Newman S, 2012, J AEROSOL MED PULM D, V25, pS10, DOI 10.1089/jamp.2012.1Su4; O'Reilly R, 2013, DRUG DES DEV THER, V7, P929, DOI 10.2147/DDDT.S30345; Raue A, 2009, BIOINFORMATICS, V25, P1923, DOI 10.1093/bioinformatics/btp358; REGNIS JA, 1994, AM J RESP CRIT CARE, V150, P66, DOI 10.1164/ajrccm.150.1.8025774; Robinson M, 2000, J AEROSOL MED, V13, P73, DOI 10.1089/089426800418604; Sakagami M, 2002, J PHARM SCI, V91, P594, DOI 10.1002/jps.10069; Sakagami M, 2006, ADV DRUG DELIVER REV, V58, P1030, DOI 10.1016/j.addr.2006.07.012; Sturm R, 2012, J THORAC DIS, V4, P48, DOI 10.3978/j.issn.2072-1439.2011.09.09; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Weber B, 2013, AAPS J, V15, P159, DOI 10.1208/s12248-012-9420-z; YAMAOKA K, 1978, J PHARMACOKINET BIOP, V6, P165, DOI 10.1007/BF01117450	28	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e111972	10.1371/journal.pone.0111972	http://dx.doi.org/10.1371/journal.pone.0111972			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383714	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000344816700026
J	Riese, H; Munoz, LM; Hartman, CA; Ding, XH; Su, SY; Oldehinkel, AJ; van Roon, AM; van der Most, PJ; Lefrandt, J; Gansevoort, RT; van der Harst, P; Verweij, N; Licht, CMM; Boomsma, DI; Hottenga, JJ; Willemsen, G; Penninx, BWJH; Nolte, IM; de Geus, EJC; Wang, XL; Snieder, H				Riese, Harriette; Munoz, Loretto M.; Hartman, Catharina A.; Ding, Xiuhua; Su, Shaoyong; Oldehinkel, Albertine J.; van Roon, Arie M.; van der Most, Peter J.; Lefrandt, Joop; Gansevoort, Ron T.; van der Harst, Pim; Verweij, Niek; Licht, Carmilla M. M.; Boomsma, Dorret I.; Hottenga, Jouke-Jan; Willemsen, Gonneke; Penninx, Brenda W. J. H.; Nolte, Ilja M.; de Geus, Eco J. C.; Wang, Xiaoling; Snieder, Harold			Identifying Genetic Variants for Heart Rate Variability in the Acetylcholine Pathway	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MAJOR DEPRESSIVE DISORDER; RESPIRATORY SINUS ARRHYTHMIA; INDIVIDUAL-LIVES SURVEY; CHOLINE-ACETYLTRANSFERASE; CARDIOVASCULAR-DISEASE; BAROREFLEX SENSITIVITY; IDENTIFICATION; NETHERLANDS; REST	Heart rate variability is an important risk factor for cardiovascular disease and all-causemortality. The acetylcholine pathway plays a key role in explaining heart rate variability in humans. We assessed whether 443 genotyped and imputed common genetic variants in eight key genes (CHAT, SLC18A3, SLC5A7, CHRNB4, CHRNA3, CHRNA, CHRM2 and ACHE) of the acetylcholine pathway were associated with variation in an established measure of heart rate variability reflecting parasympathetic control of the heart rhythm, the root mean square of successive differences (RMSSD) of normal RR intervals. The association was studied in a two stage design in individuals of European descent. First, analyses were performed in a discovery sample of four cohorts (n = 3429, discovery stage). Second, findings were replicated in three independent cohorts (n = 3311, replication stage), and finally the two stages were combined in a meta-analysis (n = 6740). RMSSD data were obtained under resting conditions. After correction for multiple testing, none of the SNPs showed an association with RMSSD. In conclusion, no common genetic variants for heart rate variability were identified in the largest and most comprehensive candidate gene study on the acetylcholine pathway to date. Future gene finding efforts for RMSSD may want to focus on hypothesis free approaches such as the genome-wide association study.	[Riese, Harriette; Hartman, Catharina A.; Oldehinkel, Albertine J.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [Riese, Harriette; Munoz, Loretto M.; van der Most, Peter J.; Nolte, Ilja M.; Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Ding, Xiuhua] Univ Kentucky, Dept Biostat, Coll Publ Hlth, Lexington, KY USA; [Ding, Xiuhua] Univ Kentucky, Dept Epidemiol, Coll Publ Hlth, Lexington, KY USA; [Su, Shaoyong; Wang, Xiaoling] Georgia Regents Univ, Dept Pediat, Georgia Prevent Inst, Augusta, GA USA; [van Roon, Arie M.; Lefrandt, Joop] Univ Groningen, Univ Med Ctr Groningen, Dept Vasc Med, Groningen, Netherlands; [Gansevoort, Ron T.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands; [van der Harst, Pim; Verweij, Niek] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Licht, Carmilla M. M.; Penninx, Brenda W. J. H.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [Boomsma, Dorret I.; Hottenga, Jouke-Jan; Willemsen, Gonneke; de Geus, Eco J. C.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Dept Biol Psychol, Amsterdam, Netherlands; [Boomsma, Dorret I.; Hottenga, Jouke-Jan; Willemsen, Gonneke; de Geus, Eco J. C.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands	University of Groningen; University of Groningen; University of Kentucky; University of Kentucky; University System of Georgia; Augusta University; University of Groningen; University of Groningen; University of Groningen; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Riese, H (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands.	h.riese@umcg.nl; h.snieder@umcg.nl	Verweij, Niek/ABC-6249-2021; Penninx, Brenda WJH/S-7627-2017; Munoz, Loretto/K-1229-2017; Verweij, Niek/A-4499-2017; de Geus, Eco J.C./M-9318-2015; Riese, Harriëtte/E-7234-2012; Boomsma, Dorret I/AAX-4470-2020	Verweij, Niek/0000-0002-4303-7685; Penninx, Brenda WJH/0000-0001-7779-9672; Munoz, Loretto/0000-0003-2308-4158; de Geus, Eco J.C./0000-0001-6022-2666; Riese, Harriëtte/0000-0003-3661-3151; Willemsen, Gonneke/0000-0003-3755-0236	Marie Curie International Re-Integration Grant from the EU (IRG grant) [44949]; National Heart Lung and Blood Institute [HL0836530]; Netherlands Organization for Scientific Research NWO (Medical Research Council program) [GB-MW 940-38-011]; ZonMW Brainpower grant [100-001-004]; ZonMw Risk Behavior and Dependence grants [60-60600-97-118]; ZonMw Culture and Health grant [261-98-710]; Social Sciences Council medium-sized investment [GB-MaGW 480-01-006, GB-MaGW 480-07-001]; Social Sciences Council project [GB-MaGW 452-04-314, GB-MaGW 452-06-004]; NWO large-sized investment grant [175.010.2003.005]; NWO Longitudinal Survey and Panel Funding [481-08-013]; Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS project) [FP-006]; Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL [CP 32]; Accare Center for Child and Adolescent Psychiatry; Netherlands Organisation for Health Research and Development [ZonMw 904-57-130]; UK-Netherlands Partnership Program in Science [BR 56-481, BR 96-229]; British Council and the Netherlands Organization for Scientific Research (NWO); National Institute of Health [HL086530, HL69999, R21 HL086530]; American Heart Association [SDG0730156N]; Geestkracht program of ZonMW [10-000-1002]; matching funds from universities and mental health care institutes involved in NESDA (GGZ Buitenamstel-Geestgronden, Rivierduinen, University Medical Center Groningen, GGZ Lentis, GGZ Friesland, GGZ Drenthe); NEtherlands Twin-family Study of Anxious Depression (NETSAD) [ZonMW 940-37-024]; Centre for Medical Systems Biology (CMSB); WP Genetic epidemiology & gene discovery for cardiovascular risk factors (Netherlands Genomics Initiative/ Netherlands Organisation for Scientific Research NWO); Genetic Association Information Network (GAIN) of the Foundation for the US National Institutes of Health; GAIN; NIMH [MH081802]; Dutch Kidney Foundation [E033]; National Institutes of Health [LM010098]; Netherlands organisation for health research and development (NWO VENI) [916.761.70]; Dutch Inter University Cardiology Institute Netherlands; Netherlands Scientific Organization (NWO) [480-05-003 PI]; VU University Amsterdam; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL086530, R01HL105689, P01HL069999, R01HL104125] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010098] Funding Source: NIH RePORTER	Marie Curie International Re-Integration Grant from the EU (IRG grant); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Netherlands Organization for Scientific Research NWO (Medical Research Council program)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Netherlands Organization for Scientific Research (NWO)); ZonMW Brainpower grant; ZonMw Risk Behavior and Dependence grants; ZonMw Culture and Health grant; Social Sciences Council medium-sized investment; Social Sciences Council project; NWO large-sized investment grant; NWO Longitudinal Survey and Panel Funding; Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS project); Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL; Accare Center for Child and Adolescent Psychiatry; Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); UK-Netherlands Partnership Program in Science; British Council and the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Geestkracht program of ZonMW; matching funds from universities and mental health care institutes involved in NESDA (GGZ Buitenamstel-Geestgronden, Rivierduinen, University Medical Center Groningen, GGZ Lentis, GGZ Friesland, GGZ Drenthe); NEtherlands Twin-family Study of Anxious Depression (NETSAD); Centre for Medical Systems Biology (CMSB); WP Genetic epidemiology & gene discovery for cardiovascular risk factors (Netherlands Genomics Initiative/ Netherlands Organisation for Scientific Research NWO)(Netherlands Organization for Scientific Research (NWO)); Genetic Association Information Network (GAIN) of the Foundation for the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GAIN; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Dutch Kidney Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands organisation for health research and development (NWO VENI); Dutch Inter University Cardiology Institute Netherlands; Netherlands Scientific Organization (NWO)(Netherlands Organization for Scientific Research (NWO)); VU University Amsterdam; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by a Marie Curie International Re-Integration Grant from the EU to HS (IRG grant 44949) and a grant from the National Heart Lung and Blood Institute to XW (HL0836530). Participating centers of the TRacking Adolescents' Individual Lives Survey (TRAILS) include various departments of the University Medical Center and University of Groningen, the Erasmus University Medical Center Rotterdam, the University of Utrecht, the Radboud Medical Center Nijmegen, and the Parnassia Bavo group, all in the Netherlands. TRAILS has been financially supported by various grants from the Netherlands Organization for Scientific Research NWO (Medical Research Council program grant GB-MW 940-38-011; ZonMW Brainpower grant 100-001-004; ZonMw Risk Behavior and Dependence grants 60-60600-97-118; ZonMw Culture and Health grant 261-98-710; Social Sciences Council medium-sized investment grants GB-MaGW 480-01-006 and GB-MaGW 480-07-001; Social Sciences Council project grants GB-MaGW 452-04-314 and GB-MaGW 452-06-004; NWO large-sized investment grant 175.010.2003.005; NWO Longitudinal Survey and Panel Funding 481-08-013), the Dutch Ministry of Justice (WODC), the European Science Foundation (EuroSTRESS project FP-006), Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL (CP 32), the participating universities, and Accare Center for Child and Adolescent Psychiatry. The authors are grateful to all adolescents, their parents and teachers who participated in this research and to everyone who worked on this project and made it possible. TWINS was supported by the Netherlands Organisation for Health Research and Development (ZonMw 904-57-130) and the UK-Netherlands Partnership Program in Science (BR 56-481 and BR 96-229), which is jointly run and financed by the British Council and the Netherlands Organization for Scientific Research (NWO). The BP Stress Study and Georgia Cardiovascular Twin Study were supported by the National Institute of Health (HL086530 and HL69999, respectively). The genotyping conducted in this study was supported by the National Institute of Health (R21 HL086530) and American Heart Association (SDG0730156N). NESDA was supported by the Geestkracht program of ZonMW [grant 10-000-1002]; matching funds from universities and mental health care institutes involved in NESDA (GGZ Buitenamstel-Geestgronden, Rivierduinen, University Medical Center Groningen, GGZ Lentis, GGZ Friesland, GGZ Drenthe). NTR was supported by the Genetic-epidemiology of anxious depression: analyses of twin-family data in the framework of the NEtherlands Twin-family Study of Anxious Depression (NETSAD; ZonMW 940-37-024) and the Centre for Medical Systems Biology (CMSB) 1, WP Genetic epidemiology & gene discovery for cardiovascular risk factors (Netherlands Genomics Initiative/ Netherlands Organisation for Scientific Research NWO). Genotyping for NESDA and NTR was funded by the Genetic Association Information Network (GAIN) of the Foundation for the US National Institutes of Health, and analysis was supported by grants from GAIN and the NIMH (MH081802). Genotype data were obtained from dbGaP (www.ncbi.nlm.nih.gov/dbgap, accession number phs000020.v1.p1). PREVEND genetics is supported by the Dutch Kidney Foundation (Grant E033), the National Institutes of Health (grant LM010098), The Netherlands organisation for health research and development (NWO VENI grant 916.761.70), and the Dutch Inter University Cardiology Institute Netherlands. Part of the statistical analyses were carried out on the Genetic Cluster Computer (http://www.; geneticcluster.org) hosted by SURFsara and financially supported by the Netherlands Scientific Organization (NWO 480-05-003 PI: Posthuma) along with a supplement from the Dutch Brain Foundation and the VU University Amsterdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHARONPERETZ J, 1992, ARCH NEUROL-CHICAGO, V49, P919, DOI 10.1001/archneur.1992.00530330041013; Boomsma DI, 2008, EUR J HUM GENET, V16, P335, DOI 10.1038/sj.ejhg.5201979; Brodde OE, 2001, BASIC RES CARDIOL, V96, P528, DOI 10.1007/s003950170003; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Buccelletti F, 2009, EUR REV MED PHARMACO, V13, P299; Camm AJ, 1996, CIRCULATION, V93, P1043; Cook LJ, 2005, AM J MED GENET B, V132B, P5, DOI 10.1002/ajmg.b.30068; de Winter AF, 2005, EUR J EPIDEMIOL, V20, P173, DOI 10.1007/s10654-004-4948-6; DEGEUS EJC, 1995, BIOL PSYCHOL, V41, P205, DOI 10.1016/0301-0511(95)05137-6; Dekker JM, 2000, CIRCULATION, V102, P1239, DOI 10.1161/01.CIR.102.11.1239; Dekkers JC, 2002, J PEDIATR-US, V141, P770, DOI 10.1067/mpd.2002.128113; Dietrich A, 2006, J HYPERTENS, V24, P345, DOI 10.1097/01.hjh.0000200517.27356.47; Duga S, 2001, J HUM GENET, V46, P640, DOI 10.1007/s100380170015; ERICKSON JD, 1994, J BIOL CHEM, V269, P21929; Fisher JT, 2004, FASEB J, V18, P711, DOI 10.1096/fj.03-0648fje; Ganesh SK, 2013, HUM MOL GENET, V22, P1663, DOI 10.1093/hmg/dds555; Ge DL, 2006, TWIN RES HUM GENET, V9, P965, DOI 10.1375/twin.9.6.965; Giubilei F, 1998, ALZ DIS ASSOC DIS, V12, P356, DOI 10.1097/00002093-199812000-00017; Goedhart AD, 2007, PSYCHOPHYSIOLOGY, V44, P203, DOI 10.1111/j.1469-8986.2006.00490.x; Guyton AC, 2006, TEXTBOOK OF MEDICAL; Hampel R, 2012, ENVIRON RES, V112, P177, DOI 10.1016/j.envres.2011.10.007; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huisman M, 2008, INT J EPIDEMIOL, V37, P1227, DOI 10.1093/ije/dym273; Imumorin IG, 2005, CARDIOVASC TOXICOL, V5, P109, DOI 10.1385/CT:5:2:109; Joosten H, 2011, CLIN J AM SOC NEPHRO, V6, P1400, DOI 10.2215/CJN.05530610; Kupper N, 2005, PSYCHOPHYSIOLOGY, V42, P202, DOI 10.1111/j.1469-8986.2005.00276.x; Kupper NHM, 2004, CIRCULATION, V110, P2792, DOI 10.1161/01.CIR.0000146334.96820.6E; Li ZB, 2009, INT J PSYCHOPHYSIOL, V73, P212, DOI 10.1016/j.ijpsycho.2009.03.002; Licht CMM, 2008, ARCH GEN PSYCHIAT, V65, P1358, DOI 10.1001/archpsyc.65.12.1358; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mubumbila V, 2002, NEUROSCI LETT, V333, P9, DOI 10.1016/S0304-3940(02)00955-2; Mulder L. J. M., 1988, COMPUTERS PSYCHOL ME, P30; Munoz ML, 2014, VALIDITY OF ULTRA SH; Neumann SA, 2005, PSYCHOSOM MED, V67, P168, DOI 10.1097/01.psy.0000155671.90861.c2; Neumann SA, 2009, PSYCHOPHYSIOLOGY, V46, P466, DOI 10.1111/j.1469-8986.2009.00802.x; Niskanen JP, 2004, COMPUT METH PROG BIO, V76, P73, DOI 10.1016/j.cmpb.2004.03.004; Nolte IM, 2010, HANDBOOK OF BEHAVIOR; Ormel J, 2012, J AM ACAD CHILD PSY, V51, P1020, DOI 10.1016/j.jaac.2012.08.004; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Pinto-Sietsma SJ, 2000, J AM SOC NEPHROL, V11, P1882, DOI 10.1681/ASN.V11101882; Riese H, 2007, PSYCHOL MED, V37, P257, DOI 10.1017/S0033291706009160; Riese H, 2006, J HYPERTENS, V24, P1779, DOI 10.1097/01.hjh.0000242402.83709.27; Riese H, 2013, TWIN RES HUM GENET, V16, P268, DOI 10.1017/thg.2012.112; Rijsdijk FV, 2009, PSYCHOL MED, V39, P45, DOI 10.1017/S0033291708003231; Singh JP, 2002, AM J CARDIOL, V90, P1290, DOI 10.1016/S0002-9149(02)02865-5; Singh JP, 1998, HYPERTENSION, V32, P293, DOI 10.1161/01.HYP.32.2.293; Snieder H, 1997, PSYCHOPHYSIOLOGY, V34, P317, DOI 10.1111/j.1469-8986.1997.tb02402.x; Snieder H, 2002, AM J HYPERTENS, V15, P973, DOI 10.1016/S0895-7061(02)02991-6; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125; Thayer JF, 2007, BIOL PSYCHOL, V74, P224, DOI 10.1016/j.biopsycho.2005.11.013; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Verweij N, 2013, HYPERTENSION, V61, P602, DOI 10.1161/HYPERTENSIONAHA.111.203117; Wang Xiaoling, 2005, Am J Cardiol, V96, P1166, DOI 10.1016/j.amjcard.2005.06.050; Wang XL, 2009, PSYCHOPHYSIOLOGY, V46, P458, DOI 10.1111/j.1469-8986.2009.00793.x; Wesseling K.H., 1990, BLOOD PRESSURE MEASU, P161; Willemsen GHM, 1996, PSYCHOPHYSIOLOGY, V33, P184, DOI 10.1111/j.1469-8986.1996.tb02122.x; Willemsen G, 2013, TWIN RES HUM GENET, V16, P271, DOI 10.1017/thg.2012.140; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340	60	8	8	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112476	10.1371/journal.pone.0112476	http://dx.doi.org/10.1371/journal.pone.0112476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384021	Green Published, gold			2022-12-27	WOS:000344816700067
J	Vancampenhout, K; Caljon, B; Spits, C; Stouffs, K; Jonckheere, A; De Meirleir, L; Lissens, W; Vanlander, A; Smet, J; De Paepe, B; Van Coster, R; Seneca, S				Vancampenhout, Kim; Caljon, Ben; Spits, Claudia; Stouffs, Katrien; Jonckheere, An; De Meirleir, Linda; Lissens, Willy; Vanlander, Arnaud; Smet, Joel; De Paepe, Boel; Van Coster, Rudy; Seneca, Sara			A Bumpy Ride on the Diagnostic Bench of Massive Parallel Sequencing, the Case of the Mitochondrial Genome	PLOS ONE			English	Article								The advent of massive parallel sequencing (MPS) has revolutionized the field of human molecular genetics, including the diagnostic study of mitochondrial (mt) DNA dysfunction. The analysis of the complete mitochondrial genome using MPS platforms is now common and will soon outrun conventional sequencing. However, the development of a robust and reliable protocol is rather challenging. A previous pilot study for the re-sequencing of human mtDNA revealed an uneven coverage, affecting predominantly part of the plus strand. In an attempt to address this problem, we undertook a comparative study of standard and modified protocols for the Ion Torrent PGM system. We could not improve strand representation by altering the recommended shearing methodology of the standard workflow or omitting the DNA polymerase amplification step from the library construction process. However, we were able to associate coverage bias of the plus strand with a specific sequence motif. Additionally, we compared coverage and variant calling across technologies. The same samples were also sequenced on a MiSeq device which showed that coverage and heteroplasmic variant calling were much improved.	[Vancampenhout, Kim; Spits, Claudia; Stouffs, Katrien; De Meirleir, Linda; Lissens, Willy; Seneca, Sara] Vrije Univ Brussel, Res Grp Reprod & Genet REGE, Brussels, Belgium; [Caljon, Ben; Stouffs, Katrien; Lissens, Willy; Seneca, Sara] Vrije Univ Brussel, UZ Brussel, Ctr Med Genet, Brussels, Belgium; [Jonckheere, An; De Meirleir, Linda] Vrije Univ Brussel, UZ Brussel, Dept Pediat Neurol, Brussels, Belgium; [Vanlander, Arnaud; Smet, Joel; De Paepe, Boel; Van Coster, Rudy] Univ Ghent, Univ Hosp Ghent, Dept Pediat, Div Pediat Neurol & Metab, B-9000 Ghent, Belgium	Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel; Ghent University; Ghent University Hospital	Seneca, S (corresponding author), Vrije Univ Brussel, Res Grp Reprod & Genet REGE, Brussels, Belgium.	sara.seneca@uzbrussel.be	De Meirleir, Linda/D-6591-2016; Arnaud, Vanlander/ABB-5978-2021; De Paepe, Boel/B-7548-2013; Spits, Claudia/J-1964-2014; Stouffs, Katrien/L-5982-2015	De Paepe, Boel/0000-0001-9403-4401; Spits, Claudia/0000-0002-0187-5138; Stouffs, Katrien/0000-0001-8164-5692; Seneca, Sara/0000-0002-0853-9890	Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO) [G.0.200]; 'Association Belge contre les Maladies Neuro-Musculaires (ABMM)'; Vrije Universiteit Brussel [OZR1928, OZRMETH3]	Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO)(FWO); 'Association Belge contre les Maladies Neuro-Musculaires (ABMM)'; Vrije Universiteit Brussel	This work was supported by Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO; www.FWO.be) G.0.200; The 'Association Belge contre les Maladies Neuro-Musculaires (ABMM)' (http://www.hospichild.be/fr/associations/maladies-neuro-musculaires/association-belge-contre-les-maladies-neuromusculaires-asbl-abmm-maladies-genetiques), and Vrije Universiteit Brussel (with reference OZR1928 and OZRMETH3). Authors who received funding: CS LDM SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHENG S, 1994, NAT GENET, V7, P350, DOI 10.1038/ng0794-350; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li H., 2013, ARXIV13033997 Q BIO; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Oyola SO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-1; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Seneca S, 2015, EUR J HUM GENET, V23, P41, DOI 10.1038/ejhg.2014.49	9	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112950	10.1371/journal.pone.0112950	http://dx.doi.org/10.1371/journal.pone.0112950			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383547	gold, Green Published, Green Submitted			2022-12-27	WOS:000344816700105
J	Gales, A; Latrille, E; Wery, N; Steyer, JP; Godon, JJ				Gales, Amandine; Latrille, Eric; Wery, Nathalie; Steyer, Jean-Philippe; Godon, Jean-Jacques			Needles of Pinus halepensis as Biomonitors of Bioaerosol Emissions	PLOS ONE			English	Article							PHYLLOSPHERE; MICROBIOLOGY; INDICATORS; DYNAMICS	We propose using the surface of pine trees needles to biomonitor the bioaerosol emissions at a composting plant. Measurements were based on 16S rRNA gene copy numbers of Saccharopolyspora rectivirgula, a bioindicator of composting plant emissions. A sampling plan was established based on 29 samples around the emission source. The abundance of 16S rRNA gene copies of S. rectivirgula per gram of Pinus halepensis needles varied from 10(4) to 10(2) as a function of the distance. The signal reached the background level at distances around the composting plant ranging from 2 km to more than 5.4 km, depending on the local topography and average wind directions. From these values, the impacted area around the source of bioaerosols was mapped.	[Gales, Amandine; Latrille, Eric; Wery, Nathalie; Steyer, Jean-Philippe; Godon, Jean-Jacques] INRA, Lab Biotechnol Environm, UR0050, Narbonne, France	INRAE	Godon, JJ (corresponding author), INRA, Lab Biotechnol Environm, UR0050, Narbonne, France.	jean-jacques.godon@supagro.inra.fr	Wéry, Nathalie/AAR-4215-2020	Steyer, Jean-Philippe/0000-0003-0467-8081				Breitenbach M, 2008, INT ARCH ALLERGY IMM, V145, P58, DOI 10.1159/000107578; Despres V, 2012, PRIMARY BIOL AEROSOL, P64; Douwes J, 2003, ANN OCCUP HYG, V47, P187, DOI 10.1093/annhyg/meg032; Furrer R., 2010, FIELDS TOOLS SPATIAL; Hirano SS, 2000, MICROBIOL MOL BIOL R, V64, P624, DOI 10.1128/MMBR.64.3.624-653.2000; Kinkel LL, 1997, ANNU REV PHYTOPATHOL, V35, P327, DOI 10.1146/annurev.phyto.35.1.327; Le Goff O, 2012, ATMOS ENVIRON, V61, P428, DOI 10.1016/j.atmosenv.2012.07.081; Le Goff O, 2011, ATMOS ENVIRON, V45, P5342, DOI 10.1016/j.atmosenv.2011.06.052; Lighthart B., 2000, AEROBIOLOGIA, V16, P7, DOI [DOI 10.1023/A:1007694618888, 10.1023/A:1007694618888]; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Meyer KM, 2012, OECOLOGIA, V168, P621, DOI 10.1007/s00442-011-2138-2; Nali C, 2007, ENVIRON MONIT ASSESS, V131, P201, DOI 10.1007/s10661-006-9468-2; Noth EM, 2013, ATMOS ENVIRON, V77, P518, DOI 10.1016/j.atmosenv.2013.05.056; R Core Team, 2020, R LANG ENV STAT COMP; Ramette A, 2007, MICROB ECOL, V53, P197, DOI 10.1007/s00248-005-5010-2; Rastogi G, 2012, ISME J, V6, P1812, DOI 10.1038/ismej.2012.32; Redford AJ, 2009, MICROB ECOL, V58, P189, DOI 10.1007/s00248-009-9495-y; Schafer J, 2011, ANN OCCUP HYG, V55, P612, DOI 10.1093/annhyg/mer018; Suslow T, 2003, COMPR REV FOOD SCI F, V2, P38; Taha MPM, 2007, ATMOS ENVIRON, V41, P4504, DOI 10.1016/j.atmosenv.2006.12.056; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Wuytack T, 2010, ENVIRON MONIT ASSESS, V171, P197, DOI 10.1007/s10661-009-1271-4	22	6	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112182	10.1371/journal.pone.0112182	http://dx.doi.org/10.1371/journal.pone.0112182			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379901	Green Published, gold, Green Submitted			2022-12-27	WOS:000344863100059
J	Huang, RX; Wu, D; Yuan, Y; Li, XR; Holm, R; Trope, CG; Nesland, JM; Suo, ZH				Huang, Ruixia; Wu, Dan; Yuan, Yuan; Li, Xiaoran; Holm, Ruth; Trope, Claes G.; Nesland, Jahn M.; Suo, Zhenhe			CD117 Expression in Fibroblasts-Like Stromal Cells Indicates Unfavorable Clinical Outcomes in Ovarian Carcinoma Patients	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; ACTIVATION PROTEIN; STEM-CELLS; C-KIT; CANCER; TUMORS; CHALLENGES; MARKERS; BETA	The stem cell factor (SCF) receptor CD117 (c-kit), is widely used for identification of hematopoietic stem cells and cancer stem cells. Moreover, CD117 expression in carcinoma cells indicates a poor prognosis in a variety of cancers. However the potential expression in tumor microenvironment and the biological and clinical impact are currently not reported. The expression of CD117 was immunohistochemically evaluated in a serial of 242 epithelial ovarian cancer (EOC) cases. Thirty-eight out of 242 cases were CD117 positive in fibroblast-like stromal cells and 22 cases were positive in EOC cells. Four cases were both positive in fibroblast-like stromal cells and EOC cells for CD117. CD117 expression in fibroblast-like stromal cells in ovarian carcinoma was closely linked to advanced FIGO stage, poor differentiation grade and histological subtype (p<0.05), and it was significantly associated with poor overall survival (OS) and progression free survival (PFS) (Kaplan-Meier analysis; p<0.05, log-rank test). CD117 expression in ovarian carcinoma cells was not associated with these clinicopathological variables. The CD117 positive fibroblast-like stromal cells were all positive for mesenchymal stem/stromal cell (MSC) marker CD73 but negative for fibroblast markers fibroblast activation protein (FAP) and alpha smooth muscle actin (alpha-SMA), indicating that the CD117+/CD73+ fibroblast-like stromal cells are a subtype of mesenchymal stem cells in tumor stroma, although further characterization of these cells are needed. It is concluded herewith that the presence of CD117+/CD73+ fibroblast-like stromal cells in ovarian carcinoma is an unfavorable clinical outcome indication.	[Huang, Ruixia; Li, Xiaoran; Holm, Ruth; Nesland, Jahn M.; Suo, Zhenhe] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway; [Huang, Ruixia; Li, Xiaoran; Nesland, Jahn M.; Suo, Zhenhe] Univ Oslo, Fac Med, Inst Clin Med, Dept Pathol, Oslo, Norway; [Wu, Dan] Shanghai Jiao Tong Univ, Int Peace Matern & Child Hlth Hosp, Med Coll Shanghai, Dept Gynecol, Shanghai 200030, Peoples R China; [Yuan, Yuan] Capital Med Univ, Dept Pathol, Beijing, Peoples R China; [Trope, Claes G.] Univ Oslo, Fac Med, Inst Clin Med, Dept Gynecol, Oslo, Norway; [Trope, Claes G.] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Gynecol, Oslo, Norway	University of Oslo; University of Oslo; Shanghai Jiao Tong University; Capital Medical University; University of Oslo; University of Oslo	Suo, ZH (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway.	zhenhes@medisin.uio.no		Huang, Ruixia/0000-0001-7214-647X	Inger and John Fredriksen Foundation; Norwegian Radium Hospital Research Foundation; Norwegian Cancer Society	Inger and John Fredriksen Foundation; Norwegian Radium Hospital Research Foundation; Norwegian Cancer Society(Norwegian Cancer Society)	This study was financially supported by grants from Inger and John Fredriksen Foundation, Norwegian Radium Hospital Research Foundation and The Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari AS, 2010, CANCER RES, V70, P4602, DOI 10.1158/0008-5472.CAN-09-3463; Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Allard B, 2014, INT J CANCER, V134, P1466, DOI 10.1002/ijc.28456; Allard B, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/485156; Anker PSI, 2003, HAEMATOLOGICA, V88, P845; Bae S, 2008, BRIT J HAEMATOL, V142, P827, DOI 10.1111/j.1365-2141.2008.07241.x; Boxall SA, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/975871; Brennen WN, 2012, MOL CANCER THER, V11, P257, DOI 10.1158/1535-7163.MCT-11-0340; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chatterjee D, 2014, BLOOD, V123, P594, DOI 10.1182/blood-2013-09-524827; Chen DY, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-50; Cheng JD, 2003, CLIN CANCER RES, V9, P1590; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; de Silva MV, 2003, PATHOL ONCOL RES, V9, P13, DOI 10.1007/BF03033708; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Downs LS, 2008, CANCER, V112, P331, DOI 10.1002/cncr.23164; Doyle LA, 2014, HISTOPATHOLOGY, V64, P53, DOI 10.1111/his.12302; Fearon DT, 2014, CANCER IMMUNOL RES, V2, P187, DOI 10.1158/2326-6066.CIR-14-0002; Gallegos I, 2011, APPL IMMUNOHISTO M M, V19, P147, DOI 10.1097/PAI.0b013e3181f05a66; Garrity MM, 2009, HISTOPATHOLOGY, V54, P286, DOI 10.1111/j.1365-2559.2008.03189.x; Ghesquiere B, 2014, NATURE, V511, P167, DOI 10.1038/nature13312; Guppy AE, 2005, CLIN ONCOL-UK, V17, P399, DOI 10.1016/j.clon.2005.05.009; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Haniffa MA, 2009, HAEMATOL-HEMATOL J, V94, P258, DOI 10.3324/haematol.13699; Hermida-Gomez T, 2011, J RHEUMATOL, V38, P339, DOI 10.3899/jrheum.100614; Hung SC, 2006, CELL TISSUE RES, V324, P457, DOI 10.1007/s00441-006-0156-x; Ismail RS, 1999, ONCOGENE, V18, P4734, DOI 10.1038/sj.onc.1202865; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kang Y, 2013, J NUCL MED, V54, P32; Kim DJ, 2006, J KOREAN MED SCI, V21, P81, DOI 10.3346/jkms.2006.21.1.81; Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031; Li O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055319; Liu ET, 2007, NEW ENGL J MED, V357, P2537, DOI 10.1056/NEJMp0707576; Ljujic B, 2013, SCI REP-UK, V3, DOI 10.1038/srep02298; Lv FJ, 2014, STEM CELLS, V32, P1408, DOI 10.1002/stem.1681; Ma DQ, 2014, HISTOPATHOLOGY, V64, P218, DOI 10.1111/his.12212; McMillin DW, 2013, NAT REV DRUG DISCOV, V12, P217, DOI 10.1038/nrd3870; Park JS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.21; Petrim I, 2010, J THORAC ONCOL, V5, P1447, DOI 10.1097/JTO.0b013e3181e96e30; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pollack IF, 2013, NEW ENGL J MED, V368, P1942, DOI 10.1056/NEJMcibr1302851; Potdar PD, 2010, J STEM CELLS REGEN, V6, P26; Schmandt RE, 2003, CANCER-AM CANCER SOC, V98, P758, DOI 10.1002/cncr.11561; Sleeman JP, 2011, CELL, V145, DOI 10.1016/j.cell.2011.03.029; Song N, 2012, ASIAN PAC J CANCER P, V13, P2745, DOI 10.7314/APJCP.2012.13.6.2745; Stagg J, 2008, STEM CELL REV, V4, P119, DOI 10.1007/s12015-008-9030-4; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Tod J, 2013, PANCREATOLOGY, V13, P1, DOI 10.1016/j.pan.2012.11.311; Wang Shumin, 2014, Biomed Res Int, V2014, P507353, DOI 10.1155/2014/507353; Went PT, 2004, J CLIN ONCOL, V22, P4514, DOI 10.1200/JCO.2004.10.125; Wu MH, 2011, CLIN CANCER RES, V17, P1306, DOI 10.1158/1078-0432.CCR-10-1824; Xiong L, 2014, CELL TISSUE RES, V355, P365, DOI 10.1007/s00441-013-1752-1; Zhang XZ, 2014, CANCER LETT, V345, P106, DOI 10.1016/j.canlet.2013.11.020; Zivanovic O, 2010, GYNECOL ONCOL, V116, P351, DOI 10.1016/j.ygyno.2009.11.022	58	20	21	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112209	10.1371/journal.pone.0112209	http://dx.doi.org/10.1371/journal.pone.0112209			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380303	Green Published, Green Submitted, gold			2022-12-27	WOS:000344863100063
J	Panecka, J; Mura, C; Trylska, J				Panecka, Joanna; Mura, Cameron; Trylska, Joanna			Interplay of the Bacterial Ribosomal A-Site, S12 Protein Mutations and Paromomycin Binding: A Molecular Dynamics Study	PLOS ONE			English	Article							TRANSFER-RNA SELECTION; AMBER FORCE-FIELD; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; HELIX 69; STREPTOMYCIN-RESISTANT; THERMUS-THERMOPHILUS; DECODING CENTER; SUBUNIT; RECOGNITION	The conformational properties of the aminoacyl-tRNA binding site (A-site), and its surroundings in the Escherichia coli 30S ribosomal subunit, are of great relevance in designing antibacterial agents. The 30S subunit A-site is near ribosomal protein S12, which neighbors helices h27 and H69; this latter helix, of the 50S subunit, is a functionally important component of an intersubunit bridge. Experimental work has shown that specific point mutations in S12 (K42A, R53A) yield hyper-accurate ribosomes, which in turn confers resistance to the antibiotic 'paromomycin' (even when this aminoglycoside is bound to the A-site). Suspecting that these effects can be elucidated in terms of the local atomic interactions and detailed dynamics of this region of the bacterial ribosome, we have used molecular dynamics simulations to explore the motion of a fragment of the E. coli ribosome, including the A-site. We found that the ribosomal regions surrounding the A-site modify the conformational space of the flexible A-site adenines 1492/93. Specifically, we found that A-site mobility is affected by stacking interactions between adenines A1493 and A1913, and by contacts between A1492 and a flexible side-chain (K43) from the S12 protein. In addition, our simulations reveal possible indirect pathways by which the R53A and K42A mutations in S12 are coupled to the dynamical properties of the A-site. Our work extends what is known about the atomistic dynamics of the A-site, and suggests possible links between the biological effects of hyper-accurate mutations in the S12 protein and conformational properties of the ribosome; the implications for S12 dynamics help elucidate how the miscoding effects of paromomycin may be evaded in antibiotic-resistant mutants of the bacterial ribosome.	[Panecka, Joanna] Univ Warsaw, Inst Expt Phys, Div Biophys, Warsaw, Poland; [Panecka, Joanna] Univ Warsaw, Interdisciplinary Ctr Math & Computat Modelling, Warsaw, Poland; [Mura, Cameron] Univ Virginia, Dept Chem, Charlottesville, VA USA; [Trylska, Joanna] Univ Warsaw, Ctr New Technol, Warsaw, Poland	University of Warsaw; University of Warsaw; Interdisciplinary Centre for Mathematical & Computational Modelling; University of Virginia; University of Warsaw	Trylska, J (corresponding author), Univ Warsaw, Ctr New Technol, Warsaw, Poland.	joanna@cent.uw.edu.pl	Mura, Cameron/F-5872-2010; Trylska, Joanna/AAI-6785-2021	Mura, Cameron/0000-0001-7985-2561; Trylska, Joanna/0000-0002-1464-5323; Panecka-Hofman, Joanna/0000-0003-4149-9090	University of Warsaw (CeNT/BST) [BST-163500/BF]; National Science Centre [DEC-2012/05/B/NZ1/00035, DEC-2011/01/N/NZ1/01558]; Foundation for Polish Science [TEAM/2009-3/8]; Foundation for Polish Science (European Regional Development Fund operated within Innovative Economy Operational Programme); University of Virginia; Jeffress Memorial Trust [J-971]; US National Science Foundation Career Award [MCB-1350957]; European Social Fund; Direct For Biological Sciences [1350957] Funding Source: National Science Foundation	University of Warsaw (CeNT/BST); National Science Centre(National Science Centre, Poland); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Foundation for Polish Science (European Regional Development Fund operated within Innovative Economy Operational Programme); University of Virginia; Jeffress Memorial Trust; US National Science Foundation Career Award(National Science Foundation (NSF)); European Social Fund(European Social Fund (ESF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	JP and JT acknowledge support from the University of Warsaw (CeNT/BST, BST-163500/BF), National Science Centre (DEC-2012/05/B/NZ1/00035 and DEC-2011/01/N/NZ1/01558), and Foundation for Polish Science (TEAM/2009-3/8, project co-financed by European Regional Development Fund operated within Innovative Economy Operational Programme). CM acknowledges support from the University of Virginia, the Jeffress Memorial Trust (J-971), and the US National Science Foundation Career Award No. MCB-1350957. Calculations were performed using resources at the University of Warsaw (ICM/KDM/G31-4). JP has been also co-financed with the European Union funds by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aduri R, 2007, J CHEM THEORY COMPUT, V3, P1464, DOI 10.1021/ct600329w; Ali IK, 2006, MOL CELL, V23, P865, DOI 10.1016/j.molcel.2006.08.011; ALKSNE LE, 1993, P NATL ACAD SCI USA, V90, P9538, DOI 10.1073/pnas.90.20.9538; Almlof M, 2007, BIOCHEMISTRY-US, V46, P200, DOI 10.1021/bi061713i; [Anonymous], 2008, AMBER 10; AQVIST J, 1990, J PHYS CHEM-US, V94, P8021, DOI 10.1021/j100384a009; Asensio JL, 2002, CHEM-EUR J, V8, P5228, DOI 10.1002/1521-3765(20021115)8:22<5228::AID-CHEM5228>3.0.CO;2-L; Barbieri CM, 2007, TETRAHEDRON, V63, P3567, DOI 10.1016/j.tet.2006.08.107; Barthel A, 2006, BIOPHYS J, V90, P2450, DOI 10.1529/biophysj.105.076158; Bock LV, 2013, NAT STRUCT MOL BIOL, V20, P1390, DOI 10.1038/nsmb.2690; BOHMAN K, 1984, MOL GEN GENET, V198, P90, DOI 10.1007/BF00328706; Borovinskaya MA, 2007, NAT STRUCT MOL BIOL, V14, P727, DOI 10.1038/nsmb1271; Bradley RK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000392; Brandman R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029377; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; Bulkley D, 2012, J MOL BIOL, V416, P571, DOI 10.1016/j.jmb.2011.12.055; Casiano-Negroni A, 2010, THESIS U MICHIGAN; Chao PW, 2007, BIOORGAN MED CHEM, V15, P3825, DOI 10.1016/j.bmc.2007.03.025; Chen SY, 2010, J MOL RECOGNIT, V23, P423, DOI 10.1002/jmr.1008; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Demeshkina N, 2012, NATURE, V484, P256, DOI 10.1038/nature10913; Demirci H, 2013, RNA, V19, P1791, DOI 10.1261/rna.040030.113; Demirci H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2346; Dunham CM, 2007, RNA, V13, P817, DOI 10.1261/rna.367307; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fourmy D, 1998, J MOL BIOL, V277, P333, DOI 10.1006/jmbi.1997.1551; Francois B, 2005, NUCLEIC ACIDS RES, V33, P5677, DOI 10.1093/nar/gki862; FUNATSU G, 1972, J MOL BIOL, V68, P547, DOI 10.1016/0022-2836(72)90108-8; Gagnon MG, 2012, SCIENCE, V335, P1370, DOI 10.1126/science.1217443; Gregory ST, 2001, J MOL BIOL, V309, P333, DOI 10.1006/jmbi.2001.4676; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Hirabayashi N, 2006, J BIOL CHEM, V281, P17203, DOI 10.1074/jbc.M511728200; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang N, 2004, PHILOS T R SOC A, V362, P1439, DOI 10.1098/rsta.2004.1383; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Jin H, 2011, P NATL ACAD SCI USA, V108, P15798, DOI 10.1073/pnas.1112185108; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaul M, 2006, J AM CHEM SOC, V128, P1261, DOI 10.1021/ja056159z; Kipper K, 2009, J MOL BIOL, V385, P405, DOI 10.1016/j.jmb.2008.10.065; Lescoute A, 2006, BIOCHIMIE, V88, P993, DOI 10.1016/j.biochi.2006.05.018; Meroueh SO, 2007, CHEM BIOL DRUG DES, V69, P291, DOI 10.1111/j.1747-0285.2007.00505.x; Mura C, 2008, NUCLEIC ACIDS RES, V36, P4941, DOI 10.1093/nar/gkn473; O'Connor M, 2009, MOL GENET GENOMICS, V282, P371, DOI 10.1007/s00438-009-0470-6; Ogle JM, 2003, TRENDS BIOCHEM SCI, V28, P259, DOI 10.1016/S0968-0004(03)00066-5; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Panecka J, 2014, J PHYS CHEM B, V118, P6687, DOI 10.1021/jp5030685; Panecka J, 2012, AIP CONF PROC, V1456, P207, DOI 10.1063/1.4730661; Panecka J, 2011, J PHYS CHEM B, V115, P532, DOI 10.1021/jp106404u; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piekna-Przybylska D, 2008, NUCLEIC ACIDS RES, V36, pD178, DOI 10.1093/nar/gkm855; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; Reblova K, 2006, BIOPOLYMERS, V82, P504, DOI 10.1002/bip.20503; Romanowska J, 2013, PROTEINS, V81, P63, DOI 10.1002/prot.24163; Romanowska J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002099; Romanowska J, 2008, J PHYS CHEM B, V112, P15227, DOI 10.1021/jp806814s; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sakakibara Y, 2012, ACS CHEM BIOL, V7, P871, DOI 10.1021/cb200497q; Sakakibara Y, 2011, J AM CHEM SOC, V133, P8396, DOI 10.1021/ja2005658; Sanbonmatsu KY, 2006, BIOCHIMIE, V88, P1053, DOI 10.1016/j.biochi.2006.06.012; Sanbonmatsu KY, 2003, J MOL BIOL, V328, P33, DOI 10.1016/S0022-2836(03)00236-5; Scheunemann AE, 2010, NUCLEIC ACIDS RES, V38, P3094, DOI 10.1093/nar/gkp1253; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Sharma D, 2007, J MOL BIOL, V374, P1065, DOI 10.1016/j.jmb.2007.10.003; SMITH DE, 1994, J CHEM PHYS, V100, P3757, DOI 10.1063/1.466363; Synetos D, 1996, BBA-GENE STRUCT EXPR, V1309, P156, DOI 10.1016/S0167-4781(96)00128-5; Vaiana AC, 2006, BIOCHIMIE, V88, P1061, DOI 10.1016/j.biochi.2006.06.006; Vaiana AC, 2009, J MOL BIOL, V386, P648, DOI 10.1016/j.jmb.2008.12.035; Vicens Q, 2001, STRUCTURE, V9, P647, DOI 10.1016/S0969-2126(01)00629-3; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Whitford PC, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4817212; Whitford PC, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003003; Whitford PC, 2011, P NATL ACAD SCI USA, V108, P18943, DOI 10.1073/pnas.1108363108; Whitford PC, 2010, J AM CHEM SOC, V132, P13170, DOI 10.1021/ja1061399; Whitford PC, 2010, RNA, V16, P1196, DOI 10.1261/rna.2035410; Wilson DN, 2005, CRIT REV BIOCHEM MOL, V40, P243, DOI 10.1080/10409230500256523; Yang G, 2006, J MED CHEM, V49, P5478, DOI 10.1021/jm060288o; Zaher HS, 2010, MOL CELL, V39, P110, DOI 10.1016/j.molcel.2010.06.009; Zaher HS, 2009, CELL, V136, P746, DOI 10.1016/j.cell.2009.01.036; Zeng XC, 2014, J MOL BIOL, V426, P3201, DOI 10.1016/j.jmb.2014.04.029; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275	84	19	19	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111811	10.1371/journal.pone.0111811	http://dx.doi.org/10.1371/journal.pone.0111811			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379961	Green Published, gold, Green Submitted			2022-12-27	WOS:000344863100041
J	Al-Abd, AM; Al-Abbasi, FA; Nofal, SM; Khalifa, AE; Williams, RO; El-Eraky, WI; Nagy, AA; Abdel-Naim, AB				Al-Abd, Ahmed M.; Al-Abbasi, Fahad A.; Nofal, Salwa M.; Khalifa, Amani E.; Williams, Richard O.; El-Eraky, Wafaa I.; Nagy, Ayman A.; Abdel-Naim, Ashraf B.			Nimesulide Improves the Symptomatic and Disease Modifying Effects of Leflunomide in Collagen Induced Arthritis	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; COMBINATION THERAPY; BIOLOGICAL THERAPY; ACTIVE METABOLITE; IN-VITRO; MICE; METHOTREXATE; MECHANISM; DRUG; INFLAMMATION	Nimesulide is a COX-2 inhibitor used for symptomatic relief of rheumatoid arthritis. Leflunomide is an anti-pyrimidine used to manage the progression of rheumatoid arthritis. Herein we studied the influence of nimesulide and leflunomide combination in terms of disease symptoms and progression using collagen-induced arthritis model in mice, as a model for rheumatoid arthritis. Collagen induced arthritis was induced by immunization with type II collagen. Assessment of joint stiffness and articular hyperalgesia were evaluated using a locomotor activity cage and the Hargreaves method, respectively. Disease progression was assessed via arthritic index scoring, X-ray imaging, myeloperoxidase enzyme activity and histopathologic examination. Nimesulide induced only transient symptomatic alleviation on the top of decreased leucocytic infiltration compared to arthritis group. However, nimesulide alone failed to induce any significant improvement in the radiological or pathological disease progression. Leflunomide alone moderately alleviates the symptoms of arthritis and moderately retarded the radiological and pathological disease progression. Combination of nimesulide and leflunomide significantly improved symptomatic (analgesia and joint stiffness) and arthritic disease progression (radiological, pathological and Myeloperoxidase enzyme activity) in collagen induced arthritis animal model.	[Al-Abd, Ahmed M.] King Abdulaziz Univ, Fac Pharm, Dept Pharmacol & Toxicol, Jeddah 21413, Saudi Arabia; [Al-Abbasi, Fahad A.] King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah 21413, Saudi Arabia; [Nofal, Salwa M.; El-Eraky, Wafaa I.] Natl Res Ctr, Dept Pharmacol, Div Med, Giza, Egypt; [Khalifa, Amani E.; Abdel-Naim, Ashraf B.] Ain Shams Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt; [Williams, Richard O.] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England; [Nagy, Ayman A.] Tanta Univ, Fac Med, Dept Forens Med & Clin Toxicol, Tanta, Egypt	King Abdulaziz University; King Abdulaziz University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); Ain Shams University; University of Oxford; Egyptian Knowledge Bank (EKB); Tanta University	Al-Abd, AM (corresponding author), King Abdulaziz Univ, Fac Pharm, Dept Pharmacol & Toxicol, Jeddah 21413, Saudi Arabia.	amalabd@kau.edu.sa	Nagy, Ayman/K-8956-2012; Abdel-Naim, Ashraf B/J-3199-2012; Al-Abbasi, Fahad/H-8940-2012; Al-Abd, Ahmed/J-2826-2012	Abdel-Naim, Ashraf B/0000-0002-0400-9075; Al-Abd, Ahmed/0000-0001-7872-4867; Nofal, Salwa/0000-0001-5125-8181; Khalifa, Amani/0000-0002-1627-7800; Al-Abbasi, Fahad/0000-0001-5609-4913; Eleraky, Wafaa/0000-0001-5598-6960	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [D9/166/1434]; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	This work was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant No (D9/166/1434). The authors, therefore, acknowledge with thanks, DSR for technical and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Abd AM, 2010, EUR J PHARMACOL, V644, P245, DOI 10.1016/j.ejphar.2010.07.006; Asanuma Y, 2002, EUR J PHARMACOL, V435, P253, DOI 10.1016/S0014-2999(01)01555-2; Bartlett RR, 1996, TRANSPLANT P, V28, P3074; Benucci M, 2009, INT J IMMUNOPATH PH, V22, P1147, DOI 10.1177/039463200902200434; BEVILACQUA M, 1994, EUR J PHARM-MOLEC PH, V268, P415, DOI 10.1016/0922-4106(94)90067-1; Bracewell C, 2009, EXPERT OPIN BIOL TH, V9, P909, DOI 10.1517/14712590903033919; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Burger D, 2003, RHEUMATOLOGY, V42, P89, DOI 10.1093/rheumatology/keg038; Cao WW, 1996, TRANSPL P, V28, P3079; CAPECCHI PL, 1993, ARZNEIMITTEL-FORSCH, V43-2, P992; Chillingworth NL, 2003, J NEUROSCI METH, V128, P45, DOI 10.1016/S0165-0270(03)00147-X; CLARK RL, 1979, ARTHRITIS RHEUM, V22, P25, DOI 10.1002/art.1780220105; Cook AD, 2001, ARTHRITIS RES, V3, P293, DOI 10.1186/ar318; Coulthard LG, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3278; Curnock AP, 1997, J PHARMACOL EXP THER, V282, P339; Araujo FAD, 2012, J CRANIO MAXILL SURG, V40, pE346, DOI 10.1016/j.jcms.2012.01.018; de Mello S B, 1994, Sao Paulo Med J, V112, P489; Dimitrova P, 2002, J IMMUNOL, V169, P3392, DOI 10.4049/jimmunol.169.6.3392; Falgarone G, 2009, JOINT BONE SPINE, V76, P327, DOI 10.1016/j.jbspin.2008.12.007; Fox RI, 1999, CLIN IMMUNOL, V93, P198, DOI 10.1006/clim.1999.4777; Fox RI, 1998, J RHEUMATOL, V25, P20; Hamilton LC, 1999, BRIT J PHARMACOL, V127, P1589, DOI 10.1038/sj.bjp.0702708; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177; Inotai A, 2012, ACTA POL PHARM, V69, P773; Joosten LAB, 1999, J IMMUNOL, V163, P5049; KENT EF, 1990, J CLIN IMMUNOL, V10, P106, DOI 10.1007/BF00918192; Khalil NA, 2012, ARCH PHARM RES, V35, P995, DOI 10.1007/s12272-012-0606-9; McVey DC, 2001, PEPTIDES, V22, P1439, DOI 10.1016/S0196-9781(01)00463-6; MILLER EJ, 1982, METHOD ENZYMOL, V82, P33; Pelletier J P, 1993, Drugs, V46 Suppl 1, P34; Pincus T, 1999, ANN INTERN MED, V131, P768, DOI 10.7326/0003-4819-131-10-199911160-00009; Ramiro S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008886.pub2; Rozman B, 2002, CLIN PHARMACOKINET, V41, P421, DOI 10.2165/00003088-200241060-00003; Schipper LG, 2011, RHEUMATOLOGY, V50, P1320, DOI 10.1093/rheumatology/ker084; Sengupta S, 1998, INDIAN J PHARM, V31, P322; Tool ATJ, 1996, EUR RESPIR J, V9, pS141; Urakawa K, 2000, IMMUNOPHARMACOLOGY, V48, P137, DOI 10.1016/S0162-3109(00)00197-1; Walker-Bone K, 2007, CLIN EVID; Weinblatt ME, 1996, ANN INTERN MED, V124, P773, DOI 10.7326/0003-4819-124-8-199604150-00012; Wiens A, 2009, SCAND J IMMUNOL, V70, P337, DOI 10.1111/j.1365-3083.2009.02296.x; Williams RO, 1998, SPRINGER SEMIN IMMUN, V20, P165	42	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111843	10.1371/journal.pone.0111843	http://dx.doi.org/10.1371/journal.pone.0111843			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375820	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600067
J	Li, M; Liang, Z; Sun, X; Gong, T; Zhang, ZR				Li, Man; Liang, Zhen; Sun, Xun; Gong, Tao; Zhang, Zhirong			A Polymeric Prodrug of 5-Fluorouracil-1-Acetic Acid Using a Multi-Hydroxyl Polyethylene Glycol Derivative as the Drug Carrier	PLOS ONE			English	Article							DELIVERY SYSTEMS; IN-VIVO; CLINICAL PHARMACOKINETICS; MACROMOLECULAR PRODRUGS; VASCULAR-PERMEABILITY; CANCER-CHEMOTHERAPY; ANTITUMOR-ACTIVITY; LIVER-MICROSOMES; PHASE-I; TUMOR	Purpose: Macromolecular prodrugs obtained by covalently conjugating small molecular drugs with polymeric carriers were proven to accomplish controlled and sustained release of the therapeutic agents in vitro and in vivo. Polyethylene glycol (PEG) has been extensively used due to its low toxicity, low immunogenicity and high biocompatibility. However, for linear PEG macromolecules, the number of available hydroxyl groups for drug coupling does not change with the length of polymeric chain, which limits the application of PEG for drug conjugation purposes. To increase the drug loading and prolong the retention time of 5-fluorouracil (5-Fu), a macromolecular prodrug of 5-Fu, 5-fluorouracil-1 acid-PAE derivative (5-FA-PAE) was synthesized and tested for the antitumor activity in vivo. Methods: PEG with a molecular weight of 38 kDa was selected to synthesize the multi-hydroxyl polyethylene glycol derivative (PAE) through an addition reaction. 5-fluorouracil-1 acetic acid (5-FA), a 5-Fu derivative was coupled with PEG derivatives via ester bond to form a macromolecular prodrug, 5-FA-PAE. The in vitro drug release, pharmacokinetics, in vivo distribution and antitumor effect of the prodrug were investigated, respectively. Results: The PEG-based prodrug obtained in this study possessed an exceedingly high 5-FA loading efficiency of 10.58%, much higher than the maximum drug loading efficiency of unmodified PEG with the same molecular weight, which was 0.98% theoretically. Furthermore, 5-FA-PAE exhibited suitable sustained release in tumors. Conclusion: This study provides a new approach for the development of the delivery to tumors of anticancer agents with PEG derivatives.	[Li, Man; Liang, Zhen; Sun, Xun; Gong, Tao; Zhang, Zhirong] Sichuan Univ, West China Sch Pharm, Key Lab Drug Targeting & Drug Delivery Syst, Minist Educ, Chengdu 610064, Sichuan, Peoples R China	Sichuan University	Gong, T (corresponding author), Sichuan Univ, West China Sch Pharm, Key Lab Drug Targeting & Drug Delivery Syst, Minist Educ, Chengdu 610064, Sichuan, Peoples R China.	gongtaoy@126.com; zrzzl@vip.sina.com		Gong, Tao/0000-0002-9866-9911	National Natural Science Foundation of China [30873167]; National Basic Research Program of China (973 program) [2013CB932504]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 program)(National Basic Research Program of China)	The authors acknowledge the financial support from the National Natural Science Foundation of China (no. 30873167) and the National Basic Research Program of China (973 program, No: 2013CB932504). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias JL, 2008, MOLECULES, V13, P2340, DOI 10.3390/molecules13102340; AZORI M, 1987, CRIT REV THER DRUG, V4, P39; Burton SC, 1998, J CHROMATOGR A, V796, P273, DOI 10.1016/S0021-9673(97)01020-0; CHUNG SM, 1991, INT J PHARM, V68, P61; D'Souza AJM, 2004, J PHARM SCI-US, V93, P1962, DOI 10.1002/jps.20096; Dang CT, 2006, EXPERT REV ANTICANC, V6, P427, DOI 10.1586/14737140.6.3.427; Deeken JF, 2007, ANTI-CANCER DRUG, V18, P111, DOI 10.1097/CAD.0b013e3280109411; DUSCHINSKY R, 1957, J AM CHEM SOC, V79, P4559, DOI 10.1021/ja01573a087; Goh PP, 2007, CURR CANCER DRUG TAR, V7, P743, DOI 10.2174/156800907783220462; Greenwald RB, 1996, J MED CHEM, V39, P424, DOI 10.1021/jm950475e; Guo Z, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.2556; Gupta Y, 2007, J DRUG TARGET, V15, P231, DOI 10.1080/10611860701289719; Hao AJ, 2006, DRUG DEV IND PHARM, V32, P757, DOI 10.1080/03639040600683436; Hoste K, 2004, INT J PHARMACEUT, V277, P119, DOI 10.1016/j.ijpharm.2003.07.016; Huang YZ, 2010, CURR PHARM DESIGN, V16, P2369, DOI 10.2174/138161210791920441; Hwu WJ, 2006, CANCER-AM CANCER SOC, V106, P2445, DOI 10.1002/cncr.21909; Iyer L, 1999, CANCER INVEST, V17, P494; Kang NI, 2002, POLYM INT, V51, P443, DOI 10.1002/pi.786; KELLOFF GJ, 1993, BASIC LIFE SCI, V61, P373; KINTZEL PE, 1995, CANCER TREAT REV, V21, P33, DOI 10.1016/0305-7372(95)90010-1; Koyama Y, 1996, BIOCONJUGATE CHEM, V7, P298, DOI 10.1021/bc9600123; Macdonald JS, 1999, ONCOLOGY-NY, V13, P33; Maeda H, 2003, INT IMMUNOPHARMACOL, V3, P319, DOI 10.1016/S1567-5769(02)00271-0; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Maeda H, 2009, EUR J PHARM BIOPHARM, V71, P409, DOI 10.1016/j.ejpb.2008.11.010; Malet-Martino M, 2002, ONCOLOGIST, V7, P288, DOI 10.1634/theoncologist.7-4-288; Meada H, 2001, ADV DRUG DELIV REV, V46, P169; Menei P, 1999, CANCER, V86, P325, DOI 10.1002/(SICI)1097-0142(19990715)86:2<325::AID-CNCR17>3.0.CO;2-S; Milano G, 2002, CHRONOBIOL INT, V19, P177, DOI 10.1081/CBI-120002597; Na Y, 2009, J PHARM PHARMACOL, V61, P707, DOI [10.1211/jpp/61.06.0002, 10.1211/jpp.61.06.0002]; OGISO T, 1976, JPN J PHARMACOL, V26, P445, DOI 10.1254/jjp.26.445; OGISO T, 1978, JPN J PHARMACOL, V28, P175, DOI 10.1254/jjp.28.175; Onishi H, 2008, MOLECULES, V13, P2136, DOI 10.3390/molecules13092136; PARKER WB, 1990, PHARMACOL THERAPEUT, V48, P381, DOI 10.1016/0163-7258(90)90056-8; Pasut G, 2007, PROG POLYM SCI, V32, P933, DOI 10.1016/j.progpolymsci.2007.05.008; Pasut G, 2009, ADV DRUG DELIVER REV, V61, P1177, DOI 10.1016/j.addr.2009.02.010; Pazdur R, 1998, ONCOLOGY-NY, V12, P48; RICHTER AW, 1983, INT ARCH ALLER A IMM, V70, P124, DOI 10.1159/000233309; Riebeseel K, 2002, BIOCONJUGATE CHEM, V13, P773, DOI 10.1021/bc010098m; Rowinsky EK, 2003, J CLIN ONCOL, V21, P148, DOI 10.1200/JCO.2003.03.143; Sarkar FH, 2010, MINI-REV MED CHEM, V10, P357; Sartor O, 2010, CLIN GENITOURIN CANC, V8, P23, DOI 10.3816/CGC.2010.n.004; Sawa T, 2000, CANCER RES, V60, P666; SCHALHORN A, 1992, SEMIN ONCOL, V19, P82; Sheridan W, 1998, Stem Cells, V16 Suppl 2, P193; SHUEY DL, 1995, TOXICOLOGY, V102, P207, DOI 10.1016/0300-483X(95)03049-L; SMYTH HF, 1950, J AM PHARM ASSOC SCI, V39, P349, DOI 10.1002/jps.3030390615; TAKAKURA Y, 1995, CRIT REV ONCOL HEMAT, V18, P207, DOI 10.1016/1040-8428(94)00131-C; Thompson N, 2005, CURR OPIN PHARMACOL, V5, P350, DOI 10.1016/j.coph.2005.04.007; Ton NC, 2007, CLIN CANCER RES, V13, P7113, DOI 10.1158/1078-0432.CCR-07-1550; Udo K, 2010, INT J PHARMACEUT, V388, P95, DOI 10.1016/j.ijpharm.2009.12.039; van Kuilenburg ABP, 2004, NUCLEOS NUCLEOT NUCL, V23, P1371, DOI 10.1081/NCN-200027624; Veronese FM, 2002, ADV DRUG DELIVER REV, V54, P453; Wang JX, 2002, EUR J PHARM BIOPHARM, V54, P285, DOI 10.1016/S0939-6411(02)00083-8; Yang ZY, 2000, J RARE EARTH, V18, P140; ZALIPSKY S, 1983, EUR POLYM J, V19, P1177, DOI 10.1016/0014-3057(83)90016-2; Zhao H, 2008, BIOCONJUGATE CHEM, V19, P849, DOI 10.1021/bc700333s; Zuo DS, 2001, MOLECULES, V6, P647, DOI 10.3390/60800647	58	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112888	10.1371/journal.pone.0112888	http://dx.doi.org/10.1371/journal.pone.0112888			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389968	Green Submitted, Green Published, gold			2022-12-27	WOS:000349144400138
J	Alvarez, GG; Van Dyk, DD; Davies, N; Aaron, SD; Cameron, DW; Desjardins, M; Mallick, R; Obed, N; Baikie, M				Alvarez, Gonzalo G.; Van Dyk, Deborah D.; Davies, Naomi; Aaron, Shawn D.; Cameron, D. William; Desjardins, Marc; Mallick, Ranjeeta; Obed, Natan; Baikie, Maureen			The Feasibility of the Interferon Gamma Release Assay and Predictors of Discordance with the Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in a Remote Aboriginal Community	PLOS ONE			English	Article							HEALTH-CARE WORKERS; BCG VACCINATION; CHILDREN; COST	Background: The tuberculin skin test (TST) is the standard test used to screen for latent TB infection (LTBI) in the northern Canadian territory of Nunavut. Interferon gamma release assays (IGRA) are T cell blood-based assays to diagnose LTBI. The Bacillus Calmette-Guerin (BCG) vaccine is part of the routine immunization schedule in Nunavut. The objective of this study was to test the feasibility, and predictors of discordance between the Tuberculin Skin Test (TST) and the IGRA assay in a medically under-serviced remote arctic Aboriginal population. Methods: Both the TST and QuantiFERON-TB Gold (Qiagen group) IGRA tests were offered to people in their homes as part of a public health campaign aimed at high TB risk residential areas in Iqaluit, Nunavut, Canada. Feasibility was measured by the capacity of the staff to do the test successfully as measured by the proportion of results obtained. Results: In this population of predominantly young Inuit who were mostly BCG vaccinated, the use of IGRA for the diagnosis of LTBI was feasible. IGRA testing resulted in more available test results reaching patients (95.6% vs 90.9% p = 0.02) but took longer (median 8 days (IGRA) vs 2 days (TST), p value <0.0001). 44/256 participants (17.2%) had discordant results. Multivariable regression analysis suggested that discordant results were most likely to have received multiple BCG vaccinations (RR 20.03, 95% CI, 3.94-101.82)), followed by BCG given post infancy (RR 8.13, 95% CI, 2.54-26.03)) and then to a lesser degree when BCG was given in infancy (RR 6.43, 95% CI, 1.72-24.85). Interpretation: IGRA is feasible in Iqaluit, Nunavut, a remote Arctic community. IGRA testing results in more test results available to patients compared to TST. This test could result in fewer patients requiring latent TB treatment among those previously vaccinated with BCG in a region with limited public health human resources.	[Alvarez, Gonzalo G.; Van Dyk, Deborah D.; Aaron, Shawn D.; Cameron, D. William; Desjardins, Marc; Mallick, Ranjeeta] Univ Ottawa, Ottawa Hosp Res Inst, Div Respirol, Ottawa, ON, Canada; [Alvarez, Gonzalo G.; Van Dyk, Deborah D.; Aaron, Shawn D.; Cameron, D. William; Desjardins, Marc; Mallick, Ranjeeta] Ottawa Hosp, Dept Med, Div Infect Dis, Ottawa, ON, Canada; [Alvarez, Gonzalo G.; Van Dyk, Deborah D.; Aaron, Shawn D.; Cameron, D. William; Desjardins, Marc; Mallick, Ranjeeta] Ottawa Hosp, Dept Microbiol, Ottawa, ON, Canada; [Van Dyk, Deborah D.; Davies, Naomi; Baikie, Maureen] Govt Nunavut, Iqaluit, NU, Canada; [Obed, Natan] Nunavut Tunngavik Inc, Iqaluit, NU, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute	Alvarez, GG (corresponding author), Univ Ottawa, Ottawa Hosp Res Inst, Div Respirol, Ottawa, ON, Canada.	galvarez@ohri.ca	Cameron, Bill/E-9180-2010	Cameron, Bill/0000-0002-0090-3539; Alvarez, Gonzalo G/0000-0003-1562-5305; Aaron, Shawn/0000-0002-4762-3542	Public Health Agency of Canada; National Lung Health Framework	Public Health Agency of Canada; National Lung Health Framework	The Public Health Agency of Canada, The National Lung Health Framework. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Nunavut Tunngavik Inc. did not provide support in the form of salaries and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this authors is articulated in the 'author contributions' section.	Alvarez GG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100975; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Dewan PK, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-47; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28; FRIEDLAND IR, 1990, S AFR MED J, V77, P387; Government of Nunavut Nunavut TB, CONTR EL MAN; GRINDULIS H, 1984, ARCH DIS CHILD, V59, P614, DOI 10.1136/adc.59.7.614; GRZYBOWSKI S, 1976, TUBERCLE, V57, pS1, DOI 10.1016/0041-3879(76)90059-3; Jacobs S, 2011, PEDIATR INFECT DIS J, V30, P754, DOI 10.1097/INF.0b013e31821b8f54; Machado A, 2009, INT J TUBERC LUNG D, V13, P446; Machingaidze S, 2012, AM J RESP CRIT CARE, V186, P1051, DOI 10.1164/rccm.201206-1134OC; Mancuso JD, 2012, AM J RESP CRIT CARE, V185, P427, DOI 10.1164/rccm.201107-1244OC; Menzies D, 2013, CANADIAN RESP J, V20; Nienhaus A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-247; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; Pai M, 2012, CAN RESPIR J, V19, P81, DOI 10.1155/2012/420392; Proctor E, 2011, ADM POLICY MENT HLTH, V38, P65, DOI 10.1007/s10488-010-0319-7; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Shah M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036551; Soborg B, 2010, EUR RESPIR J, V36, P878, DOI 10.1183/09031936.00015510; Zwerling A, 2012, THORAX, V67, P62, DOI 10.1136/thx.2010.143180	23	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111986	10.1371/journal.pone.0111986	http://dx.doi.org/10.1371/journal.pone.0111986			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386908	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400034
J	Campisano, A; Antonielli, L; Pancher, M; Yousaf, S; Pindo, M; Pertot, I				Campisano, Andrea; Antonielli, Livio; Pancher, Michael; Yousaf, Sohail; Pindo, Massimo; Pertot, Ilaria			Bacterial Endophytic Communities in the Grapevine Depend on Pest Management	PLOS ONE			English	Article							VITIS-VINIFERA L.; DIVERSITY; ROOTS; SOIL; SEQUENCE; BIOCONTROL; INFECTION; RHIZOBIA; NUMBER; LEAVES	Microbial plant endophytes are receiving ever-increasing attention as a result of compelling evidence regarding functional interaction with the host plant. Microbial communities in plants were recently reported to be influenced by numerous environmental and anthropogenic factors, including soil and pest management. In this study we used automated ribosomal intergenic spacer analysis (ARISA) fingerprinting and pyrosequencing of 16S rDNA to assess the effect of organic production and integrated pest management (IPM) on bacterial endophytic communities in two widespread grapevines cultivars (Merlot and Chardonnay). High levels of the dominant Ralstonia, Burkholderia and Pseudomonas genera were detected in all the samples We found differences in the composition of endophytic communities in grapevines cultivated using organic production and IPM. Operational taxonomic units (OTUs) assigned to the Mesorhizobium, Caulobacter and Staphylococcus genera were relatively more abundant in plants from organic vineyards, while Ralstonia, Burkholderia and Stenotrophomonas were more abundant in grapevines from IPM vineyards. Minor differences in bacterial endophytic communities were also found in the grapevines of the two cultivars.	[Campisano, Andrea; Antonielli, Livio; Pancher, Michael; Yousaf, Sohail; Pindo, Massimo; Pertot, Ilaria] Fdn Edmund Mach, Res & Innovat Ctr, San Michele All Adige, TN, Italy; [Antonielli, Livio] Austrian Inst Technol GmbH, Dept Hlth & Environm, Bioresources Unit, Tulln, Austria; [Yousaf, Sohail] Quaid I Azam Univ, Dept Environm Sci, Islamabad, Pakistan	Fondazione Edmund Mach; Quaid I Azam University	Campisano, A (corresponding author), Fdn Edmund Mach, Res & Innovat Ctr, San Michele All Adige, TN, Italy.	andrea.campisano@fmach.it	Campisano, Andrea/F-2077-2010	Campisano, Andrea/0000-0003-4865-5105	Provincia Autonoma di Trento; progetto PAT - Call 2 Team - Incoming - Mecagrafic; COST Action [FA1103]; Austrian Institute of Technology GmbH	Provincia Autonoma di Trento(Autonomous Province of Trento); progetto PAT - Call 2 Team - Incoming - Mecagrafic; COST Action(European Cooperation in Science and Technology (COST)); Austrian Institute of Technology GmbH	This work was supported by Provincia Autonoma di Trento, progetto PAT - Call 2 Team 2009 - Incoming - Mecagrafic and COST Action FA1103. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Livio Antonielli is currently employed by Austrian Institute of Technology GmbH. Austrian Institute of Technology GmbH provided support in the form of salary for author Livio Antonielli, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bienhold C, 2012, ISME J, V6, P724, DOI 10.1038/ismej.2011.140; Bloemberg GV, 2001, CURR OPIN PLANT BIOL, V4, P343, DOI 10.1016/S1369-5266(00)00183-7; Bokulich NA, 2014, P NATL ACAD SCI USA, V111, pE139, DOI 10.1073/pnas.1317377110; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Bulgari D, 2011, APPL ENVIRON MICROB, V77, P5018, DOI 10.1128/AEM.00051-11; Bulgari D, 2009, J MICROBIOL, V47, P393, DOI 10.1007/s12275-009-0082-1; BUNGE J, 1993, J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; Burke C, 2011, P NATL ACAD SCI USA, V108, P14288, DOI 10.1073/pnas.1101591108; Caffarra A, 2011, AUST J GRAPE WINE R, V17, P52, DOI 10.1111/j.1755-0238.2010.00118.x; Calbrix R, 2003, ABSTR PAP AM CHEM S, V225, pU911; Campisano A, 2014, MOL BIOL EV IN PRESS; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CHAO A, 1984, SCAND J STAT, V11, P265; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Chi F, 2005, APPL ENVIRON MICROB, V71, P7271, DOI 10.1128/AEM.71.11.7271-7278.2005; Compant S, 2005, APPL ENVIRON MICROB, V71, P1685, DOI 10.1128/AEM.71.4.1685-1693.2005; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Corneo PE, 2013, FEMS MICROBIOL ECOL, V84, P588, DOI 10.1111/1574-6941.12087; Corneo PE, 2013, PLANT SOIL, P1; De Caceres M, 2009, ECOLOGY, V90, P3566, DOI 10.1890/08-1823.1; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Estrada-de los Santos P, 2013, CURR MICROBIOL, V67, P51, DOI 10.1007/s00284-013-0330-9; Fernandez O, 2012, MOL PLANT MICROBE IN, V25, P496, DOI 10.1094/MPMI-09-11-0245; Gage DJ, 2004, MICROBIOL MOL BIOL R, V68, P280, DOI 10.1128/MMBR.68.2.280-300.2004; Ghyselinck J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071360; Gobet A, 2014, ENVIRON MICROBIOL, V16, P2672, DOI 10.1111/1462-2920.12308; Gowen JC, 2005, QUAL QUANT, V39, P359, DOI 10.1007/s11135-005-3005-1; Granado J, 2008, MICROB ECOL, V56, P720, DOI 10.1007/s00248-008-9391-x; Halary S, 2010, P NATL ACAD SCI USA, V107, P127, DOI 10.1073/pnas.0908978107; Hallmann J, 1997, CAN J MICROBIOL, V43, P895, DOI 10.1139/m97-131; Hardoim PR, 2011, FEMS MICROBIOL ECOL, V77, P154, DOI 10.1111/j.1574-6941.2011.01092.x; Hartmann M, 2014, ISME J, V8, P226, DOI 10.1038/ismej.2013.141; Hartmann M, 2012, ISME J, V6, P2199, DOI 10.1038/ismej.2012.84; Heungens K, 2000, APPL ENVIRON MICROB, V66, P5192, DOI 10.1128/AEM.66.12.5192-5200.2000; Hilton S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059859; Ikeda S, 2010, PLANT CELL PHYSIOL, V51, P1398, DOI 10.1093/pcp/pcq119; Jabbour R, 2009, BIOL CONTROL, V51, P435, DOI 10.1016/j.biocontrol.2009.08.004; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Legendre P., 2012, NUMERICAL ECOLOGY; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Manter DK, 2010, MICROB ECOL, V60, P157, DOI 10.1007/s00248-010-9658-x; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Moy M, 2002, PLANT PHYSIOL, V130, P1298, DOI 10.1104/pp.010108; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Pancher M, 2012, APPL ENVIRON MICROB, V78, P4308, DOI 10.1128/AEM.07655-11; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Pinamonti F, 1997, RESOUR CONSERV RECY, V21, P129, DOI 10.1016/S0921-3449(97)00032-3; Pinto C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085622; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmid F, 2011, APPL ENVIRON MICROB, V77, P2188, DOI 10.1128/AEM.02187-10; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sessitsch A, 2012, MOL PLANT MICROBE IN, V25, P28, DOI 10.1094/MPMI-08-11-0204; Setati ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052609; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Theocharis A, 2012, MOL PLANT MICROBE IN, V25, P241, DOI 10.1094/MPMI-05-11-0124; Toju H, 2013, ECOL EVOL, V3, P3112, DOI 10.1002/ece3.706; Ulrich K, 2008, FEMS MICROBIOL ECOL, V63, P169, DOI 10.1111/j.1574-6941.2007.00419.x; van Elsas JD, 2008, TRENDS BIOTECHNOL, V26, P591, DOI 10.1016/j.tibtech.2008.07.004; van Overbeek LS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00104; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; West ER, 2010, CAN J MICROBIOL, V56, P209, DOI [10.1139/w10-004, 10.1139/W10-004]; Wright KM, 2013, PHYTOPATHOLOGY, V103, P333, DOI 10.1094/PHYTO-08-12-0209-FI; Yousaf S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00327; Zabalgogeazcoa I, 2008, SPAN J AGRIC RES, V6, P138, DOI 10.5424/sjar/200806S1-382	76	68	70	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112763	10.1371/journal.pone.0112763	http://dx.doi.org/10.1371/journal.pone.0112763			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25387008	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400091
J	Fastner, C; Mairbaurl, H; Weber, NC; van der Sluijs, K; Hackl, F; Hotz, L; Dahan, A; Hollmann, MW; Berger, MM				Fastner, Christian; Mairbaeurl, Heimo; Weber, Nina C.; van der Sluijs, Koen; Hackl, Florian; Hotz, Lorenz; Dahan, Albert; Hollmann, Markus W.; Berger, Marc M.			Intravenous S-Ketamine Does Not Inhibit Alveolar Fluid Clearance in a Septic Rat Model	PLOS ONE			English	Article							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; EPITHELIAL SODIUM-CHANNELS; EDEMA-CLEARANCE; TRANSPORT; HYPOXIA; INFUSION; ANESTHESIA; CHILDREN; SEDATION	We previously demonstrated that intratracheally administered S-ketamine inhibits alveolar fluid clearance (AFC), whereas an intravenous (IV) bolus injection had no effect. The aim of the present study was to characterize whether continuous IV infusion of S-ketamine, yielding clinically relevant plasma concentrations, inhibits AFC and whether its effect is enhanced in acute lung injury (ALI) which might favor the appearance of IV S-ketamine at the alveolar surface. AFC was measured in fluid-instilled rat lungs. S-ketamine was administered IV over 6 h (loading dose: 20 mg/kg, followed by 20 mg/kg/h), or intratracheally by addition to the instillate (75 mu g/ml). ALI was induced by IV lipopolysaccharide (LPS; 7 mg/kg). Interleukin (IL)-6 and cytokine-induced neutrophil chemoattractant (CINC)-3 were measured by ELISA in plasma and bronchoalveolar lavage fluid. Isolated rat alveolar type-II cells were exposed to S-ketamine (75 mu g/ml) and/or LPS (1 mg/ml) for 6 h, and transepithelial ion transport was measured as short circuit current (ISC). AFC was 27 +/- 5% (mean +/- SD) over 60 min in control rats and was unaffected by IV S-ketamine. Tracheal S-ketamine reduced AFC to 18 +/- 9%. In LPS-treated rats, AFC decreased to 16 +/- 6%. This effect was not enhanced by IV S-ketamine. LPS increased IL-6 and CINC-3 in plasma and bronchoalveolar lavage fluid. In alveolar type-II cells, S-ketamine reduced ISC by 37% via a decrease in amiloride-inhibitable sodium transport. Continuous administration of IV S-ketamine does not affect rat AFC even in endotoxin-induced ALI. Tracheal application with direct exposure of alveolar epithelial cells to S-ketamine decreases AFC by inhibition of amiloride-inhibitable sodium transport.	[Fastner, Christian; Hotz, Lorenz; Berger, Marc M.] Univ Heidelberg Hosp, Dept Anesthesiol, Heidelberg, Germany; [Fastner, Christian; Mairbaeurl, Heimo] Univ Heidelberg Hosp, Med Clin 7, Heidelberg, Germany; [Weber, Nina C.; van der Sluijs, Koen] Univ Amsterdam AMC, Lab Expt Intens Care & Anesthesiol, Amsterdam, Netherlands; [Dahan, Albert] Univ Med Ctr, Dept Anesthesiol, Leiden, Netherlands; [Hollmann, Markus W.] Univ Amsterdam AMC, Dept Anesthesiol, Amsterdam, Netherlands; [Hackl, Florian; Hotz, Lorenz; Berger, Marc M.] Paracelsus Med Univ, Salzburg Gen Hosp, Dept Anesthesiol Crit Care & Pain Med, Salzburg, Austria	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Paracelsus Private Medical University	Berger, MM (corresponding author), Univ Heidelberg Hosp, Dept Anesthesiol, Heidelberg, Germany.	ma.berger@salk.at	Berger, Marc/AAN-2887-2020; Dahan, Albert/B-8845-2008; Weber, Nina/CAH-0231-2022	Dahan, Albert/0000-0003-3161-3945; Weber, Nina/0000-0003-1111-9042; Berger, Marc Moritz/0000-0001-6771-3193	Pfizer; Eurocept	Pfizer(Pfizer); Eurocept	The authors of this manuscript have the following competing interests: Markus Hollmann has received speaker fees and research support from Pfizer and Eurocept. For the remaining authors, none were declared. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Berger MM, 2010, ANESTH ANALG, V111, P164, DOI 10.1213/ANE.0b013e3181e21cc9; Berger MM, 2009, ANESTH ANALG, V108, P225, DOI 10.1213/ane.0b013e31818881a8; Berthiaume Y, 2002, J APPL PHYSIOL, V93, P2207, DOI 10.1152/japplphysiol.01201.2001; Bourgoin A, 2005, CRIT CARE MED, V33, P1109, DOI 10.1097/01.CCM.0000162491.26292.98; Craven R, 2007, ANAESTHESIA, V62, P48, DOI 10.1111/j.1365-2044.2007.05298.x; Cui Y, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/460596; Dallimore D, 2008, PEDIATR ANESTH, V18, P708, DOI 10.1111/j.1460-9592.2008.02665.x; DOBBS LG, 1990, AM J PHYSIOL, V258, pL134, DOI 10.1152/ajplung.1990.258.4.L134; Durmus M, 2003, ANESTH ANALG, V97, P1377, DOI 10.1213/01.ANE.0000080611.29106.9E; Haitsma JJ, 2009, ACTA ANAESTH SCAND, V53, P176, DOI 10.1111/j.1399-6576.2008.01844.x; Herd DW, 2008, PEDIATR ANESTH, V18, P36, DOI 10.1111/j.1460-9592.2007.02384.x; Laffon M, 2002, ANESTHESIOLOGY, V96, P392, DOI 10.1097/00000542-200202000-00026; LASH JM, 1992, J APPL PHYSIOL, V72, P1247, DOI 10.1152/jappl.1992.72.4.1247; Mairbaurl H, 2002, AM J PHYSIOL-LUNG C, V282, pL659, DOI 10.1152/ajplung.00355; MATALON S, 1991, AM J PHYSIOL, V261, pC727, DOI 10.1152/ajpcell.1991.261.5.C727; Matthay MA, 2002, J APPL PHYSIOL, V93, P1533, DOI 10.1152/japplphysiol.01210.2001; MATTHAY MA, 1990, AM REV RESPIR DIS, V142, P1250, DOI 10.1164/ajrccm/142.6_Pt_1.1250; Miller AC, 2011, MINERVA ANESTESIOL, V77, P812; Molina R, 2011, BBA-BIOMEMBRANES, V1808, P1818, DOI 10.1016/j.bbamem.2011.03.004; Ostermann ME, 2000, JAMA-J AM MED ASSOC, V283, P1451, DOI 10.1001/jama.283.11.1451; Perez-Gil J, 2010, PHYSIOLOGY, V25, P132, DOI 10.1152/physiol.00006.2010; Perkins GD, 2008, THORAX, V63, P215, DOI 10.1136/thx.2007.080382; Perkins GD, 2006, AM J RESP CRIT CARE, V173, P281, DOI 10.1164/rccm.200508-1302OC; Planes C, 1997, AM J RESP CELL MOL, V17, P508, DOI 10.1165/ajrcmb.17.4.2680; Sakuma T, 2006, CRIT CARE MED, V34, P676, DOI 10.1097/01.CCM.0000201403.70636.0F; Sakuma T, 2002, J THORAC CARDIOV SUR, V124, P668, DOI 10.1067/mtc.2002.122549; Sakuma T, 2001, J APPL PHYSIOL, V91, P1766, DOI 10.1152/jappl.2001.91.4.1766; SAKUMA T, 1993, J APPL PHYSIOL, V74, P176, DOI 10.1152/jappl.1993.74.1.176; Sartori C, 2002, EUR RESPIR J, V20, P1299, DOI 10.1183/09031936.02.00401602; Sinner B., 2008, V182, P313, DOI 10.1007/978-3-540-74806-9_15; Vivona ML, 2001, AM J RESP CELL MOL, V25, P554, DOI 10.1165/ajrcmb.25.5.4420; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035; Welters ID, 2011, BRIT J ANAESTH, V106, P172, DOI 10.1093/bja/aeq341; Yamasawa H, 1999, INFLAMMATION, V23, P263; Zeyed YF, 2012, AM J PHYSIOL-LUNG C, V303, pL550, DOI 10.1152/ajplung.00190.2012	36	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112622	10.1371/journal.pone.0112622	http://dx.doi.org/10.1371/journal.pone.0112622			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386677	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400073
J	Khosravi, Y; Dieye, Y; Loke, MF; Goh, KL; Vadivelu, J				Khosravi, Yalda; Dieye, Yakhya; Loke, Mun Fai; Goh, Khean Lee; Vadivelu, Jamuna			Streptococcus mitis Induces Conversion of Helicobacter pylori to Coccoid Cells during Co-Culture In Vitro	PLOS ONE			English	Article							GUT MICROBIOTA; MONGOLIAN GERBILS; INFECTION; STOMACH; FORMS; FLORA	Helicobacter pylori (H. pylori) is a major gastric pathogen that has been associated with humans for more than 60,000 years. H. pylori causes different gastric diseases including dyspepsia, ulcers and gastric cancers. Disease development depends on several factors including the infecting H. pylori strain, environmental and host factors. Another factor that might influence H. pylori colonization and diseases is the gastric microbiota that was overlooked for long because of the belief that human stomach was a hostile environment that cannot support microbial life. Once established, H. pylori mainly resides in the gastric mucosa and interacts with the resident bacteria. How these interactions impact on H. pylori-caused diseases has been poorly studied in human. In this study, we analyzed the interactions between H. pylori and two bacteria, Streptocccus mitis and Lactobacillus fermentum that are present in the stomach of both healthy and gastric disease human patients. We have found that S. mitis produced and released one or more diffusible factors that induce growth inhibition and coccoid conversion of H. pylori cells. In contrast, both H. pylori and L. fermentum secreted factors that promote survival of S. mitis during the stationary phase of growth. Using a metabolomics approach, we identified compounds that might be responsible for the conversion of H. pylori from spiral to coccoid cells. This study provide evidences that gastric bacteria influences H. pylori physiology and therefore possibly the diseases this bacterium causes.	[Khosravi, Yalda; Loke, Mun Fai; Vadivelu, Jamuna] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Dieye, Yakhya] Univ Malaya, Vice Chancellors Off, Kuala Lumpur, Malaysia; [Goh, Khean Lee] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Vadivelu, J (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	jamuna@ummc.edu.my	Dieye, Yakhya/P-9086-2019; VADIVELU, JAMUNARANI S/B-8696-2010; Loke, Mun Fai/B-1060-2011; Goh, Khean-Lee/B-6404-2009; Dieye, Yakhya/A-5175-2012	VADIVELU, JAMUNARANI S/0000-0001-7322-3676; Loke, Mun Fai/0000-0002-3554-5313; Goh, Khean-Lee/0000-0002-9965-1561; Dieye, Yakhya/0000-0003-2461-6558	University of Malaya-Ministry of Higher Education, UM-MOHE; High Impact Research (HIR) [UM.C/625/1/HIR/MOHE/CHAN-02, A000002-50001]	University of Malaya-Ministry of Higher Education, UM-MOHE; High Impact Research (HIR)	This work was supported by University of Malaya-Ministry of Higher Education, UM-MOHE, High Impact Research (HIR) grant UM.C/625/1/HIR/MOHE/CHAN-02; account no. A000002-50001, "Molecular Genetics''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer T, 2006, FEMS IMMUNOL MED MIC, V46, P221, DOI 10.1111/rp10.1016-j.femsim.2004.05.008; CATRENICH CE, 1991, SCAND J GASTROENTERO, V26, P58, DOI 10.3109/00365529109093209; CELLINI L, 1994, MICROBIOL IMMUNOL, V38, P25, DOI 10.1111/j.1348-0421.1994.tb01740.x; CHAN WY, 1994, AM J CLIN PATHOL, V102, P503, DOI 10.1093/ajcp/102.4.503; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Cox AJ, 2010, BRIT J SPORT MED, V44, P222, DOI 10.1136/bjsm.2007.044628; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Denapaite D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009426; Donelli G, 1998, FEMS MICROBIOL LETT, V168, P9, DOI 10.1016/S0378-1097(98)00405-4; Engstrand L, 2013, BEST PRACT RES CL GA, V27, P39, DOI 10.1016/j.bpg.2013.03.016; Figura N, 2012, NEW MICROBIOL, V35, P335; Hu Y, 2012, WORLD J GASTROENTERO, V18, P1257, DOI 10.3748/wjg.v18.i11.1257; Khalifa MM, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-2; Khosravi Y, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-25; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Lee CW, 2009, CANCER RES, V69, P8166, DOI 10.1158/0008-5472.CAN-08-3856; Li N, 2013, J BASIC MICROB, V53, P147, DOI 10.1002/jobm.201100370; Li XX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007985; Lofgren JL, 2011, GASTROENTEROLOGY, V140, P210, DOI 10.1053/j.gastro.2010.09.048; Maldonado J, 2012, J PEDIATR GASTR NUTR, V54, P55, DOI 10.1097/MPG.0b013e3182333f18; McCarthy AR, 2012, BIOORGAN MED CHEM, V20, P1779, DOI 10.1016/j.bmc.2012.01.001; Mikelsaar Marika, 2009, Microbial Ecology in Health and Disease, V21, P1, DOI 10.1080/08910600902815561; Mitchell J, 2011, MOL ORAL MICROBIOL, V26, P89, DOI 10.1111/j.2041-1014.2010.00601.x; Moodley Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002693; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; NILIUS M, 1993, ZBL BAKT-INT J MED M, V280, P259; Nilsson HO, 2002, APPL ENVIRON MICROB, V68, P11, DOI 10.1128/AEM.68.1.11-19.2002; Osaki T, 2012, MICROB PATHOGENESIS, V53, P12, DOI 10.1016/j.micpath.2012.03.008; Pacifico L, 2014, WORLD J GASTROENTERO, V20, P673, DOI 10.3748/wjg.v20.i3.673; Ricci V, 2011, WORLD J GASTROENTERO, V17, P1383, DOI 10.3748/wjg.v17.i11.1383; Rolig AS, 2013, INFECT IMMUN, V81, P1382, DOI 10.1128/IAI.00044-13; Ruiz-Moyano S, 2011, FOOD MICROBIOL, V28, P839, DOI 10.1016/j.fm.2011.01.006; Saito Nagahito, 2008, Hokkaido Igaku Zasshi, V83, P291; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sheh A, 2013, GUT MICROBES, V4, P505, DOI 10.4161/gmic.26205; Sun YQ, 2003, HELICOBACTER, V8, P149, DOI 10.1046/j.1523-5378.2003.00136.x; Ueno T, 2013, ONCOL RES, V21, P155, DOI 10.3727/096504013X13854886566598; van Leeuwen IMM, 2012, CELL CYCLE, V11, P1851, DOI 10.4161/cc.20254; Wang ZK, 2013, WORLD J GASTROENTERO, V19, P1541, DOI 10.3748/wjg.v19.i10.1541; Yin YN, 2011, HELICOBACTER, V16, P389, DOI 10.1111/j.1523-5378.2011.00862.x; Zaman C, 2014, J MED MICROBIOL, V63, P129, DOI 10.1099/jmm.0.061135-0	41	25	26	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112214	10.1371/journal.pone.0112214	http://dx.doi.org/10.1371/journal.pone.0112214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386948	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400050
J	Ota, L; Uchitomi, H; Ogawa, K; Orimo, S; Miyake, Y				Ota, Leo; Uchitomi, Hirotaka; Ogawa, Ken-ichiro; Orimo, Satoshi; Miyake, Yoshihiro			Relationship between Neural Rhythm Generation Disorders and Physical Disabilities in Parkinson's Disease Patients' Walking	PLOS ONE			English	Article							LONG-RANGE CORRELATIONS; BASAL GANGLIA DYSFUNCTION; FRACTAL DYNAMICS; STRIDE-INTERVAL; AUDITORY-STIMULATION; HUNTINGTONS-DISEASE; GAIT DISTURBANCES; TIME-SERIES; FLUCTUATIONS; FALLS	Walking is generated by the interaction between neural rhythmic and physical activities. In fact, Parkinson's disease (PD), which is an example of disease, causes not only neural rhythm generation disorders but also physical disabilities. However, the relationship between neural rhythm generation disorders and physical disabilities has not been determined. The aim of this study was to identify the mechanism of gait rhythm generation. In former research, neural rhythm generation disorders in PD patients' walking were characterized by stride intervals, which are more variable and fluctuate randomly. The variability and fluctuation property were quantified using the coefficient of variation (CV) and scaling exponent alpha. Conversely, because walking is a dynamic process, postural reflex disorder (PRD) is considered the best way to estimate physical disabilities in walking. Therefore, we classified the severity of PRD using CV and alpha. Specifically, PD patients and healthy elderly were classified into three groups: no-PRD, mild-PRD, and obvious-PRD. We compared the contributions of CV and alpha to the accuracy of this classification. In this study, 45 PD patients and 17 healthy elderly people walked 200 m. The severity of PRD was determined using the modified Hoehn-Yahr scale (mH-Y). People with mH-Y scores of 2.5 and 3 had mild-PRD and obvious-PRD, respectively. As a result, CV differentiated no-PRD from PRD, indicating the correlation between CV and PRD. Considering that PRD is independent of neural rhythm generation, this result suggests the existence of feedback process from physical activities to neural rhythmic activities. Moreover, alpha differentiated obvious-PRD from mild-PRD. Considering alpha reflects the intensity of interaction between factors, this result suggests the change of the interaction. Therefore, the interaction between neural rhythmic and physical activities is thought to plays an important role for gait rhythm generation. These characteristics have potential to evaluate the symptoms of PD.	[Ota, Leo; Uchitomi, Hirotaka; Ogawa, Ken-ichiro; Miyake, Yoshihiro] Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 227, Japan; [Orimo, Satoshi] Kanto Cent Hosp, Dept Neurol, Setagaya Ku, Tokyo, Japan	Tokyo Institute of Technology	Ota, L (corresponding author), Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 227, Japan.	ohta@myk.dis.titech.ac.jp	Ota, Leo/H-8456-2012	Ota, Leo/0000-0002-1891-5095	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23300209]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) Grant-in-Aid for Scientific Research (B) to Dr. Miyake (MEXT KAKENHI Grant Number 23300209, URL: http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073239; Bloem BR, 1998, J NEUROL, V245, P669, DOI 10.1007/s004150050265; Delignieres D, 2006, J MATH PSYCHOL, V50, P525, DOI 10.1016/j.jmp.2006.07.004; Duda R.O., 2006, PATTERN CLASSIFICATI; Gates DH, 2007, PHYSICA A, V380, P259, DOI 10.1016/j.physa.2007.02.061; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; Hausdorff JM, 2007, EUR J NEUROSCI, V26, P2369, DOI 10.1111/j.1460-9568.2007.05810.x; Hausdorff JM, 2009, CHAOS, V19, DOI 10.1063/1.3147408; Hausdorff JM, 1996, J APPL PHYSIOL, V80, P1448, DOI 10.1152/jappl.1996.80.5.1448; Hausdorff JM, 1997, J APPL PHYSIOL, V82, P262; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; Hausdorff JM, 2001, PHYSICA A, V302, P138, DOI 10.1016/S0378-4371(01)00460-5; Hausdorff JM, 2000, J APPL PHYSIOL, V88, P2045, DOI 10.1152/jappl.2000.88.6.2045; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hove MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032600; Ivanov PC, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.041920; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Miyake Y, 2009, IEEE T ROBOT, V25, P638, DOI 10.1109/TRO.2009.2020350; Pearson KG, 2000, ANNU REV PHYSIOL, V62, P723, DOI 10.1146/annurev.physiol.62.1.723; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Rubinstein TC, 2002, MOVEMENT DISORD, V17, P1148, DOI 10.1002/mds.10259; Schaafsma JD, 2003, J NEUROL SCI, V212, P47, DOI 10.1016/S0022-510X(03)00104-7; TAGA G, 1991, BIOL CYBERN, V65, P147, DOI 10.1007/BF00198086; Takakusaki K, 2004, NEUROSCI RES, V50, P137, DOI 10.1016/j.neures.2004.06.015; Takakusaki K, 2003, NEUROSCIENCE, V119, P293, DOI 10.1016/S0306-4522(03)00095-2; Takakusaki K, 2008, J NEUROL, V255, P19, DOI 10.1007/s00415-008-4004-7; Thaut MH, 2010, MUSIC PERCEPT, V27, P263, DOI 10.1525/MP.2010.27.4.263; Thorbahn LDB, 1996, PHYS THER, V76, P576, DOI 10.1093/ptj/76.6.576; Tomita N, 2007, P 2007 IEEE ICME, P116; Uchitomi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072176	34	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112952	10.1371/journal.pone.0112952	http://dx.doi.org/10.1371/journal.pone.0112952			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386639	gold, Green Published, Green Submitted			2022-12-27	WOS:000345250400107
J	Ramirez-Perez, FI; Schenewerk, AL; Coffman, KL; Foote, C; Ji, TM; Rivera, RM; Martinez-Lemus, LA				Ramirez-Perez, Francisco I.; Schenewerk, Angela L.; Coffman, Katy L.; Foote, Christopher; Ji, Tieming; Rivera, Rocio M.; Martinez-Lemus, Luis A.			Effects of the Use of Assisted Reproductive Technologies and an Obesogenic Environment on Resistance Artery Function and Diabetes Biomarkers in Mice Offspring	PLOS ONE			English	Article							DIET-INDUCED OBESITY; PLASMINOGEN-ACTIVATOR INHIBITOR-1; PREIMPLANTATION MOUSE EMBRYOS; IN-VITRO FERTILIZATION; INSULIN-RESISTANCE; OXIDATIVE STRESS; WEIGHT-GAIN; BIRTH-DEFECTS; GHRELIN; EXPRESSION	Maternal obesity affects the incidence of cardiovascular disease and diabetes in offspring. Also the use of assisted reproductive technologies (ART) has been associated with cardiovascular deficiencies in offspring. Obese women often suffer from infertility and use ART to achieve a pregnancy, but the combined effects of maternal obesity and ART on cardiovascular health and incidence of diabetes in the offspring is not known. Here, we report the effects of the use of ART within an obesogenic environment, consisting of feeding a western diet (WD) to dams and offspring, on resistance artery function and presence of diabetes biomarkers in juvenile mice offspring. Our results indicate that WD and ART interacted to induce endothelial dysfunction in mesenteric resistance arteries isolated from 7-week-old mice offspring. This was determined by presence of a reduced acetylcholine-induced dilation compared to controls. The arteries from these WD-ART mice also had greater wall cross-sectional areas and wall to lumen ratios indicative of vascular hypertrophic remodeling. Of the diabetes biomarkers measured, only resistin was affected by a WD x ART interaction. Serum resistin was significantly greater in WD-ART offspring compared to controls. Diet and sex effects were observed in other diabetes biomarkers. Our conclusion is that in mice the use of ART within an obesogenic environment interacts to favor the development of endothelial dysfunction in the resistance arteries of juvenile offspring, while having marginal effects on diabetes biomarkers.	[Ramirez-Perez, Francisco I.; Foote, Christopher; Martinez-Lemus, Luis A.] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA; [Ramirez-Perez, Francisco I.; Martinez-Lemus, Luis A.] Univ Missouri, Dept Biol Engn, Columbia, MO 65211 USA; [Schenewerk, Angela L.; Rivera, Rocio M.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Coffman, Katy L.; Ji, Tieming] Univ Missouri, Dept Stat, Columbia, MO 65211 USA; [Martinez-Lemus, Luis A.] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Rivera, RM (corresponding author), Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.	riverarm@missouri.edu; martinezlemusl@missouri.edu	Ramirez-Perez, Francisco I./ABC-8674-2020	Ramirez-Perez, Francisco/0000-0003-4920-383X; Rivera, Rocio Melissa/0000-0002-9832-9618	National Institutes of Health [RO1 HL088105]; Animal Reproductive Biology Cluster [F21C]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Animal Reproductive Biology Cluster; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (RO1 HL088105 to LAM), and Animal Reproductive Biology Cluster (F21C to RMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El Gawad SS, 2012, ENDOCR PRACT, V18, P376, DOI 10.4158/EP11130.OR; Barbero A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078424; Birk RZ, 2014, BRIT J NUTR, V112, P154, DOI 10.1017/S0007114514000816; Briggs DI, 2010, ENDOCRINOLOGY, V151, P4745, DOI 10.1210/en.2010-0556; Broglio F, 2001, J CLIN ENDOCR METAB, V86, P5083, DOI 10.1210/jc.86.10.5083; Cai H, 2003, TRENDS PHARMACOL SCI, V24, P471, DOI 10.1016/S0165-6147(03)00233-5; Calvert JW, 2009, EXP PHYSIOL, V94, P805, DOI 10.1113/expphysiol.2009.047183; Chrissobolis S, 2011, FRONT BIOSCI-LANDMRK, V16, P1733, DOI 10.2741/3816; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Dahlhoff M, 2014, BBA-MOL BASIS DIS, V1842, P304, DOI 10.1016/j.bbadis.2013.11.021; del Mar Bibiloni M., 2013, ISRN OBES, V2013, DOI DOI 10.1155/2013/392747; Delporte C, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/518909; Doherty AS, 2000, BIOL REPROD, V62, P1526, DOI 10.1095/biolreprod62.6.1526; Ecker DJ, 2004, P NATL ACAD SCI USA, V101, P1595, DOI 10.1073/pnas.0306846101; Ferezou-Viala J, 2007, AM J PHYSIOL-REG I, V293, pR1056, DOI 10.1152/ajpregu.00117.2007; Gillman MW, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.3.e221; Jayaram B, 2013, J APPL PHYSIOL, V114, P734, DOI 10.1152/japplphysiol.01499.2012; Jungheim ES, 2013, NUTR REV, V71, pS3, DOI 10.1111/nure.12056; Kallen B, 2010, BIRTH DEFECTS RES A, V88, P137, DOI 10.1002/bdra.20645; Katan MB, 2010, JAMA-J AM MED ASSOC, V303, P65, DOI 10.1001/jama.2009.1912; Katz P, 2011, FERTIL STERIL, V95, P915, DOI 10.1016/j.fertnstert.2010.11.026; Kelsall CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034492; Kusminski CM, 2005, CLIN SCI, V109, P243, DOI 10.1042/CS20050078; Lacerda-Miranda G, 2012, PEPTIDES, V35, P65, DOI 10.1016/j.peptides.2012.02.025; LANDIN K, 1990, METABOLISM, V39, P1044, DOI 10.1016/0026-0495(90)90164-8; Lobo TF, 2013, J REPROD IMMUNOL, V97, P120, DOI 10.1016/j.jri.2012.10.004; Lodefalk M, 2010, HORM RES PAEDIAT, V73, P355, DOI 10.1159/000308168; Lopez-Ruiz A, 2008, AM J PHYSIOL-HEART C, V295, pH466, DOI 10.1152/ajpheart.01232.2007; Martinez-Lemus LA, 2008, J VASC RES, V45, P211, DOI 10.1159/000112513; McAllister EJ, 2009, CRIT REV FOOD SCI, V49, P868, DOI 10.1080/10408390903372599; McGillicuddy FC, 2013, AM J PHYSIOL-ENDOC M, V305, pE834, DOI 10.1152/ajpendo.00297.2013; McTernan PG, 2006, CURR OPIN LIPIDOL, V17, P170, DOI 10.1097/01.mol.0000217899.59820.9a; Olson CK, 2005, FERTIL STERIL, V84, P1308, DOI 10.1016/j.fertnstert.2005.03.086; Palik E, 2007, DIABETES RES CLIN PR, V76, P351, DOI 10.1016/j.diabres.2006.09.005; Petitt D J, 1985, Diabetes, V34 Suppl 2, P119; Reefhuis J, 2009, HUM REPROD, V24, P360, DOI 10.1093/humrep/den387; Reynolds RM, 2010, J CLIN ENDOCR METAB, V95, P5365, DOI 10.1210/jc.2010-0697; Rinaudo P, 2004, REPRODUCTION, V128, P301, DOI 10.1530/rep.1.00297; Rindler PM, 2013, AM J PHYSIOL-HEART C, V305, pH634, DOI 10.1152/ajpheart.00799.2012; Rochette L, 2014, BBA-GEN SUBJECTS, V1840, P2709, DOI 10.1016/j.bbagen.2014.05.017; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Samuelsson AM, 2010, HYPERTENSION, V55, P76, DOI 10.1161/HYPERTENSIONAHA.109.139402; Schenewerk AL, 2014, REPRODUCTION, V147, P111, DOI 10.1530/REP-13-0354; Sommovilla J, 2005, REPRODUCTION, V130, P599, DOI 10.1530/rep.1.00872; Souza-Smith FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023337; Sturm R, 2007, PUBLIC HEALTH, V121, P492, DOI 10.1016/j.puhe.2007.01.006; Suzuki K, 2013, J BIOL CHEM, V288, P1929, DOI 10.1074/jbc.M112.423137; Torrens C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050671; Tran M, 2014, AM J PHYSIOL-REG I, V306, pR607, DOI 10.1152/ajpregu.00523.2013; Verschuur M, 2005, ATHEROSCLEROSIS, V181, P275, DOI 10.1016/j.atherosclerosis.2005.01.036; Wang Jeff, 2006, Ther Clin Risk Manag, V2, P355, DOI 10.2147/tcrm.2006.2.4.355; Zhang SY, 2013, MOL MED REP, V7, P223, DOI 10.3892/mmr.2012.1154	52	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112651	10.1371/journal.pone.0112651	http://dx.doi.org/10.1371/journal.pone.0112651			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386661	Green Submitted, Green Published, gold			2022-12-27	WOS:000345250400079
J	Boddicker, RL; Seibert, JT; Johnson, JS; Pearce, SC; Selsby, JT; Gabler, NK; Lucy, MC; Safranski, TJ; Rhoads, RP; Baumgard, LH; Ross, JW				Boddicker, Rebecca L.; Seibert, Jacob T.; Johnson, Jay S.; Pearce, Sarah C.; Selsby, Joshua T.; Gabler, Nicholas K.; Lucy, Matthew C.; Safranski, Timothy J.; Rhoads, Robert P.; Baumgard, Lance H.; Ross, Jason W.			Gestational Heat Stress Alters Postnatal Offspring Body Composition Indices and Metabolic Parameters in Pigs	PLOS ONE			English	Article							MUSCLE-FIBER DEVELOPMENT; MATERNAL UNDERNUTRITION; REARING-TEMPERATURE; SKELETAL-MUSCLE; PRENATAL STRESS; BIRTH-WEIGHT; FEED-INTAKE; GROWTH; FETAL; EXPRESSION	The study objectives were to test the hypothesis that heat stress (HS) during gestational development alters postnatal growth, body composition, and biological response to HS conditions in pigs. To investigate this, 14 first parity crossbred gilts were exposed to one of four environmental treatments (TNTN, TNHS, HSTN, or HSHS) during gestation. TNTN and HSHS dams were exposed to thermal neutral (TN, cyclical 18-22 degrees C) or HS conditions (cyclical 28-34 degrees C) during the entire gestation, respectively. Dams assigned to HSTN and TNHS treatments were heat-stressed for the first or second half of gestation, respectively. Postnatal offspring were exposed to one of two thermal environments for an acute (24 h) or chronic (five weeks) duration in either constant TN (21 degrees C) or HS (35 degrees C)environment. Exposure to chronic HS during their growth phase resulted in decreased longissimus dorsi cross-sectional area (LDA) in offspring from HSHS and HSTN treated dams whereas LDA was larger in offspring from dams in TNTN and TNHS conditions. Irrespective of HS during prepubertal postnatal growth, pigs from dams that experienced HS during the first half of gestation (HSHS and HSTN) had increased (13.9%) subcutaneous fat thickness compared to pigs from dams exposed to TN conditions during the first half of gestation. This metabolic repartitioning towards increased fat deposition in pigs from dams heat-stressed during the first half of gestation was accompanied by elevated blood insulin concentrations (33%; P = 0.01). Together, these results demonstrate HS during the first half of gestation altered metabolic and body composition parameters during future development and in biological responses to a subsequent HS challenge.	[Boddicker, Rebecca L.; Seibert, Jacob T.; Johnson, Jay S.; Pearce, Sarah C.; Selsby, Joshua T.; Gabler, Nicholas K.; Baumgard, Lance H.; Ross, Jason W.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; [Lucy, Matthew C.; Safranski, Timothy J.] Univ Missouri, Div Anim Sci, Columbia, MO USA; [Rhoads, Robert P.] Virginia Tech Univ, Dept Anim & Poultry Sci, Blacksburg, VA USA	Iowa State University; University of Missouri System; University of Missouri Columbia; Virginia Polytechnic Institute & State University	Ross, JW (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA.	jwross@iastate.edu	Rhoads, Robert P/F-2861-2016; Baumgard, Lance Hall/AAZ-7090-2021	Rhoads, Robert P/0000-0002-5205-5834; Luchtel, Rebecca/0000-0002-7523-5010	National Research Initiative Competitive Grant from 440 the USDA National Institute of Food and Agriculture [2011-67003-30007]	National Research Initiative Competitive Grant from 440 the USDA National Institute of Food and Agriculture	This work was supported by the National Research Initiative Competitive Grant no. 2011-67003-30007 from 440 the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgard LH, 2012, J ANIM SCI, V90, P1855, DOI 10.2527/jas.2011-4675; Baumgard L. H., 2012, ENV STRESS AMELIORAT, P413, DOI [DOI 10.1007/978-3-642-29205-7_15, 10.1007/978-3-642-29205-7_15]; Bee G, 2004, J ANIM SCI, V82, P826; Boddicker N, 2011, J ANIM SCI, V89, P40, DOI 10.2527/jas.2010-3106; Cerisuelo A, 2009, J ANIM SCI, V87, P729, DOI 10.2527/jas.2007-0677; Chen XC, 2010, J PHYSIOL-LONDON, V588, P3539, DOI 10.1113/jphysiol.2010.192310; Close WH, 1971, ANIM PROD, V13; Crosier AE, 2002, BIOL REPROD, V67, P401, DOI 10.1095/biolreprod67.2.401; CSABA G, 1984, ACTA PHYSIOL HUNG, V63, P93; DREILING CE, 1991, J DAIRY SCI, V74, P312, DOI 10.3168/jds.S0022-0302(91)78175-7; DWYER CM, 1994, BRIT J NUTR, V72, P173, DOI 10.1079/BJN19940022; EARLY RJ, 1991, J ANIM SCI, V69, P3610, DOI 10.2527/1991.6993610x; Fahey AJ, 2005, J ANIM SCI, V83, P2564; Foxcroft G R, 2006, J Anim Sci, V84 Suppl, pE105; Foxcroft G R, 2009, Soc Reprod Fertil Suppl, V66, P213; Galan HL, 1999, AM J OBSTET GYNECOL, V180, P1278, DOI 10.1016/S0002-9378(99)70629-0; Garofano A, 1998, DIABETOLOGIA, V41, P1114, DOI 10.1007/s001250051038; Graham JM, 1998, TERATOLOGY, V58, P209, DOI 10.1002/(SICI)1096-9926(199811)58:5<209::AID-TERA8>3.0.CO;2-Q; Halevy O, 2001, AM J PHYSIOL-REG I, V281, pR302, DOI 10.1152/ajpregu.2001.281.1.R302; Hansen PJ, 2009, PHILOS T R SOC B, V364, P3341, DOI 10.1098/rstb.2009.0131; HEATH ME, 1983, COMP BIOCHEM PHYS A, V76, P363, DOI 10.1016/0300-9629(83)90338-9; HEATH ME, 1989, CAN J PHYSIOL PHARM, V67, P526, DOI 10.1139/y89-084; Johnson JS, 2013, INT J HYPERTHER, V29, P696, DOI 10.3109/02656736.2013.843723; JONSON KM, 1976, BRAIN RES BULL, V1, P133, DOI 10.1016/0361-9230(76)90056-3; Kisliouk T, 2010, DEV NEUROBIOL, V70, P100, DOI 10.1002/dneu.20763; Li GF, 2006, AM J PHYSIOL-HEART C, V291, pH1709, DOI 10.1152/ajpheart.00201.2006; Lucy MC, 2012, J ANIM SCI, V90, P574; McCoard SA, 1997, REPROD FERT DEVELOP, V9, P675, DOI 10.1071/R97061; Mueller BR, 2006, PHYSIOL BEHAV, V88, P605, DOI 10.1016/j.physbeh.2006.05.019; OMTVEDT IT, 1971, J ANIM SCI, V32, P312; Pearce SC, 2013, J ANIMAL SCI; Poston L, 2011, PROG BIOPHYS MOL BIO, V106, P315, DOI 10.1016/j.pbiomolbio.2010.11.011; Quigley SP, 2005, ANIM REPROD SCI, V87, P241, DOI 10.1016/j.anireprosci.2004.11.005; Renaudeau D, 2011, J ANIM SCI; Roseboom T, 2006, EARLY HUM DEV, V82, P485, DOI 10.1016/j.earlhumdev.2006.07.001; Seong KH, 2011, CELL, V145, P1049, DOI 10.1016/j.cell.2011.05.029; SHIOTA K, 1989, BIOL NEONATE, V56, P6; Tamashiro KLK, 2009, DIABETES, V58, P1116, DOI 10.2337/db08-1129; Tetievsky A, 2010, J APPL PHYSIOL, V109, P1552, DOI 10.1152/japplphysiol.00469.2010; Town SC, 2004, REPRODUCTION, V128, P443, DOI 10.1530/rep.1.00069; Tse WY, 2008, REPROD FERT DEVELOP, V20, P497, DOI 10.1071/RD07200; Tygesen MP, 2008, ARCH ANIM NUTR, V62, P44, DOI 10.1080/17450390701780276; VERSTEGEN MWA, 1978, CAN J ANIM SCI, V58, P1, DOI 10.4141/cjas78-001; Wang XQ, 2010, J PROTEOME RES, V9, P924, DOI 10.1021/pr900747d; WIGMORE PMC, 1983, J ANAT, V137, P235; Woodall SM, 1996, J ENDOCRINOL, V150, P231, DOI 10.1677/joe.0.1500231; Yahav S, 2001, POULTRY SCI, V80, P1662, DOI 10.1093/ps/80.12.1662; Yates DT, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/631038; Yoshihara T, 2012, ACTA PHYSL OXF, V207, P416	49	48	52	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e110859	10.1371/journal.pone.0110859	http://dx.doi.org/10.1371/journal.pone.0110859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383953	Green Published, gold			2022-12-27	WOS:000344816700012
J	Costa, SS; Druzian, JI; Machado, BAS; de Souza, CO; Guimaraes, AG				Costa, Samantha Serra; Druzian, Janice Izabel; Souza Machado, Bruna Aparecida; de Souza, Carolina Oliveira; Guimaraes, Alaise Gil			Bi-Functional Biobased Packing of the Cassava Starch, Glycerol, Licuri Nanocellulose and Red Propolis	PLOS ONE			English	Article							BARRIER PROPERTIES; FILMS; WATER	The aim of this study was to characterize and determine the bi-functional efficacy of active packaging films produced with starch (4%) and glycerol (1.0%), reinforced with cellulose nanocrystals (0-1%) and activated with alcoholic extracts of red propolis (0.4 to 1.0%). The cellulose nanocrystals used in this study were extracted from licuri leaves. The films were characterized using moisture, water-activity analyses and water vapor-permeability tests and were tested regarding their total phenolic compounds and mechanical properties. The antimicrobial and antioxidant efficacy of the films were evaluated by monitoring the use of the active films for packaging cheese curds and butter, respectively. The cellulose nanocrystals increased the mechanical strength of the films and reduced the water permeability and water activity. The active film had an antimicrobial effect on coagulase-positive staphylococci in cheese curds and reduced the oxidation of butter during storage.	[Costa, Samantha Serra] Univ Fed Bahia, Fac Pharm, BR-40171970 Salvador, BA, Brazil; [Druzian, Janice Izabel; de Souza, Carolina Oliveira; Guimaraes, Alaise Gil] Univ Fed Bahia, Fac Pharm, Dept Bromatol Anal, BR-40171970 Salvador, BA, Brazil; [Souza Machado, Bruna Aparecida] Serv Nacl Aprendizagem Ind SENAI, SENAI CIMATEC, Fac Technol, BR-41650010 Salvador, BA, Brazil	Universidade Federal da Bahia; Universidade Federal da Bahia; Faculdade de Tecnologia Senai Cimatec	Costa, SS (corresponding author), Univ Fed Bahia, Fac Pharm, Rua Barao de Geremoabo S-N, BR-40171970 Salvador, BA, Brazil.	manthasc@yahoo.com.br	Druzian, Janice Izabel/G-6884-2015; Souza, Carolina O/G-8869-2015; Machado, Bruna Aparecida Souza/C-3130-2016; Machado, Bruna/AAP-6877-2021	Machado, Bruna Aparecida Souza/0000-0003-1655-0325; Oliveira de Souza, Carolina/0000-0002-8028-5418; Druzian, Janice Izabel/0000-0001-8940-6098	CAPES (Coordination of Improvement of Higher Education Personnel)	CAPES (Coordination of Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The research was funded by CAPES (Coordination of Improvement of Higher Education Personnel), through design nanobiotec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amal AM, 2013, PLOS ONE, V8, P1; American Oil Chemists Society (AOCS), 1997, CD8B90; American Society for Testing and Materials (ASTM), 2005, E96E96M ASTM; ASTM, 2001, D88200 ASTM; Azeredo HMC, 2009, J FOOD SCI, V74, pN31, DOI 10.1111/j.1750-3841.2009.01186.x; Reis LCB, 2015, FOOD BIOPROD PROCESS, V94, P382, DOI 10.1016/j.fbp.2014.05.004; Beck-Candanedo S, 2005, BIOMACROMOLECULES, V6, P1048, DOI 10.1021/bm049300p; Cagri A, 2001, J FOOD SCI, V66, P865, DOI 10.1111/j.1365-2621.2001.tb15188.x; Coutinho Fernanda M. B., 2003, Polímeros, V13, P01, DOI 10.1590/S0104-14282003000100005; de Mesquita JP, 2011, SOFT MATTER, V7, P4405, DOI 10.1039/c0sm01168a; Gill AO, 2002, INT J FOOD MICROBIOL, V73, P83, DOI 10.1016/S0168-1605(01)00712-7; GONTARD N, 1992, J FOOD SCI, V57, P190, DOI 10.1111/j.1365-2621.1992.tb05453.x; Habibi Y, 2010, CHEM REV, V110, P3479, DOI 10.1021/cr900339w; Holt BL, 2010, J MATER CHEM, V20, P10058, DOI 10.1039/c0jm01022g; Kechichian V, 2010, LWT-FOOD SCI TECHNOL, V43, P1088, DOI 10.1016/j.lwt.2010.02.014; Luz JMR, 2013, PLOS ONE, V8, P8, DOI DOI 10.1371/J0URNAL.P0NE.0069386.G003; Massaro FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081297; Mathlouthi M, 2001, FOOD CONTROL, V12, P409, DOI 10.1016/S0956-7135(01)00032-9; Mohamed AA, 2013, PLOS ONE, V8, P1, DOI DOI 10.1371/annotation/f9aef9a9-5488-4492-8b8c-1cdded2e3d79; Park YK, 1998, BIOSCI BIOTECH BIOCH, V62, P2230, DOI 10.1271/bbb.62.2230; Pelissari FM, 2009, J AGR FOOD CHEM, V57, P7499, DOI 10.1021/jf9002363; Cavalcante DRR, 2011, BRAZ J OTORHINOLAR, V77, P278, DOI 10.1590/S1808-86942011000300002; Rohn S, 2004, J AGR FOOD CHEM, V52, P4725, DOI 10.1021/jf0496797; Rosa MF, 2010, CARBOHYD POLYM, V81, P83, DOI 10.1016/j.carbpol.2010.01.059; Samir MASA, 2005, BIOMACROMOLECULES, V6, P612, DOI 10.1021/bm0493685; Santos FA, 2002, J ETHNOPHARMACOL, V80, P1, DOI 10.1016/S0378-8741(02)00003-X; Silva JBA, 2012, J FOOD SCI, V77, P14; Siripatrawan U, 2010, FOOD HYDROCOLLOID, V24, P770, DOI 10.1016/j.foodhyd.2010.04.003; Souza CO, 2011, J AGR FOOD CHEM, V1, P1; Taketoshi H, 2012, PLOS ONE, V7, P11; Tanja P, 2013, PLOS ONE, V8, P2; Veiga-Santos P, 2007, FOOD CHEM, V103, P255, DOI 10.1016/j.foodchem.2006.07.048; Wenbin G, 2012, PLOS ONE, V7, P5; Zinoviadou KG, 2009, MEAT SCI, V82, P338, DOI 10.1016/j.meatsci.2009.02.004	34	40	41	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112554	10.1371/journal.pone.0112554	http://dx.doi.org/10.1371/journal.pone.0112554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383783	Green Submitted, Green Published, gold			2022-12-27	WOS:000344816700081
J	Myong, JP; Kim, HR; Jang, TW; Lee, HE; Koo, JW				Myong, Jun-Pyo; Kim, Hyoung-Ryoul; Jang, Tae-Won; Lee, Hye Eun; Koo, Jung-Wan			Association between Blood Cadmium Levels and 10-Year Coronary Heart Disease Risk in the General Korean Population: The Korean National Health and Nutrition Examination Survey 2008-2010	PLOS ONE			English	Article							LIPID-PEROXIDATION; URINARY COTININE; METALS; HYPERTENSION; EXPOSURE	Background: Non-occupational heavy metals are considered risk factors for coronary heart disease (CHD). Several recent epidemiologic studies have evaluated the relationship between non-occupational cadmium exposure and risk factors for cardiovascular disease (CVD). This study was designed to investigate the relationship between non-occupational cadmium exposure and risk factors for CHD using the Framingham estimate of 10 year CHD risk. Methods: The heavy metal dataset of the Korean National Health and Nutrition Examination Survey for 2008 through 2010, a cross-sectional survey of a representative sample of 4,668 non-institutionalized Koreans, was analyzed. Subjects were stratified into seven age groups to minimize the effects of age. The log-transformed blood cadmium concentrations were compared with the Framingham estimate of 10 year CHD risk in each age stratum. Results: The Framingham estimate of 10 year CHD risk was significantly associated with the log-transformed blood cadmium concentrations (p<0.05) in all age groups of Korean men, with the lowest regression coefficient (0.254) for men aged 20 to <35 years and the highest (3.354) for men aged 55 to <60 years; similar results, however, were not observed in Korean women. After adjusting for survey year, age, and urinary cotinine concentration, the log-transformed blood cadmium levels among men aged 20 to <35, 40 to <45, 50 to <55, and 60 to <65 years were significantly associated with systolic blood pressure (p<0.05), but not with total and high density lipoprotein (HDL) cholesterol concentrations. Conclusions: Cadmium exposure, even at non-occupational levels, may be associated with CHD risk in men. Despite the declines in non-occupational cadmium exposure over the past several decades, more efforts are needed.	[Myong, Jun-Pyo; Kim, Hyoung-Ryoul; Jang, Tae-Won; Lee, Hye Eun; Koo, Jung-Wan] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Occupat & Environm Med, Seoul, South Korea; [Myong, Jun-Pyo; Kim, Hyoung-Ryoul; Jang, Tae-Won; Lee, Hye Eun; Koo, Jung-Wan] Catholic Univ Korea, Seoul St Marys Hosp, Ctr Occupat & Environm Med, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital	Jang, TW (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Occupat & Environm Med, Seoul, South Korea.	om1024@hanmail.net	Lee, Hye Eun/AAE-6317-2022; Myong, Jun-Pyo/M-7351-2019	Lee, Hye Eun/0000-0003-4648-5042; Myong, Jun-Pyo/0000-0001-8674-1034				Ademuyiwa O, 2009, CHEM-BIOL INTERACT, V179, P314, DOI 10.1016/j.cbi.2008.10.057; Alissa EM, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/870125; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Eum KD, 2008, SCI TOTAL ENVIRON, V407, P147, DOI 10.1016/j.scitotenv.2008.08.037; Everett CJ, 2008, ENVIRON RES, V106, P284, DOI 10.1016/j.envres.2007.10.009; Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), 2002, 3 REP EXP PAN DET EV; Haufroid V, 1998, INT ARCH OCC ENV HEA, V71, P162, DOI 10.1007/s004200050266; Houston MC, 2007, ALTERN THER HEALTH M, V13, P128; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Jarup Lars, 1998, Scandinavian Journal of Work Environment and Health, V24, P1; Jung-Choi KH, 2012, TOB CONTROL, V21, P536, DOI 10.1136/tobaccocontrol-2011-050012; Kim KY, 2014, INT J TUBERC LUNG D, V18, P622, DOI 10.5588/ijtld.13.0677; Korea Center for Disease Control and Prevention, 2011, KOREA NAT HLTH NUTR; Lee MS, 2011, ENVIRON RES, V111, P171, DOI 10.1016/j.envres.2010.10.006; Mudipalli A, 2007, INDIAN J MED RES, V126, P518; National Statistical Information Service, 2012, MAJ CAUS DEATH KOR 2; Navas-Acien A, 2005, ENVIRON HEALTH PERSP, V113, P164, DOI 10.1289/ehp.7329; Nordberg GF, 2007, HDB TOXICOLOGY METAL, P444; Olsen L, 2012, INT J HYG ENVIR HEAL, V215, P411, DOI 10.1016/j.ijheh.2011.11.004; SARKAR S, 1995, J TRACE ELEM MED BIO, V9, P144, DOI 10.1016/S0946-672X(11)80038-6; Satarug S, 2005, TOXICOL LETT, V157, P57, DOI 10.1016/j.toxlet.2005.01.004; Sogawa N, 2001, PHARMACOL RES, V44, P53, DOI 10.1006/phrs.2001.0833; SRNT Subcommittee on Biochemical Verification, 2002, Nicotine Tob Res, V4, P149, DOI 10.1080/14622200210123581; Tellez-Plaza M, 2008, ENVIRON HEALTH PERSP, V116, P51, DOI 10.1289/ehp.10764; Tellez-Plaza M, 2012, ENVIRON HEALTH PERSP, V120, P204, DOI 10.1289/ehp.1104020; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Varoni MV, 2003, VET RES COMMUN, V27, P807, DOI 10.1023/B:VERC.0000014277.06785.6f; Yiin SJ, 1999, J TOXICOL ENV HEAL A, V57, P403, DOI 10.1080/009841099157601	28	26	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e111909	10.1371/journal.pone.0111909	http://dx.doi.org/10.1371/journal.pone.0111909			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383551	Green Published, Green Submitted, gold			2022-12-27	WOS:000344816700024
J	Papazachariadis, O; Dante, V; Verschure, PFMJ; Del Giudice, P; Ferraina, S				Papazachariadis, Odysseas; Dante, Vittorio; Verschure, Paul F. M. J.; Del Giudice, Paolo; Ferraina, Stefano			iTBS-Induced LTP-Like Plasticity Parallels Oscillatory Activity Changes in the Primary Sensory and Motor Areas of Macaque Monkeys	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; SOMATOSENSORY-EVOKED POTENTIALS; THETA-BURST STIMULATION; LOCAL-FIELD POTENTIALS; MEDIAN NERVE; CORTEX; GAMMA; SYNCHRONIZATION; FREQUENCY; EEG	Recently, neuromodulation techniques based on the use of repetitive transcranial magnetic stimulation (rTMS) have been proposed as a non-invasive and efficient method to induce in vivo long-term potentiation (LTP)-like aftereffects. However, the exact impact of rTMS-induced perturbations on the dynamics of neuronal population activity is not well understood. Here, in two monkeys, we examine changes in the oscillatory activity of the sensorimotor cortex following an intermittent theta burst stimulation (iTBS) protocol. We first probed iTBS modulatory effects by testing the iTBS-induced facilitation of somatosensory evoked potentials (SEP). Then, we examined the frequency information of the electrocorticographic signal, obtained using a custom-made miniaturised multi-electrode array for electrocorticography, after real or sham iTBS. We observed that iTBS induced facilitation of SEPs and influenced spectral components of the signal, in both animals. The latter effect was more prominent on the theta band (4-8 Hz) and the high gamma band (55-90 Hz), de-potentiated and potentiated respectively. We additionally found that the multi-electrode array uniformity of beta (13-26 Hz) and high gamma bands were also afflicted by iTBS. Our study suggests that enhanced cortical excitability promoted by iTBS parallels a dynamic reorganisation of the interested neural network. The effect in the gamma band suggests a transient local modulation, possibly at the level of synaptic strength in interneurons. The effect in the theta band suggests the disruption of temporal coordination on larger spatial scales.	[Papazachariadis, Odysseas; Ferraina, Stefano] Univ Roma La Sapienza, Dept Physiol & Pharmacol, I-00185 Rome, Italy; [Dante, Vittorio; Del Giudice, Paolo] Ist Super Sanita, I-00161 Rome, Italy; [Verschure, Paul F. M. J.] ICREA Univ Pompeu Fabra, Ctr Autonomous Syst & Neurorobot, Lab Synthet Percept Emot & Cognit Syst, Barcelona, Spain; [Del Giudice, Paolo] Ist Nazl Fis Nucl, Rome, Italy	Sapienza University Rome; Istituto Superiore di Sanita (ISS); ICREA; Pompeu Fabra University; Istituto Nazionale di Fisica Nucleare (INFN)	Papazachariadis, O (corresponding author), Univ Roma La Sapienza, Dept Physiol & Pharmacol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	odysseas.papazachariadis@gmail.com	Dante, Vittorio/E-3730-2015; ferraina, stefano/M-5230-2018; Del Giudice, Paolo/N-4655-2015; Verschure, Paul/AAR-2340-2021	ferraina, stefano/0000-0001-6100-2438; Del Giudice, Paolo/0000-0002-5633-8241; Verschure, Paul/0000-0003-3643-9544	Sapienza University in Neurophysiology; ISS-USA project "Brain reorganization under cortical stimulation - BRUCOS''; ICREA Funding Source: Custom	Sapienza University in Neurophysiology; ISS-USA project "Brain reorganization under cortical stimulation - BRUCOS''; ICREA(ICREA)	OP was supported by a doctoral fellowship of the Sapienza University in Neurophysiology. PDG, SF and VD were supported by the ISS-USA project "Brain reorganization under cortical stimulation - BRUCOS''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed OJ, 2012, J NEUROSCI, V32, P7373, DOI 10.1523/JNEUROSCI.5110-11.2012; Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Allen EA, 2007, SCIENCE, V317, P1918, DOI 10.1126/science.1146426; ALLISON T, 1991, BRAIN, V114, P2465, DOI 10.1093/brain/114.6.2465; Arnal LH, 2012, TRENDS COGN SCI, V16, P390, DOI 10.1016/j.tics.2012.05.003; Bae EH, 2007, EPILEPSY BEHAV, V10, P521, DOI 10.1016/j.yebeh.2007.03.004; Buia CI, 2008, J NEUROPHYSIOL, V99, P2158, DOI 10.1152/jn.01004.2007; Butefisch CM, 2000, P NATL ACAD SCI USA, V97, P3661, DOI 10.1073/pnas.050350297; BUZSAKI G, 1991, EUR J NEUROSCI, V3, P222, DOI 10.1111/j.1460-9568.1991.tb00083.x; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Casali AG, 2010, NEUROIMAGE, V49, P1459, DOI 10.1016/j.neuroimage.2009.09.026; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fuggetta G, 2005, NEUROIMAGE, V27, P896, DOI 10.1016/j.neuroimage.2005.05.013; GEVINS A, 1994, ELECTROEN CLIN NEURO, V92, P282, DOI 10.1016/0168-5597(94)90096-5; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Halliday DM, 1995, PROG BIOPHYS MOL BIO, V64, P237, DOI 10.1016/S0079-6107(96)00009-0; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Huerta PT, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-7; Ilmoniemi RJ, 1997, NEUROREPORT, V8, P3537, DOI 10.1097/00001756-199711100-00024; Izaki Y, 2008, EXP BRAIN RES, V184, P249, DOI 10.1007/s00221-007-1098-6; Kaas JH, 2004, ANAT REC PART A, V281A, P1148, DOI 10.1002/ar.a.20120; Kahana MJ, 2001, CURR OPIN NEUROBIOL, V11, P739, DOI 10.1016/S0959-4388(01)00278-1; Katayama T, 2007, CLIN NEUROPHYSIOL, V118, P2506, DOI 10.1016/j.clinph.2007.08.011; Katayama T, 2010, CLIN NEUROPHYSIOL, V121, P2097, DOI 10.1016/j.clinph.2010.05.014; Komssi S, 2006, BRAIN RES REV, V52, P183, DOI 10.1016/j.brainresrev.2006.01.008; Kozel FA, 2000, J NEUROPSYCH CLIN N, V12, P376, DOI 10.1176/appi.neuropsych.12.3.376; McAllister SM, 2011, EUR J NEUROSCI, V33, P1916, DOI 10.1111/j.1460-9568.2011.07673.x; Mehring C, 2003, NAT NEUROSCI, V6, P1253, DOI 10.1038/nn1158; Nasrallah FA, 2014, NEUROIMAGE, V84, P27, DOI 10.1016/j.neuroimage.2013.08.004; Noh NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035080; Oberman L, 2011, J CLIN NEUROPHYSIOL, V28, P67, DOI 10.1097/WNP.0b013e318205135f; Papazachariadis O, 2013, NEUROSCI LETT, V550, P184, DOI 10.1016/j.neulet.2013.06.024; Paus T, 2001, J NEUROPHYSIOL, V86, P1983, DOI 10.1152/jn.2001.86.4.1983; PFURTSCHELLER G, 1975, ELECTROEN CLIN NEURO, V38, P93, DOI 10.1016/0013-4694(75)90215-1; Ray S, 2008, J NEUROSCI, V28, P11526, DOI 10.1523/JNEUROSCI.2848-08.2008; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; Saglam M, 2008, CLIN NEUROPHYSIOL, V119, P2829, DOI 10.1016/j.clinph.2008.09.004; Siebner HR, 2010, J PHYSIOL-LONDON, V588, P4851, DOI 10.1113/jphysiol.2010.200857; Sinclair MD, 2003, CAN VET J, V44, P885; Thut G, 2010, BRAIN TOPOGR, V22, P219, DOI 10.1007/s10548-009-0115-4; Traub RD, 1996, J PHYSIOL-LONDON, V493, P471, DOI 10.1113/jphysiol.1996.sp021397; van Elswijk G, 2010, J NEUROSCI, V30, P4481, DOI 10.1523/JNEUROSCI.2794-09.2010; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Wang XJ, 1996, J NEUROSCI, V16, P6402	53	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112504	10.1371/journal.pone.0112504	http://dx.doi.org/10.1371/journal.pone.0112504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383621	gold, Green Submitted, Green Published			2022-12-27	WOS:000344816700070
J	Poh, YP; Domingues, VS; Hoekstra, HE; Jensen, JD				Poh, Yu-Ping; Domingues, Vera S.; Hoekstra, Hopi E.; Jensen, Jeffrey D.			On the Prospect of Identifying Adaptive Loci in Recently Bottlenecked Populations	PLOS ONE			English	Article							POSITIVE SELECTION; GENOMIC SCANS; HITCHHIKING; EVOLUTION; MOUSE; DOMESTICATION; ADAPTATION; FOOTPRINTS; MUTATIONS; SIGNATURE	Identifying adaptively important loci in recently bottlenecked populations - be it natural selection acting on a population following the colonization of novel habitats in the wild, or artificial selection during the domestication of a breed - remains a major challenge. Here we report the results of a simulation study examining the performance of available population-genetic tools for identifying genomic regions under selection. To illustrate our findings, we examined the interplay between selection and demography in two species of Peromyscus mice, for which we have independent evidence of selection acting on phenotype as well as functional evidence identifying the underlying genotype. With this unusual information, we tested whether population-genetic-based approaches could have been utilized to identify the adaptive locus. Contrary to published claims, we conclude that the use of the background site frequency spectrum as a null model is largely ineffective in bottlenecked populations. Results are quantified both for site frequency spectrum and linkage disequilibrium-based predictions, and are found to hold true across a large parameter space that encompasses many species and populations currently under study. These results suggest that the genomic footprint left by selection on both new and standing variation in strongly bottlenecked populations will be difficult, if not impossible, to find using current approaches.	[Poh, Yu-Ping; Jensen, Jeffrey D.] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01655 USA; [Poh, Yu-Ping; Domingues, Vera S.; Hoekstra, Hopi E.] Harvard Univ, Howard Hughes Med Inst, Dept Organism & Evolutionary Biol, Dept Mol & Cellular Biol,Museum Comparat Zool, Cambridge, MA 02138 USA; [Jensen, Jeffrey D.] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland; [Poh, Yu-Ping; Jensen, Jeffrey D.] Swiss Inst Bioinformat, Lausanne, Switzerland	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Howard Hughes Medical Institute; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics	Poh, YP (corresponding author), Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01655 USA.	elfinpoh@gmail.com	Hoekstra, Hopi E/I-6690-2012; Jensen, Jeffrey/S-1084-2016	Hoekstra, Hopi E/0000-0003-1431-1769; Jensen, Jeffrey/0000-0002-4786-8064	Swiss National Science Foundation; European Research Council (ERC); Howard Hughes Medical Institute	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	The work was funded by grants from the Swiss National Science Foundation and a European Research Council (ERC) Starting Grant to JDJ. Work in the Hoekstra Lab is funded by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbrandt T.S., 1980, GEOL SURV PROF PAPER, V1120, P1; Barton NH, 1996, PHILOS T R SOC B, V351, P785, DOI 10.1098/rstb.1996.0073; Barton NH, 1998, GENET RES, V72, P123, DOI 10.1017/S0016672398003462; Barton NH, 2000, PHILOS T R SOC B, V355, P1553, DOI 10.1098/rstb.2000.0716; Boyko AR, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-216; BRAVERMAN JM, 1995, GENETICS, V140, P783, DOI 10.1093/genetics/140.2.783; Chavez-Galarza J, 2013, MOL ECOL, V22, P5890, DOI 10.1111/mec.12537; Crisci Jessica L., 2013, Frontiers in Genetics, V4, P235, DOI 10.3389/fgene.2013.00235; Cutler DJ, 2010, GENETICS, V186, P41, DOI 10.1534/genetics.110.121012; Denoeud F, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r29; Domingues VS, 2012, EVOLUTION, V66, P3209, DOI 10.1111/j.1558-5646.2012.01669.x; Freedman AH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004016; Grandcolas P, 2008, PHILOS T R SOC B, V363, P3309, DOI 10.1098/rstb.2008.0122; Groeneveld LF, 2010, ANIM GENET, V41, P6, DOI 10.1111/j.1365-2052.2010.02038.x; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Harr B, 2002, P NATL ACAD SCI USA, V99, P12949, DOI 10.1073/pnas.202336899; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; HUDSON RR, 1987, GENETICS, V116, P153; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; Juan C, 2010, MOL ECOL, V19, P3865, DOI 10.1111/j.1365-294X.2010.04759.x; KAPLAN NL, 1989, GENETICS, V123, P887; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Linnen CR, 2013, SCIENCE, V339, P1312, DOI 10.1126/science.1233213; Linnen CR, 2009, SCIENCE, V325, P1095, DOI 10.1126/science.1175826; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; McNeil FS, 1950, US GEOL SURVEY, V221, P59; Molina J, 2011, P NATL ACAD SCI USA, V108, P8351, DOI 10.1073/pnas.1104686108; Mullen LM, 2009, P ROY SOC B-BIOL SCI, V276, P3809, DOI 10.1098/rspb.2009.1146; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Ocana-Macchi M, 2012, VIROLOGY, V427, P1, DOI 10.1016/j.virol.2012.01.037; Pavlidis P, 2010, GENETICS, V185, P907, DOI 10.1534/genetics.110.116459; Przeworski M, 2002, GENETICS, V160, P1179; Rottschaefer SM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000600; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Stephan W, 2006, GENETICS, V172, P2647, DOI 10.1534/genetics.105.050179; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Thornton KR, 2007, HEREDITY, V98, P340, DOI 10.1038/sj.hdy.6800967; Thornton KR, 2007, GENETICS, V175, P737, DOI 10.1534/genetics.106.064642; Tian F, 2009, P NATL ACAD SCI USA, V106, P9979, DOI 10.1073/pnas.0901122106; Tsumura Y, 2012, HEREDITY, V109, P349, DOI 10.1038/hdy.2012.50; Van Tyne D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001383; Vignieri SN, 2010, EVOLUTION, V64, P2153, DOI 10.1111/j.1558-5646.2010.00976.x; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Yoder JB, 2014, GENETICS, V196, P1263, DOI 10.1534/genetics.113.159319	47	31	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e110579	10.1371/journal.pone.0110579	http://dx.doi.org/10.1371/journal.pone.0110579			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383711	Green Submitted, Green Published, gold			2022-12-27	WOS:000344816700008
J	Yeom, SK; Fazli, S; Muller, KR; Lee, SW				Yeom, Seul-Ki; Fazli, Siamac; Mueller, Klaus-Robert; Lee, Seong-Whan			An Efficient ERP-Based Brain-Computer Interface Using Random Set Presentation and Face Familiarity	PLOS ONE			English	Article							P300 SPELLER; BCI; COMMUNICATION; CLASSIFICATION; RECOGNITION; PERFORMANCE; INTERVAL; PEOPLE	Event-related potential (ERP)-based P300 spellers are commonly used in the field of brain-computer interfaces as an alternative channel of communication for people with severe neuro-muscular diseases. This study introduces a novel P300 based brain-computer interface (BCI) stimulus paradigm using a random set presentation pattern and exploiting the effects of face familiarity. The effect of face familiarity is widely studied in the cognitive neurosciences and has recently been addressed for the purpose of BCI. In this study we compare P300-based BCI performances of a conventional row-column (RC)-based paradigm with our approach that combines a random set presentation paradigm with (non-) self-face stimuli. Our experimental results indicate stronger deflections of the ERPs in response to face stimuli, which are further enhanced when using the self-face images, and thereby improving P300-based spelling performance. This lead to a significant reduction of stimulus sequences required for correct character classification. These findings demonstrate a promising new approach for improving the speed and thus fluency of BCI-enhanced communication with the widely used P300-based BCI setup.	[Yeom, Seul-Ki; Fazli, Siamac; Mueller, Klaus-Robert; Lee, Seong-Whan] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Mueller, Klaus-Robert] Berlin Inst Technol, Machine Learning Grp, Berlin, Germany	Korea University; Technical University of Berlin	Lee, SW (corresponding author), Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea.	sw.lee@korea.ac.kr	Fazli, Siamac/GYQ-9627-2022; Mueller, Klaus-Robert/Y-3547-2019	Fazli, Siamac/0000-0003-3397-0647; Mueller, Klaus-Robert/0000-0002-3861-7685	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2012005741]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning(National Research Foundation of Korea)	This work was supported by National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (No. 2012005741). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison BZ, 2006, INT J PSYCHOPHYSIOL, V59, P127, DOI 10.1016/j.ijpsycho.2005.02.007; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bishop C. M, 2006, PATTERN RECOGNITION; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Blankertz B, 2010, NEUROIMAGE, V51, P1303, DOI 10.1016/j.neuroimage.2010.03.022; Bonferroni C. E., 1936, TEORIA STAT CLASSI C; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Fazel-Rezai R, 2009, CAN J ELECT COMPUT E, V34, P81, DOI 10.1109/CJECE.2009.5443854; Gao SK, 2014, IEEE T BIO-MED ENG, V61, P1436, DOI 10.1109/TBME.2014.2300164; Gibert G, 2008, 4 BCI WORKSH TRAIN C; Guger C, 2009, NEUROSCI LETT, V462, P94, DOI 10.1016/j.neulet.2009.06.045; Jin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049688; Jin J, 2012, MED BIOL ENG COMPUT, V50, P289, DOI 10.1007/s11517-012-0868-x; Jin J, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036006; Jin J, 2011, MED BIOL ENG COMPUT, V49, P181, DOI 10.1007/s11517-010-0689-8; KANWISHER NG, 1987, COGNITION, V27, P117, DOI 10.1016/0010-0277(87)90016-3; Kaufmann T, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/056016; Kaufmann T, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00129; Kaufmann T, 2013, CLIN NEUROPHYSIOL, V124, P893, DOI 10.1016/j.clinph.2012.11.006; Keyes H, 2010, BRAIN COGNITION, V72, P244, DOI 10.1016/j.bandc.2009.09.006; Kindermans P., 2012, ADV NEURAL INFORM PR, V25; Kindermans PJ, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/035005; Kohlmorgen J., 2007, BRAIN COMPUTER INTER, P409; Krusienski DJ, 2008, J NEUROSCI METH, V167, P15, DOI 10.1016/j.jneumeth.2007.07.017; Krusienski DJ, 2006, J NEURAL ENG, V3, P299, DOI 10.1088/1741-2560/3/4/007; Kubler A, 2001, PSYCHOL BULL, V127, P358, DOI 10.1037//0033-2909.127.3.358; Kubler A, 2008, CLIN NEUROPHYSIOL, V119, P2658, DOI 10.1016/j.clinph.2008.06.019; Lemm S, 2011, NEUROIMAGE, V56, P387, DOI 10.1016/j.neuroimage.2010.11.004; Liu T, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/3/036003; Mak Joseph N, 2009, IEEE Rev Biomed Eng, V2, P187, DOI 10.1109/RBME.2009.2035356; Martens SMM, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/2/026003; McFarland DJ, 2011, CLIN NEUROPHYSIOL, V122, P731, DOI 10.1016/j.clinph.2010.10.029; Miyakoshi M, 2010, NEUROIMAGE, V50, P1666, DOI 10.1016/j.neuroimage.2010.01.030; Muller KR, 2003, IEEE T NEUR SYS REH, V11, P165, DOI 10.1109/TNSRE.2003.814484; Nijboer F, 2008, CLIN NEUROPHYSIOL, V119, P1909, DOI 10.1016/j.clinph.2008.03.034; Ninomiya H, 1998, PSYCHIAT CLIN NEUROS, V52, P519, DOI 10.1046/j.1440-1819.1998.00445.x; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polprasert C, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/3/036012; PRITCHARD WS, 1981, PSYCHOL BULL, V89, P506, DOI 10.1037/0033-2909.89.3.506; Rakotomarnonjy A, 2008, IEEE T BIO-MED ENG, V55, P1147, DOI 10.1109/TBME.2008.915728; Riccio A, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045001; Rivet B, 2009, IEEE T BIO-MED ENG, V56, P2035, DOI 10.1109/TBME.2009.2012869; Salvaris M, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046011; Sanders AF, 2002, ACTA PSYCHOL, V109, P41, DOI 10.1016/S0001-6918(01)00048-8; Scholkopf B, 1998, NEURAL COMPUT, V10, P1299, DOI 10.1162/089976698300017467; Sellers EW, 2006, BIOL PSYCHOL, V73, P242, DOI 10.1016/j.biopsycho.2006.04.007; Serby H, 2005, IEEE T NEUR SYS REH, V13, P89, DOI 10.1109/TNSRE.2004.841878; SIEGEL S., 1956, NONPARAMETRIC STAT B; Spuler M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051077; Takano K, 2009, CLIN NEUROPHYSIOL, V120, P1562, DOI 10.1016/j.clinph.2009.06.002; Townsend G, 2010, CLIN NEUROPHYSIOL, V121, P1109, DOI 10.1016/j.clinph.2010.01.030; Townsend G, 2012, NEUROSCI LETT, V531, P63, DOI 10.1016/j.neulet.2012.08.041; Treder MS, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066003; Treder MS, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-28; Uddin LQ, 2005, NEUROIMAGE, V25, P926, DOI 10.1016/j.neuroimage.2004.12.018; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wintink AJ, 2001, BRAIN COGNITION, V46, P307, DOI 10.1016/S0278-2626(01)80090-7; Wolpaw J.R., 2012, BRAIN COMPUTER INTER, V3, P123, DOI [DOI 10.1093/ACPROF:OSO/9780195388855.001.0001, 10.1093/acprof:oso/9780195388855.003.0001]; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Xu N, 2004, IEEE T BIO-MED ENG, V51, P1067, DOI 10.1109/TBME.2004.826699; Yeom SK, 2013, PATTERN RECOGN, V46, P1159, DOI 10.1016/j.patcog.2012.10.023; Zhang Y, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026018	63	63	65	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e111157	10.1371/journal.pone.0111157	http://dx.doi.org/10.1371/journal.pone.0111157			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384045	Green Published, gold, Green Submitted			2022-12-27	WOS:000344816700014
J	Zhou, YJ; Liu, YQ; Feng, QJ; Yang, F; Huang, J; Nie, YX				Zhou, Yujia; Liu, Yaqin; Feng, Qianjin; Yang, Feng; Huang, Jing; Nie, Yixiao			Palm-Vein Classification Based on Principal Orientation Features	PLOS ONE			English	Article							IDENTIFICATION	Personal recognition using palm-vein patterns has emerged as a promising alternative for human recognition because of its uniqueness, stability, live body identification, flexibility, and difficulty to cheat. With the expanding application of palm-vein pattern recognition, the corresponding growth of the database has resulted in a long response time. To shorten the response time of identification, this paper proposes a simple and useful classification for palm-vein identification based on principal direction features. In the registration process, the Gaussian-Radon transform is adopted to extract the orientation matrix and then compute the principal direction of a palm-vein image based on the orientation matrix. The database can be classified into six bins based on the value of the principal direction. In the identification process, the principal direction of the test sample is first extracted to ascertain the corresponding bin. One-by-one matching with the training samples is then performed in the bin. To improve recognition efficiency while maintaining better recognition accuracy, two neighborhood bins of the corresponding bin are continuously searched to identify the input palm-vein image. Evaluation experiments are conducted on three different databases, namely, PolyU, CASIA, and the database of this study. Experimental results show that the searching range of one test sample in PolyU, CASIA and our database by the proposed method for palm-vein identification can be reduced to 14.29%, 14.50%, and 14.28%, with retrieval accuracy of 96.67%, 96.00%, and 97.71%, respectively. With 10,000 training samples in the database, the execution time of the identification process by the traditional method is 18.56 s, while that by the proposed approach is 3.16 s. The experimental results confirm that the proposed approach is more efficient than the traditional method, especially for a large database.	[Zhou, Yujia; Feng, Qianjin; Yang, Feng; Huang, Jing] Southern Med Univ, Sch Biomed Engn, Guangzhou 510515, Guangdong, Peoples R China; [Liu, Yaqin; Nie, Yixiao] Univ Illinois, Dept Elect & Comp Engn, Champaign, IL 61820 USA	Southern Medical University - China; University of Illinois System; University of Illinois Urbana-Champaign	Liu, YQ (corresponding author), Univ Illinois, Dept Elect & Comp Engn, Champaign, IL 61820 USA.	liuyq@fimmu.com; qianjinfeng08@gmail.com	Feng, Qianjin/Y-5438-2019; feng, qianjin/GNM-7856-2022	feng, qianjin/0000-0002-3830-5120	Natural Science Foundation of China [61271155]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the Natural Science Foundation of China (http://www.nsfc.gov.cn/) under Grant (No. 61271155). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There is no other funding to declare.	[Anonymous], 2009, P 2 INT C INT SCI IN; Biometrics Ideal Test Website, CASIA MULT SPECTR PA; Dai JF, 2012, IEEE T PATTERN ANAL, V34, P1618, DOI 10.1109/TPAMI.2011.237; Han J., 2006, DATA MINING CONCEPTS, DOI 10.1016/C2009-0-61819-5; Han WY, 2012, EXPERT SYST APPL, V39, P13225, DOI 10.1016/j.eswa.2012.05.079; Hao Y, 2008, IEEE IMAGE PROC, P281, DOI 10.1109/ICIP.2008.4711746; Jain AK, 1999, IEEE T PATTERN ANAL, V21, P348, DOI 10.1109/34.761265; Jain AK, 2004, IEEE T CIRC SYST VID, V14, P4, DOI 10.1109/TCSVT.2003.818349; Jia W, 2008, PATTERN RECOGN, V41, P1504, DOI 10.1016/j.patcog.2007.10.011; Kang WX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097548; Karu K, 1996, PATTERN RECOGN, V29, P389, DOI 10.1016/0031-3203(95)00106-9; Kong A, 2009, PATTERN RECOGN, V42, P1408, DOI 10.1016/j.patcog.2009.01.018; Kong AWK, 2004, INT C PATT RECOG, P520, DOI 10.1109/ICPR.2004.1334184; Kumar A, 2009, IEEE T IMAGE PROCESS, V18, P2127, DOI 10.1109/TIP.2009.2023153; Ladoux PO, 2009, LECT NOTES COMPUT SC, V5558, P1290, DOI 10.1007/978-3-642-01793-3_130; Lee JC, 2012, ADV SCI LETT, V8, P807; Lee JC, 2012, PATTERN RECOGN LETT, V33, P1520, DOI 10.1016/j.patrec.2012.04.007; Li Xueyan, 2007, 2007 1st International Conference on Bioinformatics and Biomedical Engineering, P612, DOI 10.1109/ICBBE.2007.160; Maltoni D., 2009, HDB FINGERPRINT RECO; Mirmohamadsadeghi L., 2011, P 5 INT C BIOM WASH, P1, DOI DOI 10.1109/IJCB.2011.6117804; Peralta D, 2014, PATTERN RECOGN, V47, P588, DOI 10.1016/j.patcog.2013.08.002; Phillips PJ, 2003, ANAL MOD FAC GEST 20, P44; Pillai JK, 2011, IEEE T PATTERN ANAL, V33, P1877, DOI 10.1109/TPAMI.2011.34; Qian X., 2009, P INT C COMP INT SOF, P1, DOI [DOI 10.1109/CISE.2009.5366021, DOI 10.1109/TENCON.2009.5396125]; RADON J, 1986, IEEE T MED IMAGING, V5, P170, DOI 10.1109/TMI.1986.4307775; Raut SD, 2014, J MANAGEMENT RES, V3, P217; Song W, 2011, PATTERN RECOGN LETT, V32, P1541, DOI 10.1016/j.patrec.2011.04.021; Wang HG, 2008, PATTERN RECOGN, V41, P1514, DOI 10.1016/j.patcog.2007.10.021; Wang R, 2014, NEURAL COMPUT APPL, V24, P161, DOI 10.1007/s00521-013-1514-8; Wang Y, 2011, IEEE T PATTERN ANAL, V33, P72, DOI 10.1109/TPAMI.2010.73; Watanabe M., 2005, P BIOM CONS C, P19; Wilson C, 2010, VEIN PATTERN RECOGNITION: A PRIVACY-ENHANCING BIOMETRIC, P1, DOI 10.1201/9781439821381; Wu KS, 2013, J SYST SOFTWARE, V86, P2870, DOI 10.1016/j.jss.2013.06.065; You J, 2004, IEEE T CIRC SYST VID, V14, P234, DOI 10.1109/TCSVT.2003.821978; You J, 2002, PATTERN RECOGN, V35, P847, DOI 10.1016/S0031-3203(01)00100-5; Yue F, 2009, PATTERN RECOGN, V42, P2841, DOI 10.1016/j.patcog.2009.03.015; Zhang D, 2003, IEEE T PATTERN ANAL, V25, P1041, DOI 10.1109/TPAMI.2003.1227981; Zhang D, 2010, IEEE T INSTRUM MEAS, V59, P480, DOI 10.1109/TIM.2009.2028772; Zhang YB, 2007, LECT NOTES COMPUT SC, V4781, P154; Zhou YB, 2011, IEEE T INF FOREN SEC, V6, P1259, DOI 10.1109/TIFS.2011.2158423	40	14	16	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112429	10.1371/journal.pone.0112429	http://dx.doi.org/10.1371/journal.pone.0112429			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383715	Green Submitted, Green Published, gold			2022-12-27	WOS:000344816700062
J	Chakhaia, T; Magee, MJ; Kempker, RR; Gegia, M; Goginashvili, L; Nanava, U; Blumberg, HM				Chakhaia, Tsira; Magee, Matthew J.; Kempker, Russell R.; Gegia, Medea; Goginashvili, Leila; Nanava, Ucha; Blumberg, Henry M.			High Utility of Contact Investigation for Latent and Active Tuberculosis Case Detection among the Contacts: A Retrospective Cohort Study in Tbilisi, Georgia, 2010-2011	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; PREVALENCE; INFECTION	Setting: The study was conducted at the National Center for Tuberculosis and Lung Diseases (NCTBLD) in Tbilisi, Georgia. Objective: To assess the utility of contact investigation for tuberculosis (TB) case detection. We also assessed the prevalence and risk factors for active TB disease and latent TB infection (LTBI) among contacts of active pulmonary TB cases. Design: A retrospective cohort study was conducted among the contacts of active pulmonary TB cases registered in 20102011 at the NCTBLD in Tbilisi, Georgia. Contacts of active TB patients were investigated according to an "invitation model": they were referred to the NCTBLD by the index case; were queried about clinical symptoms suggestive of active TB disease; tuberculin skin testing and chest radiographs were performed. Demographic, laboratory, and clinical data of TB patients and their contacts were abstracted from existing records up to February 2013. Results: 869 contacts of 396 index cases were enrolled in the study; a median of 2 contacts were referred per index case. Among the 869 contacts, 47 (5.4%) were found to have or developed active TB disease: 30 (63.8%) were diagnosed with TB during the baseline period (co-prevalent cases) and 17 (36.2%) developed active TB disease during the follow-up period (mean follow up of 21 months) (incident TB cases). The incidence rate of active TB disease among contacts was 1126.0 per 100 000 person years (95% CI 655.7-1802.0 per 100,000 person-years). Among the 402 contacts who had a tuberculin skin test (TST) performed, 52.7% (95% CI 47.7-57.7%) had LTBI. Conclusions: A high prevalence of LTBI and active TB disease was found among the contacts of TB cases in Tbilisi, Georgia. Our findings demonstrated that an "invitation" model of contact investigation was an effective method of case detection. Therefore, contact investigation should be scaled up in Georgia.	[Chakhaia, Tsira; Gegia, Medea] Univ Res Co, LLC Branch Georgia, USAID Georgia TB Prevent Project, Tbilisi, Georgia; [Magee, Matthew J.] Georgia State Univ, Sch Publ Hlth, Div Epidemiol & Biostat, Atlanta, GA 30303 USA; [Magee, Matthew J.; Blumberg, Henry M.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Magee, Matthew J.; Blumberg, Henry M.] Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA; [Kempker, Russell R.; Blumberg, Henry M.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA; [Goginashvili, Leila; Nanava, Ucha] Natl Ctr TB & Lung Dis, Tbilisi, Georgia	University System of Georgia; Georgia State University; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; Emory University	Chakhaia, T (corresponding author), Univ Res Co, LLC Branch Georgia, USAID Georgia TB Prevent Project, Tbilisi, Georgia.	tschakhaia@gmail.com	Blumberg, Henry/W-2156-2019; Magee, Matthew/W-1169-2019; Trajman, Anete/C-7679-2016	Blumberg, Henry/0000-0002-3110-2443; Trajman, Anete/0000-0002-4000-4984	National Institutes of Health (NIH) Fogarty International Center [D43TW007124]; NIH NIAID [K23AI103044]; Atlanta Clinical and Translational Science Institute (NIH/NCATS ) [UL1TR000454]; Emory Global Health Institute; FOGARTY INTERNATIONAL CENTER [D43TW007124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI103044] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Atlanta Clinical and Translational Science Institute (NIH/NCATS ); Emory Global Health Institute; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (NIH) (http://nih.gov/) Fogarty International Center (D43TW007124), NIH NIAID (K23AI103044), the Atlanta Clinical and Translational Science Institute (NIH/NCATS UL1TR000454), and the Emory Global Health Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Arnadottir T., 2009, TUBERCULOSIS PUBLIC; Becerra MC, 2005, PUBLIC HEALTH REP, V120, P271, DOI 10.1177/003335490512000309; Centers for Disease Control and Prevention, 2013, LAT TUB INF GUID PRI; Drobniewski FA, 2006, EUR RESPIR J, V28, P903, DOI 10.1183/09031936.06.00084906; Dye C, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P289; Fair E, 2013, 44 UN WORLD C LUNG H; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Gegia M, 2012, INT J TUBERC LUNG D, V16, P812, DOI 10.5588/ijtld.11.0637; Hill PC, 2010, LANCET INFECT DIS, V10, P723, DOI 10.1016/S1473-3099(10)70164-X; Ling DL, 2011, INT J TUBERC LUNG D, V15, P50; Lomtadze N, 2009, INT J TUBERC LUNG D, V13, P68; Martin DO, 1996, EPIDEMIOLOGY, V7, P29, DOI 10.1097/00001648-199601000-00006; Mdivani N, 2008, INT J INFECT DIS, V12, P635, DOI 10.1016/j.ijid.2008.03.012; Mirtskhulava V WJ, 2012, LATENT TUBERCULOSIS, pS237; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Rieder HL, 2003, INT J TUBERC LUNG D, V7, pS333; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Tuberculosis Coalition for Technical Assistance, 2009, INT STAND TUB CAR IS; Weinstock DM, 2001, INT J TUBERC LUNG D, V5, P164; Whitaker JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058202; World Health Organization, 2013, EUROSURVEILLANCE, V18, P20455; World Health Organization, 2012, REC INV CONT PERS IN; World Health Organization, 2013, GLOB TUB REP 2013 IR; Zachariah R, 2003, INT J TUBERC LUNG D, V7, P1033	26	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111773	10.1371/journal.pone.0111773	http://dx.doi.org/10.1371/journal.pone.0111773			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379809	Green Published, gold, Green Submitted			2022-12-27	WOS:000344863100040
J	Chen, J; Wong, CKH; McGhee, SM; Pang, PKP; Yu, WC				Chen, Jing; Wong, Carlos K. H.; McGhee, Sarah M.; Pang, Polly K. P.; Yu, Wai-Cho			A Comparison between the EQ-5D and the SF-6D in Patients with Chronic Obstructive Pulmonary Disease (COPD)	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH STATES; AIRWAYS DISEASE; UTILITY SCORES; POPULATION; SYMPTOMS; EUROQOL; IMPACT; VALUATIONS; COUNTRIES	Background: The appropriate use of generic preference-based measures determines the accuracy of disease assessment and further decision on healthcare policy using quality adjusted life years. The discriminative capacity of different instruments would differ across disease groups. Our study was to examine the difference in utility scores for COPD patients measured by EQ-5D and SF-6D and to assist the choice of a proper instrument in this disease group. Methods: Differences of mean utility scores of EQ-5D and SF-6D in groups defined by socio-demographic characteristics, comorbidities, health service utilisation and severity of illness were tested using Mann-Whitney test, t-test, Kruskal-Wallis test, Pearson's correlation coefficient and ANOVA, as appropriate. The discriminative properties of the two instruments were compared against indicators of quality of life using receiver operating characteristic curves. The statistical significance of the area under the curves (AUC) was tested by ANOVA and F-statistics used to compare the efficiency with which each instrument discriminated between disease severity groups. Results: Mean utility scores of EQ-5D and SF-6D were 0.644 and 0.629 respectively in the 154 subjects included in the analysis. EQ-5D scores were significantly higher than SF-6D in groups less severe and these differences corresponded to a minimally important difference of greater than 0.03 (p < 0.001). EQ-5D and SF-6D scores were strongly correlated across the whole sample (r = 0.677, p < 0.001) and in pre-defined groups (r>0.5 and p<0.05 for all correlation coefficients). AUCs were above 0.5 against the indicators of health-related quality of life for both instruments. F-ratios suggested SF-6D was more efficient in discriminating cases of different disease severity than EQ-5D. Conclusions: Both EQ-5D and SF-6D appeared to be valid preference-based measures in Chinese COPD patients. SF-6D was more efficient in detecting differences among subgroups with differing health status. EQ-5D and SF-6D measured different things and might not be used interchangeably in COPD patients.	[Chen, Jing; McGhee, Sarah M.] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Wong, Carlos K. H.] Univ Hong Kong, Dept Family Med & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Pang, Polly K. P.; Yu, Wai-Cho] Princess Margaret Hosp, Dept Med & Geriatr, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Chen, J (corresponding author), Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	pianogal@hku.hk	Wong, Carlos King Ho/B-4322-2011	Wong, Carlos King Ho/0000-0002-6895-6071; Chen, Jing/0000-0001-5972-3623	University of Hong Kong Technology and Innovation seed funding	University of Hong Kong Technology and Innovation seed funding	This work was supported by the University of Hong Kong Technology and Innovation seed funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Brazier J, 2004, HEALTH ECON, V13, P873, DOI 10.1002/hec.866; Brazier J, 2007, MEASURING VALUING HL; Buist AS, 2008, INT J TUBERC LUNG D, V12, P703; Cunillera O, 2010, QUAL LIFE RES, V19, P853, DOI 10.1007/s11136-010-9639-z; Dolan P, 1996, J HEALTH ECON, V15, P209, DOI 10.1016/0167-6296(95)00038-0; Dolan P, 1997, SOC SCI MED, V44, P1519, DOI 10.1016/S0277-9536(96)00271-7; DOLAN P, 1995, 138 U YORK; Engstrom CP, 1996, THORAX, V51, P825, DOI 10.1136/thx.51.8.825; EuroQol Group, 2013, AB EQ 5D ROTT; Ferrer M, 1997, ANN INTERN MED, V127, P1072, DOI 10.7326/0003-4819-127-12-199712150-00003; Gerard Karen, 2004, Appl Health Econ Health Policy, V3, P91, DOI 10.2165/00148365-200403020-00005; GOLD Executive Committee, 2011, GLOB IN CHRON OBSTR; Green C, 2000, PHARMACOECONOMICS, V17, P151, DOI 10.2165/00019053-200017020-00004; Grieve R, 2009, EUR J HEALTH ECON, V10, P15, DOI 10.1007/s10198-008-0097-2; Harper R, 1997, THORAX, V52, P879, DOI 10.1136/thx.52.10.879; Horsman John, 2003, Health Qual Life Outcomes, V1, P54, DOI 10.1186/1477-7525-1-54; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; JONES PW, 1994, EUR RESPIR J, V7, P55, DOI 10.1183/09031936.94.07010055; Joore M, 2010, VALUE HEALTH, V13, P222, DOI 10.1111/j.1524-4733.2009.00669.x; KAPLAN RM, 1988, HEALTH SERV RES, V23, P203; Ketelaars CAJ, 1996, THORAX, V51, P39, DOI 10.1136/thx.51.1.39; Kontodimopoulos N, 2011, EUR J HEALTH ECON, V12, P383, DOI 10.1007/s10198-010-0252-4; Kontodimopoulos N, 2009, QUAL LIFE RES, V18, P87, DOI 10.1007/s11136-008-9420-8; Lam CLK, 2008, VALUE HEALTH, V11, P295, DOI 10.1111/j.1524-4733.2007.00233.x; Lam CLK, 2000, FAM PRACT, V17, P159, DOI 10.1093/fampra/17.2.159; Lamers LA, 2006, HEALTH ECON, V15, P1229, DOI 10.1002/hec.1125; Longworth L, 2003, HEALTH ECON, V12, P1061, DOI 10.1002/hec.787; McCrone P, 2009, J MENT HEALTH POLICY, V12, P27; McGhee S M, 2011, Hong Kong Med J, V17 Suppl 6, P17; NORD E, 1991, HEALTH POLICY, V18, P25, DOI 10.1016/0168-8510(91)90141-J; QUIRK FH, 1991, EUR RESPIR J, V4, P167; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rasanen P, 2006, INT J TECHNOL ASSESS, V22, P235, DOI 10.1017/S0266462306051051; Renwick DS, 1996, THORAX, V51, P520, DOI 10.1136/thx.51.5.520; Scott NW, 2009, QUAL LIFE RES, V18, P1125, DOI 10.1007/s11136-009-9521-z; Shoup R, 1997, EUR RESPIR J, V10, P1576, DOI 10.1183/09031936.97.10071576; Sintonen H, 2001, ANN MED, V33, P328, DOI 10.3109/07853890109002086; Stahl Elisabeth, 2005, Health Qual Life Outcomes, V3, P56, DOI 10.1186/1477-7525-3-56; Sullivan PW, 2005, MED CARE, V43, P736, DOI 10.1097/01.mlr.0000172050.67085.4f; Szende A, 2009, QUAL LIFE RES, V18, P267, DOI 10.1007/s11136-008-9429-z; Tsuchiya A, 2002, HEALTH ECON, V11, P341, DOI 10.1002/hec.673; van Stel HF, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-20; Voll-Aanerud M, 2008, RESP MED, V102, P399, DOI 10.1016/j.rmed.2007.10.012; Walters SJ, 2005, QUAL LIFE RES, V14, P1523, DOI 10.1007/s11136-004-7713-0; Walters Stephen J, 2003, Health Qual Life Outcomes, V1, P4, DOI 10.1186/1477-7525-1-4; Zhao FL, 2010, VALUE HEALTH, V13, P649, DOI 10.1111/j.1524-4733.2010.00728.x	47	32	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112389	10.1371/journal.pone.0112389	http://dx.doi.org/10.1371/journal.pone.0112389			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379673	Green Published, gold, Green Submitted			2022-12-27	WOS:000344863100082
J	Hamdi, NM; Al-Hababi, FH; Eid, AE				Hamdi, Nuha Mahmoud; Al-Hababi, Fadel Hassan; Eid, Amr Ekhlas			HLA Class I and Class II Associations with ESRD in Saudi Arabian Population	PLOS ONE			English	Article							STAGE RENAL-DISEASE; CHRONIC KIDNEY-DISEASE; JAPANESE PATIENTS; POLYMORPHISM; TRANSPLANTATION; PROGRESSION; HAPLOTYPES; FAMILY; REGION; TUMOR	Background: Chronic renal failure (CRF) leads in the majority of instances to end stage renal disease (ESRD) requiring renal replacement therapy. Our interest was to evaluate the possible associations of HLA class I and class II antigens with ESRD independent of other factors, in Saudi Arabia population. Methodology: A retrospective study to determine the HLA class I and class II polymorphisms and their association with ESRD, was performed on 350 patients with ESRD, and 105 healthy unrelated control. Patients and control groups were typed by SSOP lumenix techniques. The alleles positively associated to the ESRD were: HLA-B*15, B*18, B*49 - DRB1*03, negatively associated alleles were A*26, HLA-B*39, B*50. The haplotypes positively associated with ESRD were: HLA-A*01-DRB1*13 and HLA-A*30-DRBI*03. The negatively associated haplotypes were: HLA-A*02-B*39, A*02-B*50, A*24-B*35, A*24-B*58, A*24-DRB1*16, A*68-DRB1*04, A*02-DQB1*03, A*29-DQB1*02, A*29-DOB1*05 and B*27-DRB1*07 and the last one is the most significant protective haplotypes. Conclusion: The high Relative Risk (RR) observed and its statistical correlation reflect the strength of the described association between HLA antigens and ESRD.	[Hamdi, Nuha Mahmoud] King Saud Med Complex, Riyadh Reg Lab, Dept Immunol, Riyadh, Saudi Arabia; [Al-Hababi, Fadel Hassan] King Saud Med Complex, Riyadh Reg Lab, Dept Virol, Riyadh, Saudi Arabia; [Eid, Amr Ekhlas] King Saud Med Complex, Riyadh Med Complex, Dept Nephrol, Riyadh, Saudi Arabia		Al-Hababi, FH (corresponding author), King Saud Med Complex, Riyadh Reg Lab, Dept Virol, Riyadh, Saudi Arabia.	fadelhh@hotmail.com			King Saud Medical City	King Saud Medical City	King Saud Medical City's funding division has supported lab technicians and staff nurses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghighi M, 2009, IRAN J KIDNEY DIS, V3, P192; Al-Nozha MM, 2005, SAUDI MED J, V26, P824; Al-Sayyari AA, 2011, SAUDI MED J, V32, P339; Almogren A, 2012, BRIT J BIOMED SCI, V69, P159, DOI 10.1080/09674845.2012.12069145; Alsuwaida AO, 2010, SAUDI J KIDNEY DIS T, V21, P1066; Barocci S, 2004, EUR J IMMUNOGENET, V31, P115, DOI 10.1111/j.1365-2370.2004.00460.x; Barsoum RS, 2006, NEW ENGL J MED, V354, P997, DOI 10.1056/NEJMp058318; Bloudickova S, 2011, FOLIA BIOL-PRAGUE, V57, P30; Braunwald E., 2001, HARRISONS PRINCIPLES; Crispim JC, 2008, TRANSPL P, V40, P1333, DOI 10.1016/j.transproceed.2008.02.086; Dafalla AM, 2011, SAUDI J KIDNEY DIS T, V22, P834; Davood P.P., 2008, RES J BIOL SCI, V3, P1344; El-Gezawy Ebtesam M, 2011, Egypt J Immunol, V18, P13; Federation ID, 2010, LAT DIAB FIG PAINT G; Fudenberg HH, 1984, BASIC IMMUNOGENETICS; Grassmann A, 2005, NEPHROL DIAL TRANSPL, V20, P2587, DOI 10.1093/ndt/gfi159; Hassanien Amal A, 2012, JRSM Short Rep, V3, P38, DOI 10.1258/shorts.2012.011150; Karahan GE, 2010, RENAL FAILURE, V32, P380, DOI 10.3109/08860221003615803; Kitagawa W, 2008, NEPHROL DIAL TRANSPL, V23, P3126, DOI 10.1093/ndt/gfn179; LAYRISSE Z, 1983, HUM IMMUNOL, V7, P177, DOI 10.1016/S0198-8859(83)80005-6; Ma ZJ, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/452537; McClellan W, 2007, J AM SOC NEPHROL, V18, P1344, DOI 10.1681/ASN.2006090952; Modi GK, 2006, KIDNEY INT, V70, P2131; MONOS DS, 1995, HUM IMMUNOL, V44, P70, DOI 10.1016/0198-8859(95)00060-H; Ng SW, 2011, OBES REV, V12, P1, DOI 10.1111/j.1467-789X.2010.00750.x; Obrador GT, 2008, EPIDEMIOLOGY CHRONIC; OGAHARA S, 1992, KIDNEY INT, V41, P175, DOI 10.1038/ki.1992.24; QUNIBI W, 1988, AM J MED, V84, P225, DOI 10.1016/0002-9343(88)90418-4; Ranganath P, 2009, TISSUE ANTIGENS, V74, P147, DOI 10.1111/j.1399-0039.2009.01276.x; Sanchez-Velasco P, 2001, HUM IMMUNOL, V62, P901, DOI 10.1016/S0198-8859(01)00289-0; Sergio Rivera P, 2012, J IMMUNOLOGIA, V31, P37, DOI DOI 10.1016/J.INMUNO.2011.12.001; Shaheen Noha FT, 2013, WORLD C NEPHR 2013 H; Shiina T, 2004, TISSUE ANTIGENS, V64, P631, DOI 10.1111/j.1399-0039.2004.00327.x; Stanevicha V, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2216; Tampe B, 2014, NEPHROL DIAL TRANSPL, V29, P72, DOI 10.1093/ndt/gft025; The Saudi Center for Organ Transplantation (SCOT), 2012, ANN REP SAUD CTR ORG; U.S. Renal Data System, 2008, USRDS ANN DAT REP AT; VAUGHAN RW, 1995, EUR J IMMUNOGENET, V22, P179, DOI 10.1111/j.1744-313X.1995.tb00228.x	38	18	20	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111403	10.1371/journal.pone.0111403	http://dx.doi.org/10.1371/journal.pone.0111403			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380295	Green Submitted, Green Published, gold			2022-12-27	WOS:000344863100027
J	Hugosson, F; Sjogren, C; Birve, A; Hedlund, L; Eriksson, T; Palmer, RH				Hugosson, Fredrik; Sjogren, Camilla; Birve, Anna; Hedlund, Ludmilla; Eriksson, Therese; Palmer, Ruth H.			The Drosophila Midkine/Pleiotrophin Homologues Miple1 and Miple2 Affect Adult Lifespan but Are Dispensable for Alk Signaling during Embryonic Gut Formation	PLOS ONE			English	Article							ANAPLASTIC LYMPHOMA KINASE; RECEPTOR TYROSINE KINASE; HEPARIN-BINDING PROTEIN; ELEGANS DAUER FORMATION; ACID-RESPONSIVE GENE; MOLECULE HB-GAM; GROWTH-FACTOR; CAENORHABDITIS-ELEGANS; VISCERAL MUSCLE; MONOCLONAL-ANTIBODIES	Midkine (MDK) and Pleiotrophin (PTN) are small heparin-binding cytokines with closely related structures. The Drosophila genome harbours two genes encoding members of the MDK/PTN family of proteins, known as miple1 and miple2. We have investigated the role of Miple proteins in vivo, in particular with regard to their proposed role as ligands for the Alk receptor tyrosine kinase (RTK). Here we show that Miple proteins are neither required to drive Alk signaling during Drosophila embryogenesis, nor are they essential for development in the fruit fly. Additionally we show that neither MDK nor PTN can activate hALK in vivo when ectopically co-expressed in the fly. In conclusion, our data suggest that Alk is not activated by MDK/PTN related growth factors Miple1 and Miple 2 in vivo.	[Hugosson, Fredrik; Sjogren, Camilla; Birve, Anna; Hedlund, Ludmilla; Eriksson, Therese; Palmer, Ruth H.] Umea Univ, Dept Mol Biol, Umea, Sweden; [Palmer, Ruth H.] Univ Gothenburg, Dept Med Biochem & Cell Biol, Gothenburg, Sweden	Umea University; University of Gothenburg	Palmer, RH (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.	ruth.palmer@gu.se		Hugosson, Fredrik/0000-0002-8332-7011	Swedish Cancer Society [12-0796]; Children's Cancer Foundation [13/049]; Swedish Research Council [621-2011-5181]; Lions Cancer Society, Umea [LP 12-1946]	Swedish Cancer Society(Swedish Cancer Society); Children's Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Lions Cancer Society, Umea	This work has been supported by grants from the Swedish Cancer Society, http://www.cancerfonden.se/, (Grant number 12-0796 to RHP); the Children's Cancer Foundation, http://www.barncancerfonden.se/, (Grant number 13/049 to RHP); the Swedish Research Council, http://www.vr.se/, (Grant number 621-2011-5181 to RHP); and the Lions Cancer Society, Umea, http://www.cancerforskningsfond-umea.lions.se/, (Grant number LP 12-1946 to RHP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazigou E, 2007, CELL, V128, P961, DOI 10.1016/j.cell.2007.02.024; Blondet B, 2005, J HISTOCHEM CYTOCHEM, V53, P971, DOI 10.1369/jhc.4A6574.2005; Bowden ET, 2002, J BIOL CHEM, V277, P35862, DOI 10.1074/jbc.M203963200; BRAND AH, 1993, DEVELOPMENT, V118, P401; Butchar JP, 2012, GENETICS, V191, P1213, DOI 10.1534/genetics.112.141093; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; Cheng LY, 2011, CELL, V146, P435, DOI 10.1016/j.cell.2011.06.040; COURTY J, 1991, BIOCHEM BIOPH RES CO, V180, P145, DOI 10.1016/S0006-291X(05)81267-7; De Luca M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011286; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; Englund C, 2006, DEV GENES EVOL, V216, P10, DOI 10.1007/s00427-005-0025-8; Englund C, 2003, NATURE, V425, P512, DOI 10.1038/nature01950; Eriksson T, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-86; FU C, 1994, GENE, V146, P311, DOI 10.1016/0378-1119(94)90312-3; Goddeeris MM, 2003, AGING CELL, V2, P257, DOI 10.1046/j.1474-9728.2003.00060.x; Gouzi JY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002281; Hallberg B, 2013, NAT REV CANCER, V13, P685, DOI 10.1038/nrc3580; Inoue T, 2000, GENETICS, V156, P1035; Inoue T, 2000, DEV BIOL, V217, P192, DOI 10.1006/dbio.1999.9545; Ishihara T, 2002, CELL, V109, P639, DOI 10.1016/S0092-8674(02)00748-1; KADOMATSU K, 1988, BIOCHEM BIOPH RES CO, V151, P1312, DOI 10.1016/S0006-291X(88)80505-9; Kadomatsu Kenji, 2004, Tanpakushitsu Kakusan Koso, V49, P2417; Khaliullina H, 2009, DEVELOPMENT, V136, P4111, DOI 10.1242/dev.041392; Kim S, 2007, DEV CELL, V12, P571, DOI 10.1016/j.devcel.2007.02.019; Klingseisen A, 2009, DEVELOPMENT, V136, P2393, DOI 10.1242/dev.035451; KOVESDI I, 1990, BIOCHEM BIOPH RES CO, V172, P850, DOI 10.1016/0006-291X(90)90753-A; Lasek AW, 2011, J NEUROSCI, V31, P14134, DOI 10.1523/JNEUROSCI.3415-11.2011; Lee HH, 2003, NATURE, V425, P507, DOI 10.1038/nature01916; Leips J, 2006, GENETICS, V172, P1595, DOI 10.1534/genetics.105.048520; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Loren CE, 2003, EMBO REP, V4, P781, DOI 10.1038/sj.embor.embor897; Loren CE, 2001, GENES CELLS, V6, P531, DOI 10.1046/j.1365-2443.2001.00440.x; MAEDA N, 1994, FEBS LETT, V354, P67, DOI 10.1016/0014-5793(94)01093-5; Martinsson T, 2011, CANCER RES, V71, P98, DOI 10.1158/0008-5472.CAN-10-2366; Massarwa R, 2007, DEV CELL, V12, P557, DOI 10.1016/j.devcel.2007.01.016; Mathivet T, 2007, CELL SIGNAL, V19, P2434, DOI 10.1016/j.cellsig.2007.07.011; MERENMIES J, 1990, J BIOL CHEM, V265, P16721; Mi RF, 2007, P NATL ACAD SCI USA, V104, P4664, DOI 10.1073/pnas.0603243104; Moog-Lutz C, 2005, J BIOL CHEM, V280, P26039, DOI 10.1074/jbc.M501972200; Motegi A, 2004, J CELL SCI, V117, P3319, DOI 10.1242/jcs.01183; Mourali J, 2006, MOL CELL BIOL, V26, P6209, DOI 10.1128/MCB.01515-05; Munoz-Soriano V, 2013, DEV BIOL, V377, P113, DOI 10.1016/j.ydbio.2013.02.006; Muramatsu H, 2004, J CELL SCI, V117, P5405, DOI 10.1242/jcs.01423; Muramatsu H, 2000, BIOCHEM BIOPH RES CO, V270, P936, DOI 10.1006/bbrc.2000.2549; Muramatsu H, 2006, GENES CELLS, V11, P1405, DOI 10.1111/j.1365-2443.2006.01028.x; Muramatsu T, 2002, J BIOCHEM, V132, P359, DOI 10.1093/oxfordjournals.jbchem.a003231; Nakanishi T, 1997, J BIOCHEM-TOKYO, V121, P197; Nordin SL, 2012, J ANTIMICROB CHEMOTH, V67, P1927, DOI 10.1093/jac/dks136; Nose A, 1998, DEVELOPMENT, V125, P215; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Pecot MY, 2014, NEURON, V82, P320, DOI 10.1016/j.neuron.2014.02.045; Pfeifer K, 2012, DEV GENES EVOL, V222, P165, DOI 10.1007/s00427-012-0402-z; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Powers C, 2002, J BIOL CHEM, V277, P14153, DOI 10.1074/jbc.M112354200; Rambaldi D, 2009, BIOINFORMATICS, V25, P2281, DOI 10.1093/bioinformatics/btp381; RAULO E, 1994, J BIOL CHEM, V269, P12999; RAUVALA H, 1989, EMBO J, V8, P2933, DOI 10.1002/j.1460-2075.1989.tb08443.x; Reiner DJ, 2008, CURR BIOL, V18, P1101, DOI 10.1016/j.cub.2008.06.060; Rohrbough J, 2013, DEV NEUROBIOL, V73, P189, DOI 10.1002/dneu.22056; Rohrbough J, 2010, DEVELOPMENT, V137, P3523, DOI 10.1242/dev.047878; Sakakima H, 2009, J NEUROSCI RES, V87, P2908, DOI 10.1002/jnr.22127; Schaub C, 2012, DEVELOPMENT, V139, P1001, DOI 10.1242/dev.073890; Schonherr C, 2011, BIOCHEM J, V440, P405, DOI 10.1042/BJ20101796; Stoica GE, 2002, J BIOL CHEM, V277, P35990, DOI 10.1074/jbc.M205749200; Stoica GE, 2001, J BIOL CHEM, V276, P16772, DOI 10.1074/jbc.M010660200; Stute C, 2004, DEVELOPMENT, V131, P743, DOI 10.1242/dev.00972; Sugiyama S, 2007, GENETICS, V176, P927, DOI 10.1534/genetics.107.072074; Svensson SL, 2010, J BIOL CHEM, V285, P16105, DOI 10.1074/jbc.M109.081232; TAKE M, 1994, J BIOCHEM-TOKYO, V116, P1063, DOI 10.1093/oxfordjournals.jbchem.a124628; Taravini IRE, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-40; TEZUKA K, 1990, BIOCHEM BIOPH RES CO, V173, P246, DOI 10.1016/S0006-291X(05)81048-4; TOMOMURA M, 1990, J BIOL CHEM, V265, P10765; TSUJIMURA A, 1995, BIOCHEM BIOPH RES CO, V214, P432, DOI 10.1006/bbrc.1995.2305; UNOKI K, 1994, INVEST OPHTH VIS SCI, V35, P4063; Varshney GK, 2006, BIOCHEM BIOPH RES CO, V351, P839, DOI 10.1016/j.bbrc.2006.10.117; VIGNY M, 1989, EUR J BIOCHEM, V186, P733, DOI 10.1111/j.1432-1033.1989.tb15267.x; Walker JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003958; Weiszmann R, 2009, NAT PROTOC, V4, P605, DOI 10.1038/nprot.2009.55; Winkler C, 2014, BRIT J PHARMACOL, V171, P905, DOI 10.1111/bph.12462; Witsell A, 2010, FLY, V4, P137, DOI 10.4161/fly.4.2.10918; Wolfstetter G, 2009, MECH DEVELOP, V126, P721, DOI 10.1016/j.mod.2009.05.001; Yang HL, 2007, J EXP ZOOL PART B, V308B, P269, DOI 10.1002/jez.b.21146	82	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112250	10.1371/journal.pone.0112250	http://dx.doi.org/10.1371/journal.pone.0112250			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380037	Green Submitted, gold, Green Published			2022-12-27	WOS:000344863100069
J	Marrelli, M; Gentile, S; Palmieri, F; Paduano, F; Tatullo, M				Marrelli, Massimo; Gentile, Stefano; Palmieri, Francesca; Paduano, Francesco; Tatullo, Marco			Correlation between Surgeon's Experience, Surgery Complexity and the Alteration of Stress Related Physiological Parameters	PLOS ONE			English	Article							MAXILLOFACIAL SURGEONS; NOVICE-SURGEONS; MENTAL PRACTICE; RESPONSES; BURNOUT; BIOMARKERS; CORTISOL; ANXIETY; HEART; RISK	Introduction: In the present work we analyzed the hormonal (salivary Cortisol; sC), immune (salivary Immunoglobulin A; sIgA) and cardiovascular (Heart rate, HR, and systolic blood pressure, SBP) responses induced by stress conditions in oral surgeons, randomly recruited according to their expertise level. Materials and methods: Each surgeon performed three different surgical procedures with increasing degrees of technical difficulty and under time-limited conditions, to assess whether these variants may influence the risks of stress-induced secondary hypertension among the involved health professionals. sC and sIgA samples and cardiovascular function measurements were taken up before, during, and two hours after every surgery. Salivary samples and cardiovascular measurements were taken also during non-surgical days, as baseline controls. Results: We observed that more experienced surgeons showed a higher stress management ability compared to those with less experience or, generally, younger, which are more exposed to the risks of developing secondary hypertension. Nevertheless, indipendently of sex and experience, oral surgeons are constantly exposed to high risks of developing stress-related diseases. Conclusions: On the basis of the issues addressed and the results obtained, we have highlighted the importance of the investigated stress biomarkers to monitor and to prevent stress-related pathologies among oral surgeons. This approach is aimed to emphasize the significance of these specific stress-biomarkers, which represent a powerful instrument to evaluate stress levels in oral surgeons, and that may help to reduce the most severe life-threatening risks to which they are daily exposed. In conclusion, final goal of this study is to suggest an useful guideline to monitor the stress levels of oral and maxillofacial surgeons in order to improve their quality of life, which is inevitably reflected on the quality of the performances provided and, finally, to prevent possible mistakes in their daily activities.	[Marrelli, Massimo; Tatullo, Marco] Calabrodental, Unit Maxillofacial Surg, Crotone, Italy; [Marrelli, Massimo; Gentile, Stefano; Palmieri, Francesca; Paduano, Francesco; Tatullo, Marco] Tecnol Res Inst, Biomed Sect, Crotone, Italy		Tatullo, M (corresponding author), Calabrodental, Unit Maxillofacial Surg, Crotone, Italy.	marco.tatullo@tecnologicasrl.com	Tatullo, Marco/AAI-4864-2020; Tatullo, Marco/GRQ-7439-2022; Paduano, Francesco/A-2548-2015	Tatullo, Marco/0000-0001-7340-0708; Paduano, Francesco/0000-0003-0916-8101				Alobid I, 2011, ARCH OTOLARYNGOL, V137, P487, DOI 10.1001/archoto.2011.60; Andersen LPH, 2012, SURG LAPARO ENDO PER, V22, P73, DOI 10.1097/SLE.0b013e3182420acf; Arora S, 2011, J AM COLL SURGEONS, V212, P225, DOI 10.1016/j.jamcollsurg.2010.09.025; Campos-Rodriguez R, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00086; Cocks M, 2014, J SURG EDUC, V71, P262, DOI 10.1016/j.jsurg.2013.07.002; Danhof-Pont MB, 2011, J PSYCHOSOM RES, V70, P505, DOI 10.1016/j.jpsychores.2010.10.012; Detling N, 2006, AM HEART J, V151, P522, DOI 10.1016/j.ahj.2005.03.044; Flak JN, 2014, EUR J NEUROSCI, V39, P1903, DOI 10.1111/ejn.12587; Gorter RC, 2012, EUR J ORAL SCI, V120, P69, DOI 10.1111/j.1600-0722.2011.00923.x; Gorter R C, 2010, Ned Tijdschr Tandheelkd, V117, P41; Hamer M, 2012, J CLIN ENDOCR METAB, V97, pE29, DOI 10.1210/jc.2011-2132; Huerta-Franco Maria-Raquel, 2013, World J Gastrointest Pathophysiol, V4, P108, DOI 10.4291/wjgp.v4.i4.108; Imtiaz B, 2014, BIOCHEM PHARMACOL, V88, P661, DOI 10.1016/j.bcp.2014.01.003; Inder WJ, 2012, CLIN ENDOCRINOL, V77, P645, DOI 10.1111/j.1365-2265.2012.04508.x; LaPorta LD, 2010, ORAL MAXIL SURG CLIN, V22, P495, DOI 10.1016/j.coms.2010.07.006; Malamud Daniel, 2011, Dent Clin North Am, V55, P159, DOI 10.1016/j.cden.2010.08.004; Meurman JH, 2010, ORAL ONCOL, V46, P411, DOI 10.1016/j.oraloncology.2010.03.003; Moreira A, 2013, BIOL SPORT, V30, P243, DOI 10.5604/20831862.1077548; Morino M, 2014, J PROSTHODONT RES, V58, P177, DOI 10.1016/j.jpor.2014.03.006; Obayashi K, 2013, CLIN CHIM ACTA, V425, P196, DOI 10.1016/j.cca.2013.07.028; Papadopoulos E, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/234565; Pereira VH, 2013, INT J CARDIOL, V166, P30, DOI 10.1016/j.ijcard.2012.03.165; Porto GG, 2014, INT J ORAL MAX SURG, V43, P894, DOI 10.1016/j.ijom.2013.10.025; Reshma Arunima Padmakumar, 2013, J Indian Soc Periodontol, V17, P214, DOI 10.4103/0972-124X.113076; Rog-Zielinska EA, 2013, HUM MOL GENET, V22, P3269, DOI 10.1093/hmg/ddt182; Sadi Hana, 2013, Anesth Prog, V60, P46, DOI 10.2344/0003-3006-60.2.46; Sominsky L, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00434; Tatullo M, 2012, EUR REV MED PHARMACO, V16, P1218; Thalhammer M, 2014, NEUROPSYCHIATR; Vitlic A, 2014, AGE, V36, P1169, DOI 10.1007/s11357-014-9631-6; Yfanti K, 2014, STRESS, V17, P296, DOI 10.3109/10253890.2014.918602	31	62	62	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112444	10.1371/journal.pone.0112444	http://dx.doi.org/10.1371/journal.pone.0112444			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379944	gold, Green Published, Green Submitted			2022-12-27	WOS:000344863100094
J	Nakai, T; Sakai, KL				Nakai, Tomoya; Sakai, Kuniyoshi L.			Neural Mechanisms Underlying the Computation of Hierarchical Tree Structures in Mathematics	PLOS ONE			English	Article							LEFT PREFRONTAL CORTEX; FUNCTIONAL CONNECTIVITY; LANGUAGE; NUMBER; REPRESENTATION; COMPREHENSION; SYNTAX; SPECIALIZATION; DISSOCIATION; ACQUISITION	Whether mathematical and linguistic processes share the same neural mechanisms has been a matter of controversy. By examining various sentence structures, we recently demonstrated that activations in the left inferior frontal gyrus (L. IFG) and left supramarginal gyrus (L. SMG) were modulated by the Degree of Merger (DoM), a measure for the complexity of tree structures. In the present study, we hypothesize that the DoM is also critical in mathematical calculations, and clarify whether the DoM in the hierarchical tree structures modulates activations in these regions. We tested an arithmetic task that involved linear and quadratic sequences with recursive computation. Using functional magnetic resonance imaging, we found significant activation in the L. IFG, L. SMG, bilateral intraparietal sulcus (IPS), and precuneus selectively among the tested conditions. We also confirmed that activations in the L. IFG and L. SMG were free from memory-related factors, and that activations in the bilateral IPS and precuneus were independent from other possible factors. Moreover, by fitting parametric models of eight factors, we found that the model of DoM in the hierarchical tree structures was the best to explain the modulation of activations in these five regions. Using dynamic causal modeling, we showed that the model with a modulatory effect for the connection from the L. IPS to the L. IFG, and with driving inputs into the L. IFG, was highly probable. The intrinsic, i.e., task-independent, connection from the L. IFG to the L. IPS, as well as that from the L. IPS to the R. IPS, would provide a feedforward signal, together with negative feedback connections. We indicate that mathematics and language share the network of the L. IFG and L. IPS/SMG for the computation of hierarchical tree structures, and that mathematics recruits the additional network of the L. IPS and R. IPS.	[Nakai, Tomoya; Sakai, Kuniyoshi L.] Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Meguro Ku, Tokyo, Japan; [Nakai, Tomoya] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Sakai, Kuniyoshi L.] Japan Soc Promot Sci, CREST, Chiyoda Ku, Tokyo, Japan	University of Tokyo; Japan Society for the Promotion of Science; Japan Science & Technology Agency (JST); Japan Society for the Promotion of Science	Sakai, KL (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Meguro Ku, Tokyo, Japan.	sakai@mind.c.u-tokyo.ac.jp			Core Research for Evolutional Science and Technology (CREST) grant from the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology [20220005]; Japan Society for the Promotion of Science (JSPS) [26.9945]	Core Research for Evolutional Science and Technology (CREST) grant from the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Core Research for Evolutional Science and Technology (CREST) grant from the Japan Science and Technology Agency (JST) (to KLS), by a Grant-in-Aid for Scientific Research (S) (No. 20220005) from the Ministry of Education, Culture, Sports, Science and Technology (to KLS), and by a Grant-in-Aid for JSPS Fellows (No. 26.9945) from the Japan Society for the Promotion of Science (JSPS) (to TN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Baldo JV, 2007, NEUROPSYCHOLOGIA, V45, P229, DOI 10.1016/j.neuropsychologia.2006.07.014; Benn Y, 2013, BRAIN COGNITION, V82, P254, DOI 10.1016/j.bandc.2013.04.012; Benn Y, 2012, NEUROPSYCHOLOGIA, V50, P1, DOI 10.1016/j.neuropsychologia.2011.09.045; Butterworth B., 2005, HDB MATH COGNITION, V1st, P455; Cappelletti M, 2001, NEUROPSYCHOLOGIA, V39, P1224, DOI 10.1016/S0028-3932(01)00035-5; Chomsky N., 1957, SYNTACTIC STRUCTURES; Chomsky N., 1986, KNOWLEDGE LANGUAGE I; Chomsky N, 2007, INT J PHILOS STUD, V15, P1, DOI 10.1080/09672550601143078; Chomsky Noam., 1965, ASPECTS THEORY SYNTA; CIPOLOTTI L, 1991, BRAIN, V114, P2619, DOI 10.1093/brain/114.6.2619; Dapretto M, 1999, NEURON, V24, P427, DOI 10.1016/S0896-6273(00)80855-7; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; Dehaene S, 1997, CORTEX, V33, P219, DOI 10.1016/S0010-9452(08)70002-9; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; den Ouden DB, 2012, NEUROIMAGE, V59, P815, DOI 10.1016/j.neuroimage.2011.07.057; Eger E, 2003, NEURON, V37, P719, DOI 10.1016/S0896-6273(03)00036-9; Embick D, 2000, P NATL ACAD SCI USA, V97, P6150, DOI 10.1073/pnas.100098897; ERNEST P, 1987, BRIT J EDUC PSYCHOL, V57, P343, DOI 10.1111/j.2044-8279.1987.tb00862.x; Fedorenko E, 2013, P NATL ACAD SCI USA, V110, P16616, DOI 10.1073/pnas.1315235110; Fedorenko E, 2012, CURR BIOL, V22, P2059, DOI 10.1016/j.cub.2012.09.011; Fedorenko E, 2011, P NATL ACAD SCI USA, V108, P16428, DOI 10.1073/pnas.1112937108; Friederici AD, 2003, CEREB CORTEX, V13, P170, DOI 10.1093/cercor/13.2.170; Friston KJ, 2006, NEUROIMAGE, V30, P1097, DOI 10.1016/j.neuroimage.2006.02.007; Friston KJ, 2009, PLOS BIOL, V7, P220, DOI 10.1371/journal.pbio.1000033; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Fukui Naoki., 2011, OXFORD HDB LINGUISTI, P73; Hashimoto R, 2002, NEURON, V35, P589, DOI 10.1016/S0896-6273(02)00788-2; Homae F, 2003, NEUROIMAGE, V20, P578, DOI 10.1016/S1053-8119(03)00272-6; Ischebeck A, 2007, NEUROIMAGE, V36, P993, DOI 10.1016/j.neuroimage.2007.03.051; Kinno R, 2008, HUM BRAIN MAPP, V29, P1015, DOI 10.1002/hbm.20441; Kinno R, 2014, BRAIN, V137, P1193, DOI 10.1093/brain/awu013; Klessinger N, 2007, NEUROPSYCHOLOGIA, V45, P1642, DOI 10.1016/j.neuropsychologia.2007.01.005; Klessinger N, 2012, MEM COGNITION, V40, P1289, DOI 10.3758/s13421-012-0228-y; Krueger F, 2011, HUM BRAIN MAPP, V32, P1419, DOI 10.1002/hbm.21119; KVALSETH TO, 1985, AM STAT, V39, P279, DOI 10.2307/2683704; Lee H, 2007, J NEUROSCI, V27, P1184, DOI 10.1523/JNEUROSCI.4442-06.2007; Makuuchi M, 2012, PHILOS T R SOC B, V367, P2033, DOI 10.1098/rstb.2012.0095; Maruyama M, 2012, NEUROIMAGE, V61, P1444, DOI 10.1016/j.neuroimage.2012.04.020; Monti MM, 2012, PSYCHOL SCI, V23, P914, DOI 10.1177/0956797612437427; Musso M, 2003, NAT NEUROSCI, V6, P774, DOI 10.1038/nn1077; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; Ohta S, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00204; Ohta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056230; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Park J, 2013, CEREB CORTEX, V23, P2127, DOI 10.1093/cercor/bhs193; Pattamadilok C, 2010, J NEUROSCI, V30, P8435, DOI 10.1523/JNEUROSCI.5791-09.2010; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Piazza M, 2007, NEURON, V53, P293, DOI 10.1016/j.neuron.2006.11.022; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; Price GR, 2013, J NEUROSCI, V33, P156, DOI 10.1523/JNEUROSCI.2936-12.2013; Rohrmeier M, 2011, J MATH MUSIC, V5, P35, DOI 10.1080/17459737.2011.573676; Sakai KL, 2005, SCIENCE, V310, P815, DOI 10.1126/science.1113530; Stephan KE, 2010, NEUROIMAGE, V49, P3099, DOI 10.1016/j.neuroimage.2009.11.015; Stromswold K, 1996, BRAIN LANG, V52, P452, DOI 10.1006/brln.1996.0024; Suzuki K, 2003, CEREB CORTEX, V13, P517, DOI 10.1093/cercor/13.5.517; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Varley RA, 2005, P NATL ACAD SCI USA, V102, P3519, DOI 10.1073/pnas.0407470102; Zago L, 2001, NEUROIMAGE, V13, P314, DOI 10.1006/nimg.2000.0697	60	11	11	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111439	10.1371/journal.pone.0111439	http://dx.doi.org/10.1371/journal.pone.0111439			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379713	Green Published, Green Submitted, gold			2022-12-27	WOS:000344863100029
J	Smith, DE; Metzger, S; Taylor, JR				Smith, Derek E.; Metzger, Stefan; Taylor, Jeffrey R.			A Transparent and Transferable Framework for Tracking Quality Information in Large Datasets	PLOS ONE			English	Article							EDDY-COVARIANCE MEASUREMENTS; STRATEGY	The ability to evaluate the validity of data is essential to any investigation, and manual "eyes on" assessments of data quality have dominated in the past. Yet, as the size of collected data continues to increase, so does the effort required to assess their quality. This challenge is of particular concern for networks that automate their data collection, and has resulted in the automation of many quality assurance and quality control analyses. Unfortunately, the interpretation of the resulting data quality flags can become quite challenging with large data sets. We have developed a framework to summarize data quality information and facilitate interpretation by the user. Our framework consists of first compiling data quality information and then presenting it through 2 separate mechanisms; a quality report and a quality summary. The quality report presents the results of specific quality analyses as they relate to individual observations, while the quality summary takes a spatial or temporal aggregate of each quality analysis and provides a summary of the results. Included in the quality summary is a final quality flag, which further condenses data quality information to assess whether a data product is valid or not. This framework has the added flexibility to allow "eyes on" information on data quality to be incorporated for many data types. Furthermore, this framework can aid problem tracking and resolution, should sensor or system malfunctions arise.	[Smith, Derek E.; Metzger, Stefan; Taylor, Jeffrey R.] Natl Ecol Observ Network, Boulder, CO 80301 USA; [Metzger, Stefan; Taylor, Jeffrey R.] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Smith, DE (corresponding author), Natl Ecol Observ Network, Boulder, CO 80301 USA.	dsmith@neoninc.org			National Science Foundation [EF-1029808, EF-1138160, EF-1150319, DBI-0752017]; Direct For Biological Sciences [1029808] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This material is based upon work supported by the National Science Foundation under the following grants: EF-1029808, EF-1138160, EF-1150319, and DBI-0752017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gockede M, 2004, AGR FOREST METEOROL, V127, P175, DOI 10.1016/j.agrformet.2004.07.012; Keller M, 2008, FRONT ECOL ENVIRON, V6, P282, DOI 10.1890/1540-9295(2008)6[282:ACSFTN]2.0.CO;2; Mauder M, 2011, MIKROMETEOROLOGIE, V46; Mauder M, 2013, AGR FOREST METEOROL, V169, P122, DOI 10.1016/j.agrformet.2012.09.006; Schimel D.S., 2011, NEON SCI STRATEGY EN; Taylor JR, 2013, BIOGEOSCIENCES, V10, P4957, DOI 10.5194/bg-10-4957-2013; United States Environmental Protection Agency, 2018, SOURC GREENH GAS EM; WANG RY, 1995, IEEE T KNOWL DATA EN, V7, P623, DOI 10.1109/69.404034	8	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112249	10.1371/journal.pone.0112249	http://dx.doi.org/10.1371/journal.pone.0112249			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379884	gold, Green Submitted, Green Published			2022-12-27	WOS:000344863100068
J	West, PR; Amaral, DG; Bais, P; Smith, AM; Egnash, LA; Ross, ME; Palmer, JA; Fontaine, BR; Conard, KR; Corbett, BA; Cezar, GG; Donley, ELR; Burrier, RE				West, Paul R.; Amaral, David G.; Bais, Preeti; Smith, Alan M.; Egnash, Laura A.; Ross, Mark E.; Palmer, Jessica A.; Fontaine, Burr R.; Conard, Kevin R.; Corbett, Blythe A.; Cezar, Gabriela G.; Donley, Elizabeth L. R.; Burrier, Robert E.			Metabolomics as a Tool for Discovery of Biomarkers of Autism Spectrum Disorder in the Blood Plasma of Children	PLOS ONE			English	Article							AMINO-ACIDS; MITOCHONDRIAL; ABNORMALITIES; SPECTROMETRY; PERFORMANCE; ALIGNMENT; PROFILES; SERUM; CHAIN	Background: The diagnosis of autism spectrum disorder (ASD) at the earliest age possible is important for initiating optimally effective intervention. In the United States the average age of diagnosis is 4 years. Identifying metabolic biomarker signatures of ASD from blood samples offers an opportunity for development of diagnostic tests for detection of ASD at an early age. Objectives: To discover metabolic features present in plasma samples that can discriminate children with ASD from typically developing (TD) children. The ultimate goal is to identify and develop blood-based ASD biomarkers that can be validated in larger clinical trials and deployed to guide individualized therapy and treatment. Methods: Blood plasma was obtained from children aged 4 to 6, 52 with ASD and 30 age-matched TD children. Samples were analyzed using 5 mass spectrometry-based methods designed to orthogonally measure a broad range of metabolites. Univariate, multivariate and machine learning methods were used to develop models to rank the importance of features that could distinguish ASD from TD. Results: A set of 179 statistically significant features resulting from univariate analysis were used for multivariate modeling. Subsets of these features properly classified the ASD and TD samples in the 61-sample training set with average accuracies of 84% and 86%, and with a maximum accuracy of 81% in an independent 21-sample validation set. Conclusions: This analysis of blood plasma metabolites resulted in the discovery of biomarkers that may be valuable in the diagnosis of young children with ASD. The results will form the basis for additional discovery and validation research for 1) determining biomarkers to develop diagnostic tests to detect ASD earlier and improve patient outcomes, 2) gaining new insight into the biochemical mechanisms of various subtypes of ASD 3) identifying biomolecular targets for new modes of therapy, and 4) providing the basis for individualized treatment recommendations.	[West, Paul R.; Smith, Alan M.; Egnash, Laura A.; Ross, Mark E.; Palmer, Jessica A.; Fontaine, Burr R.; Conard, Kevin R.; Cezar, Gabriela G.; Donley, Elizabeth L. R.; Burrier, Robert E.] Stemina Biomarker Discovery, Madison, WI 53719 USA; [Amaral, David G.] Univ Calif Davis, MIND Inst, Davis, CA 95616 USA; [Amaral, David G.] Univ Calif Davis, Dept Psychiat & Behav Sci, Davis, CA 95616 USA; [Bais, Preeti] Univ Connecticut, Ctr Hlth, Jackson Lab Genom Med, Farmington, CT USA; [Corbett, Blythe A.] Vanderbilt Univ, Dept Psychiat Psychol & Kennedy Ctr, Nashville, TN 37235 USA	University of California System; University of California Davis; University of California System; University of California Davis; Jackson Laboratory; University of Connecticut; Vanderbilt University	West, PR (corresponding author), Stemina Biomarker Discovery, Madison, WI 53719 USA.	pwest@stemina.com	Donley, Elizabeth/O-4916-2019	Donley, Elizabeth/0000-0002-3439-4322; Palmer, Jessica/0000-0001-7373-4118	Stemina	Stemina	Stemina funded this study. The funder provided support in the form of salaries for authors (PRW, LAE, AMS, MER, JAP, BRF, KRC, GGC, ELRD, and REB), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A J, 2005, ANAL CHEM, V77, P8086, DOI 10.1021/ac051211v; Adams JB, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-34; American Psychiatric Association, 2000, DESK REF DIAGN CRIT; American Psychiatric Association, 2013, DESK REF DIAGN CRIT; Arnold GL, 2003, J AUTISM DEV DISORD, V33, P449, DOI 10.1023/A:1025071014191; Ashwood P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019299; Belgard TG, 2014, MOL PSYCHIATR, V19, P405, DOI 10.1038/mp.2013.34; Beloborodova N, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-89; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg JM, 2012, GENOME BIOL, V13, DOI [10.1186/gb4034, 10.1186/gb-2012-13-7-247]; Blaylock RL, 2009, ALTERN THER HEALTH M, V15, P60; Bruce SJ, 2008, ANAL BIOCHEM, V372, P237, DOI 10.1016/j.ab.2007.09.037; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; Corbett BA, 2007, MOL PSYCHIATR, V12, P292, DOI 10.1038/sj.mp.4001943; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dawson G, 2010, PEDIATRICS, V125, pE17, DOI 10.1542/peds.2009-0958; Dunn WB, 2005, ANALYST, V130, P606, DOI 10.1039/b418288j; El-Ansary AK, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-62; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; Frye RE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.143; Ganz ML, 2007, ARCH PEDIAT ADOL MED, V161, P343, DOI 10.1001/archpedi.161.4.343; Ghezzo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066418; GROSS ML, 1994, J AM SOC MASS SPECTR, V5, P57, DOI 10.1016/1044-0305(94)85036-4; Haury AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028210; Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777; Huguet G, 2013, ANNU REV GENOM HUM G, V14, P191, DOI 10.1146/annurev-genom-091212-153431; James SJ, 2009, AM J CLIN NUTR, V89, P425, DOI 10.3945/ajcn.2008.26615; Kanehisa M, 1997, TRENDS GENET, V13, P375, DOI 10.1016/S0168-9525(97)01223-7; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lee RW, 2011, AUTISM RES TREAT, DOI DOI 10.1155/2011/653570; Marazziti D, 2012, EUR REV MED PHARMACO, V16, P270; Ming X, 2012, J PROTEOME RES, V11, P5856, DOI 10.1021/pr300910n; Moreno-Fuenmayor H, 1996, Invest Clin, V37, P113; Mulle JG, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-012-0337-0; Muller E, 2004, J INHERIT METAB DIS, V27, P903, DOI 10.1023/B:BOLI.0000045775.03183.48; Napolioni V, 2011, MOL NEUROBIOL, V44, P83, DOI 10.1007/s12035-011-8192-2; Novarino G, 2012, SCIENCE, V338, P394, DOI 10.1126/science.1224631; Orchard Sandra, 2007, Proteomics, V7, P3436, DOI 10.1002/pmic.200700658; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Prince JT, 2006, ANAL CHEM, V78, P6140, DOI 10.1021/ac0605344; Priya L, 2011, REDOX REP, V16, P216, DOI 10.1179/1351000211Y.0000000012; Rossignol DA, 2012, MOL PSYCHIATR, V17, P389, DOI 10.1038/mp.2011.165; Safiulina D, 2006, TOXICOL SCI, V93, P348, DOI 10.1093/toxsci/kfl064; Shinohe A, 2006, PROG NEURO-PSYCHOPH, V30, P1472, DOI 10.1016/j.pnpbp.2006.06.013; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Skafidas E, 2012, MOL PSYCHIA IN PRESS; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Sokoro AAH, 2010, J INHERIT METAB DIS, V33, pS275, DOI 10.1007/s10545-010-9148-9; State MW, 2012, SCIENCE, V337, P1301, DOI 10.1126/science.1224989; Strous RD, 2005, EUR NEUROPSYCHOPHARM, V15, P305, DOI 10.1016/j.euroneuro.2004.12.004; TORDJMAN S, 1995, J AUTISM DEV DISORD, V25, P295, DOI 10.1007/BF02179290; Valerio A, 2011, AGING-US, V3, P464, DOI 10.18632/aging.100322; Viegas CM, 2011, BRAIN RES, V1369, P235, DOI 10.1016/j.brainres.2010.10.112; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Whitaker-Azmitia PM, 2005, INT J DEV NEUROSCI, V23, P75, DOI 10.1016/j.ijdevneu.2004.07.022; Whiteley P, 2006, PEDIATR INT, V48, P292, DOI 10.1111/j.1442-200X.2006.02207.x; Wingate M, 2014, MMWR SURVEILL SUMM, V63; Wold H., 1985, ENCY STAT SCI, P581, DOI DOI 10.1002/0471667196; Yap IKS, 2010, J PROTEOME RES, V9, P2996, DOI 10.1021/pr901188e; Yin PY, 2013, CLIN CHEM, V59, P833, DOI 10.1373/clinchem.2012.199257	61	118	124	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112445	10.1371/journal.pone.0112445	http://dx.doi.org/10.1371/journal.pone.0112445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380056	Green Submitted, Green Published, gold			2022-12-27	WOS:000344863100095
J	Ding, S; Xu, LW; Yang, F; Kong, LC; Zhao, YC; Gao, LC; Wang, W; Xu, RD; Ge, H; Jiang, M; Pu, J; He, B				Ding, Song; Xu, Longwei; Yang, Fan; Kong, Lingcong; Zhao, Yichao; Gao, Lingchen; Wang, Wei; Xu, Rende; Ge, Heng; Jiang, Meng; Pu, Jun; He, Ben			Association between Tissue Characteristics of Coronary Plaque and Distal Embolization after Coronary Intervention in Acute Coronary Syndrome Patients: Insights from a Meta-Analysis of Virtual Histology-Intravascular Ultrasound Studies	PLOS ONE			English	Article							NO-REFLOW PHENOMENON; ACUTE MYOCARDIAL-INFARCTION; PROGNOSTIC VALUE; PRIMARY ANGIOPLASTY; STENT IMPLANTATION; FRAME COUNT; IMPACT; ELEVATION; CALCIFICATION; ANGIOGRAPHY	Background and Objectives: The predictive value of plaque characteristics assessed by virtual histology-intravascular ultrasound (VH-IVUS) including fibrous tissue (FT), fibrofatty (FF), necrotic core (NC) and dense calcium (DC) in identifying distal embolization after percutaneous coronary intervention (PCI) is still controversial. We performed a systematic review and meta-analysis to summarize the association of pre-PCI plaque composition and post-PCI distal embolization in acute coronary syndrome patients. Methods: Studies were identified in PubMed, OVID, EMBASE, the Cochrane Library, the Current Controlled Trials Register, reviews, and reference lists of relevant articles. A meta-analysis using both fixed and random effects models with assessment of study heterogeneity and publication bias was performed. Results: Of the 388 articles screened, 10 studies with a total of 872 subjects (199 with distal embolization and 673 with normal flow) met the eligibility of our study. Compared with normal flow groups, significant higher absolute volume of NC [weighted mean differences (WMD): 5.79 mm(3), 95% CI: 3.02 to 8.55 mm(3); p < 0.001] and DC (WMD: 2.55 mm(3), 95% CI: 0.22 to 4.88 mm(3); p = 0.03) were found in acute coronary syndrome patients with distal embolization. Further subgroup analysis demonstrated that the predictive value of tissue characteristics in determining distal embolization was correlated to clinical scenario of the patients, definition of distal embolization, and whether the percutaneous aspiration thrombectomy was applied. Conclusion: Our study that pooled current evidence showed that plaque components were closely related to the distal embolization after PCI, especially the absolute volume of NC and DC, supporting further studies with larger sample size and high-methodological quality.	[Ding, Song; Xu, Longwei; Yang, Fan; Kong, Lingcong; Zhao, Yichao; Gao, Lingchen; Wang, Wei; Xu, Rende; Ge, Heng; Jiang, Meng; Pu, Jun; He, Ben] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Cardiol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Pu, J (corresponding author), Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Cardiol, Shanghai 200030, Peoples R China.	pujun310@hotmail.com; heben1025@hotmail.com		Xu, Longwei/0000-0001-7097-8299	National Natural Science Foundation of China [81330006, 81170192, 81270282, 81070176, 81400261]; International Cooperation Program of Shanghai Committee of Science and Technology [12410708300]; Shanghai Leading Medical Talents Program; Program for New Century Excellent Talents in University from Ministry of Education of China [NCET-12-0352]; Shanghai Shuguang Program [12SG22]; Key Basic Research Program of Shanghai Committee of Science and Technology [14JC1404500]; Shanghai Jiao Tong University Science and Technology Foundation [YZ1005]; Shanghai Leading Talents Program [LJ10007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation Program of Shanghai Committee of Science and Technology; Shanghai Leading Medical Talents Program; Program for New Century Excellent Talents in University from Ministry of Education of China; Shanghai Shuguang Program; Key Basic Research Program of Shanghai Committee of Science and Technology; Shanghai Jiao Tong University Science and Technology Foundation; Shanghai Leading Talents Program	This work was supported by the National Natural Science Foundation of China (81330006, 81170192, 81270282, 81070176, and 81400261), International Cooperation Program of Shanghai Committee of Science and Technology (12410708300), Shanghai Leading Medical Talents Program and Shanghai Leading Talents Program (LJ10007), Program for New Century Excellent Talents in University from Ministry of Education of China (NCET-12-0352), Shanghai Shuguang Program (12SG22), Key Basic Research Program of Shanghai Committee of Science and Technology (14JC1404500), and Shanghai Jiao Tong University Science and Technology Foundation (Grant No. YZ1005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JH, 2008, HEART, V94, P1559, DOI 10.1136/hrt.2007.135822; Bose D, 2008, BASIC RES CARDIOL, V103, P587, DOI 10.1007/s00395-008-0745-9; Claessen BE, 2012, JACC-CARDIOVASC IMAG, V5, pS111, DOI 10.1016/j.jcmg.2011.11.018; Cura FA, 2001, AM J CARDIOL, V88, P124, DOI 10.1016/S0002-9149(01)01605-8; Detrano R, 1996, J AM COLL CARDIOL, V27, P285, DOI 10.1016/0735-1097(95)00460-2; Ding S, 2010, CATHETER CARDIO INTE, V75, P722, DOI 10.1002/ccd.22298; Gibson CM, 1996, CIRCULATION, V93, P879, DOI 10.1161/01.CIR.93.5.879; Grines CL, 1999, NEW ENGL J MED, V341, P1949, DOI 10.1056/NEJM199912233412601; Higashikuni Y, 2008, CIRC J, V72, P1235, DOI 10.1253/circj.72.1235; Hong YJ, 2011, EUR HEART J, V32, P2059, DOI 10.1093/eurheartj/ehp034; Hong YJ, 2009, JACC-CARDIOVASC IMAG, V2, P458, DOI 10.1016/j.jcmg.2008.12.020; Iijima R, 2006, AM J CARDIOL, V97, P29, DOI 10.1016/j.amjcard.2005.07.104; Jang JS, 2013, AM J CARDIOL, V111, P968, DOI 10.1016/j.amjcard.2012.12.016; Katayama T, 2006, AM J CARDIOL, V97, P301, DOI 10.1016/j.amjcard.2005.08.043; Kawaguchi R, 2007, J AM COLL CARDIOL, V50, P1641, DOI 10.1016/j.jacc.2007.06.051; Keelan PC, 2001, CIRCULATION, V104, P412, DOI 10.1161/hc2901.093112; Kusama I, 2007, J AM COLL CARDIOL, V50, P1230, DOI 10.1016/j.jacc.2007.07.004; Maehara A, 2009, CIRC-CARDIOVASC INTE, V2, P482, DOI 10.1161/CIRCINTERVENTIONS.109.868398; Morishima I, 2000, J AM COLL CARDIOL, V36, P1202, DOI 10.1016/S0735-1097(00)00865-2; Nakamura Tomohiro, 2007, J Interv Cardiol, V20, P335, DOI 10.1111/j.1540-8183.2007.00282.x; Ohshima K, 2013, INT J CARDIOL, V167, P1000, DOI 10.1016/j.ijcard.2012.03.079; Ohshima K, 2011, J CARDIOL, V57, P36, DOI 10.1016/j.jjcc.2010.08.002; Ohshima K, 2009, J CARDIOL, V54, P205, DOI 10.1016/j.jjcc.2009.05.009; Pu J, 2014, J AM COLL CARDIOL, V63, P2220, DOI 10.1016/j.jacc.2014.02.576; Pu J, 2012, EUR HEART J, V33, P372, DOI 10.1093/eurheartj/ehr387; Pu J, 2011, ATHEROSCLEROSIS, V215, P203, DOI 10.1016/j.atherosclerosis.2010.11.019; Raggi P, 2003, AM J CARDIOL, V92, P827, DOI 10.1016/S0002-9149(03)00892-0; Schmermund A, 2001, ATHEROSCLEROSIS, V155, P499, DOI 10.1016/S0021-9150(00)00598-0; Shaw LJ, 2003, RADIOLOGY, V228, P826, DOI 10.1148/radiol.2283021006; Shin ES, 2011, INT J CARDIOVAS IMAG, V27, P883, DOI 10.1007/s10554-010-9734-9; Steigen TK, 2008, INT J CARDIOVAS IMAG, V24, P453, DOI 10.1007/s10554-007-9285-x; Tanaka A, 2002, CIRCULATION, V105, P2148, DOI 10.1161/01.CIR.0000015697.59592.07; Taylor AJ, 2000, CIRCULATION, V101, P1243, DOI 10.1161/01.CIR.101.11.1243; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Yamada R, 2010, CIRC J, V74, P1658, DOI 10.1253/circj.CJ-09-0992; Zhao XY, 2013, J INT MED RES, V41, P307, DOI 10.1177/0300060513476423	36	10	10	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e106583	10.1371/journal.pone.0106583	http://dx.doi.org/10.1371/journal.pone.0106583			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375841	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600004
J	Maasoumy, B; Hunyady, B; Calvaruso, V; Makara, M; Vermehren, J; Haragh, A; Susser, S; Bremer, B; Cloherty, G; Manns, MP; Craxi, A; Wedemeyer, H; Sarrazin, C				Maasoumy, Benjamin; Hunyady, Bela; Calvaruso, Vincenza; Makara, Mihaly; Vermehren, Johannes; Haragh, Attila; Susser, Simone; Bremer, Birgit; Cloherty, Gavin; Manns, Michael P.; Craxi, Antonio; Wedemeyer, Heiner; Sarrazin, Christoph			Performance of Two HCV RNA Assays during Protease Inhibitor-Based Triple Therapy in Patients with Advanced Liver Fibrosis and Cirrhosis	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; GENOTYPE 1 INFECTION; COBAS AMPLIPREP/COBAS TAQMAN; VIRUS-INFECTION; REALTIME HCV; QUANTITATIVE TEST; CLINICAL-TRIAL; TELAPREVIR; SOFOSBUVIR; BOCEPREVIR	Introduction: On-treatment HCV RNA measurements are crucial for the prediction of a sustained virological response (SVR) and to determine treatment futility during protease inhibitor-based triple therapies. In patients with advanced liver disease an accurate risk/benefit calculation based on reliable HCV RNA results can reduce the number of adverse events. However, the different available HCV RNA assays vary in their diagnostic performance. Aim: To investigate the clinical relevance of concordant and discordant results of two HCV RNA assays during triple therapy with boceprevir and telaprevir in patients with advanced liver fibrosis/cirrhosis. Methods: We collected on-treatment samples of 191 patients with advanced liver fibrosis/cirrhosis treated at four European centers for testing with the Abbott RealTime (ART) and COBAS AmpliPrep/COBAS TaqMan HCV v2.0 (CTM) assays. Results: Discordant test results for HCV RNA detectability were observed in 23% at week 4, 17% at week 8/12 and 9% at week 24 on-treatment. The ART detected HCV RNA in 41% of week 4 samples tested negative by the CTM. However, the positive predictive value of an undetectable week 4 result for SVR was similar for both assays (80% and 82%). Discordance was also found for application of stopping rules. In 27% of patients who met stopping rules by CTM the ART measured levels below the respective cut-offs of 100 and 1000 IU/ml, respectively, which would have resulted in treatment continuation. In contrast, in nine patients with negative HCV RNA by CTM at week 24 treatment would have been discontinued due to detectable residual HCV RNA by the ART assay. Importantly, only 4 of these patients failed to achieve SVR. Conclusion: Application of stopping rules determined in approval studies by one assay to other HCV RNA assays in clinical practice may lead to over and undertreatment in a significant number of patients undergoing protease inhibitor-based triple therapy.	[Maasoumy, Benjamin; Manns, Michael P.; Wedemeyer, Heiner] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Hunyady, Bela; Haragh, Attila] Somogy Cty Kaposi Mor Teaching Hosp, Kaposvar, Hungary; [Hunyady, Bela] Univ Pecs, Pecs, Hungary; [Calvaruso, Vincenza; Craxi, Antonio] Univ Palermo, DiBiMIS, Gastroenterol Sect, Palermo, Italy; [Makara, Mihaly] St Laszlo Hosp, Outpatient Clin, Budapest, Hungary; [Vermehren, Johannes; Susser, Simone; Sarrazin, Christoph] JW Goethe Univ Hosp, Dept Med 1, Frankfurt, Germany; [Cloherty, Gavin] Abbott Mol, Des Plaines, IL USA	Hannover Medical School; University of Pecs; University of Palermo; Szent Laszlo Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Sarrazin, C (corresponding author), JW Goethe Univ Hosp, Dept Med 1, Frankfurt, Germany.	sarrazin@em.uni-frankfurt.de	; Calvaruso, Vincenza/K-8973-2016; Craxi, Antonio/K-9529-2016	Maasoumy, Benjamin/0000-0002-3250-3177; Calvaruso, Vincenza/0000-0002-0287-1059; Craxi, Antonio/0000-0002-4480-9544	Endoprogress Foundation; Foundation for Patients with Liver Diseases, Budapest, Hungary; Abbott Molecular; Pecs Hungary	Endoprogress Foundation; Foundation for Patients with Liver Diseases, Budapest, Hungary; Abbott Molecular; Pecs Hungary	This work was partially supported by research grants from the Endoprogress Foundation, Pecs Hungary, and by the Foundation for Patients with Liver Diseases, Budapest, Hungary. Abbott Molecular provided HCV RNA tests and covered the publication fees. The funder provided support in the form of salaries for authors (GC; Abbott Molecular), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Backus LI, 2014, ALIMENT PHARM THER, V39, P93, DOI 10.1111/apt.12546; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Chevaliez S, 2012, GASTROENTEROLOGY, V142, P1303, DOI 10.1053/j.gastro.2012.02.027; Cloherty G, 2013, APASL 6 10 JUN 2013; Cobb B, 2013, AM J GASTROENTEROL, V108, P471, DOI 10.1038/ajg.2012.248; Feld JJ, 2014, ANTIVIRAL RES; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Fevery B, 2014, ANTIVIR THER; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Harrington PR, 2012, HEPATOLOGY, V55, P1048, DOI 10.1002/hep.24791; Hezode C, 2013, J HEPATOL, V59, P434, DOI 10.1016/j.jhep.2013.04.035; Jacobson IM, 2012, HEPATOLOGY, V56, P567, DOI 10.1002/hep.25865; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Koff RS, 2014, ALIMENT PHARM THER, V39, P478, DOI 10.1111/apt.12601; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Lawitz E, 2014, LANCET; Maasoumy B, 2014, ALIMENT PHARM THER, V39, P85, DOI 10.1111/apt.12544; Maasoumy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055285; Maasoumy B, 2012, BEST PRACT RES CL GA, V26, P401, DOI 10.1016/j.bpg.2012.09.009; Michelin BDA, 2007, J CLIN VIROL, V38, P96, DOI 10.1016/j.jcv.2006.11.007; Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003; Osinusi A, 2013, JAMA-J AM MED ASSOC, V310, P804, DOI 10.1001/jama.2013.109309; Peiffer KH, 2012, HEPATOLOGY, V56, p560A; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Sarrazin C, 2012, Z GASTROENTEROL, V50, P57, DOI 10.1055/s-0031-1282015; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Sulkowski MS, 2014, NEW ENGL J MED, V370, P1560, DOI 10.1056/NEJMc1401726; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Vermehren J, 2014, J HEPATOL; Vermehren J, 2008, J CLIN MICROBIOL, V46, P3880, DOI 10.1128/JCM.00755-08; Vermehren J, 2011, J CLIN VIROL, V52, P133, DOI 10.1016/j.jcv.2011.07.007; Vermehren J, 2011, J CLIN MICROBIOL, V49, P3309, DOI 10.1128/JCM.00602-11; Wedemeyer H, 2012, HEPATOLOGY, V56, p676A; You DM, 2013, EXPERT OPIN PHARMACO, V14, P2581, DOI 10.1517/14656566.2013.850074; Younossi Z.M., 2013, J HEPATOL; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Zitzer H, 2013, J CLIN MICROBIOL, V51, P571, DOI 10.1128/JCM.01784-12	42	14	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e110857	10.1371/journal.pone.0110857	http://dx.doi.org/10.1371/journal.pone.0110857			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389779	gold, Green Published, Green Submitted			2022-12-27	WOS:000349144400017
J	Kopecky, J; Nesvorna, M; Mareckova-Sagova, M; Hubert, J				Kopecky, Jan; Nesvorna, Marta; Mareckova-Sagova, Marketa; Hubert, Jan			The Effect of Antibiotics on Associated Bacterial Community of Stored Product Mites	PLOS ONE			English	Article							HOUSE-DUST MITE; DERMATOPHAGOIDES-PTERONYSSINUS; GUT MICROBIOTA; IN-VITRO; ACARI; IDENTIFICATION; ENDOSYMBIONTS; INFECTION; LYSOZYME; BACILLUS	Background: Bacteria are associated with the gut, fat bodies and reproductive organs of stored product mites (Acari: Astigmata). The mites are pests due to the production of allergens. Addition of antibiotics to diets can help to characterize the association between mites and bacteria. Methodology and Principal Findings: Ampicillin, neomycin and streptomycin were added to the diets of mites and the effects on mite population growth (Acarus siro, Lepidoglyphus destructor and Tyrophagus putrescentiae) and associated bacterial community structure were assessed. Mites were treated by antibiotic supplementation (1 mgg(-1) of diet) for 21 days and numbers of mites and bacterial communities were analyzed and compared to the untreated control. Bacterial quantities, determined by real-time PCR, significantly decreased in antibiotic treated specimens from 5 to 30 times in A. siro and T. putrescentiae, while no decline was observed in L. destructor. Streptomycin treatment eliminated Bartonella-like bacteria in the both A. siro and T. putrescentiae and Cardinium in T. putrescentiae. Solitalea-like bacteria proportion increased in the communities of neomycin and streptomycin treated A. siro specimens. Kocuria proportion increased in the bacterial communities of ampicillin and streptomycin treated A. siro and neomycin and streptomycin treated L. destructor. Conclusions/Significance: The work demonstrated the changes of mite associated bacterial community under antibiotic pressure in pests of medical importance. Pre-treatment of mites by 1 mgg(-1) antibiotic diets improved mite fitness as indicated accelerated population growth of A. siro pretreated streptomycin and neomycin and L. destructor pretreated by neomycin. All tested antibiotics supplemented to diets caused the decrease of mite growth rate in comparison to the control diet.	[Kopecky, Jan; Mareckova-Sagova, Marketa] Crop Res Inst, Prague, Czech Republic; [Nesvorna, Marta; Hubert, Jan] Crop Res Inst, Biol Act Subst Crop Protect, Prague, Czech Republic	Czech Crop Research Institute (CRI); Czech Crop Research Institute (CRI)	Hubert, J (corresponding author), Crop Res Inst, Biol Act Subst Crop Protect, Prague, Czech Republic.	hubert@vurv.cz	Nesvorná, Marta/ABA-4351-2020; Hubert, Jan/K-5489-2012; Kopecky, Jan/C-7400-2013; Mareckova, Marketa/D-9898-2017; Mareckova, Marketa/AAD-7361-2021	Nesvorná, Marta/0000-0003-0572-4131; Hubert, Jan/0000-0003-0740-166X; Kopecky, Jan/0000-0002-3437-257X; Mareckova, Marketa/0000-0002-0331-8570; Mareckova, Marketa/0000-0002-0331-8570	Czech Science Foundation [GA525/09/1872]; Ministrz of education youth and sport of the Czech Republic [LD13052/COST FA1105]; Ministry of Agriculture of the Czech Republic [RO0414]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministrz of education youth and sport of the Czech Republic; Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	This work was supported by the Czech Science Foundation (http://www.gacr.cz/en/) grant No. GA525/09/1872 to JK, Ministrz of education youth and sport of the Czech Republic (www.msmt.cz/index.php? lang = 2) grant No. LD13052/COST FA1105 action to JH and Ministry of Agriculture of the Czech Republic (http://eagri.cz/public/web/en/mze/) grant NO. RO0414 to MMS and MN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlian LG, 2011, INT ARCH ALLERGY IMM, V156, P171, DOI 10.1159/000323351; Barbieri E, 2001, ENVIRON MICROBIOL, V3, P151, DOI 10.1046/j.1462-2920.2001.00172.x; Billeter SA, 2008, MED VET ENTOMOL, V22, P1, DOI 10.1111/j.1365-2915.2008.00713.x; Boczek J., 1965, Bollettino di Zoologia Agraria e Bachicoltura (2), V7, P299; Boczek J, 1968, ROCZ NAUK ROLN, V93, P579; BREZNAK JA, 1982, ANNU REV MICROBIOL, V36, P323, DOI 10.1146/annurev.mi.36.100182.001543; Castagnoli Marisa, 2006, Redia, V89, P55; Chigira A, 2005, EXP APPL ACAROL, V37, P107, DOI 10.1007/s10493-005-0592-4; CHILDS M, 1981, COMP BIOCHEM PHYS B, V70, P615, DOI 10.1016/0305-0491(81)90305-9; Diaz A, 2000, EXP APPL ACAROL, V24, P85, DOI 10.1023/A:1006304300657; Douglas A.E., 2009, FUNCT ECOL, V23, P38; Edlund A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033107; Erban T, 2008, EXP APPL ACAROL, V44, P199, DOI 10.1007/s10493-008-9138-x; Erban T, 2009, EXP APPL ACAROL, V49, P339, DOI 10.1007/s10493-009-9265-z; Fernandez-Caldas E, 2006, CURR ALLERGY ASTHM R, V6, P413, DOI 10.1007/s11882-996-0015-6; Genta FA, 2006, J INSECT PHYSIOL, V52, P593, DOI 10.1016/j.jinsphys.2006.02.007; Gotoh T, 2007, HEREDITY, V98, P13, DOI 10.1038/sj.hdy.6800881; Greewood D, 2003, ANTIBIOTIC CHEMOTHER; HAY DB, 1993, MED VET ENTOMOL, V7, P271, DOI 10.1111/j.1365-2915.1993.tb00687.x; Hubert J, 2005, EXP APPL ACAROL, V35, P281, DOI 10.1007/s10493-004-7834-8; Hubert J, 2008, EXP APPL ACAROL, V44, P315, DOI 10.1007/s10493-008-9146-x; Hubert J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048429; Hubert J, 2012, MICROB ECOL, V63, P919, DOI 10.1007/s00248-011-9969-6; Hughes AM, 1976, TECHNICAL B UK MINIS; Kafil M, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.9901; Koga R, 2007, FEMS MICROBIOL ECOL, V60, P229, DOI 10.1111/j.1574-6941.2007.00284.x; Kopecky J, 2014, EXP APPL ACAROL, V64, P21, DOI 10.1007/s10493-014-9811-1; Kopecky J, 2013, J INVERTEBR PATHOL, V112, P20, DOI 10.1016/j.jip.2012.11.001; Lundgren JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010831; Morag N, 2013, APPL ENVIRON MICROB, V79, P6260, DOI 10.1128/AEM.01793-13; Morales-Jimenez J, 2012, MICROB ECOL, V64, P268, DOI 10.1007/s00248-011-9999-0; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Morimoto S, 2006, CURR MICROBIOL, V52, P324, DOI 10.1007/s00284-005-0349-7; Oliwa-Stasiak K, 2010, J APPL MICROBIOL, V108, P266, DOI 10.1111/j.1365-2672.2009.04419.x; Palyvos NE, 2011, EXP APPL ACAROL, V54, P139, DOI 10.1007/s10493-011-9427-7; Robinson CJ, 2010, MICROB ECOL, V59, P199, DOI 10.1007/s00248-009-9595-8; Rosengaus RB, 2011, APPL ENVIRON MICROB, V77, P4303, DOI 10.1128/AEM.01886-10; Sagova-Mareckova M, 2011, APPL ENVIRON MICROB, V77, P7560, DOI 10.1128/AEM.00527-11; SALEH SM, 1991, ACAROLOGIA, V32, P257; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Smrz J, 2003, EXP APPL ACAROL, V31, P105, DOI 10.1023/B:APPA.0000005111.05959.d6; Smrz J, 2010, SYMBIOSIS, V52, P33, DOI 10.1007/s13199-010-0099-6; Tang VH, 2013, EXP APPL ACAROL, V61, P431, DOI 10.1007/s10493-013-9712-8; Van Asselt L, 1999, INDOOR BUILT ENVIRON, V8, P216, DOI 10.1177/1420326X9900800402; Van der Geest LPS, 2000, EXP APPL ACAROL, V24, P497, DOI 10.1023/A:1026518418163; Wang JJ, 2008, J ECON ENTOMOL, V101, P1711, DOI 10.1603/0022-0493(2008)101[1711:EOROCI]2.0.CO;2; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wenzel M, 2002, J APPL MICROBIOL, V92, P32, DOI 10.1046/j.1365-2672.2002.01502.x; Xia B, 2012, EXP APPL ACAROL, V56, P33, DOI 10.1007/s10493-011-9481-1; Zdarkova E., 1998, Integrated Pest Management Reviews, V3, P111, DOI 10.1023/A:1009647814477; Zindel R, 2013, FASEB J, V27, P1488, DOI 10.1096/fj.12-216242	51	26	26	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112919	10.1371/journal.pone.0112919	http://dx.doi.org/10.1371/journal.pone.0112919			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25387104	Green Published, Green Submitted, gold			2022-12-27	WOS:000345250400105
J	Bustamante, P; Tello, M; Orellana, O				Bustamante, Paula; Tello, Mario; Orellana, Omar			Toxin-Antitoxin Systems in the Mobile Genome of Acidithiobacillus ferrooxidans	PLOS ONE			English	Article							ESCHERICHIA-COLI; MESSENGER-RNA; CRYSTAL-STRUCTURE; SEQUENCE; PROTEIN; LOCI; BACTERIA; WEB; RIBONUCLEASES; EVOLUTION	Toxin-antitoxin (TA) systems are genetic modules composed of a pair of genes encoding a stable toxin and an unstable antitoxin that inhibits toxin activity. They are widespread among plasmids and chromosomes of bacteria and archaea. TA systems are known to be involved in the stabilization of plasmids but there is no consensus about the function of chromosomal TA systems. To shed light on the role of chromosomally encoded TA systems we analyzed the distribution and functionality of type II TA systems in the chromosome of two strains from Acidithiobacillus ferrooxidans (ATCC 23270 and 53993), a Gram-negative, acidophilic, environmental bacterium that participates in the bioleaching of minerals. As in other environmental microorganisms, A. ferrooxidans has a high content of TA systems (28-29) and in twenty of them the toxin is a putative ribonuclease. According to the genetic context, some of these systems are encoded near or within mobile genetic elements. Although most TA systems are shared by both strains, four of them, which are encoded in the active mobile element ICEAfe1, are exclusive to the type strain ATCC 23270. We demostrated that two TA systems from ICEAfe1 are functional in E. coli cells, since the toxins inhibit growth and the antitoxins counteract the effect of their cognate toxins. All the toxins from ICEAfe1, including a novel toxin, are RNases with different ion requirements. The data indicate that some of the chromosomally encoded TA systems are actually part of the A. ferrooxidans mobile genome and we propose that could be involved in the maintenance of these integrated mobile genetic elements.	[Bustamante, Paula; Orellana, Omar] Univ Chile, Fac Med, ICBM, Programa Biol Celular & Mol, Santiago 7, Chile; [Tello, Mario] Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Ctr Biotecnol Acuicola, Santiago, Chile	Universidad de Chile; Universidad de Santiago de Chile	Orellana, O (corresponding author), Univ Chile, Fac Med, ICBM, Programa Biol Celular & Mol, Santiago 7, Chile.	oorellan@med.uchile.cl	Tello, Mario/N-4198-2019	Tello, Mario/0000-0003-4573-6460; Bustamante, Paula/0000-0001-7200-4439	Fondecyt Chile [1110203]; Proyecto Bicentenario [PDA20]; Proyecto FIA [PYT20120056]; Conicyt, Chile [AT-24100112]	Fondecyt Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Proyecto Bicentenario; Proyecto FIA; Conicyt, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by grants from Fondecyt Chile 1110203 to OO (http://www.conicyt.cl/fondecyt/) and Proyecto Bicentenario PDA20 (www.conicyt.cl) and Proyecto FIA PYT20120056 to MT (www.fia.cl). PB was the recipient of a graduate studies fellowship and supporting fellowship AT-24100112 from Conicyt (www.conicyt.cl), Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078237; Amitai S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000390; Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; Arcus VL, 2011, PROTEIN ENG DES SEL, V24, P33, DOI 10.1093/protein/gzq081; Blower TR, 2012, NUCLEIC ACIDS RES, V40, P6158, DOI 10.1093/nar/gks231; Blower TR, 2011, CURR OPIN STRUC BIOL, V21, P109, DOI 10.1016/j.sbi.2010.10.009; Bonnefoy V, 2012, ENVIRON MICROBIOL, V14, P1597, DOI 10.1111/j.1462-2920.2011.02626.x; Budde PP, 2007, J BACTERIOL, V189, P491, DOI 10.1128/JB.00909-06; Bukowski M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3012; Bunker RD, 2008, PROTEINS, V72, P510, DOI 10.1002/prot.22048; Bustamante P, 2012, J MOL MICROB BIOTECH, V22, P399, DOI 10.1159/000346669; Cambray G, 2010, ANNU REV GENET, V44, P141, DOI 10.1146/annurev-genet-102209-163504; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Cook GM, 2013, BBA-GENE REGUL MECH, V1829, P523, DOI 10.1016/j.bbagrm.2013.02.007; DOPAZO J, 1994, J MOL EVOL, V38, P300, DOI 10.1007/BF00176092; Dy RL, 2014, NUCLEIC ACIDS RES, V42, P4590, DOI 10.1093/nar/gkt1419; Fasani RA, 2013, P NATL ACAD SCI USA, V110, pE2528, DOI 10.1073/pnas.1301023110; Fozo EM, 2010, NUCLEIC ACIDS RES, V38, P3743, DOI 10.1093/nar/gkq054; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; GERDES K, 1986, EMBO J, V5, P2023, DOI 10.1002/j.1460-2075.1986.tb04459.x; GONNET GH, 1992, SCIENCE, V256, P1443, DOI 10.1126/science.1604319; Guerout AM, 2013, J BACTERIOL, V195, P2270, DOI 10.1128/JB.01389-12; Hayes CS, 2010, ANNU REV GENET, V44, P71, DOI 10.1146/annurev.genet.42.110807.091449; Holmes DS, 2001, J BACTERIOL, V183, P4323, DOI 10.1128/JB.183.14.4323-4329.2001; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Masuda H, 2012, MOL MICROBIOL, V84, P979, DOI 10.1111/j.1365-2958.2012.08068.x; Mittenhuber Gerhard, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P295; Norton JP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002954; Oppon JC, 1998, J BACTERIOL, V180, P3007, DOI 10.1128/JB.180.11.3007-3012.1998; Orellana LH, 2011, APPL MICROBIOL BIOT, V92, P761, DOI 10.1007/s00253-011-3494-x; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sala A, 2014, TOXINS, V6, P1002, DOI 10.3390/toxins6031002; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Sevin EW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r155; Shao YC, 2011, NUCLEIC ACIDS RES, V39, pD606, DOI 10.1093/nar/gkq908; Szekeres S, 2007, MOL MICROBIOL, V63, P1588, DOI 10.1111/j.1365-2958.2007.05613.x; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian QB, 1996, BIOCHEM BIOPH RES CO, V220, P280, DOI 10.1006/bbrc.1996.0396; Tsilibaris V, 2007, J BACTERIOL, V189, P6101, DOI 10.1128/JB.00527-07; Valdes J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-597; Wang XX, 2012, NAT CHEM BIOL, V8, P855, DOI 10.1038/NCHEMBIO.1062; Wilbaux M, 2007, J BACTERIOL, V189, P2712, DOI 10.1128/JB.01679-06; Williams KP, 2010, J BACTERIOL, V192, P2305, DOI 10.1128/JB.01480-09; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382; Wozniak RAF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000786; Wozniak RAF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000439; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Yamaguchi Y, 2009, PROG MOL BIOL TRANSL, V85, P467, DOI 10.1016/S0079-6603(08)00812-X; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7	62	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112226	10.1371/journal.pone.0112226	http://dx.doi.org/10.1371/journal.pone.0112226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384039	Green Published, gold, Green Submitted			2022-12-27	WOS:000344816700041
J	Kott, M; Elke, G; Reinicke, M; Winoto-Morbach, S; Schadler, D; Zick, G; Frerichs, I; Weiler, N; Schutze, S				Kott, Matthias; Elke, Gunnar; Reinicke, Maike; Winoto-Morbach, Supandi; Schaedler, Dirk; Zick, Guenther; Frerichs, Inez; Weiler, Norbert; Schuetze, Stefan			Acid Sphingomyelinase Serum Activity Predicts Mortality in Intensive Care Unit Patients after Systemic Inflammation: A Prospective Cohort Study	PLOS ONE			English	Article							ORGAN FAILURE; SEVERE SEPSIS; PROCALCITONIN; CERAMIDE; APOPTOSIS; ALPHA; SCORE	Introduction: Acid sphingomyelinase is involved in lipid signalling pathways and regulation of apoptosis by the generation of ceramide and plays an important role during the host response to infectious stimuli. It thus has the potential to be used as a novel diagnostic marker in the management of critically ill patients. The objective of our study was to evaluate acid sphingomyelinase serum activity (ASM) as a diagnostic and prognostic marker in a mixed intensive care unit population before, during, and after systemic inflammation. Methods: 40 patients admitted to the intensive care unit at risk for developing systemic inflammation (defined as systemic inflammatory response syndrome plus a significant procalcitonin [PCT] increase) were included. ASM was analysed on ICU admission, before (PCTbefore), during (PCTpeak) and after (PCTlow) onset of SIRS. Patients undergoing elective surgery served as control (N=8). Receiver-operating characteristics curves were computed. Results: ASM significantly increased after surgery in the eight control patients. Patients from the intensive care unit had significantly higher ASM on admission than control patients after surgery. 19 out of 40 patients admitted to the intensive care unit developed systemic inflammation and 21 did not, with no differences in ASM between these two groups on admission. In patients with SIRS and PCTpeak, ASM between admission and PCTbefore was not different, but further increased at PCTpeak in non-survivors and was significantly higher at PCTlow compared to survivors. Survivors exhibited decreased ASM at PCTpeak and PCTlow. Receiver operating curve analysis on discrimination of ICU mortality showed an area under the curve of 0.79 for ASM at PCTlow. Conclusions: In summary, ASM was generally higher in patients admitted to the intensive care unit compared to patients undergoing uncomplicated surgery. ASM did not indicate onset of systemic inflammation. In contrast to PCT however, it remained high in non-surviving ICU patients after systemic inflammation.	[Kott, Matthias; Elke, Gunnar; Reinicke, Maike; Schaedler, Dirk; Zick, Guenther; Frerichs, Inez; Weiler, Norbert] Univ Med Ctr Schleswig Holstein, Dept Anesthesiol & Intens Care Med, Kiel, Germany; [Reinicke, Maike; Winoto-Morbach, Supandi; Schuetze, Stefan] Univ Med Ctr Schleswig Holstein, Inst Immunol, Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital	Kott, M (corresponding author), Univ Med Ctr Schleswig Holstein, Dept Anesthesiol & Intens Care Med, Campus Kiel, Kiel, Germany.	matthias.kott@uksh.de	Frerichs, I./AAT-3685-2021; Lindner, Matthias/O-1961-2018; Elke, Gunnar/S-8579-2016; Schädler, Dirk/A-7253-2012	Frerichs, I./0000-0002-7712-6539; Lindner, Matthias/0000-0003-2647-7790; Elke, Gunnar/0000-0002-4948-1605; Schädler, Dirk/0000-0002-5745-4797	Christian-Albrechts University Kiel, Germany; Deutsche Forschungsgemeinschaft [SCHU 733/9-2]	Christian-Albrechts University Kiel, Germany; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was funded by a restricted grant of the Christian-Albrechts University Kiel, Germany and in part supported by a grant of the Deutsche Forschungsgemeinschaft (SCHU 733/9-2) given to S. Schutze. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Castelli GP, 2004, CRIT CARE, V8, pR234, DOI 10.1186/cc2877; Castillo SS, 2007, EXP CELL RES, V313, P816, DOI 10.1016/j.yexcr.2006.12.001; Claus RA, 2005, FASEB J, V19, P1719, DOI 10.1096/fj.04-2842fje; Corda S, 2001, AM J RESP CELL MOL, V24, P762, DOI 10.1165/ajrcmb.24.6.4228; Cullen D J, 1974, Crit Care Med, V2, P57, DOI 10.1097/00003246-197403000-00001; Drobnik W, 2003, J LIPID RES, V44, P754, DOI 10.1194/jlr.M200401-JLR200; Edelmann B, 2011, EMBO J, V30, P379, DOI 10.1038/emboj.2010.326; Garcia-Ruiz C, 2003, J CLIN INVEST, V111, P197, DOI 10.1172/JCI200316010; Goggel R, 2004, NAT MED, V10, P155, DOI 10.1038/nm977; Grassme H, 2007, PROG LIPID RES, V46, P161, DOI 10.1016/j.plipres.2007.03.002; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; Herrmann W, 2000, CLIN CHEM LAB MED, V38, P41, DOI 10.1515/CCLM.2000.007; Jbeily N, 2013, J LIPID RES, V54, P410, DOI 10.1194/jlr.M031625; Jenkins RW, 2009, CELL SIGNAL, V21, P836, DOI 10.1016/j.cellsig.2009.01.026; Kornhuber J, 2010, CELL PHYSIOL BIOCHEM, V26, P9, DOI 10.1159/000315101; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Meisner M, 2006, CRIT CARE, V10, DOI 10.1186/cc3910; Prkno A, 2013, CRIT CARE, V17, DOI 10.1186/cc13157; Reinhart K, 2010, ANAESTHESIST, V59, P347, DOI 10.1007/s00101-010-1719-5; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Tokuda H, 1999, J CELL BIOCHEM, V72, P262, DOI 10.1002/(SICI)1097-4644(19990201)72:2<262::AID-JCB10>3.0.CO;2-N; Uzzan B, 2006, CRIT CARE MED, V34, P1996, DOI 10.1097/01.CCM.0000226413.54364.36; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wacker C, 2013, LANCET INFECT DIS, V13, P426, DOI 10.1016/S1473-3099(12)70323-7	27	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112323	10.1371/journal.pone.0112323	http://dx.doi.org/10.1371/journal.pone.0112323			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384060	gold, Green Published, Green Submitted			2022-12-27	WOS:000344816700050
J	Nilsson, S; Sjoberg, J; Amundin, M; Hartmann, C; Buettner, A; Laska, M				Nilsson, Sara; Sjoberg, Johanna; Amundin, Mats; Hartmann, Constanze; Buettner, Andrea; Laska, Matthias			Behavioral Responses to Mammalian Blood Odor and a Blood Odor Component in Four Species of Large Carnivores	PLOS ONE			English	Article							MONKEYS ATELES-GEOFFROYI; OLFACTORY SENSITIVITY; ALIPHATIC ESTERS; URINE-MARKING; ALCOHOLS; RATS; MICE; CONSPECIFICS; ALDEHYDES; BEARS	Only little is known about whether single volatile compounds are as efficient in eliciting behavioral responses in animals as the whole complex mixture of a behaviorally relevant odor. Recent studies analysing the composition of volatiles in mammalian blood, an important prey-associated odor stimulus for predators, found the odorant trans-4,5-epoxy-(E)-2-decenal to evoke a typical "metallic, blood-like'' odor quality in humans. We therefore assessed the behavior of captive Asian wild dogs (Cuon alpinus), African wild dogs (Lycaon pictus), South American bush dogs (Speothos venaticus), and Siberian tigers (Panthera tigris altaica) when presented with wooden logs that were impregnated either with mammalian blood or with the blood odor component trans-4,5-epoxy-(E)-2-decenal, and compared it to their behavior towards a fruity odor (iso-pentyl acetate) and a near-odorless solvent (diethyl phthalate) as control. We found that all four species displayed significantly more interactions with the odorized wooden logs such as sniffing, licking, biting, pawing, and toying, when they were impregnated with the two prey-associated odors compared to the two non-prey-associated odors. Most importantly, no significant differences were found in the number of interactions with the wooden logs impregnated with mammalian blood and the blood odor component in any of the four species. Only one of the four species, the South American bush dogs, displayed a significant decrease in the number of interactions with the odorized logs across the five sessions performed per odor stimulus. Taken together, the results demonstrate that a single blood odor component can be as efficient in eliciting behavioral responses in large carnivores as the odor of real blood, suggesting that trans-4,5-epoxy-(E)2-decenal may be perceived by predators as a "character impact compound'' of mammalian blood odor. Further, the results suggest that odorized wooden logs are a suitable manner of environmental enrichment for captive carnivores.	[Nilsson, Sara; Sjoberg, Johanna; Laska, Matthias] Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden; [Amundin, Mats] Kolmarden Wildlife Pk, Kolmarden, Sweden; [Hartmann, Constanze; Buettner, Andrea] Univ Erlangen Nurnberg, Dept Chem & Pharm, D-91054 Erlangen, Germany	Linkoping University; University of Erlangen Nuremberg	Laska, M (corresponding author), Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden.	malas@ifm.liu.se	Buettner, Andrea/E-2510-2011	Buettner, Andrea/0000-0002-6205-5125; Laska, Matthias/0000-0001-5583-2697	Kolmarden Wildlife Park	Kolmarden Wildlife Park	The animal caretakers at Kolmarden Wildlife Park involved in this study are gratefully acknowledged for their help and support.	[Anonymous], 2014, PHEROMONES ANIMAL BE; Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; Apps P, 2013, CHEM SIGNAL, V12, P417, DOI 10.1007/978-1-4614-5927-9_33; Barja I, 2010, POL J ECOL, V58, P397; Buettner A, 2001, J AGR FOOD CHEM, V49, P3881, DOI 10.1021/jf0104329; Burdock G.A., 2009, FENAROLIS HDB FLAVOR, V6th; Clark F, 2008, CHEM SIGNAL, V11, P391, DOI 10.1007/978-0-387-73945-8_37; Clubb R, 2007, APPL ANIM BEHAV SCI, V102, P303, DOI 10.1016/j.applanim.2006.05.033; Conover R.C., 2007, PREDATOR PREY DYNAMI; Drea CM, 2002, J COMP PSYCHOL, V116, P331, DOI 10.1037//0735-7036.116.4.331; Dunkel A, 2014, ANGEW CHEM INT EDIT, V53, P7124, DOI 10.1002/anie.201309508; Fox M.W., 1984, WHISTLING HUNTERS FI; Gorman M.L., 1989, P57; Gosling L.M., 1990, Chemoecology, V1, P92, DOI 10.1007/BF01241649; Grosch W, 2001, CHEM SENSES, V26, P533, DOI 10.1093/chemse/26.5.533; Hone J., 2007, ANAL VERTEBRATE PEST; HORNBUCKLE PA, 1974, BEHAV BIOL, V12, P573, DOI 10.1016/S0091-6773(74)92531-0; Hutchins M., 1999, 2 NATURE ENV ENRICHM; Laska M, 2006, AM J PHYS ANTHROPOL, V129, P112, DOI 10.1002/ajpa.20252; Laska M, 2002, BEHAV BRAIN RES, V134, P165, DOI 10.1016/S0166-4328(01)00464-8; Laska M, 2006, J CHEM ECOL, V32, P1317, DOI 10.1007/s10886-006-9090-3; Lotvedt PK, 2012, PHARMACOL BIOCHEM BE, V101, P450, DOI 10.1016/j.pbb.2012.02.013; MACKAYSIM A, 1981, PHYSIOL BEHAV, V27, P503, DOI 10.1016/0031-9384(81)90339-5; MARCH KS, 1980, AM ANTHROPOL, V82, P125, DOI 10.1525/aa.1980.82.1.02a00130; McGorrin RJ., 2012, FLAVOR FRAGRANCE ODO, P207; NOVOTNY M, 1985, P NATL ACAD SCI USA, V82, P2059, DOI 10.1073/pnas.82.7.2059; Nunley MC, 1981, AM ANTHROPOL, V82, P630; PORTON I, 1983, ANIM BEHAV, V31, P1061, DOI 10.1016/S0003-3472(83)80013-X; Rachamadugu S. K, 2012, THESIS LINKOPING U L; ROGERS LL, 1991, J WILDLIFE MANAGE, V55, P632, DOI 10.2307/3809511; RYON J, 1986, CAN J ZOOL, V64, P573, DOI 10.1139/z86-084; Salazar LTH, 2003, BEHAV NEUROSCI, V117, P1142, DOI 10.1037/0735-7044.117.6.1142; Sandnabba NK, 1997, BEHAV PROCESS, V41, P51, DOI 10.1016/S0376-6357(97)00028-4; Sarrafchi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080621; STEVENS DA, 1973, BEHAV BIOL, V8, P75, DOI 10.1016/S0091-6773(73)80008-2; Stoddart DM, 1980, ECOLOGY VERTEBRATE O, P63, DOI DOI 10.1007/978-94-009-5869-2_3; Terlouw EMC, 1998, APPL ANIM BEHAV SCI, V57, P9, DOI 10.1016/S0168-1591(97)00122-6; Wallen H, 2012, AMINO ACIDS, V42, P1475, DOI 10.1007/s00726-011-0951-x; Young RJ, 2003, ENV ENRICHMENT CAPTI, DOI DOI 10.1002/9780470751046	39	23	24	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112694	10.1371/journal.pone.0112694	http://dx.doi.org/10.1371/journal.pone.0112694			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383706	Green Submitted, Green Published, gold			2022-12-27	WOS:000344816700089
J	Descalzo, VF; Gallego, R; Sanchez-Vives, MV				Descalzo, Vanessa F.; Gallego, Roberto; Sanchez-Vives, Maria V.			Adaptation in the Visual Cortex: Influence of Membrane Trajectory and Neuronal Firing Pattern on Slow Afterpotentials	PLOS ONE			English	Article							UNDERLYING CONTRAST ADAPTATION; NEOCORTICAL PYRAMIDAL NEURONS; CORTICAL-NEURONS; SYNAPTIC DEPRESSION; POTASSIUM CURRENTS; ACTION-POTENTIALS; GAIN-CONTROL; K+ CHANNELS; IN-VITRO; RAT	The input/output relationship in primary visual cortex neurons is influenced by the history of the preceding activity. To understand the impact that membrane potential trajectory and firing pattern has on the activation of slow conductances in cortical neurons we compared the afterpotentials that followed responses to different stimuli evoking similar numbers of action potentials. In particular, we compared afterpotentials following the intracellular injection of either square or sinusoidal currents lasting 20 seconds. Both stimuli were intracellular surrogates of different neuronal responses to prolonged visual stimulation. Recordings from 99 neurons in slices of visual cortex revealed that for stimuli evoking an equivalent number of spikes, sinusoidal current injection activated a slow afterhyperpolarization of significantly larger amplitude (8.5 +/- 3.3 mV) and duration (33 +/- 17 s) than that evoked by a square pulse (6.4 +/- 3.7 mV, 28 +/- 17 s; p<0.05). Spike frequency adaptation had a faster time course and was larger during plateau (square pulse) than during intermittent (sinusoidal) depolarizations. Similar results were obtained in 17 neurons intracellularly recorded from the visual cortex in vivo. The differences in the afterpotentials evoked with both protocols were abolished by removing calcium from the extracellular medium or by application of the L- type calcium channel blocker nifedipine, suggesting that the activation of a calcium- dependent current is at the base of this afterpotential difference. These findings suggest that not only the spikes, but the membrane potential values and firing patterns evoked by a particular stimulation protocol determine the responses to any subsequent incoming input in a time window that spans for tens of seconds to even minutes.	[Descalzo, Vanessa F.; Sanchez-Vives, Maria V.] IDIBAPS Inst Invest Biomed August Pi i Sunyer, Barcelona, Spain; [Gallego, Roberto] Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alicante, Spain; [Sanchez-Vives, Maria V.] ICREA, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); ICREA	Sanchez-Vives, MV (corresponding author), IDIBAPS Inst Invest Biomed August Pi i Sunyer, Barcelona, Spain.	msanche3@clinic.ub.es	Sanchez-Vives, Maria/J-8526-2014	Sanchez-Vives, Maria/0000-0002-8437-9083; Fernandez Descalzo, Vanessa/0000-0002-3578-4947	 [BFU2011-27094]; ICREA Funding Source: Custom	; ICREA(ICREA)	This work was supported by BFU2011-27094 to MVSV, http://www.mineco.gob.es/portal/site/mineco/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Abolafia JM, 2011, CEREB CORTEX, V21, P977, DOI 10.1093/cercor/bhq163; AGHAJANIAN GK, 1989, SYNAPSE, V3, P331, DOI 10.1002/syn.890030406; ALBRECHT DG, 1984, J PHYSIOL-LONDON, V347, P713, DOI 10.1113/jphysiol.1984.sp015092; Benucci A, 2013, NAT NEUROSCI, V16, P724, DOI 10.1038/nn.3382; Bhattacharjee A, 2005, TRENDS NEUROSCI, V28, P422, DOI 10.1016/j.tins.2005.06.003; Brumberg JC, 2000, J NEUROSCI, V20, P4829; Burkitt AN, 2006, BIOL CYBERN, V95, P97, DOI 10.1007/s00422-006-0082-8; Burkitt AN, 2006, BIOL CYBERN, V95, P1, DOI 10.1007/s00422-006-0068-6; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Castro-Alamancos MA, 2004, NEURON, V41, P455, DOI 10.1016/S0896-6273(03)00853-5; CONSTANTI A, 1987, J PHYSIOL-LONDON, V387, P173, DOI 10.1113/jphysiol.1987.sp016569; Descalzo VF, 2005, J NEUROPHYSIOL, V93, P1111, DOI 10.1152/jn.00658.2004; Diaz-Quesada M, 2008, J NEUROSCI, V28, P696, DOI 10.1523/JNEUROSCI.4931-07.2008; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; FOEHRING RC, 1989, J NEUROPHYSIOL, V61, P245, DOI 10.1152/jn.1989.61.2.245; FRIEDMAN A, 1992, NEUROSCI LETT, V135, P13, DOI 10.1016/0304-3940(92)90125-Q; Haj-Dahmane S, 1998, J NEUROPHYSIOL, V80, P1197, DOI 10.1152/jn.1998.80.3.1197; Helton TD, 2005, J NEUROSCI, V25, P10247, DOI 10.1523/JNEUROSCI.1089-05.2005; Kim U, 1998, J NEUROPHYSIOL, V80, P1222, DOI 10.1152/jn.1998.80.3.1222; KUBOTA M, 1991, J PHYSIOL-LONDON, V440, P131, DOI 10.1113/jphysiol.1991.sp018700; MADISON DV, 1984, J PHYSIOL-LONDON, V354, P319, DOI 10.1113/jphysiol.1984.sp015378; MAFFEI L, 1973, SCIENCE, V182, P1036, DOI 10.1126/science.182.4116.1036; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; Martinez-Conde S, 2006, NEURON, V49, P297, DOI 10.1016/j.neuron.2005.11.033; Martinez-Conde S, 2009, TRENDS NEUROSCI, V32, P463, DOI 10.1016/j.tins.2009.05.006; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Mermelstein PG, 2000, J NEUROSCI, V20, P266, DOI 10.1523/JNEUROSCI.20-01-00266.2000; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; Patterson CA, 2013, J NEUROSCI, V33, P532, DOI 10.1523/JNEUROSCI.3345-12.2013; PENNEFATHER P, 1985, P NATL ACAD SCI USA, V82, P3040, DOI 10.1073/pnas.82.9.3040; Puccini GD, 2007, PLOS COMPUT BIOL, V3, P813, DOI 10.1371/journal.pcbi.0030082; Puccini GD, 2006, J PHYSIOL-PARIS, V100, P1, DOI 10.1016/j.jphysparis.2006.09.005; Rauch A, 2003, J NEUROPHYSIOL, V90, P1598, DOI 10.1152/jn.00293.2003; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; Safronov BV, 1996, J PHYSIOL-LONDON, V497, P727, DOI 10.1113/jphysiol.1996.sp021803; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; SCHWINDT PC, 1992, J NEUROPHYSIOL, V67, P216, DOI 10.1152/jn.1992.67.1.216; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Vogalis F, 2003, EUR J NEUROSCI, V18, P3155, DOI 10.1111/j.1460-9568.2003.03040.x; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Wang XJ, 2003, J NEUROPHYSIOL, V89, P3279, DOI 10.1152/jn.00242.2003; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X	46	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111578	10.1371/journal.pone.0111578	http://dx.doi.org/10.1371/journal.pone.0111578			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380063	gold, Green Published, Green Submitted			2022-12-27	WOS:000344863100033
J	Ghiabi, P; Jiang, J; Pasquier, J; Maleki, M; Abu-Kaoud, N; Rafii, S; Rafii, A				Ghiabi, Pegah; Jiang, Jie; Pasquier, Jennifer; Maleki, Mahtab; Abu-Kaoud, Nadine; Rafii, Shahin; Rafii, Arash			Endothelial Cells Provide a Notch-Dependent Pro-Tumoral Niche for Enhancing Breast Cancer Survival, Stemness and Pro-Metastatic Properties	PLOS ONE			English	Article							IN-VITRO PROPAGATION; VASCULAR NICHE; MESENCHYMAL TRANSITION; PERIVASCULAR NICHE; COLORECTAL-CANCER; ANGIOGENESIS; GROWTH; INDUCTION; IDENTIFICATION; THERAPY	Treating metastasis has been challenging due to tumors complexity and heterogeneity. This complexity is partly related to the crosstalk between tumor and its microenvironment. Endothelial cells -the building blocks of tumor vasculature-have been shown to have additional roles in cancer progression than angiogenesis and supplying oxygen and nutrients. Here, we show an alternative role for endothelial cells in supporting breast cancer growth and spreading independent of their vascular functions. Using endothelial cells and breast cancer cell lines MDA-MB231 and MCF-7, we developed co-culture systems to study the influence of tumor endothelium on breast tumor development by both in vitro and in vivo approaches. Our results demonstrated that endothelial cells conferred survival advantage to tumor cells under complete starvation and enriched the CD44(High) CD24(Low/-) stem cell population in tumor cells. Moreover, endothelial cells enhanced the pro-metastatic potential of breast cancer cells. The in vitro and in vivo results concordantly confirmed a role for endothelial Jagged1 to promote breast tumor through notch activation. Here, we propose a role for endothelial cells in enhancing breast cancer progression, stemness, and pro-metastatic traits through a perfusion-independent manner. Our findings may be beneficial in developing novel therapeutic approaches.	[Ghiabi, Pegah; Pasquier, Jennifer; Maleki, Mahtab; Abu-Kaoud, Nadine; Rafii, Arash] Qatar Fdn, Weill Cornell Med Coll Qatar, Stem Cell & Microenvironm Lab, Doha, Qatar; [Jiang, Jie; Pasquier, Jennifer; Rafii, Shahin; Rafii, Arash] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University	Rafii, A (corresponding author), Qatar Fdn, Weill Cornell Med Coll Qatar, Stem Cell & Microenvironm Lab, Doha, Qatar.	jat2021@qatar-med.cornell.edu		Pasquier, Jennifer/0000-0002-2465-7942	Qatar National Research Fund under its National Priorities Research Program [NPRP 09-1174-3-291, NPRP 4-640-1-096, NPRP 09-1087-3-274]	Qatar National Research Fund under its National Priorities Research Program(Qatar National Research Fund (QNRF))	This publication was made possible by grants from the Qatar National Research Fund under its National Priorities Research Program award number NPRP 09-1174-3-291, NPRP 4-640-1-096, and NPRP 09-1087-3-274. Its contents are solely the responsibility of the authors and do not necessarily represent the views of the Qatar National Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; BREM S, 1976, CANCER RES, V36, P2807; Buck E, 2007, MOL CANCER THER, V6, P532, DOI 10.1158/1535-7163.MCT-06-0462; Butler Jason M, 2012, Methods Mol Biol, V904, P221, DOI 10.1007/978-1-61779-943-3_18; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Callahan R, 2004, J MAMMARY GLAND BIOL, V9, P145, DOI 10.1023/B:JOMG.0000037159.63644.81; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Cho RW, 2008, CURR OPIN GENET DEV, V18, P48, DOI 10.1016/j.gde.2008.01.017; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lammert E, 2003, MECH DEVELOP, V120, P59, DOI 10.1016/S0925-4773(02)00332-5; Lanzkron SM, 1999, BLOOD, V93, P1916, DOI 10.1182/blood.V93.6.1916.406k15_1916_1921; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Lu J, 2013, CANCER CELL, V23, P171, DOI 10.1016/j.ccr.2012.12.021; Mailhos C, 2001, DIFFERENTIATION, V69, P135, DOI 10.1046/j.1432-0436.2001.690207.x; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Pasquier J, 2014, CANC MICROENVIRON; Pasquier J, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-94; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Phung TL, 2006, CANCER CELL, V10, P159, DOI 10.1016/j.ccr.2006.07.003; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Ramalingam R, 1999, J VIROL, V73, P10183, DOI 10.1128/JVI.73.12.10183-10190.1999; Raynaud CM, 2013, STEM CELL RES, V11, P1074, DOI 10.1016/j.scr.2013.07.010; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Seandel M, 2008, P NATL ACAD SCI USA, V105, P19288, DOI 10.1073/pnas.0805980105; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Westerweel PE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060357; Zeng QH, 2005, CANCER CELL, V8, P13, DOI 10.1016/j.ccr.2005.06.004; Zhang ZC, 2014, CANCER RES, V74, P2869, DOI 10.1158/0008-5472.CAN-13-2032	50	56	57	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112424	10.1371/journal.pone.0112424	http://dx.doi.org/10.1371/journal.pone.0112424			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380486	Green Published, gold, Green Submitted			2022-12-27	WOS:000344863100090
J	Kasahara, K; Fukuda, I; Nakamura, H				Kasahara, Kota; Fukuda, Ikuo; Nakamura, Haruki			A Novel Approach of Dynamic Cross Correlation Analysis on Molecular Dynamics Simulations and Its Application to Ets1 Dimer-DNA Complex	PLOS ONE			English	Article							TRANSCRIPTION FACTOR ETS-1; STROMELYSIN-1 PROMOTER; BINDING; MOTIONS; DOMAIN; HELIX; AUTOINHIBITION; VISUALIZATION; FLUCTUATION; PARAMETERS	The dynamic cross correlation (DCC) analysis is a popular method for analyzing the trajectories of molecular dynamics (MD) simulations. However, it is difficult to detect correlative motions that appear transiently in only a part of the trajectory, such as atomic contacts between the side-chains of amino acids, which may rapidly flip. In order to capture these multi-modal behaviors of atoms, which often play essential roles, particularly at the interfaces of macromolecules, we have developed the "multi-modal DCC (mDCC)" analysis. The mDCC is an extension of the DCC and it takes advantage of a Bayesian-based pattern recognition technique. We performed MD simulations for molecular systems modeled from the (Ets1)(2)-DNA complex and analyzed their results with the mDCC method. Ets1 is an essential transcription factor for a variety of physiological processes, such as immunity and cancer development. Although many structural and biochemical studies have so far been performed, its DNA binding properties are still not well characterized. In particular, it is not straightforward to understand the molecular mechanisms how the cooperative binding of two Ets1 molecules facilitates their recognition of Stromelysin-1 gene regulatory elements. A correlation network was constructed among the essential atomic contacts, and the two major pathways by which the two Ets1 molecules communicate were identified. One is a pathway via direct protein-protein interactions and the other is that via the bound DNA intervening two recognition helices. These two pathways intersected at the particular cytosine bases (C110/C11), interacting with the H1, H2, and H3 helices. Furthermore, the mDCC analysis showed that both pathways included the transient interactions at their intermolecular interfaces of Tyr396-C11 and Ala327-Asn380 in multi-modal motions of the amino acid side chains and the nucleotide backbone. Thus, the current mDCC approach is a powerful tool to reveal these complicated behaviors and scrutinize intermolecular communications in a molecular system.	[Kasahara, Kota; Fukuda, Ikuo; Nakamura, Haruki] Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan	Osaka University	Kasahara, K (corresponding author), Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan.	kota.kasahara@protein.osaka-u.ac.jp		Kasahara, Kota/0000-0003-0207-6271	JSPS KAKENHI [24118001]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH060220] Funding Source: NIH RePORTER	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by JSPS KAKENHI, Grant-in-Aid for Scientific Research on Innovative Areas, Grant Number 24118001, https://www.jsps.go.jp/english/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Tadaaki Mashimo for the implementation of the MD program, myPresto/psygene-G. The software for generating the 3D density maps of Gaussian mixture distributions was provided by Dr. Takeshi Kawabata.; The MD simulations performed on the TSUBAME2.5 supercomputer at the Tokyo Institute of Technology, provided through the HPCI System Research Project (Project ID: hp130061). The numerical computations for post-simulation analyses were performed by using the supercomputer system provided by the National Institute of Genetics, Research Organization of Information and Systems, Japan.	Arakawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076606; Attias H, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P21; Babayeva ND, 2010, CELL CYCLE, V9, P3054, DOI 10.4161/cc.9.14.12257; Baillat D, 2002, J BIOL CHEM, V277, P29386, DOI 10.1074/jbc.M200088200; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Donaldson LW, 1996, EMBO J, V15, P125, DOI 10.1002/j.1460-2075.1996.tb00340.x; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fukuda Ikuo, 2012, Biophys Rev, V4, P161, DOI 10.1007/s12551-012-0089-4; Fukuda I, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4739789; Fukuda I, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3582791; Gallant S, 2006, ARCH IMMUNOL THER EX, V54, P149, DOI 10.1007/s00005-006-0017-z; Gardner Kevin H, 2005, Sci STKE, V2005, ppe44, DOI 10.1126/stke.3012005pe44; Garrett-Sinha LA, 2013, CELL MOL LIFE SCI, V70, P3375, DOI 10.1007/s00018-012-1243-7; Garvie CW, 2001, MOL CELL, V8, P1267, DOI 10.1016/S1097-2765(01)00410-5; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hsu T, 2004, J CELL BIOCHEM, V91, P896, DOI 10.1002/jcb.20012; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUNENBERGER PH, 1995, J MOL BIOL, V252, P492, DOI 10.1006/jmbi.1995.0514; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Kamberaj H, 2009, BIOPHYS J, V96, P1307, DOI 10.1016/j.bpj.2008.11.019; Karolak A, 2012, BIOPHYS CHEM, V165, P74, DOI 10.1016/j.bpc.2012.03.007; Karplus M, 1996, J MOL BIOL, V263, P120, DOI 10.1006/jmbi.1996.0562; Kasahara K, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-12; Kasahara K, 2013, J CHEM INF MODEL, V53, P241, DOI 10.1021/ci300377f; Kim WY, 1999, EMBO J, V18, P1609, DOI 10.1093/emboj/18.6.1609; Lamber EP, 2008, EMBO J, V27, P2006, DOI 10.1038/emboj.2008.117; Lee GM, 2005, J BIOL CHEM, V280, P7088, DOI 10.1074/jbc.M410722200; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Mashimo T, 2013, J CHEM THEORY COMPUT, V9, P5599, DOI 10.1021/ct400342e; MCCAMMON JA, 1984, REP PROG PHYS, V47, P1, DOI 10.1088/0034-4885/47/1/001; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; PETERSEN JM, 1995, SCIENCE, V269, P1866, DOI 10.1126/science.7569926; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Reddy SY, 2003, P NATL ACAD SCI USA, V100, P15475, DOI 10.1073/pnas.1936251100; Shaikhibrahim Z, 2012, INT J ONCOL, V40, P1748, DOI 10.3892/ijo.2012.1380; Siggers T, 2014, NUCLEIC ACIDS RES, V42, P2099, DOI 10.1093/nar/gkt1112; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; WASYLYK C, 1992, GENE DEV, V6, P965, DOI 10.1101/gad.6.6.965	41	65	65	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112419	10.1371/journal.pone.0112419	http://dx.doi.org/10.1371/journal.pone.0112419			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380315	Green Submitted, Green Published, gold			2022-12-27	WOS:000344863100088
J	Pec, GJ; Carlton, GC				Pec, Gregory J.; Carlton, Gary C.			Positive Effects of Non-Native Grasses on the Growth of a Native Annual in a Southern California Ecosystem	PLOS ONE			English	Article							PLANT COEXISTENCE; INVASIVE PLANTS; EXOTIC GRASSES; HYDRAULIC LIFT; ROOT SYSTEMS; RESTORATION; FACILITATION; COMPETITION; PLASTICITY; GRASSLAND	Fire disturbance is considered a major factor in the promotion of non-native plant species. Non-native grasses are adapted to fire and can alter environmental conditions and reduce resource availability in native coastal sage scrub and chaparral communities of southern California. In these communities persistence of non-native grasses following fire can inhibit establishment and growth of woody species. This may allow certain native herbaceous species to colonize and persist beneath gaps in the canopy. A field manipulative experiment with control, litter, and bare ground treatments was used to examine the impact of non-native grasses on growth and establishment of a native herbaceous species, Cryptantha muricata. C. muricata seedling survival, growth, and reproduction were greatest in the control treatment where non-native grasses were present. C. muricata plants growing in the presence of non-native grasses produced more than twice the number of flowers and more than twice the reproductive biomass of plants growing in the treatments where non-native grasses were removed. Total biomass and number of fruits were also greater in the plants growing in the presence of non-native grasses. Total biomass and reproductive biomass was also greater in late germinants than early germinants growing in the presence of non- native grasses. This study suggests a potential positive effect of non-native grasses on the performance of a particular native annual in a southern California ecosystem.	[Pec, Gregory J.; Carlton, Gary C.] Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA	California State University System; California State Polytechnic University Pomona	Pec, GJ (corresponding author), Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA.	gpec@ualberta.ca	Pec, Gregory/L-8542-2013	Pec, Gregory/0000-0002-6781-9112	Ernest Prete Jr. Foundation	Ernest Prete Jr. Foundation	Funding was provided by an Environmental Science Fellowship to GJP from the Ernest Prete Jr. Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch JK, 2013, GLOBAL CHANGE BIOL, V19, P173, DOI 10.1111/gcb.12046; BAZZAZ FA, 1987, BIOSCIENCE, V37, P58, DOI 10.2307/1310178; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Brandt AJ, 2011, ECOL APPL, V21, P704, DOI 10.1890/10-0485.1; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Buxbaum CAZ, 2007, J ARID ENVIRON, V69, P617, DOI 10.1016/j.jaridenv.2006.11.017; Caldwell MM, 1998, OECOLOGIA, V113, P151, DOI 10.1007/s004420050363; Callaway RM, 2003, ECOLOGY, V84, P1115, DOI 10.1890/0012-9658(2003)084[1115:PPAIAP]2.0.CO;2; Cavieres LA, 2005, PERSPECT PLANT ECOL, V7, P217, DOI 10.1016/j.ppees.2005.09.002; Chesson P, 2004, OECOLOGIA, V141, P236, DOI 10.1007/s00442-004-1551-1; Corbin JD, 2004, ECOLOGY, V85, P1273, DOI 10.1890/02-0744; Cox RD, 2011, PLANT ECOL, V212, P1699, DOI 10.1007/s11258-011-9942-y; D'Antonio C, 2002, RESTOR ECOL, V10, P703, DOI 10.1046/j.1526-100X.2002.01051.x; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; DAWSON TE, 1993, OECOLOGIA, V95, P565, DOI 10.1007/BF00317442; DODORICO P, 2007, J GEOPHYS RES, V112; Dormann CF, 2002, ACTA OECOL, V23, P297, DOI 10.1016/S1146-609X(02)01158-X; Dunn Paul H., 1988, PSW104 US DEP AGR PA; Eliason SA, 1997, RESTOR ECOL, V5, P245, DOI 10.1046/j.1526-100X.1997.09729.x; Elliott Brian A., 2008, Madrono, V55, P76, DOI 10.3120/0024-9637(2008)55[76:HADOCC]2.0.CO;2; Ferrante D, 2014, J ARID ENVIRON, V104, P52, DOI 10.1016/j.jaridenv.2014.01.009; Gomez-Aparicio L, 2004, ECOL APPL, V14, P1128, DOI 10.1890/03-5084; Goodenough AE, 2010, COMMUNITY ECOL, V11, P13, DOI 10.1556/ComEc.11.2010.1.3; Griffith AB, 2010, ECOLOGY, V91, P141, DOI 10.1890/08-1446.1; GUREVITCH J, 1986, ECOLOGY, V67, P251, DOI 10.2307/1938525; Halpern BS, 2007, FRONT ECOL ENVIRON, V5, P153, DOI 10.1890/1540-9295(2007)5[153:IPIIAR]2.0.CO;2; HIRONAKA M., 1961, JOUR RANGE MANAGEMENT, V14, P263, DOI 10.2307/3894744; Keeley JE, 2006, CONSERV BIOL, V20, P375, DOI 10.1111/J.1523-1739.2006.00339.X; KEELEY JE, 1985, J ECOL, V73, P445, DOI 10.2307/2260486; Keeley JE, 2012, OECOLOGIA, V169, P1043, DOI 10.1007/s00442-012-2253-8; Keeley JE, 2007, TERRESTRIAL VEGETATION OF CALIFORNIA, 3RD EDITION, P339; KEELEY SC, 1981, ECOLOGY, V62, P1608, DOI 10.2307/1941516; Lambers H., 2008, PLANT PHYSL ECOLOGY; Leffler AJ, 2005, ECOLOGY, V86, P633, DOI 10.1890/04-0854; Leger EA, 2010, PLANT ECOL, V208, P333, DOI 10.1007/s11258-009-9710-4; Lenz TI, 2003, AUSTRAL ECOL, V28, P480, DOI 10.1046/j.1442-9993.2003.01304.x; Lepik M, 2005, OECOLOGIA, V145, P465, DOI 10.1007/s00442-005-0142-0; Lugo AE, 2004, FRONT ECOL ENVIRON, V2, P265, DOI 10.2307/3868267; Lugo AE, 1997, FOREST ECOL MANAG, V99, P9, DOI 10.1016/S0378-1127(97)00191-6; MacDougall AS, 2005, ECOLOGY, V86, P42, DOI 10.1890/04-0669; Maron JL, 1996, OECOLOGIA, V105, P302, DOI 10.1007/BF00328732; MORENO JM, 1991, ECOLOGY, V72, P1993, DOI 10.2307/1941554; Padilla FM, 2006, FRONT ECOL ENVIRON, V4, P196, DOI 10.1890/1540-9295(2006)004[0196:TRONPI]2.0.CO;2; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Team, 2013, R LANG ENV STAT COMP; Reynolds Sally A., 2001, Madrono, V48, P230; Rodriguez LF, 2006, BIOL INVASIONS, V8, P927, DOI 10.1007/s10530-005-5103-3; Schlaepfer MA, 2011, CONSERV BIOL, V25, P428, DOI 10.1111/j.1523-1739.2010.01646.x; SHMIDA A, 1981, ECOLOGY, V62, P234, DOI 10.2307/1936684; Simpson Michael G., 2009, Crossosoma, V35, P1; Sokal R.R., 2012, BIOMETRY; Stylinski CD, 1999, J APPL ECOL, V36, P544, DOI 10.1046/j.1365-2664.1999.00423.x; Talluto MV, 2008, LANDSCAPE ECOL, V23, P803, DOI 10.1007/s10980-008-9238-3; Wainwright CE, 2012, J APPL ECOL, V49, P234, DOI 10.1111/j.1365-2664.2011.02088.x; Weiner J, 2004, PERSPECT PLANT ECOL, V6, P207, DOI 10.1078/1433-8319-00083; WEINER J, 1990, J ECOL, V78, P459, DOI 10.2307/2261124; Williams JL, 2006, ECOLOGY, V87, P3200, DOI 10.1890/0012-9658(2006)87[3200:TIOIGO]2.0.CO;2; Wolkovich EM, 2011, FRONT ECOL ENVIRON, V9, P287, DOI 10.1890/100033; Zar JH., 2010, BIOSTAT ANAL, V5th; Zhang MJ, 2011, PLANT ECOL, V212, P1419, DOI 10.1007/s11258-011-9917-z; Zuur Alain F., 2009, P1	62	4	4	0	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112437	10.1371/journal.pone.0112437	http://dx.doi.org/10.1371/journal.pone.0112437			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379790	Green Published, Green Submitted, gold			2022-12-27	WOS:000344863100093
J	Severin, I; Lindstrom, ES; Ostman, O				Severin, Ina; Lindstrom, Eva S.; Ostman, Orjan			Relationships between Bacterial Community Composition, Functional Trait Composition and Functioning Are Context Dependent - but What Is the Context?	PLOS ONE			English	Article							ORGANIC-CARBON; RIBOSOMAL-RNA; DIVERSITY; LAKES	Bacterial communities are immensely diverse and drive many fundamental ecosystem processes. However, the role of bacterial community composition (BCC) for functioning is still unclear. Here we evaluate the relative importance of BCC (from 454-sequencing), functional traits (from Biolog Ecoplates) and environmental conditions for per cell biomass production (BPC; H-3-leucine incorporation) in six data sets of natural freshwater bacterial communities. BCC explained significant variation of BPC in all six data sets and most variation in four. BCC measures based on 16S rRNA (active bacteria) did not consistently explain more variation in BPC than measures based on the 16S rRNA-gene (total community), and adding phylogenetic information did not, in general, increase the explanatory power of BCC. In contrast to our hypothesis, the importance of BCC for BPC was not related to the anticipated dispersal rates in and out of communities. Functional traits, most notably the ability to use cyclic and aromatic compounds, as well as local environmental conditions, i.e. stoichiometric relationships of nutrients, explained some variation in all six data sets. In general there were weak associations between variation in BCC and variation in the functional traits contributing to productivity. This indicates that additional traits may be important for productivity as well. By comparing several data sets obtained in a similar way we conclude that no single measure of BCC was obviously better than another in explaining BPC. We identified some key functional traits for productivity, but although there was a coupling between BCC, functional traits and productivity, the strength of the coupling seems context dependent. However, the exact context is still unresolved.	[Severin, Ina; Lindstrom, Eva S.; Ostman, Orjan] Uppsala Univ, Dept Ecol & Genetics Limnol, Uppsala, Sweden	Uppsala University	Severin, I (corresponding author), Uppsala Univ, Dept Ecol & Genetics Limnol, Uppsala, Sweden.	inaseverin@gmx.de	Östman, Örjan/ABF-8714-2020; LindstrÃm, Eva/H-5930-2016	Östman, Örjan/0000-0002-1930-0148; LindstrÃm, Eva/0000-0001-8920-3071	Carl Tryggers Foundation; Olsson-Borgh foundation; Swedish Research Council [2009-5172, 2007-5932]	Carl Tryggers Foundation; Olsson-Borgh foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by a grant from the Carl Tryggers Foundation to ESL and OO, from a grant from the Olsson-Borgh foundation to IS, and by separate grants from the Swedish Research Council to ESL (project number 2009-5172) and OO (2007-5932). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; BELL RT, 1993, LIMNOL OCEANOGR, V38, P1532, DOI 10.4319/lo.1993.38.7.1532; Blazewicz SJ, 2013, ISME J, V7, P2061, DOI 10.1038/ismej.2013.102; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cardinale BJ, 2000, OIKOS, V91, P175, DOI 10.1034/j.1600-0706.2000.910117.x; Carrascal LM, 2009, OIKOS, V118, P681, DOI 10.1111/j.1600-0706.2008.16881.x; Comte J, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00112; Comte J, 2009, ENVIRON MICROBIOL, V11, P1704, DOI 10.1111/j.1462-2920.2009.01897.x; del Giorgio P. A., 2008, MICROBIAL ECOLOGY OC, P243, DOI DOI 10.1002/9780470281840.CH8; delGiorgio P, 1996, LIMNOL OCEANOGR, V41, P783, DOI 10.4319/lo.1996.41.4.0783; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Franklin RB, 2013, AQUAT MICROB ECOL, V69, P247, DOI 10.3354/ame01635; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; Gravel D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2123; Gravel D, 2011, NATURE, V469, P89, DOI 10.1038/nature09592; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Ives AR, 2010, AM NAT, V176, pE128, DOI 10.1086/656486; Jansson M, 2006, MICROB ECOL, V52, P358, DOI 10.1007/s00248-006-9013-4; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Jonsson A, 2003, ECOSYSTEMS, V6, P224, DOI 10.1007/s10021-002-0200-y; Karlsson J, 2007, LIMNOL OCEANOGR, V52, P603, DOI 10.4319/lo.2007.52.2.0603; Langenheder S, 2005, LIMNOL OCEANOGR, V50, P957, DOI 10.4319/lo.2005.50.3.0957; Leflaive J, 2008, FEMS MICROBIOL ECOL, V66, P379, DOI 10.1111/j.1574-6941.2008.00593.x; Lindstrom ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025883; Lindstrom ES, 2010, LIMNOL OCEANOGR, V55, P2052, DOI 10.4319/lo.2010.55.5.2052; Martiny AC, 2013, ISME J, V7, P830, DOI 10.1038/ismej.2012.160; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Ostman O, 2010, ECOL LETT, V13, P118, DOI 10.1111/j.1461-0248.2009.01413.x; Peter H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023225; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Reed HE, 2013, ISME J, V7, P868, DOI 10.1038/ismej.2012.154; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Severin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080825; Sjostedt J, 2013, AQUAT MICROB ECOL, V71, P15, DOI 10.3354/ame01660; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; Srivastava DS, 2012, ECOL LETT, V15, P637, DOI 10.1111/j.1461-0248.2012.01795.x; Tan JQ, 2012, ECOLOGY, V93, P1164, DOI 10.1890/11-1557.1; Thurman EM, 1985, DEV BIOGEOCHEMISTRY, P497; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; Venail PA, 2008, NATURE, V452, P210, DOI 10.1038/nature06554	42	2	2	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112409	10.1371/journal.pone.0112409	http://dx.doi.org/10.1371/journal.pone.0112409			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380200	Green Submitted, gold, Green Published			2022-12-27	WOS:000344863100086
J	Traser, L; Burdumy, M; Richter, B; Vicari, M; Echternach, M				Traser, Louisa; Burdumy, Michael; Richter, Bernhard; Vicari, Marco; Echternach, Matthias			Weight-Bearing MR Imaging as an Option in the Study of Gravitational Effects on the Vocal Tract of Untrained Subjects in Singing Phonation	PLOS ONE			English	Article							POSITION; UPRIGHT; SUPINE; CONFIGURATIONS	Magnetic Resonance Imaging (MRI) of subjects in a supine position can be used to evaluate the configuration of the vocal tract during phonation. However, studies of speech phonation have shown that gravity can affect vocal tract shape and bias measurements. This is one of the reasons that MRI studies of singing phonation have used professionally trained singers as subjects, because they are generally considered to be less affected by the supine body position and environmental distractions. A study of untrained singers might not only contribute to the understanding of intuitive singing function and aid the evaluation of potential hazards for vocal health, but also provide insights into the effect of the supine position on singers in general. In the present study, an open configuration 0.25 T MRI system with a rotatable examination bed was used to study the effect of body position in 20 vocally untrained subjects. The subjects were asked to sing sustained tones in both supine and upright body positions on different pitches and in different register conditions. Morphometric measurements were taken from the acquired images of a sagittal slice depicting the vocal tract. The analysis concerning the vocal tract configuration in the two body positions revealed differences in 5 out of 10 measured articulatory parameters. In the upright position the jaw was less protruded, the uvula was elongated, the larynx more tilted and the tongue was positioned more to the front of the mouth than in the supine position. The findings presented are in agreement with several studies on gravitational effects in speech phonation, but contrast with the results of a previous study on professional singers of our group where only minor differences between upright and supine body posture were observed. The present study demonstrates that imaging of the vocal tract using weight-bearing MR imaging is a feasible tool for the study of sustained phonation in singing for vocally untrained subjects.	[Traser, Louisa; Burdumy, Michael; Richter, Bernhard; Echternach, Matthias] Univ Med Ctr, Inst Musicians Med, Freiburg, Germany; [Traser, Louisa] Univ Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Freiburg, Germany; [Burdumy, Michael] Univ Med Ctr, Dept Radiol Med Phys, Freiburg, Germany; [Vicari, Marco] Fraunhofer MEVIS, Bremen, Germany; [Vicari, Marco] Esaote SpA, Genoa, Italy	University of Freiburg; University of Freiburg; University of Freiburg	Traser, L (corresponding author), Univ Med Ctr, Inst Musicians Med, Freiburg, Germany.	louisa.traser@uniklinik-freiburg.de	Burdumy, Michael/M-6212-2017; Echternach, Matthias/E-3464-2010	Burdumy, Michael/0000-0003-4577-5515; Echternach, Matthias/0000-0003-0095-5360	German Research Foundation, Deutsche Forschungsgemeinschaft (DFG) [Ri 1050/4-1, EC 409/1-1]; European Research Council, OVOC project [232908]	German Research Foundation, Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Research Council, OVOC project	Bernhard Richter was supported by the German Research Foundation, Deutsche Forschungsgemeinschaft (DFG), grant Ri 1050/4-1. Matthias Echternach was supported by the German Research Foundation, Deutsche Forschungsgemeinschaft (DFG), grant EC 409/1-1. Marco Vicari was supported by the European Research Council, grant #232908 as part of the OVOC project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Echternach M, 2012, CURR OPIN OTOLARYNGO, V20, P450, DOI 10.1097/MOO.0b013e3283585f87; Echternach M, 2011, J ACOUST SOC AM, V129, P3955, DOI 10.1121/1.3589249; Echternach M, 2010, FOLIA PHONIATR LOGO, V62, P278, DOI 10.1159/000312668; Echternach M, 2010, J VOICE, V24, P133, DOI 10.1016/j.jvoice.2008.06.004; Engwall O, 2006, ASSESSING MAGNETIC R; HERTEGARD S, 1990, J VOICE, V4, P220, DOI 10.1016/S0892-1997(05)80017-7; Honda K, 1999, LANG SPEECH, V42, P401, DOI 10.1177/00238309990420040301; Honda Y, 2007, J MAGN RESON IMAGING, V26, P172, DOI 10.1002/jmri.20992; Kitamura T, 2005, ACOUST SCI TECHNOL, V26, P465, DOI 10.1250/ast.26.465; Narayanan S, 2004, J ACOUST SOC AM, V115, P1771, DOI 10.1121/1.1652588; Niebergall A, 2013, MAGN RESON MED, V69, P477, DOI 10.1002/mrm.24276; SHIPP T, 1975, J SPEECH HEAR RES, V18, P707, DOI 10.1044/jshr.1804.707; Steiner I, 2014, P INT SEM SPEECH PRO, P417; Stone M, 2007, J ACOUST SOC AM, V122, P532, DOI 10.1121/1.2715659; Stone M, 2001, J SPEECH LANG HEAR R, V44, P1026, DOI 10.1044/1092-4388(2001/081); Stone M., 2002, J ACOUST SOC AM, V111, P2476, DOI [10.1121/1.4778583, DOI 10.1121/1.4778583]; Sundberg J, 2009, J VOICE, V23, P546, DOI 10.1016/j.jvoice.2008.02.003; Takemoto H, 2006, J ACOUST SOC AM, V119, P1037, DOI 10.1121/1.2151823; Tiede M.K., 2000, P 5 SEMINAR SPEECH P, P25; Traser L, 2013, J VOICE, V27, P141, DOI 10.1016/j.jvoice.2012.11.002; Trequattrini A, 2006, IEEE T APPL SUPERCON, V16, P1505, DOI 10.1109/TASC.2006.871341; Ventura SMR, 2011, J VOICE, V25, P511, DOI 10.1016/j.jvoice.2010.01.014; Williams W, 2010, NOISE HEALTH, V12, P155, DOI 10.4103/1463-1741.64970; Zhang S, 2012, J MAGN RESON IMAGING, V35, P1372, DOI 10.1002/jmri.23591; Zhu YH, 2013, IEEE T MED IMAGING, V32, P838, DOI 10.1109/TMI.2012.2230017	25	18	18	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112405	10.1371/journal.pone.0112405	http://dx.doi.org/10.1371/journal.pone.0112405			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379885	Green Published, gold, Green Submitted			2022-12-27	WOS:000344863100084
J	Wang, XY; Tong, YN; Gao, YM; Gao, PC; Liu, F; Zhao, ZP; Pang, Y				Wang, Xiaoying; Tong, Yanan; Gao, Yimin; Gao, Pengcheng; Liu, Fen; Zhao, Zuoping; Pang, Yan			Spatial and Temporal Variations of Crop Fertilization and Soil Fertility in the Loess Plateau in China from the 1970s to the 2000s	PLOS ONE			English	Article							WHEAT-MAIZE SYSTEM; LONG-TERM FERTILIZATION; NITROGEN USE EFFICIENCY; ORGANIC-CARBON POOLS; ON-FARM EVALUATION; NORTH CHINA; NUTRIENT MANAGEMENT; MANURE APPLICATION; SOUTHERN CHINA; ACID-RAIN	Increased fertilizer input in agricultural systems during the last few decades has resulted in large yield increases, but also in environmental problems. We used data from published papers and a soil testing and fertilization project in Shaanxi province during the years 2005 to 2009 to analyze chemical fertilizer inputs and yields of wheat (Triticum aestivum L.) and maize (Zea mays L.) on the farmers' level, and soil fertility change from the 1970s to the 2000s in the Loess Plateau in China. The results showed that in different regions of the province, chemical fertilizer NPK inputs and yields of wheat and maize increased. With regard to soil nutrient balance, N and P gradually changed from deficit to surplus levels, while K deficiency became more severe. In addition, soil organic matter, total nitrogen, alkali-hydrolysis nitrogen, available phosphorus and available potassium increased during the same period. The PFP of N, NP and NPK on wheat and maize all decreased from the 1970s to the 2000s as a whole. With the increase in N fertilizer inputs, both soil total nitrogen and alkali-hydrolysis nitrogen increased; P fertilizer increased soil available phosphorus and K fertilizer increased soil available potassium. At the same time, soil organic matter, total nitrogen, alkali-hydrolysis nitrogen, available phosphorus and available potassium all had positive impacts on crop yields. In order to promote food safety and environmental protection, fertilizer requirements should be assessed at the farmers' level. In many cases, farmers should be encouraged to reduce nitrogen and phosphate fertilizer inputs significantly, but increase potassium fertilizer and organic manure on cereal crops as a whole.	[Wang, Xiaoying; Tong, Yanan; Gao, Yimin; Gao, Pengcheng; Liu, Fen; Zhao, Zuoping; Pang, Yan] Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Peoples R China; [Wang, Xiaoying; Tong, Yanan] Minist Agr, Key Lab Plant Nutr & Agrienvironm Northwest China, Yangling, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs	Tong, YN (corresponding author), Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Peoples R China.	tongyanan@nwsuaf.edu.cn	gao, yi/HCI-8298-2022; Gao, Yu/HGE-1937-2022; Gao, Y./GWZ-3665-2022		Special Fund for Agro-scientific Research in the Public Interest of China [201103003]; Soil Quality Foundation of China [2012BAD05B03]	Special Fund for Agro-scientific Research in the Public Interest of China; Soil Quality Foundation of China	The authors thank the Special Fund for Agro-scientific Research in the Public Interest of China (201103003) and the Soil Quality Foundation of China (2012BAD05B03) for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, ARID METEOROL; Arshad MA, 2002, AGR ECOSYST ENVIRON, V88, P153, DOI 10.1016/S0167-8809(01)00252-3; Banger K, 2009, PLANT SOIL, V318, P27, DOI 10.1007/s11104-008-9813-z; Bierman PM, 2012, AGR SYST, V109, P43, DOI 10.1016/j.agsy.2012.02.004; [蔡艳 Cai Yan], 2013, [麦类作物学报, Journal of Triticeae Crops], V33, P983; Cao N., 2009, CHINESE AGR SCI B, V25, P220; Cui ZL, 2008, AGRON J, V100, P517, DOI 10.2134/agronj2007.0194; Cui ZL, 2008, FIELD CROP RES, V105, P48, DOI 10.1016/j.fcr.2007.07.008; Cui ZL, 2010, AMBIO, V39, P376, DOI 10.1007/s13280-010-0076-6; Dai ZH, 1998, WATER AIR SOIL POLL, V108, P377, DOI 10.1023/A:1005015526022; Department of Rural Surveys National Bureau of Statistics, 1971, CHIN RUR STAT YB; Dobermann A, 2005, SCI CHINA SER C, V48, P745, DOI 10.1360/062005-268; Fan MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074617; Gami SK, 2001, BIOL FERT SOILS, V34, P73, DOI 10.1007/s003740100377; Gao C, 2006, PEDOSPHERE, V16, P253, DOI 10.1016/S1002-0160(06)60051-9; Gao X.Z., 2001, CHINESE J SOIL SCI, V6, P258; Gao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033982; Geng YuHui, 2013, Journal of South China Agricultural University, V34, P470; Gong FuFei, 2013, Transactions of the Chinese Society of Agricultural Engineering, V29, P120; [龚伟 GONG Wei], 2011, [土壤, Soils], V43, P336; Griffin TS, 2003, SOIL SCI SOC AM J, V67, P645, DOI 10.2136/sssaj2003.0645; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Guo SL, 2012, GEODERMA, V189, P442, DOI 10.1016/j.geoderma.2012.06.012; Guo SL, 2010, PLANT SOIL, V330, P1, DOI 10.1007/s11104-009-0204-x; Hao MD, 2005, PEDOSPHERE, V15, P189; HOOSBEEK MR, 1992, GEODERMA, V55, P183, DOI 10.1016/0016-7061(92)90083-J; Huang B, 2007, GEODERMA, V139, P336, DOI 10.1016/j.geoderma.2007.02.012; Huang DY, 2009, ENVIRON POLLUT, V157, P35, DOI 10.1016/j.envpol.2008.08.001; [黄国勤 Huang Guoqin], 2004, [生态环境, Ecology and Environment], V13, P656; Huang S, 2010, AGR ECOSYST ENVIRON, V138, P44, DOI 10.1016/j.agee.2010.03.015; [林治安 LIN Zhian], 2009, [中国农业科学, Scientia Agricultura Sinica], V42, P2809; Jiang D, 2006, PEDOSPHERE, V16, P25, DOI 10.1016/S1002-0160(06)60022-2; Ju XT, 2006, ENVIRON POLLUT, V143, P117, DOI 10.1016/j.envpol.2005.11.005; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Ju XT, 2004, AMBIO, V33, P300, DOI 10.1639/0044-7447(2004)033[0300:NFSNAA]2.0.CO;2; Karlen DL, 1997, SOIL SCI SOC AM J, V61, P4, DOI 10.2136/sssaj1997.03615995006100010001x; Kautz T, 2013, SOIL BIOL BIOCHEM, V57, P1003, DOI 10.1016/j.soilbio.2012.09.014; Krusche AV, 2003, ENVIRON POLLUT, V121, P389, DOI 10.1016/S0269-7491(02)00235-X; Li H, 2010, AGR ECOSYST ENVIRON, V135, P24, DOI 10.1016/j.agee.2009.08.003; Li Juan, 2008, Agricultural Sciences in China, V7, P336, DOI 10.1016/S1671-2927(08)60074-7; Li LF, 2009, AGR RES ARID AREAS, V27, p[127, 142]; Li Q, 2013, J PLANT NUTR SOIL SC, V176, P249, DOI 10.1002/jpln.201100395; Liu EK, 2010, GEODERMA, V158, P173, DOI 10.1016/j.geoderma.2010.04.029; Liu GB, 1999, AMBIO, V28, P663; Liu Zhong, 2009, Transactions of the Chinese Society of Agricultural Engineering, V25, P168; [骆世明 LUO Shiming], 2007, [地理研究, Geographical Research], V26, P609; Ma LiHeng, 2011, Journal of Yangzhou University, Agricultural and Life Sciences Edition, V32, P48; Ma WQ, 1999, THESIS CHINA AGR U B; Majumder B, 2008, BIOL FERT SOILS, V44, P451, DOI 10.1007/s00374-007-0226-6; Mando A, 2005, SOIL USE MANAGE, V21, P25, DOI 10.1079/SUM2005287; Menz FC, 2004, ENVIRON SCI POLICY, V7, P253, DOI 10.1016/j.envsci.2004.05.005; Moharana PC, 2012, FIELD CROP RES, V136, P32, DOI 10.1016/j.fcr.2012.07.002; Mosier AR, 1996, PLANT SOIL, V181, P95, DOI 10.1007/BF00011296; MUNSON RD, 1985, POTASSIUM AGR; Peng SB, 2006, FIELD CROP RES, V96, P37, DOI 10.1016/j.fcr.2005.05.004; Richter J, 2000, NUTR CYCL AGROECOSYS, V57, P33, DOI 10.1023/A:1009802225307; Sharma A, 2010, CATENA, V82, P112, DOI 10.1016/j.catena.2010.05.009; Singh M, 2002, FIELD CROP RES, V77, P81, DOI 10.1016/S0378-4290(01)00206-4; [马文奇 Ma Wenqi], 2008, [生态环境, Ecology and Environment], V17, P1296; Smil V., 2001, ENRICHING EARTH F HA; Tan DS, 2012, AGR ECOSYST ENVIRON, V148, P65, DOI 10.1016/j.agee.2011.11.016; [汤勇华 TANG Yong-hua], 2009, [农业环境科学学报, Journal of Agro-Environment Science], V28, P1070; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tong YN, 1997, NUTR CYCL AGROECOSYS, V48, P225; van Bochove E, 2007, CAN J SOIL SCI, V87, P121, DOI 10.4141/S06-067; Wang HongTing, 2010, Plant Nutrition and Fertilizer Science, V16, P801; Wang SR, 2002, THESIS CHINA AGR U B; Wang XJ, 1998, GEODERMA, V81, P339, DOI 10.1016/S0016-7061(97)00109-2; Witter E, 2001, BIOL AGRIC HORTIC, V19, P127, DOI 10.1080/01448765.2001.9754917; Yan Xiang, 2008, Agricultural Sciences in China, V7, P469, DOI 10.1016/S1671-2927(08)60091-7; Yang SM, 2004, AGRON J, V96, P1039, DOI 10.2134/agronj2004.1039; Yang XY, 2014, J INTEGR AGR, V13, P402, DOI 10.1016/S2095-3119(13)60425-6; Yi Qiong, 2010, Plant Nutrition and Fertilizer Science, V16, P1069; Zhang F, 2007, P 9 GERM SCI C ORG A; Zhang FS, 2002, CHIN J SOIL SCI, V33, P126; Zhang FuSuo, 2008, Acta Pedologica Sinica, V45, P915; Zhang HM, 2009, PEDOSPHERE, V19, P199, DOI 10.1016/S1002-0160(09)60109-0; Zhang JF, 2008, ATMOS ENVIRON, V42, P291, DOI 10.1016/j.atmosenv.2007.09.036; [张卫峰 Zhang Weifeng], 2005, [自然资源学报, Journal of Natural Resources], V20, P378; Zhang Wenxue, 2011, J WUHAN I TECHNOLOGY, V33, P1; [张亚丽 Zhang Yali], 2012, [植物营养与肥料学报, Plant Nutrition and Fertitizer Science], V18, P307; Zhao J. R., 1997, BEIJING AGR SCI, V15, P36; Zhao Jing, 2014, Journal of Maize Sciences, V22, P123; Zhao X, 2009, SOIL BIOL BIOCHEM, V41, P2584, DOI 10.1016/j.soilbio.2009.08.022; Zhen L, 2006, J ENVIRON MANAGE, V79, P409, DOI 10.1016/j.jenvman.2005.08.009; Zhou ZC, 2013, EUR J AGRON, V45, P20, DOI 10.1016/j.eja.2012.11.002; Zhu ZL, 2002, NUTR CYCL AGROECOSYS, V63, P117, DOI 10.1023/A:1021107026067	87	8	12	8	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112273	10.1371/journal.pone.0112273	http://dx.doi.org/10.1371/journal.pone.0112273			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380401	Green Published, Green Submitted			2022-12-27	WOS:000344863100072
J	Kohsaka, A; Das, P; Hashimoto, I; Nakao, T; Deguchi, Y; Gouraud, SS; Waki, H; Muragaki, Y; Maeda, M				Kohsaka, Akira; Das, Partha; Hashimoto, Izumi; Nakao, Tomomi; Deguchi, Yoko; Gouraud, Sabine S.; Waki, Hidefumi; Muragaki, Yasuteru; Maeda, Masanobu			The Circadian Clock Maintains Cardiac Function by Regulating Mitochondrial Metabolism in Mice	PLOS ONE			English	Article							ARNT-LIKE PROTEIN-1; CONTRACTILE FUNCTION; REDOX STATE; PPAR-ALPHA; CARDIOMYOCYTE; PRESSURE; HEART; RESPONSIVENESS; INTEGRATION; BIOGENESIS	Cardiac function is highly dependent on oxidative energy, which is produced by mitochondrial respiration. Defects in mitochondrial function are associated with both structural and functional abnormalities in the heart. Here, we show that heart-specific ablation of the circadian clock gene Bmal1 results in cardiac mitochondrial defects that include morphological changes and functional abnormalities, such as reduced enzymatic activities within the respiratory complex. Mice without cardiac Bmal1 function show a significant decrease in the expression of genes associated with the fatty acid oxidative pathway, the tricarboxylic acid cycle, and the mitochondrial respiratory chain in the heart and develop severe progressive heart failure with age. Importantly, similar changes in gene expression related to mitochondrial oxidative metabolism are also observed in C57BL/6J mice subjected to chronic reversal of the light-dark cycle; thus, they show disrupted circadian rhythmicity. These findings indicate that the circadian clock system plays an important role in regulating mitochondrial metabolism and thereby maintains cardiac function.	[Kohsaka, Akira; Das, Partha; Hashimoto, Izumi; Nakao, Tomomi; Deguchi, Yoko; Gouraud, Sabine S.; Waki, Hidefumi; Maeda, Masanobu] Wakayama Med Univ, Sch Med, Dept Physiol, Wakayama, Japan; [Muragaki, Yasuteru] Wakayama Med Univ, Sch Med, Dept Pathol 1, Wakayama, Japan	Wakayama Medical University; Wakayama Medical University	Kohsaka, A (corresponding author), Wakayama Med Univ, Sch Med, Dept Physiol, Wakayama, Japan.	kohsaka@wakayama-med.ac.jp	Gouraud, Sabine S. S/N-3395-2018	Gouraud, Sabine S. S/0000-0002-4917-0647; Waki, Hidefumi/0000-0002-4278-2077	JSPS KAKENHI [25460316]; Takeda Science Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by JSPS KAKENHI Grant Number 25460316 (to A. K.) and the Takeda Science Foundation (to A. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Arjona A, 2012, TRENDS IMMUNOL, V33, P607, DOI 10.1016/j.it.2012.08.007; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bray MS, 2008, AM J PHYSIOL-HEART C, V294, pH1036, DOI 10.1152/ajpheart.01291.2007; Canaple L, 2006, MOL ENDOCRINOL, V20, P1715, DOI 10.1210/me.2006-0052; Curtis AM, 2007, P NATL ACAD SCI USA, V104, P3450, DOI 10.1073/pnas.0611680104; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Durgan DJ, 2006, J BIOL CHEM, V281, P24254, DOI 10.1074/jbc.M601704200; Durgan DJ, 2011, CHRONOBIOL INT, V28, P187, DOI 10.3109/07420528.2010.550406; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Firsov D, 2010, KIDNEY INT, V78, P640, DOI 10.1038/ki.2010.227; Grimaldi B, 2010, CELL METAB, V12, P509, DOI 10.1016/j.cmet.2010.10.005; Huss JM, 2007, CELL METAB, V6, P25, DOI 10.1016/j.cmet.2007.06.005; Hussain MM, 2009, TRENDS ENDOCRIN MET, V20, P177, DOI 10.1016/j.tem.2009.01.001; Jeyaraj D, 2012, NATURE, V483, P96, DOI 10.1038/nature10852; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lefta M, 2012, AM J PHYSIOL-HEART C, V303, pH475, DOI 10.1152/ajpheart.00238.2012; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Leone TC, 2011, COLD SH Q B, V76, P175, DOI 10.1101/sqb.2011.76.011965; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Marin-Garcia J, 2005, DEV CARDIOVASC MED, P1; Marin-Garcia J, 2013, HEART FAIL REV, V18, P439, DOI 10.1007/s10741-012-9330-2; Mavroudis PD, 2013, J INNATE IMMUN, V5, P153, DOI 10.1159/000342427; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Musiek ES, 2013, J CLIN INVEST, V123, P5389, DOI 10.1172/JCI70317; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Oishi K, 2005, BIOCHEM J, V386, P575, DOI 10.1042/BJ20041150; Pacha J, 2013, ACTA PHYSIOL, V208, P11, DOI 10.1111/apha.12090; Peek CB, 2012, TRENDS ENDOCRIN MET, V23, P312, DOI 10.1016/j.tem.2012.02.003; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sahar S, 2012, TRENDS ENDOCRIN MET, V23, P1, DOI 10.1016/j.tem.2011.10.005; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Smeets PJH, 2008, CARDIOVASC RES, V78, P79, DOI 10.1093/cvr/cvn001; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Stow LR, 2011, J AM SOC NEPHROL, V22, P598, DOI 10.1681/ASN.2010080803; Tsai JY, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.077800; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Vyas MV, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4800; Wang TA, 2012, SCIENCE, V337, P839, DOI 10.1126/science.1222826; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213	50	69	69	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112811	10.1371/journal.pone.0112811	http://dx.doi.org/10.1371/journal.pone.0112811			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389966	gold, Green Published, Green Submitted			2022-12-27	WOS:000349144400132
J	Macintosh, AA; Pinhasi, R; Stock, JT				Macintosh, Alison A.; Pinhasi, Ron; Stock, Jay T.			Divergence in Male and Female Manipulative Behaviors with the Intensification of Metallurgy in Central Europe	PLOS ONE			English	Article							CROSS-SECTIONAL GEOMETRY; QUANTITATIVE COMPUTED-TOMOGRAPHY; LONG-BONE DIAPHYSES; BILATERAL ASYMMETRY; POSTCRANIAL ROBUSTICITY; NEOLITHIC SETTLEMENT; VEDROVICE CEMETERY; SKELETAL EVIDENCE; HUMERAL TORSION; CORTICAL BONE	Humeral morphology has been shown to reflect, in part, habitual manipulative behaviors in humans. Among Central European agricultural populations, long-term social change, increasing task specialization, and technological innovation all had the potential to impact patterns of habitual activity and upper limb asymmetry. However, systematic temporal change in the skeletal morphology of agricultural populations in this region has not been well-characterized. This study investigates diachronic patterns in humeral biomechanical properties and lengths among 174 adult Central European agriculturalists through the first,5400 years of farming in the region. Greater asymmetry in biomechanical properties was expected to accompany the introduction of metallurgy, particularly in males, while upper limb loading patterns were expected to be more similar between the Bronze and Iron Ages. Results revealed a divergence in the lateralization of upper limb biomechanical properties by sex between the Early/Middle Neolithic and Early/Middle Bronze Age. Neolithic females had significantly more variable properties than males in both humeri, while Bronze Age female properties became homogeneous and very symmetrical relative to the right-biased lateralization of contemporaneous males. The Bronze Age to Iron Age transition was associated with morphological change among females, with a significant increase in right-biased asymmetry and a concomitant reduction in sexual dimorphism. Relative to biomechanical properties, humeral length variation and asymmetry were low though some significant sexual dimorphism and temporal change was found. It was among females that the lateralization of humeral biomechanical properties, and variation within them, changed most profoundly through time. This suggests that the introduction of the ard and plow, metallurgical innovation, task specialization, and socioeconomic change through,5400 years of agriculture impacted upper limb loading in Central European women to a greater extent than men.	[Macintosh, Alison A.; Stock, Jay T.] Univ Cambridge, Dept Archaeol & Anthropol, PAVE Res Grp, Cambridge, England; [Pinhasi, Ron] Univ Coll Dublin, Earth Inst, Dublin 2, Ireland; [Pinhasi, Ron] Univ Coll Dublin, Sch Archaeol, Dublin 2, Ireland	University of Cambridge; University College Dublin; University College Dublin	Macintosh, AA (corresponding author), Univ Cambridge, Dept Archaeol & Anthropol, PAVE Res Grp, Cambridge, England.	am2028@cam.ac.uk	Stock, Jay T/B-6453-2011; Pinhasi, Ron/AAT-1531-2020	Stock, Jay T/0000-0003-0147-8631; Pinhasi, Ron/0000-0003-1629-8131; Murray, Alison/0000-0003-2914-5206	Cambridge Commonwealth, European and International Trust; Social Sciences and Humanities Research Council of Canada; European Research Council [ERC-2010-StG263,441]	Cambridge Commonwealth, European and International Trust; Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); European Research Council(European Research Council (ERC)European Commission)	The authors were funded by the following: Cambridge Commonwealth, European and International Trust (AAM) (http://www.cambridgetrust.org/); Social Sciences and Humanities Research Council of Canada (AAM) (http://www.sshrc-crsh.gc.ca/); and European Research Council Starting Grant ERC-2010-StG263,441 (RP) (http://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BONE; Auerbach BM, 2006, J HUM EVOL, V50, P203, DOI 10.1016/j.jhevol.2005.09.004; Bass SL, 2002, J BONE MINER RES, V17, P2274, DOI 10.1359/jbmr.2002.17.12.2274; Bentley RA, 2013, J ANTHROPOL ARCHAEOL, V32, P303, DOI 10.1016/j.jaa.2012.01.009; Bentley RA, 2012, P NATL ACAD SCI USA, V109, P9326, DOI 10.1073/pnas.1113710109; Bentley RA, 2013, 1 FARMERS CENTRAL EU, P251; Bickle Penny, 2013, 1 FARMERS CENTRAL EU, P101; BIEWENER AA, 1994, J APPL PHYSIOL, V76, P946, DOI 10.1152/jappl.1994.76.2.946; Bintliff J, 1984, EUROPEAN SOCIAL EVOL; Blackburn A, 2011, AM J PHYS ANTHROPOL, V145, P639, DOI 10.1002/ajpa.21555; Blaskovich J, 1958, ARCHAEOL ERTESITO, V85, P202; Boric D., 1996, STARINAR, VXLVII, P67; Boric Dusan., 2009, METALS SOC STUDIES H, P191; Bottyan A, 1955, REGESZETI FUZETEK; BRIDGES PS, 1989, CURR ANTHROPOL, V30, P385, DOI 10.1086/203756; Bridges PS, 2000, AM J PHYS ANTHROPOL, V112, P217, DOI 10.1002/(SICI)1096-8644(2000)112:2<217::AID-AJPA8>3.0.CO;2-E; Brukner B., 1980, RAD VOJVODANSKIH MUZ, V26, P5; Buck LT, 2010, INT J PRIMATOL, V31, P779, DOI 10.1007/s10764-010-9428-0; Buikstra J.E., 1994, FAYETTEVILLE ARKANSA, V44; Cain EL, 2003, AM J SPORT MED, V31, P621, DOI 10.1177/03635465030310042601; Cizmarova J, 2005, KELTSKE POHREBISTE B, V14; Coles J.M, 1979, BRONZE AGE EUROPE IN; Collis J., 1984, EUROPEAN IRON AGE; Craddock P.T., 1995, EARLY METAL MINING P; Cutler GB, 1997, J STEROID BIOCHEM, V61, P3; Dacik T, 1983, ARCHEOL ROZHL, V35, P496; Daly RM, 2004, BONE, V34, P281, DOI 10.1016/j.bone.2003.11.009; Dani J, 2001, BRONZEZEITLICHE KULT, P93; Davies TG, 2012, ARCHAEOL ANTHROP SCI, V4, P277, DOI 10.1007/s12520-012-0101-8; Dockalova M, 2008, ANTHROPOL-INT J HUM, V46, P239; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Dreslerova G, 2005, VYHODNOCENI ZVIRECIC; Ducher G, 2005, BONE, V37, P457, DOI 10.1016/j.bone.2005.05.014; Fischl KP., 2013, 1600 KULTURELLER UMB, P355; Fothi E, 2006, AZ ARANYSZARVAS NYOM, P65; Frayer D. W., 2004, ANTHROPOLOGIE, V42, P71; Gale N. H., 2003, MINING METAL PRODUCT, P122; GALLOWAY M, 1992, ORTHOPEDICS, V15, P1089; Garn S M, 1972, Orthop Clin North Am, V3, P503; Garn S.M., 1970, EARLIER GAIN LATER L; Gerling C, 2009, KRISEN KULTURWANDEL, P103; Gerling C, 2007, ARCHAOLOGISCHE INFOR, V30, P43; GILMAN A, 1981, CURR ANTHROPOL, V22, P1, DOI 10.1086/202600; Gosman JH, 2011, YEARB PHYS ANTHROPOL, V54, P86; Haapasalo H, 1996, J BONE MINER RES, V11, P864; Haapasalo H, 1998, J BONE MINER RES, V13, P310, DOI 10.1359/jbmr.1998.13.2.310; Haapasalo H, 2000, BONE, V27, P351, DOI 10.1016/S8756-3282(00)00331-8; Harding A, 2002, EUROPEAN PREHISTORY, P271; Harding A.F., 2000, EUROPEAN SOC BRONZE; Heinonen A, 2001, BONE, V29, P388, DOI 10.1016/S8756-3282(01)00588-9; Hogue SH, 2002, MEDICONT J ARCHAEOL, V27, P69; Humphrey LT, 1998, AM J PHYS ANTHROPOL, V105, P57, DOI 10.1002/(SICI)1096-8644(199801)105:1<57::AID-AJPA6>3.0.CO;2-A; Humpolova A, 2001, 50 LET ARCHEOLOGICKY, P157; HUMPOLOVA A., 1999, PRAVIKD SOCIOKULTOVN, P167; Jacobi G., 1974, WERKZEUG GERAT OPPID; JANSSON JO, 1983, AM J PHYSIOL, V244, pE135, DOI 10.1152/ajpendo.1983.244.2.E135; Jarosova I, 2008, ANTHROPOL-INT J HUM, V46, P175; Jarosova I, 2008, ANTHROPOL-INT J HUM, V46, P77; JONES HH, 1977, J BONE JOINT SURG AM, V59, P204, DOI 10.2106/00004623-197759020-00012; Jovanovic B, 1982, MUYEJ RUDARSTVA META, V17; Kala J, 2008, ACTA ARCHAEOLOGICA O, P61; KANNUS P, 1995, ANN INTERN MED, V123, P27, DOI 10.7326/0003-4819-123-1-199507010-00003; Kontulainen S, 2002, J BONE MINER RES, V17, P2281, DOI 10.1359/jbmr.2002.17.12.2281; KRAHL H, 1994, AM J SPORT MED, V22, P751, DOI 10.1177/036354659402200605; Krishan K, 2011, AM J HUM BIOL, V23, P674, DOI 10.1002/ajhb.21196; Kruta V, 2007, CRUCHE CELTE BRNO CH; Le Huray JD, 2005, J ANTHROPOL ARCHAEOL, V24, P135, DOI 10.1016/j.jaa.2004.09.002; Libanati C, 1999, J CLIN ENDOCR METAB, V84, P2807, DOI 10.1210/jc.84.8.2807; Lillie M, 2008, ANTHROPOL-INT J HUM, V46, P135; Lukes A, 2008, ANTHROPOL-INT J HUM, V46, P117; Macintosh AA, 2013, AM J PHYS ANTHROPOL, V150, P442, DOI 10.1002/ajpa.22218; Marchi D, 2006, AM J PHYS ANTHROPOL, V131, P447, DOI 10.1002/ajpa.20449; Mauras N, 1996, HORM RES, V45, P74, DOI 10.1159/000184763; Mays SA, 2002, J ARCHAEOL SCI, V29, P435, DOI 10.1006/jasc.2002.0729; MEGAW J.V.S., 1970, ART EUROPEAN IRON AG; Milasinovic L, 2009, RAD MUZEJA VOYVODINA, V51, P65; Milisauskas S, 2002, EUROPEAN PREHISTORY, P143; Milisauskas S., 2002, EUROPEAN PREHISTORY, P193; Nieszery N., 1995, INT ARCHAOLOGIE, V16; Ogilvie MD, 2011, AM J PHYS ANTHROPOL, V144, P11, DOI 10.1002/ajpa.21362; Ondrus V, 2002, DVE POHREBISTE NEOLI, P9; Osbahr DC, 2002, AM J SPORT MED, V30, P347, DOI 10.1177/03635465020300030801; Ottaway BS, 1979, RAD VOJVODANSKIH MUZ, V25, P53; Pankowska A, 2009, ANTHROPOL-INT J HUM, V47, P215; Parducz M, 1966, ACTA ARCHAEOL, V18, P39; Pavuk J., 1972, SLOVENSKA ARCHEOLOGI, V20, P5; Pettitt P, 2008, ANTHROPOL-INT J HUM, V46, P125; Pieper HG, 1998, AM J SPORT MED, V26, P247, DOI 10.1177/03635465980260021501; Pleinerova I, 1981, ARCHEOL ROZHL, V23, P133; Podborsky V., 2002, DVE POHREBISTE NEOLI; Podborsky V., 1993, PRAVEKE DEJINY MORAV, V3rd; Poulik J, 1942, Z MAHRISCHEN LANDESM, V2, P49; Price T., 2003, FUNDBERICHTE BADEN W, P23; Rhodes JA, 2005, AM J PHYS ANTHROPOL, V128, P536, DOI 10.1002/ajpa.20147; Richards MP, 2008, ANTHROPOL-INT J HUM, V46, P185; Rolle R, 1989, WORLD SCYTHIANS; Ruff C, 2003, BONE, V33, P317, DOI 10.1016/S8756-3282(03)00161-3; RUFF CB, 1994, AM J PHYS ANTHROPOL, V93, P35, DOI 10.1002/ajpa.1330930103; RUFF CB, 1983, AM J PHYS ANTHROPOL, V60, P359, DOI 10.1002/ajpa.1330600308; RUFF CB, 2008, BIOL ANTHR HUMAN SKE, P183, DOI DOI 10.1002/9780470245842.CH6; Ruff CB, 2012, AM J PHYS ANTHROPOL, V148, P601, DOI 10.1002/ajpa.22087; Schmitt D, 2003, J ARCHAEOL SCI, V30, P103, DOI 10.1006/jasc.2001.0814; Schoenau E, 2001, J CLIN ENDOCR METAB, V86, P613, DOI 10.1210/jc.86.2.613; Schwab LM, 2009, PHYS THER SPORT, V10, P51, DOI 10.1016/j.ptsp.2008.11.006; Seeman E, 2003, NEW ENGL J MED, V349, P320, DOI 10.1056/NEJMp038101; Shaw CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040349; Shaw CN, 2011, J HUM EVOL, V61, P480, DOI 10.1016/j.jhevol.2011.06.004; Shaw CN, 2009, AM J PHYS ANTHROPOL, V140, P160, DOI 10.1002/ajpa.21063; SHENNAN SJ, 1993, J WORLD PREHIST, V7, P121, DOI 10.1007/BF00975449; Sherratt A. G., 1981, PATTERN OF THE PAST, P261; Skutil J, 1941, WIENER PRAHISTORISCH, V28, P21; Sladek V, 2007, AM J PHYS ANTHROPOL, V133, P669, DOI 10.1002/ajpa.20551; Slizewski A, 2014, ANAT REC, V297, P1103, DOI 10.1002/ar.22917; Smrcka V, 2006, SLUZBACH ARCHEOLOGIE, V7, P329; Smrcka V, 2005, ANTHROPOL-INT J HUM, V43, P315; Sparacello VS, 2011, AM J PHYS ANTHROPOL, V144, P119, DOI 10.1002/ajpa.21377; Sparacello VS, 2010, AM J PHYS ANTHROPOL, V143, P612, DOI 10.1002/ajpa.21361; Sparacello V, 2008, AM J PHYS ANTHROPOL, V136, P485, DOI 10.1002/ajpa.20832; Stadler P, 1999, JUNGSTEINZEIT OSTEN, P210; STEELE J, 1995, INT J OSTEOARCHAEOL, V5, P39, DOI 10.1002/oa.1390050105; Stock JT, 2007, AM J PHYS ANTHROPOL, V134, P412, DOI 10.1002/ajpa.20686; Stock JT, 2013, ANN NY ACAD SCI, V1288, P86, DOI 10.1111/nyas.12067; Stock JT, 2004, J ARCHAEOL SCI, V31, P999, DOI 10.1016/j.jas.2003.12.012; Stock JT, 2002, INT J OSTEOARCHAEOL, V12, P335, DOI 10.1002/oa.629; Sumner DR, 1996, BONE, V19, P121, DOI 10.1016/8756-3282(96)00166-4; Tasic N, 2003, STARINAR, V53-54, P25; Tasic N., 1972, ARCHAEOLOGIA IUGOSLA, V13, P27; Tayler RE, 2007, COMPUT METHOD BIOMEC, V12, P83; Thomas A, 2014, AM J PHYS ANTHROPOL, V154, P279, DOI 10.1002/ajpa.22504; TRINKAUS E, 1994, AM J PHYS ANTHROPOL, V93, P1, DOI 10.1002/ajpa.1330930102; Trubacova T, 2005, KELTSKE POHREBISTE B, V14, P27; TUPMAN GS, 1962, J BONE JOINT SURG BR, V44, P42, DOI 10.1302/0301-620X.44B1.42; Ubelaker DH, 1998, INT J OSTEOARCHAEOL, V8, P231, DOI 10.1002/(SICI)1099-1212(199807/08)8:4<231::AID-OA423>3.3.CO;2-2; Villotte S, 2014, J ARCHAEOL SCI, V43, P168, DOI 10.1016/j.jas.2013.12.009; Warden SJ, 2009, BONE, V45, P931, DOI 10.1016/j.bone.2009.07.075; Weiss E, 2003, AM J PHYS ANTHROPOL, V121, P293, DOI 10.1002/ajpa.10240; Wells PS, 2002, EUROPEAN PREHISTORY, P335; Wescott DJ, 2006, J ARCHAEOL SCI, V33, P1022, DOI 10.1016/j.jas.2005.11.007; Whiteley R, 2006, J SCI MED SPORT, V9, P310, DOI 10.1016/j.jsams.2006.05.012; Whittle A., 1996, EUROPE NEOLITHIC CRE; Whittle A, 2013, 1 FARMERS CENTRAL EU, P49; Wilson K.E., 1976, PROBLEMS EC SOC ARCH, P513; Zvelebil M, 2013, J ANTHROPOL ARCHAEOL, V32, P313, DOI 10.1016/j.jaa.2012.01.011; Zvelebil M., 2004, LBK DIALOGUES STUDIE, P183; Zvelebil M., 2000, ARCHAEOGENETICS DNA, P57; Zvelebil M, 2008, ANTHROPOL-INT J HUM, V46, P195	146	19	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112116	10.1371/journal.pone.0112116	http://dx.doi.org/10.1371/journal.pone.0112116			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CP	25389972	gold, Green Published			2022-12-27	WOS:000349144400054
J	Schnyder, HA; Vanderelst, D; Bartenstein, S; Firzlaff, U; Luksch, H				Schnyder, Hans A.; Vanderelst, Dieter; Bartenstein, Sophia; Firzlaff, Uwe; Luksch, Harald			The Avian Head Induces Cues for Sound Localization in Elevation	PLOS ONE			English	Article							BARN OWL; LOCATION; PREY	Accurate sound source localization in three-dimensional space is essential for an animal's orientation and survival. While the horizontal position can be determined by interaural time and intensity differences, localization in elevation was thought to require external structures that modify sound before it reaches the tympanum. Here we show that in birds even without external structures like pinnae or feather ruffs, the simple shape of their head induces sound modifications that depend on the elevation of the source. Based on a model of localization errors, we show that these cues are sufficient to locate sounds in the vertical plane. These results suggest that the head of all birds induces acoustic cues for sound localization in the vertical plane, even in the absence of external ears.	[Schnyder, Hans A.; Bartenstein, Sophia; Firzlaff, Uwe; Luksch, Harald] Tech Univ Munich, Chair Zool, D-80290 Munich, Germany; [Vanderelst, Dieter] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Vanderelst, Dieter] Univ Antwerp, Act Percept Lab, B-2020 Antwerp, Belgium	Technical University of Munich; University of Bristol; University of Antwerp	Schnyder, HA (corresponding author), Tech Univ Munich, Chair Zool, D-80290 Munich, Germany.	hansa.schnyder@gmail.com		Firzlaff, Uwe/0000-0003-2803-3587; Luksch, Harald/0000-0002-9835-7715	Bernstein Center for Computational Neuroscience Munich (BMBF) fund [FKZ01GQ1004B]; Research Foundation - Flanders (FWO); Marie Curie Intra-European Fellowship	Bernstein Center for Computational Neuroscience Munich (BMBF) fund(Federal Ministry of Education & Research (BMBF)); Research Foundation - Flanders (FWO)(FWO); Marie Curie Intra-European Fellowship(European Commission)	The project was supported by a Bernstein Center for Computational Neuroscience Munich (BMBF) fund to HL (FKZ01GQ1004B), http://www.bccn-munich.de; a postdoctoral fellowship from the Research Foundation - Flanders (FWO); and a Marie Curie Intra-European Fellowship to DV, http://ec.europa.eu/research/mariecurieactions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blauert J., 1997, SPATIAL HEARING PSYC; Christensen-Dalsgaard J, 2005, SPR HDB AUD, V25, P67, DOI 10.1007/0-387-28863-5_4; Dooling RJ, 2000, SPR HDB AUD, V13, P308; Fay R. R., 1988, HEARING VERTEBRATES; Firzlaff U, 2003, HEARING RES, V185, P109, DOI 10.1016/S0378-5955(03)00278-8; GARDNER MB, 1973, J ACOUST SOC AM, V53, P400, DOI 10.1121/1.1913336; Harmening WM, 2011, J COMP PHYSIOL A, V197, P1031, DOI 10.1007/s00359-011-0664-3; Hausmann L, 2010, J COMP PHYSIOL A, V196, P601, DOI 10.1007/s00359-010-0546-0; Hausmann L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007721; Hill EM, 2014, J COMP PHYSL A; Hofman PM, 1998, NAT NEUROSCI, V1, P417, DOI 10.1038/1633; Iwaniuk AN, 2008, J COMP PHYSIOL A, V194, P267, DOI 10.1007/s00359-007-0304-0; Keller CH, 1998, HEARING RES, V118, P13, DOI 10.1016/S0378-5955(98)00014-8; Klump GM, 2000, SPR HDB AUD, V13, P249; Koka K, 2011, HEARING RES, V272, P135, DOI 10.1016/j.heares.2010.10.007; Larsen ON, 2004, AN ACAD BRAS CIENC, V76, P267, DOI 10.1590/S0001-37652004000200013; McAlpine D, 2003, TRENDS NEUROSCI, V26, P347, DOI 10.1016/S0166-2236(03)00140-1; Middlebrooks J, 1991, ANN REV PSYCHOL; Mills AW., 1972, FOUNDATIONS MODERN A, P303; MOISEFF A, 1989, J COMP PHYSIOL A, V164, P629, DOI 10.1007/BF00614505; MOORE BCJ, 1989, J ACOUST SOC AM, V85, P820, DOI 10.1121/1.397554; PAYNE RS, 1971, J EXP BIOL, V54, P535; Pena JL, 2001, SCIENCE, V292, P249, DOI 10.1126/science.1059201; Reijniers J, 2014, BIOL CYBERN, V108, P169, DOI 10.1007/s00422-014-0588-4; Reijniers J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.148701; RICE WR, 1982, AUK, V99, P403; Vanderelst D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002268; Viete S, 1997, J NEUROSCI, V17, P1815; Welch TE, 2011, J ACOUST SOC AM, V130, P2293, DOI 10.1121/1.3628335; WIENER FM, 1947, J ACOUST SOC AM, V19, P444, DOI 10.1121/1.1916501; Witten IB, 2005, NEURON, V48, P489, DOI 10.1016/j.neuron.2005.10.020; WRIGHT D, 1974, J ACOUST SOC AM, V56, P957, DOI 10.1121/1.1903355; Young ED, 1996, J ACOUST SOC AM, V99, P3064, DOI 10.1121/1.414883	33	15	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112178	10.1371/journal.pone.0112178	http://dx.doi.org/10.1371/journal.pone.0112178			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390036	Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400060
J	Biagi, E; Candela, M; Centanni, M; Consolandi, C; Rampelli, S; Turroni, S; Severgnini, M; Peano, C; Ghezzo, A; Scurti, M; Salvioli, S; Franceschi, C; Brigidi, P				Biagi, Elena; Candela, Marco; Centanni, Manuela; Consolandi, Clarissa; Rampelli, Simone; Turroni, Silvia; Severgnini, Marco; Peano, Clelia; Ghezzo, Alessandro; Scurti, Maria; Salvioli, Stefano; Franceschi, Claudio; Brigidi, Patrizia			Gut Microbiome in Down Syndrome	PLOS ONE			English	Article							PHYLOGENETIC MICROARRAY; CHILDREN; AUTISM; PERSPECTIVE; BACTERIA	Background: Premature aging seriously compromises the health status of Down Syndrome (DS) persons. Since human aging has been associated with a deterioration of the gut microbiota (GM)-host mutualism, here we investigated the composition of GM in DS. Methods: The observational study presented involved 17 adult DS persons. We characterized the GM structure by 454 pyrosequencing of the V4 region of the 16S rRNA gene. DS microbiome was compared with that of age-matched healthy non-trisomic adults enrolled in the same geographic area. Results and Conclusions: The dominant GM fraction of DS persons showed an overall mutualistic immune-modulatory layout, comparable to that of healthy controls. This makes GM a possible factor counteracting the genetic determined acceleration of immune senescence in DS persons. However, we also found detectable signatures specific for DS among subdominant GM components, such as the increase of Parasporobacterium and Sutterella. In particular, the abundance of this last microorganism significantly correlated with the Aberrant Behavior Checklist (ABC) total score, allowing us to hypothesize a possible role for this microbial genus in behavioral features in DS.	[Biagi, Elena; Candela, Marco; Centanni, Manuela; Rampelli, Simone; Turroni, Silvia; Brigidi, Patrizia] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy; [Consolandi, Clarissa; Severgnini, Marco; Peano, Clelia] Italian Natl Res Council, Inst Biomed Technol, Milan, Italy; [Ghezzo, Alessandro; Scurti, Maria; Salvioli, Stefano; Franceschi, Claudio] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Scurti, Maria; Salvioli, Stefano; Franceschi, Claudio] Univ Bologna, Interdept Ctr L Galvani CIG, Bologna, Italy	University of Bologna; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Bologna; University of Bologna	Candela, M (corresponding author), Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy.	marco.candela@unibo.it	Turroni, Silvia/J-7195-2016; Rampelli, Simone/K-5675-2016; Severgnini, Marco/F-5832-2013; Franceschi, Claudio/L-4484-2017; Peano, Clelia/C-4015-2018; Salvioli, Stefano/K-6663-2016	Turroni, Silvia/0000-0003-2345-9482; Rampelli, Simone/0000-0002-5655-6695; Severgnini, Marco/0000-0001-8655-1206; Franceschi, Claudio/0000-0001-9841-6386; Peano, Clelia/0000-0001-7055-3629; Salvioli, Stefano/0000-0002-6191-1225; Brigidi, Patrizia/0000-0001-8375-6150	European Union's Seventh Framework Programme (FP7) (IDEAL) [259679]; Italian Ministry of Health, Progetto Ricerca Finalizzata	European Union's Seventh Framework Programme (FP7) (IDEAL); Italian Ministry of Health, Progetto Ricerca Finalizzata	The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2011) under grant agreement n. 259679 (IDEAL), and the Italian Ministry of Health, Progetto Ricerca Finalizzata 2008, convenzione 35: ''An integrated approach to identify functional, biochemical and genetic markers for diagnostic and prognostic purposes in the elderly, in the centenarians and in people with dementia, Alzheimer's disease, mild cognitive impairment'' to CF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J. B., 2008, Toxicological and Environmental Chemistry, V90, P739, DOI 10.1080/02772240701699294; AMAN MG, 1985, AM J MENT DEF, V89, P485; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Balboni G., 2003, ADATTAMENTO ITALIANO; Benach JL, 2012, MBIO, V3, DOI 10.1128/mBio.00019-12; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Biagi E, 2013, PHARMACOL RES, V69, P11, DOI 10.1016/j.phrs.2012.10.005; Biagi E, 2011, AGEING RES REV, V10, P428, DOI 10.1016/j.arr.2011.03.004; Biagi E, 2012, AGE, V34, P247, DOI 10.1007/s11357-011-9217-5; Bittles AH, 2004, DEV MED CHILD NEUROL, V46, P282, DOI 10.1017/S0012162204000441; Broers CJM, 2012, J CLIN IMMUNOL, V32, P323, DOI 10.1007/s10875-011-9625-4; Carter JC, 2007, AM J MED GENET B, V144B, P87, DOI 10.1002/ajmg.b.30407; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; COSSARIZZA A, 1991, BLOOD, V77, P1263; COSSARIZZA A, 1990, AM J MED GENET, P213; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Fanning S, 2012, P NATL ACAD SCI USA, V109, P2108, DOI 10.1073/pnas.1115621109; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Fischbach MA, 2011, CELL HOST MICROBE, V10, P336, DOI 10.1016/j.chom.2011.10.002; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; Ji NY, 2011, J INTELL DISABIL RES, V55, P1064, DOI 10.1111/j.1365-2788.2011.01465.x; Kamada N, 2013, NAT IMMUNOL, V14, P685, DOI 10.1038/ni.2608; Kang DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068322; Li C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049130; Lozupone CA, 2013, GENOME RES, V23, P1704, DOI 10.1101/gr.151803.112; Nakamura E, 1998, MECH AGEING DEV, V105, P89, DOI 10.1016/S0047-6374(98)00081-5; Parker SE, 2010, BIRTH DEFECTS RES A, V88, P1008, DOI 10.1002/bdra.20735; Patterson D, 2012, MECH AGEING DEV, V133, P133, DOI 10.1016/j.mad.2011.10.001; Rampelli S, 2013, AGING-US, V5, P902, DOI 10.18632/aging.100623; Roizen NJ, 2003, LANCET, V361, P1281, DOI 10.1016/S0140-6736(03)12987-X; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; Sparrow S. S., 2016, VINELAND ADAPTIVE BE, V3rd; Trotta MBF, 2011, IMMUN AGEING, V8, DOI 10.1186/1742-4933-8-4; Wang L, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-42; Williams BL, 2012, MBIO, V3, DOI 10.1128/mBio.00261-11; Zigman WB, 2013, DEV DISABIL RES REV, V18, P51, DOI 10.1002/ddrr.1128	44	34	35	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112023	10.1371/journal.pone.0112023	http://dx.doi.org/10.1371/journal.pone.0112023			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386941	Green Published, Green Submitted, gold			2022-12-27	WOS:000345250400036
J	Hussain, S; Nasare, V; Kumari, M; Sharma, S; Khan, MA; Das, BC; Bharadwaj, M				Hussain, Showket; Nasare, Vilas; Kumari, Malasha; Sharma, Shashi; Khan, Mohammad Aijaz; Das, Bhudev C.; Bharadwaj, Mausumi			Perception of Human Papillomavirus Infection, Cervical Cancer and HPV Vaccination in North Indian Population	PLOS ONE			English	Article							COLLEGE-STUDENTS; PARENTAL ACCEPTANCE; FEMALE STUDENTS; SOUTHERN WOMEN; RISK-FACTORS; YOUNG-WOMEN; RURAL INDIA; KNOWLEDGE; AWARENESS; ATTITUDES	Background: Human Papillomavirus (HPV) -associated cervical cancer is the second-most common cancer in women worldwide but it is the most frequent gynaecological cancer and cancer associated death in India women. The objective of this study was to assess knowledge about cervical cancer, HPV, HPV vaccine, HPV vaccine acceptance among school and undergraduates students and their parent's perception about acceptance of HPV vaccine in Northern part of India (Delhi and NCR regions). Materials and Methods: A qualitative questionnaire based survey among 2500 urban/rural students aged 12-22 years was conducted. Results: Overall, a low frequency (15%) of HPV and cervical cancer awareness was observed in students and their parents. However, the awareness was much higher in females belonging to urban setup compared to boys with a perception that HPV causes cervical cancer in women only. Additionally, only (13%) participants who were aware of cervical cancer and HPV) were willing to accept HPV vaccination. Apparently, parents of female students were two times more willing to accept HPV vaccination for their ward than male students (p<0.001; OR 95%CI = 2.09 (1.58-2.76). Conclusion: Cervical cancer and HPV awareness among school, undergraduate students and also to their parents was found to be very low in this part of India. The level of awareness and education appears to be insignificant determinants in rural compared to urban setup. Better health education will be needed to maximize public awareness for cervical cancer prevention.	[Hussain, Showket; Nasare, Vilas; Bharadwaj, Mausumi] Inst Cytol & Prevent Oncol ICMR, Div Mol Genet & Biochem, Noida, Uttar Pradesh, India; [Kumari, Malasha] Inst Cytol & Prevent Oncol ICMR, Div Clin Oncol, Noida, Uttar Pradesh, India; [Sharma, Shashi] Inst Cytol & Prevent Oncol ICMR, Div Biostat & Epidemiol, Noida, Uttar Pradesh, India; [Khan, Mohammad Aijaz] Inst Cytol & Prevent Oncol ICMR, Div Behav Oncol, Noida, Uttar Pradesh, India; [Das, Bhudev C.] Inst Cytol & Prevent Oncol ICMR, Div Mol Oncol, Noida, Uttar Pradesh, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cancer Prevention & Research (NICPR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cancer Prevention & Research (NICPR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cancer Prevention & Research (NICPR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cancer Prevention & Research (NICPR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cancer Prevention & Research (NICPR)	Khan, MA (corresponding author), Inst Cytol & Prevent Oncol ICMR, Div Behav Oncol, Noida, Uttar Pradesh, India.	madrkhan@gmail.com; bharadwajm@icmr.org.in		Nasare, Vilas/0000-0002-0016-9610				Abotchie PN, 2009, INT J GYNECOL CANCER, V19, P412, DOI 10.1111/IGC.0b013e3181a1d6de; Bair RM, 2008, J PEDIATR ADOL GYNEC, V21, P329, DOI 10.1016/j.jpag.2008.02.007; Bharadwaj M, 2009, INDIAN J MED RES, V130, P327; Bingham A, 2009, ARCH PEDIAT ADOL MED, V163, P455, DOI 10.1001/archpediatrics.2009.50; Brabin L, 2006, VACCINE, V24, P3087, DOI 10.1016/j.vaccine.2006.01.048; Brewer NT, 2007, PREV MED, V45, P107, DOI 10.1016/j.ypmed.2007.05.013; Brinton L A, 1992, IARC Sci Publ, P3; BRINTON LA, 1989, AM J EPIDEMIOL, V130, P486, DOI 10.1093/oxfordjournals.aje.a115362; Caskey R, 2009, J ADOLESCENT HEALTH, V45, P453, DOI 10.1016/j.jadohealth.2009.04.021; Cates JR, 2012, PERSPECT SEX REPRO H, V44, P39, DOI 10.1363/4403912; Cates JR, 2009, J RURAL HEALTH, V25, P93, DOI 10.1111/j.1748-0361.2009.00204.x; Chelimo C, 2010, SEX HEALTH, V7, P394, DOI 10.1071/SH10005; Conroy K, 2009, J WOMENS HEALTH, V18, P1679, DOI 10.1089/jwh.2008.1329; Constantine NA, 2007, J ADOLESCENT HEALTH, V40, P108, DOI 10.1016/j.jadohealth.2006.10.007; Crosby R, 2007, SEX HEALTH, V4, P71, DOI 10.1071/SH06046; Das BC, 2008, VACCINE, V26, P2669, DOI 10.1016/j.vaccine.2008.03.056; Dell DL, 2000, OBSTET GYNECOL, V96, P653, DOI 10.1016/S0029-7844(00)01009-7; Dempsey AF, 2006, PEDIATRICS, V117, P1486, DOI 10.1542/peds.2005-1381; Di Giuseppe G, 2008, BRIT J CANCER, V99, P225, DOI 10.1038/sj.bjc.6604454; Dinh TA, 2007, J ADOLESCENT HEALTH, V40, P559, DOI 10.1016/j.jadohealth.2007.02.003; Donadiki EM, 2012, HUM VACCIN IMMUNOTHE, V9; DUrso J, 2007, J AM COLL HEALTH, V56, P159, DOI 10.3200/JACH.56.2.159-164; Fazekas KI, 2008, J WOMENS HEALTH, V17, P539, DOI 10.1089/jwh.2007.0489; Gerend MA, 2008, J ADOLESCENT HEALTH, V42, P237, DOI 10.1016/j.jadohealth.2007.08.022; Gerend MA, 2007, SEX TRANSM DIS, V34, P468, DOI 10.1097/01.olq.0000245915.38315.bd; Gottvall M, 2009, EUR J CONTRACEP REPR, V14, P399, DOI 10.3109/13625180903229605; Hilton S, 2011, VACCINE, V29, P4409, DOI 10.1016/j.vaccine.2011.03.101; Holly EA, 1996, ANNU REV PUBL HEALTH, V17, P69; Hoover D R, 2000, Health Care Women Int, V21, P375; Hoque ME, 2013, J CANCER RES THER, V9, P25, DOI 10.4103/0973-1482.110350; Hsu Yu-Yun, 2011, Oncol Nurs Forum, V38, pE297, DOI 10.1188/11.ONF.E297-E304; Hussain S, 2012, J MED VIROL, V84, P298, DOI 10.1002/jmv.22261; Joy T, 2011, ASIAN PAC J CANCER P, V12, P1707; Kahn JA, 2008, OBSTET GYNECOL, V111, P1103, DOI 10.1097/AOG.0b013e31817051fa; Kamzol W, 2013, EUR J OBSTET GYN R B, V166, P196, DOI 10.1016/j.ejogrb.2012.10.019; Kim JJ, 2009, ANN INTERN MED, V151, P538, DOI 10.7326/0003-4819-151-8-200910200-00007; 한유정, 2007, Obstetrics & Gynecology Science, V50, P1090; Klug SJ, 2008, PREV MED, V46, P87, DOI 10.1016/j.ypmed.2007.09.003; Kohaar I, 2007, CELL ONCOL, V29, P249; Kohaar I, 2009, HUM IMMUNOL, V70, P222, DOI 10.1016/j.humimm.2009.01.003; Lambert E C, 2001, J Am Board Fam Pract, V14, P178; Lee PWH, 2007, PREV MED, V45, P130, DOI 10.1016/j.ypmed.2007.07.013; Lenselink CH, 2008, EUR J OBSTET GYN R B, V137, P103, DOI 10.1016/j.ejogrb.2007.02.012; Li J, 2009, VACCINE, V27, P1210, DOI 10.1016/j.vaccine.2008.12.020; Lopez R., 2007, CALIFORNIAN J HLTH P, V5, P12, DOI [10.32398/cjhp.v5i3.1246, DOI 10.32398/CJHP.V5I3.1246]; Marlow LAV, 2007, VACCINE, V25, P1945, DOI 10.1016/j.vaccine.2007.01.059; Mehta Sumita, 2013, Indian J Community Med, V38, P92, DOI 10.4103/0970-0218.112438; Morison LA, 2010, BRIT J HEALTH PSYCH, V15, P151, DOI 10.1348/135910709X437092; Nnodu Obiageli, 2010, Afr J Reprod Health, V14, P95; Ogilvie GS, 2007, CAN MED ASSOC J, V177, P1506, DOI 10.1503/cmaj.071022; Oh JK, 2010, VACCINE, V28, P1854, DOI 10.1016/j.vaccine.2009.11.079; Pandey D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040619; PARAZZINI F, 1989, BRIT J CANCER, V59, P805, DOI 10.1038/bjc.1989.168; Pelucchi C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-378; Pitts MK, 2007, SEX HEALTH, V4, P177, DOI 10.1071/SH07023; Pitts MK, 2010, SEX HEALTH, V7, P299, DOI 10.1071/SH09150; Ralston JD, 2003, J COMMUN HEALTH, V28, P41, DOI 10.1023/A:1021381105325; Saha A, 2010, ASIAN PAC J CANCER P, V11, P1085; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Sehgal A, 2009, INDIAN J MED RES, V130, P234; Singh E, 2012, J GYNECOL ONCOL, V23, P141, DOI 10.3802/jgo.2012.23.3.141; Sperber NR, 2008, CANCER CAUSE CONTROL, V19, P115, DOI 10.1007/s10552-007-9074-9; Tiro JA, 2008, CANCER-AM CANCER SOC, V113, P3013, DOI 10.1002/cncr.23760; Uzunlar O, 2013, VACCINE, V31, P2191, DOI 10.1016/j.vaccine.2013.01.033; Vogtmann E, 2011, HEALTH SOC CARE COMM, V19, P148, DOI 10.1111/j.1365-2524.2010.00954.x; Walsh CD, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-368; Wheeler CM, 2007, NAT CLIN PRACT ONCOL, V4, P224, DOI 10.1038/ncponc0770; Wong LP, 2009, SINGAP MED J, V50, P49; Woodhall SC, 2007, J ADOLESCENT HEALTH, V40, P466, DOI 10.1016/j.jadohealth.2007.01.005; Zimet GD, 2006, VACCINE, V24, P201, DOI 10.1016/j.vaccine.2006.06.017	70	33	34	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112861	10.1371/journal.pone.0112861	http://dx.doi.org/10.1371/journal.pone.0112861			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT9MC	25386964	gold, Green Published, Green Submitted			2022-12-27	WOS:000345250400097
J	Li, YX; Zhang, GP; Galvin, JJ; Fu, QJ				Li, Yongxin; Zhang, Guoping; Galvin, John J., III; Fu, Qian-Jie			Mandarin Speech Perception in Combined Electric and Acoustic Stimulation	PLOS ONE			English	Article							COCHLEAR IMPLANT USERS; USE HEARING-AIDS; FUNDAMENTAL-FREQUENCY; BIMODAL HEARING; TONE RECOGNITION; OPPOSITE EARS; CHILDREN; BENEFITS; INFORMATION; CONJUNCTION	For deaf individuals with residual low-frequency acoustic hearing, combined use of a cochlear implant (CI) and hearing aid (HA) typically provides better speech understanding than with either device alone. Because of coarse spectral resolution, CIs do not provide fundamental frequency (F0) information that contributes to understanding of tonal languages such as Mandarin Chinese. The HA can provide good representation of F0 and, depending on the range of aided acoustic hearing, first and second formant (F1 and F2) information. In this study, Mandarin tone, vowel, and consonant recognition in quiet and noise was measured in 12 adult Mandarin-speaking bimodal listeners with the CI-only and with the CI+HA. Tone recognition was significantly better with the CI+HA in noise, but not in quiet. Vowel recognition was significantly better with the CI+HA in quiet, but not in noise. There was no significant difference in consonant recognition between the CI-only and the CI+HA in quiet or in noise. There was a wide range in bimodal benefit, with improvements often greater than 20 percentage points in some tests and conditions. The bimodal benefit was compared to CI subjects' HA-aided pure-tone average (PTA) thresholds between 250 and 2000 Hz; subjects were divided into two groups: "better'' PTA (<50 dB HL) or "poorer'' PTA (>50 dB HL). The bimodal benefit differed significantly between groups only for consonant recognition. The bimodal benefit for tone recognition in quiet was significantly correlated with CI experience, suggesting that bimodal CI users learn to better combine low-frequency spectro-temporal information from acoustic hearing with temporal envelope information from electric hearing. Given the small number of subjects in this study (n = 12), further research with Chinese bimodal listeners may provide more information regarding the contribution of acoustic and electric hearing to tonal language perception.	[Li, Yongxin; Zhang, Guoping] Capital Med Univ, Beijing TongRen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing 100730, Peoples R China; [Galvin, John J., III; Fu, Qian-Jie] Univ Calif Los Angeles, David Geffen Sch Med, Dept Head & Neck Surg, Los Angeles, CA 90095 USA	Capital Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Fu, QJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Head & Neck Surg, Los Angeles, CA 90095 USA.	qfu@mednet.ucla.edu			National Institute of Health [R01-DC004792, R01-DC004993]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004993, R01DC004792] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	QF and JG were supported by the National Institute of Health, grants R01-DC004792 and R01-DC004993. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown CA, 2009, EAR HEARING, V30, P489, DOI 10.1097/AUD.0b013e3181ab2b87; Chen ZN, 2009, ORL-J OTO-RHIN-LARYN, V71, P187, DOI 10.1159/000229296; Ching TYC, 2004, EAR HEARING, V25, P9, DOI 10.1097/01.AUD.0000111261.84611.C8; Dillon MT, 2014, J AM ACAD AUDIOL, V25, P133, DOI 10.3766/jaaa.25.2.2; Dorman MF, 2008, AUDIOL NEURO-OTOL, V13, P105, DOI 10.1159/000111782; Fu Q-J, 2000, ASIA PAC J SPEECH LA, V5, P45, DOI DOI 10.1179/136132800807547582; Fu QJ, 1998, J ACOUST SOC AM, V104, P505, DOI 10.1121/1.423251; Fu QJ, 2004, EAR HEARING, V25, P501, DOI 10.1097/01.aud.0000145125.50433.19; Geurts L, 2004, J ACOUST SOC AM, V115, P844, DOI 10.1121/1.1642623; Geurts L, 2001, J ACOUST SOC AM, V109, P713, DOI 10.1121/1.1340650; Gifford RH, 2007, J SPEECH LANG HEAR R, V50, P835, DOI 10.1044/1092-4388(2007/058); Green T, 2005, J ACOUST SOC AM, V118, P375, DOI 10.1121/1.1925827; Gstoettner W, 2004, ACTA OTO-LARYNGOL, V124, P348, DOI 10.1080/00016480410016432; Hamzavi J, 2004, INT J AUDIOL, V43, P61, DOI 10.1080/14992020400050010; Huang T S, 1995, Ann Otol Rhinol Laryngol Suppl, V166, P294; Jang JH, 2014, OTOL NEUROTOL; Kiefer J, 2005, AUDIOL NEURO-OTOL, V10, P134, DOI 10.1159/000084023; Kong YY, 2011, J SPEECH LANG HEAR R, V54, P959, DOI 10.1044/1092-4388(2010/10-0197); Kong YY, 2005, J ACOUST SOC AM, V117, P1351, DOI 10.1121/1.1857526; Lee KYS, 2002, INT J PEDIATR OTORHI, V63, P137, DOI 10.1016/S0165-5876(02)00005-8; Li B, 2014, INT J PEDIATR OTORHI, V78, P1000, DOI 10.1016/j.ijporl.2014.03.020; Lin M., 1988, J CHINESE LINGUIST, V204, P182; Luo X, 2008, EAR HEARING, V29, P957, DOI 10.1097/AUD.0b013e3181888f61; Luo X, 2006, J ACOUST SOC AM, V120, P2260, DOI 10.1121/1.2336990; Luo X, 2009, HEARING RES, V256, P75, DOI 10.1016/j.heares.2009.07.001; Mok M, 2006, J SPEECH LANG HEAR R, V49, P338, DOI 10.1044/1092-4388(2006/027); Morera C, 2012, ACTA OTO-LARYNGOL, V132, P1084, DOI 10.3109/00016489.2012.677546; Neuman AC, 2013, EAR HEARING, V34, P553, DOI 10.1097/AUD.0b013e31828e86e8; Shannon RV, 2004, ACTA OTO-LARYNGOL, V124, P50, DOI 10.1080/03655230410017562; Sheffield BM, 2012, J ACOUST SOC AM, V131, P518, DOI 10.1121/1.3662074; Sheffield SW, 2014, AUDIOL NEURO-OTOL, V19, P151, DOI 10.1159/000357588; Tao D, 2014, EAR HEAR; Turner CW, 2004, J ACOUST SOC AM, V115, P1729, DOI 10.1121/1.1687425; Wang RH, 1993, STANDARD CHINESE DAT; Wang WQ, 2011, INT J AUDIOL, V50, P270, DOI 10.3109/14992027.2010.542490; Wei WI, 2000, ACTA OTO-LARYNGOL, V120, P218; WHALEN DH, 1992, PHONETICA, V49, P25, DOI 10.1159/000261901; Wu JL, 2006, INT J PEDIATR OTORHI, V70, P207, DOI 10.1016/j.ijporl.2005.06.013; Wu JL, 2003, INT J PEDIATR OTORHI, V67, P247, DOI 10.1016/S0165-5876(02)00378-6; Xin L, 2004, J ACOUST SOC AM, V116, P3659, DOI 10.1121/1.1783352; Yoon YS, 2012, J SPEECH LANG HEAR R, V55, P105, DOI 10.1044/1092-4388(2011/10-0325); Zhang T, 2013, EAR HEARING, V34, P133, DOI 10.1097/AUD.0b013e31826709af; Zhang T, 2012, EAR HEARING, V33, pE70, DOI 10.1097/AUD.0b013e318259e5dd; Zhang T, 2010, EAR HEARING, V31, P63, DOI 10.1097/AUD.0b013e3181b7190c; Zhou N, 2013, OTOL NEUROTOL, V34, P499, DOI 10.1097/MAO.0b013e318287ca86	45	9	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112471	10.1371/journal.pone.0112471	http://dx.doi.org/10.1371/journal.pone.0112471			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386962	Green Published, Green Submitted, gold			2022-12-27	WOS:000345250400064
J	Choi, MS; Lee, HY; Cho, CS				Choi, Myoung Su; Lee, Ho Yun; Cho, Chin Saeng			Optimal Dosage of Methylprednisolone for the Treatment of Sudden Hearing Loss in Geriatric Patients: A Propensity Score-Matched Analysis	PLOS ONE			English	Article							PULSE THERAPY; RECOVERY; EFFICACY	We aimed to compare the treatment outcomes and the occurrence rates of adverse events associated with different steroid regimens in geriatric patients (aged 65 years or older) with unilateral idiopathic sudden sensorineural hearing loss (ISSNHL). After thorough medical chart reviews of 109 patients with ISSNHL between May 2006 and December 2013, we performed a propensity score-matched analysis using previously known prognostic factors, steroid regimens, and other cointerventions. Patients were divided based on their steroid regimens into group I (which initially received 48 mg of methylprednisolone daily with a subsequently tapered dose) and group II (which initially received 24 mg of methylprednisolone daily with a subsequently tapered dose). We compared final hearing and the occurrence of adverse events between the two groups. As a result, 20 pairs of propensity score-matched patients (n = 40) were enrolled. Group I patients showed better final hearing levels compared with group II patients (42.00 +/- 22.35 dB and 57.38 +/- 26.40 dB, respectively), although this difference was marginally significant (p = 0.058). Based on the comparative analysis of each of the frequencies in the final audiograms, lower hearing thresholds at 2 KHz were observed in group I (p = 0.049). There was no significant difference in the occurrence of adverse effects between the two groups (p > 0.05). In conclusion, conventional steroid regimens produced adverse event occurrence rates that were similar to those of low-dose treatment but may also have produced superior hearing recovery. The use of steroid dose reduction in geriatric patients with ISSNHL is not preferable to conventional steroid regimens.	[Choi, Myoung Su; Lee, Ho Yun; Cho, Chin Saeng] Eulji Univ, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Dept Otorhinolaryngol,Sch Med, Taejon, South Korea	Eulji University	Lee, HY (corresponding author), Eulji Univ, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Dept Otorhinolaryngol,Sch Med, Taejon, South Korea.	hoyun1004@gmail.com			EMBRI Grants from Eulji University [2013 EMBRI-DJ-0005]	EMBRI Grants from Eulji University	This research was supported by EMBRI Grants 2013 EMBRI-DJ-0005 from Eulji University. The funders had no role in study design, data collection and analysis, decision to publish, and had a role in the preparation of the manuscript.	AGARWAL L, 2009, COCHRANE DB SYST REV, V7; Austin PC, 2011, INT J BIOSTAT, V7, DOI 10.2202/1557-4679.1285; Awad Z, 2012, COCHRANE DB SYST REV, V15; Bennett MH, 2012, COCHRANE DB SYST REV, V17; BOLLA R, 1980, MECH AGEING DEV, V12, P249, DOI 10.1016/0047-6374(80)90048-2; Caughey GE, 2013, DIABETES CARE, V36, P3009, DOI 10.2337/dc12-2197; Coelho DH, 2011, OTOLARYNG HEAD NECK, V145, P813, DOI 10.1177/0194599811412721; Cvorovic L, 2008, OTOL NEUROTOL, V29, P464, DOI 10.1097/MAO.0b013e31816fdcb4; Free RH, 2009, OTOL NEUROTOL, V30, P691, DOI 10.1097/MAO.0b013e3181ab3380; Hikita-Watanabe N, 2010, ACTA OTO-LARYNGOL, V130, P79, DOI 10.3109/00016480902897715; Kang HS, 2013, EUR ARCH OTO-RHINO-L, V270, P2631, DOI 10.1007/s00405-012-2294-y; KANZAKI J, 1988, ACTA OTO-LARYNGOL, P31; Kaya H, 2015, EUR ARCH OTO-RHINO-L, V272, P1119, DOI 10.1007/s00405-014-2922-9; Kim MG, 2011, AM J OTOLARYNG, V32, P91, DOI 10.1016/j.amjoto.2009.10.004; Kirkman MS, 2012, DIABETES CARE, V35, P2650, DOI 10.2337/dc12-1801; Lionakis N, 2012, WORLD J CARDIOL, V4, P135, DOI 10.4330/wjc.v4.i5.135; Ogino-Nishimura E, 2013, CASE REP OTOLARYNGOL, V2013, DOI 10.1155/2013/734131; Rauch SD, 2008, NEW ENGL J MED, V359, P833, DOI 10.1056/NEJMcp0802129; Rauch SD, 2011, JAMA-J AM MED ASSOC, V305, P2071, DOI 10.1001/jama.2011.679; Schmucker DL, 2001, DRUG AGING, V18, P837, DOI 10.2165/00002512-200118110-00005; Schreiber BE, 2010, LANCET, V375, P1203, DOI 10.1016/S0140-6736(09)62071-7; Stachler RJ, 2012, OTOLARYNG HEAD NECK, V146, pS1, DOI 10.1177/0194599812436449; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Suzuki H, 2012, LARYNGOSCOPE, V122, P1154, DOI 10.1002/lary.23245; Wei BPC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003998.pub3; Westerlaken BO, 2007, LARYNGOSCOPE, V117, P684, DOI 10.1097/mlg.0b013e3180316d3b; Xenellis J, 2006, J LARYNGOL OTOL, V120, P718, DOI 10.1017/S0022215106002362; Yang CH, 2011, LARYNGOSCOPE, V121, P617, DOI 10.1002/lary.21291	28	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e111479	10.1371/journal.pone.0111479	http://dx.doi.org/10.1371/journal.pone.0111479			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383617	Green Published, Green Submitted, gold			2022-12-27	WOS:000344816700016
J	Rajasundaram, D; Runavot, JL; Guo, XY; Willats, WGT; Meulewaeter, F; Selbig, J				Rajasundaram, Dhivyaa; Runavot, Jean-Luc; Guo, Xiaoyuan; Willats, William G. T.; Meulewaeter, Frank; Selbig, Joachim			Understanding the Relationship between Cotton Fiber Properties and Non-Cellulosic Cell Wall Polysaccharides	PLOS ONE			English	Article							PARTIAL LEAST-SQUARES; CARBOHYDRATE MICROARRAYS; MONOCLONAL-ANTIBODIES; ARABINOGALACTAN-PROTEIN; GENE-EXPRESSION; ELONGATION; PECTIN; BIOINFORMATICS; BINDING; ARRAY	A detailed knowledge of cell wall heterogeneity and complexity is crucial for understanding plant growth and development. One key challenge is to establish links between polysaccharide-rich cell walls and their phenotypic characteristics. It is of particular interest for some plant material, like cotton fibers, which are of both biological and industrial importance. To this end, we attempted to study cotton fiber characteristics together with glycan arrays using regression based approaches. Taking advantage of the comprehensive microarray polymer profiling technique (CoMPP), 32 cotton lines from different cotton species were studied. The glycan array was generated by sequential extraction of cell wall polysaccharides from mature cotton fibers and screening samples against eleven extensively characterized cell wall probes. Also, phenotypic characteristics of cotton fibers such as length, strength, elongation and micronaire were measured. The relationship between the two datasets was established in an integrative manner using linear regression methods. In the conducted analysis, we demonstrated the usefulness of regression based approaches in establishing a relationship between glycan measurements and phenotypic traits. In addition, the analysis also identified specific polysaccharides which may play a major role during fiber development for the final fiber characteristics. Three different regression methods identified a negative correlation between micronaire and the xyloglucan and homogalacturonan probes. Moreover, homogalacturonan and callose were shown to be significant predictors for fiber length. The role of these polysaccharides was already pointed out in previous cell wall elongation studies. Additional relationships were predicted for fiber strength and elongation which will need further experimental validation.	[Rajasundaram, Dhivyaa; Selbig, Joachim] Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany; [Rajasundaram, Dhivyaa; Selbig, Joachim] Max Planck Inst Mol Plant Physiol, D-14476 Potsdam, Germany; [Runavot, Jean-Luc; Meulewaeter, Frank] Bayer CropSci NV, Innovat Ctr, B-9052 Ghent, Belgium; [Guo, Xiaoyuan; Willats, William G. T.] Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, DK-1871 Frederiksberg C, Denmark	University of Potsdam; Max Planck Society; Bayer AG; Bayer CropScience; University of Copenhagen	Selbig, J (corresponding author), Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany.	jselbig@uni-potsdam.de	; Runavot, Jean-Luc/F-6930-2012	Meulewaeter, Frank/0000-0002-3589-6471; Runavot, Jean-Luc/0000-0001-5451-2616	European Union Seventh Framework Programme (FP7) under the WallTraC project [263916]	European Union Seventh Framework Programme (FP7) under the WallTraC project	This work was supported by the European Union Seventh Framework Programme (FP7 2007-2013) under the WallTraC project (grant agreement No. 263916). This paper reflects the authors' views only. The European Community is not liable for any use that may be made of the information contained herein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ghazi Y, 2009, PLANT CELL PHYSIOL, V50, P1364, DOI 10.1093/pcp/pcp084; Aoki-Kinoshita KF, 2006, CURR OPIN MOL THER, V8, P514; Avci U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056315; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Boulesteix AL, 2007, BRIEF BIOINFORM, V8, P32, DOI 10.1093/bib/bb1016; Bowling AJ, 2011, PROTOPLASMA, V248, P579, DOI 10.1007/s00709-010-0212-y; Bowman MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082634; Bryan MC, 2004, TETRAHEDRON LETT, V45, P3639, DOI 10.1016/j.tetlet.2004.03.035; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Chapple C, 1998, CURR OPIN PLANT BIOL, V1, P179, DOI 10.1016/S1369-5266(98)80022-8; Chun H, 2010, J R STAT SOC B, V72, P3, DOI 10.1111/j.1467-9868.2009.00723.x; de Paz JL, 2006, J AM CHEM SOC, V128, P2766, DOI 10.1021/ja057584v; Dejean S., 2013, MIXOMICS OMICS DATA; Disney MD, 2007, BIOCHEMISTRY-US, V46, P11223, DOI 10.1021/bi701071h; Ekins R, 1999, TRENDS BIOTECHNOL, V17, P217, DOI 10.1016/S0167-7799(99)01329-3; Ellis M, 2010, PLANT PHYSIOL, V153, P403, DOI 10.1104/pp.110.156000; Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810; Gilbert MK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-403; Goldberg R, 1996, PROGR BIOTECHNOL, V14, P151, DOI 10.1016/S0921-0423(96)80253-X; Gonzalez I, 2009, J BIOL SYST, V17, P173, DOI 10.1142/S0218339009002831; Gonzalez I, 2012, BIODATA MIN, V5, DOI 10.1186/1756-0381-5-19; Gou JY, 2007, CELL RES, V17, P422, DOI 10.1038/sj.cr.7310150; Gupta G, 2010, OMICS, V14, P419, DOI 10.1089/omi.2009.0150; Haigler CH, 2012, FRONT PLANT SCI, P3; Hair J., 2010, MULTIVARIATE DATA AN, V7; Hanson SR, 2007, J AM CHEM SOC, V129, P7266, DOI 10.1021/ja0724083; Hao ZY, 2014, CRIT REV BIOCHEM MOL, V49, P212, DOI 10.3109/10409238.2014.889651; HEREDIA A, 1995, Z LEBENSM UNTERS FOR, V200, P24, DOI 10.1007/BF01192903; Hsu TL, 2007, P NATL ACAD SCI USA, V104, P2614, DOI 10.1073/pnas.0611307104; Huang CY, 2006, P NATL ACAD SCI USA, V103, P15, DOI 10.1073/pnas.0509693102; Huang GQ, 2013, PLANT PHYSIOL, V161, P1278, DOI 10.1104/pp.112.203760; Keegstra K, 2010, PLANT PHYSIOL, V154, P483, DOI 10.1104/pp.110.161240; Lacape JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048855; Lawrie CH, 2006, INT J CANCER, V118, P3161, DOI 10.1002/ijc.21762; Le Cao KA, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-34; Le Cao KA, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1390; Liang PH, 2007, J AM CHEM SOC, V129, P11177, DOI 10.1021/ja072931h; LUTZ JG, 1994, EDUC PSYCHOL MEAS, V54, P666, DOI 10.1177/0013164494054003009; Marchal I, 2003, BIOCHIMIE, V85, P75, DOI 10.1016/S0300-9084(03)00068-3; Marcus SE, 2010, PLANT J, V64, P191, DOI 10.1111/j.1365-313X.2010.04319.x; Marcus SE, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-60; McCann M, 2010, PLANT PHYSIOL, V153, P365, DOI 10.1104/pp.110.900324; McCartney L, 2005, J HISTOCHEM CYTOCHEM, V53, P543, DOI 10.1369/jhc.4B6578.2005; MEIKLE PJ, 1991, PLANTA, V185, P1, DOI 10.1007/BF00194507; Minorsky Peter V., 2002, Plant Physiology (Rockville), V128, P345, DOI 10.1104/pp.900022; Moller I, 2008, GLYCOCONJUGATE J, V25, P37, DOI 10.1007/s10719-007-9059-7; Morris GA, 2010, BIOTECHNOL GENET ENG, V27, P257, DOI 10.1080/02648725.2010.10648153; Mutwil M, 2008, CURR OPIN PLANT BIOL, V11, P252, DOI 10.1016/j.pbi.2008.03.007; Park S, 2008, CHEM COMMUN, P4389, DOI 10.1039/b806699j; Pedersen HL, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.396598; Pettolino FA, 2001, PLANTA, V214, P235, DOI 10.1007/s004250100606; Pilling E, 2003, CURR OPIN PLANT BIOL, V6, P611, DOI 10.1016/j.pbi.2003.09.004; Qin LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059115; R Core Team, 2013, LANG ENV STAT COMP; Rambani A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-3; Ratner DM, 2007, CURR PHARM DESIGN, V13, P173, DOI 10.2174/138161207779313650; Rencher A.C., 2003, METHODS MULTIVARIATE, P361, DOI [DOI 10.1002/0471271357.CH11, 10.1002/0471271357.ch11]; Roberts K, 2001, PLANT PHYSIOL, V125, P127, DOI 10.1104/pp.125.1.127; Ruan YL, 2004, PLANT PHYSIOL, V136, P4104, DOI 10.1104/pp.104.051540; SADAVA D, 1973, DEV BIOL, V30, P49, DOI 10.1016/0012-1606(73)90047-X; Salnikov VV, 2003, PROTOPLASMA, V221, P175, DOI 10.1007/s00709-002-0079-7; Schena M, 1996, BIOESSAYS, V18, P427, DOI 10.1002/bies.950180513; Schneider A, 2010, DTSCH ARZTEBL INT, V107, P776, DOI [10.3238/arztebl.2010.0799, 10.3238/arztebl.2010.0776]; Shin I, 2005, CHEM-EUR J, V11, P2894, DOI 10.1002/chem.200401030; Singh B, 2009, PLANT PHYSIOL, V150, P684, DOI 10.1104/pp.109.135459; SMALLWOOD M, 1994, PLANT J, V5, P237, DOI 10.1046/j.1365-313X.1994.05020237.x; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Sticklen MB, 2008, NAT REV GENET, V9, P433, DOI 10.1038/nrg2336; Tabachnick B. G.., 2012, USING MULTIVARIATE S; Tenenhaus A, 2014, BIOSTATISTICS, V15, P569, DOI 10.1093/biostatistics/kxu001; Thakur BR, 1997, CRIT REV FOOD SCI, V37, P47, DOI 10.1080/10408399709527767; Thompson B., 1984, CANONICAL CORRELATIO; Tokumoto H, 2002, PLANT CELL PHYSIOL, V43, P411, DOI 10.1093/pcp/pcf048; Uchiyama N, 2006, METHOD ENZYMOL, V415, P341, DOI 10.1016/S0076-6879(06)15021-1; Vaughn KC, 1999, PROTOPLASMA, V209, P226, DOI 10.1007/BF01453451; Verhertbruggen Y, 2009, CARBOHYD RES, V344, P1858, DOI 10.1016/j.carres.2008.11.010; von der Lieth CW, 2004, BRIEF BIOINFORM, V5, P164, DOI 10.1093/bib/5.2.164; Wang DN, 2003, PROTEOMICS, V3, P2167, DOI 10.1002/pmic.200300601; Wang HH, 2010, PLANT MOL BIOL, V72, P397, DOI 10.1007/s11103-009-9578-7; Wang LX, 2004, CHEM BIOL, V11, P127, DOI 10.1016/j.chembiol.2003.12.020; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; Wang RB, 2005, METH MOL B, V310, P241; Wendel Jonathan F., 2009, V3, P3, DOI 10.1007/978-0-387-70810-2_1; Willats WGT, 2000, CARBOHYD RES, V327, P309, DOI 10.1016/S0008-6215(00)00039-2; Witten DM, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1470; Yates EA, 1996, GLYCOBIOLOGY, V6, P131, DOI 10.1093/glycob/6.2.131	87	10	11	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112168	10.1371/journal.pone.0112168	http://dx.doi.org/10.1371/journal.pone.0112168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383868	Green Published, Green Submitted, gold			2022-12-27	WOS:000344816700037
J	Van Campenhout, J; Derycke, S; Moens, T; Vanreusel, A				Van Campenhout, Jelle; Derycke, Sofie; Moens, Tom; Vanreusel, Ann			Differences in Life-Histories Refute Ecological Equivalence of Cryptic Species and Provide Clues to the Origin of Bathyal Halomonhystera (Nematoda)	PLOS ONE			English	Article							FREE-LIVING MARINE; BRACKISH-WATER NEMATODES; MOSBY-MUD-VOLCANO; MONHYSTERA-DISJUNCTA; GENETIC-STRUCTURE; TEMPERATURE; COEXISTENCE; SALINITY; NICHE; SPECIATION	The discovery of morphologically very similar but genetically distinct species complicates a proper understanding of the link between biodiversity and ecosystem functioning. Cryptic species have been frequently observed to co-occur and are thus expected to be ecological equivalent. The marine nematode Halomonhystera disjuncta contains five cryptic species (GD1-5) that co-occur in the Westerschelde estuary. In this study, we investigated the effect of three abiotic factors (salinity, temperature and sulphide) on life-history traits of three cryptic H. disjuncta species (GD1-3). Our results show that temperature had the most profound influence on all life-cycle parameters compared to a smaller effect of salinity. Life-history traits of closely related cryptic species were differentially affected by temperature, salinity and presence of sulphides which shows that cryptic H. disjuncta species are not ecologically equivalent. Our results further revealed that GD1 had the highest tolerance to a combination of sulphides, high salinities and low temperatures. The close phylogenetic position of GD1 to Halomonhystera hermesi, the dominant species in sulphidic sediments of the Hakon Mosby mud volcano (Barent Sea, 1280 m depth), indicates that both species share a recent common ancestor. Differential life-history responses to environmental changes among cryptic species may have crucial consequences for our perception on ecosystem functioning and coexistence of cryptic species.	[Van Campenhout, Jelle; Derycke, Sofie; Moens, Tom; Vanreusel, Ann] Univ Ghent, Dept Biol, Res Grp Marine Biol, B-9000 Ghent, Belgium; [Van Campenhout, Jelle; Derycke, Sofie; Moens, Tom] Univ Ghent, Ctr Mol Phylogenet & Evolut CeMoFe, B-9000 Ghent, Belgium	Ghent University; Ghent University	Van Campenhout, J (corresponding author), Univ Ghent, Dept Biol, Res Grp Marine Biol, B-9000 Ghent, Belgium.	Jelle.Vancampenhout@ugent.be	Moens, Tom/AAB-8701-2019		GOA funds from Ghent University; 7th FP MIDAS [603418]	GOA funds from Ghent University; 7th FP MIDAS	This work was supported by GOA funds from Ghent University and by the 7th FP MIDAS (Grant agreement No. 603418). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2003, INT J PLANT SCI, V164, pS1, DOI 10.1086/374729; Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Anderson M. J., 2008, PLYMOUTH; [Anonymous], 2004, PERMDISP FORTRAN COM; Bernardino AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033515; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Bik HM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-389; Boffe A, 1985, VERGELIJKEND TOXICOL, P70; Bottcher ME, 2000, CONT SHELF RES, V20, P1749, DOI 10.1016/S0278-4343(00)00046-7; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Cothran RD, 2013, OIKOS, V122, P1429, DOI 10.1111/j.1600-0706.2013.00294.x; Cunning R, 2013, CORAL REEFS, V32, P795, DOI 10.1007/s00338-013-1036-y; De Meester N, 2011, MAR BIOL, V158, P2717, DOI 10.1007/s00227-011-1769-5; De Meester N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042674; De Oliveira DAS, 2012, ZOOL J LINN SOC-LOND, V164, P18, DOI 10.1111/j.1096-3642.2011.00758.x; Derycke S, 2008, MOL ECOL, V17, P3306, DOI 10.1111/j.1365-294X.2008.03846.x; Derycke S, 2007, LIMNOL OCEANOGR, V52, P992, DOI 10.4319/lo.2007.52.3.0992; Derycke S, 2007, MAR BIOL, V151, P1799, DOI 10.1007/s00227-007-0609-0; Derycke S, 2005, MAR ECOL PROG SER, V300, P91, DOI 10.3354/meps300091; FERRIS H, 1995, SOIL BIOL BIOCHEM, V27, P319, DOI 10.1016/0038-0717(94)00186-5; Fonseca G, 2008, BIOL J LINN SOC, V94, P737, DOI 10.1111/j.1095-8312.2008.01015.x; Gabaldon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057087; GERLACH SA, 1971, MAR BIOL, V9, P274, DOI 10.1007/BF00351390; Gomez A, 2002, EVOLUTION, V56, P1431; Harvey P.H., 1991, COMP METHOD EVOLUTIO; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; Hubbell SP, 2006, ECOLOGY, V87, P1387, DOI 10.1890/0012-9658(2006)87[1387:NTATEO]2.0.CO;2; Jelle V, 2014, J ZOOL SYST EVOL RES, V52, P203, DOI 10.1111/jzs.12054; Knowlton N, 2000, HYDROBIOLOGIA, V420, P73, DOI 10.1023/A:1003933603879; Lambshead PJD, 2003, J BIOGEOGR, V30, P475, DOI 10.1046/j.1365-2699.2003.00843.x; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; Levin LA, 2005, OCEANOGR MAR BIOL, V43, P1, DOI 10.1201/9781420037449.ch1; Levins R., 1968, EVOLUTION CHANGING E; LEVINTON JS, 1970, LETHAIA, V3, P69, DOI 10.1111/j.1502-3931.1970.tb01264.x; Lonsdale DJ, 1998, J MARINE SYST, V15, P1, DOI 10.1016/S0924-7963(97)00044-4; Lowe CD, 2007, MAR BIOL, V150, P377, DOI 10.1007/s00227-006-0366-5; Moens T, 2000, J EXP MAR BIOL ECOL, V243, P137, DOI 10.1016/S0022-0981(99)00114-8; Moens T, 1998, HELGOLANDER MEERESUN, V52, P115, DOI 10.1007/BF02908742; Moens T, 2000, J EXP MAR BIOL ECOL, V243, P115, DOI 10.1016/S0022-0981(99)00113-6; Moens T, 1999, FEEDING ECOLOGY FREE; Mokievsky VO, 2005, OCEANOLOGY+, V45, P689; Montero-Pau J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021530; Montero-Pau J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020314; Nicholls B, 2006, ECOGRAPHY, V29, P697, DOI 10.1111/j.2006.0906-7590.04575.x; Ortells R, 2003, FRESHWATER BIOL, V48, P2194, DOI 10.1046/j.1365-2427.2003.01159.x; Ott J, 2004, SYMBIOSIS, V36, P103; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Portnova D, 2010, 14 INT MEIOF C FOURT, P174; Sauter EJ, 2006, EARTH PLANET SC LETT, V243, P354, DOI 10.1016/j.epsl.2006.01.041; Schmidt AL, 2012, LIMNOL OCEANOGR, V57, P1389, DOI 10.4319/lo.2012.57.5.1389; Smith KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051219; STANHOPE MJ, 1992, J CHEM ECOL, V18, P1871, DOI 10.1007/BF02751110; Tahseen Qudsia, 2012, Biodiversity Journal, V3, P13; Tchesunov AV, 2015, HELGOLAND MAR RES, V69, P57, DOI 10.1007/s10152-014-0416-1; Thiermann F, 2000, MAR ECOL PROG SER, V193, P251, DOI 10.3354/meps193251; TROTTER D, 1983, MAR BIOL, V78, P39, DOI 10.1007/BF00392969; Van Gaever S, 2006, MAR ECOL PROG SER, V321, P143, DOI 10.3354/meps321143; Van Gaever S, 2009, MAR BIOL, V156, P1289, DOI 10.1007/s00227-009-1170-9; VRANKEN G, 1988, MAR ENVIRON RES, V26, P161, DOI 10.1016/0141-1136(88)90025-6; VRANKEN G, 1989, MAR ENVIRON RES, V27, P127, DOI 10.1016/0141-1136(89)90004-4; Vranken G., 1984, Ecotoxiciological testing for the marine environmental. Volume 2., P271; Vranken G., 1987, Mededelingen van de Koninklijke Academie voor Wetenschappen Letteren en Schone Kunsten van Belgie Klasse der Wetenschappen, V49, P73; VRANKEN G, 1988, OECOLOGIA, V77, P296, DOI 10.1007/BF00378033; VRANKEN G, 1985, DIS AQUAT ORGAN, V1, P49, DOI 10.3354/dao001049; Wellborn GA, 2007, OECOLOGIA, V154, P175, DOI 10.1007/s00442-007-0816-x; Westram AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069576; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x; Zhang DY, 1998, J THEOR BIOL, V193, P465, DOI 10.1006/jtbi.1998.0712; Zhao YL, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/564093	71	24	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e111889	10.1371/journal.pone.0111889	http://dx.doi.org/10.1371/journal.pone.0111889			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384013	Green Submitted, Green Published, gold			2022-12-27	WOS:000344816700022
J	Zipkin, AM; Wagner, M; McGrath, K; Brooks, AS; Lucas, PW				Zipkin, Andrew M.; Wagner, Mark; McGrath, Kate; Brooks, Alison S.; Lucas, Peter W.			An Experimental Study of Hafting Adhesives and the Implications for Compound Tool Technology	PLOS ONE			English	Article							MIDDLE STONE-AGE; RESIDUE ANALYSIS; HOWIESONS POORT; COMPLEX COGNITION; OCHRE; CAVE; IDENTIFICATION; AFRICA	Experimental studies of hafting adhesives and modifications to compound tool components can demonstrate the extent to which human ancestors understood and exploited material properties only formally defined by science within the last century. Discoveries of Stone Age hafting adhesives at archaeological sites in Europe, the Middle East, and Africa have spurred experiments that sought to replicate or create models of such adhesives. Most of these studies, however, have been actualistic in design, focusing on replicating ancient applications of adhesive technology. In contrast, this study tested several glues based on Acacia resin within a materials science framework to better understand the effect of each adhesive ingredient on compound tool durability. Using an overlap joint as a model for a compound tool, adhesives formulated with loading agents from a range of particle sizes and mineral compositions were tested for toughness on smooth and rough substrates. Our results indicated that overlap joint toughness is significantly increased by using a roughened joint surface. Contrary to some previous studies, there was no evidence that particle size diversity in a loading agent improved adhesive effectiveness. Generally, glues containing quartz or ochre loading agents in the silt and clay-sized particle class yielded the toughest overlap joints, with the effect of particle size found to be more significant for rough rather than smooth substrate joints. Additionally, no particular ochre mineral or mineral mixture was found to be a clearly superior loading agent. These two points taken together suggest that Paleolithic use of ochre-loaded adhesives and the criteria used to select ochres for this purpose may have been mediated by visual and symbolic considerations rather than purely functional concerns.	[Zipkin, Andrew M.; McGrath, Kate; Brooks, Alison S.; Lucas, Peter W.] George Washington Univ, Ctr Adv Study Hominid Paleobiol, Dept Anthropol, Washington, DC 20052 USA; [Wagner, Mark] George Washington Univ, Dept Mech & Aerosp Engn, Washington, DC USA; [Brooks, Alison S.] US Natl Museum Nat Hist, Smithsonian Inst, Human Origins Program, Washington, DC USA; [Lucas, Peter W.] Kuwait Univ, Dept Bioclin Sci, Kuwait, Kuwait	George Washington University; George Washington University; Smithsonian Institution; Smithsonian National Museum of Natural History; Kuwait University	Zipkin, AM (corresponding author), George Washington Univ, Ctr Adv Study Hominid Paleobiol, Dept Anthropol, Washington, DC 20052 USA.	amzipkin@gwmail.gwu.edu	Zipkin, Andrew M/AAI-9285-2020	Zipkin, Andrew M/0000-0002-3813-8051; McGrath, Kate/0000-0003-1533-4313	National Science Foundation [DGE-0801634, 2011116368, BCS-1240694]; Wenner-Gren Foundation [8623]; Direct For Social, Behav & Economic Scie [1240694] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Wenner-Gren Foundation; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This study was made possible by funding from National Science Foundation (http://www.nsf.gov/) grants IGERT #DGE-0801634, GRF #2011116368, and DDIG #BCS-1240694 and Wenner-Gren Foundation (http://www.wennergren.org/) grant DFG #8623. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAIN J, 1986, ANTHROPOLOGIE, V90, P713; Allen KW, 1996, INT J ADHES ADHES, V16, P47, DOI 10.1016/0143-7496(96)88486-7; Ambrose SH, 2010, CURR ANTHROPOL, V51, pS135, DOI 10.1086/650296; [Anonymous], 1999, JOINT FAO WHO EXP CO; Barham LS, 2013, HAND HANDLE 1 IND RE, P177; Boeda E, 1999, ANTIQUITY, V73, P394, DOI 10.1017/S0003598X00088335; Boeda E, 2008, ANTIQUITY, V82, P853, DOI 10.1017/S0003598X00097623; Brandt SA, 2002, ARCHAEOLOGY, V55, P50; Carciumaru M, 2012, J ARCHAEOL SCI, V39, P1942, DOI 10.1016/j.jas.2012.02.016; Charrie-Duhaut A, 2013, J ARCHAEOL SCI, V40, P3506, DOI 10.1016/j.jas.2012.12.026; Delagnes A., 2006, SO AFRICAN HUMANITIE, V18, P43; EVANS AG, 1990, MAT SCI ENG A-STRUCT, V126, P53, DOI 10.1016/0921-5093(90)90113-H; Fauvelle M, 2012, J ARCHAEOL SCI, V39, P2802, DOI 10.1016/j.jas.2012.04.014; Frey SH, 2007, CORTEX, V43, P368, DOI 10.1016/S0010-9452(08)70462-3; Frison GC, 1991, PREHISTORIC HUNTERS, P39; Gibson N. E., 2004, SOUTH AFR HUMANIT, V16, P1; Groom P, 2015, ARCHAEOL ANTHROP SCI, V7, P47, DOI 10.1007/s12520-013-0144-5; Grunberg JM, 2002, ANTIQUITY, V76, P15, DOI 10.1017/S0003598X00089638; Helwig K, 2014, J ARCHAEOL SCI, V41, P655, DOI 10.1016/j.jas.2013.09.010; Hodgskiss T, 2005, MIX REPLICATION STUD, P15; Islam AM, 1997, FOOD HYDROCOLLOID, V11, P493, DOI 10.1016/S0268-005X(97)80048-3; KENDALL K, 1975, J PHYS D APPL PHYS, V8, P512, DOI 10.1088/0022-3727/8/5/010; Kendall K, 2001, MOL ADHESION ITS APP, P353; LAHREN L, 1974, SCIENCE, V186, P147, DOI 10.1126/science.186.4159.147; Lombard M, 2005, J HUM EVOL, V48, P279, DOI 10.1016/j.jhevol.2004.11.006; Lombard M, 2008, J ARCHAEOL SCI, V35, P26, DOI 10.1016/j.jas.2007.02.021; Lombard M, 2007, J HUM EVOL, V53, P406, DOI 10.1016/j.jhevol.2007.05.004; Lombard M, 2010, ANTIQUITY, V84, P635, DOI 10.1017/S0003598X00100134; Mazza PPA, 2006, J ARCHAEOL SCI, V33, P1310, DOI 10.1016/j.jas.2006.01.006; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Monnier GF, 2013, J ARCHAEOL SCI, V40, P3722, DOI 10.1016/j.jas.2013.03.018; Palgrave KC, 1984, TREES SO AFRICA, P463; Pawlik AF, 2011, J ARCHAEOL SCI, V38, P1699, DOI 10.1016/j.jas.2011.03.001; Powell O, 2013, ECON BOT, V67, P210, DOI 10.1007/s12231-013-9238-3; Rots V, 2014, PROJECTILES ABUSE US; TANKERSLEY KB, 1994, J ARCHAEOL SCI, V21, P117, DOI 10.1006/jasc.1994.1012; Wadley L, 2005, J HUM EVOL, V49, P587, DOI 10.1016/j.jhevol.2005.06.007; Wadley L, 2004, ANTIQUITY, V78, P661, DOI 10.1017/S0003598X00113298; Wadley L, 2010, CURR ANTHROPOL, V51, pS111, DOI 10.1086/649836; Wadley L, 2009, P NATL ACAD SCI USA, V106, P9590, DOI 10.1073/pnas.0900957106; Weniger G. C., 2000, CHASSE PREHISTOIRE, P79; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910; Wilkins J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104514; Wilkins J, 2012, SCIENCE, V338, P942, DOI 10.1126/science.1227608; Williamson BS, 2004, S AFR J SCI, V100, P174; Wynn T, 2009, P NATL ACAD SCI USA, V106, P9544, DOI 10.1073/pnas.0904369106	46	33	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112560	10.1371/journal.pone.0112560	http://dx.doi.org/10.1371/journal.pone.0112560			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AT3DP	25383871	gold, Green Published, Green Submitted			2022-12-27	WOS:000344816700082
J	Cho, JA; Zhang, X; Miller, GM; Lencer, WI; Nery, FC				Cho, Jin A.; Zhang, Xuan; Miller, Gregory M.; Lencer, Wayne I.; Nery, Flavia C.			4-Phenylbutyrate Attenuates the ER Stress Response and Cyclic AMP Accumulation in DYT1 Dystonia Cell Models	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; DEPENDENT PROTEIN-KINASE; CYCLOHYDROLASE-I GENE; TORSION DYSTONIA; TYROSINE-HYDROXYLASE; CHEMICAL CHAPERONES; HUNTINGTONS-DISEASE; PHARMACOLOGICAL STRATEGY; DOPAMINE-RECEPTORS; CERVICAL DYSTONIA	Dystonia is a neurological disorder in which sustained muscle contractions induce twisting and repetitive movements or abnormal posturing. DYT1 early-onset primary dystonia is the most common form of hereditary dystonia and is caused by deletion of a glutamic acid residue (302/303) near the carboxyl-terminus of encoded torsinA. TorsinA is localized primarily within the contiguous lumen of the endoplasmic reticulum (ER) and nuclear envelope (NE), and is hypothesized to function as a molecular chaperone and an important regulator of the ER stress-signaling pathway, but how the mutation in torsinA causes disease remains unclear. Multiple lines of evidence suggest that the clinical symptoms of dystonia result from abnormalities in dopamine (DA) signaling, and possibly involving its down-stream effector adenylate cyclase that produces the second messenger cyclic adenosine-3', 5'-monophosphate (cAMP). Here we find that mutation in torsinA induces ER stress, and inhibits the cyclic adenosine-3', 5'-monophosphate (cAMP) response to the adenylate cyclase agonist forskolin. Both defective mechanins are corrected by the small molecule 4-phenylbutyrate (4-PBA) that alleviates ER stress. Our results link torsinA, the ER-stress-response, and cAMP-dependent signaling, and suggest 4-PBA could also be used in dystonia treatment. Other pharmacological agents known to modulate the cAMP cascade, and ER stress may also be therapeutic in dystonia patients and can be tested in the models described here, thus supplementing current efforts centered on the dopamine pathway.	[Cho, Jin A.; Lencer, Wayne I.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Gastroenterol Cell Biol, Boston, MA USA; [Zhang, Xuan; Nery, Flavia C.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Neurosci,Dept Neurol, Boston, MA 02114 USA; [Zhang, Xuan; Nery, Flavia C.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Mol Imaging Res,Dept Radiol, Boston, MA USA; [Zhang, Xuan; Nery, Flavia C.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA USA; [Miller, Gregory M.] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA; [Miller, Gregory M.] Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA; [Lencer, Wayne I.] Harvard Univ, Sch Med, Harvard Digest Dis Ctr, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Northeastern University; Northeastern University; Harvard University; Harvard Medical School	Nery, FC (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Neurosci,Dept Neurol, Boston, MA 02114 USA.	nery.flavia@mgh.harvard.edu		Lencer, Wayne/0000-0001-7346-2730	National Institute of Neurological Disorders and Stroke [NS037409]; Harvard Digestive Diseases Center [P30 DK34854]; CCFA;  [DK48106];  [DK084424];  [DK090603];  [DK083894]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048106, R01DK084424, P30DK034854, F32DK083894, R21DK090603, R37DK048106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS037409, P01NS037409] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Harvard Digestive Diseases Center; CCFA; ; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke, Grant NS037409 (F.C.N.; investigator); DK48106 (W.I.L., PI), DK084424 (W.I.L., PI), DK090603 (W.I.L., PI) and the Harvard Digestive Diseases Center P30 DK34854 (W.I.L., PI); DK083894 (W.I.L., PI) and CCFA Fellowship (J.A.C.; postdoc). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassi C, 2004, EUR J HUM GENET, V12, P59, DOI 10.1038/sj.ejhg.5201102; Atai NA, 2012, INT J CELL BIOL, V2012; Augood Sarah J, 2004, Adv Neurol, V94, P53; Augood SJ, 2002, NEUROLOGY, V59, P445, DOI 10.1212/WNL.59.3.445; Bakowska JC, 2003, GENE THER, V10, P1691, DOI 10.1038/sj.gt.3302061; Batshaw ML, 2001, J PEDIATR-US, V138, pS46, DOI 10.1067/mpd.2001.111836; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Bragg DC, 2011, NEUROBIOL DIS, V42, P136, DOI 10.1016/j.nbd.2010.11.015; Brashear A, 1999, MOVEMENT DISORD, V14, P132, DOI 10.1002/1531-8257(199901)14:1<132::AID-MDS1022>3.0.CO;2-J; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; BREAKEFIELD XO, 1981, J NEUROSCI RES, V6, P349, DOI 10.1002/jnr.490060310; Bronte-Stewart Helen, 2003, Curr Neurol Neurosci Rep, V3, P296, DOI 10.1007/s11910-003-0006-0; BURKE RE, 1986, NEUROLOGY, V36, P160, DOI 10.1212/WNL.36.2.160; Burrows JAJ, 2000, P NATL ACAD SCI USA, V97, P1796, DOI 10.1073/pnas.97.4.1796; Cao SS, 2010, DIS MODEL MECH, V3, P386, DOI 10.1242/dmm.003715; Chen P, 2010, HUM MOL GENET, V19, P3502, DOI 10.1093/hmg/ddq266; Chen XQ, 2008, MOL PHARMACOL, V73, P1816, DOI 10.1124/mol.107.043968; Cherry JA, 2001, BBA-GENE STRUCT EXPR, V1518, P27, DOI 10.1016/S0167-4781(01)00164-6; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Cousin MA, 2011, J PHYSIOL-LONDON, V589, P1943, DOI 10.1113/jphysiol.2010.200477; Dang MT, 2006, NEUROSCI RES, V56, P470, DOI 10.1016/j.neures.2006.09.005; Dang MT, 2005, EXP NEUROL, V196, P452, DOI 10.1016/j.expneurol.2005.08.025; DARFLER FJ, 1982, J BIOL CHEM, V257, P1901; Del Signore SJ, 2009, AMYOTROPH LATERAL SC, V10, P85, DOI 10.1080/17482960802226148; Esapa CT, 2007, HUM MOL GENET, V16, P327, DOI 10.1093/hmg/ddl472; Fonseca SG, 2012, NAT CELL BIOL, V14, P1105, DOI 10.1038/ncb2578; Fuchs T, 2013, NAT GENET, V45, P88, DOI 10.1038/ng.2496; Fujiwara M, 2013, J PHARMACOL SCI, V122, P71, DOI 10.1254/jphs.12194FP; Furukawa Y, 2001, NEUROLOGY, V56, P260, DOI 10.1212/WNL.56.2.260; Gardian G, 2005, J BIOL CHEM, V280, P556, DOI 10.1074/jbc.M410210200; Gatti R, 1997, J INHERIT METAB DIS, V20, P803, DOI 10.1023/A:1005323918923; Gines S, 2003, HUM MOL GENET, V12, P497, DOI 10.1093/hmg/ddg046; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Granata A, 2008, J BIOL CHEM, V283, P7568, DOI 10.1074/jbc.M704097200; Herve D, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00048; Hettich J, 2014, HUM MUTAT; Hewett JW, 2008, HUM MOL GENET, V17, P1436, DOI 10.1093/hmg/ddn032; Hewett JW, 2007, P NATL ACAD SCI USA, V104, P7271, DOI 10.1073/pnas.0701185104; Hewett JW, 2006, NEUROBIOL DIS, V22, P98, DOI 10.1016/j.nbd.2005.10.012; Hirayama K, 2001, J NEUROCHEM, V79, P576, DOI 10.1046/j.1471-4159.2001.00583.x; Huang NK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020934; ICHINOSE H, 1994, NAT GENET, V8, P236, DOI 10.1038/ng1194-236; Inden M, 2007, J NEUROCHEM, V101, P1491, DOI 10.1111/j.1471-4159.2006.04440.x; Kachi T, 2001, Rinsho Shinkeigaku, V41, P1181; Kanellopoulos AK, 2012, J NEUROSCI, V32, P13111, DOI 10.1523/JNEUROSCI.1347-12.2012; Kang HL, 2002, P NATL ACAD SCI USA, V99, P838, DOI 10.1073/pnas.022631999; Kelley DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000931; Kothe M, 2005, J BIOL CHEM, V280, P28127, DOI 10.1074/jbc.M503138200; Kouraklis G, 2006, ONCOL REP, V15, P489; Kubota K, 2006, J NEUROCHEM, V97, P1259, DOI 10.1111/j.1471-4159.2006.03782.x; Lin JT, 2013, MOL CELL BIOL, V33, P1073, DOI 10.1128/MCB.01434-12; Maestri NE, 1996, NEW ENGL J MED, V335, P855, DOI 10.1056/NEJM199609193351204; Mezaki Takahiro, 2005, Rinsho Shinkeigaku, V45, P634; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Naumann M, 1998, MOVEMENT DISORD, V13, P319, DOI 10.1002/mds.870130219; Nery FC, 2008, J CELL SCI, V121, P3476, DOI 10.1242/jcs.029454; Nery FC, 2014, J NEUROSCI METH, V232, P181, DOI 10.1016/j.jneumeth.2014.05.027; Nery FC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1383; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oliveira RF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002383; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Perlmutter DH, 2002, PEDIATR RES, V52, P832, DOI 10.1203/01.PDR.0000036878.28942.14; Perlmutter Joel S, 2004, Adv Neurol, V94, P163; Perlmutter JS, 1997, J NEUROSCI, V17, P843; Placzek MR, 2001, J NEUROL NEUROSUR PS, V71, P262, DOI 10.1136/jnnp.71.2.262; POLLOCK RJ, 1981, J NEUROCHEM, V37, P855, DOI 10.1111/j.1471-4159.1981.tb04471.x; Qi X, 2004, MOL PHARMACOL, V66, P899, DOI 10.1124/mol.104.001339; Ricobaraza A, 2012, HIPPOCAMPUS, V22, P1040, DOI 10.1002/hipo.20883; Rubenstein RC, 2000, AM J PHYSIOL-CELL PH, V278, pC259, DOI 10.1152/ajpcell.2000.278.2.C259; Sancesario G, 2004, EUR J NEUROSCI, V20, P989, DOI 10.1111/j.1460-9568.2004.03566.x; Sharma N, 2005, J NEUROSCI, V25, P5351, DOI 10.1523/JNEUROSCI.0855-05.2005; Sharma N, 2001, AM J PATHOL, V159, P339, DOI 10.1016/S0002-9440(10)61700-2; Torres GE, 2004, P NATL ACAD SCI USA, V101, P15650, DOI 10.1073/pnas.0308088101; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; Walker RH, 2003, MOVEMENT DISORD, V18, P1102, DOI 10.1002/mds.10549; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Zhang FX, 2007, J BIOL CHEM, V282, P22460, DOI 10.1074/jbc.M702439200; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhao LH, 2006, CURR OPIN CELL BIOL, V18, P444, DOI 10.1016/j.ceb.2006.06.005	80	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e110086	10.1371/journal.pone.0110086	http://dx.doi.org/10.1371/journal.pone.0110086			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379658	Green Published, gold, Green Submitted			2022-12-27	WOS:000344863100010
J	McCall-Hosenfeld, JS; Mukherjee, S; Lehman, EB				McCall-Hosenfeld, Jennifer S.; Mukherjee, Sucharita; Lehman, Erik B.			The Prevalence and Correlates of Lifetime Psychiatric Disorders and Trauma Exposures in Urban and Rural Settings: Results from the National Comorbidity Survey Replication (NCS-R)	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MAJOR DEPRESSIVE DISORDER; MENTAL-HEALTH; EPIDEMIOLOGY; DISPARITIES	Introduction: Distinctions between rural and urban environments produce different frequencies of traumatic exposures and psychiatric disorders. We examine the prevalence of psychiatric disorders and frequency of trauma exposures by position on the rural-urban continuum. Methods: The National Comorbidity Survey Replication (NCS-R) was used to evaluate psychiatric disorders among a nationally-representative sample of the U.S. population. Rurality was designated using the Department of Agriculture's 2003 rural-urban continuum codes (RUCC), which differentiate counties into levels of rurality by population density and adjacency to metropolitan areas. Lifetime psychiatric disorders included post-traumatic stress disorder (PTSD), anxiety disorders, major depressive disorder, mood disorders, impulse-control disorders, and substance abuse. Trauma exposures were classified as war-related, accident-related, disaster-related, interpersonal or other. Weighted logistic regression models examined the odds of psychiatric disorders and trauma exposures by position on the rural-urban continuum, adjusted for relevant covariates. Results: 75% of participants were metropolitan, 12.2% were suburban, and 12.8% were from rural counties. The most common disorder reported was any anxiety disorder (38.5%). Drug abuse was more common among metropolitan (8.7%, p = 0.018), compared to nonmetropolitan (5.1% suburban, 6.1% rural) participants. A one-category increase in rurality was associated with decreased odds for war-related trauma (aOR = 0.86, 95% CI 0.78-0.95). Rurality was not associated with risk for any other lifetime psychiatric disorders or trauma exposure. Discussion/Conclusions: Contrary to the expectation of some rural primary care providers, the frequencies of most psychiatric disorders and trauma exposures are similar across the rural-urban continuum, reinforcing calls to improve mental healthcare access in resource-poor rural communities.	[McCall-Hosenfeld, Jennifer S.] Penn State Univ, Coll Med, Dept Med, Hershey, PA 17033 USA; [McCall-Hosenfeld, Jennifer S.; Lehman, Erik B.] Penn State Univ, Coll Med, Dept Publ Hlth Sci, Hershey, PA USA; [Mukherjee, Sucharita] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Rochester	McCall-Hosenfeld, JS (corresponding author), Penn State Univ, Coll Med, Dept Med, Hershey, PA 17033 USA.	jmccallhosenfeld@hmc.psu.edu			National Institute of Mental Health [U01-MH60220]; National Institute of Drug Abuse; Substance Abuse and Mental Health Services Administration; Robert Wood Johnson Foundation [044780]; Pennsylvania State University College of Medicine; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH060220] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Substance Abuse and Mental Health Services Administration(United States Department of Health & Human Services); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Pennsylvania State University College of Medicine; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The parent study, The National Comorbidity study replication (NCS-R) was supported by the National Institute of Mental Health U01-MH60220, with supplemental support from the National Institute of Drug Abuse, the Substance Abuse and Mental Health Services Administration, and the Robert Wood Johnson Foundation (grant 044780). A stipend from the Pennsylvania State University College of Medicine Supported this secondary analysis. No funder had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	BLAZER D, 1985, ARCH GEN PSYCHIAT, V42, P651; BLAZER DG, 1994, AM J PSYCHIAT, V151, P979; Breslau J, 2014, ARE MENTAL DISORDERS; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; Burris JL, 2010, PSYCHO-ONCOLOGY, V19, P637, DOI 10.1002/pon.1600; Colon-Gonzalez Maria C, 2013, Ment Health Fam Med, V10, P191; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Galea S, 2004, EPIDEMIOL REV, V26, P36, DOI 10.1093/epirev/mxh007; Gamm LD, 2003, RURAL HLTH PEOPLE 20; Hinton WL, 1997, J NERV MENT DIS, V185, P39, DOI 10.1097/00005053-199701000-00007; HUMAN J, 1991, AM PSYCHOL, V46, P232, DOI 10.1037/0003-066X.46.3.232; Insel TR, 2008, AM J PSYCHIAT, V165, P663, DOI 10.1176/appi.ajp.2008.08030366; Jacobsen LK, 2001, AM J PSYCHIAT, V158, P1184, DOI 10.1176/appi.ajp.158.8.1184; KENDLER KS, 1986, AM J PSYCHIAT, V143, P279; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2004, INT J METH PSYCH RES, V13, P69, DOI 10.1002/mpr.167; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kessler RC, 2008, ANNU REV PUBL HEALTH, V29, P115, DOI 10.1146/annurev.publhealth.29.020907.090847; McGuive TG, 2008, HEALTH AFFAIR, V27, P393, DOI 10.1377/hlthaff.27.2.393; McQuaid JR, 2001, PSYCHOL MED, V31, P1249, DOI 10.1017/S0033291701004202; Merwin E, 2003, ARCH PSYCHIAT NURS, V17, P42, DOI 10.1053/apnu.2003.1; MURRAY JD, 1991, AM PSYCHOL, V46, P220, DOI 10.1037/0003-066X.46.3.220; National Household Survey on Drug Abuse, 2002, ILL DRUG US METR NON; Nickerson A, 2012, PSYCHIAT RES, V197, P128, DOI 10.1016/j.psychres.2012.01.012; ORH: VHA Office of Rural Health, 2014, INF VHA OFF RUR HLTH; Peen J, 2010, ACTA PSYCHIAT SCAND, V121, P84, DOI 10.1111/j.1600-0447.2009.01438.x; Philbrick JT, 1996, J GEN INTERN MED, V11, P9, DOI 10.1007/BF02603478; President's New Freedom Commission on Mental Health, 2003, ACH PROM TRANSF MENT; Probst JC, 2006, FAM MED, V38, P653; Ricketts TC, 1999, RURAL HEALTH IN THE UNITED STATES, P7; Rueter MA, 2007, COMMUNITY MENT HLT J, V43, P229, DOI 10.1007/s10597-007-9082-y; Rytwinski NK, 2013, J TRAUMA STRESS, V26, P299, DOI 10.1002/jts.21814; Samson AY, 1999, J FAM PRACTICE, V48, P222; Schur CL, 1999, RURAL HEALTH IN THE UNITED STATES, P25; Stein MB, 2000, BEHAV RES THER, V38, P619, DOI 10.1016/S0005-7967(99)00098-4; UNITED NATIONS HIGH COMMISSIONER FOR REFUGEES (UNHCR), 2009, UNHCR POL REF PROT S; United States Department of Agriculture, 2003, USDA ERS RUR CLASS; Vega WA, 1998, ARCH GEN PSYCHIAT, V55, P771, DOI 10.1001/archpsyc.55.9.771; West Bethany A., 2011, Morbidity and Mortality Weekly Report, V60, P52	39	30	30	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112416	10.1371/journal.pone.0112416	http://dx.doi.org/10.1371/journal.pone.0112416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT3WF	25380277	Green Published, gold, Green Submitted			2022-12-27	WOS:000344863100087
J	Pichot, H; Hennequin, M; Rouchon, B; Pereira, B; Tubert-Jeannin, S				Pichot, Helene; Hennequin, Martine; Rouchon, Bernard; Pereira, Bruno; Tubert-Jeannin, Stephanie			Dental Status of New Caledonian Children: Is There a Need for a New Oral Health Promotion Programme?	PLOS ONE			English	Article							CARIES; INEQUALITIES; CARE; INDICATORS; DISEASES; SCHOOLS; ADULTS	Background: Before implementing a new oral health promotion program in the French overseas territory of Nouvelle Caledonie, the health authorities needed recent data about dental status of the New Caledonian child population. Objectives: This study aimed to describe the dental status of 6, 9 and 12-yr-old New Caledonian children and to investigate the environmental and behavioural risk factors related to oral health. Methods: A randomly selected sample of 2734 children (744 6-yr-olds, 789 9-yr-olds, and 1201 12-yr-olds) was examined clinically by seven calibrated investigators and participants responded to a questionnaire. The main variables were objective criteria about dental status and subjective criteria about experience of dental care, dental fear, self-perception of oral health, cultural or ethnic identity and environmental and behavioural risk factors. Results: Overall, most of the children had infectious oral diseases: more than 50% had gingivitis, and 60% of 6- and 9 yr-olds had at least one deciduous or permanent tooth with untreated caries. The mean 12-yr-old number of decayed missing and filled teeth (DMFT) was 2.09 +/- 2.82. The number of carious lesions was related to the unfavourable lifestyle, deprived social status and no preventive dental care. Kanak, Polynesians and Caledonians (respectively 27%, 18% and 45% of the study sample) were more affected by caries than metropolitan French and Asian children. Children with many untreated carious lesions had negative perceptions of their oral health; they complained of chewing difficulty and had higher scores for dental anxiety. Conclusion: This study highlights the need for new strategies aimed at improving oral health and at reducing inequalities in New Caledonia. An oral health promotion program would need to be developed in connection with other health programmes using the common risk factor approach within the context of the local environment.	[Pichot, Helene; Hennequin, Martine; Tubert-Jeannin, Stephanie] Univ Auvergne, Clermont Univ, Ctr Rech Odontol Clin, EA 4847, Clermont Ferrand, France; [Pichot, Helene; Rouchon, Bernard] Sanit & Social Agcy New Caledonia, Noumea, New Caledonia; [Hennequin, Martine; Pereira, Bruno; Tubert-Jeannin, Stephanie] CHU Clermont Ferrand, Clermont Ferrand, France	Universite Clermont Auvergne (UCA); CHU Clermont Ferrand	Hennequin, M (corresponding author), Univ Auvergne, Clermont Univ, Ctr Rech Odontol Clin, EA 4847, BP 10448, Clermont Ferrand, France.	martine.hennequin@udamail.fr	Hennequin, Martine/AAB-3004-2021	Hennequin, Martine/0000-0001-8173-2606; Tubert-jeannin, stephanie/0000-0002-8360-8948; Pereira, Bruno/0000-0003-3778-7161	Regional Public Health Services of New Caledonia; Sanitary and Social Agency of New Caledonia; University of Auvergne, Clermont-1, France; University Hospital of Clermont-Ferrand, France	Regional Public Health Services of New Caledonia; Sanitary and Social Agency of New Caledonia; University of Auvergne, Clermont-1, France; University Hospital of Clermont-Ferrand, France	The Regional Public Health Services of New Caledonia, the Sanitary and Social Agency of New Caledonia, the University of Auvergne, Clermont-1, France, and the University Hospital of Clermont-Ferrand, France, financed this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam C, 2005, COMMUNITY DENT ORAL, V33, P333, DOI 10.1111/j.1600-0528.2005.00224.x; Azogui-Levy S, 2003, COMMUNITY DENT ORAL, V31, P285, DOI 10.1034/j.1600-0528.2003.00007.x; Baelum V, 2011, J DENT, V39, pS9, DOI 10.1016/j.jdent.2011.10.015; Bedos C, 2004, REV EPIDEMIOL SANTE, V52, P261, DOI 10.1016/S0398-7620(04)99051-7; Bolden A J, 1993, J Dent Educ, V57, P888; Bourgeois D, 1996, Community Dent Health, V13, P93; Bratthall D, 2000, INT DENT J, V50, P378, DOI 10.1111/j.1875-595X.2000.tb00572.x; Burt BA, 1982, VITAL HLTH STAT, V11, P1; Catteau C, 2011, Bull Group Int Rech Sci Stomatol Odontol, V50, P15; Decerle N, 2013, CARIES RES, V47, P330, DOI 10.1159/000348397; DONALD A, 1987, STAT MED, V6, P491, DOI 10.1002/sim.4780060408; EKSTRAND KR, 1995, CARIES RES, V29, P243, DOI 10.1159/000262076; El Osta N, 2014, CLIN NUTR, V33, P316, DOI 10.1016/j.clnu.2013.05.012; Enjary C, 2006, COMMUNITY DENT ORAL, V34, P363, DOI 10.1111/j.1600-0528.2006.00284.x; Godlewski A E, 2008, Odontostomatol Trop, V31, P25; Goldstein H, 1995, MULTILEVEL STAT MODE, V2nd; Guarnizo-Herreno CC, 2013, J EPIDEMIOL COMMUN H, V67, P728, DOI 10.1136/jech-2013-202714; Guittet Lydia, 2006, BMC Med Res Methodol, V6, P17, DOI 10.1186/1471-2288-6-17; Hennequin M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002564; Hox JJ, 2010, MULTILEVEL ANAL TECH, V2nd; Joseph C, 2011, EUR ARCH PAEDIATR DE, V12, P256, DOI 10.1007/BF03262818; Kerry SM, 2001, STAT MED, V20, P377, DOI 10.1002/1097-0258(20010215)20:3<377::AID-SIM799>3.0.CO;2-N; Kwan SYL, 2005, B WORLD HEALTH ORGAN, V83, P677; LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240; Marshman Z, 2012, COMMUNITY DENT ORAL, V40, P306, DOI 10.1111/j.1600-0528.2012.00675.x; Marthaler TM, 2004, CARIES RES, V38, P173, DOI 10.1159/000077752; Millstein P, 2001, J AM DENT ASSOC, V132, P1280, DOI 10.14219/jada.archive.2001.0373; Nicolas E, 2010, INT J PAEDIATR DENT, V20, P366, DOI 10.1111/j.1365-263X.2010.01054.x; Petersen PE, 2005, B WORLD HEALTH ORGAN, V83, P661; Petersen PE, 2003, COMMUNITY DENT ORAL, V31, P3, DOI 10.1046/j..2003.com122.x; Petersen PE, 2011, COMMUNITY DENT ORAL, V39, P481, DOI 10.1111/j.1600-0528.2011.00623.x; Pichot H, 2010, J DISABIL ORAL HLTH, V11; Plutzer K, 2008, COMMUNITY DENT ORAL, V36, P335, DOI 10.1111/j.1600-0528.2007.00414.x; Shi LY, 2005, PUBLIC HEALTH REP, V120, P431, DOI 10.1177/003335490512000410; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Verbeke G, 2000, LINEAR MIXED MODELS; Wigen TI, 2010, COMMUNITY DENT ORAL, V38, P19, DOI 10.1111/j.1600-0528.2009.00502.x; Zander A, 2013, RURAL REMOTE HEALTH, V13	38	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112452	10.1371/journal.pone.0112452	http://dx.doi.org/10.1371/journal.pone.0112452			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380304	Green Submitted, Green Published, gold			2022-12-27	WOS:000344863100098
J	Qadri, MAJ; Sayde, JM; Cook, RG				Qadri, Muhammad A. J.; Sayde, Justin M.; Cook, Robert G.			Discrimination of Complex Human Behavior by Pigeons (Columba livia) and Humans	PLOS ONE			English	Article							NEURAL MECHANISMS; MOTION; CATEGORIZATION; RECOGNITION; PERCEPTION; SIMULATION; IMITATION; MOVEMENTS; IMAGES; MODEL	The cognitive and neural mechanisms for recognizing and categorizing behavior are not well understood in non-human animals. In the current experiments, pigeons and humans learned to categorize two non-repeating, complex human behaviors ("martial arts" vs. "Indian dance"). Using multiple video exemplars of a digital human model, pigeons discriminated these behaviors in a go/no-go task and humans in a choice task. Experiment 1 found that pigeons already experienced with discriminating the locomotive actions of digital animals acquired the discrimination more rapidly when action information was available than when only pose information was available. Experiments 2 and 3 found this same dynamic superiority effect with naive pigeons and human participants. Both species used the same combination of immediately available static pose information and more slowly perceived dynamic action cues to discriminate the behavioral categories. Theories based on generalized visual mechanisms, as opposed to embodied, species-specific action networks, offer a parsimonious account of how these different animals recognize behavior across and within species.	[Qadri, Muhammad A. J.; Sayde, Justin M.; Cook, Robert G.] Tufts Univ, Dept Psychol, Medford, MA 02155 USA	Tufts University	Qadri, MAJ (corresponding author), Tufts Univ, Dept Psychol, Medford, MA 02155 USA.	Muhammad.Qadri@tufts.edu	Qadri, Muhammad A. J./CAI-2467-2022	Qadri, Muhammad A. J./0000-0003-2518-7919	National Eye Institute [RO1EY022655]; NATIONAL EYE INSTITUTE [R01EY022655] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by a grant from the National Eye Institute (#RO1EY022655). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asen Y, 2012, PSYCHOL SCI, V23, P617, DOI 10.1177/0956797611433333; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; Buccino G, 2004, BRAIN LANG, V89, P370, DOI 10.1016/S0093-934X(03)00356-0; Buccino G, 2004, J COGNITIVE NEUROSCI, V16, P114, DOI 10.1162/089892904322755601; Cook, 2001, AVIAN VISUAL COGNITI; Cook R G, 2001, Anim Cogn, V4, P137, DOI 10.1007/s100710100097; Cook RG, 2000, CURR DIR PSYCHOL SCI, V9, P83, DOI 10.1111/1467-8721.00066; Cook RG, 2007, J EXP PSYCHOL ANIM B, V33, P287, DOI 10.1037/0097-7403.33.3.287; Cook RG, 2012, COGNITION, V124, P284, DOI 10.1016/j.cognition.2012.05.007; Cook RG, 2011, J EXP PSYCHOL ANIM B, V37, P175, DOI 10.1037/a0022105; COOPER WE, 1981, ANIM BEHAV, V29, P1127, DOI 10.1016/S0003-3472(81)80065-6; D'eath RB, 1998, BIOL REV, V73, P267, DOI 10.1017/S0006323198005179; Decety J, 1999, TRENDS COGN SCI, V3, P172, DOI 10.1016/S1364-6613(99)01312-1; DITTRICH WH, 1993, J EXP ANAL BEHAV, V59, P115, DOI 10.1901/jeab.1993.59-115; Dittrich WH, 1998, J EXP ANAL BEHAV, V70, P281, DOI 10.1901/jeab.1998.70-281; DOMJAN M, 1988, ANIM BEHAV, V36, P1006, DOI 10.1016/S0003-3472(88)80060-5; Fleischer F, 2013, J NEUROSCI, V33, P6563, DOI 10.1523/JNEUROSCI.4129-12.2013; Gallese V, 2007, PHILOS T R SOC B, V362, P659, DOI 10.1098/rstb.2006.2002; Giese MA, 2003, NAT REV NEUROSCI, V4, P179, DOI 10.1038/nrn1057; Gobbini MI, 2011, J COGNITIVE NEUROSCI, V23, P1911, DOI 10.1162/jocn.2010.21574; Grafton ST, 2009, ANN NY ACAD SCI, V1156, P97, DOI 10.1111/j.1749-6632.2009.04425.x; Grezes J, 2009, NEUROPSYCHOLOGIA, V47, P1816, DOI 10.1016/j.neuropsychologia.2009.02.021; HERRNSTEIN RJ, 1976, J EXP PSYCHOL ANIM B, V2, P285, DOI 10.1037/0097-7403.2.4.285; Heyes C, 2010, NEUROIMAGE, V51, P789, DOI 10.1016/j.neuroimage.2010.02.034; Heyes C, 2010, NEUROSCI BIOBEHAV R, V34, P575, DOI 10.1016/j.neubiorev.2009.11.007; Hickok G, 2009, J COGNITIVE NEUROSCI, V21, P1229, DOI 10.1162/jocn.2009.21189; Husband S., 2001, AVIAN VISUAL COGNITI; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Jastorff J, 2006, J VISION, V6, P791, DOI 10.1167/6.8.3; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Koban A, 2009, J EXP PSYCHOL ANIM B, V35, P250, DOI 10.1037/a0013874; Kourtzi Z, 2000, J COGNITIVE NEUROSCI, V12, P48, DOI 10.1162/08989290051137594; LEA SEG, 2000, PICTURE PERCEPTION A, P143; Nguyen AP, 2004, J NEUROSCI, V24, P4962, DOI 10.1523/JNEUROSCI.0146-04.2004; Polosecki P, 2013, J NEUROSCI, V33, P11768, DOI 10.1523/JNEUROSCI.5402-11.2013; Qadri MAJ, 2014, J VISION, V14, DOI 10.1167/14.5.16; Rees G, 2008, CURR BIOL, V18, P40; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; RUGGIERO LF, 1979, AM NAT, V113, P749, DOI 10.1086/283430; Smith JD, 2011, PSYCHON B REV, V18, P414, DOI 10.3758/s13423-010-0047-8; Springer A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00387; Verfaillie K, 2002, VIS COGN, V9, P217, DOI 10.1080/13506280143000403; Weinland D, 2011, COMPUT VIS IMAGE UND, V115, P224, DOI 10.1016/j.cviu.2010.10.002; Wilson M, 2005, PSYCHOL BULL, V131, P460, DOI 10.1037/0033-2909.131.3.460	45	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112342	10.1371/journal.pone.0112342	http://dx.doi.org/10.1371/journal.pone.0112342			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379777	gold, Green Published, Green Submitted			2022-12-27	WOS:000344863100076
J	Traikov, S; Stange, C; Wassmer, T; Paul-Gilloteaux, P; Salamero, J; Raposo, G; Hoflack, B				Traikov, Sofia; Stange, Christoph; Wassmer, Thomas; Paul-Gilloteaux, Perrine; Salamero, Jean; Raposo, Graca; Hoflack, Bernard			Septin6 and Septin7 GTP Binding Proteins Regulate AP-3-and ESCRT-Dependent Multivesicular Body Biogenesis	PLOS ONE			English	Article							HERMANSKY-PUDLAK-SYNDROME; ADAPTER COMPLEX; FILAMENT FORMATION; MAMMALIAN SEPTIN; BETA-3A SUBUNIT; TRANSPORT; ACTIN; TRAFFICKING; CLATHRIN; RECEPTOR	Septins (SEPTs) form a family of GTP-binding proteins implicated in cytoskeleton and membrane organization, cell division and host/pathogen interactions. The precise function of many family members remains elusive. We show that SEPT6 and SEPT7 complexes bound to F-actin regulate protein sorting during multivesicular body (MVB) biogenesis. These complexes bind AP-3, an adapter complex sorting cargos destined to remain in outer membranes of maturing endosomes, modulate AP-3 membrane interactions and the motility of AP-3-positive endosomes. These SEPT-AP interactions also influence the membrane interaction of ESCRT (endosomal-sorting complex required for transport)-I, which selects ubiquitinated cargos for degradation inside MVBs. Whereas our findings demonstrate that SEPT6 and SEPT7 function in the spatial, temporal organization of AP-3- and ESCRT-coated membrane domains, they uncover an unsuspected coordination of these sorting machineries during MVB biogenesis. This requires the E3 ubiquitin ligase LRSAM1, an AP-3 interactor regulating ESCRT-I sorting activity and whose mutations are linked with Charcot-Marie-Tooth neuropathies.	[Traikov, Sofia; Stange, Christoph; Wassmer, Thomas; Hoflack, Bernard] Tech Univ Dresden, Ctr Biotechnol, D-01062 Dresden, Germany; [Wassmer, Thomas] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Paul-Gilloteaux, Perrine; Salamero, Jean; Raposo, Graca] Inst Curie, CNRS, Mol Mech Intracellular Transport Lab, F-75231 Paris, France; [Paul-Gilloteaux, Perrine; Salamero, Jean] Inst Curie, CNRS, PICT IBiSA, Cell & Tissue Imaging Facil, F-75231 Paris, France; [Paul-Gilloteaux, Perrine; Salamero, Jean] Inst Curie, CNRS, Nikon Imaging Ctr, F-75231 Paris, France	Technische Universitat Dresden; Aston University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Hoflack, B (corresponding author), Tech Univ Dresden, Ctr Biotechnol, D-01062 Dresden, Germany.	bernard.hoflack@biotec.tu-dresden.de	HOFLACK, Bernard/AAZ-6668-2020; Paul-Gilloteaux, Perrine/L-8287-2018	Paul-Gilloteaux, Perrine/0000-0002-4822-165X; salamero, jean/0000-0002-2610-5826; Raposo, graca/0000-0001-9590-1298	DFG [TRR 83/2-2014, HO 2584/1-1, HO 2584/2-1, HO 2584/6-1, HO 2584/8-1, HO 2584/9-1]; TU-Dresden; CAMINEMS FP7 project [228980]	DFG(German Research Foundation (DFG)); TU-Dresden(European Commission); CAMINEMS FP7 project	BH's research was supported in part by grants from DFG (TRR 83/2-2014, HO 2584/1-1, HO 2584/2-1, HO 2584/6-1, HO 2584/8-1, HO 2584/9-1), and TU-Dresden, JS's research by CAMINEMS FP7 project (grant number 228980). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit I, 2004, GENE DEV, V18, P1737, DOI 10.1101/gad.294904; Angenieux C, 2005, TRAFFIC, V6, P286, DOI 10.1111/j.1600-0854.2005.00272.x; ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131; Barral Y, 2008, CURR OPIN CELL BIOL, V20, P12, DOI 10.1016/j.ceb.2007.12.001; Baust T, 2008, MOL BIOL CELL, V19, P1942, DOI 10.1091/mbc.E08-02-0110; Chih B, 2012, NAT CELL BIOL, V14, P61, DOI 10.1038/ncb2410; Chow CY, 2007, NATURE, V448, P68, DOI 10.1038/nature05876; Cowles CR, 1997, CELL, V91, P109, DOI 10.1016/S0092-8674(01)80013-1; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Dell'Angelica EC, 2009, CURR OPIN CELL BIOL, V21, P552, DOI 10.1016/j.ceb.2009.04.014; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Feng LJ, 1999, HUM MOL GENET, V8, P323, DOI 10.1093/hmg/8.2.323; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; Guernsey DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001081; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hu JL, 2012, CURR BIOL, V22, P1109, DOI 10.1016/j.cub.2012.04.019; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Joberty G, 2001, NAT CELL BIOL, V3, P861, DOI 10.1038/ncb1001-861; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kinoshita M, 2006, CURR OPIN CELL BIOL, V18, P54, DOI 10.1016/j.ceb.2005.12.005; Kremer BE, 2007, CELL, V130, P837, DOI 10.1016/j.cell.2007.06.053; Kural C, 2012, CELL REP, V2, P1111, DOI 10.1016/j.celrep.2012.09.025; Le Borgne R, 1998, J BIOL CHEM, V273, P29451, DOI 10.1074/jbc.273.45.29451; Low C, 2006, J BIOL CHEM, V281, P30697, DOI 10.1074/jbc.M605179200; Mavrakis M, 2014, NAT CELL BIOL, V16, P322, DOI 10.1038/ncb2921; Morel E, 2009, DEV CELL, V16, P445, DOI 10.1016/j.devcel.2009.01.007; Mostowy S, 2012, NAT REV MOL CELL BIO, V13, P183, DOI 10.1038/nrm3284; Mostowy S, 2011, AUTOPHAGY, V7, P780, DOI 10.4161/auto.7.7.15593; Nagata K, 2003, J BIOL CHEM, V278, P18538, DOI 10.1074/jbc.M205246200; Ooi CE, 1998, J CELL BIOL, V142, P391, DOI 10.1083/jcb.142.2.391; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Pal A, 2006, J CELL BIOL, V172, P605, DOI 10.1083/jcb.200509091; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Press B, 1998, J CELL BIOL, V140, P1075, DOI 10.1083/jcb.140.5.1075; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raposo G, 1999, MOL BIOL CELL, V10, P1477, DOI 10.1091/mbc.10.5.1477; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rusten TE, 2012, NAT CELL BIOL, V14, P38, DOI 10.1038/ncb2381; Saarikangas J, 2011, EMBO REP, V12, P1118, DOI 10.1038/embor.2011.193; Salas-Cortes L, 2005, J CELL SCI, V118, P4823, DOI 10.1242/jcs.02607; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Spiliotis ET, 2008, J CELL BIOL, V180, P295, DOI 10.1083/jcb.200710039; Spiliotis ET, 2012, TRAFFIC, V13, P195, DOI 10.1111/j.1600-0854.2011.01268.x; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Theos AC, 2005, MOL BIOL CELL, V16, P5356, DOI 10.1091/mbc.E05-07-0626; Tsang CW, 2008, MOL CELL BIOL, V28, P7012, DOI 10.1128/MCB.00035-08; Vaccari I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002319; Waguri S, 2003, MOL BIOL CELL, V14, P142, DOI 10.1091/mbc.E02-06-0338	53	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e109372	10.1371/journal.pone.0109372	http://dx.doi.org/10.1371/journal.pone.0109372			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380047	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000344863100006
J	Xu, LD; Muller, S; Thoppe, SR; Hellborg, F; Kanter, L; Lerner, M; Zheng, BY; Lagercrantz, SB; Grander, D; Wallin, KL; Wiman, KG; Larsson, C; Andersson, S				Xu, Li-Di; Muller, Susanne; Thoppe, Srinivasan R.; Hellborg, Fredrik; Kanter, Lena; Lerner, Mikael; Zheng, Biying; Lagercrantz, Svetlana Bajalica; Grander, Dan; Wallin, Keng Ling; Wiman, Klas G.; Larsson, Catharina; Andersson, Sonia			Expression of the p53 Target Wig-1 Is Associated with HPV Status and Patient Survival in Cervical Carcinoma	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; SQUAMOUS-CELL CARCINOMAS; TELOMERASE GENE TERC; ZINC-FINGER PROTEIN; MESSENGER-RNA STABILITY; GENOMIC AMPLIFICATION; CANCER; LUNG; CARCINOGENESIS; ADENOCARCINOMA	The p53 target gene WIG-1 (ZMAT3) is located in chromosomal region 3q26, that is frequently amplified in human tumors, including cervical cancer. We have examined the status of WIG-1 and the encoded Wig-1 protein in cervical carcinoma cell lines and tumor tissue samples. Our analysis of eight cervical cancer lines (Ca Ski, ME-180, MS751, SiHa, SW756, C-4I, C-33A, and HT-3) by spectral karyotype, comparative genomic hybridization and Southern blotting revealed WIG-1 is not the primary target for chromosome 3 gains. However, WIG-1/Wig-1 were readily expressed and WIG-1 mRNA expression was higher in the two HPV-negative cervical cell lines (C33-A, HT-3) than in HPV-positive lines. We then assessed Wig-1 expression by immunohistochemistry in 38 cervical tumor samples. We found higher nuclear Wig-1 expression levels in HPV-negative compared to HPV positive cases (p = 0.002) and in adenocarcinomas as compared to squamous cell lesions (p<0.0001). Cases with moderate nuclear Wig-1 staining and positive cytoplasmic Wig-1 staining showed longer survival than patients with strong nuclear and negative cytoplasmic staining (p = 0.042). Nuclear Wig-1 expression levels were positively associated with age at diagnosis (p = 0.023) and histologic grade (p = 0.034). These results are consistent with a growth-promoting and/or anti-cell death function of nuclear Wig-1 and suggest that Wig-1 expression can serve as a prognostic marker in cervical carcinoma.	[Xu, Li-Di; Hellborg, Fredrik; Kanter, Lena; Lerner, Mikael; Lagercrantz, Svetlana Bajalica; Grander, Dan; Wallin, Keng Ling; Wiman, Klas G.; Larsson, Catharina] Karolinska Univ Hosp Solna, CCK, Dept Oncol Pathol, Stockholm, Sweden; [Muller, Susanne; Andersson, Sonia] Karolinska Univ Hosp Solna, Dept Womens & Childrens Hlth, Div Obstet & Gynecol, Stockholm, Sweden; [Thoppe, Srinivasan R.; Zheng, Biying] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Wiman, KG (corresponding author), Karolinska Univ Hosp Solna, CCK, Dept Oncol Pathol, Stockholm, Sweden.	Klas.Wiman@ki.se	Wiman, Klas/AAB-8399-2021	Wiman, Klas/0000-0002-7113-524X	Swedish Research Council (VR) [K2013-66X-15385-09-5, 521-2008-2899, K2014-66X-11622-19-3]; Swedish Cancer Society [13 0623]; Radiumhemmets Forskningsfonder [131271]; Karolinska Institutet DPA-Klas Wiman; StratCan-Klas Wiman; Swedish Cancer Foundatio [110544, CAN 2011/471, 13 0543]	Swedish Research Council (VR)(Swedish Research Council); Swedish Cancer Society(Swedish Cancer Society); Radiumhemmets Forskningsfonder; Karolinska Institutet DPA-Klas Wiman; StratCan-Klas Wiman; Swedish Cancer Foundatio	Professor Klas G. Wiman received the following funding: The Swedish Research Council (VR)-number K2013-66X-15385-09-5; The Swedish Cancer Society-number 13 0623; Radiumhemmets Forskningsfonder -number 131271; Karolinska Institutet DPA-Klas Wiman; and StratCan-Klas Wiman. Professor Sonia Andersson received the following funding: Swedish Cancer Foundation (110544, CAN 2011/471) and the Swedish Research Council (521-2008-2899). Professor Catharina Larsson received the following funding: Swedish Research Council K2014-66X-11622-19-3 and Swedish Cancer Foundation 13 0543. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S, 2006, BRIT J CANCER, V95, P331, DOI 10.1038/sj.bjc.6603253; Andersson S, 2003, ACTA OBSTET GYN SCAN, V82, P960, DOI 10.1034/j.1600-0412.2003.00263.x; Andersson S, 2003, ONCOL REP, V10, P175; Andersson S, 2001, EUR J CANCER, V37, P246, DOI 10.1016/S0959-8049(00)00376-2; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bersani C, 2014, ONCOGENE, V33, P4407, DOI 10.1038/onc.2013.594; Bosch FX, 2002, VIRUS RES, V89, P183, DOI 10.1016/S0168-1702(02)00187-9; Castellsague X, 2006, JNCI-J NATL CANCER I, V98, P303, DOI 10.1093/jnci/djj067; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; de Gonzalez AB, 2007, INT J CANCER, V120, P885, DOI 10.1002/ijc.22357; Farnebo F, 1999, J CLIN ENDOCR METAB, V84, P3775, DOI 10.1210/jc.84.10.3775; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Hellborg F, 2004, INT J ONCOL, V24, P1559; Hellborg F, 2001, ONCOGENE, V20, P5466, DOI 10.1038/sj.onc.1204722; HERRINGTON CS, 1992, DIAGNOSTIC MOL PATHO; Heselmeyer K, 1996, P NATL ACAD SCI USA, V93, P479, DOI 10.1073/pnas.93.1.479; Heselmeyer-Haddad K, 2005, AM J PATHOL, V166, P1229, DOI 10.1016/S0002-9440(10)62341-3; Heselmeyer-Haddad K, 2003, AM J PATHOL, V163, P1405, DOI 10.1016/S0002-9440(10)63498-0; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Hussenet T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008960; Kim BC, 2012, EMBO J, V31, P4289, DOI 10.1038/emboj.2012.286; Kytola S, 2000, GENE CHROMOSOME CANC, V28, P308, DOI 10.1002/1098-2264(200007)28:3<308::AID-GCC9>3.0.CO;2-B; Maier S, 2011, HUM PATHOL, V42, P1078, DOI 10.1016/j.humpath.2010.11.010; MANOS M, 1990, LANCET, V335, P734, DOI 10.1016/0140-6736(90)90855-Y; Massion PP, 2003, CANCER RES, V63, P7113; Mendez-Vidal C, 2002, NUCLEIC ACIDS RES, V30, P1991, DOI 10.1093/nar/30.9.1991; Pett MR, 2004, CANCER RES, V64, P1359, DOI 10.1158/0008-5472.CAN-03-3214; Pihan GA, 2003, CANCER RES, V63, P1398; SCHEFFNER M, 1991, P NATL ACAD SCI USA, V88, P5523, DOI 10.1073/pnas.88.13.5523; Schmitt M, 2006, J CLIN MICROBIOL, V44, P504, DOI 10.1128/JCM.44.2.504-512.2006; Soederlund-Strand A, 2009, J CLIN MICROBIOL, V47, P541, DOI 10.1128/JCM.02007-08; Tommasino M, 2003, HUM MUTAT, V21, P307, DOI 10.1002/humu.10178; Varmeh-Ziaie S, 2001, CANCER LETT, V174, P179, DOI 10.1016/S0304-3835(01)00699-1; VarmehZiaie S, 1997, ONCOGENE, V15, P2699, DOI 10.1038/sj.onc.1201454; Vilborg A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.33; Vilborg A, 2011, CELL DEATH DIFFER, V18, P1434, DOI 10.1038/cdd.2011.20; Vilborg A, 2010, J MOL MED, V88, P645, DOI 10.1007/s00109-010-0609-2; Vilborg A, 2009, P NATL ACAD SCI USA, V106, P15756, DOI 10.1073/pnas.0900862106; Zhang A, 2002, INT J CANCER, V101, P427, DOI 10.1002/ijc.10627; Zielinski GD, 2004, OBSTET GYNECOL SURV, V59, P543, DOI 10.1097/00006254-200407000-00024; zur Hausen H, 2000, JNCI-J NATL CANCER I, V92, P690, DOI 10.1093/jnci/92.9.690	41	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111125	10.1371/journal.pone.0111125	http://dx.doi.org/10.1371/journal.pone.0111125			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379706	gold, Green Published, Green Submitted			2022-12-27	WOS:000344863100020
J	Huang, RE; Ren, XL; Qiu, YF; Zhao, ZY				Huang, Ren-E; Ren, Xiaoliang; Qiu, Yifei; Zhao, Zhongying			Description of Caenorhabditis sinica sp n. (Nematoda: Rhabditidae), a Nematode Species Used in Comparative Biology for C-elegans	PLOS ONE			English	Article							EVOLUTION; PHYLOGENY; DIVERSITY; PATTERNS; MUTATION; DNA	We re-isolated in China a relative of the nematode model Caenorhabditis elegans that was previously referred to informally as C. sp. 5. In spite of its importance for comparative biology, C. sp. 5 has remained morphologically uncharacterized. Therefore, we now provide detailed description of morphology and anatomy, assigning the name of Caenorhabditis sinica sp. n. to this nematode that is found frequently in China. C. sinica sp. n. belongs to the Elegans group in the genus Caenorhabditis, being phylogenetically close to C. briggsae although differing in reproductive mode. The gonochoristic C. sinica sp. n. displays two significantly larger distal parts of uteri filled with sperms in the female/hermaphroditic gonad than does the androdioecious C. briggsae. The new species can be differentiated morphologically from all known Caenorhabditis species within the Elegans group by presenting a uniquely shaped, three-pointed hook structure on the male precloacal lip. The lateral field of C. sinica sp. n. is marked by three ridges that are flanked by two additional incisures, sometimes appearing as five ridges in total. This study ends the prolonged period of the 'undescribed' anonymity for C. sinica sp. n. since its discovery and use in comparative biological research. Significant and crossing-direction dependent hybrid incompatibilities in F1 and F2 crossing progeny make C. sinica sp. n. an excellent model for studies of population and speciation genetics. The abundance of nematode species lacking detailed taxonomic characterization deserves renewed attention to address the species description gap for this important yet morphologically 'difficult' group of animals.	[Huang, Ren-E] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Huang, Ren-E; Ren, Xiaoliang; Qiu, Yifei; Zhao, Zhongying] Hong Kong Baptist Univ, Fac Sci, Dept Biol, Hong Kong, Hong Kong, Peoples R China	Tsinghua University; Hong Kong Baptist University	Zhao, ZY (corresponding author), Hong Kong Baptist Univ, Fac Sci, Dept Biol, Hong Kong, Hong Kong, Peoples R China.	zyzhao@hkbu.edu.hk	Zhao, Zhongying/C-3261-2015; Zhao, Zhongying/ABF-9458-2021	Zhao, Zhongying/0000-0003-2743-9008	National Natural Science Foundation of China [31201700]; Early Career Scheme (ECS) of Hong Kong Research Grant Council [HKBU263512]; National Institutes of Health - Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Early Career Scheme (ECS) of Hong Kong Research Grant Council; National Institutes of Health - Office of Research Infrastructure Programs; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the National Natural Science Foundation of China (Grant No. 31201700) to Ren-E Huang. Dr. Zhongying Zhao was supported by Early Career Scheme (ECS) of Hong Kong Research Grant Council (Grant No. HKBU263512). Some nematode strains were provided by Caenorhabditis Genetics Center, which was supported by National Institutes of Health - Office of Research Infrastructure Programs (P40 OD010440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi C, 2011, CURR BIOL, V21, P1416, DOI 10.1016/j.cub.2011.07.034; Blaxter M, 2012, PARASITE IMMUNOL, V34, P108, DOI 10.1111/j.1365-3024.2011.01342.x; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Brauchle M, 2009, DEV BIOL, V335, P253, DOI 10.1016/j.ydbio.2009.07.033; Cutter AD, 2008, MOL BIOL EVOL, V25, P778, DOI 10.1093/molbev/msn024; Cutter AD, 2008, GENETICS, V178, P2093, DOI 10.1534/genetics.107.085787; Cutter AD, 2012, MOL ECOL, V21, P1345, DOI 10.1111/j.1365-294X.2012.05475.x; deMan J.G, 1880, TIJDSCHRIFT NEDERLAN, V5, P1; Dey A, 2012, GENETICS, V191, P1257, DOI 10.1534/genetics.112.140418; Dolgin ES, 2008, HEREDITY, V100, P304, DOI 10.1038/sj.hdy.6801079; Felix MA, 2007, CURR BIOL, V17, P103, DOI 10.1016/j.cub.2006.12.024; Felix MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094723; Haber M, 2005, MOL BIOL EVOL, V22, P160, DOI 10.1093/molbev/msh264; Kiontke K, 2007, CURR BIOL, V17, P1925, DOI 10.1016/j.cub.2007.10.061; Kiontke Karin, 2005, P1; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; Meldal BHM, 2007, MOL PHYLOGENET EVOL, V42, P622, DOI 10.1016/j.ympev.2006.08.025; Nadler SA, 1998, MOL PHYLOGENET EVOL, V10, P221, DOI 10.1006/mpev.1998.0514; Nuez I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029811; Pazdernik N, 2013, ADV EXP MED BIOL, V757, P1, DOI 10.1007/978-1-4614-4015-4_1; Penigault JB, 2011, DEV BIOL, V357, P419, DOI 10.1016/j.ydbio.2011.05.675; Raboin MJ, 2010, MOL BIOL EVOL, V27, P1087, DOI 10.1093/molbev/msp318; Ryss AY, 2003, ZOOSYSTEMATICA ROSSI, V11, P257; Sudhaus W., 2003, Journal of Nematode Morphology and Systematics, V6, P43; Sudhaus W, 2007, ZOOTAXA, P45, DOI 10.11646/zootaxa.1456.1.2; Thomas WK, 1997, J NEMATOL, V29, P250; Wang GX, 2010, MOL ECOL, V19, P5022, DOI 10.1111/j.1365-294X.2010.04862.x; Wergin W. P., 1981, Plant parasitic nematodes. Volume III., P175; Yokoo T., 1968, AGR BULL SAGA U, V25, P69	29	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e110957	10.1371/journal.pone.0110957	http://dx.doi.org/10.1371/journal.pone.0110957			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375770	Green Published, gold			2022-12-27	WOS:000344402600022
J	Buitrago-Florez, FJ; Restrepo, S; Riano-Pacho, DM				Javier Buitrago-Florez, Francisco; Restrepo, Silvia; Riano-Pacho, Diego Mauricio			Identification of Transcription Factor Genes and Their Correlation with the High Diversity of Stramenopiles	PLOS ONE			English	Article							REGRESSION; PHYLOGENY	The biological diversity among Stramenopiles is striking; they range from large multicellular seaweeds to tiny unicellular species, they embrace many ecologically important autothrophic (e.g., diatoms, brown algae), and heterotrophic (e.g., oomycetes) groups. Transcription factors (TFs) and other transcription regulators (TRs) regulate spatial and temporal gene expression. A plethora of transcriptional regulatory proteins have been identified and classified into families on the basis of sequence similarity. The purpose of this work is to identify the TF and TR complement in diverse species belonging to Stramenopiles in order to understand how these regulators may contribute to their observed diversity. We identified and classified 63 TF and TR families in 11 species of Stramenopiles. In some species we found gene families with high relative importance. Taking into account the 63 TF and TR families identified, 28 TF and TR families were established to be positively correlated with specific traits like number of predicted proteins, number of flagella and number of cell types during the life cycle. Additionally, we found gains and losses in TF and TR families specific to some species and clades, as well as, two families with high abundance specific to the autotrophic species and three families with high abundance specific to the heterotropic species. For the first time, there is a systematic search of TF and TR families in Stramenopiles. The attempts to uncover relationships between these families and the complexity of this group may be of great impact, considering that there are several important pathogens of plants and animals, as well as, important species involved in carbon cycling. Specific TF and TR families identified in this work appear to be correlated with particular traits in the Stramenopiles group and may be correlated with the high complexity and diversity in Stramenopiles.	[Javier Buitrago-Florez, Francisco] Univ Los Andes, Grp Computat & Evolutionary Biol, Bogota, Colombia; [Javier Buitrago-Florez, Francisco; Restrepo, Silvia] Univ Los Andes, Micol & Plant Pathol Lab, Bogota, Colombia; [Riano-Pacho, Diego Mauricio] CNPEM, Lab Nacl Ciecancia & Tecnol Bioetanol CTBE, Campinas, SP, Brazil	Universidad de los Andes (Colombia); Universidad de los Andes (Colombia)	Riano-Pacho, DM (corresponding author), CNPEM, Lab Nacl Ciecancia & Tecnol Bioetanol CTBE, Campinas, SP, Brazil.	diego.riano@bioetanol.org.br	Riaño-Pachón, Diego Mauricio/B-4891-2014	Riaño-Pachón, Diego Mauricio/0000-0001-9803-3465; Restrepo, Silvia/0000-0001-9016-1040	School of Sciences, Universidad de los Andes	School of Sciences, Universidad de los Andes	This work was funded by the program "Support for Assistant Professors" from the School of Sciences, Universidad de los Andes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Andersen RA, 2004, AM J BOT, V91, P1508, DOI 10.3732/ajb.91.10.1508; Bhattacharya D, 2004, BIOESSAYS, V26, P50, DOI 10.1002/bies.10376; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Cavalier-Smith T, 2003, EUR J PROTISTOL, V39, P338, DOI 10.1078/0932-4739-00002; Cavalier-Smith T, 2010, PHILOS T R SOC B, V365, P111, DOI 10.1098/rstb.2009.0161; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Felsenstein J, 1985, AM NAT, V125, P15; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745; Gregory TR, 2001, BIOL REV, V76, P65, DOI 10.1017/S1464793100005595; Ives AR, 2010, SYST BIOL, V59, P9, DOI 10.1093/sysbio/syp074; Iyer LM, 2008, INT J PARASITOL, V38, P1, DOI 10.1016/j.ijpara.2007.07.018; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kuck P, 2010, MOL PHYLOGENET EVOL, V56, P1115, DOI 10.1016/j.ympev.2010.04.024; Lang D, 2010, GENOME BIOL EVOL, V2, P488, DOI 10.1093/gbe/evq032; Latchman DS, 2001, TRENDS BIOCHEM SCI, V26, P211, DOI 10.1016/S0968-0004(01)01812-6; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Riano-Pachon DM, 2008, GENETICS, V179, P31, DOI 10.1534/genetics.107.086090; Riano-Pachon DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-42; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strimmer K, 2008, BIOINFORMATICS, V24, P1461, DOI 10.1093/bioinformatics/btn209; Team RDC, 2019, R LANG ENV STAT COMP; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Zhang H, 2011, NUCLEIC ACIDS RES, V39, pD1114, DOI 10.1093/nar/gkq1141	28	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111841	10.1371/journal.pone.0111841	http://dx.doi.org/10.1371/journal.pone.0111841			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375671	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402600066
J	Nakamae, T; Sakai, Y; Abe, Y; Nishida, S; Fukui, K; Yamada, K; Kubota, M; Denys, D; Narumoto, J				Nakamae, Takashi; Sakai, Yuki; Abe, Yoshinari; Nishida, Seiji; Fukui, Kenji; Yamada, Kei; Kubota, Manabu; Denys, Damiaan; Narumoto, Jin			Altered Fronto-Striatal Fiber Topography and Connectivity in Obsessive-Compulsive Disorder	PLOS ONE			English	Article							WHITE-MATTER ABNORMALITIES; DEEP BRAIN-STIMULATION; SURFACE-BASED ANALYSIS; DIFFUSION-TENSOR; FUNCTIONAL CONNECTIVITY; HUMAN THALAMUS; BASAL GANGLIA; TRACTOGRAPHY; MRI; SEGMENTATION	Fronto-striatal circuits are hypothesized to be involved in the pathophysiology of obsessive-compulsive disorder (OCD). Within this circuitry, ventral frontal regions project fibers to the ventral striatum (VS) and dorsal frontal regions to the dorsal striatum. Resting state fMRI research has shown higher functional connectivity between the orbitofrontal cortex (OFC) and the dorsal part of the VS in OCD patients compared to healthy controls (HC). Therefore, we hypothesized that in OCD the OFC predominantly project fibers to the more dorsal part of the VS, and that the structural connectivity between the OFC and VS is higher compared to HC. A total of 20 non-medicated OCD patients and 20 HC underwent diffusion-weighted imaging. Connectivity-based parcellation analyses were performed with the striatum as seed region and the OFC, dorsolateral prefrontal cortex, and dorsal anterior cingulate cortex as target regions. Obtained connectivity maps for each frontal region of interest (ROI) were normalized into standard space, and Z-component (dorsal-ventral) coordinate of center-of-gravity (COG) were compared between two groups. Probabilistic tractography was performed to investigate diffusion indices of fibers between the striatum and frontal ROIs. COG Z-component coordinates of connectivity maps for OFC ROI were located in the more dorsal part of the VS in OCD patients compared to HC. Fractional anisotropy of fibers between the OFC and the striatum was higher in OCD patients compared to HC. Part of the pathophysiology of OCD might be understood by altered topography and structural connectivity of fibers between the OFC and the striatum.	[Nakamae, Takashi; Sakai, Yuki; Abe, Yoshinari; Nishida, Seiji; Fukui, Kenji; Narumoto, Jin] Kyoto Prefectural Univ Med, Dept Psychiat, Grad Sch Med Sci, Kyoto, Japan; [Nakamae, Takashi; Sakai, Yuki; Narumoto, Jin] Adv Telecommun Res Inst Int, Computat Neurosci Labs, Kyoto, Japan; [Yamada, Kei] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Radiol, Kyoto, Japan; [Kubota, Manabu] Kyoto Univ, Grad Sch Med, Dept Psychiat, Kyoto, Japan; [Denys, Damiaan] Univ Amsterdam, Acad Med Ctr, Dept Neuropsychiat, NL-1105 AZ Amsterdam, Netherlands; [Denys, Damiaan] Inst Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands	Kyoto Prefectural University of Medicine; Advanced Telecommunications Research Institute International; Kyoto Prefectural University of Medicine; Kyoto University; University of Amsterdam; Academic Medical Center Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Nakamae, T (corresponding author), Kyoto Prefectural Univ Med, Dept Psychiat, Grad Sch Med Sci, Kyoto, Japan.	nakamae@koto.kpu-m.ac.jp	Sakai, Yuki/AAV-6231-2021; Yamada, Kei/AAY-8398-2020; Nakamae, Takashi/E-7545-2018	Sakai, Yuki/0000-0003-2475-8548; Nakamae, Takashi/0000-0003-4265-198X; Abe, Yoshinari/0000-0001-8348-0801; Narumoto, Jin/0000-0002-8262-3177	MEXT KAKENHI [24791223, 23591724]; SENSHIN Medical Research Foundation	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation)	TN received grant support from MEXT KAKENHI (No.24791223, http://www.jsps.go.jp/j-grantsinaid/) and SENSHIN Medical Research Foundation (http://www.mt-pharma.co.jp/zaidan/). JN received grant support from MEXT KAKENHI (No. 23591724, http://www.jsps.go.jp/j-grantsinaid/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors report no financial relationships with commercial interests.	Ahmari SE, 2013, SCIENCE, V340, P1234, DOI 10.1126/science.1234733; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Benedetti F, 2013, EUR NEUROPSYCHOPHARM, V23, P581, DOI 10.1016/j.euroneuro.2012.07.002; Beucke JC, 2013, JAMA PSYCHIAT, V70, P619, DOI 10.1001/jamapsychiatry.2013.173; Burguiere E, 2013, SCIENCE, V340, P1243, DOI 10.1126/science.1232380; Cohen MX, 2009, NAT NEUROSCI, V12, P32, DOI 10.1038/nn.2228; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de Wit SJ, 2014, AM J PSYCHIAT, V171, P340, DOI 10.1176/appi.ajp.2013.13040574; Del Casale A, 2011, NEUROPSYCHOBIOLOGY, V64, P61, DOI 10.1159/000325223; Denys D, 2010, ARCH GEN PSYCHIAT, V67, P1061, DOI 10.1001/archgenpsychiatry.2010.122; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Fan Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035889; Figee M, 2013, NAT NEUROSCI, V16, P386, DOI 10.1038/nn.3344; First MB, 1997, STRUCTURES CLIN INTE; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Giorgio A, 2010, NEUROIMAGE, V49, P94, DOI 10.1016/j.neuroimage.2009.08.003; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Harrison BJ, 2013, BIOL PSYCHIAT, V73, P321, DOI 10.1016/j.biopsych.2012.10.006; Harrison BJ, 2009, ARCH GEN PSYCHIAT, V66, P1189, DOI 10.1001/archgenpsychiatry.2009.152; Jakab A, 2012, BRAIN IMAGING BEHAV, V6, P472, DOI 10.1007/s11682-012-9172-5; Jakab A, 2012, BRAIN TOPOGR, V25, P264, DOI 10.1007/s10548-011-0205-y; Jayarajan RN, 2012, DEPRESS ANXIETY, V29, P780, DOI 10.1002/da.21890; Jbabdi S, 2013, J NEUROSCI, V33, P3190, DOI 10.1523/JNEUROSCI.2457-12.2013; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Jones D.K., 2010, IMAGING MED, V2, P341, DOI [10.2217/iim.10.21, DOI 10.2217/IIM.10.21]; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Jones DK, 2005, NEUROIMAGE, V26, P546, DOI 10.1016/j.neuroimage.2005.02.013; Jung WH, 2013, NEUROIMAGE-CLIN, V3, P27, DOI 10.1016/j.nicl.2013.06.013; Kanaan RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091109; Klein A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00171; Lehman JF, 2011, J NEUROSCI, V31, P10392, DOI 10.1523/JNEUROSCI.0595-11.2011; Lochner C, 2012, J PSYCHIATR NEUROSCI, V37, P193, DOI 10.1503/jpn.110059; Marenco S, 2012, NEUROPSYCHOPHARMACOL, V37, P499, DOI 10.1038/npp.2011.215; Menzies L, 2008, NEUROSCI BIOBEHAV R, V32, P525, DOI 10.1016/j.neubiorev.2007.09.005; NAKAJIMA T, 1995, PSYCHIAT CLIN NEUROS, V49, P121, DOI 10.1111/j.1440-1819.1995.tb01875.x; Nakamae T, 2011, J PSYCHIATR RES, V45, P687, DOI 10.1016/j.jpsychires.2010.09.016; Piras F, 2013, NEUROSCI BIOBEHAV R, V37, P2856, DOI 10.1016/j.neubiorev.2013.10.008; Posner J, 2014, HUM BRAIN MAPP, V35, P2852, DOI 10.1002/hbm.22371; Putnam MC, 2010, J COGNITIVE NEUROSCI, V22, P1662, DOI 10.1162/jocn.2009.21290; Radua J, 2009, BRIT J PSYCHIAT, V195, P393, DOI 10.1192/bjp.bp.108.055046; Rotge JY, 2009, BIOL PSYCHIAT, V65, P75, DOI 10.1016/j.biopsych.2008.06.019; Sakai Y, 2011, EUR PSYCHIAT, V26, P463, DOI 10.1016/j.eurpsy.2010.09.005; Samanez-Larkin GR, 2012, J NEUROSCI, V32, P5333, DOI 10.1523/JNEUROSCI.5756-11.2012; Schmithorst VJ, 2002, RADIOLOGY, V222, P212, DOI 10.1148/radiol.2221010626; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Tziortzi AC, 2014, CEREB CORTEX, V24, P1165, DOI 10.1093/cercor/bhs397; van den Heuvel M, 2008, J NEUROSCI, V28, P10844, DOI 10.1523/JNEUROSCI.2964-08.2008; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165; Yoo SY, 2007, ACTA PSYCHIAT SCAND, V116, P211, DOI 10.1111/j.1600-0447.2007.01046.x; Zarei M, 2011, BIOL PSYCHIAT, V70, P1083, DOI 10.1016/j.biopsych.2011.06.032	60	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112075	10.1371/journal.pone.0112075	http://dx.doi.org/10.1371/journal.pone.0112075			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XM	25375933	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600096
J	Szyniszewska, AM; Tatem, AJ				Szyniszewska, Anna M.; Tatem, Andrew J.			Global Assessment of Seasonal Potential Distribution of Mediterranean Fruit Fly, Ceratitis capitata (Diptera: Tephritidae)	PLOS ONE			English	Article							ANASTREPHA-FRATERCULUS DIPTERA; DOMINANT ANOPHELES VECTORS; FLIES DIPTERA; SPP. DIPTERA; SPATIOTEMPORAL DISTRIBUTION; GEOGRAPHICAL-DISTRIBUTION; POPULATION FLUCTUATIONS; DISTRIBUTION PATTERNS; WIEDEMANN DIPTERA; DISTRIBUTION MAPS	The Mediterranean fruit fly (Medfly) is one of the world's most economically damaging pests. It displays highly seasonal population dynamics, and the environmental conditions suitable for its abundance are not constant throughout the year in most places. An extensive literature search was performed to obtain the most comprehensive data on the historical and contemporary spatio-temporal occurrence of the pest globally. The database constructed contained 2328 unique geolocated entries on Medfly detection sites from 43 countries and nearly 500 unique localities, as well as information on hosts, life stages and capture method. Of these, 125 localities had information on the month when Medfly was recorded and these data were complemented by additional material found in comprehensive databases available online. Records from 1980 until present were used for medfly environmental niche modeling. Maximum Entropy Algorithm (MaxEnt) and a set of seasonally varying environmental covariates were used to predict the fundamental niche of the Medfly on a global scale. Three seasonal maps were also produced: January-April, May-August and September-December. Models performed significantly better than random achieving high accuracy scores, indicating a good discrimination of suitable versus unsuitable areas for the presence of the species.	[Szyniszewska, Anna M.] Univ Florida, Dept Geog, Gainesville, FL 32611 USA; [Tatem, Andrew J.] Univ Southampton, Dept Geog & Environm, Highland Hts, KY USA; [Tatem, Andrew J.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Szyniszewska, AM (corresponding author), Univ Florida, Dept Geog, Gainesville, FL 32611 USA.	aniasz@gmail.com	Szyniszewska, Anna/A-3232-2016	Szyniszewska, Anna/0000-0002-4897-3878; Tatem, Andrew/0000-0002-7270-941X	USDA-APHIS-PPQ-CPHST Cooperative Agreement [12-8130-0158-CA]; NIH/NIAID [U19A1089674]; Bill & Melinda Gates Foundation [OPP110642749446, 1032350]; RAPIDD program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089674] Funding Source: NIH RePORTER	USDA-APHIS-PPQ-CPHST Cooperative Agreement; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); RAPIDD program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was financed by the USDA-APHIS-PPQ-CPHST Cooperative Agreement No. 12-8130-0158-CA titled "Construction of Multi-Disciplinary Tools to Assess Seasonal Risk of Mediterranean Fruit Fly Ceratitis Capitata (Medfly) importation to Florida and California.' AJT is supported by funding from NIH/NIAID (U19A1089674), the Bill & Melinda Gates Foundation (OPP110642749446, 1032350), and the RAPIDD program of the Science and Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Galil FA, 2009, ARCH PHYTOPATHOL PLA, V43, DOI [10.1080/03235400R02021272, DOI 10.1080/03235400R02021272]; Aguiar EE, 1996, POPULATION DYNAMICS; Aguiar-Menezes EL, 2001, FLA ENTOMOL, V84, P706, DOI 10.2307/3496405; Alemany A., 2004, BOLET N SANIDAD VEGE, V30, P255; Aluja M, 2005, ENVIRON ENTOMOL, V34, P1507, DOI 10.1603/0046-225X-34.6.1507; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; [Anonymous], 2012, EEA Technical Report; [Anonymous], 2003, TRAPP GUID AR WID FR; APHIS, 1999, MED FRUIT FLY FACTSH; APHJS, 1992, RISK ASS MED FRUIT F; Argov Y, 2008, BIOL CONTROL, V46, P502, DOI 10.1016/j.biocontrol.2008.04.021; Augier L, 2007, FRUIT FLIES ADULTS M; AVERY JW, 1994, J ENTOMOL SCI, V29, P543, DOI 10.18474/0749-8004-29.4.543; Back EA, 1914, J AGRIC RES, V3, P311; Baker RHA, 2000, AGR ECOSYST ENVIRON, V82, P57, DOI 10.1016/S0167-8809(00)00216-4; Bariani R, OSSERVAZIONI BIOL CO; Barr NB, 2009, J ECON ENTOMOL, V102, P401, DOI 10.1603/029.102.0153; Batllori L., 2008, IOBC/WPRS Bulletin, V37, P73; Bjelis M., 2007, Zbornik predavanj in referatov, 8. Slovenskega postvetovanja o varstvu Rastlin, Radenci, Slovenija, 6-7 Marec, 2007, P321; Bjelis M., 2006, INT S FRUIT FLIES EC; Bjelis M, 2004, TEPHRITID FRUIT FLY, p[325, 329]; Bloem K, 1993, RELATIVE EFFECTIVENE; Bohonak Andrew J., 2001, Biological Invasions, V3, P103, DOI 10.1023/A:1014559617282; Bonizzoni M, 2004, MOL ECOL, V13, P3845, DOI 10.1111/j.1365-294X.2004.02371.x; Borge MNR, 1997, B ENTOMOL RES, V87, P405, DOI 10.1017/S000748530003741X; CABI, 2000, CER CAP DISTR MAPS P; Caceres C, 2007, FLA ENTOMOL, V90, P103, DOI 10.1653/0015-4040(2007)90[103:APFSAL]2.0.CO;2; Carey JR, 2008, AGING CELL, V7, P426, DOI 10.1111/j.1474-9726.2008.00390.x; Carey JR, 2011, EXP GERONTOL, V46, P404, DOI 10.1016/j.exger.2010.09.009; Carey JR, 1996, ECOLOGY, V77, P1690, DOI 10.2307/2265775; Carey JR, 1996, BIOL CONSERV, V78, P35, DOI 10.1016/0006-3207(96)00016-X; CAREY JR, 1991, SCIENCE, V253, P1369, DOI 10.1126/science.1896848; CAYOL JP, 1993, J APPL ENTOMOL, V116, P94, DOI 10.1111/j.1439-0418.1993.tb01172.x; Cayol JP, 2004, FRUIT FLY CONTROL MO, P155; CELEDONIOHURTADO H, 1995, ENVIRON ENTOMOL, V24, P861, DOI 10.1093/ee/24.4.861; Cohen Y, 2008, COMPUT ELECTRON AGR, V62, P107, DOI 10.1016/j.compag.2007.12.005; Copeland RS, 2002, ANN ENTOMOL SOC AM, V95, P672, DOI 10.1603/0013-8746(2002)095[0672:IHOCCD]2.0.CO;2; Cross E, 2004, CUST BORD PROT TODAY; Dantas L, 2004, STT PROGRAMME MEDFLY, P127; Davies N, 1999, GENETICS, V153, P351; De Lima CPF, 2008, ACTA HORTIC, V803, P51; De Meyer M, 2008, J BIOGEOGR, V35, P270, DOI 10.1111/j.1365-2699.2007.01769.x; Demirel N., 2007, Journal of Entomology, V4, P129; Diamantidis AD, 2011, BIOL J LINN SOC, V102, P334, DOI 10.1111/j.1095-8312.2010.01579.x; Dominiak BC, 2012, AUST J ENTOMOL, V51, P104, DOI 10.1111/j.1440-6055.2011.00842.x; Duyck P, 2006, J ANIM ECOL J, V75, P526; Duyck PF, 2006, J ANIM ECOL, V75, P518, DOI 10.1111/j.1365-2656.2006.01072.x; Duyck PF, 2002, B ENTOMOL RES, V92, P461, DOI 10.1079/BER2002188; El Keroumi A, 2010, BIOCONTROL SCI TECHN, V20, P751, DOI 10.1080/09583151003734651; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Enkerlin W, 1997, J ECON ENTOMOL, V90, P1066, DOI 10.1093/jee/90.5.1066; EPPO, 2009, DAT SHEETS QUAR PEST; EPPO, 2001, PQR EPPO DAT QUAR PE; Escudero-Colomar LA, 2008, J APPL ENTOMOL, V132, P714, DOI 10.1111/j.1439-0418.2008.01372.x; Eskafi F, 1990, BIOCONTROL, V35, P355, DOI [DOI 10.1007/BF02375259, 10.1007/BF02375259]; ESKAFI FM, 1990, ENVIRON ENTOMOL, V19, P1371, DOI 10.1093/ee/19.5.1371; ESKAFI FM, 1990, ENVIRON ENTOMOL, V19, P148, DOI 10.1093/ee/19.1.148; Fimiani P., 1989, World Crop Pests, V3A, P39; Fischer-Colbrie P., 1989, World Crop Pests, V3A, P91; Gallejas C, 2004, SOD SEQUENCES CERATI, P435; Gasparich GE, 1997, ANN ENTOMOL SOC AM, V90, P790, DOI 10.1093/aesa/90.6.790; Gasperi G, 2002, GENETICA, V116, P125, DOI 10.1023/A:1020971911612; Gevrey M, 2006, J ECON ENTOMOL, V99, P979, DOI 10.1603/0022-0493-99.3.979; Gjullin CM, 1931, ECOLOGY, V12, P248, DOI 10.2307/1931632; Grout TG, 2007, ENVIRON ENTOMOL, V36, P1310, DOI 10.1603/0046-225X(2007)36[1310:DRACTO]2.0.CO;2; Gutierrez AP, 2011, BIOL INVASIONS, V13, P2661, DOI 10.1007/s10530-011-9937-6; HARRIS EJ, 1993, ENVIRON ENTOMOL, V22, P404, DOI 10.1093/ee/22.2.404; HARRIS EJ, 1991, ENVIRON ENTOMOL, V20, P174, DOI 10.1093/ee/20.1.174; Hay SI, 2006, ADV PARASIT, V62, P37, DOI 10.1016/S0065-308X(05)62002-7; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000209; He M, 1999, MOL ECOL, V8, P1247, DOI 10.1046/j.1365-294X.1999.00685.x; HEDSTROM I, 1993, INT J PEST MANAGE, V39, P400, DOI 10.1080/09670879309371831; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HONEK A, 1990, Zoologische Jahrbuecher Abteilung fuer Systematik Oekologie und Geographie der Tiere, V117, P401; Hunt MK, 2004, BIOL J LINN SOC, V81, P347, DOI 10.1111/j.1095-8312.2003.00300.x; (IAEA) International Atomic Energy Agency, 2013, TEPHR WORK DAT; Israely N, 2005, J ECON ENTOMOL, V98, P739, DOI 10.1603/0022-0493-98.3.739; Israely N, 2005, ANN ENTOMOL SOC AM, V98, P77, DOI 10.1603/0013-8746(2005)098[0077:SDPOMF]2.0.CO;2; Israely N, 2004, J ECON ENTOMOL, V97, P33, DOI 10.1603/0022-0493-97.1.33; Israely N, 1997, ENVIRON ENTOMOL, V26, P1263, DOI 10.1093/ee/26.6.1263; Jang EB, 2007, FRUIT ILIES THEIR IM; Katsoyannos BI, 1999, J ECON ENTOMOL, V92, P583, DOI 10.1093/jee/92.3.583; Katsoyannos BI, 1998, ANN ENTOMOL SOC AM, V91, P43, DOI 10.1093/aesa/91.1.43; Katsoyarmos BI, 2004, EFFECTS CITRUS PEEL, P13; KOURTI A, 1992, ENTOMOL EXP APPL, V63, P63, DOI 10.1007/BF00350347; Kwasi W., 2009, J DEV SUSTAIN AGR, V3, P117; Lanzavecchia SB, 2008, ANN ENTOMOL SOC AM, V101, P627, DOI 10.1603/0013-8746(2008)101[627:OADOCC]2.0.CO;2; Larcher-Carvalho A, 2004, COST BENEFIT ANAL SU, P143; Leza MM, 2008, J APPL ENTOMOL, V132, P753, DOI 10.1111/j.1439-0418.2008.01370.x; Li BN, 2009, J ECON ENTOMOL, V102, P1781, DOI 10.1603/029.102.0508; Liquido NJ, 1990, J ECON ENTOMOL, V83, P1863; Livingston MJ, 2007, MEDITERRANEAN FRUIT; Lobo Aguirre C., 1997, DISTRIBUCION REGISTR; Lysandrou M., 2009, Arab Journal of Plant Protection, V27, P236; Maelzer DA, 2004, AUST J EXP AGR, V44, P109, DOI 10.1071/EA01128; Malacrida AR, 2007, GENETICA, V131, P1, DOI 10.1007/s10709-006-9117-2; Malacrida AR, 1998, J HERED, V89, P501, DOI 10.1093/jhered/89.6.501; Martinez-Ferrer MT, 2010, SPAN J AGRIC RES, V8, P757, DOI 10.5424/sjar/2010083-1275; Mavrikakis PG, 2000, ENVIRON ENTOMOL, V29, P1180, DOI 10.1603/0046-225X-29.6.1180; McPheron BA, 1996, FRUIT FLY PESTS WORL; Meats A, 2007, J APPL ENTOMOL, V131, P518, DOI 10.1111/j.1439-0418.2007.01168.x; Medeiros Aida, 2007, Arquipelago Boletim da Universidade dos Acores Ciencias Biologicas e Marinhas, P33; Meixner MD, 2002, MOL ECOL, V11, P891, DOI 10.1046/j.1365-294X.2002.01488.x; Merz B, 2005, REV SUISSE ZOOL, V112, P983, DOI 10.5962/bhl.part.80334; Michelakis SE, 1992, ISRAEL J ENTOMOL, V25, P177; Midgarden D, 2006, P 7 INT S FRUIT FLIE, P10; Mirsardoo S., 2010, Journal of Entomological Research, V2, P143; Mkize N, 2008, BIOCONTROL SCI TECHN, V18, P991, DOI 10.1080/09583150802450154; Mohamed SA, 2006, BIOL CONTROL, V39, P262, DOI 10.1016/j.biocontrol.2006.08.016; Morales P., ENTOMOTROPICA, V19, P51; Muller HG, 2009, P ROY SOC B-BIOL SCI, V276, P4409, DOI 10.1098/rspb.2009.1461; Navarro-Campos C, 2011, ENVIRON ENTOMOL, V40, P931, DOI 10.1603/EN10302; Navarro-Llopis V, 2008, J ECON ENTOMOL, V101, P126, DOI 10.1603/0022-0493(2008)101[126:EOTALF]2.0.CO;2; Nestel D, 2004, SPATIAL ANAL MEDFLY, P35; Nyamukondiwa C, 2009, J THERM BIOL, V34, P406, DOI 10.1016/j.jtherbio.2009.09.002; Orono LE, 2006, P 7 INT S FRUIT FLIE, P10; Oukil S, 1997, B OILBSROP, V20; Ovruski S, 2003, J ECON ENTOMOL, V96, P1108, DOI 10.1603/0022-0493-96.4.1108; Ovruski SM, 2008, FLA ENTOMOL, V91, P220, DOI 10.1653/0015-4040(2008)91[220:NOOHPA]2.0.CO;2; Ovruski SM, 2010, FLA ENTOMOL, V93, P277, DOI 10.1653/024.093.0219; Ovruski SM, 2004, BIOL CONTROL, V29, P43, DOI 10.1016/S1049-9644(03)00127-0; Paini DR, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1118; Papadopoulos N. T., 2002, P 6 INT FRUIT FLY S, P19; Papadopoulos NT, 1996, ANN ENTOMOL SOC AM, V89, P526, DOI 10.1093/aesa/89.4.526; Papadopoulos NT, 1998, ANN ENTOMOL SOC AM, V91, P430, DOI 10.1093/aesa/91.4.430; Papadopoulos NT, 2003, ENVIRON ENTOMOL, V32, P319, DOI 10.1603/0046-225X-32.2.319; Papadopoulos NT, 2002, ANN ENTOMOL SOC AM, V95, P564, DOI 10.1603/0013-8746(2002)095[0564:DPOTMF]2.0.CO;2; Papadopoulos NT, 2001, J ECON ENTOMOL, V94, P971, DOI 10.1603/0022-0493-94.4.971; Papadopoulos NT, 2001, ANN ENTOMOL SOC AM, V94, P41, DOI 10.1603/0013-8746(2001)094[0041:SAAOOT]2.0.CO;2; Peck SL, 2000, J ECON ENTOMOL, V93, P280, DOI 10.1603/0022-0493-93.2.280; Penarrubia-Maria E., 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/497087; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pires AO, 2004, VARIATION SYMMETRICA, P259; Puche H, 2005, FLA ENTOMOL, V88, P83, DOI 10.1653/0015-4040(2005)088[0083:EOEAHA]2.0.CO;2; Radonjic S, 2006, W PALAEARCTIC REGION, V29, P217; Reboulakis C, 2004, ORANGE FRUIT VOLATIL, P291; Rengifo JA, 2011, FLA ENTOMOL, V94, P91, DOI 10.1653/024.094.0112; Reyes A, 1998, ANN ENTOMOL SOC AM, V91, P222, DOI 10.1093/aesa/91.2.222; Ricalde MP, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.3301; Rigamonti IE, 2004, CONTRIBUTIONS KNOWLE; RIVNAY E, 1950, B ENTOMOL RES, V41, P321, DOI 10.1017/S0007485300027656; Ros J. P., 2004, Proceedings of the 6th International Symposium on fruit flies of economic importance, Stellenbosch, South Africa, 6-10 May 2002, P361; Ros JP, 2000, P AR WID CONTR FRUIT, P639; Saleh A., 2004, AN NAJAH U J RES N S, V18, P249; Schliserman P, 2004, REV MANEJO INTEGRADO, V72, P52; Sciarretta A, 2011, J APPL ENTOMOL, V135, P241, DOI 10.1111/j.1439-0418.2010.01515.x; Segura DF, 2006, ANN ENTOMOL SOC AM, V99, P70, DOI 10.1603/0013-8746(2006)099[0070:RAOCCA]2.0.CO;2; Segura DF, 2004, HOST UTILIZATION MED, P83; Segura Diego F, 2004, Ecol. austral, V14, P3; Siebert J. B., 1995, California Agriculture, V49, P7, DOI 10.3733/ca.v049n04p7; Silva JG, 2003, J ECON ENTOMOL, V96, P1711, DOI 10.1603/0022-0493-96.6.1711; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-117; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-72; Slioukrv A, 1979, ENTOMOL EXP APPL, V26, P33, DOI [10.1007/BF02996633, DOI 10.1007/BF02996633]; Souza SAS, 2005, NEOTROP ENTOMOL, V34, P639, DOI 10.1590/S1519-566X2005000400015; Souza MF, 2009, BRAZ J BIOL, V69, P31, DOI 10.1590/S1519-69842009000100004; Souza-Filho ZA, 2007, FLA ENTOMOL, V90, P783, DOI 10.1653/0015-4040(2007)90[783:EPAWAS]2.0.CO;2; Staub CG, 2008, AUST J ENTOMOL, V47, P184, DOI 10.1111/j.1440-6055.2008.00646.x; Suckling DM, 2008, PEST MANAG SCI, V64, P848, DOI 10.1002/ps.1578; Sugayama RL, 1997, ENTOMOL EXP APPL, V83, P239, DOI 10.1023/A:1002913018833; Terblanche JS, 2010, ENTOMOL EXP APPL, V137, P304, DOI 10.1111/j.1570-7458.2010.01067.x; Tormos J, 2010, ANN APPL BIOL, V156, P179, DOI 10.1111/j.1744-7348.2009.00377.x; Toth M., 2009, Protezione delle Colture, P34; UCHÔA-FERNANDES MANOEL A., 2002, Neotrop. entomol., V31, P515, DOI 10.1590/S1519-566X2002000400002; Vadora ML, 1993, PREDICTION CERATITIS; Vargas RI., 1989, SPATIAL DISTRIBUTION; Vargas RI, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.13501; Vayssieres JF, 2009, CROP PROT, V28, P477, DOI 10.1016/j.cropro.2009.01.010; Vera MT, 2002, ENVIRON ENTOMOL, V31, P1009, DOI 10.1603/0046-225X-31.6.1009; Villablanca FX, 1998, MOL ECOL, V7, P547, DOI 10.1046/j.1365-294x.1998.00351.x; Weldon CW, 2011, J THERM BIOL, V36, P479, DOI 10.1016/j.jtherbio.2011.08.005; Worner SP, 2006, J APPL ECOL, V43, P858, DOI 10.1111/j.1365-2664.2006.01202.x; Yuval B, 1998, ECOL ENTOMOL, V23, P211, DOI 10.1046/j.1365-2311.1998.00118.x; Zaborowski A, 2008, EVALUATION DUNE NOUV; Zeki Cevdet, 2008, Munis Entomology & Zoology, V3, P231	180	47	50	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111582	10.1371/journal.pone.0111582	http://dx.doi.org/10.1371/journal.pone.0111582			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375649	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600049
J	Zhao, HF; Qu, ML; Wang, Y; Wang, ZY; Shi, WY				Zhao, Haifeng; Qu, Mingli; Wang, Yao; Wang, Zhenyu; Shi, Weiyun			Xenogeneic Acellular Conjunctiva Matrix as a Scaffold of Tissue-Engineered Corneal Epithelium	PLOS ONE			English	Article							DRIED AMNIOTIC MEMBRANE; CROSS-LINKED COLLAGEN; OCULAR SURFACE; CELLS	Amniotic membrane-based tissue-engineered corneal epithelium has been widely used in the reconstruction of the ocular surface. However, it often degrades too early to ensure the success of the transplanted corneal epithelium when treating patients with severe ocular surface disorders. In the present study, we investigated the preparation of xenogeneic acellular conjunctiva matrix (aCM) and evaluated its efficacy and safety as a scaffold of tissue-engineered corneal epithelium. Native porcine conjunctiva was decellularized with 0.1% sodium dodecyl sulfate (SDS) for 12 h at 37 degrees C and sterilized via gamma-cirradiation. Compared with native conjunctiva, more than 92% of the DNA was removed, and more than 90% of the extracellular matrix components (glycosaminoglycan and collagen) remained after the decellularization treatment. Compared with denuded amniotic membrane (dAM), the aCM possessed favorable optical transmittance, tensile strength, stability and biocompatibility as well as stronger resistance to degradation both in vitro and in vivo. The corneal epithelial cells seeded on aCM formed a multilayered epithelial structure and endured longer than did those on dAM. The aCM-based tissue-engineered corneal epithelium was more effective in the reconstruction of the ocular surface in rabbits with limbal stem cell deficiency. These findings support the application of xenogeneic acellular conjunctiva matrix as a scaffold for reconstructing the ocular surface.	[Zhao, Haifeng] Wannan Med Coll, Yijishan Hosp, Dept Ophthalmol, Wuhu, Anhui, Peoples R China; [Zhao, Haifeng; Qu, Mingli; Wang, Yao; Wang, Zhenyu; Shi, Weiyun] Shandong Acad Med Sci, Shandong Eye Inst, State Key Lab Cultivat Base, Shandong Prov Key Lab Ophthalmol, Qingdao, Shandong, Peoples R China	Wannan Medical College; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Shi, WY (corresponding author), Shandong Acad Med Sci, Shandong Eye Inst, State Key Lab Cultivat Base, Shandong Prov Key Lab Ophthalmol, Qingdao, Shandong, Peoples R China.	weiyunshi@163.com			National Basic Research Program of China [2013CB967004]; National High Technology Research and Development Program of China [2006AA02A132]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	The National Basic Research Program of China (2013CB967004), the National High Technology Research and Development Program of China (2006AA02A132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaminos M, 2006, INVEST OPHTH VIS SCI, V47, P3311, DOI 10.1167/iovs.05-1647; Brown S, 2001, BIOTECHNIQUES, V30, P38, DOI 10.2144/01301bm06; Carlsson David J, 2003, Curr Opin Ophthalmol, V14, P192, DOI 10.1097/00055735-200308000-00004; Dua HS, 2004, SURV OPHTHALMOL, V49, P51, DOI 10.1016/j.survophthal.2003.10.004; Duan X, 2006, BIOMATERIALS, V27, P4608, DOI 10.1016/j.biomaterials.2006.04.022; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Gomes ME, 2001, BIOMATERIALS, V22, P1911, DOI 10.1016/S0142-9612(00)00377-X; Han B, 2002, CORNEA, V21, P505, DOI 10.1097/00003226-200207000-00013; Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016; Kirkeby S, 2002, XENOTRANSPLANTATION, V9, P260, DOI 10.1034/j.1399-3089.2002.01078.x; Koizumi N, 2000, INVEST OPHTH VIS SCI, V41, P2506; Koizumi N, 2002, INVEST OPHTH VIS SCI, V43, P2114; Lee SH, 1997, AM J OPHTHALMOL, V123, P303, DOI 10.1016/S0002-9394(14)70125-4; Liu L, 2007, BIOMATERIALS, V28, P3807, DOI 10.1016/j.biomaterials.2007.04.025; Liu W, 2008, BIOMATERIALS, V29, P1147, DOI 10.1016/j.biomaterials.2007.11.011; Nakamura T, 2004, INVEST OPHTH VIS SCI, V45, P93, DOI 10.1167/iovs.03-0752; Nakamura T, 2008, BIOMATERIALS, V29, P3729, DOI 10.1016/j.biomaterials.2008.05.023; Rafat M, 2008, BIOMATERIALS, V29, P3960, DOI 10.1016/j.biomaterials.2008.06.017; Sasaki S, 2009, MOL VIS, V15, P2022; Swift GJ, 1996, TRANSPLANTATION, V62, P568, DOI 10.1097/00007890-199609150-00005; Torbet J, 2007, BIOMATERIALS, V28, P4268, DOI 10.1016/j.biomaterials.2007.05.024; Whitcher John P., 2002, International Ophthalmology Clinics, V42, P71; Wilshaw SP, 2006, TISSUE ENG, V12, P2117, DOI 10.1089/ten.2006.12.2117; Woods T, 2005, BIOMATERIALS, V26, P7339, DOI 10.1016/j.biomaterials.2005.05.066	24	14	14	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111846	10.1371/journal.pone.0111846	http://dx.doi.org/10.1371/journal.pone.0111846			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375996	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402600069
J	Schneiderova, I; Zouhar, J				Schneiderova, Irena; Zouhar, Jan			Resting-Associated Vocalization Emitted by Captive Asian House Shrews (Suncus murinus): Acoustic Structure and Variability in an Unusual Mammalian Vocalization	PLOS ONE			English	Article							VOCAL REPERTOIRE; CROCIDURA-RUSSULA; GROUND-SQUIRRELS; NEOMYS-FODIENS; CONTACT CALLS; WATER-SHREW; COMMUNICATION; BEHAVIOR; SORICIDAE; GUAM	Shrews have rich vocal repertoires that include vocalizations within the human audible frequency range and ultrasonic vocalizations. Here, we recorded and analyzed in detail the acoustic structure of a vocalization with unclear functional significance that was spontaneously produced by 15 adult, captive Asian house shrews (Suncus murinus) while they were lying motionless and resting in their nests. This vocalization was usually emitted repeatedly in a long series with regular intervals. It showed some structural variability; however, the shrews most frequently emitted a tonal, low-frequency vocalization with minimal frequency modulation and a low, non-vocal click that was clearly noticeable at its beginning. There was no effect of sex, but the acoustic structure of the analyzed vocalizations differed significantly between individual shrews. The encoded individuality was low, but it cannot be excluded that this individuality would allow discrimination of family members, i.e., a male and female with their young, collectively resting in a common nest. The question remains whether the Asian house shrews indeed perceive the presence of their mates, parents or young resting in a common nest via the resting-associated vocalization and whether they use it to discriminate among their family members. Additional studies are needed to explain the possible functional significance of resting-associated vocalizations emitted by captive Asian house shrews. Our study highlights that the acoustic communication of shrews is a relatively understudied topic, particularly considering that they are highly vocal mammals.	[Schneiderova, Irena] Czech Univ Life Sci, Fac Forestry & Wood Sci, Dept Game Management & Wildlife Biol, Prague, Czech Republic; [Zouhar, Jan] Univ Econ, Fac Informat & Stat, Dept Econometr, Prague, Czech Republic	Czech University of Life Sciences Prague; Prague University of Economics & Business	Schneiderova, I (corresponding author), Czech Univ Life Sci, Fac Forestry & Wood Sci, Dept Game Management & Wildlife Biol, Prague, Czech Republic.	schneiderova@fld.czu.cz	Zouhar, Jan/E-9659-2013	Zouhar, Jan/0000-0002-1164-7948; Schneiderova, Irena/0000-0001-5485-7630	Internal Grant Agency of the Czech University of Life Sciences in Prague (CIGA) [20134311]	Internal Grant Agency of the Czech University of Life Sciences in Prague (CIGA)	IS was supported by Internal Grant Agency of the Czech University of Life Sciences in Prague (CIGA), project no. 20134311. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, WALKERS MAMMALS WORL; Arnold BD, 2011, BEHAV ECOL SOCIOBIOL, V65, P1581, DOI 10.1007/s00265-011-1168-4; BEECHER MD, 1989, ANIM BEHAV, V38, P248, DOI 10.1016/S0003-3472(89)80087-9; Bezerra BM, 2008, INT J PRIMATOL, V29, P671, DOI 10.1007/s10764-008-9250-0; Blumstein DT, 2005, ANIM BEHAV, V69, P353, DOI 10.1016/j.anbehav.2004.10.001; CANTONI D, 1989, ANIM BEHAV, V38, P205, DOI 10.1016/S0003-3472(89)80083-1; Cap H, 2008, CLADISTICS, V24, P917, DOI 10.1111/j.1096-0031.2008.00223.x; Carter GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038791; Clay Z, 2012, ANIM BEHAV, V83, P323, DOI 10.1016/j.anbehav.2011.12.008; Credner S, 1997, J COMP PHYSIOL A, V180, P245, DOI 10.1007/s003590050045; DRYDEN GL, 1968, J MAMMAL, V49, P51, DOI 10.2307/1377727; Ehrlich C, 2006, KLEINSAUGER TERRARIU; Fitch W.T., 2002, ACOUSTIC COMMUNICATI, V16, P65; Fitch WT, 2002, ANIM BEHAV, V63, P407, DOI 10.1006/anbe.2001.1912; Fons R, 1974, TERRE VIE, V1, P131; Fritts TH, 1998, ANNU REV ECOL SYST, V29, P113, DOI 10.1146/annurev.ecolsys.29.1.113; Gillam EH, 2012, ANIM BEHAV, V83, P269, DOI 10.1016/j.anbehav.2011.11.002; Gould E., 1969, Communications in Behavioral Biology (Ser A), V3, P11; Hashimoto H, 2004, EXP ANIM TOKYO, V53, P53, DOI 10.1538/expanim.53.53; HASKELL D, 1994, P ROY SOC B-BIOL SCI, V257, P161, DOI 10.1098/rspb.1994.0110; HASLER MJ, 1977, J MAMMAL, V58, P285, DOI 10.2307/1379327; HUTTERER R, 1977, Bonner Zoologische Beitraege, V28, P218; HUTTERER R, 1978, Z SAUGETIERKD, V43, P330; Hutterer R, 2008, IUCN 2013 IUCN RED L; Jones C.G, 1993, P ROYAL SOC ARTS SCI, V5, P71; Jones G, 2007, P R SOC B, V274, P905, DOI 10.1098/rspb.2006.0200; Klump GM, 1984, J COMP ETHOL, V66, P189; Knornschild M, 2010, ACTA CHIROPTEROL, V12, P205, DOI 10.3161/150811010X504707; KOHLER D, 1987, ZOOL JAHRB ALLG ZOOL, V91, P89; Kohler D, 1998, BUB, V3, P91; Long CV, 2007, BIOACOUSTICS, V16, P223, DOI 10.1080/09524622.2007.9753579; Long JL, 2003, INTRO MAMMALS WORLD; LOUCH CD, 1966, J MAMMAL, V47, P73, DOI 10.2307/1378070; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; Matrosova VA, 2007, BEHAV ECOL SOCIOBIOL, V62, P181, DOI 10.1007/s00265-007-0452-9; Maurello MA, 2000, J MAMMAL, V81, P415, DOI 10.1644/1545-1542(2000)081<0415:SCICCO>2.0.CO;2; Messeri P, 1987, ITAL J ZOOL, V19, P341; MOVCHAN VN, 1982, ZOOL ZH, V61, P1695; Mumm CAS, 2014, ANIM BEHAV, V88, P243, DOI 10.1016/j.anbehav.2013.12.005; PEPPER JW, 1991, BIOL NAKED MOLE RAT, P241; Peters Gustav, 1999, Journal of Mammalian Evolution, V6, P129, DOI 10.1023/A:1020620121416; Romanow P, 1996, CONTRIB ZOOL, V66, P43; Rutovskaya MV, 2011, BIOL BULL+, V38, P927, DOI 10.1134/S1062359011090068; Schneiderova I, 2014, ACTA THERIOL, V59, P149, DOI 10.1007/s13364-013-0141-1; Shapiro A. D., 2009, HDB MAMMALIAN VOCALI, P495; Siemers BM, 2009, BIOL LETTERS, V5, P593, DOI 10.1098/rsbl.2009.0378; Simeonovska-Nikolova DM, 2004, ACTA THERIOL, V49, P157, DOI 10.1007/BF03192517; SOLOW AR, 1990, ECOLOGY, V71, P2379, DOI 10.2307/1938650; Temple JL, 2004, ILAR J, V45, P25, DOI 10.1093/ilar.45.1.25; TSUJI K, 1984, BEHAVIOUR, V90, P167, DOI 10.1163/156853984X00605; Tsuji Keiichiro, 1999, Japanese Journal of Animal Psychology, V49, P1; VOGEL P, 1981, J ZOOL, V195, P549; Volodina EV, 2010, BIOACOUSTICS, V20, P87; ZIMMERMANN E, 1985, BEHAVIOUR, V94, P212, DOI 10.1163/156853985X00190	54	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111571	10.1371/journal.pone.0111571	http://dx.doi.org/10.1371/journal.pone.0111571			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390304	Green Submitted, Green Published, gold			2022-12-27	WOS:000349144400025
J	Lendvai, AZ; Ouyang, JQ; Schoenle, LA; Fasanello, V; Haussmann, MF; Bonier, F; Moore, IT				Lendvai, Adam Z.; Ouyang, Jenny Q.; Schoenle, Laura A.; Fasanello, Vincent; Haussmann, Mark F.; Bonier, Frances; Moore, Ignacio T.			Experimental Food Restriction Reveals Individual Differences in Corticosterone Reaction Norms with No Oxidative Costs	PLOS ONE			English	Article							STRESS-INDUCED CORTICOSTERONE; LIFE-HISTORY; BASE-LINE; PHENOTYPIC PLASTICITY; PLASMA-CORTICOSTERONE; REPRODUCTIVE SUCCESS; ANIMAL PERSONALITY; NATURAL-SELECTION; HOUSE SPARROWS; RESPONSES	Highly plastic endocrine traits are thought to play a central role in allowing organisms to respond rapidly to environmental change. Yet, not all individuals display the same degree of plasticity in these traits, and the costs of this individual variation in plasticity are unknown. We studied individual differences in corticosterone levels under varying conditions to test whether there are consistent individual differences in (1) baseline corticosterone levels; (2) plasticity in the hormonal response to an ecologically relevant stressor (food restriction); and (3) whether individual differences in plasticity are related to fitness costs, as estimated by oxidative stress levels. We took 25 wild-caught house sparrows into captivity and assigned them to repeated food restricted and control treatments (60% and 110% of their daily food intake), such that each individual experienced both food restricted and control diets twice. We found significant individual variation in baseline corticosterone levels and stress responsiveness, even after controlling for changes in body mass. However, these individual differences in hormonal responsiveness were not related to measures of oxidative stress. These results have implications for how corticosterone levels may evolve in natural populations and raise questions about what we can conclude from phenotypic correlations between hormone levels and fitness measures.	[Lendvai, Adam Z.; Ouyang, Jenny Q.; Schoenle, Laura A.; Moore, Ignacio T.] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA; [Ouyang, Jenny Q.] Netherlands Inst Ecol NIOO KNAW, Wageningen, Netherlands; [Fasanello, Vincent; Haussmann, Mark F.] Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA; [Bonier, Frances] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada	Virginia Polytechnic Institute & State University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Bucknell University; Queens University - Canada	Lendvai, AZ (corresponding author), Univ Debrecen, Dept Evolutionary Zool, H-4012 Debrecen, Hungary.	lendvai@vt.edu	Schoenle, Laura/J-7978-2016; Schoenle, Laura A/M-9614-2017; Lendvai, Adam Z/B-8546-2008; Fasanello, Vincent/ABC-8322-2020; KNAW, NIOO-KNAW/A-4320-2012	Schoenle, Laura/0000-0002-9591-1194; Lendvai, Adam Z/0000-0002-8953-920X; KNAW, NIOO-KNAW/0000-0002-3835-159X	U.S. National Science Foundation (NSF) [IOS-1145625]; Natural Sciences and Engineering Research Council of Canada; Eotvos State Grant from the Hungarian Scholarship Board (Balassi Institute); NSF [DBI-1306025]	U.S. National Science Foundation (NSF)(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Eotvos State Grant from the Hungarian Scholarship Board (Balassi Institute); NSF(National Science Foundation (NSF))	Funding was provided by a U.S. National Science Foundation (NSF) grant (FB, ITM, and MFH; IOS-1145625), and by the Natural Sciences and Engineering Research Council of Canada Banting Postdoctoral Fellowship (FB). AZL was supported by an Eotvos State Grant from the Hungarian Scholarship Board (Balassi Institute), LS by the Virginia Tech Institute for Critical Technology and Applied Science. During the preparation of the manuscript, JQO was supported by a NSF postdoctoral grant (DBI-1306025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins-Regan E, 2008, PHILOS T R SOC B, V363, P1599, DOI 10.1098/rstb.2007.0005; Angelier F, 2009, P ROY SOC B-BIOL SCI, V276, P3545, DOI 10.1098/rspb.2009.0868; Baugh AT, 2012, GEN COMP ENDOCR, V175, P488, DOI 10.1016/j.ygcen.2011.12.012; Bennett AJ, 2008, DEV PSYCHOBIOL, V50, P48, DOI 10.1002/dev.20263; Biro PA, 2010, TRENDS ECOL EVOL, V25, P653, DOI 10.1016/j.tree.2010.08.003; Bokony V, 2009, AM NAT, V173, P589, DOI 10.1086/597610; Bonier F, 2010, TRENDS ECOL EVOL, V25, P262, DOI 10.1016/j.tree.2010.01.009; Bonier F, 2009, TRENDS ECOL EVOL, V24, P634, DOI 10.1016/j.tree.2009.04.013; Breuner CW, 1999, J EXP ZOOL, V284, P334, DOI 10.1002/(SICI)1097-010X(19990801)284:3<334::AID-JEZ11>3.3.CO;2-R; Brommer JE, 2013, CURR ZOOL, V59, P485, DOI 10.1093/czoolo/59.4.485; Brommer JE, 2013, BEHAV ECOL SOCIOBIOL, V67, P1027, DOI 10.1007/s00265-013-1527-4; Buck CL, 2007, GEN COMP ENDOCR, V150, P430, DOI 10.1016/j.ygcen.2006.10.011; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Chevin LM, 2013, AM NAT, V182, P13, DOI 10.1086/670613; Cockrem JF, 2010, BRIT POULTRY SCI, V51, P453, DOI 10.1080/00071668.2010.503637; Cockrem JF, 2013, GEN COMP ENDOCR, V181, P45, DOI 10.1016/j.ygcen.2012.11.025; Cockrem JF, 2009, GEN COMP ENDOCR, V163, P158, DOI 10.1016/j.ygcen.2009.03.029; Conti G, 2012, P NATL ACAD SCI USA, V109, P8866, DOI 10.1073/pnas.1205340109; Costantini D, 2008, ECOL LETT, V11, P1238, DOI 10.1111/j.1461-0248.2008.01246.x; Costantini D, 2008, J COMP PHYSIOL B, V178, P829, DOI 10.1007/s00360-008-0270-z; Costantini D, 2011, J COMP PHYSIOL B, V181, P447, DOI 10.1007/s00360-011-0566-2; Crespi EJ, 2013, FUNCT ECOL, V27, P93, DOI 10.1111/1365-2435.12009; Dingemanse NJ, 2013, J ANIM ECOL, V82, P39, DOI 10.1111/1365-2656.12013; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P261, DOI 10.1016/j.tree.2010.01.008; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; Dingemanse NJ, 2013, ANIM BEHAV; Dochtermann NA, 2013, BEHAV ECOL, V24, P806, DOI 10.1093/beheco/art002; Epel ES, 2009, HORM-INT J ENDOCRINO, V8, P7, DOI 10.14310/horm.2002.1217; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Evans MR, 2006, J EVOLUTION BIOL, V19, P343, DOI 10.1111/j.1420-9101.2005.01034.x; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fokidis HB, 2012, J EXP BIOL, V215, P2920, DOI 10.1242/jeb.071043; Fokidis HB, 2011, PHYSIOL BIOCHEM ZOOL, V84, P595, DOI 10.1086/662068; Fokidis HB, 2009, GEN COMP ENDOCR, V160, P259, DOI 10.1016/j.ygcen.2008.12.005; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gomez-Mestre I, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1869; Goutte A, 2011, HORM BEHAV, V59, P167, DOI 10.1016/j.yhbeh.2010.11.004; Groscolas R, 2008, HORM BEHAV, V53, P51, DOI 10.1016/j.yhbeh.2007.08.010; Hadfield JD, 2010, J EVOLUTION BIOL, V23, P494, DOI 10.1111/j.1420-9101.2009.01915.x; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Haussmann MF, 2012, P ROY SOC B-BIOL SCI, V279, P1447, DOI 10.1098/rspb.2011.1913; Haussmann MF, 2010, CURR ZOOL, V56, P714, DOI 10.1093/czoolo/56.6.714; Hill GE, 2011, ECOL LETT, V14, P625, DOI 10.1111/j.1461-0248.2011.01622.x; Jenkins BR, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1302; Kitaysky AS, 2001, BEHAV ECOL, V12, P619, DOI 10.1093/beheco/12.5.619; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Lendvai AZ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1734; Lendvai AZ, 2008, HORM BEHAV, V53, P395, DOI 10.1016/j.yhbeh.2007.11.011; Lendvai AZ, 2007, P ROY SOC B-BIOL SCI, V274, P391, DOI 10.1098/rspb.2006.3735; Lessells CM, 2008, PHILOS T R SOC B, V363, P1589, DOI 10.1098/rstb.2007.0008; Love OP, 2008, HORM BEHAV, V54, P496, DOI 10.1016/j.yhbeh.2008.01.006; Love OP, 2014, GEN COMP ENDOCR, V199, P65, DOI 10.1016/j.ygcen.2014.01.001; Love OP, 2013, FUNCT ECOL, V27, P81, DOI 10.1111/j.1365-2435.2012.02040.x; MacDougall-Shackleton SA, 2009, BIOL LETTERS, V5, P746, DOI 10.1098/rsbl.2009.0382; MacDougall-Shackleton SA, 2013, GEN COMP ENDOCR, V190, P188, DOI 10.1016/j.ygcen.2013.05.026; Malueg AL, 2009, BEHAV ECOL SOCIOBIOL, V63, P687, DOI 10.1007/s00265-008-0702-5; Martin LB, 2012, J EXP BIOL, V215, P4097, DOI 10.1242/jeb.073049; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; McGlothlin JW, 2010, AM NAT, V175, P687, DOI 10.1086/652469; Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Narayan EJ, 2013, COMP BIOCHEM PHYS A, V164, P21, DOI 10.1016/j.cbpa.2012.10.001; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Ottinger MA, 2005, MECH AGEING DEV, V126, P967, DOI 10.1016/j.mad.2005.03.017; Ouyang JQ, 2013, J EVOLUTION BIOL, V26, P1988, DOI 10.1111/jeb.12202; Ouyang JQ, 2011, P ROY SOC B-BIOL SCI, V278, P2537, DOI 10.1098/rspb.2010.2490; Overli O, 2005, INTEGR COMP BIOL, V45, P463, DOI 10.1093/icb/45.3.463; Patterson SH, 2014, J EVOLUTION BIOL, V27, P259, DOI 10.1111/jeb.12286; Pigliucci M., 2001, SYN ECO EVO; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; R Core Team, 2021, R LANGUAGE ENV STAT; Rensel MA, 2011, HORM BEHAV, V59, P497, DOI 10.1016/j.yhbeh.2011.01.010; Romero LM, 2008, GEN COMP ENDOCR, V156, P27, DOI 10.1016/j.ygcen.2007.10.001; Romero LM, 2006, GEN COMP ENDOCR, V149, P58, DOI 10.1016/j.ygcen.2006.05.004; Romero LM, 2010, P ROY SOC B-BIOL SCI, V277, P3157, DOI 10.1098/rspb.2010.0678; Schmidt KL, 2014, GEN COMP ENDOCR, V196, P72, DOI 10.1016/j.ygcen.2013.11.014; Schoech SJ, 2013, FUNCT ECOL, V27, P1100, DOI 10.1111/1365-2435.12142; Selman C, 2012, TRENDS ECOL EVOL, V27, P570, DOI 10.1016/j.tree.2012.06.006; Speakman JR, 2014, BIOESSAYS, V36, P93, DOI 10.1002/bies.201300108; Spencer KA, 2009, ENDOCRINOLOGY, V150, P1931, DOI 10.1210/en.2008-1471; Strochlic DE, 2008, COMP BIOCHEM PHYS A, V149, P68, DOI 10.1016/j.cbpa.2007.10.011; Treidel LA, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0684; van de Pol MV, 2009, ANIM BEHAV, V77, P753, DOI 10.1016/j.anbehav.2008.11.006; Wilcoxen TE, 2011, GEN COMP ENDOCR, V173, P461, DOI 10.1016/j.ygcen.2011.07.007; Williams TD, 2008, PHILOS T R SOC B, V363, P1687, DOI 10.1098/rstb.2007.0003; Wingfield JC, 2003, J NEUROENDOCRINOL, V15, P711, DOI 10.1046/j.1365-2826.2003.01033.x; WINGFIELD JC, 1994, PERSPECTIVES IN COMPARATIVE ENDOCRINOLOGY, P520; WINGFIELD JC, 1992, HORM BEHAV, V26, P145, DOI 10.1016/0018-506X(92)90038-W; Wolf M, 2008, P NATL ACAD SCI USA, V105, P15825, DOI 10.1073/pnas.0805473105	91	50	50	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e110564	10.1371/journal.pone.0110564	http://dx.doi.org/10.1371/journal.pone.0110564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386675	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400010
J	Muscarella, R; Uriarte, M; Erickson, DL; Swenson, NG; Zimmerman, JK; Kress, WJ				Muscarella, Robert; Uriarte, Maria; Erickson, David L.; Swenson, Nathan G.; Zimmerman, Jess K.; Kress, W. John			A Well-Resolved Phylogeny of the Trees of Puerto Rico Based on DNA Barcode Sequence Data	PLOS ONE			English	Article							MISSING DATA; COMMUNITY STRUCTURE; PLANT-COMMUNITIES; DIVERSITY; TRAIT; ACCURACY; ECOLOGY; COEXISTENCE; PATTERNS; HISTORY	Background: The use of phylogenetic information in community ecology and conservation has grown in recent years. Two key issues for community phylogenetics studies, however, are (i) low terminal phylogenetic resolution and (ii) arbitrarily defined species pools. Methodology/principal findings: We used three DNA barcodes (plastid DNA regions rbcL, matK, and trnH-psbA) to infer a phylogeny for 527 native and naturalized trees of Puerto Rico, representing the vast majority of the entire tree flora of the island (89%). We used a maximum likelihood (ML) approach with and without a constraint tree that enforced monophyly of recognized plant orders. Based on 50% consensus trees, the ML analyses improved phylogenetic resolution relative to a comparable phylogeny generated with PHYLOMATIC (proportion of internal nodes resolved: constrained ML = 74%, unconstrained ML = 68%, PHYLOMATIC = 52%). We quantified the phylogenetic composition of 15 protected forests in Puerto Rico using the constrained ML and PHYLOMATIC phylogenies. We found some evidence that tree communities in areas of high water stress were relatively phylogenetically clustered. Reducing the scale at which the species pool was defined (from island to soil types) changed some of our results depending on which phylogeny (ML vs. PHYLOMATIC) was used. Overall, the increased terminal resolution provided by the ML phylogeny revealed additional patterns that were not observed with a less-resolved phylogeny. Conclusions/significance: With the DNA barcode phylogeny presented here (based on an island-wide species pool), we show that a more fully resolved phylogeny increases power to detect nonrandom patterns of community composition in several Puerto Rican tree communities. Especially if combined with additional information on species functional traits and geographic distributions, this phylogeny will (i) facilitate stronger inferences about the role of historical processes in governing the assembly and composition of Puerto Rican forests, (ii) provide insight into Caribbean biogeography, and (iii) aid in incorporating evolutionary history into conservation planning.	[Muscarella, Robert; Uriarte, Maria] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Erickson, David L.; Kress, W. John] Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, MRC 166, Washington, DC 20013 USA; [Swenson, Nathan G.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Zimmerman, Jess K.] Univ Puerto Rico, Dept Environm Sci, San Juan, PR 00925 USA	Columbia University; Smithsonian Institution; Smithsonian National Museum of Natural History; Michigan State University; University of Puerto Rico; University of Puerto Rico Rio Piedras	Muscarella, R (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA.	bob.muscarella@gmail.com			NSF DEB [1050957, 1311367]; Smithsonian Institution; Division Of Environmental Biology [1239764, 1311367] Funding Source: National Science Foundation	NSF DEB(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Smithsonian Institution(Smithsonian Institution); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by NSF DEB 1050957 to MU, NSF DEB 1311367 to MU and RM, and the Smithsonian Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Rodriguez P., 2011, FLORA W INDIES CATAL; Ackerly DD, 2007, ECOL LETT, V10, P135, DOI 10.1111/j.1461-0248.2006.01006.x; Adler PB, 2013, ECOL LETT, V16, P1294, DOI 10.1111/ele.12157; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Axelrod F.S., 2011, SYSTEMATIC VADEMECUM; Bawiec W. J., 1998, 9838 GEOL SURV US; Beaulieu JM, 2012, ECOLOGY, V93, pS4, DOI 10.1890/11-0638.1; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Brunbjerg AK, 2014, J PLANT ECOL, V7, P101, DOI 10.1093/jpe/rtt069; Cavender-Bares J, 2004, AM NAT, V163, P823, DOI 10.1086/386375; Cavender-Bares J, 2006, ECOLOGY, V87, pS109, DOI 10.1890/0012-9658(2006)87[109:PSOFPC]2.0.CO;2; Cavender-Bares J, 2012, ECOLOGY, V93, pS1, DOI 10.1890/12-0092.1; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Crozier RH, 1997, ANNU REV ECOL SYST, V28, P243, DOI 10.1146/annurev.ecolsys.28.1.243; Daly C, 2003, INT J CLIMATOL, V23, P1359, DOI 10.1002/joc.937; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davies TJ, 2012, ECOLOGY, V93, P242, DOI 10.1890/11-1360.1; de Bello F, 2012, ECOLOGY, V93, P2263, DOI 10.1890/11-1394.1; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards EJ, 2010, P NATL ACAD SCI USA, V107, P2532, DOI 10.1073/pnas.0909672107; Eiserhardt WL, 2013, BOT J LINN SOC, V171, P244, DOI 10.1111/j.1095-8339.2012.01276.x; Ewel J.J., 1973, ECOLOGICAL LIFE ZONE; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Felsenstein J., 2004, INFERRING PHYLOGENIE; Gesch D. B., 2007, DIGITAL ELEVATION MO, P99; Gotelli NJ, 2012, OIKOS, V121, P171, DOI 10.1111/j.1600-0706.2011.20301.x; Gould W., 2008, IITFGTR39 USDA FOR S, V165, DOI DOI 10.2737/IITF-GTR-39; Hardy OJ, 2008, J ECOL, V96, P914, DOI 10.1111/j.1365-2745.2008.01421.x; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; HOLDRIDGE LR, 1947, SCIENCE, V105, P367, DOI 10.1126/science.105.2727.367; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kembel SW, 2006, ECOLOGY, V87, pS86, DOI 10.1890/0012-9658(2006)87[86:TPSOAN]2.0.CO;2; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kivlin SN, 2011, SOIL BIOL BIOCHEM, V43, P2294, DOI 10.1016/j.soilbio.2011.07.012; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015409; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lessard JP, 2012, TRENDS ECOL EVOL, V27, P600, DOI 10.1016/j.tree.2012.07.006; Lessard JP, 2012, P ROY SOC B-BIOL SCI, V279, P266, DOI 10.1098/rspb.2011.0552; Letcher SG, 2012, PERSPECT PLANT ECOL, V14, P79, DOI 10.1016/j.ppees.2011.09.005; Letcher SG, 2010, P ROY SOC B-BIOL SCI, V277, P97, DOI 10.1098/rspb.2009.0865; Little E.L., 1964, COMMON TREES PUERTO; Little E. L., 1974, TREES PUERTO RICO VI; Liu K, 2012, SYST BIOL, V61, P90, DOI 10.1093/sysbio/syr095; Losos JB, 1996, ECOLOGY, V77, P1344, DOI 10.2307/2265532; Magallon S, 2009, AM J BOT, V96, P349, DOI 10.3732/ajb.0800060; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; McMahon MM, 2006, SYST BIOL, V55, P818, DOI 10.1080/10635150600999150; Mi XC, 2012, AM NAT, V180, pE17, DOI 10.1086/665999; Miller GL, 2009, IITFGTR35 USDA FOR S, P437; Miller M.A., 2010, P GAT COMP ENV WORKS; Munkemuller T, 2014, GLOBAL ECOL BIOGEOGR, V23, P620, DOI 10.1111/geb.12137; Nabhan AR, 2012, BRIEF BIOINFORM, V13, P122, DOI 10.1093/bib/bbr014; Parmentier I, 2014, J ECOL, V102, P1008, DOI 10.1111/1365-2745.12254; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; PICKETT STA, 1978, ECOLOGY, V59, P1248, DOI 10.2307/1938238; Poe S, 1999, NATURE, V398, P299, DOI 10.1038/18592; Poe S, 2003, SYST BIOL, V52, P423, DOI 10.1080/10635150390197046; R Development Core Team, 2012, R LANG ENV STAT COMP; Rannala B, 1998, SYST BIOL, V47, P702, DOI 10.1080/106351598260680; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Ricklefs RE, 2011, PHILOS T R SOC B, V366, P2438, DOI 10.1098/rstb.2011.0066; Schoch CL, 2009, STUD MYCOL, P1, DOI 10.3114/sim.2009.64.01; Sedio BE, 2012, J ECOL, V100, P1183, DOI 10.1111/j.1365-2745.2012.01993.x; Silvertown J, 2006, ECOLOGY, V87, pS39, DOI 10.1890/0012-9658(2006)87[39:PATHOO]2.0.CO;2; Smith SA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-37; Stefanovic S, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-35; STEVENS PF, 2001, ANGIOSPERM PHYLOGENY; Swenson NG, 2007, ECOLOGY, V88, P1770, DOI 10.1890/06-1499.1; Swenson NG, 2014, J PLANT ECOL, V7, P166, DOI 10.1093/jpe/rtt074; Swenson NG, 2013, ECOGRAPHY, V36, P264, DOI 10.1111/j.1600-0587.2012.00121.x; Swenson NG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004390; Swenson NG, 2012, PHYLOGENETIC FUNCTIO; Uriarte M, 2010, ECOL LETT, V13, P1503, DOI 10.1111/j.1461-0248.2010.01541.x; USFS, 2006, FOR INV AN NAT COR F; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; Vellend Mark, 2011, P194; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wiens JJ, 2006, J BIOMED INFORM, V39, P34, DOI 10.1016/j.jbi.2005.04.001; Wiens JJ, 1998, SYST BIOL, V47, P625, DOI 10.1080/106351598260635; Wiens JJ, 2011, SYST BIOL, V60, P719, DOI 10.1093/sysbio/syr025; WILLIAMS P H, 1991, Australian Systematic Botany, V4, P665, DOI 10.1071/SB9910665; Willis CG, 2008, P NATL ACAD SCI USA, V105, P17029, DOI 10.1073/pnas.0806446105	91	19	20	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112843	10.1371/journal.pone.0112843	http://dx.doi.org/10.1371/journal.pone.0112843			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386879	Green Published, Green Submitted, gold			2022-12-27	WOS:000345250400096
J	Renner, SC; Gossner, MM; Kahl, T; Kalko, EKV; Weisser, WW; Fischer, M; Allan, E				Renner, Swen C.; Gossner, Martin M.; Kahl, Tiemo; Kalko, Elisabeth K. V.; Weisser, Wolfgang W.; Fischer, Markus; Allan, Eric			Temporal Changes in Randomness of Bird Communities across Central Europe	PLOS ONE			English	Article							LAND-USE INTENSIFICATION; FOREST FRAGMENTATION; HABITAT; DIVERSITY; QUALITY	Many studies have examined whether communities are structured by random or deterministic processes, and both are likely to play a role, but relatively few studies have attempted to quantify the degree of randomness in species composition. We quantified, for the first time, the degree of randomness in forest bird communities based on an analysis of spatial autocorrelation in three regions of Germany. The compositional dissimilarity between pairs of forest patches was regressed against the distance between them. We then calculated the y-intercept of the curve, i.e. the 'nugget', which represents the compositional dissimilarity at zero spatial distance. We therefore assume, following similar work on plant communities, that this represents the degree of randomness in species composition. We then analysed how the degree of randomness in community composition varied over time and with forest management intensity, which we expected to reduce the importance of random processes by increasing the strength of environmental drivers. We found that a high portion of the bird community composition could be explained by chance (overall mean of 0.63), implying that most of the variation in local bird community composition is driven by stochastic processes. Forest management intensity did not consistently affect the mean degree of randomness in community composition, perhaps because the bird communities were relatively insensitive to management intensity. We found a high temporal variation in the degree of randomness, which may indicate temporal variation in assembly processes and in the importance of key environmental drivers. We conclude that the degree of randomness in community composition should be considered in bird community studies, and the high values we find may indicate that bird community composition is relatively hard to predict at the regional scale.	[Renner, Swen C.; Kalko, Elisabeth K. V.] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany; [Renner, Swen C.] Natl Zool Pk, Smithsonian Conservat Biol Inst, Front Royal, VA USA; [Gossner, Martin M.; Weisser, Wolfgang W.] Tech Univ Munich, Ctr Food & Life Sci Weihenstephan, Dept Ecol & Ecosyst Management, Terr Ecol Res Grp, Freising Weihenstephan, Germany; [Kahl, Tiemo] Univ Freiburg, Chair Silviculture, D-79106 Freiburg, Germany; [Fischer, Markus] Univ Bern, Inst Plant Sci & Bot Garden, Bern, Switzerland; [Allan, Eric] Univ Bern, Inst Plant Sci, Bern, Switzerland	Ulm University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Technical University of Munich; University of Freiburg; University of Bern; University of Bern	Renner, SC (corresponding author), Univ Nat Resources & Life Sci, Inst Zool, Vienna, Austria.	swen.renner@boku.ac.at	Gossner, Martin M./J-2730-2015; Fischer, Markus/C-6411-2008; Weisser, Wolfgang W/B-9718-2014; Allan, Eric/AAR-9566-2020	Gossner, Martin M./0000-0003-1516-6364; Fischer, Markus/0000-0002-5589-5900; Weisser, Wolfgang W/0000-0002-2757-8959; Allan, Eric/0000-0001-9641-9436; /0000-0002-6893-4219	German Science Foundation Priority Program 1374 Infrastructure Biodiversity-Exploratories [Ka 1241/19-1, Re 1733/6-1]	German Science Foundation Priority Program 1374 Infrastructure Biodiversity-Exploratories	The work has been funded by the German Science Foundation(www.dfg.de) Priority Program 1374 Infrastructure Biodiversity-Exploratories (Ka 1241/19-1, Re 1733/6-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alldredge MW, 2008, J APPL ECOL, V45, P1349, DOI 10.1111/j.1365-2664.2008.01517.x; Boulinier T, 2001, ECOLOGY, V82, P1159, DOI 10.1890/0012-9658(2001)082[1159:FFABCD]2.0.CO;2; Bradbury RB, 2005, IBIS, V147, P443, DOI 10.1111/j.1474-919x.2005.00438.x; Brownstein G, 2012, J ECOL, V100, P987, DOI 10.1111/j.1365-2745.2012.01973.x; Chalcraft DR, 2004, ECOLOGY, V85, P2701, DOI 10.1890/03-0561; Colwell R.K., 2006, ESTIMATES STAT ESTIM; DRAKE JA, 1999, NATURE ASSEMBLY TRAJ, P233; Eglington SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030407; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Farmer RG, 2012, AUK, V129, P76, DOI 10.1525/auk.2012.11129; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Gillies CS, 2008, P NATL ACAD SCI USA, V105, P19774, DOI 10.1073/pnas.0803530105; Glutz von Blotzheim UN, 1988, HDB VOGEL MITTELEURO; Goetz SJ, 2010, ECOLOGY, V91, P1569, DOI 10.1890/09-1670.1; Gossner MM, 2013, BIOL CONSERV, V166, P212, DOI 10.1016/j.biocon.2013.06.033; Gotelli NJ, 2012, OIKOS, V121, P171, DOI 10.1111/j.1600-0706.2011.20301.x; Grothendieck G, 2013, NLS2 NONLINEAR REGRE; Hanski I., 1999, METAPOPULATION ECOLO; Haskell JP, 2002, NATURE, V418, P527, DOI 10.1038/nature00840; Hines J, 2013, PROGRAM PRESENCE 61; Honnay O, 2001, ECOLOGY, V82, P1691, DOI 10.1890/0012-9658(2001)082[1691:PCAADN]2.0.CO;2; Hubbell S.P., 1986, COMMUNITY ECOLOGY, P314; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Kahl T, 2014, NAT CONSERV-BULGARIA, P15, DOI 10.3897/natureconservation.7.7281; Kennedy CM, 2010, ECOL MONOGR, V80, P651, DOI 10.1890/09-0904.1; Kubiczek K, 2014, PEERJ, V2, DOI 10.7717/peerj.368; Laliberte E, 2010, ECOL LETT, V13, P76, DOI 10.1111/j.1461-0248.2009.01403.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; McLoughlin PD, 2000, EVOL ECOL, V14, P39, DOI 10.1023/A:1011019031766; Mistral M, 2000, J VEG SCI, V11, P911, DOI 10.2307/3236561; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Renner SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053121; Sauer JR, 2012, N AM BREEDING BIRD S; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Stouffer PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020543; Suarez-Rubio M, 2011, J ORNITHOL, V152, P461, DOI 10.1007/s10336-010-0605-x	41	16	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112347	10.1371/journal.pone.0112347	http://dx.doi.org/10.1371/journal.pone.0112347			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386924	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400056
J	Soong, C; Kurabi, B; Wells, D; Caines, L; Morgan, MW; Ramsden, R; Bell, CM				Soong, Christine; Kurabi, Bochra; Wells, David; Caines, Lesley; Morgan, Matthew W.; Ramsden, Rebecca; Bell, Chaim M.			Do Post Discharge Phone Calls Improve Care Transitions? A Cluster-Randomized Trial	PLOS ONE			English	Article							HOSPITAL DISCHARGE; QUALITY; REHOSPITALIZATION; INTERVENTION; HOME	Importance: The transition from hospital to home can expose patients to adverse events during the post discharge period. Post discharge care including phone calls may provide support for patients returning home but the impact on care transitions is unknown. Objective: To examine the effect of a 72-hour post discharge phone call on the patient's transition of care experience. Design: Cluster-randomized control trial. Setting: Urban, academic medical center. Participants: General medical patients age 18 and older discharged home after hospitalization. Main Outcomes and Measures: Primary outcome measure was the Care Transition Measure (CTM-3) score, a validated measure of the quality of care transitions. Secondary measures included self-reported adherence to medication and follow up plans, and 30-day composite of emergency department (ED) visits and hospital readmission. Results: 328 patients were included in the study over an 6-month period. 114 (69%) received a post discharge phone call, and 214 of all patients in the study completed the follow outcome survey (65% response rate). A small difference in CTM-3 scores was observed between the intervention and control groups (1.87 points, 95% CI 0.47-3.27, p = 0.01). Self-reported adherence to treatment plans, ED visits, and emergency readmission rates were similar between the two groups (odds ratio 0.57, 95% CI 0.13-2.45, 1.20, 95% CI 0.61-2.37, and 1.18, 95% CI 0.53-2.61, respectively). Conclusions and Relevance: A single post discharge phone call had a small impact on the quality of care transitions and no effect on hospital utilization. Higher intensity post discharge support may be required to improve the patient experience upon returning home.	[Soong, Christine; Kurabi, Bochra; Morgan, Matthew W.; Bell, Chaim M.] Univ Toronto, Div Gen Internal Med, Toronto, ON, Canada; [Soong, Christine; Wells, David; Caines, Lesley; Morgan, Matthew W.; Ramsden, Rebecca; Bell, Chaim M.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Soong, C (corresponding author), Univ Toronto, Div Gen Internal Med, Toronto, ON, Canada.	christine.soong@utoronto.ca	Bell, Chaim/C-4611-2015	Bell, Chaim/0000-0002-3778-9469	Mount Sinai Hospital Department of Medicine Physician Fund Campaign	Mount Sinai Hospital Department of Medicine Physician Fund Campaign	This study was funded by a grant from the Mount Sinai Hospital Department of Medicine Physician Fund Campaign. The funding agency had no role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.	Arbaje AI, 2010, J AM GERIATR SOC, V58, P364, DOI 10.1111/j.1532-5415.2009.02682.x; Braun E, 2009, EUR J INTERN MED, V20, P221, DOI 10.1016/j.ejim.2008.07.021; Burke RE, 2013, JAMA INTERN MED, DOI [10.1001/jamain-ternmed.2013.171., DOI 10.1001/JAMAIN-TERNMED.2013.171]; Cain CH, 2012, J HOSP MED, V7, P382, DOI 10.1002/jhm.1918; Callen J, 2011, BMJ QUAL SAF, V20, P194, DOI 10.1136/bmjqs.2010.044339; Coleman E, 2012, COMMUNICATION; Coleman EA, 2005, MED CARE, V43, P246, DOI 10.1097/00005650-200503000-00007; Dedhia P, 2009, J AM GERIATR SOC, V57, P1540, DOI 10.1111/j.1532-5415.2009.02430.x; Dharmarajan K, 2013, JAMA-J AM MED ASSOC, V309, P355, DOI 10.1001/jama.2012.216476; Dudas V, 2001, AM J MED, V111, P26, DOI 10.1016/S0002-9343(01)00966-4; Forster AJ, 2004, CAN MED ASSOC J, V170, P345; Hansen LO, 2011, ANN INTERN MED, V155, P520, DOI 10.7326/0003-4819-155-8-201110180-00008; Hardin J.W., 2013, GEN ESTIMATING EQUAT, V2nd ed., DOI [https://doi.org/10.1201/b13880, DOI 10.1201/B13880]; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; Kangovi S, 2012, J HOSP MED, V7, P709, DOI 10.1002/jhm.1966; Kripalani S, 2012, ANN INTERN MED, V157, P1, DOI 10.7326/0003-4819-157-1-201207030-00003; Maslove DM, 2009, J GEN INTERN MED, V24, P995, DOI 10.1007/s11606-009-1053-2; Mistiaen P, 2006, COCHRANE DB SYST REV, V2006; National Research Corporation Canada, 2014, PAT FAM EXP; Parry C, 2008, MED CARE, V46, P317, DOI 10.1097/MLR.0b013e3181589bdc; Poon EG, 2004, ARCH INTERN MED, V164, P2223, DOI 10.1001/archinte.164.20.2223; Roy CL, 2005, ANN INTERN MED, V143, P121, DOI 10.7326/0003-4819-143-2-200507190-00011; Schillinger D, 2003, ARCH INTERN MED, V163, P83, DOI 10.1001/archinte.163.1.83; Society of Hospital Medicine, 2014, PROJ BOOST BETT OUTC; van Walraven C, 2004, J GEN INTERN MED, V19, P624, DOI 10.1111/j.1525-1497.2004.30082.x	25	32	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112230	10.1371/journal.pone.0112230	http://dx.doi.org/10.1371/journal.pone.0112230			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386678	Green Submitted, gold, Green Published			2022-12-27	WOS:000345250400052
J	Wang, XG; Yang, L; Wang, HJ; Shao, F; Yu, JF; Jiang, HL; Han, YP; Gong, DQ; Gu, ZL				Wang, Xingguo; Yang, Lei; Wang, Huijuan; Shao, Fang; Yu, JianFeng; Jiang, Honglin; Han, Yaoping; Gong, Daoqing; Gu, Zhiliang			Growth Hormone-Regulated mRNAs and miRNAs in Chicken Hepatocytes	PLOS ONE			English	Article							FOWL GALLUS-DOMESTICUS; LIPID-METABOLISM; IN-VIVO; GENE-EXPRESSION; ADIPOSE-TISSUE; ULTRADIAN RHYTHM; SECRETION; LIVER; GH; ACTIVATION	Growth hormone (GH) is a key regulatory factor in animal growth, development and metabolism. Based on the expression level of the GH receptor, the chicken liver is a major target organ of GH, but the biological effects of GH on the chicken liver are not fully understood. In this work we identified mRNAs and miRNAs that are regulated by GH in primary hepatocytes from female chickens through RNA-seq, and analyzed the functional relevance of these mRNAs and miRNAs through GO enrichment analysis and miRNA target prediction. A total of 164 mRNAs were found to be differentially expressed between GH-treated and control chicken hepatocytes, of which 112 were up-regulated and 52 were down-regulated by GH. A total of 225 chicken miRNAs were identified by the RNA-Seq analysis. Among these miRNAs 16 were up-regulated and 1 miRNA was down-regulated by GH. The GH-regulated mRNAs were mainly involved in growth and metabolism. Most of the GH-upregulated or GH-downregulated miRNAs were predicted to target the GH-downregulated or GH-upregulated mRNAs, respectively, involved in lipid metabolism. This study reveals that GH regulates the expression of many mRNAs involved in metabolism in female chicken hepatocytes, which suggests that GH plays an important role in regulating liver metabolism in female chickens. The results of this study also support the hypothesis that GH regulates lipid metabolism in chicken liver in part by regulating the expression of miRNAs that target the mRNAs involved in lipid metabolism.	[Wang, Xingguo; Yang, Lei; Wang, Huijuan; Shao, Fang; Yu, JianFeng; Han, Yaoping; Gu, Zhiliang] Changshu Inst Technol, Dept Life Sci & Technol, Changshu, Peoples R China; [Wang, Xingguo; Gong, Daoqing] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Peoples R China; [Jiang, Honglin] Virginia Polytech Inst & State Univ, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA	Changshu Institute of Technology; Yangzhou University; Virginia Polytechnic Institute & State University	Gu, ZL (corresponding author), Changshu Inst Technol, Dept Life Sci & Technol, Changshu, Peoples R China.	zhilianggu88@hotmail.com	wang, hui/GRS-4730-2022; wang, xingguo/AAF-3020-2020; wang, huimin/HDM-8421-2022	, Honglin/0000-0001-9540-5788	National Natural Science Foundation of China [31072025, 31272438]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (31072025, 31272438). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albagli O, 1999, ONCOGENE, V18, P5063, DOI 10.1038/sj.onc.1202892; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartke A, 2000, J ANDROL, V21, P181; Bergen WG, 2005, J NUTR, V135, P2499, DOI 10.1093/jn/135.11.2499; Brooks AJ, 2010, NAT REV ENDOCRINOL, V6, P515, DOI 10.1038/nrendo.2010.123; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Bu SY, 2009, J BIOL CHEM, V284, P30474, DOI 10.1074/jbc.M109.036665; BUONOMO FC, 1984, COMP BIOCHEM PHYS C, V78, P409, DOI 10.1016/0742-8413(84)90107-5; CAMPBELL RM, 1988, P SOC EXP BIOL MED, V188, P177; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Chen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031426; Chen YL, 2009, ENDOCRINOLOGY, V150, P3645, DOI 10.1210/en.2009-0212; Cheung L, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-13; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; CUPO MA, 1989, COMP BIOCHEM PHYS B, V94, P355, DOI 10.1016/0305-0491(89)90355-6; DAVIDSON MB, 1987, ENDOCR REV, V8, P115, DOI 10.1210/edrv-8-2-115; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Estabrook RW, 1996, P NATL ACAD SCI USA, V93, P13552, DOI 10.1073/pnas.93.24.13552; Gent J, 2002, P NATL ACAD SCI USA, V99, P9858, DOI 10.1073/pnas.152294299; Gerin I, 2010, J BIOL CHEM, V285, P33652, DOI 10.1074/jbc.M110.152090; Harvey S, 2013, GEN COMP ENDOCR, V190, P3, DOI 10.1016/j.ygcen.2013.01.008; Herrington J, 2000, ONCOGENE, V19, P2585, DOI 10.1038/sj.onc.1203526; Hull KL, 2001, J ENDOCRINOL, V168, P1, DOI 10.1677/joe.0.1680001; Jaye M, 1999, NAT GENET, V21, P424, DOI 10.1038/7766; JOHNSON RJ, 1988, J ENDOCRINOL, V119, P101, DOI 10.1677/joe.0.1190101; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lanning NJ, 2006, REV ENDOCR METAB DIS, V7, P225, DOI 10.1007/s11154-007-9025-5; LEVEILLE GA, 1968, P SOC EXP BIOL MED, V128, P398; Li RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038716; Marlow R, 2008, CANCER RES, V68, P7819, DOI 10.1158/0008-5472.CAN-08-1357; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001; OHEA EK, 1968, COMP BIOCHEM PHYSIOL, V26, P111, DOI 10.1016/0010-406X(68)90317-4; Ono M, 2007, MOL ENDOCRINOL, V21, P1443, DOI 10.1210/me.2006-0543; PRESS M, 1988, DIABETES METAB REV, V4, P391, DOI 10.1002/dmr.5610040406; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Ren H, 2013, BBA-MOL CELL BIOL L, V1831, P126, DOI 10.1016/j.bbalip.2012.07.012; Sidhu RS, 2005, J BIOL CHEM, V280, P21933, DOI 10.1074/jbc.M412966200; Stroh T, 2009, J NEUROSCI, V29, P8198, DOI 10.1523/JNEUROSCI.0336-09.2009; SUGAWARA T, 1995, BIOCHEMISTRY-US, V34, P12506, DOI 10.1021/bi00039a004; TANNENBAUM GS, 1976, ENDOCRINOLOGY, V98, P562, DOI 10.1210/endo-98-3-562; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vijayakumar A, 2010, GROWTH HORM IGF RES, V20, P1, DOI 10.1016/j.ghir.2009.09.002; Wang X, 2007, CYTOGENET GENOME RES, V117, P174, DOI 10.1159/000103178; Wang XG, 2013, POULTRY SCI, V92, P1888, DOI 10.3382/ps.2012-02919; Waters MJ, 2012, ENDOCR DEV, V23, P86, DOI 10.1159/000341761; Wells JA, 1996, P NATL ACAD SCI USA, V93, P1, DOI 10.1073/pnas.93.1.1; Winston LA, 1995, J BIOL CHEM, V270, P30837, DOI 10.1074/jbc.270.52.30837; Wu MH, 2011, INT J MOL MED, V27, P655, DOI 10.3892/ijmm.2011.624; Xie SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016235; Zhang YJ, 2012, MOL CELL BIOL, V32, P880, DOI 10.1128/MCB.06312-11; Zhang YH, 2013, DIABETES RES CLIN PR, V99, P327, DOI 10.1016/j.diabres.2012.11.025; Zhao JT, 2011, J CLIN ENDOCR METAB, V96, pE1188, DOI 10.1210/jc.2010-2679	57	19	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112896	10.1371/journal.pone.0112896	http://dx.doi.org/10.1371/journal.pone.0112896			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386791	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400102
J	Reichenbacher, B; Reichard, M				Reichenbacher, Bettina; Reichard, Martin			Otoliths of Five Extant Species of the Annual Killifish Nothobranchius from the East African Savannah	PLOS ONE			English	Article							APHANIUS-DISPAR TELEOSTEI; CYPRINODONTIFORMES NOTHOBRANCHIIDAE; SHAPE-ANALYSIS; ANNUAL FISH; INNER-EAR; KORTHAUSAE CYPRINODONTIFORMES; EVOLUTIONARY HISTORY; UTRICULAR OTOLITHS; SOUTHERN IRAN; MORPHOLOGY	This study presents, for the first time, a comprehensive dataset that documents the range of inter-and intraspecific otolith variation in aplocheiloid killifish, based on a total of 86 individuals representing five extant species of Nothobranchius PETERS, 1868, from East Africa: the sympatric pairs N. rubripinnis SEEGERS, 1986 and N. ruudwildekampi COSTA, 2009 (Eastern Tanzania), and N. orthonotus (PETERS, 1844) and N. furzeri JUBB, 1971 (Southern Mozambique), and two isolated populations of N. korthausae MEINKEN, 1973 (Eastern Tanzania). Otolith characters were analysed based on SEM images, and otolith morphometry was conducted using uni- and multivariate statistics. Two ancient clades of probably Early to Middle Miocene age in eastern Tanzania and southern Mozambique can be recognized based on otolith morphologies, which is consistent with previous work based on molecular data. The distinctive sulcus morphologies in the otoliths of sympatric species may be linked to species-specific hearing capabilities, perhaps constituting a case of character displacement in an area of secondary sympatry. The otoliths of the studied species of Nothobranchius are diagnostic at the species level, even in the case of closely related species diagnosable otherwise only by minor differences in coloration. The two populations of N. korthausae also displayed some differences in their otolith characters. The new data may facilitate future recognition of fossil species of Nothobranchius. As no fossil remains of extant aplocheiloid killifishes have yet been described, the discovery of fossil otoliths of Nothobranchius would significantly advance understanding of the evolutionary history of this interesting group of fishes.	[Reichenbacher, Bettina] Univ Munich, Dept Earth & Environm Sci, Munich, Germany; [Reichard, Martin] Acad Sci Czech Republ, Inst Vertebrate Biol, Brno, Czech Republic	University of Munich; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences	Reichenbacher, B (corresponding author), Univ Munich, Dept Earth & Environm Sci, Munich, Germany.	b.reichenbacher@lrz.uni-muenchen.de	Reichenbacher, Bettina/AAM-9684-2020; Reichard, Martin/C-6563-2009	Reichard, Martin/0000-0002-9306-0074; Reichenbacher, Bettina/0000-0001-6678-5080	CSF (Czech Science Foundation) [P505/12/G112]	CSF (Czech Science Foundation)	This work was supported by CSF (Czech Science Foundation) project P505/12/G112. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre H, 1999, J FISH BIOL, V55, P105, DOI 10.1006/jfbi.1999.0974; Altner M, 2014, PLOS ONE REV; Annabi A, 2013, SCI MAR, V77, P269, DOI 10.3989/scimar.03763.02A; Arratia Gloria, 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P9; Assis CA, 2005, SCI MAR, V69, P259, DOI 10.3989/scimar.2005.69n2259; Assis CA, 2003, J FISH BIOL, V62, P1268, DOI 10.1046/j.1095-8649.2003.00106.x; Avigliano E, 2014, FISH RES, V149, P55, DOI 10.1016/j.fishres.2013.09.013; Bartakova V, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-196; Blazek R, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-24; Brzobohaty R., 1969, FOLIA FACULTATIS SCI, V10, P1; CAMPANA SE, 1993, CAN J FISH AQUAT SCI, V50, P1062, DOI 10.1139/f93-123; Campana SE, 2004, PHOTOGRAPHIC ATLAS F; Cerling TE, 2011, NATURE, V476, P51, DOI 10.1038/nature10306; Costa WJEM, 2013, VERTEBR ZOOL, V63, P139; Costa WJEM, 2009, ICHTHYOL EXPLOR FRES, V20, P111; Costa Wilson J.E.M., 1998, P537; Doadrio I, 1996, ENVIRON BIOL FISH, V45, P259, DOI 10.1007/BF00003094; Dorn A, 2011, MOL PHYLOGENET EVOL, V61, P739, DOI 10.1016/j.ympev.2011.06.010; Dorn A, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0210-3; Esmaeili HR, 2012, ZOOTAXA, P58; Esmaeili HR, 2014, ZOOTAXA, V3786, P246, DOI 10.11646/zootaxa.3786.3.2; Fekete DM, 2003, SCIENCE, V302, P241, DOI 10.1126/science.1091171; Ferrito V, 2013, MAR BIOL, V160, P3193, DOI 10.1007/s00227-013-2307-4; Froese R., 2014, FISHBASE WORLD WIDE; Gauldie RW, 2002, J FISH BIOL, V60, P1204, DOI 10.1006/jfbi.2002.1938; Gholami Z, 2014, J ZOOL SYST EVOL RES, V52, P130, DOI 10.1111/jzs.12052; Gierl C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064117; HAAS R, 1976, EVOLUTION, V30, P614, DOI 10.1111/j.1558-5646.1976.tb00938.x; Horstkotte J, 2005, BIOL J LINN SOC, V85, P125, DOI 10.1111/j.1095-8312.2005.00476.x; Hrbek T, 2003, J EVOLUTION BIOL, V16, P17, DOI 10.1046/j.1420-9101.2003.00475.x; LEVELS PJ, 1986, COMP BIOCHEM PHYS A, V84, P767, DOI 10.1016/0300-9629(86)90403-2; LOMBARTE A, 1993, ENVIRON BIOL FISH, V37, P297, DOI 10.1007/BF00004637; Lombarte A, 2010, ENVIRON BIOL FISH, V89, P607, DOI 10.1007/s10641-010-9673-2; MALZ H, 1978, Senckenbergiana Lethaea, V59, P441; Tuset VM, 2012, SCI MAR, V76, P289, DOI 10.3989/scimar.03420.18E; Martin CH, 2011, EVOLUTION, V65, P2197, DOI 10.1111/j.1558-5646.2011.01294.x; Nolf D, 1995, BEL BAR LIB, P513; Nolf D., 2013, DIVERSITY FISH OTOLI; Nolf Dirk, 2006, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V76, P147; Oliva-Paterna FJ, 2006, ENVIRON BIOL FISH, V75, P415, DOI 10.1007/s10641-005-0001-1; Parenti LR, 1981, B AM MUS NAT HIST, V168, P335, DOI DOI 10.1080/00222930210135631; PARKER A, 1995, COPEIA, P8; Plath M, 2008, BEHAV ECOL SOCIOBIOL, V62, P1727, DOI 10.1007/s00265-008-0601-9; Polacik M, 2014, HYDROBIOLOGIA, V721, P99, DOI 10.1007/s10750-013-1652-0; Polacik M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022684; Polacik M, 2009, BEHAV ECOL SOCIOBIOL, V63, P1427, DOI 10.1007/s00265-009-0798-2; Popper AN, 2005, MAR FRESHWATER RES, V56, P497, DOI 10.1071/MF04267; POPPER AN, 1976, SCIENCE, V192, P1020, DOI 10.1126/science.1273585; Ramcharitar JU, 2004, J COMP NEUROL, V475, P531, DOI 10.1002/cne.20192; Reichard M, 2009, J FISH BIOL, V74, P198, DOI 10.1111/j.1095-8649.2008.02129.x; Reichard M, 2010, ZOOTAXA, P49; Reichard M, 2010, BIOL J LINN SOC, V100, P62, DOI 10.1111/j.1095-8312.2010.01406.x; Reichenbacher B, 2003, ECLOGAE GEOL HELV, V96, P509, DOI 10.1007/s00015-003-1098-x; Reichenbacher B, 2001, GEOBIOS-LYON, V34, P69, DOI 10.1016/S0016-6995(01)80047-4; Reichenbacher B, 2007, J MORPHOL, V268, P898, DOI 10.1002/jmor.10561; Reichenbacher B, 2009, ENVIRON BIOL FISH, V86, P507, DOI 10.1007/s10641-009-9549-5; Reichenbacher B, 2009, PALAEOGEOGR PALAEOCL, V281, P43, DOI 10.1016/j.palaeo.2009.07.008; Reichenbacher B, 2009, J MORPHOL, V270, P469, DOI 10.1002/jmor.10702; Ruckert-Ulkumen N, 2002, MITTEILUNGEN BAYERIS, V42, P51; Sadighzadeh Z, 2014, SCI MAR, V78, P353, DOI 10.3989/scimar.03982.16C; Schulz-Mirbach T, 2008, GEODIVERSITAS, V30, P577; Schulz-Mirbach T, 2008, NEUES JAHRB GEOL P-A, V249, P223, DOI 10.1127/0077-7749/2008/0249-0223; Schulz-Mirbach T, 2008, EVOL ECOL RES, V10, P537; Schulz-Mirbach T, 2006, ACTA PALAEONTOL POL, V51, P283; Schulz-Mirbach T, 2012, MAR FRESHWATER RES, V63, P934, DOI 10.1071/MF12132; Schulz-Mirbach T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027734; Schwarzhans W., 1993, PISCIUM CATALOGUS PA, VI; Schwarzhans W, 2012, ACTA PALAEONTOL POL, V57, P319, DOI 10.4202/app.2010.0127; Seegers L., 1997, KILLIFISHES WORLD OL; Shidlovskiy KM, 2010, ZOOTAXA, P37; Skelton P.H., 2001, COMPLETE GUTIDE FRES, V2nd ed.; Smale M J, 1995, OTOLITH ATLAS SO AFR, P253; Stransky C, 2008, FISH RES, V89, P159, DOI 10.1016/j.fishres.2007.09.017; Teimori A, 2014, ZOOL ANZ, V253, P327, DOI 10.1016/j.jcz.2013.12.001; Teimori A, 2012, SCI MAR, V76, P637, DOI 10.3989/scimar.03635.26C; Teimori A, 2012, J ZOOL SYST EVOL RES, V50, P289, DOI 10.1111/j.1439-0469.2012.00667.x; Teimori A, 2012, ZOOKEYS, P55, DOI 10.3897/zookeys.215.1731; Terzibasi E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003866; Torres GJ, 2000, FISH RES, V46, P5, DOI 10.1016/S0165-7836(00)00128-4; Tozzini ET, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-77; Tuset VM, 2008, SCI MAR, V72, P7, DOI 10.3989/scimar.2008.72s1199; VALDESALICI S, 2008, INT J ICHTHYOLOGY, V14, P187; Valdesalici S, 2007, ZOOTAXA, P61, DOI 10.11646/zootaxa.1587.1.5; Valdesalici S, 2012, ICHTHYOL EXPLOR FRES, V23, P19; Valdesalici Stefano, 2011, Bonn Zoological Bulletin, V60, P89; Valdesalicil S, 2003, P ROY SOC B-BIOL SCI, V270, pS189, DOI 10.1098/rsbl.2003.0048; Vignon M, 2008, J FISH BIOL, V73, P2305, DOI 10.1111/j.1095-8649.2008.02070.x; Vignon M, 2010, MAR ECOL PROG SER, V411, P231, DOI 10.3354/meps08651; Volpedo A, 2003, FISH RES, V60, P551, DOI 10.1016/S0165-7836(02)00170-4; Volpedo A., 2000, CATALOGO CLAVES OTOL, V1; Watters B.R., 2009, J AM KILLFISH ASSOC, V42, P37; Watters B.R., 2007, J AM KILLIFISH ASS, V40, P129; Wildekamp R. H., 1993, WORLD KILLIES ATLAS, VI; Wildekamp RH, 2004, WORLD KILLIES ATLAS, VIV; Wildekamp RH, 2009, ICHTHYOL EXPLOR FRES, V20, P237	95	34	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112459	10.1371/journal.pone.0112459	http://dx.doi.org/10.1371/journal.pone.0112459			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383789	Green Published, gold			2022-12-27	WOS:000344816700063
J	Spencer, NJ; Kyloh, M; Duffield, M				Spencer, Nick J.; Kyloh, Melinda; Duffield, Michael			Identification of Different Types of Spinal Afferent Nerve Endings That Encode Noxious and Innocuous Stimuli in the Large Intestine Using a Novel Anterograde Tracing Technique	PLOS ONE			English	Article							INTRAGANGLIONIC LAMINAR; RECTAL MECHANORECEPTORS; COLORECTAL DISTENSION; SMOOTH-MUSCLE; MOUSE; NEURONS; INNERVATION; GUT	In mammals, sensory stimuli in visceral organs, including those that underlie pain perception, are detected by spinal afferent neurons, whose cell bodies lie in dorsal root ganglia (DRG). One of the major challenges in visceral organs has been how to identify the different types of nerve endings of spinal afferents that transduce sensory stimuli into action potentials. The reason why spinal afferent nerve endings have been so challenging to identify is because no techniques have been available, until now, that can selectively label only spinal afferents, in high resolution. We have utilized an anterograde tracing technique, recently developed in our laboratory, which facilitates selective labeling of only spinal afferent axons and their nerve endings in visceral organs. Mice were anesthetized, lumbosacral DRGs surgically exposed, then injected with dextran-amine. Seven days post-surgery, the large intestine was removed. The characteristics of thirteen types of spinal afferent nerve endings were identified in detail. The greatest proportion of nerve endings was in submucosa (32%), circular muscle (25%) and myenteric ganglia (22%). Two morphologically distinct classes innervated myenteric ganglia. These were most commonly a novel class of intraganglionic varicose endings (IGVEs) and occasionally rectal intraganglionic laminar endings (rIGLEs). Three distinct classes of varicose nerve endings were found to innervate the submucosa and circular muscle, while one class innervated internodal strands, blood vessels, crypts of lieberkuhn, the mucosa and the longitudinal muscle. Distinct populations of sensory endings were CGRP-positive. We present the first complete characterization of the different types of spinal afferent nerve endings in a mammalian visceral organ. The findings reveal an unexpectedly complex array of different types of primary afferent endings that innervate specific layers of the large intestine. Some of the novel classes of nerve endings identified must underlie the transduction of noxious and/or innocuous stimuli from the large intestine.	[Spencer, Nick J.] Flinders Univ South Australia, Sch Med, Discipline Human Physiol, Adelaide, SA, Australia; Flinders Univ South Australia, Sch Med, Ctr Neurosci, Adelaide, SA, Australia	Flinders University South Australia; Flinders University South Australia	Spencer, NJ (corresponding author), Flinders Univ South Australia, Sch Med, Discipline Human Physiol, Adelaide, SA, Australia.	nicholas.spencer@flinders.edu.au		Spencer, Nicholas/0000-0003-2190-5303	National Health & Medical Research Council (NH& MRC) of Australia [10257566]	National Health & Medical Research Council (NH& MRC) of Australia	The authors would like to acknowledge the financial support provided by the National Health & Medical Research Council (NH& MRC) of Australia, grant #10257566, to NS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthoud HR, 1997, ANAT EMBRYOL, V195, P183, DOI 10.1007/s004290050037; BERTHOUD HR, 1992, ANAT EMBRYOL, V186, P431; BERTHOUD HR, 1992, J COMP NEUROL, V319, P261, DOI 10.1002/cne.903190206; Bornstein JC, 2006, J NEUROPHYSIOL, V96, P973, DOI 10.1152/jn.00511.2006; Brierley SM, 2004, GASTROENTEROLOGY, V127, P166, DOI 10.1053/j.gastro.2004.04.008; Brookes SJH, 2013, NAT REV GASTRO HEPAT, V10, P286, DOI 10.1038/nrgastro.2013.29; COSTA M, 1982, CIBA F SYMP, V91, P129; Costa M, 1996, NEUROSCIENCE, V75, P949, DOI 10.1016/0306-4522(96)00275-8; Furness J.B., 2006, ENTERIC NERVOUS SYST; Furness JB, 2004, CELL TISSUE RES, V317, P1, DOI 10.1007/s00441-004-0895-5; Furness JB, 2006, AUTON NEUROSCI-BASIC, V125, P81, DOI 10.1016/j.autneu.2006.01.007; Hibberd TJ, 2012, NEUROSCIENCE, V225, P118, DOI 10.1016/j.neuroscience.2012.08.040; Ivanusic JJ, 2013, J COMP NEUROL, V521, P877, DOI 10.1002/cne.23207; Kyloh M, 2014, NEUROGASTROENT MOTIL, V26, P440, DOI 10.1111/nmo.12266; Kyloh M, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00016; Lynn PA, 2011, NEUROGASTROENT MOTIL, V23, P88, DOI 10.1111/j.1365-2982.2010.01593.x; Lynn PA, 2003, GASTROENTEROLOGY, V125, P786, DOI 10.1016/S0016-5085(03)01050-3; Powley TL, 2011, NEUROSCIENCE, V186, P188, DOI 10.1016/j.neuroscience.2011.04.036; Powley TL, 2011, J COMP NEUROL, V519, P644, DOI 10.1002/cne.22541; POWLEY TL, 1991, J NEUROSCI METH, V36, P9, DOI 10.1016/0165-0270(91)90132-J; Robinson DR, 2004, NEUROGASTROENT MOTIL, V16, P113, DOI 10.1046/j.1365-2982.2003.00456.x; Song XY, 2009, GASTROENTEROLOGY, V137, P274, DOI 10.1053/j.gastro.2009.02.061; Spencer NJ, 2008, NEUROSCIENCE, V153, P518, DOI 10.1016/j.neuroscience.2008.02.054; Spencer NJ, 2008, AM J PHYSIOL-GASTR L, V294, pG855, DOI 10.1152/ajpgi.00502.2007; Tan LL, 2008, NEUROSCIENCE, V156, P334, DOI 10.1016/j.neuroscience.2008.06.071; Tan LL, 2010, NEUROSCIENCE, V166, P564, DOI 10.1016/j.neuroscience.2009.12.034; Tassicker BC, 1999, CELL TISSUE RES, V295, P437, DOI 10.1007/s004410051250; Traub RJ, 2000, NEUROREPORT, V11, P2113, DOI 10.1097/00001756-200007140-00011; Yu SY, 2005, J PHYSIOL-LONDON, V563, P831, DOI 10.1113/jphysiol.2004.079574; Zagorodnyuk VP, 2011, J PHYSIOL-LONDON, V589, P1691, DOI 10.1113/jphysiol.2010.202820	30	53	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112466	10.1371/journal.pone.0112466	http://dx.doi.org/10.1371/journal.pone.0112466			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383884	Green Published, gold			2022-12-27	WOS:000344816700065
J	Wang, HY; Feng, H; Zhang, YR; Chen, H				Wang, Haiyang; Feng, Hui; Zhang, Yanru; Chen, Hong			Contrasting Regeneration Strategies in Climax and Long-Lived Pioneer Tree Species in a Subtropical Forest	PLOS ONE			English	Article							BROAD-LEAVED FOREST; RESPROUTING ABILITY; DESERT ANNUALS; OLD-GROWTH; ALLOCATION; LIFE; COEXISTENCE; PERSISTENCE; EVERGREEN; DYNAMICS	1: This study investigated 15 coexisting dominant species in a humid subtropical evergreen broad-leaved forest in southwest China, consisting of long-lived pioneers and climax species occurring in natural and disturbed regimes. The authors hypothesized that there would be non-tradeoff scaling relationships between sprouting and seed size among species, with the aim of uncovering the ecological relationship between plant sprouting and seed characteristics in the two functional groups. 2: The sprouting variations of the species were initially examined using pairwise comparisons between natural and disturbed habitats within and across species and were noted to show a continuum in persistence niches across the forest dominants, which may underlie the maintenance of plant diversity. Second, a significantly positive, rather than tradeoff, relationship between sprout number and seed size across species within each of the two functional groups was observed, and an obvious elevational shift with a common slope among the two groups in their natural habitat was examined. The results indicate the following: 1) the relationship of seed size vs. sprouts in the natural habitat is more likely to be bet-hedging among species within a guild in a forest; 2) climax species tend to choose seeding rather than sprouting regeneration, and vice versa for the long-lived pioneers; and 3) the negative correlation between sprouting and seed dispersal under disturbed conditions may imply a tradeoff between dispersal and persistence in situ during the process of plant regeneration. 3: These findings may be of potential significance for urban greening using native species.	[Wang, Haiyang; Chen, Hong] Southwest Univ, Inst Landscape Ecol Montane Hort, Chongqing 400716, Peoples R China; [Feng, Hui; Zhang, Yanru; Chen, Hong] Southwest Univ, Dept Bot, Coll Hort & Landscape Architecture, Chongqing 400716, Peoples R China	Southwest University - China; Southwest University - China	Chen, H (corresponding author), Southwest Univ, Inst Landscape Ecol Montane Hort, Chongqing 400716, Peoples R China.	chenh.swu@gmail.com			Special Research Program for Public-Welfare Forestry [201004064]; Southwest University [SWU110032]	Special Research Program for Public-Welfare Forestry; Southwest University(Southwest University - China)	This research was funded by Special Research Program for Public-Welfare Forestry (201004064) and Southwest University (SWU110032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekare P, 2003, ECOL LETT, V6, P1109, DOI 10.1046/j.1461-0248.2003.00530.x; Bellingham PJ, 2000, OIKOS, V89, P409, DOI 10.1034/j.1600-0706.2000.890224.x; Bellingham PJ, 1996, ECOL RES, V11, P229, DOI 10.1007/BF02347781; Bond WJ, 2001, TRENDS ECOL EVOL, V16, P45, DOI 10.1016/S0169-5347(00)02033-4; Bond WJ, 2003, INT J PLANT SCI, V164, pS103, DOI 10.1086/374191; Bullock J. M., 2000, Seeds: the ecology of regeneration in plant communities, P375, DOI 10.1079/9780851994321.0375; Burrows GE, 2008, AUST J BOT, V56, P254, DOI 10.1071/BT07164; Chen H, 2010, AM J BOT, V97, P611, DOI 10.3732/ajb.0900204; Chen H, 2009, NEW PHYTOL, V183, P1212, DOI 10.1111/j.1469-8137.2009.02878.x; Clarke PJ, 2013, NEW PHYTOL, V197, P19, DOI 10.1111/nph.12001; Clauss MJ, 2000, AM NAT, V155, P168, DOI 10.1086/303314; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Da L, 2003, ACTA PHYTOECOLOGICAL, V28, P376; Del Tredici P, 2001, BOT REV, V67, P121, DOI 10.1007/BF02858075; Dietze MC, 2008, ECOL MONOGR, V78, P331, DOI 10.1890/07-0271.1; Falster D. S., 2006, SMATR STANDARDISED M; Fenner M., 2000, SEEDS ECOLOGY REGENE; Fenner M., 2005, ECOLOGY SEEDS; Gutierrez AG, 2008, J BIOGEOGR, V35, P1674, DOI 10.1111/j.1365-2699.2008.01908.x; Hodgkinson KC, 1998, OECOLOGIA, V115, P64, DOI 10.1007/s004420050492; HOUSSARD C, 1995, OECOLOGIA, V102, P70, DOI 10.1007/BF00333312; Knox KJE, 2005, FUNCT ECOL, V19, P690, DOI 10.1111/j.1365-2435.2005.01006.x; Kruger LM, 1997, FUNCT ECOL, V11, P101, DOI 10.1046/j.1365-2435.1997.00064.x; Lamont BB, 2003, EVOL ECOL, V17, P277, DOI 10.1023/A:1025535223021; Lasso E, 2009, OECOLOGIA, V161, P43, DOI 10.1007/s00442-009-1353-6; Leps J, 2003, MULTIVARIATE ANAL EC; Liu Y, 1988, ECOLOGY STUDY EVERGR; Lohier T, 2014, ANN BOT-LONDON, V114, P513, DOI 10.1093/aob/mcu128; Lusk CH, 1999, PLANT ECOL, V140, P111, DOI 10.1023/A:1009764705942; MARTINS EP, 2004, COMPARE COMPUTER PRO; Meier AR, 2012, TREE PHYSIOL, V32, P565, DOI 10.1093/treephys/tps040; Miura M, 2003, ECOL RES, V18, P115, DOI 10.1046/j.1440-1703.2003.00540.x; Miyawaki A., 1999, PLANT BIOTECHNOLOGY, V16, P15, DOI DOI 10.5511/plantbiotechnology.16.15; Moreira B, 2012, OIKOS, V121, P1577, DOI 10.1111/j.1600-0706.2011.20258.x; Nzunda EF, 2011, PLANT ECOL, V212, P1991, DOI 10.1007/s11258-011-9991-2; Nzunda EF, 2014, EVOL ECOL, V28, P735, DOI 10.1007/s10682-014-9698-7; Pake CE, 1996, ECOLOGY, V77, P1427, DOI 10.2307/2265540; PHILIPPI T, 1993, AM NAT, V142, P488, DOI 10.1086/285551; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Pratt RB, 2012, AM J BOT, V99, P1464, DOI 10.3732/ajb.1200193; SAKAI A, 1995, J PLANT RES, V108, P377, DOI 10.1007/BF02344363; Salk CF, 2011, OECOLOGIA, V166, P485, DOI 10.1007/s00442-010-1850-7; Shibata R, 2014, J ECOL, V102, P209, DOI 10.1111/1365-2745.12174; Starrfelt J, 2012, BIOL REV, V87, P742, DOI 10.1111/j.1469-185X.2012.00225.x; Turnbull C., 2005, PLANT ARCHITECTURE I; Turner I.M., 2001, CAM TROP B, DOI 10.1017/CBO9780511542206; Van Bloem SJ, 2007, TREE PHYSIOL, V27, P475, DOI 10.1093/treephys/27.3.475; Venable DL, 2007, ECOLOGY, V88, P1086, DOI 10.1890/06-1495; Vesk PA, 2004, J ECOL, V92, P310, DOI 10.1111/j.0022-0477.2004.00871.x; Wang XH, 2007, FOREST ECOL MANAG, V245, P76, DOI 10.1016/j.foreco.2007.03.043; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Warton DI, 2002, BIOMETRICAL J, V44, P161, DOI 10.1002/1521-4036(200203)44:2<161::AID-BIMJ161>3.0.CO;2-N; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Weiher E, 1999, J VEG SCI, V10, P609, DOI 10.2307/3237076; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; Wu LC, 2008, NEW FOREST, V36, P239, DOI 10.1007/s11056-008-9096-5; XIONG JH, 2005, PLANT INDEX MT JINYU; Zeng J, 1995, J SW CHINA NORMAL U, V20, P686; Zhong Z, 1988, ECOLOGICAL STUDY EVE, P696; Zhu WZ, 2012, FOREST ECOL MANAG, V278, P118, DOI 10.1016/j.foreco.2012.04.032	61	3	3	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112385	10.1371/journal.pone.0112385	http://dx.doi.org/10.1371/journal.pone.0112385			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383688	Green Submitted, gold, Green Published			2022-12-27	WOS:000344816700053
J	Wright, DK; MacEachern, S; Lee, J				Wright, David K.; MacEachern, Scott; Lee, Jaeyong			Analysis of Feature Intervisibility and Cumulative Visibility Using GIS, Bayesian and Spatial Statistics: A Study from the Mandara Mountains, Northern Cameroon	PLOS ONE			English	Article							MONUMENTAL ARCHITECTURE; VIEWSHED ANALYSIS; LANDSCAPES; ARCHAEOLOGY; PATTERNS; MICHIGAN; AFRICA; POWER	The locations of diy-ge delta-bay (DGB) sites in the Mandara Mountains, northern Cameroon are hypothesized to occur as a function of their ability to see and be seen from points on the surrounding landscape. A series of geostatistical, two-way and Bayesian logistic regression analyses were performed to test two hypotheses related to the intervisibility of the sites to one another and their visual prominence on the landscape. We determine that the intervisibility of the sites to one another is highly statistically significant when compared to 10 stratified-random permutations of DGB sites. Bayesian logistic regression additionally demonstrates that the visibility of the sites to points on the surrounding landscape is statistically significant. The location of sites appears to have also been selected on the basis of lower slope than random permutations of sites. Using statistical measures, many of which are not commonly employed in archaeological research, to evaluate aspects of visibility on the landscape, we conclude that the placement of DGB sites improved their conspicuousness for enhanced ritual, social cooperation and/or competition purposes.	[Wright, David K.] Seoul Natl Univ, Dept Archaeol & Art Hist, Seoul, South Korea; [MacEachern, Scott] Bowdoin Coll, Dept Anthropol, Brunswick, ME 04011 USA; [Lee, Jaeyong] Seoul Natl Univ, Dept Stat, Seoul, South Korea	Seoul National University (SNU); Bowdoin College; Seoul National University (SNU)	Wright, DK (corresponding author), Seoul Natl Univ, Dept Archaeol & Art Hist, Seoul, South Korea.	msafiri@snu.ac.kr	Wright, David K./H-3311-2019	Wright, David K./0000-0003-1704-0423; MacEachern, Scott/0000-0002-4859-3998	international faculty research grant from Seoul National University; National Geographic Society's Committee for Research and Exploration [9494-13]; National Research Foundation of Korea [2013S1A5B6043901]; Korean government	international faculty research grant from Seoul National University; National Geographic Society's Committee for Research and Exploration(National Geographic Society); National Research Foundation of Korea(National Research Foundation of Korea); Korean government(Korean Government)	This work was supported by an international faculty research grant from Seoul National University, the National Geographic Society's Committee for Research and Exploration (grant # 9494-13), and the National Research Foundation of Korea Grant # 2013S1A5B6043901 funded by the Korean government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, J STAT MODELING ANAL, DOI DOI 10.1515/BILE-2015-0008; [Anonymous], 2001, ANAESTHESIA UNCOMMON, DOI DOI 10.1177/14634990122228638; Bauer A, 2004, GEOARCHAEOLOGY, V19, P711, DOI 10.1002/gea.20021; Bevan A, 2006, CONFRONTING SCALE IN ARCHAEOLOGY, P217; BINFORD LR, 1980, AM ANTIQUITY, V45, P4, DOI 10.2307/279653; BONANNO A, 1990, WORLD ARCHAEOL, V22, P190, DOI 10.1080/00438243.1990.9980140; Bongers J, 2012, J ARCHAEOL SCI, V39, P1687, DOI 10.1016/j.jas.2011.11.018; Bradley R, 1993, P PREHIST SOC, V59, P129; Bruck J, 2001, J ROY ANTHROPOL INST, V7, P649, DOI 10.1111/1467-9655.00082; Chan ISF, 2003, STAT METHODS MED RES, V12, P37, DOI 10.1191/0962280203sm314ra; CHAPMAN HP, 2003, OXFORD J ARCHAEOL, V22, P345; Connah G., 1987, AFRICAN CIVILIZATION; Conolly J., 2006, GEOGRAPHIC INFORM SY; Cox DR., 1970, ANAL BINARY DATA; Crema ER, 2010, J ARCHAEOL SCI, V37, P1118, DOI 10.1016/j.jas.2009.12.012; Datouang Djoussou JM, 2011, ARCHAEOLOGY CULTURAL; David N., 2008, BRIT ARCHAEOLOGICAL; Dillehay TD, 2004, J SOC ARCHAEOL, V4, P239, DOI 10.1177/1469605304042396; Dixon P.M., 2002, ENCY ENV, VVolume 3, P1796, DOI DOI 10.1002/9780470057339.VAR046; EARLE TK, 1987, CURR ANTHROPOL, V28, P501, DOI 10.1086/203551; Elangwe HN, 1979, CARTE GEOLOGIQUE REP; Fisher P, 1997, J ARCHAEOL SCI, V24, P581, DOI 10.1006/jasc.1996.0142; FITTON JG, 1985, EARTH PLANET SC LETT, V72, P23, DOI 10.1016/0012-821X(85)90114-1; Fraser D, 1983, BRIT SERIES, P117; Garlake P.S., 2002, EARLY ART ARCHITECTU; Goreaud F, 1999, J VEG SCI, V10, P433, DOI 10.2307/3237072; Guastaferro F, 2010, PRECIS AGRIC, V11, P600, DOI 10.1007/s11119-010-9183-4; HASSAN FA, 1981, DEMOGRAPHIC ARCHAEOL; Hildebrand EA, 2013, AZANIA, V48, P155, DOI 10.1080/0067270X.2013.789224; Hodder I, 1991, MEANINGS THINGS MAT, P64; Howey MCL, 2007, J ARCHAEOL SCI, V34, P1830, DOI 10.1016/j.jas.2007.01.002; Jones EE, 2006, AM ANTIQUITY, V71, P523, DOI 10.2307/40035363; Jones EE, 2010, J ANTHROPOL ARCHAEOL, V29, P1, DOI 10.1016/j.jaa.2009.09.002; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kay S., 2001, ARCHEOL CALCOLATORI, V12, P167; KIRCH PV, 1990, WORLD ARCHAEOL, V22, P206, DOI 10.1080/00438243.1990.9980141; Kohler TA, 1986, ADV ARCHAEOLOGICAL M, P397, DOI [10.1016/B978-0-12-003109-2.50011-8, DOI 10.1016/B978-0-12-003109-2.50011-8]; KRIST FJ, 1994, PHOTOGRAMM ENG REM S, V60, P1129; KVAMME KL, 1990, AM ANTIQUITY, V55, P367, DOI 10.2307/281655; Lake MW, 1998, J ARCHAEOL SCI, V25, P27, DOI 10.1006/jasc.1997.0197; Letesson Q., 2006, J MEDITERR ARCHAEOL, V19, P91, DOI DOI 10.1558/JMEA.2006.19.1.91; Letouzey R., 1985, CARTE PHYTOGEOGRAPHI; Llobera M, 2011, J ARCHAEOL SCI, V38, P843, DOI 10.1016/j.jas.2010.11.006; Llobera M, 2001, J ARCHAEOL SCI, V28, P1005, DOI 10.1006/jasc.2001.0720; MACEACHERN S, 1993, J AFR HIST, V34, P247, DOI 10.1017/S002185370003334X; MacEachern S, 2002, J SOC ARCHAEOL, V2, P179; MacEachern S, 2012, AFR ARCHAEOL REV, P1; MacEachern S, 2012, WANDALA DGB SITES PO; MacEachern S, 2013, AZANIA, V48, P241, DOI 10.1080/0067270X.2013.790653; McIntosh Susan Keech, 1999, CHIEFDOMS PATHWAYS C; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; O'Brien M, 2004, ANTHROPOL THEOR, V4, P173; O'Sullivan D, 2001, INT J GEOGR INF SCI, V15, P221, DOI 10.1080/13658810010011393; Ogburn DE, 2006, J ARCHAEOL SCI, V33, P405, DOI 10.1016/j.jas.2005.08.005; PARSONS JR, 1972, ANNU REV ANTHROPOL, V1, P127, DOI 10.1146/annurev.an.01.100172.001015; PATIL KD, 1975, J AM STAT ASSOC, V70, P186, DOI 10.2307/2285400; Sakaguchi T, 2010, J ARCHAEOL SCI, V37, P1171, DOI 10.1016/j.jas.2009.12.015; Sauerbier Martin, 2006, RECORDING MODELING V, P249; Scarsini M, 1984, STOCHASTICA, V8, P201; Sevenant M, 2007, LANDSCAPE URBAN PLAN, V80, P362, DOI 10.1016/j.landurbplan.2006.09.004; SHAW T., 1993, ARCHAEOLOGY AFRICA F; SINOPOLI CM, 1994, ANNU REV ANTHROPOL, V23, P159; [汤孟平 Tang Mengping], 2003, [生态学报, Acta Ecologica Sinica], V23, P1533; Vanacker V, 2001, J ARCHAEOL SCI, V28, P661, DOI 10.1006/jasc.2001.0654; von Graffenried C, 1984, JAHR STIERES OPFERRI; Voorrips A., 1990, BONN STUDIES MODERN, V3, P257; Warren R.E., 2000, PRACTICAL APPL GIS A, P6; WHEATLEY D, 1995, ARCHAEOLOGY AND GEOGRAPHICAL INFORMATION SYSTEMS: A EUROPEAN PERSPECTIVE, P171	68	20	20	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112191	10.1371/journal.pone.0112191	http://dx.doi.org/10.1371/journal.pone.0112191			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AT3DP	25383883	Green Published, Green Submitted, gold			2022-12-27	WOS:000344816700038
J	Jakovljevic, M; Jovanovic, M; Rancic, N; Vyssoki, B; Djordjevic, N				Jakovljevic, Mihajlo; Jovanovic, Mirjana; Rancic, Nemanja; Vyssoki, Benjamin; Djordjevic, Natasa			LAT Software Induced Savings on Medical Costs of Alcohol Addicts' Care - Results from a Matched-Pairs Case-Control Study	PLOS ONE			English	Article							DEPENDENT PATIENTS; HEALTH-POLICY; GLOBAL BURDEN; GUIDELINES; ABSTINENCE; CONSUMPTION; ACAMPROSATE; PREVENTION; THERAPY; IMPACT	Lesch Alcoholism Typology (LAT) is one of the most widely used clinical typologies of alcohol addiction. Study tested whether introduction of LAT software in clinical practice leaded to improved outcomes and reduced costs. Retrospective matched-pairs case-control cost comparison study was conducted at the Regional Addiction Center of the University Clinic in Serbia involving 250 patients during the four-year period. Mean relapse frequency followed by outpatient detoxification was 0.42 +/- 0.90 vs. 0.70 +/- 1.66 (LAT/non-LAT; p = 0.267). Adding relapses after inpatient treatment total mean-number of relapses per patient was 0.70 +/- 1.74 vs. 0.97 +/- 1.89 (LAT/non-LAT; p = 0.201). However, these relapse frequency differentials were not statistically significant. Total hospital costs of Psychiatry clinic based non-LAT addicts' care (sic54,660) were significantly reduced to sic36,569 after initiation of LAT. Mean total cost per patient was reduced almost by half after initiation of LAT based treatment: sic331 +/- 381 vs. sic626 +/- 795 (LAT/non-LAT; p = 0.001). Mean cost of single psychiatry clinic admission among non-LAT treatment group was sic320 +/- 330 (CI 95% 262-378) and among LAT sic197 +/- 165 (CI 95% 168-226) (p = 0.019). Mean LAT software induced net savings on psychiatric care costs were sic144 per patient. Total net savings on hospital care including F10 associated somatic co-morbidities amounted to sic295 per patient. More sensitive diagnostic assessment and sub-type specific pharmacotherapy and psychotherapy following implementation of LAT software lead to significant savings on costs of hospital care.	[Jakovljevic, Mihajlo; Djordjevic, Natasa] Univ Kragujevac, Fac Med Sci, Dept Pharmacol & Toxicol, Kragujevac, Serbia; [Jovanovic, Mirjana] Univ Kragujevac, Fac Med Sci, Dept Psychiat, Kragujevac, Serbia; [Rancic, Nemanja] Univ Def, Med Fac Mil Med Acad, Ctr Clin Pharmacol, Belgrade, Serbia; [Vyssoki, Benjamin] Med Univ Vienna, Dept Psychiat & Psychotherapy, Vienna, Austria	University of Kragujevac; University of Kragujevac; Medical University of Vienna	Jakovljevic, M (corresponding author), Univ Kragujevac, Fac Med Sci, Dept Pharmacol & Toxicol, Kragujevac, Serbia.	jakovljevicm@medf.kg.ac.rs	Djordjevic, Natasa/K-4692-2019; Jakovljevic, Mihajlo/B-3002-2014; Rancic, Nemanja/L-6271-2019	Djordjevic, Natasa/0000-0003-4525-6723; Jakovljevic, Mihajlo/0000-0002-9160-6846; Rancic, Nemanja/0000-0002-5122-8094	Ministry of Education, Science and Technological Development of the Republic of Serbia through OI Grant [175014]	Ministry of Education, Science and Technological Development of the Republic of Serbia through OI Grant	The Ministry of Education, Science and Technological Development of the Republic of Serbia through OI Grant No 175014, has fully financed this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando B, 2013, SUBST USE MISUSE; BABOR TF, 1992, BRIT J ADDICT, V87, P1415; Bleich S, 2004, ALCOHOL ALCOHOLISM, V39, P493, DOI 10.1093/alcalc/agh094; Caputo F, 2014, J PSYCHOPHARMACOL, V28, P23, DOI 10.1177/0269881113504015; Chisholm D, 2004, J STUD ALCOHOL, V65, P782, DOI 10.15288/jsa.2004.65.782; Ciaranello AL, 2013, CLIN INFECT DIS, V56, P430, DOI 10.1093/cid/cis858; CLONINGER CR, 1981, ARCH GEN PSYCHIAT, V38, P861; Djordjevic ND, 2006, VOJNOSANIT PREGL, p[63, 279]; Drozda JP, 2013, JAMA INTERN MED, V173, P1097, DOI 10.1001/jamainternmed.2013.820; French MT, 2002, HEALTH SERV RES, V37, P433, DOI 10.1111/1475-6773.031; Haas L, 2013, APPL HEALTH ECON HEA, V11, P359, DOI 10.1007/s40258-013-0042-0; Hussey AM, 2013, STAT BIOPHARMACEUTIC, V5; Jakovljevic M, 2013, VALUE HEALTH, V16, pA542, DOI 10.1016/j.jval.2013.08.1376; Jakovljevic M, 2011, SER J EXP CLIN RES, V12, P161, DOI DOI 10.5937/SJECR1104161J; Jakovljevic M, 2011, HLTH BEHAV PUBLIC HL, V1, P1; Jakovljevic Mihajlo, 2013, Value Health Reg Issues, V2, P218, DOI 10.1016/j.vhri.2013.07.002; Jakovljevic M, 2013, ALCOHOL ALCOHOLISM, V48, P505, DOI 10.1093/alcalc/agt011; Jakovljevic MB, 2013, EUR J HEALTH ECON, V14, P153, DOI 10.1007/s10198-012-0439-y; JOHNSON RS, 1992, ADDICT BEHAV, V17, P159, DOI 10.1016/0306-4603(92)90020-V; Jovanovic M, 2011, ALCOHOL ALCOHOLISM, V46, P364, DOI 10.1093/alcalc/agr010; Kiefer F, 2005, EUR ADDICT RES, V11, P83, DOI 10.1159/000083037; Leggio L, 2009, NEUROPSYCHOL REV, V19, P115, DOI 10.1007/s11065-008-9080-z; Lesch OM, 1996, ALCOHOL ALCOHOLISM, V31, P63; Lesch OM, 2011, ALCOHOL AND TOBACCO: MEDICAL AND SOCIOLOGICAL ASPECTS OF USE, ABUSE AND ADDICTION, P1, DOI 10.1007/978-3-7091-0146-9; Lesch W C, 1991, J Health Soc Policy, V2, P23, DOI 10.1300/J045v02n03_02; Neighbors CJ, 2010, J STUD ALCOHOL DRUGS, V71, P384, DOI 10.15288/jsad.2010.71.384; Palmer AJ, 2000, ALCOHOL ALCOHOLISM, V35, P478, DOI 10.1093/alcalc/35.5.478; Picon PD, 2013, INT J TECHNOL ASSESS, V29, P198, DOI 10.1017/S0266462313000056; Perez EJP, 2008, ADICCIONES, V20, P251; Rankovic A, 2013, VOJNOSANIT PREGL, V70, P709; Rychlik R, 2003, EUR ADDICT RES, V9, P59, DOI 10.1159/000068810; Shield KD, 2013, ADDICTION, V108, P912, DOI 10.1111/add.12112; Stockwell T, 1998, ALCOHOL CLIN EXP RES, V22, p63S, DOI 10.1111/j.1530-0277.1998.tb04375.x; Walters D, 2009, J ADDICT DIS, V28, P137, DOI 10.1080/10550880902772456; Westermeyer J, 1999, AM J ADDICTION, V8, P332; WESTERMEYER J, 1977, J NERV MENT DIS, V164, P351, DOI 10.1097/00005053-197705000-00007; Wutzke SE, 2001, SOC SCI MED, V52, P863, DOI 10.1016/S0277-9536(00)00189-1; Zweifel P, 2012, EUR J HEALTH ECON, V13, P677, DOI 10.1007/s10198-012-0420-9	38	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111931	10.1371/journal.pone.0111931	http://dx.doi.org/10.1371/journal.pone.0111931			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT3WF	25379730	gold, Green Published			2022-12-27	WOS:000344863100048
J	Puig, C; Grau, I; Marti, S; Tubau, F; Calatayud, L; Pallares, R; Linares, J; Ardanuy, C				Puig, Carmen; Grau, Imma; Marti, Sara; Tubau, Fe; Calatayud, Laura; Pallares, Roman; Linares, Josefina; Ardanuy, Carmen			Clinical and Molecular Epidemiology of Haemophilus influenzae Causing Invasive Disease in Adult Patients	PLOS ONE			English	Article							PENICILLIN-BINDING PROTEIN-3; AMPICILLIN RESISTANCE GENES; ANTIBIOTIC-RESISTANCE; CHANGING EPIDEMIOLOGY; SUSCEPTIBILITY; INFECTIONS; VACCINATION; MANITOBA; CANADA; SPAIN	Objectives: The epidemiology of invasive Haemophilus influenzae (Hi) has changed since the introduction of the Hi type b (Hib) vaccine. The aim of this study was to analyze the clinical and molecular epidemiology of Hi invasive disease in adults. Methods: Clinical data of the 82 patients with Hi invasive infections were analyzed. Antimicrobial susceptibility, serotyping, and genotyping were studied (2008-2013). Results: Men accounted for 63.4% of patients (whose mean age was 64.3 years). The most frequent comorbidities were immunosuppressive therapy (34.1%), malignancy (31.7%), diabetes, and COPD (both 22%). The 30-day mortality rate was 20.7%. The majority of the strains (84.3%) were nontypeable (NTHi) and serotype f was the most prevalent serotype in the capsulated strains. The highest antimicrobial resistance was for cotrimoxazole (27.1%) and ampicillin (14.3%). Twenty-three isolates (32.9%) had amino acid changes in the PBP3 involved in resistance. Capsulated strains were clonal and belonged to clonal complexes 6 (serotype b), 124 (serotype f), and 18 (serotype e), whereas NTHi were genetically diverse. Conclusions: Invasive Hi disease occurred mainly in elderly and those with underlying conditions, and it was associated with a high mortality rate. NTHi were the most common cause of invasive disease and showed high genetic diversity.	[Puig, Carmen; Marti, Sara; Tubau, Fe; Calatayud, Laura; Linares, Josefina; Ardanuy, Carmen] Univ Barcelona IDIBELL, Hosp Univ Bellvitge, Dept Microbiol, Barcelona, Spain; [Grau, Imma; Pallares, Roman] Univ Barcelona IDIBELL, Hosp Univ Bellvitge, Dept Infect Dis, Barcelona, Spain; [Puig, Carmen; Grau, Imma; Marti, Sara; Tubau, Fe; Calatayud, Laura; Pallares, Roman; Linares, Josefina; Ardanuy, Carmen] CIBER Enfermedades Resp CIBERes, ISCIII, Madrid, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III	Marti, S (corresponding author), Univ Barcelona IDIBELL, Hosp Univ Bellvitge, Dept Microbiol, Barcelona, Spain.	smartinm@bellvitgehospital.cat; c.ardanuy@bellvitgehospital.cat	Liñares, Josefina/N-9450-2014; Ardanuy, Carmen/C-4463-2015; PALLARES, Roman/B-5710-2008; Marti, Sara/D-4823-2014	PALLARES, Roman/0000-0003-3262-8508; Marti, Sara/0000-0002-0405-2305; Grau, Imma/0000-0002-3040-8184; Ardanuy, Carmen/0000-0003-0225-607X	Fondo de Investigaciones Sanitarias de la Seguridad Social [PI0901904]; CIBER de Enfermedades Respiratorias (CIBERES) [CB06/06/0037]; ISCIII (Instituto de Salud Carlos III, Madrid, Spain); FPU (Formacion de Profesorado Universitario, Ministerio de Educacion, Spain) [AP2010-3202]; Instituto de Salud Carlos III (ISCIII), Madrid, Spain [CD10/00298]	Fondo de Investigaciones Sanitarias de la Seguridad Social(Instituto de Salud Carlos III); CIBER de Enfermedades Respiratorias (CIBERES); ISCIII (Instituto de Salud Carlos III, Madrid, Spain)(Instituto de Salud Carlos III); FPU (Formacion de Profesorado Universitario, Ministerio de Educacion, Spain)(German Research Foundation (DFG)); Instituto de Salud Carlos III (ISCIII), Madrid, Spain(Instituto de Salud Carlos III)	Funding was provided by Fondo de Investigaciones Sanitarias de la Seguridad Social (PI0901904), and by CIBER de Enfermedades Respiratorias (CIBERES - CB06/06/0037), run by the ISCIII (Instituto de Salud Carlos III, Madrid, Spain). CP was supported by an FPU Grant AP2010-3202 (Formacion de Profesorado Universitario, Ministerio de Educacion, Spain). SM was supported by "Sara Borrell postdoctoral contract CD10/00298'' from the Instituto de Salud Carlos III (ISCIII), Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam HJ, 2010, VACCINE, V28, P4073, DOI 10.1016/j.vaccine.2010.03.075; Agrawal A, 2011, J CLIN MICROBIOL, V49, P3728, DOI 10.1128/JCM.05476-11; Bajanca-Lavado MP, 2014, EUR J CLIN MICROBIOL, V33, P603, DOI 10.1007/s10096-013-1994-6; Binks MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034083; Campos J, 2004, J CLIN MICROBIOL, V42, P524, DOI 10.1128/JCM.42.2.524-529.2004; Clinical and Laboratory Standards Institute, 2012, M7A9 CLIN LAB STAND; Clinical and Laboratory Standards Institute, 2013, M100S23 CLSI; Dabernat H, 2002, ANTIMICROB AGENTS CH, V46, P2208, DOI 10.1128/AAC.46.7.2208-2218.2002; Dominguez A, 2004, ANN EPIDEMIOL, V14, P31, DOI 10.1016/S1047-2797(03)00070-X; Dworkin MS, 2007, CLIN INFECT DIS, V44, P810, DOI 10.1086/511861; Eldika N, 2006, CURR OPIN PULM MED, V12, P118, DOI 10.1097/01.mcp.0000208451.50231.8f; Erwin AL, 2007, TRENDS MICROBIOL, V15, P355, DOI 10.1016/j.tim.2007.06.004; FALLA TJ, 1994, J CLIN MICROBIOL, V32, P2382, DOI 10.1128/JCM.32.10.2382-2386.1994; Foxwell AR, 1998, MICROBIOL MOL BIOL R, V62, P294, DOI 10.1128/MMBR.62.2.294-308.1998; Garcia-Cobos S, 2008, ANTIMICROB AGENTS CH, V52, P2760, DOI 10.1128/AAC.01674-07; Garcia-Cobos S, 2014, J ANTIMICROB CHEMOTH, V69, P111, DOI 10.1093/jac/dkt324; Giufre M, 2011, VACCINE, V29, P3857, DOI 10.1016/j.vaccine.2011.03.059; Heilmann KP, 2005, ANTIMICROB AGENTS CH, V49, P2561, DOI 10.1128/aac.49.6.2561-2564.2005; Hotomi M, 2010, AURIS NASUS LARYNX, V37, P594, DOI 10.1016/j.anl.2010.02.005; Jansen WTM, 2006, J ANTIMICROB CHEMOTH, V58, P873, DOI 10.1093/jac/dkl310; Kim IS, 2007, ANTIMICROB AGENTS CH, V51, P453, DOI 10.1128/AAC.00960-06; Ladhani S, 2008, J ANTIMICROB CHEMOTH, V62, P776, DOI 10.1093/jac/dkn274; Ladhani S, 2010, EMERG INFECT DIS, V16, P455, DOI 10.3201/eid1603.090290; Laupland KB, 2011, J INFECTION, V62, P142, DOI 10.1016/j.jinf.2010.11.009; MacNeil JR, 2011, CLIN INFECT DIS, V53, P1230, DOI 10.1093/cid/cir735; Meats E, 2003, J CLIN MICROBIOL, V41, P1623, DOI 10.1128/JCM.41.4.1623-1636.2003; Peltola H, 2000, CLIN MICROBIOL REV, V13, P302, DOI 10.1128/CMR.13.2.302-317.2000; Perdue DG, 2000, JAMA-J AM MED ASSOC, V283, P3089, DOI 10.1001/jama.283.23.3089; Perez-Trallero E, 2010, ANTIMICROB AGENTS CH, V54, P2953, DOI 10.1128/AAC.01548-09; Puig C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082515; Resman F, 2012, ANTIMICROB AGENTS CH, V56, P4408, DOI 10.1128/AAC.00415-12; Rubach MP, 2011, EMERG INFECT DIS, V17, P1645, DOI 10.3201/eid1709.101991; Sarangi J, 2000, EPIDEMIOL INFECT, V124, P441, DOI 10.1017/S0950268899003611; Shuel M, 2011, INT J INFECT DIS, V15, pE167, DOI 10.1016/j.ijid.2010.10.005; Shuel M, 2010, FEMS IMMUNOL MED MIC, V58, P277, DOI 10.1111/j.1574-695X.2009.00634.x; Shuel ML, 2009, DIAGN MICR INFEC DIS, V63, P379, DOI 10.1016/j.diagmicrobio.2008.12.015; Sill ML, 2008, ANTIMICROB AGENTS CH, V52, P1551, DOI 10.1128/AAC.01580-07; Sill ML, 2007, FEMS IMMUNOL MED MIC, V51, P270, DOI 10.1111/j.1574-695X.2007.00299.x; TENOVER FC, 1994, J CLIN MICROBIOL, V32, P2729, DOI 10.1128/JCM.32.11.2729-2737.1994; Tsang RSW, 2007, CLIN INFECT DIS, V44, P1611, DOI 10.1086/518283	40	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112711	10.1371/journal.pone.0112711	http://dx.doi.org/10.1371/journal.pone.0112711			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379704	Green Submitted, gold, Green Published			2022-12-27	WOS:000344863100110
J	Turchiano, G; Latella, MC; Gogol-Doring, A; Cattoglio, C; Mavilio, F; Izsvak, Z; Ivics, Z; Recchia, A				Turchiano, Giandomenico; Latella, Maria Carmela; Gogol-Doering, Andreas; Cattoglio, Claudia; Mavilio, Fulvio; Izsvak, Zsuzsanna; Ivics, Zoltan; Recchia, Alessandra			Genomic Analysis of Sleeping Beauty Transposon Integration in Human Somatic Cells	PLOS ONE			English	Article							STABLE GENE-TRANSFER; GERMLINE TRANSGENESIS; PRONUCLEAR MICROINJECTION; RETROVIRAL INTEGRATION; SITE SELECTION; T-CELLS; VECTOR; EXPRESSION; DNA; EVOLUTION	The Sleeping Beauty (SB) transposon is a non-viral integrating vector system with proven efficacy for gene transfer and functional genomics. However, integration efficiency is negatively affected by the length of the transposon. To optimize the SB transposon machinery, the inverted repeats and the transposase gene underwent several modifications, resulting in the generation of the hyperactive SB100X transposase and of the high-capacity "sandwich'' (SA) transposon. In this study, we report a side-by-side comparison of the SA and the widely used T2 arrangement of transposon vectors carrying increasing DNA cargoes, up to 18 kb. Clonal analysis of SA integrants in human epithelial cells and in immortalized keratinocytes demonstrates stability and integrity of the transposon independently from the cargo size and copy number-dependent expression of the cargo cassette. A genome-wide analysis of unambiguously mapped SA integrations in keratinocytes showed an almost random distribution, with an overrepresentation in repetitive elements (satellite, LINE and small RNAs) compared to a library representing insertions of the first-generation transposon vector and to gammaretroviral and lentiviral libraries. The SA transposon/SB100X integrating system therefore shows important features as a system for delivering large gene constructs for gene therapy applications.	[Turchiano, Giandomenico; Latella, Maria Carmela; Mavilio, Fulvio; Recchia, Alessandra] Univ Modena & Reggio Emilia, Ctr Regenerat Med, Dept Life Sci, Modena, Italy; [Gogol-Doering, Andreas] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Gogol-Doering, Andreas] Univ Halle Wittenberg, Inst Comp Sci, D-06108 Halle, Germany; [Cattoglio, Claudia] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Mavilio, Fulvio] Genethon, Evry, France; [Izsvak, Zsuzsanna] Max Delbruck Ctr Mol Med, Berlin, Germany; [Ivics, Zoltan] Paul Ehrlich Inst, Div Med Biotechnol, Langen, Germany	Universita di Modena e Reggio Emilia; Martin Luther University Halle Wittenberg; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Paul Ehrlich Institute	Recchia, A (corresponding author), Univ Modena & Reggio Emilia, Ctr Regenerat Med, Dept Life Sci, Modena, Italy.	alessandra.recchia@unimore.it		Izsvak, Zsuzsanna/0000-0002-2053-2384; Mavilio, Fulvio/0000-0003-0459-4320; Turchiano, Giandomenico/0000-0001-9980-6810	Italian Ministry of University and Research-FIRB; DEBRA international; European Research Council (GT-SKIN)	Italian Ministry of University and Research-FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); DEBRA international; European Research Council (GT-SKIN)	Funding was received for this study from Italian Ministry of University and Research-FIRB 2008 (AR), DEBRA international (AR) and the European Research Council (GT-SKIN) (FM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiuti A, 2007, J CLIN INVEST, V117, P2233, DOI 10.1172/JCI31666; Ammar I, 2012, NUCLEIC ACIDS RES, V40, P6693, DOI 10.1093/nar/gks317; Belur LR, 2003, MOL THER, V8, P501, DOI 10.1016/S1525-0016(03)00211-9; Biffi A, 2011, BLOOD, V117, P5332, DOI 10.1182/blood-2010-09-306761; Borradori L, 1998, EXP CELL RES, V239, P463, DOI 10.1006/excr.1997.3923; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; Bushman FD, 2007, J CLIN INVEST, V117, P2083, DOI 10.1172/JCI32949; Carteau S, 1998, J VIROL, V72, P4005, DOI 10.1128/JVI.72.5.4005-4014.1998; Cattoglio C, 2007, BLOOD, V110, P1770, DOI 10.1182/blood-2007-01-068759; Cavazza A, 2013, GENE THER, V20, P949, DOI 10.1038/gt.2013.18; Cesana D, 2012, J CLIN INVEST, V122, P1667, DOI 10.1172/JCI62189; Cui ZB, 2002, J MOL BIOL, V318, P1221, DOI 10.1016/S0022-2836(02)00237-1; de Jong J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004250; De Luca M, 2009, BRIT J DERMATOL, V161, P19, DOI 10.1111/j.1365-2133.2009.09243.x; Field AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068201; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Galla M, 2011, NUCLEIC ACIDS RES, V39, P7147, DOI 10.1093/nar/gkr384; Garrels W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096673; Garrels W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023573; Grabundzija I, 2013, NUCLEIC ACIDS RES, V41, P1829, DOI 10.1093/nar/gks1305; Hackett P, 2013, TRANSLATIONAL RES; Hackett PB, 2010, MOL THER, V18, P674, DOI 10.1038/mt.2010.2; Holkers M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1446; Huang X, 2006, BLOOD, V107, P483, DOI 10.1182/blood-2005-05-2133; Huang X, 2010, MOL THER, V18, P1803, DOI 10.1038/mt.2010.141; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Ivics Z, 2004, CURR ISSUES MOL BIOL, V6, P43; Ivics Z, 1996, P NATL ACAD SCI USA, V93, P5008, DOI 10.1073/pnas.93.10.5008; Ivics Z, 2014, NAT PROTOC, V9, P810, DOI 10.1038/nprot.2014.010; Ivics Z, 2014, NAT PROTOC, V9, P794, DOI 10.1038/nprot.2014.009; Ivics Z, 2014, NAT PROTOC, V9, P773, DOI 10.1038/nprot.2014.008; Izsvak Z, 2000, J MOL BIOL, V302, P93, DOI 10.1006/jmbi.2000.4047; Jin Z, 2011, GENE THER, V18, P849, DOI 10.1038/gt.2011.40; Katter K, 2013, FASEB J, V27, P930, DOI 10.1096/fj.12-205526; Liu GY, 2005, J MOL BIOL, V346, P161, DOI 10.1016/j.jmb.2004.09.086; Liu L, 2004, MOL THER, V10, P97, DOI 10.1016/j.ymthe.2004.04.006; Masumoto H, 2004, CHROMOSOME RES, V12, P543, DOI 10.1023/B:CHRO.0000036593.72788.99; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; McCormack WM, 2006, J THROMB HAEMOST, V4, P1218, DOI 10.1111/j.1538-7836.2006.01901.x; Moiani A, 2012, J CLIN INVEST, V122, P1653, DOI 10.1172/JCI61852; Moldt B, 2011, MOL THER, V19, P1499, DOI 10.1038/mt.2011.47; Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630; Olson WK, 2011, CURR OPIN STRUC BIOL, V21, P348, DOI 10.1016/j.sbi.2011.03.006; Sambrook J., 2001, MOL CLONING LAB MANU; Schmidt M, 2001, HUM GENE THER, V12, P743, DOI 10.1089/104303401750148649; Smit A, 1996, REPEATMASKER OPEN 30; Titeux M, 2010, MOL THER, V18, P1509, DOI 10.1038/mt.2010.91; Vigdal TJ, 2002, J MOL BIOL, V323, P441, DOI 10.1016/S0022-2836(02)00991-9; Voigt K, 2012, MOL THER, V20, P1852, DOI 10.1038/mt.2012.126; Wang YM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004103; Wilber A, 2007, STEM CELLS, V25, P2919, DOI 10.1634/stemcells.2007-0026; Yant SR, 2002, NAT BIOTECHNOL, V20, P999, DOI 10.1038/nbt738; Yant SR, 2005, MOL CELL BIOL, V25, P2085, DOI 10.1128/MCB.25.6.2085-2094.2005; Zayed H, 2004, MOL THER, V9, P292, DOI 10.1016/j.ymthe.2003.11.024; Zhang WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075344; Zhang Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064601, 10.1371/journal.pone.0071243, 10.1371/journal.pone.0067564]; Zhu JH, 2007, BIOCHEMISTRY-US, V46, P6844, DOI 10.1021/bi6024484	57	27	29	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112712	10.1371/journal.pone.0112712	http://dx.doi.org/10.1371/journal.pone.0112712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390293	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000349144400121
J	Wangpraseurt, D; Tamburic, B; Szabo, M; Suggett, D; Ralph, PJ; Kuhl, M				Wangpraseurt, Daniel; Tamburic, Bojan; Szabo, Milan; Suggett, David; Ralph, Peter J.; Kuhl, Michael			Spectral Effects on Symbiodinium Photobiology Studied with a Programmable Light Engine	PLOS ONE			English	Article							SCLERACTINIAN CORALS; PHOTOCHEMICAL EFFICIENCY; DIURNAL CHANGES; PHOTOSYNTHESIS; ZOOXANTHELLAE; PHOTOPROTECTION; ACCLIMATION; RESPIRATION; IRRADIANCE; PHOTON	The spectral light field of Symbiodinium within the tissue of the coral animal host can deviate strongly from the ambient light field on a coral reef and that of artificial light sources used in lab studies on coral photobiology. Here, we used a novel approach involving light microsensor measurements and a programmable light engine to reconstruct the spectral light field that Symbiodinium is exposed to inside the coral host and the light field of a conventional halogen lamp in a comparative study of Symbiodinium photobiology. We found that extracellular gross photosynthetic O-2 evolution was unchanged under different spectral illumination, while the more red-weighted halogen lamp spectrum decreased PSII electron transport rates and there was a trend towards increased light-enhanced dark respiration rates under excess irradiance. The approach provided here allows for reconstructing and comparing intra-tissue coral light fields and other complex spectral compositions of incident irradiance. This novel combination of sensor technologies provides a framework to studying the influence of macro- and microscale optics on Symbiodinium photobiology with unprecedented spectral resolution.	[Wangpraseurt, Daniel; Tamburic, Bojan; Szabo, Milan; Suggett, David; Ralph, Peter J.; Kuhl, Michael] Univ Technol Sydney, Plant Funct Biol & Climate Change Cluster, Sydney, NSW 2007, Australia; [Kuhl, Michael] Univ Copenhagen, Dept Biol, Marine Biol Sect, Helsingor, Denmark; [Kuhl, Michael] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Sch Biol Sci, Singapore 639798, Singapore	University of Technology Sydney; University of Copenhagen; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Kuhl, M (corresponding author), Univ Technol Sydney, Plant Funct Biol & Climate Change Cluster, Sydney, NSW 2007, Australia.	mkuhl@bio.ku.dk	Ralph, Peter J/C-5029-2009; Suggett, David J/G-9212-2017; Ralph, Peter/L-1527-2019; Szabo, Milan/L-9942-2014; Tamburic, Bojan/G-8484-2013; Kühl, Michael/A-1977-2009	Ralph, Peter J/0000-0002-3103-7346; Suggett, David J/0000-0001-5326-2520; Ralph, Peter/0000-0002-3103-7346; Szabo, Milan/0000-0001-6235-2894; Tamburic, Bojan/0000-0001-5720-9380; Kühl, Michael/0000-0002-1792-4790; Wangpraseurt, Daniel/0000-0003-4834-8981	Australian Research Council (Future Fellowship); Danish Council for Independent Research|Natural Sciences; Carlsberg Foundation; Plant Functional Biology and Climate Change Cluster; University of Technology Sydney president's scholarship	Australian Research Council (Future Fellowship)(Australian Research Council); Danish Council for Independent Research|Natural Sciences(Det Frie Forskningsrad (DFF)); Carlsberg Foundation(Carlsberg Foundation); Plant Functional Biology and Climate Change Cluster; University of Technology Sydney president's scholarship	This research was funded by grants from the Australian Research Council (PJR; DS, Future Fellowship), the Danish Council for Independent Research|Natural Sciences (MK), the Carlsberg Foundation (MK), the Plant Functional Biology and Climate Change Cluster (DW, MK, PJR, MS, BT) and the University of Technology Sydney president's scholarship (DW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Horani FA, 2005, CORAL REEFS, V24, P173, DOI 10.1007/s00338-004-0461-3; Asada K, 2000, PHILOS T ROY SOC B, V355, P1419, DOI 10.1098/rstb.2000.0703; Bader MR, 2000, PHILOS T R SOC B, V355, P1433, DOI 10.1098/rstb.2000.0704; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Brown BE, 1999, CORAL REEFS, V18, P99; Buxton L, 2012, J PHYCOL, V48, P117, DOI 10.1111/j.1529-8817.2011.01099.x; Cooper TF, 2011, P ROY SOC B-BIOL SCI, V278, P1840, DOI 10.1098/rspb.2010.2321; Crawley A, 2010, GLOBAL CHANGE BIOL, V16, P851, DOI 10.1111/j.1365-2486.2009.01943.x; Dubinsky Z, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P107, DOI 10.1007/978-94-007-0114-4_8; DUSTAN P, 1982, MAR BIOL, V68, P253, DOI 10.1007/BF00409592; EDMUNDS PJ, 1988, CORAL REEFS, V7, P7, DOI 10.1007/BF00301975; GARCIA HE, 1992, LIMNOL OCEANOGR, V37, P1307, DOI 10.4319/lo.1992.37.6.1307; Gorbunov MY, 2001, LIMNOL OCEANOGR, V46, P75, DOI 10.4319/lo.2001.46.1.0075; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; HALLDAL P, 1968, BIOL BULL, V134, P411, DOI 10.2307/1539860; Hennige SJ, 2009, CORAL REEFS, V28, P179, DOI 10.1007/s00338-008-0444-x; Hennige SJ, 2008, MAR ECOL PROG SER, V369, P77, DOI 10.3354/meps07612; Hill R, 2012, CORAL REEFS, V31, P963, DOI 10.1007/s00338-012-0914-z; Hill R, 2008, SYMBIOSIS, V46, P45; Hochberg EJ, 2003, REMOTE SENS ENVIRON, V85, P159, DOI 10.1016/S0034-4257(02)00201-8; Iglesias-Prieto R, 1997, MAR BIOL, V130, P23, DOI 10.1007/s002270050221; IGLESIASPRIETO R, 1994, MAR ECOL PROG SER, V113, P163, DOI 10.3354/meps113163; Jerlov N. G., 1976, MARINE OPTICS; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Jones RJ, 2001, PLANT CELL ENVIRON, V24, P89, DOI 10.1046/j.1365-3040.2001.00648.x; Kanazawa A, 2014, BBA-BIOENERGETICS, V1837, P1227, DOI 10.1016/j.bbabio.2014.03.019; KINZIE RA, 1987, MAR BIOL, V94, P95, DOI 10.1007/BF00392902; KINZIE RA, 1984, MAR BIOL, V78, P239, DOI 10.1007/BF00393009; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Kramer WE, 2012, PHOTOCHEM PHOTOBIOL, V88, P398, DOI 10.1111/j.1751-1097.2011.01048.x; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; LASSEN C, 1992, FEMS MICROBIOL ECOL, V86, P247, DOI 10.1111/j.1574-6968.1992.tb04816.x; Lavaud J, 2002, PHOTOSYNTH RES, V74, P51, DOI 10.1023/A:1020890625141; Lesser MP, 1996, LIMNOL OCEANOGR, V41, P271, DOI 10.4319/lo.1996.41.2.0271; Mass T, 2010, J EXP BIOL, V213, P4084, DOI 10.1242/jeb.039891; MOREL A, 1987, LIMNOL OCEANOGR, V32, P1066, DOI 10.4319/lo.1987.32.5.1066; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; Platt T, 1981, J MAR RES, V38, P222; Ragni M, 2010, MAR ECOL PROG SER, V406, P57, DOI 10.3354/meps08571; Ralph PJ, 2005, AQUAT BOT, V82, P222, DOI 10.1016/j.aquabot.2005.02.006; Reynolds JM, 2008, P NATL ACAD SCI USA, V105, P13674, DOI 10.1073/pnas.0805187105; Robison JD, 2006, J PHYCOL, V42, P568, DOI 10.1111/j.1529-8817.2006.00232.x; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; Saragosti E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012508; Schreiber U., 2011, PAM APPL NOTES, V1, P1; Schreiber U, 2012, PHOTOSYNTH RES, V113, P127, DOI 10.1007/s11120-012-9758-1; Smith ER, 2013, CLIN CHEM LAB MED, P1; Sorek M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00536; Suggett DJ, 2008, J PHYCOL, V44, P948, DOI 10.1111/j.1529-8817.2008.00537.x; Szabo M, 2014, PLANT PHYSIOL BIOCH, V83, P159, DOI 10.1016/j.plaphy.2014.07.015; Ulstrup KE, 2007, MAR BIOL, V153, P225, DOI 10.1007/s00227-007-0806-x; Ulstrup KE, 2006, MAR BIOL, V149, P1325, DOI 10.1007/s00227-006-0286-4; Ulstrup KE, 2011, AQUAT BIOL, V12, P241, DOI 10.3354/ab00338; Wagner H, 2006, NEW PHYTOL, V169, P95, DOI 10.1111/j.1469-8137.2005.01550.x; Wang DL, 2012, FRONT MICROBIOL, V3, DOI [10.3389/fmicb.2012.00427, 10.3389/fmicb.2012.00316]; Wangpraseurt D, 2014, LIMNOL OCEANOGR, V59, P917, DOI 10.4319/lo.2014.59.3.0917; Wangpraseurt D, 2014, PROC SPIE, V8941, DOI 10.1117/12.2038339; Wangpraseurt D, 2014, J EXP BIOL, V217, P489, DOI 10.1242/jeb.091116; Wangpraseurt D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031192; Xue XP, 1996, PLANT PHYSIOL, V112, P1005, DOI 10.1104/pp.112.3.1005	60	22	22	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112809	10.1371/journal.pone.0112809	http://dx.doi.org/10.1371/journal.pone.0112809			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389753	Green Published, gold			2022-12-27	WOS:000349144400131
J	Christian, JR				Christian, James R.			Timing of the Departure of Ocean Biogeochemical Cycles from the Preindustrial State	PLOS ONE			English	Article							ANTHROPOGENIC CLIMATE-CHANGE; ECOSYSTEM MODEL; ACIDIFICATION; VARIABILITY; LIMITATION; SYSTEM; TRENDS	Changes in ocean chemistry and climate induced by anthropogenic CO2 affect a broad range of ocean biological and biogeochemical processes; these changes are already well underway. Direct effects of CO2 (e.g. on pH) are prominent among these, but climate model simulations with historical greenhouse gas forcing suggest that physical and biological processes only indirectly forced by CO2 (via the effect of atmospheric CO2 on climate) begin to show anthropogenically-induced trends as early as the 1920s. Dates of emergence of a number of representative ocean fields from the envelope of natural variability are calculated for global means and for spatial 'fingerprints' over a number of geographic regions. Emergence dates are consistent among these methods and insensitive to the exact choice of regions, but are generally earlier with more spatial information included. Emergence dates calculated for individual sampling stations are more variable and generally later, but means across stations are generally consistent with global emergence dates. The last sign reversal of linear trends calculated for periods of 20 or 30 years also functions as a diagnostic of emergence, and is generally consistent with other measures. The last sign reversal among 20 year trends is found to be a conservative measure (biased towards later emergence), while for 30 year trends it is found to have an early emergence bias, relative to emergence dates calculated by departure from the preindustrial mean. These results are largely independent of emission scenario, but the latest-emerging fields show a response to mitigation. A significant anthropogenic component of ocean variability has been present throughout the modern era of ocean observation.	[Christian, James R.] Canadian Ctr Climate Modelling & Anal, Victoria, BC, Canada; [Christian, James R.] Inst Ocean Sci, Fisheries & Oceans Canada, Sidney, BC V8L 4B2, Canada	Environment & Climate Change Canada; Canadian Centre for Climate Modelling & Analysis (CCCma); Fisheries & Oceans Canada	Christian, JR (corresponding author), Canadian Ctr Climate Modelling & Anal, Victoria, BC, Canada.	jim.christian@ec.gc.ca						Andrews OD, 2013, BIOGEOSCIENCES, V10, P1799, DOI 10.5194/bg-10-1799-2013; ARMSTRONG RA, 1994, LIMNOL OCEANOGR, V39, P597, DOI 10.4319/lo.1994.39.3.0597; Arora VK, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046270; Arora VK, 2009, J CLIMATE, V22, P6066, DOI 10.1175/2009JCLI3037.1; Barnett T, 2005, J CLIMATE, V18, P1291, DOI 10.1175/JCLI3329.1; Barnett TP, 2001, SCIENCE, V292, P270, DOI 10.1126/science.1058304; Bates NR, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003759; Beaulieu C, 2013, BIOGEOSCIENCES, V10, P2711, DOI 10.5194/bg-10-2711-2013; Bindoff NL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P867; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Chou SH, 2003, J CLIMATE, V16, P3256, DOI 10.1175/1520-0442(2003)016<3256:STHAMF>2.0.CO;2; Christian JR, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2008JG000920; Deutsch C, 2011, SCIENCE, V333, P336, DOI 10.1126/science.1202422; Dore JE, 2009, P NATL ACAD SCI USA, V106, P12235, DOI 10.1073/pnas.0906044106; Durack PJ, 2012, SCIENCE, V336, P455, DOI 10.1126/science.1212222; Easterling DR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037810; Flato G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P741; Friedrich T, 2012, NAT CLIM CHANGE, V2, P167, DOI [10.1038/NCLIMATE1372, 10.1038/nclimate1372]; HASSELMANN K, 1976, TELLUS, V28, P473, DOI 10.1111/j.2153-3490.1976.tb00696.x; HASSELMANN K, 1993, J CLIMATE, V6, P1957, DOI 10.1175/1520-0442(1993)006<1957:OFFTDO>2.0.CO;2; Hegerl G, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/044025; Hegerl GC, 1997, CLIM DYNAM, V13, P613, DOI 10.1007/s003820050186; Helm KP, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044222; Henson SA, 2010, BIOGEOSCIENCES, V7, P621, DOI 10.5194/bg-7-621-2010; Huybers P, 2006, NATURE, V441, P329, DOI 10.1038/nature04745; KARL DM, 1995, NATURE, V373, P230, DOI 10.1038/373230a0; Mahlstein I, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034009; Moore JK, 2001, DEEP-SEA RES PT II, V49, P403, DOI 10.1016/S0967-0645(01)00108-4; Mora C, 2013, NATURE, V502, P183, DOI 10.1038/nature12540; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Muir L, 2013, CAWCR RES LETT, V10, P8; Najjar R., 1998, DESIGN OCMIP 2 SIMUL; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Santer BD, 1995, CLIMATE CHANGE 1995: THE SCIENCE OF CLIMATE CHANGE, P407; SANTER BD, 1995, J GEOPHYS RES-OCEANS, V100, P10693, DOI 10.1029/95JC00683; Sarmiento JL, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001919; Taucher J, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045934; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Taylor KE, 2001, J GEOPHYS RES-ATMOS, V106, P7183, DOI 10.1029/2000JD900719; Wang MY, 2010, J MARINE SYST, V79, P258, DOI 10.1016/j.jmarsys.2008.11.028; Zahariev K, 2008, PROG OCEANOGR, V77, P56, DOI 10.1016/j.pocean.2008.01.007	41	13	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e109820	10.1371/journal.pone.0109820	http://dx.doi.org/10.1371/journal.pone.0109820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386910	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400006
J	Gower, DJ; Hancox, PJ; Botha-Brink, J; Sennikov, AG; Butler, RJ				Gower, David J.; Hancox, P. John; Botha-Brink, Jennifer; Sennikov, Andrey G.; Butler, Richard J.			A New Species of Garjainia Ochev, 1958 (Diapsida: Archosauriformes: Erythrosuchidae) from the Early Triassic of South Africa	PLOS ONE			English	Article							BONE-GROWTH RATE; SEXUAL SELECTION; BEAUFORT-GROUP; LIFE-STYLE; PHYLOGENETIC SIGNAL; BIZARRE STRUCTURES; EARLY EVOLUTION; AMPRINOS RULE; EARLY HISTORY; KAROO BASIN	A new species of the erythrosuchid archosauriform reptile Garjainia Ochev, 1958 is described on the basis of disarticulated but abundant and well-preserved cranial and postcranial material from the late Early Triassic (late Olenekian) Subzone A of the Cynognathus Assemblage Zone of the Burgersdorp Formation (Beaufort Group) of the Karoo Basin of South Africa. The new species, G. madiba, differs from its unique congener, G. prima from the late Olenekian of European Russia, most notably in having large bony bosses on the lateral surfaces of the jugals and postorbitals. The new species also has more teeth and a proportionately longer postacetabular process of the ilium than G. prima. Analysis of G. madiba bone histology reveals thick compact cortices comprised of highly vascularized, rapidly forming fibro-lamellar bone tissue, similar to Erythrosuchus africanus from Subzone B of the Cynognathus Assemblage Zone. The most notable differences between the two taxa are the predominance of a radiating vascular network and presence of annuli in the limb bones of G. madiba. These features indicate rapid growth rates, consistent with data for many other Triassic archosauriforms, but also a high degree of developmental plasticity as growth remained flexible. The diagnoses of Garjainia and of Erythrosuchidae are addressed and revised. Garjainia madiba is the geologically oldest erythrosuchid known from the Southern Hemisphere, and demonstrates that erythrosuchids achieved a cosmopolitan biogeographical distribution by the end of the Early Triassic, within five million years of the end-Permian mass extinction event. It provides new insights into the diversity of the Subzone A vertebrate assemblage, which partially fills a major gap between classic 'faunal' assemblages from the older Lystrosaurus Assemblage Zone (earliest Triassic) and the younger Subzone B of the Cynognathus Assemblage Zone (early Middle Triassic).	[Gower, David J.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Hancox, P. John; Butler, Richard J.] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [Botha-Brink, Jennifer] Natl Museum, Bloemfontein, South Africa; [Botha-Brink, Jennifer] Univ Orange Free State, Dept Zool & Entomol, Bloemfontein, South Africa; [Sennikov, Andrey G.] Russian Acad Sci, Borissiak Paleontol Inst, Moscow, Russia; [Sennikov, Andrey G.] Kazan Fed Univ, Kazan, Russia; [Butler, Richard J.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England; [Butler, Richard J.] Univ Munich, GeoBioctr, Munich, Germany	Natural History Museum London; University of Witwatersrand; University of the Free State; Russian Academy of Sciences; Paleontological Institute of the Russian Academy of Sciences; Kazan Federal University; University of Birmingham; University of Munich	Gower, DJ (corresponding author), Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England.	d.gower@nhm.ac.uk	Botha, Jennifer/N-1893-2013; Butler, Richard J./A-5239-2011; Сенников, Андрей Г/I-9907-2017	Botha, Jennifer/0000-0001-8824-9334; Butler, Richard J./0000-0003-2136-7541; Sennikov, Andrey/0000-0002-1932-0907	National Research Foundation [UID 80587]; Palaeontological Scientific Trust; Russian Foundation for Basic Research [13-05-00274, 14-04-00185, 14-05-93964]; Program of Basic Research of the Presidium of the Russian Academy of Sciences [28]; Russian Government; Marie Curie Career Integration Grant [PCIG-GA-2013-630123 ARCHOSAUR RISE]; DFG [BU 2587/3-1]; NERC at the University of Bristol	National Research Foundation; Palaeontological Scientific Trust; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Program of Basic Research of the Presidium of the Russian Academy of Sciences(Russian Academy of Sciences); Russian Government; Marie Curie Career Integration Grant; DFG(German Research Foundation (DFG)); NERC at the University of Bristol	DJG carried out much of the comparative work for this project during tenure of a NERC PhD studentship at the University of Bristol (1990-1994), supervised by Mike Benton. PJH was supported by the NRF African Origins Platform and the DST/NRF Centre of Excellence for Palaeosciences. JBB is supported by the National Research Foundation (UID 80587) and the Palaeontological Scientific Trust. AGS was supported by the Russian Foundation for Basic Research (projects 13-05-00274, 14-04-00185 and 14-05-93964), the Program of Basic Research of the Presidium of the Russian Academy of Sciences no. 28, and the Russian Government funded Program of Competitive Growth of Kazan Federal University. RJB is supported by a Marie Curie Career Integration Grant (PCIG-GA-2013-630123 ARCHOSAUR RISE) and an Emmy Noether Programme Award from the DFG (BU 2587/3-1), which also supported visits to Munich and Moscow by DJG as part of the completion of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala F, 2006, ZOOL J LINN SOC-LOND, V147, P383, DOI 10.1111/j.1096-3642.2006.00224.x; Amprino R., 1947, ARCH BIOL SCI, V58, P315; [Anonymous], 1990, SKELETAL BIOMINERALI, DOI DOI 10.1029/SC005P0175; Azzie BA, 1994, THESIS U WITWATERSRA; BENTON MJ, 1983, Q REV BIOL, V58, P29, DOI 10.1086/413056; Benton MJ, 1993, PHILOS T R SOC B, V302, P605; Botha-Brink J, 2011, J VERTEBR PALEONTOL, V31, P1238, DOI 10.1080/02724634.2011.621797; Broom R., 1905, RECORDS ALBANY MUSEU, V1, P331, DOI DOI 10.1111/J.1096-3642.1948.TB00384.X; Broom R., 1903, ANN S AFR MUS, V4, P159; Broom R, 1906, ANN S AFR MUS, V5, P187; Butler RJ, 2013, J VERTEBRATE PALEO S, P97; Canoville A, 2010, BIOL J LINN SOC, V100, P384, DOI 10.1111/j.1095-8312.2010.01431.x; Charig A. J, 1970, Biol. J., V2, P125, DOI 10.1111/j.1095-8312.1970.tb01708.x; Charig AJ, 1976, HDB PALAOHERPETOLOGI, V13, P11; Cheng Z.W., 1980, MESOZOIC STRATIGRAPH, P114; CHINSAMY A, 1995, J VERTEBR PALEONTOL, V15, P96, DOI 10.1080/02724634.1995.10011209; Chinsamy A., 1992, Palaeontologia Africana, V29, P39; CHINSAMY A, 1990, Palaeontologia Africana, V27, P77; Chinsamy A, 1991, THESIS U WITWATERSRA; Cisneros JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013425; CORMACK DH, 1987, HAMS HISTOLOGY; Cox, 1976, MORPHOLOGY BIOL REPT, P123; Cruickshank A.R.I., 1972, P89; Cubo J, 2005, SYST BIOL, V54, P562, DOI 10.1080/10635150591003461; Cubo J, 2012, PALEOBIOLOGY, V38, P335, DOI 10.1666/08093.1; CURREY JD, 1985, J ZOOL, V206, P453; Damiani RJ, 2001, ZOOL J LINN SOC-LOND, V133, P379, DOI 10.1006/zjls.2001.0304; de Buffrenil V., 1990, Journal of Vertebrate Paleontology, V10, P455; de Margerie E, 2004, J EXP BIOL, V207, P869, DOI 10.1242/jeb.00841; de Margerie E, 2002, CR BIOL, V325, P221, DOI 10.1016/S1631-0691(02)01429-4; de Ricqles A, 2008, ANN PALEONTOL, V94, P57, DOI 10.1016/j.annpal.2008.03.002; Evans S.E., 1986, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V173, P181; Evans Susan E., 2008, Contributions to Herpetology, V23, P1; Ezcurra MD, 2013, GEOL SOC SPEC PUBL, V379, P9, DOI 10.1144/SP379.11; Ezcurra MD, 2010, J VERTEBR PALEONTOL, V30, P1433, DOI 10.1080/02724634.2010.501446; Fraser NC, 1994, SHADOW DINOSAURS EAR; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Germain D, 2005, ZOOL SCR, V34, P335, DOI 10.1111/j.1463-6409.2005.00198.x; Girondot M, 2003, J VERTEBR PALEONTOL, V23, P458, DOI 10.1671/0272-4634(2003)023[0458:BPATTQ]2.0.CO;2; Gow C.E., 1999, Palaeontologia Africana, V35, P21; Gower David J., 2000, P140; Gower David J., 1999, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V280, P1; Gower David John, 2003, Annals of the South African Museum, V110, P1; Gower DJ, 2006, J VERTEBR PALEONTOL, V26, P79, DOI 10.1671/0272-4634(2006)26[79:TBOABE]2.0.CO;2; Gower DJ, 1997, J ZOOL, V242, P557; Gower DJ, 1997, J VERTEBR PALEONTOL, V17, P60, DOI 10.1080/02724634.1997.10010954; Gower DJ, 1998, BIOL REV, V73, P367, DOI 10.1017/S0006323198005222; Gower DJ, 1996, ZOOL J LINN SOC-LOND, V116, P347, DOI 10.1006/zjls.1996.0024; Gower DJ, 1996, PALAEONTOLOGY, V39, P883; Groenewald GH, 2001, PALAIOS, V16, P148, DOI 10.2307/3515526; GROSS WALTER, 1934, ZEITSCHR ANAT U ENTWICKLUNGSGESCH, V103, P731, DOI 10.1007/BF02118752; Hancox P. J., 2000, ZENTRALBLATT GEOLOGI, V1998, P1285; Hancox P.J, 1998, THESIS U WITWATERSRA; Hancox PJ, 2001, J AFR EARTH SCI, V33, P563, DOI 10.1016/S0899-5362(01)00081-1; HANCOX PJ, 1995, S AFR J SCI, V91, P143; Horner JR, 1999, PALEOBIOLOGY, V25, P295, DOI 10.1017/S0094837300021308; Hua S, 1996, J VERTEBR PALEONTOL, V16, P703, DOI 10.1080/02724634.1996.10011359; Huene F. F. von, 1960, Palaeontographica A, V114, P105; HUTTON JM, 1986, COPEIA, P332, DOI 10.2307/1444994; King Gillian M., 1996, Annals of the South African Museum, V104, P379; Knell RJ, 2011, J ZOOL, V283, P18, DOI 10.1111/j.1469-7998.2010.00758.x; Laurin M, 2004, PALEOBIOLOGY, V30, P589, DOI 10.1666/0094-8373(2004)030<0589:TEOLBM>2.0.CO;2; Lee AH, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P217; Miall A.D., 1996, GEOLOGY FLUVIAL DEPO; Modesto SP, 2008, J VERTEBR PALEONTOL, V28, P914, DOI 10.1671/0272-4634(2008)28[914:EOASLA]2.0.CO;2; Montes L, 2010, ANIM BIOL, V60, P25, DOI 10.1163/157075610X12610595764093; Nesbitt Sterling J., 2005, Historical Biology, V17, P19, DOI 10.1080/08912960500476499; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Nesbitt SJ, 2008, J VERTEBR PALEONTOL, V28, P1063, DOI 10.1671/0272-4634-28.4.1063; Ochev V, 1975, PALEONTOL J, V1980, P98; Ochev V.G., 1980, Paleontologicheskii Zhurnal, V1980, P101; OCHEV VG, 1958, DOKL AKAD NAUK SSSR+, V123, P749; Ochev VG, 1981, VOPROSY GEOLOGII YUZ, V22, P3; Oelrich T. M., 1956, Miscellaneous Publications Museum of Zoology University of Michigan, V94, P1; Osborn HF, 1903, MEM AM MUS NAT HIST, V1, P449; Padian K, 2011, J ZOOL, V283, P23, DOI 10.1111/j.1469-7998.2010.00761.x; Padian K, 2011, J ZOOL, V283, P3, DOI 10.1111/j.1469-7998.2010.00719.x; Parrish J.M., 1992, Journal of Vertebrate Paleontology, V12, P93; Peng Jianghua, 1991, Vertebrata Palasiatica, V29, P95; Reid REH., 1996, GEOLOGY STUDIES, V41, P25; Rubidge BS, 2005, S AFR J GEOL, V108, P135, DOI 10.2113/108.1.135; Rutherford AB, 2009, THESIS U WITWATERSRA; Sennikov AG, 2011, PALEONTOL J+, V45, P90, DOI 10.1134/S0031030111010151; Sennikov A.G., 1995, Trudy Paleontologicheskogo Instituta, V263, P1; Sennikov AG, 1996, PALAEOGEOGR PALAEOCL, V120, P331, DOI 10.1016/0031-0182(95)00041-0; Shishkin MA, 2006, PALEONTOL J+, V40, P1, DOI 10.1134/S0031030106010011; Shishkin MA, 1995, 6 S MES TERR EC BIOT, P39; Shishkin Mikhail A., 2000, P120; Smith R, 2005, CR PALEVOL, V4, P623, DOI 10.1016/j.crpv.2005.07.005; Smith R, 2012, FORERUNNERS MAMMALS, P31; Sookias RB, 2012, P ROY SOC B-BIOL SCI, V279, P2180, DOI 10.1098/rspb.2011.2441; Starck JM, 2002, J MORPHOL, V254, P232, DOI 10.1002/jmor.10029; von Huene F, 1911, GEOLOGISCHE PALAONTO, V10, P67, DOI DOI 10.1086/621900; von Huene FRF, 1946, BIOL ZBL, V65, P268; WALL WP, 1983, J PALEONTOL, V57, P197; Watson DMS, 1917, P ZOOL SOC LOND, V1917, P167; WELLS JW, 1963, NATURE, V197, P948, DOI 10.1038/197948a0; Welman J., 1991, South African Journal of Geology, V94, P245; Werning S, 2011, 4 C LAT PAL VERT, P73; Werning S, 2011, J VERTEBR PALEONTOL, V31, P213; Wilkinson Mark, 1995, Historical Biology, V10, P137; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson J, 2011, TLS-TIMES LIT SUPPL, P6; Young C. C., 1964, Palaeontologia Sinica No 151 NS G, VNo. 19, P1; Young C-C, 1973, MEMOIRS I VERTEBRATE, V10, P38	106	32	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111154	10.1371/journal.pone.0111154	http://dx.doi.org/10.1371/journal.pone.0111154			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386937	gold, Green Published			2022-12-27	WOS:000345250400014
J	Gunnelius, L; Kurkela, J; Hakkila, K; Koskinen, S; Parikainen, M; Tyystjarvi, T				Gunnelius, Liisa; Kurkela, Juha; Hakkila, Kaisa; Koskinen, Satu; Parikainen, Marjaana; Tyystjarvi, Taina			The omega Subunit of RNA Polymerase Is Essential for Thermal Acclimation of the Cyanobacterium Synechocystis Sp PCC 6803	PLOS ONE			English	Article							HEAT-SHOCK RESPONSE; INORGANIC CARBON LIMITATION; GENE-EXPRESSION; PHOTOSYSTEM-II; SIGMA FACTORS; MORPHOLOGICAL-DIFFERENTIATION; PHYCOBILISOME DEGRADATION; ELECTRON-TRANSPORT; GROWTH TEMPERATURE; MEMBRANE-LIPIDS	The rpoZ gene encodes the small omega subunit of RNA polymerase. A Delta rpoZ strain of the cyanobacterium Synechocystis sp. PCC 6803 grew well in standard conditions (constant illumination at 40 mu mol photons m(-2) s(-1); 32 degrees C; ambient CO2) but was heat sensitive and died at 40 degrees C. In the control strain, 71 genes were at least two-fold up-regulated and 91 genes down-regulated after a 24-h treatment at 40 degrees C, while in Delta rpoZ 394 genes responded to heat. Only 62 of these heat-responsive genes were similarly regulated in both strains, and 80% of heat-responsive genes were unique for Delta rpoZ. The RNA polymerase core and the primary sigma factor SigA were down-regulated in the control strain at 40 degrees C but not in Delta rpoZ. In accordance with reduced RNA polymerase content, the total RNA content of mild-heat-stress-treated cells was lower in the control strain than in Delta rpoZ. Light-saturated photosynthetic activity decreased more in Delta rpoZ than in the control strain upon mild heat stress. The amounts of photosystem II and rubisco decreased at 40 degrees C in both strains while PSI and the phycobilisome antenna protein allophycocyanin remained at the same level as in standard conditions. The phycobilisome rod proteins, phycocyanins, diminished during the heat treatment in Delta rpoZ but not in the control strain, and the nblA1 and nblA2 genes (encode NblA proteins required for phycobilisome degradation) were up-regulated only in Delta rpoZ. Our results show that the omega subunit of RNAP is essential in heat stress because it is required for heat acclimation of diverse cellular processes.	[Gunnelius, Liisa; Kurkela, Juha; Hakkila, Kaisa; Koskinen, Satu; Parikainen, Marjaana; Tyystjarvi, Taina] Univ Turku, Dept Biochem, SF-20500 Turku, Finland	Finland National Institute for Health & Welfare; University of Turku	Tyystjarvi, T (corresponding author), Univ Turku, Dept Biochem, SF-20500 Turku, Finland.	taityy@utu.fi	Hakkila, Kaisa/K-2172-2015	Hakkila, Kaisa/0000-0003-3529-6895; Koskinen, Satu/0000-0003-0149-2070; Tyystjarvi, Taina/0000-0003-0591-8630	Academy of Finland; Finnish Cultural Foundation;  [265807]	Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); 	This work was supported by the Academy of Finland, grant 265807, and the Finnish Cultural Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Refaii A, 2009, MOL MICROBIOL, V71, P748, DOI 10.1111/j.1365-2958.2008.06561.x; Allakhverdiev SI, 2008, PHOTOSYNTH RES, V98, P529, DOI 10.1007/s11120-008-9334-x; Azuma M, 2011, PLANT CELL PHYSIOL, V52, P404, DOI 10.1093/pcp/pcq204; Baier A, 2014, J BIOL CHEM, V289, P11755, DOI 10.1074/jbc.M113.520601; Baier K, 2001, FEMS MICROBIOL LETT, V195, P35, DOI 10.1111/j.1574-6968.2001.tb10494.x; Cameron JC, 2013, CELL, V155, P1131, DOI 10.1016/j.cell.2013.10.044; Decker KB, 2013, ANNU REV MICROBIOL, V67, P113, DOI 10.1146/annurev-micro-092412-155756; Eisenhut M, 2007, PLANT PHYSIOL, V144, P1946, DOI 10.1104/pp.107.103341; Fang F, 2003, CURR MICROBIOL, V47, P341, DOI 10.1007/s00284-002-4015-z; Garcia-Dominguez M, 1997, PLANT MOL BIOL, V35, P723, DOI 10.1023/A:1005846626187; GENTRY DR, 1989, J BACTERIOL, V171, P1271, DOI 10.1128/jb.171.3.1271-1277.1989; Ghosh P, 2001, EUR J BIOCHEM, V268, P4621, DOI 10.1046/j.1432-1327.2001.02381.x; Gunnelius L, 2014, NUCLEIC ACIDS RES, V42, P4606, DOI 10.1093/nar/gku084; Gunnelius L, 2010, MICROBIOL-SGM, V156, P220, DOI 10.1099/mic.0.032565-0; Hakkila K, 2013, PLANT CELL PHYSIOL, V54, P1780, DOI 10.1093/pcp/pct123; Imamura S, 2003, J MOL BIOL, V325, P857, DOI 10.1016/S0022-2836(02)01242-1; Inoue N, 2001, PLANT CELL PHYSIOL, V42, P1140, DOI 10.1093/pcp/pce147; Karradt A, 2008, J BIOL CHEM, V283, P32394, DOI 10.1074/jbc.M805823200; Kojima I, 2002, J BACTERIOL, V184, P6417, DOI 10.1128/JB.184.23.6417-6423.2002; Lee S, 2000, CURR MICROBIOL, V40, P283, DOI 10.1007/s002849910056; LEHEL C, 1993, PLANT PHYSIOL BIOCH, V31, P81; Lehmann R, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-133; MAMEDOV M, 1993, BIOCHIM BIOPHYS ACTA, V1142, P1, DOI 10.1016/0005-2728(93)90077-S; Mathew R, 2006, MICROBIOL-SGM, V152, P1741, DOI 10.1099/mic.0.28879-0; Minakhin L, 2001, P NATL ACAD SCI USA, V98, P892, DOI 10.1073/pnas.98.3.892; Mironov KS, 2012, MOL BIOL+, V46, P134, DOI 10.1134/S002689331201013X; Nakamoto H, 2003, FEBS LETT, V549, P57, DOI 10.1016/S0014-5793(03)00768-3; Nishiyama Y, 1997, PLANT PHYSIOL, V115, P1473, DOI 10.1104/pp.115.4.1473; Pollari M, 2011, J BACTERIOL, V193, P265, DOI 10.1128/JB.01045-10; ROSS W, 1993, SCIENCE, V262, P1407, DOI 10.1126/science.8248780; Rowland JG, 2010, PROTEOMICS, V10, P1917, DOI 10.1002/pmic.200900337; Rowland JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010511; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Santos-Beneit F, 2011, APPL ENVIRON MICROB, V77, P7586, DOI 10.1128/AEM.00465-11; SCHNEIDER GJ, 1988, J BACTERIOL, V170, P4136, DOI 10.1128/jb.170.9.4136-4140.1988; Singh AK, 2006, ARCH MICROBIOL, V186, P273, DOI 10.1007/s00203-006-0138-0; Suzuki I, 2006, J EXP BOT, V57, P1573, DOI 10.1093/jxb/erj148; Suzuki I, 2005, PLANT PHYSIOL, V138, P1409, DOI 10.1104/pp.104.059097; Tasaka Y, 1996, EMBO J, V15, P6416, DOI 10.1002/j.1460-2075.1996.tb01033.x; Tuominen I, 2006, FEBS LETT, V580, P319, DOI 10.1016/j.febslet.2005.11.082; Tuominen I, 2003, J BACTERIOL, V185, P1116, DOI 10.1128/JB.185.3.1116-1119.2003; Tuominen I, 2008, FEBS LETT, V582, P346, DOI 10.1016/j.febslet.2007.12.030; Tyystjarvi T, 1998, FEBS LETT, V436, P483, DOI 10.1016/S0014-5793(98)01181-8; Tyystjarvi T, 2001, MOL MICROBIOL, V40, P476, DOI 10.1046/j.1365-2958.2001.02402.x; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; WADA A, 1990, P NATL ACAD SCI USA, V87, P2657, DOI 10.1073/pnas.87.7.2657; Wang H, 2004, J BIOL CHEM, V279, P1468, DOI 10.1074/jbc.M309106200; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Wosten MMSM, 1998, FEMS MICROBIOL REV, V22, P127, DOI 10.1016/S0168-6445(98)00011-4; Yoshida H, 2014, WIRES RNA, V5, P723, DOI 10.1002/wrna.1242; Zhang PP, 2004, PLANT CELL, V16, P3326, DOI 10.1105/tpc.104.026526	51	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112599	10.1371/journal.pone.0112599	http://dx.doi.org/10.1371/journal.pone.0112599			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386944	Green Published, Green Submitted, gold			2022-12-27	WOS:000345250400071
J	Lin, CM; Yen, TH; Juang, YY; Lin, JL; Lee, SH				Lin, Chemin; Yen, Tzung-Hai; Juang, Yeong-Yuh; Lin, Ja-Liang; Lee, Shwu-Hua			Psychiatric Comorbidity and Its Impact on Mortality in Patients Who Attempted Suicide by Paraquat Poisoning during 2000-2010	PLOS ONE			English	Article							PULSE THERAPY; DEXAMETHASONE THERAPY; MENTAL-DISORDERS; SUBSTANCE USE; DEPRESSION; METHYLPREDNISOLONE; CYCLOPHOSPHAMIDE; RISK; PREVALENCE; PREVENTION	Background: Paraquat poisoning is a lethal method of suicide used around the world. Although restricting its accessibility had been widely discussed, the underlying psychopathological mechanism of paraquat self-poisoning and its association with mortality have not yet been explicitly evaluated. Methods: We included all patients admitted to a tertiary general hospital in Taiwan between 2000 and 2010 following a suicide attempt by paraquat self-administration. Diagnoses were made upon psychiatric consultation based on the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria. The risk of mortality was calculated by logistic regression with various psychiatric or medical covariates. Results: The consultation-liaison psychiatry team assessed 157 patients who attempted suicide by paraquat poisoning. Mood disorders (54.0%), including dysthymic (26.7%) and major depressive disorders (24.7%), were the most common psychiatric diagnoses among the self-poisoning patients. Among those who attempted suicide, 87 patients (58.0%) died and dysthymic disorder (OR = 5.58, 95% CI: 1.13-27.69; p<0.05) significantly increased the mortality risk after adjustment for relevant medical variables, including age, gender, severity index of paraquat poisoning (SIPP), and risk for respiratory failure. Conclusions: Awareness of comorbid psychiatric illnesses, especially dysthymic disorder, is vital in the prevention and treatment of suicide by paraquat poisoning.	[Lin, Chemin] Chang Gung Mem Hosp, Keelung Branch, Dept Psychiat, Keelung, Taiwan; [Lin, Chemin; Juang, Yeong-Yuh; Lee, Shwu-Hua] Chang Gung Mem Hosp, Linkou Branch, Dept Psychiat, Taoyuan, Taiwan; [Yen, Tzung-Hai; Lin, Ja-Liang] Chang Gung Mem Hosp, Dept Nephrol, Taipei 10591, Taiwan; [Yen, Tzung-Hai; Lin, Ja-Liang] Chang Gung Mem Hosp, Div Clin Toxicol, Taipei 10591, Taiwan; [Yen, Tzung-Hai; Juang, Yeong-Yuh; Lin, Ja-Liang; Lee, Shwu-Hua] Chang Gung Univ, Sch Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Lee, SH (corresponding author), Chang Gung Mem Hosp, Linkou Branch, Dept Psychiat, Taoyuan, Taiwan.	shlee@adm.cgmh.org.tw	Yen, Tzung-Hai/AAQ-4525-2020; Lin, Chemin/AAG-9983-2019	Yen, Tzung-Hai/0000-0002-0907-1505; Lee, Shwu-Hua/0000-0001-5606-1118; Lin, Chemin/0000-0001-6889-4686				Association AP, 2013, DIAGN STAT MAN MENT, V5; Baltazar T, 2013, BRIT J PHARMACOL, V168, P44, DOI 10.1111/j.1476-5381.2012.02017.x; Bertolote JM, 2006, BRIT J PSYCHIAT, V189, P201, DOI 10.1192/bjp.bp.105.020834; Bertolote JM, 2006, B WORLD HEALTH ORGAN, V84, P260; Borges G, 2000, AM J EPIDEMIOL, V151, P781; Bostwick JM, 2000, AM J PSYCHIAT, V157, P1925, DOI 10.1176/appi.ajp.157.12.1925; Chang SS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-260; Chen GH, 2002, CRIT CARE MED, V30, P2584, DOI 10.1097/00003246-200211000-00030; Cristancho MA, 2012, FOCUS J LIFELONG LEA, V10, P422, DOI DOI 10.1176/APPI.F0CUS.10.4.422; Cuijpers P, 2002, J AFFECT DISORDERS, V72, P227, DOI 10.1016/S0165-0327(01)00413-X; Cuijpers Pim, 2004, Curr Psychiatry Rep, V6, P430, DOI 10.1007/s11920-004-0007-y; Dawson AH, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000357; Desapriya EBR, 2004, INJURY PREV, V10, P125, DOI 10.1136/ip.2003.004283; Fu TST, 2013, LANCET, V381, P235, DOI 10.1016/S0140-6736(12)61264-1; Gawarammana IB, 2011, BRIT J CLIN PHARMACO, V72, P745, DOI 10.1111/j.1365-2125.2011.04026.x; Gunnell D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-357; HENRIKSSON MM, 1993, AM J PSYCHIAT, V150, P935; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Hsu Hsiang-Hao, 2003, Journal of Toxicology Clinical Toxicology, V41, P87, DOI 10.1081/CLT-120018278; Hutchinson G, 1999, SUICIDE LIFE-THREAT, V29, P186; Ji JL, 2001, HARVARD REV PSYCHIAT, V9, P1; Keller MB, 1982, AM J PSYCHIAT; Kiecolt-Glaser JK, 2002, J PSYCHOSOM RES, V53, P873, DOI 10.1016/S0022-3999(02)00309-4; Klein DN, 2008, J ABNORM PSYCHOL, V117, P552, DOI 10.1037/0021-843X.117.3.552; Klein DN, 2006, AM J PSYCHIAT, V163, P872, DOI 10.1176/appi.ajp.163.5.872; Koenig HG, 1997, AM J PSYCHIAT, V154, P1376; Lee W.J., 2009, J RURAL MED, V4, P53, DOI [10.2185/jrm.4.53, DOI 10.2185/JRM.4.53]; Lin CM, 2012, GEN HOSP PSYCHIAT, V34, P552, DOI 10.1016/j.genhosppsych.2012.03.015; Lin JJ, 2010, BMC PUBLIC HEALTH, V10, P1471; Lin JL, 1999, AM J RESP CRIT CARE, V159, P357, DOI 10.1164/ajrccm.159.2.9803089; Lin JL, 2006, CRIT CARE MED, V34, P368, DOI 10.1097/01.CCM.0000195013.47004.A8; Lin JL, 1996, THORAX, V51, P661, DOI 10.1136/thx.51.7.661; Lin NC, 2003, J TOXICOL-CLIN TOXIC, V41, P877, DOI 10.1081/CLT-120025356; London L, 2005, AM J IND MED, V47, P308, DOI 10.1002/ajim.20147; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Mishara BL, 2007, CRISIS, V28, P10, DOI 10.1027/0227-5910.28.S1.10; Nagami H, 2005, INT J OCCUP ENV HEAL, V11, P180, DOI 10.1179/oeh.2005.11.2.180; Nagami H, 2007, J RURAL MED, V2, P85; O'Keeffe N, 2007, CLIN MED, V7, P478, DOI 10.7861/clinmedicine.7-5-478; Pai L, 1987, CHINESE J MENTAL HLT, V3, P195; Phillips MR, 2009, RESTRICTIONS ACCESS; Rhebergen D, 2009, J AFFECT DISORDERS, V115, P450, DOI 10.1016/j.jad.2008.10.018; SAWADA Y, 1988, LANCET, V1, P1333; Schneider B, 2009, ARCH SUICIDE RES, V13, P303, DOI 10.1080/13811110903263191; Schulz R, 2002, BIOL PSYCHIAT, V52, P205, DOI 10.1016/S0006-3223(02)01423-3; Senarathna L, 2009, QJM-INT J MED, V102, P251, DOI 10.1093/qjmed/hcp006; Seok Su-Jin, 2009, Korean Journal of Internal Medicine, V24, P247, DOI 10.3904/kjim.2009.24.3.247; von Elm E, 2008, GAC SANIT, V22, P144, DOI 10.1157/13119325; Wananukul W, 2007, CLIN TOXICOL, V45, P582, DOI 10.1080/15563650701382789; Weng CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082695; Weng CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051743; Wesseling C, 2001, Int J Occup Environ Health, V7, P275; Wilks MF, 2008, PLOS MED, V5, P250, DOI 10.1371/journal.pmed.0050049; Wulsin LR, 1999, PSYCHOSOM MED, V61, P6, DOI 10.1097/00006842-199901000-00003; Yang CJ, 2012, LIVER INT, V32, P1400, DOI 10.1111/j.1478-3231.2012.02829.x; Yip PSF, 2006, BRIT J PSYCHIAT, V189, P465, DOI 10.1192/bjp.bp.106.021816	56	14	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112160	10.1371/journal.pone.0112160	http://dx.doi.org/10.1371/journal.pone.0112160			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT9MC	25386676	Green Published, Green Submitted, gold			2022-12-27	WOS:000345250400045
J	da Costa, DCS; Palmeiro, MR; Moreira, JS; Martins, ACD; da Silva, AF; Madeira, MD; Quintella, LP; Confort, EM; Schubach, AD; Silva, FD; Valete-Rosalino, CM				Silva da Costa, Daniel Cesar; Palmeiro, Mariana Reuter; Moreira, Joao Soares; da Costa Martins, Ana Cristina; da Silva, Aline Fagundes; Madeira, Maria de Fatima; Quintella, Leonardo Pereira; Confort, Eliame Mouta; Schubach, Armando de Oliveira; Silva, Fatima da Conceicao; Valete-Rosalino, Claudia Maria			Oral Manifestations in the American Tegumentary Leishmaniasis	PLOS ONE			English	Article							MUCOSAL LEISHMANIASIS; CUTANEOUS LEISHMANIASIS; SODIUM STIBOGLUCONATE; RISK-FACTORS; EFFICACY	Introduction: American tegumentary leishmaniasis (ATL) can affect the skin or mucosa (mucocutaneous leishmaniasis MCL) including the oral cavity. MCL oral lesions are often confused with other oral diseases, delaying diagnosis and specific treatment, and increasing the likelihood of sequelae. Thus, increasing the knowledge of the evolution of ATL oral lesions can facilitate its early diagnosis improving the prognosis of healing. Objectives: Evaluate the frequency of ATL oral lesion and describe its clinical, laboratory and therapeutic peculiarities. Methods: A descriptive transversal study was carried out, using data from medical records of 206 patients with MCL examined at the outpatient clinics-IPEC-Fiocruz between 1989 and 2013. Proportions were calculated for the categorical variables and the association among them was assessed by the Pearson's chi-square test. Measures of central tendency and dispersion were used for the continuous variables and their differences were assessed by both parametric (t test) and non parametric (Mann-Whitney) tests. P-values, <0.05 were considered as significant. Results: The most affected site was the nose, followed by the mouth, pharynx and larynx. Seventy eight (37.9%) have oral lesions and the disease presented a lower median of the evolution time than in other mucous sites as well as an increased time to heal. The presence of oral lesion was associated with: the presence of lesions in the other three mucosal sites; a smaller median of the leishmanin skin test values; a longer healing time of the mucosal lesions; a higher recurrence frequency; and a smaller frequency of treatment finishing and healing. When the oral lesion was isolated, it was associated with an age 20 years lower than when the oral lesion was associated with other mucosal sites. Conclusion: Considering the worst therapy results associated with the presence of oral lesions, we suggest that lesions in this location represent a factor of worse prognosis for MCL.	[Silva da Costa, Daniel Cesar; Palmeiro, Mariana Reuter; Moreira, Joao Soares; da Costa Martins, Ana Cristina; da Silva, Aline Fagundes; Madeira, Maria de Fatima; Quintella, Leonardo Pereira; Confort, Eliame Mouta; Schubach, Armando de Oliveira; Valete-Rosalino, Claudia Maria] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, RJ, Brazil; [Silva, Fatima da Conceicao] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Immunoparasitol, Rio De Janeiro, RJ, Brazil; [Valete-Rosalino, Claudia Maria] Univ Fed Rio de Janeiro, Dept Otorhinolaryngol & Ophthalmol, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Silva, FD (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Immunoparasitol, Rio De Janeiro, RJ, Brazil.	fconcei@ioc.fiocruz.br; claudia.valete@ini.fiocruz.br	Silva, Aline/AAP-4691-2021; Fagundes, Aline/E-1471-2015; Valete-Rosalino, Cláudia Maria/AAR-4293-2021	Silva, Aline/0000-0001-7345-0350; Fagundes, Aline/0000-0001-7345-0350; 	IPEC [(PA2010-2013)-FIOCRUZ]; Papes VI/FIOCRUZ/Brazilian National Council for Scientific and Technological Development (CNPQ) [407758/2012-7]; CNPq [470886/2003-0]; PROEP-CNPq [402557/2011-5]; Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ), Brazil [E-26/102.183/2013, E26.111.717/2012]; CNPq, Brazil; FAPERJ, Brazil	IPEC; Papes VI/FIOCRUZ/Brazilian National Council for Scientific and Technological Development (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PROEP-CNPq; Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ), Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ, Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was funded by IPEC (PA2010-2013)-FIOCRUZ, Papes VI/FIOCRUZ/Brazilian National Council for Scientific and Technological Development (CNPQ) (407758/2012-7), CNPq (470886/2003-0) PROEP-CNPq 402557/2011-5 and Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ) (E-26/102.183/2013; E26.111.717/2012), Brazil. AOS is the recipient of fellowships from CNPq and FAPERJ, Brazil. CMVR is the recipient of fellowships from FAPERJ. The funders had no role in study design data collection and analysis, decision to publish, or preparing the manuscript.	Aliaga L, 2003, MEDICINE, V82, P147, DOI 10.1097/00005792-200305000-00001; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Amato VS, 2009, J EUR ACAD DERMATOL, V23, P1026, DOI 10.1111/j.1468-3083.2009.03238.x; Amato VS, 2008, ACTA TROP, V105, P1, DOI 10.1016/j.actatropica.2007.08.003; Amato VS, 2003, ACTA TROP, V85, P39, DOI 10.1016/S0001-706X(02)00260-7; Antonio LF, 2014, I MED TROP IN PRESS; Boaventura VS, 2006, AM J TROP MED HYG, V75, P267, DOI 10.4269/ajtmh.2006.75.267; Brasil DATASUS, 2013, LEISHM TEG AM CAS CO; CARVALHO EM, 1985, J IMMUNOL, V135, P4144; Daneshbod Y, 2011, ARCH PATHOL LAB MED, V135, P478, DOI 10.1043/2010-0069-OA.1; Guerra JAD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000980; FRANKE ED, 1994, AM J TROP MED HYG, V51, P77, DOI 10.4269/ajtmh.1994.51.77; FRANKE ED, 1990, ANN INTERN MED, V113, P934, DOI 10.7326/0003-4819-113-12-934; Genaro O, 2002, LEISHMANIOSE TEGUMEN, P36; Gontijo Bernardo, 2003, Rev. Soc. Bras. Med. Trop., V36, P71, DOI 10.1590/S0037-86822003000100011; KANAN MW, 1975, BRIT J DERMATOL, V92, P663, DOI 10.1111/j.1365-2133.1975.tb03147.x; Lawn SD, 2004, QJM-INT J MED, V97, P781, DOI 10.1093/qjmed/hch127; LLANOSCUENTAS EA, 1984, LANCET, V2, P295, DOI 10.1016/S0140-6736(84)90346-5; MARSDEN PD, 1986, T ROY SOC TROP MED H, V80, P859, DOI 10.1016/0035-9203(86)90243-9; Ministerio da Saude, 2010, MAN CONTR LEISHM TEG; Lessa Marcus Miranda, 2007, Rev. Bras. Otorrinolaringol., V73, P843, DOI [10.1590/S0034-72992007000600016, 10.1016/S1808-8694(15)31181-2]; Motta ACF, 2007, ORAL DIS, V13, P335, DOI 10.1111/j.1601-0825.2006.01296.x; Oliveira AGL, 2013, ACTA TROP, V128, P36, DOI 10.1016/j.actatropica.2013.06.005; Oliveira-Neto Manoel Paes de, 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P321, DOI 10.1590/S0036-46652000000600004; Palmeiro MR, 2012, PARASITE IMMUNOL, V34, P23, DOI 10.1111/j.1365-3024.2011.01343.x; Palmeiro MR, 2007, ORAL SURG ORAL MED O, V104, pE12, DOI 10.1016/j.tripleo.2007.07.008; Schubach A, 1998, J INFECT DIS, V178, P911, DOI 10.1086/515355; Tuon FF, 2008, CLIN IMMUNOL, V128, P442, DOI 10.1016/j.clim.2008.05.007; WHO, 2010, WHO TECH REP SER, V949, P1	29	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e109790	10.1371/journal.pone.0109790	http://dx.doi.org/10.1371/journal.pone.0109790			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386857	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400005
J	Carstensen, DW; Sabatino, M; Trojelsgaard, K; Morellato, LPC				Carstensen, Daniel W.; Sabatino, Malena; Trojelsgaard, Kristian; Morellato, Leonor Patricia C.			Beta Diversity of Plant-Pollinator Networks and the Spatial Turnover of Pairwise Interactions	PLOS ONE			English	Article							SPECIALIZATION	Interactions between species form complex networks that vary across space and time. Even without spatial or temporal constraints mutualistic pairwise interactions may vary, or rewire, across space but this variability is not well understood. Here, we quantify the beta diversity of species and interactions and test factors influencing the probability of turnover of pairwise interactions across space. We ask: 1) whether beta diversity of plants, pollinators, and interactions follow a similar trend across space, and 2) which interaction properties and site characteristics are related to the probability of turnover of pairwise interactions. Geographical distance was positively correlated with plant and interaction beta diversity. We find that locally frequent interactions are more consistent across space and that local flower abundance is important for the realization of pairwise interactions. While the identity of pairwise interactions is highly variable across space, some species-pairs form interactions that are locally frequent and spatially consistent. Such interactions represent cornerstones of interacting communities and deserve special attention from ecologists and conservation planners alike.	[Carstensen, Daniel W.; Morellato, Leonor Patricia C.] Univ Estadual Paulista, Dept Bot, UNESP, Plant Phenol & Seed Dispersal Grp,Lab Fenol, Sao Paulo, Brazil; [Sabatino, Malena] Univ Nacl Comahue, Lab Ecotono CRUB, San Carlos De Bariloche, Rio Negro, Argentina; [Sabatino, Malena] Consejo Nacl Invest Cient & Tecn, San Carlos De Bariloche, Rio Negro, Argentina; [Trojelsgaard, Kristian] Aarhus Univ, Dept Biosci, Aarhus, Denmark; [Trojelsgaard, Kristian] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Aalborg, Denmark	Universidade Estadual Paulista; Universidad Nacional del Comahue; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Aarhus University; Aalborg University	Carstensen, DW (corresponding author), Univ Estadual Paulista, Dept Bot, UNESP, Plant Phenol & Seed Dispersal Grp,Lab Fenol, Sao Paulo, Brazil.	daniel.carstensen@gmail.com	Trøjelsgaard, Kristian/U-4442-2018; Morellato, Patricia/B-6026-2013	Trøjelsgaard, Kristian/0000-0001-6807-8363; Morellato, Patricia/0000-0001-5265-8988	Sao Paulo Research Foundation [2010/51307-0, 2011/22635-2, 2013/05920-0]; UNESP; CNPq	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); UNESP; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Sao Paulo Research Foundation grant # 2010/51307-0 (FAPESP-VALE), grant # 2011/22635-2 and # 2013/05920-0 to DWC. UNESP grant to MS. Research Productivity fellowship CNPq to LPCM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2012, SCIENCE, V335, P1486, DOI 10.1126/science.1215320; Alarcon R, 2008, OIKOS, V117, P1796, DOI 10.1111/j.0030-1299.2008.16987.x; ALVES RJV, 1994, VEGETATIO, V113, P125; Bascompte J., 2013, MUTUALISTIC NETWORKS; Basilio AM, 2006, AUSTRAL ECOL, V31, P975, DOI 10.1111/j.1442-9993.2006.01666.x; Benites Vinicius M., 2007, Braz. J. Bot., V30, P569, DOI 10.1590/S0100-84042007000400003; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Brosi BJ, 2013, P NATL ACAD SCI USA, V110, P13044, DOI 10.1073/pnas.1307438110; Burkle LA, 2011, AM J BOT, V98, P528, DOI 10.3732/ajb.1000391; Canard E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038295; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Dattilo W, 2013, OIKOS, V122, P1643, DOI 10.1111/j.1600-0706.2013.00562.x; Dunne JA, 2006, SFI S SCI C, P27; Dupont YL, 2003, ECOGRAPHY, V26, P301, DOI 10.1034/j.1600-0587.2003.03443.x; Dupont YL, 2009, OIKOS, V118, P1261, DOI 10.1111/j.1600-0706.2009.17594.x; Echternacht L, 2011, FLORA, V206, P782, DOI 10.1016/j.flora.2011.04.003; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; FARIA GM, 1994, THESIS U ESTADUAL PA; Gaston KJ, 2007, P ROY SOC B-BIOL SCI, V274, P1567, DOI 10.1098/rspb.2007.0236; Giulietti AM, 1987, B BOT U SAO PAULO, V9, P1, DOI DOI 10.11606/ISSN.2316-9052.V9I0P1-151; Giulietti AM., 1997, CTR PLANT DIVERSITY; Gravel D, 2013, METHODS ECOL EVOL, V4, P1083, DOI 10.1111/2041-210X.12103; Hagen M, 2012, ADV ECOL RES, V46, P89, DOI 10.1016/B978-0-12-396992-7.00002-2; Hubbell Stephen P., 2001, V32, pi; Johnson SD, 2000, TRENDS ECOL EVOL, V15, P140, DOI 10.1016/S0169-5347(99)01811-X; JORDANO P, 1987, AM NAT, V129, P657, DOI 10.1086/284665; Kaiser-Bunbury CN, 2010, ECOL LETT, V13, P442, DOI 10.1111/j.1461-0248.2009.01437.x; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Krishna A, 2008, OIKOS, V117, P1609, DOI 10.1111/j.1600-0706.2008.16540.x; Lazaro A, 2010, OIKOS, V119, P825, DOI 10.1111/j.1600-0706.2009.18017.x; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Novotny V, 2009, INSECT CONSERV DIVER, V2, P5, DOI 10.1111/j.1752-4598.2008.00035.x; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; Olesen JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026455; Olesen JM, 2011, P ROY SOC B-BIOL SCI, V278, P725, DOI 10.1098/rspb.2010.1371; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; PIMM SL, 1992, SCIENCE, V255, P940, DOI 10.1126/science.1546290; Poisot T, 2015, OIKOS, V124, P243, DOI 10.1111/oik.01719; Poisot T, 2013, PARASITOLOGY, V140, P1340, DOI 10.1017/S0031182013000851; Poisot T, 2012, ECOL LETT, V15, P1353, DOI 10.1111/ele.12002; R Core Team, 2018, R LANG ENV STAT COMP; Rasmussen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081694; Sabatino M, 2010, ECOL APPL, V20, P1491, DOI 10.1890/09-1626.1; Santamaria L, 2007, PLOS BIOL, V5, P354, DOI 10.1371/journal.pbio.0050031; Stang M, 2006, OIKOS, V112, P111, DOI 10.1111/j.0030-1299.2006.14199.x; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; Thompson JD., 1994, COEVOLUTIONARY PROCE; Vazquez DP, 2007, OIKOS, V116, P1120, DOI 10.1111/j.0030-1299.2007.15828.x; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057; Vazquez DP, 2009, ECOLOGY, V90, P2039, DOI 10.1890/08-1837.1; Vazquez DP, 2005, ECOL LETT, V8, P1088, DOI 10.1111/j.1461-0248.2005.00810.x; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; Wiersma YF, 2005, CONSERV BIOL, V19, P1262, DOI 10.1111/j.1523-1739.2005.00099.x	53	84	85	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112903	10.1371/journal.pone.0112903	http://dx.doi.org/10.1371/journal.pone.0112903			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384058	Green Submitted, gold, Green Published			2022-12-27	WOS:000344816700103
J	Kwon, HN; Lee, YJ; Kang, JH; Choi, JH; An, YJ; Kang, S; Lee, DH; Suh, YJ; Heo, Y; Park, S				Kwon, Hyuk Nam; Lee, Yeon Ji; Kang, Ju-Hee; Choi, Ji-Ho; An, Yong Jin; Kang, Sunmi; Lee, Dae Hyun; Suh, Young Ju; Heo, Yoonseok; Park, Sunghyouk			Prediction of Glycated Hemoglobin Levels at 3 Months after Metabolic Surgery Based on the 7-Day Plasma Metabolic Profile	PLOS ONE			English	Article							HYPOTHALAMIC LEPTIN; INSULIN SENSITIVITY; BARIATRIC SURGERY; TYPE-2; RISK; WEIGHT; REDUCTION; THERAPY; OBESITY; DIET	Metabolic surgery has been shown to provide better glycemic control for type 2 diabetes than conventional therapies. Still, the outcomes of the surgery are variable, and prognostic markers reflecting the metabolic changes by the surgery are yet to be established. NMR-based plasma metabolomics followed by multivariate regression was used to test the correlation between the metabolomic profile at 7-days after surgery and glycated hemoglobin (HbA1c) levels at 3-months (and up to 12 months with less patients), and to identify the relevant markers. Metabolomic profiles at 7-days could differentiate the patients according to the HbA1c improvement status at 3-months. The HbA1c values were predicted based on the metabolomics profile with partial least square regression, and found to be correlated with the observed values. Metabolite analysis suggested that 3-Hydroxybutyrate (3-HB) and glucose contributes to this prediction, and the [3-HB]/[glucose] exhibited a modest to good correlation with the HbA1c level at 3-months. The prediction of 3-month HbA1c using 7-day metabolomic profile and the suggested new criterion [3-HB]/[glucose] could augment current prognostic modalities and help clinicians decide if drug therapy is necessary.	[Kwon, Hyuk Nam; An, Yong Jin; Kang, Sunmi; Park, Sunghyouk] Seoul Natl Univ, Coll Pharm, Inst Nat Prod Res, Seoul 151742, South Korea; [Lee, Yeon Ji; Choi, Ji-Ho] Inha Univ, Sch Med, Inha Univ Hosp, Dept Family Med,Obes Ctr, Inchon 400712, South Korea; [Kang, Ju-Hee] Inha Univ, Sch Med, Inha Univ Hosp, Dept Pharmacol & Hypoxia Related Dis Res, Inchon 400712, South Korea; [Lee, Dae Hyun] Inha Univ, Sch Med, Inha Univ Hosp, Dept Med, Inchon 400712, South Korea; [Suh, Young Ju] Inha Univ, Sch Med, Inha Univ Hosp, Dept Biostat, Inchon 400712, South Korea; [Heo, Yoonseok] Inha Univ, Sch Med, Inha Univ Hosp, Dept Gen Surg, Inchon 400712, South Korea	Seoul National University (SNU); Inha University; Inha University Hospital; Inha University; Inha University Hospital; Inha University; Inha University Hospital; Inha University; Inha University Hospital; Inha University; Inha University Hospital	Heo, Y (corresponding author), Inha Univ, Sch Med, Inha Univ Hosp, Dept Gen Surg, Inchon 400712, South Korea.	gshur@inha.ac.kr; psh@snu.ac.kr	Kwon, Hyuk Nam/V-2301-2018; Lee, Dae Hyun/AAZ-6007-2021; Suh, Young Ju/AAD-5737-2021; Lee, Dae Hyun/T-9838-2019	Kwon, Hyuk Nam/0000-0003-4096-4712; An, Yong Jin/0000-0001-8010-8035; Lee, Dae Hyun/0000-0001-8141-0404	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012011362, 2014009392, 2009-93144]; National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [1420290]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(National Research Foundation of Korea); National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012011362, 2014009392, and 2009-93144), and by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (1420290). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle J, 2012, EXP CLIN ENDOCR DIAB, V120, P152, DOI 10.1055/s-0031-1285911; [Anonymous], 2009, DIABETES CARE, V32, pS6, DOI 10.2337/dc09-S006; Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Buchwald H., 1978, METABOLIC SURG; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Chikayama E, 2010, ANAL CHEM, V82, P1653, DOI 10.1021/ac9022023; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; DePaula AL, 2008, SURG ENDOSC, V22, P2670, DOI 10.1007/s00464-008-9808-0; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Geloneze B, 2012, ANN SURG, V256, P72, DOI 10.1097/SLA.0b013e3182592c62; HALVERSON JD, 1982, SURGERY, V92, P235; Hosokawa YA, 1996, J CLIN INVEST, V97, P180, DOI 10.1172/JCI118387; de Moura EGH, 2011, OBES SURG, V21, P941, DOI 10.1007/s11695-011-0387-0; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; International Diabetes Federation, 2011, MODULE 2 2B NUTR THE; Kang J, 2008, J AGR FOOD CHEM, V56, P11589, DOI 10.1021/jf802088a; Laferrere B, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002043; Li JV, 2011, GUT, V60, P1214, DOI 10.1136/gut.2010.234708; Mingrone G, 2012, N ENGL J MED; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Park S, 2011, BRAIN RES, V1401, P95, DOI 10.1016/j.brainres.2011.05.040; Park S, 2011, EXP BIOL MED, V236, P194, DOI 10.1258/ebm.2010.010186; Pirsch JD, 1996, AM J KIDNEY DIS, V27, P444, DOI 10.1016/S0272-6386(96)90372-8; PORIES WJ, 1995, ANN SURG, V222, P339, DOI 10.1097/00000658-199509000-00011; Schauer PR, 2012, N ENGL J MED; Umpierrez Guillermo E, 2003, Treat Endocrinol, V2, P95, DOI 10.2165/00024677-200302020-00003; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1	30	9	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e109609	10.1371/journal.pone.0109609	http://dx.doi.org/10.1371/journal.pone.0109609			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384027	gold, Green Published, Green Submitted			2022-12-27	WOS:000344816700005
J	Liu, CY; Zhao, LN; Liu, CC				Liu, Chengyu; Zhao, Lina; Liu, Changchun			Effects of Blood Pressure and Sex on the Change of Wave Reflection: Evidence from Gaussian Fitting Method for Radial Artery Pressure Waveform	PLOS ONE			English	Article							CENTRAL PULSE PRESSURE; STIFFNESS; AORTA; AGE	An early return of the reflected component in the arterial pulse has been recognized as an important indicator of cardiovascular risk. This study aimed to determine the effects of blood pressure and sex factor on the change of wave reflection using Gaussian fitting method. One hundred and ninety subjects were enrolled. They were classified into four blood pressure categories based on the systolic blood pressures (i.e., <= 110, 111-120, 121-130 and >= 131 mmHg). Each blood pressure category was also stratified for sex factor. Electrocardiogram (ECG) and radial artery pressure waveforms (RAPW) signals were recorded for each subject. Ten consecutive pulse episodes from the RAPW signal were extracted and normalized. Each normalized pulse episode was fitted by three Gaussian functions. Both the peak position and peak height of the first and second Gaussian functions, as well as the peak position interval and peak height ratio, were used as the evaluation indices of wave reflection. Two-way ANOVA results showed that with the increased blood pressure, the peak position of the second Gaussian significantly shorten (P<0.01), the peak height of the first Gaussian significantly decreased (P<0.01) and the peak height of the second Gaussian significantly increased (P<0.01), inducing the significantly decreased peak position interval and significantly increased peak height ratio (both P<0.01). Sex factor had no significant effect on all evaluation indices (all P>0.05). Moreover, the interaction between sex and blood pressure factors also had no significant effect on all evaluation indices (all P>0.05). These results showed that blood pressure has significant effect on the change of wave reflection when using the recently developed Gaussian fitting method, whereas sex has no significant effect. The results also suggested that the Gaussian fitting method could be used as a new approach for assessing the arterial wave reflection.	[Liu, Chengyu; Zhao, Lina; Liu, Changchun] Shandong Univ, Sch Control Sci & Engn, Jinan 250100, Shandong, Peoples R China; [Liu, Chengyu] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Shandong University; Newcastle University - UK	Liu, CY (corresponding author), Shandong Univ, Sch Control Sci & Engn, Jinan 250100, Shandong, Peoples R China.	bestlcy@sdu.edu.cn	Liu, Chengyu/I-6411-2012	Liu, Chengyu/0000-0003-1965-3020	National Natural Science Foundation of China [61201049]; Hi-Tech Research and Development Program of China [2009AA02Z408]; Excellent Young Scientist Awarded Foundation of Shandong Province in China [BS2013DX029]; China Postdoctoral Science Foundation [2013M530323]; Postdoctoral Innovation Foundation of Shandong Province in China [201303102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Excellent Young Scientist Awarded Foundation of Shandong Province in China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Postdoctoral Innovation Foundation of Shandong Province in China	This work was supported by the National Natural Science Foundation of China (61201049), the Hi-Tech Research and Development Program of China (2009AA02Z408), the Excellent Young Scientist Awarded Foundation of Shandong Province in China (BS2013DX029), the China Postdoctoral Science Foundation (2013M530323), and the Postdoctoral Innovation Foundation of Shandong Province in China (201303102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baruch Martin C, 2011, Nonlinear Biomed Phys, V5, P1, DOI 10.1186/1753-4631-5-1; Beevers G, 2001, BMJ-BRIT MED J, V322, P1043, DOI 10.1136/bmj.322.7293.1043; Carlson RV, 2004, BRIT J CLIN PHARMACO, V57, P695, DOI 10.1111/j.1365-2125.2004.02103.x; Chirinos JA, 2005, AM J CARDIOL, V96, P645, DOI 10.1016/j.amjcard.2005.04.036; CHIU YC, 1991, AM HEART J, V121, P1460, DOI 10.1016/0002-8703(91)90153-9; Frimodt-Moller M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041757; Hermeling E, 2010, HYPERTENSION, V55, P124, DOI 10.1161/HYPERTENSIONAHA.109.143867; Hughes AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059371; Huotari M., 2011, J STRUCT MECH, V44, P345; Huotari M., 2012, P WORLD C MED PHYS B, V39, P526; Khalil A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006134; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Lisheng Xu, 2011, Proceedings 2011 International Conference on Information and Automation (ICIA 2011), P544, DOI 10.1109/ICINFA.2011.5949053; Liu CY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/923260; Liu CY, 2014, BIO-MED MATER ENG, V24, P271, DOI 10.3233/BME-130808; Liu CY, 2013, BIOMED SIGNAL PROCES, V8, P449, DOI 10.1016/j.bspc.2013.01.003; Liu CY, 2012, J MED BIOL ENG, V32, P245, DOI 10.5405/jmbe.1006; Martinez JP, 2004, IEEE T BIO-MED ENG, V51, P570, DOI 10.1109/TBME.2003.821031; Millasseau SC, 2005, HYPERTENSION, V45, P222, DOI 10.1161/01.HYP.0000154229.97341.d2; Mitchell GF, 2004, HYPERTENSION, V43, P1239, DOI 10.1161/01.HYP.0000128420.01881.aa; Munir S, 2008, HYPERTENSION, V51, P112, DOI 10.1161/HYPERTENSIONAHA.107.096016; Nichols W., 2005, MCDONALDS BLOOD FLOW, V5th; O'Rourke MF, 2004, HYPERTENSION, V44, pE10, DOI 10.1161/01.HYP.0000146403.99648.c6; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; Roman MJ, 2007, HYPERTENSION, V50, P197, DOI 10.1161/HYPERTENSIONAHA.107.089078; Roman MJ, 2009, J AM COLL CARDIOL, V54, P1730, DOI 10.1016/j.jacc.2009.05.070; Rubins U, 2008, MED BIOL ENG COMPUT, V46, P1271, DOI 10.1007/s11517-008-0406-z; Safar ME, 2002, HYPERTENSION, V39, P735, DOI 10.1161/hy0202.098325; Segers P, 2007, PHYSIOL MEAS, V28, P1045, DOI 10.1088/0967-3334/28/9/006; Sugawara J, 2010, HYPERTENSION, V56, P920, DOI 10.1161/HYPERTENSIONAHA.110.160549; Sugawara J, 2008, JACC-CARDIOVASC IMAG, V1, P739, DOI 10.1016/j.jcmg.2008.06.010; Wang L, 2013, COMPUT BIOL MED, V43, P1661, DOI 10.1016/j.compbiomed.2013.08.004; Westerhof BE, 2006, HYPERTENSION, V48, P595, DOI 10.1161/01.HYP.0000238330.08894.17	34	6	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112895	10.1371/journal.pone.0112895	http://dx.doi.org/10.1371/journal.pone.0112895			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384042	Green Published, Green Submitted, gold			2022-12-27	WOS:000344816700102
J	Pepin, E; Higa, A; Schuster-Klein, C; Bernard, C; Sulpice, T; Guardiola, B; Chevet, E; Alquier, T				Pepin, Emilie; Higa, Arisa; Schuster-Klein, Carole; Bernard, Catherine; Sulpice, Thierry; Guardiola, Beatrice; Chevet, Eric; Alquier, Thierry			Deletion of Apoptosis Signal-Regulating Kinase 1 (ASK1) Protects Pancreatic Beta-Cells from Stress-Induced Death but Not from Glucose Homeostasis Alterations under Pro-Inflammatory Conditions	PLOS ONE			English	Article							FACTOR-KAPPA-B; DIET-INDUCED OBESITY; INSULIN-RESISTANCE; ADIPOSE-TISSUE; FATTY-ACID; EXPRESSION; ACTIVATION; SECRETION; MICE; TLR4	Background: Type 2 diabetes is characterized by pancreatic beta-cell dysfunction and is associated with low-grade inflammation. Recent observations suggest that apoptosis signal-regulating kinase 1 (ASK1) is involved in beta-cell death in response to different stressors. In this study, we tested whether ASK1 deficiency protects beta-cells from glucolipotoxic conditions and cytokines treatment or from glucose homeostasis alteration induced by endotoxemia. Methodology/Principal Findings: Insulin secretion was neither affected upon shRNA-mediated downregulation of ASK1 in MIN6 cells nor in islets from ASK1-deficient mice. ASK1 silencing in MIN6 cells and deletion in islets did not prevent the deleterious effect of glucolipotoxic conditions or cytokines on insulin secretion. However, it protected MIN6 cells from death induced by ER stress or palmitate and islets from short term caspase activation in response to cytokines. Moreover, endotoxemia induced by LPS infusion increased insulin secretion during hyperglycemic clamps but the response was similar in wild-type and ASK1-deficient mice. Finally, insulin sensitivity in the presence of LPS was not affected by ASK1-deficiency. Conclusions/Significance: Our study demonstrates that ASK1 is not involved in beta-cell function and dysfunction but controls stress-induced beta-cell death.	[Pepin, Emilie; Sulpice, Thierry] Betagenex Inc, Laval, PQ H7V 5B7, Canada; [Higa, Arisa; Chevet, Eric] Univ Bordeaux, Team Endoplasm Reticulum Stress & Canc, INSERM, U1053, F-33076 Bordeaux, France; [Sulpice, Thierry] Physiogenex SAS, F-31670 Labege, France; [Schuster-Klein, Carole; Bernard, Catherine; Guardiola, Beatrice] Grp Rech Servier, F-92284 Suresnes, France; [Alquier, Thierry] Univ Montreal, Montreal Diabet Res Ctr, Ctr Rech Ctr Hosp Univ Montreal, Montreal, PQ H3T 1J4, Canada; [Alquier, Thierry] Univ Montreal, Dept Med, Montreal, PQ H3T 1J4, Canada; [Alquier, Thierry] Univ Montreal, Dept Biochem, Montreal, PQ H3T 1J4, Canada; [Alquier, Thierry] Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ H3T 1J4, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Servier; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Alquier, T (corresponding author), Univ Montreal, Montreal Diabet Res Ctr, Ctr Rech Ctr Hosp Univ Montreal, Montreal, PQ H3T 1J4, Canada.	thierry.alquier@umontreal.ca	chevet, eric/E-4992-2016; Alquier, Thierry/Z-1917-2019	chevet, eric/0000-0001-5855-4522; Alquier, Thierry/0000-0001-8171-802X	Les Laboratoires Servier (Suresnes, France); Fonds de Recherche Quebec-Sante (FRQS)	Les Laboratoires Servier (Suresnes, France); Fonds de Recherche Quebec-Sante (FRQS)	This work was supported by Les Laboratoires Servier (Suresnes, France). Servier was involved in the study design, data collection and analysis and preparation of the manuscript for publication. Thierry Alquier was supported by a salary award from Fonds de Recherche Quebec-Sante (FRQS).	Alquier T, 2009, DIABETES, V58, P2607, DOI 10.2337/db09-0362; Amyot J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036200; Nguyen AT, 2014, DIABETES, V63, P471, DOI 10.2337/db13-0903; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cani PD, 2012, GUT MICROBES, V3, P279, DOI 10.4161/gmic.19625; Cani PD, 2009, AM J CLIN NUTR, V90, P1236, DOI 10.3945/ajcn.2009.28095; Chan JY, 2012, DIABETOLOGIA, V55, P2999, DOI 10.1007/s00125-012-2657-3; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Donath MY, 2013, CELL METAB, V17, P860, DOI 10.1016/j.cmet.2013.05.001; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023; Ferdaoussi M, 2012, DIABETOLOGIA, V55, P2682, DOI 10.1007/s00125-012-2650-x; Garay-Malpartida HM, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-18; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Jayashree B, 2014, MOL CELL BIOCHEM, V388, P203, DOI 10.1007/s11010-013-1911-4; Kaji T, 2010, BIOCHEM BIOPH RES CO, V395, P213, DOI 10.1016/j.bbrc.2010.03.164; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Larsen L, 2005, DIABETOLOGIA, V48, P2582, DOI 10.1007/s00125-005-0039-9; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Maedler K, 2004, DIABETES, V53, P1706, DOI 10.2337/diabetes.53.7.1706; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Mulligan KX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030160; Nackiewicz D, 2014, DIABETOLOGIA; Nishiki Y, 2013, MOL ENDOCRINOL, V27, P336, DOI 10.1210/me.2012-1230; Park HK, 2011, DIABETES, V60, P775, DOI 10.2337/db10-1416; Pilon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015912; Poggi M, 2007, DIABETOLOGIA, V50, P1267, DOI 10.1007/s00125-007-0654-8; Poitout V, 2010, BBA-MOL CELL BIOL L, V1801, P289, DOI 10.1016/j.bbalip.2009.08.006; Shao CL, 2010, J BIOL CHEM, V285, P19710, DOI 10.1074/jbc.M109.087486; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shiizaki Shigeru, 2013, Advances in Biological Regulation, V53, P135, DOI 10.1016/j.jbior.2012.09.006; Suganami T, 2007, BIOCHEM BIOPH RES CO, V354, P45, DOI 10.1016/j.bbrc.2006.12.190; Taouji S, 2013, J BIOL CHEM, V288, P17190, DOI 10.1074/jbc.M112.409185; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Vives-Pi M, 2003, CLIN EXP IMMUNOL, V133, P208, DOI 10.1046/j.1365-2249.2003.02211.x; Widenmaier SB, 2009, J BIOL CHEM, V284, P30372, DOI 10.1074/jbc.M109.060178; Yamaguchi K, 2013, BBA-GEN SUBJECTS, V1830, P3656, DOI 10.1016/j.bbagen.2013.01.029	42	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112714	10.1371/journal.pone.0112714	http://dx.doi.org/10.1371/journal.pone.0112714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383781	gold, Green Submitted, Green Published			2022-12-27	WOS:000344816700090
J	Samuni-Blank, M; Izhaki, I; Gerchman, Y; Dearing, MD; Karasov, WH; Trabelcy, B; Edwards, TM; Arad, Z				Samuni-Blank, Michal; Izhaki, Ido; Gerchman, Yoram; Dearing, M. Denise; Karasov, William H.; Trabelcy, Beny; Edwards, Thea M.; Arad, Zeev			Taste and Physiological Responses to Glucosinolates: Seed Predator versus Seed Disperser	PLOS ONE			English	Article							SECONDARY METABOLITES; BITTER-TASTE; BREAKDOWN PRODUCTS; RIPE FRUIT; BIRDS; ADIPOSITY; DEFENSE; RODENTS; PLANT; BOMB	In contrast to most other plant tissues, fleshy fruits are meant to be eaten in order to facilitate seed dispersal. Although fleshy fruits attract consumers, they may also contain toxic secondary metabolites. However, studies that link the effect of fruit toxins with seed dispersal and predation are scarce. Glucosinolates (GLSs) are a family of bitter-tasting compounds. The fleshy fruit pulp of Ochradenus baccatus was previously found to harbor high concentrations of GLSs, whereas the myrosinase enzyme, which breaks down GLSs to produce foul tasting chemicals, was found only in the seeds. Here we show the differential behavioral and physiological responses of three rodent species to high dose (80%) Ochradenus' fruits diets. Acomys russatus, a predator of Ochradenus' seeds, was the least sensitive to the taste of the fruit and the only rodent to exhibit taste-related physiological adaptations to deal with the fruits' toxins. In contrast, Acomys cahirinus, an Ochradenus seed disperser, was more sensitive to a diet containing the hydrolyzed products of the GLSs. A third rodent (Mus musculus) was deterred from Ochradenus fruits consumption by the GLSs and their hydrolyzed products. We were able to alter M. musculus avoidance of whole fruit consumption by soaking Ochradenus fruits in a water solution containing 1% adenosine monophosphate, which blocks the bitter taste receptor in mice. The observed differential responses of these three rodent species may be due to evolutionary pressures that have enhanced or reduced their sensitivity to the taste of GLSs.	[Samuni-Blank, Michal; Arad, Zeev] Technion Israel Inst Technol, Dept Biol, IL-3200003 Haifa, Israel; [Samuni-Blank, Michal; Izhaki, Ido; Trabelcy, Beny] Univ Haifa, Fac Nat Sci, Dept Evolutionary & Environm Biol, IL-3498838 Haifa, Israel; [Gerchman, Yoram] Univ Haifa, Dept Biol & Environm, Fac Nat Sci, IL-3600672 Oranim, Tivon, Israel; [Dearing, M. Denise] Univ Utah, Dept Biol, Salt Lake City, UT 84103 USA; [Karasov, William H.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA; [Edwards, Thea M.] Sewanee Univ South, Dept Biol, Sewanee, TN 37383 USA	Technion Israel Institute of Technology; University of Haifa; University of Haifa; Utah System of Higher Education; University of Utah; University of Wisconsin System; University of Wisconsin Madison; Sewanee: University of the South	Samuni-Blank, M (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-3200003 Haifa, Israel.	michal.samuni@gmail.com	Gerchman, Yoram/F-5226-2015; Gerchman, Yoram/H-4698-2019; Izhaki, Ido/I-9712-2019	Gerchman, Yoram/0000-0002-8637-9589; Izhaki, Ido/0000-0002-4525-4683	U.S.-Israel Bi-National Science Foundation [2006043]; Israel Science Foundation [189/08]; Middle East Regional Cooperation [TA-MOU-08-M28-013]	U.S.-Israel Bi-National Science Foundation(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); Middle East Regional Cooperation	Support for this study was available through grants from the U.S.-Israel Bi-National Science Foundation Grant (#2006043), Israel Science Foundation (#189/08) and Middle East Regional Cooperation (#TA-MOU-08-M28-013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNEA A, 1993, BIOCHEM SYST ECOL, V21, P421, DOI 10.1016/0305-1978(93)90100-6; Burns KC, 2012, CURR BIOL, V22, pR535, DOI 10.1016/j.cub.2012.05.014; Cederroth CR, 2007, ENVIRON HEALTH PERSP, V115, P1467, DOI 10.1289/ehp.10413; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Cipollini ML, 1997, AM NAT, V150, P346, DOI 10.1086/286069; Cipollini ML, 1997, ECOLOGY, V78, P782; Cipollini ML, 2000, REV CHIL HIST NAT, V73, P421; CORLETT RT, 1990, OECOLOGIA, V82, P166, DOI 10.1007/BF00323531; Dillaway D., 2014, ENDOCR DISRUPTORS AU, V2, DOI [10.4161/endo.28490, DOI 10.4161/ENDO.28490]; Drewnowski A, 2000, AM J CLIN NUTR, V72, P1424; Ehrhardt N, 2005, J COMP PHYSIOL B, V175, P193, DOI 10.1007/s00360-005-0475-3; FENWICK GR, 1983, J SCI FOOD AGR, V34, P73, DOI 10.1002/jsfa.2740340111; FENWICK GR, 1983, FOOD CHEM, V11, P249, DOI 10.1016/0308-8146(83)90074-2; Glendinning J.I., 1990, Chemoecology, V1, P124, DOI 10.1007/BF01241653; Glendinning JI, 2008, PHYSIOL BEHAV, V93, P757, DOI 10.1016/j.physbeh.2007.11.029; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; HERRERA CM, 1982, AM NAT, V120, P218, DOI 10.1086/283984; IZHAKI I, 1989, OIKOS, V54, P23, DOI 10.2307/3565893; IZHAKI I, 1992, CONDOR, V94, P912, DOI 10.2307/1369288; Izhaki I, 2002, NEW PHYTOL, V155, P205, DOI 10.1046/j.1469-8137.2002.00459.x; Janzen DH, 1975, ECOLOGY PLANTS TROPI, V71; Kelt DA, 2004, J BIOGEOGR, V31, P931, DOI 10.1111/j.1365-2699.2004.01045.x; Ming D, 1999, P NATL ACAD SCI USA, V96, P9903, DOI 10.1073/pnas.96.17.9903; Norconk MA, 1998, AM J PRIMATOL, V45, P103, DOI 10.1002/(SICI)1098-2345(1998)45:1<103::AID-AJP8>3.0.CO;2-#; Oka Y, 2014, PLANT PATHOL, V63, P221, DOI 10.1111/ppa.12079; Rask L, 2000, PLANT MOL BIOL, V42, P93, DOI 10.1023/A:1006380021658; Samuni-Blank M, 2013, EVOL ECOL, V27, P1069, DOI 10.1007/s10682-013-9655-x; Samuni-Blank M, 2013, J EXP BIOL, V216, P3667, DOI 10.1242/jeb.089664; Samuni-Blank M, 2012, CURR BIOL, V22, P1218, DOI 10.1016/j.cub.2012.04.051; Stanley MC, 2001, AUST J ZOOL, V49, P633, DOI 10.1071/ZO01042; Tepper BJ, 2008, OBESITY, V16, P2289, DOI 10.1038/oby.2008.357; Torregrossa AM, 2011, FUNCT ECOL, V25, P1232, DOI 10.1111/j.1365-2435.2011.01896.x; Wittstock U, 2002, TRENDS PLANT SCI, V7, P263, DOI 10.1016/S1360-1385(02)02273-2	33	3	3	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112505	10.1371/journal.pone.0112505	http://dx.doi.org/10.1371/journal.pone.0112505			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383693	Green Submitted, Green Published, gold			2022-12-27	WOS:000344816700071
J	Wong, JKF; Metcalfe, AD; Wong, R; Bush, J; Platt, C; Garcon, A; Goldspink, N; McGrouther, DA; Ferguson, MWJ				Wong, Jason K. F.; Metcalfe, Anthony D.; Wong, Richard; Bush, Jim; Platt, Chris; Garcon, Arnaud; Goldspink, Nick; McGrouther, Duncan A.; Ferguson, Mark W. J.			Reduction of Tendon Adhesions following Administration of Adaprev, a Hypertonic Solution of Mannose-6-Phosphate: Mechanism of Action Studies	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ZONE-II; TGF-BETA; OSMOTIC-STRESS; ACTIVATION; REPAIR; P38; 5-FLUOROURACIL; EXPRESSION; 2-STRAND	Repaired tendons may be complicated by progressive fibrosis, causing adhesion formation or tendon softening leading to tendon rupture and subsequent reduced range of motion. There are few therapies available which improve the gliding of damaged tendons in the hand. We investigate the role of Mannose 6-phosphate (M6P) in a 600 mM hypertonic solution (Adaprev) on tendon adhesion formation in vivo using a mouse model of severed tendon in conjunction with analysis of collagen synthesis, cellular proliferation and receptors involved in TGF beta signalling. Cytotoxicity was assessed by measuring tissue residency, mechanical strength and cell viability of tendons after treatment with Adaprev. To elicit potential modes of action, in vitro and ex vivo studies were performed investigating phosphorylation of p38, cell migration and proliferation. Adaprev treatment significantly (p<0.05) reduced the development of adhesions and improved collagen organisation without reducing overall collagen synthesis following tendon injury in vivo. The bioavailability of Adaprev saw a 40% reduction at the site of administration over 45 minutes and tendon fibroblasts tolerated up to 120 minutes of exposure without significant loss of cell viability or tensile strength. These favourable effects were independent of CI-MPR and TGF-beta signalling and possibly highlight a novel mechanism of action related to cellular stress demonstrated by phosphorylation of p38. The effect of treatment reduced tendon fibroblast migration and transiently halted tendon fibroblast proliferation in vitro and ex vivo. Our studies demonstrate that the primary mode of action for Adaprev is potentially via a physical, non-chemical, hyperosmotic effect.	[Wong, Jason K. F.; Wong, Richard; McGrouther, Duncan A.] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England; [Metcalfe, Anthony D.; Bush, Jim; Platt, Chris; Garcon, Arnaud; Goldspink, Nick; Ferguson, Mark W. J.] Renovo Ltd, Core Technol Facil, Manchester, Lancs, England	University of Manchester; University of Manchester	Wong, JKF (corresponding author), Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England.	Jason.k.wong@manchester.ac.uk	Wong, Richard/H-5189-2015; Wong, Jason/AAQ-9239-2020	Wong, Richard/0000-0002-4382-1568; Wong, Jason/0000-0003-2592-3226; Metcalfe, Anthony/0000-0002-1633-6831; Platt, Christopher/0000-0002-0525-3221	UK Centre for Tissue Engineering - Research Councils (EPSRC, BBSRC, MRC); European Commission; National Institute of Health Research (NIHR); National Institute for Health Research [CL-2006-06-004] Funding Source: researchfish	UK Centre for Tissue Engineering - Research Councils (EPSRC, BBSRC, MRC); European Commission(European CommissionEuropean Commission Joint Research Centre); National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	Support was received from the UK Centre for Tissue Engineering funded by the Research Councils (EPSRC, BBSRC, MRC), European Commission and small and major biomedical industries, and the National Institute of Health Research (NIHR). Renovo Plc provided support in the form of salaries for authors MWJF, ADM, JB, CP, AG, and NG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions'' section. Experimental design was largely performed by JW and DAM, who are employees of the University of Manchester and independent of Renovo Plc. They have no financial interests to disclose.	Akali A, 1999, PLAST RECONSTR SURG, V103, P151, DOI 10.1097/00006534-199901000-00024; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Arsenijevic T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.189; Barnes J, 2012, J BIOL CHEM, V287, P7526, DOI 10.1074/jbc.M111.308825; Bates SJ, 2006, J BONE JOINT SURG AM, V88A, P2465, DOI 10.2106/JBJS.E.00143; Birch HL, 1997, J EXP BIOL, V200, P1703; Bullough R, 2008, DISABIL REHABIL, V30, P1746, DOI 10.1080/09638280701788258; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Caulfield RH, 2008, J HAND SURG-EUR VOL, V33E, P412, DOI 10.1177/1753193408090758; Chang J, 1997, PLAST RECONSTR SURG, V100, P937, DOI 10.1097/00006534-199709001-00016; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Cruz-Orive LM, 1999, J MICROSC-OXFORD, V193, P182, DOI 10.1046/j.1365-2818.1999.00460.x; Dallas SL, 2005, J BIOL CHEM, V280, P18871, DOI 10.1074/jbc.M410762200; DENNIS PA, 1991, P NATL ACAD SCI USA, V88, P580, DOI 10.1073/pnas.88.2.580; Fenn PD, 1995, 10907 IRN 155051; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Finan JD, 2010, J CELL BIOCHEM, V109, P460, DOI 10.1002/jcb.22437; Fujisawa M, 2012, J ENDODONT, V38, P931, DOI 10.1016/j.joen.2012.03.023; Gatidis S, 2011, CELL PHYSIOL BIOCHEM, V28, P1279, DOI 10.1159/000335859; Godar S, 1999, EUR J IMMUNOL, V29, P1004, DOI 10.1002/(SICI)1521-4141(199903)29:03<1004::AID-IMMU1004>3.0.CO;2-Q; Golash A, 2003, J HAND SURG-BRIT EUR, V28B, P113, DOI 10.1016/S0266-7681(02)00249-8; Gorvy DA, 2005, AM J PATHOL, V167, P1005, DOI 10.1016/S0002-9440(10)61190-X; Hardwicke JT, 2014, J HAND SURG-AM, V39, P686, DOI 10.1016/j.jhsa.2013.12.037; Heinemeier KM, 2011, J MUSCULOSKEL NEURON, V11, P115; Hoffmann GL, 2008, J HAND SURG-EUR VOL, V33E, P418, DOI 10.1177/1753193408091570; Howell JW, 2013, INJURY; Hsu C, 2004, J HAND SURG-AM, V29A, P551, DOI 10.1016/j.jhsa.2004.04.020; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Jiang HY, 2013, BIOPHYS J, V105, P609, DOI 10.1016/j.bpj.2013.06.021; Khan U, 1997, PLAST RECONSTR SURG, V99, P465, DOI 10.1097/00006534-199702000-00023; Lee SH, 2010, J BIOL CHEM, V285, P41280, DOI 10.1074/jbc.M110.182188; Leksa V, 2005, J CELL SCI, V118, P4577, DOI 10.1242/jcs.02587; Lin TW, 2006, J BIOMECH, V39, P61, DOI 10.1016/j.jbiomech.2004.11.009; Lunn JA, 2004, J BIOL CHEM, V279, P45266, DOI 10.1074/jbc.M314132200; Ly DL, 2013, AM J PHYSIOL-CELL PH, V304, pC115, DOI 10.1152/ajpcell.00290.2012; Ngo M, 2001, PLAST RECONSTR SURG, V108, P1260, DOI 10.1097/00006534-200110000-00025; Occleston NL, 2010, DERMAT RES PRACT, V2010, DOI 10.1155/2010/405262; Peck FH, 2004, BRIT J PLAST SURG, V57, P45, DOI 10.1016/j.bjps.2003.10.003; Ponder E, 1944, J GEN PHYSIOL, V27, P273, DOI 10.1085/jgp.27.4.273; Renovo, 2008, SINGL SIT PLAC CONTR; Rosberg HE, 2005, SCAND J PLAST RECONS, V39, P360, DOI 10.1080/02844310500340046; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHAH M, 1994, J CELL SCI, V107, P1137; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Strickland JW, 2000, J HAND SURG-AM, V25A, P214; TONG PY, 1989, J BIOL CHEM, V264, P7970; WInter J, 2013, HOSP EPISODE STAT MA; Wong JKF, 2009, AM J PATHOL, V175, P1938, DOI 10.2353/ajpath.2009.090380; Xia CS, 2012, ORTHOPEDICS, V35, pE1056, DOI 10.3928/01477447-20120621-21; Xia Changsuo, 2011, Orthopedics, V34, P21, DOI 10.3928/01477447-20101123-09; Zhou XM, 2008, P NATL ACAD SCI USA, V105, P5620, DOI 10.1073/pnas.0801453105	51	11	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112672	10.1371/journal.pone.0112672	http://dx.doi.org/10.1371/journal.pone.0112672			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383548	Green Published, gold			2022-12-27	WOS:000344816700087
J	Garba, M; Dalecky, A; Kadaoure, I; Kane, M; Hima, K; Veran, S; Gagare, S; Gauthier, P; Tatard, C; Rossi, JP; Dobigny, G				Garba, Madougou; Dalecky, Ambroise; Kadaoure, Ibrahima; Kane, Mamadou; Hima, Karmadine; Veran, Sophie; Gagare, Sama; Gauthier, Philippe; Tatard, Caroline; Rossi, Jean-Pierre; Dobigny, Gauthier			Spatial Segregation between Invasive and Native Commensal Rodents in an Urban Environment: A Case Study in Niamey, Niger	PLOS ONE			English	Article							RATTUS-RATTUS; ECOLOGY; RATS; CITY; GEOSTATISTICS; BIODIVERSITY; INFESTATIONS; NORVEGICUS; ABUNDANCE; ZOONOSES	Invasive rodents have been responsible for the diffusion worldwide of many zoonotic agents, thus representing major threats for public health. Cities are important hubs for people and goods exchange and are thus expected to play a pivotal role in invasive commensal rodent dissemination. Yet, data about urban rodents' ecology, especially invasive vs. native species interactions, are dramatically scarce. Here, we provide results of an extensive survey of urban rodents conducted in Niamey, Niger, depicting the early stages of rodent bioinvasions within a city. We explore the species-specific spatial distributions throughout the city using contrasted approaches, namely field sampling, co-occurrence analysis, occupancy modelling and indicator geostatistics. We show that (i) two species (i. e. rural-like vs. truly commensal) assemblages can be identified, and that (ii) within commensal rodents, invasive (Rattus rattus and Mus musculus) and native (Mastomys natalensis) species are spatially segregated. Moreover, several pieces of arguments tend to suggest that these exclusive distributions reflect an ongoing native-to-invasive species turn over. The underlying processes as well as the possible consequences for humans are discussed.	[Garba, Madougou; Gagare, Sama; Dobigny, Gauthier] Ctr Reg Agrhymet, Dept Format Rech, Niamey, Niger; [Garba, Madougou; Hima, Karmadine] Univ Abdou Moumouni, Fac Sci, Niamey, Niger; [Garba, Madougou] Minist Agr, Direct Generale Protect Vegetaux, Niamey, Niger; [Dalecky, Ambroise] Aix Marseille Univ, IRD, LPED UMR AMU, Marseille, France; [Dalecky, Ambroise; Gauthier, Philippe] IRD, CBGP UMR INRA Cirad SupAgro Montpellier, Montferrier Sur Lez, France; [Kadaoure, Ibrahima] Ctr Reg Agrhymet, USAid Fews Net, Niamey, Niger; [Kane, Mamadou] IRD, CBGP, Dakar, Senegal; [Tatard, Caroline] INRA, CBGP, Montferrier Sur Lez, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); INRAE; Institut de Recherche pour le Developpement (IRD)	Dobigny, G (corresponding author), Ctr Reg Agrhymet, Dept Format Rech, Niamey, Niger.	gauthier.dobigny@ird.fr	Dalecky, Ambroise/AAF-9578-2021	Dalecky, Ambroise/0000-0002-5075-4121; Rossi, Jean-Pierre/0000-0002-8139-1116; GAUTHIER, Philippe/0000-0001-8363-6845	"Institut de Recherche pour le Developpement" (France); "Service de Renforcement des Capacites'' (Institut de Recherche pour le Developpement), France	"Institut de Recherche pour le Developpement" (France); "Service de Renforcement des Capacites'' (Institut de Recherche pour le Developpement), France	Lab and field work were funded by the "Institut de Recherche pour le Developpement" (France). Funding support was partly provided to Mr. Garba by a 'BEST' bursary from the "Service de Renforcement des Capacites'' (Institut de Recherche pour le Developpement), France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamou A, 2012, THESIS A MOUMOUNI U; Panti-May JA, 2012, INT BIODETER BIODEGR, V66, P77, DOI 10.1016/j.ibiod.2011.10.006; Angelici FM, 2005, J ZOOL, V265, P9, DOI 10.1017/S0952836904005977; [Anonymous], 2013, GLOB INV SPEC DAT; Aplin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026357; Audoin-Rouzeau Frederique, 1994, Revue de Paleobiologie, V13, P125; Bastos AD, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-26; Belmain SR., 2003, ACIAR MONOGRAPH, V96, P440; Bergmans W., 1999, RONGEURS BENIN ESPEC, P23; Bonhomme F, 2011, P ROY SOC B-BIOL SCI, V278, P1034, DOI 10.1098/rspb.2010.1228; Bradman A, 2005, ENVIRON HEALTH PERSP, V113, P1795, DOI 10.1289/ehp.7588; Cavia R, 2009, LANDSCAPE URBAN PLAN, V90, P11, DOI 10.1016/j.landurbplan.2008.10.017; Gomez MD, 2008, J PEST SCI, V81, P235, DOI 10.1007/s10340-008-0212-2; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Djidingar D, 1997, B SOC PATHOL EXOT, V90, P27; Dobigny G, 2002, MAMMALIA, V66, P495, DOI 10.1515/mamm.2002.66.4.495; Dobigny G, 2008, J ZOOL, V276, P368, DOI 10.1111/j.1469-7998.2008.00500.x; Dobigny G, 2011, ACTA TROP, V117, P183, DOI 10.1016/j.actatropica.2010.11.004; Duplantier J.M., 1991, RONGEUR ESPACE, P339; Duplantier Jean-Marc, 1997, Journal of African Zoology, V111, P17; Feng AYT, 2014, URBAN ECOSYST, V17, P149, DOI 10.1007/s11252-013-0305-4; Fernandez IC, 2013, URBAN ECOSYST, V16, P377, DOI 10.1007/s11252-012-0272-1; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Galan M, 2004, MOL ECOL NOTES, V4, P321, DOI 10.1111/j.1471-8286.2004.00681.x; Garba M, 2012, THESIS A MOUMOUNI U; Garba M, 2014, MAMMALIA IN PRESS; Garba M, 2014, URBAN ECOSY IN PRESS; Gilabert A, 2007, CAN J ZOOL, V85, P965, DOI 10.1139/Z07-083; Goovaerts P, 1998, BIOL FERT SOILS, V27, P315, DOI 10.1007/s003740050439; Goovaerts P, 1999, GEODERMA, V89, P1, DOI 10.1016/S0016-7061(98)00078-0; Goovaerts P., 1997, GEOSTATISTICS NATURA, P483; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gotelli NJ, 2006, ECOSIM NULL MODELS S; GRANJON L, 1989, CR ACAD SCI III-VIE, V309, P571; Granjon L., 2009, RONGEURS AFRIQUE SAH; Granjon L, 1986, ETUDES RELATIONS SOC, P628; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Himsworth CG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002270; Himsworth CG, 2013, VECTOR-BORNE ZOONOT, V13, P349, DOI 10.1089/vbz.2012.1195; Houemenou G, 2013, THESIS LIEGE U BELGI; Houemenou G, 2013, LEPTOSPIRA SPP PREVA, V2013; Howie S, 2006, PLOS MED, V3, P1508, DOI 10.1371/journal.pmed.0030355; Isaaks E.H., 1989, ISA; Journel A. G., 1978, MINING GEOSTATISTICS; Kaleme PK, 2011, AFR ZOOL, V46, P133, DOI 10.3377/004.046.0104; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Konecny A, 2013, MOL ECOL, V22, P286, DOI 10.1111/mec.12112; Lack JB, 2013, BIOL INVASIONS, V15, P1067, DOI 10.1007/s10530-012-0351-5; Langton SD, 2001, J APPL ECOL, V38, P699, DOI 10.1046/j.1365-2664.2001.00631.x; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Lecompte E, 2005, BIOCHEM SYST ECOL, V33, P681, DOI 10.1016/j.bse.2004.12.015; Legendre P., 2012, NUMERICAL ECOLOGY; Loiseau A, 2008, MOL ECOL RESOUR, V8, P916, DOI 10.1111/j.1755-0998.2008.02115.x; Loiseau A, 2007, MOL ECOL NOTES, V7, P684, DOI 10.1111/j.1471-8286.2006.01677.x; Luniak M, 2004, 4 INT URB WILDL S, P50; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Matisoo-Smith E, 2004, P NATL ACAD SCI USA, V101, P9167, DOI 10.1073/pnas.0403120101; Meerburg BG, 2009, CRIT REV MICROBIOL, V35, P221, DOI 10.1080/10408410902989837; Mercier A, 2013, MEM I OSWALDO CRUZ, V108, P399, DOI 10.1590/S0074-0276108042013002; Monadjem A, 2011, WILDLIFE RES, V38, P603, DOI 10.1071/WR10130; Murphy R.G., 2003, ACIAR MONOGR SER, V96, P469; OLASEHA IO, 1994, J ROY SOC HEALTH, V114, P300, DOI 10.1177/146642409411400604; Olayemi A, 2012, ZOOL J LINN SOC-LOND, V165, P700, DOI 10.1111/j.1096-3642.2012.00823.x; Omudu E. A., 2010, Research Journal of Agriculture and Biological Sciences, V6, P144; Pickering Jane, 1996, Australian Mammalogy, V19, P19; Promkerd P, 2008, INTEGR ZOOL, V3, P11, DOI 10.1111/j.1749-4877.2008.00069.x; ROBERTSON GP, 1987, ECOLOGY, V68, P744, DOI 10.2307/1938482; Rosevear D, 1969, RODENTS W AFRICA; Salifou A, 2010, HIST NIGER EPOQUES P; Sidikou HA, 2011, NIAMEYA360; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; Taylor PJ, 2008, INTEGR ZOOL, V3, P38, DOI 10.1111/j.1749-4877.2008.00072.x; United Nations Development Program, 2012, WORLD URB PROSP 2011; Veyrunes F, 2005, MOL PHYLOGENET EVOL, V36, P358, DOI 10.1016/j.ympev.2005.02.011; WEBSTER R, 1990, STAT METHODS SOIL LA; Wilson DE, 2005, MAMMAL SPECIES WORL; Wyatt KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003602	78	21	22	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e110666	10.1371/journal.pone.0110666	http://dx.doi.org/10.1371/journal.pone.0110666			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379785	Green Published, gold			2022-12-27	WOS:000344863100013
J	Iwata, A; Morrison, ML; Roth, MB				Iwata, Akiko; Morrison, Michael L.; Roth, Mark B.			Iodide Protects Heart Tissue from Reperfusion Injury	PLOS ONE			English	Article							ANIMATION-LIKE STATE; OXIDATIVE STRESS; KINETICS; MICE	Iodine is an elemental nutrient that is essential for mammals. Here we provide evidence for an acute therapeutic role for iodine in ischemia reperfusion injury. Infusion of the reduced form, iodide, but not the oxidized form iodate, reduces heart damage by as much as 75% when delivered intravenously following temporary loss of blood flow but prior to reperfusion of the heart in a mouse model of acute myocardial infarction. Normal thyroid function may be required because loss of thyroid activity abrogates the iodide benefit. Given the high degree of protection and the high degree of safety, iodide should be explored further as a therapy for reperfusion injury.	[Iwata, Akiko; Morrison, Michael L.; Roth, Mark B.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center	Roth, MB (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA.	mroth@fhcrc.org			Defense Advanced Research Projects Administration [D12AP00008]	Defense Advanced Research Projects Administration	This work was funded by Defense Advanced Research Projects Administration grant # D12AP00008. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, COMPREHENSIVE HDB IO; Billat LV, 1996, SPORTS MED, V22, P90, DOI 10.2165/00007256-199622020-00004; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; Blackstone E, 2007, SHOCK, V27, P370, DOI 10.1097/SHK.0b013e31802e27a0; Carpenter KJ, 2005, J NUTR, V135, P675, DOI 10.1093/jn/135.4.675; COFFMAN JD, 1961, AM J PHYSIOL, V201, P881, DOI 10.1152/ajplegacy.1961.201.5.881; COOPER DS, 1984, NEW ENGL J MED, V311, P1353, DOI 10.1056/NEJM198411223112106; Crockford SJ, 2009, INTEGR COMP BIOL, V49, P155, DOI 10.1093/icb/icp053; Dabrowski MJ, 2013, POSTEP KARDIOL INTER, V9, P41, DOI 10.5114/pwki.2013.34027; Kloner RA, 2011, J CARDIOVASC PHARM T, V16, P244, DOI 10.1177/1074248411405990; Leung AM, 2014, NAT REV ENDOCRINOL, V10, P136, DOI 10.1038/nrendo.2013.251; McCall AS, 2014, CELL, V157, P1380, DOI 10.1016/j.cell.2014.05.009; Panneels V, 2009, COMPREHENSIVE HDB IO; Pavelka S, 2000, BIOL TRACE ELEM RES, V76, P67, DOI 10.1385/BTER:76:1:67; Radak Z, 2013, ANTIOXID REDOX SIGN, V18, P1208, DOI 10.1089/ars.2011.4498; Risher J DG, 2004, TOXICOLOGY; Schwartz Longacre L, 2011, CIRCULATION, V124, P1172, DOI 10.1161/CIRCULATIONAHA.111.032698; Senthil SS, 2004, CLIN CHIM ACTA, V348, P131, DOI 10.1016/j.cccn.2004.05.004; Sterling JB, 2000, J AM ACAD DERMATOL, V43, P691, DOI 10.1067/mjd.2000.107247; Tatzber F, 2003, ANAL BIOCHEM, V316, P147, DOI 10.1016/S0003-2697(02)00652-8; TAUROG A, 1966, J BIOL CHEM, V241, P4686; WOLFF J, 1948, ENDOCRINOLOGY, V43, P174, DOI 10.1210/endo-43-3-174; Wong GTF, 2008, MAR CHEM, V111, P22, DOI 10.1016/j.marchem.2007.04.007	23	13	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112458	10.1371/journal.pone.0112458	http://dx.doi.org/10.1371/journal.pone.0112458			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379708	Green Submitted, gold, Green Published			2022-12-27	WOS:000344863100101
J	Li, J; Inada, S; Schneider, JE; Zhang, HG; Dobrzynski, H; Boyett, MR				Li, Jue; Inada, Shin; Schneider, Jurgen E.; Zhang, Henggui; Dobrzynski, Halina; Boyett, Mark R.			Three-Dimensional Computer Model of the Right Atrium Including the Sinoatrial and Atrioventricular Nodes Predicts Classical Nodal Behaviours	PLOS ONE			English	Article							RECTIFIER POTASSIUM CURRENT; ACTION-POTENTIAL DURATION; MATHEMATICAL-MODEL; PACEMAKER ACTIVITY; ELECTRICAL-ACTIVITY; IONIC MECHANISMS; SINUS NODE; ELECTROPHYSIOLOGICAL MODEL; REGIONAL DIFFERENCES; MEMBRANE CURRENTS	The aim of the study was to develop a three-dimensional (3D) anatomically-detailed model of the rabbit right atrium containing the sinoatrial and atrioventricular nodes to study the electrophysiology of the nodes. A model was generated based on 3D images of a rabbit heart (atria and part of ventricles), obtained using high-resolution magnetic resonance imaging. Segmentation was carried out semi-manually. A 3D right atrium array model (similar to 3.16 million elements), including eighteen objects, was constructed. For description of cellular electrophysiology, the Rogers-modified FitzHugh-Nagumo model was further modified to allow control of the major characteristics of the action potential with relatively low computational resource requirements. Model parameters were chosen to simulate the action potentials in the sinoatrial node, atrial muscle, inferior nodal extension and penetrating bundle. The block zone was simulated as passive tissue. The sinoatrial node, crista terminalis, main branch and roof bundle were considered as anisotropic. We have simulated normal and abnormal electrophysiology of the two nodes. In accordance with experimental findings: (i) during sinus rhythm, conduction occurs down the interatrial septum and into the atrioventricular node via the fast pathway (conduction down the crista terminalis and into the atrioventricular node via the slow pathway is slower); (ii) during atrial fibrillation, the sinoatrial node is protected from overdrive by its long refractory period; and (iii) during atrial fibrillation, the atrioventricular node reduces the frequency of action potentials reaching the ventricles. The model is able to simulate ventricular echo beats. In summary, a 3D anatomical model of the right atrium containing the cardiac conduction system is able to simulate a wide range of classical nodal behaviours.	[Li, Jue; Inada, Shin; Schneider, Jurgen E.; Zhang, Henggui; Dobrzynski, Halina; Boyett, Mark R.] Univ Manchester, Inst Cardiovasc Sci, Core Technol Facil, Manchester, Lancs, England	University of Manchester	Boyett, MR (corresponding author), Univ Manchester, Inst Cardiovasc Sci, Core Technol Facil, Manchester, Lancs, England.	mark.boyett@manchester.ac.uk	Zhang, Henggui/D-6712-2011; Li, Jue/G-9935-2015; Zhang, Henggui/AAM-1043-2020	Li, Jue/0000-0001-7902-0263; Dobrzynski, Halina/0000-0003-4754-5975; Boyett, Mark/0000-0003-3931-2020	British Heart Foundation [RG/11/18/29257]; BHF Senior Basic Science Research [FS/11/50/29038]; British Heart Foundation [FS/14/5/30533, FS/11/50/29038] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J00958X/1] Funding Source: researchfish; EPSRC [EP/J00958X/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); BHF Senior Basic Science Research; British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This study is financially supported by a programme grant from the British Heart Foundation (RG/11/18/29257). Jurgen E. Schneider is a BHF Senior Basic Science Research Fellow (FS/11/50/29038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslanidi OV, 2011, PROG BIOPHYS MOL BIO, V107, P156, DOI 10.1016/j.pbiomolbio.2011.06.011; Aslanidi OV, 2010, BIOPHYS J, V98, P2420, DOI 10.1016/j.bpj.2010.02.033; Aslanidi OV, 2009, BIOPHYS J, V96, P798, DOI 10.1016/j.bpj.2008.09.057; BEELER GW, 1977, J PHYSIOL-LONDON, V268, P177, DOI 10.1113/jphysiol.1977.sp011853; Benson AP, 2008, PROG BIOPHYS MOL BIO, V96, P187, DOI 10.1016/j.pbiomolbio.2007.08.002; Bernus O, 2003, INT J BIFURCAT CHAOS, V13, P3693, DOI 10.1142/S021812740300896X; Bernus O, 2002, AM J PHYSIOL-HEART C, V282, pH2296, DOI 10.1152/ajpheart.00731.2001; BLEEKER WK, 1980, CIRC RES, V46, P11, DOI 10.1161/01.RES.46.1.11; Bondarenko VE, 2004, AM J PHYSIOL-HEART C, V287, pH1378, DOI 10.1152/ajpheart.00185.2003; Boyett MR, 2000, CARDIOVASC RES, V47, P658, DOI 10.1016/S0008-6363(00)00135-8; Boyett MR, 2005, J ELECTROCARDIOL, V38, P113, DOI 10.1016/j.jelectrocard.2005.06.102; Boyett MR, 1999, AM J PHYSIOL-HEART C, V276, pH686, DOI 10.1152/ajpheart.1999.276.2.H686; Chandler N, 2011, ANAT REC, V294, P970, DOI 10.1002/ar.21379; Clayton RH, 2009, PHYSICA D, V238, P951, DOI 10.1016/j.physd.2008.06.008; COAKLEY JB, 1959, J ANAT, V93, P30; Courtemanche M, 1998, AM J PHYSIOL-HEART C, V275, pH301, DOI 10.1152/ajpheart.1998.275.1.H301; DECARVALHO AP, 1960, CIRC RES, V8, P801, DOI 10.1161/01.RES.8.4.801; DECARVALHO AP, 1959, AM J PHYSIOL, V196, P483, DOI 10.1152/ajplegacy.1959.196.3.483; Decker KF, 2009, AM J PHYSIOL-HEART C, V296, pH1017, DOI 10.1152/ajpheart.01216.2008; Demir SS, 1999, AM J PHYSIOL-HEART C, V276, pH2221, DOI 10.1152/ajpheart.1999.276.6.H2221; DEMIR SS, 1994, AM J PHYSIOL, V266, pC832, DOI 10.1152/ajpcell.1994.266.3.C832; DENYER JC, 1990, J PHYSIOL-LONDON, V428, P405, DOI 10.1113/jphysiol.1990.sp018219; DIFRANCESCO D, 1985, PHILOS T ROY SOC B, V307, P353, DOI 10.1098/rstb.1985.0001; Dobrzynski H, 2005, CIRCULATION, V111, P846, DOI 10.1161/01.CIR.0000152100.04087.DB; Dokos S, 1996, J THEOR BIOL, V181, P245, DOI 10.1006/jtbi.1996.0129; Efimov IR, 2004, ANAT REC PART A, V280A, P952, DOI 10.1002/ar.a.20108; EIFLER WJ, 1981, CIRC RES, V48, P168, DOI 10.1161/01.RES.48.2.168; Fedorov VV, 2006, AM J PHYSIOL-HEART C, V291, pH612, DOI 10.1152/ajpheart.00022.2006; Fenton F, 1998, CHAOS, V8, P20, DOI 10.1063/1.166311; Fink M, 2008, PROG BIOPHYS MOL BIO, V96, P357, DOI 10.1016/j.pbiomolbio.2007.07.011; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Fozzard HA., 1991, HEART CARDIOVASCULAR; Grandi E, 2010, J MOL CELL CARDIOL, V48, P112, DOI 10.1016/j.yjmcc.2009.09.019; Harrild DM, 2000, CIRC RES, V87, pE25; HILGEMANN DW, 1987, PROC R SOC SER B-BIO, V230, P163, DOI 10.1098/rspb.1987.0015; HOLDEN AV, 1993, J CHEM SOC FARADAY T, V89, P2833, DOI 10.1039/ft9938902833; Hund TJ, 2004, CIRCULATION, V110, P3168, DOI 10.1161/01.CIR.0000147231.69595.D3; Inada S, 2009, BIOPHYS J, V97, P2117, DOI 10.1016/j.bpj.2009.06.056; Iyer V, 2004, BIOPHYS J, V87, P1507, DOI 10.1529/biophysj.104.043299; KERR CR, 1980, CIRC RES, V47, P742, DOI 10.1161/01.RES.47.5.742; Kharche S, 2011, AM J PHYSIOL-HEART C, V301, pH945, DOI 10.1152/ajpheart.00143.2010; KIRCHHOF CJHJ, 1992, CIRCULATION, V86, P263, DOI 10.1161/01.CIR.86.1.263; Kneller J, 2002, CIRC RES, V90, pE73, DOI 10.1161/01.RES.0000019783.88094.BA; Kodama I, 1997, AM J PHYSIOL-HEART C, V272, pH2793, DOI 10.1152/ajpheart.1997.272.6.H2793; Kurata Y, 2002, AM J PHYSIOL-HEART C, V283, pH2074, DOI 10.1152/ajpheart.00900.2001; Lei M, 2002, CARDIOVASC RES, V53, P68, DOI 10.1016/S0008-6363(01)00459-X; Li H, 2014, J AGING RES, V2014; Li J, 2005, COMPUT CARDIOL, V32, P603; Li J, 2004, COMPUT CARDIOL, V31, P89, DOI 10.1109/CIC.2004.1442878; Li J, 2009, COMPUT CARDIOL, V36, P65; Li J, 2008, CIRC RES, V102, P975, DOI 10.1161/CIRCRESAHA.108.172403; Lin LJ, 2001, J CARDIOVASC ELECTR, V12, P479, DOI 10.1046/j.1540-8167.2001.00479.x; Lindblad DS, 1996, AM J PHYSIOL-HEART C, V271, pH1666, DOI 10.1152/ajpheart.1996.271.4.H1666; Litchenberg WH, 2000, CARDIOVASC RES, V45, P379, DOI 10.1016/S0008-6363(99)00363-6; LORANGE M, 1993, J ELECTROCARDIOL, V26, P245, DOI 10.1016/0022-0736(93)90047-H; LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071; MAZGALEV T, 1982, AM J PHYSIOL, V243, pH754, DOI 10.1152/ajpheart.1982.243.5.H754; Mazgalev T., 2000, ATRIAL AV NODAL ELEC; MCALLISTER RE, 1975, J PHYSIOL-LONDON, V251, P1; NAKAYAMA T, 1984, PFLUG ARCH EUR J PHY, V402, P248, DOI 10.1007/BF00585507; NIELSEN PMF, 1991, AM J PHYSIOL, V260, pH1365, DOI 10.1152/ajpheart.1991.260.4.H1365; Nikolski VP, 2003, CIRC RES, V92, P469, DOI 10.1161/01.RES.0000059304.97120.2F; Noble D, 1998, CAN J CARDIOL, V14, P123; Nygren A, 1998, CIRC RES, V82, P63; Oehmen CS, 2002, J CARDIOVASC ELECTR, V13, P1131, DOI 10.1046/j.1540-8167.2002.01131.x; Oliveira M, 2011, EXP PHYSIOL, V96, P125, DOI 10.1113/expphysiol.2010.053280; ONO K, 1995, AM J PHYSIOL-HEART C, V269, pH453, DOI 10.1152/ajpheart.1995.269.2.H453; Priebe L, 1998, CIRC RES, V82, P1206, DOI 10.1161/01.RES.82.11.1206; Puglisi JL, 2001, AM J PHYSIOL-CELL PH, V281, pC2049, DOI 10.1152/ajpcell.2001.281.6.C2049; Ramirez RJ, 2000, AM J PHYSIOL-HEART C, V279, pH1767, DOI 10.1152/ajpheart.2000.279.4.H1767; Reid MC, 2003, J CARDIOVASC ELECTR, V14, P1342, DOI 10.1046/j.1540-8167.2003.03382.x; ROGERS JM, 1994, IEEE T BIO-MED ENG, V41, P743, DOI 10.1109/10.310090; Sachse FB, 2000, P 3 US C NAT LIB MED; Seemann G, 2006, PHILOS T R SOC A, V364, P1465, DOI 10.1098/rsta.2006.1781; Shannon TR, 2004, BIOPHYS J, V87, P3351, DOI 10.1529/biophysj.104.047449; Shaw RM, 1997, CARDIOVASC RES, V35, P256, DOI 10.1016/S0008-6363(97)00093-X; SPACH MS, 1971, CIRC RES, V29, P156, DOI 10.1161/01.RES.29.2.156; Stephenson RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035299; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; Toshida N, 2001, J CARDIOVASC ELECTR, V12, P1256, DOI 10.1046/j.1540-8167.2001.01256.x; VANGINNEKEN ACG, 1991, J PHYSIOL-LONDON, V434, P57, DOI 10.1113/jphysiol.1991.sp018459; VERHEIJCK EE, 1995, CIRC RES, V76, P607, DOI 10.1161/01.RES.76.4.607; Vetter FJ, 1998, PROG BIOPHYS MOL BIO, V69, P157, DOI 10.1016/S0079-6107(98)00006-6; Viswanathan PC, 1999, CIRCULATION, V99, P2466, DOI 10.1161/01.CIR.99.18.2466; Wilders R, 1996, AM J PHYSIOL-HEART C, V271, pH2168, DOI 10.1152/ajpheart.1996.271.5.H2168; WILDERS R, 1991, BIOPHYS J, V60, P1202, DOI 10.1016/S0006-3495(91)82155-5; WINSLOW RL, 1993, P ROY SOC B-BIOL SCI, V254, P55, DOI 10.1098/rspb.1993.0126; Winslow RL, 1999, CIRC RES, V84, P571, DOI 10.1161/01.RES.84.5.571; Wu JY, 2001, AM J PHYSIOL-HEART C, V280, pH1232, DOI 10.1152/ajpheart.2001.280.3.H1232; Xianda C., 2003, CHINESE J CARDIAC PA, V17, P22; Xiao JJ, 2010, MED SCI MONITOR, V16, pBR353; Yamamoto M, 1998, CARDIOVASC RES, V39, P360, DOI 10.1016/S0008-6363(98)00091-1; YAMASHITA T, 1995, CIRCULATION, V92, P3061, DOI 10.1161/01.CIR.92.10.3061; YANAGIHARA K, 1980, JPN J PHYSIOL, V30, P841; ZENG JL, 1995, CIRC RES, V77, P140, DOI 10.1161/01.RES.77.1.140; Zhang H, 2000, AM J PHYSIOL-HEART C, V279, pH397, DOI 10.1152/ajpheart.2000.279.1.H397	96	13	13	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112547	10.1371/journal.pone.0112547	http://dx.doi.org/10.1371/journal.pone.0112547			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380074	gold, Green Published, Green Submitted			2022-12-27	WOS:000344863100106
J	Wang, LZ; Huang, ZG; Rong, ZH; Wang, XF; Lai, YC				Wang, Le-Zhi; Huang, Zi-Gang; Rong, Zhi-Hai; Wang, Xiao-Fan; Lai, Ying-Cheng			Emergence, Evolution and Scaling of Online Social Networks	PLOS ONE			English	Article								Online social networks have become increasingly ubiquitous and understanding their structural, dynamical, and scaling properties not only is of fundamental interest but also has a broad range of applications. Such networks can be extremely dynamic, generated almost instantaneously by, for example, breaking-news items. We investigate a common class of online social networks, the user-user retweeting networks, by analyzing the empirical data collected from Sina Weibo (a massive twitter-like microblogging social network in China) with respect to the topic of the 2011 Japan earthquake. We uncover a number of algebraic scaling relations governing the growth and structure of the network and develop a probabilistic model that captures the basic dynamical features of the system. The model is capable of reproducing all the empirical results. Our analysis not only reveals the basic mechanisms underlying the dynamics of the retweeting networks, but also provides general insights into the control of information spreading on such networks.	[Wang, Le-Zhi; Huang, Zi-Gang; Lai, Ying-Cheng] Arizona State Univ, Sch Elect Comp & Energy Engn, Tempe, AZ 85287 USA; [Huang, Zi-Gang] Lanzhou Univ, Sch Phys Sci & Technol, Lanzhou 730000, Peoples R China; [Rong, Zhi-Hai] Univ Elect Sci & Technol China, Web Sci Ctr, Sch Comp Sci & Engn, Chengdu, Sichuan, Peoples R China; [Wang, Xiao-Fan] Shanghai Jiao Tong Univ, Dept Automat, Shanghai 200030, Peoples R China; [Lai, Ying-Cheng] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Lanzhou University; University of Electronic Science & Technology of China; Shanghai Jiao Tong University; Arizona State University; Arizona State University-Tempe	Huang, ZG (corresponding author), Arizona State Univ, Sch Elect Comp & Energy Engn, Tempe, AZ 85287 USA.	huangzg@lzu.edu.cn; Ying-Cheng.Lai@asu.edu	Rong, Zhihai/G-6907-2011; Huang, Zi-Gang/D-1353-2009; Rong, Zhihai/G-6911-2011	Rong, Zhihai/0000-0003-2009-1053; Huang, Zi-Gang/0000-0001-9648-3067	AFOSR [FA9550-10-1-0083]; NSF [CDI-1026710]; NSF of China [61473060, 11275003]; NBRPC [2010CB731403]	AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF(National Science Foundation (NSF)); NSF of China(National Natural Science Foundation of China (NSFC)); NBRPC(National Basic Research Program of China)	This work was partially supported by AFOSR under Grant No. FA9550-10-1-0083, NSF under Grant No. CDI-1026710, NSF of China under Grants Nos. 61473060 and 11275003, and NBRPC under Grant No. 2010CB731403. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borondo J, 2012, CHAOS, V22, DOI 10.1063/1.4729139; Boyd D., 2010, 43 HAW INT C SYST SC, V2010, P1, DOI DOI 10.1109/HICSS.2010.412; Burkit L, 2011, WALL STREET J; Cha M., 2010, 4 INT AAAI C WEBL SO, V14, P8; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Foster JG, 2010, P NATL ACAD SCI USA, V107, P10815, DOI 10.1073/pnas.0912671107; Goel S., P 13 ACM C EL COMM, P623, DOI DOI 10.1145/2229012.2229058; Goncalves B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022656; Holme P, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056108; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Kwak H., 2010, PROC 19 INT C WORLD, P591, DOI 10.1145/1772690.1772751; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lu LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021202; Mocanu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061981; Oka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060398; Qi Gao, 2012, User Modeling, Adaptation, and Personalization. Proceedings 20th International Conference, UMAP 2012, P88, DOI 10.1007/978-3-642-31454-4_8; Romero D. M., 2011, P 20 INT C WORLD WID, P695, DOI [10.1145/1963405.1963503, DOI 10.1145/1963405.1963503]; Singh P, 2013, SCI REP-UK, V3, DOI 10.1038/srep02330; Yu L., 2011, ARXIV11073522	20	4	4	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111013	10.1371/journal.pone.0111013	http://dx.doi.org/10.1371/journal.pone.0111013			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380140	Green Published, Green Submitted, gold			2022-12-27	WOS:000344863100016
J	Zheng, XJ; Demirci, FY; Barmada, MM; Richardson, GA; Lopez, OL; Sweet, RA; Kamboh, MI; Feingold, E				Zheng, Xiaojing; Demirci, F. Yesim; Barmada, M. Michael; Richardson, Gale A.; Lopez, Oscar L.; Sweet, Robert A.; Kamboh, M. Ilyas; Feingold, Eleanor			A Rare Duplication on Chromosome 16p11.2 Is Identified in Patients with Psychosis in Alzheimer's Disease	PLOS ONE			English	Article							COPY NUMBER VARIATION; DOWN-REGULATION; MICRODELETION; RISK; SCHIZOPHRENIA; ASSOCIATION; LYMPHOCYTES; EXPRESSION; PRECURSOR; DELETIONS	Epidemiological and genetic studies suggest that schizophrenia and autism may share genetic links. Besides common single nucleotide polymorphisms, recent data suggest that some rare copy number variants (CNVs) are risk factors for both disorders. Because we have previously found that schizophrenia and psychosis in Alzheimer's disease (AD+P) share some genetic risk, we investigated whether CNVs reported in schizophrenia and autism are also linked to AD+P. We searched for CNVs associated with AD+P in 7 recurrent CNV regions that have been previously identified across autism and schizophrenia, using the Illumina HumanOmni1-Quad BeadChip. A chromosome 16p11.2 duplication CNV (chr16: 29,554,843-30,105,652) was identified in 2 of 440 AD+P subjects, but not in 136 AD subjects without psychosis, or in 593 AD subjects with intermediate psychosis status, or in 855 non-AD individuals. The frequency of this duplication CNV in AD+P (0.46%) was similar to that reported previously in schizophrenia (0.46%). This duplication CNV was further validated using the NanoString nCounter CNV Custom CodeSets. The 16p11.2 duplication has been associated with developmental delay, intellectual disability, behavioral problems, autism, schizophrenia (SCZ), and bipolar disorder. These two AD+P patients had no personal of, nor any identified family history of, SCZ, bipolar disorder and autism. To the best of our knowledge, our case report is the first suggestion that 16p11.2 duplication is also linked to AD+P. Although rare, this CNV may have an important role in the development of psychosis.	[Zheng, Xiaojing; Feingold, Eleanor] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Demirci, F. Yesim; Barmada, M. Michael; Kamboh, M. Ilyas; Feingold, Eleanor] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Richardson, Gale A.; Sweet, Robert A.; Kamboh, M. Ilyas] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15261 USA; [Lopez, Oscar L.; Sweet, Robert A.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Lopez, Oscar L.; Sweet, Robert A.; Kamboh, M. Ilyas] VA Pittsburgh Healthcare Syst, VISN Mental Illness Res Educ & Clin Ctr 4, Pittsburgh, PA USA; [Richardson, Gale A.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Zheng, Xiaojing] Univ N Carolina, Sch Med, Dept Pediat, Chapel Hill, NC USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Zheng, XJ (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA.	xiaojinz@email.unc.edu		Kamboh, M. Ilyas/0000-0002-3453-1438; Demirci, F. Yesim/0000-0001-6907-9843; Barmada, M Michael/0000-0002-3604-6460; Feingold, Eleanor/0000-0003-2898-6484	National Institute on Aging [AG030653, AG041718, AG005133, AG027224]; NanoString award; NIMH Grant [T32 MH015169]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030653, R01AG041718, P50AG005133, R01AG027224] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NanoString award; NIMH Grant; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institute on Aging grants AG030653, AG041718 (MIK), AG005133 (OLL), and AG027224 (RAS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the Department of Veterans Affairs or the United States Government. Funding for experimental validation was provided by NanoString award. This work was conducted in partial fulfillment of requirements for the first author's doctoral degree, supported by NIMH Grant T32 MH015169 (G.A.R., Program Director). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacanu SA, 2005, AM J GERIAT PSYCHIAT, V13, P624, DOI 10.1176/appi.ajgp.13.7.624; Bartolome F, 2007, CELL MOL LIFE SCI, V64, P1437, DOI 10.1007/s00018-007-7081-3; Bedoyan JK, 2010, AM J MED GENET A, V152A, P1567, DOI 10.1002/ajmg.a.33415; Bowden NA, 2006, SCHIZOPHR RES, V82, P175, DOI 10.1016/j.schres.2005.11.012; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Carroll LS, 2009, GENOME MED, V1, DOI 10.1186/gm102; Carson R, 2008, NEUROMOL MED, V10, P377, DOI 10.1007/s12017-008-8048-8; Chong YH, 2006, J BIOL CHEM, V281, P20315, DOI 10.1074/jbc.M601016200; DeMichele-Sweet MA, 2010, J ALZHEIMERS DIS, V19, P761, DOI 10.3233/JAD-2010-1274; DeMichele-Sweet MAA, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.10.003; Esteras N, 2013, NEUROBIOL AGING, V34, P1090, DOI 10.1016/j.neurobiolaging.2012.10.014; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Feld M, 2014, J ALZHEIMERS DIS, V40, P69, DOI 10.3233/JAD-131076; Ghebranious N, 2007, AM J MED GENET A, V143A, P1462, DOI 10.1002/ajmg.a.31837; Go RCP, 2005, AM J MED GENET B, V139B, P28, DOI 10.1002/ajmg.b.30219; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Ravetti MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010153; Grayton HM, 2012, PROG NEUROBIOL, V99, P81, DOI 10.1016/j.pneurobio.2012.07.005; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; Heinzen EL, 2010, J ALZHEIMERS DIS, V19, P69, DOI 10.3233/JAD-2010-1212; Hollingworth P, 2012, MOL PSYCHIATR, V17, P1316, DOI 10.1038/mp.2011.125; Jordan-Sciutto KL, 2000, BIOCHEMISTRY-US, V39, P3206, DOI 10.1021/bi992211q; Kamboh MI, 2012, MOL PSYCHIATR, V17, P1340, DOI 10.1038/mp.2011.135; Kamboh MI, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.45; Matsuo A, 1996, J NEUROIMMUNOL, V71, P81, DOI 10.1016/S0165-5728(96)00134-8; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Miller CL, 2008, NEUROCHEM INT, V52, P1297, DOI 10.1016/j.neuint.2008.01.013; Moreno-De-Luca D, 2010, AM J HUM GENET, V87, P618, DOI 10.1016/j.ajhg.2010.10.004; Morris DW, 2014, HUM MOL GENET, V23, P3316, DOI 10.1093/hmg/ddu025; Poon HF, 2005, MOL BRAIN RES, V138, P8, DOI 10.1016/j.molbrainres.2005.02.020; Quintero-Rivera F, 2010, AM J MED GENET A, V152A, P2459, DOI 10.1002/ajmg.a.33573; R Development Core Team, 2012, R LANG ENV STAT COMP; Ropacki SA, 2005, AM J PSYCHIAT, V162, P2022, DOI 10.1176/appi.ajp.162.11.2022; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; Simons VIP Consortium, 2012, NEURON, V73, P1063, DOI 10.1016/j.neuron.2012.02.014; Spitzer Philipp, 2011, Int J Alzheimers Dis, V2011, P739847, DOI 10.4061/2011/739847; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Steinberg S, 2014, MOL PSYCHIATR, V19, P108, DOI 10.1038/mp.2012.157; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sweet RA, 2003, MOL PSYCHIATR, V8, P383, DOI 10.1038/sj.mp.4001262; TARIOT PN, 1995, AM J PSYCHIAT, V152, P1349; Ting KK, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-36; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974	46	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111462	10.1371/journal.pone.0111462	http://dx.doi.org/10.1371/journal.pone.0111462			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379732	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000344863100030
J	Lopez-Antonanzas, R; Pelaez-Campomanes, P; Alvarez-Sierra, A				Lopez-Antonanzas, Raquel; Pelaez-Campomanes, Pablo; Alvarez-Sierra, Angeles			New Species of Rotundomys (Cricetinae) from the Late Miocene of Spain and Its Bearing on the Phylogeny of Cricetulodon and Rotundomys	PLOS ONE			English	Article							SUCCESSION; RODENTIA; HISTORY; BASIN	The material of Rotundomys (Rodentia, Cricetinae) from the Late Miocene fossiliferous complex of Cerro de los Batallones (Madrid, Spain) is described and compared with all species currently placed in the genera Rotundomys and Cricetulodon. Both the morphology and size variation encompassed in the collection of specimens from Batallones suggest they belong to a single taxon different from the other known species of these genera. A new species Rotundomys intimus sp. nov. is, therefore, named for it. A cladistic analysis, which is the first ever published concernig these taxa, has been conducted to clear up the phylogenetic position of the new species. Our results suggest that Rotundomys intimus sp. nov. inserts between R. mundi and R. sabatieri as a relatively primitive taxon inside the clade Rotundomys. The new taxon is more derived than R. mundi in having a transversal connection between the metalophulid and the anterolophulid on some m1 but more primitive than R. sabatieri and the most evolved species of Rotundomys (R. montisrotuni + R. bressanus) in its less developed lophodonty showing distinct cusps, shallower valleys, and the presence of a subdivided anteroloph on the M1. The species of Cricetulodon do not form a monophyletic group. As a member of Rotundomys, Rotundomys intimus sp. nov. is more derived than all of these taxa in its greater lophodonty and the complete loss of the anterior protolophule, mesolophs, and mesolophids.	[Lopez-Antonanzas, Raquel; Pelaez-Campomanes, Pablo] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Lopez-Antonanzas, Raquel] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain; [Alvarez-Sierra, Angeles] Univ Complutense, Fac Ciencias Geol, Inst Geociencias IGEO,Dept Paleontol, CSIC,Dept Geol Sedimentaria & Cambio Medioambient, E-28040 Madrid, Spain	University of Bristol; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UCM - Instituto de Geociencias (IGEO)	Lopez-Antonanzas, R (corresponding author), Univ Bristol, Sch Earth Sci, Bristol, Avon, England.	r.lopez-antonanzas@bristol.ac.uk	Peláez-Campomanes, Pablo/G-4561-2010	Peláez-Campomanes, Pablo/0000-0002-6551-1026; Lopez-Antonanzas, Raquel/0000-0003-3025-0476; ALVAREZ SIERRA, MARIA DE LOS ANGELES/0000-0002-2649-5887	Ministerio de EconomA-a y Competitividad, Madrid [CGL2008-05813-CO2-01, CGL2011-25754, CGL2011-24829, CGL2011-28877]; Research Group UCM [910607]; RamA3n y Cajal Program; Marie Curie Actions	Ministerio de EconomA-a y Competitividad, Madrid; Research Group UCM; RamA3n y Cajal Program; Marie Curie Actions(European Commission)	This is a contribution to the research projects CGL2008-05813-CO2-01, CGL2011-25754, CGL2011-24829, and CGL2011-28877 (Ministerio de EconomA-a y Competitividad, Madrid) and the Research Group UCM 910607. RLA has been supported by the RamA3n y Cajal Program from 2009 until 2014 and by the Marie Curie Actions since then. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J.-P., 1982, Palaeovertebrata (Montpellier), V12, P75; Aguilar Jean-Pierre, 2007, Geologie de la France, V1, P63; Aguilar JP, 1999, PALAEOGEOGR PALAEOCL, V145, P215, DOI 10.1016/S0031-0182(98)00103-5; AGUSTI J, 1986, Geobios (Villeurbanne), V19, P5, DOI 10.1016/S0016-6995(86)80032-8; Agusti J, 1997, PALAEOGEOGR PALAEOCL, V133, P149, DOI 10.1016/S0031-0182(97)00084-9; Agusti J., 1982, Paleontologia i Evolucio, V17, P29; Agusti J, 2003, J HUM EVOL, V45, P145, DOI 10.1016/S0047-2484(03)00091-5; Agusti J., 1979, Paleontologia i Evolucio, V14, P17; Agusti J., 1981, THESIS U BARCELONA B; Alvarez-Sierra MA, 1983, THESIS U COMPLUTENSE; [Anonymous], 1821, ANAL NATURAL CLASSIF; [Anonymous], 1984, VOLUME HOMMAGE GEOLO, P257; ANTUNES M T, 1979, Geobios (Villeurbanne), V12, P913, DOI 10.1016/S0016-6995(79)80009-1; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Calvo J., 1978, BOL GEOL MIN, V89, P407; Calvo JP, 2013, SEDIMENTOLOGY, V60, P1681, DOI 10.1111/sed.12048; Casanovas Vilar I, 2007, THESIS U BARCELONA B; Chaline J, 1999, ANN ZOOL FENN, V36, P239; Checa L, 1998, TRIB ARQUEOL, V1999-2000, P19; De Bruijn H., 1971, P KONINKLIJKE NEDE B, V74, P1; Farjanel G, 1984, GEOL FR, V12, P131; Fejfar O, 2011, PALAEONTOL ELECTRON, V14; Fischer de Waldheim G., 1817, MEMOIRES SOC IMPERIA, V5, P357; FREUDENTHAL M, 1967, PROC K NED AKAD B-PH, V70, P298; Freudenthal M., 1994, Scripta Geologica, V104, P57; Freudenthal M., 1991, Scripta Geologica, V96, P9; Freudenthal Matthijs, 1998, Treballs del Museu de Geologia de Barcelona, V7, P11; Garcia Moreno E., 1988, PALEONTOLOGIA EVOLUC, V22, P103; Goloboff PA, 2001, CLADISTICS, V17, pS26, DOI 10.1111/j.1096-0031.2001.tb00102.x; Goloboff P, 2008, CLADISTICS, V24, P91; Guerin C, 1971, DOCUMENTS LAB GEOLOG, P131; Guerra-Merchan A, 2001, GEOBIOS-LYON, V34, P85, DOI 10.1016/S0016-6995(01)80049-8; Hartenberger J. L., 1965, Bulletin de la Societe Geologique de France Ser 7, V7, P487; Kalin Daniel, 1999, P373; Lopez-Antonanzas R, 2010, ZOOL J LINN SOC-LOND, V160, P725, DOI 10.1111/j.1096-3642.2010.00618.x; Lopez-Martinez N, 1986, STUD GEOL SALMANTICE, V22, P191; Mein P., 1975, COLLOQ INT CNRS, V218, P759; Mein P., 1999, HOMINOID EVOLUTION C, V1, P140; Mein P, 1965, B SOC GEOLOGIQUE FRA, V7, P421; Morales J., 2008, Publicaciones del Seminario de Paleontologia de Zaragoza, V8, P41; MORENO EG, 1987, THESIS U COMPLUTENSE; Pineda-Munoz S, 2011, VIAJANDO MUNDOS PRET, P289; Schaub S., 1944, ECLOGAE GEOL HELV, V37, P453; Van Dam Jan A., 1997, Geologica Ultraiectina, V156, P1	44	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112704	10.1371/journal.pone.0112704	http://dx.doi.org/10.1371/journal.pone.0112704			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389967	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400120
J	Brotons, L				Brotons, Lluis			Species Distribution Models and Impact Factor Growth in Environmental Journals: Methodological Fashion or the Attraction of Global Change Science	PLOS ONE			English	Article							CITED PAPERS; ECOLOGY; QUALITY; BIOLOGY; TIME	In this work, I evaluate the impact of species distribution models (SDMs) on the current status of environmental and ecological journals by asking the question to which degree development of SDMs in the literature is related to recent changes in the impact factors of ecological journals. The hypothesis evaluated states that research fronts are likely to attract research attention and potentially drive citation patterns, with journals concentrating papers related to the research front receiving more attention and benefiting from faster increases in their impact on the ecological literature. My results indicate a positive relationship between the number of SDM related articles published in a journal and its impact factor (IF) growth during the period 2000-09. However, the percentage of SDM related papers in a journal was strongly and positively associated with the percentage of papers on climate change and statistical issues. The results support the hypothesis that global change science has been critical in the development of SDMs and that interest in climate change research in particular, rather than the usage of SDM per se, appears as an important factor behind journal IF increases in ecology and environmental sciences. Finally, our results on SDM application in global change science support the view that scientific interest rather than methodological fashion appears to be the major driver of research attraction in the scientific literature.	[Brotons, Lluis] Forest Sci Ctr Catalonia, CEMFOR CTFC, Solsona, Catalonia, Spain; [Brotons, Lluis] Ctr Ecol Res & Forestry Applicat, CREAF, Cerdanyola Del Valles, Catalonia, Spain	Centre Tecnologic Forestal de Catalunya (CTFC); Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF)	Brotons, L (corresponding author), Forest Sci Ctr Catalonia, CEMFOR CTFC, Solsona, Catalonia, Spain.	lluis.brotons@ctfc.cat	Brotons, Lluís/D-1570-2009	Brotons, Lluís/0000-0002-4826-4457	Spanish Ministry of Education and Science (MEC) [CGL2011-29539/BOS, Consolider Montes CSD2008-00040]; Catalan government [2010 BE 272]; SCALES [FP7-226852]	Spanish Ministry of Education and Science (MEC)(Spanish Government); Catalan government; SCALES	This study has received financial support from the projects CGL2011-29539/BOS and Consolider Montes CSD2008-00040 granted by the Spanish Ministry of Education and Science (MEC) and it is also a contribution to the FP7-226852 project SCALES. Additional funding to LB was received from the Catalan government through project 2010 BE 272. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althouse BM, 2009, J AM SOC INF SCI TEC, V60, P27, DOI 10.1002/asi.20936; Barbosa FG, 2012, BRAZ J BIOL, V72, P821, DOI 10.1590/S1519-69842012000500007; Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; Groesser SN, 2012, SYST RES BEHAV SCI, V29, P624, DOI 10.1002/sres.2142; Institute for Scientific Information&REG, 2005, THOMS ISI ESS SCI IN; Ioannidis JPA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000005; Leimu R, 2005, TRENDS ECOL EVOL, V20, P28, DOI 10.1016/j.tree.2004.10.010; Lortie CJ, 2013, SCIENTOMETRICS, V94, P675, DOI 10.1007/s11192-012-0822-6; Mac Nally R, 2002, BIODIVERS CONSERV, V11, P1397, DOI 10.1023/A:1016250716679; Neff BD, 2010, BIOSCIENCE, V60, P455, DOI 10.1525/bio.2010.60.6.9; Neff MW, 2009, SCIENTOMETRICS, V80, P657, DOI 10.1007/s11192-008-2099-3; Olden JD, 2007, ECOSCIENCE, V14, P370, DOI 10.2980/1195-6860(2007)14[370:HDEJSR]2.0.CO;2; Pysek P, 2006, PRESLIA, V78, P437; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Venables WN., 2002, MODERN APPL STAT S 4; Walsh C., 2005, HIER PART PACKAGE VE; Wilson AE, 2007, BIOSCIENCE, V57, P550, DOI 10.1641/B570702	19	15	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111996	10.1371/journal.pone.0111996	http://dx.doi.org/10.1371/journal.pone.0111996			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT9MC	25386926	Green Submitted, gold, Green Published			2022-12-27	WOS:000345250400035
J	Martin-Sanchez, E; Odqvist, L; Rodriguez-Pinilla, SM; Sanchez-Beato, M; Roncador, G; Dominguez-Gonzalez, B; Blanco-Aparicio, C; Collazo, AMG; Cantalapiedra, EG; Fernandez, JP; del Olmo, SC; Pisonero, H; Madureira, R; Almaraz, C; Mollejo, M; Alves, FJ; Menarguez, J; Gonzalez-Palacios, F; Rodriguez-Peralto, JL; Ortiz-Romero, PL; Real, FX; Garcia, JF; Bischoff, JR; Piris, MA				Martin-Sanchez, Esperanza; Odqvist, Lina; Rodriguez-Pinilla, Socorro M.; Sanchez-Beato, Margarita; Roncador, Giovanna; Dominguez-Gonzalez, Beatriz; Blanco-Aparicio, Carmen; Garcia Collazo, Ana M.; Gonzalez Cantalapiedra, Esther; Pastor Fernandez, Joaquin; Curiel del Olmo, Soraya; Pisonero, Helena; Madureira, Rebeca; Almaraz, Carmen; Mollejo, Manuela; Javier Alves, F.; Menarguez, Javier; Gonzalez-Palacios, Fernando; Luis Rodriguez-Peralto, Jose; Ortiz-Romero, Pablo L.; Real, Francisco X.; Garcia, Juan F.; Bischoff, James R.; Piris, Miguel A.			PIM Kinases as Potential Therapeutic Targets in a Subset of Peripheral T Cell Lymphoma Cases	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; DOUBLE-STRAND BREAKS; GENE-EXPRESSION; DNA-DAMAGE; INHIBITOR; CANCER; GAMMA-H2AX; SURVIVAL; SGI-1776; SPECTRUM	Currently, there is no efficient therapy for patients with peripheral T cell lymphoma (PTCL). The Proviral Integration site of Moloney murine leukemia virus (PIM) kinases are important mediators of cell survival. We aimed to determine the therapeutic value of PIM kinases because they are overexpressed in PTCL patients, T cell lines and primary tumoral T cells. PIM kinases were inhibited genetically (using small interfering and short hairpin RNAs) and pharmacologically (mainly with the pan-PIM inhibitor (PIMi) ETP-39010) in a panel of 8 PTCL cell lines. Effects on cell viability, apoptosis, cell cycle, key proteins and gene expression were evaluated. Individual inhibition of each of the PIM genes did not affect PTCL cell survival, partially because of a compensatory mechanism among the three PIM genes. In contrast, pharmacological inhibition of all PIM kinases strongly induced apoptosis in all PTCL cell lines, without cell cycle arrest, in part through the induction of DNA damage. Therefore, pan-PIMi synergized with Cisplatin. Importantly, pharmacological inhibition of PIM reduced primary tumoral T cell viability without affecting normal T cells ex vivo. Since anaplastic large cell lymphoma (ALK+ ALCL) cell lines were the most sensitive to the pan-PIMi, we tested the simultaneous inhibition of ALK and PIM kinases and found a strong synergistic effect in ALK+ ALCL cell lines. Our findings suggest that PIM kinase inhibition could be of therapeutic value in a subset of PTCL, especially when combined with ALK inhibitors, and might be clinically beneficial in ALK+ ALCL.	[Martin-Sanchez, Esperanza; Odqvist, Lina; Dominguez-Gonzalez, Beatriz; Real, Francisco X.; Piris, Miguel A.] Spanish Natl Canc Res Ctr CNIO, Mol Pathol Programme, Madrid, Spain; [Martin-Sanchez, Esperanza; Curiel del Olmo, Soraya; Pisonero, Helena; Madureira, Rebeca; Almaraz, Carmen; Piris, Miguel A.] Hosp Univ Marques de Valdecilla, Marques de Valdecilla Res Inst IDIVAL, Canc Genom Grp, Santander, Spain; [Martin-Sanchez, Esperanza; Curiel del Olmo, Soraya; Pisonero, Helena; Madureira, Rebeca; Almaraz, Carmen; Piris, Miguel A.] Hosp Univ Marques de Valdecilla, Dept Pathol, Santander, Spain; [Rodriguez-Pinilla, Socorro M.] Fdn Jimenez Diaz, Dept Pathol, E-28040 Madrid, Spain; [Sanchez-Beato, Margarita] Hosp Univ Puerta de Hierro Majadahonda, Inst Invest Sanitaria, Oncohematol Area, Madrid, Spain; [Roncador, Giovanna] Spanish Natl Canc Res Ctr CNIO, Monoclonal Antibodies Core Unit, Madrid, Spain; [Blanco-Aparicio, Carmen; Garcia Collazo, Ana M.; Gonzalez Cantalapiedra, Esther; Pastor Fernandez, Joaquin] Spanish Natl Canc Res Ctr CNIO, Expt Therapeut Programme, Madrid, Spain; [Mollejo, Manuela] Hosp Virgen de la Salud, Dept Pathol, Toledo, Spain; [Javier Alves, F.] Hosp La Paz, Dept Pathol, Madrid, Spain; [Menarguez, Javier] Hosp Gregorio Maranon, Dept Pathol, Madrid, Spain; [Gonzalez-Palacios, Fernando] Hosp Ramon & Cajal, Dept Pathol, E-28034 Madrid, Spain; [Luis Rodriguez-Peralto, Jose] Univ Complutense Madrid, Sch Med, Octubre Univ Hosp 12, Pathol Dept,Inst I 12, Madrid, Spain; [Ortiz-Romero, Pablo L.] Univ Complutense Madrid, Sch Med, Octubre Univ Hosp 12, Dermatol Dept,Inst I 12, Madrid, Spain; [Garcia, Juan F.] MD Anderson Canc Ctr Madrid, Translat Res Lab, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Hospital Puerta de Hierro-Majadahonda; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Complejo Hospitalario de Toledo; Hospital Universitario La Paz; General University Gregorio Maranon Hospital; Hospital Universitario Ramon y Cajal; Complutense University of Madrid; Hospital Universitario 12 de Octubre; Complutense University of Madrid; Hospital Universitario 12 de Octubre; University of Texas System; UTMD Anderson Cancer Center	Piris, MA (corresponding author), Spanish Natl Canc Res Ctr CNIO, Mol Pathol Programme, Madrid, Spain.	mapiris@humv.es	Arribas, Francisco X Real/H-5275-2015; MENARGUEZ, JAVIER/ABC-7303-2020; Piris, Miguel A/B-7067-2008; Cantalapiedra, Esther González/N-2079-2015; Piris, Miguel A/AAP-1445-2020; Fernandez, Joaquin Pastor/I-4567-2015; Blanco-Aparicio, Carmen/I-3162-2015; Sanchez-Beato, Margarita/G-8753-2012; GARCIA, JUAN/L-2118-2016; Martín-Sánchez, Esperanza/M-7578-2015; Roncador, Giovanna/L-1764-2014	Arribas, Francisco X Real/0000-0001-9501-498X; MENARGUEZ, JAVIER/0000-0001-5318-9976; Piris, Miguel A/0000-0001-5839-3634; Cantalapiedra, Esther González/0000-0002-4883-9492; Piris, Miguel A/0000-0001-5839-3634; Fernandez, Joaquin Pastor/0000-0003-0553-8021; Blanco-Aparicio, Carmen/0000-0002-3249-6595; Sanchez-Beato, Margarita/0000-0002-0058-7599; Martín-Sánchez, Esperanza/0000-0002-8155-9185; Almaraz Pro, Maria del Carmen/0000-0002-6714-4450; Rodriguez-Peralto, Jose Luis/0000-0002-6578-7153; Roncador, Giovanna/0000-0002-9807-2875; Mollejo, Manuela/0000-0001-5658-0532	Asociacion Espanola Contra el Cancer; Fondo de Investigaciones Sanitarias [PI051623, PI052800, FIS 11/1759, CP11/00018]; RTICC [RD06/0020/0107]; Ministerio de Ciencia e Innovacion [SAF2008-0387-1]; Department of Education, Universities and Research of the Basque Government [BFI08.207]	Asociacion Espanola Contra el Cancer; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); RTICC(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Department of Education, Universities and Research of the Basque Government	This work was supported by grants from the Asociacion Espanola Contra el Cancer, Fondo de Investigaciones Sanitarias (PI051623, PI052800 and FIS 11/1759), RTICC (RD06/0020/0107) and Ministerio de Ciencia e Innovacion (SAF2008-0387-1). EMS was supported by a grant from the Department of Education, Universities and Research of the Basque Government (BFI08.207). MSB was supported by a Contract Miguel Servet from Fondo de Investigaciones Sanitarias (CP11/00018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado Y, 2012, EXPERT REV HEMATOL, V5, P81, DOI [10.1586/EHM.11.69, 10.1586/ehm.11.69]; An NF, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-12; Armitage JO, 2012, AM J HEMATOL, V87, P512, DOI 10.1002/ajh.23144; Barreca A, 2011, J MOL ENDOCRINOL, V47, pR11, DOI 10.1530/JME-11-0004; Bednarski JJ, 2012, J EXP MED, V209, P11, DOI 10.1084/jem.20112078; Blanco-Aparicio C, 2013, BIOCHEM PHARMACOL, V85, P629, DOI 10.1016/j.bcp.2012.09.018; Blanco-Aparicio C, 2011, CANCER LETT, V300, P145, DOI 10.1016/j.canlet.2010.09.016; Brault L, 2010, HAEMATOL-HEMATOL J, V95, P1004, DOI 10.3324/haematol.2009.017079; Chen LS, 2011, BLOOD, V118, P693, DOI 10.1182/blood-2010-12-323022; Chen LS, 2009, BLOOD, V114, P4150, DOI 10.1182/blood-2009-03-212852; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; de Leval L, 2007, BLOOD, V109, P4952, DOI 10.1182/blood-2006-10-055145; de Leval L, 2009, CRIT REV ONCOL HEMAT, V72, P125, DOI 10.1016/j.critrevonc.2009.01.002; Drygin D, 2012, J MED CHEM, V55, P8199, DOI 10.1021/jm3009234; Dunleavy K, 2010, CLIN CANCER RES, V16, P5608, DOI 10.1158/1078-0432.CCR-09-1995; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Foss FM, 2011, BLOOD, V117, P6756, DOI 10.1182/blood-2010-05-231548; Gambacorti-Passerini C, 2011, NEW ENGL J MED, V364, P775, DOI 10.1056/NEJMc1013224; Garcia PD, 2014, CLIN CANC RES; Horwitz SM, 2014, OBJECTIVE RESPONSES; Hsu JL, 2012, CANCER LETT, V319, P214, DOI 10.1016/j.canlet.2012.01.004; Intlekofer AM, 2014, INT J HEMATOL, V99, P249, DOI 10.1007/s12185-014-1521-2; Jackson LJ, 2012, CELL IMMUNOL, V272, P200, DOI 10.1016/j.cellimm.2011.10.011; Keeton EK, 2014, BLOOD, V123, P905, DOI 10.1182/blood-2013-04-495366; Laimer D, 2012, NAT MED, V18, P1699, DOI 10.1038/nm.2966; Lin YW, 2010, BLOOD, V115, P824, DOI 10.1182/blood-2009-07-233445; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Mahalingam D, 2011, BRIT J CANCER, V105, P1563, DOI 10.1038/bjc.2011.426; Mak V, 2013, J CLIN ONCOL, V31, P1970, DOI 10.1200/JCO.2012.44.7524; Martin-Sanchez E, 2013, HAEMATOL-HEMATOL J, V98, P57, DOI 10.3324/haematol.2012.068510; Martin-Sanchez E, 2011, BRIT J HAEMATOL, V152, P352, DOI 10.1111/j.1365-2141.2010.08401.x; Min XW, 2012, J HUAZHONG U SCI-MED, V32, P17, DOI 10.1007/s11596-012-0003-0; Mologni L, 2012, EXPERT OPIN INV DRUG, V21, P985, DOI 10.1517/13543784.2012.690031; Moskowitz AJ, 2014, BLOOD; Mumenthaler SM, 2009, MOL CANCER THER, V8, P2882, DOI 10.1158/1535-7163.MCT-09-0293; Nawijn MC, 2011, NAT REV CANCER, V11, P23, DOI 10.1038/nrc2986; O'Leary H, 2009, CURR OPIN HEMATOL, V16, P292, DOI 10.1097/MOH.0b013e32832b89a9; Pastor Fernandez J, 2011, TRICYCLIC COMPOUNDS; Pearson JD, 2012, J SIGNAL TRANSDUCT, V2012, DOI DOI 10.1155/2012/123253.EPUB; Sak A, 2010, SEMIN RADIAT ONCOL, V20, P223, DOI 10.1016/j.semradonc.2010.05.004; Scarisbrick JJ, 2014, BR J DERMATOL; Siu A, 2011, ONCOTARGET, V2, P1134; Song JH, 2012, CANCER RES, V72, P294, DOI 10.1158/0008-5472.CAN-11-3240; Yang Qingshan, 2013, Clin Lymphoma Myeloma Leuk, V13 Suppl 2, pS355, DOI 10.1016/j.clml.2013.05.024; Yang QS, 2012, BLOOD, V120, P3491, DOI 10.1182/blood-2012-02-412643; Zhang Y, 2010, J NEUROCHEM, V112, P497, DOI 10.1111/j.1471-4159.2009.06476.x	46	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112148	10.1371/journal.pone.0112148	http://dx.doi.org/10.1371/journal.pone.0112148			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386922	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400042
J	Dai, ZZ; Ji, J; Xiao, G; Yan, G; Li, SK; Zhang, GS; Lin, Y; Shen, ZW; Wu, RH				Dai, Zhuozhi; Ji, Jim; Xiao, Gang; Yan, Gen; Li, Shengkai; Zhang, Guishan; Lin, Yan; Shen, Zhiwei; Wu, Renhua			Magnetization Transfer Prepared Gradient Echo MRI for CEST Imaging	PLOS ONE			English	Article							EXCHANGE SATURATION-TRANSFER; IN-VIVO; CONTRAST AGENT; PH; RELAXATION; ACIDOSIS; RATIO	Chemical exchange saturation transfer (CEST) is an emerging MRI contrast mechanism that is capable of noninvasively imaging dilute CEST agents and local properties such as pH and temperature, augmenting the routine MRI methods. However, the routine CEST MRI includes a long RF saturation pulse followed by fast image readout, which is associated with high specific absorption rate and limited spatial resolution. In addition, echo planar imaging (EPI)-based fast image readout is prone to image distortion, particularly severe at high field. To address these limitations, we evaluated magnetization (MT) prepared gradient echo (GRE) MRI for CEST imaging. We proved the feasibility using numerical simulations and experiments in vitro and in vivo. Then we optimized the sequence by serially evaluating the effects of the number of saturation steps, MT saturation power (B1), GRE readout flip angle (FA), and repetition time (TR) upon the CEST MRI, and further demonstrated the endogenous amide proton CEST imaging in rats brains (n = 5) that underwent permanent middle cerebral artery occlusion. The CEST images can identify ischemic lesions in the first 3 hours after occlusion. In summary, our study demonstrated that the readily available MT-prepared GRE MRI, if optimized, is CEST-sensitive and remains promising for translational CEST imaging.	[Dai, Zhuozhi; Yan, Gen; Li, Shengkai; Zhang, Guishan; Lin, Yan; Wu, Renhua] Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Med Imaging, Shantou 515000, Guangdong, Peoples R China; [Dai, Zhuozhi] Univ Alberta, Fac Med, Dept Biomed Engn, Edmonton, AB T6G 2V2, Canada; [Ji, Jim] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX USA; [Xiao, Gang] Hanshan Normal Univ, Dept Math & Informat Technol, Chaozhou 521000, Guangdong, Peoples R China; [Shen, Zhiwei; Wu, Renhua] Prov Key Lab Med Mol Imaging, Shantou 515000, Guangdong, Peoples R China	Shantou University; University of Alberta; Texas A&M University System; Texas A&M University College Station; Hanshan Normal University	Wu, RH (corresponding author), Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Med Imaging, Shantou 515000, Guangdong, Peoples R China.	rhwu@stu.edu.cn		Ji, Jim/0000-0001-7147-7920	NSF [S2011010004973, B2013281];  [NSFC-30930027];  [NSFC-81101102]	NSF(National Science Foundation (NSF)); ; 	This study was funded in part by NSFC-30930027 (Wu RH), NSFC-81101102 (Lin Y), NSF of Guangdong Province-S2011010004973 (Lin Y), MSF of Guangdong Province-B2013281 (Dai ZZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai KJ, 2012, NAT MED, V18, P302, DOI 10.1038/nm.2615; Dixon WT, 2010, MAGN RESON MED, V63, P253, DOI 10.1002/mrm.22193; Dula AN, 2011, MAGN RESON MED, V66, P831, DOI 10.1002/mrm.22862; Gilad AA, 2007, NAT BIOTECHNOL, V25, P217, DOI 10.1038/nbt1277; Jokivarsi KT, 2007, MAGN RESON MED, V57, P647, DOI 10.1002/mrm.21181; Jones CK, 2012, MAGN RESON MED, V67, P1579, DOI 10.1002/mrm.23141; Li YG, 2011, CONTRAST MEDIA MOL I, V6, P219, DOI 10.1002/cmmi.421; Ling W, 2008, P NATL ACAD SCI USA, V105, P2266, DOI 10.1073/pnas.0707666105; Longo DL, 2011, MAGN RESON MED, V65, P202, DOI 10.1002/mrm.22608; Opina ACL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027370; Shah T, 2011, MAGN RESON MED, V65, P432, DOI 10.1002/mrm.22637; Singh A, 2012, MAGN RESON MED, V68, P588, DOI 10.1002/mrm.23250; Sun PZ, 2008, MAGN RESON MED, V59, P1175, DOI 10.1002/mrm.21591; Sun PZ, 2007, MAGN RESON MED, V57, P405, DOI 10.1002/mrm.21151; Sun PZ, 2013, PHYS MED BIOL, V58, pN229, DOI 10.1088/0031-9155/58/17/N229; Sun PZ, 2013, CONTRAST MEDIA MOL I, V8, P246, DOI 10.1002/cmmi.1524; Sun PZ, 2012, NEUROIMAGE, V60, P1, DOI 10.1016/j.neuroimage.2011.11.091; Sun PZ, 2011, MAGN RESON MED, V66, P1042, DOI 10.1002/mrm.22894; Sun PZ, 2011, J CEREBR BLOOD F MET, V31, P1743, DOI 10.1038/jcbfm.2011.23; Sun PZ, 2010, STROKE, V41, pS147, DOI 10.1161/STROKEAHA.110.595777; Terreno E, 2010, CHEM REV, V110, P3019, DOI 10.1021/cr100025t; Terreno E, 2009, CONTRAST MEDIA MOL I, V4, P237, DOI 10.1002/cmmi.290; Togao O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077019; van Zijl PCM, 2007, P NATL ACAD SCI USA, V104, P4359, DOI 10.1073/pnas.0700281104; van Zijl PCM, 2011, MAGN RESON MED, V65, P927, DOI 10.1002/mrm.22761; Ward KM, 2000, J MAGN RESON, V143, P79, DOI 10.1006/jmre.1999.1956; Wei M, 2011, IMAGING PH PHANTOMS, P329; Wu RH, 2012, CONTRAST MEDIA MOL I, V7, P384, DOI 10.1002/cmmi.505; Zhang SR, 2003, J AM CHEM SOC, V125, P15288, DOI 10.1021/ja038345f; Zhou JY, 2008, MAGN RESON MED, V60, P842, DOI 10.1002/mrm.21712; Zhou JY, 2003, NAT MED, V9, P1085, DOI 10.1038/nm907; Zu ZL, 2011, MAGN RESON MED, V66, P1100, DOI 10.1002/mrm.22884	32	17	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112219	10.1371/journal.pone.0112219	http://dx.doi.org/10.1371/journal.pone.0112219			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384020	gold, Green Published, Green Submitted			2022-12-27	WOS:000344816700040
J	Mo, GY; Ding, Q; Chen, ZS; Li, YB; Yan, M; Bu, LJ; Song, YP; Yin, GH				Mo, Guoyan; Ding, Qin; Chen, Zhongshan; Li, Yunbo; Yan, Ming; Bu, Lijing; Song, Yanping; Yin, Guohua			A Novel Mutation in the RPE65 Gene Causing Leber Congenital Amaurosis and Its Transcriptional Expression In Vitro	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; VISUAL CYCLE; RETINITIS-PIGMENTOSA; KEY RESIDUES; ISOMEROHYDROLASE; DYSTROPHY; IDENTIFICATION; DEGENERATION; ISOMERASE; CHILDREN	The retinal pigment epithelium-specific 65 kDa protein is an isomerase encoded by the RPE65 gene (MIM 180069) that is responsible for an essential enzymatic step required for the function of the visual cycle. Mutations in the RPE65 gene cause not only subtype II of Leber congenital amaurosis (LCA) but also early-onset severe retinal dystrophy (EOSRD). This study aims to investigate a Chinese case diagnosed as EOSRD and to characterize the polymorphisms of the RPE65 gene. A seven-year-old girl with clinical symptoms of EOSRD and her parents were recruited into this study. Ophthalmologic examinations, including best-corrected visual acuity, slit-lamp, Optical coherence tomography (OCT), and fundus examination with dilated pupils, were performed to determine the clinical characteristics of the whole family. We amplified and sequenced the entire coding region and adjacent intronic sequences of the coding regions of the RPE65 gene for the whole family to explore the possible mutation. Our results demonstrate that the patient exhibited the typical clinically features of EOSRD. Her bilateral decimal visual acuity was 0.3 and 0.4 in the left and right eyes, respectively. Spectral-domain optical coherence tomography (SD-OCT) was used to assess the retinal stratification for the whole family. All together, we identified four mutations within the RPE65 gene (c.1056G>A, c.1243+2T>A, c.1338+20A>C and c.1590C>A) in the patient. Among the four mutations, c.1056G>A and c.1338+20A>C had been reported previously and another two were found for the first time in this study. Her mother also carried the novel mutation (c.1243+2T>A). Either a single or a compound heterozygous or a homozygous one mutation is expected to cause EOSRD because mutations of RPE65 gene usually cause an autosomal recessive disease. Therefore, we speculate that the c.1590C>A mutation together with the c.1243+2T>A mutation may cause the patient's phenotype.	[Mo, Guoyan] Hubei Univ Chinese Med, Minist Educ, China Key Lab TCM Resource & Prescript, Wuhan 430065, Peoples R China; [Ding, Qin; Chen, Zhongshan; Yan, Ming; Song, Yanping] Wuhan Gen Hosp Guangzhou Mil Command, Dept Ophthalmol, Wuhan 430070, Peoples R China; [Li, Yunbo] Beijing Univ Chinese Med, Affiliated Hosp 3, Beijing 100029, Peoples R China; [Bu, Lijing] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Yin, Guohua] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08901 USA; [Yin, Guohua] Wuhan Sheng Biotech Serv Co Ltd, Wuhan, Peoples R China	Hubei University of Chinese Medicine; Beijing University of Chinese Medicine; University of New Mexico; Rutgers State University New Brunswick	Song, YP (corresponding author), Wuhan Gen Hosp Guangzhou Mil Command, Dept Ophthalmol, Wuhan 430070, Peoples R China.	songyanping@medmail.com.cn; guohuayin1997@gmail.com		Bu, Lijing/0000-0001-8625-2732	National Science Foundation of Hubei Province of China [2013CFB069]	National Science Foundation of Hubei Province of China	This research was funded by the National Science Foundation of Hubei Province of China [Grant No. 2013CFB069]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Al-Khayer K, 2004, AM J OPHTHALMOL, V137, P375, DOI 10.1016/S0002-9394(03)00913-9; BAVIK CO, 1992, J BIOL CHEM, V267, P23035; Bereta G, 2008, BIOCHEMISTRY-US, V47, P9856, DOI 10.1021/bi800905v; den Hollander AI, 2007, INVEST OPHTH VIS SCI, V48, P5690, DOI 10.1167/iovs.07-0610; Dharmaraj S R, 2000, Ophthalmic Genet, V21, P135; Ehnes A, 2014, TRANSL VIS SCI TECHN, V3, DOI 10.1167/tvst.3.1.1; FOXMAN SG, 1985, ARCH OPHTHALMOL-CHIC, V103, P1502; Galvin JA, 2005, RETINA-J RET VIT DIS, V25, P919, DOI 10.1097/00006982-200510000-00016; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; HAMEL CP, 1994, GENOMICS, V20, P509, DOI 10.1006/geno.1994.1212; HAMEL CP, 1993, J NEUROSCI RES, V34, P414, DOI 10.1002/jnr.490340406; Hanein S, 2004, HUM MUTAT, V23, P306, DOI 10.1002/humu.20010; Henderson RH, 2007, INVEST OPHTH VIS SCI, V48, P5684, DOI 10.1167/iovs.07-0207; Hood DC, 2011, INVEST OPHTH VIS SCI, V52, P101, DOI 10.1167/iovs.10-5799; Hood DC, 2009, INVEST OPHTH VIS SCI, V50, P2328, DOI 10.1167/iovs.08-2936; Hufnagel RB, 2012, GRAEF ARCH CLIN EXP, V250, P1117, DOI 10.1007/s00417-012-2028-2; Jacobson SG, 2008, INVEST OPHTH VIS SCI, V49, P4573, DOI 10.1167/iovs.08-2121; Jacobson SG, 2007, INVEST OPHTH VIS SCI, V48, P332, DOI 10.1167/iovs.06-0599; Jacobson SG, 2009, INVEST OPHTH VIS SCI, V50, P2368, DOI 10.1167/iovs.08-2696; Jacobson SG, 2005, P NATL ACAD SCI USA, V102, P6177, DOI 10.1073/pnas.0500646102; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Kiser PD, 2009, P NATL ACAD SCI USA, V106, P17325, DOI 10.1073/pnas.0906600106; Klein D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086304; Leber T., 1869, ALBRECHT GRAEFES ARC, V15, P1, DOI [DOI 10.1007/BF02721213, 10.1007/BF02721213]; Leber T, 1871, ARCH OPHTHALMOL-CHIC, V17, P249, DOI [10.1007/BF01694557, DOI 10.1007/BF01694557]; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019458; Li YM, 2009, INVEST OPHTH VIS SCI, V50, P1336, DOI 10.1167/iovs.08-2589; Lorenz B, 2000, INVEST OPHTH VIS SCI, V41, P2735; Lorenz B, 2008, INVEST OPHTH VIS SCI, V49, P5235, DOI 10.1167/iovs.07-1671; Lotery AJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P538; Mamatha G, 2008, OPHTHALMIC GENET, V29, P73, DOI 10.1080/13816810802008259; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; McKibbin M, 2010, ARCH OPHTHALMOL-CHIC, V128, P107, DOI 10.1001/archophthalmol.2010.309; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; NAKAI K, 1994, GENE, V141, P171, DOI 10.1016/0378-1119(94)90567-3; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Perrault I, 1999, AM J HUM GENET, V64, P1225, DOI 10.1086/302335; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Simonelli F, 2007, INVEST OPHTH VIS SCI, V48, P4284, DOI 10.1167/iovs.07-0068; Simovich M J, 2001, Hum Mutat, V18, P164, DOI 10.1002/humu.1168; Sitorus RS, 2003, VISION RES, V43, P3087, DOI 10.1016/j.visres.2003.08.008; Song YP, 2013, INT OPHTHALMOL, V33, P269, DOI 10.1007/s10792-012-9686-2; Stone EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/j.ajo.2007.08.022; Takahashi Y, 2005, FEBS LETT, V579, P5414, DOI 10.1016/j.febslet.2005.09.002; Thompson DA, 2000, INVEST OPHTH VIS SCI, V41, P4293; Verma A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073172; Woodruff ML, 2007, J NEUROSCI, V27, P8805, DOI 10.1523/JNEUROSCI.2751-07.2007; Xu F, 2012, MOL VIS, V18, P744; Yzer S, 2006, INVEST OPHTH VIS SCI, V47, P1167, DOI 10.1167/iovs.05-0848; Zernant J, 2005, INVEST OPHTH VIS SCI, V46, P3052, DOI 10.1167/iovs.05-0111	53	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112400	10.1371/journal.pone.0112400	http://dx.doi.org/10.1371/journal.pone.0112400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383945	gold, Green Submitted, Green Published			2022-12-27	WOS:000344816700056
J	Colwell, LJ; Brenner, MP; Murray, AW				Colwell, Lucy J.; Brenner, Michael P.; Murray, Andrew W.			Conservation Weighting Functions Enable Covariance Analyses to Detect Functionally Important Amino Acids	PLOS ONE			English	Article							STRUCTURAL BASIS; ALLOSTERIC REGULATION; CORRELATED MUTATIONS; SIGNAL-TRANSDUCTION; PROTEIN FAMILIES; SPECIFICITY; HEMOGLOBIN; DOMAINS; DETERMINANTS; EVOLUTIONARY	The explosive growth in the number of protein sequences gives rise to the possibility of using the natural variation in sequences of homologous proteins to find residues that control different protein phenotypes. Because in many cases different phenotypes are each controlled by a group of residues, the mutations that separate one version of a phenotype from another will be correlated. Here we incorporate biological knowledge about protein phenotypes and their variability in the sequence alignment of interest into algorithms that detect correlated mutations, improving their ability to detect the residues that control those phenotypes. We demonstrate the power of this approach using simulations and recent experimental data. Applying these principles to the protein families encoded by Dscam and Protocadherin allows us to make testable predictions about the residues that dictate the specificity of molecular interactions.	[Colwell, Lucy J.] Univ Cambridge, Univ Chem Lab, Cambridge, England; [Brenner, Michael P.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Murray, Andrew W.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA	University of Cambridge; Harvard University; Harvard University	Colwell, LJ (corresponding author), Univ Cambridge, Univ Chem Lab, Cambridge, England.	ljc37@cam.ac.uk			National Science Foundation Division of Mathematical Sciences; National Institute for General Medical Sciences grant for National Centers of Systems Biology [GM068763]; Roche Pharmaceuticals; Engineering and Physical Sciences Research Council Fellowship [EP/H028064/2]; EPSRC [EP/H028064/1, EP/H028064/2] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/H028064/1, EP/H028064/2] Funding Source: researchfish	National Science Foundation Division of Mathematical Sciences(National Science Foundation (NSF)); National Institute for General Medical Sciences grant for National Centers of Systems Biology; Roche Pharmaceuticals(Roche Holding); Engineering and Physical Sciences Research Council Fellowship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was funded by grants from the National Science Foundation Division of Mathematical Sciences (MPB), National Institute for General Medical Sciences grant GM068763 for National Centers of Systems Biology (AWM), and Roche Pharmaceuticals (MPB LJC). LJC acknowledges support from Engineering and Physical Sciences Research Council Fellowship EP/H028064/2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUH D, 1987, J MOL BIOL, V193, P693, DOI 10.1016/0022-2836(87)90352-4; Armitage SAO, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-53; Ashenberg O, 2011, J MOL BIOL, V413, P222, DOI 10.1016/j.jmb.2011.08.011; Atchley WR, 2000, MOL BIOL EVOL, V17, P164, DOI 10.1093/oxfordjournals.molbev.a026229; Capra EJ, 2012, CELL, V150, P222, DOI 10.1016/j.cell.2012.05.033; Capra EJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001220; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; HENIKOFF S, 1993, PROTEINS, V17, P49, DOI 10.1002/prot.340170108; Ibrahim BS, 2005, J MOL BIOL, V348, P1191, DOI 10.1016/j.jmb.2005.03.034; Jin XS, 2012, P NATL ACAD SCI USA, V109, pE127, DOI 10.1073/pnas.1117538108; Kaneko R, 2006, J BIOL CHEM, V281, P30551, DOI 10.1074/jbc.M605677200; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; KOMIYAMA NH, 1995, NATURE, V373, P244, DOI 10.1038/373244a0; Lo LW, 2003, P NATL ACAD SCI USA, V100, P4463, DOI 10.1073/pnas.0737647100; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Meijers R, 2007, NATURE, V449, P487, DOI 10.1038/nature06147; Milo R, 2007, P NATL ACAD SCI USA, V104, P16998, DOI 10.1073/pnas.0707673104; Morishita H, 2006, J BIOL CHEM, V281, P33650, DOI 10.1074/jbc.M603298200; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; PERUTZ MF, 1981, NATURE, V291, P682, DOI 10.1038/291682a0; Posy S, 2008, J MOL BIOL, V378, P954, DOI 10.1016/j.jmb.2008.02.063; Ranganathan R, 2011, NOTE 109 SUMMARY SCA; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Sawaya MR, 2008, CELL, V134, P1007, DOI 10.1016/j.cell.2008.07.042; Schreiner D, 2010, P NATL ACAD SCI USA, V107, P14893, DOI 10.1073/pnas.1004526107; SHINDYALOV IN, 1994, PROTEIN ENG, V7, P349, DOI 10.1093/protein/7.3.349; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; White RA, 2007, METHOD ENZYMOL, V422, P75, DOI 10.1016/S0076-6879(06)22004-4; Wojtowicz WM, 2007, CELL, V130, P1134, DOI 10.1016/j.cell.2007.08.026; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211; Zapf J, 2000, STRUCTURE, V8, P851, DOI 10.1016/S0969-2126(00)00174-X	35	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e107723	10.1371/journal.pone.0107723	http://dx.doi.org/10.1371/journal.pone.0107723			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379728	gold, Green Published, Green Submitted			2022-12-27	WOS:000344863100003
J	Miyata, A; Ishizawa, T; Kamiya, M; Shimizu, A; Kaneko, J; Ijichi, H; Shibahara, J; Fukayama, M; Midorikawa, Y; Urano, Y; Kokudo, N				Miyata, Akinori; Ishizawa, Takeaki; Kamiya, Mako; Shimizu, Atsushi; Kaneko, Junichi; Ijichi, Hideaki; Shibahara, Junji; Fukayama, Masashi; Midorikawa, Yutaka; Urano, Yasuteru; Kokudo, Norihiro			Photoacoustic Tomography of Human Hepatic Malignancies Using Intraoperative Indocyanine Green Fluorescence Imaging	PLOS ONE			English	Article							CHOLANGIOGRAPHY; ULTRASONOGRAPHY; TUMORS	Recently, fluorescence imaging following the preoperative intravenous injection of indocyanine green has been used in clinical settings to identify hepatic malignancies during surgery. The aim of this study was to evaluate the ability of photoacoustic tomography using indocyanine green as a contrast agent to produce representative fluorescence images of hepatic tumors by visualizing the spatial distribution of indocyanine green on ultrasonographic images. Indocyanine green (0.5 mg/kg, intravenous) was preoperatively administered to 9 patients undergoing hepatectomy. Intraoperatively, photoacoustic tomography was performed on the surface of the resected hepatic specimens (n = 10) under excitation with an 800 nm pulse laser. In 4 hepatocellular carcinoma nodules, photoacoustic imaging identified indocyanine green accumulation in the cancerous tissue. In contrast, in one hepatocellular carcinoma nodule and five adenocarcinoma foci (one intrahepatic cholangiocarcinoma and 4 colorectal liver metastases), photoacoustic imaging delineated indocyanine green accumulation not in the cancerous tissue but rather in the peri-cancerous hepatic parenchyma. Although photoacoustic tomography enabled to visualize spatial distribution of ICG on ultrasonographic images, which was consistent with fluorescence images on cut surfaces of the resected specimens, photoacoustic signals of ICG-containing tissues decreased approximately by 40% even at 4 mm depth from liver surfaces. Photoacoustic tomography using indocyanine green also failed to identify any hepatocellular carcinoma nodules from the body surface of model mice with non-alcoholic steatohepatitis. In conclusion, photoacoustic tomography has a potential to enhance cancer detectability and differential diagnosis by ultrasonographic examinations and intraoperative fluorescence imaging through visualization of stasis of bile-excreting imaging agents in and/ or around hepatic tumors. However, further technical advances are needed to improve the visibility of photoacoustic signals emitted from deeply-located lesions.	[Miyata, Akinori; Ishizawa, Takeaki; Shimizu, Atsushi; Kaneko, Junichi; Kokudo, Norihiro] Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo, Japan; [Kamiya, Mako; Urano, Yasuteru] Univ Tokyo, Grad Sch Med, Lab Chem Biol & Mol Imaging, Tokyo, Japan; [Ijichi, Hideaki] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Shibahara, Junji; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo, Japan; [Midorikawa, Yutaka] Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Div, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Ishizawa, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo, Japan.	tish-tky@umin.ac.jp	Ijichi, Hideaki/V-2720-2019; Ijichi, Hideaki/AAE-6692-2022; IJICHI, Hideaki/AGZ-2874-2022	Ijichi, Hideaki/0000-0002-2379-7986; IJICHI, Hideaki/0000-0002-2379-7986	Takeda Science Foundation, the Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare of Japan	Takeda Science Foundation, the Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants from the Takeda Science Foundation, the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chino K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045764; De La Zerda A, 2008, NAT NANOTECHNOL, V3, P557, DOI 10.1038/nnano.2008.231; Fujii M, 2013, MED MOL MORPHOL, V46, P141, DOI 10.1007/s00795-013-0016-1; Gotoh K, 2009, J SURG ONCOL, V100, P75, DOI 10.1002/jso.21272; Ishizawa T, 2010, BRIT J SURG, V97, P1369, DOI 10.1002/bjs.7125; Ishizawa T, 2014, ANN SURG ONCOL, V21, P440, DOI 10.1245/s10434-013-3360-4; Ishizawa Takeaki, 2009, J Am Coll Surg, V208, pe1, DOI 10.1016/j.jamcollsurg.2008.09.024; Ishizawa T, 2009, CANCER-AM CANCER SOC, V115, P2491, DOI 10.1002/cncr.24291; Kaneko J, 2014, J GASTROENTEROL, V49, P110, DOI 10.1007/s00535-013-0775-4; Kawaguchi Y, 2013, J HEPATOL, V58, P247, DOI 10.1016/j.jhep.2012.09.028; Kim C, 2010, RADIOLOGY, V255, P442, DOI 10.1148/radiol.10090281; Kitai Toshiyuki, 2005, Breast Cancer, V12, P211, DOI 10.2325/jbcs.12.211; KRUGER RA, 1994, MED PHYS, V21, P127, DOI 10.1118/1.597367; Kudo H, 2014, SURG ENDOSC, V28, P2504, DOI 10.1007/s00464-014-3468-z; Mitsuhashi N, 2008, J HEPATO-BILIARY-PAN, V15, P508, DOI 10.1007/s00534-007-1307-5; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nam SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037267; Needles A, 2013, IEEE T ULTRASON FERR, V60, P888, DOI 10.1109/TUFFC.2013.2646; Ogata F, 2007, ANN PLAS SURG, V58, P652, DOI 10.1097/01.sap.0000250896.42800.a2; Oraevsky AA, 1997, APPL OPTICS, V36, P402, DOI 10.1364/AO.36.000402; Raabe A, 2005, J NEUROSURG, V103, P982, DOI 10.3171/jns.2005.103.6.0982; Rajian JR, 2011, OPT EXPRESS, V19, P14335, DOI 10.1364/OE.19.014335; Ris F, 2014, SURG ENDOSC, V28, P2221, DOI 10.1007/s00464-014-3432-y; Rubens FD, 2002, HEART SURG FORUM, V5, P141; Schols RM, 2013, SURG ENDOSC, V27, P1530, DOI 10.1007/s00464-012-2635-3; Spinoglio G, 2013, SURG ENDOSC, V27, P2156, DOI 10.1007/s00464-012-2733-2; Takahashi M, 2012, BRIT J SURG, V99, P1271, DOI 10.1002/bjs.8844; Taruttis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030491; van der Vorst JR, 2013, CANCER-AM CANCER SOC, V119, P3411, DOI 10.1002/cncr.28203; Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210; Wang LV, 2009, NAT PHOTONICS, V3, P503, DOI 10.1038/NPHOTON.2009.157; Yokoyama N, 2012, CANCER-AM CANCER SOC, V118, P2813, DOI 10.1002/cncr.26594; Zhang K, 2007, ARCH SURG-CHICAGO, V142, P1170, DOI 10.1001/archsurg.142.12.1170	33	27	37	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112667	10.1371/journal.pone.0112667	http://dx.doi.org/10.1371/journal.pone.0112667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379674	Green Published, gold, Green Submitted			2022-12-27	WOS:000344863100109
J	Jung, WY; Lee, SS; Kim, CW; Kim, HS; Min, SR; Moon, JS; Kwon, SY; Jeon, JH; Cho, HS				Jung, Won Yong; Lee, Sang Sook; Kim, Chul Wook; Kim, Hyun-Soon; Min, Sung Ran; Moon, Jae Sun; Kwon, Suk-Yoon; Jeon, Jae-Heung; Cho, Hye Sun			RNA-Seq Analysis and De Novo Transcriptome Assembly of Jerusalem Artichoke (Helianthus tuberosus Linne)	PLOS ONE			English	Article							FALSE DISCOVERY RATE; SEQUENCING TECHNOLOGIES; MICROSATELLITE MARKERS; GENERATION; ANNOTATION; INULIN; BIOSYNTHESIS; DATABASE; GROWTH; L.	Jerusalem artichoke (Helianthus tuberosus L.) has long been cultivated as a vegetable and as a source of fructans (inulin) for pharmaceutical applications in diabetes and obesity prevention. However, transcriptomic and genomic data for Jerusalem artichoke remain scarce. In this study, Illumina RNA sequencing (RNA-Seq) was performed on samples from Jerusalem artichoke leaves, roots, stems and two different tuber tissues (early and late tuber development). Data were used for de novo assembly and characterization of the transcriptome. In total 206,215,632 paired-end reads were generated. These were assembled into 66,322 loci with 272,548 transcripts. Loci were annotated by querying against the NCBI non-redundant, Phytozome and UniProt databases, and 40,215 loci were homologous to existing database sequences. Gene Ontology terms were assigned to 19,848 loci, 15,434 loci were matched to 25 Clusters of Eukaryotic Orthologous Groups classifications, and 11,844 loci were classified into 142 Kyoto Encyclopedia of Genes and Genomes pathways. The assembled loci also contained 10,778 potential simple sequence repeats. The newly assembled transcriptome was used to identify loci with tissue-specific differential expression patterns. In total, 670 loci exhibited tissue-specific expression, and a subset of these were confirmed using RT-PCR and qRT-PCR. Gene expression related to inulin biosynthesis in tuber tissue was also investigated. Exsiting genetic and genomic data for H. tuberosus are scarce. The sequence resources developed in this study will enable the analysis of thousands of transcripts and will thus accelerate marker-assisted breeding studies and studies of inulin biosynthesis in Jerusalem artichoke.	[Jung, Won Yong; Lee, Sang Sook; Kim, Hyun-Soon; Min, Sung Ran; Moon, Jae Sun; Kwon, Suk-Yoon; Jeon, Jae-Heung; Cho, Hye Sun] Korea Res Inst Biosci & Biotechnol, Plant Syst Engn Res Ctr, Taejon, South Korea; [Jung, Won Yong; Kim, Chul Wook] Gyeongnam Natl Univ Sci & Technol, Jinju, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Gyeongnam National University of Science and Technology	Jeon, JH (corresponding author), Korea Res Inst Biosci & Biotechnol, Plant Syst Engn Res Ctr, Taejon, South Korea.	jeonjh@kribb.re.kr; hscho@kribb.re.kr		Jung, WonYong/0000-0002-1751-8418	The Cabbage Genomics assisted breeding supporting center (CGsC) research programs - Ministry for Food, Agriculture, Forestry and Fisheries of the Korean Government; Next Generation of Bio Green 21 Project, National Center for GM Crops from RDA [PJ009043]; Bio-industry Technology Development Program, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea [310006-5]; KRIBB Research Initiative Program	The Cabbage Genomics assisted breeding supporting center (CGsC) research programs - Ministry for Food, Agriculture, Forestry and Fisheries of the Korean Government; Next Generation of Bio Green 21 Project, National Center for GM Crops from RDA; Bio-industry Technology Development Program, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea; KRIBB Research Initiative Program	This work was supported by KRIBB Research Initiative Program, The Cabbage Genomics assisted breeding supporting center (CGsC) research programs funded by the Ministry for Food, Agriculture, Forestry and Fisheries of the Korean Government, The Next Generation of Bio Green 21 Project, The National Center for GM Crops (PJ009043) from RDA to HSC, and Bio-industry Technology Development Program (No. 310006-5), Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea to J-HJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aoki-Kinoshita Kiyoko F., 2007, V396, P71; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bock DG, 2014, NEW PHYTOL, V201, P1021, DOI 10.1111/nph.12560; Chow Keng-See, 2014, BMC Res Notes, V7, P69, DOI 10.1186/1756-0500-7-69; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; De Mastro G, 2004, ACTA HORTIC, P365, DOI 10.17660/ActaHortic.2004.629.47; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; DORRELL DG, 1977, CAN J PLANT SCI, V57, P591, DOI 10.4141/cjps77-084; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Feng C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-732; Fernandez P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045899; Firon N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-460; Flores HE, 1999, TRENDS PLANT SCI, V4, P220, DOI 10.1016/S1360-1385(99)01411-9; Fuchs A, 1993, INULIN INULIN CONTAI, P309; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; He CY, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-119; HGaW RK, 1993, SCI TECHNOLOGY FRUCT, P119; Hinrichs WLJ, 2001, INT J PHARMACEUT, V215, P163, DOI 10.1016/S0378-5173(00)00677-3; Hisano H, 2007, DNA RES, V14, P271, DOI 10.1093/dnares/dsm025; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jain M, 2012, BRIEF FUNCT GENOMICS, V11, P63, DOI 10.1093/bfgp/elr038; Johnson MTJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050226; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kays S.J., 2008, BIOL CHEM JERUSALEM, P478; Kim HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092087; Knapp S, 2014, NEW PHYTOL, V201, P710, DOI 10.1111/nph.12624; KOSARIC N, 1984, BIOMASS, V5, P1, DOI 10.1016/0144-4565(84)90066-0; La Rota M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-23; Li CQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-552; Li CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047442; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Liu ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057338; Massa AN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026801; McLaurin WJ, 1999, J PLANT NUTR, V22, P1303, DOI 10.1080/01904169909365714; Meijer W. J. M., 1992, Industrial Crops and Products, V1, P175, DOI 10.1016/0926-6690(92)90016-O; Monti A, 2005, EUR J AGRON, V23, P136, DOI 10.1016/j.eja.2004.11.001; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Mutz KO, 2013, CURR OPIN BIOTECH, V24, P22, DOI 10.1016/j.copbio.2012.09.004; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Sasaki E, 2013, PHYTOCHEMISTRY, V87, P30, DOI 10.1016/j.phytochem.2012.11.023; Schilling EE, 1998, SYST BOT, V23, P177, DOI 10.2307/2419587; SCHILLING EE, 1981, TAXON, V30, P393, DOI 10.2307/1220139; Schittenhelm S, 1999, CROP SCI, V39, P1815, DOI 10.2135/cropsci1999.3961815x; Schliesky S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00220; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Stevens CV, 2001, BIOMACROMOLECULES, V2, P1, DOI 10.1021/bm005642t; Straub SCK, 2012, AM J BOT, V99, P349, DOI 10.3732/ajb.1100335; SWANTON CJ, 1989, CAN J BOT, V67, P2880, DOI 10.1139/b89-369; SWANTON CJ, 1992, CAN J PLANT SCI, V72, P1367, DOI 10.4141/cjps92-169; Taha H., 2012, J GENET ENG BIOTECHN, V10, P33, DOI DOI 10.1016/J.JGEB.2012.02.002; Tao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036234; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Timme RE, 2007, AM J BOT, V94, P1837, DOI 10.3732/ajb.94.11.1837; van Bekkum H., 1996, CARBOHYDRATES ORGANI, P67; Van den Ende Wim, 2002, ScientificWorldJournal, V2, P1281; Van LJ CJ, 1995, CRITICAL REV FOOD SC, V35, pS25; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Vervoort L, 1997, PHARM RES-DORDR, V14, P1730, DOI 10.1023/A:1012179813102; Wang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062293; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Weston LA, 2013, J CHEM ECOL, V39, P283, DOI 10.1007/s10886-013-0248-5; Xie FL, 2012, PLANTA, V236, P101, DOI 10.1007/s00425-012-1591-4; Yildiz G, 2006, CZECH J ANIM SCI, V51, P349, DOI 10.17221/3950-CJAS; Yu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059831; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	72	46	48	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111982	10.1371/journal.pone.0111982	http://dx.doi.org/10.1371/journal.pone.0111982			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375764	gold, Green Submitted, Green Published			2022-12-27	WOS:000344402600085
J	Mathiassen, SE; Hallman, DM; Lyskov, E; Hygge, S				Mathiassen, Svend Erik; Hallman, David M.; Lyskov, Eugene; Hygge, Staffan			Can Cognitive Activities during Breaks in Repetitive Manual Work Accelerate Recovery from Fatigue? A Controlled Experiment	PLOS ONE			English	Article							TRAPEZIUS MUSCLE-ACTIVITY; INTERMITTENT STATIC WORK; JOB ROTATION SCHEDULES; HEART-RATE-VARIABILITY; UPPER EXTREMITY; ASSEMBLY WORK; DIVERTING ACTIVITIES; OCCUPATIONAL-HEALTH; PHYSICAL WORKLOAD; MUSCULAR FATIGUE	Neurophysiologic theory and some empirical evidence suggest that fatigue caused by physical work may be more effectively recovered during "diverting'' periods of cognitive activity than during passive rest; a phenomenon of great interest in working life. We investigated the extent to which development and recovery of fatigue during repeated bouts of an occupationally relevant reaching task was influenced by the difficulty of a cognitive activity between these bouts. Eighteen male volunteers performed three experimental sessions, consisting of six 7-min bouts of reaching alternating with 3 minutes of a memory test differing in difficulty between sessions. Throughout each session, recordings were made of upper trapezius muscle activity using electromyography (EMG), heart rate and heart rate variability (HRV) using electrocardiography, arterial blood pressure, and perceived fatigue (Borg CR10 scale and SOFI). A test battery before, immediately after and 1 hour after the work period included measurements of maximal shoulder elevation strength (MVC), pressure pain threshold (PPT) over the trapezius muscles, and a submaximal isometric contraction. As expected, perceived fatigue and EMG amplitude increased during the physical work bouts. Recovery did occur between the bouts, but fatigue accumulated throughout the work period. Neither EMG changes nor recovery of perceived fatigue during breaks were influenced by cognitive task difficulty, while heart rate and HRV recovered the most during breaks with the most difficult task. Recovery of perceived fatigue after the 1 hour work period was also most pronounced for the most difficult cognitive condition, while MVC and PPT showed ambiguous patterns, and EMG recovered similarly after all three cognitive protocols. Thus, we could confirm that cognitive tasks between bouts of fatiguing physical work can, indeed, accelerate recovery of some factors associated with fatigue, even if benefits may be moderate and some responses may be equivocal. Our results encourage further research into combinations of physical and mental tasks in an occupational context.	[Mathiassen, Svend Erik; Hallman, David M.; Lyskov, Eugene] Univ Gavle, Dept Occupat & Publ Hlth Sci, Ctr Musculoskeletal Res, Gavle, Sweden; [Hygge, Staffan] Univ Gavle, Dept Bldg Energy & Environm Engn, Gavle, Sweden	University of Gavle; University of Gavle	Mathiassen, SE (corresponding author), Univ Gavle, Dept Occupat & Publ Hlth Sci, Ctr Musculoskeletal Res, Gavle, Sweden.	SvendErik.Mathiassen@hig.se	Mathiassen, Svend Erik/ABF-3165-2020	Mathiassen, Svend Erik/0000-0003-1443-6211; Hygge, Staffan/0000-0003-4298-7459	University of Gavle	University of Gavle	The study was funded by internal grants at the University of Gavle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsberg E, 2000, SCAND J PSYCHOL, V41, P231, DOI 10.1111/1467-9450.00192; Arvidsson I, 2006, INT J IND ERGONOM, V36, P613, DOI 10.1016/j.ergon.2006.03.002; Arvidsson I, 2012, APPL ERGON, V43, P1026, DOI 10.1016/j.apergo.2012.03.001; ASMUSSEN E, 1978, EUR J APPL PHYSIOL O, V38, P1, DOI 10.1007/BF00436747; ASMUSSEN E, 1978, EUR J APPL PHYSIOL O, V38, P9, DOI 10.1007/BF00436748; Au AK, 2007, J ELECTROMYOGR KINES, V17, P578, DOI 10.1016/j.jelekin.2006.06.005; Bao SH, 1996, APPL ERGON, V27, P89, DOI 10.1016/0003-6870(95)00063-1; BECHTOLD SE, 1984, MANAGE SCI, V30, P1442, DOI 10.1287/mnsc.30.12.1442; Beissner F, 2013, J NEUROSCI, V33, P10503, DOI 10.1523/JNEUROSCI.1103-13.2013; Birch L, 2000, SCAND J WORK ENV HEA, V26, P299, DOI 10.5271/sjweh.546; Bjorklund M, 2000, EUR J APPL PHYSIOL, V81, P361, DOI 10.1007/s004210050055; Blangsted AK, 2004, EUR J APPL PHYSIOL, V91, P253, DOI 10.1007/s00421-003-0979-z; Borg G., 1998, BORGS PERCEIVED EXER; Bosch T, 2012, ERGONOMICS, V55, P863, DOI 10.1080/00140139.2012.682739; Bunting M, 2006, Q J EXP PSYCHOL, V59, P1691, DOI 10.1080/17470210600848402; Carnahan BJ, 2000, ERGONOMICS, V43, P543, DOI 10.1080/001401300184404; Christensen H, 2000, INT J IND ERGONOM, V25, P367, DOI 10.1016/S0169-8141(99)00025-6; Christmansson M, 1999, APPL ERGON, V30, P463, DOI 10.1016/S0003-6870(98)00060-X; Cote P, 2008, SPINE, V33, pS60, DOI 10.1097/BRS.0b013e3181643ee4; Dababneh AJ, 2001, ERGONOMICS, V44, P164, DOI 10.1080/001401301750048196; Davis K, 2005, J OCCUP ENVIRON HYG, V2, pD1, DOI 10.1080/15459620590894760; Davis KG, 2002, SPINE, V27, P2645, DOI 10.1097/00007632-200212010-00003; Diego-Mas JA, 2009, INT J IND ERGONOM, V39, P23, DOI 10.1016/j.ergon.2008.07.009; Enoka RM, 2012, J BIOMECH, V45, P427, DOI 10.1016/j.jbiomech.2011.11.047; Falla D, 2007, EXP BRAIN RES, V182, P99, DOI 10.1007/s00221-007-0974-4; Farina D, 2002, EUR J APPL PHYSIOL, V86, P469, DOI 10.1007/s00421-001-0574-0; Finsen L, 2001, J ELECTROMYOGR KINES, V11, P373, DOI 10.1016/S1050-6411(01)00015-3; Flodgren GM, 2009, EUR J APPL PHYSIOL, V107, P31, DOI 10.1007/s00421-009-1095-5; Frazer MB, 2003, ERGONOMICS, V46, P904, DOI 10.1080/001401303000090161; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; GANDEVIA SC, 1989, RESP PHYSIOL, V77, P203, DOI 10.1016/0034-5687(89)90007-8; GENAIDY AM, 1995, ERGONOMICS, V38, P326, DOI 10.1080/00140139508925107; HAGG GM, 1991, INT CONGR SER, V949, P141; Hagg GM, 2000, J ELECTROMYOGR KINES, V10, P301, DOI 10.1016/S1050-6411(00)00022-5; Hakkanen M, 1997, APPL ERGON, V28, P99, DOI 10.1016/S0003-6870(96)00040-3; Henning RA, 1997, ERGONOMICS, V40, P78, DOI 10.1080/001401397188396; Hermans V, 1997, CLIN PHYSIOL, V17, P95, DOI 10.1046/j.1365-2281.1997.01515.x; Horton LM, 2012, ERGONOMICS, V55, P1205, DOI 10.1080/00140139.2012.704406; JANARO RE, 1985, HUM FACTORS, V27, P459, DOI 10.1177/001872088502700409; Joyce J, 2009, BRAIN COGNITION, V71, P14, DOI 10.1016/j.bandc.2009.03.004; Keir PJ, 2011, APPL ERGON, V42, P814, DOI 10.1016/j.apergo.2011.01.006; Konz S, 1998, INT J IND ERGONOM, V22, P73, DOI 10.1016/S0169-8141(97)00069-3; Kuijer PPFM, 2005, AM J IND MED, V47, P394, DOI 10.1002/ajim.20159; Leyman ELC, 2004, ERGONOMICS, V47, P625, DOI 10.1080/00140130310001629766; Luger T, 2014, ERGONOMICS, V57, P162, DOI 10.1080/00140139.2014.885088; LUNDBERG U, 1994, INT J BEHAV MED, V1, P354, DOI 10.1207/s15327558ijbm0104_5; Mathiassen SE, 1996, INT ARCH OCC ENV HEA, V68, P94; MATHIASSEN SE, 1993, EUR J APPL PHYSIOL O, V67, P528, DOI 10.1007/BF00241650; Mathiassen SE, 2006, APPL ERGON, V37, P419, DOI 10.1016/j.apergo.2006.04.006; Mehta RK, 2012, ERGONOMICS, V55, P1166, DOI 10.1080/00140139.2012.703695; Mehta RK, 2012, EUR J APPL PHYSIOL, V112, P2891, DOI 10.1007/s00421-011-2264-x; Mehta RK, 2011, INT J IND ERGONOM, V41, P647, DOI 10.1016/j.ergon.2011.07.005; Mital A, 1991, INT J IND ERGON, V8, P165, DOI DOI 10.1016/0169-8141(91)90017-G; MONOD H, 1957, CR SOC BIOL, V151, P1358; Palmer KT, 2007, SCAND J WORK ENV HEA, V33, P165, DOI 10.5271/sjweh.1134; Parent-Thirion A., 2007, 4 EUROPEAN WORKING C; PRICE ADF, 1990, APPL ERGON, V21, P318, DOI 10.1016/0003-6870(90)90203-A; Punnett L, 2000, SCAND J WORK ENV HEA, V26, P283, DOI 10.5271/sjweh.544; ROHMERT W., 1960, INTERNATL ZEITSCHR ANGEW PHYSIOL, V18, P123; Schmidt R. A, 2011, MOTOR CONTROL LEARNI; Sechenov I., 1935, SELECTED WORKS, P246; Sjogaard G, 1996, ACTA PHYSIOL SCAND, V156, P257, DOI 10.1046/j.1365-201X.1996.207000.x; Srinivasan D, 2012, CLIN BIOMECH, V27, P979, DOI 10.1016/j.clinbiomech.2012.08.007; Stock MS, 2011, J STRENGTH COND RES, V25, P1911, DOI 10.1519/JSC.0b013e318220d8dc; SUNDELIN G, 1989, ERGONOMICS, V32, P527, DOI 10.1080/00140138908966123; Thayer JF, 2012, NEUROSCI BIOBEHAV R, V36, P747, DOI 10.1016/j.neubiorev.2011.11.009; Togo F, 2009, IND HEALTH, V47, P589, DOI 10.2486/indhealth.47.589; Tomporowski PD, 2003, ACTA PSYCHOL, V112, P297, DOI 10.1016/S0001-6918(02)00134-8; van den Heuvel SG, 2003, SCAND J WORK ENV HEA, V29, P106, DOI 10.5271/sjweh.712; van der Windt DAWM, 2000, OCCUP ENVIRON MED, V57, P433, DOI 10.1136/oem.57.7.433; van Rijn RM, 2010, SCAND J WORK ENV HEA, V36, P189, DOI 10.5271/sjweh.2895; Vernon HM, 1924, 2 STUDIES REST PAUSE; Visser B, 2006, J ELECTROMYOGR KINES, V16, P1, DOI 10.1016/j.jelekin.2005.06.005; Vogel K, 2013, APPL ERGON, V44, P996, DOI 10.1016/j.apergo.2013.03.016; Wang YL, 2011, EUR J APPL PHYSIOL, V111, P2791, DOI 10.1007/s00421-011-1908-1; Wells R, 2007, APPL ERGON, V38, P733, DOI 10.1016/j.apergo.2006.12.003; Winkel J, 1995, J ELECTROMYOGR KINES, V5, P195, DOI 10.1016/1050-6411(96)85581-7; Yoon T, 2009, J APPL PHYSIOL, V107, P1486, DOI 10.1152/japplphysiol.00238.2009; Zijdewind I, 2006, CLIN NEUROPHYSIOL, V117, P660, DOI 10.1016/j.clinph.2005.11.016; 1996, EUR HEART J, V93, P1043	80	29	31	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112090	10.1371/journal.pone.0112090	http://dx.doi.org/10.1371/journal.pone.0112090			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XM	25375644	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600102
J	Miller, EM				Miller, Elizabeth M.			Iron Status and Reproduction in US Women: National Health and Nutrition Examination Survey, 1999-2006	PLOS ONE			English	Article							SERUM TRANSFERRIN RECEPTOR; DANISH WOMEN; HEMOGLOBIN CONCENTRATION; MULTIPLE IMPUTATION; PREGNANCY; DEFICIENCY; MENSTRUATION; ANEMIA; HOMEOSTASIS; FERRITIN	Women experience significant changes in iron status throughout their reproductive lifespans. While this is evident in regions with high rates of malnutrition and infectious disease, the extent of reproductive-related changes is less well known in countries with low rates of iron deficiency anemia, such as the United States. The goal of this study is determine the relationship between women's reproductive variables (pregnancy, parity, currently breastfeeding, regular menstruation, hormonal contraceptive use, and age at menarche) and iron status (hemoglobin, ferritin, transferrin receptor, and % transferrin saturation) using an anthropological framework for interpreting the results. Data from women aged 18-49 were taken from the 1999-2006 US NHANES, a nationally representative cross-sectional sample of US women. Using multiple imputation and complex survey statistics, women's reproductive variables were regressed against indicators of iron status. Pregnant women had significantly poorer iron status, by most indicators, than non-pregnant women. All biomarkers demonstrated significantly lower iron levels with increasing parity. Women who were having regular periods had iron indicators that suggested decreased iron levels, while women who used hormonal contraceptives had iron indicators that suggested increased iron levels. Despite relatively good iron status and widespread availability of iron-rich foods in the US, women still exhibit patterns of iron depletion across several reproductive variables of interest. These results contribute to an ecological approach to iron status that seeks to understand variation in iron status, with the hopes that appropriate, population-specific recommendations can be developed to improve women's health.	Univ S Florida, Dept Anthropol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Miller, EM (corresponding author), Univ S Florida, Dept Anthropol, Tampa, FL 33620 USA.	emm3@usf.edu		Miller, Elizabeth/0000-0002-5046-380X				Abrams ET, 2009, AM J HUM BIOL, V21, P643, DOI 10.1002/ajhb.20919; Akesson A, 1998, AM J CLIN NUTR, V68, P1241, DOI 10.1093/ajcn/68.6.1241; Allen LH, 1997, NUTR REV, V55, P91, DOI 10.1111/j.1753-4887.1997.tb06460.x; Allen LH, 2000, AM J CLIN NUTR, V71, p1280S, DOI 10.1093/ajcn/71.5.1280s; Allison PD, 2005, SAS US GROUP INT 30; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Beard JL, 2000, J NUTR, V130, p440S, DOI 10.1093/jn/130.2.440S; Beaton GH, 2000, AM J CLIN NUTR, V72, p265S, DOI 10.1093/ajcn/72.1.265S; Berglund PA, 2010, SAS GLOB FOR P; Bothwell TH, 2000, AM J CLIN NUTR, V72, p257S, DOI 10.1093/ajcn/72.1.257S; Cao C, 2013, NUTR REV, V71, P35, DOI 10.1111/j.1753-4887.2012.00550.x; CARRIAGA MT, 1991, AM J CLIN NUTR, V54, P1077, DOI 10.1093/ajcn/54.6.1077; CDC, 2006, AN REP GUID; Centers for Disease Control and Prevention National Center for Health Statistics (NCHS), 2006, NATL HLTH NUTR EXAMI; Chang SC, 2003, J NUTR, V133, P2348, DOI 10.1093/jn/133.7.2348; Choi JW, 2000, CLIN CHEM, V46, P725; Clancy KBH, 2006, AM J HUM BIOL, V18, P710, DOI 10.1002/ajhb.20538; Cook J D, 1992, Nutr Res Rev, V5, P198, DOI 10.1079/NRR19920014; DESALEGN S, 1993, ETHIOPIAN MED J, V31, P251; Dewey KG, 2007, MATERN CHILD NUTR, V3, P151, DOI 10.1111/j.1740-8709.2007.00092.x; Dewey KG, 2004, ADV EXP MED BIOL, V554, P91; FRANSSON GB, 1980, J PEDIATR-US, V96, P380, DOI 10.1016/S0022-3476(80)80676-7; Gambling L, 2011, AM J CLIN NUTR, V94, p1903S, DOI 10.3945/ajcn.110.000885; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; Horton NJ, 2003, AM STAT, V57, P229, DOI 10.1198/0003130032314; Hou YL, 2012, GENE, V511, P398, DOI 10.1016/j.gene.2012.09.060; Ikeda Y, 2012, PLOS ONE, V7; JACOBS A, 1972, BRIT MED J, V4, P206, DOI 10.1136/bmj.4.5834.206; Kassebaum NJ, 2013, LANCET, V381, P72; KESSEL E, 1985, ACTA PAEDIATR SCAND, P120; Labbok MH, 2001, PEDIATR CLIN N AM, V48, P143, DOI 10.1016/S0031-3955(05)70290-X; Little R. J. A., 2002, STAT ANAL MISSING DA; Lonnerdal B., 1984, Nestle Nutrition Workshop Series, V4, P95; Looker AC, 1997, JAMA-J AM MED ASSOC, V277, P973, DOI 10.1001/jama.277.12.973; McArdle HJ, 2014, P NUTR SOC, V73, P9, DOI 10.1017/S0029665113003637; Mei ZG, 2012, CLIN CHIM ACTA, V413, P1479, DOI 10.1016/j.cca.2012.05.022; Mei ZG, 2011, AM J CLIN NUTR, V93, P1312, DOI 10.3945/ajcn.110.007195; Miller EM, 2010, AM J HUM BIOL, V22, P768, DOI 10.1002/ajhb.21078; MILMAN N, 1993, ACTA OBSTET GYN SCAN, V72, P601, DOI 10.3109/00016349309021150; Milman N, 1998, ANN HEMATOL, V77, P13, DOI 10.1007/s002770050405; MILMAN N, 1992, ANN HEMATOL, V65, P96, DOI 10.1007/BF01698138; Milman N, 2006, ANN HEMATOL, V85, P559, DOI 10.1007/s00277-006-0108-2; National Center for Health Statistics, 2005 2006 NAT HLTH N; National Center for Health Statistics, 2001 2002 NAT HLTH N; National Center for Health Statistics, 2003 2004 NAT HLTH N; National Center for Health Statistics, 1999 2000 NAT HLTH N; Pena-Rosas Juan Pablo, 2015, Cochrane Database Syst Rev, pCD009997, DOI [10.1002/14651858.CD009997, 10.1002/14651858.CD009997.pub2]; Quinn EA, 2014, AM J HUM BIOL, V26, P10, DOI 10.1002/ajhb.22476; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Scholl TO, 2005, AM J CLIN NUTR, V81, p1218S; Scholl TO, 2000, J NUTR, V130, p443S, DOI 10.1093/jn/130.2.443S; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Strassmann BI, 1997, CURR ANTHROPOL, V38, P123, DOI 10.1086/204592; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; Van Santen S, 2011, AM J TROP MED HYG, V84, P148, DOI 10.4269/ajtmh.2011.10-0250; WINKVIST A, 1992, AM J PUBLIC HEALTH, V82, P691, DOI 10.2105/AJPH.82.5.691; Xiong X, 2000, AM J PERINAT, V17, P137, DOI 10.1055/s-2000-9508; Yang Q, 2012, ENDOCRINOLOGY, V153, P3170, DOI 10.1210/en.2011-2045; Yip R, 2000, AM J CLIN NUTR, V72, p272S, DOI 10.1093/ajcn/72.1.272S	60	24	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112216	10.1371/journal.pone.0112216	http://dx.doi.org/10.1371/journal.pone.0112216			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XM	25375360	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600120
J	Nogueira, LD; Domingues, CD; Poggetti, RS; de Sousa, RMC				Nogueira, Lilia de Souza; Domingues, Cristiane de Alencar; Poggetti, Renato Sergio; Cardoso de Sousa, Regina Marcia			Nursing Workload in Intensive Care Unit Trauma Patients: Analysis of Associated Factors	PLOS ONE			English	Article							INJURY SEVERITY SCORE; MULTIPLE INJURIES; SYSTEM; MULTICENTER; MORBIDITY; MORTALITY	Background: From the perspective of nurses, trauma patients in the Intensive Care Unit (ICU) demand a high degree of nursing workload due to hemodynamic instability and the severity of trauma injuries. This study aims to identify the factors related to the high nursing workload required for trauma victims admitted to the ICU. Methods: This is a prospective, cross-sectional study using descriptive and correlation analyses, conducted with 200 trauma patients admitted to an ICU in the city of Sao Paulo, Brazil. The nursing workload was measured using the Nursing Activities Score (NAS). The distribution of the NAS values into tertiles led to the identification of two research groups: medium/low workload and high workload. The Chi-square, Fisher's exact, Mann-Whitney and multiple logistic regression tests were utilized for the analyses. Findings: The majority of patients were male (82.0%) and suffered blunt trauma (94.5%), with traffic accidents (57.5%) and falls (31.0%) being prevalent. The mean age was 40.7 years (+/- 18.6) and the mean NAS was 71.3% (+/- 16.9). Patient gender, the presence of pulmonary failure, the number of injured body regions and the risk of death according to the Simplified Acute Physiology Score II were factors associated with a high degree of nursing workload in the first 24 hours following admission to the ICU. Conclusion: Workload demand was higher in male patients with physiological instability and multiple severe trauma injuries who developed pulmonary failure.	[Nogueira, Lilia de Souza; Domingues, Cristiane de Alencar; Cardoso de Sousa, Regina Marcia] Univ Sao Paulo, Sch Nursing, Med Surg Nursing Dept, BR-05508 Sao Paulo, Brazil; [Poggetti, Renato Sergio] Univ Sao Paulo, Hosp Clin, Sch Med, Dept Surg, BR-05508 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Nogueira, LD (corresponding author), Univ Sao Paulo, Sch Nursing, Med Surg Nursing Dept, BR-05508 Sao Paulo, Brazil.	lilianogueira@usp.br	Sousa, Regina M/H-1108-2012; de Alencar Domingues, Cristiane/AAU-6043-2020; Nogueira, Lilia S/H-7202-2012	Sousa, Regina M/0000-0002-2575-7937; de Alencar Domingues, Cristiane/0000-0002-2163-0672; Nogueira, Lilia/0000-0001-5387-3807	Sao Paulo Research Foundation (FAPESP) [2009/50355-4]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Support was provided by grant 2009/50355-4 - Sao Paulo Research Foundation (FAPESP) to LSN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angele Martin K., 2006, Clinics, V61, P479, DOI 10.1590/S1807-59322006000500017; Association for the Advancement of Automotive Medicine (AAAM), 2008, ABBR INJ SCAL AIS 20; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Adell AB, 2005, ENFERM INTENSIV, V16, P164; Brattstrom O, 2010, ACTA ANAESTH SCAND, V54, P1007, DOI 10.1111/j.1399-6576.2010.02266.x; Chalya PL, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-61; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Daud-Gallotti RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052342; Coelho FUD, 2011, TEXTO CONTEXTO ENFER, V20, P735; de Sousa CR, 2008, REV LAT-AM ENFERM, V16, P218, DOI 10.1590/S0104-11692008000200008; Ducci AJ, 2008, REV ESC ENFERM USP, V42, P672, DOI 10.1590/S0080-62342008000400009; Durham RM, 2003, J TRAUMA, V55, P608, DOI 10.1097/01.TA.0000092378.10660.D1; Frink M, 2007, SHOCK, V27, P151, DOI 10.1097/01.shk.0000239767.64786.de; Fueglistaler P, 2010, AM J SURG, V200, P204, DOI 10.1016/j.amjsurg.2009.08.035; Goncalves LA, 2007, REV ESC ENFERM USP, V41, P645, DOI 10.1590/S0080-62342007000400015; Gross T, 2012, ACTA ANAESTH SCAND, V56, P1163, DOI 10.1111/j.1399-6576.2012.02724.x; Honarmand A, 2008, ULUS TRAVMA ACIL CER, V14, P110; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kwok WWY, 2005, J CRIT CARE, V20, P257, DOI 10.1016/j.jcrc.2005.06.004; Lavoie A, 2005, INJURY, V36, P477, DOI 10.1016/j.injury.2004.09.039; LeGall JR, 1996, JAMA-J AM MED ASSOC, V276, P802, DOI 10.1001/jama.276.10.802; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Miranda DR, 2003, CRIT CARE MED, V31, P374, DOI 10.1097/01.CCM.0000045567.78801.CC; Miranda DR, 1996, CRIT CARE MED, V24, P64, DOI 10.1097/00003246-199601000-00012; Mitchell Rebecca, 2012, J Trauma Nurs, V19, P80, DOI 10.1097/JTN.0b013e3182562955; da Silva MCM, 2010, REV LAT-AM ENFERM, V18, P224, DOI 10.1590/S0104-11692010000200013; Mostafa G, 2002, J TRAUMA, V53, P430, DOI 10.1097/00005373-200209000-00006; Muehler N, 2010, J CRIT CARE, V25, P620, DOI 10.1016/j.jcrc.2010.03.008; Nogueira LD, 2009, REV LAT-AM ENFERM, V17, P1037, DOI 10.1590/S0104-11692009000600017; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Padilha KG, 2010, INTENS CRIT CARE NUR, V26, P108, DOI 10.1016/j.iccn.2009.12.002; Padilha KG, 2008, INTENS CRIT CARE NUR, V24, P197, DOI 10.1016/j.iccn.2007.09.004; Queijo A., 2008, THESIS; Seguin P, 2006, INTENS CARE MED, V32, P398, DOI 10.1007/s00134-005-0032-2; Servia L, 2012, J CRIT CARE, V27, P58, DOI 10.1016/j.jcrc.2011.07.001; Stafseth Siv K, 2011, Intensive Crit Care Nurs, V27, P290, DOI 10.1016/j.iccn.2011.07.003; Vincent JL, 2010, CRIT CARE, V14, DOI 10.1186/cc8204	37	26	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112125	10.1371/journal.pone.0112125	http://dx.doi.org/10.1371/journal.pone.0112125			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375369	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600110
J	Haeler, E; Fiedler, K; Grill, A				Haeler, Elena; Fiedler, Konrad; Grill, Andrea			What Prolongs a Butterfly's Life?: Trade-Offs between Dormancy, Fecundity and Body Size	PLOS ONE			English	Article							MANIOLA-JURTINA LEPIDOPTERA; PHENOTYPIC PLASTICITY; REPRODUCTIVE DIAPAUSE; STRESS RESISTANCE; SPAN; HISTORY; DIFFERENTIATION; EVOLUTION; TEMPERATURE; MATURATION	In butterflies, life span often increases only at the expense of fecundity. Prolonged life span, on the other hand, provides more opportunities for oviposition. Here, we studied the association between life span and summer dormancy in two closely related species of Palearctic Meadow Brown butterflies, the endemic Maniola nurag and the widespread M. jurtina, from two climatic provenances, a Mediterranean and a Central European site, and tested the relationships between longevity, body size and fecundity. We experimentally induced summer dormancy and hence prolonged the butterflies' life in order to study the effects of such a prolonged life. We were able to modulate longevity only in Mediterranean females by rearing them under summer photoperiodic conditions (light 16 h : dark 8 h), thereby more than doubling their natural life span, to up to 246 days. Central European individuals kept their natural average live span under all treatments, as did Mediterranean individuals under autumn treatment (light 11: dark 13). Body size only had a significant effect in the smaller species, M. nurag, where it affected the duration of dormancy and lifetime fecundity. In the larger species, M. jurtina, a prolonged adult life span did, surprisingly, not convey any fecundity loss. In M. nurag, which generally deposited fewer eggs, extended life had a fecundity cost. We conclude that Mediterranen M. jurtina butterflies have an extraordinary plasticity in aging which allows them to extend life span in response to adverse environmental conditions and relieve the time limitation on egg-laying while maintaining egg production at equal levels.	[Haeler, Elena; Fiedler, Konrad; Grill, Andrea] Univ Vienna, Dept Bot & Biodivers Res, Vienna, Austria	University of Vienna	Grill, A (corresponding author), Univ Vienna, Dept Bot & Biodivers Res, Vienna, Austria.	a.grill@univie.ac.at	Fiedler, Konrad/H-8788-2019	Fiedler, Konrad/0000-0002-4789-3753; Haeler, Elena/0000-0002-3732-4565	Austrian Science Foundation [V169-B17]; University of Vienna; Austrian Science Fund (FWF) [V 169] Funding Source: researchfish	Austrian Science Foundation(Austrian Science Fund (FWF)); University of Vienna; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was funded by an Elise Richter grant number V169-B17 from the Austrian Science Foundation (Fonds zur Forderung von Wissenschaft und Forschung) to Andrea Grill and a scholarship by the University of Vienna to E. Haeler. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck J, 2008, EVOL ECOL, V22, P507, DOI 10.1007/s10682-007-9179-3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger D, 2012, J ANIM ECOL, V81, P1244, DOI 10.1111/j.1365-2656.2012.02010.x; Berger D, 2012, AM NAT, V180, P464, DOI 10.1086/667594; Braby MF, 2002, EVOL ECOL, V16, P399, DOI 10.1023/A:1020226426031; Bradshaw WE, 2010, ANNU REV PHYSIOL, V72, P147, DOI 10.1146/annurev-physiol-021909-135837; BRAKEFIELD P, 1979, HEREDITY, V42, P259, DOI 10.1038/hdy.1979.27; Brakefield PM, 2007, J BIOSCIENCES, V32, P465, DOI 10.1007/s12038-007-0046-8; BRAKEFIELD PM, 1991, ECOL ENTOMOL, V16, P291, DOI 10.1111/j.1365-2311.1991.tb00220.x; BRAKEFIELD PM, 1982, J ANIM ECOL, V51, P713, DOI 10.2307/4000; BRAKEFIELD PM, 1982, J ANIM ECOL, V51, P727, DOI 10.2307/4001; Brakefield PM, 1997, ENV STRESS ADAPTATIO, P66; Bubli OA, 2005, J EVOLUTIONARY BIOL, V14, P148; Carey JR, 2001, ANNU REV ENTOMOL, V46, P79, DOI 10.1146/annurev.ento.46.1.79; DANKS HV, 1987, BIOL SURVEY CANADA M, V1; Dapporto L, 2011, BIOL J LINN SOC, V103, P571, DOI 10.1111/j.1095-8312.2011.01639.x; DUNLAPPIANKA H, 1977, SCIENCE, V197, P487, DOI 10.1126/science.197.4302.487; Fischer K, 2007, ECOLOGICAL ENTOMOLOG, V32, P212; Fischer K, 2012, EVOL ECOL, V26, P1067, DOI 10.1007/s10682-011-9547-x; Flatt T, 2011, MECHANISMS OF LIFE HISTORY EVOLUTION: THE GENETICS AND PHYSIOLOGY OF LIFE HISTORY TRAITS AND TRADE-OFFS, P1; Flatt T, 2013, Q REV BIOL, V88, P185, DOI 10.1086/671484; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; GOULSON D, 1993, BIOL J LINN SOC, V49, P127, DOI 10.1111/j.1095-8312.1993.tb00894.x; Grill A, 2006, BIOL J LINN SOC, V89, P561, DOI 10.1111/j.1095-8312.2006.00683.x; Grill A, 2006, EUR J ENTOMOL, V103, P613, DOI 10.14411/eje.2006.082; Grill A, 2013, CONTRIB ZOOL, V82, P27, DOI 10.1163/18759866-08201002; Hamilton WJ, 1937, AM NAT, V71, P500, DOI 10.1086/280735; Heinze J, 2013, BEHAV ECOL SOCIOBIOL, V67, P1555, DOI 10.1007/s00265-013-1567-9; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Hulbert AJ, 2007, PHYSIOL REV, V87, P1175, DOI 10.1152/physrev.00047.2006; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Jervis MA, 2005, ECOL ENTOMOL, V30, P359, DOI 10.1111/j.0307-6946.2005.00712.x; Karl I, 2009, FUNCT ECOL, V23, P1132, DOI 10.1111/j.1365-2435.2009.01607.x; Karlsson B, 2008, FUNCT ECOL, V22, P121, DOI 10.1111/j.1365-2435.2007.01334.x; Kengeri SS, 2013, AGE, V35, P2503, DOI 10.1007/s11357-013-9529-8; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kirkwood TBL, 2005, MECH AGEING DEV, V126, P439, DOI 10.1016/j.mad.2004.09.008; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Kirkwood TBL, 2002, MECH AGEING DEV, V123, P737, DOI 10.1016/S0047-6374(01)00419-5; Kirkwood TBL, 2011, CURR BIOL, V21, pR701, DOI 10.1016/j.cub.2011.07.020; Kraus C, 2013, AM NAT, V181, P492, DOI 10.1086/669665; Le Bourg E, 2007, AGEING RES REV, V6, P141, DOI 10.1016/j.arr.2007.04.002; Lefranc A, 2000, HEREDITAS, V132, P243, DOI 10.1111/j.1601-5223.2000.00243.x; Lehtovaara A, 2013, AM NAT, V182, P653, DOI 10.1086/673296; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; Loewy KJ, 2013, J LEPID SOC, V67, P196; Molleman F, 2007, EXP GERONTOL, V42, P472, DOI 10.1016/j.exger.2007.01.008; Moraiti CA, 2012, J INSECT PHYSIOL, V58, P1128, DOI 10.1016/j.jinsphys.2012.05.012; Pijpe J, 2008, AM NAT, V171, P81, DOI 10.1086/524200; Pijpe J, 2007, EVOL ECOL, V21, P589, DOI 10.1007/s10682-006-9137-5; R Core Team, 2021, R LANGUAGE ENV STAT; SAUNDERS DS, 1989, P NATL ACAD SCI USA, V86, P3748, DOI 10.1073/pnas.86.10.3748; SCALI V, 1971, J ANIM ECOL, V40, P467, DOI 10.2307/3255; Schmidt PS, 2008, EVOLUTION, V62, P1204, DOI 10.1111/j.1558-5646.2008.00351.x; Spieth HR, 2011, EUR J ENTOMOL, V108, P377, DOI 10.14411/eje.2011.047; Stearns S.C., 1992, pi; Tatar M, 2001, EXP GERONTOL, V36, P723, DOI 10.1016/S0531-5565(00)00238-2; Tauber M.J., 1986, SEASONAL ADAPTATIONS; Trager MD, 2011, J INSECT BEHAV, V24, P34, DOI 10.1007/s10905-010-9234-8; Xiao HJ, 2012, B ENTOMOL RES, V102, P267, DOI 10.1017/S0007485311000587; Ziehm M, 2013, AGING CELL, V12, P917, DOI 10.1111/acel.12123	62	15	16	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111955	10.1371/journal.pone.0111955	http://dx.doi.org/10.1371/journal.pone.0111955			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390334	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400043
J	MacNulty, DR; Tallian, A; Stahler, DR; Smith, DW				MacNulty, Daniel R.; Tallian, Aimee; Stahler, Daniel R.; Smith, Douglas W.			Influence of Group Size on the Success of Wolves Hunting Bison	PLOS ONE			English	Article							YELLOWSTONE-NATIONAL-PARK; BEHAVIOR; LIONS; PREY; PREDATION; WOLF; SYSTEM; RATES	An intriguing aspect of social foraging behaviour is that large groups are often no better at capturing prey than are small groups, a pattern that has been attributed to diminished cooperation (i.e., free riding) in large groups. Although this suggests the formation of large groups is unrelated to prey capture, little is known about cooperation in large groups that hunt hard-to-catch prey. Here, we used direct observations of Yellowstone wolves (Canis lupus) hunting their most formidable prey, bison (Bison bison), to test the hypothesis that large groups are more cooperative when hunting difficult prey. We quantified the relationship between capture success and wolf group size, and compared it to previously reported results for Yellowstone wolves hunting elk (Cervus elaphus), a prey that was, on average, 3 times easier to capture than bison. Whereas improvement in elk capture success levelled off at 2-6 wolves, bison capture success levelled off at 9-13 wolves with evidence that it continued to increase beyond 13 wolves. These results are consistent with the hypothesis that hunters in large groups are more cooperative when hunting more formidable prey. Improved ability to capture formidable prey could therefore promote the formation and maintenance of large predator groups, particularly among predators that specialize on such prey.	[MacNulty, Daniel R.; Tallian, Aimee] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Tallian, Aimee] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [Stahler, Daniel R.; Smith, Douglas W.] Yellowstone Ctr Resources, Yellowstone Wolf Project, Mammoth, WY USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	MacNulty, DR (corresponding author), Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA.	dan.macnulty@usu.edu	MacNulty, Dan/L-3965-2016		National Science Foundation [DEB-0613730, DEB-1245373]; Yellowstone National Park; Yellowstone Park Foundation; Canon USA; National Science Foundation Graduate Research Fellowship [DGE-1147384]; Direct For Biological Sciences [1245373] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Yellowstone National Park; Yellowstone Park Foundation; Canon USA; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the National Science Foundation (DEB-0613730, DEB-1245373), Yellowstone National Park, and many donors through the Yellowstone Park Foundation, including an anonymous donor, Canon USA, Annie and Bob Graham, and Frank and Kay Yeager. Aimee Tallian was also supported by a National Science Foundation Graduate Research Fellowship (DGE-1147384). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Bangs EE, 1996, WILDLIFE SOC B, V24, P402; Becker MS, 2009, TERR ECOL SER, V3, P305, DOI 10.1016/S1936-7961(08)00216-9; BOESCH C, 1994, ANIM BEHAV, V48, P653, DOI 10.1006/anbe.1994.1285; BOESCH C, 1989, AM J PHYS ANTHROPOL, V78, P547, DOI 10.1002/ajpa.1330780410; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carbyn L.N., 1993, WOLVES BISON DYNAMIC; CARBYN LN, 1987, CAN J ZOOL, V65, P2072, DOI 10.1139/z87-317; Caro T., 1994, CHEETAHS SERENGETI P; CLARK CW, 1986, THEOR POPUL BIOL, V30, P45, DOI 10.1016/0040-5809(86)90024-9; CREEL S, 1995, ANIM BEHAV, V50, P1325, DOI 10.1016/0003-3472(95)80048-4; Creel S, 2002, AFRICAN WILD DOG; Cubaynes S, 2014, J ANIMAL ECOLOGY; EATON R L, 1970, Journal of Wildlife Management, V34, P56, DOI 10.2307/3799492; Escobedo R, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0204; EUBANK RL, 1984, COMMUN STAT-THEOR M, V13, P433, DOI 10.1080/03610928408828695; FANSHAWE JH, 1993, ANIM BEHAV, V45, P479, DOI 10.1006/anbe.1993.1059; FULLER W. A., 1959, JOUR WILDLIFE MANAGEMENT, V23, P342, DOI 10.2307/3796894; Funston PJ, 2001, J ZOOL, V253, P419, DOI 10.1017/S0952836901000395; Garrott RA, 2009, TERR ECOL SER, V3, P191, DOI 10.1016/S1936-7961(08)00211-X; Gittleman J.L., 1989, P183; Holekamp KE, 1997, J ZOOL, V242, P1, DOI 10.1111/j.1469-7998.1997.tb02925.x; Houston D.B., 1982, NO YELLOWSTONE ELK E; Kim K, 2005, BEHAV ECOL SOCIOBIOL, V59, P92, DOI 10.1007/s00265-005-0013-z; Kruuk H, 1975, FUNCTION EVOLUTION B, P521; KRUUK H, 1972, SPOTTED HYENA; MacNulty DR, 2008, J WILDLIFE MANAGE, V72, P1834, DOI 10.2193/2008-069; MacNulty DR, 2007, J MAMMAL, V88, P595, DOI 10.1644/06-MAMM-A-119R1.1; MacNulty DR, 2012, BEHAV ECOL, V23, P75, DOI 10.1093/beheco/arr159; MacNulty DR, 2009, ECOL LETT, V12, P1347, DOI 10.1111/j.1461-0248.2009.01385.x; MacNulty DR, 2009, J ANIM ECOL, V78, P532, DOI 10.1111/j.1365-2656.2008.01517.x; MacNulty DR, 2001, CAN FIELD NAT, V115, P495; MacNulty DR, 2002, PREDATORY SEQUENCE I; Mech L. David, 2003, P131; Metz MC, 2012, J ANIM ECOL, V81, P553, DOI 10.1111/j.1365-2656.2011.01945.x; MILLS MGL, 1985, NATURE, V316, P61, DOI 10.1038/316061a0; Mukherjee S, 2013, BIOL REV, V88, P550, DOI 10.1111/brv.12014; PACKER C, 1988, AM NAT, V132, P159, DOI 10.1086/284844; Pulliam HR, 1984, BEHAV ECOLOGY EVOLUT, P122; Rose LM, 1997, INT J PRIMATOL, V18, P727, DOI 10.1023/A:1026343812980; Schaller G. B., 1972, SERENGETI LION; SCHEEL D, 1991, ANIM BEHAV, V41, P697, DOI 10.1016/S0003-3472(05)80907-8; Seber G. A. F., 2003, NONLINEAR REGRESSION; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Smith DW, 2004, J WILDLIFE MANAGE, V68, P153, DOI 10.2193/0022-541X(2004)068[0153:WPSAEO]2.0.CO;2; Smith DW, 2000, J MAMMAL, V81, P1128, DOI 10.1644/1545-1542(2000)081<1128:WBIIYN>2.0.CO;2; Stahler DR, 2013, J ANIM ECOL, V82, P222, DOI 10.1111/j.1365-2656.2012.02039.x; STANDER PE, 1992, CAN J ZOOL, V70, P8, DOI 10.1139/z92-002; VANORSDOL KG, 1984, AFR J ECOL, V22, P79; Weiss RE., 2005, MODELING LONGITUDINA, DOI 10.1007/0-387-28314-5; White PJ, 2011, BIOL CONSERV, V144, P1322, DOI 10.1016/j.biocon.2011.01.003; WOLD S, 1974, TECHNOMETRICS, V16, P1, DOI 10.2307/1267485	52	83	85	3	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112884	10.1371/journal.pone.0112884	http://dx.doi.org/10.1371/journal.pone.0112884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389760	gold, Green Published			2022-12-27	WOS:000349144400137
J	Choudhry, V; Ostergren, PO; Ambresin, AE; Kyagaba, E; Agardh, A				Choudhry, Vikas; Ostergren, Per-Olof; Ambresin, Anne-Emmanuelle; Kyagaba, Emmanuel; Agardh, Anette			Giving or Receiving Something for Sex: A Cross-Sectional Study of Transactional Sex among Ugandan University Students	PLOS ONE			English	Article							GENDER-BASED VIOLENCE; ADOLESCENT GIRLS; AFRICAN TOWNSHIP; CAPE-TOWN; WOMEN; RISK; PREVALENCE; CURRENCY; ALCOHOL	Objective: This study sought to determine the prevalence of transactional sex among university students in Uganda and to assess the possible relationship between transactional sex and sexual coercion, physical violence, mental health, and alcohol use. Methods: In 2010, 1954 undergraduate students at a Ugandan university responded to a self-administered questionnaire that assessed mental health, substance use, physical violence and sexual behaviors including sexual coercion and transactional sex. The prevalence of transactional sex was assessed and logistic regression analysis was performed to measure the associations between various risk factors and reporting transactional sex. Results: Approximately 25% of the study sample reported having taken part in transactional sex, with more women reporting having accepted money, gifts or some compensation for sex, while more men reporting having paid, given a gift or otherwise compensated for sex. Sexual coercion in men and women was significantly associated with having accepted money, gifts or some compensation for sex. Men who were victims of physical violence in the last 12 months had higher probability of having accepted money, gifts or some compensation for sex than other men. Women who were victims of sexual coercion reported greater likelihood of having paid, given a gift or otherwise compensated for sex. Respondents who had been victims of physical violence in last 12 months, engaged in heavy episodic drinking and had poor mental health status were more likely to have paid, given a gift or otherwise compensated for sex. Conclusions: University students in Uganda are at high risk of transactional sex. Young men and women may be equally vulnerable to the risks and consequences of transactional sex and should be included in program initiatives to prevent transactional sex. The role of sexual coercion, physical violence, mental health, and alcohol use should be considered when designing interventions for countering transactional sex.	[Choudhry, Vikas; Ostergren, Per-Olof; Agardh, Anette] Lund Univ, Fac Med, Dept Clin Sci, Div Social Med & Global Hlth, Malmo, Sweden; [Ambresin, Anne-Emmanuelle] CHU Vaudois, Lausanne Univ Hospital, Dept Pediat, Multidisciplinary Unit Adolescent Hlth, CH-1011 Lausanne, Switzerland; [Kyagaba, Emmanuel] Mbarara Univ Sci & Technol, Dept Dean Students, Mbarara, Uganda	Lund University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Mbarara University of Science & Technology	Choudhry, V (corresponding author), Lund Univ, Fac Med, Dept Clin Sci, Div Social Med & Global Hlth, Malmo, Sweden.	vikas.choudhry@med.lu.se		Ambresin, Anne-emmanuelle/0000-0001-8386-4231	Swedish International Development Cooperation Agency [SWE-2004-200A]	Swedish International Development Cooperation Agency	This study was supported by grants from the Swedish International Development Cooperation Agency (http://www.sida.se/english/), project grant number SWE-2004-200A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051424; Agardh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023670; Agardh A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-527; Chatterji M, 2007, SOC BIOL, V52, P56; Clowes L, 2009, AGENDA-EMPOWER WOMEN, V23, P22, DOI 10.1080/10130950.2009.9676236; Dunkle KL, 2004, SOC SCI MED, V59, P1581, DOI 10.1016/j.socscimed.2004.02.003; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Dunkle KL, 2007, SOC SCI MED, V65, P1235, DOI 10.1016/j.socscimed.2007.04.029; EAC/EALP, 2010, HIV SER BEH STUD 6 U; French BH, SEXUAL COERCION CONT; Gibbs A, 2012, COMBINED STRUCTURAL; Hunter Mark., 2002, AFR STUD-UK, V61, P99, DOI [DOI 10.1080/00020180220140091, 10.1080/00020180220140091]; Jewkes R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040821; Kaestle CE, 2012, PREV SCI, V13, P314, DOI 10.1007/s11121-011-0268-8; Kalichman SC, 2004, AIDS CARE, V16, P681, DOI 10.1080/09540120410331269530; Knight RA, 2003, ANN NY ACAD SCI, V989, P72, DOI 10.1111/j.1749-6632.2003.tb07294.x; Leclerc-Madlala S, 2003, SOC DYNAMICS, V29, P213, DOI 10.1080/02533950308628681; Lee B, 2008, INT J SOC PSYCHIATR, V54, P7, DOI 10.1177/0020764006074995; Lewin B., 1998, SEX SVERIGE SEXUALLI; Luke N, 2003, STUD FAMILY PLANN, V34, P67, DOI 10.1111/j.1728-4465.2003.00067.x; Luke N., 2002, CROSS GENERATIONAL T; Lundberg P, 2009, BRIT J PSYCHIAT, V195, P156, DOI 10.1192/bjp.bp.108.051953; Meekers D, 1997, Health Transit Rev, V7 Suppl, P361; Messman-Moore TL, 2010, CHILD ABUSE NEGLECT, V34, P967, DOI 10.1016/j.chiabu.2010.06.004; Moore Ann M, 2007, Afr J Reprod Health, V11, P62, DOI 10.2307/25549732; Moore Ann M, 2007, Afr J Reprod Health, V11, P44, DOI 10.2307/25549731; Moore MA, 2006, T SEX ADOLESCENTS SU; Norris AH, 2009, SOC SCI MED, V69, P1167, DOI 10.1016/j.socscimed.2009.07.015; Nyanzi S, 2001, AIDS CARE, V13, P83, DOI 10.1080/09540120020018206; Pedersen W, 2003, SOC SCI MED, V56, P135, DOI 10.1016/S0277-9536(02)00015-1; Pitpitan EV, 2013, ANN BEHAV MED, V45, P153, DOI 10.1007/s12160-012-9420-3; Sadgrove J., 2007, J RELIG AFR, V37, P116, DOI DOI 10.1163/157006607X166618; Samara Suesanne, 2010, J Health Organ Manag, V24, P512; Silberschmidt M, 2001, SOC SCI MED, V52, P1815, DOI 10.1016/S0277-9536(00)00299-9; Stephenson R, 2013, AIDS CARE, V25, P784, DOI 10.1080/09540121.2012.748161; stergren P, 2004, 15 INT AIDS C BANGK; Svedin CG, 2007, ARCH SEX BEHAV, V36, P21, DOI 10.1007/s10508-006-9083-x; Townsend L, 2011, QUAL HEALTH RES, V21, P41, DOI 10.1177/1049732310378296; Uganda Ministry of Health and ICF International, 2012, 2011 UG AIDS IND SUR; Watt MH, 2012, SOC SCI MED, V74, P1005, DOI 10.1016/j.socscimed.2011.12.022; Wojcicki JM, 2002, MED ANTHROPOL Q, V16, P267, DOI 10.1525/maq.2002.16.3.267; World Health Organization, 2007, ENG MEN BOYS CHANG G; World Health Organization, 2002, WORLD REPORT VIOLENC	43	20	20	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112431	10.1371/journal.pone.0112431	http://dx.doi.org/10.1371/journal.pone.0112431			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT9MC	25386901	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400062
J	Searle, KR; Barber, J; Stubbins, F; Labuschagne, K; Carpenter, S; Butler, A; Denison, E; Sanders, C; Mellor, PS; Wilson, A; Nelson, N; Gubbins, S; Purse, BV				Searle, Kate R.; Barber, James; Stubbins, Francesca; Labuschagne, Karien; Carpenter, Simon; Butler, Adam; Denison, Eric; Sanders, Christopher; Mellor, Philip S.; Wilson, Anthony; Nelson, Noel; Gubbins, Simon; Purse, Bethan V.			Environmental Drivers of Culicoides Phenology: How Important Is Species-Specific Variation When Determining Disease Policy?	PLOS ONE			English	Article							MIDGES DIPTERA-CERATOPOGONIDAE; BLUETONGUE VIRUS SEROTYPE-8; BITING MIDGES; SCHMALLENBERG-VIRUS; NORTHERN EUROPE; VECTORS; NETHERLANDS; SPP.; IDENTIFICATION; CLIMATE	Since 2006, arboviruses transmitted by Culicoides biting midges (Diptera: Ceratopogonidae) have caused significant disruption to ruminant production in northern Europe. The most serious incursions involved strains of bluetongue virus (BTV), which cause bluetongue (BT) disease. To control spread of BTV, movement of susceptible livestock is restricted with economic and animal welfare impacts. The timing of BTV transmission in temperate regions is partly determined by the seasonal presence of adult Culicoides females. Legislative measures therefore allow for the relaxation of ruminant movement restrictions during winter, when nightly light-suction trap catches of Culicoides fall below a threshold (the 'seasonally vector free period': SVFP). We analysed five years of time-series surveillance data from light-suction trapping in the UK to investigate whether significant inter-specific and yearly variation in adult phenology exists, and whether the SVFP is predictable from environmental factors. Because female vector Culicoides are not easily morphologically separated, interspecific comparisons in phenology were drawn from male populations. We demonstrate significant inter-specific differences in Culicoides adult phenology with the season of Culicoides scoticus approximately eight weeks shorter than Culicoides obsoletus. Species-specific differences in the length of the SVFP were related to host density and local variation in landscape habitat. When the Avaritia Culicoides females were modelled as a group (as utilised in the SFVP), we were unable to detect links between environmental drivers and phenological metrics. We conclude that the current treatment of Avaritia Culicoides as a single group inhibits understanding of environmentally-driven spatial variation in species phenology and hinders the development of models for predicting the SVFP from environmental factors. Culicoides surveillance methods should be adapted to focus on concentrated assessments of species-specific abundance during the start and end of seasonal activity in temperate regions to facilitate refinement of ruminant movement restrictions thereby reducing the impact of Culicoides-borne arboviruses.	[Searle, Kate R.; Purse, Bethan V.] Ctr Ecol & Hydrol, Penicuik, Midlothian, Scotland; [Barber, James; Stubbins, Francesca; Carpenter, Simon; Denison, Eric; Sanders, Christopher; Mellor, Philip S.; Wilson, Anthony; Gubbins, Simon] Pirbright Inst, Woking, Surrey, England; [Labuschagne, Karien] ARC Onderstepoort Vet Inst, PVVD, Onderstepoort, South Africa; [Butler, Adam] Biomath & Stat Scotland, Edinburgh, Midlothian, Scotland; [Nelson, Noel] Pirbright Inst, Met Off, Woking, Surrey, England	UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council; James Hutton Institute; Met Office - UK; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Searle, KR (corresponding author), Ctr Ecol & Hydrol, Bush Estate, Penicuik, Midlothian, Scotland.	katrle@ceh.ac.uk	Labuschagne, Karien/J-9084-2019; Carpenter, Simon T/C-2718-2013; Searle, Kate R/F-4922-2011; Purse, Bethan V/I-6640-2012	Carpenter, Simon T/0000-0001-5775-045X; Searle, Kate R/0000-0003-4624-9023; Purse, Bethan V/0000-0001-5140-2710; Gubbins, Simon/0000-0003-0538-4173; Labuschagne, Karien/0000-0002-8352-0313; Wilson, Anthony/0000-0002-2000-2914	EU grant EDENext [FP7-261504]; EDENext Steering Committee [EDENext268]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001701] Funding Source: researchfish; Natural Environment Research Council [ceh010010] Funding Source: researchfish; BBSRC [BBS/E/I/00001701] Funding Source: UKRI	EU grant EDENext; EDENext Steering Committee; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by EU grant FP7-261504 EDENext and is catalogued by the EDENext Steering Committee as EDENext268 (http://www.edenext.eu). The contents of this publication are the sole responsibility of the authors and don't necessarily reflect the views of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartsch S, 2009, PARASITOL RES, V105, P373, DOI 10.1007/s00436-009-1408-y; Bessell PR, 2013, SCI REP-UK, V3, DOI 10.1038/srep01178; Blackwell A, 1997, MED VET ENTOMOL, V11, P361, DOI 10.1111/j.1365-2915.1997.tb00423.x; Campbell J. A., 1960, Proceedings of the Royal Society of Edinburgh (Sect B), V67, P181; Capela R, 2003, MED VET ENTOMOL, V17, P165, DOI 10.1046/j.1365-2915.2003.00419.x; Carpenter S, 2009, OUTLOOKS PEST MANAGE, V20, P161; Carpenter S, 2008, J APPL ECOL, V45, P1237, DOI 10.1111/j.1365-2664.2008.01511.x; Carpenter S, 2009, TRENDS MICROBIOL, V17, P172, DOI 10.1016/j.tim.2009.01.001; Davies I, 2012, IN PRACTICE, V34, P598, DOI 10.1136/inp.e7372; De Regge N, 2012, TRANSBOUND EMERG DIS, V59, P471, DOI 10.1111/tbed.12000; DYCE A L, 1969, Journal of the Australian Entomological Society, V8, P11; EFSA, 2008, ANN REPORT, P108; Elbers ARW, 2013, EMERG INFECT DIS, V19, P106, DOI 10.3201/eid1901.121054; Fisher NI, 1995, STAT ANAL CIRCULAR D; Garcia-Saenz A, 2011, MED VET ENTOMOL, V25, P113, DOI 10.1111/j.1365-2915.2010.00904.x; Gariglinany MM, 2012, EMERG INFECT DIS; Garros C, 2011, INFECT GENET EVOL, V11, P1103, DOI 10.1016/j.meegid.2011.04.002; Gelman A., 2007, DATA ANAL USING REGR; Gubbins S, 2008, J R SOC INTERFACE, V5, P363, DOI 10.1098/rsif.2007.1110; Harrup LE, 2013, MED VET ENTOMOLOGY; Hartemink NA, 2009, EPIDEMICS-NETH, V1, P153, DOI 10.1016/j.epidem.2009.05.004; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; Hofmann MA, 2008, EMERG INFECT DIS, V14, P1855, DOI 10.3201/eid1412.080818; KETTLE DS, 1952, B ENTOMOL RES, V43, P421, DOI 10.1017/S000748530002945X; Kluiters G, 2013, J APPL ECOL, V50, P232, DOI 10.1111/1365-2664.12030; Lassen SB, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-143; Lassen SB, 2011, PARASITOL RES, V108, P823, DOI 10.1007/s00436-010-2123-4; Lievaart-Peterson K, 2012, SMALL RUMINANT RES, V106, P71, DOI 10.1016/j.smallrumres.2012.03.006; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Maan S, 2008, VIROLOGY, V377, P308, DOI 10.1016/j.virol.2008.04.028; Martinez-de la Puente J, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-147; Mathieu B, 2011, VET PARASITOL, V182, P297, DOI 10.1016/j.vetpar.2011.05.052; Meiswinkel R, 2008, PREV VET MED, V87, P182, DOI 10.1016/j.prevetmed.2008.06.008; Mellor P. S., 2004, VET ITAL, V40, P715; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Mintiens K, 2008, PREV VET MED, V87, P131, DOI 10.1016/j.prevetmed.2008.06.011; Modlin D, 2012, ENVIRONMETRICS, V23, P46, DOI 10.1002/env.1133; Morton D., 2011, 1107NERC CTR EC HYDR; Ninio C, 2001, PARASITOL RES, V108, P657; Purse BV, 2012, MED VET ENTOMOL, V26, P168, DOI 10.1111/j.1365-2915.2011.00991.x; Purse BV, 2004, MED VET ENTOMOL, V18, P90, DOI 10.1111/j.0269-283X.2004.00492.x; Sanders CJ, 2011, J APPL ECOL, V48, P1355, DOI 10.1111/j.1365-2664.2011.02051.x; Schley D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005481; Searle KR, 2013, B ENTOMOL RES, V103, P155, DOI 10.1017/S0007485312000466; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Takken W, 2008, PREV VET MED, V87, P41, DOI 10.1016/j.prevetmed.2008.06.015; van Rijn PA, 2012, VET MICROBIOL, V158, P23, DOI 10.1016/j.vetmic.2012.01.022; Vandenbussche F, 2009, TRANSBOUND EMERG DIS, V56, P346, DOI 10.1111/j.1865-1682.2009.01093.x; Viennet E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048120; Viennet E, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-119; Wilson A, 2007, VET REC, V161, P487, DOI 10.1136/vr.161.14.487	51	30	30	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111876	10.1371/journal.pone.0111876	http://dx.doi.org/10.1371/journal.pone.0111876			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386940	gold, Green Accepted, Green Published			2022-12-27	WOS:000345250400029
J	Song, ZM; Liu, Y; Hao, BS; Yu, SJ; Zhang, H; Liu, DH; Zhou, B; Wu, L; Wang, M; Xiong, ZJ; Wu, CD; Zhu, JM; Qian, XX				Song, Zhiming; Liu, Yong; Hao, Baoshun; Yu, Shujie; Zhang, Hui; Liu, Dinghui; Zhou, Bin; Wu, Lin; Wang, Min; Xiong, Zhaojun; Wu, Chaodong; Zhu, Jieming; Qian, Xiaoxian			Ginsenoside Rb1 Prevents H2O2-Induced HUVEC Senescence by Stimulating Sirtuin-1 Pathway	PLOS ONE			English	Article							INDUCED PREMATURE SENESCENCE; HUMAN ENDOTHELIAL-CELLS; NITRIC-OXIDE SYNTHASE; PEROXIDE-INDUCED APOPTOSIS; HUMAN-DIPLOID FIBROBLASTS; OXIDATIVE STRESS; CELLULAR SENESCENCE; SIRT1; ATHEROSCLEROSIS; DYSFUNCTION	Purposes: We have previously reported that Ginsenoside Rb1 may effectively prevent HUVECs from senescence, however, the detailed mechanism has not demonstrated up to now. Recent studies have shown that sirtuin-1 (Sirt1) plays an important role in the development of endothelial senescence. The purpose of this study was to explore whether Sirt1 is involved in the action of Ginsenoside Rb1 regarding protection against H2O2-induced HUVEC Senescence. Methods and Results: Senescence induced by hydrogen peroxide (H2O2) in human umbilical vein endothelial cells (HUVECs) was examined by analyzing plasminogen activator inhibitor-1 (PAI-1) expression, cell morphology, and senescence-associated beta-galactosidase (SA-beta-gal) activity. The results revealed that 42% of control-treated HUVECs were SA-b-gal positive after treatment by 60 mmol/L H2O2, however, this particular effect of H2O2 was decreased more than 2-fold (19%) in the HUVECs when pretreated with Rb1 (20 mu mol/L) for 30 min. Additionally, Rb1 decreased eNOS acetylation, as well as promoted more NO production that was accompanied by an increase in Sirt1 expression. Furthermore, upon knocking down Sirt1, the effect of Rb1 on HUVEC senescence was blunted. Conclusions: The present study indicated that Ginsenoside Rb1 acts through stimulating Sirt1 in order to protect against endothelial senescence and dysfunction. As such, Sirt1 appears to be of particular importance in maintaining endothelial functions and delaying vascular aging.	[Song, Zhiming; Liu, Yong; Hao, Baoshun; Yu, Shujie; Liu, Dinghui; Zhou, Bin; Wu, Lin; Wang, Min; Xiong, Zhaojun; Zhu, Jieming; Qian, Xiaoxian] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Cardiol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Hui] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Ultrasonog, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Chaodong] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX USA; [Qian, Xiaoxian] Sun Yat Sen Univ, Inst Integrated Tradit Chinese & Western Med, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Texas A&M University System; Texas A&M University College Station; Sun Yat Sen University	Zhu, JM (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Cardiol, Guangzhou 510275, Guangdong, Peoples R China.	zhujieming2011@126.com; xiaoxianq@qq.com		song, zhiming/0000-0002-4004-7052	National Natural Science Foundation of China [81370447]; Natural Science Foundation of Guangdong Province [8151008901000209, S2012020010924]; Science and Technology Planning Project of Guangdong Province [2007B060401024, 2011B031800024, 2011B031800155]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095828] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the grants from the National Natural Science Foundation of China (grant number: 81370447, to XQ); Natural Science Foundation of Guangdong Province (grant number: 8151008901000209 and S2012020010924, to XQ); Science and Technology Planning Project of Guangdong Province (grant number: 2007B060401024, 2011B031800024 and 2011B031800155 to XQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shaer MH, 2006, INT J CARDIOL, V109, P201, DOI 10.1016/j.ijcard.2005.06.002; Albrecht EWJA, 2003, J PATHOL, V199, P8, DOI 10.1002/path.1250; Arunachalam G, 2010, BIOCHEM BIOPH RES CO, V393, P66, DOI 10.1016/j.bbrc.2010.01.080; Bai B, 2012, CIRCULATION, V126, P729, DOI 10.1161/CIRCULATIONAHA.112.118778; Barnes Patricia M, 2008, Natl Health Stat Report, P1; Baudin B, 2007, NAT PROTOC, V2, P481, DOI 10.1038/nprot.2007.54; Caito S, 2010, FASEB J, V24, P3145, DOI 10.1096/fj.09-151308; Coleman PR, 2010, BLOOD, V116, P4016, DOI 10.1182/blood-2009-11-252700; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Fabian D., 2011, NATURE ED KNOWLEDGE; Finegold JA, 2013, INT J CARDIOL, V168, P934, DOI 10.1016/j.ijcard.2012.10.046; Francia P, 2004, CIRCULATION, V110, P2889, DOI 10.1161/01.CIR.0000147731.24444.4D; Furukawa A, 2007, CELL PHYSIOL BIOCHEM, V20, P45, DOI 10.1159/000104152; Gao ZG, 2011, J BIOL CHEM, V286, P22227, DOI 10.1074/jbc.M111.228874; Gomes P, 2009, OXID MED CELL LONGEV, V2, P138, DOI 10.4161/oxim.2.3.8819; Gong GH, 2010, EUR J PHARMACOL, V628, P27, DOI 10.1016/j.ejphar.2009.11.028; Gorenne I, 2013, CIRCULATION, V127, P386, DOI 10.1161/CIRCULATIONAHA.112.124404; Haines DD, 2013, J CELL MOL MED, V17, P936, DOI 10.1111/jcmm.12074; Hayashi T, 2006, P NATL ACAD SCI USA, V103, P17018, DOI 10.1073/pnas.0607873103; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Huang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001710; Hwang JW, 2013, FREE RADICAL BIO MED, V61, P95, DOI 10.1016/j.freeradbiomed.2013.03.015; Ido Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035092; Zarzuelo MJ, 2013, BIOCHEM PHARMACOL, V85, P1288, DOI 10.1016/j.bcp.2013.02.015; Kao CL, 2010, J ATHEROSCLER THROMB, V17, P970, DOI 10.5551/jat.4333; Lan TH, 2011, BIOCHEM PHARMACOL, V82, P148, DOI 10.1016/j.bcp.2011.04.001; Li LX, 2010, ANN NY ACAD SCI, V1203, P151, DOI 10.1111/j.1749-6632.2010.05555.x; Lin YJ, 2011, ACTA PHARMACOL SIN, V32, P1246, DOI 10.1038/aps.2011.101; Liu DH, 2011, BIOL PHARM BULL, V34, P1072, DOI 10.1248/bpb.34.1072; Liu L, 2013, EUR REV MED PHARMACO, V17, P88; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Matsushita H, 2001, CIRC RES, V89, P793, DOI 10.1161/hh2101.098443; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Oeseburg H, 2009, HYPERTENSION, V53, P417, DOI 10.1161/HYPERTENSIONAHA.108.123729; Ota H, 2008, ARTERIOSCL THROM VAS, V28, P1634, DOI 10.1161/ATVBAHA.108.164368; Ota H, 2007, J MOL CELL CARDIOL, V43, P571, DOI 10.1016/j.yjmcc.2007.08.008; Ota H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029598; Ota H, 2010, ARTERIOSCL THROM VAS, V30, P2205, DOI 10.1161/ATVBAHA.110.210500; Ota H, 2010, J ATHEROSCLER THROMB, V17, P431, DOI 10.5551/jat.3525; Rajendrasozhan S, 2008, AM J RESP CRIT CARE, V177, P861, DOI 10.1164/rccm.200708-1269OC; Rippe C, 2012, EXP GERONTOL, V47, P45, DOI 10.1016/j.exger.2011.10.004; Seals DR, 2011, CLIN SCI, V120, P357, DOI 10.1042/CS20100476; Sun L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043186; Sun Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080859; Toussaint O, 2000, EXP GERONTOL, V35, P927, DOI 10.1016/S0531-5565(00)00180-7; Xia N, 2013, NITRIC OXIDE-BIOL CH, V32, P29, DOI 10.1016/j.niox.2013.04.001; Zdanov S, 2006, ANN NY ACAD SCI, V1067, P210, DOI 10.1196/annals.1354.025; Zhou W, 2005, J VASC SURG, V41, P861, DOI 10.1016/j.jvs.2005.01.054; Zu Y, 2010, CIRC RES, V106, P1384, DOI 10.1161/CIRCRESAHA.109.215483	49	53	63	6	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112699	10.1371/journal.pone.0112699	http://dx.doi.org/10.1371/journal.pone.0112699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386949	Green Submitted, Green Published, gold			2022-12-27	WOS:000345250400084
J	Valentini, E; Koch, K; Aglioti, SM				Valentini, Elia; Koch, Katharina; Aglioti, Salvatore Maria			Thoughts of Death Modulate Psychophysical and Cortical Responses to Threatening Stimuli	PLOS ONE			English	Article							TERROR MANAGEMENT THEORY; EVOKED EEG RESPONSES; NEED SELF-ESTEEM; MORTALITY SALIENCE; PAIN PERCEPTION; POTENTIALS; ACCESSIBILITY; SUPPRESSION; NEUROTICISM; COVARIANCE	Existential social psychology studies show that awareness of one's eventual death profoundly influences human cognition and behaviour by inducing defensive reactions against end-of-life related anxiety. Much less is known about the impact of reminders of mortality on brain activity. Therefore we explored whether reminders of mortality influence subjective ratings of intensity and threat of auditory and painful thermal stimuli and the associated electroencephalographic activity. Moreover, we explored whether personality and demographics modulate psychophysical and neural changes related to mortality salience (MS). Following MS induction, a specific increase in ratings of intensity and threat was found for both nociceptive and auditory stimuli. While MS did not have any specific effect on nociceptive and auditory evoked potentials, larger amplitude of theta oscillatory activity related to thermal nociceptive activity was found after thoughts of death were induced. MS thus exerted a top-down modulation on theta electroencephalographic oscillatory amplitude, specifically for brain activity triggered by painful thermal stimuli. This effect was higher in participants reporting higher threat perception, suggesting that inducing a death-related mind-set may have an influence on body-defence related somatosensory representations.	[Valentini, Elia; Koch, Katharina; Aglioti, Salvatore Maria] Univ Roma La Sapienza, Dipartimento Psicol, I-00185 Rome, Italy; [Valentini, Elia; Koch, Katharina; Aglioti, Salvatore Maria] Fdn Santa Lucia, Ist Ricovero & Cura Carattere Sci, Rome, Italy	Sapienza University Rome; IRCCS Santa Lucia	Valentini, E (corresponding author), Univ Roma La Sapienza, Dipartimento Psicol, I-00185 Rome, Italy.	elia.valentini@uniroma1.it	Aglioti, Salvatore M/E-9829-2012; Valentini, Elia/H-3188-2019	Valentini, Elia/0000-0003-0259-6824; Aglioti, Salvatore Maria/0000-0001-8175-7563	Avvio alla Ricerca Sapienza grant scheme; European Union Information and Communication Technologies Grant (VERE project, FP7-ICT-5) [257695]; Italian Ministry of Health [RC11.G, RF-2010-2312912]	Avvio alla Ricerca Sapienza grant scheme; European Union Information and Communication Technologies Grant (VERE project, FP7-ICT-5); Italian Ministry of Health(Ministry of Health, Italy)	E. Valentini is supported by the Avvio alla Ricerca Sapienza grant scheme. S. M. Aglioti was funded by the European Union Information and Communication Technologies Grant (VERE project, FP7-ICT-2009-5, Prot. Num. 257695) and the Italian Ministry of Health (grant RC11.G and RF-2010-2312912). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt J, 1997, J PERS SOC PSYCHOL, V73, P5, DOI 10.1037/0022-3514.73.1.5; Arndt J, 1998, PERS SOC PSYCHOL B, V24, P1216, DOI 10.1177/01461672982411008; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Burke BL, 2010, PERS SOC PSYCHOL REV, V14, P155, DOI 10.1177/1088868309352321; CARLSSON AM, 1983, PAIN, V16, P87, DOI 10.1016/0304-3959(83)90088-X; Cruccu G, 2003, BRAIN, V126, P2246, DOI 10.1093/brain/awg227; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dimitrov Dimiter M, 2003, Work, V20, P159; FRUHSTOR.H, 1970, ELECTROEN CLIN NEURO, V28, P153, DOI 10.1016/0013-4694(70)90183-5; Goldenberg JL, 2006, PERS SOC PSYCHOL B, V32, P1264, DOI 10.1177/0146167206289505; Gontkovsky ST, 2004, APPL NEUROPSYCHOL, V11, P75, DOI 10.1207/s15324826an1102_2; GREENBERG J, 1992, J PERS SOC PSYCHOL, V63, P212, DOI 10.1037/0022-3514.63.2.212; GREENBERG J, 1994, J PERS SOC PSYCHOL, V67, P627, DOI 10.1037/0022-3514.67.4.627; GREENBERG J, 1992, J PERS SOC PSYCHOL, V63, P913, DOI 10.1037/0022-3514.63.6.913; Han SH, 2010, NEUROPSYCHOLOGIA, V48, P3436, DOI 10.1016/j.neuropsychologia.2010.07.026; Harmon-Jones E, 1997, J PERS SOC PSYCHOL, V72, P24, DOI 10.1037/0022-3514.72.1.24; Hayes J, 2010, PSYCHOL BULL, V136, P699, DOI 10.1037/a0020524; Henry EA, 2010, SOC COGN AFFECT NEUR, V5, P77, DOI 10.1093/scan/nsp041; Hirsh JB, 2008, PSYCHOL SCI, V19, P962, DOI 10.1111/j.1467-9280.2008.02183.x; Hu L, 2010, NEUROIMAGE, V50, P99, DOI 10.1016/j.neuroimage.2009.12.010; Hu L, 2013, J PAIN, V14, P89, DOI 10.1016/j.jpain.2012.10.008; Iannetti GD, 2008, J NEUROPHYSIOL, V100, P815, DOI 10.1152/jn.00097.2008; Iannetti GD, 2005, NEUROIMAGE, V28, P708, DOI 10.1016/j.neuroimage.2005.06.060; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; KASTENBAUM R, 1977, ANNU REV PSYCHOL, V28, P225, DOI 10.1146/annurev.ps.28.020177.001301; Klackl J, 2013, SOC COGN AFFECT NEUR, V8, P333, DOI 10.1093/scan/nss003; Legrain V, 2012, NEUROPHYSIOL CLIN, V42, P325, DOI 10.1016/j.neucli.2012.06.003; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Luck S.J., 2005, INTRO EVENT RELATED; Luo S, 2013, SOC COGN AFFECT NEUR; Maxfield M, 2007, PSYCHOL AGING, V22, P341, DOI 10.1037/0882-7974.22.2.341; Mitsis GD, 2008, NEUROIMAGE, V40, P121, DOI 10.1016/j.neuroimage.2007.11.026; Mouraux A, 2008, MAGN RESON IMAGING, V26, P1041, DOI 10.1016/j.mri.2008.01.011; Mouraux A, 2003, CLIN NEUROPHYSIOL, V114, P710, DOI 10.1016/S1388-2457(03)00027-0; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Plaghki Leon, 2005, Curr Opin Investig Drugs, V6, P58; Ploner M, 2006, CEREB CORTEX, V16, P537, DOI 10.1093/cercor/bhj001; PORTER AC, 1987, J COUNS PSYCHOL, V34, P383; Pyszczynski T, 1999, PSYCHOL REV, V106, P835, DOI 10.1037/0033-295X.106.4.835; Pyszczynski T, 2004, PSYCHOL BULL, V130, P435, DOI 10.1037/0033-2909.130.3.435; Quirin M, 2012, SOC COGN AFFECT NEUR, V7, P193, DOI 10.1093/scan/nsq106; Rausch JR, 2003, J CLIN CHILD ADOLESC, V32, P467, DOI 10.1207/S15374424JCCP3203_15; Rengachary J, 2011, FRONT HUM NEUROSCI, V5, DOI [10.3389/fnhum.2011.00029, 10.3389/fnhum.2011.00069]; Ronga I, 2013, J NEUROPHYSIOL, V109, P692, DOI 10.1152/jn.00464.2012; ROSENBLATT A, 1989, J PERS SOC PSYCHOL, V57, P681, DOI 10.1037/0022-3514.57.4.681; Schlereth T, 2001, PAIN, V92, P187, DOI 10.1016/S0304-3959(00)00484-X; Schulz E, 2012, CEREB CORTEX, V22, P1118, DOI 10.1093/cercor/bhr186; Schulz E, 2011, CEREB CORTEX, V21, P2408, DOI 10.1093/cercor/bhr027; Senn S, 2006, STAT MED, V25, P4334, DOI 10.1002/sim.2682; Spielberger C. D., 1973, MANUAL STATE TRAIT I; TARKKA IM, 1993, J CLIN NEUROPHYSIOL, V10, P513, DOI 10.1097/00004691-199310000-00009; Todorovic A, 2012, J NEUROSCI, V32, P13389, DOI 10.1523/JNEUROSCI.2227-12.2012; Torta DM, 2012, EXP BRAIN RES, V218, P361, DOI 10.1007/s00221-012-3019-6; Tritt SM, 2012, SOC COGNITION, V30, P715, DOI 10.1521/soco.2012.30.6.715; Valentini E, 2013, CORTEX, V49, P446, DOI 10.1016/j.cortex.2012.02.005; Valentini E, 2012, HUM BRAIN MAPP, V33, P2873, DOI 10.1002/hbm.21408; Valentini E, 2011, J COGNITIVE NEUROSCI, V23, P2822, DOI 10.1162/jocn.2011.21609; Walton KD, 2010, PAIN, V150, P41, DOI 10.1016/j.pain.2010.02.023; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Zhang ZG, 2012, J NEUROSCI, V32, P7429, DOI 10.1523/JNEUROSCI.5877-11.2012	60	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112324	10.1371/journal.pone.0112324	http://dx.doi.org/10.1371/journal.pone.0112324			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT9MC	25386905	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000345250400055
J	Dhakal, KR; Gu, L; Shivalingaiah, S; Dennis, TS; Morris-Bobzean, SA; Li, T; Perrotti, LI; Mohanty, SK				Dhakal, Kamal R.; Gu, Ling; Shivalingaiah, Shivaranjani; Dennis, Torry S.; Morris-Bobzean, Samara A.; Li, Ting; Perrotti, Linda I.; Mohanty, Samarendra K.			Non-Scanning Fiber-Optic Near-Infrared Beam Led to Two-Photon Optogenetic Stimulation In-Vivo	PLOS ONE			English	Article							MILLISECOND-TIMESCALE; OPTICAL-PROPERTIES; EXCITABLE CELLS; DELTA-FOSB; EXCITATION; BRAIN; LIGHT; ABSORPTION; ACTIVATION; CHANNELRHODOPSIN-2	Stimulation of specific neurons expressing opsins in a targeted region to manipulate brain function has proved to be a powerful tool in neuroscience. However, the use of visible light for optogenetic stimulation is invasive due to low penetration depth and tissue damage owing to larger absorption and scattering. Here, we report, for the first time, in-depth non-scanning fiber-optic two-photon optogenetic stimulation (FO-TPOS) of neurons in-vivo in transgenic mouse models. In order to optimize the deep-brain stimulation strategy, we characterized two-photon activation efficacy at different near-infrared laser parameters. The significantly-enhanced in-depth stimulation efficiency of FO-TPOS as compared to conventional single-photon beam was demonstrated both by experiments and Monte Carlo simulation. The non-scanning FO-TPOS technology will lead to better understanding of the in-vivo neural circuitry because this technology permits more precise and less invasive anatomical delivery of stimulation.	[Dhakal, Kamal R.; Gu, Ling; Shivalingaiah, Shivaranjani; Mohanty, Samarendra K.] Univ Texas Arlington, Biophys & Physiol Lab, Arlington, TX 76019 USA; [Dennis, Torry S.; Morris-Bobzean, Samara A.; Perrotti, Linda I.] Univ Texas Arlington, Dept Psychol, Arlington, TX 76019 USA; [Li, Ting] Univ Elect Sci & Technol China, Minist Educ, Key Lab Neuroinformat, Chengdu, Sichuan, Peoples R China	University of Texas System; University of Texas Arlington; University of Texas System; University of Texas Arlington; University of Electronic Science & Technology of China	Mohanty, SK (corresponding author), Univ Texas Arlington, Biophys & Physiol Lab, Arlington, TX 76019 USA.	smohanty@uta.edu		Perrotti, Linda/0000-0002-6297-2572	Office of President and Provost, The University of Texas at Arlington; National Institute of Health [NS084311]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS084311] Funding Source: NIH RePORTER	Office of President and Provost, The University of Texas at Arlington; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	SKM is thankful for the support from Office of President and Provost, The University of Texas at Arlington, the National Institute of Health (NS084311), and Mr. Harvey Wiggins (Plexon Inc.) for providing the Plexon Omniplex system and Plexon staff for electrophysiological recording support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albota MA, 1998, APPL OPTICS, V37, P7352, DOI 10.1364/AO.37.007352; Andrasfalvy BK, 2010, P NATL ACAD SCI USA, V107, P11981, DOI 10.1073/pnas.1006620107; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Bestvater F, 2002, J MICROSC-OXFORD, V208, P108, DOI 10.1046/j.1365-2818.2002.01074.x; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Butson CR, 2006, J NEURAL ENG, V3, P1, DOI 10.1088/1741-2560/3/1/001; Butson CR, 2005, CLIN NEUROPHYSIOL, V116, P2490, DOI 10.1016/j.clinph.2005.06.023; Cao H, 2012, IEEE T BIOMED ENG; CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354; Denton ML, 2006, INVEST OPHTH VIS SCI, V47, P3065, DOI 10.1167/iovs.05-1066; Dhakal K, 2013, OPT LETT, V38, P1927, DOI 10.1364/OL.38.001927; Fu L, 2006, OPT EXPRESS, V14, P1027, DOI 10.1364/OE.14.001027; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Hirase H, 2002, J NEUROBIOL, V51, P237, DOI 10.1002/neu.10056; JACQUES SL, 1989, APPL OPTICS, V28, P2223, DOI 10.1364/AO.28.002223; Johansson JD, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3495719; Kanneganti A, 2011, BIOPHYS J, V100, P95; Kienle A, 1996, APPL OPTICS, V35, P2304, DOI 10.1364/AO.35.002304; Kim TI, 2013, SCIENCE, V340, P211, DOI 10.1126/science.1232437; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Miller G, 2006, SCIENCE, V314, P1674, DOI 10.1126/science.314.5806.1674; Mishra YN, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3643340; Mohanty SK, 2008, BIOPHYS J, V95, P3916, DOI 10.1529/biophysj.108.130187; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Packer AM, 2012, NAT METHODS, V9, P1202, DOI [10.1038/NMETH.2249, 10.1038/nmeth.2249]; Papagiakoumou E, 2010, NAT METHODS, V7, P848, DOI [10.1038/NMETH.1505, 10.1038/nmeth.1505]; Perrotti LI, 2008, SYNAPSE, V62, P358, DOI 10.1002/syn.20500; Perrotti LI, 2004, J NEUROSCI, V24, P10594, DOI 10.1523/JNEUROSCI.2542-04.2004; Rickgauer JP, 2009, P NATL ACAD SCI USA, V106, P15025, DOI 10.1073/pnas.0907084106; Seung HS, 2009, NEURON, V62, P17, DOI 10.1016/j.neuron.2009.03.020; Shapiro MG, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1742; Shivalingaiah S, 2011, PROC SPIE, V7883, DOI 10.1117/12.875996; So PTC, 2000, ANNU REV BIOMED ENG, V2, P399, DOI 10.1146/annurev.bioeng.2.1.399; Vivas MG, 2010, J PHYS CHEM A, V114, P3466, DOI 10.1021/jp910010g; Voon V, 2006, MOVEMENT DISORD, V21, pS305, DOI 10.1002/mds.20963; WANG LH, 1995, COMPUT METH PROG BIO, V47, P131, DOI 10.1016/0169-2607(95)01640-F; Wang LH, 1997, COMPUT METH PROG BIO, V54, P141, DOI 10.1016/S0169-2607(97)00021-7; WILSON BC, 1990, IEEE J QUANTUM ELECT, V26, P2186, DOI 10.1109/3.64355; Yamaguchi S, 2003, CHEM PHYS LETT, V376, P237, DOI 10.1016/S0009-2614(03)00984-9; Yaroslavsky AN, 2002, PHYS MED BIOL, V47, P2059, DOI 10.1088/0031-9155/47/12/305; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120	44	8	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e111488	10.1371/journal.pone.0111488	http://dx.doi.org/10.1371/journal.pone.0111488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383687	Green Published, gold, Green Submitted			2022-12-27	WOS:000344816700017
J	Szule, J; Kondor, D; Dobos, L; Csabai, I; Vattay, G				Szuele, Janos; Kondor, Daniel; Dobos, Laszlo; Csabai, Istvan; Vattay, Gabor			Lost in the City: Revisiting Milgram's Experiment in the Age of Social Networks	PLOS ONE			English	Article							SMALL WORLD; DIMENSION; SEARCH	As more and more users access social network services from smart devices with GPS receivers, the available amount of geo-tagged information makes repeating classical experiments possible on global scales and with unprecedented precision. Inspired by the original experiments of Milgram, we simulated message routing within a representative sub-graph of the network of Twitter users with about 6 million geo-located nodes and 122 million edges. We picked pairs of users from two distant metropolitan areas and tried to find a route between them using local geographic information only; our method was to forward messages to a friend living closest to the target. We found that the examined network is navigable on large scales, but navigability breaks down at the city scale and the network becomes unnavigable on intra-city distances. This means that messages usually arrived to the close proximity of the target in only 3-6 steps, but only in about 20% of the cases was it possible to find a route all the way to the recipient, in spite of the network being connected. This phenomenon is supported by the distribution of link lengths; on larger scales the distribution behaves approximately as P(d) similar to 1/d, which was found earlier by Kleinberg to allow efficient navigation, while on smaller scales, a fractal structure becomes apparent. The intra-city correlation dimension of the network was found to be D-2 = 1.25, less than the dimension D-2 = 1.78 of the distribution of the population.	[Szuele, Janos; Kondor, Daniel; Dobos, Laszlo; Csabai, Istvan; Vattay, Gabor] Eotvos Lorand Univ, Dept Phys Complex Syst, Budapest, Hungary	Eotvos Lorand University	Szule, J (corresponding author), Eotvos Lorand Univ, Dept Phys Complex Syst, Budapest, Hungary.	szule@complex.elte.hu	Vattay, Gabor/Q-4266-2019; Csabai, Istvan/F-6045-2011; Vattay, Gabor/G-9638-2017; Kondor, Daniel/AAD-9871-2019; Dobos, Laszlo/E-6071-2012	Csabai, Istvan/0000-0001-9232-9898; Vattay, Gabor/0000-0002-0919-9429; Kondor, Daniel/0000-0003-3720-7462; Dobos, Laszlo/0000-0001-7679-9478	European Union; European Social Fund [TAMOP-4.2.2.C-11/1/KONV-2012-0013]; Hungarian Government [EITKIC_12-1-2012-0001]; Research and Technology Innovation Fund; MAKOG Foundation	European Union(European Commission); European Social Fund(European Social Fund (ESF)); Hungarian Government; Research and Technology Innovation Fund; MAKOG Foundation	The authors are thankful for the partial support of the European Union and the European Social Fund through project FuturICT.hu (grant no. TAMOP-4.2.2.C-11/1/KONV-2012-0013). EITKIC_12-1-2012-0001 project was partially supported by the Hungarian Government, managed by the National Development Agency, and financed by the Research and Technology Innovation Fund and the MAKOG Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleby S, 1996, GEOGR ANAL, V28, P147; Bakhshandeh R, 2011, P S COMB SEARCH; Bliss CA, 2012, J COMPUT SCI-NETH, V3, P388, DOI 10.1016/j.jocs.2012.05.001; Boguna M, 2009, NAT PHYS, V5, P74, DOI 10.1038/NPHYS1130; Boillot A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052708, 10.1371/journal.pone.0064417]; Cartozo CC, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.238703; Cho Eunjoon, 2011, KDD, P1082, DOI [10.1145/2020408.2020579, DOI 10.1145/2020408.2020579]; Chung F, 2002, P NATL ACAD SCI USA, V99, P15879, DOI 10.1073/pnas.252631999; Dodds PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026752; Dodds PS, 2003, SCIENCE, V301, P827, DOI 10.1126/science.1081058; Frank MR, 2013, SCI REP-UK, V3, DOI 10.1038/srep02625; Goldenberg J, 2009, DISTANCE IS NOT DEAD; GRASSBERGER P, 1983, PHYSICA D, V9, P189, DOI 10.1016/0167-2789(83)90298-1; Hu YQ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.108701; Klein J.T., 2000, P 19 ACM SIGACT SIGM, P1; Kleinberg JM, 2000, NATURE, V406, P845, DOI 10.1038/35022643; Kondor D, 2013, PHYSICA A, V392, P4160, DOI 10.1016/j.physa.2013.04.046; Lambiotte R, 2008, PHYSICA A, V387, P5317, DOI 10.1016/j.physa.2008.05.014; Dobos L, 2013, INT CONF COGN INFO, P289, DOI 10.1109/CogInfoCom.2013.6719259; Li DQ, 2011, NAT PHYS, V7, P481, DOI [10.1038/NPHYS1932, 10.1038/nphys1932]; Liben-Nowell D, 2005, P NATL ACAD SCI USA, V102, P11623, DOI 10.1073/pnas.0503018102; Matray P, 2012, COMPUT NETW, V56, P2237, DOI 10.1016/j.comnet.2012.03.005; MILGRAM S, 1967, PSYCHOL TODAY, V1, P61; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Roberson MR, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.017101; Sakaki T., 2010, P 19 INT C WORLD WID, P851, DOI [10.1145/1772690.1772777, DOI 10.1145/1772690.1772777, 10.1145/1772690.1772777.]; Shen GQ, 2002, INT J GEOGR INF SCI, V16, P419, DOI 10.1080/13658810210137013; TRAVERS J, 1969, SOCIOMETRY, V32, P425, DOI 10.2307/2786545; Ugander J., 2011, ARXIV11114503; Watts DJ, 2002, SCIENCE, V296, P1302, DOI 10.1126/science.1070120; Westerman D, 2012, COMPUT HUM BEHAV, V28, P199, DOI 10.1016/j.chb.2011.09.001; Yook SH, 2002, P NATL ACAD SCI USA, V99, P13382, DOI 10.1073/pnas.172501399; Zhang X, 2011, PROCD SOC BEHV, V26, DOI 10.1016/j.sbspro.2011.10.562	33	10	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e111973	10.1371/journal.pone.0111973	http://dx.doi.org/10.1371/journal.pone.0111973			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT3DP	25383796	gold, Green Published, Green Submitted			2022-12-27	WOS:000344816700027
J	Zanier, K; Stutz, C; Kintscher, S; Reinz, E; Sehr, P; Bulkescher, J; Hoppe-Seyler, K; Trave, G; Hoppe-Seyler, F				Zanier, Katia; Stutz, Christina; Kintscher, Susanne; Reinz, Eileen; Sehr, Peter; Bulkescher, Julia; Hoppe-Seyler, Karin; Trave, Gilles; Hoppe-Seyler, Felix			The E6AP Binding Pocket of the HPV16 E6 Oncoprotein Provides a Docking Site for a Small Inhibitory Peptide Unrelated to E6AP, Indicating Druggability of E6	PLOS ONE			English	Article							POSITIVE CANCER-CELLS; PATHWAYS; PROTEINS; P53; PAPILLOMAVIRUSES; ASSOCIATION; DEGRADATION; INDUCTION; APOPTOSIS; DESIGN	The HPV E6 oncoprotein maintains the malignant phenotype of HPV-positive cancer cells and represents an attractive therapeutic target. E6 forms a complex with the cellular E6AP ubiquitin ligase, ultimately leading to p53 degradation. The recently elucidated x-ray structure of a HPV16 E6/E6AP complex showed that HPV16 E6 forms a distinct binding pocket for E6AP. This discovery raises the question whether the E6AP binding pocket is druggable, i.e. whether it provides a docking site for functional E6 inhibitors. To address these issues, we performed a detailed analysis of the HPV16 E6 interactions with two small peptides: (i) E6APpep, corresponding to the E6 binding domain of E6AP, and (ii) pep11**, a peptide that binds to HPV16 E6 and, in contrast to E6APpep, induces apoptosis, specifically in HPV16-positive cancer cells. Surface plasmon resonance, NMR chemical shift perturbation, and mammalian two-hybrid analyses coupled to mutagenesis indicate that E6APpep contacts HPV16 E6 amino acid residues within the E6AP pocket, both in vitro and intracellularly. Many of these amino acids were also important for binding to pep11**, suggesting that the binding sites for the two peptides on HPV16 E6 overlap. Yet, few E6 amino acids were differentially involved which may contribute to the higher binding affinity of pep11**. Data from the HPV16 E6/pep11** interaction allowed the rational design of single amino acid exchanges in HPV18 and HPV31 E6 that enabled their binding to pep11**. Taken together, these results suggest that E6 molecular surfaces mediating E6APpep binding can also accommodate pro-apoptotic peptides that belong to different sequence families. As proof of concept, this study provides the first experimental evidence that the E6AP binding pocket is druggable, opening new possibilities for rational, structure-based drug design.	[Zanier, Katia; Trave, Gilles] Ecole Biotechnol Strasbourg IREBS, Inst Rech, F-67412 Illkirch Graffenstaden, France; [Stutz, Christina; Kintscher, Susanne; Reinz, Eileen; Bulkescher, Julia; Hoppe-Seyler, Karin; Hoppe-Seyler, Felix] German Canc Res Ctr, Program Infect & Canc, D-69120 Heidelberg, Germany; [Sehr, Peter] European Mol Biol Lab, EMBL DKFZ Chem Biol Core Facil, D-69117 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL)	Zanier, K (corresponding author), Ecole Biotechnol Strasbourg IREBS, Inst Rech, F-67412 Illkirch Graffenstaden, France.	zanier@unistra.fr; hoppe-seyler@dkfz.de	TRAVE, Gilles/P-8577-2016	Sehr, Peter/0000-0002-4348-5066; Hoppe-Seyler, Felix/0000-0002-1864-300X	Deutsche Krebshilfe [109392]; National Institutes of Health [R01CA134737]; NATIONAL CANCER INSTITUTE [R01CA134737] Funding Source: NIH RePORTER	Deutsche Krebshilfe(Deutsche Krebshilfe); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant (# 109392) of the Deutsche Krebshilfe (http://www.krebshilfe.de/metanavigation/english.html) to F. H. S. and a National Institutes of Health (http://www.nih.gov/)grant (# R01CA134737) to G.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butz K, 2000, P NATL ACAD SCI USA, V97, P6693, DOI 10.1073/pnas.110538897; Butz K, 2003, ONCOGENE, V22, P5938, DOI 10.1038/sj.onc.1206894; Butz K, 2001, ONCOGENE, V20, P6579, DOI 10.1038/sj.onc.1204805; Cherry JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084506; Clifford G, 2006, VACCINE, V24, P26, DOI 10.1016/j.vaccine.2006.05.026; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dymalla S, 2009, J MOL MED, V87, P321, DOI 10.1007/s00109-008-0432-1; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Goodwin EC, 2000, P NATL ACAD SCI USA, V97, P12513, DOI 10.1073/pnas.97.23.12513; Griffin H, 2006, J MOL BIOL, V355, P360, DOI 10.1016/j.jmb.2005.10.077; Hoppe-Seyler F, 2011, INT J CANCER, V129, P1289, DOI 10.1002/ijc.26087; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P4918, DOI 10.1128/MCB.13.8.4918; Keller RLJ., 2004, OPTIMIZING PROCESS N; Lagrange M, 2007, BIOCHEM BIOPH RES CO, V361, P487, DOI 10.1016/j.bbrc.2007.07.040; Mason JM, 2010, FUTURE MED CHEM, V2, P1813, DOI [10.4155/fmc.10.259, 10.4155/FMC.10.259]; McLaughlin-Drubin ME, 2009, VIRUS RES, V143, P195, DOI 10.1016/j.virusres.2009.06.008; Nomine Y, 2006, MOL CELL, V21, P665, DOI 10.1016/j.molcel.2006.01.024; Perot S, 2010, DRUG DISCOV TODAY, V15, P656, DOI 10.1016/j.drudis.2010.05.015; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Tomaic V, 2009, VIROLOGY, V393, P7, DOI 10.1016/j.virol.2009.07.029; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Wells SI, 2000, EMBO J, V19, P5762, DOI 10.1093/emboj/19.21.5762; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Yamato K, 2006, CANCER GENE THER, V13, P234, DOI 10.1038/sj.cgt.7700891; Zanier K, 2005, J MOL BIOL, V349, P401, DOI 10.1016/j.jmb.2005.03.071; Zanier K, 2007, PROTEIN EXPRES PURIF, V51, P59, DOI 10.1016/j.pep.2006.07.029; Zanier K, 2013, SCIENCE, V339, P694, DOI 10.1126/science.1229934; Zanier K, 2012, STRUCTURE, V20, P604, DOI 10.1016/j.str.2012.02.001; Zheng XL, 2013, AAPS J, V15, P228, DOI 10.1208/s12248-012-9426-6; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	32	26	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112514	10.1371/journal.pone.0112514	http://dx.doi.org/10.1371/journal.pone.0112514			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383876	Green Published, Green Submitted, gold			2022-12-27	WOS:000344816700073
J	Alfonso-Rodriguez, CA; Garzon, I; Garrido-Gomez, J; Oliveira, ACX; Martin-Piedra, MA; Scionti, G; Carriel, V; Hernandez-Cortes, P; Campos, A; Alaminos, M				Alfonso-Rodriguez, Camilo-Andres; Garzon, Ingrid; Garrido-Gomez, Juan; Oliveira, Ana-Celeste-Ximenes; Martin-Piedra, Miguel-Angel; Scionti, Giuseppe; Carriel, Victor; Hernandez-Cortes, Pedro; Campos, Antonio; Alaminos, Miguel			Identification of Histological Patterns in Clinically Affected and Unaffected Palm Regions in Dupuytren's Disease	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; CONTRACTURE; CELLS; FIBROBLASTS; COLLAGENASE; MANAGEMENT; MYOFIBROBLASTS; PATHOGENESIS; MIGRATION; VERSICAN	Dupuytren's disease is a fibro-proliferative disease characterized by a disorder of the extracellular matrix (ECM) and high myofibroblast proliferation. However, studies failed to determine if the whole palm fascia is affected by the disease. The objective of this study was to analyze several components of the extracellular matrix of three types of tissues-Dupuytren's diseased contracture cords (DDC), palmar fascia clinically unaffected by Dupuytren's disease contracture (NPF), and normal forehand fascia (NFF). Histological analysis, quantification of cells recultured from each type of tissue, mRNA microarrays and immunohistochemistry for smooth muscle actin (SMA), fibrillar ECM components and non-fibrillar ECM components were carried out. The results showed that DDC samples had abundant fibrosis with reticular fibers and few elastic fibers, high cell proliferation and myofibroblasts, laminin and glycoproteins, whereas NFF did not show any of these findings. Interestingly, NPF tissues had more cells showing myofibroblasts differentiation and more collagen and reticular fibers, laminin and glycoproteins than NFF, although at lower level than DDC, with similar elastic fibers than DDC. Immunohistochemical expression of decorin was high in DDC, whereas versican was highly expressed NFF, with no differences for aggrecan. Cluster analysis revealed that the global expression profile of NPF was very similar to DDC, and reculturing methods showed that cells corresponding to DDC tissues proliferated more actively than NPF, and NPF more actively than NFF. All these results suggest that NPF tissues may be affected, and that a modification of the therapeutic approach used for the treatment of Dupuytren's disease should be considered.	[Alfonso-Rodriguez, Camilo-Andres; Garzon, Ingrid; Oliveira, Ana-Celeste-Ximenes; Martin-Piedra, Miguel-Angel; Scionti, Giuseppe; Carriel, Victor; Campos, Antonio; Alaminos, Miguel] Univ Granada, Dept Histol, Tissue Engn Grp, Granada, Spain; [Alfonso-Rodriguez, Camilo-Andres; Garzon, Ingrid; Oliveira, Ana-Celeste-Ximenes; Martin-Piedra, Miguel-Angel; Scionti, Giuseppe; Carriel, Victor; Campos, Antonio; Alaminos, Miguel] Inst Invest Biosanit Ibs, Granada, Spain; [Alfonso-Rodriguez, Camilo-Andres] Univ Granada, Ph D Programme Biomed, Granada, Spain; [Garrido-Gomez, Juan; Hernandez-Cortes, Pedro] Univ Hosp San Cecilio, Div Trauma & Orthoped Surg, Granada, Spain	University of Granada; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; Hospital Universitario San Cecilio	Alaminos, M (corresponding author), Univ Granada, Dept Histol, Tissue Engn Grp, Granada, Spain.	malaminos@ugr.es	Oliveira, Ana Carolina/GRF-1435-2022; Martin-Piedra, Miguel Angel/F-3664-2019; ARAYA, VICTOR CARRIEL/H-9425-2018; ALAMINOS, MIGUEL/N-9960-2016; Scionti, Giuseppe/I-6454-2013; Hernández-Cortés, Pedro/AAS-7691-2020; Scionti, Giuseppe/I-6454-2013	Martin-Piedra, Miguel Angel/0000-0002-4639-3175; ARAYA, VICTOR CARRIEL/0000-0002-8114-5644; ALAMINOS, MIGUEL/0000-0003-4876-2672; Scionti, Giuseppe/0000-0003-2128-0104; Alfonso Rodriguez, Camilo Andres/0000-0001-7243-9272; Campos, A/0000-0003-4061-8182; Scionti, Giuseppe/0000-0002-1030-6711	Tissue Engineering Group, University of Granada/Spain [CTS-115]	Tissue Engineering Group, University of Granada/Spain	This work was supported by CTS-115 (Tissue Engineering Group), University of Granada/Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge HL, 2009, J BIOL CHEM, V284, P8427, DOI 10.1074/jbc.M805582200; Bainbridge C, 2012, J PLAST SURG HAND SU, V46, P177, DOI 10.3109/2000656X.2012.683795; Berdasco M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003306; BERNDT A, 1994, PATHOBIOLOGY, V62, P55, DOI 10.1159/000163879; Black EM, 2011, J AM ACAD ORTHOP SUR, V19, P746, DOI 10.5435/00124635-201112000-00005; Carriel VS, 2011, J HISTOCHEM CYTOCHEM, V59, P270, DOI 10.1369/0022155410398001; Oliveira AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066538; Couchman JR, 2012, J HISTOCHEM CYTOCHEM, V60, P885, DOI 10.1369/0022155412464638; Dolmans GH, 2011, NEW ENGL J MED, V365, P307, DOI 10.1056/NEJMoa1101029; EKBLOM P, 1996, LAMININS; Freeman SD, 2008, DEV BIOL, V320, P436, DOI 10.1016/j.ydbio.2008.05.554; Garg M, 2014, J CLIN ENDOCR METAB, V99, pE62, DOI 10.1210/jc.2013-2994; Hindocha S, 2011, BRIT J SURG, V98, P308, DOI 10.1002/bjs.7307; Iqbal SA, 2012, STEM CELLS DEV, V21, P609, DOI 10.1089/scd.2011.0140; Kaplan FTD, 2011, DRUG TODAY, V47, P653, DOI 10.1358/dot.2011.47.9.1656502; Kreis T, 1999, GUIDEBOOK EXTRACELLU; Lam WL, 2010, J HAND SURG-EUR VOL, V35E, P312, DOI 10.1177/1753193410362848; LANDOLT RM, 1995, DEVELOPMENT, V121, P2303; LUCK JV, 1959, J BONE JOINT SURG AM, V41, P635, DOI 10.2106/00004623-195941040-00008; Michou L, 2012, JOINT BONE SPINE, V79, P7, DOI 10.1016/j.jbspin.2011.05.027; MILLESI H, 1995, CLIN BIOMECH, V10, P29, DOI 10.1016/0268-0033(95)90434-B; MURRELL GAC, 1991, J HAND SURG-BRIT EUR, V16B, P263, DOI 10.1016/0266-7681(91)90050-X; Ojwang JO, 2010, J HAND SURG-AM, V35A, P2039, DOI 10.1016/j.jhsa.2010.08.008; PASQUALIRONCHETTI I, 1993, J HAND SURG-BRIT EUR, V18B, P262, DOI 10.1016/0266-7681(93)90125-Y; Picardo NE, 2012, SURG-J R COLL SURG E, V10, P151, DOI 10.1016/j.surge.2012.01.004; Plumb DA, 2007, J BIOL CHEM, V282, P12791, DOI 10.1074/jbc.C700021200; Ratkaj I, 2012, CELL PHYSIOL BIOCHEM, V30, P927, DOI 10.1159/000341470; Rayan GM, 1999, HAND CLIN, V15, P73; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; Rehman S, 2008, J HAND SURG-AM, V33A, P359, DOI 10.1016/j.jhsa.2007.11.010; Rehman S, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3438; Ricard-Blum S., 2011, COLD SPRING HARBOR P, V3; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sampson S, 2011, J AM OSTEOPATH ASSOC, V111, P113; Satish L, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-15; Satish L, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-113; Satish L, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-10; Shih B, 2010, NAT REV RHEUMATOL, V6, P715, DOI 10.1038/nrrheum.2010.180; Thomas A, 2010, THER CLIN RISK MANAG, V6, P557, DOI 10.2147/TCRM.S8591; Verhoekx JSN, 2013, J INVEST DERMATOL, V133, P2664, DOI 10.1038/jid.2013.219; Verjee LS, 2013, P NATL ACAD SCI USA, V110, pE928, DOI 10.1073/pnas.1301100110; Vi L, 2009, EXP CELL RES, V315, P3574, DOI 10.1016/j.yexcr.2009.07.015; Vi L, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-72; Wenstrup RJ, 2004, J BIOL CHEM, V279, P53331, DOI 10.1074/jbc.M409622200; Wilkinson JM, 2012, BBA-MOL BASIS DIS, V1822, P897, DOI 10.1016/j.bbadis.2012.02.001; Zhang Y, 1998, J BIOL CHEM, V273, P21342, DOI 10.1074/jbc.273.33.21342	46	16	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112457	10.1371/journal.pone.0112457	http://dx.doi.org/10.1371/journal.pone.0112457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379672	Green Published, Green Submitted, gold			2022-12-27	WOS:000344863100100
J	Bai, YJ; Zhao, M; Zhang, CF; Li, SS; Qi, Y; Wang, B; Huang, LZ; Li, XX				Bai, Yujing; Zhao, Min; Zhang, Chunfang; Li, Shanshan; Qi, Yun; Wang, Bin; Huang, Lvzhen; Li, Xiaoxin			Anti-Angiogenic Effects of a Mutant Endostatin: A New Prospect for Treating Retinal and Choroidal Neovascularization	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; POLYETHYLENE-GLYCOL; OCULAR NEOVASCULARIZATION; EYE	Purpose: Pathological fundus angiogenesis is a major cause of vision loss in retina diseases. Endostatin, a C-terminal fragment of collagen XVIII, is an endogenous anti-angiogenic protein. The present study aimed to investigate the in vitro and in vivo anti-angiogenic properties of two proteins: an N-terminal H1D/H3D mutant endostatin (M-ES) and a polyethylene glycol propionaldehyde (PEG) covalent M-ES (PEG-M-ES). Methods: M-ES and PEG-M-ES properties were characterized in vitro using a zinc ion binding assay and a stability test. Activity assays, including migration, proliferation, and tube formation assays, were performed with human retinal microvascular endothelial cells (HRMECs) and human umbilical vein endothelial cells (HUVECs). Mouse oxygen-induced retinopathy (OIR) and choroidal neovascularization (CNV) models were used to evaluate in vivo anti-angiogenic effects. In addition, a rabbit model was used to study the retinal pharmacokinetic profile following an intravitreal injection. Results: The results indicated that the H1D/H3D mutations of endostatin reduced the zinc binding capacity of M-ES and facilitated PEG covalent binding. PEG-M-ES was more stable and persisted longer in the retina compared with M-ES. The in vitro studies demonstrated that M-ES and PEG-M-ES inhibited HRMEC and HUVEC proliferation, migration, and tube formation more efficiently than ES. In vivo, a single intravitreal injection of M-ES and PEG-M-ES significantly decreased neovascularization in both the OIR and CNV animal models. Conclusion: The present study demonstrated for the first time that PEG-M-ES exhibits a long-term inhibitory effect on neovascularization in vitro and in vivo. These data suggest that PEG-M-ES may represent an innovative therapeutic strategy to prevent fundus neovascularization.	[Bai, Yujing; Zhao, Min; Li, Shanshan; Qi, Yun; Wang, Bin; Huang, Lvzhen; Li, Xiaoxin] Peking Univ, Peoples Hosp, Dept Ophthalmol,Key Lab Vis Loss & Restorat,Minis, Beijing Key Lab Diag & Treatment Retinal & Choroi, Beijing 100871, Peoples R China; [Zhang, Chunfang] Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China	Peking University; Peking University	Huang, LZ (corresponding author), Peking Univ, Peoples Hosp, Dept Ophthalmol,Key Lab Vis Loss & Restorat,Minis, Beijing Key Lab Diag & Treatment Retinal & Choroi, Beijing 100871, Peoples R China.	huanglvzhen@sina.com; drlixiaoxin@163.com		Zhao, Min/0000-0003-0521-9186	National Basic Research Program of China [973 Program] [2011CB510200]; Beijing Nova Program [Z131102000413004]; National Natural Science Foundation of China [81200690]	National Basic Research Program of China [973 Program](National Basic Research Program of China); Beijing Nova Program(Beijing Municipal Science & Technology Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China [973 Program, 2011CB510200] to XXL, the Beijing Nova Program (Z131102000413004) to YJB, and the National Natural Science Foundation of China Grant (81200690) to YJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2005, DRUG RESIST UPDATE, V8, P59, DOI 10.1016/j.drup.2005.03.001; ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3582; Avery RL, 2013, BR J OPHTHALMOL; Bai YJ, 2013, J OCUL PHARMACOL TH, V29, P619, DOI 10.1089/jop.2012.0225; Bai YJ, 2012, J PHARMACOL EXP THER, V342, P131, DOI 10.1124/jpet.112.192575; Bakri SJ, 2007, OPHTHALMOLOGY, V114, P2179, DOI 10.1016/j.ophtha.2007.09.012; Barkmeier AJ, 2011, SEMIN OPHTHALMOL, V26, P94, DOI 10.3109/08820538.2011.571055; Boehm T, 1998, BIOCHEM BIOPH RES CO, V252, P190, DOI 10.1006/bbrc.1998.9617; Bressler SB, 2009, OPHTHALMOLOGY, V116, pS1, DOI 10.1016/j.ophtha.2009.06.045; Campochiaro PA, 2013, J MOL MED, V91, P311, DOI 10.1007/s00109-013-0993-5; Cao YH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003149; CHAFFEE S, 1992, J CLIN INVEST, V89, P1643, DOI 10.1172/JCI115761; Chapman AP, 2002, ADV DRUG DELIVER REV, V54, P531, DOI 10.1016/S0169-409X(02)00026-1; Doguizi S, 2013, RETINA; Folkman J, 1996, Harvey Lect, V92, P65; Fu Y, 2009, IUBMB LIFE, V61, P613, DOI 10.1002/iub.215; Fujita Y, 2008, CURR PHARM DESIGN, V14, P3820, DOI 10.2174/138161208786898680; Fulton AB, 2009, PROG RETIN EYE RES, V28, P452, DOI 10.1016/j.preteyeres.2009.06.003; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Haller JA, 2013, OPHTHALMOLOGY, V120, pS3, DOI 10.1016/j.ophtha.2013.01.057; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Karamouzis MV, 2009, EXPERT OPIN BIOL TH, V9, P641, DOI [10.1517/14712590902882118 , 10.1517/14712590902882118]; Marneros AG, 2005, FASEB J, V19, P716, DOI 10.1096/fj.04-2134rev; Montero JA, 2010, CURR DRUG TARGETS, V11, P630; Neely KA, 1998, AM J PATHOL, V153, P665, DOI 10.1016/S0002-9440(10)65607-6; Pai SS, 2009, AAPS J, V11, P88, DOI 10.1208/s12248-009-9081-8; Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001; Quaggin SE, 2012, J CLIN INVEST, V122, P3849, DOI 10.1172/JCI65509; Reddy KR, 2000, ANN PHARMACOTHER, V34, P915, DOI 10.1345/aph.10054; Shultz RW, 2011, SEMIN OPHTHALMOL, V26, P361, DOI 10.3109/08820538.2011.585368; Wang F, 2013, GRAEF ARCH CLIN EXP, V251, P2131, DOI 10.1007/s00417-013-2392-6; Xu HL, 2008, CURR PROTEIN PEPT SC, V9, P275, DOI 10.2174/138920308784534050; Yowell SL, 2002, CANCER TREAT REV, V28, P3, DOI 10.1016/S0305-7372(02)80002-0; Yu WZ, 2003, OPHTHALMIC RES, V35, P239, DOI 10.1159/000072143; Zeuzem S, 2000, NEW ENGL J MED, V343, P1666, DOI 10.1056/NEJM200012073432301; Zhang SX, 2007, PROG RETIN EYE RES, V26, P1, DOI 10.1016/j.preteyeres.2006.09.002	36	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112448	10.1371/journal.pone.0112448	http://dx.doi.org/10.1371/journal.pone.0112448			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380141	Green Published, gold, Green Submitted			2022-12-27	WOS:000344863100096
J	Boillot, T; Rosolen, SG; Dulaurent, T; Goulle, F; Thomas, P; Isard, PF; Azoulay, T; Lafarge-Beurlet, S; Woods, M; Lavillegrand, S; Ivkovic, I; Neveux, N; Sahel, JA; Picaud, S; Froger, N				Boillot, Thomas; Rosolen, Serge G.; Dulaurent, Thomas; Goulle, Frederic; Thomas, Philippe; Isard, Pierre-Francois; Azoulay, Thierry; Lafarge-Beurlet, Stephanie; Woods, Mike; Lavillegrand, Sylvie; Ivkovic, Ivana; Neveux, Nathalie; Sahel, Jose-Alain; Picaud, Serge; Froger, Nicolas			Determination of Morphological, Biometric and Biochemical Susceptibilities in Healthy Eurasier Dogs with Suspected Inherited Glaucoma	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; PECTINATE LIGAMENT DYSPLASIA; OPTIC-NERVE HEAD; IRIDOCORNEAL ANGLE; INTRAOCULAR-PRESSURE; ULTRASOUND BIOMICROSCOPY; NORMOTENSIVE DOGS; SPRINGER-SPANIEL; CYP1B1 MUTATIONS; CLOSURE GLAUCOMA	In both humans and dogs, the primary risk factor for glaucoma is high intraocular pressure (IOP), which may be caused by iridocorneal angle (ICA) abnormalities. Oxidative stress has also been implicated in retinal ganglion cell damage associated with glaucoma. A suspected inherited form of glaucoma was recently identified in Eurasier dogs (EDs), a breed for which pedigrees are readily available. Because of difficulties in assessing ICA morphology in dogs with advanced glaucoma, we selected a cohort of apparently healthy dogsfor the investigation of ICA morphological status, IOP and plasma concentrations of oxidative stress biomarkers. We aimed to establish correlations between these factors, to identify predictive markers of glaucoma in this dog breed. A cohort of 28 subjects, volunteered for inclusion by their owners, was selected by veterinary surgeons. These dogs were assigned to four groups: young males, young females (1-3 years old), adult males and adult females (4-8 years old). Ocular examination included ophthalmoscopy, tonometry, gonioscopy, biometry and ultrasound biomicroscopy (UBM), and the evaluation of oxidative stress biomarkers consisting of measurements of plasma glutathione peroxidase (GP) activity and taurine and metabolic precursor (methionine and cysteine) concentrations in plasma. The prevalence of pectinate ligament abnormalities was significantly higher in adult EDs than in young dogs. Moreover, in adult females, high IOP was significantly correlated with a short axial globe length, and a particularly large distance between Schwalbe's line and the anterior lens capsule. GP activity levels were significantly lower in EDs than in a randomized control group of dogs, and plasma taurine concentrations were higher. Hence, ICA abnormalities were associated with weaker antioxidant defenses in EDs, potentially counteracted by higher plasma taurine concentrations. This study suggests that EDs may constitute an appropriate canine model for the development of glaucoma. This cohort will be used as a sentinel for longitudinal monitoring.	[Boillot, Thomas] Clin Vet Vetea, Saintes, France; [Rosolen, Serge G.; Ivkovic, Ivana; Sahel, Jose-Alain; Picaud, Serge; Froger, Nicolas] INSERM, Inst Vis, U968, Paris, France; [Rosolen, Serge G.; Ivkovic, Ivana; Sahel, Jose-Alain; Picaud, Serge; Froger, Nicolas] Univ Paris 06, Univ Sorbonne, Inst Vis, UMR S 968, Paris, France; [Rosolen, Serge G.; Ivkovic, Ivana; Sahel, Jose-Alain; Picaud, Serge; Froger, Nicolas] CNRS, Inst Vis, UMR 7210, Paris, France; [Rosolen, Serge G.] Clin Vet Voltaire, Asnieres, France; [Dulaurent, Thomas] Ctr Hosp Vet St Martin, St Martin Bellevue, France; [Goulle, Frederic] Clin Vet Aquivet, Eysines, France; [Thomas, Philippe] Clin Vet St Pierre, St Chamond, France; [Azoulay, Thierry] Clin Vet Halles, Strasbourg, France; [Lafarge-Beurlet, Stephanie] Vebio, Arcueil, France; [Woods, Mike] Pimrose Hill Vet Clin, Dun Laoghaire, Co Dublin, Ireland; [Neveux, Nathalie] Paris Descartes Univ, Fac Pharm, Dept Nutr, Paris, France; [Neveux, Nathalie] Hop Hotel Dieu, Cochin Hosp, AP HP, Clin Chem, Paris, France; [Sahel, Jose-Alain; Picaud, Serge] Fdn Ophtalmol Adolphe Rothschild, Paris, France; [Sahel, Jose-Alain] Ctr Hosp Ophtalmol Quize Vingts, Paris, France; [Sahel, Jose-Alain] UCL, London, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Fondation Adolphe de Rothschild; University of London; University College London	Rosolen, SG (corresponding author), INSERM, Inst Vis, U968, Paris, France.	sg.rosolen@orange.fr; nicolas.froger@inserm.fr	Picaud, Serge/H-4012-2014; Sahel, Jose-Alain/F-3172-2017	Picaud, Serge/0000-0002-0548-5145; Sahel, Jose-Alain/0000-0002-4831-1153; Rosolen, Serge/0000-0003-4419-3257	Institut National de la Sante et de la Recherche Medicale (INSERM); Pierre et Marie Curie University (UPMC); Centre National de la Recherche Scientifique (CNRS); Fondation pour la Recherche Medicale; Fondation Rolland Bailly; Agence Nationale pour la Recherche (ANR:GLAUCOME, VISIOWEST); Federation des Aveugles de France; IRRP; city of Paris; Regional Council of Ile-de-France; French State program "Investissements d'Avenir'' [ANR-10-LABX-65]	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Pierre et Marie Curie University (UPMC); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation Rolland Bailly; Agence Nationale pour la Recherche (ANR:GLAUCOME, VISIOWEST)(French National Research Agency (ANR)); Federation des Aveugles de France; IRRP; city of Paris(Region Ile-de-France); Regional Council of Ile-de-France(Region Ile-de-France); French State program "Investissements d'Avenir''(French National Research Agency (ANR))	This work was supported by Institut National de la Sante et de la Recherche Medicale (INSERM), Pierre et Marie Curie University (UPMC), Centre National de la Recherche Scientifique (CNRS), the Fondation pour la Recherche Medicale and from the Fondation Rolland Bailly, Agence Nationale pour la Recherche (ANR:GLAUCOME, VISIOWEST), the Federation des Aveugles de France, IRRP, the city of Paris, the Regional Council of Ile-de-France, and the French State program "Investissements d'Avenir'' managed by the Agence Nationale de la Recherche [LIFESENSES: ANR-10-LABX-65]. Nicolas Froger received postdoctoral fellowships from the Fondation pour la Recherche Medicale and from the Fondation Rolland Bailly. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; BEDFORD PGC, 1977, J SMALL ANIM PRACT, V18, P631, DOI 10.1111/j.1748-5827.1977.tb05831.x; BEDFORD PGC, 1986, RES VET SCI, V41, P172, DOI 10.1016/S0034-5288(18)30595-2; Bjerkas E, 2002, VET OPHTHALMOL, V5, P49, DOI 10.1046/j.1463-5224.2002.00213.x; Boillot T, 2012, ESVO P 2012 VET OPHT, P1, DOI [10.1111/vop.12010, DOI 10.1111/VOP.12010]; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Burgoyne CF, 2008, J GLAUCOMA, V17, P318, DOI 10.1097/IJG.0b013e31815a343b; Ceron JJ, 2005, VET CLIN PATH, V34, P85, DOI 10.1111/j.1939-165X.2005.tb00019.x; Corcoran KA, 1994, VET COMP OPHTHALMOLO, V4, P197; COTTRELL BD, 1988, J SMALL ANIM PRACT, V29, P185, DOI 10.1111/j.1748-5827.1988.tb02276.x; Crumley W, 2009, VET OPHTHALMOL, V12, P22, DOI 10.1111/j.1463-5224.2009.00669.x; Dulaurent T, 2012, VET OPHTHALMOL, V15, P8, DOI 10.1111/j.1463-5224.2011.00898.x; Eckersall PD, 2010, VET J, V185, P23, DOI 10.1016/j.tvjl.2010.04.009; Ekesten B., 1993, Progress in Veterinary & Comparative Ophthalmology, V3, P67; EKESTEN B, 1995, AM J VET RES, V56, P1138; EKESTEN B, 1991, AM J VET RES, V52, P1875; EKESTEN B, 1995, AM J VET RES, V56, P127; Enserink M, 2007, SCIENCE, V316, P1553; Froger N, 2014, PROG RETIN EYE RES, V41, P44, DOI 10.1016/j.preteyeres.2014.03.001; Froger N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042017; Gelatt K. N., 1998, Veterinary Ophthalmology, V1, P109, DOI 10.1046/j.1463-5224.1998.00024.x; Gelatt KN, 2004, VET OPHTHALMOL, V7, P97, DOI 10.1111/j.1463-5224.2004.04006.x; Gelatt KN, 1999, VETERINARY OPHTHALMOLOGY, 3RD EDITION, P701; Gelatt KN, 2007, VET OPHTHALMOLOGY, P753; Gherghel D, 2005, INVEST OPHTH VIS SCI, V46, P877, DOI 10.1167/iovs.04-0777; Giannetto C, 2009, VET OPHTHALMOL, V12, P302, DOI 10.1111/j.1463-5224.2009.00717.x; Goel M, 2010, OPEN OPHTHALMOL J, V4, P52, DOI 10.2174/1874364101004010052; Gorig C, 2006, AM J VET RES, V67, P134, DOI 10.2460/ajvr.67.1.134; HOFFER KJ, 1993, ARCH OPHTHALMOL-CHIC, V111, P914, DOI 10.1001/archopht.1993.01090070032014; Kanemaki N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074372; Kato K, 2006, VET OPHTHALMOL, V9, P71, DOI 10.1111/j.1463-5224.2006.00438.x; Kato K, 2009, MOL VIS, V15, P2470; Kawata M, 2013, VET OPHTHALMOL, V16, P169, DOI 10.1111/j.1463-5224.2012.01043.x; Kumar A, 2007, MOL VIS, V13, P667; Leiva M, 2006, VET OPHTHALMOL, V9, P17, DOI 10.1111/j.1463-5224.2005.00429.x; Pearl R, 2013, VET OPHTHALMOL; Pennisi E, 2007, SCIENCE, V317, P1668, DOI 10.1126/science.317.5845.1668; PERKINS ES, 1988, BRIT J OPHTHALMOL, V72, P348, DOI 10.1136/bjo.72.5.348; PIATIGORSKY J, 1981, DIFFERENTIATION, V19, P134, DOI 10.1111/j.1432-0436.1981.tb01141.x; Piccione G, 2010, EXP ANIM TOKYO, V59, P215, DOI 10.1538/expanim.59.215; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; QUIGLEY HA, 1989, AM J OPHTHALMOL, V107, P453, DOI 10.1016/0002-9394(89)90488-1; Read R. A., 1998, Veterinary Ophthalmology, V1, P85, DOI 10.1046/j.1463-5224.1998.00019.x; Rosolen SG, 2013, ADV EXP MED BIOL, V775, P145, DOI 10.1007/978-1-4614-6130-2_12; SAMUELSON DA, 1984, CURR EYE RES, V3, P783, DOI 10.3109/02713688409000790; Samuelson DA, 2007, VET OPHTHALMOLOGY, P37; Schaffer SW, 2009, CAN J PHYSIOL PHARM, V87, P91, DOI 10.1139/Y08-110; SLATER MR, 1986, J AM VET MED ASSOC, V188, P1028; Strom AR, 2011, VET OPHTHALMOL, V14, P121, DOI 10.1111/j.1463-5224.2010.00855.x; Taylor NR, 2007, VET OPHTHALMOL, V10, P8, DOI 10.1111/j.1463-5224.2007.00485.x; Tsai S, 2012, VET OPHTHALMOL, V15, P60, DOI 10.1111/j.1463-5224.2011.00956.x; Vajaranant TS, 2010, CURR OPIN OPHTHALMOL, V21, P91, DOI 10.1097/ICU.0b013e3283360b7e; VANDERLINDESIPMAN JS, 1987, VET PATHOL, V24, P201, DOI 10.1177/030098588702400301; von Spiessen L, 2013, VET OPHTHALMOL; Williams DL, 2004, VET OPHTHALMOL, V7, P91, DOI 10.1111/j.1463-5224.2004.04005.x; Yang M, 2009, MOL VIS, V15, P432; Yildirim O, 2005, GRAEF ARCH CLIN EXP, V243, P327, DOI 10.1007/s00417-004-1013-9; Zinsstag J, 2005, LANCET, V366, P2142, DOI 10.1016/S0140-6736(05)67731-8	59	10	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111873	10.1371/journal.pone.0111873	http://dx.doi.org/10.1371/journal.pone.0111873			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380252	Green Published, gold			2022-12-27	WOS:000344863100044
J	Li, T; Liao, QP; Zhang, H; Gao, XL; Li, XY; Zhang, M				Li, Ting; Liao, Qinping; Zhang, Hong; Gao, Xuelian; Li, Xueying; Zhang, Miao			Anatomic Distribution of Nerves and Microvascular Density in the Human Anterior Vaginal Wall: Prospective Study	PLOS ONE			English	Article							PELVIC ORGAN PROLAPSE; G-SPOT; SEXUAL FUNCTION; FEMALE EJACULATION; GRAFENBERG SPOT; WOMEN; INNERVATION; SURGERY; STRESS	Background: The presence of the G-spot (an assumed erotic sensitive area in the anterior wall of the vagina) remains controversial. We explored the histomorphological basis of the G-spot. Methods: Biopsies were drawn from a 12 o'clock direction in the distal-and proximal-third areas of the anterior vagina of 32 Chinese subjects. The total number of protein gene product 9.5-immunoreactive nerves and smooth muscle actin-immunoreactive blood vessels in each specimen was quantified using the avidin-biotin-peroxidase assay. Results: Vaginal innervation was observed in the lamina propria and muscle layer of the anterior vaginal wall. The distal-third of the anterior vaginal wall had significantly richer small-nerve-fiber innervation in the lamina propria than the proximal-third (p = 0.000) and in the vaginal muscle layer (p = 0.006). There were abundant microvessels in the lamina propria and muscle layer, but no small vessels in the lamina propria and few in the muscle layer. Significant differences were noted in the number of microvessels when comparing the distal-with proximal-third parts in the lamina propria (p = 0.046) and muscle layer (p = 0.002). Conclusions: Significantly increased density of nerves and microvessels in the distal-third of the anterior vaginal wall could be the histomorphological basis of the G-spot. Distal anterior vaginal repair could disrupt the normal anatomy, neurovascular supply and function of the G-spot, and cause sexual dysfunction.	[Li, Ting; Liao, Qinping; Gao, Xuelian; Zhang, Miao] Peking Univ, Hosp 1, Dept Obstet & Gynecol, Beijing 100871, Peoples R China; [Zhang, Hong] Peking Univ, Hosp 1, Dept Pathol, Beijing 100871, Peoples R China; [Li, Xueying] Peking Univ, Hosp 1, Dept Stat, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Zhang, M (corresponding author), Peking Univ, Hosp 1, Dept Obstet & Gynecol, Beijing 100871, Peoples R China.	mm7526@163.com						Battaglia C, 2010, J SEX MED, V7, P2755, DOI 10.1111/j.1743-6109.2009.01651.x; Battaglia C, 2010, J SEX MED, V7, P1445, DOI 10.1111/j.1743-6109.2009.01650.x; Burri AV, 2010, J SEX MED, V7, P1842, DOI 10.1111/j.1743-6109.2009.01671.x; Lara LAD, 2009, J SEX MED, V6, P30, DOI 10.1111/j.1743-6109.2008.01052.x; DAVIDSON JK, 1989, J SEX MARITAL THER, V15, P102; Dwyer PL, 2012, INT UROGYNECOL J, V23, P135, DOI 10.1007/s00192-011-1558-1; GOLDBERG DC, 1983, J SEX MARITAL THER, V9, P27, DOI 10.1080/00926238308405831; Grafenberg E, 1950, INT J SEXOLOGY, P145; HILLIGES M, 1995, ACTA ANAT, V153, P119; Hines TM, 2001, AM J OBSTET GYNECOL, V185, P359, DOI 10.1067/mob.2001.115995; Kilchevsky A, 2012, J SEX MED, V9, P719, DOI 10.1111/j.1743-6109.2011.02623.x; KRANTZ KE, 1958, OBSTET GYNECOL, V12, P382; Liang CC, 2012, INT UROGYNECOL J, V23, P1455, DOI 10.1007/s00192-012-1713-3; Liu B, 2003, HISTOLOGY EMBRYOLOGY; Masters WH., 1966, HUMAN SEXUAL RESPONS; Mohamad S, 2009, J OBSTET GYNAECOL RE, V35, P967, DOI 10.1111/j.1447-0756.2009.01020.x; O'Connell HE, 2008, J SEX MED, V5, P1883, DOI 10.1111/j.1743-6109.2008.00875.x; Occhino JA, 2011, INT UROGYNECOL J, V22, P799, DOI 10.1007/s00192-011-1386-3; Ostrzenski A, 2012, J SEX MED, V9, P1355, DOI 10.1111/j.1743-6109.2012.02668.x; Pauls R, 2006, J SEX MED, V3, P979, DOI 10.1111/j.1743-6109.2006.00325.x; PERRY JD, 1981, J SEX RES, V17, P22, DOI 10.1080/00224498109551095; Pessina MA, 2006, ENDOCRINOLOGY, V147, P61, DOI 10.1210/en.2005-0870; Puppo V, 2012, INT UROGYNECOL J, V23, P1665, DOI 10.1007/s00192-012-1831-y; Puppo V, 2012, INT UROGYNECOL J, V23, P247, DOI 10.1007/s00192-011-1579-9; Satoh JI, 2001, NEUROPATH APPL NEURO, V27, P95, DOI 10.1046/j.1365-2990.2001.00313.x; Sentilhes L, 2008, INT UROGYNECOL J, V19, P763, DOI 10.1007/s00192-007-0521-7; SHERFEY MJ, 1974, J SEX MARITAL THER, V1, P97; Song YB, 2009, J SEX MARITAL THER, V35, P144, DOI 10.1080/00926230802716195; Thabet SMA, 2013, J OBSTET GYNAECOL RE, V39, P1339, DOI 10.1111/jog.12067; Yucel S, 2004, J UROLOGY, V172, P191, DOI 10.1097/01.ju.0000128704.51870.87; Zaviacic M, 2000, HISTOL HISTOPATHOL, V15, P131, DOI 10.14670/HH-15.131; Zhu L, 2004, INT UROGYNECOL J, V15, P272, DOI 10.1007/s00192-004-1155-7	32	15	16	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e110239	10.1371/journal.pone.0110239	http://dx.doi.org/10.1371/journal.pone.0110239			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379731	gold, Green Submitted, Green Published			2022-12-27	WOS:000344863100012
J	Munoz-Gomez, A; Corredor, M; Benitez-Paez, A; Pelaez, C				Munoz-Gomez, Amalia; Corredor, Mauricio; Benitez-Paez, Alfonso; Pelaez, Carlos			Development of Quantitative Proteomics Using iTRAQ Based on the Immunological Response of Galleria mellonella Larvae Challenged with Fusarium oxysporum Microconidia	PLOS ONE			English	Article							GREATER WAX MOTH; ALTERNATIVE INFECTION MODEL; ASPERGILLUS-FUMIGATUS; MANDUCA-SEXTA; FAT-BODY; ANTIMICROBIAL PEPTIDES; PATTERN-RECOGNITION; HEMOLYMPH-PROTEINS; APOLIPOPHORIN-III; STORAGE PROTEINS	Galleria mellonella has emerged as a potential invertebrate model for scrutinizing innate immunity. Larvae are easy to handle in host-pathogen assays. We undertook proteomics research in order to understand immune response in a heterologous host when challenged with microconidia of Fusarium oxysporum. The aim of this study was to investigate hemolymph proteins that were differentially expressed between control and immunized larvae sets, tested with F. oxysporum at two temperatures. The iTRAQ approach allowed us to observe the effects of immune challenges in a lucid and robust manner, identifying more than 50 proteins, 17 of them probably involved in the immune response. Changes in protein expression were statistically significant, especially when temperature was increased because this was notoriously affected by F. oxysporum 10(4) or 10(6) microconidia/mL. Some proteins were up-regulated upon immune fungal microconidia challenge when temperature changed from 25 to 37 degrees C. After analysis of identified proteins by bioinformatics and metaanalysis, results revealed that they were involved in transport, immune response, storage, oxide-reduction and catabolism: 20 from G. mellonella, 20 from the Lepidoptera species and 19 spread across bacteria, protista, fungi and animal species. Among these, 13 proteins and 2 peptides were examined for their immune expression, and the hypothetical 3D structures of 2 well-known proteins, unannotated for G. mellonella, i.e., actin and CREBP, were resolved using peptides matched with Bombyx mori and Danaus plexippus, respectively. The main conclusion in this study was that iTRAQ tool constitutes a consistent method to detect proteins associated with the innate immune system of G. mellonella in response to infection caused by F. oxysporum. In addition, iTRAQ was a reliable quantitative proteomic approach to detect and quantify the expression levels of immune system proteins and peptides, in particular, it was found that 10(4) microconidia/mL at 37 degrees C over expressed many more proteins than other treatments.	[Munoz-Gomez, Amalia; Pelaez, Carlos] Univ Antioquia, Inst Quim, GIEM, Medellin, Antioquia, Colombia; [Munoz-Gomez, Amalia; Corredor, Mauricio] Univ Antioquia, Inst Biol, Genet & Biochem Microorganisms Grp GEBIOMIC, Medellin, Antioquia, Colombia; [Munoz-Gomez, Amalia; Benitez-Paez, Alfonso] Ctr Invest & Desarrollo Biotecnol CIDBIO, Bioinformat Anal Grp GABi, Bogota, Distrito Capita, Colombia	Universidad de Antioquia; Universidad de Antioquia	Munoz-Gomez, A (corresponding author), Univ Antioquia, Inst Quim, GIEM, Medellin, Antioquia, Colombia.	amunoz@cidbio.org	Benitez-Paez, Alfonso/A-2018-2011; Benítez-Páez, Alfonso/AAY-7143-2020	Benitez-Paez, Alfonso/0000-0001-5707-4340; Benítez-Páez, Alfonso/0000-0001-5707-4340	University of Antioquia for Interdisciplinary Group of Molecular Studies (GIEM Grupo Interdisciplinario de Estudios Moleculares, Universidad de Antioquia)	University of Antioquia for Interdisciplinary Group of Molecular Studies (GIEM Grupo Interdisciplinario de Estudios Moleculares, Universidad de Antioquia)	This work was supported by the Sustainability Strategy 2011-2012 from University of Antioquia for Interdisciplinary Group of Molecular Studies (GIEM Grupo Interdisciplinario de Estudios Moleculares, Universidad de Antioquia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrejko M, 2009, COMP BIOCHEM PHYS B, V152, P118, DOI 10.1016/j.cbpb.2008.10.008; Aperis G, 2007, MICROBES INFECT, V9, P729, DOI 10.1016/j.micinf.2007.02.016; Applied Biosystems AB Sciex, 2010, PROT ITRAQ REAG 8 PL; Ashida M., 1990, P239; Assaf C, 2000, LANCET, V356, P1185, DOI 10.1016/S0140-6736(00)02774-4; Banville N, 2012, VIRULENCE, V3, P497, DOI 10.4161/viru.21972; Bender Jennifer K, 2013, PLoS One, V8, pe73287, DOI 10.1371/journal.pone.0073287; Bergin D, 2005, INFECT IMMUN, V73, P4161, DOI 10.1128/IAI.73.7.4161-4170.2005; Bettencourt R, 1997, EUR J BIOCHEM, V250, P630, DOI 10.1111/j.1432-1033.1997.00630.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brennan M, 2002, FEMS IMMUNOL MED MIC, V34, P153, DOI 10.1111/j.1574-695X.2002.tb00617.x; Brogden KA, 2003, INT J ANTIMICROB AG, V22, P465, DOI 10.1016/S0924-8579(03)00180-8; BRUNET PCJ, 1980, INSECT BIOCHEM, V10, P467, DOI 10.1016/0020-1790(80)90082-7; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Casteels Peter, 1998, P92; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Chamilos G, 2007, LANCET INFECT DIS, V7, P42, DOI 10.1016/S1473-3099(06)70686-7; Champion OL, 2009, MICROBIOL-SGM, V155, P1516, DOI 10.1099/mic.0.026823-0; Chaudhuri BN, 1999, ACTA CRYSTALLOGR D, V55, P1850, DOI 10.1107/S0907444999011026; Chomienne C, 1996, FASEB J, V10, P1025, DOI 10.1096/fasebj.10.9.8801163; Ciencialova A, 2008, J PEPT SCI, V14, P670, DOI 10.1002/psc.967; Coleman JJ, 2011, FUNGAL BIOL-UK, V115, P1279, DOI 10.1016/j.funbio.2011.09.005; COURGEON AM, 1993, EXP CELL RES, V204, P30, DOI 10.1006/excr.1993.1005; Cytrynska M, 2007, PEPTIDES, V28, P533, DOI 10.1016/j.peptides.2006.11.010; deKort CAD, 1996, ARCH INSECT BIOCHEM, V33, P1, DOI 10.1002/(SICI)1520-6327(1996)33:1&lt;1::AID-ARCH1&gt;3.0.CO;2-2; Dettloff M, 1999, TECHNIQUES INSECT IM, P243; Ducka AM, 2010, P NATL ACAD SCI USA, V107, P11757, DOI 10.1073/pnas.1005347107; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evans JD, 1999, P NATL ACAD SCI USA, V96, P5575, DOI 10.1073/pnas.96.10.5575; Fallon JP, 2011, VIRULENCE, V2, P413, DOI 10.4161/viru.2.5.17811; Fauvarque MO, 2011, J CELL SCI, V124, P1373, DOI 10.1242/jcs.064592; Fisher GJ, 1996, FASEB J, V10, P1002, DOI 10.1096/fasebj.10.9.8801161; FRASER MJ, 1983, J VIROL, V47, P287, DOI 10.1128/JVI.47.2.287-300.1983; Fuchs BB, 2010, VIRULENCE, V1, P475, DOI 10.4161/viru.1.6.12985; Geiser DL, 2012, BBA-GEN SUBJECTS, V1820, P437, DOI 10.1016/j.bbagen.2011.07.011; Godlewski J, 2001, J INSECT PHYSIOL, V47, P759, DOI 10.1016/S0022-1910(01)00050-6; Godlewski J, 2003, J INSECT PHYSIOL, V49, P551, DOI 10.1016/S0022-1910(03)00026-X; Hansen IA, 2003, INSECT MOL BIOL, V12, P427, DOI 10.1046/j.1365-2583.2003.00426.x; Harding CR, 2012, INFECT IMMUN, V80, P2780, DOI 10.1128/IAI.00510-12; Hultmark D, 1982, INSECT IMMUNITY ISOL, V217, P207; Jackson JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004224; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; JOLLES P, 1984, MOL CELL BIOCHEM, V63, P165; Kanost MR, 2004, IMMUNOL REV, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim CH, 2010, J BIOL CHEM, V285, P25243, DOI 10.1074/jbc.M110.134940; Kingsmore SF, 2006, NAT REV DRUG DISCOV, V5, P310, DOI 10.1038/nrd2006; KUMAGAI T, 1992, PATHOL RES PRACT, V188, P931, DOI 10.1016/S0344-0338(11)80254-2; LADENDORFF NE, 1991, ARCH INSECT BIOCHEM, V18, P285, DOI 10.1002/arch.940180410; LanzMendoza H, 1996, CELL IMMUNOL, V169, P47, DOI 10.1006/cimm.1996.0089; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lebreton F, 2011, J MOL MICROB BIOTECH, V21, P191, DOI 10.1159/000332737; Lehane M.J., 2005, BIOL BLOOD SUCKING I, V2nd; Lesch C, 2007, INSECT IMMUNOLOGY ME; Levenbook L., 1985, P307; Li B, 2006, J INSECT PHYSIOL, V52, P936, DOI 10.1016/j.jinsphys.2006.06.002; Li D, 2002, INSECT BIOCHEM MOLEC, V32, P919, DOI 10.1016/S0965-1748(02)00030-9; Lotan R, 1996, ANTICANCER RES, V16, P2415; Mak P, 2001, ACTA BIOCHIM POL, V48, P1191; MANSEAU LJ, 1988, GENETICS, V119, P407; Mansfield SG, 1998, P NATL ACAD SCI USA, V95, P6825, DOI 10.1073/pnas.95.12.6825; Martins Juliana Ramos, 2012, Insects, V3, P1039, DOI 10.3390/insects3041039; MILLER SG, 1982, INSECT BIOCHEM, V12, P277, DOI 10.1016/0020-1790(82)90086-5; Miyata S, 2003, INFECT IMMUN, V71, P2404, DOI 10.1128/IAI.71.5.2404-2413.2003; Mowlds P, 2008, MYCOPATHOLOGIA, V165, P5, DOI 10.1007/s11046-007-9069-9; Mowlds P, 2010, MICROBES INFECT, V12, P146, DOI 10.1016/j.micinf.2009.11.004; Mukherjee K, 2010, APPL ENVIRON MICROB, V76, P310, DOI 10.1128/AEM.01301-09; Mylonakis E, 2005, INFECT IMMUN, V73, P3842, DOI 10.1128/IAI.73.7.3842-3850.2005; Mylonakis E, 2008, MYCOPATHOLOGIA, V165, P1, DOI 10.1007/s11046-007-9082-z; Navarro-Velasco GY, 2011, FUNGAL GENET BIOL, V48, P1124, DOI 10.1016/j.fgb.2011.08.004; Ortoneda M, 2004, INFECT IMMUN, V72, P1760, DOI 10.1128/IAI.72.3.1760-1766.2004; Ott L, 2012, FEMS IMMUNOL MED MIC, V65, P413, DOI 10.1111/j.1574-695X.2012.00963.x; Park SY, 2005, DEV COMP IMMUNOL, V29, P43, DOI 10.1016/j.dci.2004.06.001; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; RAY A, 1987, ROUX ARCH DEV BIOL, V196, P414, DOI 10.1007/BF00399141; Renwick J, 2006, MYCOPATHOLOGIA, V161, P377, DOI 10.1007/s11046-006-0021-1; Richards EH, 1999, INSECT BIOCHEM MOLEC, V29, P557, DOI 10.1016/S0965-1748(99)00031-4; Ryan RO, 2000, ANNU REV ENTOMOL, V45, P233, DOI 10.1146/annurev.ento.45.1.233; Schmidt O, 2008, INSECT IMMUNOLOGY IN; Seed KD, 2008, INFECT IMMUN, V76, P1267, DOI 10.1128/IAI.01249-07; Seitz V, 2003, DEV COMP IMMUNOL, V27, P207, DOI 10.1016/S0145-305X(02)00097-6; Simpson AA, 1998, STRUCT FOLD DES, V6, P1355, DOI 10.1016/S0969-2126(98)00136-1; Slater JL, 2011, MED MYCOL, V49, pS107, DOI 10.3109/13693786.2010.523852; Sotelo-Mundo RR, 2007, PROTEIN PEPTIDE LETT, V14, P774; Tang B, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-65; Terenius O, 2008, DEV COMP IMMUNOL, V32, P311, DOI 10.1016/j.dci.2007.09.006; Thongboonkerd V, 2007, J PROTEOME RES, V6, P3881, DOI 10.1021/pr070328s; Unwin RD, 2010, METHODS MOL BIOL, V658, P205, DOI 10.1007/978-1-60761-780-8_12; Vogel H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-308; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; Weise C, 1998, J PROTEIN CHEM, V17, P633, DOI 10.1007/BF02780964; Whitten MMA, 2004, J IMMUNOL, V172, P2177, DOI 10.4049/jimmunol.172.4.2177; Wojda I, 2007, J INSECT PHYSIOL, V53, P1134, DOI 10.1016/j.jinsphys.2007.06.003; Wojtal KA, 2013, TOXICOL IN VITRO, V27, P1525, DOI 10.1016/j.tiv.2013.03.013; Yu XQ, 2002, INSECT BIOCHEM MOLEC, V32, P1287, DOI 10.1016/S0965-1748(02)00091-7; Zalewska M, 2009, BBA-BIOMEMBRANES, V1788, P1695, DOI 10.1016/j.bbamem.2009.04.022; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhao L, 1996, J INSECT PHYSIOL, V42, P73, DOI 10.1016/0022-1910(95)00084-4	99	17	19	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112179	10.1371/journal.pone.0112179	http://dx.doi.org/10.1371/journal.pone.0112179			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379782	Green Submitted, Green Published, gold			2022-12-27	WOS:000344863100058
J	Saito, T; Matsuyama, T; Toya, R; Fukugawa, Y; Toyofuku, T; Semba, A; Oya, N				Saito, Tetsuo; Matsuyama, Tomohiko; Toya, Ryo; Fukugawa, Yoshiyuki; Toyofuku, Takamasa; Semba, Akiko; Oya, Natsuo			Respiratory Gating during Stereotactic Body Radiotherapy for Lung Cancer Reduces Tumor Position Variability	PLOS ONE			English	Article							INTERNAL TARGET VOLUME; GATED RADIOTHERAPY; CINE-IMAGES; MOTION; FEASIBILITY; MODE; TIME; REPRODUCIBILITY; VERIFICATION; REDUCTION	Purpose: We evaluated the effects of respiratory gating on treatment accuracy in lung cancer patients undergoing lung stereotactic body radiotherapy by using electronic portal imaging device (EPID) images. Materials and Methods: Our study population consisted of 30 lung cancer patients treated with stereotactic body radiotherapy (48 Gy/4 fractions/4 to 9 days). Of these, 14 were treated with- (group A) and 16 without gating (group B); typically the patients whose tumors showed three-dimensional respiratory motion >= 5 mm were selected for gating. Tumor respiratory motion was estimated using four-dimensional computed tomography images acquired during treatment simulation. Tumor position variability during all treatment sessions was assessed by measuring the standard deviation (SD) and range of tumor displacement on EPID images. The two groups were compared for tumor respiratory motion and position variability using the Mann-Whitney U test. Results: The median three-dimensional tumor motion during simulation was greater in group A than group B (9 mm, range 3-30 mm vs. 2 mm, range 0-4 mm; p<0.001). In groups A and B the median SD of the tumor position was 1.1 mm and 0.9 mm in the craniocaudal- (p = 0.24) and 0.7 mm and 0.6 mm in the mediolateral direction (p = 0.89), respectively. The median range of the tumor position was 4.0 mm and 3.0 mm in the craniocaudal- (p = 0.21) and 2.0 mm and 1.5 mm in the mediolateral direction (p = 0.20), respectively. Conclusions: Although patients treated with respiratory gating exhibited greater respiratory tumor motion during treatment simulation, tumor position variability in the EPID images was low and comparable to patients treated without gating. This demonstrates the benefit of respiratory gating.	[Saito, Tetsuo; Matsuyama, Tomohiko; Toya, Ryo; Fukugawa, Yoshiyuki; Toyofuku, Takamasa; Semba, Akiko; Oya, Natsuo] Kumamoto Univ Hosp, Dept Radiat Oncol, Kumamoto, Japan	Kumamoto University	Saito, T (corresponding author), Kumamoto Univ Hosp, Dept Radiat Oncol, Kumamoto, Japan.	tsaito@kumamoto-u.ac.jp			Grants-in-Aid for Scientific Research [26861004] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Berbeco RI, 2007, INT J RADIAT ONCOL, V69, P258, DOI 10.1016/j.ijrobp.2007.04.051; Berbeco RI, 2006, MED PHYS, V33, P4149, DOI 10.1118/1.2358197; Butler Laura E, 2004, J Appl Clin Med Phys, V5, P16, DOI 10.1120/jacmp.26.146; Cai J, 2010, MED PHYS, V37, P3927, DOI 10.1118/1.3457329; de Koste JRV, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-32; Dzierma Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053799; Erridge SC, 2003, RADIOTHER ONCOL, V66, P75, DOI 10.1016/S0167-8140(02)00287-6; Ford EC, 2002, INT J RADIAT ONCOL, V52, P522, DOI 10.1016/S0360-3016(01)02681-5; Gaede S, 2008, INT J RADIAT ONCOL, V72, pS623, DOI 10.1016/j.ijrobp.2008.06.268; Giraud P, 2006, LUNG CANCER, V51, P41, DOI 10.1016/j.lungcan.2005.08.008; Liu HH, 2007, INT J RADIAT ONCOL, V68, P531, DOI 10.1016/j.ijrobp.2006.12.066; Mageras GS, 2004, INT J RADIAT ONCOL, V60, P933, DOI 10.1016/j.ijrobp.2004.06.021; Muirhead R, 2011, RADIOTHER ONCOL, V99, P155, DOI 10.1016/j.radonc.2011.05.037; Peguret N, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-78; Piermattei A, 2008, ACTA ONCOL, V47, P1414, DOI 10.1080/02841860802304572; Richter A, 2010, INT J RADIAT ONCOL, V78, P618, DOI 10.1016/j.ijrobp.2009.11.028; Saito T, 2011, ACTA ONCOL, V50, P1246, DOI 10.3109/0284186X.2011.566695; Saito T, 2010, J RADIAT RES, V51, P691, DOI 10.1269/jrr.10084; Saito T, 2009, RADIOTHER ONCOL, V93, P430, DOI 10.1016/j.radonc.2009.09.002; Shimizu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094971; Spoelstra FOB, 2008, RADIOTHER ONCOL, V87, P59, DOI 10.1016/j.radonc.2008.02.008; Starkschall G, 2004, INT J RADIAT ONCOL, V60, P1291, DOI 10.1016/j.ijrobp.2004.07.707; Tang XL, 2009, PHYS MED BIOL, V54, pS1, DOI 10.1088/0031-9155/54/18/S01; Ueda Y, 2012, INT J RADIAT ONCOL, V83, P1064, DOI 10.1016/j.ijrobp.2011.07.043; Underberg RWM, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-8; Van de Steene J, 1998, INT J RADIAT ONCOL, V40, P967, DOI 10.1016/S0360-3016(97)00925-5; van der Geld YG, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-43	27	7	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112824	10.1371/journal.pone.0112824	http://dx.doi.org/10.1371/journal.pone.0112824			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379729	Green Submitted, Green Published, gold			2022-12-27	WOS:000344863100111
J	Clauser, L; Ferroni, L; Gardin, C; Tieghi, R; Galie, M; Elia, G; Piattelli, A; Pinton, P; Bressan, E; Zavan, B				Clauser, Luigi; Ferroni, Letizia; Gardin, Chiara; Tieghi, Riccardo; Galie, Manlio; Elia, Giovanni; Piattelli, Adriano; Pinton, Paolo; Bressan, Eriberto; Zavan, Barbara			Selective Augmentation of Stem Cell Populations in Structural Fat Grafts for Maxillofacial Surgery	PLOS ONE			English	Article							COMPLEX RECONSTRUCTIVE SURGERY; VOLUMETRIC RESTORATION; PROGENITOR CELLS; AUTOLOGOUS FAT; TISSUE; TRANSPLANTS; FILLERS; FACE	Structural fat grafting utilizes the centrifugation of liposuction aspirates to create a graded density of adipose tissue. This study was performed to qualitatively investigate the effects of centrifugation on stem cells present in adipose tissue. Liposuction aspirates were obtained from healthy donors and either not centrifuged or centrifuged at 1,800 rpm for 3 minutes. The obtained fat volumes were divided into three layers and then analyzed. The results demonstrate that centrifugation induces a different distribution of stem cells in the three layers. The high-density layer displays the highest expression of mesenchymal stem cell and endothelial markers. The low-density layer exhibits an enrichment of multipotent stem cells. We conclude that appropriate centrifugation concentrates stem cells. This finding may influence the clinical practice of liposuction aspirate centrifugation and enhance graft uptake.	[Clauser, Luigi; Tieghi, Riccardo; Galie, Manlio; Elia, Giovanni] St Anna Hosp & Univ, Reference Ctr Rare Dis, Ctr Craniofacial Deform & Orbital Surg, Unit Cranio Maxillo Facial Surg, Ferrara, Italy; [Ferroni, Letizia; Gardin, Chiara; Zavan, Barbara] Univ Padua, Dept Biomed Sci, Padua, Italy; [Piattelli, Adriano] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy; [Pinton, Paolo] Univ Ferrara, Dept Morphol Surg & Expt Med, Sect Pathol Oncol & Expt Biol, I-44100 Ferrara, Italy; [Bressan, Eriberto] Univ Padua, Dept Neurosci, Padua, Italy	University of Ferrara; Arcispedale Sant'Anna; University of Padua; G d'Annunzio University of Chieti-Pescara; University of Ferrara; University of Padua	Zavan, B (corresponding author), Univ Padua, Dept Biomed Sci, Padua, Italy.	barbara.zavan@unipd.it	Pinton, Paolo/J-8025-2012; Galiè, Manlio/ABB-5271-2020	Pinton, Paolo/0000-0001-7108-6508; Galiè, Manlio/0000-0003-4136-7370; Ferroni, Letizia/0000-0002-5457-0338; Gardin, Chiara/0000-0003-3817-0032	Progetto di Ateneo University of Padova, Italy	Progetto di Ateneo University of Padova, Italy	The work was supported by Progetto di Ateneo University of Padova, Italy. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bucky LP, 2007, PLAST RECONSTR SURG, V120, p89S, DOI 10.1097/01.prs.0000248866.57638.40; Clauser L, 2004, J CRANIO MAXILL SURG, V32, P279, DOI 10.1016/j.jcms.2004.04.010; Clauser L, 2009, AM SOC PLAST SURG AN; Clauser L, 2009, FAT INJECTION FILLIN, P475; Clauser L, 2008, J CRANIOFAC SURG, V19, P187, DOI 10.1097/scs.0b013e31815c94f5; Clauser LC, 2011, J CRANIOFAC SURG, V22, P1695, DOI 10.1097/SCS.0b013e31822e5d5e; Clauser LC, 2010, J CRANIO MAXILL SURG, V38, P605, DOI 10.1016/j.jcms.2010.02.005; Coleman S, 2009, AESTHET PLAST SURG, V33, P14, DOI 10.1007/s00266-008-9258-z; Coleman S., 2004, STRUCTURAL FAT GRAFT; Coleman SR, 1997, CLIN PLAST SURG, V24, P347; COLEMAN SR, 1995, AESTHET PLAST SURG, V19, P421, DOI 10.1007/BF00453875; Coleman SR, 2001, CLIN PLAST SURG, V28, P111; Consorti G, 2012, J CRANIOFAC SURG, V23, pE263, DOI 10.1097/SCS.0b013e31824ef7e8; Fagrell D, 1996, PLAST RECONSTR SURG, V98, P90, DOI 10.1097/00006534-199607000-00014; Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010; Giugliano C, 2009, PLAST RECONSTR SURG, V124, P134, DOI 10.1097/PRS.0b013e3181a80539; Guallar D, 2012, NUCLEIC ACIDS RES, V40, P8993, DOI 10.1093/nar/gks686; Kawamoto HK, 2009, FAT INJECTION FILLIN, P447; Kokai LE, 2005, PLAST RECONSTR SURG, V116, P1453, DOI 10.1097/01.prs.0000182570.62814.e3; Livaoglu Murat, 2009, J Cutan Aesthet Surg, V2, P21, DOI 10.4103/0974-2077.53095; Mojallal A, 2004, Ann Chir Plast Esthet, V49, P426, DOI 10.1016/j.anplas.2004.08.005; Mojallal A, 2008, BIO-MED MATER ENG, V18, P193, DOI 10.3233/BME-2008-0524; Mojallal A, 2004, ANN CIR PLAST ESTHET, V49, P437; Mojallal A, 2009, PLAST RECONSTR SURG, V124, P471, DOI 10.1097/PRS.0b013e3181af023a; Moseley TA, 2006, PLAST RECONSTR SURG, V118, p121S, DOI 10.1097/01.prs.0000234609.74811.2e; Perrot P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010999; Pu LLQ, 2008, PLAST RECONSTR SURG, V122, P932, DOI 10.1097/PRS.0b013e3181811ff0; Rigotti G, 2007, PLAST RECONSTR SURG, V119, P1409, DOI 10.1097/01.prs.0000256047.47909.71; Rigotti G, 2009, AESTHET PLAST SURG, V33, P271, DOI 10.1007/s00266-009-9339-7; Strem Brian M., 2005, Keio Journal of Medicine, V54, P132, DOI 10.2302/kjm.54.132	30	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e110796	10.1371/journal.pone.0110796	http://dx.doi.org/10.1371/journal.pone.0110796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375632	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402600021
J	Li, CL; Zhao, K; Li, H; Farah, OI; Wang, JJ; Sun, RZ; Zhang, HP				Li, Cui-ling; Zhao, Kai; Li, Hui; Farah, Omar Ibrahim; Wang, Jiao-jiao; Sun, Rong-ze; Zhang, Hui-ping			Free Preconceptual Screening Examination Service in Rural Areas of Hubei Province, China in 2012	PLOS ONE			English	Article							HEALTH-CARE; UNITED-STATES; WOMEN; RECOMMENDATIONS; PREGNANCY; SURVEILLANCE; SUPPLEMENT; PREDICTORS; TRENDS	Objective: This work aims to collect and summarize the outcomes on free preconceptual screening examination in rural areas of Hubei Province in 2012. Moreover, this review promotes further understanding of the status of this activity to provide the Family Planning Commission valid scientific data upon which to construct effective policies. Methods: Couples, who complied with the family planning policy and were the residents in agricultural areas or lived in a local rural area for more than six months, were encouraged to participate in the free preconceptual screening examination service provided by the Hubei Provincial Population and Family Planning Commission. This service included 19 screening tests. All the data, including forms, manuals, and test results, were collected from 1 January 2012 to 31 December 2012 in rural areas in Hubei Province. Results: A total of 497,860 individuals participated in the free preconceptual screening examination service, with a coverage rate of 97.1%. 4.0% and 4.8% of the participants exhibited with abnormal blood levels of ALT and creatinine, respectively; 0.36% of the participants tested positive for syphilis; 0.44% and 3.6% of the female participants tested positive for Neisseria gonorrhoeae and Chlamydia trachomatis, respectively; and 0.84% and 1.8% of the female participants tested positive for cytomegalovirus (IgM) and Toxoplasma gondii (IgM), respectively. After risk assessment, 59,935 participants might have high-risk of adverse pregnancy outcomes. In 2012, the prevalence of birth defects among the parturient who participated in the preconceptual screening examination service was 0.04%, while the prevalence was 0.08% among those who did not participate in the service. Conclusion: Preconceptual screening examination service may help to address the risk factors that can lead to adverse pregnancy outcome. More studies on the relationship between preconceptual screening examination service and prevalence of birth defect or other adverse pregnancy outcomes should be conducted.	[Li, Cui-ling; Zhao, Kai; Farah, Omar Ibrahim; Wang, Jiao-jiao; Zhang, Hui-ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Family Planning Res Inst, Wuhan, Hunan, Peoples R China; [Li, Hui] Hubei Prov Populat & Family Planning Commiss, Dept Sci, Wuhan, Hunan, Peoples R China; [Li, Hui] Hubei Prov Populat & Family Planning Commiss, Technol Serv, Wuhan, Hunan, Peoples R China; [Sun, Rong-ze] Wuhan Univ, Renmin Hosp, Wuhan, Hunan, Peoples R China	Huazhong University of Science & Technology; Wuhan University	Zhang, HP (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Family Planning Res Inst, Wuhan, Hunan, Peoples R China.	familyplanning2013@163.com	Zhang, Hui/HHN-8494-2022		Foundation of Hubei Provincial Population and Family Planning Commission [JS-2011011]	Foundation of Hubei Provincial Population and Family Planning Commission	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was supported by the Foundation of Hubei Provincial Population and Family Planning Commission (grant no. JS-2011011).	Allaire AD, 1998, EUR J OBSTET GYN R B, V78, P163, DOI 10.1016/S0301-2115(98)00062-1; Boulet SL, 2006, MATERN CHILD HLTH J, V10, pS13, DOI 10.1007/s10995-006-0106-y; Campbell SK, 2012, MATERN CHILD HLTH J, V16, P1284, DOI 10.1007/s10995-011-0889-3; Centre BSR, 2009, PRECONCEPTION HLTH P; Chen Z, 2011, REPORT WOMEN CHILDRE; de Jong-van den Berg LTW, 2005, AM J OBSTET GYNECOL, V192, P121, DOI 10.1016/j.ajog.2004.05.085; de Weerd S, 2002, OBSTET GYNECOL, V99, P45, DOI 10.1016/S0029-7844(01)01573-3; Dunlop AL, 2007, J AM BOARD FAM MED, V20, P81, DOI 10.3122/jabfm.2007.01.060143; Dunlop AL, 2013, AM J HEALTH PROMOT, V27, pS50, DOI 10.4278/ajhp.120116-QUAN-39; Ebrahim SH, 2006, MATERN CHILD HLTH J, V10, pS37, DOI 10.1007/s10995-006-0096-9; Frey KA, 2006, MATERN CHILD HLTH J, V10, pS73, DOI 10.1007/s10995-006-0110-2; Heyes T, 2004, FAM PRACT, V21, P22, DOI 10.1093/fampra/cmh106; Jack BW, 2008, AM J OBSTET GYNECOL, V199, pS266, DOI 10.1016/j.ajog.2008.07.067; Johnson Kay, 2006, Morbidity and Mortality Weekly Report, V55, P1; Li CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072649; Liu Y, 2006, J PERINATOL, V26, P409, DOI 10.1038/sj.jp.7211537; Livingood WC, 2010, MATERN CHILD HLTH J, V14, P382, DOI 10.1007/s10995-009-0471-4; LOBO I, 2008, NATURE ED, V1; Moos MK, 2008, AM J OBSTET GYNECOL, V199, pS280, DOI 10.1016/j.ajog.2008.08.060; Morin P, 2002, PREV MED, V35, P143, DOI 10.1006/pmed.2002.1041; Tu L, 2012, IRAN J PUBLIC HEALTH, V41, P20; Weisman CS, 2011, WOMEN HEALTH ISS, V21, P265, DOI 10.1016/j.whi.2011.03.007; Witters I, 2010, GENET COUNSEL, V21, P169; Xaverius PK, 2013, J WOMENS HEALTH, V22, P203, DOI 10.1089/jwh.2012.3804	24	2	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111918	10.1371/journal.pone.0111918	http://dx.doi.org/10.1371/journal.pone.0111918			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375642	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600075
J	Matsumura, Y; Nakagawa, Y; Mikome, K; Yamamoto, H; Osakabe, N				Matsumura, Yusuke; Nakagawa, Yuta; Mikome, Katsuyuki; Yamamoto, Hiroki; Osakabe, Naomi			Enhancement of Energy Expenditure following a Single Oral Dose of Flavan-3-Ols Associated with an Increase in Catecholamine Secretion	PLOS ONE			English	Article							CHOCOLATE CONSUMPTION; SKELETAL-MUSCLE; CACAO LIQUOR; CARDIOVASCULAR RISK; HDL-CHOLESTEROL; BLOOD-PRESSURE; NORMAL-PHASE; RICH COCOA; POLYPHENOLS; PLASMA	Numerous clinical studies have reported that ingestion of chocolate reduces the risk of metabolic syndrome. However, the mechanisms by which this occurs remain unclear. In this murine study, the metabolic-enhancing activity of a 10 mg/kg mixture of flavan-3-ol fraction derived from cocoa (FL) was compared with the same single dose of (-)-epicatechin (EC). Resting energy expenditure (REE) was significantly increased in mice treated with the FL versus the group administered the distilled water vehicle (Cont) during periods of ad libitum feeding and fasting. Mice were euthanized under the effect of anesthesia 2, 5, and 20 hr after treatment with FL or Cont while subsequently fasting. The mRNA levels of the uncoupling protein-1 (UCP-1) and peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) in brown adipose tissue (BAT) were significantly increased 2 hr after administration of FL. UCP-3 and PGC-1 alpha in the gastrocnemius were significantly increased 2 and 5 hr after administration of the FL. The concentrations of phosphorylated AMP-activated protein kinase (AMPK) 1 alpha were found to be significant in the gastrocnemius of mice 2 and 5 hr after ingesting FL. However, these changes were not observed following treatment with EC. Plasma was collected for measurement of catecholamine levels in other animals euthanized by decapitation 2 and 4 hr after their respective group treatment. Plasma adrenaline level was significantly elevated 2 hr after treatment with FL; however, this change was not observed following the administration of EC alone. The present results indicated that FL significantly enhanced systemic energy expenditure, as evidenced by an accompanying increase in the type of gene expression responsible for thermogenesis and lipolysis, whereas EC exhibited this less robustly or effectively. It was suggested the possible interaction between thermogenic and lipolytic effects and the increase in plasma catecholamine concentrations after administration of a single oral dose of FL.	[Matsumura, Yusuke; Nakagawa, Yuta; Mikome, Katsuyuki; Yamamoto, Hiroki; Osakabe, Naomi] Shibaura Inst Technol, Dept Biosci & Engn, Saitama, Japan	Shibaura Institute of Technology	Osakabe, N (corresponding author), Shibaura Inst Technol, Dept Biosci & Engn, Saitama, Japan.	nao-osa@sic.shibaura-it.ac.jp			Research Project on Development of Agricultural Products and Foods with Health-promoting Benefits (NARO)	Research Project on Development of Agricultural Products and Foods with Health-promoting Benefits (NARO)	This work was supported by the Research Project on Development of Agricultural Products and Foods with Health-promoting Benefits (NARO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba S, 2000, FREE RADICAL RES, V33, P635, DOI 10.1080/10715760000301151; Baba S, 2002, FREE RADICAL BIO MED, V33, P142, DOI 10.1016/S0891-5849(02)00871-7; Baba S, 2007, J NUTR, V137, P1436, DOI 10.1093/jn/137.6.1436; Baba S, 2007, AM J CLIN NUTR, V85, P709, DOI 10.1093/ajcn/85.3.709; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Buitrago-Lopez A, 2011, CHOCOLATE CONSUMPTIO; Cuenca-Garcia M, 2014, NUTRITION, V30, P236, DOI 10.1016/j.nut.2013.07.011; Davy KP, 2009, NEUROSCI BIOBEHAV R, V33, P116, DOI 10.1016/j.neubiorev.2008.05.024; Desch S, 2010, AM J HYPERTENS, V23, P97, DOI 10.1038/ajh.2009.213; Engler MB, 2004, J AM COLL NUTR, V23, P197, DOI 10.1080/07315724.2004.10719361; Golomb BA, 2012, ARCH INTERN MED, V172, P519, DOI 10.1001/archinternmed.2011.2100; Grassi D, 2005, HYPERTENSION, V46, P398, DOI 10.1161/01.HYP.0000174990.46027.70; Grassi D, 2005, AM J CLIN NUTR, V81, P611; Grouzmann E, 2013, BEST PRACT RES CL EN, V27, P713, DOI 10.1016/j.beem.2013.06.004; Hammerstone JF, 1999, J AGR FOOD CHEM, V47, P490, DOI 10.1021/jf980760h; Hatano T, 2002, PHYTOCHEMISTRY, V59, P749, DOI 10.1016/S0031-9422(02)00051-1; Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464; Ho TK, 2006, VASCULAR, V14, P321, DOI 10.2310/6670.2006.00056; Hooper L, 2008, AM J CLIN NUTR, V88, P38, DOI 10.1093/ajcn/88.1.38; Hooper L, 2012, AM J CLIN NUTR, V95, P740, DOI 10.3945/ajcn.111.023457; Ingawa K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094853; Jezek P, 2002, INT J BIOCHEM CELL B, V34, P1190, DOI 10.1016/S1357-2725(02)00061-4; Kalili KM, 2013, J CHROMATOGR A, V1289, P69, DOI 10.1016/j.chroma.2013.03.009; Kvetnansky R, 2013, ADV PHARMACOL, V68, P359, DOI 10.1016/B978-0-12-411512-5.00017-8; Larsson SC, 2012, NEUROLOGY, V79, P1223, DOI 10.1212/WNL.0b013e31826aacfa; Le Moine CMR, 2011, AM J PHYSIOL-REG I, V301, pR1098, DOI 10.1152/ajpregu.00070.2011; Miura S, 2007, ENDOCRINOLOGY, V148, P3441, DOI 10.1210/en.2006-1646; Morrison SF, 2014, CELL METAB, V19, P741, DOI 10.1016/j.cmet.2014.02.007; Natsume M, 2000, BIOSCI BIOTECH BIOCH, V64, P2581, DOI 10.1271/bbb.64.2581; Pearen MA, 2008, ENDOCRINOLOGY, V149, P2853, DOI 10.1210/en.2007-1202; Ried K, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-39; Robbins RJ, 2012, J AOAC INT, V95, P1153, DOI 10.5740/jaoacint.12-162; Sanbongi C, 1998, J AGR FOOD CHEM, V46, P454, DOI 10.1021/jf970575o; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Schroeter H, 2006, P NATL ACAD SCI USA, V103, P1024, DOI 10.1073/pnas.0510168103; Shrime MG, 2011, J NUTR, V141, P1982, DOI 10.3945/jn.111.145482; Spencer JPE, 2001, ANTIOXID REDOX SIGN, V3, P1023, DOI 10.1089/152308601317203558; Sprague JE, 2007, J PHARMACOL EXP THER, V320, P274, DOI 10.1124/jpet.106.107755; Taubert D, 2007, ARCH INTERN MED, V167, P626, DOI 10.1001/archinte.167.7.626; Tokede OA, 2011, EUR J CLIN NUTR, V65, P879, DOI 10.1038/ejcn.2011.64; Watanabe N, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-64; Yamashita Y, 2012, ARCH BIOCHEM BIOPHYS, V527, P95, DOI 10.1016/j.abb.2012.03.018	42	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112180	10.1371/journal.pone.0112180	http://dx.doi.org/10.1371/journal.pone.0112180			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375880	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600113
J	Yang, B; Wang, FL; Ren, XL; Li, D				Yang, Bo; Wang, Feng-Lei; Ren, Xiao-Li; Li, Duo			Biospecimen Long-Chain N-3 PUFA and Risk of Colorectal Cancer: A Meta-Analysis of Data from 60,627 Individuals	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; PROSTAGLANDIN SYNTHESIS; DOCOSAHEXAENOIC ACID; FISH CONSUMPTION; DIETARY-INTAKE; ADENOMA RISK; PLASMA; TISSUE; CELLS	Background: Several prospective cohort and case-control studies reported the inconsistent association between biospecimen composition of C20 and C22 long-chain (LC) n-3 polyunsaturated fatty acid (PUFA) and colorectal cancer (CRC) risk. The aim of the present study was to investigate the association of biospecimen LC n-3 PUFA with CRC risk based on prospective cohort and case-control studies. Methods and Results: Cochrane Library, PubMed, and EMBASE database were searched up to February 2014 for eligible studies. Risk ratios (RRs) or odds ratios (ORs) from prospective and case-control studies were combined using a random-effects model in the highest vs. lowest categorical analysis. Nonlinear dose-response relationships were assessed using restricted cubic spline regression models. Difference in tissue composition of LC n-3 PUFA between cases and noncases was analyzed as standardized mean difference (SMD). Three prospective cohort studies and 8 case-control studies were included in the present study, comprising 60,627 participants (1,499 CRC cases and 59,128 noncases). Higher biospecimen LC n-3 PUFA was significantly associated with a lower risk of CRC in case-control (pooled OR: 0.76; 95% CI: 0.59, 0.97; I-2 = 10.00%) and prospective cohort studies (pooled RR: 0.70; 95% CI: 0.55, 0.88; I-2 = 0.00%), respectively. A significant dose-response association was found of biospecimen C20: 5n-3 (P for nonlinearity = 0.02) and C22: 6n-3 (P for trend = 0.01) with CRC risk, respectively. Subjects without CRC have significantly higher biospecimen compositions of C20: 5n-3 (SMD: 0.27; 95%: 0.13, 0.41), C22: 6n-3 (SMD: 0.23; 95%: 0.11, 0.34) and total LC n-3 PUFA (SMD: 0.22; 95% CI: 0.07, 0.37) compared with those with CRC. Conclusions: The present evidence suggests human tissue compositions of LC n-3 PUFA may be an independent predictive factor for CRC risk, especially C20: 5n-3 and C22: 6n-3. This needs to be confirmed with more large-scale prospective cohort studies.	[Yang, Bo; Wang, Feng-Lei; Li, Duo] Zhejiang Univ, Dept Food Sci & Nutr, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Bo] Wenzhou Med Univ, Dept Prevent Med, Wenzhou, Peoples R China; [Ren, Xiao-Li] Wenzhou Med Univ, Med Lab Anim Ctr, Wenzhou, Peoples R China	Zhejiang University; Wenzhou Medical University; Wenzhou Medical University	Li, D (corresponding author), Zhejiang Univ, Dept Food Sci & Nutr, Hangzhou 310003, Zhejiang, Peoples R China.	duoli@zju.edu.cn	Wang, Fenglei/GYE-0853-2022; Li, Duo/N-3682-2013	Li, Duo/0000-0001-5227-5565	National Natural Science Foundation of China [81273054]; PhD Programs Foundation of Ministry of Education of China [20120101110107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); PhD Programs Foundation of Ministry of Education of China(Ministry of Education, China)	This was an independent study; the study subsidies of postgraduate students were paid from grants from the National Natural Science Foundation of China (No: 81273054) and the PhD Programs Foundation of Ministry of Education of China (No: 20120101110107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baro L, 1998, BRIT J CANCER, V77, P1978, DOI 10.1038/bjc.1998.328; Busstra MC, 2003, CANCER CAUSE CONTROL, V14, P269, DOI 10.1023/A:1023650201730; Butler LM, 2008, BRIT J CANCER, V99, P1511, DOI 10.1038/sj.bjc.6604678; Cai F, 2012, CURR OPIN CLIN NUTR, V15, P99, DOI 10.1097/MCO.0b013e32834feab4; Cockbain AJ, 2012, GUT, V61, P135, DOI 10.1136/gut.2010.233718; Cottet V, 2013, CANCER EPIDEM BIOMAR, V22, P1417, DOI 10.1158/1055-9965.EPI-13-0168; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FernandezBanares F, 1996, GUT, V38, P254, DOI 10.1136/gut.38.2.254; Geelen A, 2007, AM J EPIDEMIOL, V166, P1116, DOI 10.1093/aje/kwm197; Ghadimi R, 2008, ASIAN PAC J CANCER P, V9, P111; Giuliani A, 2013, EUR J NUTR; Hall MN, 2007, CANCER EPIDEM BIOMAR, V16, P314, DOI 10.1158/1055-9965.EPI-06-0346; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; Hawcroft G, 2010, NEOPLASIA, V12, P618, DOI 10.1593/neo.10388; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HIRSCH J, 1960, AM J CLIN NUTR, V8, P499, DOI 10.1093/ajcn/8.4.499; HOPKINS GJ, 1981, J NATL CANCER I, V66, P517; Hull MA, 2011, BEST PRACT RES CL GA, V25, P547, DOI 10.1016/j.bpg.2011.08.001; Jackson D, 2010, STAT MED, V29, P1282, DOI 10.1002/sim.3602; Ji BT, 1998, CANCER EPIDEM BIOMAR, V7, P661; Kansal S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084627; KOHLMEIER L, 1995, AM J CLIN NUTR, V61, p702S, DOI 10.1093/ajcn/61.3.702S; Kojima M, 2005, AM J EPIDEMIOL, V161, P462, DOI 10.1093/aje/kwi066; Kolar SSN, 2007, AM J PHYSIOL-GASTR L, V293, pG935, DOI 10.1152/ajpgi.00312.2007; Kuriki K, 2006, CANCER EPIDEM BIOMAR, V15, P1791, DOI 10.1158/1055-9965.EPI-06-0180; Liu L, 2011, EUR J NUTR, V50, P173, DOI 10.1007/s00394-010-0128-5; Liu Q, 2009, COMPUT STAT DATA AN, V53, P4157, DOI 10.1016/j.csda.2009.05.001; Meyer N, 2014, INT J BREAST CANCER, V2014, DOI 10.1155/2014/475171; Murff HJ, 2012, AM J CLIN NUTR, V95, P703, DOI 10.3945/ajcn.111.024000; Pham NM, 2013, JPN J CLIN ONCOL, V43, P935, DOI 10.1093/jjco/hyt094; Okunoi M, 2013, IN VIVO, V27, P203; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Orsini N, 2012, AM J EPIDEMIOL, V175, P66, DOI 10.1093/aje/kwr265; Penkov A, 2011, ANN NUTR METAB, V58, P375; Poole EM, 2007, CARCINOGENESIS, V28, P1259, DOI 10.1093/carcin/bgm026; Pot GK, 2008, INT J CANCER, V123, P1974, DOI 10.1002/ijc.23729; Rogers KR, 2010, CARCINOGENESIS, V31, P1523, DOI 10.1093/carcin/bgq111; Shen XJ, 2012, BRIT J NUTR, V108, P1550, DOI 10.1017/S0007114512003546; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; THERET N, 1993, METABOLISM, V42, P562, DOI 10.1016/0026-0495(93)90213-8; Turk HF, 2013, PROSTAG LEUKOTR ESS, V88, P43, DOI 10.1016/j.plefa.2012.03.008; Yang T, 2013, J NUTR BIOCHEM, V24, P744, DOI 10.1016/j.jnutbio.2012.03.023; Zhong X, 2013, EUR J CANCER PREV, V22, P438, DOI 10.1097/CEJ.0b013e32835e88c4	44	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e110574	10.1371/journal.pone.0110574	http://dx.doi.org/10.1371/journal.pone.0110574			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375637	gold, Green Submitted, Green Published			2022-12-27	WOS:000344402600013
J	Zhao, ZY; Herman, JG; Brock, MV; Sheng, JD; Zhang, MY; Liu, BG; Guo, MZ				Zhao, Zhiyan; Herman, James G.; Brock, Malcolm V.; Sheng, Jindong; Zhang, Meiying; Liu, Baoguo; Guo, Mingzhou			Methylation of DACT2 Promotes Papillary Thyroid Cancer Metastasis by Activating Wnt Signaling	PLOS ONE			English	Article							EPIGENETIC REGULATION; CATENIN; HYPERMETHYLATION; CARCINOMA; CELL; EXPRESSION; SURVIVAL; MUTATION; DAPPER1; PATHWAY	Thyroid cancer is the most common endocrine malignant disease and the incidence is increasing. DACT2 was found frequently methylated in human lung cancer and hepatocellular carcinoma. To explore the epigenetic change and the role of DACT2 in thyroid cancer, 7 thyroid cancer cell lines, 10 cases of non-cancerous thyroid tissue samples and 99 cases of primary thyroid cancer samples were involved in this study. DACT2 was expressed and unmethylated in K1, SW579, FTC-133, TT, W3 and 8505C cell lines. Loss of expression and complete methylation was found in TPC-1 cells. Restoration of DACT2 expression was induced by 5-aza-2'deoxycytidine treatment. It demonstrates that the expression of DACT2 was regulated by promoter region methylation. In human primary papillary thyroid cancer, 64.6% (64/99) was methylated and methylation of DACT2 was related to lymph node metastasis (p<0.01). Re-expression of DACT2 suppresses cell proliferation, invasion and migration in TPC-1 cells. The activity of TCF/LEF was inhibited by DACT2 in wild-type or mutant beta-catenin cells. The activity of TCF/LEF was increased by co-transfecting DACT2 and Dvl2 in wild-type or mutant beta-catenin cells. Overexpression of wildtype beta-catenin promotes cell migration and invasion in DACT2 stably expressed cells. The expression of beta-catenin, c-myc, cyclinD1 and MMP-9 were decreased and the level of phosphorylated beta-catenin (p-beta-catenin) was increased after restoration of DACT2 expression in TPC-1 cells. The expression of beta-catenin, c-myc, cyclinD1 and MMP-9 were increased and the level of p-beta-catenin was reduced after knockdown of DACT2 in W3 and SW579 cells. These results suggest that DACT2 suppresses human papillary thyroid cancer growth and metastasis by inhibiting Wnt signaling. In conclusion, DACT2 is frequently methylated in papillary thyroid cancer. DACT2 expression was regulated by promoter region methylation. DACT2 suppresses papillary thyroid cancer proliferation and metastasis by inhibiting Wnt signaling.	[Zhao, Zhiyan; Sheng, Jindong; Liu, Baoguo] Peking Univ, Canc Hosp & Inst, Dept Head & Neck Surg, 52 Fucheng Rd, Beijing 100036, Peoples R China; [Herman, James G.; Brock, Malcolm V.] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21231 USA; [Zhao, Zhiyan; Zhang, Meiying; Guo, Mingzhou] Chinese Peoples Liberat Army Gen Hosp, Dept Gastroenterol & Hepatol, Beijing 100853, Peoples R China; [Zhang, Meiying] Nankai Univ, Coll Med, Tianjin 300071, Peoples R China	Peking University; Johns Hopkins University; Johns Hopkins Medicine; Chinese People's Liberation Army General Hospital; Nankai University	Liu, BG (corresponding author), Peking Univ, Canc Hosp & Inst, Dept Head & Neck Surg, 52 Fucheng Rd, Beijing 100036, Peoples R China.	lbg29@163.com; mzguo1@gmail.com			National Basic Research Program (973 Program) [2012CB934002, 2010CB912802]; National Key Scientific instrument Special Program of China [2011YQ03013405]; National High-tech R AMP; D Program (863 Program) [SS2012AA020314, SS2012AA020821, SS2012AA020303]; National Science Foundation of China [81121004, 81071953, 81161120432]	National Basic Research Program (973 Program)(National Basic Research Program of China); National Key Scientific instrument Special Program of China; National High-tech R AMP; D Program (863 Program); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program (973 Program No. 2012CB934002, 2010CB912802), National Key Scientific instrument Special Program of China (Grant No. 2011YQ03013405), National High-tech R & D Program (863 Program No. SS2012AA020314, SS2012AA020821, SS2012AA020303) and National Science Foundation of China (Grant No. 81121004, 81071953, 81161120432). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatu A, 2013, CLIN CANCER RES, V19, P2265, DOI 10.1158/1078-0432.CCR-12-3518; Carling T, 2014, ANNU REV MED, V65, P125, DOI 10.1146/annurev-med-061512-105739; Carvalho B, 2001, CANCER GENET CYTOGEN, V131, P54, DOI 10.1016/S0165-4608(01)00514-3; Chen HJ, 2012, BIOCHEM PHARMACOL, V84, P1143, DOI 10.1016/j.bcp.2012.08.011; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Elaraj DM, 2009, SURG-J R COLL SURG E, V7, P286, DOI 10.1016/S1479-666X(09)80006-1; Gillhouse M, 2004, DEV DYNAM, V230, P403, DOI 10.1002/dvdy.20060; Gloy J, 2002, NAT CELL BIOL, V4, P351, DOI 10.1038/ncb784; Guo M, 2007, INT J CANCER, V121, P1219, DOI 10.1002/ijc.22828; Guo MZ, 2006, INT J CANCER, V119, P2078, DOI 10.1002/ijc.22092; Guo MZ, 2006, CLIN CANCER RES, V12, P4515, DOI 10.1158/1078-0432.CCR-05-2858; Guo MZ, 2006, NEW ENGL J MED, V354, P2193, DOI 10.1056/NEJMc052698; Hegi ME, 2008, J CLIN ONCOL, V26, P4189, DOI 10.1200/JCO.2007.11.5964; Hou P, 2011, ENDOCR-RELAT CANCER, V18, P687, DOI 10.1530/ERC-11-0212; Hu J, 2002, BRIT J CANCER, V87, P218, DOI 10.1038/sj.bjc.6600430; Hundahl SA, 1998, CANCER-AM CANCER SOC, V83, P2638, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jia Y, 2013, J PATHOL, V230, P194, DOI 10.1002/path.4073; Jia Y, 2010, EPIGENETICS-US, V5, P743, DOI 10.4161/epi.5.8.13104; Katoh M, 2003, INT J ONCOL, V22, P907; Li BCY, 2003, DIAGN MOL PATHOL, V12, P193, DOI 10.1097/00019606-200312000-00003; Li X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054868; Li Y, 2014, TUMOR BIOL, V35, P4539, DOI 10.1007/s13277-013-1597-y; Liu Y, 2002, ONCOGENE, V21, P387, DOI 10.1038/sj.onc.1205067; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Minaguchi T, 1999, DNA Res, V6, P131, DOI 10.1093/dnares/6.2.131; Nixon IJ, 2013, ORAL ONCOL, V49, P654, DOI 10.1016/j.oraloncology.2013.03.439; Qu XY, 1998, DNA SEQUENCE, V9, P189, DOI 10.3109/10425179809105206; Quintavalle C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074466; Raffo D, 2011, CURR PHARM BIOTECHNO, V12, P1937, DOI 10.2174/138920111798377085; Rodriguez C, 2000, GENE CHROMOSOME CANC, V27, P76, DOI 10.1002/(SICI)1098-2264(200001)27:1<76::AID-GCC10>3.0.CO;2-E; Sastre-Perona Ana, 2012, Front Endocrinol (Lausanne), V3, P31, DOI 10.3389/fendo.2012.00031; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Sier CFM, 1996, BRIT J CANCER, V74, P413, DOI 10.1038/bjc.1996.374; Usongo M, 2013, DEV DYNAM, V242, P291, DOI 10.1002/dvdy.23919; Wang GM, 2014, ONCOL REP, V32, P573, DOI 10.3892/or.2014.3233; Wang K, 2013, MOL HUM REPROD, V19, P57, DOI 10.1093/molehr/gas051; Wang N, 2014, J MOL HISTOL, V45, P391, DOI 10.1007/s10735-013-9557-9; Waxman JS, 2005, DEV DYNAM, V233, P194, DOI 10.1002/dvdy.20301; Xing MZ, 2007, ENDOCRINOLOGY, V148, P948, DOI 10.1210/en.2006-0927; Xing MZ, 2008, OTOLARYNG CLIN N AM, V41, P1135, DOI 10.1016/j.otc.2008.07.001; Xing MZ, 2004, CANCER RES, V64, P1664, DOI 10.1158/0008-5472.CAN-03-3242; Xun WW, 2011, MUTAGENESIS, V26, P657, DOI 10.1093/mutage/ger030; Yan WJ, 2013, EPIGENETICS-US, V8, P1373, DOI 10.4161/epi.26781; Zhang XM, 2013, EPIGENETICS-US, V8, P373, DOI 10.4161/epi.24113; Zhu HB, 2013, HEPATOLOGY, V58, P2012, DOI 10.1002/hep.26587	46	30	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112336	10.1371/journal.pone.0112336	http://dx.doi.org/10.1371/journal.pone.0112336			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375359	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402600130
J	Cardini, B; Watschinger, K; Hermann, M; Obrist, P; Oberhuber, R; Brandacher, G; Chuaiphichai, S; Channon, KM; Pratschke, J; Maglione, M; Werner, ER				Cardini, Benno; Watschinger, Katrin; Hermann, Martin; Obrist, Peter; Oberhuber, Rupert; Brandacher, Gerald; Chuaiphichai, Surawee; Channon, Keith M.; Pratschke, Johann; Maglione, Manuel; Werner, Ernst R.			Crucial Role for Neuronal Nitric Oxide Synthase in Early Microcirculatory Derangement and Recipient Survival following Murine Pancreas Transplantation	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ENDOTHELIAL FUNCTION; IN-VIVO; HUMAN ATHEROSCLEROSIS; OXIDATIVE STRESS; ANGIOTENSIN-II; TETRAHYDROBIOPTERIN; MICE; RATS; KIDNEY	Objective: Aim of this study was to identify the nitric oxide synthase (NOS) isoform involved in early microcirculatory derangements following solid organ transplantation. Background: Tetrahydrobiopterin donor treatment has been shown to specifically attenuate these derangements following pancreas transplantation, and tetrahydrobiopterin-mediated protective effects to rely on its NOS-cofactor activity, rather than on its antioxidant capacity. However, the NOS-isoform mainly involved in this process has still to be defined. Methods: Using a murine pancreas transplantation model, grafts lacking one of the three NOS-isoforms were compared to grafts from wild-type controls. Donors were treated with either tetrahydrobiopterin or remained untreated. All grafts were subjected to 16 h cold ischemia time and transplanted into wild-type recipients. Following 4 h graft reperfusion, microcirculation was analysed by confocal intravital fluorescence microscopy. Recipient survival was monitored for 50 days. Results: Transplantation of the pancreas from untreated wild-type donor mice resulted in microcirculatory damage of the transplanted graft and no recipient survived more than 72 h. Transplanting grafts from untreated donor mice lacking either endothelial or inducible NOS led to similar outcomes. In contrast, donor treatment with tetrahydrobiopterin prevented microcirculatory breakdown enabling long-term survival. Sole exception was transplantation of grafts from untreated donor mice lacking neuronal NOS. It resulted in intact microvascular structure and long-term recipient survival, either if donor mice were untreated or treated with tetrahydrobiopterin. Conclusion: We demonstrate for the first time the crucial involvement of neuronal NOS in early microcirculatory derangements following solid organ transplantation. In this model, protective effects of tetrahydrobiopterin are mediated by targeting this isoform.	[Cardini, Benno; Oberhuber, Rupert; Brandacher, Gerald; Pratschke, Johann; Maglione, Manuel] Med Univ Innsbruck, Ctr Operat Med, Dept Visceral Transplant & Thorac Surg, A-6020 Innsbruck, Austria; [Cardini, Benno; Watschinger, Katrin; Werner, Ernst R.] Med Univ Innsbruck, Bioctr, Div Biol Chem, A-6020 Innsbruck, Austria; [Hermann, Martin] Med Univ Innsbruck, Dept Anaesthesiol & Crit Care Med, A-6020 Innsbruck, Austria; [Obrist, Peter] St Vinzenz Krankenhaus, Inst Pathol, Zams, Austria; [Brandacher, Gerald] Johns Hopkins Univ, Sch Med, Dept Plast & Reconstruct Surg, Baltimore, MD USA; [Chuaiphichai, Surawee; Channon, Keith M.] Univ Oxford, Radcliffe Dept Med, Wellcome Trust Ctr Human Genet, Div Cardiovasc Med, Oxford, England	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Johns Hopkins University; University of Oxford; Wellcome Centre for Human Genetics	Maglione, M (corresponding author), Med Univ Innsbruck, Ctr Operat Med, Dept Visceral Transplant & Thorac Surg, A-6020 Innsbruck, Austria.	manuel.maglione@i-med.ac.at; ernst.r.werner@i-med.ac.at	Maglione, Manuel/AAK-8599-2020; Brandacher, Gerald/L-7540-2016; Watschinger, Katrin/AHC-9948-2022	Maglione, Manuel/0000-0003-1479-6129; Watschinger, Katrin/0000-0002-1122-8444; Chuaiphichai, Surawee/0000-0002-7512-6252; Werner, Ernst R./0000-0003-1948-3391; channon, keith/0000-0002-1043-4342; Hermann, Martin/0000-0003-2213-3448	Austrian Science Funds (FWF) [P22289]; Tiroler Wissenschaftsfonds (TWF) [2008-1-596]; MRC [G0200482] Funding Source: UKRI; Austrian Science Fund (FWF) [P 22289] Funding Source: researchfish; British Heart Foundation [RG/12/5/29576] Funding Source: researchfish; Medical Research Council [G0200482] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10247] Funding Source: researchfish	Austrian Science Funds (FWF)(Austrian Science Fund (FWF)); Tiroler Wissenschaftsfonds (TWF); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the Austrian Science Funds (FWF) Project P22289 (http://www.fwf.ac.at/en/index.asp) and by grant 2008-1-596 of the Tiroler Wissenschaftsfonds (TWF) (https://www.tirol.gv.at/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamine EH, 2006, J VASC RES, V43, P309, DOI 10.1159/000093196; Antoniades C, 2007, CIRCULATION, V116, P2851, DOI 10.1161/CIRCULATIONAHA.107.704155; Antoniades C, 2011, CIRCULATION, V124, P335, DOI 10.1161/CIRCULATIONAHA.110.985150; Arciszewski MB, 2007, ANAT HISTOL EMBRYOL, V36, P375, DOI 10.1111/j.1439-0264.2007.00777.x; Bachetti T, 2004, J MOL CELL CARDIOL, V37, P939, DOI 10.1016/j.yjmcc.2004.07.006; Bendall JK, 2005, CIRC RES, V97, P864, DOI 10.1161/01.RES.0000187447.03525.72; Boer R, 2000, MOL PHARMACOL, V58, P1026, DOI 10.1124/mol.58.5.1026; Boulanger CM, 1998, CIRC RES, V83, P1271, DOI 10.1161/01.RES.83.12.1271; Cunnington C, 2010, HEART, V96, P1872, DOI 10.1136/hrt.2009.180430; Daff S, 2010, NITRIC OXIDE-BIOL CH, V23, P1, DOI 10.1016/j.niox.2010.03.001; DiMagno MJ, 2004, AM J PHYSIOL-GASTR L, V286, pG428, DOI 10.1152/ajpgi.00368.2003; Drognitz O, 2009, PANCREAS, V38, P226, DOI 10.1097/MPA.0b013e3181788e2b; Dumitrescu C, 2007, P NATL ACAD SCI USA, V104, P15081, DOI 10.1073/pnas.0702986104; FUKUSHIMA T, 1980, ANAL BIOCHEM, V102, P176, DOI 10.1016/0003-2697(80)90336-X; Gruessner AC, 2012, CURR OPIN ORGAN TRAN, V17, P100, DOI 10.1097/MOT.0b013e32834ee700; Gruessner Angelika C, 2011, Rev Diabet Stud, V8, P6, DOI 10.1900/RDS.2011.8.6; HADDAD IY, 1994, J CLIN INVEST, V94, P2407, DOI 10.1172/JCI117607; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; Kang KT, 2011, AM J PHYSIOL-HEART C, V300, pH718, DOI 10.1152/ajpheart.00393.2010; Katusic ZS, 2009, TRENDS PHARMACOL SCI, V30, P48, DOI 10.1016/j.tips.2008.10.003; Leindler L, 2004, PANCREAS, V29, P157, DOI 10.1097/00006676-200408000-00011; Long J, 2005, WORLD J GASTROENTERO, V11, P4277; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Maglione M, 2006, AM J TRANSPLANT, V6, P1551, DOI 10.1111/j.1600-6143.2006.01345.x; Maglione M, 2010, AM J TRANSPLANT, V10, P2231, DOI 10.1111/j.1600-6143.2010.03262.x; Maglione M, 2012, TRANSPL INT; Maglione M, 2007, SURGERY, V141, P682, DOI 10.1016/j.surg.2006.07.037; Maglione M, 2012, TRANSPL INT, V25, P1084, DOI 10.1111/j.1432-2277.2012.01530.x; Maier W, 2000, J CARDIOVASC PHARM, V35, P173, DOI 10.1097/00005344-200002000-00001; Mayahi L, 2007, ARTERIOSCL THROM VAS, V27, P1334, DOI 10.1161/ATVBAHA.107.142257; Melikian N, 2009, TRENDS CARDIOVAS MED, V19, P256, DOI 10.1016/j.tcm.2010.02.007; MULSCH A, 1990, N-S ARCH PHARMACOL, V341, P143; Nowak EC, 2012, J EXP MED, V209, P2127, DOI 10.1084/jem.20120408; Obermaier R, 2002, PANCREAS, V25, P142, DOI 10.1097/00006676-200208000-00005; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Schaser KD, 2005, AM J TRANSPLANT, V5, P341, DOI 10.1111/j.1600-6143.2004.00663.x; Schmid RA, 1999, J THORAC CARDIOV SUR, V118, P726, DOI 10.1016/S0022-5223(99)70019-X; SCHMIDT J, 1992, ANN SURG, V215, P44, DOI 10.1097/00000658-199201000-00007; Schneeberger S, 2009, TRANSPL INT, V22, P217, DOI 10.1111/j.1432-2277.2008.00773.x; Schulz E, 2008, ANTIOXID REDOX SIGN, V10, P1115, DOI 10.1089/ars.2007.1989; Seddon M, 2009, CIRCULATION, V119, P2656, DOI 10.1161/CIRCULATIONAHA.108.822205; Sollinger HW, 2009, ANN SURG, V250, P618, DOI [10.1097/SLA.0b013e3181b7d2b, 10.1097/SLA.0b013e3181b76d2b]; Sucher R, 2010, KIDNEY INT, V77, P681, DOI 10.1038/ki.2010.7; Sugiyama Y, 2006, DIGEST DIS SCI, V51, P1396, DOI 10.1007/s10620-006-9125-1; Tiefenbacher CP, 1996, CIRCULATION, V94, P1423, DOI 10.1161/01.CIR.94.6.1423; Um SH, 2003, J KOREAN MED SCI, V18, P520, DOI 10.3346/jkms.2003.18.4.520; Watschinger K, 2010, P NATL ACAD SCI USA, V107, P13672, DOI 10.1073/pnas.1002404107; Werner ER, 2011, BIOCHEM J, V438, P397, DOI 10.1042/BJ20110293; Xu KY, 1999, P NATL ACAD SCI USA, V96, P657, DOI 10.1073/pnas.96.2.657; Yamaleyeva LM, 2012, J CARDIOVASC PHARM, V59, P529, DOI 10.1097/FJC.0b013e31824dd15b	51	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112570	10.1371/journal.pone.0112570	http://dx.doi.org/10.1371/journal.pone.0112570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389974	Green Submitted, Green Published, gold			2022-12-27	WOS:000349144400102
J	Falconer, CJ; Slater, M; Rovira, A; King, JA; Gilbert, P; Antley, A; Brewin, CR				Falconer, Caroline J.; Slater, Mel; Rovira, Aitor; King, John A.; Gilbert, Paul; Antley, Angus; Brewin, Chris R.			Embodying Compassion: A Virtual Reality Paradigm for Overcoming Excessive Self-Criticism	PLOS ONE			English	Article							NEGATIVE AFFECT; ONESELF; CONSCIOUSNESS; EXPLORATION; PERSPECTIVE; VALIDATION; MECHANISMS; DEPRESSION; OWNERSHIP; DISORDERS	Virtual reality has been successfully used to study and treat psychological disorders such as phobias and posttraumatic stress disorder but has rarely been applied to clinically-relevant emotions other than fear and anxiety. Self-criticism is a ubiquitous feature of psychopathology and can be treated by increasing levels of self-compassion. We exploited the known effects of identification with a virtual body to arrange for healthy female volunteers high in self-criticism to experience self-compassion from an embodied first-person perspective within immersive virtual reality. Whereas observation and practice of compassionate responses reduced self-criticism, the additional experience of embodiment also increased self-compassion and feelings of being safe. The results suggest potential new uses for immersive virtual reality in a range of clinical conditions.	[Falconer, Caroline J.; King, John A.; Brewin, Chris R.] UCL, London, England; [Slater, Mel; Rovira, Aitor; Antley, Angus] UCL, Dept Comp Sci, London, England; [Slater, Mel] Univ Barcelona, Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; [Gilbert, Paul] Univ Derby, Mental Hlth Res Unit, Derby DE22 1GB, England	University of London; University College London; University of London; University College London; ICREA; University of Barcelona; University of Derby	Brewin, CR (corresponding author), UCL, London, England.	c.brewin@ucl.ac.uk	Brewin, Chris R/C-4566-2008; Slater, Mel/M-5210-2014; king, john/G-3570-2011	Brewin, Chris R/0000-0002-7462-4460; Slater, Mel/0000-0002-6223-0050; Gilbert, paul/0000-0001-8431-9892; King, John/0000-0002-0269-3790; Falconer, Caroline/0000-0002-6707-5184	U.K. Medical Research Council [MR/J009210/1]; European Research Council; Medical Research Council [MR/J009210/1] Funding Source: researchfish; ICREA Funding Source: Custom; MRC [MR/J009210/1] Funding Source: UKRI	U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ICREA(ICREA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The project was supported by the U.K. Medical Research Council grant no. MR/J009210/1 to CB, MS, PG & JK (www.mrc.ac.uk). MS is supported by the European Research Council Advance Grant TRAVERSE (erc.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alden LE, 2013, EMOTION, V13, P64, DOI 10.1037/a0027761; Banakou D, 2013, P NATL ACAD SCI USA, V110, P12846, DOI 10.1073/pnas.1306779110; Barnsley N, 2011, CURR BIOL, V21, pR945, DOI 10.1016/j.cub.2011.10.039; Blanke O, 2012, NAT REV NEUROSCI, V13, P556, DOI 10.1038/nrn3292; Blatt S. J., 2004, EXPERIENCES DEPRESSI; BLATT SJ, 1992, CLIN PSYCHOL REV, V12, P527, DOI 10.1016/0272-7358(92)90070-O; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Brewin CR, 2010, PSYCHOL REV, V117, P210, DOI 10.1037/a0018113; Castilho P., 2013, CLIN PSYCHOL PSYCHOT; Depue RA, 2005, BEHAV BRAIN SCI, V28, P313; Gerardi M, 2010, CURR PSYCHIAT REP, V12, P298, DOI 10.1007/s11920-010-0128-4; Gilbert P, 2004, MEMORY, V12, P507, DOI 10.1080/09658210444000115; Gilbert P, 2004, BRIT J CLIN PSYCHOL, V43, P31, DOI 10.1348/014466504772812959; Gilbert P, 2013, BRIT J CLIN PSYCHOL; Gilbert P., 2022, COMPASSION FOCUSED T; Gilbert P., 2008, J POSIT PSYCHOL, P182, DOI 10.1080/17439760801999461; Gilbert P, 2011, PSYCHOL PSYCHOTHER-T, V84, P239, DOI [10.1348/147608310X526511, 10.1111/j.2044-8341.2011.02046.x]; Goetz JL, 2010, PSYCHOL BULL, V136, P351, DOI 10.1037/a0018807; Hewitt P.L., 2002, PERFECTIONISM THEORY, P255, DOI [10.1037/10458-011, DOI 10.1037/10458-011]; Hofmann SG, 2011, CLIN PSYCHOL REV, V31, P1126, DOI 10.1016/j.cpr.2011.07.003; Kilteni K, 2013, IEEE T VIS COMPUT GR, V19, P597, DOI 10.1109/TVCG.2013.29; Kokkinara E, 2014, PERCEPTION, V43, P43, DOI 10.1068/p7545; Kuyken W, 2009, MEMORY, V17, P624, DOI 10.1080/09658210902984526; Leary MR, 2007, J PERS SOC PSYCHOL, V92, P887, DOI 10.1037/0022-3514.92.5.887; Libby LK, 2005, J PERS SOC PSYCHOL, V88, P50, DOI 10.1037/0022-3514.88.1.50; Mongrain M, 2011, J HAPPINESS STUD, V12, P963, DOI 10.1007/s10902-010-9239-1; Neff KD, 2013, J CLIN PSYCHOL, V69, P28, DOI 10.1002/jclp.21923; Neff KD, 2009, J PERS, V77, P23, DOI 10.1111/j.1467-6494.2008.00537.x; Pan XN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032931; Peck TC, 2013, CONSCIOUS COGN, V22, P779, DOI 10.1016/j.concog.2013.04.016; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; Rockliff H, 2011, EMOTION, V11, P1388, DOI 10.1037/a0023861; Sanchez-Vives MV, 2005, NAT REV NEUROSCI, V6, P332, DOI 10.1038/nrn1651; Shahar B, 2012, CLIN PSYCHOL PSYCHOT, V19, P496, DOI 10.1002/cpp.762; Slater M, 2008, FRONT HUM NEUROSCI, V2, DOI [10.3389/Neuro.3309.3006.3200, DOI 10.3389/NEURO.3309.3006.3200]; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Thompson ER, 2007, J CROSS CULT PSYCHOL, V38, P227, DOI 10.1177/0022022106297301; Wagner-Moore LE, 2004, PSYCHOTHERAPY, V41, P180, DOI 10.1037/0033-3204.41.2.180; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	39	64	67	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111933	10.1371/journal.pone.0111933	http://dx.doi.org/10.1371/journal.pone.0111933			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CP	25389766	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400041
J	Shuang, F; Hou, SX; Zhu, JL; Ren, DF; Cao, Z; Tang, JG				Shuang, Feng; Hou, Shu-Xun; Zhu, Jia-Liang; Ren, Dong-Feng; Cao, Zheng; Tang, Jia-Guang			Percutaneous Resolution of Lumbar Facet Joint Cysts as an Alternative Treatment to Surgery: A Meta-Analysis	PLOS ONE			English	Article							INTRASPINAL SYNOVIAL CYSTS; INDUCED RADICULAR PAIN; LOW-BACK-PAIN; STEROID INJECTION; FLUOROSCOPIC GUIDANCE; FOLLOW-UP; ASPIRATION; RUPTURE; MANAGEMENT; DIAGNOSIS	Purpose: A comprehensive review of the literature in order to analyze data about the success rate of percutaneous resolution of the lumbar facet joint cysts as a conservative management strategy. Methods: A systematic search for relevant articles published during 1980 to May 2014 was performed in several electronic databases by using the specific MeSH terms and keywords. Most relevant data was captured and pooled for the meta-analysis to achieve overall effect size of treatment along with 95% confidence intervals. Results: 29 studies were included in the meta-analysis. Follow-up duration as mean +/- sd (range) was 16 +/- 10.2 (5 days to 5.7 years). Overall the satisfactory results (after short-or long-term follow-up) were achieved in 55.8 [49.5, 62.08] % (pooled mean and 95% CI) of the 544 patients subjected to percutaneous lumbar facet joint cyst resolution procedures. 38.67 [33.3, 43.95] % of this population underwent surgery subsequently to achieve durable relief. There existed no linear relationship between the increasing average duration of follow-up period of individual studies and percent satisfaction from the percutaneous resolutions procedure. Conclusion: Results shows that the percutaneous cyst resolution procedures have potential to be an alternative to surgical interventions but identification of suitable subjects requires further research.	[Shuang, Feng; Hou, Shu-Xun; Zhu, Jia-Liang; Ren, Dong-Feng; Cao, Zheng; Tang, Jia-Guang] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Orthopaed, Beijing 100853, Peoples R China; [Shuang, Feng] 94th Hosp Chinese PLA, Dept Orthoped, Nanchang, Peoples R China	Chinese People's Liberation Army General Hospital	Hou, SX (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Orthopaed, Beijing 100853, Peoples R China.	houshuxun_2000@163.com; jiaguangtang@yahoo.com.cn			National Natural Science Foundation of China [81071514]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81071514). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULLAH AF, 1984, J NEUROSURG, V60, P617, DOI 10.3171/jns.1984.60.3.0617; Alicioglu B, 2009, Prague Med Rep, V110, P301; Allen TL, 2009, SPINE J, V9, P387, DOI 10.1016/j.spinee.2008.08.008; Amoretti N, 2012, EUR RADIOL, V22, P2836, DOI 10.1007/s00330-012-2533-z; [Anonymous], SURG NEUROL INT S3; Arnold PM, 2009, SPINE J, V9, P919, DOI [10.1016/j.spinee.2009.07.003, 10.1016/j.spinee.2008.08.010]; Ayberk G, 2008, NEUROL MED-CHIR, V48, P298, DOI 10.2176/nmc.48.298; BJORKENGREN AG, 1987, AM J ROENTGENOL, V149, P105, DOI 10.2214/ajr.149.1.105; Boissiere L, 2013, BMJ CASE REP, V2013; Boviatsis EJ, 2008, EUR SPINE J, V17, P831, DOI 10.1007/s00586-007-0563-z; Braza DW, 2005, AM J PHYS MED REHAB, V84, P911, DOI 10.1097/01.phm.0000184216.24478.7e; BUDRIS DM, 1991, ORTHOPEDICS, V14, P618; Bureau NJ, 2001, RADIOLOGY, V221, P179, DOI 10.1148/radiol.2211010213; Cambron SC, 2013, AM J NEURORADIOL, V34, P1661, DOI 10.3174/ajnr.A3441; CARRERA GF, 1980, RADIOLOGY, V137, P665, DOI 10.1148/radiology.137.3.6449717; CASSELMAN ES, 1985, AM J NEURORADIOL, V6, P971; Chang Anthony, 2009, HSS J, V5, P165, DOI 10.1007/s11420-009-9124-9; DePalma MJ, 2009, SPINE J, V9, P921, DOI 10.1016/j.spinee.2009.08.003; Deyo RA, 2001, NEW ENGL J MED, V344, P363, DOI 10.1056/NEJM200102013440508; Foley BS, 2009, AM J PHYS MED REHAB, V88, P1046, DOI 10.1097/PHM.0b013e3181b721ef; Gheyi VK, 1999, CLIN IMAG, V23, P394, DOI 10.1016/S0899-7071(99)00164-3; Gishen P, 2001, CARDIOVASC INTER RAD, V24, P351, DOI 10.1007/s00270-001-0023-9; HONG YY, 1995, ANESTHESIOLOGY, V82, P1061, DOI 10.1097/00000542-199504000-00028; Imai K, 1998, ARCH ORTHOP TRAUM SU, V118, P103, DOI 10.1007/s004020050323; Kennedy DJ, 2009, PAIN MED, V10, P1389, DOI 10.1111/j.1526-4637.2009.00728.x; Kozar S, 2014, RADIOL ONCOL, V48, P35, DOI 10.2478/raon-2013-0024; KURZ LT, 1985, J BONE JOINT SURG AM, V67A, P865, DOI 10.2106/00004623-198567060-00006; Lim AKP, 2001, CLIN RADIOL, V56, P990, DOI 10.1053/crad.2001.0710; Lin TL, 2014, J CHIN MED ASSOC, V77, P213, DOI 10.1016/j.jcma.2014.01.003; Lutz GE, 2002, ARCH PHYS MED REHAB, V83, P1789, DOI 10.1053/apmr.2002.34601; Martha JF, 2009, SPINE J, V9, P899, DOI 10.1016/j.spinee.2009.06.010; Melfi RS, 2005, PAIN MED, V6, P122, DOI 10.1111/j.1526-4637.2005.05021.x; Ortiz AO, 2014, J NEUROINTERV SURG, V6, P790, DOI 10.1136/neurintsurg-2013-010891; Parlier-Cuau C, 1999, RADIOLOGY, V210, P509, DOI 10.1148/radiology.210.2.r99fe60509; Rauchwerger JJ, 2011, PAIN PRACT, V11, P180, DOI 10.1111/j.1533-2500.2010.00411.x; Sabers SR, 2005, ARCH PHYS MED REHAB, V86, P1767, DOI 10.1016/j.apmr.2004.11.051; Sauvage PJ, 2000, J RADIOL, V81, P33; Schulz C, 2011, ORTHOPADE, V40, P600, DOI 10.1007/s00132-011-1744-3; Shah Rinoo V, 2003, Spine J, V3, P479, DOI 10.1016/S1529-9430(03)00148-7; Shin KM, 2012, KOREAN J ANESTHESIOL, V62, P375, DOI 10.4097/kjae.2012.62.4.375; Shipley JA, 1998, J BONE JOINT SURG BR, V80B, P662, DOI 10.1302/0301-620X.80B4.8323; Slipman CW, 2000, ARCH PHYS MED REHAB, V81, P973, DOI 10.1053/apmr.2000.5584; United States Department of Health and Human Services. National Institute of Health, QUAL ASS TOOL OBS CO	43	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111695	10.1371/journal.pone.0111695	http://dx.doi.org/10.1371/journal.pone.0111695			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389771	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400029
J	Zheng, MG; Liao, YS; He, JJ				Zheng, Mingguo; Liao, Yishan; He, Jijun			Sediment Delivery Ratio of Single Flood Events and the Influencing Factors in a Headwater Basin of the Chinese Loess Plateau	PLOS ONE			English	Article							SOIL-EROSION; HYPERCONCENTRATED FLOW; HILLY AREAS; LAND-USE; YIELD; TRANSPORT; IMPACTS; RUNOFF; RIVER	Little is known about the sediment delivery of single flood events although it has been well known that the sediment delivery ratio at the inter-annual time scale is close to 1 in the Chinese Loess Plateau. This study examined the sediment delivery of single flood events and the influencing factors in a headwater basin of the Loess Plateau, where hyperconcentrated flows are dominant. Data observed from plot to subwatershed over the period from 1959 to 1969 were presented. Sediment delivery ratio of a single event (SDRe) was calculated as the ratio of sediment output from the subwatershed to sediment input into the channel. It was found that SDRe varies greatly for small events (runoff depth < 5 mm or rainfall depth <30 mm) and remains fairly constant (approximately between 1.1 and 1.3) for large events (runoff depth >5 mm or rainfall depth >30 mm). We examined 11 factors of rainfall (rainfall amount, rainfall intensity, rainfall kinetic energy, rainfall erosivity and rainfall duration), flood (area-specific sediment yield, runoff depth, peak flow discharge, peak sediment concentration and flood duration) and antecedent land surface (antecedent precipitation) in relation to SDRe. Only the peak sediment concentration significantly correlates with SDRe. Contrary to popular belief, channel scour tends to occur in cases of higher peak sediment concentrations. Because small events also have chances to attain a high sediment concentration, many small events (rainfall depth <20 mm) are characterized by channel scour with an SDRe larger than 1. Such observations can be related to hyperconcentrated flows, which behave quite differently from normal stream flows. Our finding that large events have a nearly constant SDRe is useful for sediment yield predictions in the Loess Plateau and other regions where hyperconcentrated flows are well developed.	[Zheng, Mingguo] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Water Cycle & Related Land Surface Proces, Beijing, Peoples R China; [Liao, Yishan] Guangdong Inst Ecoenvironm & Soil Sci, Guangzhou, Guangdong, Peoples R China; [He, Jijun] Capital Normal Univ, Base State Lab Urban Environm Processes & Digital, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Guangdong Academy of Sciences; Institute of Eco-environmental & Soil Sciences, Guangdong Academy of Sciences	He, JJ (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Water Cycle & Related Land Surface Proces, Beijing, Peoples R China.	hejiun_200018@163.com			Non-profit Industry Financial Program of MWR [201201083]; National Natural Science Foundation of China [41401302, 41271306]	Non-profit Industry Financial Program of MWR; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support for this research was provided by Non-profit Industry Financial Program of MWR (201201083; www.cws.net.cn) and National Natural Science Foundation of China (41401302 and 41271306; www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatorre LC, 2010, J HYDROL, V391, P111, DOI 10.1016/j.jhydrol.2010.07.010; Anctil F, 2004, J HYDROL, V286, P155, DOI 10.1016/j.jhydrol.2003.09.006; Cai QG, 1998, PROCESSES SOIL EROSI; Chen Y., 1988, MODERN EROSION CONTR; Cheng X.A., 2010, THESIS HUAZHONG AGR, P54; Chien N., 1999, MECH SEDIMENT TRANSP, DOI 10.1061/9780784404003; de Vente J, 2007, PROG PHYS GEOG, V31, P155, DOI 10.1177/0309133307076485; ENGELUND F, 1984, J HYDRAUL ENG-ASCE, V110, P219, DOI 10.1061/(ASCE)0733-9429(1984)110:3(219); FERRO V, 1995, HYDROLOG SCI J, V40, P703, DOI 10.1080/02626669509491460; FOSTER GR, 1982, T ASAE, V25, P124, DOI 10.13031/2013.33490; Gong SY, 1979, YELLOW RIVER, P7; Goudie A, 2004, ENCY GEOMORPHOLOGY, V2, P932; [韩鹏 Han Peng], 2003, [水利学报, Journal of Hydraulic Engineering], V0, P51; Heggen RJ, 2001, J HYDROL ENG, V6, P377, DOI 10.1061/(ASCE)1084-0699(2001)6:5(377); Hessel R, 2006, EARTH SURF PROC LAND, V31, P1100, DOI 10.1002/esp.1307; Jiang ZS, 1983, SOIL WATER CONSERVAT, P32; Jing K, 1993, SEDIMENT ENV HUANSHE; Kinnell PIA, 2010, J HYDROL, V385, P384, DOI 10.1016/j.jhydrol.2010.01.024; Lane LJ, 1997, ENVIRON MODELL SOFTW, V12, P355, DOI 10.1016/S1364-8152(97)00027-3; Li Q., 1989, YELLOW RIVER, V3, P18; Liu QJ, 2013, GEOMORPHOLOGY, V186, P181, DOI 10.1016/j.geomorph.2013.01.012; Lu H, 2006, ENVIRON MODELL SOFTW, V21, P1297, DOI 10.1016/j.envsoft.2005.04.021; Ma TH, 2014, GEOMORPHOLOGY, V216, P187, DOI 10.1016/j.geomorph.2014.03.033; Mou J.Z., 1982, J SEDIMENT RES, V2, P223; Pierson TC, 2005, S-P BKS GEOPHYS SCI, P159; PIERSON TC, 1985, WATER RESOUR RES, V21, P1511, DOI 10.1029/WR021i010p01511; Rovira A, 2006, GEOMORPHOLOGY, V79, P58, DOI 10.1016/j.geomorph.2005.09.016; Schiettecatte W, 2008, EARTH SURF PROC LAND, V33, P1302, DOI 10.1002/esp.1642; Shi ZH, 2013, J HYDROL, V498, P165, DOI 10.1016/j.jhydrol.2013.06.031; Shi ZH, 2012, J HYDROL, V438, P156, DOI 10.1016/j.jhydrol.2012.03.016; Walling DE, 1999, HYDROBIOLOGIA, V410, P223, DOI 10.1023/A:1003825813091; WALLING DE, 1988, J HYDROL, V100, P113, DOI 10.1016/0022-1694(88)90183-7; WALLING DE, 1983, J HYDROL, V65, P209, DOI 10.1016/0022-1694(83)90217-2; Wan Z., 1994, IAHR MONOGRAPH SERIE; Wang L, 2014, J HYDROL, V512, P168, DOI 10.1016/j.jhydrol.2014.02.066; Wirtz S, 2012, CATENA, V91, P21, DOI 10.1016/j.catena.2010.12.002; Wischmeier WH, 1978, USDA HDB; Xu JX, 1999, CATENA, V36, P1, DOI 10.1016/S0341-8162(99)00009-0; Yan B, 2013, J HYDROL, V484, P26, DOI 10.1016/j.jhydrol.2013.01.008; Zhang KL, 1999, J SEDIMENT RES, P55; Zheng MG, 2013, CATENA, V109, P164, DOI 10.1016/j.catena.2013.03.017; Zheng MG, 2012, CATENA, V98, P29, DOI 10.1016/j.catena.2012.05.013; [郑明国 ZHENG MingGuo], 2007, [生态学报, Acta Ecologica Sinica], V27, P3572; Zhou P.H., 1992, J SOIL WATER CONSERV, V6, P1, DOI DOI 10.13870/J.CNID.STBC.XB.1992.03.001	44	10	11	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112594	10.1371/journal.pone.0112594	http://dx.doi.org/10.1371/journal.pone.0112594			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389752	Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400107
J	Chen, ML; Wu, RM; Tai, CH; Lin, CH				Chen, Meng-Ling; Wu, Ruey-Meei; Tai, Chun-Hwei; Lin, Chin-Hsien			Mutational Analysis of Angiogenin Gene in Parkinson's Disease	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; VARIANTS; ALS	Mutations in the angiogenic factor, angiogenin (ANG), have been identified in patients with both familial and sporadic amyotrophic lateral sclerosis (ALS) and are thought to have a neuroprotective function. Parkinsonism has been noted in kindreds with ANG mutations and variants in the ANG gene have been found to associate with PD in two Caucasian populations. We therefore hypothesized that mutations in ANG may also contribute to idiopathic Parkinson's disease (PD). We sequenced ANG gene in a total of 1498 participants comprising 750 PD patients and 748 age/gender matched controls from Taiwan. We identified one novel synonymous substitution, c.C100T (p.L10L), in a single heterozygous state in one PD patient, which was not observed in controls. The clinical phenotypes and [Tc-99m]-TORDAT-SPECT images of the p.L10L carrier were similar to that seen in idiopathic PD. In addition, we also identified one common variant, c.T330G (p.G110G, rs11701), which was previously reported to associate with PD risk in Caucasians. However, the frequency of TG/GG genotype was comparable between PD cases and controls (odds ratio: 0.85, 95% confidence interval: 0.29-2.55, P = 0.78). Our results did not support that ANG rs11701 variant is a genetic risk factor for PD in our population. We conclude that mutations in ANG are not a common cause for idiopathic PD.	[Chen, Meng-Ling; Wu, Ruey-Meei; Tai, Chun-Hwei; Lin, Chin-Hsien] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Neurol, Taipei 10764, Taiwan; [Chen, Meng-Ling] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University	Lin, CH (corresponding author), Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Neurol, Taipei 10764, Taiwan.	chlin@ntu.edu.tw		Lin, Chin-Hsien/0000-0001-8566-7573; Tai, Chun-Hwei/0000-0002-3493-8879; Wu, Ruey-Meei/0000-0002-4947-5467; Chen, Meng-Ling/0000-0003-3980-5546	National Taiwan University Hospital [NTUH.102-S2072]	National Taiwan University Hospital(National Taiwan University)	This study is funded by the National Taiwan University Hospital (NTUH.102-S2072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen RC, 2001, NEUROLOGY, V57, P1679, DOI 10.1212/WNL.57.9.1679; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Greenway MJ, 2004, NEUROLOGY, V63, P1936, DOI 10.1212/01.WNL.0000144344.39103.F6; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Lee MJ, 2009, MOVEMENT DISORD, V24, P104, DOI 10.1002/mds.22093; Lin CB, 2011, J APPL PHYS, V110, DOI 10.1063/1.3606513; Lin CH, 2008, NEUROLOGY, V71, P1727, DOI 10.1212/01.wnl.0000335167.72412.68; Lin CH, 2007, AM J MED GENET B, V144B, P434, DOI 10.1002/ajmg.b.30427; Lin CH, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00059; Liu B, 2013, PARKINSONISM RELAT D, V19, P446, DOI 10.1016/j.parkreldis.2012.11.016; MAJOORKRAKAUER D, 1994, NEUROLOGY, V44, P1872, DOI 10.1212/WNL.44.10.1872; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Rayaprolu S, 2012, ANN NEUROL, V71, P725, DOI 10.1002/ana.23586; Steidinger TU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056092; Steidinger TU, 2011, J NEUROCHEM, V116, P334, DOI 10.1111/j.1471-4159.2010.07112.x; Subramanian V, 2008, HUM MOL GENET, V17, P130, DOI 10.1093/hmg/ddm290; Thiyagarajan N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2126; van Es MA, 2009, NEUROLOGY, V72, P287, DOI 10.1212/01.wnl.0000339487.84908.00; van Es MA, 2011, ANN NEUROL, V70, P964, DOI 10.1002/ana.22611; Wu RM, 2005, ARCH NEUROL-CHICAGO, V62, P82, DOI 10.1001/archneur.62.1.82	20	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112661	10.1371/journal.pone.0112661	http://dx.doi.org/10.1371/journal.pone.0112661			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386690	Green Published, Green Submitted, gold			2022-12-27	WOS:000345250400080
J	Golenia, L; Schoemaker, MM; Mouton, LJ; Bongers, RM				Golenia, Laura; Schoemaker, Marina M.; Mouton, Leonora J.; Bongers, Raoul M.			Individual Differences in Learning a Novel Discrete Motor Task	PLOS ONE			English	Article							TOOL USE; COORDINATION; PREHENSION; MOVEMENTS; DYNAMICS; POLYMORPHISM; LEVEL; SKILL; THUMB; HAND	Many motor learning studies focus on average performance while it is known from everyday life experience that humans differ in their way of learning new motor tasks. This study emphasises the importance of recognizing individual differences in motor learning. We studied individual tool grasping profiles of individuals who learned to pick up objects with a novel tool, a pair of pliers. The pair of pliers was attached to the thumb and the index finger so that the tip of the thumb and the tip of the index finger were displaced to the beaks of the pair of pliers. The grasp component was manipulated by varying the location of the hinge of the pair of pliers, which resulted in different relations between beak opening and closing and finger opening and closing. The Wider Beak group had the hinge at 7 cm, the Same Beak group had the hinge at 10 cm (i.e., in the middle), and the Smaller Beak group had the hinge at 13 cm from the digits. Each group consisted of ten right-handed participants who picked up an object with one of the pairs of pliers 200 times on two subsequent days. Hand opening, plateau phase, hand closing, grasping time and maximum aperture were analyzed. To characterize individual changes over practice time, a log function was fitted on these dependent variables and the ratio of improvement was determined. Results showed that at the beginning stage of tool use learning the characteristic grasping profile consisted of three phases; hand opening, plateau phase and hand closing. Over practicing individual participants differed in the number of phases that changed, the amount of change in a phase and/or the direction of change. Moreover, with different pliers different learning paths were found. The importance of recognizing individual differences in motor learning is discussed.	[Golenia, Laura; Schoemaker, Marina M.; Mouton, Leonora J.; Bongers, Raoul M.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands	University of Groningen	Bongers, RM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	r.m.bongers@umcg.nl	Bongers, Raoul/C-1094-2012	Bongers, Raoul/0000-0002-3518-7464; Mouton, Leonora/0000-0001-8389-2013				Atun-Einy O, 2012, DEV PSYCHOBIOL, V54, P187, DOI 10.1002/dev.20593; BEEK PJ, 1995, HUM MOVEMENT SCI, V14, P573, DOI 10.1016/0167-9457(95)00028-5; Beisert M, 2010, J EXP PSYCHOL HUMAN, V36, P359, DOI 10.1037/a0016801; Berger SE, 2003, DEV PSYCHOL, V39, P594, DOI 10.1037/0012-1649.39.3.594; Biryukova EV, 2008, MOTOR CONTROL, V12, P181, DOI 10.1123/mcj.12.3.181; Bongers RM, 2012, HUM MOVEMENT SCI, V31, P487, DOI 10.1016/j.humov.2011.07.014; Bongers RM, 2010, LECT NOTES COMPUT SC, V6192, P271, DOI 10.1007/978-3-642-14075-4_39; Bouwsema H, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-16; Bouwsema H, 2012, J REHABIL RES DEV, V49, P1331, DOI 10.1682/JRRD.2011.09.0179; Bouwsema H, 2010, ARCH PHYS MED REHAB, V91, P1442, DOI 10.1016/j.apmr.2010.06.025; Campolo D, 2012, PLOS ONE, V9; Cesqui B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031770; Cheeran BJ, 2009, NEUROSCIENCE, V164, P156, DOI 10.1016/j.neuroscience.2009.01.054; Cheeran B, 2008, J PHYSIOL-LONDON, V586, P5717, DOI 10.1113/jphysiol.2008.159905; Cluff T, 2012, J NEUROPHYSIOL, V108, P1167, DOI 10.1152/jn.00691.2011; Cuijpers RH, 2004, J NEUROPHYSIOL, V91, P2598, DOI 10.1152/jn.00644.2003; Davare M, 2011, CURR OPIN NEUROBIOL, V21, P565, DOI 10.1016/j.conb.2011.05.021; Gentilucci M, 2004, EXP BRAIN RES, V157, P496, DOI 10.1007/s00221-004-1863-8; Hesse C, 2009, HUM MOVEMENT SCI, V28, P415, DOI 10.1016/j.humov.2009.03.001; Jacobs DM, 2007, ECOL PSYCHOL, V19, P321, DOI 10.1080/10407410701432337; Jacobs DM, 2012, J EXP PSYCHOL HUMAN, V38, P1215, DOI 10.1037/a0027632; JEANNEROD M, 1984, J MOTOR BEHAV, V16, P235; Kelso S., 1995, DYNAMIC PATTERNS SEL; King AC, 2012, NEUROSCI LETT, V529, P144, DOI 10.1016/j.neulet.2012.08.014; Kostrubiec V, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00222; Kruger M, 2012, HUM MOVEMENT SCI, V31, P1071, DOI 10.1016/j.humov.2011.12.002; Massen C, 2010, ACTA PSYCHOL, V135, P201, DOI 10.1016/j.actpsy.2010.06.007; Michaels C, 1995, ECOL PSYCHOL, V7, P259, DOI 10.1207/s15326969eco0704_2; Michaels CF, 2012, PERCEPTION, V41, P93, DOI 10.1068/p6994; Mon-Williams M, 2001, CURR BIOL, V11, P1058, DOI 10.1016/S0960-9822(01)00293-7; Newell A., 1981, COGNITIVE SKILLS THE, P1; Newell K.M., 1986, MOTOR DEV CHILDREN A, VVolume 34, P341, DOI DOI 10.1007/978-94-009-4460-2_19; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Snapp-Childs W, 2013, J CHILD NEUROL, V28, P204, DOI 10.1177/0883073812461945; Snoddy GS, 1926, J APPL PSYCHOL, V10, P1, DOI 10.1037/h0075814; Sulzenbruck S, 2009, EXP BRAIN RES, V195, P153, DOI 10.1007/s00221-009-1764-y; THELEN E, 1993, CHILD DEV, V64, P1058, DOI 10.2307/1131327; Thelen E, 1996, J EXP PSYCHOL HUMAN, V22, P1059, DOI 10.1037/0096-1523.22.5.1059; TURVEY MT, 1990, AM PSYCHOL, V45, P938, DOI 10.1037/0003-066X.45.8.938; Vegter RJK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089729; WING AM, 1983, Q J EXP PSYCHOL-A, V35, P297, DOI 10.1080/14640748308402135; Zaal FTJM, 1998, EXP BRAIN RES, V119, P427, DOI 10.1007/s002210050358; ZANONE PG, 1992, J EXP PSYCHOL HUMAN, V18, P403, DOI 10.1037/0096-1523.18.2.403; Zanone PG, 1997, J EXP PSYCHOL HUMAN, V23, P1454, DOI 10.1037/0096-1523.23.5.1454; Zheng C. L., 2007, HUM FACTORS ERGONOM, V51, P1353, DOI DOI 10.1177/154193120705101917	45	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112806	10.1371/journal.pone.0112806	http://dx.doi.org/10.1371/journal.pone.0112806			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT9MC	25386708	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400094
J	Hou, YJ; Wang, Y; Zhao, J; Li, XH; Cui, J; Ding, JQ; Wang, Y; Zeng, XL; Ling, Y; Shen, XH; Chen, SD; Huang, CG; Pei, G				Hou, Yujun; Wang, Ying; Zhao, Jian; Li, Xiaohang; Cui, Jin; Ding, Jianqing; Wang, Ying; Zeng, Xianglu; Ling, Yun; Shen, Xiaoheng; Chen, Shengdi; Huang, Chenggang; Pei, Gang			Smart Soup, a Traditional Chinese Medicine Formula, Ameliorates Amyloid Pathology and Related Cognitive Deficits	PLOS ONE			English	Article							MOUSE MODEL; ALZHEIMERS-DISEASE; MEMORY DEFICITS; BETA; DROSOPHILA; EXPRESSION; OLIGOMERS; EXTRACT; BT-11; BRAIN	Alzheimer's disease (AD) is a progressive neurodegenerative disease that causes substantial public health care burdens. Intensive efforts have been made to find effective and safe disease-modifying treatment and symptomatic intervention alternatives against AD. Smart Soup (SS), a Chinese medicine formula composed of Rhizoma Acori Tatarinowii (AT), Poria cum Radix Pini (PRP) and Radix Polygalae (RP), is a typical prescription against memory deficits. Here, we assessed the efficacy of SS against AD. Oral administration of SS ameliorated the cognitive impairment of AD transgenic mice, with reduced A beta levels, retarded A beta amyloidosis and reduced A beta-induced gliosis and neuronal loss in the brains of AD mice. Consistently, SS treatment reduced amyloid-related locomotor dysfunctions and premature death of AD transgenic Drosophila. Mechanistic studies showed that RP reduced A beta generation, whereas AT and PRP exerted neuroprotective effects against A beta. Taken together, our study indicates that SS could be effective against AD, providing a practical therapeutic strategy against the disease.	[Hou, Yujun; Zhao, Jian; Li, Xiaohang; Cui, Jin; Zeng, Xianglu; Pei, Gang] Chinese Acad Sci, Shanghai Inst Biol Sci, Grad Sch, State Key Lab Cell Biol,Inst Biochem & Cell Biol, Shanghai, Peoples R China; [Wang, Ying; Ding, Jianqing; Chen, Shengdi] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Inst Neurol, Shanghai 200030, Peoples R China; [Wang, Ying] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Neurol, Shanghai 200030, Peoples R China; [Ling, Yun; Huang, Chenggang] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China; [Shen, Xiaoheng] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Tradit Chinese Med, Shanghai 200030, Peoples R China; [Pei, Gang] Tongji Univ, Sch Life Sci & Technol, Shanghai Key Lab Signaling & Dis Res, Shanghai 200092, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Jiao Tong University; Tongji University	Zhao, J (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Grad Sch, State Key Lab Cell Biol,Inst Biochem & Cell Biol, Shanghai, Peoples R China.	jzhao@sibs.ac.cn; gpei@sibs.ac.cn	Hou, Yujun/AFX-2626-2022; Zhao, Jian/E-2008-2019	Zhao, Jian/0000-0002-8862-0591; Hou, Yujun/0000-0003-1778-1176; Li, Xiaohang/0000-0002-7316-2196	National Natural Science Foundation of China [31371419]; Chinese Academy of Sciences [KSCX2-EW-Q-1-01, KSCX2-YW-R-252]; National Science and Technology [2012BAI10B03]; Ministry of Science and Technology [2011CB910202]; Shanghai Municipal Commission for Science and Technology [13401900600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Science and Technology; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Shanghai Municipal Commission for Science and Technology	This work was supported by National Natural Science Foundation of China (31371419), Chinese Academy of Sciences (KSCX2-EW-Q-1-01, KSCX2-YW-R-252), National Science and Technology Support Program (2012BAI10B03), the Ministry of Science and Technology (2011CB910202) and Shanghai Municipal Commission for Science and Technology (13401900600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cao DF, 2007, J BIOL CHEM, V282, P36275, DOI 10.1074/jbc.M703561200; Cartier AE, 2009, J NEUROSCI, V29, P7857, DOI 10.1523/JNEUROSCI.1817-09.2009; Chakraborty R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020799; Chen YL, 2004, J ETHNOPHARMACOL, V95, P47, DOI 10.1016/j.jep.2004.06.015; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Hamilton A, 2012, BRAIN RES, V1449, P83, DOI 10.1016/j.brainres.2012.02.015; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Howes MJR, 2003, PHARMACOL BIOCHEM BE, V75, P513, DOI 10.1016/S0091-3057(03)00128-X; Iijima K, 2008, J ALZHEIMERS DIS, V15, P523; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Kraft AW, 2012, FASEB J OFFICIAL PUB; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Lee BB, 2003, LIFE SCI, V74, P435, DOI 10.1016/j.lfs.2003.06.034; Lee JY, 2009, NEUROSCI LETT, V454, P111, DOI 10.1016/j.neulet.2009.03.024; Lesne S, 2008, NEUROSCIENCE, V151, P745, DOI 10.1016/j.neuroscience.2007.10.054; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lin ZH, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/692621; Ling Y, 2013, PHYTOCHEM ANALYSIS, V24, P677, DOI 10.1002/pca.2454; Liu XS, 2013, CELL RES, V23, P351, DOI 10.1038/cr.2012.167; Lu JH, 2011, CHEMBIOCHEM, V12, P615, DOI 10.1002/cbic.201000604; McGeer EG, 2003, PROG NEURO-PSYCHOPH, V27, P741, DOI 10.1016/S0278-5846(03)00124-6; Mhatre SD, 2014, DIS MODEL MECH, V7, P373, DOI 10.1242/dmm.012104; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Muqit MMK, 2002, NAT REV NEUROSCI, V3, P237, DOI 10.1038/nrn751; Park CH, 2002, J NEUROSCI RES, V70, P484, DOI 10.1002/jnr.10429; Reiserer RS, 2007, GENES BRAIN BEHAV, V6, P54, DOI 10.1111/j.1601-183X.2006.00221.x; Selkoe DJ, 2002, J CLIN INVEST, V110, P1375, DOI 10.1172/JCI200216783; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shin KY, 2009, NEUROSCI LETT, V465, P157, DOI 10.1016/j.neulet.2009.08.033; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Teng L, 2010, CELL RES, V20, P138, DOI 10.1038/cr.2010.3; Tian XY, 2012, CHIN J INTEGR MED, V18, P539, DOI 10.1007/s11655-011-0900-2; Tong XG, 2010, J ASIAN NAT PROD RES, V12, P419, DOI 10.1080/10286021003762010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; White KE, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00205; Winslow BT, 2011, AM FAM PHYSICIAN, V83, P1403; Zhao XL, 2010, J NEUROSCI, V30, P1512, DOI 10.1523/JNEUROSCI.3699-09.2010	47	33	37	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111215	10.1371/journal.pone.0111215	http://dx.doi.org/10.1371/journal.pone.0111215			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386946	Green Published, Green Submitted, gold			2022-12-27	WOS:000345250400015
J	Jaber, L; Zhao, FL; Kolli, T; Herness, S				Jaber, Luc; Zhao, Fang-li; Kolli, Tamara; Herness, Scott			A Physiologic Role for Serotonergic Transmission in Adult Rat Taste Buds	PLOS ONE			English	Article							REUPTAKE INHIBITOR PAROXETINE; RECEPTOR-CELLS; FUNCTIONAL EXPRESSION; 5-HT1A RECEPTORS; GAP-JUNCTION; ATP RELEASE; III CELLS; G-PROTEIN; LOCALIZATION; COMMUNICATION	Of the multiple neurotransmitters and neuropeptides expressed in the mammalian taste bud, serotonin remains both the most studied and least understood. Serotonin is expressed in a subset of taste receptor cells that form synapses with afferent nerve fibers (type III cells) and was once thought to be essential to neurotransmission (now understood as purinergic). However, the discovery of the 5-HT1A serotonin receptor in a subset of taste receptor cells paracrine to type III cell suggested a role in cell-to-cell communication during the processing of taste information. Functional data describing this role are lacking. Using anatomical and neurophysiological techniques, this study proposes a modulatory role for serotonin during the processing of taste information. Double labeling immunocytochemical and single cell RT-PCR technique experiments documented that 5-HT1A-expressing cells co-expressed markers for type II cells, cells which express T1R or T2R receptors and release ATP. These cells did not co-express type III cells markers. Neurophysiological recordings from the chorda tympani nerve, which innervates anterior taste buds, were performed prior to and during intravenous injection of a 5-HT1A receptor antagonist. These experiments revealed that serotonin facilitates processing of taste information for tastants representing sweet, sour, salty, and bitter taste qualities. On the other hand, injection of ondansetron, a 5-HT3 receptor antagonist, was without effect. Collectively, these data support the hypothesis that serotonin is a crucial element in a finely-tuned feedback loop involving the 5-HT1A receptor, ATP, and purinoceptors. It is hypothesized that serotonin facilitates gustatory signals by regulating the release of ATP through ATP-release channels possibly through phosphatidylinositol 4,5-bisphosphate resynthesis. By doing so, 5-HT1A activation prevents desensitization of post-synaptic purinergic receptors expressed on afferent nerve fibers and enhances the afferent signal. Serotonin may thus play a major modulatory role within peripheral taste in shaping the afferent taste signals prior to their transmission across gustatory nerves.	[Jaber, Luc; Zhao, Fang-li; Kolli, Tamara; Herness, Scott] Ohio State Univ, Coll Dent, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Herness, S (corresponding author), Ohio State Univ, Coll Dent, Columbus, OH 43210 USA.	herness.1@osu.edu	Jaber-Luc, Fadi/AAD-9932-2020		National Institute on Deafness and Other Communication Disorders, National Institutes of Health [5R01DC00401]; Ohio State University Open Access Fund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000401] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Ohio State University Open Access Fund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institute on Deafness and Other Communication Disorders, National Institutes of Health (www.nidcd.nih.gov; 5R01DC00401). Partial funding for Open Access provided by The Ohio State University Open Access Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Antunes VR, 2005, CLIN EXP PHARMACOL P, V32, P467, DOI 10.1111/j.1440-1681.2005.04213.x; Baryshnikov SG, 2003, J NEUROPHYSIOL, V90, P3283, DOI 10.1152/jn.00312.2003; Beider L. M., 1971, HDB SENSORY PHYSL, V4, P200; Bo XN, 1999, NEUROREPORT, V10, P1107, DOI 10.1097/00001756-199904060-00037; Borroto-Escuela DO, 2012, J NEUROSCI, V32, P6295, DOI 10.1523/JNEUROSCI.4203-11.2012; Bystrova MF, 2006, CELL TISSUE RES, V323, P377, DOI 10.1007/s00441-005-0098-8; Cameron SJ, 2003, J BIOL CHEM, V278, P18682, DOI 10.1074/jbc.M213283200; Cao Y, 2009, P NATL ACAD SCI USA, V106, P4006, DOI 10.1073/pnas.0808672106; Chen K, 2010, BRAIN RES, V1325, P53, DOI 10.1016/j.brainres.2010.02.026; Cook SP, 1997, NEUROPHARMACOLOGY, V36, P1303, DOI 10.1016/S0028-3908(97)00132-9; DeFazio RA, 2006, J NEUROSCI, V26, P3971, DOI 10.1523/JNEUROSCI.0515-06.2006; Delay RJ, 1997, J NEUROPHYSIOL, V77, P2515, DOI 10.1152/jn.1997.77.5.2515; EWALD DA, 1994, J NEUROSCI, V14, P3791; Fedorov IV, 2007, BBA-BIOMEMBRANES, V1768, P1727, DOI 10.1016/j.bbamem.2007.04.002; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Florea L, 2005, GENOME RES, V15, P54, DOI 10.1101/gr.2889405; FUJIMOTO S, 1987, ACTA ANAT, V128, P80; Getchell TV, 1997, NEUROREPORT, V8, pR3; Hayato R, 2007, J PHYSIOL-LONDON, V584, P473, DOI 10.1113/jphysiol.2007.138370; He ML, 2002, MOL PHARMACOL, V62, P1187, DOI 10.1124/mol.62.5.1187; Heath TP, 2006, J NEUROSCI, V26, P12664, DOI 10.1523/JNEUROSCI.3459-06.2006; HERNESS MS, 1985, J GEN PHYSIOL, V86, P59, DOI 10.1085/jgp.86.1.59; Herness MS, 2000, J MEMBRANE BIOL, V173, P127, DOI 10.1007/s002320001014; Herness S, 1997, NEUROREPORT, V8, P3257, DOI 10.1097/00001756-199710200-00014; Herness S, 2012, PHYSL GASTROINTESTIN, V1, P741; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; HOON MA, 1995, BIOCHEM J, V309, P629, DOI 10.1042/bj3090629; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Huang YA, 2009, J NEUROSCI, V29, P13909, DOI 10.1523/JNEUROSCI.2351-09.2009; Huang YJ, 2005, J NEUROSCI, V25, P843, DOI 10.1523/JNEUROSCI.4446-04.2005; Imendra KG, 2000, NEUROSCI LETT, V294, P151, DOI 10.1016/S0304-3940(00)01567-6; Imendra KG, 2002, EUR J NEUROSCI, V16, P629, DOI 10.1046/j.1460-9568.2002.02107.x; Ishikawa M, 2011, J CELL BIOL, V193, P1257, DOI 10.1083/jcb.201101050; Kakinohana O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030561; Kataoka S, 2004, HISTOCHEM CELL BIOL, V121, P419, DOI 10.1007/s00418-004-0647-3; Kaya N, 2004, AM J PHYSIOL-REG I, V286, pR649, DOI 10.1152/ajpregu.00572.2003; KIM DJ, 1995, J COMP NEUROL, V353, P364, DOI 10.1002/cne.903530304; Kinnamon SC, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00264; Kishi M, 2001, NEUROSCIENCE, V106, P217, DOI 10.1016/S0306-4522(01)00184-1; Kokrashvili Z, 2009, ANN NY ACAD SCI, V1170, P91, DOI 10.1111/j.1749-6632.2009.04485.x; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; Ma HZ, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-5; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Mathes CM, 2013, CHEM SENSES, V38, P211, DOI 10.1093/chemse/bjs096; Mathes CM, 2011, CHEM SENSES, V36, P515, DOI 10.1093/chemse/bjr011; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; MINISCLOU C, 1995, NEUROCHEM RES, V20, P977, DOI 10.1007/BF00995549; Montmayeur JP, 2002, CURR OPIN NEUROBIOL, V12, P366, DOI 10.1016/S0959-4388(02)00345-8; Murata Y, 2010, J NEUROPHYSIOL, V104, P896, DOI 10.1152/jn.00414.2010; NADA O, 1975, HISTOCHEMISTRY, V43, P237, DOI 10.1007/BF00499704; Ni YG, 1997, MOL BRAIN RES, V51, P115, DOI 10.1016/S0169-328X(97)00225-8; Obata H, 1997, MOL BRAIN RES, V49, P29, DOI 10.1016/S0169-328X(97)00118-6; Ohmoto M, 2008, MOL CELL NEUROSCI, V38, P505, DOI 10.1016/j.mcn.2008.04.011; Ohmoto M, 2011, J COMP NEUROL, V519, P1616, DOI 10.1002/cne.22589; Raymond JR, 1999, BRIT J PHARMACOL, V127, P1751, DOI 10.1038/sj.bjp.0702723; Ren Y, 1999, MOL BRAIN RES, V74, P221, DOI 10.1016/S0169-328X(99)00253-3; Rettinger J, 2004, J BIOL CHEM, V279, P6426, DOI 10.1074/jbc.M306987200; Romanov RA, 2007, EMBO J, V26, P657, DOI 10.1038/sj.emboj.7601526; Romanov RA, 2008, J GEN PHYSIOL, V132, P731, DOI 10.1085/jgp.200810108; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; SATO T, 1983, COMP BIOCHEM PHYS A, V75, P131, DOI 10.1016/0300-9629(83)90058-0; Shindler KS, 1996, J HISTOCHEM CYTOCHEM, V44, P1331, DOI 10.1177/44.11.8918908; SHINGAI T, 1985, BRAIN RES, V335, P245, DOI 10.1016/0006-8993(85)90476-7; Simon SA, 2003, AM J PHYSIOL-REG I, V284, pR1494, DOI 10.1152/ajpregu.00544.2002; SMITH DV, 1993, J COMP NEUROL, V336, P493, DOI 10.1002/cne.903360403; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Taruno A, 2013, NATURE, V495, P223, DOI 10.1038/nature11906; THOMAS T, 1993, EXP PHYSIOL, V78, P541, DOI 10.1113/expphysiol.1993.sp003705; Uchida S, 2010, J NEUROSCI, V30, P15007, DOI 10.1523/JNEUROSCI.1436-10.2010; Uchida T., 1985, JPN J ORAL BIOL, V27, P509; Ueda K, 2006, ARCH HISTOL CYTOL, V69, P289, DOI 10.1679/aohc.69.289; Yee CL, 2001, J COMP NEUROL, V440, P97, DOI 10.1002/cne.1372; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao FL, 2009, J PHYSIOL-LONDON, V587, P363, DOI 10.1113/jphysiol.2008.165167; Zhao FL, 2005, P NATL ACAD SCI USA, V102, P11100, DOI 10.1073/pnas.0501988102; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	81	20	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112152	10.1371/journal.pone.0112152	http://dx.doi.org/10.1371/journal.pone.0112152			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386961	Green Published, gold			2022-12-27	WOS:000345250400043
J	Jaeger, P; Koscielniak-Nielsen, ZJ; Schroder, HM; Mathiesen, O; Henningsen, MH; Lund, J; Jenstrup, MT; Dahl, JB				Jaeger, Pia; Koscielniak-Nielsen, Zbigniew J.; Schroder, Henrik M.; Mathiesen, Ole; Henningsen, Maria H.; Lund, Jorgen; Jenstrup, Morten T.; Dahl, Jorgen B.			Adductor Canal Block for Postoperative Pain Treatment after Revision Knee Arthroplasty: A Blinded, Randomized, Placebo-Controlled Study	PLOS ONE			English	Article							FEMORAL NERVE BLOCK; QUADRICEPS STRENGTH; ANALGESIA; VOLUNTEERS	Background: Revision knee arthroplasty is assumed to be even more painful than primary knee arthroplasty and predominantly performed in chronic pain patients, which challenges postoperative pain treatment. We hypothesized that the adductor canal block, effective for pain relief after primary total knee arthroplasty, may reduce pain during knee flexion (primary endpoint: at 4 h) compared with placebo after revision total knee arthroplasty. Secondary endpoints were pain at rest, morphine consumption and morphine-related side effects. Methods: We included patients scheduled for revision knee arthroplasty in general anesthesia into this blinded, placebo-controlled, randomized trial. Patients were allocated to an adductor canal block via a catheter with either ropivacaine or placebo; bolus of 0.75% ropivacaine/saline, followed by infusion of 0.2% ropivacaine/saline. Clinicaltrials.gov ID: NCT01191593. Results: We enrolled 36 patients, of which 30 were analyzed. Mean pain scores during knee flexion at 4 h (primary endpoint) were: 52 +/- 22 versus 71 +/- 25 mm (mean difference 19, 95% CI: 1 to 37, P = 0.04), ropivacaine and placebo group respectively. When calculated as area under the curve (1-8 h/7 h) pain scores were 55 +/- 21 versus 69 +/- 21 mm during knee flexion (P = 0.11) and 39 +/- 18 versus 45 +/- 23 mm at rest (P = 0.43), ropivacaine and placebo group respectively. Groups were similar regarding morphine consumption and morphine-related side effects (P>0.05). Conclusions: The only statistically significant difference found between groups was in the primary endpoint: pain during knee flexion at 4 h. However, due to a larger than anticipated dropout rate and heterogeneous study population, the study was underpowered.	[Jaeger, Pia; Koscielniak-Nielsen, Zbigniew J.; Henningsen, Maria H.; Dahl, Jorgen B.] Copenhagen Univ Hosp, Rigshosp, Ctr Head & Orthopaed, Dept Anaesthesia, Copenhagen, Denmark; [Schroder, Henrik M.] Copenhagen Univ Hosp, Rigshosp, Ctr Head & Orthopaed, Dept Orthopaed Surg, Copenhagen, Denmark; [Mathiesen, Ole] Copenhagen Univ Hosp, Rigshosp, Ctr Head & Orthopaed, Sect Acute Pain Management,Dept Anaesthesia, Copenhagen, Denmark; [Lund, Jorgen; Jenstrup, Morten T.] Aleris Hamlet Hosp, Dept Anaesthesia, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Jaeger, P (corresponding author), Copenhagen Univ Hosp, Rigshosp, Ctr Head & Orthopaed, Dept Anaesthesia, Copenhagen, Denmark.	pia.therese.jaeger@regionh.dk		Mathiesen, Ole/0000-0003-4544-0619				Andersen HL, 2013, REGION ANESTH PAIN M, V38, P106, DOI 10.1097/AAP.0b013e31827900a9; Brummett CM, 2013, ANESTHESIOLOGY, V119, P1434, DOI 10.1097/ALN.0b013e3182a8eb1f; Dahl JB, 2012, ACTA ANAESTH SCAND, V56, P669, DOI 10.1111/j.1399-6576.2012.02680.x; Fischer HBJ, 2008, ANAESTHESIA, V63, P1105, DOI 10.1111/j.1365-2044.2008.05565.x; Goldberg V M, 2001, Instr Course Lect, V50, P357; Grevstad U, 2014, BRIT J ANAESTH, V112, P912, DOI 10.1093/bja/aet441; Jaeger P, 2013, REGION ANESTH PAIN M, V38, P526, DOI 10.1097/AAP.0000000000000015; Jaeger P, 2013, ANESTHESIOLOGY, V118, P409, DOI 10.1097/ALN.0b013e318279fa0b; Jenstrup MT, 2012, ACTA ANAESTH SCAND, V56, P357, DOI 10.1111/j.1399-6576.2011.02621.x; Kwofie MK, 2013, REGION ANESTH PAIN M, V38, P321, DOI 10.1097/AAP.0b013e318295df80; Liu SS, 2012, INT ORTHOP, V36, P2261, DOI 10.1007/s00264-012-1623-5; Lund J, 2011, ACTA ANAESTH SCAND, V55, P14, DOI 10.1111/j.1399-6576.2010.02333.x; van Kempen RWTM, 2013, CLIN ORTHOP RELAT R, V471, P2296, DOI 10.1007/s11999-013-2940-8; White IR, 2012, CLIN TRIALS, V9, P396, DOI 10.1177/1740774512450098	14	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111951	10.1371/journal.pone.0111951	http://dx.doi.org/10.1371/journal.pone.0111951			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386752	Green Submitted, gold, Green Published			2022-12-27	WOS:000345250400032
J	Rakotosamimanana, S; Mandrosovololona, V; Rakotonirina, J; Ramamonjisoa, J; Ranjalahy, JR; Randremanana, RV; Rakotomanana, F				Rakotosamimanana, Sitraka; Mandrosovololona, Vatsiharizandry; Rakotonirina, Julio; Ramamonjisoa, Joselyne; Ranjalahy, Justin Rasolofomanana; Randremanana, Rindra Vatosoa; Rakotomanana, Fanjasoa			Spatial Analysis of Pulmonary Tuberculosis in Antananarivo Madagascar: Tuberculosis-Related Knowledge, Attitude and Practice	PLOS ONE			English	Article							COMMUNITIES; PATTERNS; MIDDLE; AREA	Introduction: Tuberculosis infection may remain latent, but the disease is nevertheless a serious public health issue. Various epidemiological studies on pulmonary tuberculosis have considered the spatial component and taken it into account, revealing the tendency of this disease to cluster in particular locations. The aim was to assess the contribution of Knowledge Attitude and Practice (KAP) to the distribution of tuberculosis and to provide information for the improvement of the National Tuberculosis Program. Methods: We investigated the role of KAP to distribution patterns of pulmonary tuberculosis in Antananarivo. First, we performed spatial scanning of tuberculosis aggregation among permanent cases resident in Antananarivo Urban Township using the Kulldorff method, and then we carried out a quantitative study on KAP, involving TB patients. The KAP study in the population was based on qualitative methods with focus groups. Results: The disease still clusters in the same districts identified in the previous study. The principal cluster covered 22 neighborhoods. Most of them are part of the first district. A secondary cluster was found, involving 18 neighborhoods in the sixth district and two neighborhoods in the fifth. The relative risk was respectively 1.7 (p<10(-6)) in the principal cluster and 1.6 (p<10(-3)) in the secondary cluster. Our study showed that more was known about TB symptoms than about the duration of the disease or free treatment. Knowledge about TB was limited to that acquired at school or from relatives with TB. The attitude and practices of patients and the population in general indicated that there is still a stigma attached to tuberculosis. Conclusion: This type of survey can be conducted in remote zones where the tuberculosis-related KAP of the TB patients and the general population is less known or not documented; the findings could be used to adapt control measures to the local particularities.	[Rakotosamimanana, Sitraka; Ramamonjisoa, Joselyne] Univ Antananarivo, Fac Lettres & Sci Humaines, Dept Geog, Antananarivo, Madagascar; [Mandrosovololona, Vatsiharizandry; Rakotonirina, Julio; Ranjalahy, Justin Rasolofomanana] Inst Natl Sante Publ & Communautaire, Antananarivo, Madagascar; [Rakotonirina, Julio] Etab Univ Soins Sante Publ Analakely, Antananarivo, Madagascar; [Randremanana, Rindra Vatosoa; Rakotomanana, Fanjasoa] Inst Pasteur Madagascar, Antananarivo, Madagascar	University Antananarivo; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar	Rakotomanana, F (corresponding author), Inst Pasteur Madagascar, Antananarivo, Madagascar.	fanja@pasteur.mg	Rakotosamimanana, Sitraka/AAD-8165-2022	RAKOTOSAMIMANANA, Sitraka/0000-0002-1028-0427; RAKOTOMANANA, Fanjasoa/0000-0002-3373-1075	Institut Pasteur de Madagascar	Institut Pasteur de Madagascar	This work was supported by Institut Pasteur de Madagascar. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013339; Brooker S, 2004, TROP MED INT HEALTH, V9, P757, DOI 10.1111/j.1365-3156.2004.01272.x; Cadot, 1998, Sante, V8, P447; Dangendorf F, 2002, INT J HYG ENVIR HEAL, V205, P183, DOI 10.1078/1438-4639-00151; Deribew A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-400; Gelaw M, 2001, East Afr Med J, V78, P382; Gonzalez-Ochoa E, 2009, TROP MED INT HEALTH, V14, P131, DOI 10.1111/j.1365-3156.2008.02201.x; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M, 2014, SATSCAN TM USER GUID; Legesse M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-187; Maciel EL, INT J TUBERC LUNG DI, V14, P1403; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Munch Z, 2003, INT J TUBERC LUNG D, V7, P271; Mushtaq MU, 2010, INT J TUBERC LUNG D, V14, P303; Onozuka D, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-26; Rahalison L, 2003, ADV EXP MED BIOL, V529, P439; Raharimanga V., 2001, Archives de l'Institut Pasteur de Madagascar, V67, P19; Randremanana R. V., 2001, Archives de l'Institut Pasteur de Madagascar, V67, P74; Randremanana RV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-21; Randremanana RV, 2009, TROP MED INT HEALTH, V14, P429, DOI 10.1111/j.1365-3156.2009.02239.x; Singh M. Meghachandra, 2002, Journal of Communicable Diseases, V34, P203; Tadesse T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065022; Tiwari Neeraj, 2006, Int J Health Geogr, V5, P33, DOI 10.1186/1476-072X-5-33; Touray K, 2010, TROP MED INT HEALTH, V15, P664, DOI 10.1111/j.1365-3156.2010.02533.x; Vukovic DS, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-284; Wandwalo ER, 2000, INT J TUBERC LUNG D, V4, P1041; Wang T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-885; Zaffar Sadiq MGSM, GIS PUBLIC HLTH MANA; Bastida AZ, 2012, SCI WORLD J, DOI 10.1100/2012/570278	29	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e110471	10.1371/journal.pone.0110471	http://dx.doi.org/10.1371/journal.pone.0110471			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386655	Green Published, Green Submitted, gold			2022-12-27	WOS:000345250400009
J	Guldbrandt, LM; Rasmussen, TR; Rasmussen, F; Vedsted, P				Guldbrandt, Louise Mahncke; Rasmussen, Torben Riis; Rasmussen, Finn; Vedsted, Peter			Implementing Direct Access to Low-Dose Computed Tomography in General Practice-Method, Adaption and Outcome	PLOS ONE			English	Article							LUNG-CANCER; DIAGNOSIS; EXPERIENCE; STATEMENT; PATHWAYS; QUALITY; DELAY; RISK; TIME	Background: Early detection of lung cancer is crucial as the prognosis depends on the disease stage. Chest radiographs has been the principal diagnostic tool for general practitioners (GPs), but implies a potential risk of false negative results, while computed tomography (CT) has a higher sensitivity. The aim of this study was to describe the implementation of direct access to low-dose CT (LDCT) from general practice. Methods: We conducted a cohort study nested in a randomised study. A total of 119 general practices with 266 GPs were randomised into two groups. Intervention GPs were offered direct access to chest LDCT combined with a Continuing Medical Education (CME) meeting on lung cancer diagnosis. Results: During a 19-month period, 648 patients were referred to LDCT (0.18/1000 adults on GP list/month). Half of the patients needed further diagnostic work-up, and 15 (2.3%, 95% CI: 1.3-3.8%) of the patients had lung cancer; 60% (95% CI: 32.3-83.7%) in a localised stage. The GP referral rate was 61% higher for CME participants compared to non-participants. Conclusion: Of all patients referred to LDCT, 2.3% were diagnosed with lung cancer with a favourable stage distribution. Half of the referred patients needed additional diagnostic work-up. There was an association between participation in CME and use of CT scan. The proportion of cancers diagnosed through the usual fast-track evaluation was 2.2 times higher in the group of CME-participating GPs. The question remains if primary care case-finding with LDCT is a better option for patients having signs and symptoms indicating lung cancer than a screening program. Whether open access to LDCT may provide earlier diagnosis of lung cancer is yet unknown and a randomised trial is required to assess any effect on outcome.	[Guldbrandt, Louise Mahncke; Vedsted, Peter] Aarhus Univ, Res Ctr Canc Diag Primary Care, Res Unit Gen Practice, Aarhus, Denmark; [Guldbrandt, Louise Mahncke] Aarhus Univ, Dept Publ Hlth, Sect Gen Med Practice, Aarhus, Denmark; [Rasmussen, Torben Riis] Aarhus Univ Hosp, Dept Resp Dis & Allergy, DK-8000 Aarhus, Denmark; [Rasmussen, Finn] Aarhus Univ Hosp, Dept Radiol, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Guldbrandt, LM (corresponding author), Aarhus Univ, Res Ctr Canc Diag Primary Care, Res Unit Gen Practice, Aarhus, Denmark.	louise.mahncke@alm.au.dk	Vedsted, Peter/C-2583-2008	Vedsted, Peter/0000-0003-2113-5599; Rasmussen, Torben Riis/0000-0002-7030-9260	Committee for Quality Improvement and Continuing Medical Education (KEU) of the Central Denmark Region; Multi-Practice Committee (MPU) of the Danish College of General Practitioners (DSAM); Danish Cancer Society; Novo Nordisk Foundation	Committee for Quality Improvement and Continuing Medical Education (KEU) of the Central Denmark Region; Multi-Practice Committee (MPU) of the Danish College of General Practitioners (DSAM); Danish Cancer Society(Danish Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The project was supported by the Committee for Quality Improvement and Continuing Medical Education (KEU) of the Central Denmark Region, the Multi-Practice Committee (MPU) of the Danish College of General Practitioners (DSAM), the Danish Cancer Society, and the Novo Nordisk Foundation. Sponsoring organizations were not involved in any part of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2011, SCAND J PUBLIC HEALT, V39, P34, DOI 10.1177/1403494810394718; Barrett J, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-31; Bjerager M, 2006, BRIT J GEN PRACT, V56, P863; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; Elliss-Brookes L, 2012, BRIT J CANCER, V107, P1220, DOI 10.1038/bjc.2012.408; Engholm G, 2010, ACTA ONCOL, V49, P725, DOI 10.3109/02841861003782017; Frank L, 2013, SEMIN RESP CRIT CARE, V34, P738, DOI 10.1055/s-0033-1358615; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Guldbrandt LM, 2013, DAN MED J, V60; Hamilton W, 2005, THORAX, V60, P1059, DOI 10.1136/thx.2005.045880; Hamilton W, 2009, BRIT J CANCER, V101, pS80, DOI 10.1038/sj.bjc.6605396; Hansen Rikke P, 2011, BMC Health Serv Res, V11, P284, DOI 10.1186/1472-6963-11-284; Jakobsen E, 2009, EUR J CARDIO-THORAC, V35, P348, DOI 10.1016/j.ejcts.2008.09.026; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lyratzopoulos G, 2013, BRIT J CANCER, V108, P686, DOI 10.1038/bjc.2013.1; Lyratzopoulos G, 2012, LANCET ONCOL, V13, P353, DOI 10.1016/S1470-2045(12)70041-4; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; Midthun DE, 2013, J SURG ONCOL; Neal RD, 2007, BRIT J GEN PRACT, V57, P212; O'Donnell CA, 2000, FAM PRACT, V17, P462, DOI 10.1093/fampra/17.6.462; Olesen F, 2009, BRIT J CANCER, V101, pS5, DOI 10.1038/sj.bjc.6605383; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Pedersen Jesper H, 2009, J Thorac Oncol, V4, P608, DOI 10.1097/JTO.0b013e3181a0d98f; Probst HB, 2012, HEALTH POLICY, V105, P65, DOI 10.1016/j.healthpol.2011.11.001; Quekel LGBA, 1999, CHEST, V115, P720, DOI 10.1378/chest.115.3.720; Stapley S, 2006, BRIT J GEN PRACT, V56, P570	28	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112162	10.1371/journal.pone.0112162	http://dx.doi.org/10.1371/journal.pone.0112162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383780	Green Published, Green Submitted, gold			2022-12-27	WOS:000344816700036
J	Pietrzyk, AJ; Bujacz, A; Lochynska, M; Jaskolski, M; Bujacz, G				Pietrzyk, Agnieszka J.; Bujacz, Anna; Lochynska, Malgorzata; Jaskolski, Mariusz; Bujacz, Grzegorz			Crystal Structure of Bombyx mori Lipoprotein 6: Comparative Structural Analysis of the 30-kDa Lipoprotein Family	PLOS ONE			English	Article							MAJOR PLASMA-PROTEINS; INSECT-CELL APOPTOSIS; SILKWORM HEMOLYMPH; MOLECULAR-PROPERTIES; FAT-BODY; X-RAY; BINDING; GENOME; INHIBITION; SEQUENCE	The 30-kDa lipoprotein (LP) family of mulberry silkworm comprises major hemolymph proteins specific to the fifth instar larvae. The family consists of 46 members, 24 of which are referred to as typical 30-kDa LPs. To date, two crystal structures of 30-kDa LPs from Bombyx mori have been described (Bmlp3 and Bmlp7). Here, we present the crystal structure of Bmlp6, another 30-kDa LP member. Bmlp6 is comprised of two domains characteristic of this family, the VHS-type N-terminal domain and beta-trefoil C-terminal domain. The structures of the three 30-kDa LPs have been compared and a number of differences are noted, including loop conformation, the surface electrostatic potential, and the potential binding cavities. We discuss the observed structural differences in the light of the potential different roles of the particular 30-kDa LP members in silkworm physiology.	[Pietrzyk, Agnieszka J.; Jaskolski, Mariusz; Bujacz, Grzegorz] Polish Acad Sci, Inst Bioorgan Chem, Ctr Biocrystallog Res, Poznan, Poland; [Bujacz, Anna; Bujacz, Grzegorz] Tech Univ Lodz, Inst Tech Biochem, Fac Biotechnol & Food Sci, PL-90924 Lodz, Poland; [Lochynska, Malgorzata] Inst Nat Fibers & Med Plants, Poznan, Poland; [Jaskolski, Mariusz] Adam Mickiewicz Univ, Fac Chem, Dept Crystallog, PL-60780 Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Lodz University of Technology; Institute of Natural Fibres & Medicinal Plants; Adam Mickiewicz University	Bujacz, G (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Ctr Biocrystallog Res, Poznan, Poland.	grzegorz.bujacz@p.lodz.pl	Pietrzyk-Brzezinska, Agnieszka J./M-3560-2018; Bujacz, Grzegorz/M-4446-2018; Łochyńska, Małgorzata/C-7129-2016; Bujacz, Anna/M-4464-2018	Pietrzyk-Brzezinska, Agnieszka J./0000-0003-1565-7307; Bujacz, Grzegorz/0000-0002-3787-7522; Łochyńska, Małgorzata/0000-0001-8796-204X; Bujacz, Anna/0000-0002-0808-1349; Jaskolski, Mariusz/0000-0003-1587-6489	European Union within the European Regional Development Fund; European Community's Seventh Framework Programme (FP7) under BioStruct-X [283570]; National Science Centre [2011/03/B/NZ1/01238]	European Union within the European Regional Development Fund; European Community's Seventh Framework Programme (FP7) under BioStruct-X; National Science Centre(National Science Centre, Poland)	This work was supported in part by the European Union within the European Regional Development Fund and by grant 2011/03/B/NZ1/01238 from the National Science Centre to GB. The use of the BESSY and the DESY beamlines received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X (grant agreement No. 283570). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; CHEN Y L, 1990, Journal of Sericultural Science of Japan, V59, P202; Choi SS, 2005, BIOTECHNOL BIOENG, V91, P793, DOI 10.1002/bit.20550; Choi SS, 2002, BIOTECHNOL PROGR, V18, P874, DOI 10.1021/bp020001q; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Duan J, 2010, NUCLEIC ACIDS RES, V38, pD453, DOI 10.1093/nar/gkp801; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GAMO T, 1978, INSECT BIOCHEM, V8, P457, DOI 10.1016/0020-1790(78)90059-8; Hildebrand J.G., 1980, RECEPTORS NEUROTRANS, P261; Hou Y, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-45; Huang BD, 2009, OMICS, V13, P325, DOI 10.1089/omi.2009.0045; IZUMI S, 1981, BIOCHIM BIOPHYS ACTA, V670, P222, DOI 10.1016/0005-2795(81)90013-1; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim EJ, 2004, BIOTECHNOL PROGR, V20, P324, DOI 10.1021/bp034130y; Kim EJ, 2001, BIOCHEM BIOPH RES CO, V285, P224, DOI 10.1006/bbrc.2001.5148; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li XH, 2006, J PROTEOME RES, V5, P2809, DOI 10.1021/pr0603093; Maki N, 2001, INSECT BIOCHEM MOLEC, V31, P407, DOI 10.1016/S0965-1748(00)00135-1; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; MORI S, 1991, BIOCHIM BIOPHYS ACTA, V1090, P129, DOI 10.1016/0167-4781(91)90048-Q; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pakkianathan BC, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-5; Park JH, 2012, BIOMATERIALS, V33, P9127, DOI 10.1016/j.biomaterials.2012.08.063; Pietrzyk Agnieszka J., 2013, Biotechnologia (Poznan), V94, P9; Pietrzyk AJ, 2013, ACTA CRYSTALLOGR D, V69, P2353, DOI 10.1107/S0907444913021823; Pietrzyk AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061303; Pietrzyk AJ, 2012, ACTA CRYSTALLOGR D, V68, P1140, DOI 10.1107/S0907444912021555; Pietrzyk AJ, 2011, ACTA CRYSTALLOGR F, V67, P372, DOI 10.1107/S1744309110054564; Rhee WJ, 2002, BIOCHEM BIOPH RES CO, V295, P779, DOI 10.1016/S0006-291X(02)00746-5; Rhee WJ, 2001, J MICROBIOL BIOTECHN, V11, P853; Rhee WJ, 2000, BIOCHEM BIOPH RES CO, V271, P186, DOI 10.1006/bbrc.2000.2592; Rhee WJ, 1999, BIOTECHNOL PROGR, V15, P1028, DOI 10.1021/bp990093s; SAKAI N, 1988, BIOCHIM BIOPHYS ACTA, V949, P224, DOI 10.1016/0167-4781(88)90086-3; Sawada H, 2007, COMP BIOCHEM PHYS B, V146, P172, DOI 10.1016/j.cbpb.2006.10.101; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Sun Q, 2007, INSECT SCI, V14, P5, DOI 10.1111/j.1744-7919.2007.00121.x; Ujita M, 2005, BIOSCI BIOTECH BIOCH, V69, P1178, DOI 10.1271/bbb.69.1178; Ujita M, 2002, BIOSCI BIOTECH BIOCH, V66, P2264, DOI 10.1271/bbb.66.2264; Vanishree V, 2005, INVERTEBR REPROD DEV, V48, P81, DOI 10.1080/07924259.2005.9652173; Wang J, 2005, NUCLEIC ACIDS RES, V33, pD399, DOI 10.1093/nar/gki116; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WHITMORE E, 1974, COMP BIOCHEM PHYSIOL, V47, P63, DOI 10.1016/0305-0491(74)90092-3; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WYATT GR, 1956, J GEN PHYSIOL, V39, P853, DOI 10.1085/jgp.39.6.853; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Yang JP, 2011, J STRUCT BIOL, V175, P97, DOI 10.1016/j.jsb.2011.04.003; Zhang Y, 2014, AMINO ACIDS, V46, P1021, DOI 10.1007/s00726-014-1665-7; Zhang Y, 2012, FUNCT INTEGR GENOMIC, V12, P705, DOI 10.1007/s10142-012-0281-4; ZHU J, 1986, Biochimica et Biophysica Acta, V882, P427, DOI 10.1016/0304-4165(86)90267-9	60	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e108761	10.1371/journal.pone.0108761	http://dx.doi.org/10.1371/journal.pone.0108761			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379889	gold, Green Submitted, Green Published			2022-12-27	WOS:000344863100005
J	Sharma, A; Chandran, R; Barry, ES; Bhomia, M; Hutchison, MA; Balakathiresan, NS; Grunberg, NE; Maheshwari, RK				Sharma, Anuj; Chandran, Raghavendar; Barry, Erin S.; Bhomia, Manish; Hutchison, Mary Anne; Balakathiresan, Nagaraja S.; Grunberg, Neil E.; Maheshwari, Radha K.			Identification of Serum MicroRNA Signatures for Diagnosis of Mild Traumatic Brain Injury in a Closed Head Injury Model	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; ACOUSTIC STARTLE REFLEX; C-TERMINAL HYDROLASE; RAT CEREBRAL-CORTEX; FEMALE RATS; ADULT RATS; NEUROSURGICAL INTERVENTION; INTRACRANIAL LESIONS; PHYSICAL-ACTIVITY; BODY-WEIGHT	Wars in Iraq and Afghanistan have highlighted the problems of diagnosis and treatment of mild traumatic brain injury (mTBI). MTBI is a heterogeneous injury that may lead to the development of neurological and behavioral disorders. In the absence of specific diagnostic markers, mTBI is often unnoticed or misdiagnosed. In this study, mice were induced with increasing levels of mTBI and microRNA (miRNA) changes in the serum were determined. MTBI was induced by varying weight and fall height of the impactor rod resulting in four different severity grades of the mTBI. Injuries were characterized as mild by assessing with the neurobehavioral severity scale-revised (NSS-R) at day 1 post injury. Open field locomotion and acoustic startle response showed behavioral and sensory motor deficits in 3 of the 4 injury groups at day 1 post injury. All of the animals recovered after day 1 with no significant neurobehavioral alteration by day 30 post injury. Serum microRNA (miRNA) profiles clearly differentiated injured from uninjured animals. Overall, the number of miRNAs that were significantly modulated in injured animals over the sham controls increased with the severity of the injury. Thirteen miRNAs were found to identify mTBI regardless of its severity within the mild spectrum of injury. Bioinformatics analyses revealed that the more severe brain injuries were associated with a greater number of miRNAs involved in brain related functions. The evaluation of serum miRNA may help to identify the severity of brain injury and the risk of developing adverse effects after TBI.	[Sharma, Anuj; Chandran, Raghavendar; Bhomia, Manish; Balakathiresan, Nagaraja S.; Maheshwari, Radha K.] Uniformed Serv Univ Hlth Sci, Dept Pathol, Bethesda, MD 20814 USA; [Chandran, Raghavendar] Birla Inst Technol & Sci, Biol Sci Grp, Pilani, Rajasthan, India; [Barry, Erin S.; Hutchison, Mary Anne; Grunberg, Neil E.] Uniformed Serv Univ Hlth Sci, Dept Med & Clin Psychol, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA; Birla Institute of Technology & Science Pilani (BITS Pilani); Uniformed Services University of the Health Sciences - USA	Maheshwari, RK (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pathol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	radha.maheshwari@usuhs.edu	Bhomia, Manish/C-7683-2015; Chandran, Raghavendar/AAB-9402-2019; Balakathiresan, Nagaraja Sethuraman/O-3213-2019	Bhomia, Manish/0000-0003-2808-9927; Chandran, Raghavendar/0000-0002-7915-2810; Balakathiresan, Nagaraja Sethuraman/0000-0001-5756-6070; Sharma, Anuj/0000-0001-6906-190X; Barry, Erin/0000-0003-0788-7153	Congressionally Directed Medical Research Programs (CDMRP) [D10_I_AR_J6_855]	Congressionally Directed Medical Research Programs (CDMRP)(United States Department of Defense)	This study was supported by funding from Congressionally Directed Medical Research Programs (CDMRP), Project# D10_I_AR_J6_855 (PI: Radha K Maheshwari). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACRI JB, 1994, PSYCHOPHARMACOLOGY, V114, P369, DOI 10.1007/BF02244861; ACRI JB, 1991, PSYCHOPHARMACOLOGY, V104, P244, DOI 10.1007/BF02244186; Alain C, 2008, J COGNITIVE NEUROSCI, V20, P285, DOI 10.1162/jocn.2008.20014; Allegra A, 2012, INT J ONCOL, V41, P1897, DOI 10.3892/ijo.2012.1647; Allison P. D, 1990, SOCIOL METHODOL, P93; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Bao TH, 2014, J MOL NEUROSCIENCE M; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; BOWEN DJ, 1986, PHARMACOL BIOCHEM BE, V25, P1131, DOI 10.1016/0091-3057(86)90099-7; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Bryan CJ, 2013, J HEAD TRAUMA REHAB, V28, P13, DOI 10.1097/HTR.0b013e31826c73cc; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Chen HL, 2010, BIOCHEM BIOPH RES CO, V394, P921, DOI 10.1016/j.bbrc.2010.03.076; Choudhury Y, 2012, J CLIN INVEST, V122, P4059, DOI 10.1172/JCI62925; Corrigan F, 2014, J NEUROCHEM, V128, P196, DOI 10.1111/jnc.12391; Corrigan F, 2012, BRAIN RES, V1451, P87, DOI 10.1016/j.brainres.2012.02.045; D'haene Barbara, 2012, Methods Mol Biol, V822, P261, DOI 10.1007/978-1-61779-427-8_18; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Decembrini S, 2009, P NATL ACAD SCI USA, V106, P21179, DOI 10.1073/pnas.0909167106; Deo A, 2011, J BIOINF COMPUT BIOL, V9, P795, DOI 10.1142/S0219720011005793; Ekdahl Y, 2012, GENOME RES, V22, P1477, DOI 10.1101/gr.131912.111; Elliott BM, 2004, PHARMACOL BIOCHEM BE, V77, P21, DOI 10.1016/j.pbb.2003.09.016; Faraday MM, 1998, PHARMACOL BIOCHEM BE, V61, P281, DOI 10.1016/S0091-3057(98)00094-X; Faraday MM, 2003, PHARMACOL BIOCHEM BE, V74, P325, DOI 10.1016/S0091-3057(02)00999-1; Fischer H., 2013, CRS REP C, P1; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Freund Hans-Joachim, 2003, Adv Neurol, V93, P179; Frugier T, 2012, J NEUROPATH EXP NEUR, V71, P242, DOI 10.1097/NEN.0b013e3182496149; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Goh CP, 2014, EXP NEUROL, V252, P37, DOI 10.1016/j.expneurol.2013.11.017; Goossens K, 2013, STEM CELLS DEV; Griesbach GS, 2002, J NEUROTRAUM, V19, P803, DOI 10.1089/08977150260190401; GRUNBERG NE, 1985, PHARMACOL BIOCHEM BE, V23, P851, DOI 10.1016/0091-3057(85)90081-4; Grunberg NE, 2011, ANN M SOC NEUR WASH; Hamilton KR, 2012, EXP CLIN PSYCHOPHARM, V20, P345, DOI 10.1037/a0029088; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Hanell A, 2012, J NEUROTRAUM, V29, P2660, DOI 10.1089/neu.2012.2376; Hausmann R, 2001, INT J LEGAL MED, V114, P338, DOI 10.1007/s004140000199; Itoh T, 2005, NEUROREPORT, V16, P1687, DOI 10.1097/01.wnr.0000183330.44112.ab; Itoh T, 2009, MOL CELL BIOCHEM, V324, P191, DOI 10.1007/s11010-008-0013-1; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; KATZ RJ, 1981, NEUROSCI BIOBEHAV R, V5, P247, DOI 10.1016/0149-7634(81)90005-1; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kiraly MA, 2007, THESCIENTIFICWORLDJO, V7, P1768, DOI 10.1100/tsw.2007.269; Koch M, 1997, BEHAV BRAIN RES, V89, P35, DOI 10.1016/S0166-4328(97)02296-1; Kumar S, 2005, PSYCHIAT CLIN NEUROS, V59, P466, DOI 10.1111/j.1440-1819.2005.01400.x; Lee YL, 1996, J NEUROSCI, V16, P3775; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Leung AWS, 2011, NEUROIMAGE, V55, P1260, DOI 10.1016/j.neuroimage.2010.12.055; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103948; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marti M, 2005, J NEUROSCI, V25, P9591, DOI 10.1523/JNEUROSCI.2546-05.2005; Mayr M, 2013, ARTERIOSCL THROM VAS, V33, P206, DOI 10.1161/ATVBAHA.112.300141; Moon C, 2004, BRAIN RES, V1028, P238, DOI 10.1016/j.brainres.2004.09.022; Morse DE, 1997, PHARMACOL BIOCHEM BE, V56, P221, DOI 10.1016/S0091-3057(96)00214-6; Murakami N, 1998, J NEUROTRAUM, V15, P993, DOI 10.1089/neu.1998.15.993; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; OVERMIER JB, 1967, J COMP PHYSIOL PSYCH, V63, P28, DOI 10.1037/h0024166; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Rapp PE, 2012, J TRAUMA ACUTE CARE, V73, pS13, DOI 10.1097/TA.0b013e318260604b; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Schirmer L, 2013, BRAIN PATHOL, V23, P2, DOI 10.1111/j.1750-3639.2012.00608.x; SELIGMAN ME, 1967, J EXP PSYCHOL, V74, P1, DOI 10.1037/h0024514; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; Sharma Pushpa, 2012, Int J Crit Illn Inj Sci, V2, P172, DOI 10.4103/2229-5151.100931; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Song JN, 2012, DIGEST DIS SCI, V57, P897, DOI 10.1007/s10620-011-1981-7; SWERDLOW NR, 1992, J PSYCHOPHARMACOL, V6, P176, DOI 10.1177/026988119200600210; Takeuchi Satoru, 2013, Acta Neurochir Suppl, V118, P99, DOI 10.1007/978-3-7091-1434-6_17; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Theeler BJ, 2012, HEADACHE, V52, P732, DOI 10.1111/j.1526-4610.2012.02112.x; Thelin EP, 2013, J NEUROTRAUM, V30, P519, DOI 10.1089/neu.2012.2553; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Van Den Heuvel C, 1998, ACT NEUR S, V71, P209; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wahid F, 2010, BBA-MOL CELL RES, V1803, P1231, DOI 10.1016/j.bbamcr.2010.06.013; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; Xing GQ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00196; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C; Yarnell AM, 2013, BLAST TRAUMATIC BRAI, P9; Yi X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070306; Yuh EL, 2012, J NEUROTRAUM, V29, P735, DOI 10.1089/neu.2011.2008; Zhang HY, 2011, BRAIN RES, V1383, P62, DOI 10.1016/j.brainres.2011.01.067; Zhang L, 2013, INT J MOL MED, V32, P867, DOI 10.3892/ijmm.2013.1456; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	98	43	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112019	10.1371/journal.pone.0112019	http://dx.doi.org/10.1371/journal.pone.0112019			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379886	gold, Green Published, Green Submitted			2022-12-27	WOS:000344863100050
J	Wang, JF; Sun, DW; Wang, YB; Ren, FH; Pang, SN; Wang, DD; Xu, SD				Wang, Junfeng; Sun, Dawei; Wang, Yanbo; Ren, Fenghai; Pang, Sainan; Wang, Dandan; Xu, Shidong			FOSL2 Positively Regulates TGF-beta 1 Signalling in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; GENE-EXPRESSION; BREAST-CANCER; FRA-2; SMAD3; COACTIVATORS; FIBROBLASTS; METASTASIS; P300/CBP	Fos-related antigen 2 (FRA-2/FOSL2) belongs to the AP-1 transcription factor family. Although FOSL2 has been shown to be involved in diverse physiological and pathological processes, very little is known about the signalling pathways that regulate FOSL2 expression and the mechanisms of FOSL2 function. Here, we show that FOSL2 expression is regulated by TGF-beta 1 and that FOSL2 is required for TGF-beta 1-induced migration. We demonstrate that FOSL2 interacts with Smad3 in vitro and in vivo and thus up-regulates TGF-beta 1-induced signalling responses. Mechanistically, FOSL2 promotes P300 binding to Smad3 and the acetylation of Smad3 by P300. Furthermore, we show that the expression of FOSL2 correlates with activated Smad3 expression in clinical non-small cell lung cancer (NSCLC) samples. In summary, the present study indicates that FOSL2 facilitates TGF-beta 1-induced migration by interaction with Smad3 in NSCLC and suggests FOSL2 as a potential therapeutic target for NSCLC.	[Wang, Junfeng; Sun, Dawei; Wang, Yanbo; Ren, Fenghai; Pang, Sainan; Wang, Dandan; Xu, Shidong] Harbin Med Univ, Canc Hosp, Dept Thorac Surg, Harbin, Peoples R China	Harbin Medical University	Xu, SD (corresponding author), Harbin Med Univ, Canc Hosp, Dept Thorac Surg, Harbin, Peoples R China.	xusd163@163.com			National Natural Science Foundation of China [81172818, 81172215]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81172818; 81172215). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Bouyssou JMC, 2014, BBA-REV CANCER, V1845, P255, DOI 10.1016/j.bbcan.2014.02.002; Bozec A, 2013, J CELL SCI, V126, P5432, DOI 10.1242/jcs.134510; Bozec A, 2010, J CELL BIOL, V190, P1093, DOI 10.1083/jcb.201002111; Busnadiego O, 2013, MOL CELL BIOL, V33, P2388, DOI 10.1128/MCB.00036-13; Engel L, 2005, NEUROSCIENCE, V132, P511, DOI 10.1016/j.neuroscience.2004.12.014; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Ghosh AK, 2000, ONCOGENE, V19, P3546, DOI 10.1038/sj.onc.1203693; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Inoue Y, 2007, ONCOGENE, V26, P500, DOI 10.1038/sj.onc.1209826; Kamato D, 2013, CELL SIGNAL, V25, P2017, DOI 10.1016/j.cellsig.2013.06.001; Ko H, 2013, CANCER LETT, V335, P205, DOI 10.1016/j.canlet.2013.02.018; Milde-Langosch K, 2008, BREAST CANCER RES TR, V107, P337, DOI 10.1007/s10549-007-9559-y; Pickup M, 2013, NAT REV CANCER, V13, P788, DOI 10.1038/nrc3603; Reich N, 2010, ARTHRITIS RHEUM-US, V62, P280, DOI 10.1002/art.25056; Renaud SJ, 2014, J BIOL CHEM, V289, P5025, DOI 10.1074/jbc.M113.523746; Roy S, 2010, CARDIOVASC RES, V87, P647, DOI 10.1093/cvr/cvq123; Shimmi O, 2013, J BIOCHEM, V154, P11, DOI 10.1093/jb/mvt046; Tian MZ, 2011, CELL SIGNAL, V23, P951, DOI 10.1016/j.cellsig.2010.10.015; Tulchinsky E, 2000, HISTOL HISTOPATHOL, V15, P921, DOI 10.14670/HH-15.921; Warburton D, 2013, AM J PHYSIOL-LUNG C, V304, pL83, DOI 10.1152/ajplung.00258.2012; Zhang XHF, 2013, CLIN CANCER RES, V19, P6389, DOI 10.1158/1078-0432.CCR-13-0838; Zhou LX, 2013, MOL CANCER RES, V11, P272, DOI 10.1158/1541-7786.MCR-12-0395	23	22	22	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112150	10.1371/journal.pone.0112150	http://dx.doi.org/10.1371/journal.pone.0112150			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375657	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600111
J	Cho, JS; Kang, JH; Um, JY; Han, IH; Park, IH; Lee, HM				Cho, Jung-Sun; Kang, Ju-Hyung; Um, Ji-Young; Han, In-Hye; Park, Il-Ho; Lee, Heung-Man			Lipopolysaccharide Induces Pro-Inflammatory Cytokines and MMP Production via TLR4 in Nasal Polyp-Derived Fibroblast and Organ Culture	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; TISSUE INHIBITOR; EXPRESSION; EOTAXIN; CELLS; LPS	Nasal polyposis is characterized by persistent inflammation and remodeling in sinonasal mucosa. Toll-like receptors (TLRs) play a role in the innate immune response to microbes in the sinonasal cavity. The aim of this study was to evaluate whether nasal polyp-derived fibroblasts (NPDFs) and organ-cultured nasal polyps can synthesize pro-inflammatory cytokines and matrix metalloproteinases (MMPs) after exposure to lipopolysaccharide (LPS), a TLR4 agonist. NPDFs and organ-cultured nasal polyps were isolated from nasal polyps of 8 patients and exposed to LPS. The mRNA and protein expression levels of TLRs, cytokines, and MMPs were determined using a gene expression microarray, real-time RT-PCR, western blot analysis, enzyme-linked immunosorbent assay, and immunofluorescence staining. The enzymatic activities of MMPs were analyzed using collagen or gelatin zymography. The protein expression level of MMP-1 increased in nasal polyp tissues compared to inferior turbinate tissues. LPS induced mRNA expression of TLR4, IL-6, IL-8, and MMP-1 and activated MAPK signaling in NPDFs. LPS promoted the release of interleukin (IL)-6 through extracellular signal-related kinase (ERK) and IL-8 through ERK and c-Jun N-terminal kinases (JNK). Production of IL-6 and IL-8 was induced by PI3K/Akt signaling in LPS-stimulated NPDFs. LPS increased the transcript and protein expression levels of MMP-1 and induced collagenase activity of MMP-1 via ERK and p38, but did not induce gelatinase activity of MMP-2 and MMP-9. LPS from Rhodobacter sphaeroides (LPS-RS) inhibited the stimulatory effects of LPS in NPDFs as well as in organ culture of nasal polyp. LPS triggers immune response via TLR 4 and activates MAPK and PI3K/Akt signaling pathway, which is involved in remodeling of nasal polyps.	[Cho, Jung-Sun; Kang, Ju-Hyung; Um, Ji-Young; Han, In-Hye; Lee, Heung-Man] Korea Univ, Coll Med, Seoul 136705, South Korea; [Cho, Jung-Sun; Park, Il-Ho; Lee, Heung-Man] Korea Univ, Guro Hosp, Clin Trial Ctr, Inst Med Devices, Seoul, South Korea; [Park, Il-Ho; Lee, Heung-Man] Korea Univ, Dept Otorhinolaryngol Head & Neck Surg, Guro Hosp, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Lee, HM (corresponding author), Korea Univ, Coll Med, Seoul 136705, South Korea.	lhman@korea.ac.kr	Park, Il-Ho/AAI-1394-2019	Park, Il-Ho/0000-0002-7011-6071	National Research Foundation of Korea (NRF) grant - Korea Government (MEST) [2012-0005455]; Korea University Grant	National Research Foundation of Korea (NRF) grant - Korea Government (MEST); Korea University Grant	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea Government (MEST; no. 2012-0005455) and a Korea University Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein Joel M, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P39, DOI 10.1097/00020840-200502000-00010; Bromfield JJ, 2011, ENDOCRINOLOGY, V152, P5029, DOI 10.1210/en.2011-1124; Buckley CD, 2001, TRENDS IMMUNOL, V22, P199, DOI 10.1016/S1471-4906(01)01863-4; Cho JS, 2012, CLIN EXP ALLERGY, V42, P872, DOI 10.1111/j.1365-2222.2011.03931.x; Cho JS, 2013, AM J RHINOL ALLERGY, V27, P18, DOI 10.2500/ajra.2013.27.3827; Chung K.F., 2001, EUR RESPIR J, V34, P50, DOI DOI 10.1183/09031936.01.00229701; Coats SR, 2005, J IMMUNOL, V175, P4490, DOI 10.4049/jimmunol.175.7.4490; Drexler SK, 2010, INT J BIOCHEM CELL B, V42, P506, DOI 10.1016/j.biocel.2009.10.009; Eyibilen A, 2011, HISTOL HISTOPATHOL, V26, P615, DOI 10.14670/HH-26.615; Gibbs DF, 1999, AM J RESP CELL MOL, V20, P1145, DOI 10.1165/ajrcmb.20.6.3482; Harris JF, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-24; Hyc A, 2011, INT J MOL MED, V27, P127, DOI 10.3892/ijmm.2010.550; Lechapt-Zalcman E, 2001, J PATHOL, V193, P233, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH771>3.0.CO;2-W; Liu CM, 2001, ANN OTO RHINOL LARYN, V110, P1129, DOI 10.1177/000348940111001209; Ngkelo A, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-1; Nonaka M, 2004, CLIN EXP ALLERGY, V34, P804, DOI 10.1111/j.1365-2222.2004.1954.x; Norlander T, 1996, LARYNGOSCOPE, V106, P196, DOI 10.1097/00005537-199602000-00017; Park SK, 2009, BIOCHEM BIOPH RES CO, V379, P255, DOI 10.1016/j.bbrc.2008.12.034; Pawankar R, 2003, CURR OPIN ALLERGY CL, V3, P1, DOI 10.1097/01.all.0000053260.61007.d6; Rostkowska-Nadolska Beata, 2006, Otolaryngol Pol, V60, P143; Segura M, 2002, CLIN EXP IMMUNOL, V127, P243, DOI 10.1046/j.1365-2249.2002.01768.x; Shin SH, 2010, INT ARCH ALLERGY IMM, V153, P46, DOI 10.1159/000301578; Shin SH, 2004, J ALLERGY CLIN IMMUN, V114, P1369, DOI 10.1016/j.jaci.2004.08.012; Smith RS, 1997, AM J PATHOL, V151, P317; Sorsa T, 2004, ORAL DIS, V10, P311, DOI 10.1111/j.1601-0825.2004.01038.x; Takashiba S, 2003, J PERIODONTOL, V74, P103, DOI 10.1902/jop.2003.74.1.103; Teran LM, 1999, J ALLERGY CLIN IMMUN, V103, pS206; VanderMeer, 2005, ARCH OTOLARYNGOL, V131, P406; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Wang LF, 2012, AM J RHINOL ALLERGY, V26, pE1, DOI 10.2500/ajra.2012.26.3724; Wong Y, 2011, INVEST OPHTH VIS SCI, V52, P2796, DOI 10.1167/iovs.10-5459	31	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e90683	10.1371/journal.pone.0090683	http://dx.doi.org/10.1371/journal.pone.0090683			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390332	Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400001
J	Heier, CR; Guerron, AD; Korotcov, A; Lin, S; Gordish-Dressman, H; Fricke, S; Sze, RW; Hoffman, EP; Wang, P; Nagaraju, K				Heier, Christopher R.; Guerron, Alfredo D.; Korotcov, Alexandru; Lin, Stephen; Gordish-Dressman, Heather; Fricke, Stanley; Sze, Raymond W.; Hoffman, Eric P.; Wang, Paul; Nagaraju, Kanneboyina			Non-Invasive MRI and Spectroscopy of mdx Mice Reveal Temporal Changes in Dystrophic Muscle Imaging and in Energy Deficits	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; MAGNETIC-RESONANCE; CLINICAL-ASSESSMENTS; MURINE MODEL; MOUSE MODEL; DISEASE; PATHOLOGY; INVOLVEMENT; MYOPATHY	In Duchenne muscular dystrophy (DMD), a genetic disruption of dystrophin protein expression results in repeated muscle injury and chronic inflammation. Magnetic resonance imaging shows promise as a surrogate outcome measure in both DMD and rehabilitation medicine that is capable of predicting clinical benefit years in advance of functional outcome measures. The mdx mouse reproduces the dystrophin deficiency that causes DMD and is routinely used for preclinical drug testing. There is a need to develop sensitive, non-invasive outcome measures in the mdx model that can be readily translatable to human clinical trials. Here we report the use of magnetic resonance imaging and spectroscopy techniques for the non-invasive monitoring of muscle damage in mdx mice. Using these techniques, we studied dystrophic mdx muscle in mice from 6 to 12 weeks of age, examining both the peak disease phase and natural recovery phase of the mdx disease course. T2 and fat-suppressed imaging revealed significant levels of tissue with elevated signal intensity in mdx hindlimb muscles at all ages; spectroscopy revealed a significant deficiency of energy metabolites in 6-week-old mdx mice. As the mdx mice progressed from the peak disease stage to the recovery stage of disease, each of these phenotypes was either eliminated or reduced, and the cross-sectional area of the mdx muscle was significantly increased when compared to that of wild-type mice. Histology indicates that hyper-intense MRI foci correspond to areas of dystrophic lesions containing inflammation as well as regenerating, degenerating and hypertrophied myofibers. Statistical sample size calculations provide several robust measures with the ability to detect intervention effects using small numbers of animals. These data establish a framework for further imaging or preclinical studies, and they support the development of MRI as a sensitive, non-invasive outcome measure for muscular dystrophy.	[Heier, Christopher R.; Guerron, Alfredo D.; Gordish-Dressman, Heather; Hoffman, Eric P.; Nagaraju, Kanneboyina] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Korotcov, Alexandru; Lin, Stephen; Wang, Paul] Howard Univ, Coll Med, Dept Radiol, Washington, DC USA; [Gordish-Dressman, Heather; Hoffman, Eric P.; Nagaraju, Kanneboyina] George Washington Univ, Sch Med & Hlth Sci, Dept Integrat Syst Biol, Washington, DC 20052 USA; [Fricke, Stanley] Childrens Natl Med Ctr, Dept Diagnost Imaging & Radiol, Washington, DC 20010 USA; [Sze, Raymond W.] Childrens Natl Med Ctr, Dept Radiol, Washington, DC 20010 USA; [Wang, Paul] Fu Jen Catholic Univ, Dept Elect Engn, Taipei, Taiwan	Children's National Health System; Howard University; George Washington University; Children's National Health System; Children's National Health System; Fu Jen Catholic University	Nagaraju, K (corresponding author), Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA.	KNagaraju@childrensnational.org	Nagaraju, Kanneboyina/AAV-7684-2021; Nagaraju, Kanneboyina/ABA-6525-2021; Cruz, Alfredo Daniel Guerron/V-5188-2019	Cruz, Alfredo Daniel Guerron/0000-0002-4632-1681; Heier, Christopher/0000-0001-7914-2068; Hoffman, Eric/0000-0001-6470-5139	National Institutes of Health's [5T32AR056993, 5R24HD050846-02, G12MD007597, K26OD011171, P50AR060836]; United States Army Medical Research and Materiel Command [W81XWH 10-1-0767]; Muscular Dystrophy Association [30000783/4736]; United States Department of Defense [W81XWH-05-1-0659, W81XWH-11-1-0782, W81XWH-11-1-0330]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR060836, T32AR056993] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007597] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K26OD011171] Funding Source: NIH RePORTER	National Institutes of Health's(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Muscular Dystrophy Association(Muscular Dystrophy Association); United States Department of Defense(United States Department of Defense); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	CRH is supported by the National Institutes of Health's (http://www.nih.gov/) 5T32AR056993 and 5R24HD050846-02 grants. PW and this work were supported in part by the National Institutes of Health's G12MD007597 and United States Army Medical Research and Materiel Command (http://mrmc.amedd.army.mil/) W81XWH 10-1-0767 grants. KN is supported by National Institutes of Health's K26OD011171 and P50AR060836 grants, a Muscular Dystrophy Association (http://mda.org/) translational grant 30000783/4736, and the United States Department of Defense (http://www.defense.gov/) grants W81XWH-05-1-0659, W81XWH-11-1-0782, W81XWH-11-1-0330, and W81XWH-11-1-0782. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; Amthor H, 2004, NEUROMUSCULAR DISORD, V14, P791, DOI 10.1016/j.nmd.2004.08.004; ANDERSON JE, 1988, J MUSCLE RES CELL M, V9, P499, DOI 10.1007/BF01738755; Arpan I, 2013, NMR BIOMED, V26, P320, DOI 10.1002/nbm.2851; Bach JR, 2007, AM J PHYS MED REHAB, V86, P349, DOI 10.1097/PHM.0b013e31804b1d66; Banerjee B, 2010, MAGN RESON IMAGING, V28, P698, DOI 10.1016/j.mri.2010.03.008; Cahill KS, 2004, TRANSPLANTATION, V78, P1626, DOI 10.1097/01.TP.0000145528.51525.8B; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; COULTON GR, 1988, NEUROPATH APPL NEURO, V14, P299, DOI 10.1111/j.1365-2990.1988.tb00890.x; COULTON GR, 1988, NEUROPATH APPL NEURO, V14, P53, DOI 10.1111/j.1365-2990.1988.tb00866.x; DANGAIN J, 1984, MUSCLE NERVE, V7, P700, DOI 10.1002/mus.880070903; Dellorusso C, 2001, J MUSCLE RES CELL M, V22, P467, DOI 10.1023/A:1014587918367; Dunn JF, 1999, MUSCLE NERVE, V22, P1367, DOI 10.1002/(SICI)1097-4598(199910)22:10<1367::AID-MUS5>3.3.CO;2-8; Forbes SC, 2013, RADIOLOGY, V269, P198, DOI 10.1148/radiol.13121948; Heier CR, 2013, EMBO MOL MED, V5, P1569, DOI 10.1002/emmm.201302621; Hoffman EP, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008873; HUANG YM, 1994, JMRI-J MAGN RESON IM, V4, P59, DOI 10.1002/jmri.1880040113; Huynh T, 2013, J PATHOL, V231, P223, DOI 10.1002/path.4231; Jahnke VE, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-16; Kim HK, 2013, PEDIATR RADIOL, V43, P1327, DOI 10.1007/s00247-013-2696-z; Kim HK, 2010, RADIOLOGY, V255, P899, DOI 10.1148/radiol.10091547; Kinali M, 2011, NEUROLOGY, V76, P346, DOI 10.1212/WNL.0b013e318208811f; Kumar A, 2010, AM J PATHOL, V177, P248, DOI 10.2353/ajpath.2010.091176; KUSHMERICK MJ, 1987, BASIC RES CARDIOL, V82, P17; KUSHMERICK MJ, 1985, J EXP BIOL, V115, P165; Kushmerick MJ, 1995, J BIOENERG BIOMEMBR, V27, P555, DOI 10.1007/BF02111654; LAMMINEN AE, 1990, BRIT J RADIOL, V63, P946, DOI 10.1259/0007-1285-63-756-946; Lu QL, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.6; Lynch GS, 2001, J PHYSIOL-LONDON, V535, P591, DOI 10.1111/j.1469-7793.2001.00591.x; Martins-Bach AB, 2012, MAGN RESON IMAGING, V30, P1167, DOI 10.1016/j.mri.2012.04.003; Mathur S, 2011, MUSCLE NERVE, V43, P878, DOI 10.1002/mus.21986; McIntosh LM, 1998, BIOCHEM CELL BIOL, V76, P532; Mendell JR, 2013, ANN NEUROL, V74, P637, DOI 10.1002/ana.23982; Mercuri E, 2007, J MAGN RESON IMAGING, V25, P433, DOI 10.1002/jmri.20804; MUNTONI F, 1993, J NEUROL SCI, V120, P71, DOI 10.1016/0022-510X(93)90027-V; NEWMAN RJ, 1982, BRIT MED J, V284, P1072, DOI 10.1136/bmj.284.6322.1072; Odintsov B, 2011, MAGN RESON MED, V66, P1704, DOI 10.1002/mrm.22942; Pacak CA, 2007, MOL THER, V15, P1775, DOI 10.1038/sj.mt.6300246; Perrin S, 2014, NATURE, V507, P423, DOI 10.1038/507423a; Phoenix J, 1996, MUSCLE NERVE, V19, P302, DOI 10.1002/(SICI)1097-4598(199603)19:3<302::AID-MUS4>3.0.CO;2-H; Pratt Stephen J P, 2013, BMC Res Notes, V6, P262, DOI 10.1186/1756-0500-6-262; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Quinlan JG, 2004, NEUROMUSCULAR DISORD, V14, P491, DOI 10.1016/j.nmd.2004.04.007; Roos M, 2009, J CARDIOVASC ELECTR, V20, P342, DOI 10.1111/j.1540-8167.2008.01327.x; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Sharma U, 2007, MAGN RESON IMAGING, V25, P244, DOI 10.1016/j.mri.2006.09.016; Spurney CF, 2008, NEUROMUSCULAR DISORD, V18, P371, DOI 10.1016/j.nmd.2008.03.008; Spurney CF, 2009, MUSCLE NERVE, V39, P591, DOI 10.1002/mus.21211; Straub V, 2000, MAGNET RESON MED, V44, P655, DOI 10.1002/1522-2594(200010)44:4<655::AID-MRM22>3.0.CO;2-T; Stuckey DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028569; TANABE Y, 1986, ACTA NEUROPATHOL, V69, P91, DOI 10.1007/BF00687043; TAYLOR DJ, 1994, J NEUROL SCI, V127, P198, DOI 10.1016/0022-510X(94)90073-6; Walter G, 2005, MAGN RESON MED, V54, P1369, DOI 10.1002/mrm.20721; Walter GA, 2004, MAGN RESON MED, V51, P273, DOI 10.1002/mrm.10684; Willcocks RJ, 2014, NEUROMUSCULAR DISORD, V24, P393, DOI 10.1016/j.nmd.2013.12.012; Xu S, 2012, J APPL PHYSIOL, V113, P808, DOI 10.1152/japplphysiol.00530.2012; Yokota T, 2009, ANN NEUROL, V65, P667, DOI 10.1002/ana.21627; Zhang W, 2008, J MOL CELL CARDIOL, V45, P754, DOI 10.1016/j.yjmcc.2008.09.125	58	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112477	10.1371/journal.pone.0112477	http://dx.doi.org/10.1371/journal.pone.0112477			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390038	Green Submitted, Green Published, gold			2022-12-27	WOS:000349144400084
J	Wilson, EA; Sullivan, PJ; Dickinson, JL				Wilson, Ethan A.; Sullivan, Patrick J.; Dickinson, Janis L.			Spatial Distribution of Oak Mistletoe as It Relates to Habits of Oak Woodland Frugivores	PLOS ONE			English	Article							PHORADENDRON-VILLOSUM; FORAGING BEHAVIOR; DISPERSAL; EVOLUTION; PATTERNS; RESOURCE; HOST	This study addresses the underlying spatial distribution of oak mistletoe, Phoradendron villosum, a hemi-parasitic plant that provides a continuous supply of berries for frugivorous birds overwintering the oak savanna habitat of California's outer coast range. As the winter community of birds consuming oak mistletoe varies from group-living territorial species to birds that roam in flocks, we asked if mistletoe volume was spatially autocorrelated at the scale of persistent territories or whether the patterns predicted by long-term territory use by western bluebirds are overcome by seed dispersal by more mobile bird species. The abundance of mistletoe was mapped on trees within a 700 ha study site in Carmel Valley, California. Spatial autocorrelation of mistletoe volume was analyzed using the variogram method and spatial distribution of oak mistletoe trees was analyzed using Ripley's K and O-ring statistics. On a separate set of 45 trees, mistletoe volume was highly correlated with the volume of female, fruit-bearing plants, indicating that overall mistletoe volume is a good predictor of fruit availability. Variogram analysis showed that mistletoe volume was spatially autocorrelated up to approximately 250 m, a distance consistent with persistent territoriality of western bluebirds and philopatry of sons, which often breed next door to their parents and are more likely to remain home when their parents have abundant mistletoe. Using Ripley's K and O-ring analyses, we showed that mistletoe trees were aggregated for distances up to 558 m, but for distances between 558 to 724 m the O-ring analysis deviated from Ripley's K in showing repulsion rather than aggregation. While trees with mistletoe were aggregated at larger distances, mistletoe was spatially correlated at a smaller distance, consistent with what is expected based on persistent group territoriality of western bluebirds in winter and the extreme philopatry of their sons.	[Wilson, Ethan A.; Sullivan, Patrick J.; Dickinson, Janis L.] Cornell Univ, Dept Nat Resources, Ithaca, NY 14850 USA; [Dickinson, Janis L.] Cornell Lab Ornithol, Ithaca, NY 14850 USA	Cornell University; Cornell University	Wilson, EA (corresponding author), Cornell Univ, Dept Nat Resources, Ithaca, NY 14850 USA.	ethanw31@uw.edu			National Science Foundation-IOS [0097027, 0718416]; NSF REU [0718416]	National Science Foundation-IOS(National Science Foundation (NSF)); NSF REU(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by grants from National Science Foundation-IOS (0097027 and 0718416 to J.L.D.). Ethan Wilson was supported on a NSF REU Supplement to NSF grant 0718416. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aukema JE, 2004, ECOGRAPHY, V27, P137, DOI 10.1111/j.0906-7590.2004.03640.x; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Bivand RS, 2008, USE R, P191; Bunge J., J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; CHAVEZRAMIREZ F, 1994, OIKOS, V71, P40, DOI 10.2307/3546170; Dickinson JL, 2005, P ROY SOC B-BIOL SCI, V272, P2423, DOI 10.1098/rspb.2005.3269; Dickinson JL, 2014, BEHAV ECOLOGY, DOI 10.1093/beheco/aru042; eBird, 2012, EBRID ONL DAT BIRD D; EMLEN ST, 1982, AM NAT, V119, P29, DOI 10.1086/283888; EMLEN ST, 1982, AM NAT, V119, P40, DOI 10.1086/283889; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; ESRI, 2011, ARCGIS DESKT REL 10; Hirth DH, 1969, J FIELD ORNITHOL, V40, P208; HOLLINGER DY, 1983, OECOLOGIA, V60, P396, DOI 10.1007/BF00376858; Jolles AE, 2002, ECOLOGY, V83, P2373, DOI 10.1890/0012-9658(2002)083[2373:DTOAIS]2.0.CO;2; Keppie D.M., 2000, BIRDS N AM, DOI [10.2173/bna.530., DOI 10.2173/BNA.530]; Kraaijeveld K, 2001, ANIM BEHAV, V61, P109, DOI 10.1006/anbe.2000.1591; Kraft CE, 2002, ECOL APPL, V12, P749; Laland KN, 1996, J EVOLUTION BIOL, V9, P293, DOI 10.1046/j.1420-9101.1996.9030293.x; Lewontin R.C., 1982, LEARNING DEV CULTURE, P151; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Putnam L. S., 1949, Wilson Bulletin Baltimore, V61, P141; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; SALLABANKS R, 1993, J FIELD ORNITHOL, V64, P42; THOMSON VE, 1983, BOT GAZ, V144, P124, DOI 10.1086/337353; Vanderhoff N, 2016, BIRDS N AM, DOI [10.2173/bna.462, DOI 10.2173/BNA.462]; Watson DM, 2013, OECOLOGIA, V172, P925, DOI 10.1007/s00442-013-2693-9; Watson DM, 2001, ANNU REV ECOL SYST, V32, P219, DOI 10.1146/annurev.ecolsys.32.081501.114024; Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x; Witmer M. C, 2014, BIRDS N AM ONLINE DA, DOI [10.2173/bna.309, DOI 10.2173/BNA.309]	30	5	5	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111947	10.1371/journal.pone.0111947	http://dx.doi.org/10.1371/journal.pone.0111947			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389971	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400042
J	Gannavarpu, R; Bhaduri, B; Tangella, K; Popescu, G				Gannavarpu, Rajshekhar; Bhaduri, Basanta; Tangella, Krishnarao; Popescu, Gabriel			Spatiotemporal Characterization of a Fibrin Clot Using Quantitative Phase Imaging	PLOS ONE			English	Article							CONFOCAL MICROSCOPY; GEL STRUCTURE; NETWORKS; GROWTH; CELL; GENERATION; SCATTERING; THROMBIN; RHEOLOGY; SYSTEM	Studying the dynamics of fibrin clot formation and its morphology is an important problem in biology and has significant impact for several scientific and clinical applications. We present a label-free technique based on quantitative phase imaging to address this problem. Using quantitative phase information, we characterized fibrin polymerization in real-time and present a mathematical model describing the transition from liquid to gel state. By exploiting the inherent optical sectioning capability of our instrument, we measured the three-dimensional structure of the fibrin clot. From this data, we evaluated the fractal nature of the fibrin network and extracted the fractal dimension. Our non-invasive and speckle-free approach analyzes the clotting process without the need for external contrast agents.	[Gannavarpu, Rajshekhar; Bhaduri, Basanta; Popescu, Gabriel] Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Elect & Comp Engn, Quantitat Light Imaging Lab, Urbana, IL 61820 USA; [Tangella, Krishnarao] Christie Clin, Dept Pathol, Urbana, IL USA; [Tangella, Krishnarao] Univ Illinois, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Popescu, G (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Elect & Comp Engn, Quantitat Light Imaging Lab, Urbana, IL 61820 USA.	gpopescu@illinois.edu	Gannavarpu, Rajshekhar/GSE-6148-2022	Gannavarpu, Rajshekhar/0000-0002-4277-590X; Bhaduri, Basanta/0000-0001-9737-0996	National Science Foundation [CBET-1040462 MRI]; Swiss National Science Foundation [146495]	National Science Foundation(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	National Science Foundation (grant CBET-1040462 MRI) (http://www.nsf.gov) and Swiss National Science Foundation (grant 146495) (http://www.snf.ch/en/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SM, 2012, CELL MOL BIOENG, V5, P488, DOI 10.1007/s12195-012-0249-4; Baker-Groberg SM, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.1.016014; Baranski JD, 2013, P NATL ACAD SCI USA, V110, P7586, DOI 10.1073/pnas.1217796110; BAUMANN P, 1989, HAEMOSTASIS, V19, P309; Bhaduri B., 2013, PLOS ONE, V8; Blinc A, 2000, FIBRINOLYSIS PROTEOL, V14, P288, DOI 10.1054/fipr.2000.0085; BLOMBACK B, 1982, THROMB RES, V25, P51, DOI 10.1016/0049-3848(82)90214-6; Chernysh IN, 2008, BLOOD, V111, P4854, DOI 10.1182/blood-2007-08-105247; Chernysh IN, 2012, SCI REP-UK, V2, DOI 10.1038/srep00879; Colace TV, 2013, ANNU REV BIOMED ENG, V15, P283, DOI 10.1146/annurev-bioeng-071812-152406; Collet JP, 2000, ARTERIOSCL THROM VAS, V20, P1354, DOI 10.1161/01.ATV.20.5.1354; Doolittle RF, 2003, BLOOD REV, V17, P33, DOI 10.1016/S0268-960X(02)00060-7; Evans PA, 2010, BLOOD, V116, P3341, DOI 10.1182/blood-2010-02-269324; Ferri F, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.011913; Ferri F, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.031401; Hategan A, 2013, BLOOD, V121, P1455, DOI 10.1182/blood-2012-08-451518; Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327; Jorneskog G, 1996, DIABETOLOGIA, V39, P1519, DOI 10.1007/s001250050607; Kim T, 2014, NAT PHOTONICS, V8, P256, DOI [10.1038/NPHOTON.2013.350, 10.1038/nphoton.2013.350]; Laurens N, 2006, J THROMB HAEMOST, V4, P932, DOI 10.1111/j.1538-7836.2006.01861.x; Liu W, 2006, SCIENCE, V313, P634, DOI 10.1126/science.1127317; Magatti D, 2013, BIOPHYS J, V104, P1151, DOI 10.1016/j.bpj.2013.01.024; Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110; Matsumoto T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001211; Mills JD, 2002, CIRCULATION, V106, P1938, DOI 10.1161/01.CIR.0000033221.73082.06; Mir M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04434; Mir M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089000; Mir M, 2011, BIOMED OPT EXPRESS, V2, P3259, DOI 10.1364/BOE.2.003259; Mir M, 2011, P NATL ACAD SCI USA, V108, P13124, DOI 10.1073/pnas.1100506108; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; Munster S, 2013, P NATL ACAD SCI USA, V110, P12197, DOI 10.1073/pnas.1222787110; Neeves KB, 2014, J THROMB HAEMOST, V12, P418, DOI 10.1111/jth.12482; Osathanon T, 2008, BIOMATERIALS, V29, P4091, DOI 10.1016/j.biomaterials.2008.06.030; Persson BNJ, 2005, J PHYS-CONDENS MAT, V17, pR1, DOI 10.1088/0953-8984/17/1/R01; Popescu G., 2011, QUANTITATIVE PHASE I; Ryan EA, 1999, BIOPHYS J, V77, P2813, DOI 10.1016/S0006-3495(99)77113-4; Spicer PP, 2010, J CONTROL RELEASE, V148, P49, DOI 10.1016/j.jconrel.2010.06.025; Tripathi MM, 2014, BIOMED OPT EXPRESS, V5, P817, DOI 10.1364/BOE.5.000817; Undas A, 2011, ARTERIOSCL THROM VAS, V31, pE88, DOI 10.1161/ATVBAHA.111.230631; Undas A, 2009, BLOOD, V114, P4272, DOI 10.1182/blood-2009-05-222380; Undas A, 2009, STROKE, V40, P1499, DOI 10.1161/STROKEAHA.108.532812; VanCott E. M., 2001, LAB TEST HDB, P327; Vikinge TP, 2000, J BIOMED OPT, V5, P51, DOI 10.1117/1.429968; Wang Z, 2011, OPT EXPRESS, V19, P1016, DOI 10.1364/OE.19.001016; Weigandt KM, 2011, SOFT MATTER, V7, P9992, DOI 10.1039/c1sm06176c; Weigandt KM, 2009, SOFT MATTER, V5, P4321, DOI 10.1039/b906256d; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001; Woodruff RS, 2011, J THROMB THROMBOLYS, V32, P9, DOI 10.1007/s11239-011-0578-5; Yeromonahos C, 2010, BIOPHYS J, V99, P2018, DOI 10.1016/j.bpj.2010.04.059	50	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111381	10.1371/journal.pone.0111381	http://dx.doi.org/10.1371/journal.pone.0111381			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386701	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400017
J	Kurai, J; Watanabe, M; Tomita, K; Yamasaki, HSA; Shimizu, E				Kurai, Jun; Watanabe, Masanari; Tomita, Katsuyuki; Yamasaki, Hiroyuki Sano Akira; Shimizu, Eiji			Influence of Asian Dust Particles on Immune Adjuvant Effects and Airway Inflammation in Asthma Model Mice	PLOS ONE			English	Article							SAND DUST; AMORPHOUS SILICA; DESERT DUST; HOSPITALIZATION; SYMPTOMS; EXPOSURE	Objective: An Asian dust storm (ADS) contains airborne particles that affect conditions such as asthma, but the mechanism of exacerbation is unclear. The objective of this study was to compare immune adjuvant effects and airway inflammation induced by airborne particles collected on ADS days and the original ADS soil (CJ-1 soil) in asthma model mice. Methods: Airborne particles were collected on ADS days in western Japan. NC/Nga mice were co-sensitized by intranasal instillation with ADS airborne particles and/or Dermatophagoides farinae (Df), and with CJ-1 soil and/or Df for 5 consecutive days. Df-sensitized mice were stimulated with Df challenge intranasally at 7 days after the last Df sensitization. At 24 hours after challenge, serum allergen specific antibody, differential leukocyte count and inflammatory cytokines in bronchoalveolar lavage fluid (BALF) were measured, and airway inflammation was examined histopathologically. Results: Co-sensitization with ADS airborne particles and Df increased the neutrophil and eosinophil counts in BALF. Augmentation of airway inflammation was also observed in peribronchiolar and perivascular lung areas. Df-specific serum IgE was significantly elevated by ADS airborne particles, but not by CJ-1 soil. Levels of interleukin (IL)-5, IL-13, IL-6, and macrophage inflammatory protein-2 were higher in BALF in mice treated with ADS airborne particles. Conclusion: These results suggest that substances attached to ADS airborne particles that are not in the original ADS soil may play important roles in immune adjuvant effects and airway inflammation.	[Kurai, Jun; Watanabe, Masanari; Shimizu, Eiji] Tottori Univ, Fac Med, Dept Resp Med & Rheumatol, Yonago, Tottori 683, Japan; [Tomita, Katsuyuki] Yonago Med Ctr, Dept Resp Med, Yonago, Tottori, Japan; [Yamasaki, Hiroyuki Sano Akira] Kinki Univ, Fac Med, Dept Resp Med & Allergol, Osakasayama, Osaka, Japan	Tottori University; Kindai University (Kinki University)	Kurai, J (corresponding author), Tottori Univ, Fac Med, Dept Resp Med & Rheumatol, Yonago, Tottori 683, Japan.	kurajun@med.tottori-u.ac.jp			Environment Research and Technology Development Fund of the Japanese Ministry of the Environment [5C-1154]	Environment Research and Technology Development Fund of the Japanese Ministry of the Environment	This research was supported by the Environment Research and Technology Development Fund (5C-1154) of the Japanese Ministry of the Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexis N, 2001, J ALLERGY CLIN IMMUN, V107, P31, DOI 10.1067/mai.2001.111594; Alexis NE, 2006, J ALLERGY CLIN IMMUN, V117, P1185, DOI 10.1016/j.jaci.2005.12.1305; Bellido-Casado J, 2010, ARCH BRONCONEUMOL, V46, P587, DOI 10.1016/j.arbres.2010.07.002; Chen PS, 2010, ENVIRON HEALTH PERSP, V118, P1211, DOI 10.1289/ehp.0901782; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; DUCE RA, 1980, SCIENCE, V209, P1522, DOI 10.1126/science.209.4464.1522; Fukuyama T, 2011, TOXICOLOGY, V289, P132, DOI 10.1016/j.tox.2011.08.003; He M, 2013, TOXICOL APPL PHARM, V272, P647, DOI 10.1016/j.taap.2013.07.010; He M, 2010, INHAL TOXICOL, V22, P1012, DOI 10.3109/08958378.2010.510151; Honda A, 2013, J APPL TOXICOL; Ichinose T, 2008, ARCH ENVIRON CON TOX, V55, P348, DOI 10.1007/s00244-007-9128-8; Ichinose T, 2008, INHAL TOXICOL, V20, P685, DOI [10.1080/08958370801935133, 10.1080/08958370801935133 ]; Kanatani KT, 2010, AM J RESP CRIT CARE, V182, P1475, DOI 10.1164/rccm.201002-0296OC; Maki T, 2010, SCI TOTAL ENVIRON, V408, P4556, DOI 10.1016/j.scitotenv.2010.04.002; MANCINO D, 1980, INT ARCH ALLER A IMM, V61, P253, DOI 10.1159/000232443; Pepe C, 2005, J ALLERGY CLIN IMMUN, V116, P544, DOI 10.1016/j.jaci.2005.06.011; Shannon J, 2008, CHEST, V133, P420, DOI 10.1378/chest.07-1881; Shibamori M, 2006, LIFE SCI, V78, P987, DOI 10.1016/j.lfs.2005.06.020; Taylor DA, 2002, ENVIRON HEALTH PERSP, V110, pA80, DOI 10.1289/ehp.110-a80; Ueda Kayo, 2010, Environmental Health and Preventive Medicine, V15, P350, DOI 10.1007/s12199-010-0150-5; WARE JH, 1981, ENVIRON HEALTH PERSP, V41, P255, DOI 10.2307/3429322; Watanabe M, 2014, J ASTHMA; Watanabe Masanari, 2011, Allergology International, V60, P517, DOI 10.2332/allergolint.10-OA-0298; Watanabe Masanari, 2011, Allergology International, V60, P267, DOI 10.2332/allergolint.10-OA-0239; Wittkopp S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064444; Wood LG, 2012, CHEST, V142, P86, DOI 10.1378/chest.11-1838; Yoo Y, 2008, J KOREAN MED SCI, V23, P66, DOI 10.3346/jkms.2008.23.1.66	27	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111831	10.1371/journal.pone.0111831	http://dx.doi.org/10.1371/journal.pone.0111831			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386753	Green Submitted, Green Published, gold			2022-12-27	WOS:000345250400025
J	Vingtdeux, V; Tanis, JE; Chandakkar, P; Zhao, HT; Dreses-Werringloer, U; Campagne, F; Foskett, JK; Marambaud, P				Vingtdeux, Valerie; Tanis, Jessica E.; Chandakkar, Pallavi; Zhao, Haitian; Dreses-Werringloer, Ute; Campagne, Fabien; Foskett, J. Kevin; Marambaud, Philippe			Effect of the CALHM1 G330D and R154H Human Variants on the Control of Cytosolic Ca2+ and A beta Levels	PLOS ONE			English	Article							MODULATOR 1 CALHM1; ALZHEIMERS-DISEASE; ION-CHANNEL; POLYMORPHISM; HOMEOSTASIS; EXPRESSION; CSF; IDENTIFICATION; TISSUEINFO; BACE1	CALHM1 is a plasma membrane voltage-gated Ca2+-permeable ion channel that controls amyloid-beta (A beta) metabolism and is potentially involved in the onset of Alzheimer's disease (AD). Recently, Rubio-Moscardo et al. (PLoS One (2013) 8: e74203) reported the identification of two CALHM1 variants, G330D and R154H, in early-onset AD (EOAD) patients. The authors provided evidence that these two human variants were rare and resulted in a complete loss of CALHM1 function. Recent publicly available large-scale exome sequencing data confirmed that R154H is a rare CALHM1 variant (minor allele frequency (MAF) = 0.015%), but that G330D is not (MAF = 3.5% in an African American cohort). Here, we show that both CALHM1 variants exhibited gating and permeation properties indistinguishable from wild-type CALHM1 when expressed in Xenopus oocytes. While there was also no effect of the G330D mutation on Ca2+ uptake by CALHM1 in transfected mammalian cells, the R154H mutation was associated with defects in the control by CALHM1 of both Ca2+ uptake and A beta levels in this cell system. Together, our data show that the frequent CALHM1 G330D variant has no obvious functional consequences and is therefore unlikely to contribute to EOAD. Our data also demonstrate that the rare R154H variant interferes with CALHM1 control of cytosolic Ca2+ and A beta accumulation. While these results strengthen the notion that CALHM1 influences Ab metabolism, further investigation will be required to determine whether CALHM1 R154H, or other natural variants in CALHM1, is/are associated with EOAD.	[Vingtdeux, Valerie; Chandakkar, Pallavi; Zhao, Haitian; Dreses-Werringloer, Ute; Marambaud, Philippe] Feinstein Inst Med Res, Litwin Zucker Res Ctr Study Alzheimers Dis, Manhasset, NY 11030 USA; [Tanis, Jessica E.; Foskett, J. Kevin] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Campagne, Fabien] Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY USA; [Foskett, J. Kevin] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Northwell Health; University of Pennsylvania; Pennsylvania Medicine; Cornell University; University of Pennsylvania; Pennsylvania Medicine	Marambaud, P (corresponding author), Feinstein Inst Med Res, Litwin Zucker Res Ctr Study Alzheimers Dis, Manhasset, NY 11030 USA.	PMaramba@nshs.edu	Vingtdeux, Valerie/C-2463-2012	Vingtdeux, Valerie/0000-0003-4550-503X; Campagne, Fabien/0000-0001-6237-3564; Foskett, J. Kevin/0000-0002-8854-0268	National Institutes of Health [R01AG042508, R01DC012538]; American Heart Association postdoctoral fellowship [12POST11940054]; NATIONAL INSTITUTE ON AGING [R01AG042508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association postdoctoral fellowship(American Heart Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health grants R01AG042508 (to P.M.) and R01DC012538 (to J.K.F.), and an American Heart Association postdoctoral fellowship 12POST11940054 (to J.E.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar D, 2008, NUCLEIC ACIDS RES, V36, P3728, DOI 10.1093/nar/gkn233; Chami L, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-52; Chapuis J, 2011, HUM MOL GENET, V20, P2026, DOI 10.1093/hmg/ddr085; Cho HJ, 2008, AGING CELL, V7, P137, DOI 10.1111/j.1474-9726.2007.00360.x; de Leon MJ, 2007, ANN NY ACAD SCI, V1097, P114, DOI 10.1196/annals.1379.012; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Dreses-Werringloer U, 2008, CELL, V133, P1149, DOI 10.1016/j.cell.2008.05.048; Dreses-Werringloer U, 2013, J CELL SCI, V126, P1199, DOI 10.1242/jcs.117135; Duyckaerts C, 2009, ACTA NEUROPATHOL, V118, P5, DOI 10.1007/s00401-009-0532-1; Ertekin-Taner N, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt26; Gallego-Sandin S, 2011, BIOCHEM J, V437, P469, DOI 10.1042/BJ20110479; Giedraitis V, 2010, NEUROSCI LETT, V469, P265, DOI 10.1016/j.neulet.2009.12.011; Goate A, 2012, J NEUROCHEM, V120, P3, DOI 10.1111/j.1471-4159.2011.07575.x; Kauwe JSK, 2010, J ALZHEIMERS DIS, V21, P833, DOI 10.3233/JAD-2010-091711; Koppel J, 2011, MOL MED, V17, P974, DOI 10.2119/molmed.2011.00154; Lambert JC, 2007, PSYCHONEUROENDOCRINO, V32, pS62, DOI 10.1016/j.psyneuen.2007.05.015; Lambert JC, 2010, J ALZHEIMERS DIS, V22, P247, DOI 10.3233/JAD-2010-100933; Ma ZM, 2012, P NATL ACAD SCI USA, V109, pE1963, DOI 10.1073/pnas.1204023109; Marambaud P, 2005, GENES BRAIN BEHAV, V4, P134, DOI 10.1111/j.1601-183X.2005.00086.x; Moreno-Ortega AJ, 2010, BIOCHEM BIOPH RES CO, V391, P722, DOI 10.1016/j.bbrc.2009.11.127; Rubio-Moscardo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074203; Selkoe D, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011460; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Skrabanek L, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.21.e102; Stutzmann GE, 2011, PHARMACOL REV, V63, P700, DOI 10.1124/pr.110.003814; Tanis JE, 2013, J NEUROSCI, V33, P12275, DOI 10.1523/JNEUROSCI.5919-12.2013; Vingtdeux V, 2012, J NEUROCHEM, V120, P34, DOI 10.1111/j.1471-4159.2011.07477.x; Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061; Wen Y, 2008, NEURON, V57, P680, DOI 10.1016/j.neuron.2008.02.024	29	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112484	10.1371/journal.pone.0112484	http://dx.doi.org/10.1371/journal.pone.0112484			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386646	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400065
J	Sato, K; Takaishi, M; Tokuoka, S; Sano, S				Sato, Kenji; Takaishi, Mikiro; Tokuoka, Shota; Sano, Shigetoshi			Involvement of TNF-alpha Converting Enzyme in the Development of Psoriasis-Like Lesions in a Mouse Model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; STAT3 ACTIVATION; SKIN; INHIBITION; KERATINOCYTES; INFLAMMATION; EXPRESSION; THERAPY; METALLOPROTEINASE	TNF-alpha plays a crucial role in psoriasis; therefore, TNF inhibition has become a gold standard for the treatment of psoriasis. TNF-alpha is processed from a membrane-bound form by TNF-alpha converting enzyme (TACE) to soluble form, which exerts a number of biological activities. EGF receptor (EGFR) ligands, including heparin-binding EGF-like growth factor (HB-EGF), amphiregulin and transforming growth factor (TGF)-alpha are also TACE substrates and are psoriasis-associated growth factors. Vascular endothelial growth factor (VEGF), one of the downstream molecules of EGFR and TNF signaling, plays a key role in angiogenesis for developing psoriasis. In the present study, to assess the possible role of TACE in the pathogenesis of psoriasis, we investigated the involvement of TACE in TPA-induced psoriasis-like lesions in K5.Stat3C mice, which represent a mouse model of psoriasis. In this mouse model, TNF-alpha, amphiregulin, HB-EGF and TGF-alpha were significantly up-regulated in the skin lesions, similar to human psoriasis. Treatment of K5.Stat3C mice with TNF-alpha or EGFR inhibitors attenuated the skin lesions, suggesting the roles of TACE substrates in psoriasis. Furthermore, the skin lesions of K5.Stat3C mice showed down-regulation of tissue inhibitor of metalloproteinase-3, an endogenous inhibitor of TACE, and an increase in soluble TNF-alpha. A TACE inhibitor abrogated EGFR ligand-dependent keratinocyte proliferation and VEGF production in vitro, suggesting that TACE was involved in both epidermal hyperplasia and angiogenesis during psoriasis development. These results strongly suggest that TACE contributes to the development of psoriatic lesions through releasing two kinds of psoriasis mediators, TNF-alpha and EGFR ligands. Therefore, TACE could be a potential therapeutic target for the treatment of psoriasis.	[Sato, Kenji; Takaishi, Mikiro; Sano, Shigetoshi] Kochi Univ, Kochi Med Sch, Dept Dermatol, Nankoku, Kochi, Japan; [Sato, Kenji; Tokuoka, Shota] Kaken Pharmaceut Co Ltd, Dept Pharmacol, Drug Res Ctr, Kyoto, Japan	Kochi University; Kaken Pharmaceutical Co Ltd	Sano, S (corresponding author), Kochi Univ, Kochi Med Sch, Dept Dermatol, Nankoku, Kochi, Japan.	sano.derma@kochi-u.ac.jp			Kaken Pharmaceuticals Co. Ltd.; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour, and Welfare of Japan	Kaken Pharmaceuticals Co. Ltd.; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was funded in part by Kaken Pharmaceuticals Co. Ltd. KS, ST, SS received the funding. This study was additionally funded by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and by a grant for Research on Intractable Diseases from the Ministry of Health, Labour, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akman A, 2009, CLIN EXP DERMATOL, V34, pE202, DOI 10.1111/j.1365-2230.2008.02991.x; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blaydon DC, 2011, NEW ENGL J MED, V365, P1502, DOI 10.1056/NEJMoa1100721; Chan KS, 2004, CANCER RES, V64, P2382, DOI 10.1158/0008-5472.CAN-03-3197; Chun KS, 2009, CARCINOGENESIS, V30, P1620, DOI 10.1093/carcin/bgp168; Cook PW, 1997, J CLIN INVEST, V100, P2286, DOI 10.1172/JCI119766; DETMAR M, 1994, J EXP MED, V180, P1141, DOI 10.1084/jem.180.3.1141; Feng T, 2011, J IMMUNOL, V186, P6313, DOI 10.4049/jimmunol.1001454; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; FRANK S, 1995, J BIOL CHEM, V270, P12607, DOI 10.1074/jbc.270.21.12607; Gais P, 2010, J IMMUNOL, V184, P5842, DOI 10.4049/jimmunol.0902456; Gaspari AA, 2006, J AM ACAD DERMATOL, V54, pS67, DOI 10.1016/j.jaad.2005.10.057; Gordon K, 2012, J AM ACAD DERMATOL, V66, P241, DOI 10.1016/j.jaad.2010.12.005; Gottlieb AB, 2005, J IMMUNOL, V175, P2721, DOI 10.4049/jimmunol.175.4.2721; Guinea-Viniegra J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008089; Guinea-Viniegra J, 2009, GENE DEV, V23, P2663, DOI 10.1101/gad.543109; Hirai T, 2013, J IMMUNOL, V190, P4805, DOI 10.4049/jimmunol.1200901; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Johansen C, 2006, J IMMUNOL, V176, P1431, DOI 10.4049/jimmunol.176.3.1431; Johnston A, 2011, J INVEST DERMATOL, V131, P329, DOI 10.1038/jid.2010.313; Kawaguchi M, 2005, BRIT J DERMATOL, V152, P915, DOI 10.1111/j.1365-2133.2005.06440.x; Kawaguchi M, 2004, CLIN EXP DERMATOL, V29, P185, DOI 10.1111/j.1365-2230.2004.01455.x; Kim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072981; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee MH, 2002, FEBS LETT, V520, P102, DOI 10.1016/S0014-5793(02)02776-X; Lowes MA, 2013, TRENDS IMMUNOL, V34, P174, DOI 10.1016/j.it.2012.11.005; Maretzky T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1232; Menter A, 2007, J AM ACAD DERMATOL, V56, P31, DOI 10.1016/j.jaad.2006.07.017; Miyoshi K, 2011, J INVEST DERMATOL, V131, P108, DOI 10.1038/jid.2010.255; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Murakawa M, 2006, BIOCHEM PHARMACOL, V71, P1331, DOI 10.1016/j.bcp.2006.01.005; Nakai K, 2009, J DERMATOL SCI, V55, P170, DOI 10.1016/j.jdermsci.2009.06.002; Nakajima K, 2011, J IMMUNOL, V186, P4481, DOI 10.4049/jimmunol.1000148; Neyns B, 2008, CURR ONCOL, V15, P196; Oyama N, 2012, J AM ACAD DERMATOL, V66, pE251, DOI 10.1016/j.jaad.2011.08.009; Peus D, 1997, J INVEST DERMATOL, V109, P751, DOI 10.1111/1523-1747.ep12340759; Piepkorn M, 1998, J INVEST DERMATOL, V111, P715, DOI 10.1046/j.1523-1747.1998.00390.x; Sano S, 2005, CANCER RES, V65, P5720, DOI 10.1158/0008-5472.CAN-04-4359; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Sano S, 2008, J DERMATOL SCI, V50, P1, DOI 10.1016/j.jdermsci.2007.05.016; Stoll SW, 2010, J INVEST DERMATOL, V130, P2031, DOI 10.1038/jid.2010.98; Stoll SW, 2010, J INVEST DERMATOL, V130, P295, DOI 10.1038/jid.2009.211; Sugita S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3824; Terajima S, 1998, ARCH DERMATOL RES, V290, P246, DOI 10.1007/s004030050299; Tokumaru S, 2000, J CELL BIOL, V151, P209, DOI 10.1083/jcb.151.2.209; VASSAR R, 1991, GENE DEV, V5, P714, DOI 10.1101/gad.5.5.714; Weidemann AK, 2013, CLIN COSMET INV DERM, V6, P233, DOI 10.2147/CCID.S35312; Xia YP, 2003, BLOOD, V102, P161, DOI 10.1182/blood-2002-12-3793; Zaba LC, 2007, J EXP MED, V204, P3183, DOI 10.1084/jem.20071094; Zaba LC, 2009, J ALLERGY CLIN IMMUN, V124, P1022, DOI 10.1016/j.jaci.2009.08.046; Zibert JR, 2010, J DERMATOL SCI, V58, P177, DOI 10.1016/j.jdermsci.2010.03.004	52	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112408	10.1371/journal.pone.0112408	http://dx.doi.org/10.1371/journal.pone.0112408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384035	gold, Green Published, Green Submitted			2022-12-27	WOS:000344816700058
J	Wang, XH; Tolba, E; Schroder, HC; Neufurth, M; Feng, QL; Diehl-Seifert, B; Muller, WEG				Wang, Xiaohong; Tolba, Emad; Schroeder, Heinz C.; Neufurth, Meik; Feng, Qingling; Diehl-Seifert, Baerbel; Mueller, Werner E. G.			Effect of Bioglass on Growth and Biomineralization of SaOS-2 Cells in Hydrogel after 3D Cell Bioprinting	PLOS ONE			English	Article							BIOACTIVE GLASS; BIO-SILICA; SOL-GEL; BONE; MINERALIZATION; POLYPHOSPHATE; FABRICATION; BIOSILICA; ALGINATE	We investigated the effect of bioglass (bioactive glass) on growth and mineralization of bone-related SaOS-2 cells, encapsulated into a printable and biodegradable alginate/gelatine hydrogel. The hydrogel was supplemented either with polyphosphate (polyP), administered as polyP center dot Ca2+-complex, or silica, or as biosilica that had been enzymatically prepared from ortho-silicate by silicatein. These hydrogels, together with SaOS-2 cells, were bioprinted to computer-designed scaffolds. The results revealed that bioglass (nano) particles, with a size of 55 nm and a molar ratio of SiO2:CaO:P2O5 of 55:40:5, did not affect the growth of the encapsulated cells. If silica, biosilica, or polyP center dot Ca2+-complex is co-added to the cell-containing alginate/gelatin hydrogel the growth behavior of the cells is not changed. Addition of 5 mg/ml of bioglass particles to this hydrogel significantly enhanced the potency of the entrapped SaOS-2 cells to mineralize. If compared with the extent of the cells to form mineral deposits in the absence of bioglass, the cells exposed to bioglass together with 100 mu moles/L polyP center dot Ca2+-complex increased their mineralization activity from 2.1- to 3.9-fold, or with 50 mu moles/L silica from 1.8- to 2.9-fold, or with 50 mu moles/L biosilica from 2.7- to 4.8-fold or with the two components together (100 mu moles/L polyP center dot Ca2+-complex and 50 mu moles/ L biosilica) from 4.1- to 6.8-fold. Element analysis by EDX spectrometry of the mineral nodules formed by SaOS-2 revealed an accumulation of O, P, Ca and C, indicating that the mineral deposits contain, besides Ca-phosphate also Ca-carbonate. The results show that bioglass added to alginate/gelatin hydrogel increases the proliferation and mineralization of bioprinted SaOS-2 cells. We conclude that the development of cell-containing scaffolds consisting of a bioprintable, solid and cell-compatible inner matrix surrounded by a printable hard and flexible outer matrix containing bioglass, provide a suitable strategy for the fabrication of morphogenetically active and biodegradable implants.	[Wang, Xiaohong; Tolba, Emad; Schroeder, Heinz C.; Neufurth, Meik; Mueller, Werner E. G.] Johannes Gutenberg Univ Mainz, Inst Physiol Chem, Univ Med Ctr, ERC Adv Investigator Grant Res Grp, Mainz, Germany; [Tolba, Emad] Natl Res Ctr, Inorgan Chem Ind Div, Biomat Dept, Cairo, Egypt; [Feng, Qingling] Tsinghua Univ, Sch Mat Sci & Engn, Key Lab Adv Mat, Minist Educ China, Beijing 100084, Peoples R China; [Diehl-Seifert, Baerbel] NanotecMARIN GmbH, Mainz, Germany	Johannes Gutenberg University of Mainz; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Ministry of Education, China; Tsinghua University	Wang, XH (corresponding author), Johannes Gutenberg Univ Mainz, Inst Physiol Chem, Univ Med Ctr, ERC Adv Investigator Grant Res Grp, Mainz, Germany.	wang013@uni-mainz.de; wmueller@uni-mainz.de	Wang, Zhong Lin/E-2176-2011; Neufurth, Meik/N-4297-2015; Müller, W. E. G./AAR-8651-2020; wang, jie/GRS-0942-2022; Wang, Xiaohong/AAR-5526-2020; Tolba, Emad/E-1049-2016	Wang, Zhong Lin/0000-0002-5530-0380; Neufurth, Meik/0000-0002-2383-6412; Müller, W. E. G./0000-0002-8223-3689; Tolba, Emad/0000-0002-3422-2344; Schroder, Heinz C./0000-0003-0992-6427	ERC Advanced Investigator Grant [268476 BIOSILICA]; Deutsche Forschungsgemeinschaft [Schr 277/10-3]; European Commission [286059, 604036, 268476, 311848]; International Human Frontier Science Program; NanotecMARIN GmbH	ERC Advanced Investigator Grant; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); International Human Frontier Science Program(Human Frontier Science Program); NanotecMARIN GmbH	WEGM is a holder of an ERC Advanced Investigator Grant (No. 268476 BIOSILICA). This work was supported by grants from the Deutsche Forschungsgemeinschaft (Schr 277/10-3), the European Commission (Industry-Academia Partnerships and Pathways "CoreShell'': No. 286059; "Bio-Scaffolds'': No. 604036; "MarBioTec*EU-CN*'': No. 268476; and "BlueGenics'': No. 311848) and the International Human Frontier Science Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NanotecMARIN GmbH provided support in the form of salary for author BDS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Bose S, 2013, MATER TODAY, V16, P496, DOI 10.1016/j.mattod.2013.11.017; Bose S, 2013, CHARACTERIZATION OF BIOMATERIALS, P1, DOI 10.1016/B978-0-12-415800-9.00001-2; Cattalini JP, 2013, PROCEDIA ENGINEER, V59, P78, DOI 10.1016/j.proeng.2013.05.096; Chen Q., 2008, TOPICS TISSUE ENG, V4, P1; Cohen D. L., 2008, P TERMIS N AM 2008 A; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; FUJIKOSHI Y, 1993, DISCRETE MATH, V116, P315, DOI 10.1016/0012-365X(93)90410-U; Gibson I, 2010, ADDITIVE MANUFACTURING TECHNOLOGIES: RAPID PROTOTYPING TO DIRECT DIGITAL MANUFACTURING, P1, DOI 10.1007/978-1-4419-1120-9; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Han PP, 2013, BIOMATER SCI-UK, V1, P379, DOI 10.1039/c2bm00108j; Hench L. L., 2011, NEW MAT TECHNOLOGIES, P25, DOI DOI 10.1142/9781848165595_0003; Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z; Hench LL, 1971, J BIOMED MATER RES S, V5, P117, DOI [10.1002/jbm.820050611, DOI 10.1002/JBM.820050611]; Hong ZK, 2009, J NON-CRYST SOLIDS, V355, P368, DOI 10.1016/j.jnoncrysol.2008.12.003; Hong Z, 2009, J BIOMED MATER RES A, V88A, P304, DOI 10.1002/jbm.a.31848; Jazrawi LM, 1998, J ORTHOP TRAUMA, V12, P111, DOI 10.1097/00005131-199802000-00008; Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023; Kulakovskaya T, 2012, BIOCH PHYSL, V1; Leyhausen G, 1998, J BONE MINER RES, V13, P803, DOI 10.1359/jbmr.1998.13.5.803; Luo YX, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015005; Muller WEG, 2015, J TISSUE ENG REGEN M, V9, pE39, DOI 10.1002/term.1745; Muller WEG, 2013, BIOMATER SCI-UK, V1, P669, DOI 10.1039/c3bm00001j; Muller WEG, 2013, BIOMATERIALS, V34, P8671, DOI 10.1016/j.biomaterials.2013.07.096; Muller WEG, 2011, BBA-GEN SUBJECTS, V1810, P713, DOI 10.1016/j.bbagen.2011.04.009; Muller WEG, 2011, ACTA BIOMATER, V7, P2661, DOI 10.1016/j.actbio.2011.03.007; Ozbolat IT, 2013, IEEE T BIO-MED ENG, V60, P691, DOI 10.1109/TBME.2013.2243912; POWELL EO, 1956, J GEN MICROBIOL, V15, P492, DOI 10.1099/00221287-15-3-492; Ravarian R, 2013, J MATER CHEM B, V1, P1835, DOI 10.1039/c2tb00251e; SACHS L, 1984, ANGEW STAT, P242; Schlossmacher U, 2013, RSC ADV, V3, P11185, DOI 10.1039/c3ra23341c; Schroder HC, 2005, J BIOMED MATER RES B, V75B, P387, DOI 10.1002/jbm.b.30322; Shoichet MS, 1996, BIOTECHNOL BIOENG, V50, P374, DOI 10.1002/(SICI)1097-0290(19960520)50:4<374::AID-BIT4>3.0.CO;2-I; Smrdel P, 2006, DRUG DEV IND PHARM, V32, P623, DOI 10.1080/03639040600599863; Tasoglu S, 2013, TRENDS BIOTECHNOL, V31, P10, DOI 10.1016/j.tibtech.2012.10.005; Tong X, 2002, J APPL POLYM SCI, V86, P3532, DOI 10.1002/app.11152; Velasquillo C., 2013, J COSMET DERMATOL SC, V03, P85, DOI [DOI 10.4236/JCDSA.2013.31A012, 10.4236/jcdsa.2013.31a012]; Wang XH, 2013, SOFT MATTER, V9, P654, DOI 10.1039/c2sm27109e; Wang XH, 2012, SOFT MATTER, V8, P9501, DOI 10.1039/c2sm25889g; Wang XH, 2012, CURR OPIN BIOTECH, V23, P570, DOI 10.1016/j.copbio.2012.01.018; Wang XH, 2011, CHEMBIOCHEM, V12, P2316, DOI 10.1002/cbic.201100345; Welschoff J, 2014, FASEB J, V5; Wiens M, 2010, CALCIFIED TISSUE INT, V87, P513, DOI 10.1007/s00223-010-9408-6; Wiens M, 2010, BIOMATERIALS, V31, P7716, DOI 10.1016/j.biomaterials.2010.07.002; Woo YI, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/4/044109	44	59	64	1	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112497	10.1371/journal.pone.0112497	http://dx.doi.org/10.1371/journal.pone.0112497			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383549	Green Submitted, Green Published, gold			2022-12-27	WOS:000344816700069
J	Dong, YC; Li, PF; Ni, YH; Zhao, JJ; Liu, ZQ				Dong, Yingchun; Li, Pengfei; Ni, Yanhong; Zhao, Junjie; Liu, Zhiqiang			Decreased MicroRNA-125a-3p Contributes to Upregulation of p38 MAPK in Rat Trigeminal Ganglions with Orofacial Inflammatory Pain	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; DORSAL-HORN; DIFFERENTIAL EXPRESSION; TEMPOROMANDIBULAR-JOINT; CENTRAL SENSITIZATION; NOCICEPTIVE NEURONS; NEUROPATHIC PAIN; DOWN-REGULATION; NERVE INJURY; MICRORNAS	Orofacial inflammatory pain is a difficult clinical problem, and the specific molecular mechanisms for this pain remain largely unexplained. The present study aimed to determine the differential expression of microRNAs (miRNAs) and disclose the underlying role of miR-125a-3p in orofacial inflammatory pain induced by complete Freund's adjuvant (CFA). Thirty-two differentially expressed miRNAs were first screened using a microarray chip in ipsilateral trigeminal ganglions (TGs) following CFA injection into the orofacial skin innervated by trigeminal nerve, and a portion of them, including miR-23a*, -24-2*, -26a, -92a, -125a-3p, -183 and -299 were subsequently selected and validated by qPCR. The target genes were predicted based on the miRWalk website and were further analyzed by gene ontology (GO). Further studies revealed miR-125a-3p expression was down-regulated, whereas both the expression of p38 MAPK (mitogen-activated protein kinase) alpha and CGRP (calcitonin gene-related peptide) were up-regulated in ipsilateral TGs at different time points after CFA injection compared with control. Furthermore, mechanistic study revealed that miR-125a-3p negatively regulates p38 alpha gene expression and is positively correlated with the head withdrawal threshold reflecting pain. Luciferase assay showed that binding of miR-125a-3p to the 3'UTR of p38 alpha gene suppressed the transcriptional activity, and overexpression of miR-125a-3p significantly inhibited the p38 alpha mRNA level in ND8/34 cells. Taken together, our results show that miR125a-3p is negatively correlated with the development and maintenance of orofacial inflammatory pain via regulating p38 MAPK.	[Dong, Yingchun] Nanjing Univ, Inst & Hosp Stomatol, Sch Med, Dept Anesthesiol, Nanjing 210008, Jiangsu, Peoples R China; [Li, Pengfei] Nanjing Univ Tradit Chinese Med, Affiliated Hosp, Jiangsu Prov Hosp Tradit Chinese Med, Dept Lab, Nanjing, Jiangsu, Peoples R China; [Ni, Yanhong] Nanjing Univ, Inst & Hosp Stomatol, Sch Med, Cent Lab, Nanjing 210008, Jiangsu, Peoples R China; [Zhao, Junjie] Nanjing Univ, Inst & Hosp Stomatol, Sch Med, Dept Periodont, Nanjing 210008, Jiangsu, Peoples R China; [Liu, Zhiqiang] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA	Nanjing University; Nanjing University of Chinese Medicine; Nanjing University; Nanjing University; University of Texas System; UTMD Anderson Cancer Center	Dong, YC (corresponding author), Nanjing Univ, Inst & Hosp Stomatol, Sch Med, Dept Anesthesiol, Nanjing 210008, Jiangsu, Peoples R China.	dongyingchun1001@hotmail.com; liuzhiqiang0397@gmail.com	Li, Pengfei/AAQ-6289-2020	Li, Pengfei/0000-0002-5928-1578	National Natural Science Foundation of China [81100768, 81072213, 81171659]; Jiangsu Government Scholarship for Overseas Studies; Nanjing Department of Health [YKK11040, YKK09124, YKK13145, QRX11123]; Jiangsu Health International Exchange Program; Medical Science and Technology Development Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Government Scholarship for Overseas Studies; Nanjing Department of Health; Jiangsu Health International Exchange Program; Medical Science and Technology Development Foundation	The work was supported by National Natural Science Foundation of China (No. 81100768, 81072213 and No. 81171659), Jiangsu Government Scholarship for Overseas Studies, Key Project supported by Medical Science and Technology Development Foundation, Nanjing Department of Health (No. YKK11040; YKK09124; YKK13145; QRX11123) and Jiangsu Health International Exchange Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich BT, 2009, NEUROSCIENCE, V164, P711, DOI 10.1016/j.neuroscience.2009.08.033; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bai G, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-15; Bali KK, 2013, EMBO MOL MED, V5, P1740, DOI 10.1002/emmm.201302797; Botz B, 2013, PEPTIDES, V43, P105, DOI 10.1016/j.peptides.2013.03.003; Cao Y, 2013, J PAIN, V14, P793, DOI 10.1016/j.jpain.2013.02.005; Cherkas PS, 2012, NEUROSCI LETT, V526, P160, DOI 10.1016/j.neulet.2012.08.007; Favereaux A, 2011, EMBO J, V30, P3830, DOI 10.1038/emboj.2011.249; Franceschini A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052394; Hashiguchi Y, 2012, INT J ONCOL, V40, P1477, DOI 10.3892/ijo.2012.1363; Hutchins B, 2000, ARCH ORAL BIOL, V45, P335, DOI 10.1016/S0003-9969(99)00129-6; Ji Ru-Rong, 2004, Current Drug Targets - Inflammation and Allergy, V3, P299, DOI 10.2174/1568010043343804; Jiang LL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-318; Kumar M, 2014, VIROLOGY, V452, P143, DOI 10.1016/j.virol.2014.01.004; Kusuda R, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-17; Li HX, 2013, INT J MOL MED, V32, P219, DOI 10.3892/ijmm.2013.1381; Li X, 2013, J BONE MINER RES, V28, P2512, DOI 10.1002/jbmr.2002; Long I, 2013, KOREAN J PAIN, V26, P255, DOI 10.3344/kjp.2013.26.3.255; Monk CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013669; Murata K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069118; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Obata K, 2004, LIFE SCI, V74, P2643, DOI 10.1016/j.lfs.2004.01.007; Piao ZG, 2006, PAIN, V121, P219, DOI 10.1016/j.pain.2005.12.023; Piovesan EJ, 2008, ARQ NEURO-PSIQUIAT, V66, P837, DOI 10.1590/S0004-282X2008000600012; Poh KW, 2011, EUR J PAIN, V15, DOI 10.1016/j.ejpain.2011.02.002; Qiu S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003778; Ren K, 1999, PHYSIOL BEHAV, V67, P711, DOI 10.1016/S0031-9384(99)00136-5; Sakai A, 2013, BIOCHEM BIOPH RES CO, V435, P176, DOI 10.1016/j.bbrc.2013.04.089; Sato J, 2004, ORAL SURG ORAL MED O, V98, P533, DOI 10.1016/j.tripleo.2004.02.057; Tajti Janos, 2009, Neuropsychopharmacol Hung, V11, P15; Takeda M, 2004, NEUROSCIENCE, V125, P995, DOI 10.1016/j.neuroscience.2004.02.029; Tan GY, 2012, J BIOL CHEM, V287, P33036, DOI 10.1074/jbc.M112.383273; Vause CV, 2010, NEUROSCI LETT, V473, P163, DOI 10.1016/j.neulet.2010.01.074; Wang ZY, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-68; Yu B, 2011, ACTA BIOCH BIOPH SIN, V43, P909, DOI 10.1093/abbs/gmr083; Zhu Dong-wang, 2012, Zhonghua Kou Qiang Yi Xue Za Zhi, V47, P14, DOI 10.3760/cma.j.issn.1002-0098.2012.01.005	36	33	34	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111594	10.1371/journal.pone.0111594	http://dx.doi.org/10.1371/journal.pone.0111594			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380251	Green Submitted, Green Published, gold			2022-12-27	WOS:000344863100035
J	Jiang, R; Du, FZ; He, C; Gu, M; Ke, ZW; Li, JH				Jiang, Rui; Du, Fei-Zhou; He, Ci; Gu, Ming; Ke, Zhen-Wu; Li, Jian-Hao			The Value of Diffusion Tensor Imaging in Differentiating High-Grade Gliomas from Brain Metastases: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							GLIOBLASTOMA-MULTIFORME; PERFUSION METRICS; TUMORS; MRI; UTILITY; REGION; EDEMA; 3T	Purpose: Differentiation of high-grade gliomas and solitary brain metastases is an important clinical issue because the treatment strategies differ greatly. Our study aimed to investigate the potential value of diffusion tensor imaging (DTI) in differentiating high-grade gliomas from brain metastases using a meta-analytic approach. Materials and Methods: We searched Pubmed, Embase and the Cochrane Library for relevant articles published in English. Studies that both investigated high-grade gliomas and brain metastases using DTI were included. Random effect model was used to compare fractional anisotropy (FA) and mean diffusivity (MD) values in the two tumor entities. Results: Nine studies were included into the meta-analysis. In the peritumoral region, compared with brain metastases, high-grade gliomas had a significant increase of FA (SMD = 0.47; 95% CI, 0.22-0.71; P <0.01) and a significant decrease of MD (SMD = -1.49; 95% CI, -1.91 to -1.06; P < 0.01). However, in the intratumoral area, no significant change in FA (SMD = 0.16; 95% CI, -0.49 to 0.82; P = 0.73) or MD (SMD = 0.34; 95% CI, -0.91 to 1.60; P = 0.59) was detected between gliomas and metastases. Conclusions: High-grade gliomas may be distinguished from brain metastases by comparing the peritumoral FA and MD values. DTI appears to be a promising tool in diagnosing solitary intracranial lesions.	[Jiang, Rui; Du, Fei-Zhou; He, Ci; Gu, Ming; Ke, Zhen-Wu; Li, Jian-Hao] Chengdu Mil Gen Hosp, Dept Med Imaging, Chengdu, Peoples R China		Gu, M (corresponding author), Chengdu Mil Gen Hosp, Dept Med Imaging, Chengdu, Peoples R China.	gumingcd@126.com						Byrnes TJD, 2011, NMR BIOMED, V24, P54, DOI 10.1002/nbm.1555; Chen R, 2013, NEURORADIOL J, V26, P175, DOI 10.1177/197140091302600207; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoefnagels FWA, 2014, J NEURO-ONCOL, V120, P187, DOI 10.1007/s11060-014-1544-9; Kinoshita M, 2008, NEUROIMAGE, V43, P29, DOI 10.1016/j.neuroimage.2008.06.041; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee EJ, 2013, CLIN RADIOL, V68, pE689, DOI 10.1016/j.crad.2013.06.021; Lu S, 2003, AM J NEURORADIOL, V24, P937; Lu S, 2004, RADIOLOGY, V232, P221, DOI 10.1148/radiol.2321030653; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Polders DL, 2011, J MAGN RESON IMAGING, V33, P1456, DOI 10.1002/jmri.22554; Price SJ, 2003, CLIN RADIOL, V58, P455, DOI 10.1016/S0009-9260(03)00115-6; Rees JH, 1996, RADIOGRAPHICS, V16, P1413, DOI 10.1148/radiographics.16.6.8946545; Saksena S, 2013, J CLIN DIAGN RES, V7, P320, DOI 10.7860/JCDR/2013/4491.2757; Sternberg EJ, 2014, AM J NEURORADIOL, V35, P439, DOI 10.3174/ajnr.A3702; Svolos P, 2013, MAGN RESON IMAGING, V31, P1567, DOI 10.1016/j.mri.2013.06.010; Toh CH, 2011, AM J NEURORADIOL, V32, P1646, DOI 10.3174/ajnr.A2581; Tsougos I, 2012, CANCER IMAGING, V12, P423, DOI 10.1102/1470-7330.2012.0038; Tsuchiya K, 2005, BRIT J RADIOL, V78, P533, DOI 10.1259/bjr/68749637; van Westen D, 2006, ACTA RADIOL, V47, P311, DOI 10.1080/02841850500539058; Wang S, 2011, AJNR Am J Neuroradiol, V32, P507, DOI 10.3174/ajnr.A2333; Wang S, 2014, AM J NEURORADIOL, V35, P928, DOI 10.3174/ajnr.A3871; Wang SM, 2009, NEUROIMAGE, V44, P653, DOI 10.1016/j.neuroimage.2008.09.027; Wang W, 2009, AM J NEURORADIOL, V30, P203, DOI 10.3174/ajnr.A1303; White ML, 2011, AM J NEURORADIOL, V32, P374, DOI 10.3174/ajnr.A2267; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Witwer BP, 2002, J NEUROSURG, V97, P568, DOI 10.3171/jns.2002.97.3.0568; Yang G, 2014, NMR BIOMED, V27, P1103, DOI 10.1002/nbm.3163; Zamecnik J, 2005, ACTA NEUROPATHOL, V110, P435, DOI 10.1007/s00401-005-1078-5; Zijlmans M, 2009, J MAGN RESON IMAGING, V30, P256, DOI 10.1002/jmri.21811	31	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112550	10.1371/journal.pone.0112550	http://dx.doi.org/10.1371/journal.pone.0112550			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380185	gold, Green Published, Green Submitted			2022-12-27	WOS:000344863100107
J	Stevenson-Holt, CD; Watts, K; Bellamy, CC; Nevin, OT; Ramsey, AD				Stevenson-Holt, Claire D.; Watts, Kevin; Bellamy, Chloe C.; Nevin, Owen T.; Ramsey, Andrew D.			Defining Landscape Resistance Values in Least-Cost Connectivity Models for the Invasive Grey Squirrel: A Comparison of Approaches Using Expert-Opinion and Habitat Suitability Modelling	PLOS ONE			English	Article							SCIURUS-CAROLINENSIS; GENE FLOW; PATCH CONNECTIVITY; SPATIAL-ANALYSIS; RED; DISPERSAL; MOVEMENT; LINKAGES; MAXENT; FROG	Least-cost models are widely used to study the functional connectivity of habitat within a varied landscape matrix. A critical step in the process is identifying resistance values for each land cover based upon the facilitating or impeding impact on species movement. Ideally resistance values would be parameterised with empirical data, but due to a shortage of such information, expert-opinion is often used. However, the use of expert-opinion is seen as subjective, human-centric and unreliable. This study derived resistance values from grey squirrel habitat suitability models (HSM) in order to compare the utility and validity of this approach with more traditional, expert-led methods. Models were built and tested with MaxEnt, using squirrel presence records and a categorical land cover map for Cumbria, UK. Predictions on the likelihood of squirrel occurrence within each land cover type were inverted, providing resistance values which were used to parameterise a least-cost model. The resulting habitat networks were measured and compared to those derived from a least-cost model built with previously collated information from experts. The expert-derived and HSM-inferred least-cost networks differ in precision. The HSM-informed networks were smaller and more fragmented because of the higher resistance values attributed to most habitats. These results are discussed in relation to the applicability of both approaches for conservation and management objectives, providing guidance to researchers and practitioners attempting to apply and interpret a least-cost approach to mapping ecological networks.	[Stevenson-Holt, Claire D.] Univ Cumbria, Ctr Wildlife Conservat, Ambleside, Cumbria, England; [Watts, Kevin] Ctr Ecosyst Soc & Biosecur, Farnham, Surrey, England; [Bellamy, Chloe C.] Ctr Ecosyst Soc & Biosecur, Roslin, Midlothian, Scotland; [Nevin, Owen T.] Cent Queensland Univ, Sch Med & Appl Sci, Gladstone, Qld, Australia; [Ramsey, Andrew D.] Univ Derby, Sch Biol & Forens Sci, Derby, England	University of Cumbria; Central Queensland University; University of Derby	Stevenson-Holt, CD (corresponding author), Univ Cumbria, Ctr Wildlife Conservat, Ambleside, Cumbria, England.	claire.stevenson@cumbria.ac.uk	Nevin, Owen/AAW-5220-2020	Nevin, Owen/0000-0003-3513-8053; Ramsey, Andrew/0000-0002-6232-5869; Holt, Claire/0000-0003-3635-5404	Forestry Commission GB; National School of Forestry at the University of Cumbria	Forestry Commission GB; National School of Forestry at the University of Cumbria	This project was funded by the Forestry Commission GB and the National School of Forestry at the University of Cumbria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; Beier P, 2008, CONSERV BIOL, V22, P836, DOI 10.1111/j.1523-1739.2008.00942.x; Beier P, 2009, ECOL APPL, V19, P2067, DOI 10.1890/08-1898.1; Bellamy C, 2013, J APPL ECOL, V50, P892, DOI 10.1111/1365-2664.12117; Chardon JP, 2003, LANDSCAPE ECOL, V18, P561, DOI 10.1023/A:1026062530600; Clevenger AP, 2002, CONSERV BIOL, V16, P503, DOI 10.1046/j.1523-1739.2002.00328.x; Crooks K. R., 2006, CONNECTIVITY CONSERV; De Marco P, 2008, BIOL LETTERS, V4, P577, DOI 10.1098/rsbl.2008.0210; Decout S, 2010, LANDSC INT C IUFRO P, P661; Decout S, 2012, LANDSCAPE ECOL, V27, P267, DOI 10.1007/s10980-011-9694-z; Driezen K, 2007, ECOL MODEL, V209, P314, DOI 10.1016/j.ecolmodel.2007.07.002; Epps CW, 2007, J APPL ECOL, V44, P714, DOI 10.1111/j.1365-2664.2007.01325.x; Eycott AE, 2012, LANDSCAPE ECOL, V27, P1263, DOI 10.1007/s10980-012-9781-9; Eycott AE, 2011, LANDSCAPE URBAN PLAN, V103, P400, DOI 10.1016/j.landurbplan.2011.08.014; Ferreras P, 2001, BIOL CONSERV, V100, P125, DOI 10.1016/S0006-3207(00)00213-5; FITZGIBBON CD, 1993, J APPL ECOL, V30, P736, DOI 10.2307/2404251; Gonzales EK, 2000, THESIS U GUELPH; Gonzales EK, 2007, LANDSCAPE ECOL, V22, P1155, DOI 10.1007/s10980-007-9106-6; Gurnell J, 2004, J ANIM ECOL, V73, P26, DOI 10.1111/j.1365-2656.2004.00791.x; Gurnell John, 2003, P40; Howard A, 2012, MAXIMUM ENTROPY LEAS; Humphrey J, 2007, DEV LOWLAND HABITAT, V2; KENWARD RE, 1983, MAMMAL REV, V13, P159, DOI 10.1111/j.1365-2907.1983.tb00277.x; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; LOWE VPW, 1993, J ZOOL, V231, P663, DOI 10.1111/j.1469-7998.1993.tb01948.x; Merckx B, 2011, ECOL MODEL, V222, P588, DOI 10.1016/j.ecolmodel.2010.11.016; Middleton A.D., 1930, P ZOOL SOC LOND, V100, P809, DOI DOI 10.1111/J.1096-3642.1930.TB01000.X; NIXON CM, 1980, J WILDLIFE MANAGE, V44, P403, DOI 10.2307/3807971; Pearce JL, 2001, J APPL ECOL, V38, P412, DOI 10.1046/j.1365-2664.2001.00608.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Rayfield B, 2010, LANDSCAPE ECOL, V25, P519, DOI 10.1007/s10980-009-9436-7; Richards-Zawacki CL, 2009, DIVERS DISTRIB, V15, P796, DOI 10.1111/j.1472-4642.2009.00582.x; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Sawyer SC, 2011, J APPL ECOL, V48, P668, DOI 10.1111/j.1365-2664.2011.01970.x; Schadt S, 2002, ECOL APPL, V12, P1469; Seoane J, 2005, CONSERV BIOL, V19, P512, DOI 10.1111/j.1523-1739.2005.00364.x; SHORTEN M, 1957, J ANIM ECOL, V26, P287, DOI 10.2307/1748; Shorten M, 1954, SQUIRRELS; Skelcher G, 1997, CONSERVATION RED SQU, P67; Spear SF, 2010, MOL ECOL, V19, P3576, DOI 10.1111/j.1365-294X.2010.04657.x; Stevens VM, 2004, LANDSCAPE ECOL, V19, P829, DOI 10.1007/s10980-004-0166-6; Stevenson CD, 2008, MODELLING RED SQUIRR; Stevenson CD, 2013, ECOL EVOL, V3, P2350, DOI 10.1002/ece3.638; TAYLOR KD, 1971, J APPL ECOL, V8, P123, DOI 10.2307/2402132; TAYLOR PD, 1993, OIKOS, V68, P571, DOI 10.2307/3544927; Tischendorf L, 2000, OIKOS, V90, P7, DOI 10.1034/j.1600-0706.2000.900102.x; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; Verbeylen G, 2003, LANDSCAPE ECOL, V18, P791, DOI 10.1023/B:LAND.0000014492.50765.05; Wang IJ, 2010, MOL ECOL, V19, P447, DOI 10.1111/j.1365-294X.2009.04465.x; Wang YH, 2008, LANDSCAPE ECOL, V23, P989, DOI 10.1007/s10980-008-9262-3; Warton DI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079168; Watts K, 2010, LANDSCAPE ECOL, V25, P1305, DOI 10.1007/s10980-010-9507-9; Wauters LA, 1997, WILDLIFE BIOL, V3, P117, DOI 10.2981/wlb.1997.014; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Williams S, 2008, RED SQUIRREL STRONGH; Worboys G, 2009, CONNECTIVITY CONSERV; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004; Zalewski A, 2009, MOL ECOL, V18, P1601, DOI 10.1111/j.1365-294X.2009.04131.x; Zeller KA, 2012, LANDSCAPE ECOL, V27, P777, DOI 10.1007/s10980-012-9737-0	62	48	49	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112119	10.1371/journal.pone.0112119	http://dx.doi.org/10.1371/journal.pone.0112119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380289	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000344863100054
J	Kaufmann, S; Frishman, D				Kaufmann, Stefanie; Frishman, Dmitrij			Analysis of Micro-Rearrangements in 25 Eukaryotic Species Pairs by SyntenyMapper	PLOS ONE			English	Article							GENOME REARRANGEMENTS; POLYNOMIAL ALGORITHM; SLEEPING-BEAUTY	High-quality mapping of genomic regions and genes between two organisms is an indispensable prerequisite for evolutionary analyses and comparative genomics. Existing approaches to this problem focus on either delineating orthologs or finding extended sequence regions of common evolutionary origin (syntenic blocks). We propose SyntenyMapper, a novel tool for refining predefined syntenic regions. SyntenyMapper creates a set of blocks with conserved gene order between two genomes and finds all minor rearrangements that occurred since the evolutionary split of the two species considered. We also present TrackMapper, a SyntenyMapper-based tool that allows users to directly compare genome features, such as histone modifications, between two organisms, and identify genes with highly conserved features. We demonstrate SyntenyMapper's advantages by conducting a large-scale analysis of micro-rearrangements within syntenic regions of 25 eukaryotic species. Unsurprisingly, the number and length of syntenic regions is correlated with evolutionary distance, while the number of micro-rearrangements depends only on the size of the harboring region. On the other hand, the size of rearranged regions remains relatively constant regardless of the evolutionary distance between the organisms, implying a length constraint in the rearrangement process. SyntenyMapper is a useful software tool for both large-scale and gene-centric genome comparisons.	[Kaufmann, Stefanie; Frishman, Dmitrij] Tech Univ Munich, Dept Genome Oriented Bioinformat, Freising Weihenstephan, Bavaria, Germany; [Frishman, Dmitrij] German Res Ctr Environm Hlth, Inst Bioinformat & Syst Biol, Neuherberg, Bavaria, Germany; [Frishman, Dmitrij] St Petersburg State Polytechn Univ, Dept Bioinformat, St Petersburg, Russia	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Peter the Great St. Petersburg Polytechnic University	Frishman, D (corresponding author), Tech Univ Munich, Dept Genome Oriented Bioinformat, Freising Weihenstephan, Bavaria, Germany.	d.frishman@wzw.tum.de	Frishman, Dmitrij/AAT-7815-2020		German Research Foundation (DFG) International Research Training Group 'Regulation and Evolution of Cellular Systems' [GRK 1563]; Technische Universitat Munchen; Open Access Publishing	German Research Foundation (DFG) International Research Training Group 'Regulation and Evolution of Cellular Systems'(German Research Foundation (DFG)); Technische Universitat Munchen; Open Access Publishing	This work was supported by the German Research Foundation (DFG, www.dfg.de) International Research Training Group 'Regulation and Evolution of Cellular Systems' (GRK 1563). Publication was supported by the Technische Universitat Munchen within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Fu Z, 2007, J COMPUT BIOL, V14, P1160, DOI 10.1089/cmb.2007.0048; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hannenhalli S, 1999, J ACM, V46, P1, DOI 10.1145/300515.300516; Hannenhalli S, 1995, AN S FDN CO, P581, DOI 10.1109/SFCS.1995.492588; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Izsvak Z, 2000, J MOL BIOL, V302, P93, DOI 10.1006/jmbi.2000.4047; Jun J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-630; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Liao BY, 2004, BIOINFORMATICS, V20, P3156, DOI 10.1093/bioinformatics/bth380; Mani RS, 2010, NAT REV GENET, V11, P819, DOI 10.1038/nrg2883; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Munoz-Lopez M, 2010, CURR GENOMICS, V11, P115, DOI 10.2174/138920210790886871; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Peng Q, 2006, PLOS COMPUT BIOL, V2, P100, DOI 10.1371/journal.pcbi.0020014; Pevzner P, 2003, GENOME RES, V13, P37, DOI 10.1101/gr.757503; Proost S, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr955; Rieck K, 2008, J MACH LEARN RES, V9, P23; Rodelsperger C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008861; Rosenberg C, 2006, J MED GENET, V43, P180, DOI 10.1136/jmg.2005.032268; Shi GQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-10; Sinha AU, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-82; Tesler G, 2002, BIOINFORMATICS, V18, P492, DOI 10.1093/bioinformatics/18.3.492; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Wellik DM, 2007, DEV DYNAM, V236, P2454, DOI 10.1002/dvdy.21286; Woo YH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1982; Zayed H, 2004, MOL THER, V9, P292, DOI 10.1016/j.ymthe.2003.11.024	34	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112341	10.1371/journal.pone.0112341	http://dx.doi.org/10.1371/journal.pone.0112341			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375783	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600132
J	Cheng, TC; Lai, CS; Chung, MC; Kalyanam, N; Majeed, M; Ho, CT; Ho, YS; Pan, MH				Cheng, Tzu-Chun; Lai, Ching-Shu; Chung, Min-Ching; Kalyanam, Nagabhushanam; Majeed, Muhammed; Ho, Chi-Tang; Ho, Yuan-Soon; Pan, Min-Hsiung			Potent Anti-Cancer Effect of 3 '-Hydroxypterostilbene in Human Colon Xenograft Tumors	PLOS ONE			English	Article							CELL-CYCLE ARREST; CARCINOMA CELLS; PTEROSTILBENE; CANCER; APOPTOSIS; AUTOPHAGY; PATHWAYS; AGENTS; CHEMOPREVENTION; INDUCTION	Here we report that 3'-hydroxypterostilbene (HPSB), a natural pterostilbene analogue, was more potent than pterostilbene against the growth of human cancer cells (COLO 205, HCT-116, and HT-29) with measured IC50 values of 9.0, 40.2, and 70.9 mu M, respectively. We found that HPSB effectively inhibited the growth of human colon cancer cells by inducing apoptosis and autophagy. Autophagy occurred at an early stage and was observed through the formation of acidic vesicular organelles and microtubule-associated protein 1 light chain 3-II production. At the molecular levels, the results from western blot analysis showed that HPSB significantly down-regulated phosphatidylinositol 3-kinase (PI3K)/Akt and mitogen-activated protein kinases (MAPKs) signalings including decreased the phosphorylation of mammalian target of rapamycin (mTOR). Significant therapeutic effects were demonstrated in vivo by treating nude mice bearing COLO 205 tumor xenografts with HPSB (10 mg/kg i.p.). These inhibitory effects were accompanied by mechanistic down-regulation of the protein levels of cyclooxygenase-2 (COX-2), matrix metallopeptidase-9 (MMP-9), vascular endothelial growth factor (VEGF), and cyclin D1, as well as by the induction of apoptosis in colon tumors. Our findings suggest that HPSB could serve as a novel promising agent for colon cancer treatment.	[Cheng, Tzu-Chun; Ho, Yuan-Soon] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Lai, Ching-Shu; Chung, Min-Ching; Pan, Min-Hsiung] Natl Taiwan Univ, Inst Food Sci & Technol, Taipei 10764, Taiwan; [Kalyanam, Nagabhushanam; Majeed, Muhammed] Sabinsa Corp, East Windsor, NJ USA; [Ho, Chi-Tang] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08903 USA; [Ho, Yuan-Soon] Taipei Med Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Ho, Yuan-Soon] Taipei Med Univ, Coll Med Sci & Technol, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan; [Ho, Yuan-Soon] Taipei Med Univ, Ctr Comprehens Canc, Taipei, Taiwan; [Pan, Min-Hsiung] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan	Taipei Medical University; National Taiwan University; Rutgers State University New Brunswick; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Ho, YS (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.	hoyuansn@tmu.edu.tw; mhpan@ntu.edu.tw	Pan, Min-Hsiung/AAT-8865-2021	Pan, Min-Hsiung/0000-0002-5188-7030	National Science Council [NSC 101-2628-B-022-001-MY4, 102-2628-B-002-053-MY3, NTU-103R7777]; Health and welfare surcharge of tobacco products [MOHW103-TD-B-111-01]	National Science Council(Ministry of Science and Technology, Taiwan); Health and welfare surcharge of tobacco products	This study was supported by the National Science Council NSC 101-2628-B-022-001-MY4, 102-2628-B-002-053-MY3, and NTU-103R7777 (for Dr. Pan) and by the Health and welfare surcharge of tobacco products MOHW103-TD-B-111-01 (for Dr. Ho). Sabinsa Corporation provided support in the form of salaries for authors NK & MM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Berchtold MW, 2014, BBA-MOL CELL RES, V1843, P398, DOI 10.1016/j.bbamcr.2013.10.021; Blommaart EF, 1997, HISTOCHEM J, V290, P1717; Chen RJ, 2012, J AGR FOOD CHEM, V60, P11533, DOI 10.1021/jf302778a; Chen WC, 2014, FOOD FUNCT, V5, P1856, DOI [10.1039/c4fo00145a, 10.1039/C4FO00145A]; Chiu HW, 2009, AUTOPHAGY, V5, P472, DOI 10.4161/auto.5.4.7759; Dunn WJ, 1991, J CELL BIOL, V110, P1923; FENGSRUD M, 1995, EXP CELL RES, V221, P504, DOI 10.1006/excr.1995.1402; Ferrer P, 2005, NEOPLASIA, V7, P37, DOI 10.1593/neo.04337; Hong WK, 1997, SCIENCE, V278, P1073, DOI 10.1126/science.278.5340.1073; Hu Y, 2014, MICROBES INFECT; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kapoor S, 2013, AM J SURG, V205, P483, DOI 10.1016/j.amjsurg.2012.10.031; Kelloff GJ, 2000, J NUTR, V130, p467S, DOI 10.1093/jn/130.2.467S; KELLOFF GJ, 1994, CANCER EPIDEM BIOMAR, V3, P85; Ma ZJ, 2002, FITOTERAPIA, V73, P313, DOI 10.1016/S0367-326X(02)00074-6; Mukhtar E, 2012, CURR DRUG TARGETS, V13, P1831, DOI 10.2174/138945012804545489; Pan MH, 2008, CHEM SOC REV, V37, P2558, DOI 10.1039/b801558a; Pan MH, 2008, J AGR FOOD CHEM, V56, P7502, DOI 10.1021/jf800820y; Pan MH, 2008, MOL NUTR FOOD RES, V52, P43, DOI 10.1002/mnfr.200700380; Pan MH, 2007, J AGR FOOD CHEM, V55, P7777, DOI 10.1021/jf071520h; Pan MH, 2009, CARCINOGENESIS, V30, P1234, DOI 10.1093/carcin/bgp121; Rimando AM, 2002, J AGR FOOD CHEM, V50, P3453, DOI 10.1021/jf0116855; Sporn MB, 2000, CARCINOGENESIS, V21, P525, DOI 10.1093/carcin/21.3.525; Tolomeo M, 2005, INT J BIOCHEM CELL B, V37, P1709, DOI 10.1016/j.biocel.2005.03.004; Wang YS, 2012, AM J TRANSL RES, V4, P44; Zhang X, 2012, CELL PROLIFERAT, V45, P466, DOI 10.1111/j.1365-2184.2012.00833.x	26	32	32	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111814	10.1371/journal.pone.0111814	http://dx.doi.org/10.1371/journal.pone.0111814			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389774	gold, Green Published, Green Submitted			2022-12-27	WOS:000349144400035
J	Dissinger, N; Shkriabai, N; Hess, S; Al-Saleem, J; Kvaratskhelia, M; Green, PL				Dissinger, Nathan; Shkriabai, Nikoloz; Hess, Sonja; Al-Saleem, Jacob; Kvaratskhelia, Mamuka; Green, Patrick L.			Identification and Characterization of HTLV-1 HBZ Post-Translational Modifications	PLOS ONE			English	Article							T-CELL LEUKEMIA; BZIP FACTOR; TRANSCRIPTIONAL ACTIVITY; VIRAL TRANSCRIPTION; TAX ONCOPROTEIN; C-JUN; PROTEIN; TRANSFORMATION; ONCOGENESIS; RETROVIRUS	Human T-cell leukemia virus type-1 (HTLV-1) is estimated to infect 15-25 million people worldwide, with several areas including southern Japan and the Caribbean basin being endemic. The virus is the etiological agent of debilitating and fatal diseases, for which there is currently no long-term cure. In the majority of cases of leukemia caused by HTLV-1, only a single viral gene, hbz, and its cognate protein, HBZ, are expressed and their importance is increasingly being recognized in the development of HTLV-1-associated disease. We hypothesized that HBZ, like other HTLV-1 proteins, has properties and functions regulated by post-translational modifications (PTMs) that affect specific signaling pathways important for disease development. To date, PTM of HBZ has not been described. We used an affinity-tagged protein and mass spectrometry method to identify seven modifications of HBZ for the first time. We examined how these PTMs affected the ability of HBZ to modulate several pathways, as measured using luciferase reporter assays. Herein, we report that none of the identified PTMs affected HBZ stability or its regulation of tested pathways.	[Dissinger, Nathan; Shkriabai, Nikoloz; Al-Saleem, Jacob; Kvaratskhelia, Mamuka; Green, Patrick L.] Ohio State Univ, Ctr Retrovirus Res, Columbus, OH 43210 USA; [Dissinger, Nathan; Al-Saleem, Jacob; Green, Patrick L.] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Green, Patrick L.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Green, Patrick L.] Solove Res Inst, Columbus, OH USA; [Green, Patrick L.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH USA; [Shkriabai, Nikoloz; Kvaratskhelia, Mamuka] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA; [Hess, Sonja] CALTECH, Beckman Inst, Proteome Explorat Lab, Pasadena, CA 91125 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; California Institute of Technology	Green, PL (corresponding author), Ohio State Univ, Ctr Retrovirus Res, Columbus, OH 43210 USA.	green.466@osu.edu			National Cancer Institute National Institutes of Health [CA100730]; NATIONAL CANCER INSTITUTE [P01CA100730] Funding Source: NIH RePORTER	National Cancer Institute National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute National Institutes of Health CA100730 to PLG (http://www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold J, 2008, BLOOD, V112, P3788, DOI 10.1182/blood-2008-04-154286; Bangham CRM, 2005, ONCOGENE, V24, P6035, DOI 10.1038/sj.onc.1208970; Basbous J, 2003, J BIOL CHEM, V278, P43620, DOI 10.1074/jbc.M307275200; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Borowiak M, 2013, CARCINOGENESIS, V34, P2664, DOI 10.1093/carcin/bgt221; Cavanagh MH, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-15; Clerc I, 2008, J BIOL CHEM, V283, P23903, DOI 10.1074/jbc.M803116200; Clerc I, 2009, VIROLOGY, V391, P195, DOI 10.1016/j.virol.2009.06.027; Durkin SS, 2006, J BIOL CHEM, V281, P31705, DOI 10.1074/jbc.M607011200; Gaudray G, 2002, J VIROL, V76, P12813, DOI 10.1128/JVI.76.24.12813-12822.2002; Griffiths JR, 2014, J AM SOC MASS SPECTR, V25, P767, DOI 10.1007/s13361-014-0835-x; Hagiya K, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-19; Hivin P, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-14; Jeong SJ, 2009, BIOCHEM BIOPH RES CO, V381, P294, DOI 10.1016/j.bbrc.2009.02.024; Kalli A, 2012, PROTEOMICS, V12, P21, DOI 10.1002/pmic.201100464; Kannian P, 2010, VIRUSES-BASEL, V2, P2037, DOI 10.3390/v2092037; Kesic M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-105; Kuhlmann AS, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-92; Lamoliatte F, 2013, MOL CELL PROTEOMICS, V12, P2536, DOI 10.1074/mcp.M112.025569; LAROCCA D, 1989, BIOCHEM BIOPH RES CO, V163, P1006, DOI 10.1016/0006-291X(89)92322-X; Lemasson I, 2007, J VIROL, V81, P1543, DOI 10.1128/JVI.00480-06; Li A, 2006, BIOCHEM BIOPH RES CO, V350, P818, DOI 10.1016/j.bbrc.2006.08.199; Lodewick J, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-75; Lodewick J, 2009, VIROLOGY, V386, P68, DOI 10.1016/j.virol.2008.12.043; Ma G, 2013, ONCOGENE, V32, P4222, DOI 10.1038/onc.2012.450; Marban C, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-98; Matsumoto J, 2005, ONCOGENE, V24, P1001, DOI 10.1038/sj.onc.1208297; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Miyazaki M, 2007, J VIROL, V81, P5714, DOI 10.1128/JVI.02511-06; Mukai R, 2011, BIOCHEM BIOPH RES CO, V409, P328, DOI 10.1016/j.bbrc.2011.05.014; Nicot C, 2005, ONCOGENE, V24, P6026, DOI 10.1038/sj.onc.1208977; Philip S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004040; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Simonis N, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-26; Sugata K, 2012, BLOOD, V119, P434, DOI 10.1182/blood-2011-05-357459; Takatsuki K, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-16; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; TANAKA N, 1994, CELL, V77, P829, DOI 10.1016/0092-8674(94)90132-5; Tanaka-Nakanishi A, 2014, CANCER RES, V74, P188, DOI 10.1158/0008-5472.CAN-13-0436; Thebault S, 2004, FEBS LETT, V562, P165, DOI 10.1016/S0014-5793(04)00225-X; Tootle TL, 2005, BIOESSAYS, V27, P285, DOI 10.1002/bies.20198; WILLMAN CL, 1993, SCIENCE, V259, P968, DOI 10.1126/science.8438156; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; Zhao T, 2009, BLOOD, V113, P2755, DOI 10.1182/blood-2008-06-161729; Zhi HJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002025	45	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112762	10.1371/journal.pone.0112762	http://dx.doi.org/10.1371/journal.pone.0112762			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389759	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000349144400125
J	Flierl, A; Oliveira, LMA; Falomir-Lockhart, LJ; Mak, SK; Hesley, J; Soldner, F; Arndt-Jovin, DJ; Jaenisch, R; Langston, JW; Jovin, TM; Schule, B				Flierl, Adrian; Oliveira, Luis M. A.; Falomir-Lockhart, Lisandro J.; Mak, Sally K.; Hesley, Jayne; Soldner, Frank; Arndt-Jovin, Donna J.; Jaenisch, Rudolf; Langston, J. William; Jovin, Thomas M.; Schuele, Birgitt			Higher Vulnerability and Stress Sensitivity of Neuronal Precursor Cells Carrying an Alpha-Synuclein Gene Triplication	PLOS ONE			English	Article							PARKINSONS-DISEASE PATIENT; NEURAL STEM-CELLS; COMPLEX-I; CALCIUM; DIFFERENTIATION; MITOCHONDRIA; ROS; ACCUMULATION; ASSOCIATION; APOPTOSIS	Parkinson disease (PD) is a multi-factorial neurodegenerative disorder with loss of dopaminergic neurons in the substantia nigra and characteristic intracellular inclusions, called Lewy bodies. Genetic predisposition, such as point mutations and copy number variants of the SNCA gene locus can cause very similar PD-like neurodegeneration. The impact of altered alpha-synuclein protein expression on integrity and developmental potential of neuronal stem cells is largely unexplored, but may have wide ranging implications for PD manifestation and disease progression. Here, we investigated if induced pluripotent stem cell-derived neuronal precursor cells (NPCs) from a patient with Parkinson's disease carrying a genomic triplication of the SNCA gene (SNCA-Tri). Our goal was to determine if these cells these neuronal precursor cells already display pathological changes and impaired cellular function that would likely predispose them when differentiated to neurodegeneration. To achieve this aim, we assessed viability and cellular physiology in human SNCA-Tri NPCs both under normal and environmentally stressed conditions to model in vitro gene-environment interactions which may play a role in the initiation and progression of PD. Human SNCA-Tri NPCs displayed overall normal cellular and mitochondrial morphology, but showed substantial changes in growth, viability, cellular energy metabolism and stress resistance especially when challenged by starvation or toxicant challenge. Knockdown of alpha-synuclein in the SNCA-Tri NPCs by stably expressed short hairpin RNA (shRNA) resulted in reversal of the observed phenotypic changes. These data show for the first time that genetic alterations such as the SNCA gene triplication set the stage for decreased developmental fitness, accelerated aging, and increased neuronal cell loss. The observation of this "stem cell pathology" could have a great impact on both quality and quantity of neuronal networks and could provide a powerful new tool for development of neuroprotective strategies for PD.	[Flierl, Adrian; Mak, Sally K.; Langston, J. William; Schuele, Birgitt] Parkinsons Inst, Sunnyvale, CA 94085 USA; [Oliveira, Luis M. A.; Falomir-Lockhart, Lisandro J.; Arndt-Jovin, Donna J.; Jovin, Thomas M.] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Hesley, Jayne] Mol Devices LLC, Sunnyvale, CA USA; [Soldner, Frank; Jaenisch, Rudolf] MIT, Whitehead Inst, Cambridge, MA 02139 USA; [Soldner, Frank; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA USA	Max Planck Society; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Schule, B (corresponding author), Parkinsons Inst, Sunnyvale, CA 94085 USA.	bschuele@thepi.org	Demchuk, Andrew M/E-1103-2012; Falomir Lockhart, Lisandro Jorge/V-7730-2019; Oliveira, Luis M. A./I-7994-2014; Flierl, Adrian/W-3453-2019	Demchuk, Andrew M/0000-0002-4930-7789; Falomir Lockhart, Lisandro Jorge/0000-0003-4815-5768; Oliveira, Luis M. A./0000-0002-2958-181X; Schuele, Birgitt/0000-0002-9952-5776; Flierl, Adrian/0000-0003-0933-2493	California Institute for Regenerative Medicine [CIRM ET-01246]; Parkinson Alliance; Blume Foundation; German Ministry for Education and Science (BMBF grant) [315050]; Alexander von Humboldt Foundation; NATIONAL CANCER INSTITUTE [R01CA084198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH104610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088538] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Parkinson Alliance; Blume Foundation; German Ministry for Education and Science (BMBF grant)(Federal Ministry of Education & Research (BMBF)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was supported by grants from the California Institute for Regenerative Medicine (CIRM ET-01246, J. W. L., B. S.), Parkinson Alliance (B. S., J. W. L.), and Blume Foundation (B. S.), and the German Ministry for Education and Science (BMBF grant #315050, T. M. J.). L. J. F. L. acknowledges support from the Alexander von Humboldt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboud AA, 2012, NEUROTOXICOLOGY, V33, P1443, DOI 10.1016/j.neuro.2012.10.009; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Brown MK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00263; Byers B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026159; Cali T, 2012, J BIOL CHEM, V287, P18478, DOI [10.1074/jbc.M111.304733, 10.1074/jbc.M111.302794]; Chen CT, 2010, BBA-GEN SUBJECTS, V1800, P257, DOI 10.1016/j.bbagen.2009.09.001; Chinta SJ, 2010, NEUROSCI LETT, V486, P235, DOI 10.1016/j.neulet.2010.09.061; Cho EG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024027; Chung CY, 2013, SCIENCE, V342, P983, DOI 10.1126/science.1245296; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Cooper O, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003985; Csordas G, 2009, BBA-BIOENERGETICS, V1787, P1352, DOI 10.1016/j.bbabio.2009.06.004; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Enoksson M, 2005, BIOCHEM BIOPH RES CO, V327, P774, DOI 10.1016/j.bbrc.2004.12.067; Folmes CDL, 2012, CIRC RES, V110, P526, DOI 10.1161/RES.0b013e31824ae5c1; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Grimm S, 2012, BBA-MOL CELL RES, V1823, P327, DOI 10.1016/j.bbamcr.2011.11.018; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; HUNTER DR, 1976, J BIOL CHEM, V251, P5069; Hyman BT, 2012, NAT REV NEUROSCI, V13, P395, DOI 10.1038/nrn3228; Jahnke VE, 2009, AM J PHYSIOL-CELL PH, V296, pC1185, DOI 10.1152/ajpcell.00377.2008; Joo Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014203; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Koopman Werner J H, 2010, Antioxid Redox Signal, V12, P1431, DOI 10.1089/ars.2009.2743; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Lebaron P, 1998, APPL ENVIRON MICROB, V64, P2697; Lee SY, 2012, CANCER RES, V72, P3607, DOI 10.1158/0008-5472.CAN-12-0006; Liu C, 2007, J BIOL CHEM, V282, P14558, DOI 10.1074/jbc.M700422200; Liu GH, 2012, NATURE, V491, P603, DOI 10.1038/nature11557; Mak SK, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/140427; Mak SK, 2011, J PARKINSON DIS, V1, P175, DOI 10.3233/JPD-2011-11025; Mueller JC, 2005, ANN NEUROL, V57, P535, DOI 10.1002/ana.20438; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Pervaiz S, 2009, ANTIOXID REDOX SIGN, V11, P2777, DOI 10.1089/ars.2009.2804; Peterson LJ, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/401264; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rehman J, 2010, J MOL MED, V88, P981, DOI 10.1007/s00109-010-0678-2; Reinhardt P, 2013, CELL STEM CELL, V12, P354, DOI 10.1016/j.stem.2013.01.008; Reyes JF, 2014, NEUROBIOL DIS; Sanchez-Danes A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seibler P, 2011, J NEUROSCI, V31, P5970, DOI 10.1523/JNEUROSCI.4441-10.2011; Shanbhag R, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/382175; Shavali S, 2008, NEUROSCI LETT, V439, P125, DOI 10.1016/j.neulet.2008.05.005; Shen D, 2011, CELL BIOCHEM BIOPHYS, V60, P173, DOI 10.1007/s12013-010-9138-4; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Snigdha S, 2012, NEUROSCI BULL, V28, P14, DOI 10.1007/s12264-012-1057-5; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Starkov AA, 2002, J NEUROCHEM, V83, P220, DOI 10.1046/j.1471-4159.2002.01153.x; Steindler DA, 2012, MODERN PATHOL, V25, P157, DOI 10.1038/modpathol.2011.165; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Vega-Avila Elisa, 2011, Proc West Pharmacol Soc, V54, P10; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wang XJ, 2011, FREE RADICAL BIO MED, V50, P1094, DOI 10.1016/j.freeradbiomed.2011.01.032; Winkler S, 2007, NEUROLOGY, V69, P1745, DOI 10.1212/01.wnl.0000275524.15125.f4; Winklhofer KF, 2010, BBA-MOL BASIS DIS, V1802, P29, DOI 10.1016/j.bbadis.2009.08.013; Winner B, 2011, NEUROBIOL DIS, V41, P706, DOI 10.1016/j.nbd.2010.12.008; Yin F, 2012, ANTIOXID REDOX SIGNA; Zundorf G, 2009, NEUROSCIENCE, V158, P610, DOI 10.1016/j.neuroscience.2008.10.015; Zundorf G, 2011, ANTIOXID REDOX SIGN, V14, P1275, DOI 10.1089/ars.2010.3359	65	59	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112413	10.1371/journal.pone.0112413	http://dx.doi.org/10.1371/journal.pone.0112413			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390032	Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400078
J	Holt, M; Lea, T; Murphy, DA; Ellard, J; Rosengarten, M; Kippax, SC; De Wit, JBF				Holt, Martin; Lea, Toby; Murphy, Dean A.; Ellard, Jeanne; Rosengarten, Marsha; Kippax, Susan C.; De Wit, John B. F.			Australian Gay and Bisexual Men's Attitudes to HIV Treatment as Prevention in Repeated, National Surveys, 2011-2013	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; SEX; ACCEPTABILITY; INITIATION; INFECTION; BELIEFS; ERA	Objective: Assess the acceptability of HIV treatment as prevention and early antiretroviral treatment among gay and bisexual men in Australia and any changes in attitudes over time. Methods: National, online, cross-sectional surveys of gay and bisexual men were repeated in 2011 and 2013. Changes in attitudes to HIV treatment over time were assessed with multivariate analysis of variance. The characteristics of men who agreed that HIV treatment prevented transmission and thought that early treatment was necessary were identified with multivariate logistic regression. Results: In total, 2599 HIV-negative, untested and HIV-positive men participated (n = 1283 in 2011 and n = 1316 in 2013). Attitudes changed little between 2011 and 2013; most participants remained sceptical about the preventative benefits of HIV treatment. In 2013, only 2.6% of men agreed that HIV treatment prevented transmission; agreement was associated with being HIV-positive, having an HIV-positive regular partner, and having received HIV post-exposure prophylaxis. In contrast, 71.8% agreed that early antiretroviral treatment is necessary; younger men were more likely and HIV-positive men and participants with HIV-positive partners were much less likely to agree with this. Conclusions: Promoting the individual health benefits of HIV treatment rather than its preventative benefits remains more acceptable to Australian gay and bisexual men.	[Holt, Martin; Lea, Toby; Murphy, Dean A.; Rosengarten, Marsha; De Wit, John B. F.] UNSW Australia, Ctr Social Res Hlth, Sydney, NSW, Australia; [Murphy, Dean A.] Australian Federat AIDS Org, Sydney, NSW, Australia; [Ellard, Jeanne] La Trobe Univ, Australian Res Ctr Sex Hlth & Soc, Melbourne, Vic, Australia; [Rosengarten, Marsha] Univ London, Dept Sociol, London, England; [Kippax, Susan C.] UNSW Australia, Social Policy Res Ctr, Sydney, NSW, Australia; [De Wit, John B. F.] Univ Utrecht, Utrecht, Netherlands	University of New South Wales Sydney; La Trobe University; University of London; University of New South Wales Sydney; Utrecht University	Holt, M (corresponding author), UNSW Australia, Ctr Social Res Hlth, Sydney, NSW, Australia.	m.holt@unsw.edu.au	Holt, Martin/X-6482-2019	Holt, Martin/0000-0002-2586-8274; Murphy, Dean/0000-0003-2752-7091	GoldStar award; UNSW Australia	GoldStar award; UNSW Australia	The PrEPARE Project was funded by a GoldStar award and a Research Promotion Grant from UNSW Australia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], C RETR OPP INF BOST; Chen YY, 2013, CURR HIV-AIDS REP, V10, P79, DOI 10.1007/s11904-012-0144-6; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Commonwealth of Australia, 2014, 7 NAT HIV STRAT 2014; de Wit JBF, 2014, SEX HEALTH, V11, P137, DOI 10.1071/SH13142; Ezzy DM, 1998, INT J STD AIDS, V9, P579, DOI 10.1258/0956462981921152; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Holt M, 2014, SEX HEALTH, V11, P166, DOI 10.1071/SH13060; Holt M, 2013, AIDS BEHAV, V17, P2156, DOI 10.1007/s10461-012-0313-z; Holt M, 2012, SEX TRANSM INFECT, V88, P258, DOI 10.1136/sextrans-2011-050312; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Imrie J, 2007, LANCET, V370, P10, DOI 10.1016/S0140-6736(07)61026-5; Kalichman SC, 2010, HIV MED, V11, P502, DOI 10.1111/j.1468-1293.2009.00818.x; Kippax S, 2003, SOC SCI MED, V57, P1, DOI 10.1016/S0277-9536(02)00303-9; Mao LM, 2013, AIDS CARE, V25, P1375, DOI 10.1080/09540121.2013.766304; Mao LM, 2013, AIDS BEHAV, V17, P1362, DOI 10.1007/s10461-012-0406-8; Montaner JSG, 2011, LANCET, V378, P208, DOI 10.1016/S0140-6736(11)60821-0; NSW Health & New South Wales Ministry of Health, 2012, NSW HIV STRAT 2012 2; Queensland Health, 2013, QUEENSL HIV STRAT 20; Rodger AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097340; Smith AMA, 2003, AUST NZ J PUBL HEAL, V27, P138, DOI 10.1111/j.1467-842X.2003.tb00801.x; STEVENS JP, 1980, PSYCHOL BULL, V88, P728, DOI 10.1037/0033-2909.88.3.728; Van de Ven P, 2000, AIDS CARE, V12, P171, DOI 10.1080/09540120050001841; Young I, 2014, AIDS BEHAV, V18, P195, DOI 10.1007/s10461-013-0560-7; Zablotska IB, 2011, SEX HEALTH, V8, P272, DOI 10.1071/SH10125	25	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112349	10.1371/journal.pone.0112349	http://dx.doi.org/10.1371/journal.pone.0112349			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT9MC	25386943	gold, Green Submitted, Green Published			2022-12-27	WOS:000345250400057
J	Lippi, G; Salvagno, GL; Danese, E; Skafidas, S; Tarperi, C; Guidi, GC; Schena, F				Lippi, Giuseppe; Salvagno, Gian Luca; Danese, Elisa; Skafidas, Spyros; Tarperi, Cantor; Guidi, Gian Cesare; Schena, Federico			Mean Platelet Volume (MPV) Predicts Middle Distance Running Performance	PLOS ONE			English	Article							RICH PLASMA; HEMOGLOBIN CONCENTRATION; EXERCISE PERFORMANCE; RECREATIONAL FEMALE; DETERMINANTS; SIZE; PHYSIOLOGY; ASPIRIN; GEL	Background: Running economy and performance in middle distance running depend on several physiological factors, which include anthropometric variables, functional characteristics, training volume and intensity. Since little information is available about hematological predictors of middle distance running time, we investigated whether some hematological parameters may be associated with middle distance running performance in a large sample of recreational runners. Methods: The study population consisted in 43 amateur runners (15 females, 28 males; median age 47 years), who successfully concluded a 21.1 km half-marathon at 75-85% of their maximal aerobic power (VO(2)max). Whole blood was collected 10 min before the run started and immediately thereafter, and hematological testing was completed within 2 hours after sample collection. Results: The values of lymphocytes and eosinophils exhibited a significant decrease compared to pre-run values, whereas those of mean corpuscular volume (MCV), platelets, mean platelet volume (MPV), white blood cells (WBCs), neutrophils and monocytes were significantly increased after the run. In univariate analysis, significant associations with running time were found for pre-run values of hematocrit, hemoglobin, mean corpuscular hemoglobin (MCH), red blood cell distribution width (RDW), MPV, reticulocyte hemoglobin concentration (RetCHR), and post-run values of MCH, RDW, MPV, monocytes and RetCHR. In multivariate analysis, in which running time was entered as dependent variable whereas age, sex, blood lactate, body mass index, VO(2)max, mean training regimen and the hematological parameters significantly associated with running performance in univariate analysis were entered as independent variables, only MPV values before and after the trial remained significantly associated with running time. After adjustment for platelet count, the MPV value before the run (p = 0.042), but not thereafter (p = 0.247), remained significantly associated with running performance. Conclusion: The significant association between baseline MPV and running time suggest that hyperactive platelets may exert some pleiotropic effects on endurance performance.	[Lippi, Giuseppe] Acad Hosp Parma, Lab Clin Chem & Hematol, Parma, Italy; [Salvagno, Gian Luca; Danese, Elisa; Guidi, Gian Cesare] Univ Verona, Dept Life & Reprod Sci, Lab Clin Biochem, I-37100 Verona, Italy; [Skafidas, Spyros] CeRiSM Ctr Mt Sport & Hlth, Rovereto, TN, Italy; [Tarperi, Cantor; Schena, Federico] Univ Verona, Dept Neurol Neuropsychol Morphol & Movement Sci, I-37100 Verona, Italy	University of Parma; University Hospital of Parma; University of Verona; University of Verona	Lippi, G (corresponding author), Acad Hosp Parma, Lab Clin Chem & Hematol, Parma, Italy.	glippi@ao.pr.it	Guidi, Gian Cesare/AAG-8463-2019; Salvagno, Gian Luca/R-3857-2016; Danese, Elisa/N-2848-2016; Lippi, Giuseppe/X-7198-2018	Guidi, Gian Cesare/0000-0002-4682-7834; Danese, Elisa/0000-0002-2454-0410; Lippi, Giuseppe/0000-0001-9523-9054; SALVAGNO, GIAN LUCA/0000-0003-0487-9051				Andia I, 2014, BRIT MED BULL, V110, P99, DOI 10.1093/bmb/ldu007; Bakovic D, 2013, CLIN PHYSIOL FUNCT I, V33, P30, DOI 10.1111/j.1475-097X.2012.01156.x; BRANDON LJ, 1995, SPORTS MED, V19, P268, DOI 10.2165/00007256-199519040-00004; Calbet JAL, 2006, RESP PHYSIOL NEUROBI, V151, P132, DOI 10.1016/j.resp.2006.01.014; Cho HC, 2012, NEUROSCI LETT, V519, P78, DOI 10.1016/j.neulet.2012.05.025; Colkesen Y, 2012, CLIN CHEM LAB MED, V50, P631, DOI 10.1515/CCLM.2011.806; Del Coso J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057602; Everts PA, 2008, EUR SURG RES, V40, P203, DOI 10.1159/000110862; Fanning J, 2007, J MINIM INVAS GYN, V14, P633, DOI 10.1016/j.jmig.2007.05.014; Gardner MJ, 2007, INT ORTHOP, V31, P309, DOI 10.1007/s00264-006-0174-z; Guthikonda S, 2008, J AM COLL CARDIOL, V52, P743, DOI 10.1016/j.jacc.2008.05.031; Hamid MSA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090538; Hilberg T, 2008, THROMB RES, V122, P77, DOI 10.1016/j.thromres.2007.08.018; Jones AM, 2013, SPORTS MED S1, V44, pS35; Joyner MJ, 2008, J PHYSIOL-LONDON, V586, P35, DOI 10.1113/jphysiol.2007.143834; Joyner MJ, 2003, BRIT J SPORT MED, V37, P190, DOI 10.1136/bjsm.37.3.190; KANSTRUP IL, 1984, MED SCI SPORT EXER, V16, P256; Kasuya N, 2002, ATHEROSCLEROSIS, V161, P225, DOI 10.1016/S0021-9150(01)00629-3; Kennedy G, 2006, BLOOD COAGUL FIBRIN, V17, P89, DOI 10.1097/01.mbc.0000214705.80997.73; Knechtle B, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-248; Knechtle B, 2011, PHYSICIAN SPORTSMED, V39, P158, DOI 10.3810/psm.2011.05.1907; KNUDSEN JB, 1982, SCAND J HAEMATOL, V29, P425; Kokkinos P, 2010, CIRCULATION, V122, P1637, DOI 10.1161/CIRCULATIONAHA.110.948349; Kuffler DP, 2013, MOL NEUROBIOL, V48, P315, DOI 10.1007/s12035-013-8494-7; Li NL, 2007, ARTERIOSCL THROM VAS, V27, P407, DOI 10.1161/01.ATV.0000253906.19648.ac; Lippi G, 2010, BLOOD TRANSFUS, V10, P377; Lippi G, 2006, CRIT REV CL LAB SCI, V43, P349, DOI 10.1080/10408360600755313; Lippi Giuseppe, 2014, Adv Hematol, V2014, P192173, DOI 10.1155/2014/192173; Mangalpally KKR, 2010, J THROMB THROMBOLYS, V30, P251, DOI 10.1007/s11239-010-0489-x; Mei-Dan O, 2010, PHYSICIAN SPORTSMED, V38, P127, DOI 10.3810/psm.2010.12.1835; Midgley AW, 2007, SPORTS MED, V37, P857, DOI 10.2165/00007256-200737100-00003; Mishra A, 2012, CURR PHARM BIOTECHNO, V13, P1185, DOI 10.2174/138920112800624283; Otto JM, 2013, EXTREME PHYSIOL MED, V2, DOI 10.1186/2046-7648-2-33; Petidis K, 2013, J HYPERTENS, V31, DOI [10.1097/HJH.0b013e32836434ca, 10.1097/HJH.0b013e32836434ba]; Raeissadat SA, 2014, PAIN RES TREAT, V2014, DOI 10.1155/2014/191525; Ricos C, 1999, SCAND J CLIN LAB INV, V59, P491; Saunders PU, 2004, SPORTS MED, V34, P465, DOI 10.2165/00007256-200434070-00005; Wasterlain AS, 2013, AM J SPORT MED, V41, P186, DOI 10.1177/0363546512466383; Whittaker JP, 2013, MED SCI SPORT EXER, V45, P342, DOI 10.1249/MSS.0b013e31827039db; Williams C, 1983, Br J Sports Med, V17, P152; World Anti-Doping Agency, 2014 PROH LIST; Yilmaz MB, 2004, J THROMB THROMBOLYS, V17, P115, DOI 10.1023/B:THRO.0000037666.01018.8c	42	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112892	10.1371/journal.pone.0112892	http://dx.doi.org/10.1371/journal.pone.0112892			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386658	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400100
J	Shen, CJ; Yue, RQ; Yang, YJ; Zhang, L; Sun, T; Tie, SG; Wang, HZ				Shen, Chenjia; Yue, Runqing; Yang, Yanjun; Zhang, Lei; Sun, Tao; Tie, Shuanggui; Wang, Huizhong			OsARF16 Is Involved in Cytokinin-Mediated Inhibition of Phosphate Transport and Phosphate Signaling in Rice (Oryza sativa L.)	PLOS ONE			English	Article							AUXIN RESPONSE FACTOR; ACID-PHOSPHATASE; TRANSCRIPTION FACTOR; CELL-DIVISION; STARVATION RESPONSE; ROOT-FORMATION; ARABIDOPSIS; GENE; EXPRESSION; REGULATOR	Background: Plant responses to phytohormone stimuli are the most important biological features for plants to survive in a complex environment. Cytokinin regulates growth and nutrient homeostasis, such as the phosphate (Pi) starvation response and Pi uptake in plants. However, the mechanisms underlying how cytokinin participates in Pi uptake and Pi signaling are largely unknown. In this study, we found that OsARF16 is required for the cytokinin response and is involved in the negative regulation of Pi uptake and Pi signaling by cytokinin. Principal Findings: The mutant osarf16 showed an obvious resistance to exogenous cytokinin treatment and the expression level of the OsARF16 gene was considerably up-regulated by cytokinin. Cytokinin (6-BA) application suppressed Pi uptake and the Pi starvation response in wild-type Nipponbare (NIP) and all these responses were compromised in the osarf16 mutant. Our data showed that cytokinin inhibits the transport of Pi from the roots to the shoots and that OsARF16 is involved in this process. The Pi content in the osarf16 mutant was much higher than in NIP under 6-BA treatment. The expressions of PHOSPHATE TRANSPORTER1 (PHT1) genes, phosphate (Pi) starvation-induced (PSI) genes and purple PAPase genes were higher in the osarf16 mutant than in NIP under cytokinin treatment. Conclusion: Our results revealed a new biological function for OsARF16 in the cytokinin-mediated inhibition of Pi uptake and Pi signaling in rice.	[Shen, Chenjia; Yang, Yanjun; Sun, Tao; Wang, Huizhong] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou 310036, Zhejiang, Peoples R China; [Yue, Runqing; Tie, Shuanggui] Henan Acad Agr Sci, Zhengzhou 450002, Peoples R China; [Zhang, Lei] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA	Hangzhou Normal University; Henan Academy of Agricultural Sciences; Washington State University	Shen, CJ (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou 310036, Zhejiang, Peoples R China.	shencj@hznu.edu.cn; tieshuanggui@126.com; whz62@163.com			National Natural Science Foundation of China [31401935]; Zhejiang Provincial Natural Science Foundation of China [LQ14C060001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was funded by the National Natural Science Foundation of China (31401935) and Zhejiang Provincial Natural Science Foundation of China under Grant No. LQ14C060001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti J, 2011, P NATL ACAD SCI USA, V108, P20242, DOI 10.1073/pnas.1111902108; Ai PH, 2009, PLANT J, V57, P798, DOI 10.1111/j.1365-313X.2008.03726.x; An LJ, 2012, PLANT J, V72, P474, DOI 10.1111/j.1365-313X.2012.05094.x; Bielach A, 2012, PHILOS T R SOC B, V367, P1469, DOI 10.1098/rstb.2011.0233; Bozzo GG, 2006, PLANT CELL ENVIRON, V29, P303, DOI 10.1111/j.1365-3040.2005.01422.x; Chang L, 2013, J EXP BOT, V64, P5021, DOI 10.1093/jxb/ert291; De Smet I, 2010, P NATL ACAD SCI USA, V107, P2705, DOI 10.1073/pnas.0915001107; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Du LM, 2007, GENOMICS, V89, P697, DOI 10.1016/j.ygeno.2007.02.001; Essigmann B, 1998, P NATL ACAD SCI USA, V95, P1950, DOI 10.1073/pnas.95.4.1950; Franco-Zorrilla JM, 2002, PLANT J, V32, P353, DOI 10.1046/j.1365-313X.2002.01431.x; Goetz M, 2006, PLANT CELL, V18, P1873, DOI 10.1105/tpc.105.037192; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Hirose N, 2007, PLANT CELL PHYSIOL, V48, P523, DOI 10.1093/pcp/pcm022; Inukai Y, 2005, PLANT CELL, V17, P1387, DOI 10.1105/tpc.105.030981; Ito Y, 2006, GENE, V382, P57, DOI 10.1016/j.gene.2006.06.020; JEFFERSON RA, 1987, EMBO J, V6, P3901; Karthikeyan AS, 2002, PLANT PHYSIOL, V130, P221, DOI 10.1104/pp.020007; Kitomi Y, 2011, PLANT J, V67, P472, DOI 10.1111/j.1365-313X.2011.04610.x; Laplaze L, 2007, PLANT CELL, V19, P3889, DOI 10.1105/tpc.107.055863; Li JS, 2006, PLANT PHYSIOL, V140, P899, DOI 10.1104/pp.105.070987; Marhavy P, 2014, CURR BIOL, V24, P1031, DOI 10.1016/j.cub.2014.04.002; Marhavy P, 2011, DEV CELL, V21, P796, DOI 10.1016/j.devcel.2011.08.014; Martin AC, 2000, PLANT J, V24, P559, DOI 10.1046/j.1365-313x.2000.00893.x; Mockaitis K, 2008, ANNU REV CELL DEV BI, V24, P55, DOI 10.1146/annurev.cellbio.23.090506.123214; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; Perez-Torres CA, 2008, PLANT CELL, V20, P3258, DOI 10.1105/tpc.108.058719; Perilli S, 2013, PLANT CELL, V25, P4469, DOI 10.1105/tpc.113.116632; Ribot C, 2008, PLANTA, V227, P1025, DOI 10.1007/s00425-007-0677-x; Robinson WD, 2012, J EXP BOT, V63, P6531, DOI 10.1093/jxb/ers309; Sakamoto T, 2013, PLANT J, V73, P676, DOI 10.1111/tpj.12071; Schruff MC, 2006, DEVELOPMENT, V133, P251, DOI 10.1242/dev.02194; Sessions A, 1997, DEVELOPMENT, V124, P4481; Shen CJ, 2013, PLANT CELL ENVIRON, V36, P607, DOI 10.1111/pce.12001; Shin H, 2006, PLANT J, V45, P712, DOI 10.1111/j.1365-313X.2005.02629.x; Sun SB, 2012, PLANT PHYSIOL, V159, P1571, DOI 10.1104/pp.112.196345; Tian JL, 2012, J INTEGR PLANT BIOL, V54, P631, DOI 10.1111/j.1744-7909.2012.01143.x; Trull MC, 1998, PLANTA, V206, P544, DOI 10.1007/s004250050431; Vandenbussche F, 2013, AM J BOT, V100, P215, DOI 10.3732/ajb.1200264; Wang C, 2009, PLANT J, V57, P895, DOI 10.1111/j.1365-313X.2008.03734.x; Wang SK, 2014, NEW PHYTOL, V201, P91, DOI 10.1111/nph.12499; Wang XM, 2010, PLANT CELL PHYSIOL, V51, P380, DOI 10.1093/pcp/pcq004; Wang XM, 2006, PLANT CELL ENVIRON, V29, P1924, DOI 10.1111/j.1365-3040.2006.01568.x; Wu B, 2011, MOL BIOL REP, V38, P3189, DOI 10.1007/s11033-010-9990-8; Yang DL, 2013, MOL PLANT, V6, P675, DOI 10.1093/mp/sst056; Zhang WJ, 2013, CURR BIOL, V23, P1979, DOI 10.1016/j.cub.2013.08.008	47	30	37	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112906	10.1371/journal.pone.0112906	http://dx.doi.org/10.1371/journal.pone.0112906			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386911	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400104
J	Sun, ZQ; Meng, HL; Li, J; Wang, JF; Li, Q; Wang, Y; Zhang, YS				Sun, Zhiqiang; Meng, Hailin; Li, Jing; Wang, Jianfeng; Li, Qian; Wang, Yong; Zhang, Yansheng			Identification of Novel Knockout Targets for Improving Terpenoids Biosynthesis in Saccharomyces cerevisiae	PLOS ONE			English	Article							CONSTRAINT-BASED MODELS; ESCHERICHIA-COLI; QUANTITATIVE PREDICTION; CELLULAR-METABOLISM; COBRA TOOLBOX; BUDDING YEAST; EXPRESSION; GENE; MITOCHONDRIAL; PATHWAY	Many terpenoids have important pharmacological activity and commercial value; however, application of these terpenoids is often limited by problems associated with the production of sufficient amounts of these molecules. The use of Saccharomyces cerevisiae (S. cerevisiae) for the production of heterologous terpenoids has achieved some success. The objective of this study was to identify S. cerevisiae knockout targets for improving the synthesis of heterologous terpeniods. On the basis of computational analysis of the S. cerevisiae metabolic network, we identified the knockout sites with the potential to promote terpenoid production and the corresponding single mutant was constructed by molecular manipulations. The growth rates of these strains were measured and the results indicated that the gene deletion had no adverse effects. Using the expression of amorphadiene biosynthesis as a testing model, the gene deletion was assessed for its effect on the production of exogenous terpenoids. The results showed that the dysfunction of most genes led to increased production of amorphadiene. The yield of amorphadiene produced by most single mutants was 8-10-fold greater compared to the wild type, indicating that the knockout sites can be engineered to promote the synthesis of exogenous terpenoids.	[Sun, Zhiqiang; Li, Jing; Li, Qian; Zhang, Yansheng] Chinese Acad Sci, Wuhan Bot Garden, CAS Key Lab Plant Germplasm Enhancement & Special, Wuhan, Peoples R China; [Meng, Hailin; Wang, Jianfeng; Wang, Yong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China; [Meng, Hailin] Chinese Acad Sci, Guangzhou Inst Adv Technol, GIAT HKU Joint Ctr Synthet Biol Engn Res, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Wang, Y (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China.	yongwang@sibs.ac.cn; zhangys@wbgcas.cn			National Science and Technology Program of China [2012AA02A704]; Grant for One Hundred Talents Program of the Chinese Academy of Sciences [Y129441R01]; "973'' project of China [2012CB721104]	National Science and Technology Program of China; Grant for One Hundred Talents Program of the Chinese Academy of Sciences; "973'' project of China(National Basic Research Program of China)	This work was supported by the National Science and Technology Program of China during the 25th-year plan period (grant no. 2012AA02A704), the Grant for One Hundred Talents Program of the Chinese Academy of Sciences to YZ (grant no. Y129441R01) and the "973'' project of China to YW (grant no. 2012CB721104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera J, 2001, CURR GENET, V39, P273, DOI 10.1007/s002940100213; Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Albers E, 2003, J BIOL CHEM, V278, P10264, DOI 10.1074/jbc.M211692200; Arigoni D, 1997, P NATL ACAD SCI USA, V94, P10600, DOI 10.1073/pnas.94.20.10600; Asadollahi MA, 2008, BIOTECHNOL BIOENG, V99, P666, DOI 10.1002/bit.21581; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Castegna A, 2010, J BIOL CHEM, V285, P17359, DOI 10.1074/jbc.M109.097188; Claeyssen E, 2007, PHYTOCHEMISTRY, V68, P709, DOI 10.1016/j.phytochem.2006.12.001; Contreras-Shannon V, 2005, J BIOL CHEM, V280, P4469, DOI 10.1074/jbc.M410140200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Farhi M, 2011, METAB ENG, V13, P474, DOI 10.1016/j.ymben.2011.05.001; Garcia-Campusano F, 2009, CAN J MICROBIOL, V55, P368, DOI [10.1139/W08-150, 10.1139/w08-150]; Gietz RD, 2007, NAT PROTOC, V2, P1, DOI 10.1038/nprot.2007.17; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; Kaplan RS, 1996, BIOCHEM BIOPH RES CO, V226, P657, DOI 10.1006/bbrc.1996.1411; Ketchum REB, 1996, PLANT CELL TISS ORG, V46, P9, DOI 10.1007/BF00039691; Kim H, 2011, MICROBIOL-SGM, V157, P2658, DOI 10.1099/mic.0.052506-0; Lindahl AL, 2006, BIOTECHNOL LETT, V28, P571, DOI 10.1007/s10529-006-0015-6; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; McCammon MT, 2003, ARCH BIOCHEM BIOPHYS, V419, P222, DOI 10.1016/j.abb.2003.08.022; Meng HL, 2011, BIOTECHNOL BIOPROC E, V16, P205, DOI 10.1007/s12257-010-0329-z; MURAKAMI H, 1990, J BIOCHEM, V108, P859, DOI 10.1093/oxfordjournals.jbchem.a123293; NEGM FB, 1979, PLANT PHYSIOL, V64, P69, DOI 10.1104/pp.64.1.69; Newman JD, 2006, BIOTECHNOL BIOENG, V95, P684, DOI 10.1002/bit.21017; Oswald M, 2007, FEMS YEAST RES, V7, P413, DOI 10.1111/j.1567-1364.2006.00172.x; Ozaydin B, 2012, METABOLIC ENG; Paddon CJ, 2013, NATURE; Park JM, 2009, BIOTECHNOL ADV, V27, P979, DOI 10.1016/j.biotechadv.2009.05.019; Penalosa-Ruiz G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045702; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Rodriguez A, 2001, BIOCHEM J, V355, P625, DOI 10.1042/bj3550625; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schoendorf A, 2001, P NATL ACAD SCI USA, V98, P1501, DOI 10.1073/pnas.98.4.1501; Schwartz K, 2012, GENETICS, V191, P621, DOI 10.1534/genetics.112.140053; SWINDELL CS, 1994, BIOORG MED CHEM LETT, V4, P1531, DOI 10.1016/S0960-894X(01)80527-8; Takahashi S, 2007, BIOTECHNOL BIOENG, V97, P170, DOI 10.1002/bit.21216; Toivari MH, 2004, APPL ENVIRON MICROB, V70, P3681, DOI 10.1128/aem.70.6.3681-3686.2004; Urban P, 1997, J BIOL CHEM, V272, P19176, DOI 10.1074/jbc.272.31.19176; Zhang YS, 2011, PLANT BIOTECHNOL J, V9, P445, DOI 10.1111/j.1467-7652.2010.00556.x; Zomorrodi AR, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-178	42	23	25	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112615	10.1371/journal.pone.0112615	http://dx.doi.org/10.1371/journal.pone.0112615			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386654	Green Published, Green Submitted, gold			2022-12-27	WOS:000345250400072
J	Gul, T; Islam, S; Shah, RA; Khan, I; Khalid, A; Shafie, S				Gul, Taza; Islam, Saeed; Shah, Rehan Ali; Khan, Ilyas; Khalid, Asma; Shafie, Sharidan			Heat Transfer Analysis of MHD Thin Film Flow of an Unsteady Second Grade Fluid Past a Vertical Oscillating Beltl	PLOS ONE			English	Article							HOMOTOPY ASYMPTOTIC METHOD; ADOMIAN DECOMPOSITION METHOD; RELIABLE TREATMENT; STARTING SOLUTIONS; MICROFLUIDICS; CONVECTION	This article aims to study the thin film layer flowing on a vertical oscillating belt. The flow is considered to satisfy the constitutive equation of unsteady second grade fluid. The governing equation for velocity and temperature fields with subjected initial and boundary conditions are solved by two analytical techniques namely Adomian Decomposition Method (ADM) and Optimal Homotopy Asymptotic Method (OHAM). The comparisons of ADM and OHAM solutions for velocity and temperature fields are shown numerically and graphically for both the lift and drainage problems. It is found that both these solutions are identical. In order to understand the physical behavior of the embedded parameters such as Stock number, frequency parameter, magnetic parameter, Brinkman number and Prandtl number, the analytical results are plotted graphically and discussed.	[Gul, Taza; Islam, Saeed] Abdul Wali Khan Univ, Dept Math, Mardan Khyber Pakhtunkhw, Pakistan; [Shah, Rehan Ali] Univ Engn & Technol, Dept Math, Peshawar Khyber Pakhtunk, Pakistan; [Khan, Ilyas] Majmaah Univ, Coll Engn, Dept Basic Sci, Majmaah, Saudi Arabia; [Khalid, Asma; Shafie, Sharidan] Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Utm Johor Bahru, Johor, Malaysia	Majmaah University; Universiti Teknologi Malaysia	Shafie, S (corresponding author), Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Utm Johor Bahru, Johor, Malaysia.	sharidan@utm.my	Saeed, Islam/AAD-6067-2020; Gul, Taza/R-7774-2019; Khan, Ilyas/C-8770-2019	Saeed, Islam/0000-0001-5263-4871; Gul, Taza/0000-0003-1376-8345; Khan, Ilyas/0000-0002-2056-9371				Adomian G., 1994, COATINGS; Adomian G, 1992, MATH COMPUT MODEL, V13, P287; Ali F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085099; Ancey C, 2007, J NON-NEWTON FLUID, V142, P4, DOI 10.1016/j.jnnfm.2006.05.005; CHERRUAULT Y, 1989, KYBERNETES, V18, P31, DOI 10.1108/eb005812; CHERRUAULT Y, 1993, MATH COMPUT MODEL, V18, P103, DOI 10.1016/0895-7177(93)90233-O; Fetecau C, 2006, INT J ENG SCI, V44, P788, DOI 10.1016/j.ijengsci.2006.04.010; Fetecau C, 2005, INT J ENG SCI, V43, P781, DOI 10.1016/j.ijengsci.2004.12.009; Griffiths RW, 2000, ANNU REV FLUID MECH, V32, P477, DOI 10.1146/annurev.fluid.32.1.477; Gul T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097552; Gul T, 2013, J APPL MATH, DOI 10.1155/2013/707286; HAN CD, 1978, POLYM ENG SCI, V18, P1019, DOI 10.1002/pen.760181309; Kamran AM, 2012, APPL MATH COMPUT, P10413; Khan NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095423; Liao S., 2003, PERTURBATION INTRO H, DOI 10.1201/9780203491164; Mabood F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083581; Marinca V, 2008, CENT EUR J PHYS, V6, P648, DOI [10.2478/s11534-008-0061-x, 10.2478/S11534-008-0061-x]; Marinca V, 2008, INT COMMUN HEAT MASS, V35, P710, DOI 10.1016/j.icheatmasstransfer.2008.02.010; Marinca V, 2009, APPL MATH LETT, V22, P245, DOI 10.1016/j.aml.2008.03.019; Miladinova S, 2004, J NON-NEWTON FLUID, V122, P69, DOI 10.1016/j.jnnfm.2004.01.021; Qasim M, 2013, ALEX ENG J, V52, P571, DOI 10.1016/j.aej.2013.08.004; Qasim M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083930; Qasim M, 2012, Z NATURFORSCH A, V67, P195, DOI 10.5560/ZNA.2012-0006; Samiulhaq, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088766; Shah AR, 2011, J KSIAM, P201; Squires TM, 2005, REV MOD PHYS, V77, P977, DOI 10.1103/RevModPhys.77.977; Stone HA, 2004, ANNU REV FLUID MECH, V36, P381, DOI 10.1146/annurev.fluid.36.050802.122124; Wang SW, 2008, PHYS LETT A, V372, P3046, DOI 10.1016/j.physleta.2008.01.024; Wang SW, 2011, INT J HEAT FLUID FL, V32, P88, DOI 10.1016/j.ijheatfluidflow.2010.10.005; Wazwaz AM, 2005, APPL MATH COMPUT, V166, P652, DOI 10.1016/j.amc.2004.06.059; Wazwaz AM, 2005, APPL MATH COMPUT, V161, P543, DOI 10.1016/j.amc.2003.12.048; Weinstein SJ, 2004, ANNU REV FLUID MECH, V36, P29, DOI 10.1146/annurev.fluid.36.050802.122049; Zhao ML, 2014, APPL MATH MODEL, V38, P2345, DOI 10.1016/j.apm.2013.10.053; Zhao ML, 2014, J APPL MATH, DOI 10.1155/2014/489279; Zhao ML, 2013, J NON-NEWTON FLUID, V201, P135, DOI 10.1016/j.jnnfm.2013.09.002	35	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e103843	10.1371/journal.pone.0103843	http://dx.doi.org/10.1371/journal.pone.0103843			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383797	gold, Green Published, Green Submitted			2022-12-27	WOS:000344816700001
J	Hayley, AC; Williams, LJ; Kennedy, GA; Berk, M; Brennan, SL; Pasco, JA				Hayley, Amie C.; Williams, Lana J.; Kennedy, Gerard A.; Berk, Michael; Brennan, Sharon L.; Pasco, Julie A.			Excessive Daytime Sleepiness and Body Composition: A Population-Based Study of Adults	PLOS ONE			English	Article							RISK-FACTORS; WAIST CIRCUMFERENCE; GENERAL-POPULATION; MASS INDEX; OBESITY; APNEA; PREVALENCE; DISORDERS; OVERWEIGHT; WOMEN	Background: Excessive daytime sleepiness (EDS) is often associated with increased adiposity, particularly when assessed in the context of samples of sleep-disordered patients; however, it is unclear if this relationship is sustained among non-clinical, population-based cohorts. This study aimed to investigate the relationship between EDS and a number of body composition markers among a population-based sample of men and women. Methods: This study assessed 1066 women aged 21-94 yr (median = 51 yr, IQR 35-66), and 911 men aged 24-92 yr (median = 60 yr, IQR 46-73) who participated in the Geelong Osteoporosis Study (GOS) between the years 2001 and 2008. Total body fat mass was determined from whole body dual-energy X-ray absorptiometry scans, and anthropometric parameters (weight, height, and waist circumference) were measured. Lifestyle and health information was collected via self-report. Sleepiness was assessed using the Epworth Sleepiness Scale (ESS). Scores of >= 10 were considered indicative of EDS. Results: Women: After adjusting for age, alcohol intake, antidepressant medication use and physical activity, EDS was associated with greater waist circumference and body mass index (BMI). EDS was also associated with 1.5-1.6-fold increased odds of being overweight or obese. Men: After adjusting for age, alcohol use, physical activity and smoking status, EDS was associated with greater BMI. These findings were not explained by the use of sedative or antidepressant medication. EDS was also associated with 1.5-fold increased likelihood of being obese, independent of these factors. No differences in lean mass, %body fat, or %lean mass were detected between those with and without EDS for men or women. Conclusions: These data suggest that EDS is associated with several anthropometric adiposity profiles, independent of associated lifestyle and health factors. Among women, symptoms of EDS are pervasive at both overweight and obese BMI classifications; suggesting a need for further clinical examination to assess possible temporal associations with underlying sleep pathology.	[Hayley, Amie C.; Williams, Lana J.; Berk, Michael; Pasco, Julie A.] Deakin Univ, IMPACT SRC, Sch Med, Geelong, Vic 3217, Australia; [Hayley, Amie C.; Kennedy, Gerard A.] Austin Hlth, Inst Breathing & Sleep, Melbourne, Vic, Australia; [Williams, Lana J.] Univ Melbourne, Dept Psychiat, Parkville, Vic 3052, Australia; [Kennedy, Gerard A.] Cairnmillar Inst, Sch Psychol Counselling & Psychotherapy, Camberwell, Australia; [Brennan, Sharon L.; Pasco, Julie A.] Univ Melbourne, NorthWest Acad Ctr, Dept Med, St Albans, Australia; [Berk, Michael] Orygen Res Ctr, Parkville, Vic, Australia; [Berk, Michael] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Brennan, Sharon L.] Univ Melbourne, Australian Inst Musculoskeletal Sci, North West Acad Ctr, Dept Med, St Albans, Australia	Deakin University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Institute for Breathing & Sleep (IBAS); University of Melbourne; University of Melbourne; Orygen, The National Centre of Excellence in Youth Mental Health; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Hayley, AC (corresponding author), Deakin Univ, IMPACT SRC, Sch Med, Geelong, Vic 3217, Australia.		Berk, Michael/M-3585-2019; Brennan-Olsen, Sharon/AAM-8595-2020; Berk, Michael/M-7891-2013	Berk, Michael/0000-0002-5554-6946; Berk, Michael/0000-0002-5554-6946; Brennan-Olsen, Sharon/0000-0003-3269-5401; Williams, Lana/0000-0002-1377-1272; Hayley, Amie/0000-0002-4470-4718	National Institutes of Health (NIH); Simons Foundation; CRC for Mental Health; Stanley Medical Research Institute; MBF; NHMRC; Beyond Blue; Geelong Medical Research Foundation; Bristol Myers Squibb; Eli Lilly; Glaxo SmithKline; Organon; Novartis; Mayne Pharma; Servier; Astra Zeneca; Janssen Cilag; Lundbeck; Pfizer; Sanofi Synthelabo; Solvay; Wyeth; University of Melbourne; Deakin University	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; CRC for Mental Health(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Stanley Medical Research Institute; MBF; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Beyond Blue; Geelong Medical Research Foundation; Bristol Myers Squibb(Bristol-Myers Squibb); Eli Lilly(Eli Lilly); Glaxo SmithKline(GlaxoSmithKline); Organon; Novartis(Novartis); Mayne Pharma; Servier(Servier); Astra Zeneca(AstraZeneca); Janssen Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lundbeck(Lundbeck Corporation); Pfizer(Pfizer); Sanofi Synthelabo; Solvay(Solvay SA); Wyeth(Wyeth); University of Melbourne(University of Melbourne); Deakin University	The authors have read the journal's policy and have the following competing interests: MB has received Grant/Research Support from the National Institutes of Health (NIH), Simons Foundation, CRC for Mental Health, Stanley Medical Research Institute, MBF, NHMRC, Beyond Blue, Geelong Medical Research Foundation, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Organon, Novartis, Mayne Pharma, Servier and Astra Zeneca. MB has been a paid consultant for Astra Zeneca, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck and Pfizer and a paid speaker for Astra Zeneca, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck, Organon, Pfizer, Sanofi Synthelabo, Solvay and Wyeth. LJW has received Grant/Research support from Eli Lilly, Pfizer, The University of Melbourne, Deakin University and the NHMRC. ACH, GAK, SLB and JAP have no conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	AusDiab, 2008, RISK FACT DIAB; Baskin ML, 2005, OBES REV, V6, P5, DOI 10.1111/j.1467-789X.2005.00165.x; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Bixler EO, 2005, J CLIN ENDOCR METAB, V90, P4510, DOI 10.1210/jc.2005-0035; Chaput J-P, 2013, PHYSL BEHAV; Dixon JB, 2007, OBESITY, V15, P2504, DOI 10.1038/oby.2007.297; Fogelholm M, 2007, INT J OBESITY, V31, P1713, DOI 10.1038/sj.ijo.0803663; Gami AS, 2003, ENDOCRIN METAB CLIN, V32, P869, DOI 10.1016/S0889-8529(03)00069-0; Giles GG, 1996, DIETARY QUESTIONNAIR; GRUNSTEIN R, 1993, INT J OBESITY, V17, P533; Guo SS, 1999, AM J CLIN NUTR, V70, P405; Hayley AC, 2013, AUST NZ J PSYCHIAT, V47, P772, DOI 10.1177/0004867413490036; Janssen I, 2002, AM J CLIN NUTR, V75, P683, DOI 10.1093/ajcn/75.4.683; Janssen I, 2002, ARCH INTERN MED, V162, P2074, DOI 10.1001/archinte.162.18.2074; Johns M, 1997, SLEEP, V20, P844, DOI 10.1093/sleep/20.10.844; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kline CE, 2013, SLEEP, V36, P1279, DOI 10.5665/sleep.2946; LEVINSON PD, 1993, CHEST, V103, P1336, DOI 10.1378/chest.103.5.1336; Lindberg E, 2007, RESP MED, V101, P1283, DOI 10.1016/j.rmed.2006.10.015; Misra A, 2001, INT J OBESITY, V25, P1722, DOI 10.1038/sj.ijo.0801748; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Olds TS, 2010, INT J OBESITY, V34, P57, DOI 10.1038/ijo.2009.211; Parks SE, 2003, J EPIDEMIOL COMMUN H, V57, P29, DOI 10.1136/jech.57.1.29; Pasco JA, 2012, INT J EPIDEMIOL, V41, P1565, DOI 10.1093/ije/dyr148; Pasco JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029580; Pasquali R, 2000, J CLIN ENDOCR METAB, V85, P2767, DOI 10.1210/jc.85.8.2767; PISUNYER FX, 1993, ANN INTERN MED, V119, P655, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00006; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Resta O, 2001, INT J OBESITY, V25, P669, DOI 10.1038/sj.ijo.0801603; Seidell JC, 1999, ACTA PAEDIATR, V88, P46, DOI 10.1111/j.1651-2227.1999.tb14350.x; Serafini FM, 2001, OBES SURG, V11, P28, DOI 10.1381/096089201321454079; Souza JC, 2002, ARQ NEURO-PSIQUIAT, V60, P558, DOI 10.1590/S0004-282X2002000400008; Sowers JR, 2003, AM J MED, V115, P37, DOI 10.1016/j.amjmed.2003.08.012; Strobel RJ, 1996, SLEEP, V19, P104, DOI 10.1093/sleep/19.2.104; Theorell-Haglow J, 2006, SLEEP, V29, P751, DOI 10.1093/sleep/29.6.751; Thorburn AW, 2005, OBES REV, V6, P187, DOI 10.1111/j.1467-789X.2005.00187.x; Vaska VL, 2004, J PAEDIATR CHILD H, V40, P353, DOI 10.1111/j.1034-4810.2004.00401.x; Vgontzas AN, 1998, ARCH INTERN MED, V158, P1333, DOI 10.1001/archinte.158.12.1333; Vgontzas AN, 1997, J CLIN ENDOCR METAB, V82, P1313, DOI 10.1210/jc.82.5.1313; Vgontzas AN, 2001, J CLIN ENDOCR METAB, V86, P517, DOI 10.1210/jc.86.2.517; Williams LJ, 2009, J AFFECT DISORDERS, V118, P173, DOI 10.1016/j.jad.2009.02.001	42	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112238	10.1371/journal.pone.0112238	http://dx.doi.org/10.1371/journal.pone.0112238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383556	gold, Green Published			2022-12-27	WOS:000344816700042
J	Hsu, YH; Huang, CF; Tu, MC; Hua, MS				Hsu, Yen-Hsuan; Huang, Ching-Feng; Tu, Min-Chien; Hua, Mau-Sun			The Clinical Utility of Informants' Appraisals on Prospective and Retrospective Memory in Patients with Early Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; OLDER-ADULTS; LATENT STRUCTURE; EVERYDAY MEMORY; NORMATIVE DATA; QUESTIONNAIRE PRMQ; EARLY DEMENTIA; SELF-REPORTS; COMPLAINTS; INTENTIONS	Increasing studies suggest the importance of including prospective memory measures in clinical evaluation of dementia due to its sensitivity and functional relevance. The Prospective and Retrospective Memory Questionnaire (PRQM) is originally a self-rated memory inventory that offers a direct comparison between prospective and episodic memory. However, the informant's report has been recognized as a more valid source of cognitive complaints. We thus aimed to examine the validity of the informant-rated form of the PRMQ in assessing memory function of the patients and in detecting individuals with early dementia. The informants of 140 neurological outpatients with memory complaints completed the Taiwan version of the PRMQ. Tests of prospective memory, short-term memory, and general cognitive ability were also administered to non-demented participants and patients with early stages of Alzheimer's disease (AD). Results showed significant relationships between the PRMQ ratings and objective cognitive measures, and showed that higher ratings on the PRMQ were associated with increasing odds of greater dementia severity. Receiver operative characteristic (ROC) curves showed an adequate ability of the PRMQ to identify patients with dementia (93% sensitivity and 84% specificity). Hierarchical regression revealed that the PRMQ has additional explanatory power for dementia status after controlling for age, education and objective memory test results, and that the prospective memory subscale owns predictive value for dementia beyond the retrospective memory subscale. The present study demonstrated the external validity and diagnostic value of informants' evaluation of their respective patients' prospective and retrospective memory functioning, and highlighted the important role of prospective memory in early dementia detection. The proxy-version of the PRMQ is a useful tool that captures prospective and episodic memory problems in patients with early AD, in combination with standardized cognitive testing.	[Hsu, Yen-Hsuan; Hua, Mau-Sun] Natl Taiwan Univ, Coll Sci, Dept Psychol, Taipei 10764, Taiwan; [Hsu, Yen-Hsuan; Huang, Ching-Feng; Tu, Min-Chien] Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Hosp, Dept Neurol, Taichung, Taiwan; [Hua, Mau-Sun] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Psychiat, Taipei 10764, Taiwan; [Hua, Mau-Sun] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Neurol, Taipei 10764, Taiwan; [Hua, Mau-Sun] Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Taipei 10764, Taiwan; [Hua, Mau-Sun] Natl Taiwan Univ, Neurobiol & Cognit Sci Ctr, Taipei 10764, Taiwan	National Taiwan University; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Hua, MS (corresponding author), Natl Taiwan Univ, Coll Sci, Dept Psychol, Taipei 10764, Taiwan.	huams@ntu.edu.tw			National Science Council, Taipei, Taiwan [NSC102-2410-H-002-051-MY3]	National Science Council, Taipei, Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by a grant from National Science Council, Taipei, Taiwan (NSC102-2410-H-002-051-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2011, RADIOLOGY, V258, P853, DOI 10.1148/radiol.10101284; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Blanco-Campal A, 2009, J INT NEUROPSYCH SOC, V15, P154, DOI 10.1017/S1355617708090127; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Carr DB, 2000, NEUROLOGY, V55, P1724, DOI 10.1212/WNL.55.11.1724; Clune-Ryberg M, 2011, BRAIN INJURY, V25, P819, DOI 10.3109/02699052.2011.589790; COCKBURN J, 1995, CORTEX, V31, P87, DOI 10.1016/S0010-9452(13)80107-4; Cornish IM, 2000, BRIT J PSYCHOL, V91, P427, DOI 10.1348/000712600161916; Cosentino S, 2007, CORTEX, V43, P1004, DOI 10.1016/S0010-9452(08)70697-X; Costa A, 2010, NEUROPSYCHOLOGY, V24, P327, DOI 10.1037/a0018015; Crawford JR, 2003, MEMORY, V11, P261, DOI 10.1080/09658210244000027; Crawford JR, 2006, BRIT J CLIN PSYCHOL, V45, P83, DOI 10.1348/014466505X28748; CROOK TH, 1990, PSYCHOL AGING, V5, P48, DOI 10.1037/0882-7974.5.1.48; Delprado J, 2012, J INT NEUROPSYCH SOC, V18, P295, DOI 10.1017/S135561771100172X; Dieckmann P, 2006, ERGONOMICS, V49, P526, DOI 10.1080/00140130600568782; DOBBS AR, 1987, CAN J PSYCHOL, V41, P209, DOI 10.1037/h0084152; Dong YH, 2013, J ALZHEIMERS DIS, V35, P159, DOI 10.3233/JAD-122026; Duchek JM, 2006, NEUROPSYCHOLOGY, V20, P633, DOI 10.1037/0894-4105.20.6.633; Eschen A, 2009, BRAIN IMPAIR, V10, P59, DOI 10.1375/brim.10.1.59; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galvin JE, 2005, NEUROLOGY, V65, P559, DOI 10.1212/01.wnl.0000172958.95282.2a; Grady CL, 2001, BRAIN, V124, P739, DOI 10.1093/brain/124.4.739; Heffernan TM, 2012, DRUG ALCOHOL DEPEN, V120, P1, DOI 10.1016/j.drugalcdep.2011.06.010; Hsu YH, 2011, ARCH CLIN NEUROPSYCH, V26, P240, DOI 10.1093/arclin/acr012; HUPPERT FA, 1993, J CLIN EXP NEUROPSYC, V15, P805, DOI 10.1080/01688639308402597; Isella V, 2006, J NEUROL NEUROSUR PS, V77, P166, DOI 10.1136/jnnp.2005.069765; Jones S, 2006, NEUROPSYCHOLOGY, V20, P144, DOI 10.1037/0894-4105.20.2.144; JORM AF, 1989, PSYCHOL MED, V19, P1015, DOI 10.1017/S0033291700005742; Karantzoulis S, 2009, J INT NEUROPSYCH SOC, V15, P407, DOI 10.1017/S1355617709090596; Kazui H, 2005, DEMENT GERIATR COGN, V19, P331, DOI 10.1159/000084559; Kinsella GJ, 2007, NEUROPSYCHOL REHABIL, V17, P688, DOI 10.1080/09602010600892824; KOSS E, 1993, ARCH NEUROL-CHICAGO, V50, P92, DOI 10.1001/archneur.1993.00540010086023; Kvavilashvili L, 1998, APPL COGNITIVE PSYCH, V12, P533, DOI 10.1002/(SICI)1099-0720(1998120)12:6<533::AID-ACP538>3.0.CO;2-1; Lin Ker-Neng, 2012, Acta Neurol Taiwan, V21, P180; Martins SP, 2008, ARQ NEURO-PSIQUIAT, V66, P318, DOI 10.1590/S0004-282X2008000300006; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nestor PJ, 2004, NAT MED, V10, pS34, DOI 10.1038/nrn1433; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Piauilino DC, 2010, MEMORY, V18, P413, DOI 10.1080/09658211003742672; Rabin LA, 2012, J AM GERIATR SOC, V60, P1128, DOI 10.1111/j.1532-5415.2012.03956.x; Razavi M, 2013, COMP 2 INFORM QUESTI; Ready RE, 2004, ALZ DIS ASSOC DIS, V18, P11, DOI 10.1097/00002093-200401000-00003; Roberts JL, 2009, DEMENT GERIATR COGN, V28, P95, DOI 10.1159/000234911; Ronnlund M, 2011, J GENET PSYCHOL, V172, P266, DOI 10.1080/00221325.2010.538450; Salthouse TA, 2004, MEM COGNITION, V32, P1133, DOI 10.3758/BF03196887; Schnitzspahn KM, 2013, DEV PSYCHOL, V49, P1544, DOI 10.1037/a0030579; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Singer JJ, 2006, BEHAV GENET, V36, P18, DOI 10.1007/s10519-005-9011-1; Smith G, 2000, MEMORY, V8, P311, DOI 10.1080/09658210050117735; Smith GE, 1996, PSYCHOL AGING, V11, P272, DOI 10.1037/0882-7974.11.2.272; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; Thompson C, 2010, J INT NEUROPSYCH SOC, V16, P318, DOI 10.1017/S1355617709991354; Troyer AK, 2007, J INT NEUROPSYCH SOC, V13, P365, DOI 10.1017/S1355617707070452; Van der Elst W, 2008, ARCH CLIN NEUROPSYCH, V23, P787, DOI 10.1016/j.acn.2008.09.002; West R, 2005, NEUROPSYCHOLOGIA, V43, P418, DOI 10.1016/j.neuropsychologia.2004.06.012; Woods SP, 2012, J INT NEUROPSYCH SOC, V18, P134, DOI 10.1017/S1355617711001263; Woods SP, 2009, J INT NEUROPSYCH SOC, V15, P42, DOI 10.1017/S1355617708090012; Zeintl M, 2007, PSYCHOL AGING, V22, P826, DOI 10.1037/0882-7974.22.4.826; Zeintl M, 2006, DEMENT GERIATR COGN, V22, P209, DOI 10.1159/000094915; Zhuang L, 2012, NEUROLOGY, V79, P748, DOI 10.1212/WNL.0b013e3182661f4d	64	16	16	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112210	10.1371/journal.pone.0112210	http://dx.doi.org/10.1371/journal.pone.0112210			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT3DP	25383950	Green Published, gold, Green Submitted			2022-12-27	WOS:000344816700039
J	Huang, XF; Ren, LY; Ye, P; Cheng, C; Wu, J; Wang, SH; Sun, Y; Liu, Z; Xie, AN; Xia, JH				Huang, Xiaofan; Ren, Lingyun; Ye, Ping; Cheng, Chao; Wu, Jie; Wang, Sihua; Sun, Yuan; Liu, Zheng; Xie, Aini; Xia, Jiahong			Peroxisome Proliferator-Activated Receptor gamma Deficiency in T Cells Accelerates Chronic Rejection by Influencing the Differentiation of CD4+T Cells and Alternatively Activated Macrophages	PLOS ONE			English	Article							CARDIAC ALLOGRAFT-REJECTION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; VASCULOPATHY; MICE; TRANSPLANTATION; SURVIVAL; HEART; ATHEROSCLEROSIS; INFLAMMATION	Background: In a previous study, activation of the peroxisome proliferator-activated receptor gamma (PPAR gamma) inhibited chronic cardiac rejection. However, because of the complexity of chronic rejection and the fact that PPAR gamma is widely expressed in immune cells, the mechanism of the PPAR gamma - induced protective effect was unclear. Materials and Methods: A chronic rejection model was established using B6.C-H-2(bm12)KhEg(H-2(bm12)) mice as donors, and MHC II-mismatched T-cell-specific PPAR gamma knockout mice or wild type (WT) littermates as recipients. The allograft lesion was assessed by histology and immunohistochemistry. T cells infiltrates in the allograft were isolated, and cytokines and subpopulations were detected using cytokine arrays and flow cytometry. Transcription levels in the allograft were measured by RT-PCR. In vitro, the T cell subset differentiation was investigated after culture in various polarizing conditions. PPAR gamma-deficient regularory T cells (Treg) were cocultured with monocytes to test their ability to induce alternatively activated macrophages (AAM). Results: T cell-specific PPAR gamma knockout recipients displayed reduced cardiac allograft survival and an increased degree of pathology compared with WT littermates. T cell-specific PPAR gamma knockout resulted in more CD4+ T cells infiltrating into the allograft and altered the Th1/Th2 and Th17/Treg ratios. The polarization of AAM was also reduced by PPAR gamma deficiency in T cells through the action of Th2 and Treg. PPAR gamma-deficient T cells eliminated the pioglitazone-induced polarization of AAM and reduced allograft survival. Conclusions: PPAR gamma-deficient T cells influenced the T cell subset and AAM polarization in chronic allograft rejection. The mechanism of PPAR gamma activation in transplantation tolerance could yield a novel treatment without side effects.	[Huang, Xiaofan; Ren, Lingyun; Cheng, Chao; Wu, Jie; Sun, Yuan; Liu, Zheng; Xia, Jiahong] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Cardiovasc Surg, Wuhan 430074, Peoples R China; [Ye, Ping] Cent Hosp Wuhan, Dept Cardiol, Wuhan, Peoples R China; [Wang, Sihua] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Thorac Surg, Wuhan 430074, Peoples R China; [Xie, Aini] Baylor Coll Med, Dept Med, Div Endocrinol Diabet & Metab, Houston, TX 77030 USA; [Xia, Jiahong] Cent Hosp Wuhan, Dept Cardiovasc Surg, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Baylor College of Medicine	Xia, JH (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Cardiovasc Surg, Wuhan 430074, Peoples R China.	jiahong.xia@mail.hust.edu.cn			National Nature Science Foundation of China [81070205, 81130056, 81100176, 81373170]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Nature Science Foundation of China (Program No: 81070205, 81130056, 81100176 and 81373170). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Augstein P, 2003, BIOCHEM BIOPH RES CO, V304, P378, DOI 10.1016/S0006-291X(03)00590-4; Babaev VR, 2005, ARTERIOSCL THROM VAS, V25, P1647, DOI 10.1161/01.ATV.0000173413.31789.1a; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Chen Y, 2007, TRANSPLANTATION, V83, P1602, DOI 10.1097/01.tp.0000266994.39480.42; Chen Y, 2011, J HEART LUNG TRANSPL, V30, P698, DOI 10.1016/j.healun.2011.01.704; CORRY RJ, 1973, TRANSPLANTATION, V16, P343, DOI 10.1097/00007890-197310000-00010; da Rocha Junior LF, 2013, PPAR RES, V2013; Dhakal M, 2013, EUR J IMMUNOL; El-Sawy T, 2002, CURR OPIN IMMUNOL, V14, P562, DOI 10.1016/S0952-7915(02)00382-5; Fischbein MP, 2001, TRANSPLANTATION, V71, P1146, DOI 10.1097/00007890-200104270-00023; Furukawa Y, 2002, AM J PATHOL, V160, P1077, DOI 10.1016/S0002-9440(10)64928-0; Ge W, 2010, AM J TRANSPLANT, V10, P1760, DOI 10.1111/j.1600-6143.2010.03186.x; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; He XY, 1998, TRANSPLANTATION, V65, P1145, DOI 10.1097/00007890-199805150-00001; Heller NM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164795; Hontecillas R, 2007, J IMMUNOL, V178, P2940, DOI 10.4049/jimmunol.178.5.2940; Itoh S, 2011, CIRCULATION, V124, pS187, DOI 10.1161/CIRCULATIONAHA.110.014852; Klotz L, 2009, J EXP MED, V206, P2079, DOI 10.1084/jem.20082771; Koglin J, 2000, CIRCULATION, V101, P1034, DOI 10.1161/01.CIR.101.9.1034; Kosuge H, 2006, CIRCULATION, V113, P2613, DOI 10.1161/CIRCULATIONAHA.105.594101; Liu GW, 2013, J CELL PHYSIOL, V228, P502, DOI 10.1002/jcp.24157; Liu ZM, 2013, IMMUNOL REV, V252, P183, DOI 10.1111/imr.12038; Magil Alex B, 2009, Transplant Rev (Orlando), V23, P199, DOI 10.1016/j.trre.2009.06.005; Mannon RB, 2012, CURR OPIN ORGAN TRAN, V17, P20, DOI 10.1097/MOT.0b013e32834ee5b6; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinez-Nunez RT, 2011, J BIOL CHEM, V286, P1786, DOI 10.1074/jbc.M110.169367; Moraes-Vieira PMM, 2013, AM J TRANSPLANT, V13, P36, DOI 10.1111/j.1600-6143.2012.04283.x; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Park SJ, 2009, J IMMUNOL, V183, P3259, DOI 10.4049/jimmunol.0900231; Piccotti JR, 1999, TRANSPLANTATION, V67, P1548, DOI 10.1097/00007890-199906270-00008; Rahmani M, 2006, CIRC RES, V99, P801, DOI 10.1161/01.RES.0000246086.93555.f3; Schmauss D, 2008, CIRCULATION, V117, P2131, DOI 10.1161/CIRCULATIONAHA.107.711911; Stehlik J, 2012, J HEART LUNG TRANSPL, V31, P1052, DOI 10.1016/j.healun.2012.08.002; Suzuki J, 2010, CIRC J, V74, P233, DOI 10.1253/circj.CJ-09-0809; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Tay SS, 2009, CURR OPIN ORGAN TRAN, V14, P16, DOI 10.1097/MOT.0b013e32831ebdf5; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Tobiasova Z, 2011, CIRCULATION, V124, P196, DOI 10.1161/CIRCULATIONAHA.110.015396; Wang S, 2012, CLIN EXP IMMUNOL, V169, P320, DOI 10.1111/j.1365-2249.2012.04612.x; Wyburn KR, 2005, TRANSPLANTATION, V80, P1641, DOI 10.1097/01.tp.0000173903.26886.20; Ye P, 2012, J SURG RES, V173, P161, DOI 10.1016/j.jss.2010.08.052; Yuan XL, 2008, J EXP MED, V205, P3133, DOI 10.1084/jem.20081937	44	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112953	10.1371/journal.pone.0112953	http://dx.doi.org/10.1371/journal.pone.0112953			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383620	Green Submitted, Green Published, gold			2022-12-27	WOS:000344816700106
J	Ruan, J; Zheng, H; Fu, WG; Zhao, P; Su, N; Luo, RC				Ruan, Jian; Zheng, Hang; Fu, Wenguang; Zhao, Peng; Su, Ning; Luo, Rongcheng			Increased Expression of Cathepsin L: A Novel Independent Prognostic Marker of Worse Outcome in Hepatocellular Carcinoma Patients	PLOS ONE			English	Article							IN-VITRO; PROGRESSION; APOPTOSIS; INVASION; CELLS	Objectives: To investigate the expression and role of Cathepsin L (CTSL) in Hepatocellular carcinoma (HCC) tissue and cell line (MHCC-97H), and to evaluate the clinical and prognostic significance of CTSL protein in patients with HCC. Methods: The expression of CTSL was examined in HCC tissue and MHCC-97H cells by Western-blotting, Real-time PCR and immunohistochemical staining. Cell growth curve assay and colony formation assay were used to verify the effect of CTSL on the proliferation and tumor progression ability of MHCC-97H cells. Tumor formation assay in nude mice was used to analyze the effect of CTSL on the tumorigenicity of MHCC-97H cells. Results: The status of CTSL protein in carcinoma tissues is much higher than that in paracarcinoma tissues. The overall survival of the patients with high CTSL expression was significantly shorter than the low CTSL expression group. high CTSL expression was significantly correlated with advanced clinical staging, histological grade and tumor recurrence. In vitro experiments demonstrated that over-expression of CTSL in MHCC-97H cells promoted cell proliferation and tumor progression ability. Down-regulation of CTSL showed the opposite effects. Over-expression of CTSL increase the tumorigenicity of MHCC-97H cells by in vivo experiments. Moreover, multivariate analysis suggested that CTSL expression might be an independent prognostic indicator for the survival of HCC patients after curative surgery. Conclusions: CTSL might involve in the development and progression of HCC as a oncogene, and thereby may be a valuable prognostic marker for HCC patients.	[Ruan, Jian; Zheng, Hang; Luo, Rongcheng] Southern Med Univ, Tradit Chinese Med Integrated Hosp, Ctr Canc, Guangzhou, Guangdong, Peoples R China; [Fu, Wenguang] Luzhou Med Coll, Affiliated Hosp, Dept Hepatobiliary Surg, Luzhou, Sichuan, Peoples R China; [Zhao, Peng] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Su, Ning] Guangzhou Chest Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southwest Medical University; Zhejiang University	Ruan, J (corresponding author), Southern Med Univ, Tradit Chinese Med Integrated Hosp, Ctr Canc, Guangzhou, Guangdong, Peoples R China.	software23@163.com; luorc0001@126.com	ruan, jian/AAY-3629-2020; WENGUANG, FU/AAI-1142-2019; fu, wenguang/ABI-7883-2020	ruan, jian/0000-0003-1354-4720; 	National Natural Science Foundation of China [81001212]; Science and Technology Foundation of Zhejiang Province [2012C33011]; Foundation of State Key Laboratory of Oncology in South China [HN2011-03]; Zhejiang Provincial Chinese Medicine Research Foundation [2010ZB062, 2011ZQ012]; Foundation of Zhejiang Provincial Educational Committee [Y201019175]; Natural Science Foundation of Guangdong [s2012010008209]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation of Zhejiang Province; Foundation of State Key Laboratory of Oncology in South China; Zhejiang Provincial Chinese Medicine Research Foundation; Foundation of Zhejiang Provincial Educational Committee; Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province)	This project is supported by the National Natural Science Foundation of China (Grant No. 81001212), The Science and Technology Foundation of Zhejiang Province (Grant No. 2012C33011), Foundation of State Key Laboratory of Oncology in South China (Grant No. HN2011-03), Zhejiang Provincial Chinese Medicine Research Foundation (Grant No. 2010ZB062, 2011ZQ012), Foundation of Zhejiang Provincial Educational Committee (Grant No. Y201019175), and Natural Science Foundation of Guangdong (Grant No. s2012010008209). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Capocaccia R, 2007, AM J GASTROENTEROL, V102, P1661, DOI 10.1111/j.1572-0241.2007.01337.x; CHAUHAN SS, 1991, CANCER RES, V51, P1478; Colella R, 2003, BIOTECH HISTOCHEM, V78, P101, DOI 10.1080/10520290310001593856; Jagodic M, 2005, NEOPLASMA, V52, P1; Jean D, 2006, ONCOGENE, V25, P1474, DOI 10.1038/sj.onc.1209196; Kane S E, 1990, Semin Cancer Biol, V1, P127; Kenig S, 2011, APOPTOSIS, V16, P671, DOI 10.1007/s10495-011-0600-6; KIRSCHKE H, 1977, EUR J BIOCHEM, V74, P293, DOI 10.1111/j.1432-1033.1977.tb11393.x; Levicar N, 2003, CANCER GENE THER, V10, P141, DOI 10.1038/sj.cgt.7700546; Macabeo-Ong M, 2003, ORAL ONCOL, V39, P638, DOI 10.1016/S1368-8375(03)00034-4; Miyamoto K, 2011, INT J ONCOL, V39, P1109, DOI 10.3892/ijo.2011.1127; Niedergethmann M, 2004, PANCREAS, V29, P204, DOI 10.1097/00006676-200410000-00005; Poon RTP, 2000, ANN SURG, V232, P10, DOI 10.1097/00000658-200007000-00003; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Strojnik T, 2005, CANCER DETECT PREV, V29, P448, DOI 10.1016/j.cdp.2005.07.006; Sullivan S, 2009, INT J CANCER, V125, P54, DOI 10.1002/ijc.24275; Wille A, 2004, BIOL CHEM, V385, P665, DOI 10.1515/BC.2004.082; Xu X., 2009, Experimental Oncology, V31, P102; Yan JA, 2010, J INT MED RES, V38, P1913, DOI 10.1177/147323001003800604; Yang Z, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-8; Zajc I, 2006, ANTICANCER RES, V26, P3357; Zheng X, 2009, AM J PHYSIOL-CELL PH, V296, pC65, DOI 10.1152/ajpcell.00082.2008	22	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112136	10.1371/journal.pone.0112136	http://dx.doi.org/10.1371/journal.pone.0112136			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384089	Green Submitted, gold, Green Published			2022-12-27	WOS:000344816700032
J	El-Merahbi, R; Liu, YN; Eid, A; Daoud, G; Hosry, L; Monzer, A; Mouhieddine, TH; Hamade, A; Najjar, F; Abou-Kheir, W				El-Merahbi, Rabih; Liu, Yen-Nien; Eid, Assaad; Daoud, Georges; Hosry, Leina; Monzer, Alissar; Mouhieddine, Tarek H.; Hamade, Aline; Najjar, Fadia; Abou-Kheir, Wassim			Berberis libanotica Ehrenb Extract Shows Anti-Neoplastic Effects on Prostate Cancer Stem/Progenitor Cells	PLOS ONE			English	Article							STEM-CELLS; ANTITUMOR ACTIVITIES; RESISTANCE; APOPTOSIS; DEPLETION; VULGARIS; INVASION; THERAPY; ARREST; TARGET	Cancer stem cells (CSCs), including those of advanced prostate cancer, are a suggested reason for tumor resistance toward conventional tumor therapy. Therefore, new therapeutic agents are urgently needed for targeting CSCs. Despite the minimal understanding of their modes of action, natural products and herbal therapies have been commonly used in the prevention and treatment of many cancers. Berberis libanotica Ehrenb (BLE) is a plant rich in alkaloids which may possess anti-cancer activity and a high potential for eliminating CSCs. We tested the effect of BLE on prostate cancer cells and our data indicated that this extract induced significant reduction in cell viability and inhibited the proliferation of human prostate cancer cell lines (DU145, PC3 and 22Rv1) in a dose- and time-dependent manner. BLE extract induced a perturbation of the cell cycle, leading to a G0-G1 arrest. Furthermore, we noted 50% cell death, characterized by the production of high levels of reactive oxidative species (ROS). Inhibition of cellular migration and invasion was also achieved upon treatment with BLE extract, suggesting a role in inhibiting metastasis. Interestingly, BLE extract had a major effect on CSCs. Cells were grown in a 3D sphere-formation assay to enrich for a population of cancer stem/progenitor cells. Our results showed a significant reduction in sphere formation ability. Three rounds of treatment with BLE extract were sufficient to eradicate the self-renewal ability of highly resistant CSCs. In conclusion, our results suggest a high therapeutic potential of BLE extract in targeting prostate cancer and its CSCs.	[El-Merahbi, Rabih; Eid, Assaad; Daoud, Georges; Monzer, Alissar; Mouhieddine, Tarek H.; Abou-Kheir, Wassim] Amer Univ Beirut, Fac Med, Dept Anat Cell Biol & Physiol Sci, Beirut, Lebanon; [Hosry, Leina] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan; [Hamade, Aline] Lebanese Univ, Fac Sci 2, Dept Biol, Fanar, Lebanon; [Najjar, Fadia] Lebanese Univ, Fac Sci 2, Dept Chem & Biochem, Fanar, Lebanon	American University of Beirut; Taipei Medical University; Lebanese University; Lebanese University	Hamade, A (corresponding author), Lebanese Univ, Fac Sci 2, Dept Biol, Fanar, Lebanon.	alinehamade@gmail.com; Fadia.najjar@gmail.com; wa12@aub.edu.lb	Abou-Kheir, Wassim/AAP-2587-2020; Liu, Yen-Nien/AAW-4698-2021	Abou-Kheir, Wassim/0000-0001-9719-9324; Mouhieddine, Tarek/0000-0002-1190-5978; Daoud, Georges/0000-0001-8043-3882	Medical Practice Plan-MPP (AUB-FM); Lebanese National Council for Scientific Research (CNRS)	Medical Practice Plan-MPP (AUB-FM); Lebanese National Council for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This research was supported by funding from the Medical Practice Plan-MPP (AUB-FM) and the Lebanese National Council for Scientific Research (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Kheir W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026112; Abou-Kheir WG, 2010, STEM CELLS, V28, P2129, DOI 10.1002/stem.538; Aniszewski T, 2007, ALKALOIDS SECRETS LI; Bonesi M, 2013, J PHARM PHARMACOL, V65, P1726, DOI 10.1111/jphp.12172; Bournine L, 2013, PHYTOMEDICINE; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Corcoran C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050999; Domingo-Domenech J, 2012, CANCER CELL, V22, P373, DOI 10.1016/j.ccr.2012.07.016; Eid AA, 2013, DIABETES, V62, P2935, DOI 10.2337/db12-1504; Esseily F, 2012, MINERVA BIOTECNOL, V24, P129; Fetsch PA, 2006, CANCER LETT, V235, P84, DOI 10.1016/j.canlet.2005.04.024; Foster BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055062; Ho YT, 2009, PHYTOMEDICINE, V16, P887, DOI 10.1016/j.phymed.2009.02.015; Huang M, 2007, CLIN CANCER RES, V13, P1298, DOI 10.1158/1078-0432.CCR-06-1277; Imanshahidi M, 2008, PHYTOTHER RES, V22, P999, DOI 10.1002/ptr.2399; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kaseb AO, 2007, CANCER RES, V67, P7782, DOI 10.1158/0008-5472.CAN-07-1483; Kim S, 2008, MOLECULES, V13, P2975, DOI 10.3390/molecules13122975; Koncic MZ, 2010, FOOD CHEM TOXICOL, V48, P2176, DOI 10.1016/j.fct.2010.05.025; Li WH, 2007, CANCER BIOL THER, V6, P787, DOI 10.4161/cbt.6.5.4006; Liu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021416; Lou H, 2007, ONCOGENE, V26, P1357, DOI 10.1038/sj.onc.1210200; Luk SU, 2011, INT J CANCER, V128, P2182, DOI 10.1002/ijc.25546; Luk SU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019804; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; Maitland NJ, 2008, J CLIN ONCOL, V26, P2862, DOI 10.1200/JCO.2007.15.1472; Marc EB, 2008, J ETHNOPHARMACOL, V120, P315, DOI 10.1016/j.jep.2008.08.024; Peng PL, 2006, TOXICOL APPL PHARM, V214, P8, DOI 10.1016/j.taap.2005.11.010; Rafi MM, 2002, J AGR FOOD CHEM, V50, P677, DOI 10.1021/jf010774e; Refaat A, 2013, ONCOL LETT, V6, P840, DOI 10.3892/ol.2013.1434; Roberts M. F., 1998, ALKALOIDS BIOCH ECOL; Schroeder A, 2013, CANC RES; Sharifi N, 2006, CANCER BIOL THER, V5, P901, DOI 10.4161/cbt.5.8.2949; Singh J, 2009, J ETHNOPHARMACOL, V123, P22, DOI 10.1016/j.jep.2009.02.038; Singh T, 2011, CARCINOGENESIS, V32, P86, DOI 10.1093/carcin/bgq215; Slaninova I, 2013, PHYTOCHEM REV, P1; Wang Y, 2012, MUTAT RES-FUND MOL M, V734, P20, DOI 10.1016/j.mrfmmm.2012.04.005; Yu Jun, 2013, Curr Ther Res Clin Exp, V75, P8, DOI 10.1016/j.curtheres.2013.04.001; Zhang LL, 2012, CANCER LETT, V323, P48, DOI 10.1016/j.canlet.2012.03.037	39	34	35	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112453	10.1371/journal.pone.0112453	http://dx.doi.org/10.1371/journal.pone.0112453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380390	Green Published, Green Submitted, gold			2022-12-27	WOS:000344863100099
J	Martino, NA; Reshkin, SJ; Ciani, E; Dell'Aquila, ME				Martino, Nicola Antonio; Reshkin, Stephan Joel; Ciani, Elena; Dell'Aquila, Maria Elena			Calcium-Sensing Receptor-Mediated Osteogenic and Early-Stage Neurogenic Differentiation in Umbilical Cord Matrix Mesenchymal Stem Cells from a Large Animal Model	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PHENOTYPIC CHARACTERIZATION; CA2+-SENSING RECEPTOR; AMNIOTIC-FLUID; EQUINE TENDON; STROMAL CELLS; EXPRESSION; BLOOD; PROLIFERATION; THERAPY	Background: Umbilical cord matrix mesenchymal stem cells (UCM-MSCs) present a wide range of potential therapeutical applications. The extracellular calcium-sensing receptor (CaSR) regulates physiological and pathological processes. We investigated, in a large animal model, the involvement of CaSR in triggering osteogenic and neurogenic differentiation of two size-sieved UCM-MSC lines, by using AMG641, a novel potent research calcimimetic acting as CaSR agonist. Methodology/Principal Findings: Large (>8 mu m in diameter) and small (<8 mu m) equine UCM-MSC lines were cultured in medium with high calcium (Ca2+) concentration ([Ca2+](o); 2.87 mM) and dose-response effects of AMG641 (0.01 to 3 mu M) on cell proliferation were evaluated. Both cell lines were then cultured in osteogenic or neurogenic differentiation medium containing: 1) low [Ca2+] o (0.37 mM); 2) high [Ca2+](o) (2.87 mM); 3) AMG641 (0.05, 0.1 or 1 mu M) with high [Ca2+](o) and 4) the CaSR antagonist NPS2390 (10 mM for 30 min) followed by incubation with AMG641 in high [Ca2+](o). Expression of osteogenic or neurogenic differentiation biomarkers was compared among groups. In both cell lines, AMG641 dose-dependently increased cell proliferation (up to P<0.001). Osteogenic molecular markers expression was differentially regulated by AMG641, with stimulatory (OPN up-regulation) in large or inhibitory (RUNX2 and OPN down-regulation) effects in small cells, respectively. AMG641 significantly increased alkaline phosphatase activity and calcium phosphate deposition in both cell lines. Following treatment with AMG641 during osteogenic differentiation, in both cell lines CaSR expression was inversely related to that of osteogenic markers and inhibition of CaSR by NPS2390 blocked AMG641-dependent responses. Early-stage neurogenic differentiation was promoted/triggered by AMG641 in both cell lines, as Nestin and CaSR mRNA transcription up-regulation were observed. Conclusions/Significance: Calcium-and AMG641-induced CaSR stimulation promoted in vitro proliferation and osteogenic and early-stage neurogenic differentiation of UCM-MSCs. CaSR activation may play a fundamental role in selecting specific differentiation checkpoints of these two differentiation routes, as related to cell commitment status.	[Martino, Nicola Antonio; Dell'Aquila, Maria Elena] Univ Bari Aldo Moro, DETO, Sect Vet Clin & Anim Prod, Bari, Italy; [Reshkin, Stephan Joel; Ciani, Elena] Univ Bari Aldo Moro, DBBB, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Martino, NA (corresponding author), Univ Bari Aldo Moro, DETO, Sect Vet Clin & Anim Prod, Bari, Italy.	nicmartino@libero.it	Martino, Nicola/AAP-9891-2020; Reshkin, Stephan/AAI-6680-2020; Martino, Nicola Antonio/N-4096-2014	Reshkin, Stephan/0000-0001-9757-5908; Martino, Nicola Antonio/0000-0001-6853-2757; Dell'Aquila, Maria Elena/0000-0003-3629-7005; ciani, elena/0000-0001-5673-0975	ONEV MIUR [PONa3_00134 - n.254/RC]; ERA-Amgen (Amgen Inc., Thousand Oaks, California, United States of America) [2011568566]	ONEV MIUR(Ministry of Education, Universities and Research (MIUR)); ERA-Amgen (Amgen Inc., Thousand Oaks, California, United States of America)	The study was supported by ONEV MIUR PONa3_00134 - n.254/R&C 18/05/2011. The authors received AMG641 from ERA-Amgen (Amgen Inc., Thousand Oaks, California, United States of America; Research Program Agreement no 2011568566). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabzadeh A, 2009, MOL BIOTECHNOL, V43, P264, DOI 10.1007/s12033-009-9196-2; Barradas AMC, 2012, BIOMATERIALS, V33, P3205, DOI 10.1016/j.biomaterials.2012.01.020; Borjesson DL, 2011, CLIN LAB MED, V31, P109, DOI 10.1016/j.cll.2010.12.001; Brennan SC, 2013, BBA-MOL CELL RES, V1833, P1732, DOI 10.1016/j.bbamcr.2012.12.011; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; BROWN EM, 1995, CELL, V83, P679, DOI 10.1016/0092-8674(95)90180-9; Byeon YE, 2010, CYTOTHERAPY, V12, P626, DOI 10.3109/14653249.2010.481665; Corradetti B, 2011, CELL PROLIFERAT, V44, P330, DOI 10.1111/j.1365-2184.2011.00759.x; Cremonesi F, 2008, VET RES COMMUN, V32, pS139, DOI 10.1007/s11259-008-9116-0; De Santis T, 2009, REPRODUCTION, V138, P439, DOI 10.1530/REP-09-0078; de Torres C, 2009, CANCER-AM CANCER SOC, V115, P2792, DOI 10.1002/cncr.24304; Di Tomo P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073816; Dvorak MM, 2007, ENDOCRINOLOGY, V148, P3156, DOI 10.1210/en.2007-0147; Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101; Esposito M, 2013, IN VIVO, V27, P495; Gatta V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-635; Gittel C, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-221; Greco SJ, 2007, STEM CELLS DEV, V16, P811, DOI 10.1089/scd.2007.0011; Hall MS, 2013, AUST VET J, V91, P102, DOI 10.1111/avj.12015; He YH, 2012, MOL CELL BIOCHEM, V361, P321, DOI 10.1007/s11010-011-1118-5; Henaut L, 2014, CARDIOVASC RES, V101, P256, DOI 10.1093/cvr/cvt249; Henley C, 2009, EUR J PHARMACOL, V616, P306, DOI 10.1016/j.ejphar.2009.05.013; Hinrichs K, 2007, THERIOGENOLOGY, V68, P521, DOI 10.1016/j.theriogenology.2007.04.046; Hobson SA, 2003, MOL CELL ENDOCRINOL, V200, P189, DOI 10.1016/S0303-7207(01)00749-3; Hoynowski SM, 2007, BIOCHEM BIOPH RES CO, V362, P347, DOI 10.1016/j.bbrc.2007.07.182; Hua J, 2014, CELL BIOL INT, V38, P198, DOI 10.1002/cbin.10188; HUANG SX, 1995, BIOCHEM J, V310, P881, DOI 10.1042/bj3100881; Iacono E, 2012, REPRODUCTION, V143, P455, DOI 10.1530/REP-10-0408; Jung SY, 2005, EXP MOL MED, V37, P91, DOI 10.1038/emm.2005.13; Kim DW, 2013, INT J MOL SCI, V14, P11692, DOI 10.3390/ijms140611692; Koori K, 2014, CELL TISSUE RES, V357, P707, DOI 10.1007/s00441-014-1918-5; Kwak JO, 2005, EXP MOL MED, V37, P457, DOI 10.1038/emm.2005.56; Lange-Consiglio A, 2012, J TISSUE ENG REGEN M, V6, P622, DOI 10.1002/term.465; Lange-Consiglio A, 2013, CYTOTHERAPY, V15, P1011, DOI 10.1016/j.jcyt.2013.03.002; Lavreysen H, 2003, MOL PHARMACOL, V63, P1082, DOI 10.1124/mol.63.5.1082; Lee KS, 2013, RES VET SCI, V94, P144, DOI 10.1016/j.rvsc.2012.07.033; Li TX, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/218543; Liu S, 2013, J BIOSCI BIOENG; Lopez I, 2008, KIDNEY INT, V73, P300, DOI 10.1038/sj.ki.5002675; Lopez I, 2009, AM J PHYSIOL-RENAL, V296, pF1376, DOI 10.1152/ajprenal.90737.2008; Mailland M, 1997, ENDOCRINOLOGY, V138, P3601, DOI 10.1210/en.138.9.3601; Marcus AJ, 2008, J CELL MOL MED, V12, P730, DOI 10.1111/j.1582-4934.2008.00221.x; Martino NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017714; McNeil L, 1998, AM J OBSTET GYNECOL, V178, P305, DOI 10.1016/S0002-9378(98)80017-3; Mendoza FJ, 2011, J ANDROL, V33, P96, DOI 10.2164/jandrol.110.011254; Mendoza FJ, 2011, CALCIFIED TISSUE INT, V88, P169, DOI 10.1007/s00223-010-9442-4; Mendoza FJ, 2009, AM J PHYSIOL-RENAL, V296, pF605, DOI 10.1152/ajprenal.90272.2008; Mentaverri R, 2006, FASEB J, V20, P2562, DOI 10.1096/fj.06-6304fje; Mori G, 2012, INT J MED SCI, V9, P480, DOI 10.7150/ijms.4583; Noeske T, 2006, QSAR COMB SCI, V25, P134, DOI 10.1002/qsar.200510139; Pappa KI, 2009, REGEN MED, V4, P423, DOI 10.2217/RME.09.12; Passeri S, 2009, CELL BIOL INT, V33, P100, DOI 10.1016/j.cellbi.2008.10.012; Penny J, 2012, FRONT BIOSCI-LANDMRK, V17, P892, DOI 10.2741/3963; Pipino C, 2014, STEM CELLS DEV, V23, P2959, DOI 10.1089/scd.2013.0627; Reed SA, 2013, J ANIM SCI, V91, P59, DOI 10.2527/jas.2012-5736; Rho GJ, 2009, FRONT BIOSCI-LANDMRK, V14, P3942, DOI [10.2735/3503, 10.2741/3503]; Riccardi D, 2012, ANNU REV PHYSIOL, V74, P271, DOI 10.1146/annurev-physiol-020911-153318; Ricco S, 2013, INT J IMMUNOPATH PH, V26, P61, DOI 10.1177/03946320130260S108; Rodriguez M, 2008, KIDNEY INT, V74, pS50, DOI 10.1038/ki.2008.546; Seo MS, 2009, J VET SCI, V10, P181, DOI 10.4142/jvs.2009.10.3.181; Singh N, 2013, BEST PRACT RES CL EN, V27, P455, DOI 10.1016/j.beem.2013.04.001; Sun J, 2013, DIFFERENTIATION, V85, P32, DOI 10.1016/j.diff.2012.11.002; Tfelt-Hansen J, 2004, ENDOCRINOLOGY, V145, P1211, DOI 10.1210/en.2003-0749; Tondreau T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-166; Uppalapati D, 2011, MOL PHARMACEUT, V8, P1549, DOI 10.1021/mp2001582; Uranio MF, 2011, MOL REPROD DEV, V78, P361, DOI 10.1002/mrd.21311; Vizard TN, 2008, NAT NEUROSCI, V11, P285, DOI 10.1038/nn2044; Wei FL, 2012, J CELL PHYSIOL, V227, P3216, DOI 10.1002/jcp.24012; Wislet-Gendebien S, 2003, J CELL SCI, V116, P3295, DOI 10.1242/jcs.00639; Wu KH, 2013, CELL TRANSPLANT, V22, P2041, DOI 10.3727/096368912X663533; Yamaguchi T, 2002, BIOCHEM BIOPH RES CO, V299, P532, DOI 10.1016/S0006-291X(02)02690-6	72	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111533	10.1371/journal.pone.0111533	http://dx.doi.org/10.1371/journal.pone.0111533			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379789	Green Published, gold, Green Submitted			2022-12-27	WOS:000344863100031
J	Nunney, L; Ortiz, B; Russell, SA; Sanchez, RR; Stouthamer, R				Nunney, Leonard; Ortiz, Beatriz; Russell, Stephanie A.; Sanchez, Rebeca Ruiz; Stouthamer, Richard			The Complex Biogeography of the Plant Pathogen Xylella fastidiosa: Genetic Evidence of Introductions and Subspecific Introgression in Central America	PLOS ONE			English	Article							INTERSUBSPECIFIC RECOMBINATION; LEAF SCORCH; 1ST REPORT; CITRUS; STRAINS; DISEASE; COFFEE; BIOLOGY	The bacterium Xylella fastidiosa is a plant pathogen with a history of economically damaging introductions of subspecies to regions where its other subspecies are native. Genetic evidence is presented demonstrating the introduction of two new taxa into Central America and their introgression into the native subspecies, X. fastidiosa subsp. fastidiosa. The data are from 10 genetic outliers detected by multilocus sequence typing (MLST) of isolates from Costa Rica. Six (five from oleander, one from coffee) defined a new sequence type (ST53) that carried alleles at six of the eight loci sequenced (five of the seven MLST loci) diagnostic of the South American subspecies Xylella fastidiosa subsp. pauca which causes two economically damaging plant diseases, citrus variegated chlorosis and coffee leaf scorch. The two remaining loci of ST53 carried alleles from what appears to be a new South American form of X. fastidiosa. Four isolates, classified as X. fastidiosa subsp. fastidiosa, showed a low level of introgression of non-native DNA. One grapevine isolate showed introgression of an allele from X. fastidiosa subsp. pauca while the other three (from citrus and coffee) showed introgression of an allele with similar ancestry to the alleles of unknown origin in ST53. The presence of X. fastidiosa subsp. pauca in Central America is troubling given its disease potential, and establishes another route for the introduction of this economically damaging subspecies into the US or elsewhere, a threat potentially compounded by the presence of a previously unknown form of X. fastidiosa.	[Nunney, Leonard] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Ortiz, Beatriz; Sanchez, Rebeca Ruiz] Univ Costa Rica, Ctr Invest Biol Celular & Mol, San Jose, Costa Rica; [Russell, Stephanie A.; Stouthamer, Richard] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	University of California System; University of California Riverside; Universidad Costa Rica; University of California System; University of California Riverside	Nunney, L (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	leonard.nunney@ucr.edu	Sanchez, Rebeca/GXH-6596-2022	Sanchez, Rebeca/0000-0002-2073-2810; Nunney, Leonard/0000-0002-4315-3694	USDA-CSREES-NRI [2007-55605-17834]; International Foundation for Science [C/5152-1]; Vice-Rector for Research at Universidad de Costa Rica	USDA-CSREES-NRI(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); International Foundation for Science(International Foundation for Science); Vice-Rector for Research at Universidad de Costa Rica	This work was supported in part by USDA-CSREES-NRI grant 2007-55605-17834 to LN and RS. BO was supported by the International Foundation for Science (grant C/5152-1) and Vice-Rector for Research at Universidad de Costa Rica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar E, 2005, PLANT DIS, V89, P687, DOI 10.1094/PD-89-0687B; Almeida RPP, 2008, APPL ENVIRON MICROB, V74, P3690, DOI 10.1128/AEM.02388-07; AMARO AA, 1998, CITRUS VARIEGATED CH, P123; Beretta MJG, 1996, PLANT DIS, V80, P821, DOI 10.1094/PD-80-0821D; CHANG CJ, 1993, CURR MICROBIOL, V27, P137, DOI 10.1007/BF01576010; Coletta HD, 2003, PHYTOPATHOLOGY, V93, P28, DOI 10.1094/PHYTO.2003.93.1.28; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Kung SH, 2013, APPL ENVIRON MICROB, V79, P1712, DOI 10.1128/AEM.03525-12; Kung SH, 2011, APPL ENVIRON MICROB, V77, P5278, DOI 10.1128/AEM.00730-11; Li WB, 2001, PLANT DIS, V85, P501, DOI 10.1094/PDIS.2001.85.5.501; Montero-Astua M, 2008, J MICROBIOL, V46, P482, DOI 10.1007/s12275-008-0072-8; Nunney L, 2014, APPL ENVIRON MICROB, V80, P3025, DOI 10.1128/AEM.04112-13; Nunney L, 2014, APPL ENVIRON MICROB, V80, P1159, DOI 10.1128/AEM.02920-13; Nunney L, 2013, APPL ENVIRON MICROB, V79, P2189, DOI 10.1128/AEM.03208-12; Nunney L, 2012, APPL ENVIRON MICROB, V78, P4702, DOI 10.1128/AEM.01126-12; Nunney L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015488; Redak RA, 2004, ANNU REV ENTOMOL, V49, P243, DOI 10.1146/annurev.ento.49.061802.123403; Rodriguez C. M., 2001, Plant Disease, V85, P1027, DOI 10.1094/PDIS.2001.85.9.1027A; Scally M, 2005, APPL ENVIRON MICROB, V71, P8491, DOI 10.1128/AEM.71.12.8491-8499.2005; Schaad NW, 2004, SYST APPL MICROBIOL, V27, P290, DOI 10.1078/0723-2020-00263; Schuenzel EL, 2005, APPL ENVIRON MICROB, V71, P3832, DOI 10.1128/AEM.71.7.3832-3839.2005; Su CC, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00166-14; Yuan X, 2010, PHYTOPATHOLOGY, V100, P601, DOI 10.1094/PHYTO-100-6-0601	23	59	60	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							fastidiosa: e112463	10.1371/journal.pone.0112463	http://dx.doi.org/10.1371/journal.pone.0112463			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379725	Green Published, gold			2022-12-27	WOS:000344863100102
J	de Plater, L; Vincent-Salomon, A; Berger, F; Nicolas, A; Vacher, S; Gravier, E; Thuleau, A; Karboul, N; Richardson, M; Elbaz, C; Marangoni, E; Bieche, I; Paoletti, X; Roman-Roman, S; Culp, PA; Asselain, B; Dieras, V; Decaudin, D				de Plater, Ludmilla; Vincent-Salomon, Anne; Berger, Frederique; Nicolas, Andre; Vacher, Sophie; Gravier, Eleonore; Thuleau, Aurelie; Karboul, Narjesse; Richardson, Marion; Elbaz, Clement; Marangoni, Elisabetta; Bieche, Ivan; Paoletti, Xavier; Roman-Roman, Sergio; Culp, Patricia A.; Asselain, Bernard; Dieras, Veronique; Decaudin, Didier			Predictive Gene Signature of Response to the Anti-TweakR mAb PDL192 in Patient-Derived Breast Cancer Xenografts	PLOS ONE			English	Article							NECROSIS-FACTOR FAMILY; INHIBITS TUMOR-GROWTH; WEAK INDUCER; KAPPA-B; RECEPTOR; CELLS; FN14; APOPTOSIS; THERAPY; TNF	Purpose: (1) To determine TweakR expression in human breast cancers (BC), (2) evaluate the antitumor effect of the anti-TweakR antibody PDL192, used alone or after chemotherapy-induced complete remission (CR), on patient-derived BC xenografts (PDX) and (3) define predictive markers of response. Experimental Design: TweakR expression was analyzed by IHC on patients and PDXs BC samples. In vivo antitumor effect of PDL192 was evaluated on eight TweakR-positive BC PDXs alone or after complete remission induced by a combination of doxorubicin and cyclophosphamide. Using both responding and resistant PDX tumors after PDL192 administration, RT-QPCR were performed on a wide list of selected candidate genes to identify predictive markers of response. Results: TweakR protein was expressed in about half of human BC samples. In vivo PDL192 treatment had significantly antitumor activity in 4 of 8 TweakR-positive BC PDXs, but no correlation between the expression level of the Tweak receptor and response to therapy was observed. PDL192 also significantly delayed tumor relapse after CR. Finally, an 8 gene signature was defined from sensitive and resistant PDXs. Conclusions: PDL192 was highly efficient in some BC PDXs. We found 8 genes that were differentially expressed in responding and resistant tumors and could constitute a gene expression signature which would need to be extended to other xenograft models for confirmation. These data confirm the therapeutic potential of TweakR targeting in BC and the possibility of prospectively selecting patients who might benefit from therapy.	[de Plater, Ludmilla; Thuleau, Aurelie; Karboul, Narjesse; Elbaz, Clement; Marangoni, Elisabetta; Decaudin, Didier] Inst Curie, Translat Res Dept, Lab Preclin Invest, Paris, France; [Vincent-Salomon, Anne; Nicolas, Andre; Richardson, Marion] Inst Curie, Dept Tumor Biol, Paris, France; [Berger, Frederique; Gravier, Eleonore; Paoletti, Xavier; Asselain, Bernard] Inst Curie, Dept Biostat, Paris, France; [Berger, Frederique; Paoletti, Xavier; Asselain, Bernard] INSERM, U900, Paris, France; [Vacher, Sophie; Bieche, Ivan] Inst Curie, Dept Genet, Paris, France; [Roman-Roman, Sergio] Inst Curie, Translat Res Dept, Paris, France; [Culp, Patricia A.] AbbVie Biotherapeut, Redwood City, CA USA; [Dieras, Veronique; Decaudin, Didier] Inst Curie, Dept Oncogenet, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; AbbVie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Decaudin, D (corresponding author), Inst Curie, Translat Res Dept, Lab Preclin Invest, Paris, France.	didier.decaudin@curie.fr	Bièche, Ivan/O-7399-2017; Marangoni, Elisabetta/GSO-3945-2022; Roman-Roman, Sergio/K-9993-2014; BERGER, Frederique/A-8893-2008	Bièche, Ivan/0000-0002-2430-5429; Marangoni, Elisabetta/0000-0002-3337-6448; Roman-Roman, Sergio/0000-0001-6459-2613; BERGER, Frederique/0000-0002-3251-4060; VACHER, Sophie/0000-0002-0042-6023	AbbVie Biotherapeutics; Institut Curie	AbbVie Biotherapeutics(AbbVie); Institut Curie	The funding was provided both by AbbVie Biotherapeutics (TweakR expression study and in vivo experiments) and by the Institut Curie (determination of predictive genes in the response to PDL192). AbbVie Biotherapeutics provided support in the form of salary for author PC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bieche I, 2005, VIROLOGY, V332, P130, DOI 10.1016/j.virol.2004.11.009; Bieche I, 2001, CANCER RES, V61, P1652; Bieche I, 1999, CLIN CHEM, V45, P1148; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Briolay A, 2013, BIOCHEM BIOPH RES CO, V430, P1072, DOI 10.1016/j.bbrc.2012.12.036; Chao DT, 2013, J CANCER RES CLIN, V139, P315, DOI 10.1007/s00432-012-1332-x; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Chorianopoulos E, 2010, BASIC RES CARDIOL, V105, P301, DOI 10.1007/s00395-009-0046-y; Creighton Chad J, 2013, Cancer Manag Res, V5, P187, DOI 10.2147/CMAR.S35171; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Croft M, 2013, NAT REV DRUG DISCOV, V12, P147, DOI 10.1038/nrd3930; Culp PA, 2010, CLIN CANCER RES, V16, P497, DOI 10.1158/1078-0432.CCR-09-1929; Currie MJ, 2013, HUM PATHOL, V44, P402, DOI 10.1016/j.humpath.2012.06.004; Decaudin D, 2011, ANTI-CANCER DRUG, V22, P827, DOI 10.1097/CAD.0b013e3283475f70; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Donohue PJ, 2003, ARTERIOSCL THROM VAS, V23, P594, DOI 10.1161/01.ATV.0000062883.93715.37; Feng SLY, 2000, AM J PATHOL, V156, P1253, DOI 10.1016/S0002-9440(10)64996-6; Filusch A, 2011, CLIN RES CARDIOL, V100, P879, DOI 10.1007/s00392-011-0318-z; Fortin SP, 2009, MOL CANCER RES, V7, P1871, DOI 10.1158/1541-7786.MCR-09-0194; Han HY, 2002, CANCER RES, V62, P2890; Ho DH, 2004, CANCER RES, V64, P8968, DOI 10.1158/0008-5472.CAN-04-1879; Ikner A, 2011, J BIOL CHEM, V286, P21546, DOI 10.1074/jbc.M110.203745; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lynch CN, 1999, J BIOL CHEM, V274, P8455, DOI 10.1074/jbc.274.13.8455; Marangoni E, 2009, BRIT J CANCER, V100, P918, DOI 10.1038/sj.bjc.6604953; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Michaelson JS, 2012, CANCER BIOL THER, V13, P812, DOI 10.4161/cbt.20564; Michaelson JS, 2011, MABS-AUSTIN, V3, P362, DOI 10.4161/mabs.3.4.16090; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rauner M, 2012, J BONE MINER RES, V27, P575, DOI 10.1002/jbmr.1488; Segal B, 2008, ORAL SURG ORAL MED O, V106, P778, DOI 10.1016/j.tripleo.2008.07.025; Servant N, 2010, BMC RES NOTES, V3; Tamada K, 2006, CANCER IMMUNOL IMMUN, V55, P355, DOI 10.1007/s00262-005-0081-y; Tran NL, 2006, CANCER RES, V66, P9535, DOI 10.1158/0008-5472.CAN-06-0418; Tran NL, 2005, J BIOL CHEM, V280, P3483, DOI 10.1074/jbc.M409906200; Tran NL, 2003, AM J PATHOL, V162, P1313, DOI 10.1016/S0002-9440(10)63927-2; Wang S, 2006, ONCOGENE, V25, P3346, DOI 10.1038/sj.onc.1209357; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Willis AL, 2008, MOL CANCER RES, V6, P725, DOI 10.1158/1541-7786.MCR-08-0005; Xu Bu-fang, 2011, Zhonghua Fu Chan Ke Za Zhi, V46, P355; Yin XF, 2013, CLIN CANCER RES, V19, P5686, DOI 10.1158/1078-0432.CCR-13-0405; Younes A, 2003, J CLIN ONCOL, V21, P3526, DOI 10.1200/JCO.2003.09.037	43	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e104227	10.1371/journal.pone.0104227	http://dx.doi.org/10.1371/journal.pone.0104227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375638	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402600002
J	Limpitikul, W; Henpraserttae, N; Saksawad, R; Laoprasopwattana, K				Limpitikul, Wannee; Henpraserttae, Narong; Saksawad, Rachanee; Laoprasopwattana, Kamolwish			Typhoid Outbreak in Songkhla, Thailand 2009-2011: Clinical Outcomes, Susceptibility Patterns, and Reliability of Serology Tests	PLOS ONE			English	Article							BONE-MARROW; PARATYPHOID FEVER; SALMONELLA-TYPHI; DIPSTICK ASSAY; ENTERIC FEVER; DIAGNOSIS; CHILDREN; BLOOD; CULTURES; AREA	Objective: To determine the clinical manifestations and outcomes, the reliability of Salmonella enterica serotype Typhi (S ser. Typhi) IgM and IgG rapid tests, and the susceptibility patterns and the response to treatment during the 2009-2011 typhoid outbreak in Songkhla province in Thailand. Method: The medical records of children aged <15 years with S ser. Typhi bacteremia were analysed. The efficacy of the typhoid IgM and IgG rapid tests and susceptibility of the S ser. Typhi to the current main antibiotics used for typhoid (amoxicillin, ampicillin, cefotaxime, ceftriaxone, co-trimoxazole, and ciprofloxacin), were evaluated. Results: S ser. Typhi bacteremia was found in 368 patients, and all isolated strains were susceptible to all 6 antimicrobials tested. Most of the patients were treated with ciprofloxacin for 7-14 days. The median time (IQR) of fever before treatment and duration of fever after treatment were 5 (4, 7) days and 4 (3, 5) days, respectively. Complications of ascites, lower respiratory symptoms, anemia (Hct <30%), and ileal perforation were found in 7, 7, 22, and 1 patients, respectively. None of the patients had recurrent infection or died. The sensitivities of the typhoid IgM and IgG tests were 58.3% and 25.6% respectively, and specificities were 74.1% and 50.5%, respectively. Conclusion: Most of the patients were diagnosed at an early stage and treated with a good outcome. All S ser. Typhi strains were susceptible to standard first line antibiotic typhoid treatment. The typhoid IgM and IgG rapid tests had low sensitivity and moderate specificity.	[Limpitikul, Wannee] Songkhla Hosp, Dept Pediat, Songkhla, Thailand; [Henpraserttae, Narong] Minist Publ Hlth Songkhla, Dept Dis Control, Bur Epidemiol, Songkhla, Thailand; [Saksawad, Rachanee] Hat Yai Hosp, Hat Yai Educ Ctr, Dept Pediat, Songkhla, Thailand; [Laoprasopwattana, Kamolwish] Prince Songkla Univ, Fac Med, Dept Pediat, Hat Yai, Thailand	Prince of Songkla University; Prince of Songkla University	Laoprasopwattana, K (corresponding author), Prince Songkla Univ, Fac Med, Dept Pediat, Hat Yai, Thailand.	kamolwish@gmail.com	laoprasopwattana, kamolwish/AAQ-9092-2020		Faculty of Medicine, Prince of Songkla University [56-210-01-1-3]	Faculty of Medicine, Prince of Songkla University	The only funding received for this manuscript was grant no. 56-210-01-1-3 from the Faculty of Medicine, Prince of Songkla University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begum Z, 2009, Mymensingh Med J, V18, P13; Bhutta ZA, 1999, AM J TROP MED HYG, V61, P654, DOI 10.4269/ajtmh.1999.61.654; Buckle Geoffrey C, 2012, J Glob Health, V2, P010401, DOI 10.7189/jogh.02.010401; CHOO KE, 1993, J PAEDIATR CHILD H, V29, P36, DOI 10.1111/j.1440-1754.1993.tb00437.x; Clinical and Laboratory Standards Institute, 2009, M100S19 CLSI; Connor BA, 2005, LANCET INFECT DIS, V5, P623, DOI 10.1016/S1473-3099(05)70239-5; Das S, 2013, DIAGN MICR INFEC DIS, V76, P5, DOI 10.1016/j.diagmicrobio.2013.01.012; Dolecek C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002188; Dutta S, 2006, DIAGN MICR INFEC DIS, V56, P359, DOI 10.1016/j.diagmicrobio.2006.06.024; Effa EE, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004530.pub4; Emary K, 2012, T ROY SOC TROP MED H, V106, P718, DOI 10.1016/j.trstmh.2012.08.007; FAROOQUI BJ, 1991, J CLIN PATHOL, V44, P258, DOI 10.1136/jcp.44.3.258; Gasem MH, 2002, J MED MICROBIOL, V51, P173, DOI 10.1099/0022-1317-51-2-173; Hatta M, 2002, AM J TROP MED HYG, V66, P416, DOI 10.4269/ajtmh.2002.66.416; Henpraserttae N, 2010, TYPHOID OUTBREAK SON; House D, 2001, J CLIN MICROBIOL, V39, P1002, DOI 10.1128/JCM.39.3.1002-1007.2001; Kawano RL, 2007, J CLIN MICROBIOL, V45, P246, DOI 10.1128/JCM.01403-06; Keddy KH, 2011, B WORLD HEALTH ORGAN, V89, P640, DOI 10.2471/BLT.11.087627; Khanam F, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002316; Lewis MD, 2005, CLIN INFECT DIS, V40, P554, DOI 10.1086/427503; Lynch MF, 2009, JAMA-J AM MED ASSOC, V302, P859, DOI 10.1001/jama.2009.1229; Martin LB, 2012, CURR OPIN INFECT DIS, V25, P489, DOI 10.1097/QCO.0b013e328356ffeb; Naheed A, 2008, DIAGN MICR INFEC DIS, V61, P381, DOI 10.1016/j.diagmicrobio.2008.03.018; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Saxe JM, 2005, AM J SURG, V189, P342, DOI 10.1016/j.amjsurg.2004.11.032; SIMANJUNTAK CH, 1991, LANCET, V338, P1055, DOI 10.1016/0140-6736(91)91910-M; Thaver D, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1865; THISYAKORN U, 1987, AM J DIS CHILD, V141, P862, DOI 10.1001/archpedi.1987.04460080048025; Thriemer K, 2013, PLOS ONE, V7; Ugwu B T, 2005, West Afr J Med, V24, P1; VALLENAS C, 1985, PEDIATR INFECT DIS J, V4, P496, DOI 10.1097/00006454-198509000-00011; Wain J, 2001, J CLIN MICROBIOL, V39, P1571, DOI 10.1128/JCM.39.4.1571-1576.2001; WARD LR, 1987, EPIDEMIOL INFECT, V99, P291, DOI 10.1017/S0950268800067765; Yang HH, 2001, J INFECT DIS, V183, P1775, DOI 10.1086/320729	34	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111768	10.1371/journal.pone.0111768	http://dx.doi.org/10.1371/journal.pone.0111768			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375784	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402600060
J	Salter, C; Brainard, J; McDaid, L; Loke, Y				Salter, Charlotte; Brainard, Julii; McDaid, Lisa; Loke, Yoon			Challenges and Opportunities: What Can We Learn from Patients Living with Chronic Musculoskeletal Conditions, Health Professionals and Carers about the Concept of Health Literacy Using Qualitative Methods of Inquiry?	PLOS ONE			English	Article							SHARED DECISION-MAKING; UNINTENTIONAL NONADHERENCE; COMMUNICATION; FRAMEWORK	The field of health literacy continues to evolve and concern public health researchers and yet remains a largely overlooked concept elsewhere in the healthcare system. We conducted focus group discussions in England UK, about the concept of health literacy with older patients with chronic musculoskeletal conditions (mean age = 73.4 years), carers and health professionals. Our research posed methodological, intellectual and practical challenges. Gaps in conceptualisation and expectations were revealed, reiterating deficiencies in predominant models for understanding health literacy and methodological shortcomings of using focus groups in qualitative research for this topic. Building on this unique insight into what the concept of health literacy meant to participants, we present analysis of our findings on factors perceived to foster and inhibit health literacy and on the issue of responsibility in health literacy. Patients saw health literacy as a result of an inconsistent interactive process and the implications as wide ranging; healthcare professionals had more heterogeneous views. All focus group discussants agreed that health literacy most benefited from good inter-personal communication and partnership. By proposing a needs-based approach to health literacy we offer an alternative way of conceptualising health literacy to help improve the health of older people with chronic conditions.	[Salter, Charlotte; Brainard, Julii; McDaid, Lisa; Loke, Yoon] Univ E Anglia, Fac Med & Hlth Sci, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Salter, C (corresponding author), Univ E Anglia, Fac Med & Hlth Sci, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England.	c.salter@uea.ac.uk	Morris, Josephine D./F-3366-2018	Morris, Josephine D./0000-0001-9404-5602; McDaid, Lisa/0000-0001-5032-2380	National Institute for Health Research under its Research for Patient Benefit Programme (RfPB); ESRC [ES/J022497/1] Funding Source: UKRI	National Institute for Health Research under its Research for Patient Benefit Programme (RfPB); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was funded by the National Institute for Health Research under its Research for Patient Benefit Programme (RfPB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Sayah F, 2012, CAN J DIABETES, V36, P27, DOI 10.1016/j.jcjd.2011.08.001; Appleby R, 2009, COLD WILL IT BE PROS; Australian Bureau of Statistics, 2009, AUSTR SOC TRENDS CAN; Baker DW, 2006, J GEN INTERN MED, V21, P878, DOI 10.1111/j.1525-1497.2006.00540.x; Baker DW, 2000, J GERONTOL B-PSYCHOL, V55, pS368, DOI 10.1093/geronb/55.6.S368; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Berkman ND, 2010, J HEALTH COMMUN, V15, P9, DOI 10.1080/10810730.2010.499985; Chew LD, 2008, J GEN INTERN MED, V23, P561, DOI 10.1007/s11606-008-0520-5; Chinn D, 2011, SOC SCI MED, V73, P60, DOI 10.1016/j.socscimed.2011.04.004; Collins SA, 2012, J BIOMED INFORM, V45, P598, DOI 10.1016/j.jbi.2012.04.001; Deveugele M, 2002, BRIT MED J, V325, P472, DOI 10.1136/bmj.325.7362.472; Easton P, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-319; Entwistle VA, 2012, J ROY SOC MED, V105, P416, DOI 10.1258/jrsm.2012.120039; Entwistle VA, 2010, J GEN INTERN MED, V25, P741, DOI 10.1007/s11606-010-1292-2; Gazmararian J, 2010, ANN PHARMACOTHER, V44, P80, DOI 10.1345/aph.1M328; Halkier B, 2010, QUAL RES, V10, P71, DOI 10.1177/1468794109348683; HLS-EU CONSORTIUM, 2012, COMP REP HLTH LIT 8; Jochelson K, 2007, HLTH LITERACY REV PA, P21; Jordan JE, 2011, J CLIN EPIDEMIOL, V64, P366, DOI 10.1016/j.jclinepi.2010.04.005; Joseph-Williams N, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3178; Kmietowicz Z, 2004, BRIT MED J, V329, P14; Kramer G, 2013, HLTH LITERACY LETS T; Kwan B., 2006, U BRIT COLUMBIA I HL, P1; Lindquist LA, 2012, J GEN INTERN MED, V27, P173, DOI 10.1007/s11606-011-1886-3; Loke YK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040210; Loke YK, 2012, ANN PHARMACOTHER, V46, P863, DOI 10.1345/aph.1Q718; Lupton Deborah, 2012, MED CULTURE ILLNESS, V3rd ed, DOI DOI 10.4135/9781446254530; McCaffery KJ, 2010, MED DECIS MAKING, V30, P35, DOI 10.1177/0272989X09342279; McCann L, 2014, YOU CANT DO BOTH SOM; Mol Annemarie, 2008, LOGIC CARE HLTH PROB, DOI DOI 10.4324/9780203927076; Moser C., 1999, IMPROVING LITERACY N; Nielsen-Bohlman L, 2004, HLTH LITERACY PRESCR; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; Nutbeam D, 2009, INT J PUBLIC HEALTH, V54, P303, DOI 10.1007/s00038-009-0050-x; Nutbeam D, 2008, SOC SCI MED, V67, P2072, DOI 10.1016/j.socscimed.2008.09.050; Paasche-Orlow MK, 2007, AM J HEALTH BEHAV, V31, pS19; Paasche-Orlow MK, 2005, J GEN INTERN MED, V20, P175, DOI 10.1111/j.1525-1497.2005.40245.x; Peerson A, 2009, HEALTH PROMOT INT, V24, P285, DOI 10.1093/heapro/dap014; Protheroe J, 2013, J HEALTH PSYCHOL, V18, P1046, DOI 10.1177/1359105312459876; Raynor DKT, 2012, BMJ, V344; Ritchie J., 2003, GUIDE SOCIAL SCI STU, P77; Salter B.G., 2004, NEW POLITICS MED; Schulz PJ, 2013, PATIENT EDUC COUNS, V90, P4, DOI 10.1016/j.pec.2012.09.006; Sheridan SL, 2011, J HEALTH COMMUN, V16, P30, DOI 10.1080/10810730.2011.604391; Smith SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074373; Smith SK, 2009, SOC SCI MED, V69, P1805, DOI 10.1016/j.socscimed.2009.09.056; Smith SK, 2013, J HLTH PSYCHOL; Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80; Volandes AE, 2007, AM J BIOETHICS, V7, P5, DOI 10.1080/15265160701638520; von Wagner C, 2009, HEALTH EDUC BEHAV, V36, P860, DOI 10.1177/1090198108322819; Weiss B, 2007, HLTH LITERACY PATIEN; Wolf MS, 2007, J HEALTH COMMUN, V12, P721, DOI 10.1080/10810730701672173; Wroe AL, 2002, J BEHAV MED, V25, P355, DOI 10.1023/A:1015866415552	53	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112041	10.1371/journal.pone.0112041	http://dx.doi.org/10.1371/journal.pone.0112041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XM	25375767	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000344402600094
J	Grattan, LE; Glimcher, PW				Grattan, Lauren E.; Glimcher, Paul W.			Absence of Spatial Tuning in the Orbitofrontal Cortex	PLOS ONE			English	Article							ORBITAL PREFRONTAL CORTEX; MONKEY SUPERIOR COLLICULUS; INTRAPARIETAL NEURONS; REWARD PREFERENCE; RESPONSES; CHOICES; REPRESENTATION; COMPUTATION; LESIONS; FIELDS	There is limited data in the literature to explicitly support the notion that neurons in OFC are truly action-independent in their coding. We set out to specifically test the hypothesis that OFC value-related neurons in area 13 m of the monkey do not carry information about the action required to obtain that reward - that activity in this area represents reward values in an abstract and action-independent manner. To accomplish that goal we had two monkeys select and execute saccadic eye movements to 81 locations in the visual field for three different kinds of juice rewards. Our detailed analysis of the response fields indicates that these neurons are insensitive to the amplitude or direction of the saccade required to obtain these rewards. Our data thus validate earlier proposals that neurons of 13 m in the OFC encode subjective value independent of the saccadic action required to obtain that reward.	[Grattan, Lauren E.; Glimcher, Paul W.] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Glimcher, PW (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	glimcher@cns.nyu.edu			NIH/NEI [R01EY010536]; NATIONAL EYE INSTITUTE [R01EY010536] Funding Source: NIH RePORTER	NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The NIH/NEI grant R01EY010536 provided financial support for this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYLIS LL, 1995, NEUROSCIENCE, V64, P801, DOI 10.1016/0306-4522(94)00449-F; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Feierstein CE, 2006, NEURON, V51, P495, DOI 10.1016/j.neuron.2006.06.032; Gnadt JW, 1996, VISION RES, V36, P3525, DOI 10.1016/0042-6989(96)00049-1; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Izquierdo A, 2004, J NEUROPHYSIOL, V91, P2023, DOI 10.1152/jn.00968.2003; Kennerley SW, 2009, J NEUROPHYSIOL, V102, P3352, DOI 10.1152/jn.00273.2009; Levy I, 2011, J NEUROSCI, V31, P118, DOI 10.1523/JNEUROSCI.3214-10.2011; MAYS LE, 1980, J NEUROPHYSIOL, V43, P207, DOI 10.1152/jn.1980.43.1.207; MOORS J, 1979, EXP BRAIN RES, V35, P333; MORECRAFT RJ, 1992, J COMP NEUROL, V323, P341, DOI 10.1002/cne.903230304; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2007, ANN NY ACAD SCI, V1121, P232, DOI 10.1196/annals.1401.011; Padoa-Schioppa C, 2008, NAT NEUROSCI, V11, P95, DOI 10.1038/nn2020; Padoa-Schioppa C, 2011, ANN NY ACAD SCI, V1239, P130, DOI 10.1111/j.1749-6632.2011.06262.x; Padoa-Schioppa C, 2011, ANNU REV NEUROSCI, V34, P333, DOI 10.1146/annurev-neuro-061010-113648; Platt ML, 1997, J NEUROPHYSIOL, V78, P1574, DOI 10.1152/jn.1997.78.3.1574; Platt ML, 1998, EXP BRAIN RES, V121, P65, DOI 10.1007/s002210050438; Pritchard TC, 2007, ANN NY ACAD SCI, V1121, P121, DOI 10.1196/annals.1401.007; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Tsujimoto S, 2009, J NEUROSCI, V29, P2569, DOI 10.1523/JNEUROSCI.5777-08.2009; WALKER MF, 1995, J NEUROPHYSIOL, V73, P1988, DOI 10.1152/jn.1995.73.5.1988; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Walton ME, 2010, NEURON, V65, P927, DOI 10.1016/j.neuron.2010.02.027; Wunderlich K, 2010, P NATL ACAD SCI USA, V107, P15005, DOI 10.1073/pnas.1002258107	29	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112750	10.1371/journal.pone.0112750	http://dx.doi.org/10.1371/journal.pone.0112750			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386837	Green Published, gold			2022-12-27	WOS:000345250400089
J	Jin, J; Sui, BW; Gou, JX; Liu, JS; Tang, X; Xu, H; Zhang, Y; Jin, XQ				Jin, Jian; Sui, Bowen; Gou, Jingxin; Liu, Jingshuo; Tang, Xing; Xu, Hui; Zhang, Yu; Jin, Xiangqun			PSMA Ligand Conjugated PCL-PEG Polymeric Micelles Targeted to Prostate Cancer Cells	PLOS ONE			English	Article							BLOCK-COPOLYMER MICELLES; MEMBRANE ANTIGEN; DRUG-DELIVERY; NANOPARTICLES; EXPRESSION; BIODISTRIBUTION; EFFICACY; HYDROGEL; BEHAVIOR	In this content, a small molecular ligand of prostate specific membrane antigen (SMLP) conjugated poly (caprolactone) (PCL)-b-poly (ethylene glycol) (PEG) copolymers with different block lengths were synthesized to construct a satisfactory drug delivery system. Four different docetaxel-loaded polymeric micelles (DTX-PMs) were prepared by dialysis with particle sizes less than 60 nm as characterized by dynamic light scattering (DLS) and transmission electron microscope (TEM). Optimization of the prepared micelles was conducted based on short-term stability and drug-loading content. The results showed that optimized systems were able to remain stable over 7 days. Compared with Taxotere, DTX-PMs with the same ratio of hydrophilic/hydrophobic chain length displayed similar sustained release behaviors. The cytotoxicity of the optimized targeted DTX-PCL12K-PEG(5K)-SMLP micelles (DTX-PMs2) and non-targeted DTX-PCL12K-mPEG(5K) micelles (DTX-PMs1) were evaluated by MTT assays using prostate specific membrane antigen (PSMA) positive prostate adenocarcinoma cells (LNCaP). The results showed that the targeted micelles had a much lower IC50 than their non-targeted counterparts (48 h: 0.87 +/- 0.27 vs 13.48 +/- 1.03 mu g/ml; 72 h: 0.02 +/- 0.008 vs 1.35 +/- 0.54 mu g/ml). In vitro cellular uptake of PMs2 showed 5-fold higher fluorescence intensity than that of PMs1 after 4 h incubation. According to these results, the novel nano-sized drug delivery system based on DTX-PCL-PEG-SMLP offers great promise for the treatment of prostatic cancer.	[Jin, Jian; Sui, Bowen; Liu, Jingshuo; Jin, Xiangqun] Jilin Univ, Coll Pharm Sci, Dept Pharmaceut, Changchun 130023, Peoples R China; [Gou, Jingxin; Tang, Xing; Xu, Hui; Zhang, Yu] Shenyang Pharmaceut Univ, Dept Pharmaceut, Shenyang, Peoples R China	Jilin University; Shenyang Pharmaceutical University	Jin, XQ (corresponding author), Jilin Univ, Coll Pharm Sci, Dept Pharmaceut, Changchun 130023, Peoples R China.	jinxq@jlu.edu.cn						Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m; Bae SJ, 2005, MACROMOLECULES, V38, P5260, DOI 10.1021/ma050489m; Branco MC, 2009, ACTA BIOMATER, V5, P817, DOI 10.1016/j.actbio.2008.09.018; Chang SS, 1999, CLIN CANCER RES, V5, P2674; Chung YM, 2002, BIOMACROMOLECULES, V3, P511, DOI 10.1021/bm0156431; Colombatti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004608; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; Denmeade SR, 2003, PROSTATE, V54, P249, DOI 10.1002/pros.10199; Dhar S, 2008, J AM CHEM SOC, V130, P11467, DOI 10.1021/ja803036e; Esmaeili F, 2009, J PHARM SCI-US, V98, P2718, DOI 10.1002/jps.21599; Farokhzad OC, 2004, CANCER RES, V64, P7668, DOI 10.1158/0008-5472.CAN-04-2550; Farokhzad OC, 2006, P NATL ACAD SCI USA, V103, P6315, DOI 10.1073/pnas.0601755103; Gaucher G, 2005, J CONTROL RELEASE, V109, P169, DOI 10.1016/j.jconrel.2005.09.034; Ghosh A, 2004, J CELL BIOCHEM, V91, P528, DOI 10.1002/jcb.10661; Gou ML, 2009, J PHYS CHEM B, V113, P12928, DOI 10.1021/jp905781g; Gu PF, 2012, INT J NANOMED, V7, P109, DOI 10.2147/IJN.S27475; Haag R, 2004, ANGEW CHEM INT EDIT, V43, P278, DOI 10.1002/anie.200301694; Hinterwirth H, 2012, ANAL CHIM ACTA, V733, P90, DOI 10.1016/j.aca.2012.04.036; Hrkach J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003651; Hu Y, 2004, BIOMACROMOLECULES, V5, P1756, DOI 10.1021/bm049845j; Huang W, 2010, ACTA BIOMATER, V6, P3927, DOI 10.1016/j.actbio.2010.04.021; ISRAELI RS, 1994, CANCER RES, V54, P1807; KATAOKA K, 1993, J CONTROL RELEASE, V24, P119; Li J, 2006, BIOMATERIALS, V27, P4132, DOI 10.1016/j.biomaterials.2006.03.025; Li JM, 2012, J BIOMED NANOTECHNOL, V8, P809, DOI 10.1166/jbn.2012.1433; Liu CB, 2007, COLLOID SURFACE A, V302, P430, DOI 10.1016/j.colsurfa.2007.03.006; Maresca KP, 2009, J MED CHEM, V52, P347, DOI 10.1021/jm800994j; Murphy GP, 1998, CANCER-AM CANCER SOC, V83, P2259, DOI 10.1002/(SICI)1097-0142(19981201)83:11<2259::AID-CNCR5>3.0.CO;2-T; Nie SF, 2011, INT J NANOMED, V6, P151, DOI 10.2147/IJN.S15057; Qi RG, 2011, J CONTROL RELEASE, V152, pE167, DOI 10.1016/j.jconrel.2011.08.067; Rofstad EK, 2006, CANCER RES, V66, P6699, DOI 10.1158/0008-5472.CAN-06-0983; Samarajeewa S, 2013, MOL PHARMACEUT, V10, P1092, DOI 10.1021/mp3005897; Sanna V, 2011, MOL PHARMACEUT, V8, P748, DOI 10.1021/mp100360g; Savic R, 2006, J DRUG TARGET, V14, P343, DOI 10.1080/10611860600874538; Saxena V, 2013, J BIOMED NANOTECHNOL, V9, P1146, DOI 10.1166/jbn.2013.1632; Torchilin V, 2011, ADV DRUG DELIVER REV, V63, P131, DOI 10.1016/j.addr.2010.03.011; Wang YJ, 2012, J BIOMED NANOTECHNOL, V8, P450, DOI 10.1166/jbn.2012.1390; Wolf P, 2010, PROSTATE, V70, P562, DOI 10.1002/pros.21090; Yamamichi F, 2012, UROLOGY, V80, DOI 10.1016/j.urology.2012.06.023; Zamani S, 2012, POLYMER, V53, P5723, DOI 10.1016/j.polymer.2012.09.051	41	34	34	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112200	10.1371/journal.pone.0112200	http://dx.doi.org/10.1371/journal.pone.0112200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386942	gold, Green Submitted, Green Published			2022-12-27	WOS:000345250400049
J	Ohri, SS; Mullins, A; Hetman, M; Whittemore, SR				Ohri, Sujata Saraswat; Mullins, Ashley; Hetman, Michal; Whittemore, Scott R.			Inhibition of GADD34, the Stress-Inducible Regulatory Subunit of the Endoplasmic Reticulum Stress Response, Does Not Enhance Functional Recovery after Spinal Cord Injury	PLOS ONE			English	Article							XBP1 MESSENGER-RNA; PROTEIN-SYNTHESIS; ER STRESS; APOPTOSIS; DEATH; ATF6	Activation of the endoplasmic reticulum stress response (ERSR) is a hallmark of various pathological diseases and/or traumatic injuries. Restoration of ER homeostasis can contribute to improvement in the functional outcome of these diseases. Using genetic and pharmacological inhibition of the PERK-CHOP arm of the ERSR, we recently demonstrated improvements in hindlimb locomotion after spinal cord injury (SCI) and implicated oligodendrocyte survival as a potential mechanism. Here, we investigated the contribution of stress-inducible PPP1R15A/GADD34, an ERSR signaling effector downstream of CHOP that dephosphorylates eIF2 alpha, in the pathogenesis of SCI. We show that although genetic ablation of GADD34 protects oligodendrocyte precursor cells (OPCs) against ER stress-mediated cell death in vitro and results in differential ERSR attenuation in vivo after SCI, there is no improvement in hindlimb locomotor function. Guanabenz, a FDA approved antihypertensive drug, was recently shown to reduce the burden of misfolded proteins in the ER by directly targeting GADD34. Guanabenz protected OPCs from ER stress-mediated cell death in vitro and attenuated the ERSR in vivo after SCI. However, guanabenz administration failed to rescue the locomotor deficits after SCI. These data suggest that deletion of GADD34 alone is not sufficient to improve functional recovery after SCI.	[Ohri, Sujata Saraswat; Mullins, Ashley; Hetman, Michal; Whittemore, Scott R.] Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA; [Ohri, Sujata Saraswat; Mullins, Ashley; Hetman, Michal; Whittemore, Scott R.] Univ Louisville, Dept Neurol Surg, Louisville, KY 40292 USA; [Hetman, Michal] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [Hetman, Michal; Whittemore, Scott R.] Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville	Whittemore, SR (corresponding author), Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA.	swhittemore@louisville.edu			Kentucky Spinal Cord and Head Injury Research Trust [10-13]; Norton Healthcare; Commonwealth of Kentucky Challenge for Excellence;  [NS073584];  [NS054708];  [RR15576/GM103507]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054708, R01NS073584] Funding Source: NIH RePORTER	Kentucky Spinal Cord and Head Injury Research Trust; Norton Healthcare; Commonwealth of Kentucky Challenge for Excellence; ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by NS073584, NS054708, RR15576/GM103507, Kentucky Spinal Cord and Head Injury Research Trust, 10-13, Norton Healthcare and the Commonwealth of Kentucky Challenge for Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler HT, 1999, MOL CELL BIOL, V19, P7050; Almad A, 2011, NEUROTHERAPEUTICS, V8, P262, DOI 10.1007/s13311-011-0033-5; Baptiste DC, 2007, PROG BRAIN RES, V161, P217, DOI 10.1016/S0079-6123(06)61015-7; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Benton RL, 2008, J COMP NEUROL, V507, P1031, DOI 10.1002/cne.21570; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; D'Antonio M, 2013, J EXP MED, V210, P821, DOI 10.1084/jem.20122005; D'Antonio M, 2009, J NEUROSCI RES, V87, P3241, DOI 10.1002/jnr.22066; Dincman TA, 2012, J NEUROSCI METH, V209, P219, DOI 10.1016/j.jneumeth.2012.06.017; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; Guest JD, 2005, EXP NEUROL, V192, P384, DOI 10.1016/j.expneurol.2004.11.033; Han S, 2010, BRAIN, V133, P1026, DOI 10.1093/brain/awq034; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hirota Morihiko, 2006, Journal of Toxicological Sciences, V31, P149, DOI 10.2131/jts.31.149; Hollander MC, 1997, J BIOL CHEM, V272, P13731, DOI 10.1074/jbc.272.21.13731; Hurlbert RJ, 2013, NEUROSURGERY, V72, P93, DOI 10.1227/NEU.0b013e31827765c6; Kojima E, 2003, FASEB J, V17, P1573, DOI 10.1096/fj.02-1184fje; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; Lin WS, 2008, AM J PATHOL, V173, P1508, DOI 10.2353/ajpath.2008.080449; Lin WS, 2009, NAT NEUROSCI, V12, P379, DOI 10.1038/nn.2273; Magnuson DSK, 1999, EXP NEUROL, V156, P191, DOI 10.1006/exnr.1999.7016; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; McTigue DM, 2008, J NEUROCHEM, V107, P1, DOI 10.1111/j.1471-4159.2008.05570.x; Monk KR, 2013, DIS MODEL MECH, V6, P135, DOI 10.1242/dmm.009217; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Ohri SS, 2013, NEUROBIOL DIS, V58, P29, DOI 10.1016/j.nbd.2013.04.021; Ohri SS, 2012, J NEUROTRAUM, V29, P579, DOI 10.1089/neu.2011.1940; Ohri SS, 2011, GLIA, V59, P1489, DOI 10.1002/glia.21191; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Penas C, 2007, J NEUROCHEM, V102, P1242, DOI 10.1111/j.1471-4159.2007.04671.x; Rowland JW, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E2; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Simon CM, 2009, J NEUROTRAUM, V26, P563, DOI 10.1089/neu.2008.0523; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tator CH, 2006, NEUROSURGERY, V59, P957, DOI 10.1227/01.NEU.0000245591.16087.89; Tribouillard-Tanvier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001981; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Valenzuela V, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.8; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	42	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e109703	10.1371/journal.pone.0109703	http://dx.doi.org/10.1371/journal.pone.0109703			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386686	Green Submitted, Green Published, gold			2022-12-27	WOS:000345250400003
J	Rafiq, MT; Aziz, R; Yang, XE; Xiao, WD; Stoffella, PJ; Saghir, A; Azam, M; Li, TQ				Rafiq, Muhammad Tariq; Aziz, Rukhsanda; Yang, Xiaoe; Xiao, Wendan; Stoffella, Peter J.; Saghir, Aamir; Azam, Muhammad; Li, Tingqiang			Phytoavailability of Cadmium (Cd) to Pak Choi (Brassica chinensis L.) Grown in Chinese Soils: A Model to Evaluate the Impact of Soil Cd Pollution on Potential Dietary Toxicity	PLOS ONE			English	Article							ORYZA-SATIVA L.; EXCHANGE CAPACITY; HEAVY-METALS; RICE; ACCUMULATION; ACID; PHYTOEXTRACTION; PHYTOTOXICITY; VEGETABLES; CHROMIUM	Food chain contamination by soil cadmium (Cd) through vegetable consumption poses a threat to human health. Therefore, an understanding is needed on the relationship between the phytoavailability of Cd in soils and its uptake in edible tissues of vegetables. The purpose of this study was to establish soil Cd thresholds of representative Chinese soils based on dietary toxicity to humans and develop a model to evaluate the phytoavailability of Cd to Pak choi (Brassica chinensis L.) based on soil properties. Mehlich-3 extractable Cd thresholds were more suitable for Stagnic Anthrosols, Calcareous, Ustic Cambosols, Typic Haplustalfs, Udic Ferrisols and Periudic Argosols with values of 0.30, 0.25, 0.18, 0.16, 0.15 and 0.03 mg kg(-1), respectively, while total Cd is adequate threshold for Mollisols with a value of 0.86 mg kg(-1). A stepwise regression model indicated that Cd phytoavailability to Pak choi was significantly influenced by soil pH, organic matter, total Zinc and Cd concentrations in soil. Therefore, since Cd accumulation in Pak choi varied with soil characteristics, they should be considered while assessing the environmental quality of soils to ensure the hygienically safe food production.	[Rafiq, Muhammad Tariq; Aziz, Rukhsanda; Yang, Xiaoe; Xiao, Wendan; Li, Tingqiang] Zhejiang Univ, Coll Environm & Resource Sci, Minist Educ, Key Lab Environm Remediat & Ecol Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Rafiq, Muhammad Tariq] Int Islamic Univ, Dept Environm Sci, Islamabad, Pakistan; [Stoffella, Peter J.] Univ Florida, Inst Food & Agr Sci, Indian River Res & Educ Ctr, Ft Pierce, FL USA; [Saghir, Aamir] Zhejiang Univ, Inst Stat, Hangzhou 310003, Zhejiang, Peoples R China; [Azam, Muhammad] Zhejiang Univ, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; International Islamic University, Pakistan; State University System of Florida; University of Florida; Zhejiang University; Zhejiang University	Li, TQ (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, Minist Educ, Key Lab Environm Remediat & Ecol Hlth, Hangzhou 310003, Zhejiang, Peoples R China.	litq@zju.edu.cn	Azam, Muhammad/AAX-5514-2020; Li, Tingqiang/B-2592-2017; Azam, Muhammad/AAZ-2627-2020	Li, Tingqiang/0000-0003-4448-4871; Xiao, Wendan/0000-0002-7188-4056; Saghir, Aamir/0000-0002-7988-7913	Ministry of Environmental Protection of China [2011467057]; ministry of Science and Technology of China [2012AA100605]; Fundamental Research Funds for the Central Universities of China	Ministry of Environmental Protection of China; ministry of Science and Technology of China(Ministry of Science and Technology, China); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This study was supported by the Ministry of Environmental Protection of China (grant no. 2011467057), the ministry of Science and Technology of China (grant no. 2012AA100605), and by the Fundamental Research Funds for the Central Universities of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULLA M, 1990, BIOL TRACE ELEM RES, V23, P25, DOI 10.1007/BF02917176; Ali B, 2013, J PLANT GROWTH REGUL, V32, P604, DOI 10.1007/s00344-013-9328-6; Ali B, 2013, ECOTOX ENVIRON SAFE, V92, P271, DOI 10.1016/j.ecoenv.2013.02.006; Bo- HYL, 2013, INT J ENV RES PUB HE, V10, P5284, DOI 10.3390/ijerph10115284; Chapman PM, 2002, SCI TOTAL ENVIRON, V288, P131, DOI 10.1016/S0048-9697(01)01120-2; Chaturvedi R., 2006, LAB MANUAL PHYSICOCH; Chen HS, 2010, PEDOSPHERE, V20, P63, DOI 10.1016/S1002-0160(09)60283-6; Cui YJ, 2004, J ENVIRON SCI, V16, P962; Day P.R., 1965, METHODS SOIL ANAL 1, P545, DOI DOI 10.2134/AGRONMONOGR9.1.C43; de Villiers S, 2010, ENVIRON GEOCHEM HLTH, V32, P451, DOI 10.1007/s10653-010-9288-8; Di Salvatore M, 2009, J FOOD AGRIC ENVIRON, V7, P683; Du T.P., 2005, PRODUCT RES, V6, P139; Eriksson JE, 1996, ACTA AGR SCAND B-S P, V46, P240, DOI 10.1080/09064719609410957; FAO/WHO, 2003, 61 M JOINT FAO WHO E; Franz E, 2008, J FOOD PROTECT, V71, P2504, DOI 10.4315/0362-028X-71.12.2504; Ge Y, 2000, ENVIRON POLLUT, V107, P137, DOI 10.1016/S0269-7491(99)00119-0; GIORDANO PM, 1979, J ENVIRON QUAL, V8, P233, DOI 10.2134/jeq1979.00472425000800020020x; GU JG, 2003, J BASIC SCI ENG, V11, P143; Halim M, 2003, CHEMOSPHERE, V52, P265, DOI 10.1016/S0045-6535(03)00185-1; HENDERSHOT WH, 1986, SOIL SCI SOC AM J, V50, P605, DOI 10.2136/sssaj1986.03615995005000030013x; IARC, 1993, MON EV CARC RISKS HU, P119; Ide G, 1995, INT C HEAV MET ENV H, V2, P302; Jung MC, 1996, APPL GEOCHEM, V11, P53, DOI 10.1016/0883-2927(95)00075-5; Kabata-Pendias A, 2010, TRACE ELEMENTS SOILS, Vfourth, DOI [DOI 10.1201/B10158, 10.1201/9781420039900]; KAMINEK M, 1992, TRENDS BIOTECHNOL, V10, P159, DOI 10.1016/0167-7799(92)90204-9; Kobayashi E, 2008, TOXICOL LETT, V179, P108, DOI 10.1016/j.toxlet.2008.04.013; Laura W, 2011, J AGR FOOD SYS COMM; Lebeau T, 2002, SCI TOTAL ENVIRON, V291, P73, DOI 10.1016/S0048-9697(01)01093-2; Li S, 2006, GEODERMA, V136, P260, DOI 10.1016/j.geoderma.2006.03.054; Liang ZF, 2013, ECOTOX ENVIRON SAFE, V93, P180, DOI 10.1016/j.ecoenv.2013.04.003; Liu JG, 2007, J HAZARD MATER, V143, P443, DOI 10.1016/j.jhazmat.2006.09.057; Liu L, 2009, J HAZARD MATER, V163, P563, DOI 10.1016/j.jhazmat.2008.07.004; Liu WT, 2010, J HAZARD MATER, V173, P737, DOI 10.1016/j.jhazmat.2009.08.147; Liu XQ, 2010, CHEMOSPHERE, V78, P1136, DOI 10.1016/j.chemosphere.2009.12.030; MAHLER RJ, 1978, J ENVIRON QUAL, V7, P274, DOI 10.2134/jeq1978.00472425000700020025x; McBride M, 2002, SOIL SCI, V15, P84; McCauley A., 2009, NUTR MANAG MODUL, V8, P1; MEHLICH A, 1984, COMMUN SOIL SCI PLAN, V15, P1409, DOI 10.1080/00103628409367568; MOYA JL, 1993, PHOTOSYNTH RES, V36, P75, DOI 10.1007/BF00016271; Nyitrai P, 2003, J PLANT PHYSIOL, V160, P1175, DOI 10.1078/0176-1617-00770; OLIVER DP, 1994, J ENVIRON QUAL, V23, P705, DOI 10.2134/jeq1994.00472425002300040013x; Rafiq MT, 2014, ECOTOX ENVIRON SAFE, V103, P101, DOI 10.1016/j.ecoenv.2013.10.016; Rattan RK, 2005, AGR ECOSYST ENVIRON, V109, P310, DOI 10.1016/j.agee.2005.02.025; Romkens PFAM, 2009, ENVIRON POLLUT, V157, P2435, DOI 10.1016/j.envpol.2009.03.009; Ryan J, 2001, SOIL PLANT ANAL LAB, V2; Shentu JL, 2008, J AGR FOOD CHEM, V56, P6382, DOI 10.1021/jf800882q; Shute T, 2006, SCI TOTAL ENVIRON, V371, P63, DOI 10.1016/j.scitotenv.2006.07.034; Stohs Sidney J., 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P201; Szteke B, 1995, INT C HEAV MET ENV H, V2, P228; Wang XL, 2005, SCI TOTAL ENVIRON, V350, P28, DOI 10.1016/j.scitotenv.2004.09.044; Wang XP, 2004, CHEMOSPHERE, V55, P811, DOI 10.1016/j.chemosphere.2003.12.003; Xiao WD, 2013, J ENVIRON QUAL, V42, P758, DOI 10.2134/jeq2012.0419; Xiao WD, 2013, J AGR FOOD CHEM, V61, P2925, DOI 10.1021/jf400467s; Yang JX, 2010, J ENVIRON SCI, V22, P1246, DOI 10.1016/S1001-0742(09)60245-X; Yang Y, 2009, J ENVIRON MANAGE, V90, P1117, DOI 10.1016/j.jenvman.2008.05.004; 顾继光, 2002, [生态科学, Ecologic Science], V21, P352	57	37	39	9	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111461	10.1371/journal.pone.0111461	http://dx.doi.org/10.1371/journal.pone.0111461			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386790	Green Submitted, Green Published, gold			2022-12-27	WOS:000345250400018
J	Han, XX; Sun, SK; Zhao, M; Cheng, X; Chen, GZ; Lin, S; Guan, YF; Yu, XD				Han, Xiaoxi; Sun, Shengkun; Zhao, Ming; Cheng, Xiang; Chen, Guozhu; Lin, Song; Guan, Yifu; Yu, Xiaodan			Celastrol Stimulates Hypoxia-Inducible Factor-1 Activity in Tumor Cells by Initiating the ROS/Akt/p70S6K Signaling Pathway and Enhancing Hypoxia-Inducible Factor-1 alpha Protein Synthesis	PLOS ONE			English	Article							HUMAN PROSTATE-CANCER; ENDOTHELIAL GROWTH-FACTOR; UP-REGULATION; DNA-DAMAGE; AUTOPHAGY; ACTIVATION; EXPRESSION; BNIP3; HIF-1-ALPHA; INDUCTION	Celastrol, a tripterine derived from the traditional Chinese medicine plant Tripterygium wilfordii Hook F. ("Thunder of God Vine''), has been reported to have multiple effects, such as anti-inflammation, suppression of tumor angiogenesis, inhibition of tumor growth, induction of apoptosis and protection of cells against human neurodegenerative diseases. However, the mechanisms that underlie these functions are not well defined. In this study, we reported for the first time that Celastrol could induce HIF-1 alpha protein accumulation in multiple cancer cell lines in an oxygen-independent manner and that the enhanced HIF-1 alpha protein entered the nucleus and promoted the transcription of the HIF-1 target genes VEGF and Glut-1. Celastrol did not influence HIF-1 alpha transcription. Instead, Celastrol induced the accumulation of the HIF-1 alpha protein by inducing ROS and activating Akt/p70S6K signaling to promote HIF-1 alpha translation. In addition, we found that the activation of Akt by Celastrol was transient. With increased exposure time, inhibition of Hsp90 chaperone function by Celastrol led to the subsequent depletion of the Akt protein and thus to the suppression of Akt activity. Moreover, in HepG2 cells, the accumulation of HIF-1 alpha increased the expression of BNIP3, which induced autophagy. However, HIF-1 alpha and BNIP3 did not influence the cytotoxicity of Celastrol because the main mechanism by which Celastrol kills cancer cells is through stimulating ROS-mediated JNK activation and inducing apoptosis. Furthermore, our data showed that the dose required for Celastrol to induce HIF-1 alpha protein accumulation and enhance HIF-1 alpha transcriptional activation was below its cytotoxic threshold. A cytotoxic dose of Celastrol for cancer cells did not display cytotoxicity in LO2 normal human liver cells, which indicated that the novel functions of Celastrol in regulating HIF-1 signaling and inducing autophagy might be used in new applications, such as in anti-inflammation and protection of cells against human neurodegenerative diseases. Future studies regarding these applications are required.	[Han, Xiaoxi; Guan, Yifu] China Med Univ, Dept Biochem & Mol Biol, Shenyang, Peoples R China; [Sun, Shengkun] Gen Hosp PLA, Dept Urol, Beijing, Peoples R China; [Zhao, Ming; Cheng, Xiang; Chen, Guozhu; Lin, Song; Yu, Xiaodan] Cognit & Mental Hlth Res Ctr, Inst Basic Med Sci, Dept Cognit Sci, Beijing, Peoples R China	China Medical University; Chinese People's Liberation Army General Hospital	Guan, YF (corresponding author), China Med Univ, Dept Biochem & Mol Biol, Shenyang, Peoples R China.	yfguan@mail.cmu.edu.cn; yuxd@bmi.ac.cn			"973'' Program of the Ministry of Science and Technology of China [2012CB518200]; National Natural Science Foundation of China [31371434]	"973'' Program of the Ministry of Science and Technology of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by Grant 2012CB518200 from the "973'' Program of the Ministry of Science and Technology of China (to X. Yu) and by Grants 31371434 (to X. Yu) from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agani F, 2013, CURR CANCER DRUG TAR, V13, P245, DOI 10.2174/1568009611313030003; Band M, 2009, FASEB J, V23, P2327, DOI 10.1096/fj.08-122978; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Bernhardt WM, 2006, J AM SOC NEPHROL, V17, P1970, DOI 10.1681/ASN.2005121302; Calixto Joao B., 2004, Planta Medica, V70, P93, DOI 10.1055/s-2004-815483; Chadli A, 2010, J BIOL CHEM, V285, P4224, DOI 10.1074/jbc.M109.081018; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chen GZ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-170; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; Dai Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014153; Dai Y, 2009, INT J RADIAT ONCOL, V74, P1217, DOI 10.1016/j.ijrobp.2009.03.057; Deng YN, 2013, NEUROCHEM INT, V63, P1, DOI 10.1016/j.neuint.2013.04.005; Faust K, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-109; Gao N, 2002, J BIOL CHEM, V277, P31963, DOI 10.1074/jbc.M200082200; Ge PF, 2010, NEUROL RES, V32, P94, DOI 10.1179/016164109X12518779082273; Guo LL, 2012, BBA-MOL BASIS DIS, V1822, P852, DOI 10.1016/j.bbadis.2012.02.004; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Hamacher-Brady A, 2006, AUTOPHAGY, V2, P307, DOI 10.4161/auto.2947; Harada H, 2007, ONCOGENE, V26, P7508, DOI 10.1038/sj.onc.1210556; Harada H, 2009, J BIOL CHEM, V284, P5332, DOI 10.1074/jbc.M806653200; Huang LL, 2011, INT J MOL MED, V27, P407, DOI 10.3892/ijmm.2011.600; Jo H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010318; Kaluzova M, 2004, MOL CELL BIOL, V24, P5757, DOI 10.1128/MCB.24.13.5757-5766.2004; Kannaiyan R, 2011, APOPTOSIS, V16, P1028, DOI 10.1007/s10495-011-0629-6; Kim Y, 2011, CELL PHYSIOL BIOCHEM, V28, P175, DOI 10.1159/000331729; Koshikawa N, 2009, J BIOL CHEM, V284, P33185, DOI 10.1074/jbc.M109.054221; Kurokawa T, 2003, BRIT J CANCER, V89, P1042, DOI 10.1038/sj.bjc.6601186; Lee HW, 2014, BMB REP; Lerman OZ, 2010, BLOOD, V116, P3669, DOI 10.1182/blood-2009-03-213629; Lin MT, 2008, J BIOL CHEM, V283, P15807, DOI 10.1074/jbc.M708933200; Liu XH, 1999, CLIN EXP METASTAS, V17, P687, DOI 10.1023/A:1006728119549; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Mazure NM, 2009, AUTOPHAGY, V5, P868, DOI 10.4161/auto.9042; Minet E, 1999, FEBS LETT, V460, P251, DOI 10.1016/S0014-5793(99)01359-9; Mou HB, 2011, TOXICOL IN VITRO, V25, P1027, DOI 10.1016/j.tiv.2011.03.023; O'Rourke JF, 1997, ONCOL RES, V9, P327; Obacz J, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-93; Pang XF, 2010, CANCER RES, V70, P1951, DOI 10.1158/0008-5472.CAN-09-3201; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philipp S, 2006, EUR J HEART FAIL, V8, P347, DOI 10.1016/j.ejheart.2005.10.009; Pore N, 2006, MOL CANCER RES, V4, P471, DOI 10.1158/1541-7786.MCR-05-0234; Schnitzer SE, 2005, FEBS LETT, V579, P529, DOI 10.1016/j.febslet.2004.12.023; Sen Banerjee S, 2012, TOXICOL MECH METHOD, V22, P347, DOI 10.3109/15376516.2012.673088; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Sha Min, 2013, Cancer Cell Int, V13, P50, DOI 10.1186/1475-2867-13-50; Tracy K, 2007, AUTOPHAGY, V3, P616, DOI 10.4161/auto.4892; Venkatesha SH, 2011, J BIOL CHEM, V286, P15138, DOI 10.1074/jbc.M111.226365; Walcott SE, 2010, COMP BIOCHEM PHYS A, V156, P285, DOI 10.1016/j.cbpa.2010.02.015; Wei W, 2007, CANCER LETT, V257, P145, DOI 10.1016/j.canlet.2007.08.009; Whitney LK, 2004, BRIT J CANCER, V91, pS50; Xie SR, 2012, PHYTOTHER RES, V26, P1133, DOI 10.1002/ptr.3696; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang T, 2009, J BIOL CHEM, V284, P35381, DOI 10.1074/jbc.M109.051532; Zhou YX, 2009, CHINESE MED J-PEKING, V122, P1666, DOI 10.3760/cma.j.issn.0366-6999.2009.14.012; Zhu H, 2010, J PHARMACOL EXP THER, V334, P489, DOI 10.1124/jpet.110.165654; Zhu H, 2010, CANCER INVEST, V28, P23, DOI 10.3109/07357900903095664	58	6	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112470	10.1371/journal.pone.0112470	http://dx.doi.org/10.1371/journal.pone.0112470			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383959	Green Published, Green Submitted, gold			2022-12-27	WOS:000344816700066
J	Kummer, S; Stahl-Pehe, A; Castillo, K; Bachle, C; Graf, C; Strassburger, K; Salgin, B; Mayatepek, E; Giani, G; Holl, RW; Meissner, T; Rosenbauer, J				Kummer, Sebastian; Stahl-Pehe, Anna; Castillo, Katty; Baechle, Christina; Graf, Christine; Strassburger, Klaus; Salgin, Burak; Mayatepek, Ertan; Giani, Guido; Holl, Reinhard W.; Meissner, Thomas; Rosenbauer, Joachim			Health Behaviour in Children and Adolescents with Type 1 Diabetes Compared to a Representative Reference Population	PLOS ONE			English	Article							QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; GLYCEMIC CONTROL; CARDIOVASCULAR-DISEASE; SEDENTARY BEHAVIOR; CIGARETTE-SMOKING; GERMAN HEALTH; RISK-FACTORS; MEDIA USE; KIGGS	Objective: We provide a population-based overview of health behaviours of children and adolescents with type 1 diabetes in comparison to the general population, and analyse their relevance for glycaemic control and self-rated health status. Methods: Data from questionnaires of 11- to 17-year-old children and adolescents with diabetes (n = 629) were compared to a representative sample (n = 6,813). Results: Children and adolescents with type 1 diabetes had a significantly increased odds of infrequent physical activity (adjusted OR 1.56), short overall duration of physical activity per week (OR 1.55, difference -1.3 hours/week), and high daily computer use (OR 2.51). They had a lower odds of active and passive smoking (OR 0.31 and OR 0.29), and high daily television time (OR 0.68). The odds of an at least good and excellent self-rated health status was increased with intense physical activity, and decreased with active smoking and prolonged daily use of computer and television. Active smoking and prolonged daily use of computer were associated with higher HbA1c. Conclusions: Children and adolescents with type 1 diabetes showed a different profile of health behaviour. Their overall health may improve if their education stresses specifically frequent physical activity with longer overall duration and less frequent television or computer use.	[Kummer, Sebastian; Mayatepek, Ertan; Meissner, Thomas] Univ Childrens Hosp, Dept Gen Pediat Neonatol & Pediat Cardiol, Dusseldorf, Germany; [Stahl-Pehe, Anna; Castillo, Katty; Baechle, Christina; Strassburger, Klaus; Giani, Guido; Rosenbauer, Joachim] Univ Dusseldorf, Inst Biometr & Epidemiol, German Diabet Ctr DDZ, Leibniz Inst Diabet Res, Dusseldorf, Germany; [Graf, Christine] German Sport Univ Cologne, Inst Movement & Neurosci, Cologne, Germany; [Salgin, Burak] Univ Cambridge, Addenbrookes Hosp, Dept Paediat, Cambridge CB2 2QQ, England; [Holl, Reinhard W.] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; German Sport University Cologne; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Ulm University	Kummer, S (corresponding author), Univ Childrens Hosp, Dept Gen Pediat Neonatol & Pediat Cardiol, Dusseldorf, Germany.	Sebastian.kummer@med.uni-duesseldorf.de		Stahl-Pehe, Anna/0000-0002-5281-6023; Holl, Reinhard/0000-0003-1395-4842	Competence Network for Diabetes Mellitus - Federal Ministry of Education and Research [01GI0802, 01GI1109A, 01GI1106]; German Ministry of Health; Ministry of Innovation, Sciences and Research of the Federal State of North Rhine-Westphalia	Competence Network for Diabetes Mellitus - Federal Ministry of Education and Research; German Ministry of Health; Ministry of Innovation, Sciences and Research of the Federal State of North Rhine-Westphalia	The study was supported by the Competence Network for Diabetes Mellitus funded by the Federal Ministry of Education and Research (support code 01GI0802, 01GI1109A, 01GI1106). The German Diabetes Center is institutionally funded by the German Ministry of Health and the Ministry of Innovation, Sciences and Research of the Federal State of North Rhine-Westphalia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnio M, 2002, BRIT J SPORT MED, V36, P360, DOI 10.1136/bjsm.36.5.360; Agresti A., 2010, ANALYSIS OF ORDINAL; Aman J, 2009, PEDIATR DIABETES, V10, P234, DOI 10.1111/j.1399-5448.2008.00495.x; Berman LJ, 2012, DIABETES-METAB RES, V28, P395, DOI 10.1002/dmrr.2292; Brazeau AS, 2008, DIABETES CARE, V31, P2108, DOI 10.2337/dc08-0720; Britto MT, 1998, PEDIATRICS, V101, P250, DOI 10.1542/peds.101.2.250; Clarke W, 2009, PEDIATR DIABETES, V10, P134, DOI 10.1111/j.1399-5448.2009.00583.x; Daneman D, 2005, HORM RES, V63, P75, DOI 10.1159/000083692; Daniels SR, 2011, CIRCULATION, V124, P1673, DOI 10.1161/CIRCULATIONAHA.110.016170; DCCT Res Grp, 1994, J PEDIATR-US, V125, P177, DOI 10.1016/S0022-3476(94)70190-3; Fulton JE, 2009, J PHYS ACT HEALTH, V6, pS28, DOI 10.1123/jpah.6.s1.s28; Galler A, 2011, DIABETES CARE, V34, P2356, DOI 10.2337/dc11-0838; Herbst A, 2007, DIABETES CARE, V30, P2098, DOI 10.2337/dc06-2636; Herbst A, 2006, ARCH PEDIAT ADOL MED, V160, P573, DOI 10.1001/archpedi.160.6.573; Heyman E, 2012, DIABETES METAB, V38, P337, DOI 10.1016/j.diabet.2012.03.001; Hofer SE, 2009, J PEDIATR-US, V154, P20, DOI 10.1016/j.jpeds.2008.07.052; Kamtsiuris P, 2007, BUNDESGESUNDHEITSBLA, V50, P547, DOI 10.1007/s00103-007-0215-9; Kriska A, 2013, PEDIATRICS, V131, pE850, DOI 10.1542/peds.2012-0620; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Kurth BM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-196; Lampert T, 2014, BUNDESGESUNDHEITSBLA, V57, P830, DOI 10.1007/s00103-014-1982-8; Lampert T, 2007, DTSCH ARZTEBLATT, V104, P2944; Lange M, 2007, BUNDESGESUNDHEITSBLA, V50, P578, DOI 10.1007/s00103-007-0219-5; Li CL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-277; Lindholm E, 2003, QUAL LIFE RES, V12, P575, DOI 10.1023/A:1025034919526; Margeirsdottir HD, 2007, DIABETES CARE, V30, P1567, DOI 10.2337/dc06-2112; Marshall SJ, 2006, J ADOLESCENCE, V29, P333, DOI 10.1016/j.adolescence.2005.08.016; Marshall SJ, 2004, INT J OBESITY, V28, P1238, DOI 10.1038/sj.ijo.0802706; Mays D, 2012, J DIABETES COMPLICAT, V26, P148, DOI 10.1016/j.jdiacomp.2012.03.005; MOY CS, 1990, CIRCULATION, V82, P37, DOI 10.1161/01.CIR.82.1.37; Palladino DK, 2013, J PEDIATR PSYCHOL, V38, P506, DOI 10.1093/jpepsy/jst002; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; PETERSON B, 1990, J R STAT SOC C-APPL, V39, P205; Rewers M, 2009, PEDIATR DIABETES, V10, P71, DOI 10.1111/j.1399-5448.2009.00582.x; Salardi S, 2012, DIABETES CARE, V35, P829, DOI 10.2337/dc11-1489; Shah AS, 2014, J PEDIATR-US, V165, P110, DOI 10.1016/j.jpeds.2014.02.024; Stahl A, 2012, DIABETES CARE, V35, P1736, DOI 10.2337/dc11-2438; Stehno-Bittel L., 2012, ISRN ENDOCRINOL, V2012, P318194, DOI [10.5402/2012/318194, DOI 10.5402/2012/318194]; Strasburger VC, 2013, PEDIATRICS, V132, P958, DOI 10.1542/peds.2013-2656; Strasburger VC, 2010, PEDIATRICS, V125, P756, DOI 10.1542/peds.2009-2563; Swift PGF, 2009, PEDIATR DIABETES, V10, P51, DOI 10.1111/j.1399-5448.2009.00570.x; World Health Organization, 2010, GLOBAL RECOMMENDATIO	42	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112083	10.1371/journal.pone.0112083	http://dx.doi.org/10.1371/journal.pone.0112083			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT3DP	25384048	Green Submitted, gold, Green Published			2022-12-27	WOS:000344816700030
J	Ma, ZY; LeBard, DN; Loverde, SM; Sharp, KA; Klein, ML; Discher, DE; Finkel, TH				Ma, Zhengyu; LeBard, David N.; Loverde, Sharon M.; Sharp, Kim A.; Klein, Michael L.; Discher, Dennis E.; Finkel, Terri H.			TCR Triggering by pMHC Ligands Tethered on Surfaces via Poly(Ethylene Glycol) Depends on Polymer Length	PLOS ONE			English	Article							T-CELL-ACTIVATION; STEERED MOLECULAR-DYNAMICS; GRAPHICS PROCESSING UNITS; KINETICS; MODEL; SURFACTANTS; RECEPTORS; PROTEINS; COMPLEX; BINDING	Antigen recognition by T cells relies on the interaction between T cell receptor (TCR) and peptide-major histocompatibility complex (pMHC) at the interface between the T cell and the antigen presenting cell (APC). The pMHC-TCR interaction is two-dimensional (2D), in that both the ligand and receptor are membrane-anchored and their movement is limited to 2D diffusion. The 2D nature of the interaction is critical for the ability of pMHC ligands to trigger TCR. The exact properties of the 2D pMHC-TCR interaction that enable TCR triggering, however, are not fully understood. Here, we altered the 2D pMHC-TCR interaction by tethering pMHC ligands to a rigid plastic surface with flexible poly(ethylene glycol) (PEG) polymers of different lengths, thereby gradually increasing the ligands' range of motion in the third dimension. We found that pMHC ligands tethered by PEG linkers with long contour length were capable of activating T cells. Shorter PEG linkers, however, triggered TCR more efficiently. Molecular dynamics simulation suggested that shorter PEGs exhibit faster TCR binding on-rates and off-rates. Our findings indicate that TCR signaling can be triggered by surface-tethered pMHC ligands within a defined 3D range of motion, and that fast binding rates lead to higher TCR triggering efficiency. These observations are consistent with a model of TCR triggering that incorporates the dynamic interaction between T cell and antigen-presenting cell.	[Ma, Zhengyu] Nemours AI duPont Hosp Children, Dept Biomed Res, Wilmington, DE 19803 USA; [LeBard, David N.] Yeshiva Univ, Dept Chem, New York, NY 10033 USA; [Loverde, Sharon M.] CUNY Coll Staten Isl, Dept Chem, Staten Isl, NY 10301 USA; [Sharp, Kim A.] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Klein, Michael L.] Temple Univ, Inst Computat Mol Sci, Philadelphia, PA 19122 USA; [Klein, Michael L.] Temple Univ, Dept Chem, Philadelphia, PA 19122 USA; [Discher, Dennis E.] Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA; [Finkel, Terri H.] Nemours Childrens Hosp, Dept Pediat, Orlando, FL USA; [Finkel, Terri H.] Univ Cent Florida, Coll Med, Dept Biomed Sci, Orlando, FL 32816 USA	Nemours Alfred I. duPont Hospital for Children; Yeshiva University; City University of New York (CUNY) System; College of Staten Island (CUNY); University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; State University System of Florida; University of Central Florida	Ma, ZY (corresponding author), Nemours AI duPont Hosp Children, Dept Biomed Res, Wilmington, DE 19803 USA.	zma@nemours.org		discher, dennis/0000-0001-6163-2229	NIH [1R21 AI087516, 1R21 AI078387, P20GM103464]; University of Pennsylvania Center for AIDS Research pilot grant [2-P30-AI-045008-11]; Children's Hospital of Philadelphia (CHOP); CHOP Research Institute; Nemours Foundation; Nemours Children's Hospital; NATIONAL CANCER INSTITUTE [F32CA134157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008, R21AI078387, R21AI087516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103464] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Center for AIDS Research pilot grant; Children's Hospital of Philadelphia (CHOP); CHOP Research Institute; Nemours Foundation; Nemours Children's Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH 1R21 AI087516, NIH 1R21 AI078387, NIH P20GM103464, the University of Pennsylvania Center for AIDS Research pilot grant (2-P30-AI-045008-11), the Children's Hospital of Philadelphia (CHOP) and the CHOP Research Institute, and the Nemours Foundation and Nemours Children's Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALON R, 1990, BIOCHEM BIOPH RES CO, V170, P1236, DOI 10.1016/0006-291X(90)90526-S; Anderson JA, 2008, J COMPUT PHYS, V227, P5342, DOI 10.1016/j.jcp.2008.01.047; Choudhuri K, 2007, SEMIN IMMUNOL, V19, P255, DOI 10.1016/j.smim.2007.04.005; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Cuendet MA, 2008, BIOPHYS J, V95, P3575, DOI 10.1529/biophysj.108.131383; Cuendet MA, 2011, PROTEINS, V79, P3007, DOI 10.1002/prot.23104; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Dustin ML, 2001, ANNU REV CELL DEV BI, V17, P133, DOI 10.1146/annurev.cellbio.17.1.133; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Knapp B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011653; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; LeBard DN, 2012, SOFT MATTER, V8, P2385, DOI 10.1039/c1sm06787g; Levine BG, 2011, J CHEM THEORY COMPUT, V7, P4135, DOI 10.1021/ct2005193; Li YC, 2010, J IMMUNOL, V184, P5959, DOI 10.4049/jimmunol.0900775; London CA, 2000, J IMMUNOL, V164, P265, DOI 10.4049/jimmunol.164.1.265; Ma ZY, 2008, PLOS BIOL, V6, P328, DOI 10.1371/journal.pbio.0060043; Ma ZY, 2008, FASEB J, V22, P1002, DOI 10.1096/fj.07-9331hyp; Ma ZY, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00217; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Oesterhelt F, 1999, NEW J PHYS, V1, DOI 10.1088/1367-2630/1/1/006; Pardigon N, 1998, INT IMMUNOL, V10, P619, DOI 10.1093/intimm/10.5.619; Robert P, 2012, BIOPHYS J, V102, P248, DOI 10.1016/j.bpj.2011.11.4018; Rubenstein MC, 2003, POLYM PHYS; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; Shinoda W, 2007, MOL SIMULAT, V33, P27, DOI 10.1080/08927020601054050; Shinoda W, 2010, J PHYS CHEM B, V114, P6836, DOI 10.1021/jp9107206; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; van der Merwe PA, 2001, IMMUNITY, V14, P665, DOI 10.1016/S1074-7613(01)00155-8	32	18	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112292	10.1371/journal.pone.0112292	http://dx.doi.org/10.1371/journal.pone.0112292			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383949	Green Published, gold			2022-12-27	WOS:000344816700047
J	Mansoori, N; Timmers, J; Desprez, T; Kamei, CLA; Dees, DCT; Vincken, JP; Visser, RGF; Hofte, H; Vernhettes, S; Trindade, LM				Mansoori, Nasim; Timmers, Jaap; Desprez, Thierry; Kamei, Claire L. A.; Dees, Dianka C. T.; Vincken, Jean-Paul; Visser, Richard G. F.; Hoefte, Herman; Vernhettes, Samantha; Trindade, Luisa M.			KORRIGAN1 Interacts Specifically with Integral Components of the Cellulose Synthase Machinery	PLOS ONE			English	Article							SECONDARY CELL-WALL; ARABIDOPSIS-THALIANA; ENDO-1,4-BETA-GLUCANASE; EXPRESSION; MEMBRANES; PROTEIN; SYSTEM; PLANTS; GENE; ENDO-1,4-BETA-D-GLUCANASE	Cellulose is synthesized by the so called rosette protein complex and the catalytic subunits of this complex are the cellulose synthases (CESAs). It is thought that the rosette complexes in the primary and secondary cell walls each contains at least three different non-redundant cellulose synthases. In addition to the CESA proteins, cellulose biosynthesis almost certainly requires the action of other proteins, although few have been identified and little is known about the biochemical role of those that have been identified. One of these proteins is KORRIGAN (KOR1). Mutant analysis of this protein in Arabidopsis thaliana showed altered cellulose content in both the primary and secondary cell wall. KOR1 is thought to be required for cellulose synthesis acting as a cellulase at the plasma membrane-cell wall interface. KOR1 has recently been shown to interact with the primary cellulose synthase rosette complex however direct interaction with that of the secondary cell wall has never been demonstrated. Using various methods, both in vitro and in planta, it was shown that KOR1 interacts specifically with only two of the secondary CESA proteins. The KOR1 protein domain(s) involved in the interaction with the CESA proteins were also identified by analyzing the interaction of truncated forms of KOR1 with CESA proteins. The KOR1 transmembrane domain has shown to be required for the interaction between KOR1 and the different CESAs, as well as for higher oligomer formation of KOR1.	[Mansoori, Nasim; Timmers, Jaap; Kamei, Claire L. A.; Dees, Dianka C. T.; Vincken, Jean-Paul; Visser, Richard G. F.; Trindade, Luisa M.] Univ Wageningen & Res Ctr, Wageningen, Netherlands; [Mansoori, Nasim; Timmers, Jaap] Wageningen Univ, Grad Sch Expt Plant Sci, NL-6700 AP Wageningen, Netherlands; [Timmers, Jaap] Univ Wageningen & Res Ctr, Carbohydrate Res Ctr, Wageningen, Netherlands; [Desprez, Thierry; Hoefte, Herman; Vernhettes, Samantha] INRA, Inst Jean Pierre Bourgin, Biol Cellulaire Lab, Versailles, France	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Trindade, LM (corresponding author), Univ Wageningen & Res Ctr, Wageningen, Netherlands.	luisa.trindade@wur.nl	Trindade, Luisa M/F-8824-2010; Visser, Richard GF/B-3423-2012	Visser, Richard GF/0000-0002-0213-4016; Vincken, Jean-Paul/0000-0001-8540-4327				Bhandari S, 2006, PLANTA, V224, P828, DOI 10.1007/s00425-006-0269-1; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; BREEDEN L, 1985, COLD SPRING HARB SYM, V50, P643, DOI 10.1101/SQB.1985.050.01.078; Brummell DA, 1997, P NATL ACAD SCI USA, V94, P4794, DOI 10.1073/pnas.94.9.4794; Carroll A, 2011, FRONTIERS PLANT GENE, V2, P1; Delmer DP, 1999, ANNU REV PLANT PHYS, V50, P245, DOI 10.1146/annurev.arplant.50.1.245; Desprez T, 2007, P NATL ACAD SCI USA, V104, P15572, DOI 10.1073/pnas.0706569104; Fetchko M, 2004, METHODS, V32, P349, DOI 10.1016/j.ymeth.2003.10.010; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; JOHNSSON N, 1994, EMBO J, V13, P2686, DOI 10.1002/j.1460-2075.1994.tb06559.x; Lane DR, 2001, PLANT PHYSIOL, V126, P278, DOI 10.1104/pp.126.1.278; Maloney VJ, 2010, PLANT BIOTECHNOL J, V8, P294, DOI 10.1111/j.1467-7652.2009.00483.x; Master ER, 2004, BIOCHEMISTRY-US, V43, P10080, DOI 10.1021/bi049453x; MATTHYSSE AG, 1995, J BACTERIOL, V177, P1069, DOI 10.1128/jb.177.4.1069-1075.1995; Molhoj M, 2002, PLANT CELL PHYSIOL, V43, P1399, DOI 10.1093/pcp/pcf163; Molhoj M, 2001, PLANT PHYSIOL, V127, P674, DOI 10.1104/pp.010269; Morel J, 2006, MOL CELL PROTEOMICS, V5, P1396, DOI 10.1074/mcp.M600044-MCP200; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nicol F, 1998, EMBO J, V17, P5563, DOI 10.1093/emboj/17.19.5563; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Peng LC, 2000, PLANTA, V211, P406, DOI 10.1007/s004250000301; Peng LC, 2002, SCIENCE, V295, P147, DOI 10.1126/science.1064281; Reinders A, 2002, STRUCTURE, V10, P763, DOI 10.1016/S0969-2126(02)00773-6; Robert S, 2005, PLANT CELL, V17, P3378, DOI 10.1105/tpc.105.036228; Sato S, 2001, PLANT CELL PHYSIOL, V42, P251, DOI 10.1093/pcp/pce045; Seki M, 1998, PLANT J, V15, P707, DOI 10.1046/j.1365-313x.1998.00237.x; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; STANDAL R, 1994, J BACTERIOL, V176, P665, DOI 10.1128/jb.176.3.665-672.1994; Szyjanowicz PMJ, 2004, PLANT J, V37, P730, DOI 10.1111/j.1365-313X.2003.02000.x; Timmers J, 2009, FEBS LETT, V583, P978, DOI 10.1016/j.febslet.2009.02.035; Vain T, 2014, PLANT PHYSL IN PRESS; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Yu L, 2014, TREE PHYSIOL, V00, P1; Zuo JR, 2000, PLANT CELL, V12, P1137, DOI 10.1105/tpc.12.7.1137	34	38	39	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112387	10.1371/journal.pone.0112387	http://dx.doi.org/10.1371/journal.pone.0112387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383767	gold, Green Published, Green Submitted			2022-12-27	WOS:000344816700054
J	Nagumo, Y; Iguchi-Manaka, A; Yamashita-Kanemaru, Y; Abe, F; Bernhardt, G; Shibuya, A; Shibuya, K				Nagumo, Yoko; Iguchi-Manaka, Akiko; Yamashita-Kanemaru, Yumi; Abe, Fumie; Bernhardt, Guenter; Shibuya, Akira; Shibuya, Kazuko			Increased CD112 Expression in Methylcholanthrene-Induced Tumors in CD155-Deficient Mice	PLOS ONE			English	Article							POLIOVIRUS RECEPTOR CD155; DNAM-1 CD226; ADHESION MOLECULE; TRANSCRIPTION FACTORS; FAMILY LIGANDS; NECTIN-2 CD112; CELL-ADHESION; PVR CD155; CANCER; IDENTIFICATION	Tumor recognition by immune effector cells is mediated by antigen receptors and a variety of adhesion and costimulatory molecules. The evidence accumulated since the identification of CD155 and CD112 as ligands for DNAM-1 in humans and mice has suggested that the interactions between DNAM-1 and its ligands play an important role in T cell- and natural killer (NK) cell-mediated recognition and lysis of tumor cells. We have previously demonstrated that methylcholanthrane (MCA) accelerates tumor development in DNAM-1-deficient mice, and the Cd155 level on MCA-induced tumors is significantly higher in DNAM-1-deficient mice than in wild-type (WT) mice. By contrast, Cd112 expression on the tumors is similar in WT and DNAM-1-deficient mice, suggesting that CD155 plays a major role as a DNAM-1 ligand in activation of T cells and NK cells for tumor immune surveillance. To address this hypothesis, we examined MCA-induced tumor development in CD155-deficient mice. Unexpectedly, we observed no significant difference in tumor development between WT and CD155-deficient mice. Instead, we found that Cd112 expression was significantly higher in the MCA-induced tumors of CD155-deficient mice than in those of WT mice. We also observed higher expression of DNAM-1 and lower expression of an inhibitory receptor, TIGIT, on CD8(+) T cells in CD155-deficient mice. These results suggest that modulation of the expression of receptors and CD112 compensates for CD155 deficiency in immune surveillance against MCA-induced tumors.	[Nagumo, Yoko] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Nagumo, Yoko; Iguchi-Manaka, Akiko; Yamashita-Kanemaru, Yumi; Abe, Fumie; Shibuya, Akira; Shibuya, Kazuko] Univ Tsukuba, Fac Med, Dept Immunol, Tsukuba, Ibaraki, Japan; [Iguchi-Manaka, Akiko] Univ Tsukuba, Fac Med, Dept Breast & Endocrine Surg, Tsukuba, Ibaraki, Japan; [Yamashita-Kanemaru, Yumi; Abe, Fumie; Shibuya, Akira] Univ Tsukuba, Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tsukuba, Ibaraki, Japan; [Shibuya, Akira] Univ Tsukuba, Life Sci Ctr, Tsukuba Adv Res Alliance, Tsukuba, Ibaraki, Japan; [Bernhardt, Guenter] Hannover Med Sch, Inst Immunol, Hannover, Germany	University of Tsukuba; University of Tsukuba; University of Tsukuba; Japan Science & Technology Agency (JST); University of Tsukuba; University of Tsukuba; Hannover Medical School	Shibuya, A (corresponding author), Univ Tsukuba, Fac Med, Dept Immunol, Tsukuba, Ibaraki, Japan.	ashibuya@md.tsukuba.ac.jp; kazukos@md.tsukuba.ac.jp	Bernhardt, Günter/F-6946-2012	Bernhardt, Günter/0000-0002-0510-2853; Iguchi, Akiko/0000-0002-0338-130X	Ministry of Education, Culture, Sports, Science and Technology of Japan [24249021, 25114701]; Grants-in-Aid for Scientific Research [25293091] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant Number 24249021 and 25114701 to AS and KS, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Carlsten M, 2007, CANCER RES, V67, P1317, DOI 10.1158/0008-5472.CAN-06-2264; Castriconi R, 2004, CANCER RES, V64, P9180, DOI 10.1158/0008-5472.CAN-04-2682; Chan CJ, 2014, NAT IMMUNOL, V15, P431, DOI 10.1038/ni.2850; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; El-Sherbiny YM, 2007, CANCER RES, V67, P8444, DOI 10.1158/0008-5472.CAN-06-4230; Fuchs A, 2004, J IMMUNOL, V172, P3994, DOI 10.4049/jimmunol.172.7.3994; Iguchi-Manaka A, 2008, J EXP MED, V205, P2959, DOI 10.1084/jem.20081611; Iwasaki A, 2002, J INFECT DIS, V186, P585, DOI 10.1086/342682; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Liu J, 2012, J IMMUNOL, V188, P5511, DOI 10.4049/jimmunol.1200324; Lopez M, 1998, BLOOD, V92, P4602, DOI 10.1182/blood.V92.12.4602.424k21_4602_4611; Lui WY, 2006, J CELL PHYSIOL, V207, P144, DOI 10.1002/jcp.20545; Maier MK, 2007, EUR J IMMUNOL, V37, P2214, DOI 10.1002/eji.200737072; Masson D, 2001, GUT, V49, P236, DOI 10.1136/gut.49.2.236; Nabekura T, 2011, P NATL ACAD SCI USA, V108, pE34, DOI 10.1073/pnas.1018806108; Nabekura T, 2010, P NATL ACAD SCI USA, V107, P18593, DOI 10.1073/pnas.1005582107; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Pende D, 2005, BLOOD, V105, P2066, DOI 10.1182/blood-2004-09-3548; Sakamoto KM, 2009, CLIN CANCER RES, V15, P2583, DOI 10.1158/1078-0432.CCR-08-1137; Seth S, 2011, J BIOL CHEM, V286, P39153, DOI 10.1074/jbc.M111.264697; Seth S, 2011, P NATL ACAD SCI USA, V108, pE32, DOI 10.1073/pnas.1017969108; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Stanietsky N, 2009, P NATL ACAD SCI USA, V106, P17858, DOI 10.1073/pnas.0903474106; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Tahara-Hanaoka S, 2006, BLOOD, V107, P1491, DOI 10.1182/blood-2005-04-1684; Tahara-Hanaoka S, 2005, BIOCHEM BIOPH RES CO, V329, P996, DOI 10.1016/j.bbrc.2005.02.067; Tahara-Hanaoka S, 2004, INT IMMUNOL, V16, P533, DOI 10.1093/intimm/dxh059; WANG PL, 1992, J IMMUNOL, V148, P2600; Yu X, 2009, NAT IMMUNOL, V10, P48, DOI 10.1038/ni.1674	33	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112415	10.1371/journal.pone.0112415	http://dx.doi.org/10.1371/journal.pone.0112415			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384044	Green Published, gold, Green Submitted			2022-12-27	WOS:000344816700059
J	Eng, KH; Tsuji, T				Eng, Kevin H.; Tsuji, Takemasa			Differential Antigen Expression Profile Predicts Immunoreactive Subset of Advanced Ovarian Cancers	PLOS ONE			English	Article							T-CELLS; INFILTRATION; SIGNATURES; PROGNOSIS	The presence and composition of lymphocytes characterizing an immune response has been connected to prognosis in advanced ovarian cancer. Our aim is to establish novel associations between prognosis and the expression of immune-related genes through a focused screen utilizing publicly available high-throughput assays. We consider transcriptome profiles from n=1137 advanced ovarian cancer patients observed in four separate studies divided into discovery/validation sets (n=503/n=634). We focus on a subset of lymphocyte markers, antigen presentation and processing genes, T cell receptor associated co-stimulatory/repressor genes and cancer testis (CT) antigens. We modeled differential expression and co-expression using these subsets and tested for association with overall survival. Fifteen of 64 immune-related genes are associated with survival of which 5 are reproduced in the validation set. The expression of these genes defines an immunoreactive (IR) subgroup of patients with a favorable prognosis. Phenotypic characterization of the immune compartment signal includes upregulation of markers of CD8(+) T-cell activation in these patients. Using multivariate model building, we find that the expression of 6 CT antigens can predict IR status in the discovery and validation sets. These analyses confirm that a genomic approach can reproducibly detect lymphocyte signals in tumor tissue suggesting a novel way to study the tumor microenvironment. Our search has identified new candidate prognostic markers associated with immune components and uncovered preliminary evidence of prognostic subgroups associated with different immune mechanisms.	[Eng, Kevin H.] Roswell Pk Canc Inst, Dept Biostat & Bioinformat, Buffalo, NY 14263 USA; [Tsuji, Takemasa] Roswell Pk Canc Inst, Ctr Immunotherapy, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute	Eng, KH (corresponding author), Roswell Pk Canc Inst, Dept Biostat & Bioinformat, Buffalo, NY 14263 USA.	kevin.eng@roswellpark.org		Tsuji, Takemasa/0000-0001-7563-2211; Eng, Kevin/0000-0001-5636-0812	National Cancer Institute core grant [CA016056]; Roswell Park Alliance Foundation award; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	National Cancer Institute core grant; Roswell Park Alliance Foundation award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	CA016056 www.cancer.gov National Cancer Institute core grant to Roswell Park Cancer Institute. Roswell Park Alliance Foundation www.roswellpark.org/giving award to KHE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida LG, 2009, NUCLEIC ACIDS RES, V37, pD816, DOI 10.1093/nar/gkn673; Baggerly KA, 2008, J CLIN ONCOL, V26, P1186, DOI 10.1200/JCO.2007.15.1951; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Callahan MJ, 2008, CLIN CANCER RES, V14, P7667, DOI 10.1158/1078-0432.CCR-08-0479; Carlson M, 2014, HTHGU133A DB AFFYMET; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dressman HK, 2007, J CLIN ONCOL, V25, P517, DOI 10.1200/JCO.2006.06.3743; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Emery P, 1996, NUCLEIC ACIDS RES, V24, P803, DOI 10.1093/nar/24.5.803; Gnjatic S, 2010, P NATL ACAD SCI USA, V107, P5088, DOI 10.1073/pnas.0914213107; Lee JK, 2007, P NATL ACAD SCI USA, V104, P13086, DOI 10.1073/pnas.0610292104; Leffers N, 2010, BRIT J CANCER, V103, P685, DOI 10.1038/sj.bjc.6605820; Matsuzaki J, 2008, CANCER IMMUNOL IMMUN, V57, P1185, DOI 10.1007/s00262-008-0450-4; Matsuzaki J, 2010, P NATL ACAD SCI USA, V107, P7875, DOI 10.1073/pnas.1003345107; Preston CC, 2011, IMMUNOTHERAPY-UK, V3, P539, DOI [10.2217/IMT.11.20, 10.2217/imt.11.20]; Qian Feng, 2004, Cancer Immun, V4, P12; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Verhaak RGW, 2013, J CLIN INVEST, V123, P517, DOI 10.1172/JCI65833; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Yoshihara K, 2012, CLIN CANCER RES, V18, P1374, DOI 10.1158/1078-0432.CCR-11-2725; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	25	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111586	10.1371/journal.pone.0111586	http://dx.doi.org/10.1371/journal.pone.0111586			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380171	Green Submitted, Green Published, gold			2022-12-27	WOS:000344863100034
J	Ranaker, L; Persson, J; Jonsson, M; Nilsson, PA; Bronmark, C				Ranaker, Lynn; Persson, Jens; Jonsson, Mikael; Nilsson, P. Anders; Bronmark, Christer			Piscivore-Prey Fish Interactions: Mechanisms behind Diurnal Patterns in Prey Selectivity in Brown and Clear Water	PLOS ONE			English	Article							PERCH PERCA-FLUVIATILIS; PIKE ESOX-LUCIUS; LIGHT-INTENSITY; VISUAL CONDITIONS; HABITAT CHOICE; TURBIDITY; PIKEPERCH; LUCIOPERCA; EFFICIENCY; PREDATION	Environmental change may affect predator-prey interactions in lakes through deterioration of visual conditions affecting foraging success of visually oriented predators. Environmental change in lakes includes an increase in humic matter causing browner water and reduced visibility, affecting the behavioural performance of both piscivores and prey. We studied diurnal patterns of prey selection in piscivorous pikeperch (Sander lucioperca) in both field and laboratory investigations. In the field we estimated prey selectivity and prey availability during day and night in a clear and a brown water lake. Further, prey selectivity during day and night conditions was studied in the laboratory where we manipulated optical conditions (humic matter content) of the water. Here, we also studied the behaviours of piscivores and prey, focusing on foraging-cycle stages such as number of interests and attacks by the pikeperch as well as the escape distance of the prey fish species. Analyses of gut contents from the field study showed that pikeperch selected perch (Perca fluviatilis) over roach (Rutilus rutilus) prey in both lakes during the day, but changed selectivity towards roach in both lakes at night. These results were corroborated in the selectivity experiments along a brown-water gradient in day and night light conditions. However, a change in selectivity from perch to roach was observed when the optical condition was heavily degraded, from either brown-stained water or light intensity. At longer visual ranges, roach initiated escape at distances greater than pikeperch attack distances, whereas perch stayed inactive making pikeperch approach and attack at the closest range possible. Roach anti-predatory behaviour decreased in deteriorated visual conditions, altering selectivity patterns. Our results highlight the importance of investigating both predator and prey responses to visibility conditions in order to understand the effects of degrading optical conditions on piscivore-prey interaction strength and thereby ecosystem responses to brownification of waters.	[Ranaker, Lynn; Jonsson, Mikael; Nilsson, P. Anders; Bronmark, Christer] Lund Univ, Dept Biol, Lund, Sweden; [Persson, Jens] Swedish Agcy Marin & Water Management, Gothenburg, Sweden; [Nilsson, P. Anders] Karlstad Univ, Dept Environm & Life Sci, Karlstad, Sweden	Lund University; Karlstad University	Ranaker, L (corresponding author), Lund Univ, Dept Biol, Ecol Bldg, Lund, Sweden.	Lynn.Ranaker@biol.lu.se	Jönsson, Mikael/M-7449-2013; Nilsson, Anders/H-6836-2014	Jönsson, Mikael/0000-0002-9799-6435; Nilsson, Anders/0000-0002-3541-9835	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning [223-2005-1393]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas)	This research was funded by a grant from The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (grant #223-2005-1393). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams M, 1997, BEHAV ECOL SOCIOBIOL, V40, P169, DOI 10.1007/s002650050330; Aksnes DL, 1997, SARSIA, V82, P137, DOI 10.1080/00364827.1997.10413647; ALI MA, 1977, J FISH RES BOARD CAN, V34, P1475, DOI 10.1139/f77-212; Appelberg Magnus, 2000, Fiskeriverket Information, V1, P1; Beauchamp DA, 1999, CAN J FISH AQUAT SCI, V56, P128, DOI 10.1139/cjfas-56-S1-128; Bronmark C., 1995, Ecology of Freshwater Fish, V4, P85, DOI 10.1111/j.1600-0633.1995.tb00121.x; BRONMARK C, 1992, SCIENCE, V258, P1348, DOI 10.1126/science.258.5086.1348; CARPENTER SR, 1988, BIOSCIENCE, V38, P764, DOI 10.2307/1310785; CHESSON J, 1978, ECOLOGY, V59, P211, DOI 10.2307/1936364; Davies-Colley R. J, 1993, COLOUR CLARITY NATUR; DAVIESCOLLEY RJ, 1988, LIMNOL OCEANOGR, V33, P616, DOI 10.4319/lo.1988.33.4.0616; De Robertis A, 2003, CAN J FISH AQUAT SCI, V60, P1517, DOI 10.1139/F03-123; DOBLER E, 1977, OECOLOGIA, V27, P93, DOI 10.1007/BF00345687; Einfalt LM, 2012, ECOL FRESHW FISH, V21, P560, DOI 10.1111/j.1600-0633.2012.00576.x; EKLOV P, 1989, OIKOS, V56, P149, DOI 10.2307/3565330; EKLOV P, 1995, BEHAV ECOL SOCIOBIOL, V37, P169, DOI 10.1007/s002650050178; Endler J.A., 1991, P169; Engstrom-Ost J, 2008, MAR ECOL PROG SER, V359, P275, DOI 10.3354/meps07345; Erlandsson M, 2008, GLOBAL CHANGE BIOL, V14, P1191, DOI 10.1111/j.1365-2486.2008.01551.x; Graneli W, 2012, BROWNIFICATION LAKES; Greenberg LA, 1995, OIKOS, V74, P522, DOI 10.2307/3545998; HEMMINGS CC, 1966, J EXP BIOL, V45, P449; Holling C. S., 1965, Mem ent Soc Canada Ottawa, Vno. 45, P1; Horky P, 2008, HYDROBIOLOGIA, V614, P151, DOI 10.1007/s10750-008-9503-0; Ivlev V.S., 1961, EXPT ECOLOGY FEEDING; Janssen J, 1997, J FISH BIOL, V51, P921; Jonsson M, 2011, J FISH BIOL, V79, P290, DOI 10.1111/j.1095-8649.2011.03004.x; Jonsson M, 2013, CAN J FISH AQUAT SCI, V70, P1685, DOI 10.1139/cjfas-2013-0150; Kangur K, 2007, ECOL MODEL, V203, P34, DOI 10.1016/j.ecolmodel.2006.03.039; Karlsson J, 2009, NATURE, V460, P506, DOI 10.1038/nature08179; Keskinen T, 2003, J FISH BIOL, V63, P1274, DOI 10.1046/j.1095-8649.2003.00249.x; LEHTONEN H, 1984, Aqua Fennica, V14, P189; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Ljunggren L, 2007, J FISH BIOL, V70, P1319, DOI 10.1111/j.1095-8649.2007.01412.x; Luchiari AC, 2006, AQUAC RES, V37, P1572, DOI 10.1111/j.1365-2109.2006.01599.x; Mazur MM, 2003, ENVIRON BIOL FISH, V67, P397, DOI 10.1023/A:1025807711512; Meager JJ, 2006, J EXP BIOL, V209, P4174, DOI 10.1242/jeb.02489; Miner JG, 1996, T AM FISH SOC, V125, P97, DOI 10.1577/1548-8659(1996)125<0097:DOPAHC>2.3.CO;2; Miyazaki T, 2000, MAR ECOL PROG SER, V192, P267, DOI 10.3354/meps192267; Monteith DT, 2007, NATURE, V450, P537, DOI 10.1038/nature06316; Nurminen L, 2006, LIMNOL OCEANOGR, V51, P1550, DOI 10.4319/lo.2006.51.3.1550; POPOVA OA, 1977, J FISH RES BOARD CAN, V34, P1559, DOI 10.1139/f77-219; Radke R, 2005, NATURWISSENSCHAFTEN, V92, P91, DOI 10.1007/s00114-004-0596-7; Ranaker L, 2012, PISCIVORE PREY FISH, P100; Ranaker L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038411; Reid SM, 1999, CAN J FISH AQUAT SCI, V56, P1362, DOI 10.1139/cjfas-56-8-1362; Roulet N, 2006, NATURE, V444, P283, DOI 10.1038/444283a; Ryer CH, 1998, MAR ECOL PROG SER, V167, P215, DOI 10.3354/meps167215; Schulze T, 2006, CAN J FISH AQUAT SCI, V63, P2202, DOI 10.1139/F06-099; Shoup DE, 2009, T AM FISH SOC, V138, P1018, DOI 10.1577/T09-015.1; Svanback R, 2011, EVOLUTION, V65, P3515, DOI 10.1111/j.1558-5646.2011.01398.x; SVARDSON G, 1973, Institute of Freshwater Research Drottningholm Report, P112; Turesson H, 2004, J FISH BIOL, V65, P363, DOI 10.1111/j.0022-1112.2004.00455.x; Turesson H, 2003, THESIS LUND U LUND; Turesson H, 2007, OECOLOGIA, V153, P281, DOI 10.1007/s00442-007-0728-9; Utne-Palm AC, 2002, MAR FRESHW BEHAV PHY, V35, P111, DOI 10.1080/10236240290025644; Winfield IJ, 1991, CYPRINID FISHES SYST; Wissel B, 2003, LIMNOL OCEANOGR, V48, P1965, DOI 10.4319/lo.2003.48.5.1965	58	14	15	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e102002	10.1371/journal.pone.0102002	http://dx.doi.org/10.1371/journal.pone.0102002			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379665	Green Published, Green Submitted, gold			2022-12-27	WOS:000344863100001
J	Dheilly, NM; Jouaux, A; Boudry, P; Favrel, P; Lelong, C				Dheilly, Nolwenn M.; Jouaux, Aude; Boudry, Pierre; Favrel, Pascal; Lelong, Christophe			Transcriptomic Profiling of Gametogenesis in Triploid Pacific Oysters Crassostrea gigas: Towards an Understanding of Partial Sterility Associated with Triploidy	PLOS ONE			English	Article							GENE-EXPRESSION; THUNBERG; GROWTH; FISH; SEX; SPERMATOGENESIS; DIFFERENTIATION; IDENTIFICATION; TEMPERATURE; PERFORMANCE	Background: Triploidy can occur in many animal species but is often lethal. Among invertebrates, amphibians and fishes, triploids are viable although often sterile or infertile. Most triploids of the Pacific oyster Crassostrea gigas are almost sterile (named "3n beta'') yet a low but significant proportion show an advanced gametogenesis (named "3n alpha''). These oysters thus constitute an interesting model to study the effect of triploidy on germ cell development. We used microarrays to compare the gonad transcriptomes of diploid 2n and the abovementioned triploid 3n beta and 3n alpha male and female oysters throughout gametogenesis. Results: All triploids displayed an upregulation of genes related to DNA repair and apoptosis and a downregulation of genes associated with cell division. The comparison of 3n alpha and 3n beta transcriptomes with 2n revealed the likely involvement of a cell cycle checkpoint during mitosis in the successful but delayed development of gonads in 3n alpha individuals. In contrast, a disruption of sex differentiation mechanisms may explain the sterility of 3n beta individuals with 3n beta females expressing male-specific genes and 3n beta males expressing female-specific genes. Conclusions: The disruption of sex differentiation and mitosis may be responsible for the impaired gametogenesis of triploid Pacific oysters. The function of the numerous candidate genes identified in our study should now be studied in detail in order to elucidate their role in sex determination, mitosis/meiosis control, pachytene cell cycle checkpoint, and the control of DNA repair/apoptosis.	[Dheilly, Nolwenn M.; Jouaux, Aude; Favrel, Pascal; Lelong, Christophe] UPMC, IRD 207, UMR BOREA Biol ORganismes & Ecosyst Aquat, UNICAEN,MNHN,CNRS 7208, Caen, France; [Dheilly, Nolwenn M.; Boudry, Pierre] IFREMER, UMR LEMAR Lab Sci Environm MARin 6539, UBO CNRS IRD, Plouzane, France	Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite de Caen Normandie; Ifremer; Institut de Recherche pour le Developpement (IRD)	Lelong, C (corresponding author), UPMC, IRD 207, UMR BOREA Biol ORganismes & Ecosyst Aquat, UNICAEN,MNHN,CNRS 7208, Caen, France.	christophe.lelong@unicaen.fr	Boudry, Pierre/M-3213-2019; Dheilly, Nolwenn Marie M/A-7213-2011; Boudry, Pierre/G-2406-2010	Dheilly, Nolwenn Marie M/0000-0002-3675-5013; Boudry, Pierre/0000-0002-5150-2276; Favrel, Pascal/0000-0002-2504-9957	Regional Council of Basse Normandie; National Agency of Research; UNICAEN	Regional Council of Basse Normandie(Region Normandie); National Agency of Research(French National Research Agency (ANR)); UNICAEN	Financial support for this work was provided by the Regional Council of Basse Normandie, National Agency of Research, UNICAEN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN SK, 1986, J EXP MAR BIOL ECOL, V102, P197, DOI 10.1016/0022-0981(86)90176-0; Allen SK, 1990, PERFORMANCE TRIPLOID; Baron D, 2005, REPROD NUTR DEV, V45, P377, DOI 10.1051/rnd:2005028; Bhalla N, 2005, SCIENCE, V310, P1683, DOI 10.1126/science.1117468; BLOOM SE, 1972, CHROMOSOMA, V37, P309, DOI 10.1007/BF00319873; Boudry P, 2008, GENETIC BASIS SUMMER; Cal RM, 2006, AQUACULTURE, V251, P99, DOI 10.1016/j.aquaculture.2005.05.010; DeLuca JG, 2007, CURR BIOL, V17, pR966, DOI 10.1016/j.cub.2007.09.040; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Dheilly NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036353; Dheilly NM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-468; Didier G, 2002, BIOINFORMATICS, V18, P490, DOI 10.1093/bioinformatics/18.3.490; EIBEN B, 1990, AM J HUM GENET, V47, P656; Elvin JA, 2000, MOL CELL ENDOCRINOL, V159, P1, DOI 10.1016/S0303-7207(99)00185-9; Emanuele MJ, 2007, CELL, V130, P893, DOI 10.1016/j.cell.2007.07.023; Ernande B, 2004, J EVOLUTION BIOL, V17, P342, DOI 10.1046/j.1420-9101.2003.00674.x; Fabioux C, 2005, AQUACULTURE, V250, P458, DOI 10.1016/j.aquaculture.2005.02.038; Franco A, 2008, TISSUE CELL, V40, P251, DOI 10.1016/j.tice.2007.12.006; Gong N, 2004, HEREDITY, V93, P408, DOI 10.1038/sj.hdy.6800517; GOOD PJ, 1995, P NATL ACAD SCI USA, V92, P4557, DOI 10.1073/pnas.92.10.4557; Guo XM, 1996, AQUACULTURE, V142, P149, DOI 10.1016/0044-8486(95)01243-5; GUO XM, 1994, BIOL BULL-US, V187, P309, DOI 10.2307/1542288; Guo XM, 1997, GENOME, V40, P397, DOI 10.1139/g97-053; GUO XM, 2012, J SHELLFISH RES, V31, P292; Hayashi Y, 2009, J CELL BIOL, V187, P473, DOI 10.1083/jcb.200904118; Heng YW, 2010, INT J BIOCHEM CELL B, V42, P1622, DOI 10.1016/j.biocel.2010.04.007; Hudson AM, 2002, ANNU REV GENET, V36, P455, DOI 10.1146/annurev.genet.36.052802.114101; Hulata G, 2001, GENETICA, V111, P155, DOI 10.1023/A:1013776931796; Husband BC, 2004, BIOL J LINN SOC, V82, P537, DOI 10.1111/j.1095-8312.2004.00339.x; Janssens S, 2006, CELL DEATH DIFFER, V13, P773, DOI 10.1038/sj.cdd.4401843; Jouaux A, 2010, J EXP MAR BIOL ECOL, V395, P162, DOI 10.1016/j.jembe.2010.08.030; Kim Y, 2012, DEVELOPMENT, V139, P1133, DOI 10.1242/dev.073478; Kocabas AM, 2006, P NATL ACAD SCI USA, V103, P14027, DOI 10.1073/pnas.0603227103; LINCOLN RF, 1983, AQUACULTURE, V30, P375, DOI 10.1016/0044-8486(83)90179-5; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; Maxime V, 2008, FISH FISH, V9, P67, DOI 10.1111/j.1467-2979.2007.00269.x; Naimi A, 2009, COMP BIOCHEM PHYS B, V154, P134, DOI 10.1016/j.cbpb.2009.05.011; Nell JA, 2005, AQUAC RES, V36, P530, DOI 10.1111/j.1365-2109.2005.01229.x; Nell JA, 2002, AQUACULTURE, V210, P69, DOI 10.1016/S0044-8486(01)00861-4; NIEBUHR E, 1974, HUMANGENETIK, V21, P103, DOI 10.1007/BF00281030; Normand J, 2009, AQUAT BIOL, V7, P229, DOI 10.3354/ab00190; Normand Julien, 2008, COMP HISTOLOGICAL ST; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Piferrer F, 2009, AQUACULTURE, V293, P125, DOI 10.1016/j.aquaculture.2009.04.036; Roig I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001062; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Santerre C, 2012, SEX DEV, V6, P210, DOI 10.1159/000338085; Santerre C, 2013, COMP BIOCHEM PHYS A, V165, P61, DOI 10.1016/j.cbpa.2013.02.007; Sekii K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-62; Shibayama H, 2004, J EXP MED, V199, P581, DOI 10.1084/jem.20031858; Smiley S, 2005, J ELECT MICROSCOP TE, V16, P93; Song HH, 2002, BBA-GEN SUBJECTS, V1573, P241, DOI 10.1016/S0304-4165(02)00390-2; STANLEY JG, 1981, AQUACULTURE, V23, P1, DOI 10.1016/0044-8486(81)90002-8; Tye BK, 1999, ANNU REV BIOCHEM, V68, P649, DOI 10.1146/annurev.biochem.68.1.649; Warrillow JA, 1997, CAN J FISH AQUAT SCI, V54, P1808, DOI 10.1139/cjfas-54-8-1808; WOLTERS WR, 1982, T AM FISH SOC, V111, P102, DOI 10.1577/1548-8659(1982)111<102:EOTOGA>2.0.CO;2; Xiao Xiang, 2007, Journal of Zhejiang University-Science B, V8, P498, DOI 10.1631/jzus.2007.B0498; Yao HHC, 2004, DEV DYNAM, V230, P210, DOI 10.1002/dvdy.20042; Ye Y, 2009, MOL CANCER RES, V7, P1984, DOI 10.1158/1541-7786.MCR-09-0119; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371; Zhang QQ, 2010, AQUAC RES, V41, P1658, DOI 10.1111/j.1365-2109.2010.02541.x	62	27	29	5	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112094	10.1371/journal.pone.0112094	http://dx.doi.org/10.1371/journal.pone.0112094			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375782	Green Submitted, gold, Green Published			2022-12-27	WOS:000344402600103
J	Chauhan, A; Chauhan, D; Rout, C				Chauhan, Arun; Chauhan, Devesh; Rout, Chittaranjan			Role of Gist and PHOG Features in Computer-Aided Diagnosis of Tuberculosis without Segmentation	PLOS ONE			English	Article							TEXTURE FEATURES; CANCER-DETECTION; MAMMOGRAPHY; SCENE	Purpose: Effective diagnosis of tuberculosis (TB) relies on accurate interpretation of radiological patterns found in a chest radiograph (CXR). Lack of skilled radiologists and other resources, especially in developing countries, hinders its efficient diagnosis. Computer-aided diagnosis (CAD) methods provide second opinion to the radiologists for their findings and thereby assist in better diagnosis of cancer and other diseases including TB. However, existing CAD methods for TB are based on the extraction of textural features from manually or semi-automatically segmented CXRs. These methods are prone to errors and cannot be implemented in X-ray machines for automated classification. Methods: Gabor, Gist, histogram of oriented gradients (HOG), and pyramid histogram of oriented gradients (PHOG) features extracted from the whole image can be implemented into existing X-ray machines to discriminate between TB and non-TB CXRs in an automated manner. Localized features were extracted for the above methods using various parameters, such as frequency range, blocks and region of interest. The performance of these features was evaluated against textural features. Two digital CXR image datasets (8-bit DA and 14-bit DB) were used for evaluating the performance of these features. Results: Gist (accuracy 94.2% for DA, 86.0% for DB) and PHOG (accuracy 92.3% for DA, 92.0% for DB) features provided better results for both the datasets. These features were implemented to develop a MATLAB toolbox, TB-Xpredict, which is freely available for academic use at http://sourceforge.net/projects/tbxpredict/. This toolbox provides both automated training and prediction modules and does not require expertise in image processing for operation. Conclusion: Since the features used in TB-Xpredict do not require segmentation, the toolbox can easily be implemented in X-ray machines. This toolbox can effectively be used for the mass screening of TB in high-burden areas with improved efficiency.	[Chauhan, Arun; Rout, Chittaranjan] Jaypee Univ Informat Technol, Dept Biotechnol & Bioinformat, Solan, Himachal Prades, India; [Chauhan, Devesh] Natl Inst TB & Resp Dis, Dept Radiol, New Delhi, India	Jaypee University of Information Technology	Rout, C (corresponding author), Jaypee Univ Informat Technol, Dept Biotechnol & Bioinformat, Solan, Himachal Prades, India.	chittaranjan.rout@juit.ac.in	Rout, Chandra Sekhar/P-9472-2016	Rout, Chandra Sekhar/0000-0003-4380-5549				Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Arzhaeva Y, 2009, PATTERN RECOGN, V42, P1768, DOI 10.1016/j.patcog.2009.01.016; Arzhaeva Y, 2009, LECT NOTES COMPUT SC, V5762, P724, DOI 10.1007/978-3-642-04271-3_88; Bosch A., 2007, P 6 ACM INT C IM VID, V5, P401, DOI [10.1145/1282280.1282340, DOI 10.1145/1282280, DOI 10.1145/1282280.1282340]; Chan TE, 2000, J VIS COMMUN IMAGE R, V11, P130, DOI 10.1006/jvci.1999.0442; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dalal N., 2005, IEEE COMPUTER SOC C, V1, P886, DOI DOI 10.1109/CVPR.2005.177; Dean JC, 2006, AM J ROENTGENOL, V187, P20, DOI 10.2214/AJR.05.0111; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Doi K, 2007, COMPUT MED IMAG GRAP, V31, P198, DOI 10.1016/j.compmedimag.2007.02.002; Ginneken BV, 2012, ANN M RAD SOC N AM; Global TB, 2012, GLOB TB CONTR REP 20; Grigorescu SE, 2002, IEEE T IMAGE PROCESS, V11, P1160, DOI 10.1109/TIP.2002.804262; Gur D, 2004, J NATL CANCER I, V96, P185, DOI 10.1093/jnci/djh067; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hogeweg L, 2010, LECT NOTES COMPUT SC, V6363, P650; Itti L, 2010, J VIS, V8, P734, DOI [10.1167/8.6.734, DOI 10.1167/8.6.734]; Ludwig O, 2009, 2009 12TH INTERNATIONAL IEEE CONFERENCE ON INTELLIGENT TRANSPORTATION SYSTEMS (ITSC 2009), P432; Luisier F, 2007, IEEE T IMAGE PROCESS, V16, P593, DOI 10.1109/TIP.2007.891064; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Noble M, 2009, ARCH GYNECOL OBSTET, V279, P881, DOI 10.1007/s00404-008-0841-y; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Oliva A, 2006, PROG BRAIN RES, V155, P23, DOI 10.1016/S0079-6123(06)55002-2; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Shen R, 2010, IEEE T BIO-MED ENG, V57, P2646, DOI 10.1109/TBME.2010.2057509; Siagian C, 2007, IEEE T PATTERN ANAL, V29, P300, DOI 10.1109/TPAMI.2007.40; Tan JH, 2012, J MED SYST, V36, P2751, DOI 10.1007/s10916-011-9751-9; van Ginneken B, 2002, IEEE T MED IMAGING, V21, P139, DOI 10.1109/42.993132; Wong LP, 2005, P 3 APT TEL WORKSH K, V3, P210; Yang Y, 2008, IEEE IMAGE PROC, P1852, DOI 10.1109/ICIP.2008.4712139; ZWEIG MH, 1993, CLIN CHEM, V39, P561	34	44	45	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112980	10.1371/journal.pone.0112980	http://dx.doi.org/10.1371/journal.pone.0112980			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390291	Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400145
J	Lai, XQ; Chen, GD; Qiu, J; Wang, CX; Chen, LZ				Lai, Xingqiang; Chen, Guodong; Qiu, Jiang; Wang, Changxi; Chen, Lizhong			Recipient-Related Risk Factors for Graft Failure and Death in Elderly Kidney Transplant Recipients	PLOS ONE			English	Article							RENAL-ALLOGRAFT SURVIVAL; ACUTE REJECTION; AGE; CYTOMEGALOVIRUS; DIALYSIS; DISEASE; IMPROVEMENT; MORTALITY; DURATION; PATIENT	Background: Elderly patients with end-stage renal disease have become the fastest growing population of kidney transplant candidates in recent years. However, the risk factors associated with long-term outcomes in these patients remain unclear. Methods: We retrospectively analyzed 166 recipients aged 60 years or older who underwent primary deceased kidney transplantation between 2002 and 2013 in our center. The main outcomes included 1-, 3- and 5-year patient survival as well as overall and death-censored graft survival. The independent risk factors affecting graft and patient survival were analyzed using Cox regression analysis. Results: The 1-, 3-, 5-year death-censored graft survival rates were 93.6%, 89.4% and 83.6%, respectively. Based on the Cox multivariate analysis, panel reactive antibody (PRA). 5% [hazard ratio (HR) 4.295, 95% confidence interval (CI) 1.321-13.97], delayed graft function (HR 4.744, 95% CI 1.611-13.973) and acute rejection (HR 4.971, 95% CI 1.516-16.301) were independent risk factors for graft failure. The 1-, 3-, 5-year patient survival rates were 84.8%, 82.1% and 77.1%, respectively. Longer dialysis time (HR 1.011 for 1-month increase, 95% CI 1.002-1.020), graft loss (HR 3.501, 95% CI 1.559-7.865) and low-dose ganciclovir prophylaxis (1.5 g/d for 3 months) (HR 3.173, 95% CI 1.063-9.473) were risk factors associated with patient death. Conclusions: The five-year results show an excellent graft and patient survival in elderly kidney transplant recipients aged >= 60 years. PRA. 5%, delayed graft function, and acute rejection are risk factors for graft failure, while longer duration of dialysis, graft loss and low-dose ganciclovir prophylaxis are risk factors for mortality in elderly recipients. These factors represent potential targets for interventions aimed at improving graft and patient survival in elderly recipients.	[Lai, Xingqiang; Chen, Guodong; Qiu, Jiang; Wang, Changxi; Chen, Lizhong] Sun Yat Sen Univ, Affiliated Hosp 1, Organ Transplant Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Chen, LZ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Organ Transplant Ctr, Guangzhou 510275, Guangdong, Peoples R China.	clz@medmail.com.cn			5010 Clinical Research Project of Sun Yat-sen University [2007003]; National Natural Science Fund Youth Science project [81302549]	5010 Clinical Research Project of Sun Yat-sen University; National Natural Science Fund Youth Science project	This study was supported by the 5010 Clinical Research Project of Sun Yat-sen University (2007003) and the National Natural Science Fund Youth Science project (81302549). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed J, 2004, TRANSPLANTATION, V78, P1689, DOI 10.1097/01.TP.0000141364.85454.37; Brennan DC, 2001, J AM SOC NEPHROL, V12, P848, DOI 10.1681/ASN.V124848; Cainelli F, 2002, LANCET INFECT DIS, V2, P539, DOI 10.1016/S1473-3099(02)00370-5; Campbell TC, 1998, AM J CARDIOL, V82, p18T; Cardinal H, 2005, KIDNEY INT, V68, P345, DOI 10.1111/j.1523-1755.2005.00410.x; Danovitch GM, 2007, TRANSPLANTATION, V84, P285, DOI 10.1097/01.tp.0000275423.69689.dc; De Keyzer K, 2011, AM J KIDNEY DIS, V58, P118, DOI 10.1053/j.ajkd.2011.04.010; Doyle SE, 2000, KIDNEY INT, V57, P2144, DOI 10.1046/j.1523-1755.2000.00066.x; Fabrizii V, 2004, J AM SOC NEPHROL, V15, P1052, DOI 10.1097/01.ASN.0000120370.35927.40; Faravardeh A, 2013, TRANSPLANTATION, V96, P1089, DOI 10.1097/TP.0b013e3182a688e5; George MJ, 1997, AM J MED, V103, P106, DOI 10.1016/S0002-9343(97)80021-6; Goldfarb-Rumyantzev A, 2005, NEPHROL DIAL TRANSPL, V20, P167, DOI 10.1093/ndt/gfh541; Helantera I, 2014, TRANSPLANTATION, V98, P458, DOI 10.1097/TP.0000000000000085; Heldal K, 2009, TRANSPLANTATION, V87, P1045, DOI 10.1097/TP.0b013e31819cdddd; Himmelfarb J, 2010, NEW ENGL J MED, V363, P1833, DOI 10.1056/NEJMra0902710; Johnson DW, 2000, TRANSPLANTATION, V69, P794; Kauffman HM, 2007, TRANSPLANTATION, V83, P404, DOI 10.1097/01.tp.0000251780.01031.81; Morales JM, 2012, NEPHROL DIAL TRANSPL, V27, piv39, DOI 10.1093/ndt/gfs544; Martins PNA, 2005, TRANSPLANTATION, V79, P127, DOI 10.1097/01.TP.0000146258.79425.04; McCullough KP, 2009, AM J TRANSPLANT, V9, P894, DOI 10.1111/j.1600-6143.2009.02566.x; Meier-Kriesche HU, 2000, KIDNEY INT, V58, P1311, DOI 10.1046/j.1523-1755.2000.00287.x; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P378, DOI 10.1111/j.1600-6143.2004.00332.x; Meier-Kriesche HU, 2001, TRANSPLANT P, V33, P3425, DOI 10.1016/S0041-1345(01)02477-0; Meier-Kriesche HU, 2001, TRANSPLANT P, V33, P1113, DOI 10.1016/S0041-1345(00)02452-0; Meier-Kriesche HU, 2001, KIDNEY INT, V59, P1539, DOI 10.1046/j.1523-1755.2001.0590041539.x; Moreso F, 2010, TRANSPL INT, V23, P907, DOI 10.1111/j.1432-2277.2010.01075.x; Oniscu GC, 2004, NEPHROL DIAL TRANSPL, V19, P945, DOI 10.1093/ndt/gfh022; Patel SJ, 2011, CLIN TRANSPLANT, V25, pE250, DOI 10.1111/j.1399-0012.2010.01393.x; Remport A, 2011, INT UROL NEPHROL, V43, P215, DOI 10.1007/s11255-009-9700-4; Roodnat JI, 1999, TRANSPLANTATION, V67, P576, DOI 10.1097/00007890-199902270-00015; TAO SC, 1989, INT J EPIDEMIOL, V18, pS159; Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303	33	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112938	10.1371/journal.pone.0112938	http://dx.doi.org/10.1371/journal.pone.0112938			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389964	gold, Green Published, Green Submitted			2022-12-27	WOS:000349144400144
J	Wallmann-Sperlich, B; Froboese, I				Wallmann-Sperlich, Birgit; Froboese, Ingo			Physical Activity during Work, Transport and Leisure in Germany - Prevalence and Socio-Demographic Correlates	PLOS ONE			English	Article							ACTIVITY QUESTIONNAIRE; ADULTS PARTICIPATION; TIME; RELIABILITY; TRENDS; OLDER; RISK	Background: This study aimed 1) to provide data estimates concerning overall moderate-and vigorous-intensity physical activity (MVPA) as well as MVPA during work, transport and leisure in Germany and 2) to investigate MVPA and possible associations with socio-demographic correlates. Methods: A cross-sectional telephone survey interviewed 2248 representative participants in the age of 18-65 years (1077 men; 42.4 +/- 13.4 years; body mass index: 25.3 +/- 4.5kg.m(-2)) regarding their self-reported physical activity across Germany. The Global Physical Activity Questionnaire was applied to investigate MVPA during work, transport and leisure and questions were answered concerning their demographics. MVPA was stratified by gender, age, body mass index, residential setting, educational and income level. To identify socio-demographic correlates of overall MVPA as well as in the domains, we used a series of linear regressions. Results: 52.8% of the sample achieved physical activity recommendations (53.7% men/52.1% women). Overall MVPA was highest in the age group 18-29 years (p<.05), in participants with 10 years of education (p<.05) and in participants with lowest income levels <1.500(sic) (p<.05). Regression analyses revealed that age, education and income were negatively associated with overall and work MVPA. Residential setting and education was positively correlated with transport MVPA, whereas income level was negatively associated with transport MVPA. Education was the only correlate for leisure MVPA with a positive association. Conclusions: The present data underlines the importance of a comprehensive view on physical activity engagement according to the different physical activity domains and discloses a need for future physical activity interventions that consider socio-demographic variables, residential setting as well as the physical activity domain in Germany.	[Wallmann-Sperlich, Birgit] Univ Wurzburg, Inst Sport Sci, D-97070 Wurzburg, Germany; [Wallmann-Sperlich, Birgit; Froboese, Ingo] German Sport Univ Cologne, Inst Hlth Promot & Clin Movement Sci, Cologne, Germany	University of Wurzburg; German Sport University Cologne	Wallmann-Sperlich, B (corresponding author), Univ Wurzburg, Inst Sport Sci, D-97070 Wurzburg, Germany.	birgit.sperlich@uni-wuerzburg.de			German Sport University; German Research Foundation (DFG); University of Wuerzburg	German Sport University; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	The ERGO insurance group AG (http://www.ergo.com/) funded the data collection. Data analysis and the preparation of the manuscript was possible through funding of the German Sport University within the research project Modulation of Metabolic Fluxes by Physical Activity Patterns and by the program "Equal Opportunities for Women in Research and Teaching" Bavarian State Government. This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, J PHYS ACT HEALTH, V7, pS370; Armstrong T, 2006, J PUBLIC HEALTH-HEID, V14, P66, DOI 10.1007/s10389-006-0024-x; Arnadottir SA, 2009, SCAND J PUBLIC HEALT, V37, P409, DOI 10.1177/1403494809102776; Bauman A, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-21; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Beenackers MA, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-116; Bicalho Paula Gonçalves, 2010, Rev. Saúde Pública, V44, P884, DOI 10.1590/S0034-89102010005000023; Borodulin K, 2007, PREV MED, V45, P157, DOI 10.1016/j.ypmed.2007.02.007; Brownson RC, 2000, AM J PUBLIC HEALTH, V90, P264, DOI 10.2105/AJPH.90.2.264; Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790; Bundesministerium fur Ernahrung Landwirtschaft und Verbraucherschutz (BMELV) Bundesministerium fur Gesundheit (BMG), 2011, FORM DEUTSCHL IN GES; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P1097; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hu G, 2002, MED SCI SPORT EXER, V34, P234, DOI 10.1097/00005768-200202000-00009; Jordan S, 2012, BUNDESGESUNDHEITSBLA, V55, P73, DOI 10.1007/s00103-011-1396-9; Kirk MA, 2011, AM J PREV MED, V40, P476, DOI 10.1016/j.amepre.2010.12.015; Knuth AG, 2009, J PHYS ACT HEALTH, V6, P548, DOI 10.1123/jpah.6.5.548; Krug S, 2013, BUNDESGESUNDHEITSBLA, V56, P765, DOI 10.1007/s00103-012-1661-6; Kwasniewska M, 2010, PREV MED, V50, P257, DOI 10.1016/j.ypmed.2010.02.011; Kwasniewska M, 2010, PREV MED, V51, P482, DOI 10.1016/j.ypmed.2010.09.003; Lampert T, 2005, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V48, P1357, DOI 10.1007/s00103-005-1169-4; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Mensink GBM., 1999, GESUNDHEITSWESEN, V61, P126; Meyer K, 2005, SOZ PRAVENTIV MED, V50, P218, DOI 10.1007/s00038-005-4093-3; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Reilly T, 2006, SPORTS MED, V36, P473, DOI 10.2165/00007256-200636060-00002; [Robert-Koch-Institut Institut RK], 2012, BEITR GES BUND; Rutten A, 2004, SOZ PRAVENTIV MED, V49, P281; Saelens BE, 2003, ANN BEHAV MED, V25, P80, DOI 10.1207/S15324796ABM2502_03; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Salmon J, 2000, PREV MED, V30, P191, DOI 10.1006/pmed.1999.0619; Schneider S, 2007, DEUT Z SPORTMED, V58, P433; Sjostrom M, 2006, J PUBLIC HEALTH-HEID, V14, P291, DOI 10.1007/s10389-006-0031-y; Steele R, 2003, J SCI MED SPORT, V6, P398, DOI 10.1016/S1440-2440(03)80266-9; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; Van Dyck D, 2011, J URBAN HEALTH, V88, P154, DOI 10.1007/s11524-010-9536-3; Wallmann-Sperlich B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-196; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; WHO, 2011, GLOB STAT REP NONC D	40	25	25	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112333	10.1371/journal.pone.0112333	http://dx.doi.org/10.1371/journal.pone.0112333			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CP	25390071	Green Submitted, gold, Green Published			2022-12-27	WOS:000349144400072
J	Wu, JW; Chen, ME; Wen, WS; Chen, WA; Li, CT; Chang, CK; Lo, CH; Liu, HS; Wang, SSS				Wu, Josephine W.; Chen, Mei-Er; Wen, Wen-Sing; Chen, Wei-An; Li, Chien-Ting; Chang, Chih-Kai; Lo, Chun-Hsien; Liu, Hwai-Shen; Wang, Steven S. -S.			Comparative Analysis of Human gamma D-Crystallin Aggregation under Physiological and Low pH Conditions	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; HYDROPHOBIC FLUORESCENT-PROBE; AMYLOID FIBRIL FORMATION; PARTICLE-MESH EWALD; GREEK KEY DOMAINS; IN-VITRO; CATARACT FORMATION; THIOFLAVIN-T; HUMAN LENS; MOLECULAR CHAPERONE	Cataract, a major cause of visual impairment worldwide, is the opacification of the eye's crystalline lens due to aggregation of the crystallin proteins. The research reported here is aimed at investigating the aggregating behavior of gamma-crystallin proteins in various incubation conditions. Thioflavin T binding assay, circular dichroism spectroscopy, 1-anilinonaphthalene-8-sulfonic acid fluorescence spectroscopy, intrinsic (tryptophan) fluorescence spectroscopy, light scattering, and electron microscopy were used for structural characterization. Molecular dynamics simulations and bioinformatics prediction were performed to gain insights into the gamma D-crystallin mechanisms of fibrillogenesis. We first demonstrated that, except at pH 7.0 and 37 degrees C, the aggregation of gamma D-crystallin was observed to be augmented upon incubation, as revealed by turbidity measurements. Next, the types of aggregates (fibrillar or non-fibrillar aggregates) formed under different incubation conditions were identified. We found that, while a variety of non-fibrillar, granular species were detected in the sample incubated under pH 7.0, the fibrillogenesis of human gamma D-crystallin could be induced by acidic pH (pH 2.0). In addition, circular dichroism spectroscopy, 1-anilinonaphthalene-8-sulfonic acid fluorescence spectroscopy, and intrinsic fluorescence spectroscopy were used to characterize the structural and conformational features in different incubation conditions. Our results suggested that incubation under acidic condition led to a considerable change in the secondary structure and an enhancement in solvent-exposure of the hydrophobic regions of human gamma D-crystallin. Finally, molecular dynamics simulations and bioinformatics prediction were performed to better explain the differences between the structures and/or conformations of the human gamma D-crystallin samples and to reveal potential key protein region involved in the varied aggregation behavior. Bioinformatics analyses revealed that the initiation of amyloid formation of human gamma D-crystallin may be associated with a region within the gamma-terminal domain. We believe the results from this research may contribute to a better understanding of the possible mechanisms underlying the pathogenesis of senile nuclear cataract.	[Wu, Josephine W.] Cent Taiwan Univ Sci & Technol, Dept Optometry, Taichung 40601, Taiwan; [Chen, Mei-Er] Natl Chung Hsing Univ, Dept Entomol, Taichung 402, Taiwan; [Wen, Wen-Sing; Chen, Wei-An; Li, Chien-Ting; Chang, Chih-Kai; Lo, Chun-Hsien; Liu, Hwai-Shen; Wang, Steven S. -S.] Natl Taiwan Univ, Dept Chem Engn, Taipei 10617, Taiwan	Central Taiwan University Science & Technology; National Chung Hsing University; National Taiwan University	Wu, JW (corresponding author), Cent Taiwan Univ Sci & Technol, Dept Optometry, Taichung 40601, Taiwan.	107658@ctust.edu.tw; sswang@ntu.edu.tw	Li, Chien-Ting/I-7080-2019		Ministry of Science and Technology, Taiwan [MOST 102-2221-E-002-161, MOST 103-2221-E-002- 208, NSC 101-2113-M-166-001-MY2, MOST 103-2113-M-166-001-MY2]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the grants from the Ministry of Science and Technology, Taiwan (MOST 102-2221-E-002-161 and MOST 103-2221-E-002- 208 to SSW, and NSC 101-2113-M-166-001-MY2 and MOST 103-2113-M-166-001-MY2 to JWW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham MJ, 2011, J COMPUT CHEM, V32, P2031, DOI 10.1002/jcc.21773; AlGhoul KJ, 1996, EXP EYE RES, V62, P237, DOI 10.1006/exer.1996.0029; Biswas S, 2004, TRENDS MOL MED, V10, P78, DOI 10.1016/j.molmed.2003.12.007; Block H, 2008, PROTEIN EXPRES PURIF, V57, P244, DOI 10.1016/j.pep.2007.09.019; Bourhim M, 2007, J NEUROSCI METH, V160, P264, DOI 10.1016/j.jneumeth.2006.09.013; Bradford JR, 2005, BIOINFORMATICS, V21, P1487, DOI 10.1093/bioinformatics/bti242; Brubaker WD, 2011, BIOPHYS J, V100, P498, DOI 10.1016/j.bpj.2010.12.3691; Chennamsetty N, 2009, P NATL ACAD SCI USA, V106, P11937, DOI 10.1073/pnas.0904191106; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; CRABBE MJC, 1995, COMPUT CHEM, V19, P343, DOI 10.1016/0097-8485(95)90316-X; Darghal N, 2006, BIOCHEM BIOPH RES CO, V343, P623, DOI 10.1016/j.bbrc.2006.03.024; Das P, 2011, P NATL ACAD SCI USA, V108, P10514, DOI 10.1073/pnas.1019152108; Das P, 2010, PROTEIN SCI, V19, P131, DOI 10.1002/pro.296; Day R, 2002, J MOL BIOL, V322, P189, DOI 10.1016/S0022-2836(02)00672-1; Di Stasio E, 2004, BIOPHYS CHEM, V107, P197, DOI 10.1016/j.bpc.2003.09.005; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Eckert R, 2002, PFLUG ARCH EUR J PHY, V443, P843, DOI 10.1007/s00424-001-0760-2; EFTINK MR, 1991, METHOD BIOCHEM ANAL, V35, P127; Eftink MR, 1998, BIOCHEMISTRY-MOSCOW+, V63, P276; Ellozy AR, 1996, PHOTOCHEM PHOTOBIOL, V64, P344, DOI 10.1111/j.1751-1097.1996.tb02469.x; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Flaugh SL, 2006, J BIOL CHEM, V281, P30782, DOI 10.1074/jbc.M603882200; Flaugh SL, 2005, PROTEIN SCI, V14, P2030, DOI 10.1110/ps.051460505; Flaugh SL, 2005, PROTEIN SCI, V14, P571, DOI 10.1110/ps.041111405; Frederikse PH, 2000, CURR EYE RES, V20, P462, DOI 10.1076/0271-3683(200006)20:6;1-Y;FT462; Gilliland KO, 2001, MOL VIS, V7, P120; Hains PG, 2010, INVEST OPHTH VIS SCI, V51, P3107, DOI 10.1167/iovs.09-4308; Hanson SRA, 2000, EXP EYE RES, V71, P195, DOI 10.1006/exer.2000.0868; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Hudson SA, 2009, FEBS J, V276, P5960, DOI 10.1111/j.1742-4658.2009.07307.x; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kingsbury JS, 2007, PROTEIN EXPRES PURIF, V53, P370, DOI 10.1016/j.pep.2007.01.004; Kong FR, 2011, PROTEIN SCI, V20, P513, DOI 10.1002/pro.583; Kosinski-Collins MS, 2004, PROTEIN SCI, V13, P2223, DOI 10.1110/ps.04627004; Kosinski-Collins MS, 2003, PROTEIN SCI, V12, P480, DOI 10.1110/ps.0225503; Liu CP, 2005, BIOCHIMIE, V87, P1023, DOI 10.1016/j.biochi.2005.03.017; Meehan S, 2004, J BIOL CHEM, V279, P3413, DOI 10.1074/jbc.M308203200; Mills IA, 2007, PROTEIN SCI, V16, P2427, DOI 10.1110/ps.072970207; Moran SD, 2012, P NATL ACAD SCI USA, V109, P3329, DOI 10.1073/pnas.1117704109; Moreau KL, 2009, J BIOL CHEM, V284, P33285, DOI 10.1074/jbc.M109.031344; Ohno A, 1998, J MOL BIOL, V282, P421, DOI 10.1006/jmbi.1998.2022; Oyster CW., 1999, HUMAN EYE STRUCTURE; Pande A, 2000, P NATL ACAD SCI USA, V97, P1993, DOI 10.1073/pnas.040554397; Papanikolopoulou K, 2008, MOL VIS, V14, P81; Poon S, 2002, J BIOL CHEM, V277, P39532, DOI 10.1074/jbc.M204855200; Rabbani G, 2014, APPL MICROBIOL BIOT, V98, P2533, DOI 10.1007/s00253-013-5123-3; Rabbani G, 2011, CELL BIOCHEM BIOPHYS, V61, P551, DOI 10.1007/s12013-011-9237-x; Rosinke B, 1997, J MOL BIOL, V271, P645, DOI 10.1006/jmbi.1997.1184; Rousseau F, 2006, CURR OPIN STRUC BIOL, V16, P118, DOI 10.1016/j.sbi.2006.01.011; Sahin E, 2011, BIOCHEMISTRY-US, V50, P628, DOI 10.1021/bi100978r; Sandilands A, 2002, EMBO J, V21, P6005, DOI 10.1093/emboj/cdf609; Santhoshkumar P, 2008, J BIOL CHEM, V283, P8477, DOI 10.1074/jbc.M705876200; Schuler LD, 2001, J COMPUT CHEM, V22, P1205, DOI 10.1002/jcc.1078; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Shearer T R, 1997, Mol Vis, V3, P8; Sirangelo I, 1998, BBA-PROTEIN STRUCT M, V1385, P69, DOI 10.1016/S0167-4838(98)00038-7; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Smoot AL, 2001, BIOCHEMISTRY-US, V40, P4484, DOI 10.1021/bi001822b; Takemoto L, 1996, EXP EYE RES, V63, P585, DOI 10.1006/exer.1996.0149; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Varshney A, 2010, AMINO ACIDS, V39, P899, DOI 10.1007/s00726-010-0524-4; Wang GZ, 2009, BIOCHEM ENG J, V46, P7, DOI 10.1016/j.bej.2009.04.005; Wang SSS, 2010, MOL VIS, V16, P2777; Wang YT, 2010, INVEST OPHTH VIS SCI, V51, P672, DOI 10.1167/iovs.09-3987; Wen WS, 2011, J TAIWAN INST CHEM E, V42, P547, DOI 10.1016/j.jtice.2010.10.002; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; WISTOW G, 1990, J MOL EVOL, V30, P140, DOI 10.1007/BF02099940; Wu JW, 2012, J BIOMOL STRUCT DYN, V29, P937, DOI 10.1080/07391102.2012.10507420; Zhang WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026581	75	24	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112309	10.1371/journal.pone.0112309	http://dx.doi.org/10.1371/journal.pone.0112309			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389780	Green Submitted, gold, Green Published			2022-12-27	WOS:000349144400071
J	Hoque, ME; Ghuman, S; Coopoosmay, R; Van Hal, G				Hoque, Muhammad Ehsanu; Ghuman, Shanaz; Coopoosmay, Roger; Van Hal, Guido			Cervical Cancer Screening among University Students in South Africa: A Theory Based Study	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; RISK; PREVALENCE; KNOWLEDGE; BELIEFS; WOMEN	Introduction: Cervical cancer is a serious public health problem in South Africa. Even though the screening is free in health facilities in South Africa, the Pap smear uptake is very low. The objective of the study is to investigate the knowledge and beliefs of female university students in South Africa. Methods: A cross sectional study was conducted among university women in South Africa to elicit information about knowledge and beliefs, and screening history. Results: A total of 440 students completed the questionnaire. The average age of the participants was 20.39 years (SD = 1.71 years). Regarding cervical cancer, 55.2% (n = 243) had ever heard about it. Results indicated that only 15% (22/147) of the students who had ever had sex and had heard about cervical cancer had taken a Pap test. Pearson correlation analysis showed that cervical cancer knowledge had a significantly negative relationship with barriers to cervical cancer screening. Susceptibility and seriousness score were significantly moderately correlated with benefit and motivation score as well as barrier score. Self-efficacy score also had a moderate correlation with benefit and motivation score. Students who had had a Pap test showed a significantly lower score in barriers to being screened compared to students who had not had a Pap test. Conclusion: This study showed that educated women in South Africa lack complete information on cervical cancer. Students who had had a Pap test had significantly lower barriers to cervical cancer screening than those students who had not had a Pap test.	[Hoque, Muhammad Ehsanu] Univ KwaZulu Natal, Grad Sch Business & Leadership, Durban, South Africa; [Ghuman, Shanaz] Durban Univ Technol, Dept Environm Hlth, Durban, South Africa; [Coopoosmay, Roger] Mangosuthu Univ Technol, Dept Nat Conversat, Durban, South Africa; [Van Hal, Guido] Univ Antwerp, B-2020 Antwerp, Belgium	University of Kwazulu Natal; Durban University of Technology; Mangosuthu University of Technology; University of Antwerp	Hoque, ME (corresponding author), Univ KwaZulu Natal, Grad Sch Business & Leadership, Durban, South Africa.	hoque@ukzn.ac.za	Van Hal, Guido F/B-5948-2017	Van Hal, Guido F/0000-0002-4611-4076				Abotchie PN, 2009, INT J GYNECOL CANCER, V19, P412, DOI 10.1111/IGC.0b013e3181a1d6de; Blair AR, 2009, PRIMARY CARE, V36, P115, DOI 10.1016/j.pop.2008.10.001; Byrd TL, 2004, PREV MED, V38, P192, DOI 10.1016/j.ypmed.2003.09.017; Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9; Collins SI, 2005, INT J CANCER, V114, P498, DOI 10.1002/ijc.20732; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; Demirtas B, 2013, ASIAN PAC J CANCER P, V14, P333, DOI 10.7314/APJCP.2013.14.1.333; Fonn S, 2002, SAMJ S AFR MED J, V92, P148; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Gakidou E, 2008, PLOS MED, V5, P863, DOI 10.1371/journal.pmed.0050132; Gollwitzer PM, 2006, ADV EXP SOC PSYCHOL, V38, P69, DOI 10.1016/S0065-2601(06)38002-1; Guner H, 2007, TURK J OBSTET GYNECO, V4, P11; Guvenc G, 2011, J ADV NURS, V67, P428, DOI 10.1111/j.1365-2648.2010.05450.x; Hoque E., 2009, Southern African Journal of Epidemiology & Infection, V24, P21; Hoque Monjurul, 2008, East Afr J Public Health, V5, P111; HPV center WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre), HPV CTR WHO ICO INF; Hughes Cathy, 2009, Nurs Stand, V23, P48; Irwin MR, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403; Issah F, 2011, EUR J ONCOL NURS, V15, P67, DOI 10.1016/j.ejon.2010.06.003; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Maree JE, 2011, EUR J ONCOL NURS, V15, P118, DOI 10.1016/j.ejon.2010.06.008; McCaffery K, 2005, J MED SCREEN, V12, P134, DOI 10.1258/0969141054855238; Moscicki AB, 2008, J ADOLESCENT HEALTH, V43, pS1, DOI 10.1016/j.jadohealth.2008.07.008; National Department of Health, 2000, NAT GUID CERV CANC S; Philips Z, 2003, HEALTH EDUC RES, V18, P318, DOI 10.1093/her/cyf022; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Smith JS, 2003, LANCET, V361, P1159, DOI 10.1016/S0140-6736(03)12949-2; Tacken MAJB, 2007, EUR J PUBLIC HEALTH, V17, P178, DOI 10.1093/eurpub/ckl082; Twinn S, 2006, J CLIN NURS, V15, P1140, DOI 10.1111/j.1365-2702.2006.01497.x; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; Woodman CBJ, 2001, LANCET, V357, P1831, DOI 10.1016/S0140-6736(00)04956-4; World Health Organization, 2012, HUM PAP INF CERV CAN	32	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111557	10.1371/journal.pone.0111557	http://dx.doi.org/10.1371/journal.pone.0111557			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT9MC	25387105	Green Published, Green Submitted, gold			2022-12-27	WOS:000345250400021
J	Kalampoki, LG; Flytzanis, CN				Kalampoki, Lamprini G.; Flytzanis, Constantin N.			Cis-Regulatory Control of the Nuclear Receptor Coup-TF Gene in the Sea Urchin Paracentrotus lividus Embryo	PLOS ONE			English	Article							PROMOTER-TRANSCRIPTION FACTORS; RETINOIC ACID; DEVELOPMENTAL EXPRESSION; THYROID-HORMONE; SPCOUP-TF; MEMBER; IDENTIFICATION; SPECIFICATION; SUPERFAMILY; REPRESSION	Coup-TF, an orphan member of the nuclear receptor super family, has a fundamental role in the development of metazoan embryos. The study of the gene's regulatory circuit in the sea urchin embryo will facilitate the placement of this transcription factor in the well-studied embryonic Gene Regulatory Network (GRN). The Paracentrotus lividus Coup-TF gene (PlCoup-TF) is expressed throughout embryonic development preferentially in the oral ectoderm of the gastrula and the ciliary band of the pluteus stage. Two overlapping l genomic clones, containing three exons and upstream sequences of PlCoup-TF, were isolated from a genomic library. The transcription initiation site was determined and 59 deletions and individual segments of a 1930 bp upstream region were placed ahead of a GFP reporter cassette and injected into fertilized P. lividus eggs. Module a (2532 to 2232), was necessary and sufficient to confer ciliary band expression to the reporter. Comparison of P. lividus and Strongylocentrotus purpuratus upstream Coup-TF sequences, revealed considerable conservation, but none within module a. 59 and internal deletions into module a, defined a smaller region that confers ciliary band specific expression. Putative regulatory cis-acting elements (RE1, RE2 and RE3) within module a, were specifically bound by proteins in sea urchin embryonic nuclear extracts. Site-specific mutagenesis of these elements resulted in loss of reporter activity (RE1) or ectopic expression (RE2, RE3). It is proposed that sea urchin transcription factors, which bind these three regulatory sites, are necessary for spatial and quantitative regulation of the PlCoup-TF gene at pluteus stage sea urchin embryos. These findings lead to the future identification of these factors and to the hierarchical positioning of PlCoup-TF within the embryonic GRN.	[Kalampoki, Lamprini G.; Flytzanis, Constantin N.] Univ Patras, Dept Biol, Patras 26504, Greece	University of Patras	Flytzanis, CN (corresponding author), Univ Patras, Dept Biol, Patras 26504, Greece.	kostas@bcm.edu			'Alexander S. Onassis' Foundation; University of Patras; EU program ASSEMBLE	'Alexander S. Onassis' Foundation; University of Patras; EU program ASSEMBLE	LGK was supported by a graduate fellowship from'Alexander S. Onassis' Foundation. Support for this work was obtained by a 'Karatheodoris' grant from the University of Patras to CNF. The EU program ASSEMBLE supported CNF for a visit to Dr. Arnone's laboratory at Stazione Zoologica Napoli. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achatz G, 1997, MOL CELL BIOL, V17, P4914, DOI 10.1128/MCB.17.9.4914; Arenas-Mena C, 2000, DEVELOPMENT, V127, P4631; Arnone MI, 1998, DEVELOPMENT, V125, P1381; Arnone MI, 1997, DEVELOPMENT, V124, P4649; Brown CT, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-70; Brown CT, 2002, DEV BIOL, V246, P86, DOI 10.1006/dbio.2002.0619; CALZONE FJ, 1988, GENE DEV, V2, P1074, DOI 10.1101/gad.2.9.1074; Cameron RA, 2004, GENE EXPR PATTERNS, V4, P205, DOI 10.1016/j.modgep.2003.08.007; CHAN SM, 1992, P NATL ACAD SCI USA, V89, P10568, DOI 10.1073/pnas.89.22.10568; Consales C, 2002, GENE, V287, P75, DOI 10.1016/S0378-1119(01)00891-5; COONEY AJ, 1993, J BIOL CHEM, V268, P4152; FJOSE A, 1995, MECH DEVELOP, V52, P233, DOI 10.1016/0925-4773(95)00404-O; FJOSE A, 1993, EMBO J, V12, P1403, DOI 10.1002/j.1460-2075.1993.tb05784.x; FLYTZANIS CN, 1985, DEV BIOL, V108, P431, DOI 10.1016/0012-1606(85)90046-6; HIROMI Y, 1993, DEVELOPMENT, V118, P1123; JONK LJC, 1994, MECH DEVELOP, V47, P81, DOI 10.1016/0925-4773(94)90098-1; Krishnan V, 1997, SCIENCE, V278, P1947, DOI 10.1126/science.278.5345.1947; Kruse SW, 2008, PLOS BIOL, V6, P2002, DOI 10.1371/journal.pbio.0060227; LADIAS JAA, 1991, SCIENCE, V251, P561, DOI 10.1126/science.1899293; Laudet V, 1997, J MOL ENDOCRINOL, V19, P207, DOI 10.1677/jme.0.0190207; LAUDET V, 1992, EMBO J, V11, P1003, DOI 10.1002/j.1460-2075.1992.tb05139.x; LUTZ B, 1994, DEVELOPMENT, V120, P25, DOI 10.1242/dev.120.1.25; MCMAHON AP, 1985, DEV BIOL, V108, P420, DOI 10.1016/0012-1606(85)90045-4; MLODZIK M, 1990, CELL, V60, P211, DOI 10.1016/0092-8674(90)90737-Y; Oliveri P, 2004, CURR OPIN GENET DEV, V14, P351, DOI 10.1016/j.gde.2004.06.004; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; PEREIRA FA, 1995, J STEROID BIOCHEM, V53, P503, DOI 10.1016/0960-0760(95)00097-J; Qiu YH, 1997, GENE DEV, V11, P1925, DOI 10.1101/gad.11.15.1925; QIU YH, 1994, P NATL ACAD SCI USA, V91, P4451, DOI 10.1073/pnas.91.10.4451; Rizzo F, 2006, DEV BIOL, V300, P35, DOI 10.1016/j.ydbio.2006.08.012; Salas R, 2002, EUR J BIOCHEM, V269, P317, DOI 10.1046/j.0014-2956.2001.02655.x; Saudemont A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001259; Shan G, 2008, DEV BIOL, V322, P11, DOI 10.1016/j.ydbio.2008.06.034; Su YH, 2009, DEV BIOL, V329, P410, DOI 10.1016/j.ydbio.2009.02.029; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; vanderWees J, 1996, MECH DEVELOP, V54, P173, DOI 10.1016/0925-4773(95)00471-8; Vlahou A, 1996, DEVELOPMENT, V122, P521; Vlahou A, 2000, DEV BIOL, V218, P284, DOI 10.1006/dbio.1999.9456; Walton KD, 2006, DEV BIOL, V300, P153, DOI 10.1016/j.ydbio.2006.08.064; WANG LH, 1989, NATURE, V340, P163, DOI 10.1038/340163a0; Xu ND, 1996, MECH DEVELOP, V60, P151, DOI 10.1016/S0925-4773(96)00604-1; Zhou HM, 1998, J NEUROSCI, V18, P10438	42	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e109274	10.1371/journal.pone.0109274	http://dx.doi.org/10.1371/journal.pone.0109274			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386650	Green Submitted, Green Published, gold			2022-12-27	WOS:000345250400002
J	Mauer, M; Glynn, E; Svarstad, E; Tondel, C; Gubler, MC; West, M; Sokolovskiy, A; Whitley, C; Najafian, B				Mauer, Michael; Glynn, Emily; Svarstad, Einar; Tondel, Camilla; Gubler, Marie-Claire; West, Michael; Sokolovskiy, Alexey; Whitley, Chester; Najafian, Behzad			Mosaicism of Podocyte Involvement Is Related to Podocyte Injury in Females with Fabry Disease	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; FOOT PROCESS EFFACEMENT; ALPHA-GALACTOSIDASE; X-INACTIVATION; ENDOTHELIAL FENESTRATION; CLINICAL-MANIFESTATIONS; DIABETIC-NEPHROPATHY; OUTCOME SURVEY; RENAL-FAILURE; GENE	Background: Fabry disease. an X-linked deficiency of alpha-galactosidase A coded by the GLA gene, leads to intracellular globotriaosylceramide (GL-3) accumulation. Although less common than in males, chronic kidney disease, occurs in,similar to 15% of females. Recent studies highlight the importance of podocyte injury in Fabry nephropathy development and progression. We hypothesized that the greater the % of podocytes with active wild-type GLA gene (due to X-inactivation of the mutant copy) the less is the overall podocyte injury. Methods: Kidney biopsies from 12 treatment-naive females with Fabry disease, ages 15 (8-63), median [range], years were studied by electron microscopy and compared with 4 treatment-naive male patients. Results: In females, 51 (13-100)% of podocytes (PC) per glomerulus had no GL-3 inclusions, this consistent with a non-Fabry podocyte phenotype (NFPC). In PC with GL-3 inclusions [Fabry podocyte phenotype (FPC)], GL-3 volume density per podocyte was virtually identical in females and males, consistent with little or no cross-correction between FPC and NFPC. % NFPC per glomerulus (%NFPC/glom) correlated with age in females (r = 0.65, p = 0.02), suggesting a survival disadvantage for FPC over time. Age-adjusted %NFPC/glom was inversely related to foot process width (FPW) (r = 20.75, p = 0.007), an indicator of PC injury. GL-3 volume density in FPC in females correlated directly with FPW. Conclusions: These findings support important relationships between podocyte mosaicism and podocyte injury in female Fabry patients. Kidney biopsy, by providing information about podocyte mosaicism, may help to stratify females with Fabry disease for kidney disease risk and to guide treatment decisions.	[Mauer, Michael; Whitley, Chester] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Mauer, Michael] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Glynn, Emily; Sokolovskiy, Alexey; Najafian, Behzad] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Svarstad, Einar] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway; [Svarstad, Einar; Tondel, Camilla] Univ Bergen, Dept Clin Med, Bergen, Norway; [Tondel, Camilla] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway; [Gubler, Marie-Claire] Univ Paris 05, Hop Necker Enfants Malad, AP HP, U983, Paris, France; [West, Michael] Dalhousie Univ, Dept Med, Div Nephrol, Halifax, NS, Canada	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Dalhousie University	Najafian, B (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	najafian@u.washington.edu	Mauer, Michael/ABD-5415-2020	Gubler, Marie-Claire/0000-0002-3526-5661; west, michael/0000-0003-4897-1378; Najafian, Behzad/0000-0002-0904-6721	NIH RDCRN U54 grant [5U54NS065768-04]; Genzyme; Sanofi Company; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS065768] Funding Source: NIH RePORTER	NIH RDCRN U54 grant; Genzyme(Sanofi-AventisGenzyme Corporation); Sanofi Company; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by an NIH RDCRN U54 grant (5U54NS065768-04) and an investigator initiated grant from Genzyme, a Sanofi Company. The funder provided support in the form of research grants for authors [BN, MM, and MLW], and travel support and honoraria for authors [BN, MM, CT, and MLW] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Aerts JM, 2008, P NATL ACAD SCI USA, V105, P2812, DOI 10.1073/pnas.0712309105; [Anonymous], 2013, HUMAN GENE MUTATION; Ashton-Prolla P, 2000, J INVEST MED, V48, P227; Bekri S, 2005, NEPHRON CLIN PRACT, V101, pC33, DOI 10.1159/000085709; Deegan PB, 2006, J MED GENET, V43, P347, DOI 10.1136/jmg.2005.036327; Deegens JKJ, 2008, KIDNEY INT, V74, P1568, DOI 10.1038/ki.2008.413; Dobrovolny R, 2005, J MOL MED, V83, P647, DOI 10.1007/s00109-005-0656-2; Elstein D, 2012, GENE, V505, P266, DOI 10.1016/j.gene.2012.06.013; Eng CM, 1997, MOL MED, V3, P174, DOI 10.1007/BF03401671; Germain DP, 2007, J AM SOC NEPHROL, V18, P1547, DOI 10.1681/ASN.2006080816; Gibas Andrea L, 2008, J Genet Couns, V17, P528, DOI 10.1007/s10897-008-9179-7; GUBLER MC, 1978, KIDNEY INT, V13, P223, DOI 10.1038/ki.1978.32; Kriz W, 2005, KIDNEY INT, V67, P404, DOI 10.1111/j.1523-1755.2005.67097.x; Kriz W, 2013, AM J PHYSIOL-RENAL, V304, pF333, DOI 10.1152/ajprenal.00478.2012; MacDermot KD, 2001, J MED GENET, V38, P769, DOI 10.1136/jmg.38.11.769; Maier EM, 2006, ACTA PAEDIATR, V95, P30, DOI 10.1080/08035320600618809; Matsusaka T, 2011, J AM SOC NEPHROL, V22, P1275, DOI 10.1681/ASN.2010090963; Mehta A, 2004, EUR J CLIN INVEST, V34, P236, DOI 10.1111/j.1365-2362.2004.01309.x; Migeon BR, 2006, JAMA-J AM MED ASSOC, V295, P1428, DOI 10.1001/jama.295.12.1428; Najafian B, 2013, PEDIATR NEPHROL, V28, P679, DOI 10.1007/s00467-012-2222-9; Najafian B, 2011, AM J NEPHROL, V33, P34, DOI 10.1159/000327075; Najafian B, 2011, KIDNEY INT, V79, P663, DOI 10.1038/ki.2010.484; Pinto LLC, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-14; Reiser J, 2013, ANNU REV MED, V64, P357, DOI 10.1146/annurev-med-050311-163340; Terryn W, 2013, NEPHROL DIAL TRANSPL, V28, P505, DOI 10.1093/ndt/gfs526; Thurberg BL, 2002, KIDNEY INT, V62, P1933, DOI 10.1046/j.1523-1755.2002.00675.x; Tondel C, 2013, J AM SOC NEPHROL, V24, P137, DOI 10.1681/ASN.2012030316; Topham PS, 1999, KIDNEY INT, V55, P1763, DOI 10.1046/j.1523-1755.1999.00407.x; Toyoda M, 2007, DIABETES, V56, P2155, DOI 10.2337/db07-0019; Valbuena C, 2008, VIRCHOWS ARCH, V453, P329, DOI 10.1007/s00428-008-0653-2; Wang CL, 2013, KIDNEY BLOOD PRESS R, V37, P221, DOI 10.1159/000350147; Wang RY, 2007, GENET MED, V9, P34, DOI 10.1097/GIM.0b013e31802d8321; Warnock DG, 2012, NEPHROL DIAL TRANSPL, V27, P1042, DOI 10.1093/ndt/gfr420; Warnock DG, 2014, J AM SOC NEPHROL; Whybra C, 2004, CLIN GENET, V65, P299, DOI 10.1111/j.1399-0004.2004.00219.x; Wilcox WR, 2008, MOL GENET METAB, V93, P112, DOI 10.1016/j.ymgme.2007.09.013; Wolf G, 2005, DIABETES, V54, P1626, DOI 10.2337/diabetes.54.6.1626; Zarate YA, 2008, LANCET, V372, P1427, DOI 10.1016/S0140-6736(08)61589-5	38	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112188	10.1371/journal.pone.0112188	http://dx.doi.org/10.1371/journal.pone.0112188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386848	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400047
J	Raikwar, NS; Liu, KZ; Thomas, CP				Raikwar, Nandita S.; Liu, Kang Z.; Thomas, Christie P.			N-Terminal Cleavage and Release of the Ectodomain of Flt1 Is Mediated via ADAM10 and ADAM 17 and Regulated by VEGFR2 and the Flt1 Intracellular Domain	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR-1; INTRAMEMBRANE PROTEOLYSIS; SIGNAL-TRANSDUCTION; ENDOTHELIAL-CELLS; TYROSINE KINASE; METALLOPROTEINASES; ANGIOGENESIS; PREECLAMPSIA; PATHWAYS; VARIANT	Flt is one of the cell surface VEGF receptors which can be cleaved to release an N-terminal extracellular fragment which, like alternately transcribed soluble Flt1 (sFlt1), can antagonize the effects of VEGF. In HUVEC and in HEK293 cells where Flt1 was expressed, metalloprotease inhibitors reduced Flt1 N-terminal cleavage. Overexpression of ADAM10 and ADAM17 increased cleavage while knockdown of ADAM10 and ADAM17 reduced N-terminal cleavage suggesting that these metalloproteases were responsible for Flt1 cleavage. Protein kinase C (PKC) activation increased the abundance and the cleavage of Flt1 but this did not require any residues within the intracellular portion of Flt1. ALLN, a proteasomal inhibitor, increased the abundance of Flt1 which was additive to the effect of PKC. Removal of the entire cytosolic region of Flt1 appeared to stimulate cleavage of Flt1 and Flt1 was no longer sensitive to ALLN suggesting that the cytosolic region contained a degradation domain. Knock down of c-CBL, a ring finger ubiquitin ligase, in HEK293 cells increased the expression of Flt1 although it did not appear to require a previously published tyrosine residue (1333Y) in the C-terminus of Flt1. Increasing VEGFR2 expression increased VEGF-stimulated sFlt1 expression and progressively reduced the cleavage of Flt1 with Flt1 staying bound to VEGFR2 as a heterodimer. Our results imply that secreted sFlt1 and cleaved Flt1 will tend to have local effects as a VEGF antagonist when released from cells expressing VEGFR2 and more distant effects when released from cells lacking VEGFR2.	[Raikwar, Nandita S.; Liu, Kang Z.; Thomas, Christie P.] Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Thomas, Christie P.] Univ Iowa, Coll Med, Dept Pediat, Iowa City, IA 52242 USA; [Thomas, Christie P.] Univ Iowa, Coll Med, Dept Obstet, Iowa City, IA 52242 USA; [Thomas, Christie P.] Univ Iowa, Coll Med, Dept Mol & Cellular Biol, Iowa City, IA 52242 USA; [Thomas, Christie P.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Thomas, CP (corresponding author), Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA.	christie-thomas@uiowa.edu		Thomas, Christie/0000-0002-5989-9685	American Society of Nephrology; National Institutes of Health [RO1 DK090053]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090053] Funding Source: NIH RePORTER	American Society of Nephrology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	New Directions Grant from the American Society of Nephrology; RO1 DK090053 from National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai J, 2006, J BIOL CHEM, V281, P3604, DOI 10.1074/jbc.M507401200; Ciechanover A, 2012, BBA-PROTEINS PROTEOM, V1824, P3, DOI 10.1016/j.bbapap.2011.03.007; Cross MJ, 2003, TRENDS BIOCHEM SCI, V28, P488, DOI 10.1016/S0968-0004(03)00193-2; Cudmore MJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1977; Dang M, 2013, P NATL ACAD SCI USA, V110, P9776, DOI 10.1073/pnas.1307478110; Dunk C, 2001, AM J PATHOL, V158, P265, DOI 10.1016/S0002-9440(10)63965-X; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Hinkle CL, 2004, J BIOL CHEM, V279, P24179, DOI 10.1074/jbc.M312141200; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Kobayashi S, 2004, FASEB J; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Kveiborg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017168; Lal M, 2011, PHYSIOLOGY, V26, P34, DOI 10.1152/physiol.00028.2010; Lemjabbar-Alaoui H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017489; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Murphy G, 2009, SEMIN CELL DEV BIOL, V20, P138, DOI 10.1016/j.semcdb.2008.09.004; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Rahimi N, 2000, J BIOL CHEM, V275, P16986, DOI 10.1074/jbc.M000528200; Rahimi N, 2009, CANCER RES, V69, P2607, DOI 10.1158/0008-5472.CAN-08-2905; Raikwar NS, 2008, AM J PHYSIOL-RENAL, V295, pF1440, DOI 10.1152/ajprenal.90239.2008; Raikwar NS, 2013, EXP CELL RES, V319, P2578, DOI 10.1016/j.yexcr.2013.07.005; Roskoski R, 2008, BIOCHEM BIOPH RES CO, V375, P287, DOI 10.1016/j.bbrc.2008.07.121; Sawano A, 1997, BIOCHEM BIOPH RES CO, V238, P487, DOI 10.1006/bbrc.1997.7327; Thomas CP, 2009, J CLIN ENDOCR METAB, V94, P2524, DOI 10.1210/jc.2009-0017; Thomas C, 2007, ANIMAL, V1, P1, DOI 10.1017/S1751731107658467; Yanez-Mo M, 2011, BIOCHEM SOC T, V39, P541, DOI 10.1042/BST0390541; Yoda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054412	29	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112794	10.1371/journal.pone.0112794	http://dx.doi.org/10.1371/journal.pone.0112794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25387128	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400092
J	Sak, B; Petrzelkova, KJ; Kvetonova, D; Mynarova, A; Pomajbikova, K; Modry, D; Cranfield, MR; Mudakikwa, A; Kvac, M				Sak, Bohumil; Petrzelkova, Klara J.; Kvetonova, Dana; Mynarova, Anna; Pomajbikova, Katerina; Modry, David; Cranfield, Michael R.; Mudakikwa, Antoine; Kvac, Martin			Diversity of Microsporidia, Cryptosporidium and Giardia in Mountain Gorillas (Gorilla beringei beringei) in Volcanoes National Park, Rwanda	PLOS ONE			English	Article							FREE-RANGING GORILLAS; ENTEROCYTOZOON-BIENEUSI; ENCEPHALITOZOON-CUNICULI; MURIS INFECTION; GREAT APES; IDENTIFICATION; GENOTYPE; EPIDEMIOLOGY; PREVALENCE; DUODENALIS	Background: Infectious diseases represent the greatest threats to endangered species, and transmission from humans to wildlife under increased anthropogenic pressure has been always stated as a major risk of habituation. Aims: To evaluate the impact of close contact with humans on the occurrence of potentially zoonotic protists in great apes, one hundred mountain gorillas (Gorilla beringei beringei) from seven groups habituated either for tourism or for research in Volcanoes National Park, Rwanda were screened for the presence of microsporidia, Cryptosporidium spp. and Giardia spp. using molecular diagnostics. Results: The most frequently detected parasites were Enterocytozoon bieneusi found in 18 samples (including genotype EbpA, D, C, gorilla 2 and five novel genotypes gorilla 4-8) and Encephalitozoon cuniculi with genotype II being more prevalent (10 cases) compared to genotype I (1 case). Cryptosporidium muris (2 cases) and C. meleagridis (2 cases) were documented in great apes for the first time. Cryptosporidium sp. infections were identified only in research groups and occurrence of E. cuniculi in research groups was significantly higher in comparison to tourist groups. No difference in prevalence of E. bieneusi was observed between research and tourist groups. Conclusion: Although our data showed the presence and diversity of important opportunistic protists in Volcanoes gorillas, the source and the routes of the circulation remain unknown. Repeated individual sampling, broad sampling of other hosts sharing the habitat with gorillas and quantification of studied protists would be necessary to acquire more complex data.	[Sak, Bohumil; Petrzelkova, Klara J.; Kvetonova, Dana; Modry, David; Kvac, Martin] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Vvi, CR-37005 Ceske Budejovice, Czech Republic; [Petrzelkova, Klara J.] Acad Sci Czech Republ, Inst Vertebrate Biol, Vvi, Brno, Czech Republic; [Petrzelkova, Klara J.] Liberec Zoo, Liberec, Czech Republic; [Petrzelkova, Klara J.; Pomajbikova, Katerina; Modry, David] Univ Vet & Pharmaceut Sci, Fac Vet Med, Dept Pathol & Parasitol, Brno, Czech Republic; [Mynarova, Anna] Univ South Bohemia Ceske Budejovice, Fac Sci, Ceske Budejovice, Czech Republic; [Modry, David] Univ Vet & Pharmaceut Sci, CEITEC Cent European Inst Technol, Brno, Czech Republic; [Cranfield, Michael R.] Karen C Drayer Wildlife Hlth Ctr, Gorilla Doctors, Davis, CA USA; [Mudakikwa, Antoine] Rwanda Dev Board, Kigali, Rwanda; [Kvac, Martin] Univ South Bohemia Ceske Budejovice, Fac Agr, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; University of Veterinary Sciences Brno; University of South Bohemia Ceske Budejovice; University of Veterinary Sciences Brno; University of South Bohemia Ceske Budejovice	Sak, B (corresponding author), Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Vvi, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.	casio@paru.cas.cz	Jirků (Pomajbíková), Katerina/G-9858-2014; Kvac, Martin/G-7299-2014; Kvac, Martin/AAT-9533-2020; Modry, David/G-7815-2014; Petrzelkova, Klara Judita/G-7111-2014; Sak, Bohumil/G-9262-2014	Jirků (Pomajbíková), Katerina/0000-0001-5411-6082; Kvac, Martin/0000-0003-0013-6090; Modry, David/0000-0001-9649-6255; 	European Regional Development Fund [CZ.1.05/1.1.00/02.0068]; European Social Fund; state budget of the Czech Republic [OPVK CZ.1.07/2.3.00/20.0300]; Grant Agency of the Czech Republic [206/09/0927]; Praemium Academiae award	European Regional Development Fund(European Commission); European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Praemium Academiae award	This work was supported by the project "CEITEC" - Central European Institute of Technology (CZ.1.05/1.1.00/02.0068) from the European Regional Development Fund, co-financed from the European Social Fund and the state budget of the Czech Republic (project OPVK CZ.1.07/2.3.00/20.0300), by a grant from the Grant Agency of the Czech Republic (206/09/0927), and by institutional support of Institute of Vertebrate Biology Academy of Sciences of the Czech Republic (RVO:68081766). K.J.P. was also supported by the Praemium Academiae award to Julius Lukes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breitenmoser AC, 1999, PARASITOLOGY, V118, P447, DOI 10.1017/S0031182099004229; Buckholt MA, 2002, APPL ENVIRON MICROB, V68, P2595, DOI 10.1128/AEM.68.5.2595-2599.2002; Butynski Thomas M., 1998, P294, DOI 10.1002/9781444313598.ch12; Caldecott J.O., 2005, WORLD ATLAS GREAT AP; CANNING EU, 1987, PARASITOL TODAY, V3, P267, DOI 10.1016/0169-4758(87)90103-7; Didier ES, 2006, CURR OPIN INFECT DIS, V19, P485, DOI 10.1097/01.qco.0000244055.46382.23; DIDIER ES, 1995, PARASITOLOGY, V111, P411, DOI 10.1017/S0031182000065914; Dubey JP, 2002, VET PATHOL, V39, P363, DOI 10.1354/vp.39-3-363; Franzen C., 2008, OPEN PARASITOL J, V2, P1, DOI [10.2174/1874421400802010001, DOI 10.2174/1874421400802010001]; Gatei W, 2002, EMERG INFECT DIS, V8, P204, DOI 10.3201/eid0802.010256; Gatei W, 2003, J CLIN MICROBIOL, V41, P1458, DOI 10.1128/JCM.41.4.1458-1462.2003; Gatei W, 2006, AM J TROP MED HYG, V75, P78, DOI 10.4269/ajtmh.2006.75.78; Gillespie TR, 2009, ECOHEALTH, V6, P557, DOI 10.1007/s10393-010-0283-4; Gillespie TR, 2008, YEARB PHYS ANTHROPOL, V51, P53, DOI 10.1002/ajpa.20949; Goldsmith ML, 2000, AM J PHYS ANTHROPOL, P161; Goldsmith ML, 2005, GORILLA J, V30, P14; Graczyk TK, 2002, J PARASITOL, V88, P905, DOI 10.1645/0022-3395(2002)088[0905:AGDGAA]2.0.CO;2; Graczyk TK, 2002, PARASITOL RES, V88, P926, DOI 10.1007/s00436-002-0693-5; Graczyk TK, 2001, PARASITOL RES, V87, P368, DOI 10.1007/s004360000337; Gray M, 2005, BIODIVERS CONSERV, V14, P2723, DOI 10.1007/s10531-005-8406-x; Harcourt AH, 2001, BIODIVERS CONSERV, V10, P1011, DOI 10.1023/A:1016680327755; Hofmannova L, 2014, VET PARASITOL, V205, P357, DOI 10.1016/j.vetpar.2014.07.008; Hogan JN, 2014, J WILDLIFE DIS, V50, P21, DOI 10.7589/2012-09-229; Jiang JL, 2005, APPL ENVIRON MICROB, V71, P4446, DOI 10.1128/AEM.71.8.4446-4454.2005; Johnston AR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000683; Kasickova D, 2009, VET PARASITOL, V165, P125, DOI 10.1016/j.vetpar.2009.06.033; Katsumata T, 2000, AM J TROP MED HYG, V62, P70, DOI 10.4269/ajtmh.2000.62.70; KatzwinkelWladarsch S, 1996, TROP MED INT HEALTH, V1, P373, DOI 10.1046/j.1365-3156.1996.d01-51.x; Klailova M, 2010, AM J PRIMATOL, V72, P897, DOI 10.1002/ajp.20829; Kodadkova A, 2010, J PARASITOL, V96, P211, DOI 10.1645/GE-2212.1; Kotkova M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060941; Kvac M, 2009, EMERG INFECT DIS, V15, P982, DOI [10.3201/eid1506.07621, 10.3201/eid1506.071621]; Li W, 2011, J CLIN MICROBIOL, V49, P4326, DOI 10.1128/JCM.05051-11; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Maekawa M, 2013, NAT RESOUR FORUM, V37, P127, DOI 10.1111/1477-8947.12020; Mathis A, 2005, CLIN MICROBIOL REV, V18, P423, DOI 10.1128/CMR.18.3.423-445.2005; Mudakikwa A., 2001, MOUNTAIN GORILLAS 3, P341; Muthusamy D, 2006, J CLIN MICROBIOL, V44, P632, DOI 10.1128/JCM.44.2.632-634.2006; Ng J, 2006, APPL ENVIRON MICROB, V72, P7548, DOI 10.1128/AEM.01352-06; Nichols Gordon, 2007, P79, DOI 10.1201/9781420052275.ch4; Nizeyi JB, 2002, PARASITOL RES, V88, P380, DOI 10.1007/s00436-001-0543-x; Nizeyi JB, 1999, J PARASITOL, V85, P1084, DOI 10.2307/3285672; OWIUNJI I, 2005, BIODIVERSITY S UNPUB; Petrasova J, 2011, INT J PARASITOL, V41, P1113, DOI 10.1016/j.ijpara.2011.06.010; PLUMPTRE AJ, 2001, MOUNTAIN GORILLAS 3, P361; Qi M, 2011, EXP PARASITOL, V128, P336, DOI 10.1016/j.exppara.2011.04.003; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reetz J, 1993, Tierarztl Prax, V21, P429; Rinder H., 2000, Mitteilungen der Oesterreichischen Gesellschaft fuer Tropenmedizin und Parasitologie, V22, P1; ROBBINS M, 2008, IUCN 2013 IUCN RED L; Robinson G, 2008, EMERG INFECT DIS, V14, P1800, DOI 10.3201/eid1411.080239; *RWAND DEV BOARD, 2011, HIGHL NAT PARK UNPUB; Ryan U, 2003, APPL ENVIRON MICROB, V69, P4302, DOI 10.1128/AEM.69.7.4302-4307.2003; Sak B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071840; Sak B, 2011, FOLIA PARASIT, V58, P81, DOI 10.14411/fp.2011.008; Sak B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001162; Sak B, 2011, J CLIN MICROBIOL, V49, P1064, DOI 10.1128/JCM.01147-10; Sak B, 2010, VET PARASITOL, V168, P196, DOI 10.1016/j.vetpar.2009.11.012; Salyer SJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001597; Salzer JS, 2007, J PARASITOL, V93, P439, DOI 10.1645/GE-970R1.1; Santin M, 2011, RES VET SCI, V90, P363, DOI 10.1016/j.rvsc.2010.07.014; Sleeman JM, 2000, J ZOO WILDLIFE MED, V31, P322, DOI 10.1638/1042-7260(2000)031[0322:GPOMGG]2.0.CO;2; Stark D, 2009, CLIN MICROBIOL REV, V22, P634, DOI 10.1128/CMR.00017-09; Sulaiman IM, 2003, EMERG INFECT DIS, V9, P1444, DOI 10.3201/eid0911.030084; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanriverdi S, 2003, MOL BIOCHEM PARASIT, V130, P13, DOI 10.1016/S0166-6851(03)00138-5; Thellier M, 2008, PARASITE, V15, P349, DOI 10.1051/parasite/2008153349; Thompson RCA, 2004, WORLD CL PARASITES, V8, P1; VEDDER AL, 1984, AM J PRIMATOL, V7, P73, DOI 10.1002/ajp.1350070202; Wagnerova P, 2012, VET PARASITOL, V190, P573, DOI 10.1016/j.vetpar.2012.07.013; Waldron LS, 2010, EMERG INFECT DIS, V16, P2006, DOI 10.3201/eid1612.100715; WATTS DP, 1984, AM J PRIMATOL, V7, P323, DOI 10.1002/ajp.1350070403; WEBER R, 1992, AM REV RESPIR DIS, V146, P1603, DOI 10.1164/ajrccm/146.6.1603; Williamson EA, 2008, SCIENCE AND CONSERVATION IN AFRICAN FORESTS: THE BENEFITS OF LONG-TERM RESEARCH, P213; Williamson Elizabeth A., 2003, P25; Woodford MH, 2002, ORYX, V36, P153, DOI 10.1017/S0030605302000224; Zommers Z, 2013, CONSERV LETT, V6, P264, DOI 10.1111/j.1755-263X.2012.00288.x	77	34	36	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e109751	10.1371/journal.pone.0109751	http://dx.doi.org/10.1371/journal.pone.0109751			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386754	gold, Green Published, Green Submitted			2022-12-27	WOS:000345250400004
J	Schuler, E; Parris, TZ; Helou, K; Forssell-Aronsson, E				Schueler, Emil; Parris, Toshima Z.; Helou, Khalil; Forssell-Aronsson, Eva			Distinct microRNA Expression Profiles in Mouse Renal Cortical Tissue after Lu-177-octreotate Administration	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; IONIZING-RADIATION; RADIONUCLIDE THERAPY; RADIOLABELED SOMATOSTATIN; MIRNA EXPRESSION; MESSENGER-RNAS; KIDNEY TISSUE; HUMAN-CELLS; NUDE-MICE; DOSE-RATE	Aim: The aim of this study was to investigate the variation of the miRNA expression levels in normal renal cortical tissue after Lu-177-octreotate administration, a radiopharmaceutical used for treatment of neuroendocrine cancers. Methods: Female BALB/c nude mice were i.v. injected with 1.3, 3.6, 14, 45, or 140 MBq Lu-177-octreotate, while control animals received saline. The animals were killed at 24 h after injection and total RNA, including miRNA, was extracted from the renal cortical tissue and hybridized to the Mouse miRNA Oligo chip 4plex to identify differentially regulated miRNAs between exposed and control samples. Results: In total, 57 specific miRNAs were differentially regulated in the exposed renal cortical tissues with 1, 29, 21, 27, and 31 miRNAs identified per dose-level (0.13, 0.34, 1.3, 4.3, and 13 Gy, respectively). No miRNAs were commonly regulated at all dose levels. miR-194, miR-107, miR-3090, and miR-3077 were commonly regulated at 0.34, 1.3, 4.3, and 13 Gy. Strong effects on cellular mechanisms ranging from immune response to p53 signaling and cancer-related pathways were observed at the highest absorbed dose. Thirty-nine of the 57 differentially regulated miRNAs identified in the present study have previously been associated with response to ionizing radiation, indicating common radiation responsive pathways. Conclusion: In conclusion, the Lu-177-octreotate associated miRNA signatures were generally dose-specific, thereby illustrating transcriptional regulation of radiation responsive miRNAs. Taken together, these results imply the importance of miRNAs in early immunological responses in the kidneys following Lu-177-octreotate administration.	[Schueler, Emil; Forssell-Aronsson, Eva] Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Dept Radiat Phys,Inst Clin Sci,Sahlgrenska Canc C, Gothenburg, Sweden; [Parris, Toshima Z.; Helou, Khalil] Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Dept Oncol,Inst Clin Sci,Sahlgrenska Canc Ctr, Gothenburg, Sweden; [Forssell-Aronsson, Eva] Sahlgrens Univ Hosp, Dept Med Phys & Biomed Engn, Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital	Schuler, E (corresponding author), Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Dept Radiat Phys,Inst Clin Sci,Sahlgrenska Canc C, Gothenburg, Sweden.	emil.schuler@gu.se	Parris, Toshima/Q-5427-2018	Parris, Toshima/0000-0003-0834-5540; Forssell-Aronsson, Eva/0000-0002-7558-4368	Swedish Research Council [21073]; Swedish Cancer Society [3427]; BioCARE-a National Strategic Research Program at the University of Gothenburg; King Gustav V Jubilee Clinic Cancer Research Foundation; Sahlgrenska University Hospital Research Funds; Assar Gabrielsson Cancer Research Foundation; Lions cancer foundation; Adlerbertska Research Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); BioCARE-a National Strategic Research Program at the University of Gothenburg; King Gustav V Jubilee Clinic Cancer Research Foundation; Sahlgrenska University Hospital Research Funds; Assar Gabrielsson Cancer Research Foundation; Lions cancer foundation; Adlerbertska Research Foundation	This study was supported by grants from the Swedish Research Council (grant no. 21073), the Swedish Cancer Society (grant no. 3427), BioCARE-a National Strategic Research Program at the University of Gothenburg, the King Gustav V Jubilee Clinic Cancer Research Foundation, the Sahlgrenska University Hospital Research Funds, the Assar Gabrielsson Cancer Research Foundation, Lions cancer foundation, and the Adlerbertska Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ach RA, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-69; Barone R, 2005, J NUCL MED, V46, p99S; Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Chaudhry MA, 2012, MOL BIOL REP, V39, P7549, DOI 10.1007/s11033-012-1589-9; Chaudhry MA, 2010, INT J RADIAT BIOL, V86, P569, DOI 10.3109/09553001003734568; Chen J, 2011, ONCOL REP, V25, P173, DOI 10.3892/or_00001058; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dalmo J, 2012, ONCOL REP, V27, P174, DOI 10.3892/or.2011.1494; de Jong M, 2004, J NUCL MED, V45, P1168; Dickey JS, 2011, RADIAT ENVIRON BIOPH, V50, P491, DOI 10.1007/s00411-011-0386-5; Ferracin M, 2010, EXPERT REV MOL DIAGN, V10, P297, DOI 10.1586/ERM.10.11; Forssell-Aronsson E, 2013, NEUROENDOCRINOLOGY, V97, P86, DOI 10.1159/000336086; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hu HL, 2011, J MOL CELL BIOL, V3, P151, DOI 10.1093/jmcb/mjq042; Jacobs LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080844; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Joly-Tonetti N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-184; Kasinski AL, 2010, CURR OPIN MOL THER, V12, P147; Lambert B, 2004, RADIAT RES, V161, P607, DOI 10.1667/RR3105; Langen B, 2013, J NUCL MED, V54, P990, DOI 10.2967/jnumed.112.114462; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Loevinger R, 1988, MIRD PRIMER ABSORBED; Melis M, 2005, EUR J NUCL MED MOL I, V32, P1136, DOI 10.1007/s00259-005-1793-0; Melis M, 2007, NUCL MED BIOL, V34, P633, DOI 10.1016/j.nucmedbio.2007.05.002; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Metheetrairut C, 2013, CURR OPIN GENET DEV, V23, P12, DOI 10.1016/j.gde.2013.01.002; Miller WH, 2005, CANCER BIOTHER RADIO, V20, P436, DOI 10.1089/cbr.2005.20.436; Moncayo R, 2005, EUR J NUCL MED MOL I, V32, P1131, DOI 10.1007/s00259-005-1885-x; Mueller AC, 2013, ONCOGENE, V32, P1164, DOI 10.1038/onc.2012.131; Ofir M, 2011, MOL CANCER RES, V9, P440, DOI 10.1158/1541-7786.MCR-10-0344; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Osada H, 2007, CARCINOGENESIS, V28, P2, DOI 10.1093/carcin/bgl185; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; RUBIN P, 1995, INT J RADIAT ONCOL, V33, P99, DOI 10.1016/0360-3016(95)00095-G; Rudqvist N, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-32; Schuler E, 2014, NUCL MED BIOL, V41, P825, DOI 10.1016/j.nucmedbio.2014.07.010; Schuler E, 2014, NUCL MED BIOL, V41, P238, DOI 10.1016/j.nucmedbio.2013.12.001; Schuler E, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-29; Shkumatava A, 2009, GENE DEV, V23, P466, DOI 10.1101/gad.1745709; Simone NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006377; Svensson J, 2012, NUCL MED BIOL, V39, P756, DOI 10.1016/j.nucmedbio.2012.02.003; Templin T, 2012, INT J RADIAT BIOL, V88, P531, DOI 10.3109/09553002.2012.690549; Templin T, 2011, INT J RADIAT BIOL, V87, P653, DOI 10.3109/09553002.2010.549537; Vegt E, 2010, J NUCL MED, V51, P1049, DOI 10.2967/jnumed.110.075101; Wagner-Ecker M, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-25; Wan YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087782; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858; Williams J, 2003, SEMIN RADIAT ONCOL, V13, P182, DOI 10.1016/S1053-4296(03)00045-6	51	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112645	10.1371/journal.pone.0112645	http://dx.doi.org/10.1371/journal.pone.0112645			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386939	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400077
J	Fischer, MC; Foll, M; Heckel, G; Excoffier, L				Fischer, Martin C.; Foll, Matthieu; Heckel, Gerald; Excoffier, Laurent			Continental-Scale Footprint of Balancing and Positive Selection in a Small Rodent (Microtus arvalis)	PLOS ONE			English	Article							SICKLE-CELL GENE; COMMON VOLE; GENOME SCANS; POPULATION-STRUCTURE; NATURAL-SELECTION; LOCI; AFLP; POLYMORPHISMS; COLONIZATION; DIVERGENCE	Genetic adaptation to different environmental conditions is expected to lead to large differences between populations at selected loci, thus providing a signature of positive selection. Whereas balancing selection can maintain polymorphisms over long evolutionary periods and even geographic scale, thus leads to low levels of divergence between populations at selected loci. However, little is known about the relative importance of these two selective forces in shaping genomic diversity, partly due to difficulties in recognizing balancing selection in species showing low levels of differentiation. Here we address this problem by studying genomic diversity in the European common vole (Microtus arvalis) presenting high levels of differentiation between populations (average F-ST = 0.31). We studied 3,839 Amplified Fragment Length Polymorphism (AFLP) markers genotyped in 444 individuals from 21 populations distributed across the European continent and hence over different environmental conditions. Our statistical approach to detect markers under selection is based on a Bayesian method specifically developed for AFLP markers, which treats AFLPs as a nearly codominant marker system, and therefore has increased power to detect selection. The high number of screened populations allowed us to detect the signature of balancing selection across a large geographic area. We detected 33 markers potentially under balancing selection, hence strong evidence of stabilizing selection in 21 populations across Europe. However, our analyses identified four-times more markers (138) being under positive selection, and geographical patterns suggest that some of these markers are probably associated with alpine regions, which seem to have environmental conditions that favour adaptation. We conclude that despite favourable conditions in this study for the detection of balancing selection, this evolutionary force seems to play a relatively minor role in shaping the genomic diversity of the common vole, which is more influenced by positive selection and neutral processes like drift and demographic history.	[Fischer, Martin C.; Foll, Matthieu; Heckel, Gerald; Excoffier, Laurent] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland; [Fischer, Martin C.] ETH, Inst Integrat Biol, Zurich, Switzerland; [Foll, Matthieu] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland; [Foll, Matthieu; Heckel, Gerald; Excoffier, Laurent] Swiss Inst Bioinformat, Lausanne, Switzerland	University of Bern; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics	Fischer, MC (corresponding author), Univ Bern, Inst Ecol & Evolut, Bern, Switzerland.	martin.fischer@env.ethz.ch	Fischer, Martin C/D-4326-2012; Excoffier, Laurent/D-3498-2013; Foll, Matthieu/A-8561-2014; Fischer, Martin C./AAE-7287-2019	Fischer, Martin C/0000-0002-1888-1809; Excoffier, Laurent/0000-0002-7507-6494; Foll, Matthieu/0000-0001-9006-8436; Fischer, Martin C./0000-0002-1888-1809; Heckel, Gerald/0000-0002-0162-323X	University of Bern Research Foundation; Swiss National Science Foundation [3100A0-126074, 31003A-143393]	University of Bern Research Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by grants from the University of Bern Research Foundation and the Swiss National Science Foundation (grants 3100A0-126074 and 31003A-143393 to LE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; Albertson RC, 1999, P NATL ACAD SCI USA, V96, P5107, DOI 10.1073/pnas.96.9.5107; Ali HS, 2014, VIRUSES-BASEL, V6, P340, DOI 10.3390/v6010340; Allen SJ, 1997, P NATL ACAD SCI USA, V94, P14736, DOI 10.1073/pnas.94.26.14736; Amambua-Ngwa A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002992; Andres AM, 2009, MOL BIOL EVOL, V26, P2755, DOI 10.1093/molbev/msp190; Asthana S, 2005, TRENDS GENET, V21, P30, DOI 10.1016/j.tig.2004.11.001; Balding DJ, 2003, THEOR POPUL BIOL, V63, P221, DOI 10.1016/S0040-5809(03)00007-8; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Baum J, 2002, MOL BIOL EVOL, V19, P223, DOI 10.1093/oxfordjournals.molbev.a004075; Beaumont MA, 2005, TRENDS ECOL EVOL, V20, P435, DOI 10.1016/j.tree.2005.05.017; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beysard M, 2014, MOL ECOL, V23, P673, DOI 10.1111/mec.12613; Braaker S, 2009, MOL ECOL, V18, P2518, DOI 10.1111/j.1365-294X.2009.04189.x; Bubb KL, 2006, GENETICS, V173, P2165, DOI 10.1534/genetics.106.055715; Calafell F, 2008, HUM GENET, V124, P123, DOI 10.1007/s00439-008-0530-8; Caracristi G, 2003, MOL BIOL EVOL, V20, P792, DOI 10.1093/molbev/msg091; CAVALLIS.LL, 1966, PROC R SOC SER B-BIO, V164, P362, DOI 10.1098/rspb.1966.0038; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; Cho SC, 2006, GENOME RES, V16, P1366, DOI 10.1101/gr.4695306; Cork JM, 2005, GENETICS, V170, P1897, DOI 10.1534/genetics.104.036152; Cutter AD, 2013, NAT REV GENET, V14, P262, DOI 10.1038/nrg3425; Delph LF, 2014, NEW PHYTOL, V201, P45, DOI 10.1111/nph.12441; DOBZHANSKY T, 1955, COLD SPRING HARB SYM, V20, P1; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; Ellegren H, 2008, MOL ECOL, V17, P1629, DOI 10.1111/j.1365-294X.2008.03699.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; FELSENSTEIN J, 1976, ANNU REV GENET, V10, P253, DOI 10.1146/annurev.ge.10.120176.001345; Fink S, 2004, MOL ECOL, V13, P3501, DOI 10.1111/j.1365-294X.2004.02351.x; Fink S, 2010, SYST BIOL, V59, P548, DOI 10.1093/sysbio/syq042; Fischer MC, 2013, MOL ECOL, V22, P5594, DOI 10.1111/mec.12521; Fischer MC, 2011, MOL ECOL, V20, P1450, DOI 10.1111/j.1365-294X.2011.05015.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Foll M, 2010, MOL ECOL, V19, P4638, DOI 10.1111/j.1365-294X.2010.04820.x; Gaggiotti OE, 2010, MOL ECOL, V19, P4586, DOI 10.1111/j.1365-294X.2010.04821.x; Garrigan D, 2003, EVOLUTION, V57, P1707; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Hamilton G, 2005, GENETICS, V170, P409, DOI 10.1534/genetics.104.034199; Hausser J., 1995, SAUGETIERE SCHWEIZ, V103; Heckel G, 2005, EVOLUTION, V59, P2231; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; HOLM S, 1979, SCAND J STAT, V6, P65; Huang YH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004527; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; KIMURA M, 1968, GENET RES, V11, P247, DOI 10.1017/S0016672300011459; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Kimura M., 1983, P208; Klopfstein S, 2006, MOL BIOL EVOL, V23, P482, DOI 10.1093/molbev/msj057; Kosman E, 2003, PLANT PATHOL, V52, P533, DOI 10.1046/j.1365-3059.2003.00923.x; LEVENE H, 1953, AM NAT, V87, P331, DOI 10.1086/281792; LEWONTIN RC, 1973, GENETICS, V74, P175; Lischer HEL, 2014, MOL BIOL EVOL, V31, P817, DOI 10.1093/molbev/mst271; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Makinen HS, 2008, MOL ECOL, V17, P3565, DOI 10.1111/j.1365-294X.2008.03714.x; Martinkova N, 2013, MOL ECOL, V22, P5205, DOI 10.1111/mec.12462; Maruki T, 2012, MOL BIOL EVOL, V29, P3617, DOI 10.1093/molbev/mss187; Mitchell-Olds T, 2007, NAT REV GENET, V8, P845, DOI 10.1038/nrg2207; MitchellJones A.J., 1999, ATLAS EUROPEAN MAMMA; Nei M., 1987, MOL EVOLUTIONARY GEN; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Niethammer J., 1982, HDB SAUGETIERE EUROP; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Paris M, 2012, MOL ECOL, V21, P1672, DOI 10.1111/j.1365-294X.2012.05499.x; Perez-Figueroa A, 2010, J EVOLUTION BIOL, V23, P2267, DOI 10.1111/j.1420-9101.2010.02093.x; Piel FB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1104; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raj SM, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-87; Rannala B, 1996, GENET RES, V67, P147, DOI 10.1017/S0016672300033607; Rellstab C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080422; Roesti M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-94; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schlotterer C, 2003, TRENDS GENET, V19, P32, DOI 10.1016/S0168-9525(02)00012-4; Schmidt S, 2014, VECTOR BORN IN PRESS; Schmidt-Chanasit J, 2010, J VIROL, V84, P459, DOI 10.1128/JVI.01226-09; SCHROEDER SA, 1995, NAT MED, V1, P703, DOI 10.1038/nm0795-703; Schweizer M, 2007, MOL ECOL, V16, P2463, DOI 10.1111/j.1365-294X.2007.03284.x; Storz JF, 2010, SCIENCE, V329, P40, DOI 10.1126/science.1192481; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; Sutter A, 2013, HEREDITY, V110, P398, DOI 10.1038/hdy.2012.124; Tan Z, 2005, HUM MOL GENET, V14, P3619, DOI 10.1093/hmg/ddi389; Tautz D, 2010, MOL ECOL, V19, P1, DOI 10.1111/j.1365-294X.2009.04489.x; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Thomas JC, 2012, MOL BIOL EVOL, V29, P1175, DOI 10.1093/molbev/msr286; Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515; Ulrich RG, 2009, BUNDESGESUNDHEITSBLA, V52, P352, DOI 10.1007/s00103-009-0798-4; Ulrich RG, 2008, PARASITOL RES, V103, pS121, DOI 10.1007/s00436-008-1054-9; Verrelli BC, 2002, AM J HUM GENET, V71, P1112, DOI 10.1086/344345; Vitalis R, 2003, J HERED, V94, P429, DOI 10.1093/jhered/esg083; Vitalis R, 2001, GENETICS, V158, P1811; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Weedall GD, 2010, TRENDS PARASITOL, V26, P363, DOI 10.1016/j.pt.2010.04.002; Wooding S, 2005, AM J HUM GENET, V76, P291, DOI 10.1086/427927	98	13	13	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112332	10.1371/journal.pone.0112332	http://dx.doi.org/10.1371/journal.pone.0112332			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383542	Green Published, Green Submitted, gold			2022-12-27	WOS:000344816700051
J	Lin, LC; Vanier, DR; London, SE				Lin, Lynda C.; Vanier, David R.; London, Sarah E.			Social Information Embedded in Vocalizations Induces Neurogenomic and Behavioral Responses	PLOS ONE			English	Article							FEMALE ZEBRA-FINCHES; SONG CONTROL-SYSTEM; TAENIOPYGIA-GUTTATA; GENE-EXPRESSION; MATE CHOICE; AROMATASE EXPRESSION; ADULT FEMALE; BRAIN; ARC; DISCRIMINATION	Social cues facilitate relationships within communities. Zebra finches form long-term stable mate pairs and produce offspring within a multi-family, multi-generational community that can include hundreds of birds. Males use song to communicate in this complex environment. Males sing as part of their courtship display but also abundantly throughout each day, suggesting a role for their vocal signature outside of a reproductive context. One advantage of a vocal social cue is that it can be exchanged when birds are out of visual contact, as regularly occurs in a zebra finch community. Previous works have demonstrated that females hearing song are affected by their social relationship to the bird singing it, and the immediate social context. Here, we probed the question of whether or not the song itself carried social information, as would be expected from the situations when males sing outside of view of the female. We quantified behavioral and neurogenomic responses to two songs we predicted would have distinct "attractive'' qualities in adult females housed in either mixed sex or female-only social communities. Our results show that only mixed sex-housed females show distinctive behavioral and neurogenomic responses to attractive songs. These data are consistent with the idea that the acoustic properties of song carry social information, and that the current social situation modulates the neural and behavioral responses to these signals.	[Lin, Lynda C.; Vanier, David R.; London, Sarah E.] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; [London, Sarah E.] Univ Chicago, Inst Mind & Biol, Chicago, IL 60637 USA; [London, Sarah E.] Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	London, SE (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA.	london@uchicago.edu		London, Sarah/0000-0002-7839-2644	David Greenstone Fund; University of Chicago; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	David Greenstone Fund; University of Chicago(University of Chicago); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by The David Greenstone Fund and The University of Chicago (to SEL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey DJ, 2005, BEHAV BRAIN RES, V162, P108, DOI 10.1016/j.bbr.2005.03.016; Balzer AL, 1998, BEHAVIOUR, V135, P297, DOI 10.1163/156853998793066230; Blumstein D. T., 2007, QUANTIFYING BEHAV JW; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Brazas ML, 2002, ANIM COGN, V5, P91, DOI 10.1007/s10071-002-0136-9; Buchanan KL, 2003, P ROY SOC B-BIOL SCI, V270, P1149, DOI 10.1098/rspb.2003.2330; Caras ML, 2012, J NEUROSCI, V32, P17597, DOI 10.1523/JNEUROSCI.3938-12.2012; Martinez MC, 2012, NEUROBIOL LEARN MEM, V98, P165, DOI 10.1016/j.nlm.2012.05.007; Chen YC, 2005, J NEUROBIOL, V64, P4, DOI 10.1002/neu.20150; CLAYTON N, 1989, ANIM BEHAV, V38, P352, DOI 10.1016/S0003-3472(89)80096-X; Dong S, 2008, GENES BRAIN BEHAV, V7, P802, DOI 10.1111/j.1601-183X.2008.00423.x; Dong S, 2009, P NATL ACAD SCI USA, V106, P11364, DOI 10.1073/pnas.0812998106; Freking F, 2000, GEN COMP ENDOCR, V119, P140, DOI 10.1006/gcen.2000.7503; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Hauber ME, 2010, EMU, V110, P209, DOI 10.1071/MU10003; Holveck MJ, 2007, ANIM BEHAV, V74, P297, DOI 10.1016/j.anbehav.2006.08.016; Korb E, 2011, TRENDS NEUROSCI, V34, P591, DOI 10.1016/j.tins.2011.08.007; Lauay C, 2005, J COMP NEUROL, V487, P119, DOI 10.1002/cne.20591; Lauay C, 2004, ANIM BEHAV, V68, P1249, DOI 10.1016/j.anbehav.2003.12.025; Leadbeater E, 2005, ANIM BEHAV, V70, P909, DOI 10.1016/j.anbehav.2005.02.007; Lohr B, 1998, J COMP PSYCHOL, V112, P36, DOI 10.1037/0735-7036.112.1.36; London SE, 2008, NAT NEUROSCI, V11, P579, DOI 10.1038/nn.2103; London SE, 2006, ENDOCRINOLOGY, V147, P5975, DOI 10.1210/en.2006-0154; MELLO C, 1995, J NEUROSCI, V15, P6919; Mello CV, 2004, FRONT BIOSCI, V9, P63, DOI 10.2741/1201; MELLO CV, 1994, J NEUROSCI, V14, P6652; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; Neubauer RL, 1999, EVOL ECOL, V13, P365, DOI 10.1023/A:1006708826432; Nowicki S, 2005, AUK, V122, P1, DOI 10.1642/0004-8038(2005)122[0001:SAMCIB]2.0.CO;2; Nowicki S, 2004, ANN NY ACAD SCI, V1016, P704, DOI 10.1196/annals.1298.012; Okuno H, 2012, CELL, V149, P886, DOI 10.1016/j.cell.2012.02.062; Okuno Hiroyuki, 2004, Tanpakushitsu Kakusan Koso, V49, P411; Remage-Healey L, 2008, NAT NEUROSCI, V11, P1327, DOI 10.1038/nn.2200; Riebel K, 2009, ADV STUD BEHAV, V40, P197, DOI 10.1016/S0065-3454(09)40006-8; Riters LV, 2004, BEHAV BRAIN RES, V155, P307, DOI 10.1016/j.bbr.2004.05.002; Saldanha CJ, 2000, J COMP NEUROL, V423, P619, DOI 10.1002/1096-9861(20000807)423:4<619::AID-CNE7>3.0.CO;2-U; Sanders J, 2012, J NEUROSCI, V32, P12570, DOI 10.1523/JNEUROSCI.1131-12.2012; SHEN P, 1994, MOL BRAIN RES, V24, P227, DOI 10.1016/0169-328X(94)90136-8; SOSSINKA R, 1980, J EXP ZOOL, V211, P225, DOI 10.1002/jez.1402110211; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Stripling R, 2003, NEUROBIOL LEARN MEM, V79, P41, DOI 10.1016/S1074-7427(02)00005-9; Svec LA, 2009, BEHAV BRAIN RES, V199, P298, DOI 10.1016/j.bbr.2008.12.006; Tchernichovski O, 1998, ANIM BEHAV, V55, P1003, DOI 10.1006/anbe.1997.0673; Tchernichovski O, 2004, ANN NY ACAD SCI, V1016, P348, DOI 10.1196/annals.1298.031; Tomaszycki ML, 2005, ANIM BEHAV, V70, P785, DOI 10.1016/j.anbehav.2005.01.010; Tremere LA, 2011, J NEUROSCI, V31, P3271, DOI 10.1523/JNEUROSCI.4355-10.2011; VALLET E, 1995, ANIM BEHAV, V49, P1603, DOI 10.1016/0003-3472(95)90082-9; Velho TAF, 2005, EUR J NEUROSCI, V22, P1667, DOI 10.1111/j.1460-9568.2005.04369.x; Vignal C, 2005, EUR J NEUROSCI, V22, P949, DOI 10.1111/j.1460-9568.2005.04254.x; Vyas A, 2009, HORM BEHAV, V55, P50, DOI 10.1016/j.yhbeh.2008.08.005; Woodgate JL, 2012, ANIM BEHAV, V83, P773, DOI 10.1016/j.anbehav.2011.12.027; Woolley SC, 2008, PLOS BIOL, V6, P525, DOI 10.1371/journal.pbio.0060062	52	4	4	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112905	10.1371/journal.pone.0112905	http://dx.doi.org/10.1371/journal.pone.0112905			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384071	Green Published, Green Submitted, gold			2022-12-27	WOS:000344816700104
J	Zhang, J; Yu, HC; Zhang, Y; Zhang, XS; Zheng, GX; Gao, Y; Wang, CX; Zhou, LQ				Zhang, Jian; Yu, Hongchen; Zhang, Yi; Zhang, Xiaoshi; Zheng, Guixin; Gao, Yang; Wang, Chuanxin; Zhou, Liqing			A Functional TNFAIP2 3 '-UTR rs8126 Genetic Polymorphism Contributes to Risk of Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; CANCER; CHINA; VARIANTS; PLCE1; ALPHA	Background: Accumulated evidences demonstrated that single nucleotide polymorphisms (SNPs) in mRNA 3'-untranslated region (3'-UTR) may impact microRNAs (miRNAs)-mediated expression regulation of oncogenes and tumor suppressors. There is a TNFAIP2 3'-UTR rs8126 T>C genetic variant which has been proved to be associated with head and neck cancer susceptibility. This SNP could disturb binding of miR-184 with TNFAIP2 mRNA and influence TNFAIP2 regulation. However, it is still unclear how this polymorphism is involved in development of esophageal squamous cell carcinoma (ESCC). Therefore, we hypothesized that the functional TNFAIP2 rs8126 SNP may affect TNFAIP2 expression and, thus, ESCC risk. Methods: We investigated the association between the TNFAIP2 rs8126 variant and ESCC risk as well as the functional relevance on TNFAIP2 expression in vivo. Genotypes were determined in a case-control set consisted of 588 ESCC patients and 600 controls. The allele-specific regulation on TNFAIP2 expression by the rs8126 SNP was examined in normal and cancerous tissue specimens of esophagus. Results: We found that individuals carrying the rs8126 CC or CT genotype had an OR of 1.89 (95%CI = 1.23-2.85, P = 0.003) or 1.38 (95%CI = 1.05-1.73, P = 0.017) for developing ESCC in Chinese compared with individual carrying the TT genotype. Carriers of the rs8126 CC and CT genotypes had significantly lower TNFAIP2 mRNA levels than those with the TT genotypes in normal esophagus tissues (P<0.05). Conclusions: Our data demonstrate that functional TNFAIP2 rs8126 genetic variant is a ESCC susceptibility SNP. These results support the hypothesis that genetic variants interrupting miRNA-mediated gene regulation might be important genetic modifiers of cancer risk.	[Zhang, Jian; Zhang, Yi; Zhang, Xiaoshi; Zheng, Guixin; Gao, Yang; Wang, Chuanxin] Shandong Univ, Qilu Hosp, Dept Clin Lab, Jinan 250100, Shandong, Peoples R China; [Yu, Hongchen] Shandong Univ, Qingdao Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Zhou, Liqing] Huaian 2 Hosp, Dept Radiat Oncol, Huaian, Jiangsu, Peoples R China	Shandong University; Shandong University	Wang, CX (corresponding author), Shandong Univ, Qilu Hosp, Dept Clin Lab, Jinan 250100, Shandong, Peoples R China.	cxwangsd@163.com; zlq-hill@163.com						Abnet CC, 2012, HUM MOL GENET, V21, P2132, DOI 10.1093/hmg/dds029; Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Chen LC, 2011, MODERN PATHOL, V24, P175, DOI 10.1038/modpathol.2010.193; Cui R, 2009, GASTROENTEROLOGY, V137, P1768, DOI 10.1053/j.gastro.2009.07.070; GAO YT, 1994, INT J CANCER, V58, P192, DOI 10.1002/ijc.2910580208; HU JF, 1994, INT J CANCER, V57, P38, DOI 10.1002/ijc.2910570108; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Lehmann U, 2001, METHODS, V25, P409, DOI 10.1006/meth.2001.1263; Liu L, 2012, CARCINOGENESIS, V33, P119, DOI 10.1093/carcin/bgr250; Liu ZS, 2011, CARCINOGENESIS, V32, P1668, DOI 10.1093/carcin/bgr209; Ma Y, 2003, ONCOGENE, V22, P4924, DOI 10.1038/sj.onc.1206728; Park DJ, 2003, BLOOD, V102, P3727, DOI 10.1182/blood-2003-02-0412; Rusiniak ME, 2000, CANCER RES, V60, P1824; SARMA V, 1992, J IMMUNOL, V148, P3302; Venkitaraman AR, 2009, ANNU REV PATHOL-MECH, V4, P461, DOI 10.1146/annurev.pathol.3.121806.151422; Wang JF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0104882, 10.1371/journal.pone.0094096]; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wu C, 2012, NAT GENET, V44, P1090, DOI 10.1038/ng.2411; Wu C, 2011, NAT GENET, V43, P679, DOI 10.1038/ng.849; Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064973; Zhang XJ, 2013, CARCINOGENESIS, V34, P2309, DOI 10.1093/carcin/bgt213; Zhou LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064331	22	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e109318	10.1371/journal.pone.0109318	http://dx.doi.org/10.1371/journal.pone.0109318			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383966	Green Submitted, Green Published, gold			2022-12-27	WOS:000344816700004
J	Babeluk, R; Jutz, S; Mertlitz, S; Matiasek, J; Klaus, C				Babeluk, Rita; Jutz, Sabrina; Mertlitz, Sarah; Matiasek, Johannes; Klaus, Christoph			Hand Hygiene - Evaluation of Three Disinfectant Hand Sanitizers in a Community Setting	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; HEALTH-CARE; ALCOHOL; EFFICACY; INFECTION; INTERVENTION; PROGRAM; RISK; SOAP; RUBS	Hand hygiene is acknowledged as the single most important measure to prevent nosocomial infections in the healthcare setting. Similarly, in non-clinical settings, hand hygiene is recognised as a key element in helping prevent the spread of infectious diseases. The aim of this study was to evaluate the efficacy of three different disinfectant hand sanitizers in reducing the burden of bacterial hand contamination in 60 healthy volunteers in a community setting, both before and after education about the correct use of hand sanitizers. The study is the first to evaluate the efficacy and ease of use of different formulations of hand rubs used by the general population. The products tested were: Sterillium (perfumed, liquid), desderman pure gel (odorless, gel) and Lavit (perfumed, spray). Sterillium and desderman are EN1500 (hygienic hand rub) certified products (available in pharmacy) and Lavit is non EN1500 certified and available in supermarkets. The two EN1500 certified products were found to be significantly superior in terms of reducing bacterial load. desderman pure gel, Sterillium and Lavit reduced the bacterial count to 6.4%, 8.2% and 28.0% respectively. After education in the correct use of each hand rub, the bacterial load was reduced even further, demonstrating the value of education in improving hand hygiene. Information about the testers' perceptions of the three sanitizers, together with their expectations of a hand sanitizer was obtained through a questionnaire. Efficacy, followed by skin compatibility were found to be the two most important attributes of a hand disinfectant in our target group.	[Babeluk, Rita] Med Univ Vienna, Dept Surg, Vienna, Austria; [Jutz, Sabrina; Mertlitz, Sarah] Univ Appl Sci Campus Vienna, Dept Biotechnol, Vienna, Austria; [Matiasek, Johannes] Wilhelminen Hosp Vienna, Dept Plast Aesthet & Reconstruct Surg, Vienna, Austria; [Klaus, Christoph] Schulke & Mayr GmbH, Int Sci Affairs, Vienna, Austria	Medical University of Vienna; Wilhelminenspital	Klaus, C (corresponding author), Schulke & Mayr GmbH, Int Sci Affairs, Vienna, Austria.	christoph.klaus@schuelke.com		Mertlitz, Sarah/0000-0002-7245-5616	Schulke Mayr	Schulke Mayr	HYCON plates PA (Merck) were provided by Schulke & Mayr Ges.m.b.H. Schulke & Mayr provided support in the form of salaries for author CK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aiello AE, 2008, AM J PUBLIC HEALTH, V98, P1372, DOI 10.2105/AJPH.2007.124610; [Anonymous], DIN EN 1500 2013; Barbut F, 2007, J HOSP INFECT, V66, P167, DOI 10.1016/j.jhin.2007.03.021; Best M, 2004, QUAL SAF HEALTH CARE, V13, P233, DOI 10.1136/qshc.2004.010918; Cartner T, 2013, HIGH COMPLIANCE ALCO; COREN S, 1977, SCIENCE, V198, P631, DOI 10.1126/science.335510; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; Erasmus V, 2010, J HOSP INFECT, V76, P161, DOI 10.1016/j.jhin.2010.04.024; Harrington G, 2007, INFECT CONT HOSP EP, V28, P837, DOI 10.1086/518844; Hilburn J, 2003, AM J INFECT CONTROL, V31, P109, DOI 10.1067/mic.2003.15; Johnson PDR, 2005, MED J AUSTRALIA, V183, P509, DOI 10.5694/j.1326-5377.2005.tb07151.x; Judah G, 2009, AM J PUBLIC HEALTH, V99, pS405, DOI 10.2105/AJPH.2009.164160; Kampf G, 2004, CLIN MICROBIOL REV, V17, P863, DOI 10.1128/CMR.17.4.863-893.2004; Kramer A, 2002, LANCET, V359, P1489, DOI 10.1016/S0140-6736(02)08426-X; Larson EL, 2000, BEHAV MED, V26, P14, DOI 10.1080/08964280009595749; Larson EL, 1998, AM J INFECT CONTROL, V26, P513, DOI 10.1016/S0196-6553(98)70025-2; LAUHARANTA J, 1991, J HOSP INFECT, V17, P207, DOI 10.1016/0195-6701(91)90232-W; Loffler H, 2007, BRIT J DERMATOL, V157, P74, DOI 10.1111/j.1365-2133.2007.07944.x; Nagtegaal MJC, 2012, CONTACT DERMATITIS, V67, P28, DOI 10.1111/j.1600-0536.2012.02055.x; Neuhauser D, 2003, QUAL SAF HEALTH CARE, V12, P317, DOI 10.1136/qhc.12.4.317; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Pittet D, 2009, INFECT CONT HOSP EP, V30, P611, DOI 10.1086/600379; Randle J, 2013, J HOSP INFECT, V85, P220, DOI 10.1016/j.jhin.2013.07.013; Randle J, 2010, J HOSP INFECT, V76, P252, DOI 10.1016/j.jhin.2010.06.027; Son C, 2011, AM J INFECT CONTROL, V39, P716, DOI 10.1016/j.ajic.2010.12.008; Suchomel M, 2013, J HOSP INFECT, V83, P284, DOI 10.1016/j.jhin.2012.11.030; Tambekar D, 2007, CONT J BIOMED SCI, V1, P6; WHO, 2000, WORLD HLTH REP 2000, P164; Winnefeld M, 2000, BRIT J DERMATOL, V143, P546	29	24	24	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111969	10.1371/journal.pone.0111969	http://dx.doi.org/10.1371/journal.pone.0111969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379773	Green Submitted, Green Published, gold			2022-12-27	WOS:000344863100049
J	Chambers, KF; Mosaad, EMO; Russell, PJ; Clements, JA; Doran, MR				Chambers, Karen F.; Mosaad, Eman M. O.; Russell, Pamela J.; Clements, Judith A.; Doran, Michael R.			3D Cultures of Prostate Cancer Cells Cultured in a Novel High-Throughput Culture Platform Are More Resistant to Chemotherapeutics Compared to Cells Cultured in Monolayer	PLOS ONE			English	Article							GENE-EXPRESSION; SOLID TUMORS; EXTRACELLULAR-MATRIX; METABOLIC-ACTIVITY; STROMAL CELLS; STEM-CELLS; TISSUE; EPITHELIUM; DIFFERENTIATION; MORPHOGENESIS	Despite monolayer cultures being widely used for cancer drug development and testing, 2D cultures tend to be hypersensitive to chemotherapy and are relatively poor predictors of whether a drug will provide clinical benefit. Whilst generally more complicated, three dimensional (3D) culture systems often better recapitulate true cancer architecture and provide a more accurate drug response. As a step towards making 3D cancer cultures more accessible, we have developed a microwell platform and surface modification protocol to enable high throughput manufacture of 3D cancer aggregates. Herein we use this novel system to characterize prostate cancer cell microaggregates, including growth kinetics and drug sensitivity. Our results indicate that prostate cancer cells are viable in this system, however some non-cancerous prostate cell lines are not. This system allows us to consistently control for the presence or absence of an apoptotic core in the 3D cancer microaggregates. Similar to tumor tissues, the 3D microaggregates display poor polarity. Critically the response of 3D microaggregates to the chemotherapeutic drug, docetaxel, is more consistent with in vivo results than the equivalent 2D controls. Cumulatively, our results demonstrate that these prostate cancer microaggregates better recapitulate the morphology of prostate tumors compared to 2D and can be used for high-throughput drug testing.	[Chambers, Karen F.; Mosaad, Eman M. O.; Doran, Michael R.] Queensland Univ Technol, Translat Res Inst, Stem Cell Therapies Lab, Brisbane, Qld 4001, Australia; [Chambers, Karen F.; Mosaad, Eman M. O.; Russell, Pamela J.; Clements, Judith A.; Doran, Michael R.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Chambers, Karen F.; Mosaad, Eman M. O.; Russell, Pamela J.; Clements, Judith A.; Doran, Michael R.] Translat Res Inst, Australian Prostate Canc Res Ctr, Brisbane, Qld, Australia; [Doran, Michael R.] Univ Queensland, Translat Res Inst, Mater Res Inst, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); Mater Research; University of Queensland	Doran, MR (corresponding author), Queensland Univ Technol, Translat Res Inst, Stem Cell Therapies Lab, Brisbane, Qld 4001, Australia.	michael.doran@qut.edu.au	Russell, Pamela/O-8504-2019; Russell, Pamela J/G-1685-2010	Russell, Pamela J/0000-0002-3995-1239; Chambers, Karen/0000-0002-6216-4794; Doran, Michael/0000-0001-5876-4757; Clements, Judith/0000-0001-6026-1964; Mosaad, Eman/0000-0001-6030-9796	Movember New Concept awarded through Prostate Cancer Foundation of Australia's Research Program [NCG 3212]; National Health and Medical Research Council of Australia Principal Research Fellowship	Movember New Concept awarded through Prostate Cancer Foundation of Australia's Research Program; National Health and Medical Research Council of Australia Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	MRD is funded by a Movember New Concept Grant (NCG 3212) awarded through Prostate Cancer Foundation of Australia's Research Program (http://www.prostate.org.au). JAC is supported by a National Health and Medical Research Council of Australia Principal Research Fellowship (http://www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatangelo MD, 2005, AM J PATHOL, V167, P475, DOI 10.1016/S0002-9440(10)62991-4; Au JLS, 2001, J CONTROL RELEASE, V74, P31, DOI 10.1016/S0168-3659(01)00308-X; Babur BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058865; Ballangrud AM, 1999, CLIN CANCER RES, V5, p3171S; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Bello-DeOcampo D, 2001, MUTAT RES-FUND MOL M, V480, P209, DOI 10.1016/S0027-5107(01)00201-9; Bissell M J, 1981, Int Rev Cytol, V70, P27, DOI 10.1016/S0074-7696(08)61130-4; Chambers KF, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-45; Chambers KF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018796; Chambers KF, 2009, PROSTATE, V69, P1411, DOI 10.1002/pros.20986; Cook MM, 2012, TISSUE ENG PART C-ME, V18, P319, DOI [10.1089/ten.tec.2011.0159, 10.1089/ten.TEC.2011.0159]; Doran MR, 2010, TISSUE ENG PART C-ME, V16, P407, DOI [10.1089/ten.tec.2009.0367, 10.1089/ten.TEC.2009.0367]; Dow LE, 2007, ONCOGENE, V26, P2272, DOI 10.1038/sj.onc.1210016; Dufau I, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-15; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Grantab R, 2006, CANCER RES, V66, P1033, DOI 10.1158/0008-5472.CAN-05-3077; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Hakanson M, 2011, INTEGR BIOL-UK, V3, P31, DOI 10.1039/c0ib00074d; Hartman O, 2010, BIOMATERIALS, V31, P5700, DOI 10.1016/j.biomaterials.2010.03.017; Hebner C, 2008, ANNU REV PATHOL-MECH, V3, P313, DOI 10.1146/annurev.pathmechdis.3.121806.151526; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Hongisto V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077232; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; HOWLETT AR, 1993, EPITHELIAL CELL BIOL, V2, P79; Kabiri M, 2012, BIOCHEM BIOPH RES CO, V419, P142, DOI 10.1016/j.bbrc.2012.01.017; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kim JE, 2011, P NATL ACAD SCI USA, V108, P3005, DOI 10.1073/pnas.1007753108; Kollmannsberger P, 2011, SOFT MATTER, V7, P9549, DOI 10.1039/c1sm05588g; Li Q, 2011, J BIOMOL SCREEN, V16, P141, DOI 10.1177/1087057110392995; Mackler NJ, 2005, NAT CLIN PRACT UROL, V2, P92, DOI 10.1038/ncpuro0099; Markway BD, 2010, CELL TRANSPLANT, V19, P29, DOI 10.3727/096368909X478560; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Montero A, 2005, LANCET ONCOL, V6, P229, DOI 10.1016/S1470-2045(05)70094-2; Ochsner M, 2007, LAB CHIP, V7, P1074, DOI 10.1039/b704449f; Ohmori T, 1998, EXP CELL RES, V245, P350, DOI 10.1006/excr.1998.4261; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Plachot C, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-77; Quent VMC, 2010, J CELL MOL MED, V14, P1003, DOI 10.1111/j.1582-4934.2010.01013.x; Rhee S, 2007, ADV DRUG DELIVER REV, V59, P1299, DOI 10.1016/j.addr.2007.08.006; Sieh S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040217; Takagi A, 2007, ANTICANCER RES, V27, P45; Winkenwerder JJ, 2003, ONCOL REP, V10, P783; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G	43	65	66	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111029	10.1371/journal.pone.0111029	http://dx.doi.org/10.1371/journal.pone.0111029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380249	gold, Green Published, Green Submitted			2022-12-27	WOS:000344863100017
J	Clark-Knowles, KV; Dewar-Darch, D; Jardine, KE; McBurney, MW				Clark-Knowles, Katherine V.; Dewar-Darch, Danielle; Jardine, Karen E.; McBurney, Michael W.			Modulation of Tumorigenesis by Dietary Intervention Is Not Mediated by SIRT1 Catalytic Activity	PLOS ONE			English	Article							PROTEIN DEACETYLASE ACTIVITY; BREAST-CANCER; CELL-SURVIVAL; CALORIE RESTRICTION; HISTONE DEACETYLASE; PROSTATE-CANCER; RESVERATROL; MICE; METASTASIS; GROWTH	The protein deacetylase SIRT1 is involved in the regulation of a large number of cellular processes that are thought to be required for cancer initiation and progression. Both SIRT1 activity and tumorigenesis can be influenced by dietary fat and polyphenolics. We set out to determine whether dietary modulations of tumorigenesis are mediated by SIRT1 catalytic functions. We introduced a mammary gland tumor-inducing transgene, MMTV-PyMT, into stocks of mice bearing a H355Y point mutation in the Sirt1 gene that abolishes SIRT1 catalytic activity. Tumor latency was reduced in animals fed a high fat diet but this effect was not dependent on SIRT1 activity. Resveratrol had little effect on tumor formation except in animals heterozygous for the mutant Sirt1 gene. We conclude that the effects of these dietary interventions on tumorigenesis are not mediated by modulation of SIRT1 catalytic activity.	[Clark-Knowles, Katherine V.; Dewar-Darch, Danielle; Jardine, Karen E.; McBurney, Michael W.] Ottawa Hosp Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada; [McBurney, Michael W.] Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Clark-Knowles, KV (corresponding author), Ottawa Hosp Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada.	kaclark@ohri.ca			Canadian Institute of Health Research [74511]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institute of Health Research #74511 (www.cihr.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2012, AM J HUM BIOL, V24, P101, DOI 10.1002/ajhb.22243; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beane J, 2012, CANCER RES, V72, P5702, DOI 10.1158/0008-5472.CAN-12-1043; BERNSTEIN L, 1993, EPIDEMIOL REV, V15, P48, DOI 10.1093/oxfordjournals.epirev.a036116; Bhat KPL, 2001, CANCER RES, V61, P7456; Block G, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-30; Boily G, 2009, ONCOGENE, V28, P2882, DOI 10.1038/onc.2009.147; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Bugge TH, 1998, ONCOGENE, V16, P3097, DOI 10.1038/sj.onc.1201869; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Caron AZ, 2014, FASEB J, V28, P1306, DOI 10.1096/fj.13-243568; Castillo-Pichardo L, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-6; Chalkiadaki A, 2012, CELL METAB, V16, P180, DOI 10.1016/j.cmet.2012.07.003; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Clark-Knowles KV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082106; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Dabrosin C, 2003, BREAST CANCER RES TR, V78, P1, DOI 10.1023/A:1022133219353; Dai JM, 2007, J CELL PHYSIOL, V210, P161, DOI 10.1002/jcp.20831; Elangovan S, 2011, CANCER RES, V71, P6654, DOI 10.1158/0008-5472.CAN-11-1446; Enns LC, 2012, J CANC THERAPY, V3, P718; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Han J, 2013, CELL CYCLE, V12, P263, DOI 10.4161/cc.23056; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herranz D, 2013, ONCOGENE, V32, P4052, DOI 10.1038/onc.2012.407; Herranz D, 2010, NAT REV CANCER, V10, P819, DOI 10.1038/nrc2962; Hsieh TC, 2012, CARCINOGENESIS, V33, P670, DOI 10.1093/carcin/bgs016; Hu Y, 2011, FREE RADICAL BIO MED, V51, P250, DOI 10.1016/j.freeradbiomed.2011.04.034; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Imai S, 2009, CELL BIOCHEM BIOPHYS, V53, P65, DOI 10.1007/s12013-008-9041-4; Jang SH, 2012, J CLIN PATHOL, V65, P735, DOI 10.1136/jclinpath-2012-200685; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lee H, 2011, HUM PATHOL, V42, P204, DOI 10.1016/j.humpath.2010.05.023; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Llaverias G, 2011, AM J PATHOL, V178, P402, DOI 10.1016/j.ajpath.2010.11.005; Longo VD, 2009, EXP GERONTOL, V44, P70, DOI 10.1016/j.exger.2008.06.005; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; McBurney Michael W, 2013, Genes Cancer, V4, P125, DOI 10.1177/1947601912474893; Menzies KJ, 2013, J BIOL CHEM, V288, P6968, DOI 10.1074/jbc.M112.431155; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Ming M, 2015, ONCOGENE, V34, P281, DOI 10.1038/onc.2013.583; Moore RL, 2013, J ENDOCRINOL, V216, P273, DOI 10.1530/JOE-12-0102; Morris BJ, 2013, FREE RADICAL BIO MED, V56, P133, DOI 10.1016/j.freeradbiomed.2012.10.525; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Park S, 2012, ENDOCRINOLOGY, V153, P3982, DOI 10.1210/en.2012-1044; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Santidrian AF, 2013, J CLIN INVEST, V123, P1068, DOI 10.1172/JCI64264; Seifert EL, 2012, FASEB J, V26, P555, DOI 10.1096/fj.11-193979; Sestito R, 2011, FASEB J, V25, P916, DOI 10.1096/fj.10-172288; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Song NY, 2012, ANN NY ACAD SCI, V1271, P10, DOI 10.1111/j.1749-6632.2012.06762.x; Stuenkel Walter, 2007, Biotechnology Journal, V2, P1360, DOI 10.1002/biot.200700087; Suter MA, 2012, FASEB J, V26, P5106, DOI 10.1096/fj.12-212878; Suzuki K, 2012, ONCOL REP, V27, P1726, DOI 10.3892/or.2012.1750; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Villalba JM, 2012, BIOFACTORS, V38, P349, DOI 10.1002/biof.1032; Wakeling LA, 2012, FASEB J, V26; Wang RH, 2008, MOL CELL, V32, P11, DOI 10.1016/j.molcel.2008.09.011; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wong S, 2007, BIOCHEM J, V407, P451, DOI 10.1042/BJ20070151; Wu MQ, 2012, MED ONCOL, V29, P3240, DOI 10.1007/s12032-012-0260-6; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; Yao Y, 2010, CARCINOGENESIS, V31, P382, DOI 10.1093/carcin/bgp308; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yuan J, 2009, J CELL BIOL, V185, P203, DOI 10.1083/jcb.200809167; Yun JM, 2012, J NUTR BIOCHEM, V23, P699, DOI 10.1016/j.jnutbio.2011.03.012; Zhang JD, 2006, BIOCHEM J, V397, P519, DOI 10.1042/BJ20050977	74	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112406	10.1371/journal.pone.0112406	http://dx.doi.org/10.1371/journal.pone.0112406			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380034	Green Published, Green Submitted, gold			2022-12-27	WOS:000344863100085
J	Waggoner, JJ; Balassiano, I; Abeynayake, J; Sahoo, MK; Mohamed-Hadley, A; Liu, YY; Vital-Brazil, JM; Pinsky, BA				Waggoner, Jesse J.; Balassiano, Ilana; Abeynayake, Janaki; Sahoo, Malaya K.; Mohamed-Hadley, Alisha; Liu, Yuanyuan; Vital-Brazil, Juliana Magalhaes; Pinsky, Benjamin A.			Sensitive Real-Time PCR Detection of Pathogenic Leptospira spp. and a Comparison of Nucleic Acid Amplification Methods for the Diagnosis of Leptospirosis	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MEDIATED ISOTHERMAL AMPLIFICATION; TESTS; IDENTIFICATION; ASSAY; TOOL; VALIDATION; CULTURE	Background: Bacteria of the genus Leptospira, the causative agents of leptospirosis, are categorized into pathogenic and non-pathogenic species. However, the benefit of using a clinical diagnostic that is specific for pathogenic species remains unclear. In this study, we present the development of a real-time PCR (rtPCR) for the detection of pathogenic Leptospira (the pathogenic rtPCR), and we perform a comparison of the pathogenic rtPCR with a published assay that detects all Leptospira species [the undifferentiated febrile illness (UFI) assay] and a reference 16S Leptospira rtPCR, which was originally designed to detect pathogenic species. Methodology/Principal Findings: For the pathogenic rtPCR, a new hydrolysis probe was designed for use with primers from the UFI assay, which targets the 16S gene. The pathogenic rtPCR detected Leptospira DNA in 37/37 cultured isolates from 5 pathogenic and one intermediate species. Two strains of the non-pathogenic L. biflexa produced no signal. Clinical samples from 65 patients with suspected leptospirosis were then tested using the pathogenic rtPCR and a reference Leptospira 16S rtPCR. All 65 samples had tested positive for Leptospira using the UFI assay; 62 (95.4%) samples tested positive using the pathogenic rtPCR (p = 0.24). Only 24 (36.9%) samples tested positive in the reference 16S rtPCR (p<0.0001 for comparison with the pathogenic rtPCR and UFI assays). Amplicon sequencing confirmed the detection of pathogenic Leptospira species in 49/50 cases, including 3 cases that were only detected using the UFI assay. Conclusions/Significance: The pathogenic rtPCR displayed similar sensitivity to the UFI assay when testing clinical specimens with no difference in specificity. Both assays proved significantly more sensitive than a real-time molecular test used for comparison. Future studies are needed to investigate the clinical and epidemiologic significance of more sensitive Leptospira detection using these tests.	[Waggoner, Jesse J.; Pinsky, Benjamin A.] Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; [Balassiano, Ilana; Vital-Brazil, Juliana Magalhaes] Inst Oswaldo Cruz, FIOCRUZ, WHO PAHO Ctr Colaborador Leptospirose, Ctr Referencia Nacl Leptospirose,Lab Zoonoses Bac, BR-20001 Rio De Janeiro, Brazil; [Abeynayake, Janaki; Sahoo, Malaya K.; Mohamed-Hadley, Alisha; Liu, Yuanyuan; Pinsky, Benjamin A.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA USA	Stanford University; Fundacao Oswaldo Cruz; Stanford University	Pinsky, BA (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA.	bpinsky@stanford.edu	liu, yuanyuan/GWZ-5838-2022; Balassiano, Ilana/GXH-4826-2022; Sahoo, Malaya Kumar/AAS-6907-2020	Sahoo, Malaya Kumar/0000-0001-9837-4032; Balassiano, Ilana/0000-0001-8036-1081; Pinsky, Benjamin/0000-0001-8751-4810	National Institutes of Health (NIH) [RC4 TW008781-01, 2T32AI007502-16A1]; Thrasher Research Fund Award [11979]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI110528, T32AI007502] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thrasher Research Fund Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the National Institutes of Health (NIH) (grant RC4 TW008781-01) and the Thrasher Research Fund Award (11979). Salary support was provided by the NIH (grant 2T32AI007502-16A1 to JJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agampodi SB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002626; Agampodi SB, 2012, CLIN INFECT DIS, V54, P1249, DOI 10.1093/cid/cis035; Ahmed A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007093; Ahmed Niyaz, 2006, Ann Clin Microbiol Antimicrob, V5, P28, DOI 10.1186/1476-0711-5-28; Balassiano IT, 2012, DIAGN MICR INFEC DIS, V74, P11, DOI 10.1016/j.diagmicrobio.2012.05.028; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Boonsilp S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-338; Branger C, 2005, FEMS MICROBIOL LETT, V243, P437, DOI 10.1016/j.femsle.2005.01.007; Brett-Major DM, 2012, COCHRANE DATABASE SY, V2; Bruce MG, 2005, ACTA TROP, V96, P36, DOI 10.1016/j.actatropica.2005.07.001; Burd EM, 2010, CLIN MICROBIOL REV, V23, P550, DOI 10.1128/CMR.00074-09; Fonseca CDA, 2006, TROP MED INT HEALTH, V11, P1699, DOI 10.1111/j.1365-3156.2006.01727.x; Goris MGA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002290; Kawabata H, 2001, MICROBIOL IMMUNOL, V45, P491, DOI 10.1111/j.1348-0421.2001.tb02649.x; Koizumi N, 2012, J CLIN MICROBIOL, V50, P2072, DOI 10.1128/JCM.00481-12; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Levett PN, 2005, J MED MICROBIOL, V54, P45, DOI 10.1099/jmm.0.45860-0; Limmathurotsakul D, 2012, CLIN INFECT DIS, V55, P322, DOI 10.1093/cid/cis403; Merien F, 2005, FEMS MICROBIOL LETT, V249, P139, DOI 10.1016/j.femsle.2005.06.011; MERIEN F, 1992, J CLIN MICROBIOL, V30, P2219; MERIEN F, 1995, J INFECT DIS, V172, P281, DOI 10.1093/infdis/172.1.281; Moon JE, 2007, J ANTIMICROB CHEMOTH, V59, P148, DOI 10.1093/jac/dkl453; Murgia R, 1997, FEMS MICROBIOL LETT, V148, P27, DOI 10.1016/S0378-1097(97)00008-6; Pan American Health O, 2011, CAS DEF DENG LEPT, P1; Picardeau M, 2014, DIAGN MICR INFEC DIS, V78, P1, DOI 10.1016/j.diagmicrobio.2013.09.012; Slack AT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-95; Slack AT, 2009, INT J SYST EVOL MICR, V59, P1199, DOI 10.1099/ijs.0.000992-0; Smythe LD, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-13; Sonthayanon P, 2011, AM J TROP MED HYG, V84, P614, DOI 10.4269/ajtmh.2011.10-0473; Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014; Thaipadunpanit J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016236; van de Werve C, 2013, J TRAVEL MED, V20, P228, DOI 10.1111/jtm.12035; Viau EJ, 2011, J WATER HEALTH, V9, P637, DOI 10.2166/wh.2011.064; Vital-Brazil JM, 2010, MEM I OSWALDO CRUZ, V105, P353, DOI 10.1590/S0074-02762010000300020; Waggoner JJ, 2013, J CLIN MICROBIOL, V51, P2172, DOI 10.1128/JCM.00548-13; Waggoner JJ, 2014, J CLIN MICROBIOL; Woo THS, 1998, ANAL BIOCHEM, V256, P132, DOI 10.1006/abio.1997.2503; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	38	25	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112356	10.1371/journal.pone.0112356	http://dx.doi.org/10.1371/journal.pone.0112356			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379890	Green Published, gold, Green Submitted			2022-12-27	WOS:000344863100077
J	Gabarrot, GG; Vega, ML; Giffoni, GP; Hernandez, S; Cardinal, P; Felix, V; Gabastou, JM; Camou, T				Garcia Gabarrot, Gabriela; Lopez Vega, Mariana; Perez Giffoni, Gabriel; Hernandez, Silvia; Cardinal, Pablo; Felix, Viviana; Marc Gabastou, Jean; Camou, Teresa		Uruguayan SIREVA II Grp	Effect of Pneumococcal Conjugate Vaccination in Uruguay, a Middle-Income Country	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; LATIN-AMERICA; CHILDREN; DISEASE; SEROTYPES; VACCINES; SUSCEPTIBILITY; EVOLUTION; STRAINS	Background: In 2008, a 7-valent pneumococcal conjugate vaccine (PCV7) was introduced into the routine childhood immunization program in Uruguay, with a 2+1 schedule. In 2010, PCV13 replaced PCV7, and the same 2+1 schedule was used. The effect of these pneumococcal vaccines on the incidence of invasive pneumococcal infections (IPD) and on serotype distribution was analyzed retrospectively, based on passive national laboratory surveillance. Methods: Data from 1,887 IPD isolates from 5 years before and 5 years after PCV7 introduction (7 before and 3 after PCV13 introduction) was examined to assess the incidence rate per 100,000 age-specific population of all IPD, PCV7-serotypes, and PCV13-serotypes associated IPD among children <2 years and 2 to 4 years old, and patients >= 5 years old. Trends of frequency for each serotype were also analyzed. Results: Comparison of pre-vaccination (2003-2007) and post-vaccination (2008-2012) periods showed a significant decrease in IPD incidence among children <2 years old (IR 68.7 to IR 29.6, p < 0.001) and children 2 to 4 years (p < 0.04). IPD caused by serotypes in PCV7 was reduced by 95.6% and IPD caused by 6 serotypes added in PCV13 was reduced by 83.9% in children <5 years old. Indirect effects of both conjugate vaccines were observed among patients >= 5 years old one year after the introduction of each vaccine, in 2010 for PCV7 and in 2012 for PCV13. Nevertheless, for reasons that still need to be explained, perhaps due to ascertainment bias, total IPD in this group increased after 2007. In 2012, the relative frequency of vaccine serotypes among vaccinated and unvaccinated population declined, except for serotype 3. Non vaccine serotypes with increasing frequency were identified, in rank order: 12F, 8, 24F, 22F, 24A, 15C, 9N, 10A and 33. Conclusion: Consecutive immunization with PCV7 and PCV13 has significantly reduced IPD in children <5 years of age in Uruguay.	[Garcia Gabarrot, Gabriela; Lopez Vega, Mariana; Perez Giffoni, Gabriel; Hernandez, Silvia; Felix, Viviana; Camou, Teresa] Minist Salud Publ, Dept Labs, Montevideo, Uruguay; [Cardinal, Pablo] CASMU IAMPP, Unidad Terapia Intens, Montevideo, Uruguay; [Marc Gabastou, Jean] Pan Amer Hlth Org, Area Technol & Hlth Serv Delivery, Washington, DC USA; [Uruguayan SIREVA II Grp] Minist Salud Publ, Red Labs, Montevideo, Uruguay	Pan American Health Organization	Camou, T (corresponding author), Minist Salud Publ, Dept Labs, Montevideo, Uruguay.	tcamou@msp.gub.uy			Pan-American Health Organization; Canadian International Development Agency	Pan-American Health Organization; Canadian International Development Agency	The study has been partially supported by Pan-American Health Organization and the Canadian International Development Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PROYECC POBL; Bettinger JA, 2010, VACCINE, V28, P2130, DOI 10.1016/j.vaccine.2009.12.026; Black S, 2007, PEDIATR INFECT DIS J, V26, P771, DOI 10.1097/INF.0b013e318124a494; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Camou T, 2003, VACCINE, V21, P2093, DOI 10.1016/S0264-410X(02)00806-X; Cardinal-Fernandez P, 2013, REV CLIN ESP, V213, P88, DOI 10.1016/j.rce.2012.09.011; Carvalho MD, 2009, J CLIN MICROBIOL, V47, P554, DOI 10.1128/JCM.01919-08; Castaneda Elizabeth, 2009, Pediatr Infect Dis J, V28, pe265, DOI 10.1097/INF.0b013e3181a74b22; Pirez MC, 2011, PEDIATR INFECT DIS J, V30, P669, DOI 10.1097/INF.0b013e3182152bf1; Comision Honoraria para la Lucha Antituberculosa y enfermedades prevalentes, PROGR NAC OP INM; Di Fabio JL, 2001, PEDIATR INFECT DIS J, V20, P959, DOI 10.1097/00006454-200110000-00009; Esposito S, 2010, CLIN VACCINE IMMUNOL, V17, P1017, DOI 10.1128/CVI.00062-10; Gabastou JM, 2008, REV PANAM SALUD PUBL, V24, P1, DOI 10.1590/S1020-49892008000700001; Harboe ZB, 2010, CLIN INFECT DIS, V50, P329, DOI 10.1086/649872; Hortal M, 1997, MICROB DRUG RESIST, V3, P159, DOI 10.1089/mdr.1997.3.159; Hortal M, 2012, VACCINE, V30, P4934, DOI 10.1016/j.vaccine.2012.05.054; Isaacman DJ, 2010, INT J INFECT DIS, V14, pE197, DOI 10.1016/j.ijid.2009.05.010; Karstaedt AS, 2000, PEDIATR INFECT DIS J, V19, P454, DOI 10.1097/00006454-200005000-00012; Lehmann D, 2010, CLIN INFECT DIS, V50, P1477, DOI 10.1086/652440; Lovgren M, 2007, J CLIN MICROBIOL, V45, P3184, DOI 10.1128/JCM.00789-07; Miller E, 2011, VACCINE, V29, P9127, DOI 10.1016/j.vaccine.2011.09.112; MOGDASY MC, 1992, PEDIATR INFECT DIS J, V11, P648; Obaro SK, 1996, LANCET, V348, P271, DOI 10.1016/S0140-6736(05)65585-7; Picon T, 2013, VACCINE, V31, pC109, DOI 10.1016/j.vaccine.2013.01.059; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Richter SS, 2013, EMERG INFECT DIS, V19, P1074, DOI 10.3201/eid1907.121830; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Wenger JD, 2010, PEDIATR INFECT DIS J, V29, P251, DOI 10.1097/INF.0b013e3181bdbed5; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; World Health Organization, 2012, WKLY EPIDEMIOL REC	30	26	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112337	10.1371/journal.pone.0112337	http://dx.doi.org/10.1371/journal.pone.0112337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375647	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600131
J	Harkonen, L; Pekcan-Hekim, Z; Hellen, N; Ojala, A; Horppila, J				Harkonen, Laura; Pekcan-Hekim, Zeynep; Hellen, Noora; Ojala, Anne; Horppila, Jukka			Combined Effects of Turbulence and Different Predation Regimes on Zooplankton in Highly Colored Water-Implications for Environmental Change in Lakes	PLOS ONE			English	Article							SMALL-SCALE TURBULENCE; DISSOLVED ORGANIC-CARBON; PERCH PERCA-FLUVIATILIS; ROACH RUTILUS-RUTILUS; CLIMATE-CHANGE; LARVAL FISH; INVERTEBRATE PREDATORS; CHAOBORUS-FLAVICANS; COMMUNITY STRUCTURE; ENCOUNTER RATES	In aquatic ecosystems, predation is affected both by turbulence and visibility, but the combined effects are poorly known. Both factors are changing in lakes in the Northern Hemisphere; the average levels of turbulence are predicted to increase due to increasing wind activities, while water transparency is decreasing, e.g., due to variations in precipitation, and sediment resuspension. We explored experimentally how turbulence influenced the effects of planktivorous fish and invertebrate predators on zooplankton when it was combined with low visibility caused by high levels of water color. The study was conducted as a factorial design in 24 outdoor ponds, using the natural zooplankton community as a prey population. Perch and roach were used as vertebrate predators and Chaoborus flavicans larvae as invertebrate predators. In addition to calm conditions, the turbulent dissipation rate used in the experiments was 10(-6) m(2) s(-3), and the water color was 140 mg Pt L-1. The results demonstrated that in a system dominated by invertebrates, predation pressure on cladocerans increased considerably under intermediate turbulence. Under calm conditions, chaoborids caused only a minor reduction in the crustacean biomass. The effect of fish predation on cladocerans was slightly reduced by turbulence, while predation on cyclopoids was strongly enhanced. Surprisingly, under turbulent conditions fish reduced cyclopoid biomass, whereas in calm water it increased in the presence of fish. We thus concluded that turbulence affects fish selectivity. The results suggested that in dystrophic invertebrate-dominated lakes, turbulence may severely affect the abundance of cladocerans. In fish-dominated dystrophic lakes, on the other hand, turbulence-induced changes in planktivory may considerably affect copepods instead of cladocerans. In lakes inhabited by both invertebrates and fish, the response of top-down regulation to turbulence resembles that in fish-dominated systems, due to intraguild predation. The changes in planktivorous predation induced by abiotic factors may possibly cascade to primary producers.	[Harkonen, Laura; Pekcan-Hekim, Zeynep; Hellen, Noora; Ojala, Anne; Horppila, Jukka] Univ Helsinki, Dept Environm Sci, Helsinki, Finland	University of Helsinki	Harkonen, L (corresponding author), Univ Helsinki, Dept Environm Sci, Helsinki, Finland.	laura.harkonen@helsinki.fi		Harkonen, Laura/0000-0003-1399-5978	Academy of Finland [131579]	Academy of Finland(Academy of Finland)	The study was funded by the Academy of Finland (project 131579). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksnes DL, 2004, LIMNOL OCEANOGR, V49, P233, DOI 10.4319/lo.2004.49.1.0233; Arvola L, 2010, AQUAT ECOL SER, V4, P85, DOI 10.1007/978-90-481-2945-4_6; BORKENT A, 1981, CAN J ZOOL, V59, P122, DOI 10.1139/z81-019; BOTTRELL HH, 1976, NORW J ZOOL, V24, P419; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; BRYDSTEN L, 1992, HYDROBIOLOGIA, V235, P71, DOI 10.1007/BF00026201; BUTORINA LG, 1986, ARCH HYDROBIOL, V105, P355; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; Carpenter SR, 2001, ECOL MONOGR, V71, P163, DOI 10.1890/0012-9615(2001)071[0163:TCNALP]2.0.CO;2; Clarke RD, 2005, MAR BIOL, V146, P1145, DOI 10.1007/s00227-004-1528-y; CUKER BE, 1993, ECOLOGY, V74, P944, DOI 10.2307/1940818; CULVER DA, 1985, CAN J FISH AQUAT SCI, V42, P1380, DOI 10.1139/f85-173; DILL LM, 1987, CAN J ZOOL, V65, P803, DOI 10.1139/z87-128; Dower JF, 1998, CAN J FISH AQUAT SCI, V55, P128, DOI 10.1139/cjfas-55-1-128; DUMONT HJ, 1975, OECOLOGIA, V19, P75, DOI 10.1007/BF00377592; Eiane K, 1997, ECOL MODEL, V98, P123, DOI 10.1016/S0304-3800(96)01909-6; Eie J. A., 1981, VERH INT VER THEOR A, V21, P1257; ELSER MM, 1987, CAN J ZOOL, V65, P2846, DOI 10.1139/z87-433; Estlander S, 2010, J FISH BIOL, V77, P241, DOI 10.1111/j.1095-8649.2010.02682.x; Estlander S, 2009, HYDROBIOLOGIA, V620, P109, DOI 10.1007/s10750-008-9621-8; Ficke AD, 2007, REV FISH BIOL FISHER, V17, P581, DOI 10.1007/s11160-007-9059-5; *FINN STAND ASS, 1993, 5772 FINN STAND ASS; Freeman C, 2004, NATURE, V430, P195, DOI 10.1038/nature02707; George G, 2010, IMPACT CLIMATE CHANG; GERRITSEN J, 1977, J FISH RES BOARD CAN, V34, P73, DOI 10.1139/f77-008; Giorgi F., 2004, MEAN INTERANNUAL VAR; Gosselin A, 2003, J N AM BENTHOL SOC, V22, P575, DOI 10.2307/1468354; Haertel SS, 2002, J FISH BIOL, V60, P876, DOI [10.1006/jfbi.2002.1890, 10.1111/j.1095-8649.2002.tb02415.x]; Harkonen L, 2014, HYDROBIOLOGIA, V722, P9, DOI 10.1007/s10750-013-1670-y; HERZIG A, 1995, HYDROBIOLOGIA, V307, P273, DOI 10.1007/BF00032021; Heuschele J, 2014, MAR BIOL, V161, P1653, DOI 10.1007/s00227-014-2449-z; Holt RD, 1997, AM NAT, V149, P745, DOI 10.1086/286018; Horppila J, 2005, RESTOR ECOL, V13, P242, DOI 10.1111/j.1526-100X.2005.00031.x; Horppila J, 2010, ECOL FRESHW FISH, V19, P257, DOI 10.1111/j.1600-0633.2010.00410.x; Horppila J, 2000, J FISH BIOL, V56, P51, DOI 10.1006/jfbi.1999.1140; Imboden D. M., 1995, PHYS CHEM LAKES, P83, DOI [10.1007/978-3-642-85132-2, DOI 10.1007/978-3-642-85132-2, DOI 10.1007/978-3-642-85132-2_4]; JAMET JL, 1990, ARCH HYDROBIOL, V118, P371; Jeppesen E, 2003, LIMNOL OCEANOGR, V48, P1346; Joensuu L, 2013, FRESHWATER BIOL, V58, P1997, DOI 10.1111/fwb.12186; KAJAK Z, 1970, Polskie Archiwum Hydrobiologii, V17, P225; KIORBOE T, 1995, MAR ECOL PROG SER, V122, P135, DOI 10.3354/meps122135; Koroleff F., 1979, MERI, V7, P1; Kundu RK, 2002, FLUID MECH-SOV RES, Vsecond; Lampert W, 1997, LIMNOECOLOGY ECOLOGY; Liljendahl-Nurminen A, 2003, ARCH HYDROBIOL, V158, P75, DOI 10.1127/0003-9136/2003/0158-0075; LUECKE C, 1987, FRESHWATER BIOL, V18, P185, DOI 10.1111/j.1365-2427.1987.tb01306.x; MacIntyre S, 1999, LIMNOL OCEANOGR, V44, P512, DOI 10.4319/lo.1999.44.3.0512; MACKENZIE BR, 1993, MAR ECOL PROG SER, V94, P207, DOI 10.3354/meps094207; MacKenzie BR, 1995, LIMNOL OCEANOGR, V40, P1278, DOI 10.4319/lo.1995.40.7.1278; MACKENZIE BR, 1991, MAR ECOL PROG SER, V73, P149, DOI 10.3354/meps073149; MACKENZIE BR, 1994, LIMNOL OCEANOGR, V39, P1790, DOI 10.4319/lo.1994.39.8.1790; MacKenzie BR, 2000, LIMNOL OCEANOGR, V45, P1; MARRASE C, 1990, P NATL ACAD SCI USA, V87, P1653, DOI 10.1073/pnas.87.5.1653; Mooij WM, 2005, AQUAT ECOL, V39, P381, DOI 10.1007/s10452-005-9008-0; Moum JN, 1996, J GEOPHYS RES-OCEANS, V101, P14095, DOI 10.1029/96JC00507; Osborn T, 1996, J PLANKTON RES, V18, P185, DOI 10.1093/plankt/18.2.185; Osborn T, 1996, MAR ECOL PROG SER, V139, P302, DOI 10.3354/meps139302; Packard AT, 2001, HYDROBIOLOGIA, V442, P177, DOI 10.1023/A:1017582323631; PASTOROK RA, 1980, LIMNOL OCEANOGR, V25, P910, DOI 10.4319/lo.1980.25.5.0910; PASTOROK RA, 1981, ECOLOGY, V62, P1311, DOI 10.2307/1937295; Pekcan-Hekim Z, 2013, CAN J FISH AQUAT SCI, V70, P854, DOI 10.1139/cjfas-2012-0466; Peters F, 1997, SCI MAR, V61, P205; Pringle JM, 2007, CONT SHELF RES, V27, P670, DOI 10.1016/j.csr.2006.11.011; Pryor SC, 2005, CLIM DYNAM, V25, P815, DOI 10.1007/s00382-005-0072-x; RASK M, 1986, ARCH HYDROBIOL, V106, P351; Read JS, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051886; Reiss CS, 2002, FISH OCEANOGR, V11, P156, DOI 10.1046/j.1365-2419.2002.00194.x; RIESSEN HP, 1984, ECOLOGY, V65, P514, DOI 10.2307/1941413; ROSEN RA, 1981, J FRESHWATER ECOL, V1, P225, DOI 10.1080/02705060.1981.9664034; ROTHSCHILD BJ, 1988, J PLANKTON RES, V10, P465, DOI 10.1093/plankt/10.3.465; Saggio A, 1998, LIMNOL OCEANOGR, V43, P1780; SAIZ E, 1992, MAR ECOL PROG SER, V80, P229, DOI 10.3354/meps080229; SAIZ E, 1992, J PLANKTON RES, V14, P1085, DOI 10.1093/plankt/14.8.1085; Salonen K, 1990, ACIDIFICATION FINLAN, P1145; Samuelsson P, 2010, AQUAT ECOL SER, V4, P15, DOI 10.1007/978-90-481-2945-4_2; Sanford LP, 1997, MAR ECOL PROG SER, V161, P265, DOI 10.3354/meps161265; Sarvala Jouko, 1999, P173; SHAPIRO J, 1990, HYDROBIOLOGIA, V200, P13, DOI 10.1007/BF02530325; Sluss TD, 2008, FRESHWATER BIOL, V53, P1999, DOI 10.1111/j.1365-2427.2008.02023.x; SMYLY WJP, 1980, HYDROBIOLOGIA, V70, P179, DOI 10.1007/BF00015504; Sobek S, 2007, LIMNOL OCEANOGR, V52, P1208, DOI 10.4319/lo.2007.52.3.1208; Sorf M, 2014, ANN LIMNOL-INT J LIM, V50, P71, DOI 10.1051/limn/2014001; STENSON JAE, 1990, HYDROBIOLOGIA, V198, P205, DOI 10.1007/BF00048635; SWIFT MC, 1975, LIMNOL OCEANOGR, V20, P418, DOI 10.4319/lo.1975.20.3.0418; Tennekes H., 1972, 1 COURSE TURBULENCE; Tolonen KT, 2000, ECOL FRESHW FISH, V9, P153, DOI 10.1111/j.1600-0633.2000.eff090304.x; Toth LG, 2011, LIMNOL OCEANOGR, V56, P2211, DOI 10.4319/lo.2011.56.6.2211; UNGER PA, 1983, ECOLOGY, V64, P1136, DOI 10.2307/1937824; Utne-Palm AC, 2002, MAR FRESHW BEHAV PHY, V35, P111, DOI 10.1080/10236240290025644; Uusitalo L, 2003, INT REV HYDROBIOL, V88, P34, DOI 10.1002/iroh.200390003; Valonen T., 2009, THESIS U HELSINKI; VANNI MJ, 1988, CAN J FISH AQUAT SCI, V45, P1758, DOI 10.1139/f88-207; VINYARD GL, 1976, J FISH RES BOARD CAN, V33, P2845, DOI 10.1139/f76-342; WERNER EE, 1983, ECOLOGY, V64, P1540, DOI 10.2307/1937508; Weyhenmeyer GA, 1998, ERGEB LIMNOL, V51, P185; Wissel B, 2003, LIMNOL OCEANOGR, V48, P1965, DOI 10.4319/lo.2003.48.5.1965; Wrona FJ, 2006, AMBIO, V35, P359, DOI 10.1579/0044-7447(2006)35[359:CCEOAB]2.0.CO;2; ZARET TM, 1980, PREDATION FRESHWATER; [No title captured]	99	20	22	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111942	10.1371/journal.pone.0111942	http://dx.doi.org/10.1371/journal.pone.0111942			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375952	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402600078
J	Jeong, HW; Heo, JY; Park, JS; Kim, WJ				Jeong, Hye Won; Heo, Jung Yeon; Park, Jung Soo; Kim, Woo Joo			Effect of the Influenza Virus Rapid Antigen Test on a Physician's Decision to Prescribe Antibiotics and on Patient Length of Stay in the Emergency Department	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; A H1N1; DIAGNOSIS; MANAGEMENT	Background: Influenza virus infection is a common reason for visits to the emergency department (ED) during the influenza season. A rapid and accurate diagnosis of influenza virus infection is important to reduce unnecessary antibiotic prescription and to improve patient care. The aim of this study was to examine whether using the Influenza Virus Rapid Antigen Test (IVRAT) in the ED affects the decision to prescribe antibiotics or the length of hospital stay (LOS). Methods: Data from patients suffering from an influenza-like illness (ILI) and who were discharged after visiting the ED at Chungbuk National University Hospital were reviewed over two influenza seasons: 2010-2011, when IVRAT was not used in the ED, and 2011-2012, when it was. The numbers of antibiotic prescriptions issued and the ED LOS during these two seasons were then compared. Results: The number of antibiotic prescriptions was significantly lower in 2011-2012 (54/216, 25.0%) than in 2010-2011 (97/221, 43.9%; P < 0.01). However, the median ED LOS for patients in 2011-2012 was much longer than that of patients in 2010-2011 (213 minutes vs. 257 minutes; P < 0.01). During the 2011-2012 influenza season, 73 ILI patients showed a positive IVRAT result whereas 123 showed a negative result. Upon discharge, antibiotics were given to 42/123 (34.1%) ILI patients with a negative IVRAT result, but to only 7/73 (9.6%) patients with a positive IVRAT result (P < 0.01). Conclusions: Performing IVRAT in the ED reduced the prescription of antibiotics to ILI patients discharged after ED care. However, the ED LOS for patients who underwent IVRAT was longer than that for patients who did not. Thus, performing IVRAT in the ED reduces the unnecessary prescription of antibiotics to ILI patients during the influenza season.	[Jeong, Hye Won; Heo, Jung Yeon] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Cheongju, South Korea; [Park, Jung Soo] Chungbuk Natl Univ, Coll Med, Dept Emergency Med, Cheongju, South Korea; [Kim, Woo Joo] Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul 136705, South Korea; [Kim, Woo Joo] Transgovt Enterprise Pandem Influenza Korea, Seoul, South Korea	Chungbuk National University; Chungbuk National University; Korea University; Korea University Medicine (KU Medicine)	Jeong, HW (corresponding author), Chungbuk Natl Univ, Coll Med, Dept Internal Med, Cheongju, South Korea.	hwjeong@chungbuk.ac.kr	; Kim, Woo Joo/D-2733-2015	Park, jung soo/0000-0002-4283-5423; Kim, Woo Joo/0000-0002-4546-3880; Heo, Jung Yeon/0000-0002-6548-1939	Health and Medical Technology Research and Development Project of Ministry of Health and Welfare [A103001]	Health and Medical Technology Research and Development Project of Ministry of Health and Welfare	This study was supported by the Health and Medical Technology Research and Development Project of Ministry of Health and Welfare (grant number: A103001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoritsas K, 2006, J CLIN MICROBIOL, V44, P2638, DOI 10.1128/JCM.02644-05; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; Cho CH, 2013, J VIROL METHODS, V187, P51, DOI 10.1016/j.jviromet.2012.09.003; Clezen WP, 1991, AM J EPIDEMIOL, V133, P296; DAGAN R, 1984, PEDIATR INFECT DIS J, V3, P218, DOI 10.1097/00006454-198405000-00007; Doan Q, 2012, COCHRANE DB SYST REV, V5; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; He J, 2009, J CLIN MICROBIOL, V47, P2772, DOI 10.1128/JCM.00998-09; Hojat K, 2013, PEDIATR EMERG CARE, V29, P696, DOI 10.1097/PEC.0b013e3182948f11; Kyriacou DN, 1999, ANN EMERG MED, V34, P326, DOI 10.1016/S0196-0644(99)70126-5; Lenzi L, 2013, REV SOC BRAS MED TRO, V46, P135, DOI 10.1590/0037-8682-0024-2012; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Murray Michael, 2004, CJEM, V6, P421; Noyola DE, 2000, PEDIATR INFECT DIS J, V19, P303, DOI 10.1097/00006454-200004000-00008; Petersen I, 2007, BMJ-BRIT MED J, V335, P982, DOI 10.1136/bmj.39345.405243.BE; Reina J, 1996, DIAGN MICR INFEC DIS, V25, P143, DOI 10.1016/S0732-8893(96)00131-9; Richardson DB, 2002, MED J AUSTRALIA, V177, P492, DOI 10.5694/j.1326-5377.2002.tb04917.x; Sharma V, 2002, ARCH PEDIAT ADOL MED, V156, P41, DOI 10.1001/archpedi.156.1.41; Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012; Smucny J, 2004, COCHRANE DB SYST REV, V18; Song JY, 2013, J MED VIROL, V85, P910, DOI 10.1002/jmv.23548; Spurling GKP, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004417.pub3; Zambon M, 2001, ARCH INTERN MED, V161, P2116, DOI 10.1001/archinte.161.17.2116	23	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e110978	10.1371/journal.pone.0110978	http://dx.doi.org/10.1371/journal.pone.0110978			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375835	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600023
J	Blair, C; Raver, CC				Blair, Clancy; Raver, C. Cybele			Closing the Achievement Gap through Modification of Neurocognitive and Neuroendocrine Function: Results from a Cluster Randomized Controlled Trial of an Innovative Approach to the Education of Children in Kindergarten	PLOS ONE			English	Article							EXECUTIVE FUNCTION; PREVENTIVE INTERVENTION; CORTISOL RESPONSE; CHILDHOOD POVERTY; YOUNG-CHILDREN; CHRONIC STRESS; BRAIN-FUNCTION; PRESCHOOL; PROGRAM; CORTEX	Effective early education is essential for academic achievement and positive life outcomes, particularly for children in poverty. Advances in neuroscience suggest that a focus on self-regulation in education can enhance children's engagement in learning and establish beneficial academic trajectories in the early elementary grades. Here, we experimentally evaluate an innovative approach to the education of children in kindergarten that embeds support for self-regulation, particularly executive functions, into literacy, mathematics, and science learning activities. Results from a cluster randomized controlled trial involving 29 schools, 79 classrooms, and 759 children indicated positive effects on executive functions, reasoning ability, the control of attention, and levels of salivary cortisol and alpha amylase. Results also demonstrated improvements in reading, vocabulary, and mathematics at the end of kindergarten that increased into the first grade. A number of effects were specific to high-poverty schools, suggesting that a focus on executive functions and associated aspects of self-regulation in early elementary education holds promise for closing the achievement gap.	[Blair, Clancy; Raver, C. Cybele] NYU, Steinhardt Sch Culture Educ & Human Dev, Dept Appl Psychol, New York, NY 10012 USA		Blair, C (corresponding author), NYU, Steinhardt Sch Culture Educ & Human Dev, Dept Appl Psychol, New York, NY 10012 USA.	clancy.blair@nyu.edu		Blair, Clancy/0000-0003-2738-238X	Institute of Education Sciences grant [R305A100058]	Institute of Education Sciences grant	Support for this research was provided by Institute of Education Sciences grant R305A100058. http://ies.ed.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Barnett WS, 2008, EARLY CHILD RES Q, V23, P299, DOI 10.1016/j.ecresq.2008.03.001; Berkman ET, 2012, CHILD DEV PERSPECT, V6, P374, DOI 10.1111/j.1750-8606.2012.00248.x; Blair C, 2005, CHILD DEV, V76, P554, DOI 10.1111/j.1467-8624.2005.00863.x; Blair C., 2011, HDB SELF REGULATION, P300; Blair C, 2008, DEV PSYCHOL, V44, P1095, DOI 10.1037/0012-1649.44.4.1095; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Blair C, 2012, AM PSYCHOL, V67, P309, DOI 10.1037/a0027493; Blair C, 2011, CHILD DEV, V82, P1970, DOI 10.1111/j.1467-8624.2011.01643.x; Bodrova E., 2001, TOOLS MIND CASE STUD; Bodrova E., 2012, APPROACHES EARLY CHI, V6th ed., P241; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Brotman LM, 2007, ARCH GEN PSYCHIAT, V64, P1172, DOI 10.1001/archpsyc.64.10.1172; Brownell R., 2000, EXPRESSIVE ONE WORD, DOI DOI 10.1007/978-0-387-79948-3_1544; Brownstone D, 2001, J ECON PERSPECT, V15, P129, DOI 10.1257/jep.15.4.129; Bruce J, 2009, PREV SCI, V10, P129, DOI 10.1007/s11121-008-0115-8; Bryck RL, 2012, AM PSYCHOL, V67, P87, DOI 10.1037/a0024657; Bull R, 2011, DEVELOPMENTAL SCI, V14, P679, DOI 10.1111/j.1467-7687.2010.01012.x; Cameron AC, 2008, REV ECON STAT, V90, P414, DOI 10.1162/rest.90.3.414; Chetty R, 2011, Q J ECON, V126, P1593, DOI 10.1093/qje/qjr041; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; Davis EP, 2002, DEV PSYCHOBIOL, V40, P43, DOI 10.1002/dev.10012; de Kloet ER, 2008, FRONT NEUROENDOCRIN, V29, P268, DOI 10.1016/j.yfrne.2007.10.002; DENCKLA MB, 1976, NEUROPSYCHOLOGIA, V14, P471, DOI 10.1016/0028-3932(76)90075-0; Diamond A, 2007, SCIENCE, V318, P1387, DOI 10.1126/science.1151148; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Diamond A, 2011, SCIENCE, V333, P959, DOI 10.1126/science.1204529; Dozier M, 2008, DEV PSYCHOPATHOL, V20, P845, DOI 10.1017/S0954579408000400; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Evans GW, 2009, P NATL ACAD SCI USA, V106, P6545, DOI 10.1073/pnas.0811910106; Evans GW, 2003, DEV PSYCHOL, V39, P924, DOI 10.1037/0012-1649.39.5.924; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Farran D., 2012, SOC RES ED EFF SPRIN; Fisher PA, 2007, PSYCHONEUROENDOCRINO, V32, P892, DOI 10.1016/j.psyneuen.2007.06.008; Fisher PA, 2006, ANN NY ACAD SCI, V1094, P215, DOI 10.1196/annals.1376.023; Fitzpatrick C, 2014, LEARN INSTR, V30, P25, DOI 10.1016/j.learninstruc.2013.11.003; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; Gianaros PJ, 2013, CEREB CORTEX, V23, P2058, DOI 10.1093/cercor/bhs191; Gunnar MR, 2010, CHILD DEV, V81, P851, DOI 10.1111/j.1467-8624.2010.01438.x; Hanson JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018712; Jaffe LE, 2009, ASSESSMENT SERVICE B, V11; Kim P, 2013, P NATL ACAD SCI USA, V110, P18442, DOI 10.1073/pnas.1308240110; Kujawa AJ, 2011, J ABNORM CHILD PSYCH, V39, P125, DOI 10.1007/s10802-010-9438-6; Lisonbee JA, 2010, MIND BRAIN EDUC, V4, P171, DOI 10.1111/j.1751-228X.2010.01096.x; Mackey AP, 2011, DEVELOPMENTAL SCI, V14, P582, DOI 10.1111/j.1467-7687.2010.01005.x; Magnuson KA, 2004, AM EDUC RES J, V41, P115, DOI 10.3102/00028312041001115; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Nelson CA, 2011, WHITHER OPPORTUNITY?: RISING INEQUALITY, SCHOOLS, AND CHILDREN'S LIFE CHANCES, P27; Neville HJ, 2013, P NATL ACAD SCI USA, V110, P12138, DOI 10.1073/pnas.1304437110; Noble KG, 2007, DEVELOPMENTAL SCI, V10, P464, DOI 10.1111/j.1467-7687.2007.00600.x; Nye B, 1999, EDUC EVAL POLICY AN, V21, P127, DOI 10.3102/01623737021002127; Pears KC, 2010, CHILD DEV, V81, P1550, DOI 10.1111/j.1467-8624.2010.01491.x; Ramos BP, 2007, PHARMACOL THERAPEUT, V113, P523, DOI 10.1016/j.pharmthera.2006.11.006; Raven JC, 1956, COLORED PROGR MATRIC; Raver CC, 2013, DEV PSYCHOL, V49, P292, DOI 10.1037/a0028343; Raver CC, 2011, CHILD DEV, V82, P362, DOI 10.1111/j.1467-8624.2010.01561.x; Reardon SF, 2011, WHITHER OPPORTUNITY?: RISING INEQUALITY, SCHOOLS, AND CHILDREN'S LIFE CHANCES, P91; Reynolds AJ, 2008, ANNU REV CLIN PSYCHO, V4, P109, DOI 10.1146/annurev.clinpsy.3.022806.091411; RUDEL RG, 1974, NEUROPSYCHOLOGIA, V12, P109, DOI 10.1016/0028-3932(74)90032-3; Rueda MR, 2005, P NATL ACAD SCI USA, V102, P14931, DOI 10.1073/pnas.0506897102; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sheridan MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035744; Watamura SE, 2009, J APPL DEV PSYCHOL, V30, P475, DOI 10.1016/j.appdev.2008.12.027; Watamura SE, 2010, PSYCHONEUROENDOCRINO, V35, P1156, DOI 10.1016/j.psyneuen.2010.02.001; Wechsler D., 1997, ADM SCORING MANUAL W; Weiland C, 2013, CHILD DEV, V84, P2112, DOI 10.1111/cdev.12099; Woodcock R, 2001, WOODCOCK JOHNSON TES; Woodcock RW, 2003, DIAGNOSTIC SUPPLEMEN; Zelazo P. D., 2013, NIH TOOLBOX COGNITIO	71	213	214	15	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112393	10.1371/journal.pone.0112393	http://dx.doi.org/10.1371/journal.pone.0112393			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CP	25389751	gold, Green Published			2022-12-27	WOS:000349144400077
J	Wielputz, MO; Bardarova, D; Weinheimer, O; Kauczor, HU; Eichinger, M; Jobst, BJ; Eberhardt, R; Koenigkam-Santos, M; Puderbach, M; Heussel, CP				Wielpuetz, Mark O.; Bardarova, Diana; Weinheimer, Oliver; Kauczor, Hans-Ulrich; Eichinger, Monika; Jobst, Bertram J.; Eberhardt, Ralf; Koenigkam-Santos, Marcel; Puderbach, Michael; Heussel, Claus P.			Variation of Densitometry on Computed Tomography in COPD - Influence of Different Software Tools	PLOS ONE			English	Article							ITERATIVE RECONSTRUCTION; QUANTITATIVE-ANALYSIS; PULMONARY-EMPHYSEMA; CT; LUNG; QUANTIFICATION; DENSITY; REPRODUCIBILITY; PROGRESSION; INCREASE	Objectives: Quantitative multidetector computed tomography (MDCT) as a potential biomarker is increasingly used for severity assessment of emphysema in chronic obstructive pulmonary disease (COPD). Aim of this study was to evaluate the user-independent measurement variability between five different fully-automatic densitometry software tools. Material and Methods: MDCT and full-body plethysmography incl. forced expiratory volume in 1s and total lung capacity were available for 49 patients with advanced COPD (age = 64 +/- 9 years, forced expiratory volume in 1s = 31 +/- 6% predicted). Measurement variation regarding lung volume, emphysema volume, emphysema index, and mean lung density was evaluated for two scientific and three commercially available lung densitometry software tools designed to analyze MDCT from different scanner types. Results: One scientific tool and one commercial tool failed to process most or all datasets, respectively, and were excluded. One scientific and another commercial tool analyzed 49, the remaining commercial tool 30 datasets. Lung volume, emphysema volume, emphysema index and mean lung density were significantly different amongst these three tools (p < 0.001). Limits of agreement for lung volume were [-0.195, -0.052l], [-0.305, -0.131l], and [-0.123, -0.052l] with correlation coefficients of r = 1.00 each. Limits of agreement for emphysema index were [-6.2, 2.9%], [-27.0, 16.9%], and [-25.5, 18.8%], with r = 0.79 to 0.98. Correlation of lung volume with total lung capacity was good to excellent (r = 0.77 to 0.91, p< 0.001), but segmented lung volume (6.7 +/- 1.3 - 6.8 +/- 1.3l) were significantly lower than total lung capacity (7.7 +/- 1.7l, p<0.001). Conclusions: Technical incompatibilities hindered evaluation of two of five tools. The remaining three showed significant measurement variation for emphysema, hampering quantitative MDCT as a biomarker in COPD. Follow-up studies should currently use identical software, and standardization efforts should encompass software as well.	[Wielpuetz, Mark O.; Bardarova, Diana; Weinheimer, Oliver; Kauczor, Hans-Ulrich; Eichinger, Monika; Jobst, Bertram J.; Koenigkam-Santos, Marcel; Puderbach, Michael; Heussel, Claus P.] Univ Heidelberg Hosp, Dept Diagnost & Intervent Radiol, Heidelberg, Germany; [Wielpuetz, Mark O.; Bardarova, Diana; Weinheimer, Oliver; Kauczor, Hans-Ulrich; Eichinger, Monika; Jobst, Bertram J.; Koenigkam-Santos, Marcel; Puderbach, Michael; Heussel, Claus P.] Translat Lung Res Ctr Heidelberg, Heidelberg, Germany; [Wielpuetz, Mark O.; Bardarova, Diana; Kauczor, Hans-Ulrich; Eichinger, Monika; Jobst, Bertram J.; Koenigkam-Santos, Marcel; Puderbach, Michael; Heussel, Claus P.] Heidelberg Univ, Thoraxklin, Dept Diagnost & Intervent Radiol Nucl Med, Heidelberg, Germany; [Wielpuetz, Mark O.; Koenigkam-Santos, Marcel; Puderbach, Michael] German Canc Res Ctr, Dept Radiol, Heidelberg, Germany; [Eberhardt, Ralf] Heidelberg Univ, Dept Pneumol & Resp Crit Care Med, Thoraxklin, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Wielputz, MO (corresponding author), Univ Heidelberg Hosp, Dept Diagnost & Intervent Radiol, Heidelberg, Germany.	mark.wielpuetz@med.uni-heidelberg.de	Weinheimer, Oliver/AAN-3652-2021; Wielpütz, Mark Oliver/ADP-0499-2022; Wielpuetz, Mark/ABE-1790-2020; Kauczor, HU/AAX-6033-2021; Kauczor, Hans-Ulrich/AAU-5955-2021; Santos, Marcel Koenigkam/B-8177-2013	Wielpütz, Mark Oliver/0000-0001-6962-037X; Wielpuetz, Mark/0000-0001-6962-037X; Santos, Marcel Koenigkam/0000-0002-7160-4691	Bundesministerium fur Bildung und Forschung [82DZL00401, 82DZL00402, 82DZL00404]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This study was supported by grants from the Bundesministerium fur Bildung und Forschung (www.bmbf.de) to the German Center for Lung Research (DZL) (82DZL00401, 82DZL00402, 82DZL00404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashraf H, 2010, EUR RADIOL, V20, P1878, DOI 10.1007/s00330-010-1749-z; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Choo JY, 2014, EUR RADIOL, V24, P799, DOI 10.1007/s00330-013-3078-5; Coxson HO, 2013, LANCET RESP MED, V1, P129, DOI 10.1016/S2213-2600(13)70006-7; Coxson HO, 2009, AM J RESP CRIT CARE, V180, P588, DOI 10.1164/rccm.200901-0159PP; Coxson HO, 1999, AM J RESP CRIT CARE, V159, P851, DOI 10.1164/ajrccm.159.3.9805067; Coxson HO, 2005, ACAD RADIOL, V12, P1457, DOI 10.1016/j.acra.2005.08.013; de Hoop B, 2009, EUR RADIOL, V19, P800, DOI 10.1007/s00330-008-1229-x; Diciotti S, 2011, ACAD RADIOL, V18, P1403, DOI 10.1016/j.acra.2011.08.001; Garfield JL, 2012, INT J CHRONIC OBSTR, V7, P119, DOI 10.2147/COPD.S26419; Gevenois PA, 1996, AM J RESP CRIT CARE, V154, P187, DOI 10.1164/ajrccm.154.1.8680679; Gierada DS, 2010, ACAD RADIOL, V17, P146, DOI 10.1016/j.acra.2009.08.007; Gietema HA, 2007, RADIOLOGY, V244, P890, DOI 10.1148/radiol.2443061330; Han MLK, 2011, RADIOLOGY, V261, P274, DOI 10.1148/radiol.11110173; HARRIS EK, 1979, AM J CLIN PATHOL, V72, P374; Heussel CP, 2006, ROFO-FORTSCHR RONTG, V178, P987, DOI 10.1055/s-2006-926823; Heussel CP, 2010, EUR J RADIOL, V74, P473, DOI 10.1016/j.ejrad.2009.03.023; Heussel CP, 2009, EUR RADIOL, V19, P2391, DOI 10.1007/s00330-009-1437-z; Hoesein FAAM, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-55; HOLM S, 1979, SCAND J STAT, V6, P65; Kauczor HU, 2013, LANCET RESP MED, V1, P95, DOI 10.1016/S2213-2600(13)70011-0; Kauczor HU, 2011, J THORAC IMAG, V26, P290, DOI 10.1097/RTI.0b013e3182277113; Ley-Zaporozhan J, 2008, EUR J RADIOL, V65, P228, DOI 10.1016/j.ejrad.2007.03.034; Ley-Zaporozhan J, 2010, J MAGN RESON IMAGING, V32, P1340, DOI 10.1002/jmri.22376; Madani A, 2010, RADIOLOGY, V257, P260, DOI 10.1148/radiol.10091446; Mets OM, 2012, EUR RADIOL, V22, P2103, DOI 10.1007/s00330-012-2489-z; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Oberoi S, 2014, AM J ROENTGENOL, V202, pW43, DOI 10.2214/AJR.13.11225; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Sciurba FC, 2010, NEW ENGL J MED, V363, P1233, DOI 10.1056/NEJMoa0900928; Shaker SB, 2004, ACTA RADIOL, V45, P424, DOI 10.1080/02841850410005642; Sieren JP, 2012, MED PHYS, V39, P5757, DOI 10.1118/1.4747342; Hoffman Eric A, 2006, Proc Am Thorac Soc, V3, P519, DOI 10.1513/pats.200603-086MS; Smith BM, 2013, J THORAC IMAG, V28, P280, DOI 10.1097/RTI.0b013e3182a0d805; Soejima K, 2000, AM J RESP CRIT CARE, V161, P1264, DOI 10.1164/ajrccm.161.4.9905040; Stoel Berend C, 2008, Proc Am Thorac Soc, V5, P919, DOI 10.1513/pats.200804-040QC; Weinheimer O., 2011, P 4 INT WORKSH PULM, P241; Weinheimer O, 2008, IEEE T MED IMAGING, V27, P64, DOI 10.1109/TMI.2007.902798; Wielputz MO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073142; Wielputz MO, 2013, J THORAC IMAG, V28, P104, DOI 10.1097/RTI.0b013e3182765785; Yuan R, 2007, CHEST, V132, P617, DOI 10.1378/chest.06-2325; Zaporozhan J, 2006, J COMPUT ASSIST TOMO, V30, P460, DOI 10.1097/00004728-200605000-00018	44	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112898	10.1371/journal.pone.0112898	http://dx.doi.org/10.1371/journal.pone.0112898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386874	Green Submitted, Green Published, gold			2022-12-27	WOS:000345250400103
J	Gainetdinov, IV; Skvortsova, YV; Stukacheva, EA; Bychenko, OS; Kondratieva, SA; Zinovieva, MV; Azhikina, TL				Gainetdinov, Ildar V.; Skvortsova, Yulia V.; Stukacheva, Elena A.; Bychenko, Oksana S.; Kondratieva, Sofia A.; Zinovieva, Marina V.; Azhikina, Tatyana L.			Expression Profiles of PIWIL2 Short Isoforms Differ in Testicular Germ Cell Tumors of Various Differentiation Subtypes	PLOS ONE			English	Article							POLYADENYLATION REGULATORY ELEMENTS; PRECANCEROUS STEM-CELLS; HUMAN CSTF-64 PROTEIN; DNA METHYLATION; RETINOIC ACID; NEURONAL DIFFERENTIATION; INTERACTING RNAS; GENOME BROWSER; COLON-CANCER; CARCINOMA	PIWI family proteins have recently emerged as essential contributors in numerous biological processes including germ cell development, stem cell maintenance and epigenetic reprogramming. Expression of some of the family members has been shown to be elevated in tumors. In particular, PIWIL2 has been probed as a potential neoplasia biomarker in many cancers in humans. Previously, PIWIL2 was shown to be expressed in most tumours as a set of its shorter isoforms. In this work, we demonstrated the presence of its 60 kDa (PL2L60A) and 80 kDa (PL2L80A) isoforms in testicular cancer cell lines. We also ascertained the transcriptional boundaries of mRNAs and alternative promoter regions for these PIWIL2 isoforms. Further, we probed a range of testicular germ cell tumor (TGCT) samples and found PIWIL2 to be predominantly expressed as PL2L60A in most of them. Importantly, the levels of both PL2L60A mRNA and protein products were found to vary depending on the differentiation subtype of TGCTs, i.e., PL2L60A expression is significantly higher in undifferentiated seminomas and appears to be substantially decreased in mixed and nonseminomatous TGCTs. The higher level of PL2L60A expression in undifferentiated TGCTs was further validated in the model system of retinoic acid induced differentiation in NT2/D1 cell line. Therefore, both PL2L60A mRNA and protein abundance could serve as an additional marker distinguishing between seminomas and nonseminomatous tumors with different prognosis and therapy approaches.	[Gainetdinov, Ildar V.; Skvortsova, Yulia V.; Stukacheva, Elena A.; Bychenko, Oksana S.; Kondratieva, Sofia A.; Zinovieva, Marina V.; Azhikina, Tatyana L.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Gainetdinov, IV (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia.	ildargv@gmail.com	Kondrateva, Sofia/ABB-3389-2020; Azhikina, Tatyana/X-8411-2018; Bychenko, Oksana/AAP-7635-2021; Skvortsova, Yulia/AAP-4597-2021	Skvortsova, Yuliya/0000-0002-7605-8570; Kondratieva, Sofia/0000-0002-1354-5275; Gainetdinov, Ildar/0000-0003-1719-043X	Russian Foundation for Basic Research [14-04-32314-mol_a, 11-04-12071-ofi-m]; program of the Presidium of the Russian Academy of Sciences "Molecular and Cellular Biology"	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); program of the Presidium of the Russian Academy of Sciences "Molecular and Cellular Biology"	This work was supported by the Russian Foundation for Basic Research (project nos. 14-04-32314-mol_a and 11-04-12071-ofi-m) and the program of the Presidium of the Russian Academy of Sciences "Molecular and Cellular Biology." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; ANDREWS PW, 1984, LAB INVEST, V50, P147; Bak Chong Won, 2011, Clin Exp Reprod Med, V38, P61, DOI 10.5653/cerm.2011.38.2.61; Berretta J, 2009, EMBO REP, V10, P973, DOI 10.1038/embor.2009.181; BRODEUR GM, 1976, CYTOBIOS, V16, P133; Canadillas JMP, 2003, EMBO J, V22, P2821, DOI 10.1093/emboj/cdg259; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chen C, 2013, CANCER BIOMARK, V13, P315, DOI 10.3233/CBM-130360; Chen L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000293; Chieffi P, 2013, J CELL PHYSIOL, V228, P1641, DOI 10.1002/jcp.24328; Chieffi P, 2009, INT REV CEL MOL BIO, V278, P277, DOI 10.1016/S1937-6448(09)78006-2; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; Cook MS, 2013, CURR TOP DEV BIOL, V102, P159, DOI 10.1016/B978-0-12-416024-8.00006-4; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Deka P, 2005, J MOL BIOL, V347, P719, DOI 10.1016/j.jmb.2005.01.046; Domansky AN, 2000, FEBS LETT, V472, P191, DOI 10.1016/S0014-5793(00)01460-5; Elkahloun AG, 1996, GENE CHROMOSOME CANC, V17, P205, DOI 10.1002/(SICI)1098-2264(199612)17:4<205::AID-GCC2>3.3.CO;2-#; EPSTEIN MA, 1965, J NATL CANCER I, V34, P231, DOI 10.1093/jnci/34.2.231; Esposito F, 2011, J PATHOL, V224, P110, DOI 10.1002/path.2846; Feng DQ, 2009, ONCOL REP, V22, P1129, DOI 10.3892/or_00000545; Ferreira HJ, 2013, EPIGENETICS, P9; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; Franco R, 2008, J PATHOL, V214, P58, DOI 10.1002/path.2249; Gao JX, 2008, J CELL MOL MED, V12, P67, DOI 10.1111/j.1582-4934.2007.00170.x; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Greither T, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-272; He G, 2010, AM J TRANSL RES, V2, P156; Heyn H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047892; Hoei-Hansen CE, 2005, HISTOPATHOLOGY, V47, P48, DOI 10.1111/j.1365-2559.2005.02182.x; Honda S, 2014, METHODS MOL BIOL, V1093, P137, DOI 10.1007/978-1-62703-694-8_11; Honda S, 2013, RNA, V19, P1405, DOI 10.1261/rna.040428.113; Juliano C, 2011, ANNU REV GENET, V45, P447, DOI 10.1146/annurev-genet-110410-132541; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KEYDAR I, 1979, EUR J CANCER, V15, P659, DOI 10.1016/0014-2964(79)90139-7; KLEIN E, 1968, CANCER RES, V28, P1300; Klenov MS, 2011, P NATL ACAD SCI USA, V108, P18760, DOI 10.1073/pnas.1106676108; Lai F, 2014, CURR OPIN GENET DEV, V25, P38, DOI 10.1016/j.gde.2013.11.017; Le Thomas A, 2014, GENOME BIOL, V15, DOI 10.1186/gb4154; Le Thomas A, 2013, GENE DEV, V27, P390, DOI 10.1101/gad.209841.112; Lee JH, 2010, CANCER RES, V70, P4569, DOI 10.1158/0008-5472.CAN-09-2670; Lee JH, 2006, HUM MOL GENET, V15, P201, DOI 10.1093/hmg/ddi430; Li DW, 2012, EXP BIOL MED, V237, P1231, DOI 10.1258/ebm.2012.011380; Li L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-38; Lin HF, 1997, DEVELOPMENT, V124, P2463; Liu JJ, 2010, INT J CLIN EXP PATHO, V3, P328; Looijenga LHJ, 2014, VIRCHOWS ARCH, V464, P301, DOI 10.1007/s00428-013-1522-1; Looijenga LHJ, 2003, CANCER RES, V63, P2244; Lu YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030999; Luteijn MJ, 2013, NAT REV GENET, V14, P523, DOI 10.1038/nrg3495; Mani SR, 2013, MOL REPROD DEV, V80, P632, DOI 10.1002/mrd.22195; Mathioudakis N, 2012, RNA, V18, P2056, DOI 10.1261/rna.034181.112; MATTHAEI KI, 1983, EXP CELL RES, V143, P471, DOI 10.1016/0014-4827(83)90076-9; Mazaheri Zohreh, 2012, Avicenna Journal of Medical Biotechnology, V4, P55; Mei YP, 2013, CANCER LETT, V336, P46, DOI 10.1016/j.canlet.2013.04.008; MILLER WH, 1994, DIFFERENTIATION, V55, P145, DOI 10.1046/j.1432-0436.1994.5520145.x; Nikpour P, 2009, CANCER EPIDEMIOL, V33, P271, DOI 10.1016/j.canep.2009.06.011; Oh SJ, 2012, KOREAN J PATHOL, V46, P318, DOI 10.4132/KoreanJPathol.2012.46.4.318; Olovnikov I, 2012, CURR OPIN GENET DEV, V22, P164, DOI 10.1016/j.gde.2012.01.002; Orom UA, 2013, CELL, V154, P1190, DOI 10.1016/j.cell.2013.08.028; Pan Y, 2012, CELL TISSUE RES, V350, P177, DOI 10.1007/s00441-012-1447-z; Pandey RR, 2013, P NATL ACAD SCI USA, V110, P16492, DOI 10.1073/pnas.1316316110; Parker JS, 2006, TRENDS BIOCHEM SCI, V31, P622, DOI 10.1016/j.tibs.2006.09.010; Patil VS, 2013, CRIT REV BIOCH MOL B; Peng JC, 2013, CURR OPIN CELL BIOL, V25, P190, DOI 10.1016/j.ceb.2013.01.010; Plank JL, 2014, MOL CELL, V55, P5, DOI 10.1016/j.molcel.2014.06.015; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; PULVERTAFT RJV, 1964, LANCET, V1, P238; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; ROSFJORD E, 1994, BIOCHEM BIOPH RES CO, V203, P1795, DOI 10.1006/bbrc.1994.2395; Ross RJ, 2014, NATURE, V505, P353, DOI 10.1038/nature12987; Rougemaille M, 2010, ADV EXP MED BIOL, V702, P122, DOI 10.1007/978-1-4419-7841-7_10; Sambrook J., 2001, MOL CLONING LAB MANU; Sato K, 2013, ESSAYS BIOCHEM, V54, P39, DOI [10.1042/bse0540039, 10.1042/BSE0540039]; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Shahali M, 2013, CELL J, V15, P250; Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Smith E, 2014, NAT STRUCT MOL BIOL, V21, P210, DOI 10.1038/nsmb.2784; Smolle M, 2013, BBA-GENE REGUL MECH, V1829, P84, DOI 10.1016/j.bbagrm.2012.08.008; Snow GE, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-383; Stuwe E, 2014, GENE DEV, V28, P423, DOI 10.1101/gad.236414.113; Suzuki Ryusuke, 2012, Frontiers in Genetics, V3, P204, DOI 10.3389/fgene.2012.00204; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; TUMILOWICZ JJ, 1970, CANCER RES, V30, P2110; Vagin VV, 2009, GENE DEV, V23, P1749, DOI 10.1101/gad.1814809; Wang QE, 2011, MUTAT RES-FUND MOL M, V708, P59, DOI 10.1016/j.mrfmmm.2011.02.001; Wang Y, 2012, INT J CLIN EXP PATHO, V5, P315; Watanabe T, 2011, SCIENCE, V332, P848, DOI 10.1126/science.1203919; Wu QL, 2010, BIOCHEM BIOPH RES CO, V396, P915, DOI 10.1016/j.bbrc.2010.05.022; Yakushev EY, 2013, BIOCHEMISTRY-MOSCOW+, V78, P585, DOI 10.1134/S0006297913060047; Yazarloo F, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0368-8; Ye Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013406; Yin DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027154; Yin De-tao, 2011, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V46, P237; Zhang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041973	99	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112528	10.1371/journal.pone.0112528	http://dx.doi.org/10.1371/journal.pone.0112528			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384072	Green Published, gold, Green Submitted			2022-12-27	WOS:000344816700077
J	Stefansson, TS; McDonald, BA; Willi, Y				Stefansson, Tryggvi S.; McDonald, Bruce A.; Willi, Yvonne			The Influence of Genetic Drift and Selection on Quantitative Traits in a Plant Pathogenic Fungus	PLOS ONE			English	Article							BARLEY SCALD PATHOGEN; POPULATION-STRUCTURE; FITNESS ATTRIBUTES; LOCAL ADAPTATION; EVOLUTIONARY; HERITABILITY; DIVERSITY; DIVERGENCE; MARKERS	Genetic drift and selection are ubiquitous evolutionary forces acting to shape genetic variation in populations. While their relative importance has been well studied in plants and animals, less is known about their relative importance in fungal pathogens. Because agro-ecosystems are more homogeneous environments than natural ecosystems, stabilizing selection may play a stronger role than genetic drift or diversifying selection in shaping genetic variation among populations of fungal pathogens in agro-ecosystems. We tested this hypothesis by conducting a Q(ST)/F-ST analysis using agricultural populations of the barley pathogen Rhynchosporium commune. Population divergence for eight quantitative traits (Q(ST)) was compared with divergence at eight neutral microsatellite loci (F-ST) for 126 pathogen strains originating from nine globally distributed field populations to infer the effects of genetic drift and types of selection acting on each trait. Our analyses indicated that five of the eight traits had Q(ST) values significantly lower than F-ST, consistent with stabilizing selection, whereas one trait, growth under heat stress (22 degrees C), showed evidence of diversifying selection and local adaptation (Q(ST)>F-ST). Estimates of heritability were high for all traits (means ranging between 0.55-0.84), and average heritability across traits was negatively correlated with microsatellite gene diversity. Some trait pairs were genetically correlated and there was significant evidence for a trade-off between spore size and spore number, and between melanization and growth under benign temperature. Our findings indicate that many ecologically and agriculturally important traits are under stabilizing selection in R. commune and that high within-population genetic variation is maintained for these traits.	[Stefansson, Tryggvi S.; McDonald, Bruce A.] ETH, Inst Integrat Biol, Zurich, Switzerland; [Willi, Yvonne] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Neuchatel	Willi, Y (corresponding author), Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland.	yvonne.willi@unine.ch	McDonald, Bruce A/A-2748-2008	McDonald, Bruce A/0000-0002-5332-2172	ETH Zurich [TH-02 07-1]; Swiss National Science Foundation [PP00P3-123396]; Fondation Pierre Mercier pour la Science	ETH Zurich(ETH Zurich); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation Pierre Mercier pour la Science	The research was supported by grants from ETH Zurich (TH-02 07-1 to YW and BAM), the Swiss National Science Foundation (PP00P3-123396 to YW), and the Fondation Pierre Mercier pour la Science (to YW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2010, FUNGAL GENET BIOL, V47, P828, DOI 10.1016/j.fgb.2010.07.002; Barrett LG, 2008, MOL ECOL, V17, P3401, DOI 10.1111/j.1365-294X.2008.03843.x; Bever JD, 1999, AM J BOT, V86, P1209, DOI 10.2307/2656768; Falconer D. S., 1996, INTRO QUANTITATIVE G; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; HAMID AH, 1982, PHYTOPATHOLOGY, V72, P1166, DOI 10.1094/Phyto-72-1166; HILL JP, 1982, PHYTOPATHOLOGY, V72, P525, DOI 10.1094/Phyto-72-525; HOULE D, 1989, EVOLUTION, V43, P1767, DOI 10.1111/j.1558-5646.1989.tb02625.x; Hufbauer RA, 2012, EVOL APPL, V5, P89, DOI 10.1111/j.1752-4571.2011.00211.x; King KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072536; KNAPP SJ, 1989, GENETICS, V121, P891; Lamari L., 2002, ASSESS IMAGE ANAL SO; Lebarbenchon C, 2008, MOL ECOL, V17, P475, DOI 10.1111/j.1365-294X.2007.03375.x; Leinonen T, 2008, J EVOLUTION BIOL, V21, P1, DOI 10.1111/j.1420-9101.2007.01445.x; Leinonen T, 2013, NAT REV GENET, V14, P179, DOI 10.1038/nrg3395; Linde CC, 2009, MOL PHYLOGENET EVOL, V51, P454, DOI 10.1016/j.ympev.2009.03.002; Linde CC, 2005, MOL ECOL NOTES, V5, P546, DOI 10.1111/j.1471-8286.2005.00983.x; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; McKay JK, 2002, TRENDS ECOL EVOL, V17, P285, DOI 10.1016/S0169-5347(02)02478-3; Merila J, 2001, J EVOLUTION BIOL, V14, P892, DOI 10.1046/j.1420-9101.2001.00348.x; MILLER RG, 1968, ANN MATH STAT, V39, P567, DOI 10.1214/aoms/1177698418; MOUSSEAU TA, 1987, HEREDITY, V59, P181, DOI 10.1038/hdy.1987.113; Murray GM, 2009, CURRENT POTENTIAL CO; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Reed DH, 2001, EVOLUTION, V55, P1095, DOI 10.1111/j.0014-3820.2001.tb00629.x; SAS, 2008, SAS ONLINEDOC VERS 9; SHIPTON W A, 1974, Review of Plant Pathology, V53, P839; SPITZE K, 1993, GENETICS, V135, P367; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Stefansson TS, 2014, PLANT PATHOL, V63, P405, DOI 10.1111/ppa.12111; Stefansson TS, 2013, EVOL APPL, V6, P524, DOI 10.1111/eva.12039; Stukenbrock EH, 2008, ANNU REV PHYTOPATHOL, V46, P75, DOI 10.1146/annurev.phyto.010708.154114; Thrall PH, 2011, EVOL APPL, V4, P200, DOI 10.1111/j.1752-4571.2010.00179.x; TURELLI M, 1984, THEOR POPUL BIOL, V25, P138, DOI 10.1016/0040-5809(84)90017-0; Van Buskirk J, 2006, EVOLUTION, V60, P2428, DOI 10.1111/j.0014-3820.2006.tb01879.x; Whitlock MC, 2008, MOL ECOL, V17, P1885, DOI 10.1111/j.1365-294X.2008.03712.x; Willi Y, 2006, ANNU REV ECOL EVOL S, V37, P433, DOI 10.1146/annurev.ecolsys.37.091305.110145; Willi Y, 2011, GENETICA, V139, P903, DOI 10.1007/s10709-011-9594-9; Willi Y, 2010, EVOL ECOL RES, V12, P761; Wright S, 1931, GENETICS, V16, P0097; Zaffarano PL, 2008, EVOLUTION, V62, P1418, DOI 10.1111/j.1558-5646.2008.00390.x; Zaffarano PL, 2006, PHYTOPATHOLOGY, V96, P941, DOI 10.1094/PHYTO-96-0941; Zaffarano PL, 2011, MYCOLOGIA, V103, P195, DOI 10.3852/10-119; Zhan J, 2006, MOL PLANT PATHOL, V7, P259, DOI 10.1111/J.1364-3703.2006.00336.X; Zhan J, 2005, MOL ECOL, V14, P2683, DOI 10.1111/j.1365-294X.2005.02638.x; Zhan JS, 2011, MOL ECOL, V20, P1689, DOI 10.1111/j.1365-294X.2011.05023.x	47	14	14	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112523	10.1371/journal.pone.0112523	http://dx.doi.org/10.1371/journal.pone.0112523			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383967	Green Published, gold, Green Submitted			2022-12-27	WOS:000344816700075
J	Atta, H; El-Rehany, M; Hammam, O; Abdel-Ghany, H; Ramzy, M; Roderfeld, M; Roeb, E; Al-Hendy, A; Raheim, SA; Allam, H; Marey, H				Atta, Hussein; El-Rehany, Mahmoud; Hammam, Olfat; Abdel-Ghany, Hend; Ramzy, Maggie; Roderfeld, Martin; Roeb, Elke; Al-Hendy, Ayman; Raheim, Salama Abdel; Allam, Hatem; Marey, Heba			Mutant MMP-9 and HGF Gene Transfer Enhance Resolution of CCl4-Induced Liver Fibrosis in Rats: Role of ASH1 and EZH2 Methyltransferases Repression	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; HEPATIC STELLATE CELLS; ACTIVATED RECEPTOR-GAMMA; TISSUE INHIBITOR; MESSENGER-RNA; C-MET; MYOFIBROBLAST TRANSDIFFERENTIATION; INTRAVENOUS-INJECTION; PARTIAL-HEPATECTOMY; IMPROVES SURVIVAL	Hepatocyte growth factor (HGF) gene transfer inhibits liver fibrosis by regulating aberrant cellular functions, while mutant matrix metalloproteinase-9 (mMMP-9) enhances matrix degradation by neutralizing the elevated tissue inhibitor of metalloproteinase-1 (TIMP-1). It was shown that ASH1 and EZH2 methyltransferases are involved in development of liver fibrosis; however, their role in the resolution phase of liver fibrosis has not been investigated. This study evaluated the role of ASH1 and EZH2 in two mechanistically different therapeutic modalities, HGF and mMMP-9 gene transfer in CCl4 induced rat liver fibrosis. Liver fibrosis was induced in rats with twice a week intraperitoneal injection of CCl4 for 8 weeks. Adenovirus vectors encoding mMMP-9 or HGF genes were injected through tail vein at weeks six and seven and were sacrificed one week after the second injection. A healthy animal group was likewise injected with saline to serve as a negative control. Rats treated with mMMP-9 showed significantly lower fibrosis score, less Sirius red stained collagen area, reduced hydroxyproline and ALT concentration, decreased transforming growth factor beta 1 (TGF-beta 1) mRNA and lower labeling indices of alpha smooth muscle actin (alpha-SMA) and proliferating cell nuclear antigen (PCNA) stained cells compared with HGF- or saline-treated rats. Furthermore, TIMP-1 protein expression in mMMP-9 group was markedly reduced compared with all fibrotic groups. ASH1 and EZH2 protein expression was significantly elevated in fibrotic liver and significantly decreased in mMMP-9- and HGF-treated compared to saline-treated fibrotic livers with further reduction in the mMMP-9 group. Conclusion: Gene transfer of mMMP-9 and HGF reduced liver fibrosis in rats. ASH1 and EZH2 methyltransferases are significantly reduced in mMMP-9 and HGF treated rats which underlines the central role of these enzymes during fibrogenesis. Future studies should evaluate the role of selective pharmacologic inhibitors of ASH1 and EZH2 in resolution of liver fibrosis.	[Atta, Hussein] Menia Univ, Fac Med, Dept Surg, El Minia, Egypt; [El-Rehany, Mahmoud; Abdel-Ghany, Hend; Ramzy, Maggie; Raheim, Salama Abdel; Allam, Hatem; Marey, Heba] Menia Univ, Fac Med, Dept Biochem, El Minia, Egypt; [Hammam, Olfat] Theodor Bilharz Res Inst, Dept Pathol, Giza, Egypt; [Roderfeld, Martin; Roeb, Elke] Univ Giessen, Dept Gastroenterol, Giessen, Germany; [Al-Hendy, Ayman] Georgia Regents Univ, Dept Obstet & Gynecol, Augusta, GA USA	Egyptian Knowledge Bank (EKB); Minia University; Egyptian Knowledge Bank (EKB); Minia University; Egyptian Knowledge Bank (EKB); Theodor Bilharz Research Institute (TBRI); Justus Liebig University Giessen; University System of Georgia; Augusta University	Atta, H (corresponding author), Menia Univ, Fac Med, Dept Surg, El Minia, Egypt.	atta@mu.edu.eg	Atta, Hussein/B-9059-2009; Al-hendy, Ayman/J-9324-2019; Hammam, Olfat/D-4613-2015; , Martin/AHD-5202-2022	Atta, Hussein/0000-0003-1118-8347; Hammam, Olfat/0000-0002-4965-5804; , Martin/0000-0002-3232-1277; abdelraheim, salama/0000-0002-7544-9510; Ramzy, Maggie/0000-0003-3396-2073	Egyptian Science and Technology Fund [1550/2010]; Deutsche Forschungsgemeinschaft [RO 957/7-1, RO 957/8-1]	Egyptian Science and Technology Fund(Science and Technology Development Fund (STDF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Egyptian Science and Technology Fund (1550/2010) to Dr. Hussein Atta and by grants from the Deutsche Forschungsgemeinschaft to Dr. Elke Roeb (RO 957/7-1 and RO 957/8-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hendy A, 2000, AM J OBSTET GYNECOL, V182, P553, DOI 10.1067/mob.2000.104837; Atta HM, 2009, LIVER INT, V29, P1022, DOI 10.1111/j.1478-3231.2009.02056.x; BATTS KP, 1995, AM J SURG PATHOL, V19, P1409, DOI 10.1097/00000478-199512000-00007; BOROS P, 1995, LANCET, V345, P293, DOI 10.1016/S0140-6736(95)90279-1; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cohen-Naftaly Michal, 2011, Therap Adv Gastroenterol, V4, P391, DOI 10.1177/1756283X11413002; DErrico A, 1996, HEPATOLOGY, V24, P60, DOI 10.1002/hep.510240112; Esposito C, 2009, GROWTH FACTORS, V27, P173, DOI 10.1080/08977190902834077; FLAUMENHAFT R, 1992, MOL BIOL CELL, V3, P1057, DOI 10.1091/mbc.3.10.1057; FUJIWARA K, 1993, HEPATOLOGY, V18, P1443, DOI 10.1016/0270-9139(93)90237-H; Gregory GD, 2007, MOL CELL BIOL, V27, P8466, DOI 10.1128/MCB.00993-07; Hazra S, 2004, J BIOL CHEM, V279, P11392, DOI 10.1074/jbc.M310284200; HE CJ, 1995, AM J PHYSIOL-CELL PH, V269, pC554, DOI 10.1152/ajpcell.1995.269.3.C554; Inagaki Y, 2008, GASTROENTEROLOGY, V134, P1180, DOI 10.1053/j.gastro.2008.01.014; Inoue H, 2006, INT J MOL MED, V17, P857; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018; Iredale JP, 1996, HEPATOLOGY, V24, P176, DOI 10.1002/hep.510240129; ISHIKI Y, 1992, HEPATOLOGY, V16, P1227, DOI 10.1016/0270-9139(92)90019-6; Kim WH, 2005, AM J PATHOL, V166, P1017, DOI 10.1016/S0002-9440(10)62323-1; Kusumoto K, 2006, INT J MOL MED, V17, P503; Lee HS, 2001, HEPATO-GASTROENTEROL, V48, P1114; Li L, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/560345; Liu JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053392; Liu WB, 2003, WORLD J GASTROENTERO, V9, P316, DOI 10.3748/wjg.v9.i2.316; Liu YH, 2000, KIDNEY INT, V58, P2028, DOI 10.1046/j.1523-1755.2000.00375.x; Liu YH, 1998, EXP CELL RES, V242, P174, DOI 10.1006/excr.1998.4107; Mann J, 2010, GASTROENTEROLOGY, V138, P705, DOI 10.1053/j.gastro.2009.10.002; Matsuda Y, 1997, HEPATOLOGY, V26, P81; Mizuno S, 2011, CLIN EXP PHARMACOL P, V38, P192, DOI 10.1111/j.1440-1681.2011.05483.x; Murphy FR, 2002, J BIOL CHEM, V277, P11069, DOI 10.1074/jbc.M111490200; MURPHY G, 1994, ANN NY ACAD SCI, V732, P31, DOI 10.1111/j.1749-6632.1994.tb24722.x; Nishino M, 2008, SURGERY, V144, P374, DOI 10.1016/j.surg.2008.04.011; Nomi T, 2000, BIOCHEM BIOPH RES CO, V278, P338, DOI 10.1006/bbrc.2000.3793; OCONNELL JP, 1994, J BIOL CHEM, V269, P14967; Oe H, 2004, HEPATO-GASTROENTEROL, V51, P1641; Ozawa S, 2006, SURGERY, V139, P563, DOI 10.1016/j.surg.2005.10.003; Parsons CJ, 2004, HEPATOLOGY, V40, P1106, DOI 10.1002/hep.20425; Perugorria MJ, 2012, HEPATOLOGY, V56, P1129, DOI 10.1002/hep.25754; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; Phaneuf D, 2000, MOL MED, V6, P96, DOI 10.1007/BF03401777; Popov Y, 2009, HEPATOLOGY, V50, P1294, DOI 10.1002/hep.23123; Prosser CC, 2006, WORLD J GASTROENTERO, V12, P509, DOI 10.3748/wjg.v12.i4.509; Rampino T, 2001, AM J PATHOL, V159, P1275, DOI 10.1016/S0002-9440(10)62514-X; Roderfeld M, 2006, FASEB J, V20, P444, DOI 10.1096/fj.05-4828com; Roeb E, 2000, FASEB J, V14, P1671; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Seto S, 1998, J SURG RES, V80, P194, DOI 10.1006/jsre.1998.5472; TAKAHARA T, 1995, HEPATOLOGY, V21, P787; TASHIRO K, 1990, P NATL ACAD SCI USA, V87, P3200, DOI 10.1073/pnas.87.8.3200; Tsochatzis EA, 2012, HEPATOLOGY, V56, P1983, DOI 10.1002/hep.25915; Ueki T, 1999, NAT MED, V5, P226, DOI 10.1038/5593; Ueno M, 2007, SURGERY, V141, P511, DOI 10.1016/j.surg.2006.10.006; Volkel P, 2007, BIOCHIMIE, V89, P1, DOI 10.1016/j.biochi.2006.07.009; Xie GH, 2013, AM J PHYSIOL-GASTR L, V305, pG881, DOI 10.1152/ajpgi.00289.2013; Yang MD, 2012, HEPATOLOGY, V55, P1271, DOI 10.1002/hep.24792; Yasuda H, 1996, HEPATOLOGY, V24, P636, DOI 10.1002/hep.510240328; Yoshiji H, 2002, HEPATOLOGY, V36, P850, DOI 10.1053/jhep.2002.35625; Yu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074870; Zeybel M, 2013, J HEPATOL, V59, P1349, DOI 10.1016/j.jhep.2013.05.039	60	36	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112384	10.1371/journal.pone.0112384	http://dx.doi.org/10.1371/journal.pone.0112384			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380300	Green Published, Green Submitted, gold			2022-12-27	WOS:000344863100081
J	Salloum-Asfar, S; Teruel-Montoya, R; Arroyo, AB; Garcia-Barbera, N; Chaudhry, A; Schuetz, E; Luengo-Gil, G; Vicente, V; Gonzalez-Conejero, R; Martinez, C				Salloum-Asfar, Salam; Teruel-Montoya, Raul; Arroyo, Ana B.; Garcia-Barbera, Nuria; Chaudhry, Amarjit; Schuetz, Erin; Luengo-Gil, Gines; Vicente, Vicente; Gonzalez-Conejero, Rocio; Martinez, Constantino			Regulation of Coagulation Factor XI Expression by MicroRNAs in the Human Liver	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; MESSENGER-RNAS; TARGETS; GENE; HEMOSTASIS; INHIBITION; PREDICTION; SURVIVAL; SEPSIS; RISK	High levels of factor XI (FXI) increase the risk of thromboembolic disease. However, the genetic and environmental factors regulating FXI expression are still largely unknown. The aim of our study was to evaluate the regulation of FXI by microRNAs (miRNAs) in the human liver. In silico prediction yielded four miRNA candidates that might regulate FXI expression. HepG2 cells were transfected with miR-181a-5p, miR-23a-3p, miR-16-5p and miR-195-5p. We used mir-494, which was not predicted to bind to F11, as a negative control. Only miR-181a-5p caused a significant decrease both in FXI protein and F11 mRNA levels. In addition, transfection with a miR-181a-5p inhibitor in PLC/PRF/5 hepatic cells increased both the levels of F11 mRNA and extracellular FXI. Luciferase assays in human colon cancer cells deficient for Dicer (HCT-DK) demonstrated a direct interaction between miR-181a-5p and 39untranslated region of F11. Additionally, F11 mRNA levels were inversely and significantly correlated with miR-181a-5p levels in 114 healthy livers, but not with miR-494. This study demonstrates that FXI expression is directly regulated by a specific miRNA, miR-181a-5p, in the human liver. Future studies are necessary to further investigate the potential consequences of miRNA dysregulation in pathologies involving FXI.	[Salloum-Asfar, Salam; Teruel-Montoya, Raul; Arroyo, Ana B.; Garcia-Barbera, Nuria; Luengo-Gil, Gines; Vicente, Vicente; Gonzalez-Conejero, Rocio; Martinez, Constantino] Univ Murcia, Ctr Reg Hemodonac, Inst Murciano Invest Biosanitaria Virgen Arrixaca, Murcia, Spain; [Chaudhry, Amarjit; Schuetz, Erin] St Jude Childrens Res Hosp, Dept Pharmacol, Memphis, TN 38105 USA	Hospital Clinico Universitario Virgen de la Arrixaca; University of Murcia; St Jude Children's Research Hospital	Gonzalez-Conejero, R (corresponding author), Univ Murcia, Ctr Reg Hemodonac, Inst Murciano Invest Biosanitaria Virgen Arrixaca, Murcia, Spain.	rocio.gonzalez@carm.es; constant@um.es	Martinez, Constantino/R-8972-2019; Luengo-Gil, Ginés/AAB-6780-2019; Rodríguez, Ana Belén Arroyo/AAF-4759-2021; Salloum-Asfar, Salam/AAQ-4772-2021; Vicente, Vicente/L-6185-2019; Teruel-Montoya, Raúl/H-9012-2017; Gonzalez-Conejero, Rocio/H-9254-2017	Luengo-Gil, Ginés/0000-0001-9940-0415; Rodríguez, Ana Belén Arroyo/0000-0002-0150-2331; Salloum-Asfar, Salam/0000-0002-8357-2180; Vicente, Vicente/0000-0002-4278-3264; Teruel-Montoya, Raúl/0000-0002-6741-9725; Gonzalez-Conejero, Rocio/0000-0002-4772-9822; Martinez, Constantino/0000-0002-2976-2354	Instituto de Salud Carlos III; Fondo Europeo de Desarrollo Regional (FEDER) [PI11/00566]; Instituto de Salud Carlos III, Red RIC [RD12/0042/0050]; NIH/NIGMS [R01 GM094418]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094418] Funding Source: NIH RePORTER	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Instituto de Salud Carlos III, Red RIC; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional (FEDER) [PI11/00566]: CMG, RT-M, NG-B, Instituto de Salud Carlos III, Red RIC (RD12/0042/0050): W, RG-C, CM and NIH/NIGMS R01 GM094418: AC, ES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre X, 2012, LEUKEMIA, V26, P395, DOI 10.1038/leu.2011.344; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bezemer ID, 2008, JAMA-J AM MED ASSOC, V299, P1306, DOI 10.1001/jama.299.11.1306; Chen ZY, 2010, HUM GENET, V128, P443, DOI 10.1007/s00439-010-0866-8; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Fort A, 2010, BLOOD, V116, P2608, DOI 10.1182/blood-2010-02-268011; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He R, 2012, THROMB RES, V129, P541, DOI 10.1016/j.thromres.2011.11.051; Itakura A, 2011, J LEUKOCYTE BIOL, V90, P923, DOI 10.1189/jlb.0411182; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Kravtsov DV, 2009, BLOOD, V114, P452, DOI 10.1182/blood-2009-02-203604; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lamba V, 2010, J PHARMACOL EXP THER, V332, P1088, DOI 10.1124/jpet.109.160804; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Y, 2009, J THROMB HAEMOST, V7, P1802, DOI 10.1111/j.1538-7836.2009.03544.x; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Marchand A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044532; Meijers JCM, 2000, NEW ENGL J MED, V342, P696, DOI 10.1056/NEJM200003093421004; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Muller F, 2011, CURR OPIN HEMATOL, V18, P349, DOI 10.1097/MOH.0b013e3283497e61; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Nagalla S, 2011, BLOOD, V117, P5189, DOI 10.1182/blood-2010-09-299719; Perez-Andreu V, 2012, MOL MED, V18, P1466, DOI 10.2119/molmed.2012.00062; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; ROSENTHAL RL, 1953, P SOC EXP BIOL MED, V82, P171; Saba R, 2012, MOL CELL BIOL, V32, P619, DOI 10.1128/MCB.05896-11; Sabater-Lleal M, 2012, ARTERIOSCL THROM VAS, V32, P2008, DOI 10.1161/ATVBAHA.112.248492; Salomon O, 2011, THROMB HAEMOSTASIS, V105, P269, DOI 10.1160/TH10-05-0307; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Seligsohn U, 2007, THROMB HAEMOSTASIS, V98, P84, DOI 10.1160/Th07-04-0246; Tay JW, 2013, J THROMB HAEMOST, V11, P1547, DOI 10.1111/jth.12331; Taylor MA, 2013, J CLIN INVEST, V123, P150, DOI 10.1172/JCI64946; Teruel R, 2011, J THROMB HAEMOST, V9, P1985, DOI 10.1111/j.1538-7836.2011.04451.x; Teruel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017648; Tucker EI, 2008, J INFECT DIS, V198, P271, DOI 10.1086/589514; Tucker EI, 2012, BLOOD, V119, P4762, DOI 10.1182/blood-2011-10-386185; Vlieg AV, 2003, J THROMB HAEMOST, V1, P516, DOI 10.1046/j.1538-7836.2003.00080.x; Whichard ZL, 2011, J BIOL CHEM, V286, P4742, DOI 10.1074/jbc.M110.166348; Witkos TM, 2011, CURR MOL MED, V11, P93; Zhang H, 2010, BLOOD, V116, P4684, DOI 10.1182/blood-2010-04-277798	44	26	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111713	10.1371/journal.pone.0111713	http://dx.doi.org/10.1371/journal.pone.0111713			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379760	gold, Green Published, Green Submitted			2022-12-27	WOS:000344863100039
J	Sun, G; Srinivasan, R; Lopez-Anido, C; Hung, HA; Svaren, J; Keles, S				Sun, Guannan; Srinivasan, Rajini; Lopez-Anido, Camila; Hung, Holly A.; Svaren, John; Keles, Suenduez			In Silico Pooling of ChIP-seq Control Experiments	PLOS ONE			English	Article							GENOME; BINDING; DESIGN	As next generation sequencing technologies are becoming more economical, large-scale ChIP-seq studies are enabling the investigation of the roles of transcription factor binding and epigenome on phenotypic variation. Studying such variation requires individual level ChIP-seq experiments. Standard designs for ChIP-seq experiments employ a paired control per ChIP-seq sample. Genomic coverage for control experiments is often sacrificed to increase the resources for ChIP samples. However, the quality of ChIP-enriched regions identifiable from a ChIP-seq experiment depends on the quality and the coverage of the control experiments. Insufficient coverage leads to loss of power in detecting enrichment. We investigate the effect of in silico pooling of control samples within multiple biological replicates, multiple treatment conditions, and multiple cell lines and tissues across multiple datasets with varying levels of genomic coverage. Our computational studies suggest guidelines for performing in silico pooling of control experiments. Using vast amounts of ENCODE data, we show that pairwise correlations between control samples originating from multiple biological replicates, treatments, and cell lines/tissues can be grouped into two classes representing whether or not in silico pooling leads to power gain in detecting enrichment between the ChIP and the control samples. Our findings have important implications for multiplexing samples.	[Sun, Guannan; Keles, Suenduez] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA; [Srinivasan, Rajini; Lopez-Anido, Camila; Hung, Holly A.; Svaren, John] Univ Wisconsin, Waisman Ctr, Dept Comparat Biosci, Madison, WI 53706 USA; [Keles, Suenduez] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Keles, S (corresponding author), Univ Wisconsin, Dept Stat, Madison, WI 53706 USA.	keles@stat.wisc.edu	Svaren, John/A-1605-2010	Svaren, John/0000-0003-2963-7921; Lopez-Anido, Camila/0000-0003-0601-3980	National Institutes of Health [HG006716, HG007019]; NINDS [NS075269]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003747, U01HG007019, R21HG006716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM081061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075269] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants (HG006716 and HG007019) to S. K. and (NINDS (NS075269)) to J. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blahnik KR, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1012; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chen YW, 2012, NAT METHODS, V9, P609, DOI [10.1038/NMETH.1985, 10.1038/nmeth.1985]; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ho JWK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-134; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kuan PF, 2011, J AM STAT ASSOC, V106, P891, DOI 10.1198/jasa.2011.ap09706; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Liang K, 2012, BIOINFORMATICS, V28, P121, DOI 10.1093/bioinformatics/btr605; Mathelier A., 2013, NUCL ACIDS RES; Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523; Turatsinze JV, 2008, NAT PROTOC, V3, P1578, DOI 10.1038/nprot.2008.97; Vicky W, 2010, NATURE REV GENETICS, P718; Zhang ZD, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000158; Zhong WW, 2006, SCIENCE, V311, P1481, DOI 10.1126/science.1123287	16	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e109691	10.1371/journal.pone.0109691	http://dx.doi.org/10.1371/journal.pone.0109691			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380244	Green Published, Green Submitted, gold			2022-12-27	WOS:000344863100008
J	Tseng, YR; Wu, JF; Kong, MS; Hu, FC; Yang, YJ; Yeung, CY; Huang, FC; Huang, IF; Ni, YH; Hsu, HY; Chang, MH; Chen, HL				Tseng, Yu-Ru; Wu, Jia-Feng; Kong, Man-Shan; Hu, Fu-Chang; Yang, Yao-Jong; Yeung, Chun-Yan; Huang, Fu-Chen; Huang, I-Fei; Ni, Yen-Hsuan; Hsu, Hong-Yuan; Chang, Mei-Hwei; Chen, Huey-Ling			Infantile Hepatitis B in Immunized Children: Risk for Fulminant Hepatitis and Long-Term Outcomes	PLOS ONE			English	Article							E-ANTIGEN SEROCONVERSION; VIRUS-INFECTION; HEPATOCELLULAR-CARCINOMA; MASS VACCINATION; VIRAL-HEPATITIS; PRECORE REGION; UNITED-STATES; TAIWAN; PROGRAM; HBV	Background: Infantile hepatitis B after neonatal immunoprophylaxis is a rare yet distinct disease. This study aimed to analyze the long-term outcomes and risk factors in immunized infants with hepatitis B. Methods: The clinical parameters and outcomes of 41 infants born after universal immunization, and admitted for HBV-positive hepatitis were studied. All patients were followed for at least 6 months (median = 4.4 years, range 0.6-18.1 years). Patient survival, changes of HBsAg and HBeAg status, and complications were analyzed. Results: Among the 41 cases (32 males, 9 females), 21 presented with fulminant hepatitis (FH), and 20 with non-fulminant hepatitis (NFH). Ninety-five percent (36/38) of the mothers were positive for hepatitis B surface antigen (HBsAg). Multivariate analyses revealed younger age of onset (age <7 months) and negative maternal hepatitis B e antigen (HBeAg) were associated with FH (p = 0.03 and p = 0.01, respectively). An infantile fulminant hepatitis B risk score using maternal/infant HBeAg positivity and onset age was proposed. Among the FH cases, the rate of mortality, HBsAg clearance, and chronic HBV infection were 47.6%, 38.1%, and 14.3%, respectively. Among the NFH cases, 35% developed chronic infection. Of the 9 chronically infected children received long-term follow-up, 8 had HBeAg seroconversion before 4 years of age. One case of FH developed hepatocellular carcinoma 14 years later. Conclusions: Maternal HBsAg + /HBeAg-and early onset age were risk factors for FH in immunized infants. A significant portion of patients with FH or NFH evolve to chronic HBV infection, with HBeAg seroconversion in young childhood. Close surveillance for hepatocellular carcinoma is warranted in patients surviving infantile hepatitis B.	[Tseng, Yu-Ru; Wu, Jia-Feng; Ni, Yen-Hsuan; Hsu, Hong-Yuan; Chang, Mei-Hwei; Chen, Huey-Ling] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Kong, Man-Shan] Chang Gung Mem Hosp, Dept Pediat, Taoyuan, Taiwan; [Hu, Fu-Chang] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Yang, Yao-Jong] Natl Cheng Kung Univ & Hosp, Coll Med, Inst Clin Med, Dept Pediat, Tainan, Taiwan; [Yeung, Chun-Yan] Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan; [Huang, Fu-Chen] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Kaohsiung Med Ctr,Dept Pediat, Kaohsiung, Taiwan; [Huang, I-Fei] Vet Gen Hosp, Dept Pediat, Kaohsiung, Taiwan; [Hsu, Hong-Yuan; Chen, Huey-Ling] Natl Taiwan Univ, Coll Med, Dept Med Educ & Bioeth, Taipei 10764, Taiwan; [Chang, Mei-Hwei; Chen, Huey-Ling] Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; Chang Gung Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; Mackay Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Chen, HL (corresponding author), Natl Taiwan Univ Hosp, Dept Pediat, 1 Chang Te St, Taipei 10016, Taiwan.	hueyling@ntu.edu.tw	Wu, Jia-Feng/H-8125-2019	Wu, Jia-Feng/0000-0001-6343-1658; Hsu, Hong-Yuan/0000-0002-5720-4835; Chang, Mei Hwei/0000-0002-3648-9261; Ni, Yen-Hsuan/0000-0002-1158-5249	Center of Disease Control, Ministry of Health and Welfare, Taiwan [DOH-99-DC-1001]	Center of Disease Control, Ministry of Health and Welfare, Taiwan	The study was supported by grants from the Center of Disease Control, Ministry of Health and Welfare, Taiwan (DOH-99-DC-1001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beasley RP, 2009, ANN EPIDEMIOL, V19, P231, DOI 10.1016/j.annepidem.2009.01.017; BEASLEY RP, 1982, J INFECT DIS, V146, P198, DOI 10.1093/infdis/146.2.198; BORTOLOTTI F, 1986, INFECTION, V14, P64, DOI 10.1007/BF01644444; Cacciola I, 2002, J HEPATOL, V36, P426, DOI 10.1016/S0168-8278(01)00295-1; Chang MH, 2010, CLIN LIVER DIS, V14, P521, DOI 10.1016/j.cld.2010.05.010; Chang MH, 2009, JNCI-J NATL CANCER I, V101, P1348, DOI 10.1093/jnci/djp288; CHANG MH, 1995, HEPATOLOGY, V22, P1387, DOI 10.1016/0270-9139(95)90141-8; Chang MH, 2005, CLIN CANCER RES, V11, P7953, DOI 10.1158/1078-0432.CCR-05-1095; Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602; CHANG MH, 1987, J PEDIATR-US, V111, P34, DOI 10.1016/S0022-3476(87)80338-4; CHEN DS, 1987, JAMA-J AM MED ASSOC, V257, P2597; Chen HL, 1996, JAMA-J AM MED ASSOC, V276, P906, DOI 10.1001/jama.276.11.906; Chen HL, 2004, HEPATOLOGY, V39, P58, DOI 10.1002/hep.20006; Chen HL, 2012, GASTROENTEROLOGY, V142, P773, DOI 10.1053/j.gastro.2011.12.035; Chen SCC, 2013, PEDIATRICS, V131, pE1135, DOI 10.1542/peds.2012-1262; DUPUY JM, 1975, LANCET, V1, P191; FORTUIN M, 1993, LANCET, V341, P1129, DOI 10.1016/0140-6736(93)93137-P; Friedt M, 1999, HEPATOLOGY, V29, P1252, DOI 10.1002/hep.510290418; Haber BA, 2009, PEDIATRICS, V124, pE1007, DOI 10.1542/peds.2009-0567; HSU HY, 1992, HEPATOLOGY, V15, P770, DOI 10.1002/hep.1840150505; HSU HY, 1995, J INFECT DIS, V171, P776, DOI 10.1093/infdis/171.4.776; HYAMS KC, 1995, CLIN INFECT DIS, V20, P992, DOI 10.1093/clinids/20.4.992; Kellerman SE, 2003, J INFECT DIS, V188, P571, DOI 10.1086/377135; LIANG TJ, 1994, J CLIN INVEST, V93, P550, DOI 10.1172/JCI117006; Liaw YF, 2010, DIGEST DIS SCI, V55, P2727, DOI 10.1007/s10620-010-1179-4; LOK ASF, 1985, J HEPATOL, V1, P671, DOI 10.1016/S0168-8278(85)80010-6; McMahon BJ, 2011, HEPATOLOGY, V54, P801, DOI 10.1002/hep.24442; Mu SC, 2009, J HEPATOL, V50, P264, DOI 10.1016/j.jhep.2008.09.017; Ni YH, 2007, GASTROENTEROLOGY, V132, P2340, DOI 10.1053/j.gastro.2007.03.111; Ni YH, 2007, GASTROENTEROLOGY, V132, P1287, DOI 10.1053/j.gastro.2007.02.055; OGRADY JG, 1989, GASTROENTEROLOGY, V97, P439, DOI 10.1016/0016-5085(89)90081-4; OMATA M, 1991, NEW ENGL J MED, V324, P1699, DOI 10.1056/NEJM199106133242404; Pollicino T, 1997, HEPATOLOGY, V26, P495, DOI 10.1002/hep.510260235; ROSH JR, 1994, ARCH PEDIAT ADOL MED, V148, P1349, DOI 10.1001/archpedi.1994.02170120111024; Squires RH, 2006, J PEDIATR-US, V148, P652, DOI 10.1016/j.jpeds.2005.12.051; Su WJ, 2012, J INFECT DIS, V205, P757, DOI 10.1093/infdis/jir852; Wasley Annemarie, 2007, MMWR Surveill Summ, V56, P1; Wen WH, 2004, J PEDIATR-US, V144, P397, DOI 10.1016/j.jpeds.2003.11.022; Wirth S, 2002, J PEDIATR GASTR NUTR, V34, P77, DOI 10.1097/00005176-200201000-00018	39	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111825	10.1371/journal.pone.0111825	http://dx.doi.org/10.1371/journal.pone.0111825			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380075	Green Submitted, Green Published, gold			2022-12-27	WOS:000344863100042
J	Zhang, WW; Tian, DK; Huang, X; Xu, YX; Mo, HB; Liu, YB; Meng, J; Zhang, DS				Zhang, Weiwei; Tian, Daike; Huang, Xiu; Xu, Yuxian; Mo, Haibo; Liu, Yanbo; Meng, Jing; Zhang, Dasheng			Characterization of Flower-Bud Transcriptome and Development of Genic SSR Markers in Asian Lotus (Nelumbo nucifera Gaertn.)	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; EST-DERIVED SSR; SACRED LOTUS; MICROSATELLITE MARKERS; GENETIC DIVERSITY; CD-HIT; L.; DISCOVERY; DNA; GENOMICS	Background: Asian lotus (Nelumbo nucifera Gaertn.) is the national flower of India, Vietnam, and one of the top ten traditional Chinese flowers. Although lotus is highly valued for its ornamental, economic and cultural uses, genomic information, particularly the expressed sequence based (genic) markers is limited. High-throughput transcriptome sequencing provides large amounts of transcriptome data for promoting gene discovery and development of molecular markers. Results: In this study, 68,593 unigenes were assembled from 1.34 million 454 GS-FLX sequence reads of a mixed flower-bud cDNA pool derived from three accessions of N. nucifera. A total of 5,226 SSR loci were identified, and 3,059 primer pairs were designed for marker development. Di-nucleotide repeat motifs were the most abundant type identified with a frequency of 65.2%, followed by tri- (31.7%), tetra- (2.1%), penta- (0.5%) and hexa-nucleotide repeats (0.5%). A total of 575 primer pairs were synthesized, of which 514 (89.4%) yielded PCR amplification products. In eight Nelumbo accessions, 109 markers were polymorphic. They were used to genotype a sample of 44 accessions representing diverse wild and cultivated genotypes of Nelumbo. The number of alleles per locus varied from 2 to 9 alleles and the polymorphism information content values ranged from 0.6 to 0.9. We performed genetic diversity analysis using 109 polymorphic markers. A UPGMA dendrogram was constructed based on Jaccard's similarity coefficients revealing distinct clusters among the 44 accessions. Conclusions: Deep transcriptome sequencing of lotus flower buds developed 3,059 genic SSRs, making a significant addition to the existing SSR markers in lotus. Among them, 109 polymorphic markers were successfully validated in 44 accessions of Nelumbo. This comprehensive set of genic SSR markers developed in our study will facilitate analyses of genetic diversity, construction of linkage maps, gene mapping, and marker-assisted selection breeding for lotus.	[Zhang, Weiwei; Tian, Daike; Huang, Xiu; Xu, Yuxian; Mo, Haibo; Liu, Yanbo; Meng, Jing; Zhang, Dasheng] Chinese Acad Sci, Shanghai Chenshan Plant Sci Res Ctr, Chenshan Bot Garden, Shanghai, Peoples R China; [Xu, Yuxian] Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai, Peoples R China; [Liu, Yanbo] Northeast Agr Univ, Coll Hort, Harbin, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Normal University; Northeast Agricultural University - China	Tian, DK (corresponding author), Chinese Acad Sci, Shanghai Chenshan Plant Sci Res Ctr, Chenshan Bot Garden, Shanghai, Peoples R China.	dktian@sibs.ac.cn			Special Fund for Shanghai Landscaping Administration Bureau Program [F112421]	Special Fund for Shanghai Landscaping Administration Bureau Program	This work was supported by the Special Fund for Shanghai Landscaping Administration Bureau Program (grant No. F112421). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Blanca J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-104; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Chen WH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-320; Chen YY, 2008, AQUAT BOT, V89, P311, DOI 10.1016/j.aquabot.2008.03.006; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Diao Y, 2006, CARYOLOGIA, V59, P25, DOI 10.1080/00087114.2006.10797894; Dutta S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-17; Eveland AL, 2008, PLANT PHYSIOL, V146, P32, DOI 10.1104/pp.107.108597; Fu J, 2011, J AM SOC HORTIC SCI, V136, P339, DOI 10.21273/JASHS.136.5.339; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Hiremath PJ, 2011, PLANT BIOTECHNOL J, V9, P922, DOI 10.1111/j.1467-7652.2011.00625.x; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Hu JH, 2012, MOL BIOL REP, V39, P3637, DOI 10.1007/s11033-011-1138-y; Huang X. Q., 1992, Acta Horticulturae Sinica, V19, P164; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Kaur S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-265; Kubo Nakao, 2009, Plant Genetic Resources Characterization and Utilization, V7, P260, DOI 10.1017/S1479262109356580; Kubo N, 2009, AQUAT BOT, V90, P191, DOI 10.1016/j.aquabot.2008.06.006; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; Kumpatla SP, 2005, GENOME, V48, P985, DOI 10.1139/G05-060; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li S, 2004, BIOINFORMATICS, V20, P2865, DOI 10.1093/bioinformatics/bth302; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li Z, 2010, SCI HORTIC-AMSTERDAM, V125, P724, DOI 10.1016/j.scienta.2010.05.005; Liang XQ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-35; Liao XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062308; Libault M, 2010, PLANT J, V63, P86, DOI 10.1111/j.1365-313X.2010.04222.x; Liu YL, 2012, J AM SOC HORTIC SCI, V137, P180; Lu FH, 2012, MOL BIOL REP, V39, P3327, DOI 10.1007/s11033-011-1102-x; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Ming R, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r41; Mundry M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031410; Nishiyama T, 2003, P NATL ACAD SCI USA, V100, P8007, DOI 10.1073/pnas.0932694100; Niu SH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-263; Pan L, 2011, ANN APPL BIOL, V159, P428, DOI 10.1111/j.1744-7348.2011.00509.x; Pan L, 2007, MOL ECOL NOTES, V7, P1054, DOI 10.1111/j.1471-8286.2007.01774.x; Pan L, 2010, J HERED, V101, P71, DOI 10.1093/jhered/esp070; Parra-Gonzalez LB, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-425; Peng J. H., 2005, Functional & Integrative Genomics, V5, P80, DOI 10.1007/s10142-004-0128-8; Powell W, 1996, TRENDS PLANT SCI, V1, P215, DOI 10.1016/1360-1385(96)86898-1; Raju NL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-45; Rolf J, 2000, NUMERICAL TAXONOMY M; Rozen S, 2000, Methods Mol Biol, V132, P365; Shen-Miller J, 2002, SEED SCI RES, V12, P131, DOI 10.1079/SSR2002112; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Tanase K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-292; Tian HL, 2008, CONSERV GENET, V9, P1385, DOI 10.1007/s10592-007-9503-z; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; VanBuren R, 2013, PLANT OMICS, V6, P311; Varshney RK, 2006, THEOR APPL GENET, V113, P239, DOI 10.1007/s00122-006-0289-z; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Varshney RK, 2002, CELL MOL BIOL LETT, V7, P537; Vendramin E, 2007, MOL ECOL NOTES, V7, P307, DOI 10.1111/j.1471-8286.2006.01590.x; Wang Q, 2005, COLORED ILLUSTRATION; Wang SF, 2012, PLANT CELL REP, V31, P1437, DOI 10.1007/s00299-012-1259-3; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080464; Yang M, 2014, ANN APPL BIOL, V165, P73, DOI 10.1111/aab.12119; Yang M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-653; Zagrobelny M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-574; Zeng SH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-94; Zhang X., 2011, NEW LOTUS FLOWER CUL; Zheng XF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-490; Zhou YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-266	70	15	22	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112223	10.1371/journal.pone.0112223	http://dx.doi.org/10.1371/journal.pone.0112223			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379700	Green Submitted, Green Published, gold			2022-12-27	WOS:000344863100065
J	Yokota, PKO; Marra, AR; Martino, MDV; Victor, ES; Durao, MS; Edmond, MB; dos Santos, OFP				Yokota, Paula K. O.; Marra, Alexandre R.; Martino, Marines D. V.; Victor, Elivane S.; Durao, Marcelino S.; Edmond, Michael B.; dos Santos, Oscar F. P.			Impact of Appropriate Antimicrobial Therapy for Patients with Severe Sepsis and Septic Shock - A Quality Improvement Study	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; DEFINITIONS; ANTIBIOTICS; GUIDELINES	Background: There is ample literature available on the association between both time to antibiotics and appropriateness of antibiotics and clinical outcomes from sepsis. In fact, the current state of debate surrounds the balance to be struck between prompt empirical therapy and care in the choice of appropriate antibiotics (both in terms of the susceptibility of infecting organism and minimizing resistance arising from use of broad-spectrum agents). The objective of this study is to determine sepsis bundle compliance and the appropriateness of antimicrobial therapy in patients with severe sepsis and septic shock and its impact on outcomes. Material: This study was conducted in the ICU of a tertiary care, private hospital in Sao Paulo, Brazil. A retrospective cohort study was conducted from July 2005 to December 2012 in patients with severe sepsis and septic shock. Results: A total of 1,279 patients were identified with severe sepsis and septic shock, of which 358 (32.1%) had bloodstream infection (BSI). The inpatient mortality rate was 29%. In evaluation of the sepsis bundle, over time there was a progressive increase in serum arterial lactate collection, obtaining blood cultures prior to antibiotic administration, administration of broad-spectrum antibiotics within 1 hour, and administration of appropriate antimicrobials, with statistically significant differences in the later years of the study. We also observed a significant decrease in mortality. In patients with bloodstream infection, after adjustment for other covariates the administration of appropriate antimicrobial therapy was associated with a decrease in mortality in patients with severe sepsis and septic shock (p = 0.023). Conclusions: The administration of appropriate antimicrobial therapy was independently associated with a decline in mortality in patients with severe sepsis and septic shock due to bloodstream infection. As protocol adherence increased over time, the crude mortality rate decreased, which reinforces the need to implement institutional guidelines and monitor appropriate antimicrobial therapy compliance.	[Yokota, Paula K. O.; Marra, Alexandre R.; Durao, Marcelino S.; dos Santos, Oscar F. P.] Hosp Israelita Albert Einstein, Div Med Practice, Sao Paulo, Brazil; [Martino, Marines D. V.] Hosp Israelita Albert Einstein, Microbiol Lab, Sao Paulo, Brazil; [Victor, Elivane S.] Hosp Israelita Albert Einstein, IIEP, Dept Stat, Sao Paulo, Brazil; [Edmond, Michael B.] Virginia Commonwealth Univ, Sch Med, Dept Internal Med, Richmond, VA USA	Hospital Israelita Albert Einstein; Hospital Israelita Albert Einstein; Hospital Israelita Albert Einstein; Virginia Commonwealth University	Marra, AR (corresponding author), Hosp Israelita Albert Einstein, Div Med Practice, Sao Paulo, Brazil.	alexandre.marra@einstein.br	Santos, Oscar Fernando Pavão dos/B-8761-2017	Santos, Oscar Fernando Pavão dos/0000-0002-8731-1201; Edmond, Michael/0000-0002-4144-8974				Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Barochia AV, 2013, CURR INFECT DIS REP, V15, P385, DOI 10.1007/s11908-013-0351-3; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Calandra T, 2005, CRIT CARE MED, V33, P1538, DOI 10.1097/01.CCM.0000168253.91200.83; Cardoso T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058418; *CLIN LAB STAND I, 2006, M100S16 CLSI; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Durao MS, 2010, ANAESTH INTENS CARE, V38, P467, DOI 10.1177/0310057X1003800309; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Gaieski DF, 2010, CRIT CARE MED, V38, P1045, DOI 10.1097/CCM.0b013e3181cc4824; Global Sepsis Alliance, WORLD SEPS DAY; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; Kang CI, 2003, CLIN INFECT DIS, V37, P745, DOI 10.1086/377200; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Marra AR, 2010, AM J INFECT CONTROL, V38, P434, DOI 10.1016/j.ajic.2009.11.012; Marra AR, 2009, AM J INFECT CONTROL, V37, P619, DOI 10.1016/j.ajic.2009.03.009; Ministerio da Saude. Informacoes de Saude. DATASUS, TAX MORT HOSP LOC IN; Nygard ST, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-121; Shiramizo SCPL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026790; Proudfoot AG, 2011, CURR OPIN CRIT CARE, V17, P495, DOI 10.1097/MCC.0b013e32834a4b19; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Goncales PDS, 2012, EINSTEIN-SAO PAULO, V10, P442, DOI 10.1590/S1679-45082012000400009; Zaragoza R, 2003, CLIN MICROBIOL INFEC, V9, P412, DOI 10.1046/j.1469-0691.2003.00656.x; Zubert S, 2010, CRIT CARE MED, V38, P1211, DOI 10.1097/CCM.0b013e3181d69db7	26	42	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e104475	10.1371/journal.pone.0104475	http://dx.doi.org/10.1371/journal.pone.0104475			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375775	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402600003
J	Zhang, XZ; Lv, TY; Yang, XY; Zhang, B				Zhang, Xizhe; Lv, Tianyang; Yang, XueYing; Zhang, Bin			Structural Controllability of Complex Networks Based on Preferential Matching	PLOS ONE			English	Article							DYNAMICS	Minimum driver node sets (MDSs) play an important role in studying the structural controllability of complex networks. Recent research has shown that MDSs tend to avoid high-degree nodes. However, this observation is based on the analysis of a small number of MDSs, because enumerating all of the MDSs of a network is a #P problem. Therefore, past research has not been sufficient to arrive at a convincing conclusion. In this paper, first, we propose a preferential matching algorithm to find MDSs that have a specific degree property. Then, we show that the MDSs obtained by preferential matching can be composed of high-and medium-degree nodes. Moreover, the experimental results also show that the average degree of the MDSs of some networks tends to be greater than that of the overall network, even when the MDSs are obtained using previous research method. Further analysis shows that whether the driver nodes tend to be high-degree nodes or not is closely related to the edge direction of the network.	[Zhang, Xizhe; Yang, XueYing; Zhang, Bin] Northeastern Univ, Coll Informat Sci & Engn, Shenyang, Peoples R China; [Lv, Tianyang] Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Peoples R China; [Lv, Tianyang] Tsinghua Univ, Coll Comp Sci & Technol, Beijing 100084, Peoples R China; [Lv, Tianyang] Natl Audit Off, Audit Res Inst, Beijing, Peoples R China	Northeastern University - China; Harbin Engineering University; Tsinghua University	Zhang, XZ (corresponding author), Northeastern Univ, Coll Informat Sci & Engn, Shenyang, Peoples R China.	zhangxizhe@ise.neu.edu.cn	Zhang, Xizhe/H-3429-2019; Zhang, Xizhe/B-9848-2019	Zhang, Xizhe/0000-0002-8684-4591	Fundamental Research Funds for the Central Universities of China [N120404011]; Natural Science Foundation of China [60903009, 60903080, 71272216]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2012BAH08B02]; Supporting Plan Project for Youth Scholar Backbone of General Colleges and Universities of Heilongjiang [1253G017]	Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Supporting Plan Project for Youth Scholar Backbone of General Colleges and Universities of Heilongjiang	This work is sponsored by the Fundamental Research Funds for the Central Universities of China under grant number N120404011; the Natural Science Foundation of China under grant numbers 60903009, 60903080, and 71272216; the National Key Technology Research and Development Program of the Ministry of Science and Technology of China under grant number 2012BAH08B02; and the Supporting Plan Project for Youth Scholar Backbone of General Colleges and Universities of Heilongjiang under grant number 1253G017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; [Anonymous], [No title captured]; Balaji S, 2006, J MOL BIOL, V360, P213, DOI 10.1016/j.jmb.2006.04.029; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BERGE C, 1957, P NATL ACAD SCI USA, V43, P842, DOI 10.1073/pnas.43.9.842; Christian RR, 1999, ECOL MODEL, V117, P99, DOI 10.1016/S0304-3800(99)00022-8; Commault C, 2002, KYBERNETIKA, V38, P503; Cowan NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038398; De Nooy W, 1999, POETICS, V26, P385, DOI 10.1016/S0304-422X(99)00009-1; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Foster JG, 2010, P NATL ACAD SCI USA, V107, P10815, DOI 10.1073/pnas.0912671107; Ghoshal G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1396; Hopcroft J. E., 1973, SIAM Journal on Computing, V2, P225, DOI 10.1137/0202019; Leskovec J., 2005, P 11 ACM SIGKDD INT, P177, DOI 10.1145/1081870.1081893; Leskovec J, 2009, INTERNET MATH, V6, P29, DOI 10.1080/15427951.2009.10129177; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; LIN CT, 1974, IEEE T AUTOMAT CONTR, VAC19, P201, DOI 10.1109/TAC.1974.1100557; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; Muller FJ, 2011, NATURE, V478, pE4, DOI 10.1038/nature10543; Nepusz T, 2012, NAT PHYS, V8, P568, DOI [10.1038/nphys2327, 10.1038/NPHYS2327]; NORLEN K, 2002, P INT TEL SOC 14 BIE; Opsahl T, 2009, SOC NETWORKS, V31, P155, DOI 10.1016/j.socnet.2009.02.002; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Papadopoulos F, 2012, NATURE, V489, P537, DOI 10.1038/nature11459; Patricio J, 2004, ESTUAR COAST SHELF S, V60, P23, DOI 10.1016/j.ecss.2003.11.017; Ruths J, 2014, SCIENCE, V343, P1373, DOI 10.1126/science.1242063; SMITH DA, 1992, SOC FORCES, V70, P857, DOI 10.2307/2580193; Stanoev A, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046102; Ulanowicz RE, 2005, NETWORK ANAL TROPHIC, P114; Vespignani A, 2012, NAT PHYS, V8, P32, DOI 10.1038/nphys2160; Wang WX, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026115; Watts DJ, 1999, AM J SOCIOL, V105, P493, DOI 10.1086/210318; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yan G, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.218703; Zdeborova L, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/05/P05003	39	12	12	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112039	10.1371/journal.pone.0112039	http://dx.doi.org/10.1371/journal.pone.0112039			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375628	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402600093
J	Cramer, H; Lauche, R; Azizi, H; Dobos, G; Langhorst, J				Cramer, Holger; Lauche, Romy; Azizi, Hoda; Dobos, Gustav; Langhorst, Jost			Yoga for Multiple Sclerosis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							EXERCISE; FATIGUE; PEOPLE; SCHIZOPHRENIA; COMMUNITY; MEDICINE; DISEASE; MOOD; BIAS; MS	While yoga seems to be effective in a number of neuropsychiatric disorders, the evidence of efficacy in multiple sclerosis remains unclear. The aim of this review was to systematically assess and meta-analyze the available data on efficacy and safety of yoga in patients with multiple sclerosis. Medline/PubMed, Scopus, the Cochrane Central Register of Controlled Trials, PsycINFO, CAM-Quest, CAMbase, and IndMED were searched through March 2014. Randomized controlled trials (RCTs) of yoga for patients with multiple sclerosis were included if they assessed health-related quality of life, fatigue, and/or mobility. Mood, cognitive function, and safety were defined as secondary outcome measures. Risk of bias was assessed using the Cochrane tool. Seven RCTs with a total of 670 patients were included. Evidence for short-term effects of yoga compared to usual care were found for fatigue (standardized mean difference [SMD] = -0.52; 95% confidence intervals (CI) = -1.02 to -0.02; p = 0.04; heterogeneity: I-2 = 60%; Chi(2) = 7.43; p = 0.06) and mood (SMD = -0.55; 95% CI = -0.96 to -0.13; p = 0.01; heterogeneity: I-2 = 0%; Chi(2) = 1.25; p = 0.53), but not for health-related quality of life, muscle function, or cognitive function. The effects on fatigue and mood were not robust against bias. No short-term or longer term effects of yoga compared to exercise were found. Yoga was not associated with serious adverse events. In conclusion, since no methodological sound evidence was found, no recommendation can be made regarding yoga as a routine intervention for patients with multiple sclerosis. Yoga might be considered a treatment option for patients who are not adherent to recommended exercise regimens.	[Cramer, Holger; Lauche, Romy; Dobos, Gustav; Langhorst, Jost] Univ Duisburg Essen, Fac Med, Kliniken Essen Mitte, Dept Internal & Integrat Med, Essen, Germany; [Azizi, Hoda] Mashhad Univ Med Sci, Dept Complementary Med, Mashhad, Iran	Kliniken Essen-Mitte; University of Duisburg Essen; Mashhad University Medical Science	Cramer, H (corresponding author), Univ Duisburg Essen, Fac Med, Kliniken Essen Mitte, Dept Internal & Integrat Med, Essen, Germany.	h.cramer@kliniken-essen-mitte.de	Azizi, Hoda/A-6149-2018; Cramer, Holger/AAH-1794-2019; Lauche, Romy/AAQ-7175-2021	Azizi, Hoda/0000-0003-1120-2217; Lauche, Romy/0000-0002-4171-7935; Cramer, Holger/0000-0002-3640-8046	Rut- and Klaus-Bahlsen-Foundation	Rut- and Klaus-Bahlsen-Foundation	This review was supported by a grant from the Rut- and Klaus-Bahlsen-Foundation. The funding source had no influence on the design or conduct of the review; the collection, management, analysis, or interpretation of the data; or in the preparation, review, or approval of the manuscript.	Ahmadi A, 2013, IRAN RED CRESCENT ME, V15, P449, DOI 10.5812/ircmj.3597; Ahmadi A, 2010, J HUM KINET, V23, P71, DOI 10.2478/v10078-010-0009-2; [Anonymous], 2009, ARCH SEX BEHAV, DOI DOI 10.1007/s10508-008-9314-4; Armijo-Olivo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096920; Barnes Patricia M, 2004, Adv Data, P1; Barnes Patricia M, 2008, Natl Health Stat Report, P1; Boehm K, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/124703; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Cramer H, 2015, EUR J PREV CARDIOL, V22, P284, DOI 10.1177/2047487314523132; Cramer H, 2014, INT J CARDIOL, V173, P170, DOI 10.1016/j.ijcard.2014.02.017; Cramer H, 2013, DEPRESS ANXIETY, V30, P1068, DOI 10.1002/da.22166; Cramer H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075515; Cramer H, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-172; Cramer H, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/702914; Cramer H, 2013, CLIN J PAIN, V29, P450, DOI 10.1097/AJP.0b013e31825e1492; Cramer H, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-32; Cramer H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-412; Cramer H, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/863905; Doulatabad SN, 2013, AFR J TRADIT COMPLEM, V10, P49, DOI 10.4314/ajtcam.v10i1.8; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M, 2003, Health Technol Assess, V7, P1; Feuerstein G, 1998, THE YOGA TRADITION; Garrett M, 2013, MULT SCLER J, V19, P782, DOI 10.1177/1352458512461966; Garrett M, 2013, MULT SCLER J, V19, P790, DOI 10.1177/1352458512461390; Gartlehner G, 2008, Z EVIDENZ FORTBILD Q, V102, P497, DOI 10.1016/j.zefq.2008.08.028; HETHERINGTON J, 1989, PEDIATRICS, V84, P374; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hogan N, 2014, MULT SCLER INT, V2014, DOI 10.1155/2014/109142; Latimer-Cheung AE, 2013, ARCH PHYS MED REHAB, V94, P1829, DOI 10.1016/j.apmr.2013.05.015; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; National Multiple Sclerosis Society, 2008, MAN MS REL FAT; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Oken BS, 2004, NEUROLOGY, V62, P2058, DOI 10.1212/01.WNL.0000129534.88602.5C; Paul L, 2013, 29 C EUR COMM TREATM; Rahnama N, 2011, J ISFAHAN MED SCH, V29, P483; Riazi A, 2003, J NEUROL NEUROSUR PS, V74, P710, DOI 10.1136/jnnp.74.6.710; Sa MJ, 2014, J NEUROL, V261, P1651, DOI 10.1007/s00415-013-7183-9; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Senders A, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/567324; The National Collaborating Centre for Chronic Conditions, 2004, MULT SCLER NAT CLIN; Vancampfort D, 2012, ACTA PSYCHIAT SCAND, V126, P12, DOI 10.1111/j.1600-0447.2012.01865.x; Velikonja O, 2010, CLIN NEUROL NEUROSUR, V112, P597, DOI 10.1016/j.clineuro.2010.03.006; Yadav V, 2014, SUMMARY EVIDENCE BAS; Yadav V, 2014, NEUROLOGY, V82, P1083, DOI 10.1212/WNL.0000000000000250	46	50	51	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112414	10.1371/journal.pone.0112414	http://dx.doi.org/10.1371/journal.pone.0112414			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390344	Green Submitted, gold, Green Published			2022-12-27	WOS:000349144400079
J	Hara, T; Matsui, H; Shimizu, H				Hara, Takeshi; Matsui, Hiroshi; Shimizu, Hironori			Suppression of Microbial Metabolic Pathways Inhibits the Generation of the Human Body Odor Component Diacetyl by Staphylococcus spp.	PLOS ONE			English	Article							FATTY-ACID SYNTHESIS; HUMAN AXILLA; SUCCINATE-DEHYDROGENASE; ENERGY-CHARGE; IDENTIFICATION; BIOSYNTHESIS; PERCEPTION; PRECURSORS; SUBTILIS; MALODOR	Diacetyl (2,3-butanedione) is a key contributor to unpleasant odors emanating from the axillae, feet, and head regions. To investigate the mechanism of diacetyl generation on human skin, resident skin bacteria were tested for the ability to produce diacetyl via metabolism of the main organic acids contained in human sweat. L-Lactate metabolism by Staphylococcus aureus and Staphylococcus epidermidis produced the highest amounts of diacetyl, as measured by high-performance liquid chromatography. Glycyrrhiza glabra root extract (GGR) and alpha-tocopheryl-L-ascorbate-2-O-phosphate diester potassium salt (EPC-K1), a phosphate diester of alpha-tocopherol and ascorbic acid, effectively inhibited diacetyl formation without bactericidal effects. Moreover, a metabolic flux analysis revealed that GGR and EPC-K1 suppressed diacetyl formation by inhibiting extracellular bacterial conversion of L-lactate to pyruvate or by altering intracellular metabolic flow into the citrate cycle, respectively, highlighting fundamentally distinct mechanisms by GGR and EPC-K1 to suppress diacetyl formation. These results provide new insight into diacetyl metabolism by human skin bacteria and identify a regulatory mechanism of diacetyl formation that can facilitate the development of effective deodorant agents.	[Hara, Takeshi; Matsui, Hiroshi; Shimizu, Hironori] Mandom Corp, Tech Dev Ctr, Osaka, Japan		Hara, T (corresponding author), Mandom Corp, Tech Dev Ctr, Osaka, Japan.	hara-t@mandom.co.jp			Mandom Corp.	Mandom Corp.	Financial support for this research was provided by Mandom Corp. The authors' employer (Mandom Corp.) played no role in the study design, data acquisition, or decision to publish.	[Anonymous], AUT MASS SPECTR DEC; [Anonymous], 2008, 082008 NIST; Ara K, 2006, CAN J MICROBIOL, V52, P357, DOI 10.1139/W05-130; ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Austin C, 2003, J STEROID BIOCHEM, V87, P105, DOI 10.1016/S0960-0760(03)00387-X; BENNETT G, 1965, J FOOD SCI, V30, P35, DOI 10.1111/j.1365-2621.1965.tb00259.x; Berg J, 2007, BIOCHEMISTRY-US, P428; CAPASSO F, 1983, J PHARM PHARMACOL, V35, P332, DOI 10.1111/j.2042-7158.1983.tb02949.x; DAILEY HA, 1976, J BACTERIOL, V127, P1286, DOI 10.1128/JB.127.3.1286-1291.1976; Dasari S, 2011, APPL ENVIRON MICROB, V77, P727, DOI 10.1128/AEM.01579-10; Diarra MS, 2013, BMC COMPLEM ALTERN M, V27, P13; Dormont L, 2013, J CHEM ECOL, V39, P569, DOI 10.1007/s10886-013-0286-z; Garcia-Quintans N, 2008, APPL ENVIRON MICROB, V74, P1988, DOI 10.1128/AEM.01851-07; GARVIE EI, 1980, MICROBIOL REV, V44, P106, DOI 10.1128/MMBR.44.1.106-139.1980; Gaupp R, 2010, J BACTERIOL, V192, P2385, DOI 10.1128/JB.01472-09; GOETZ N, 1988, J SOC COSMET CHEM, V39, P1; GOWER DB, 1993, J ENDOCRINOL, V137, P167, DOI 10.1677/joe.0.1370167; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hara T, 2013, 22 C INT FED SOC COS, P213; Hara T, 2014, CHEM BIODIV IN PRESS; Hasegawa Y, 2004, CHEM BIODIVERS, V1, P2042, DOI 10.1002/cbdv.200490157; HEDERSTEDT L, 1980, J BACTERIOL, V144, P941, DOI 10.1128/JB.144.3.941-951.1980; James A G, 2004, Int J Cosmet Sci, V26, P149, DOI 10.1111/j.1467-2494.2004.00214.x; KANDA F, 1990, BRIT J DERMATOL, V122, P771, DOI 10.1111/j.1365-2133.1990.tb06265.x; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Kuribayashi Y, 1996, INT J TISSUE REACT, V18, P73; Kutyshenko VP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028824; LABOWS JN, 1982, J SOC COSMET CHEM, V33, P193; Laden K, 1999, COSMET SCI TECHNOL S, V20, P1; LEYDEN JJ, 1981, J INVEST DERMATOL, V77, P413, DOI 10.1111/1523-1747.ep12494624; MARSHALL J, 1988, J APPL BACTERIOL, V65, P61, DOI 10.1111/j.1365-2672.1988.tb04318.x; MATSUURA H, 1990, BUNSEKI KAGAKU, V39, P405; Natsch A, 2004, CHEM BIODIVERS, V1, P1058, DOI 10.1002/cbdv.200490079; Natsch A, 2003, J BIOL CHEM, V278, P5718, DOI 10.1074/jbc.M210142200; OKU H, 1988, J BIOL CHEM, V263, P18386; Parsons JB, 2011, P NATL ACAD SCI USA, V108, P15378, DOI 10.1073/pnas.1109208108; Poole K, 2012, J ANTIMICROB CHEMOTH, V67, P2069, DOI 10.1093/jac/dks196; REEVES HC, 1967, ANNU REV MICROBIOL, V21, P225, DOI 10.1146/annurev.mi.21.100167.001301; RENNIE PJ, 1991, BRIT J DERMATOL, V124, P596, DOI 10.1111/j.1365-2133.1991.tb04958.x; Sastry S.D., 1972, BIOCH APPL MASS SPEC, P1085; Schujman GE, 2006, EMBO J, V25, P4074, DOI 10.1038/sj.emboj.7601284; SHEN LC, 1968, BIOCHEMISTRY-US, V7, P4041, DOI 10.1021/bi00851a035; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Starkenmann C, 2005, CHEM BIODIVERS, V2, P705, DOI 10.1002/cbdv.200590048; STOCKLAND AE, 1969, J BACTERIOL, V100, P347, DOI 10.1128/JB.100.1.347-353.1969; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; Swindell SR, 1996, APPL ENVIRON MICROB, V62, P2641, DOI 10.1128/AEM.62.7.2641-2643.1996; Takayama H, 2003, CIRC J, V67, P1046, DOI 10.1253/circj.67.1046; Troccaz M, 2004, CHEM BIODIVERS, V1, P1022, DOI 10.1002/cbdv.200490077; Tynecka Z, 1999, RES MICROBIOL, V150, P555, DOI 10.1016/S0923-2508(99)00102-3; WHITE DC, 1968, J BACTERIOL, V95, P2198, DOI 10.1128/JB.95.6.2198-2209.1968; ZENG XN, 1991, J CHEM ECOL, V17, P1469, DOI 10.1007/BF00983777	56	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111833	10.1371/journal.pone.0111833	http://dx.doi.org/10.1371/journal.pone.0111833			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390046	gold, Green Published, Green Submitted			2022-12-27	WOS:000349144400036
J	Yoshida, K; Yoshioka, M; Okamura, H; Moriyama, S; Kawazoe, K; Grenier, D; Hinode, D				Yoshida, Kaya; Yoshioka, Masami; Okamura, Hirohiko; Moriyama, Satomi; Kawazoe, Kazuyoshi; Grenier, Daniel; Hinode, Daisuke			Preventive Effect of Daiokanzoto (TJ-84) on 5-Fluorouracil-Induced Human Gingival Cell Death through the Inhibition of Reactive Oxygen Species Production	PLOS ONE			English	Article							NLRP3 INFLAMMASOME; NITRIC-OXIDE; NALP3 INFLAMMASOME; HERBAL MEDICINE; KAMPO MEDICINE; ACTIVATION; EXPRESSION; IL-1-BETA; SECRETION; MUCOSITIS	Daiokanzoto (TJ-84) is a traditional Japanese herbal medicine (Kampo formulation). While many Kampo formulations have been reported to regulate inflammation and immune responses in oral mucosa, there is no evidence to show that TJ-84 has beneficial effects on oral mucositis, a disease resulting from increased cell death induced by chemotherapeutic agents such as 5-fluorouracil (5-FU). In order to develop effective new therapeutic strategies for treating oral mucositis, we investigated (i) the mechanisms by which 5-FU induces the death of human gingival cells and (ii) the effects of TJ-84 on biological events induced by 5-FU. 5-FU-induced lactate dehydrogenase (LDH) release and pore formation in gingival cells (Sa3 cell line) resulted in cell death. Incubating the cells with 5-FU increased the expression of nucleotide-binding domain and leucine-rich repeat containing PYD-3 (NLRP3) and caspase-1. The cleavage of caspase-1 was observed in 5-FU-treated cells, which was followed by an increased secretion of interleukin (IL)-1 beta. The inhibition of the NLRP3 pathway slightly decreased the effects of 5-FU on cell viability and LDH release, suggesting that NLRP3 may be in part involved in 5-FU-induced cell death. TJ-84 decreased 5-FU-induced LDH release and cell death and also significantly inhibited the depolarization of mitochondria and the up-regulation of 5-FU-induced reactive oxygen species (ROS) and nitric oxide (NO) production. The transcriptional factor, nuclear factor-kappa B (NF-kappa B) was not involved in the 5-FU-induced cell death in Sa3 cells. In conclusion, we provide evidence suggesting that the increase of ROS production in mitochondria, rather than NLRP3 activation, was considered to be associated with the cell death induced by 5-FU. The results also suggested that TJ-84 may attenuate 5-FU-induced cell death through the inhibition of mitochondrial ROS production.	[Yoshida, Kaya] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Healthcare Educ, Tokushima 770, Japan; [Yoshioka, Masami] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Hlth Sci & Social Welf, Tokushima 770, Japan; [Okamura, Hirohiko] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Histol & Oral Histol, Tokushima 770, Japan; [Moriyama, Satomi; Hinode, Daisuke] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Hyg & Oral Hlth Sci, Tokushima 770, Japan; [Kawazoe, Kazuyoshi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Clin Pharm, Tokushima 770, Japan; [Grenier, Daniel] Univ Laval, Fac Dent, Oral Ecol Res Grp, Quebec City, PQ, Canada	Tokushima University; Tokushima University; Tokushima University; Tokushima University; Laval University	Yoshida, K (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Healthcare Educ, Tokushima 770, Japan.	kaya@tokushima-u.ac.jp	Okamura, Hirohiko/I-5917-2019; Grenier, Daniel/E-5557-2015	Okamura, Hirohiko/0000-0002-3254-5238; Grenier, Daniel/0000-0003-0878-4674; Yoshida, Kaya/0000-0002-3202-0634	Ministry of Education, Culture, Sports, Science & Technology (MEXT) [24390471]	Ministry of Education, Culture, Sports, Science & Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was funded by a Grant-in-Aid for Scientific Research (B), Ministry of Education, Culture, Sports, Science & Technology (MEXT) (DH, 24390471). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ara T, 2008, BIOL PHARM BULL, V31, P1141, DOI 10.1248/bpb.31.1141; Ara T, 2010, BIOL PHARM BULL, V33, P611, DOI 10.1248/bpb.33.611; Arifa RDN, 2014, AM J PATHOL, V184, P2023, DOI 10.1016/j.ajpath.2014.03.012; Belibasakis GN, 2013, INNATE IMMUN-LONDON, V19, P3, DOI 10.1177/1753425912444767; Bostanci N, 2011, CELL IMMUNOL, V270, P88, DOI 10.1016/j.cellimm.2011.04.002; Brown GC, 2002, FREE RADICAL BIO MED, V33, P1440, DOI 10.1016/S0891-5849(02)01112-7; Brown GC, 2010, NITRIC OXIDE-BIOL CH, V23, P153, DOI 10.1016/j.niox.2010.06.001; Bruchard M, 2013, NAT MED, V19, P57, DOI 10.1038/nm.2999; Brune B, 1998, EUR J PHARMACOL, V351, P261, DOI 10.1016/S0014-2999(98)00274-X; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Das S K, 1989, J Assoc Physicians India, V37, P647; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; DREIZEN S, 1983, ORAL SURG ORAL MED O, V55, P113, DOI 10.1016/0030-4220(83)90164-0; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Duprez L, 2009, MICROBES INFECT, V11, P1050, DOI 10.1016/j.micinf.2009.08.013; Elting LS, 1997, CLIN INFECT DIS, V25, P247, DOI 10.1086/514550; Fata F, 1999, CANCER-AM CANCER SOC, V86, P1129, DOI 10.1002/(SICI)1097-0142(19991001)86:7<1129::AID-CNCR5>3.0.CO;2-4; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hernandez-Cuellar E, 2012, J IMMUNOL, V189, P5113, DOI 10.4049/jimmunol.1202479; Hiroshima Y, 2010, J PERIODONTAL RES, V45, P79, DOI 10.1111/j.1600-0765.2009.01203.x; Jabaut J, 2013, FREE RADICAL BIO MED, V60, P233, DOI 10.1016/j.freeradbiomed.2013.01.025; Kono Toru, 2010, World J Oncol, V1, P232, DOI 10.4021/wjon263w; Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006; Lawlor KE, 2014, BBA-GEN SUBJECTS, V1840, P1433, DOI 10.1016/j.bbagen.2013.08.014; Lee BC, 2014, BBA-MOL BASIS DIS, V1842, P446, DOI 10.1016/j.bbadis.2013.05.017; Liao J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/436206; Liao J, 2013, PHARM BIOL, V51, P1538, DOI 10.3109/13880209.2013.801995; MAJNO G, 1995, AM J PATHOL, V146, P3; Masters SL, 2012, IMMUNITY, V37, P1009, DOI 10.1016/j.immuni.2012.08.027; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Okada K, 2007, AM J PHYSIOL-GASTR L, V292, pG1450, DOI 10.1152/ajpgi.00302.2006; Okamoto M, 2010, J BIOL CHEM, V285, P6477, DOI 10.1074/jbc.M109.064907; Okamura H, 2013, FEBS LETT, V587, P48, DOI 10.1016/j.febslet.2012.10.041; Ouyang XS, 2013, BBA-MOL BASIS DIS, V1832, P979, DOI 10.1016/j.bbadis.2013.03.020; Peterson DE, 2011, ANN ONCOL, V22, pvi78, DOI 10.1093/annonc/mdr391; Saadeh CE, 2005, PHARMACOTHERAPY, V25, P540, DOI 10.1592/phco.25.4.540.61035; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Sonis ST, 2010, ORAL DIS, V16, P597, DOI 10.1111/j.1601-0825.2010.01681.x; Sonis SL, 2002, CRIT REV ORAL BIOL M, V13, P380, DOI 10.1177/154411130201300502; Sonis ST, 2004, NAT REV CANCER, V4, P277, DOI 10.1038/nrc1318; Takuma K, 2001, J BIOL CHEM, V276, P48093, DOI 10.1074/jbc.M108622200; Tang T, 2007, EUR J PHARMACOL, V567, P177, DOI 10.1016/j.ejphar.2007.02.033; Tassi S, 2010, P NATL ACAD SCI USA, V107, P9789, DOI 10.1073/pnas.1000779107; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Watanabe K, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq067; Wright TH, 2009, CANCER BIOL THER, V8, P923, DOI 10.4161/cbt.8.10.8146; Wu ZQ, 2010, BIOMED PHARMACOTHER, V64, P589, DOI 10.1016/j.biopha.2010.06.006; Yamamoto M, 2000, GASTROENTEROLOGY, V118, P380, DOI 10.1016/S0016-5085(00)70220-4; Yilmaz O, 2010, CELL MICROBIOL, V12, P188, DOI 10.1111/j.1462-5822.2009.01390.x; Yoshino F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082834; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	52	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112689	10.1371/journal.pone.0112689	http://dx.doi.org/10.1371/journal.pone.0112689			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389767	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400119
J	Zhang, QF; Shi, YZ; Ma, LF; Yi, XY; Ruan, JY				Zhang, Qunfeng; Shi, Yuanzhi; Ma, Lifeng; Yi, Xiaoyun; Ruan, Jianyun			Metabolomic Analysis Using Ultra-Performance Liquid Chromatography-Quadrupole-Time of Flight Mass Spectrometry (UPLC-Q-TOF MS) Uncovers the Effects of Light Intensity and Temperature under Shading Treatments on the Metabolites in Tea	PLOS ONE			English	Article							CAMELLIA-SINENSIS; FLAVONOID BIOSYNTHESIS; GREEN TEA; ANTHOCYANIN BIOSYNTHESIS; EXPRESSION; ACCUMULATION; PHENOLICS; ENZYMES; GENES; COLOR	To investigate the effect of light intensity and temperature on the biosynthesis and accumulation of quality-related metabolites, field grown tea plants were shaded by Black Net and Nano-insulating Film (with additional 2-4 degrees C cooling effect) with un-shaded plants as a control. Young shoots were subjected to UPLC-Q-TOF MS followed by multivariate statistical analysis. Most flavonoid metabolites (mainly flavan-3-ols,flavonols and their glycosides) decreased significantly in the shading treatments, while the contents of chlorophyll, beta-carotene, neoxanthin and free amino acids, caffeine, benzoic acid derivatives and phenylpropanoids increased. Comparison between two shading treatments indicated that the lower temperature under Nano shading decreased flavonols and their glycosides but increased accumulation of flavan-3-ols and proanthocyanidins. The comparison also showed a greater effect of temperature on galloylation of catechins than light intensity. Taken together, there might be competition for substrates between the up-and down-stream branches of the phenylpropanoid/flavonoid pathway, which was influenced by light intensity and temperature.	[Zhang, Qunfeng] Chinese Acad Agr Sci, Grad Sch, Beijing 100081, Peoples R China; [Zhang, Qunfeng; Shi, Yuanzhi; Ma, Lifeng; Yi, Xiaoyun; Ruan, Jianyun] Chinese Acad Agr Sci, Tea Res Inst, Hangzhou 310058, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Graduate School, CAAS; Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS	Ruan, JY (corresponding author), Chinese Acad Agr Sci, Tea Res Inst, Hangzhou 310058, Zhejiang, Peoples R China.	jruan@mail.tricaas.com		shi, yuanzhi/0000-0002-7234-0341	Ministry of Agriculture of China through the Earmarked Fund for China Agriculture Research System [CARS 23]; Chinese Academy of Agricultural Sciences through an Innovation Project for Agricultural Sciences and Technology	Ministry of Agriculture of China through the Earmarked Fund for China Agriculture Research System; Chinese Academy of Agricultural Sciences through an Innovation Project for Agricultural Sciences and Technology	The work was supported financially by the Ministry of Agriculture of China through the Earmarked Fund for China Agriculture Research System (CARS 23) and the Chinese Academy of Agricultural Sciences through an Innovation Project for Agricultural Sciences and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma A, 2012, PLANTA, V236, P1067, DOI 10.1007/s00425-012-1650-x; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; Cheynier V, 2013, PLANT PHYSIOL BIOCH, V72, P1, DOI 10.1016/j.plaphy.2013.05.009; Cohen SD, 2012, J EXP BOT, V63, P2655, DOI 10.1093/jxb/err449; Cohen SD, 2010, CRIT REV FOOD SCI, V50, P620, DOI 10.1080/10408390802603441; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Deng WW, 2013, PLANT GROWTH REGUL, V71, P295, DOI 10.1007/s10725-013-9828-1; Dixon RA, 2005, NEW PHYTOL, V165, P9, DOI 10.1111/j.1469-8137.2004.01217.x; Eungwanichayapant PD, 2009, PLANT PHYSIOL BIOCH, V47, P94, DOI 10.1016/j.plaphy.2008.11.002; Fraser K, 2013, FOOD RES INT, V53, P827, DOI 10.1016/j.foodres.2012.10.015; Fujimura Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023426; Harbowy ME, 1997, CRIT REV PLANT SCI, V16, P415, DOI 10.1080/713608154; Jaakola L, 2013, TRENDS PLANT SCI, V18, P477, DOI 10.1016/j.tplants.2013.06.003; Jayasekera S, 2014, FOOD CHEM, V152, P546, DOI 10.1016/j.foodchem.2013.12.005; Jiang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062315; Kalili KM, 2011, J SEP SCI, V34, P854, DOI 10.1002/jssc.201000811; Koricheva J, 1998, OIKOS, V83, P212, DOI 10.2307/3546833; Ku KM, 2010, J AGR FOOD CHEM, V58, P418, DOI 10.1021/jf902929h; Lee JE, 2011, J AGR FOOD CHEM, V59, P10579, DOI 10.1021/jf202304z; Lee JE, 2010, J AGR FOOD CHEM, V58, P10582, DOI 10.1021/jf102415m; Lee LS, 2013, J AGR FOOD CHEM, V61, P332, DOI 10.1021/jf304161y; Lin-Wang K, 2011, PLANT CELL ENVIRON, V34, P1176, DOI 10.1111/j.1365-3040.2011.02316.x; Liu YJ, 2012, J BIOL CHEM, V287, P44406, DOI 10.1074/jbc.M112.403071; Lo SCC, 1998, PLANT PHYSIOL, V116, P979, DOI 10.1104/pp.116.3.979; Lovdal T, 2010, PHYTOCHEMISTRY, V71, P605, DOI 10.1016/j.phytochem.2009.12.014; Lu JL, 2009, INT J FOOD SCI TECH, V44, P2505, DOI 10.1111/j.1365-2621.2009.02069.x; Mori K, 2005, SCI HORTIC-AMSTERDAM, V105, P319, DOI 10.1016/j.scienta.2005.01.032; Pang YZ, 2013, PLANT PHYSIOL, V161, P1103, DOI 10.1104/pp.112.212050; Punyasiri PAN, 2004, ARCH BIOCHEM BIOPHYS, V431, P22, DOI 10.1016/j.abb.2004.08.003; Rodriguez-Amaya PD, 2001, GUIDE CAROTENOID ANA, P1; Sandmann G, 2006, METAB ENG, V8, P291, DOI 10.1016/j.ymben.2006.01.005; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Tounekti T, 2013, CRIT REV PLANT SCI, V32, P192, DOI 10.1080/07352689.2012.747384; Vrhovsek U, 2012, J AGR FOOD CHEM, V60, P8831, DOI 10.1021/jf2051569; Wang LY, 2011, EUR FOOD RES TECHNOL, V233, P1049, DOI 10.1007/s00217-011-1588-4; Wang YS, 2012, SCI HORTIC-AMSTERDAM, V141, P7, DOI 10.1016/j.scienta.2012.04.013; Wang YS, 2012, SCI HORTIC-AMSTERDAM, V133, P72, DOI 10.1016/j.scienta.2011.10.017; Yang YY, 2013, RUSS J PLANT PHYSL+, V60, P91, DOI 10.1134/S1021443712060180	38	78	84	10	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112572	10.1371/journal.pone.0112572	http://dx.doi.org/10.1371/journal.pone.0112572			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390340	gold, Green Published, Green Submitted			2022-12-27	WOS:000349144400103
J	Li, ST; Li, LN; Lee, G; Zhang, H				Li, Shoutao; Li, Lina; Lee, Gordon; Zhang, Hao			A Hybrid Search Algorithm for Swarm Robots Searching in an Unknown Environment	PLOS ONE			English	Article								This paper proposes a novel method to improve the efficiency of a swarm of robots searching in an unknown environment. The approach focuses on the process of feeding and individual coordination characteristics inspired by the foraging behavior in nature. A predatory strategy was used for searching; hence, this hybrid approach integrated a random search technique with a dynamic particle swarm optimization (DPSO) search algorithm. If a search robot could not find any target information, it used a random search algorithm for a global search. If the robot found any target information in a region, the DPSO search algorithm was used for a local search. This particle swarm optimization search algorithm is dynamic as all the parameters in the algorithm are refreshed synchronously through a communication mechanism until the robots find the target position, after which, the robots fall back to a random searching mode. Thus, in this searching strategy, the robots alternated between two searching algorithms until the whole area was covered. During the searching process, the robots used a local communication mechanism to share map information and DPSO parameters to reduce the communication burden and overcome hardware limitations. If the search area is very large, search efficiency may be greatly reduced if only one robot searches an entire region given the limited resources available and time constraints. In this research we divided the entire search area into several subregions, selected a target utility function to determine which subregion should be initially searched and thereby reduced the residence time of the target to improve search efficiency.	[Li, Shoutao; Li, Lina] Jilin Univ, Coll Commun Engn, Changchun 130023, Jilin Province, Peoples R China; [Lee, Gordon] San Diego State Univ, Dept Elect & Comp Engn, San Diego, CA 92182 USA; [Zhang, Hao] Jilin Univ, Coll Comp Sci & Technol, Symbol Computat & Knowledge Engn Minist Educ, Changchun 130023, Peoples R China	Jilin University; California State University System; San Diego State University; Jilin University	Zhang, H (corresponding author), Jilin Univ, Coll Comp Sci & Technol, Symbol Computat & Knowledge Engn Minist Educ, Changchun 130023, Peoples R China.	zhangh@jlu.edu.cn	Zhang, Hao/AAR-8325-2020	Zhang, Hao/0000-0002-2058-7123				BO A, 2012, AUTOMATED NEGOTIATIO, P262; Cai Y, 2013, INT J ROBOT AUTOM, V28, DOI [10.2316/Journal.206.2013.4.206-3769, DOI 10.2316/JOURNAL.206.2013.4.206-3769]; Darvishzadah A, 2011, THESIS U CALIFORNIA; Darvishzadeh A., 2014, P 2014 C COMP GEN EV, P169; Das Sharma K, 2014, MACH VISION APPL, V25, P405, DOI 10.1007/s00138-013-0515-z; Geoffrey AH, 2010, 37 CARN MELL U; Guizzo E., 2011, GOOGLES SELF DRIVING; Hoff N. R., 2010, 2010 IEEE International Conference on Robotics and Biomimetics (ROBIO), P123, DOI 10.1109/ROBIO.2010.5723314; Kruijff G-JM, 2014, FIELD SERVICE ROBOTI, P111, DOI DOI 10.1007/978-3-642-40686-7_8; Nanjanath M, 2010, ROBOT AUTON SYST, V58, P900, DOI 10.1016/j.robot.2010.03.011; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Sheh R, 2014, SPRINGER TRACTS ADV, V92, P127; Sisso I, 2010, IEEE T ROBOT, V26, P1032, DOI 10.1109/TRO.2010.2073050; Tang Q, 2013, LNCS, V7928, P64; Wang P, 2014, ADV MECH ENG, P1; Wood JG, 2011, SEARCH TRACKING UNKN; Zhang JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021787	17	3	4	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111970	10.1371/journal.pone.0111970	http://dx.doi.org/10.1371/journal.pone.0111970			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386855	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400033
J	Lin, WC; Licht, S				Lin, Wan-Chen; Licht, Stuart			Poly(Ethylene Glycol) as a Scaffold for High-Affinity Open-Channel Blockers of the Mouse Nicotinic Acetylcholine Receptor	PLOS ONE			English	Article							CONGENITAL MYASTHENIC SYNDROME; SINGLE-CHANNEL; MOLECULAR COMPLEXITY; ACTIVATION; BLOCKADE; KINETICS; INHIBITION; CURRENTS; THERAPY; BINDING	High-affinity blockers for an ion channel often have complex molecular structures that are synthetically challenging and/or laborious. Here we show that high-affinity blockers for the mouse nicotinic acetylcholine receptor (AChR) can be prepared from a structurally simple material, poly(ethylene glycol) (PEG). The PEG-based blockers (PQ1-5), comprised of a flexible octa(ethylene glycol) scaffold and two terminal quaternary ammonium groups, exert low-tosub-micromolar affinities for the open AChR pore (measured via single-channel analysis of AChRs expressed in human embryonic kidney cells). PQ1-5 are comparable in pore-binding affinity to the strongest AChR open-channel blockers previously reported, which have complex molecular structures. These results suggest a general approach for designing potent open-channel blockers from a structurally flexible polymer. This design strategy involves simple synthetic procedures and does not require detailed information about the structure of an ion-channel pore.	[Lin, Wan-Chen; Licht, Stuart] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Licht, S (corresponding author), Sanofi US, Div Oncol, Cambridge, MA 02139 USA.	stuart.licht@sanofi.com	Lin, Wan-Chen/S-5121-2019	Lin, Wan-Chen/0000-0001-7842-3036	MIT Department of Chemistry; Beckman Foundation	MIT Department of Chemistry; Beckman Foundation	Funding provided by MIT Department of Chemistry; Beckman Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akk G, 2003, J PHYSIOL-LONDON, V551, P155, DOI 10.1113/jphysiol.2003.043885; AMADOR M, 1991, SYNAPSE, V7, P207, DOI 10.1002/syn.890070305; BAKRY NM, 1982, MOL PHARMACOL, V22, P63; BERTZ SH, 1981, J AM CHEM SOC, V103, P3599, DOI 10.1021/ja00402a071; BOUZAT C, 1994, NEURON, V13, P1395, DOI 10.1016/0896-6273(94)90424-3; Bufler J, 1996, J PHYSIOL-LONDON, V495, P83, DOI 10.1113/jphysiol.1996.sp021575; CARTER AA, 1993, BIOPHYS J, V65, P840, DOI 10.1016/S0006-3495(93)81103-2; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; DiFrancesco D, 2006, PHARMACOL RES, V53, P399, DOI 10.1016/j.phrs.2006.03.006; Engel AG, 2007, NEUROTHERAPEUTICS, V4, P252, DOI 10.1016/j.nurt.2007.01.001; Gussin HA, 2006, J AM CHEM SOC, V128, P15701, DOI 10.1021/ja064324k; Harper CM, 2003, NEUROLOGY, V60, P1710, DOI 10.1212/01.WNL.0000061483.11417.1B; HENDRICKSON JB, 1987, J CHEM INF COMP SCI, V27, P63, DOI 10.1021/ci00054a004; Hilf RJC, 2010, NAT STRUCT MOL BIOL, V17, P1330, DOI 10.1038/nsmb.1933; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Kramer RH, 1998, NATURE, V395, P710, DOI 10.1038/27227; Lin WC, 2008, BIOCHEMISTRY-US, V47, P9163, DOI 10.1021/bi800737j; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; MARSHALL CG, 1991, J PHYSIOL-LONDON, V433, P73, DOI 10.1113/jphysiol.1991.sp018415; Militante J, 2008, MOL PHARMACOL, V74, P764, DOI 10.1124/mol.108.047134; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; NEHER E, 1978, J PHYSIOL-LONDON, V277, P153, DOI 10.1113/jphysiol.1978.sp012267; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; NOJIMA H, 1993, J PHARM PHARMACOL, V45, P309, DOI 10.1111/j.2042-7158.1993.tb05558.x; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Salamone FN, 1999, J PHYSIOL-LONDON, V516, P315, DOI 10.1111/j.1469-7793.1999.0315v.x; Sonawane ND, 2008, CHEM BIOL, V15, P718, DOI 10.1016/j.chembiol.2008.05.015; Tantama M, 2008, J AM CHEM SOC, V130, P15766, DOI 10.1021/ja805868x; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Valles AS, 2007, NEUROREPORT, V18, P45, DOI 10.1097/01.wnr.0000246323.66438.94	33	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112088	10.1371/journal.pone.0112088	http://dx.doi.org/10.1371/journal.pone.0112088			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386750	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400039
J	Song, L; Liu, JX; Jin, XT; Li, ZY; Zhao, MR; Liu, WP				Song, Li; Liu, Jianxin; Jin, Xiaoting; Li, Zhuoyu; Zhao, Meirong; Liu, Weiping			p, p '-Dichlorodiphenyldichloroethylene Induces Colorectal Adenocarcinoma Cell Proliferation through Oxidative Stress	PLOS ONE			English	Article							HEDGEHOG SIGNALING PATHWAY; WNT/BETA-CATENIN PATHWAY; SONIC HEDGEHOG; ADIPOSE-TISSUE; COLON-CANCER; PESTICIDE LEVELS; BETA-CATENIN; EXPRESSION; ROS; EXPOSURE	p, p'-Dichlorodiphenyldichloroethylene (DDE), the major metabolite of Dichlorodiphenyltrichloroethane (DDT), is an organochlorine pollutant and associated with cancer progression. The present study investigated the possible effects of p, p'-DDE on colorectal cancer and the involved molecular mechanism. The results indicated that exposure to low concentrations of p, p'-DDE from 10(-10) to 10(-7) M for 96 h markedly enhanced proliferations of human colorectal adenocarcinoma cell lines. Moreover, p, p'-DDE exposure could activate Wnt/beta-catenin and Hedgehog/Gli1 signaling cascades, and the expression level of c-Myc and cyclin D1 was significantly increased. Consistently, p, p'-DDE-induced cell proliferation along with upregulated c-Myc and cyclin D1 were impeded by beta-catenin siRNA or Gli1 siRNA. In addition, p, p'-DDE was able to activate NADPH oxidase, generate reactive oxygen species (ROS) and reduce GSH content, superoxide dismutase (SOD) and calatase (CAT) activities. Treatment with antioxidants prevented p, p'-DDE-induced cell proliferation and signaling pathways of Wnt/beta-catenin and Hedgehog/Gli1. These results indicated that p, p'-DDE promoted colorectal cancer cell proliferation through Wnt/beta-catenin and Hedgehog/Gli1 signalings mediated by oxidative stress. The finding suggests an association between p, p'-DDE exposure and the risk of colorectal cancer progression.	[Song, Li; Liu, Jianxin; Jin, Xiaoting; Li, Zhuoyu] Shanxi Univ, Natl Minist Educ, Key Lab Chem Biol & Mol Engn, Inst Biotechnol, Taiyuan, Peoples R China; [Song, Li; Liu, Weiping] Zhejiang Univ, Coll Environm & Resource Sci, MOE Key Lab Environm Remediat & Ecosyst Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Zhuoyu] Zhejiang Chinese Med Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Zhao, Meirong] Zhejiang Univ Technol, Res Ctr Environm Sci, Hangzhou, Zhejiang, Peoples R China	Shanxi University; Zhejiang University; Zhejiang Chinese Medical University; Zhejiang University of Technology	Li, ZY (corresponding author), Shanxi Univ, Natl Minist Educ, Key Lab Chem Biol & Mol Engn, Inst Biotechnol, Taiyuan, Peoples R China.	lzy@sxu.edu.cn; Wliu@zju.edu.cn	Liu, Weiping/E-9208-2010	Liu, Weiping/0000-0002-1173-892X	National Natural Sciences Foundation of China [31271516, 21207084]; Research Fund for the Doctoral Program of Higher Education of China [20111401110011]; China Postdoctoral Science Foundation [2012M521178]; Natural Sciences Foundation of Shanxi [2014011027-5]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Sciences Foundation of Shanxi	This work was supported by the National Natural Sciences Foundation of China (No. 31271516, No. 21207084), Research Fund for the Doctoral Program of Higher Education of China (20111401110011), China Postdoctoral Science Foundation (2012M521178) and Natural Sciences Foundation of Shanxi (2014011027-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren M, 2004, GENE, V330, P101, DOI 10.1016/j.gene.2004.01.010; Arrebola JP, 2012, ENVIRON RES, V112, P40, DOI 10.1016/j.envres.2011.10.006; Bazensky Ivy, 2007, Medsurg Nurs, V16, P46; Beard J, 2006, SCI TOTAL ENVIRON, V355, P78, DOI 10.1016/j.scitotenv.2005.02.022; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bian YH, 2007, WORLD J GASTROENTERO, V13, P1659, DOI 10.3748/wjg.v13.i11.1659; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; CALDWELL GG, 1981, CANCER, V48, P774, DOI 10.1002/1097-0142(19810801)48:3<774::AID-CNCR2820480319>3.0.CO;2-T; Chen Kun, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P479; Coant N, 2010, MOL CELL BIOL, V30, P2636, DOI 10.1128/MCB.01194-09; Colosio C, 2003, NEUROTOXICOLOGY, V24, P577, DOI 10.1016/S0161-813X(03)00055-X; Dai RL, 2011, NEUROCHEM RES, V36, P67, DOI 10.1007/s11064-010-0264-6; De Jager C, 2006, J ANDROL, V27, P16, DOI 10.2164/jandrol.05121; Ducarouge B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079335; El-Tawil AM, 2010, WORLD J GASTROENTERO, V16, P3475, DOI 10.3748/wjg.v16.i28.3475; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Galassi S, 2008, SCI TOTAL ENVIRON, V390, P45, DOI 10.1016/j.scitotenv.2007.09.029; Gianni D, 2010, MOL BIOL CELL, V21, P4287, DOI 10.1091/mbc.E10-08-0685; Gunasekaran K, 2005, TROP MED INT HEALTH, V10, P160, DOI 10.1111/j.1365-3156.2004.01369.x; HOAR SK, 1985, LANCET, V1, P1277; Howsam M, 2004, ENVIRON HEALTH PERSP, V112, P1460, DOI 10.1289/ehp.7143; Jaga K, 1999, ARCH ENVIRON HEALTH, V54, P217; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Juhasz A, 2009, FREE RADICAL RES, V43, P523, DOI 10.1080/10715760902918683; Katoh Y, 2006, INT J MOL MED, V18, P1019; Kim MJ, 2010, BIOCHEM PHARMACOL, V80, P2092, DOI 10.1016/j.bcp.2010.08.014; Korswagen HC, 2006, DEV CELL, V10, P687, DOI 10.1016/j.devcel.2006.05.007; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Li J, 2008, TOXICOL LETT, V183, P65, DOI 10.1016/j.toxlet.2008.10.002; Lobjois V, 2004, DEV BIOL, V273, P195, DOI 10.1016/j.ydbio.2004.05.031; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Moon Randall T, 2004, Nat Rev Genet, V5, P691, DOI 10.1038/nrg1427; Mrema EJ, 2013, TOXICOLOGY, V307, P74, DOI 10.1016/j.tox.2012.11.015; Oniscu A, 2004, J PATHOL, V203, P909, DOI 10.1002/path.1591; Polakis P, 2000, GENE DEV, V14, P1837; Ribas-Fito N, 2003, PEDIATRICS, V111, pE580, DOI 10.1542/peds.111.5.e580; Rocha-Amador D, 2009, NEUROTOXICOLOGY, V30, P1149, DOI 10.1016/j.neuro.2009.09.003; Rogan WJ, 2005, LANCET, V366, P763, DOI 10.1016/S0140-6736(05)67182-6; Shi YQ, 2010, TOXICOL LETT, V193, P79, DOI 10.1016/j.toxlet.2009.12.008; Shi YQ, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/181282; Soliman AS, 1997, ARCH ENVIRON HEALTH, V52, P409, DOI 10.1080/00039899709602219; Son YO, 2012, TOXICOL APPL PHARM, V264, P153, DOI 10.1016/j.taap.2012.07.028; Song L, 2014, TOXICOL LETT, V229, P284, DOI 10.1016/j.toxlet.2014.06.003; Song Y, 2008, TOXICOLOGY, V253, P53, DOI 10.1016/j.tox.2008.08.013; Song Y, 2011, TOXICOL LETT, V202, P55, DOI 10.1016/j.toxlet.2011.01.020; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; Waliszewski SM, 2011, B ENVIRON CONTAM TOX, V87, P539, DOI 10.1007/s00128-011-0341-9; Wang H, 2012, ASIAN PAC J CANCER P, V13, P2319, DOI 10.7314/APJCP.2012.13.5.2319; Wang N, 2011, CHEMOSPHERE, V84, P964, DOI 10.1016/j.chemosphere.2011.05.062; Wang X, 2012, TOXICOL APPL PHARM, V262, P11, DOI 10.1016/j.taap.2012.04.014; Watson AJM, 2011, DIGEST DIS, V29, P222, DOI 10.1159/000323926; Wilmink ABM, 1997, DIS COLON RECTUM, V40, P483, DOI 10.1007/BF02258397; Xia YP, 2012, NEUROSCIENCE, V209, P1, DOI 10.1016/j.neuroscience.2012.02.019; Yang J, 2013, NEOPLASMA, V60, P364, DOI 10.4149/neo_2013_048; Yoon JW, 2002, J BIOL CHEM, V277, P5548, DOI 10.1074/jbc.M105708200; Yoshikawa K, 2009, J GASTROENTEROL, V44, P1113, DOI 10.1007/s00535-009-0110-2; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zhang DY, 2013, MOL CELL BIOCHEM, V374, P13, DOI 10.1007/s11010-012-1498-1; Zhang Z, 2011, TOXICOL APPL PHARM, V256, P114, DOI 10.1016/j.taap.2011.07.016	59	18	20	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112700	10.1371/journal.pone.0112700	http://dx.doi.org/10.1371/journal.pone.0112700			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386960	Green Submitted, Green Published, gold			2022-12-27	WOS:000345250400085
J	Good, DW; Khan, A; Hammer, S; Scanlan, P; Shu, WM; Phipps, S; Parson, SH; Stewart, GD; Reuben, R; McNeill, SA				Good, Daniel W.; Khan, Ashfaq; Hammer, Steven; Scanlan, Paul; Shu, Wenmiao; Phipps, Simon; Parson, Simon H.; Stewart, Grant D.; Reuben, Robert; McNeill, S. Alan			Tissue Quality Assessment Using a Novel Direct Elasticity Assessment Device (The E-Finger): A Cadaveric Study of Prostatectomy Dissection	PLOS ONE			English	Article							ASSISTED RADICAL PROSTATECTOMY; METAANALYSIS; CANCER; SURGERY	Introduction: Minimally invasive radical prostatectomy (RP) (robotic and laparoscopic), have brought improvements in the outcomes of RP due to improved views and increased degrees of freedom of surgical devices. Robotic and laparoscopic surgeries do not incorporate haptic feedback, which may result in complications secondary to inadequate tissue dissection (causing positive surgical margins, rhabdosphincter damage, etc). We developed a micro-engineered device (6 mm 2 sized) [E-finger]) capable of quantitative elasticity assessment, with amplitude ratio, mean ratio and phase lag representing this. The aim was to assess the utility of the device in differentiating peri-prostatic tissue types in order to guide prostate dissection. Material and Methods: Two embalmed and 2 fresh frozen cadavers were used in the study. Baseline elasticity values were assessed in bladder, prostate and rhabdosphincter of pre-dissected embalmed cadavers using the micro-engineered device. A measurement grid was created to span from the bladder, across the prostate and onto the rhabdosphincter of fresh frozen cadavers to enable a systematic quantitative elasticity assessment of the entire area by 2 independent assessors. Tissue was sectioned along each row of elasticity measurement points, and stained with haematoxylin and eosin (H&E). Image analysis was performed with Image Pro Premier to determine the histology at each measurement point. Results: Statistically significant differences in elasticity were identified between bladder, prostate and sphincter in both embalmed and fresh frozen cadavers (p = <0.001). Intra-class correlation (ICC) reliability tests showed good reliability (average ICC = 0.851). Sensitivity and specificity for tissue identification was 77% and 70% respectively to a resolution of 6 mm(2). Conclusions: This cadaveric study has evaluated the ability of our elasticity assessment device to differentiate bladder, prostate and rhabdosphincter to a resolution of 6 mm 2. The results provide useful data for which to continue to examine the use of elasticity assessment devices for tissue quality assessment with the aim of giving haptic feedback to surgeons performing complex surgery.	[Good, Daniel W.; Phipps, Simon; Stewart, Grant D.; McNeill, S. Alan] Univ Edinburgh, Western Gen Hosp, Edinburgh Urol Canc Grp, Edinburgh EH2 4XU, Midlothian, Scotland; [Hammer, Steven; Scanlan, Paul; Shu, Wenmiao; Reuben, Robert] Heriot Watt Univ, Sch Engn & Phys Sci, Edinburgh, Midlothian, Scotland; [Khan, Ashfaq; Parson, Simon H.] Univ Edinburgh, Dept Anat, Edinburgh EH2 4XU, Midlothian, Scotland; [Good, Daniel W.; Phipps, Simon; Stewart, Grant D.; McNeill, S. Alan] NHS Lothian, Western Gen Hosp, Dept Urol, Edinburgh, Midlothian, Scotland	University of Edinburgh; Heriot Watt University; University of Edinburgh; University of Edinburgh	Good, DW (corresponding author), Univ Edinburgh, Western Gen Hosp, Edinburgh Urol Canc Grp, Edinburgh EH2 4XU, Midlothian, Scotland.	daniel.good@ed.ac.uk	Hammer, Steven J/L-1430-2016	Hammer, Steven J/0000-0002-5091-3161; Shu, Wenmiao/0000-0002-1220-361X; Stewart, Grant D./0000-0003-3188-9140; Reuben, Bob/0000-0003-3686-2131; Parson, Simon/0000-0002-8848-8738	Engineering and Physical Sciences Research Council (UK) [EP/I020101/1]; EPSRC [EP/I019472/1, EP/I020101/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I019472/1, EP/I020101/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Engineering and Physical Sciences Research Council (UK): Grant Ref: EP/I020101/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboumarzouk OM, 2012, BJU INT, V110, P1414, DOI 10.1111/j.1464-410X.2012.11106.x; Ahn BM, 2010, UROLOGY, V76, P1007, DOI 10.1016/j.urology.2010.02.025; Burnett AL, 1998, J UROLOGY, V160, P1301, DOI 10.1016/S0022-5347(01)62521-7; Carson WC, 2011, MED ENG PHYS, V33, P302, DOI 10.1016/j.medengphy.2010.10.013; Culmer P, 2012, INT J MED ROBOT COMP, V8, P146, DOI 10.1002/rcs.1421; Ferlay J, 2010, GLOBOCAN 2008 V1 2 C; Ficarra V, 2012, EUR UROL, V62, P405, DOI 10.1016/j.eururo.2012.05.045; Ficarra V, 2012, EUR UROL, V62, P418, DOI 10.1016/j.eururo.2012.05.046; Good DW, 2013, BJU INT; Hammer S, 2012, DISTINGUISHING TISSU; Heidenreich A, 2011, EUR UROL, V59, P61, DOI 10.1016/j.eururo.2010.10.039; Hoyt K, 2008, CANCER BIOMARK, V4, P213, DOI 10.3233/CBM-2008-44-505; Javed S, 2013, BJU INT; Lakshmanan V, 2008, ST HEAL T, V133, P166; McNeill SA, 2013, BJU INT; Novara G, 2012, EUR UROL, V62, P382, DOI 10.1016/j.eururo.2012.05.047; OELRICH TM, 1980, AM J ANAT, V158, P229, DOI 10.1002/aja.1001580211; Patel VR, 2011, EUR UROL, V59, P702, DOI 10.1016/j.eururo.2011.01.032; Peng QY, 2011, IEEE ENG MED BIO, P8515, DOI 10.1109/IEMBS.2011.6092101; Phipps S, 2005, UROLOGY, V66, P447, DOI 10.1016/j.urology.2005.03.017; Reisaeter LA, 2014, ACTA RADIOL; van der Meijden OAJ, 2009, SURG ENDOSC, V23, P1180, DOI 10.1007/s00464-008-0298-x	22	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112872	10.1371/journal.pone.0112872	http://dx.doi.org/10.1371/journal.pone.0112872			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384014	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000344816700101
J	Gu, Y; Chen, X; Shang, CW; Singh, K; Barzegar, M; Mahdavian, E; Salvatore, BA; Jiang, SX; Huang, SL				Gu, Ying; Chen, Xin; Shang, Chaowei; Singh, Karnika; Barzegar, Mansoureh; Mahdavian, Elahe; Salvatore, Brian A.; Jiang, Shanxiang; Huang, Shile			Fusarochromanone Induces G(1) Cell Cycle Arrest and Apoptosis in COS7 and HEK293 Cells	PLOS ONE			English	Article							BCL-2 PROTEIN FAMILY; KASHIN-BECK-DISEASE; TIBIAL DYSCHONDROPLASIA; FUSARIUM-EQUISETI; BROILER-CHICKENS; PHASE ARREST; DEATH; MECHANISMS; MYCOTOXIN; TRICHOTHECENES	Fusarochromanone (FC101), a mycotoxin produced by the fungus Fusarium equiseti, is frequently observed in the contaminated grains and feedstuffs, which is toxic to animals and humans. However, the underlying molecular mechanism remains to be defined. In this study, we found that FC101 inhibited cell proliferation and induced cell death in COS7 and HEK293 cells in a concentration-dependent manner. Flow cytometric analysis showed that FC101 induced G(1) cell cycle arrest and apoptosis in the cells. Concurrently, FC101 downregulated protein expression of cyclin D1, cyclin-dependent kinases (CDK4 and CDK6), and Cdc25A, and upregulated expression of the CDK inhibitors (p21(Cip1) and p27(Kip1)), resulting in hypophosphorylation of Rb. FC101 also inhibited protein expression of Bcl-2, Bcl-xL, Mcl-1 and survivin, and induced expression of BAD, leading to activation of caspase 3 and cleavage of PARP, indicating caspase-dependent apoptosis. However, Z-VAD-FMK, a pan-caspase inhibitor, only partially prevented FC101-induced cell death, implying that FC101 may induce cell death through both caspase-dependent and -independent mechanisms. Our results support the notion that FC101 executes its toxicity at least by inhibiting cell proliferation and inducing cell death.	[Gu, Ying; Chen, Xin; Jiang, Shanxiang] Nanjing Agr Univ, Coll Vet Med, Lab Vet Pharmacol & Toxicol, Nanjing, Jiangsu, Peoples R China; [Gu, Ying; Chen, Xin; Shang, Chaowei; Singh, Karnika; Barzegar, Mansoureh; Huang, Shile] Louisiana State Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, Shreveport, LA USA; [Shang, Chaowei; Huang, Shile] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71105 USA; [Mahdavian, Elahe; Salvatore, Brian A.] Louisiana State Univ, Dept Chem & Phys, Shreveport, LA 71105 USA	Nanjing Agricultural University; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Jiang, SX (corresponding author), Nanjing Agr Univ, Coll Vet Med, Lab Vet Pharmacol & Toxicol, Nanjing, Jiangsu, Peoples R China.	nauvy@sina.com; shuan1@lsuhsc.edu	Huang, Shile/I-1632-2019; Barzegar, Mansoureh/ABB-7572-2021	Huang, Shile/0000-0002-3239-1072; 	National Natural Science Foundation of China [090600253]; National Institutes of Health (National Cancer Institute [NCI]) [CA115414]; National Institutes of Health (National Institute of General Medical Sciences [NIGMS]) [5P20RR016456-11]; National Institutes of Health (National Center for Research Resources [NCRR]) [8 P20 GM103424-11]; American Cancer Society [RSG-08-135-01-CNE]; Nanjing Agricultural University; Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center; NATIONAL CANCER INSTITUTE [R01CA115414] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103424] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health (National Cancer Institute [NCI])(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (National Institute of General Medical Sciences [NIGMS])(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health (National Center for Research Resources [NCRR])(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Cancer Society(American Cancer Society); Nanjing Agricultural University; Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the grants from National Natural Science Foundation of China (No. 090600253, Shanxiang Jiang), National Institutes of Health (National Cancer Institute [NCI] CA115414, Shile Huang; National Institute of General Medical Sciences [NIGMS] 5P20RR016456-11, Thomas R. Klei/Elahe Mahdavian; National Center for Research Resources [NCRR] 8 P20 GM103424-11, Thomas R. Klei/Elahe Mahdavian), American Cancer Society (RSG-08-135-01-CNE, Shile Huang), Nanjing Agricultural University, and the Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBAS HK, 1989, MYCOPATHOLOGIA, V105, P143, DOI 10.1007/BF00437246; Abid-Essefi S, 2003, TOXICOLOGY, V192, P237, DOI 10.1016/S0300-483X(03)00329-9; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Dreau D, 2007, ANTI-CANCER DRUG, V18, P897; Fang HQ, 2012, APOPTOSIS, V17, P895, DOI 10.1007/s10495-012-0724-3; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Furmanski BD, 2009, MICROSC MICROANAL, V15, P545, DOI 10.1017/S1431927609090825; Kasibhatla S, 2003, MOL CANCER THER, V2, P573; KROGH P, 1989, APPL ENVIRON MICROB, V55, P3184, DOI 10.1128/AEM.55.12.3184-3188.1989; Lavecchia A, 2012, MINI-REV MED CHEM, V12, P62, DOI 10.2174/138955712798868940; LEE YW, 1985, APPL ENVIRON MICROB, V50, P102, DOI 10.1128/AEM.50.1.102-107.1985; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Liu J, 2012, TOXICOL LETT, V211, P164, DOI 10.1016/j.toxlet.2012.03.800; Mahdavian E, 2014, INT J MOL MED, V34, P880, DOI 10.3892/ijmm.2014.1842; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Minervini F, 2004, TOXICOL IN VITRO, V18, P21, DOI 10.1016/S0887-2333(03)00130-9; Minervini Fiorenza, 1992, Natural Toxins, V1, P15, DOI 10.1002/nt.2620010105; MIROCHA CJ, 1989, APPL ENVIRON MICROB, V55, P254, DOI 10.1128/AEM.55.1.254-255.1989; Morrison E, 2002, MYCOPATHOLOGIA, V153, P49, DOI 10.1023/A:1015201709070; ORTH MW, 1994, VET PATHOL, V31, P403, DOI 10.1177/030098589403100401; Patsoukis N, 2012, CELL CYCLE, V11, P4305, DOI 10.4161/cc.22135; PENG A, 1992, J TOXICOL ENV HEALTH, V35, P79, DOI 10.1080/15287399209531597; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sudre P, 2001, INT ORTHOP, V25, P175, DOI 10.1007/s002640000179; Tait SWG, 2008, ONCOGENE, V27, P6452, DOI 10.1038/onc.2008.311; Tang L, 2013, CELL CYCLE, V12, P2665, DOI 10.4161/cc.25728; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; WALSER MM, 1988, AVIAN DIS, V32, P84, DOI 10.2307/1590953; Wang Y, 2012, TOXICOL LETT, V209, P186, DOI 10.1016/j.toxlet.2011.12.011; WU W, 1993, AVIAN DIS, V37, P302, DOI 10.2307/1591653; XIE WP, 1989, APPL ENVIRON MICROB, V55, P794, DOI 10.1128/AEM.55.4.794-797.1989; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Xui XD, 2008, INT J MOL MED, V21, P145; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	36	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112641	10.1371/journal.pone.0112641	http://dx.doi.org/10.1371/journal.pone.0112641			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384025	Green Published, Green Submitted, gold			2022-12-27	WOS:000344816700085
J	Ibanez, L; Velli, PS; Font, R; Jaen, A; Royo, J; Irigoyen, D; Cairo, M; De la Sierra, A; Arranz, MJ; Gallardo, D; Dalmau, D				Ibanez, Laura; Sebastian Velli, Pablo; Font, Roser; Jaen, Angeles; Royo, Josep; Irigoyen, Daniel; Cairo, Mireia; De la Sierra, Alejandro; Jesus Arranz, Maria; Gallardo, David; Dalmau, David			HIV-Infection, Atherosclerosis and the Inflammatory Pathway: Candidate Gene Study in a Spanish HIV-Infected Population	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; C-REACTIVE PROTEIN; CORONARY-ARTERY-DISEASE; RECEPTOR ANTAGONIST GENE; COAT GLYCOPROTEIN GP120; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; HEART-DISEASE; CAROTID ATHEROSCLEROSIS; ARACHIDONATE CASCADE	Background: Higher prevalence of atherosclerosis and higher cardiovascular risk is observed in HIV-infected individuals. The biological mechanisms underlying these processes are unclear. Several studies have implicated genetic variants in the inflammatory genes in cardiovascular disease and in HIV natural course infection. Methods & Findings: In this study we have tested the possible association between genetic variants in several inflammatory genes and asymptomatic cardiovascular disease measured by carotid intima media thickness (cIMT) and atherosclerotic plaque presence as dependent variables in 213 HIV-infected individuals. A total of 101 genetic variants in 25 candidate genes have been genotyped. Results were analyzed using Plink and SPSS statistical packages. We have found several polymorphisms in the genes ALOX5 (rs2115819 p = 0.009), ALOX5AP (rs9578196 p = 0.007; rs4769873 p = 0.004 and rs9315051 p = 0.0004), CX3CL1 (rs4151117 p = 0.040 and rs614230 p = 0.015) and CCL5 (rs3817655 p = 0.018 and rs2107538 p = 0.018) associated with atherosclerotic plaque. cIMT mean has been associated with CRP (1130864 p = 0.0003 and rs1800947 p = 0.008), IL1RN (rs380092 p = 0.002) and ALOX5AP (rs3885907 p = 0.02) genetic variants. Conclusions: In this study we have found modest associations between genetic variants in several inflammatory genes and atherosclerotic plaque or cIMT. Nevertheless, our study adds evidence to the association between inflammatory pathway genetic variants and the atherosclerotic disease in HIV-infected individuals.	[Ibanez, Laura; Jaen, Angeles; Jesus Arranz, Maria; Dalmau, David] Fundacio Docencia & Recerca MutuaTerrassa, Terrassa, Catalonia, Spain; [Sebastian Velli, Pablo; Font, Roser; Royo, Josep; Irigoyen, Daniel; Cairo, Mireia; De la Sierra, Alejandro; Dalmau, David] Hosp Univ MutuaTerrassa, Terrassa, Catalonia, Spain; [Sebastian Velli, Pablo; Font, Roser; Royo, Josep; Irigoyen, Daniel; Cairo, Mireia; De la Sierra, Alejandro; Dalmau, David] Univ Barcelona, Terrassa, Catalonia, Spain; [Gallardo, David] Univ Autonoma Barcelona, Serv Vet Genet Mol, Bellaterra, Catalonia, Spain	Hospital Universitario Mutua Terrassa; University of Barcelona; Autonomous University of Barcelona	Gallardo, D (corresponding author), Univ Autonoma Barcelona, Serv Vet Genet Mol, Bellaterra, Catalonia, Spain.	libanez@mutuaterrassa.es	Jaen, Angeles/J-9780-2013	Jaen, Angeles/0000-0002-6815-2022; mireia, cairo/0000-0003-2386-2765; Ibanez, Laura/0000-0003-2381-7059	Plan Nacional R+D+I [RD12/0017/0027]; ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER); MutuaTerrassa Fundation; Spanish HIV Research Fundation (Fundacion para la Investigacion y la Prevencion del Sida en Espana) [FIPSE-36093410]; Catalan Government (La Generalitat de Catalunya) [FI-DGR-00202]	Plan Nacional R+D+I; ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER); MutuaTerrassa Fundation; Spanish HIV Research Fundation (Fundacion para la Investigacion y la Prevencion del Sida en Espana); Catalan Government (La Generalitat de Catalunya)	This work has been (partially) funded by the RD12/0017/0027 project as part of the Plan Nacional R+D+I and cofinanced by ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER), a grant from MutuaTerrassa Fundation, and a grant from the Spanish HIV Research Fundation (Fundacion para la Investigacion y la Prevencion del Sida en Espana (FIPSE-36093410)) to Dr. David Dalmau. Laura Ibanez was supported by a PhD studentship from the Catalan Government (La Generalitat de Catalunya (FI-DGR-00202)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; Apostolakis S, 2013, ACTA PHARMACOL SIN, V34, P1251, DOI 10.1038/aps.2013.92; Bots ML, 2002, J HYPERTENS, V20, P2317, DOI 10.1097/00004872-200212000-00002; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; Debette S, 2009, STROKE, V40, P2212, DOI 10.1161/STROKEAHA.108.537159; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Albuquerque VMG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-274; Guo J, 2013, ACTA NEUROL SCAND; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Henry K, 1998, LANCET, V351, P1328, DOI 10.1016/S0140-6736(05)79053-X; Hileman CO, 2014, JAIDS-J ACQ IMM DEF, V65, P340, DOI 10.1097/QAI.0000000000000063; Ho JE, 2009, HEART, V95, P1193, DOI 10.1136/hrt.2008.161463; Hsue PY, 2012, J INFECT DIS, V205, pS375, DOI 10.1093/infdis/jis200; Islam FM, 2012, HIV MED, V13, P453, DOI 10.1111/j.1468-1293.2012.00996.x; Jang Y, 2007, CLIN SCI, V113, P349, DOI 10.1042/CS20070014; Jones KL, 2011, BRIT J PHARMACOL, V162, P1453, DOI 10.1111/j.1476-5381.2010.01147.x; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Lee CC, 2009, CLIN CHEM, V55, P351, DOI 10.1373/clinchem.2008.117176; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Longenecker CT, 2012, TRANSL RES, V159, P127, DOI 10.1016/j.trsl.2011.10.007; Maccarrone M, 2000, J NEUROCHEM, V75, P196, DOI 10.1046/j.1471-4159.2000.0750196.x; Maccarrone M, 1998, BIOCHEM J, V333, P45, DOI 10.1042/bj3330045; Maggi P, 2007, CORONARY ARTERY DIS, V18, P23, DOI 10.1097/01.mca.0000236292.86930.e3; Olsson S, 2012, STROKE, V43, P2278, DOI 10.1161/STROKEAHA.111.647446; Piconi S, 2013, AIDS, V27, P1521, DOI 10.1097/QAD.0b013e32835fffb2; Piconi S, 2013, AIDS, V27, P381, DOI 10.1097/QAD.0b013e32835abcc9; Poupel L, 2013, ARTERIOSCL THROM VAS, V33, P2297, DOI 10.1161/ATVBAHA.112.300930; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rotger M, 2013, CLIN INFECT DIS, V57, P112, DOI 10.1093/cid/cit196; Roy H, 2009, HUM GENET, V125, P467, DOI 10.1007/s00439-009-0654-5; Shrestha S, 2012, AIDS, V26, P1571, DOI 10.1097/QAD.0b013e328355359f; Shrestha S, 2010, AIDS, V24, P583, DOI 10.1097/QAD.0b013e3283353c9e; Tarr PE, 2010, PHARMACOGENOMICS, V11, P587, DOI 10.2217/PGS.10.35; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; Triant VA, 2012, J INFECT DIS, V205, pS355, DOI 10.1093/infdis/jis195; van Minkelen R, 2009, ATHEROSCLEROSIS, V203, P201, DOI 10.1016/j.atherosclerosis.2008.06.029; Vohnout B, 2003, HAEMATOLOGICA, V88, P54; Wensley F, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d548; Worrall BB, 2003, STROKE, V34, P790, DOI 10.1161/01.STR.0000057815.79289.EC; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402	42	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112279	10.1371/journal.pone.0112279	http://dx.doi.org/10.1371/journal.pone.0112279			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383745	Green Submitted, Green Published, gold			2022-12-27	WOS:000344816700044
J	Bhattacharya, S; Srinivasan, P; Polgreen, P				Bhattacharya, Sanmitra; Srinivasan, Padmini; Polgreen, Phil			Engagement with Health Agencies on Twitter	PLOS ONE			English	Article							COUNT DATA; REGRESSION; MODELS; MEDIA; UMLS	Objective: To investigate factors associated with engagement of U. S. Federal Health Agencies via Twitter. Our specific goals are to study factors related to a) numbers of retweets, b) time between the agency tweet and first retweet and c) time between the agency tweet and last retweet. Methods: We collect 164,104 tweets from 25 Federal Health Agencies and their 130 accounts. We use negative binomial hurdle regression models and Cox proportional hazards models to explore the influence of 26 factors on agency engagement. Account features include network centrality, tweet count, numbers of friends, followers, and favorites. Tweet features include age, the use of hashtags, user-mentions, URLs, sentiment measured using Sentistrength, and tweet content represented by fifteen semantic groups. Results: A third of the tweets (53,556) had zero retweets. Less than 1% (613) had more than 100 retweets (mean = 284). The hurdle analysis shows that hashtags, URLs and user-mentions are positively associated with retweets; sentiment has no association with retweets; and tweet count has a negative association with retweets. Almost all semantic groups, except for geographic areas, occupations and organizations, are positively associated with retweeting. The survival analyses indicate that engagement is positively associated with tweet age and the follower count. Conclusions: Some of the factors associated with higher levels of Twitter engagement cannot be changed by the agencies, but others can be modified (e.g., use of hashtags, URLs). Our findings provide the background for future controlled experiments to increase public health engagement via Twitter.	[Bhattacharya, Sanmitra; Srinivasan, Padmini] Univ Iowa, Dept Comp Sci, Iowa City, IA 52242 USA; [Polgreen, Phil] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Bhattacharya, S (corresponding author), Linguamat Solut Inc, Westborough, MA USA.	sanmitra-bhattacharya@uiowa.edu		Srinivasan, Padmini/0000-0001-8791-403X; Polgreen, Philip/0000-0002-0630-5898				Aronson AR, 2007, P WORKSH BIONLP 2007, P105; Bhattacharya S, 2012, P AAAI FALL S INF RE; Bhattacharya S, 2012, PROCEEDINGS OF THE 3RD ANNUAL ACM WEB SCIENCE CONFERENCE, 2012, P43; Bhattacharya S, 2011, BIOINFORMATICS, V27, pI120, DOI 10.1093/bioinformatics/btr223; Bian J, 2012, PROCEEDINGS OF THE 2012 INTERNATIONAL WORKSHOP ON SMART HEALTH AND WELLBEING, P25, DOI 10.1145/2389707.2389713; Bin Cheung Y, 2002, STAT MED, V21, P1461, DOI 10.1002/sim.1088; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Bruns A, 2011, COMMUN POLITICS CULT, V44, P37; Cameron A. C., 2013, REGRESSION ANAL COUN, V53, DOI [10.1017/CBO9781139013567, DOI 10.1017/CBO9781139013567]; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; COX DR, 1972, J R STAT SOC B, V34, P187; Dodds PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026752; ELANDT R, 1980, SURVIVAL MODELS DATA; Eysenbach G, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1157; Freifeld CC, 2008, J AM MED INFORM ASSN, V15, P150, DOI 10.1197/jamia.M2544; HANSEN LK, 2011, GOOD FRIENDS BAD NEW, V185, P34; Hermida A., 2010, MEDIA CULTURE J, V13; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; Hu MC, 2011, AM J DRUG ALCOHOL AB, V37, P367, DOI 10.3109/00952990.2011.597280; Jiang K, 2013, MINING TWITTER DATA, P434; Kalbfleisch J.D., 2011, STAT ANAL FAILURE TI, DOI DOI 10.1016/0197-2456(81)90009-X; Kamal H, 2010, P 2 ACM SIGMM WORKSH, P47, DOI DOI 10.1145/1878151.1878167; Kwak H., 2010, PROC 19 INT C WORLD, P591, DOI 10.1145/1772690.1772751; Lawless J., 2011, STAT MODELS METHODS, V2nd; Lewis F, 2011, METHODS ECOL EVOL, V2, P155, DOI 10.1111/j.2041-210X.2010.00063.x; Lipscomb CE, 2000, B MED LIBR ASSOC, V88, P265; McCray AT, 2001, STUD HEALTH TECHNOL, V84, P216; Messner M, 2011, P 12 INT S ONLINE JO; MULLAHY J, 1986, J ECONOMETRICS, V33, P341, DOI 10.1016/0304-4076(86)90002-3; Naveed Nasir, 2011, P 3 INT WEB SCI C; Neiger BL, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2775; Neiger BL, 2013, HEALTH PROMOT PRACT, V14, P157, DOI 10.1177/1524839912469378; Nielsen F. ., 2011, P ESWC2011 WORKSH MA; Petrovic S., 2011, P 5 INT AAAI C WEBL; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Singh S, 2013, INT C TREND COMPUT C, P398, DOI 10.1109/ICE-CCN.2013.6528531; Stieglitz S., 2012, 2012 45th Hawaii International Conference on System Sciences (HICSS), P3500, DOI 10.1109/HICSS.2012.476; Suh B, 2010, 2010 IEEE 2 INT C SO, V2, P177, DOI [10.1109/SocialCom.2010.33, DOI 10.1109/SOCIALCOM.2010.33]; Sullivan SJ, 2012, BRIT J SPORT MED, V46, P258, DOI 10.1136/bjsm.2010.080341; Thackeray R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-242; Thelwall M, 2011, J AM SOC INF SCI TEC, V62, P406, DOI 10.1002/asi.21462; Thelwall M, 2010, J AM SOC INF SCI TEC, V61, P2544, DOI 10.1002/asi.21416; Weitzel L, 2012, INT CON ADV INFO NET, P655, DOI 10.1109/AINA.2012.41; Winkelmann R., 1995, J ECON SURV, V9, P1, DOI [10.1111/j.1467-6419.1995.tb00108.x, DOI 10.1111/J.1467-6419.1995.TB00108.X]; Wu S., 2012, P 6 ACM C REC SYST, P265; Yang J, 2010, ICIM 2010: PROCEEDINGS OF THE TENTH INTERNATIONAL CONFERENCE ON INDUSTRIAL MANAGEMENT, P356; Zarrella D., 2009, SCI RETWEETS, V15, P2009; Zhao WNX, 2011, LECT NOTES COMPUT SC, V6611, P338, DOI 10.1007/978-3-642-20161-5_34	48	36	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112235	10.1371/journal.pone.0112235	http://dx.doi.org/10.1371/journal.pone.0112235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT3WF	25379727	gold, Green Published			2022-12-27	WOS:000344863100066
J	Davaadelger, B; Shen, H; Maki, CG				Davaadelger, Batzaya; Shen, Hong; Maki, Carl G.			Novel Roles for P53 in the Genesis and Targeting of Tetraploid Cancer Cells	PLOS ONE			English	Article							EUKARYOTIC DNA-REPLICATION; CYCLIN-E; EXPRESSION; PROMOTES; GEMININ; ARREST; P21; ENDOREDUPLICATION; SENSITIVITY; INHIBITION	Tetraploid (4N) cells are considered important in cancer because they can display increased tumorigenicity, resistance to conventional therapies, and are believed to be precursors to whole chromosome aneuploidy. It is therefore important to determine how tetraploid cancer cells arise, and how to target them. P53 is a tumor suppressor protein and key regulator of tetraploidy. As part of the "tetraploidy checkpoint", p53 inhibits tetraploid cell proliferation by promoting a G1-arrest in incipient tetraploid cells (referred to as a tetraploid G1 arrest). Nutlin-3a is a preclinical drug that stabilizes p53 by blocking the interaction between p53 and MDM2. In the current study, Nutlin-3a promoted a p53-dependent tetraploid G1 arrest in two diploid clones of the HCT116 colon cancer cell line. Both clones underwent endoreduplication after Nutlin removal, giving rise to stable tetraploid clones that showed increased resistance to ionizing radiation (IR) and cisplatin (CP)-induced apoptosis compared to their diploid precursors. These findings demonstrate that transient p53 activation by Nutlin can promote tetraploid cell formation from diploid precursors, and the resulting tetraploid cells are therapy (IR/CP) resistant. Importantly, the tetraploid clones selected after Nutlin treatment expressed approximately twice as much P53 and MDM2 mRNA as diploid precursors, expressed approximately twice as many p53-MDM2 protein complexes (by co-immunoprecipitation), and were more susceptible to p53-dependent apoptosis and growth arrest induced by Nutlin. Based on these findings, we propose that p53 plays novel roles in both the formation and targeting of tetraploid cells. Specifically, we propose that 1) transient p53 activation can promote a tetraploid-G1 arrest and, as a result, may inadvertently promote formation of therapy-resistant tetraploid cells, and 2) therapy-resistant tetraploid cells, by virtue of having higher P53 gene copy number and expressing twice as many p53-MDM2 complexes, are more sensitive to apoptosis and/or growth arrest by anti-cancer MDM2 antagonists (e.g. Nutlin).	[Davaadelger, Batzaya; Shen, Hong; Maki, Carl G.] Rush Univ, Med Ctr, Dept Anat & Cell Biol, Chicago, IL 60612 USA	Rush University	Maki, CG (corresponding author), Rush Univ, Med Ctr, Dept Anat & Cell Biol, Chicago, IL 60612 USA.	Carl_Maki@rush.edu			National Institutes of Health from the National Cancer Institute (NCI) [1RO1CA137598-01A1]; NATIONAL CANCER INSTITUTE [R01CA137598] Funding Source: NIH RePORTER	National Institutes of Health from the National Cancer Institute (NCI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant 1RO1CA137598-01A1 from the National Cancer Institute (NCI) (to C.G.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aylon Y, 2011, MOL ONCOL, V5, P315, DOI 10.1016/j.molonc.2011.07.007; Badie C, 2000, MOL CELL BIOL, V20, P2358, DOI 10.1128/MCB.20.7.2358-2366.2000; Bellanger S, 2007, ONCOGENE, V26, P7175, DOI 10.1038/sj.onc.1210539; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Carvajal LA, 2013, EMBO REP, V14, P414, DOI 10.1038/embor.2013.25; Castedo M, 2006, ANN NY ACAD SCI, V1090, P35, DOI 10.1196/annals.1378.004; Castedo M, 2006, EMBO J, V25, P2584, DOI 10.1038/sj.emboj.7601127; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Davoli T, 2011, ANNU REV CELL DEV BI, V27, P585, DOI 10.1146/annurev-cellbio-092910-154234; de Toledo SM, 1998, CELL GROWTH DIFFER, V9, P887; FAN SJ, 1995, CANCER RES, V55, P1649; Fan SJ, 1997, ONCOGENE, V14, P2127, DOI 10.1038/sj.onc.1201052; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Galipeau PC, 1996, P NATL ACAD SCI USA, V93, P7081, DOI 10.1073/pnas.93.14.7081; Gudkov AV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001180; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Itzhaki JE, 1997, NAT GENET, V15, P258, DOI 10.1038/ng0397-258; JACKSON PK, 1995, J CELL BIOL, V130, P755, DOI 10.1083/jcb.130.4.755; Khan SH, 1998, CANCER RES, V58, P396; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Mechali M, 2010, NAT REV MOL CELL BIO, V11, P728, DOI 10.1038/nrm2976; Mihaylov IS, 2002, MOL CELL BIOL, V22, P1868, DOI 10.1128/MCB.22.6.1868-1880.2002; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Pestell KE, 2000, MOL PHARMACOL, V57, P503, DOI 10.1124/mol.57.3.503; Polyak K, 1996, GENE DEV, V10, P1945, DOI 10.1101/gad.10.15.1945; Reid BJ, 2011, CANCER BIOMARK, V9, P307, DOI 10.3233/CBM-2011-0162; Shen H, 2008, CANCER RES, V68, P8260, DOI 10.1158/0008-5472.CAN-08-1901; Shen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059848; Shen H, 2010, J BIOL CHEM, V285, P23103, DOI 10.1074/jbc.M110.124990; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Stewart ZA, 1999, MOL CELL BIOL, V19, P205; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yoshida K, 2004, ONCOGENE, V23, P3802, DOI 10.1038/sj.onc.1207488	34	9	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e110844	10.1371/journal.pone.0110844	http://dx.doi.org/10.1371/journal.pone.0110844			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380055	Green Published, gold, Green Submitted			2022-12-27	WOS:000344863100015
J	Nordin, N; Salama, SM; Golbabapour, S; Hajrezaie, M; Hassandarvish, P; Kamalidehghan, B; Majid, NA; Hashim, NM; Omar, H; Fadaienasab, M; Karimian, H; Taha, H; Ali, HM; Abdulla, MA				Nordin, Noraziah; Salama, Suzy Munir; Golbabapour, Shahram; Hajrezaie, Maryam; Hassandarvish, Pouya; Kamalidehghan, Behnam; Majid, Nazia Abdul; Hashim, Najihah Mohd; Omar, Hanita; Fadaienasab, Mehran; Karimian, Hamed; Taha, Hairin; Ali, Hapipah Mohd; Abdulla, Mahmood Ameen			Anti-Ulcerogenic Effect of Methanolic Extracts from Enicosanthellum pulchrum (King) Heusden against Ethanol-Induced Acute Gastric Lesion in Animal Models	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; NITRIC-OXIDE; ANTIOXIDANT PROPERTIES; MUCOSAL DEFENSE; ULCER; PROTEINS; MUCUS; HEAT-SHOCK-PROTEIN-70; PROSTAGLANDINS; LANSOPRAZOLE	A natural source of medicine, Enicosanthellum pulchrum is a tropical plant which belongs to the family Annonaceae. In this study, methanol extract from the leaves and stems of this species was evaluated for its gastroprotective potential against mucosal lesions induced by ethanol in rats. Seven groups of rats were assigned, groups 1 and 2 were given Tween 20 (10% v/v) orally. Group 3 was administered omeprazole 20 mg/kg (10% Tween 20) whilst the remaining groups received the leaf and stem extracts at doses of 150 and 300 mg/kg, respectively. After an additional hour, the rats in groups 2-7 received ethanol (95% v/v; 8 mL/kg) orally while group 1 received Tween 20 (10% v/v) instead. Rats were sacrificed after 1 h and their stomachs subjected to further studies. Macroscopically and histologically, group 2 rats showed extremely severe disruption of the gastric mucosa compared to rats pre-treated with the E. pulchrum extracts based on the ulcer index, where remarkable protection was noticed. Meanwhile, a significant percentage of inhibition was shown with the stem extract at 62% (150 mg/kg) and 65% (300 mg/kg), whilst the percentage with the leaf extract at doses of 150 and 300 mg/kg was 63% and 75%, respectively. An increase in mucus content, nitric oxide, glutathione, prostaglandin E2, superoxide dismutase, protein and catalase, and a decrease in malondialdehyde level compared to group 2 were also obtained. Furthermore, immunohistochemical staining of groups 4-7 exhibited down-regulation of Bax and up-regulation of Hsp70 proteins. The methanol extract from the leaves and the stems showed notable gastroprotective potential against ethanol.	[Nordin, Noraziah; Kamalidehghan, Behnam; Hashim, Najihah Mohd; Karimian, Hamed] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Salama, Suzy Munir; Golbabapour, Shahram; Hajrezaie, Maryam; Hassandarvish, Pouya; Abdulla, Mahmood Ameen] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia; [Nordin, Noraziah; Omar, Hanita; Fadaienasab, Mehran; Taha, Hairin; Ali, Hapipah Mohd] Univ Malaya, Fac Sci, Dept Chem, Kuala Lumpur, Malaysia; [Golbabapour, Shahram; Hajrezaie, Maryam; Majid, Nazia Abdul] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Omar, Hanita] Univ Malaya, Ctr Fdn Studies Sci, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Salama, SM (corresponding author), Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia.	s.salama999@hotmail.com; ammeen@um.edu.my	Fadaeinasab, Mehran/A-8810-2016; Hashim, Najihah Mohd/J-5508-2015; Kamalidehghan, Behnam/B-5401-2013; Hassandarvish, Pouya/K-8112-2012; Salama Fanous, Suzy Munir/AAX-6100-2020; MAJID, NAZIA ABDUL/B-9215-2010	Fadaeinasab, Mehran/0000-0002-2501-894X; Hashim, Najihah Mohd/0000-0003-1133-7998; Kamalidehghan, Behnam/0000-0001-8530-8124; Hassandarvish, Pouya/0000-0003-0364-5587; Salama Fanous, Suzy Munir/0000-0003-0430-1436; MAJID, NAZIA ABDUL/0000-0002-6817-8046	University of Malaya; Ministry of Higher Education Malaysia under High Impact Research Grant [UM-MOHE UM.C/625/1/HIR/MOHE/SC/09.]	University of Malaya(Universiti Malaya); Ministry of Higher Education Malaysia under High Impact Research Grant	This research has been supported by University of Malaya and Ministry of Higher Education Malaysia under High Impact Research Grant UM-MOHE UM.C/625/1/HIR/MOHE/SC/09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahab SI, 2013, J ETHNOPHARMACOL, V148, P277, DOI 10.1016/j.jep.2013.04.027; Abdulla MA, 2009, BIOMED RES-INDIA, V20, P35; Al Batran R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064751; Ali T, 2009, GASTROENTEROL CLIN N, V38, P245, DOI 10.1016/j.gtc.2009.03.002; Allen A, 2005, AM J PHYSIOL-CELL PH, V288, pC1, DOI 10.1152/ajpcell.00102.2004; ALLEN A, 1980, GUT, V21, P249, DOI 10.1136/gut.21.3.249; AlRashdi AS, 2012, EVIDENCE BASED COMPL, V2012; Alvarez-Suarez JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025878; [Anonymous], 1950, NATURE; Arafa HMM, 2003, PHARMACOL RES, V48, P285, DOI 10.1016/S1043-6618(03)00154-3; Balamurugan R, 2005, MOL BIOSYST, V1, P36, DOI 10.1039/b503623b; BEHMER O, 1976, MANUAL HISTOLOGIA NO; Biswas K, 2003, J BIOL CHEM, V278, P10993, DOI 10.1074/jbc.M210328200; Blandizzi C, 2000, FUNDAM CLIN PHARM, V14, P89, DOI 10.1111/j.1472-8206.2000.tb00396.x; Blandizzi C, 2005, WORLD J GASTROENTERO, V11, P4052, DOI 10.3748/wjg.v11.i26.4052; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breinbauer R, 2002, ANGEW CHEM INT EDIT, V41, P2879; Brown Lance F., 1999, Comprehensive Therapy, V25, P30, DOI 10.1007/BF02889832; Brucker MC, 1997, J NURSE-MIDWIFERY, V42, P145, DOI 10.1016/S0091-2182(97)00031-1; Brzozowski T, 2005, WORLD J GASTROENTERO, V11, P6450, DOI 10.3748/wjg.v11.i41.6450; Chemicals D., 2005, OECD GUIDELINE TESTI; Chittchang M, 2010, EUR J MED CHEM, V45, P2165, DOI 10.1016/j.ejmech.2010.01.053; CORNE SJ, 1974, J PHYSIOL-LONDON, V242, pP116; Dotevall G, 1971, CLIN VALUE GASTRIC S; Dursun H, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-36; Falcao HD, 2008, MOLECULES, V13, P3198, DOI 10.3390/molecules13123198; Golbabapour S, 2013, BIOMED RES INT, V2013, DOI DOI 10.1155/2013/974185; GORNALL AG, 1949, J BIOL CHEM, V177, P751; Hajrezaie M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051537; HERENDEEN SL, 1979, J BACTERIOL, V139, P185, DOI 10.1128/JB.139.1.185-194.1979; Hirokawa M, 1998, ALCOHOL CLIN EXP RES, V22, p111S, DOI 10.1111/acer.1998.22.s3_part1.111s; Hoogerwerf WA, 2001, GOODMAN GILMANS PHAR, V10th, P1005; Ibrahim IAA, 2012, MOLECULES, V17, P2796, DOI 10.3390/molecules17032796; Ismail IF, 2012, EVIDENCE BASED COMPL, V2012; Jaattela M, 1999, EXP CELL RES, V248, P30, DOI 10.1006/excr.1999.4455; Jelski W, 2009, DIGEST DIS SCI, V54, P725, DOI 10.1007/s10620-008-0422-8; Junaidi M, 2013, INT J PHARM RES REV, V1, P380; Ketuly KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059296; Khazaei M., 2006, IRAN J PHARM THER, V5, P43; Kong DX, 2009, J CHEM INF MODEL, V49, P2376, DOI 10.1021/ci900229c; Konturek PC, 1999, J PHYSIOL PHARMACOL, V50, P211; La Casa C, 2000, J ETHNOPHARMACOL, V71, P45, DOI 10.1016/S0378-8741(99)00174-9; Laine L, 2008, GASTROENTEROLOGY, V135, P41, DOI 10.1053/j.gastro.2008.05.030; LAVAULT M, 1990, PHYTOCHEMISTRY, V29, P3845, DOI 10.1016/0031-9422(90)85344-F; Li CY, 2008, ALCOHOL, V42, P683, DOI 10.1016/j.alcohol.2008.08.009; Li XQ, 2004, DRUG METAB DISPOS, V32, P821, DOI 10.1124/dmd.32.8.821; Mcmanus J, 1964, PAS REACTION STAININ; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Nassif A, 1996, DIS COLON RECTUM, V39, P217, DOI 10.1007/BF02068079; Nordin N, 2012, PHARM BIOL, V50, P284, DOI 10.3109/13880209.2011.602416; OBERRINGER M, 1995, BIOCHEM BIOPH RES CO, V214, P1009, DOI 10.1006/bbrc.1995.2386; OECD (Organisation for Economic Co-operation and Development), 2002, SER HARM REG OV BIOT, V20, P1; Oh TY, 2005, WORLD J GASTROENTERO, V11, P7450, DOI 10.3748/wjg.v11.i47.7450; Penissi AB, 1999, DIGEST DIS SCI, V44, P708, DOI 10.1023/A:1026601506677; Perry Lily M., 1980, MED PLANTS E SE ASIA; Peskar BM, 1998, DIGEST DIS SCI, V43, p23S; Repetto MG, 2002, BRAZ J MED BIOL RES, V35, P523, DOI 10.1590/S0100-879X2002000500003; Royer M, 2011, FOOD CHEM TOXICOL, V49, P2180, DOI 10.1016/j.fct.2011.06.003; Salama SM, 2012, EVIDENCE BASED COMPL, V2012; Salama SM, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/157456; Salama SM, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-279; Schneeweiss S, 2006, CLIN PHARMACOL THER, V79, P379, DOI 10.1016/j.clpt.2005.12.304; Sharma RK., 2011, INT J DRUG DEV RES, V3, P351; Shichijo K, 2003, DIGEST DIS SCI, V48, P340, DOI 10.1023/A:1021939829515; Sidahmed H, 2013, EVIDENCE BASED COMPL, V2013; Sidahmed HMA, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-183; Singh J., 2012, INT J PHARM SCI, V4, P412; Stermer E, 2002, ISR MED ASSOC J, V4, P200; SZABO S, 1981, SCIENCE, V214, P200, DOI 10.1126/science.7280691; Araujo DAOV, 2011, REV BRAS FARMACOGN, V21, P721, DOI 10.1590/S0102-695X2011005000117; Rios ERV, 2010, CHEM-BIOL INTERACT, V188, P246, DOI 10.1016/j.cbi.2010.07.020; Wallace JL, 1997, AM J PHYSIOL-GASTR L, V273, pG1246, DOI 10.1152/ajpgi.1997.273.6.G1246; WALLACE JL, 1992, GASTROENTEROL CLIN N, V21, P631; Wallace JL, 2000, GASTROENTEROLOGY, V119, P512, DOI 10.1053/gast.2000.9304; WEI YQ, 1995, CANCER IMMUNOL IMMUN, V40, P73, DOI 10.1007/s002620050146; Yadav DK, 2011, FITOTERAPIA, V82, P666, DOI 10.1016/j.fitote.2011.02.005	76	35	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111925	10.1371/journal.pone.0111925	http://dx.doi.org/10.1371/journal.pone.0111925			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379712	gold, Green Submitted, Green Published			2022-12-27	WOS:000344863100047
J	Wojtal-Frankiewicz, A; Bernasinska, J; Frankiewicz, P; Gwozdzinski, K; Jurczak, T				Wojtal-Frankiewicz, Adrianna; Bernasinska, Joanna; Frankiewicz, Piotr; Gwozdzinski, Krzysztof; Jurczak, Tomasz			Response of Daphnia's Antioxidant System to Spatial Heterogeneity in Cyanobacteria Concentrations in a Lowland Reservoir	PLOS ONE			English	Article							DRINKING-WATER RESERVOIR; TOXIC CYANOBACTERIUM; OXIDATIVE STRESS; MICROCYSTIN-LR; GLUTATHIONE; BLOOMS; PHYTOPLANKTON; POPULATION; RESISTANCE; TOLERANCE	Many species and clones of Daphnia inhabit ecosystems with permanent algal blooms, and they can develop tolerance to cyanobacterial toxins. In the current study, we examined the spatial differences in the response of Daphnia longispina to the toxic Microcystis aeruginosa in a lowland eutrophic dam reservoir between June (before blooms) and September (during blooms). The reservoir showed a distinct spatial pattern in cyanobacteria abundance resulting from the wind direction: the station closest to the dam was characterised by persistently high Microcystis biomass, whereas the upstream stations had a significantly lower biomass of Microcystis. Microcystin concentrations were closely correlated with the cyanobacteria abundance (r = 0.93). The density of daphniids did not differ among the stations. The main objective of this study was to investigate how the distribution of toxic Microcystis blooms affects the antioxidant system of Daphnia. We examined catalase (CAT) activity, the level of the low molecular weight antioxidant glutathione (GSH), glutathione S-transferase (GST) activity and oxidative stress parameters, such as lipid peroxidation (LPO). We found that the higher the abundance (and toxicity) of the cyanobacteria, the lower the values of the antioxidant parameters. The CAT activity and LPO level were always significantly lower at the station with the highest M. aeruginosa biomass, which indicated the low oxidative stress of D. longispina at the site with the potentially high toxic thread. However, the low concentration of GSH and the highest activity of GST indicated the occurrence of detoxification processes at this site. These results demonstrate that daphniids that have coexisted with a high biomass of toxic cyanobacteria have effective mechanisms that protect them against the toxic effects of microcystins. We also conclude that Daphnia's resistance capacity to Microcystis toxins may differ within an ecosystem, depending on the bloom's spatial distribution.	[Wojtal-Frankiewicz, Adrianna; Frankiewicz, Piotr; Jurczak, Tomasz] Univ Lodz, Dept Appl Ecol, PL-90131 Lodz, Poland; [Bernasinska, Joanna; Gwozdzinski, Krzysztof] Univ Lodz, Dept Mol Biophys, PL-90131 Lodz, Poland	University of Lodz; University of Lodz	Wojtal-Frankiewicz, A (corresponding author), Univ Lodz, Dept Appl Ecol, PL-90131 Lodz, Poland.	adwoj@biol.uni.lodz.pl		Jurczak, Tomasz/0000-0002-1576-6741; Gwozdzinski, Krzysztof/0000-0003-2590-7496; Frankiewicz, Piotr/0000-0003-1782-9539; Bernasinska-Slomczewska, Joanna/0000-0002-1915-9834; Wojtal-Frankiewicz, Adrianna/0000-0003-3509-6076	Polish Ministry of Science and Higher Education [3988/B/P01/2010/39]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This study was supported by the Polish Ministry of Science and Higher Education (Grant No. 3988/B/P01/2010/39). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Amado LL, 2010, ENVIRON INT, V36, P226, DOI 10.1016/j.envint.2009.10.010; Benzie JAH, 2005, GUIDES IDENTIFICATIO; Blanchette ML, 2002, UNH CTR FRESHWATER B, V4, P1; Cagnard O, 2006, WAT QUAL TECHN C WQT, P1; Campos A, 2010, INT J MOL SCI, V11, P268, DOI 10.3390/ijms11010268; Dao TS, 2010, TOXICON, V55, P1244, DOI 10.1016/j.toxicon.2010.01.014; Demott WR, 1999, FRESHWATER BIOL, V42, P263, DOI 10.1046/j.1365-2427.1999.444494.x; Gagala I, 2013, THESIS U LODZ POLAND; Gagala I, 2014, MICROB ECOL, V67, P465, DOI 10.1007/s00248-013-0303-3; Gustafsson S, 2004, AQUAT ECOL, V38, P37, DOI 10.1023/B:AECO.0000020985.47348.5e; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hairston NG, 1999, NATURE, V401, P446, DOI 10.1038/46731; Hairston NG, 2001, EVOLUTION, V55, P2203, DOI 10.1111/j.0014-3820.2001.tb00736.x; Izydorczyk K, 2008, INT REV HYDROBIOL, V93, P257, DOI 10.1002/iroh.200710959; Izydorczyk K, 2009, WATER RES, V43, P989, DOI 10.1016/j.watres.2008.11.048; Izydorczyk Katarzyna, 2005, Ecohydrology & Hydrobiology, V5, P195; Jiang XD, 2013, J PLANKTON RES, V35, P1177, DOI 10.1093/plankt/fbt062; Jurczak T, 2005, WATER RES, V39, P2394, DOI 10.1016/j.watres.2005.04.031; Jurczak T, 2004, CHROMATOGRAPHIA, V59, P571, DOI 10.1365/s10337-004-0279-8; KOMAREK J, 1991, ARCH HYDROBIOL, P115; Komarek J, 1999, SUSSWASSERFLORA MITT, V19; LAMPERT W, 1982, ARCH HYDROBIOL, V95, P207; Lemaire V, 2012, EVOL APPL, V5, P168, DOI 10.1111/j.1752-4571.2011.00225.x; Livingstone DR, 2003, REV MED VET-TOULOUSE, V154, P427; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Pflugmacher S, 1998, BBA-GEN SUBJECTS, V1425, P527, DOI 10.1016/S0304-4165(98)00107-X; Reichwaldt ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066674; Repka S, 1997, FRESHWATER BIOL, V38, P675, DOI 10.1046/j.1365-2427.1997.00236.x; Rice-Evans CA, 1991, LAB TECHNIQUES BIOCH, P147; Richardson TL, 2010, WATER RES, V44, P2461, DOI 10.1016/j.watres.2010.01.012; Rikans LE, 1997, BBA-MOL BASIS DIS, V1362, P116, DOI 10.1016/S0925-4439(97)00067-7; Roy S, 2008, J BIOL PHYS, V34, P459, DOI 10.1007/s10867-008-9100-5; Sarnelle O, 2005, LIMNOL OCEANOGR, V50, P1565, DOI 10.4319/lo.2005.50.5.1565; SARNELLE O, 1993, ECOL MONOGR, V63, P129, DOI 10.2307/2937177; Sarnelle O, 2010, J PLANKTON RES, V32, P471, DOI 10.1093/plankt/fbp151; Senft AP, 2000, ANAL BIOCHEM, V280, P80, DOI 10.1006/abio.2000.4498; Starmach K, 1966, FLORA SLODKOWODNA PO; STOCKS J, 1971, BRIT J HAEMATOL, V20, P95, DOI 10.1111/j.1365-2141.1971.tb00790.x; Tarczynska M, 2001, WA SCI TECHNOL, V1, P237, DOI 10.2166/ws.2001.0043; Tillmanns AR, 2008, FUND APPL LIMNOL, V171, P285, DOI 10.1127/1863-9135/2008/0171-0285; von Elert E, 2012, J EXP BIOL, V215, P2051, DOI 10.1242/jeb.068742; Wagner I., 2009, Ecohydrology and Hydrobiology, V9, P13, DOI 10.2478/V10104-009-0042-8; Wiegand C, 2005, TOXICOL APPL PHARM, V203, P201, DOI 10.1016/j.taap.2004.11.002; Wiegand C, 2002, ENVIRON TOXICOL, V17, P400, DOI 10.1002/tox.10065; Wojtal-Frankiewicz A, 2013, J LIMNOL, V72, P154, DOI 10.4081/jlimnol.2013.e13	46	15	15	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112597	10.1371/journal.pone.0112597	http://dx.doi.org/10.1371/journal.pone.0112597			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380273	Green Submitted, Green Published, gold			2022-12-27	WOS:000344863100108
J	den Hartog, G; Jacobino, S; Bont, L; Cox, L; Ulfman, LH; Leusen, JHW; van Neerven, RJJ				den Hartog, Gerco; Jacobino, Shamir; Bont, Louis; Cox, Linda; Ulfman, Laurien H.; Leusen, Jeanette H. W.; van Neerven, R. J. Joost			Specificity and Effector Functions of Human RSV-Specific IgG from Bovine Milk	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; ACUTE OTITIS-MEDIA; IMMUNE-RESPONSE; INVERSE ASSOCIATION; CHILDHOOD ASTHMA; INFLUENZA-VIRUS; INFECTION; ANTIBODY; RECEPTOR; CONSUMPTION	Background: Respiratory syncytial virus (RSV) infection is the second most important cause of death in the first year of life, and early RSV infections are associated with the development of asthma. Breastfeeding and serum IgG have been shown to protect against RSV infection. Yet, many infants depend on bovine milk-based nutrition, which at present lacks intact immunoglobulins. Objective: To investigate whether IgG purified from bovine milk (bIgG) can modulate immune responses against human RSV. Methods: ELISAs were performed to analyse binding of bIgG to human respiratory pathogens. bIgG or hRSV was coated to plates to assess dose-dependent binding of bIgG to human Fc gamma receptors (Fc gamma R) or bIgG-mediated binding of myeloid cells to hRSV respectively. S. Epidermidis and RSV were used to test bIgG-mediated binding and internalisation of pathogens by myeloid cells. Finally, the ability of bIgG to neutralise infection of HEp2 cells by hRSV was evaluated. Results: bIgG recognised human RSV, influenza haemagglutinin and Haemophilus influenza. bIgG bound to Fc gamma RII on neutrophils, monocytes and macrophages, but not to Fc gamma RI and Fc gamma RIII, and could bind simultaneously to hRSV and human Fc gamma RII on neutrophils. In addition, human neutrophils and dendritic cells internalised pathogens that were opsonised with bIgG. Finally, bIgG could prevent infection of HEp2 cells by hRSV. Conclusions: The data presented here show that bIgG binds to hRSV and other human respiratory pathogens and induces effector functions through binding to human Fc gamma RII on phagocytes. Thus bovine IgG may contribute to immune protection against RSV.	[den Hartog, Gerco; Jacobino, Shamir; Bont, Louis; Leusen, Jeanette H. W.] UMC Utrecht, Immunotherapy Grp, Lab Translat Immunol, Utrecht, Netherlands; [den Hartog, Gerco; van Neerven, R. J. Joost] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [Bont, Louis] UMC Utrecht, Dept Pediat, Utrecht, Netherlands; [Cox, Linda] Bioceros, Utrecht, Netherlands; [Ulfman, Laurien H.; van Neerven, R. J. Joost] FrieslandCampina, Amersfoort, Netherlands	Utrecht University; Utrecht University Medical Center; Wageningen University & Research; Utrecht University; Utrecht University Medical Center	Leusen, JHW (corresponding author), UMC Utrecht, Immunotherapy Grp, Lab Translat Immunol, Utrecht, Netherlands.	jleusen@umcutrecht.nl	Hartog, Gerco den/AAB-6329-2019; , Jeanette/AAG-3736-2019; van Neerven, Joost/GWZ-3214-2022	Hartog, Gerco den/0000-0002-2103-6315; Leusen, Jeanette/0000-0003-4982-6914; van Neerven, R.J.Joost/0000-0002-3991-5297	FrieslandCampina; Bioceros	FrieslandCampina; Bioceros(Bioceros B.V.)	The study was funded by FrieslandCampina (www.frieslandcampina.com). The funder provided support in the form of salaries for authors LU and RJJvN, but FrieslandCampina did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The salary for author LC was provided by Bioceros. Bioceros did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ANDERSON CL, 1990, J EXP MED, V171, P1333, DOI 10.1084/jem.171.4.1333; Banki Z, 2003, J IMMUNOL, V170, P3963, DOI 10.4049/jimmunol.170.8.3963; Bezerra PGM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018928; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Blanken MO, 2013, NEW ENGL J MED, V368, P1791, DOI 10.1056/NEJMoa1211917; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; COX RJ, 1994, VACCINE, V12, P993, DOI 10.1016/0264-410X(94)90334-4; den Hartog G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018188; Dullaers M, 2009, IMMUNITY, V30, P120, DOI 10.1016/j.immuni.2008.11.008; EBINA T, 1985, MED MICROBIOL IMMUN, V174, P177, DOI 10.1007/BF02123694; Ege MJ, 2007, J ALLERGY CLIN IMMUN, V119, P1140, DOI 10.1016/j.jaci.2007.01.037; Elvander M, 1996, VET REC, V138, P101, DOI 10.1136/vr.138.5.101; ESPOSITOFARESE ME, 1995, J IMMUNOL, V155, P1725; GOSSELIN EJ, 1992, J IMMUNOL, V149, P3477; Harris NL, 2006, J IMMUNOL, V177, P6256, DOI 10.4049/jimmunol.177.9.6256; HILPERT H, 1987, J INFECT DIS, V156, P158, DOI 10.1093/infdis/156.1.158; Koenderman L, 2010, THROMB HAEMOSTASIS, V104, P599, DOI 10.1160/TH09-10-0740; Korhonen H, 2000, BRIT J NUTR, V84, pS135; Kramski M, 2012, EUROPEAN J IMMUNOLOG, V42; Loss G, 2011, J ALLERGY CLIN IMMUN, V128, P766, DOI 10.1016/j.jaci.2011.07.048; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Maijo M, 2012, J NUTR, V142, P264, DOI 10.3945/jn.111.149070; Mohapatra SS, 2008, CLIN MICROBIOL REV, V21, P495, DOI 10.1128/CMR.00054-07; Mora JR, 2009, SEMIN IMMUNOL, V21, P28, DOI 10.1016/j.smim.2008.08.002; Mora JR, 2006, TRENDS IMMUNOL, V27, P235, DOI 10.1016/j.it.2006.03.007; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nishimura T, 2009, PEDIATR INT, V51, P812, DOI 10.1111/j.1442-200X.2009.02877.x; Ochola R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008088; Oddy WH, 2004, J ASTHMA, V41, P605, DOI 10.1081/JAS-200026402; OGILVIE MM, 1981, J MED VIROL, V7, P263, DOI 10.1002/jmv.1890070403; PALLADINO G, 1995, J VIROL, V69, P2075, DOI 10.1128/JVI.69.4.2075-2081.1995; Perez-Yarza EG, 2007, PEDIATR INFECT DIS J, V26, P733, DOI 10.1097/INF.0b013e3180618c42; Perkin MR, 2006, J ALLERGY CLIN IMMUN, V117, P1374, DOI 10.1016/j.jaci.2006.03.008; Pitkaranta A, 1998, PEDIATRICS, V102, P291, DOI 10.1542/peds.102.2.291; Regnier SA, 2013, PEDIATR INFECT DIS J, V32, P820, DOI 10.1097/INF.0b013e31829061e8; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; RUUSKANEN O, 1989, PEDIATR INFECT DIS J, V8, P94; STEVENS SK, 1982, J IMMUNOL, V128, P844; van der Poel CE, 2010, BLOOD, V116, P5327, DOI 10.1182/blood-2010-04-280214; van Neerven RJJ, 2012, J ALLERGY CLIN IMMUN, V130, P853, DOI 10.1016/j.jaci.2012.06.050; VANDERPOEL WHM, 1993, ARCH VIROL, V133, P309, DOI 10.1007/BF01313771; Walsh EE, 2004, J INFECT DIS, V190, P373, DOI 10.1086/421524; Waser M, 2007, CLIN EXP ALLERGY, V37, P661, DOI 10.1111/j.1365-2222.2006.02640.x; Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4; Wilson SD, 2000, J MED VIROL, V61, P81, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;81::AID-JMV13&gt;3.0.CO;2-O	47	22	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112047	10.1371/journal.pone.0112047	http://dx.doi.org/10.1371/journal.pone.0112047			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375837	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402600095
J	Floor, SL; Hebrant, A; Pita, JM; Saiselet, M; Tresallet, C; Libert, F; Andry, G; Dumont, JE; van Staveren, WC; Maenhaut, C				Floor, Sebastien L.; Hebrant, Aline; Pita, Jaime M.; Saiselet, Manuel; Tresallet, Christophe; Libert, Frederick; Andry, Guy; Dumont, Jacques E.; van Staveren, Wilma C.; Maenhaut, Carine			MiRNA Expression May Account for Chronic but Not for Acute Regulation of mRNA Expression in Human Thyroid Tumor Models	PLOS ONE			English	Article							GENE-EXPRESSION; CELL PROLIFERATION; HUMAN THYROCYTES; CANCER-CELLS; IN-VITRO; CARCINOMAS; MICRORNAS; THYROTROPIN; PHENOTYPE; GROWTH	Background: For thyroid tumorigenesis, two main human in vitro models are available: primary cultures of human thyrocytes treated with TSH or EGF/serum as models for autonomous adenomas (AA) or papillary thyroid carcinomas (PTC) respectively, and human thyroid tumor derived cell lines. Previous works of our group have assessed properties of those models, with a special emphasis on mRNA regulations. It is often assumed that miRNA may be one of the primary events inducing these mRNA regulations. Methods: The purpose of this study was to investigate the representativity of those models to study microRNA regulations and their relation with mRNA expression. To achieve this aim, the miRNA expressions profiles of primary cultures treated with TSH or EGF/serum and of 6 thyroid cancer cell lines were compared to the expression profiles of 35 tumor tissues obtained by microarrays. Results: Our data on primary cultures have shown that the TSH or EGF/serum treatment did not greatly modify the microRNA expression profiles, which is contrary to what is observed for mRNA expression profiles, although they still evolved differently according to the treatment. The analysis of miRNA and mRNA expressions profiles in the cell lines has shown that they have evolved into a common, dedifferentiated phenotype, closer to ATC than to the tumors they are derived from. Conclusions: Long-terms TSH or EGF/serum treatments do not mimic AA or PTC respectively in terms of miRNA expression as they do for mRNA, suggesting that the regulations of mRNA expression induced by these physiological agents occur independently of miRNA. The general patterns of miRNA expression in the cell lines suggest that they represent a useful model for undifferentiated thyroid cancer. Mirna probably do not mediate the rapid changes in gene expression in rapid cell biology regulation.	[Floor, Sebastien L.; Hebrant, Aline; Pita, Jaime M.; Saiselet, Manuel; Libert, Frederick; Dumont, Jacques E.; van Staveren, Wilma C.; Maenhaut, Carine] Free Univ Brussels ULB, Inst Interdisciplinary Res IRIBHM, Brussels, Belgium; [Maenhaut, Carine] Free Univ Brussels, Welbio, Brussels, Belgium; [Tresallet, Christophe] Univ Paris 06, Pitie Salpetriere Hosp, Paris, France; [Andry, Guy] Inst J Bordet, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Vrije Universiteit Brussel; WELBIO; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut Jules Bordet	Maenhaut, C (corresponding author), Free Univ Brussels ULB, Inst Interdisciplinary Res IRIBHM, Brussels, Belgium.	cmaenhau@ulb.ac.be		andry, guy/0000-0001-7410-6519	Fonds de la Recherche Scientifique FNRS-FRSM; Welbio; Fondation contre le Cancer; FRIA; Fondation Van Buuren; les Amis de l'Institut Bordet	Fonds de la Recherche Scientifique FNRS-FRSM(Fonds de la Recherche Scientifique - FNRS); Welbio(WELBIO); Fondation contre le Cancer; FRIA(Fonds de la Recherche Scientifique - FNRS); Fondation Van Buuren; les Amis de l'Institut Bordet	Funding sources for this study were provided by the Fonds de la Recherche Scientifique FNRS-FRSM, Welbio, Fondation contre le Cancer, FRIA, Fondation Van Buuren, les Amis de l'Institut Bordet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama T, 2012, MOL ENDOCRINOL, V26, P493, DOI 10.1210/me.2011-1004; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Braun J, 2010, ONCOGENE, V29, P4237, DOI 10.1038/onc.2010.169; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Corvilain B, 2001, CLIN ENDOCRINOL, V55, P143, DOI 10.1046/j.1365-2265.2001.01365.x; Delys L, 2007, ONCOGENE, V26, P7894, DOI 10.1038/sj.onc.1210588; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Giordano TJ, 2005, ONCOGENE, V24, P6646, DOI 10.1038/sj.onc.1208822; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hebrant A, 2007, EXP CELL RES, V313, P3276, DOI 10.1016/j.yexcr.2007.06.019; Kimura T, 2001, ENDOCR REV, V22, P631, DOI 10.1210/er.22.5.631; Leone V, 2012, J CLIN ENDOCR METAB, V97, P3292, DOI 10.1210/jc.2012-1349; Leone V, 2011, MOL ENDOCRINOL, V25, P1819, DOI 10.1210/me.2011-0014; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Pallante P, 2014, NAT REV ENDOCRINOL, V10, P88, DOI 10.1038/nrendo.2013.223; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; ROGER P, 1988, J CLIN ENDOCR METAB, V66, P1158, DOI 10.1210/jcem-66-6-1158; Roger PP, 2010, MOL CELL ENDOCRINOL, V321, P3, DOI 10.1016/j.mce.2009.11.015; Roger PP, 1997, EUR J ENDOCRINOL, V137, P579, DOI 10.1530/eje.0.1370579; Saiselet Manuel, 2012, Front Endocrinol (Lausanne), V3, P133, DOI 10.3389/fendo.2012.00133; Saito T, 1997, J CLIN ENDOCR METAB, V82, P3331, DOI 10.1210/jc.82.10.3331; Schweppe RE, 2013, J CLIN ENDOCR METAB, V98, P956, DOI 10.1210/jc.2012-4182; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; van Staveren WCG, 2009, BBA-REV CANCER, V1795, P92, DOI 10.1016/j.bbcan.2008.12.004; van Staveren WCG, 2006, P NATL ACAD SCI USA, V103, P413, DOI 10.1073/pnas.0507354102; van Staveren WCG, 2007, CANCER RES, V67, P8113, DOI 10.1158/0008-5472.CAN-06-4026; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Zang SZ, 2007, J BIOMED INFORM, V40, P552, DOI 10.1016/j.jbi.2007.01.002	31	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111581	10.1371/journal.pone.0111581	http://dx.doi.org/10.1371/journal.pone.0111581			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375362	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600048
J	Sato, Y; Miyauchi, Y; Yoshida, S; Morita, M; Kobayashi, T; Kanagawa, H; Katsuyama, E; Fujie, A; Hao, W; Tando, T; Watanabe, R; Miyamoto, K; Morioka, H; Matsumoto, M; Toyama, Y; Miyamoto, T				Sato, Yuiko; Miyauchi, Yoshiteru; Yoshida, Shigeyuki; Morita, Mayu; Kobayashi, Tami; Kanagawa, Hiroya; Katsuyama, Eri; Fujie, Atsuhiro; Hao, Wu; Tando, Toshimi; Watanabe, Ryuichi; Miyamoto, Kana; Morioka, Hideo; Matsumoto, Morio; Toyama, Yoshiaki; Miyamoto, Takeshi			The Vitamin D Analogue ED71 but Not 1,25(OH)(2)D-3 Targets HIF1 alpha Protein in Osteoclasts	PLOS ONE			English	Article							BODY GIANT-CELLS; D-RECEPTOR; IMMUNOCYTOCHEMICAL LOCALIZATION; OSTEOPOROTIC FRACTURES; BONE; 1,25-DIHYDROXYVITAMIN-D3; DIFFERENTIATION; OSTEOBLASTS; METABOLISM; DISEASE	Although both an active form of the vitamin D metabolite, 1,25(OH)(2)D-3, and the vitamin D analogue, ED71 have been used to treat osteoporosis, anti-bone resorbing activity is reportedly seen only in ED71-but not in 1,25(OH)(2)D-3-treated patients. In addition, how ED71 inhibits osteoclast activity in patients has not been fully characterized. Recently, HIF1 alpha expression in osteoclasts was demonstrated to be required for development of post-menopausal osteoporosis. Here we show that ED71 but not 1,25(OH)(2)D-3, suppress HIF1 alpha protein expression in osteoclasts in vitro. We found that 1,25(OH)(2)D-3 or ED71 function in osteoclasts requires the vitamin D receptor (VDR). ED71 was significantly less effective in inhibiting M-CSF and RANKL-stimulated osteoclastogenesis than was 1,25(OH)(2)D-3 in vitro. Downregulation of c-Fos protein and induction of Ifn beta mRNA in osteoclasts, both of which reportedly block osteoclastogenesis induced by 1,25(OH)(2)D-3 in vitro, were both significantly higher following treatment with 1,25(OH)(2)D-3 than with ED71. Thus, suppression of HIF1 alpha protein activity in osteoclasts in vitro, which is more efficiently achieved by ED71 rather than by 1,25(OH)(2)D-3, could be a reliable read-out in either developing or screening reagents targeting osteoporosis.	[Sato, Yuiko; Miyauchi, Yoshiteru; Kobayashi, Tami; Kanagawa, Hiroya; Katsuyama, Eri; Fujie, Atsuhiro; Hao, Wu; Tando, Toshimi; Watanabe, Ryuichi; Miyamoto, Kana; Morioka, Hideo; Matsumoto, Morio; Toyama, Yoshiaki; Miyamoto, Takeshi] Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, Tokyo, Japan; [Sato, Yuiko] Keio Univ, Sch Med, Dept Musculoskeletal Reconstruct & Regenerat Surg, Shinjuku Ku, Tokyo, Japan; [Yoshida, Shigeyuki; Morita, Mayu] Keio Univ, Sch Med, Dept Dent & Oral Surg, Shinjuku Ku, Tokyo, Japan; [Kobayashi, Tami; Miyamoto, Takeshi] Keio Univ, Sch Med, Dept Integrated Bone Metab & Immunol, Shinjuku Ku, Tokyo, Japan	Keio University; Keio University; Keio University; Keio University	Miyamoto, T (corresponding author), Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, Tokyo, Japan.	miyamoto@z5.keio.jp	hao, wu/HDM-1705-2022					BERGER U, 1988, J CLIN ENDOCR METAB, V67, P607, DOI 10.1210/jcem-67-3-607; BOIVIN G, 1987, BONE MINER, V3, P125; CLEMENS TL, 1988, ENDOCRINOLOGY, V122, P1224, DOI 10.1210/endo-122-4-1224; Ettinger B, 1998, J CLIN ENDOCR METAB, V83, P2239, DOI 10.1210/jc.83.7.2239; Johnson JA, 1996, J BONE MINER RES, V11, P56; Kikuta J, 2013, P NATL ACAD SCI USA, V110, P7009, DOI 10.1073/pnas.1218799110; Langub MC, 2000, BONE, V27, P383, DOI 10.1016/S8756-3282(00)00335-5; Matsumoto T, 2011, BONE, V49, P605, DOI 10.1016/j.bone.2011.07.011; Mee AP, 1996, BONE, V18, P295, DOI 10.1016/8756-3282(96)00011-7; Menaa C, 2000, J BONE MINER RES, V15, P228, DOI 10.1359/jbmr.2000.15.2.228; MERKE J, 1986, J CLIN INVEST, V77, P312, DOI 10.1172/JCI112292; Migliorati CA, 2003, J CLIN ONCOL, V21, P4253, DOI 10.1200/JCO.2003.99.132; Miyamoto H, 2012, J BONE MINER RES, V27, P1289, DOI 10.1002/jbmr.1575; Miyamoto Takeshi, 2003, Keio J Med, V52, P1; Miyauchi Y, 2013, P NATL ACAD SCI USA, V110, P16568, DOI 10.1073/pnas.1308755110; NARBAITZ R, 1981, J HISTOCHEM CYTOCHEM, V29, P91, DOI 10.1177/29.1.7009732; Nelson ER, 2013, BONE, V53, P42, DOI 10.1016/j.bone.2012.11.011; Nishikaw K, 2010, P NATL ACAD SCI USA, V107, P3117, DOI 10.1073/pnas.0912779107; Plum LA, 2010, NAT REV DRUG DISCOV, V9, P941, DOI 10.1038/nrd3318; Report of a WHO Study Group, 1994, WHO TECH REP SER, V10, P1; Sakai S, 2009, J BONE MINER METAB, V27, P643, DOI 10.1007/s00774-009-0084-4; Sakuma M, 2011, J ORTHOP SCI, V16, P418, DOI 10.1007/s00776-011-0089-4; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Takasu H, 2006, J CLIN INVEST, V116, P528, DOI 10.1172/JCI24742; Visekruna M, 2008, J CLIN ENDOCR METAB, V93, P2948, DOI 10.1210/jc.2007-2803; Wang YJ, 2014, J BONE MINER RES, V29, P685, DOI 10.1002/jbmr.2081; Winzenberg T, 2013, CALCIFIED TISSUE INT, V92, P140, DOI 10.1007/s00223-012-9615-4; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007	31	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111845	10.1371/journal.pone.0111845	http://dx.doi.org/10.1371/journal.pone.0111845			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375896	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600068
J	Dong, LL; Duan, WW; Chen, JL; Sun, H; Qiao, CH; Xia, CM				Dong, Lanlan; Duan, Wenwen; Chen, Jinglei; Sun, Huan; Qiao, Chunhua; Xia, Chao-ming			An Artemisinin Derivative of Praziquantel as an Orally Active Antischistosomal Agent	PLOS ONE			English	Article							SCHISTOSOMA-JAPONICUM; MANSONI; CHEMOTHERAPY; ARTEMETHER; RESISTANCE; MECHANISMS; JUVENILE; ANALOGS	Background: Schistosomiasis is a major health problem in tropical and sub-tropical areas caused by species of trematode belonging to the genus Schistosoma. The treatment and control of this disease has been relying on the use of a single drug praziquantel. However, the drug resistance concern urged the development of new drugs against schistosoma. Here, we report our systematic biological evaluation of DW-3-15, a new lead compound developed based on our conjugation design rationale as an effective anti-schistosomal agent. Methodology/Principal Findings: The antischistosomal activity of DW-3-15 was systematically evaluated in S. japonicum infected mouse model for its stage-sensitivity and dose response. The results revealed that DW-3-15 exhibited 60-85% worm reduction rate against different development stage of worm. Scanning electron microscopy (SEM) observation indicated that DW-3-15 may damage to the tegument of male schistosomes. Conclusions/Significance: Our results demonstrated that DW-3-15 showed potent anti-schistosomal activities in vivo. The results strongly support our conjugation design strategy of artemisinin analogs and further development of DW-3-15 as a new lead compound as anti-schistosomal agent.	[Dong, Lanlan; Duan, Wenwen; Chen, Jinglei; Sun, Huan; Qiao, Chunhua; Xia, Chao-ming] Soochow Univ, Coll Med Sci, Suzhou, Peoples R China	Soochow University - China	Qiao, CH (corresponding author), Soochow Univ, Coll Med Sci, Suzhou, Peoples R China.	qiaochunhua@suda.edu.cn; xiachaoming@suda.edu.cn			National 863 Program of China [2012AA0203006]; Priority Academic Program Development of Jiangsu Higher Education Institutions; "333" Project of Jiangsu Province; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	National 863 Program of China; Priority Academic Program Development of Jiangsu Higher Education Institutions; "333" Project of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This project is funded by National 863 Program of China (NO. 2012AA0203006) and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The authors are indebted to the financial support from "333" Project of Jiangsu Province. This project is also sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MH, 2007, PLOS MED, V4, P130, DOI 10.1371/journal.pmed.0040014; ANDREWS P, 1985, PHARMACOL THERAPEUT, V29, P129, DOI 10.1016/0163-7258(85)90020-8; Botros S, 2005, INT J PARASITOL, V35, P787, DOI 10.1016/j.ijpara.2005.02.005; Botros S, 2003, ANTIMICROB AGENTS CH, V47, P3853, DOI 10.1128/AAC.47.12.3853-3858.2003; Caffrey CR, 2007, CURR OPIN CHEM BIOL, V11, P433, DOI 10.1016/j.cbpa.2007.05.031; Cioli D, 2004, INT J PARASITOL, V34, P979, DOI 10.1016/j.ijpara.2004.05.001; Doenhoff MJ, 2008, CURR OPIN INFECT DIS, V21, P659, DOI 10.1097/QCO.0b013e328318978f; Dong YX, 2010, BIOORG MED CHEM LETT, V20, P2481, DOI 10.1016/j.bmcl.2010.03.001; Duan WW, 2012, BIOORG MED CHEM LETT, V22, P1587, DOI 10.1016/j.bmcl.2011.12.133; El Ridi R, 2010, ANTIMICROB AGENTS CH, V54, P3383, DOI 10.1128/AAC.00173-10; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Huang JG, 2010, DRUG METAB PHARMACOK, V25, P487, DOI 10.2133/dmpk.DMPK-10-RG-041; Keiser J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000350; Laurent SAL, 2008, EUR J ORG CHEM, V2008, P895, DOI 10.1002/ejoc.200700975; Meunier B, 2010, ACCOUNTS CHEM RES, V43, P1444, DOI 10.1021/ar100070k; Patra M, 2013, J MED CHEM, V56, P9192, DOI 10.1021/jm401287m; Patra M, 2012, J MED CHEM, V55, P8790, DOI 10.1021/jm301077m; Pica-Mattoccia L, 2007, EXP PARASITOL, V115, P344, DOI 10.1016/j.exppara.2006.09.017; Portela J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001474; Sayed AA, 2008, NAT MED, V14, P407, DOI 10.1038/nm1737; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Utzinger J, 2003, ANTIMICROB AGENTS CH, V47, P1487, DOI 10.1128/AAC.47.5.1487-1495.2003; Utzinger J, 2001, INT J PARASITOL, V31, P1549, DOI 10.1016/S0020-7519(01)00297-1; Utzinger J, 2001, ACTA TROP, V80, P9, DOI 10.1016/S0001-706X(01)00138-3; Utzinger J, 2004, EXPERT OPIN PHARMACO, V5, P263, DOI 10.1517/eoph.5.2.263.26469; XIAO SH, 1987, CHINESE MED J-PEKING, V100, P759; Xiao SH, 2000, PARASITOL INT, V49, P25, DOI 10.1016/S1383-5769(00)00029-5; Xiao SH, 2009, PARASITOL RES, V106, P131, DOI 10.1007/s00436-009-1640-5; YOLLES TK, 1947, J PARASITOL, V33, P419, DOI 10.2307/3273678; You J, 1994, CHIN J PARASITIC DIS, V7, P50	30	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112163	10.1371/journal.pone.0112163	http://dx.doi.org/10.1371/journal.pone.0112163			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386745	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400046
J	Etxebarria, A; Benito-Vicente, A; Alves, AC; Ostolaza, H; Bourbon, M; Martin, C				Etxebarria, Aitor; Benito-Vicente, Asier; Alves, Ana C.; Ostolaza, Helena; Bourbon, Mafalda; Martin, Cesar			Advantages and Versatility of Fluorescence-Based Methodology to Characterize the Functionality of LDLR and Class Mutation Assignment	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; MOLECULAR-GENETICS; MISSENSE MUTATIONS; CYTOPLASMIC DOMAIN; HUMAN FIBROBLASTS; LIGAND-BINDING; CELLS; INTERNALIZATION; IDENTIFICATION	Familial hypercholesterolemia (FH) is a common autosomal codominant disease with a frequency of 1:500 individuals in its heterozygous form. The genetic basis of FH is most commonly mutations within the LDLR gene. Assessing the pathogenicity of LDLR variants is particularly important to give a patient a definitive diagnosis of FH. Current studies of LDLR activity ex vivo are based on the analysis of I-125-labeled lipoproteins (reference method) or fluorescent-labelled LDL. The main purpose of this study was to compare the effectiveness of these two methods to assess LDLR functionality in order to validate a functional assay to analyse LDLR mutations. LDLR activity of different variants has been studied by flow cytometry using FITC-labelled LDL and compared with studies performed previously with I-125-labeled lipoproteins. Flow cytometry results are in full agreement with the data obtained by the I-125 methodology. Additionally confocal microscopy allowed the assignment of different class mutation to the variants assayed. Use of fluorescence yielded similar results than I-125-labeled lipoproteins concerning LDLR activity determination, and also allows class mutation classification. The use of FITC-labelled LDL is easier in handling and disposal, cheaper than radioactivity and can be routinely performed by any group doing LDLR functional validations.	[Etxebarria, Aitor; Benito-Vicente, Asier; Ostolaza, Helena; Martin, Cesar] Univ Basque Country, Unidad Biofis, CSIC, UPV EHU, E-48080 Bilbao, Spain; [Etxebarria, Aitor; Benito-Vicente, Asier; Ostolaza, Helena; Martin, Cesar] Univ Basque Country, Dept Bioquim & Biol Mol, E-48080 Bilbao, Spain; [Alves, Ana C.; Bourbon, Mafalda] Inst Nacl Saude Dr Ricardo Jorge, Dept Promocao Saude & Prevencao Doencas Nao Trans, Unidade I&D, Grp Invest Cardiovasc, P-1649040 Lisbon, Portugal; [Alves, Ana C.; Bourbon, Mafalda] Univ Lisbon, Fac Sci, Ctr Biodivers, P-1749016 Lisbon, Portugal	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; Instituto Nacional de Saude Dr. Ricardo Jorge; Universidade de Lisboa	Martin, C (corresponding author), Univ Basque Country, Unidad Biofis, CSIC, UPV EHU, Apdo 644, E-48080 Bilbao, Spain.	cesar.martin@ehu.es	Alves, Ana Catarina/K-6455-2014; Bourbon, Mafalda/K-6866-2014; marttin, cesar/GWC-4638-2022; martin, cesar/L-1303-2014	Alves, Ana Catarina/0000-0003-3157-7542; Bourbon, Mafalda/0000-0001-8843-3799; martin, cesar/0000-0002-4087-8729; OSTOLAZA ECHABE, ELENA AMAYA/0000-0003-2933-9975	Spanish Ministry of Economy and Competitiveness, Programa INNPACTO [IPT-2011-0817-010000]; Spanish Ministerio de Ciencia y Tecnologia [BFU 2012-36241]; Basque Government (Grupos Consolidados) [IT849-13]; Basque Government (ETORTEK Program); Portuguese Science and Technology Foundation [SFRH/BD/27990/2006, PEst-OE/BIA/UI4046/2011]	Spanish Ministry of Economy and Competitiveness, Programa INNPACTO; Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Basque Government (Grupos Consolidados)(Basque Government); Basque Government (ETORTEK Program)(Basque Government); Portuguese Science and Technology Foundation(Portuguese Foundation for Science and Technology)	This work was supported by the Spanish Ministry of Economy and Competitiveness, Programa INNPACTO (grant No IPT-2011-0817-010000) and from the Spanish Ministerio de Ciencia y Tecnologia (Project BFU 2012-36241), and the Basque Government (Grupos Consolidados IT849-13 and ETORTEK Program). The authors would like to thank the Portuguese Science and Technology Foundation for A.C. Alves's PhD grant (SFRH/BD/27990/2006) and strategic project (PEst-OE/BIA/UI4046/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alves AC, 2010, REV PORT CARDIOL, V29, P907; Beglova N, 2004, MOL CELL, V16, P281, DOI 10.1016/j.molcel.2004.09.038; Brice P, 2013, ATHEROSCLEROSIS, V231, P223, DOI 10.1016/j.atherosclerosis.2013.09.019; BROWN MS, 1975, CELL, V6, P307, DOI 10.1016/0092-8674(75)90182-8; Dardik R, 2000, THROMB HAEMOSTASIS, V83, P338; DAVIS CG, 1986, CELL, V45, P15, DOI 10.1016/0092-8674(86)90533-7; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Etxebarria A, 2012, HUM MUTAT, V33, P232, DOI 10.1002/humu.21630; GOLDSTEIN JL, 1974, J BIOL CHEM, V249, P5153; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; Goldstein JL, 2001, FAMILIAL HYPERCHOLES; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Haase A, 2012, CURR OPIN LIPIDOL, V23, P282, DOI 10.1097/MOL.0b013e3283556c33; HED J, 1987, J IMMUNOL METHODS, V101, P119, DOI 10.1016/0022-1759(87)90224-9; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; HOBBS HH, 1988, J CLIN INVEST, V81, P909, DOI 10.1172/JCI113402; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; KNIGHT BL, 1982, EUR J BIOCHEM, V125, P407, DOI 10.1111/j.1432-1033.1982.tb06698.x; LEHRMAN MA, 1985, CELL, V41, P735, DOI 10.1016/S0092-8674(85)80054-4; Leigh SEA, 2008, ANN HUM GENET, V72, P485, DOI 10.1111/j.1469-1809.2008.00436.x; Leren TP, 1997, J INTERN MED, V241, P185, DOI 10.1046/j.1365-2796.1997.78119000.x; Minino Arialdi M, 2009, NCHS Data Brief, P1; Ned RM, 2011, PLOS CURR, V3, pRRN1238, DOI DOI 10.1371/CURRENTS.RRN1238; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Ranheim T, 2006, CLIN CHEM, V52, P1469, DOI 10.1373/clinchem.2006.068627; Romano M, 2011, J LIPID RES, V52, P2095, DOI 10.1194/jlr.D017772; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Silva S, 2012, ATHEROSCLEROSIS, V225, P128, DOI 10.1016/j.atherosclerosis.2012.08.017; SOUTAR AK, 1989, P NATL ACAD SCI USA, V86, P4166, DOI 10.1073/pnas.86.11.4166; Sun XM, 1997, ARTERIOSCL THROM VAS, V17, P3092, DOI 10.1161/01.ATV.17.11.3092; Tada H, 2009, CLIN CHIM ACTA, V400, P42, DOI 10.1016/j.cca.2008.10.010; Taschner PEM, 2011, HUM MUTAT, V32, P507, DOI 10.1002/humu.21427; Terzic A, 2011, CTS-CLIN TRANSL SCI, V4, P225, DOI 10.1111/j.1752-8062.2011.00295.x; Usifo E, 2012, ANN HUM GENET, V76, P387, DOI 10.1111/j.1469-1809.2012.00724.x; Waldman SA, 2011, CLIN PHARMACOL THER, V90, P483, DOI 10.1038/clpt.2011.213	39	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112677	10.1371/journal.pone.0112677	http://dx.doi.org/10.1371/journal.pone.0112677			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386756	Green Submitted, Green Published, gold			2022-12-27	WOS:000345250400081
J	Tsai, YC; Chiu, YW; Kuo, HT; Chen, SC; Hwang, SJ; Chen, TH; Kuo, MC; Chen, HC				Tsai, Yi-Chun; Chiu, Yi-Wen; Kuo, Hung-Tien; Chen, Szu-Chia; Hwang, Shang-Jyh; Chen, Tzu-Hui; Kuo, Mei-Chuan; Chen, Hung-Chun			Fluid Overload, Pulse Wave Velocity, and Ratio of Brachial Pre-Ejection Period to Ejection Time in Diabetic and Non-Diabetic Chronic Kidney Disease	PLOS ONE			English	Article							HEMODIALYSIS-PATIENTS; BIOIMPEDANCE SPECTROSCOPY; ARTERIAL STIFFNESS; VOLUME OVERLOAD; MORTALITY; ULTRAFILTRATION; ASSOCIATION; PARAMETER; INDEX; MANAGEMENT	Fluid overload is one of the characteristics in chronic kidney disease (CKD). Changes in extracellular fluid volume are associated with progression of diabetic nephropathy. Not only diabetes but also fluid overload is associated with cardiovascular risk factors The aim of the study was to assess the interaction between fluid overload, diabetes, and cardiovascular risk factors, including arterial stiffness and left ventricular function in 480 patients with stages 4-5 CKD. Fluid status was determined by bioimpedance spectroscopy method, Body Composition Monitor. Brachial-ankle pulse wave velocity (baPWV), as a good parameter of arterial stiffness, and brachial pre-ejection period (bPEP)/brachial ejection time (bET), correlated with impaired left ventricular function were measured by ankle-brachial index (ABI)-form device. Of all patients, 207 (43.9%) were diabetic and 240 (50%) had fluid overload. For non-diabetic CKD, fluid overload was associated with being female (beta = -2.87, P = 0.003), heart disease (beta = 2.69, P = 0.04), high baPWV (beta = 0.27, P = 0.04), low hemoglobin (beta = -1.10, P<0.001), and low serum albumin (beta = -5.21, P<0.001) in multivariate analysis. For diabetic CKD, fluid overload was associated with diuretics use (beta = 3.69, P = 0.003), high mean arterial pressure (beta = 0.14, P = 0.01), low bPEP/ET (beta = -0.19, P = 0.03), low hemoglobin (beta = -1.55, P = 0.001), and low serum albumin (beta = -9.46, P<0.001). In conclusion, baPWV is associated with fluid overload in non-diabetic CKD and bPEP/bET is associated with fluid overload in diabetic CKD. Early and accurate assessment of these associated cardiovascular risk factors may improve the effects of entire care in late CKD.	[Tsai, Yi-Chun; Hwang, Shang-Jyh; Kuo, Mei-Chuan] Kaohsiung Med Univ, Grad Inst Clin Med, Kaohsiung, Taiwan; [Tsai, Yi-Chun; Chiu, Yi-Wen; Kuo, Hung-Tien; Hwang, Shang-Jyh; Kuo, Mei-Chuan; Chen, Hung-Chun] Kaohsiung Med Univ Hosp, Div Nephrol, Kaohsiung, Taiwan; [Chen, Tzu-Hui] Kaohsiung Med Univ Hosp, Dept Nursing, Kaohsiung, Taiwan; [Tsai, Yi-Chun; Chiu, Yi-Wen; Kuo, Hung-Tien; Chen, Szu-Chia; Hwang, Shang-Jyh; Kuo, Mei-Chuan; Chen, Hung-Chun] Kaohsiung Med Univ, Fac Renal Care, Kaohsiung, Taiwan; [Chen, Szu-Chia] Kaohsiung Municipal Hsiaokang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Hwang, Shang-Jyh] Natl Hlth Res Inst, Inst Populat Sci, Miaoli, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; National Health Research Institutes - Taiwan	Kuo, MC (corresponding author), Kaohsiung Med Univ, Grad Inst Clin Med, Kaohsiung, Taiwan.	mechku@cc.kmu.edu.tw	蘇, 河名/AAE-9843-2019	Kuo, Hung-Tien/0000-0002-9931-4354	Kaohsiung Medical University Faculty of Renal Care; Kaohsiung Medical University Research Foundation [KMU-Q103011]	Kaohsiung Medical University Faculty of Renal Care; Kaohsiung Medical University Research Foundation	Dr. Tsai's research was supported by the Kaohsiung Medical University Faculty of Renal Care and a grant from the Kaohsiung Medical University Research Foundation (KMU-Q103011). The author(s) received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen CH, 1998, J AM COLL CARDIOL, V32, P1221, DOI 10.1016/S0735-1097(98)00374-X; Chen SC, 2012, AM J MED SCI, V344, P457, DOI 10.1097/MAJ.0b013e31825141bf; Chen SC, 2011, NEPHROL DIAL TRANSPL, V26, P1895, DOI 10.1093/ndt/gfq639; Chen SC, 2010, CIRC J, V74, P2206, DOI 10.1253/circj.CJ-10-0273; Chen SC, 2010, HYPERTENS RES, V33, P492, DOI 10.1038/hr.2010.24; Crepaldi C, 2009, CONTRIB NEPHROL, V163, P1, DOI 10.1159/000223772; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Hung SC, 2014, KIDNEY INT, V85, P703, DOI 10.1038/ki.2013.336; Hur E, 2013, AM J KIDNEY DIS, V61, P957, DOI 10.1053/j.ajkd.2012.12.017; Kim WJ, 2012, ATHEROSCLEROSIS, V225, P237, DOI 10.1016/j.atherosclerosis.2012.08.034; Kimoto E, 2003, DIABETES, V52, P448, DOI 10.2337/diabetes.52.2.448; Levey AS, 1999, MORE ACCURATE; Moissl UM, 2006, PHYSIOL MEAS, V27, P921, DOI 10.1088/0967-3334/27/9/012; Moody WE, 2013, HEART, V99, P365, DOI 10.1136/heartjnl-2012-302818; Movilli E, 2007, NEPHROL DIAL TRANSPL, V22, P3547, DOI 10.1093/ndt/gfm466; Paniagua R, 2010, NEPHROL DIAL TRANSPL, V25, P551, DOI 10.1093/ndt/gfp395; Saran R, 2006, KIDNEY INT, V69, P1222, DOI 10.1038/sj.ki.5000186; Su HM, 2009, AM J HYPERTENS, V22, P871, DOI 10.1038/ajh.2009.94; Tsai YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082566; Tsai YC, 2014, AM J KIDNEY DIS, V63, P68, DOI 10.1053/j.ajkd.2013.06.011; Tsuchikura S, 2010, ATHEROSCLEROSIS, V211, P480, DOI 10.1016/j.atherosclerosis.2010.03.037; TUCKER BJ, 1991, KIDNEY INT, V39, P1176, DOI 10.1038/ki.1991.149; Van Biesen W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017148; Wabel P, 2009, BLOOD PURIFICAT, V27, P75, DOI 10.1159/000167013; Wieskotten S, 2008, PHYSIOL MEAS, V29, P639, DOI 10.1088/0967-3334/29/5/009; WIZEMANN V, 1995, NEPHROL DIAL TRANSPL, V10, P2114; WIZEMANN V, 1995, ARTIF ORGANS, V19, P416, DOI 10.1111/j.1525-1594.1995.tb02352.x; Wizemann V, 2008, WHOLE BODY SPECTROSC; Wizemann V, 2009, NEPHROL DIAL TRANSPL, V24, P1574, DOI 10.1093/ndt/gfn707; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Yokoyama Hisayo, 2003, J Atheroscler Thromb, V10, P253; Zheng D, 2009, CORRELATION BETWEEN	32	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111000	10.1371/journal.pone.0111000	http://dx.doi.org/10.1371/journal.pone.0111000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386836	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400012
J	Abrahams, AC; Habib, SM; Dendooven, A; Riser, BL; van der Veer, JW; Toorop, RJ; Betjes, MGH; Verhaar, MC; Watson, CJE; Nguyen, TQ; Boer, WH				Abrahams, Alferso C.; Habib, Sayed M.; Dendooven, Amelie; Riser, Bruce L.; van der Veer, Jan Willem; Toorop, Raechel J.; Betjes, Michiel G. H.; Verhaar, Marianne C.; Watson, Christopher J. E.; Nguyen, Tri Q.; Boer, Walther H.			Patients with Encapsulating Peritoneal Sclerosis Have Increased Peritoneal Expression of Connective Tissue Growth Factor (CCN2), Transforming Growth Factor-beta 1, and Vascular Endothelial Growth Factor	PLOS ONE			English	Article							TGF-BETA; MORPHOLOGIC CHANGES; FACTOR CTGF/CCN2; GENE-EXPRESSION; MEMBRANE; CTGF; TGF-BETA-1; INHIBITOR; CYTOKINES; FIBROSIS	Introduction: Encapsulating peritoneal sclerosis (EPS) is a devastating complication of peritoneal dialysis (PD). The pathogenesis is not exactly known and no preventive strategy or targeted medical therapy is available. CCN2 has both pro-fibrotic and pro-angiogenic actions and appears an attractive target. Therefore, we studied peritoneal expression of CCN2, as well as TGFb1 and VEGF, in different stages of peritoneal fibrosis. Materials and methods: Sixteen PD patients were investigated and compared to 12 hemodialysis patients and four pre-emptively transplanted patients. Furthermore, expression was investigated in 12 EPS patients in comparison with 13 PD and 12 non-PD patients without EPS. Peritoneal tissue was taken during kidney transplantation procedure or during EPS surgery. In a subset of patients, CCN2 protein levels in peritoneal effluent and plasma were determined. Samples were examined by qPCR, histology, immunohistochemistry, and ELISA. Results: Peritoneal CCN2 expression was 5-fold higher in PD patients compared to pre-emptively transplanted patients (P<0.05), but did not differ from hemodialysis patients. Peritoneal expression of TGF beta 1 and VEGF were not different between the three groups; neither was peritoneal thickness. Peritoneum of EPS patients exhibited increased expression of CCN2 (35-fold, P<0.001), TGF beta 1 (24-fold, P<0.05), and VEGF (77-fold, P<0.001) compared to PD patients without EPS. In EPS patients, CCN2 protein was mainly localized in peritoneal endothelial cells and fibroblasts. CCN2 protein levels were significantly higher in peritoneal effluent of EPS patients compared to levels in dialysate of PD patients (12.0 +/- 4.5 vs. 0.91 +/- 0.92 ng/ml, P<0.01), while plasma CCN2 levels were not increased. Conclusions: Peritoneal expression of CCN2, TGF beta 1, and VEGF are significantly increased in EPS patients. In early stages of peritoneal fibrosis, only CCN2 expression is slightly increased. Peritoneal CCN2 overexpression in EPS patients is a locally driven response. The potential of CCN2 as biomarker and target for CCN2-inhibiting agents to prevent or treat EPS warrants further study.	[Abrahams, Alferso C.; van der Veer, Jan Willem; Verhaar, Marianne C.; Boer, Walther H.] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, NL-3584 CX Utrecht, Netherlands; [Habib, Sayed M.; Betjes, Michiel G. H.] Erasmus MC, Dept Internal Med, Div Nephrol & Transplantat, Rotterdam, Netherlands; [Dendooven, Amelie; Nguyen, Tri Q.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Riser, Bruce L.] Rosalind Franklin Univ Med & Sci, Dept Physiol & Biophys, Chicago, IL 60064 USA; [Toorop, Raechel J.] Univ Med Ctr Utrecht, Dept Vasc Surg, Utrecht, Netherlands; [Watson, Christopher J. E.] Addenbrookes Hosp, Dept Surg, Cambridge CB2 2QQ, England; [Watson, Christopher J. E.] Cambridge NIHR Biomed Res Ctr, Cambridge, England	Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Chicago Medical School; Rosalind Franklin University Medical & Science; Utrecht University; Utrecht University Medical Center; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Abrahams, AC (corresponding author), Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, NL-3584 CX Utrecht, Netherlands.	A.C.Abrahams@umcutrecht.nl	Verhaar, Marianne/AAM-6788-2020; Dendooven, Amélie/AAC-1192-2021; Nguyen, Tri/A-9508-2009; Nguyen, Tri Q/AAN-9673-2021	Verhaar, Marianne/0000-0002-3276-6428; Nguyen, Tri/0000-0001-6475-0706; Nguyen, Tri Q/0000-0001-6475-0706; Watson, Christopher/0000-0002-0590-4901; Dendooven, Amelie/0000-0002-9900-7952; Betjes, Michiel/0000-0001-9435-6208; boer, walther/0000-0001-5048-2755	Dutch Kidney Foundation [C10.2344]; Clinical Evidence Council grant from Baxter Healthcare [10CECEU1007]	Dutch Kidney Foundation; Clinical Evidence Council grant from Baxter Healthcare	This study was supported by a grant from the Dutch Kidney Foundation (C10.2344) and a Clinical Evidence Council grant from Baxter Healthcare (10CECEU1007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler SG, 2010, CLIN J AM SOC NEPHRO, V5, P1420, DOI 10.2215/CJN.09321209; Barreto DL, 2013, AM J KIDNEY DIS, V62, P823, DOI 10.1053/j.ajkd.2013.01.031; Braun N, 2009, NEPHRON CLIN PRACT, V113, pC88, DOI 10.1159/000228540; Braun N, 2012, PLOS ONE, V7; Dendooven A, 2011, BIOMARKERS, V16, P289, DOI 10.3109/1354750X.2011.561366; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; DIPAOLO N, 1986, NEPHRON, V44, P204, DOI 10.1159/000183987; DOBBIE JW, 1989, BLOOD PURIFICAT, V7, P74, DOI 10.1159/000169580; Habib SM, 2011, NETH J MED, V69, P500; Habib SM, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-203; Hall-Glenn F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030562; Hall-Glenn F, 2011, CELL MOL LIFE SCI, V68, P3209, DOI 10.1007/s00018-011-0782-7; Honda K, 2005, PERITON DIALYSIS INT, V25, pS19; Honda K, 1996, NEPHRON, V72, P171, DOI 10.1159/000188837; Honda K, 2008, CLIN J AM SOC NEPHRO, V3, P720, DOI 10.2215/CJN.03630807; Io H, 2004, KIDNEY INT, V65, P1927, DOI 10.1111/j.1523-1755.2004.00599.x; Katz LH, 2013, EXPERT OPIN THER TAR, V17, P743, DOI 10.1517/14728222.2013.782287; Kawaguchi Y, 2000, PERITON DIALYSIS INT, V20, pS43; Kawanishi H, 2005, PERITON DIALYSIS INT, V25, pS39; Korte MR, 2011, NAT REV NEPHROL, V7, P528, DOI 10.1038/nrneph.2011.93; Krediet RT, 2013, NAT REV NEPHROL, V9, P419, DOI 10.1038/nrneph.2013.99; La Milia V, 2010, J NEPHROL, V23, P633; Leask A, 2009, J CELL COMMUN SIGNAL, V3, P89, DOI 10.1007/s12079-009-0037-7; Leung JCK, 2009, NEPHROL DIAL TRANSPL, V24, P458, DOI 10.1093/ndt/gfn524; Liu FY, 2007, CHINESE MED J-PEKING, V120, P231, DOI 10.1097/00029330-200702010-00012; Liu LM, 2009, PERITON DIALYSIS INT, V29, P508; Liu Y, 2014, RENAL FAILURE, V36, P292, DOI 10.3109/0886022X.2013.844645; Loureiro J, 2011, J AM SOC NEPHROL, V22, P1682, DOI 10.1681/ASN.2010111197; Margetts PJ, 2003, PERITON DIALYSIS INT, V23, P530; Margetts PJ, 2005, PERITON DIALYSIS INT, V25, pS15; Margetts PJ, 2001, J AM SOC NEPHROL, V12, P2029, DOI 10.1681/ASN.V12102029; Mateijsen MAM, 1999, PERITON DIALYSIS INT, V19, P517; Mizutani M, 2010, AM J PHYSIOL-RENAL, V298, pF721, DOI 10.1152/ajprenal.00368.2009; Mori T, 1999, J CELL PHYSIOL, V181, P153, DOI 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K; Pardali E, 2009, FRONT BIOSCI-LANDMRK, V14, P4848, DOI 10.2741/3573; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; POLLOCK CA, 1989, AM J NEPHROL, V9, P198, DOI 10.1159/000167965; Riser BL, 2000, J AM SOC NEPHROL, V11, P25, DOI 10.1681/ASN.V11125; Riser BL, 2012, J CELL COMMUN SIGNAL, V6, P97, DOI 10.1007/s12079-012-0164-4; Riser BL, 2009, AM J PATHOL, V174, P1725, DOI 10.2353/ajpath.2009.080241; Sakamoto N, 2005, INT J MOL MED, V15, P907; Sampimon DE, 2010, PERITON DIALYSIS INT, V30, P163, DOI 10.3747/pdi.2009.00022; Summers AM, 2009, PERITON DIALYSIS INT, V29, P499; Tanabe K, 2007, KIDNEY INT, V71, P227, DOI 10.1038/sj.ki.5002040; Tsoutsman T, 2013, J MOL CELL CARDIOL, V62, P164, DOI 10.1016/j.yjmcc.2013.05.019; Wang QJ, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-4; Wang X, 2010, NEPHROL DIAL TRANSPL, V25, P399, DOI 10.1093/ndt/gfp480; Williams JD, 2002, J AM SOC NEPHROL, V13, P470, DOI 10.1681/ASN.V132470; Williams JD, 2003, KIDNEY INT, V64, pS43, DOI 10.1046/j.1523-1755.2003.08805.x; Xiao L, 2010, THER APHER DIAL, V14, P27, DOI 10.1111/j.1744-9987.2009.00701.x; Yoshimura A, 2011, CURR TOP MICROBIOL, V350, P127, DOI 10.1007/82_2010_87; Yoshimura A, 2010, J BIOCHEM, V147, P781, DOI 10.1093/jb/mvq043; Yoshio Y, 2004, KIDNEY INT, V66, P1677, DOI 10.1111/j.1523-1755.2004.00935.x; Zarrinkalam KH, 2003, KIDNEY INT, V64, P331, DOI 10.1046/j.1523-1755.2003.00069.x; Zweers MM, 1999, J LAB CLIN MED, V134, P124, DOI 10.1016/S0022-2143(99)90116-6	55	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112050	10.1371/journal.pone.0112050	http://dx.doi.org/10.1371/journal.pone.0112050			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384022	Green Submitted, Green Published, gold			2022-12-27	WOS:000344816700029
J	Genard-Zielinski, AC; Ormeno, E; Boissard, C; Fernandez, C				Genard-Zielinski, Anne-Cyrielle; Ormeno, Elena; Boissard, Christophe; Fernandez, Catherine			Isoprene Emissions from Downy Oak under Water Limitation during an Entire Growing Season: What Cost for Growth?	PLOS ONE			English	Article							QUERCUS-PUBESCENS; DROUGHT; STRESS; VOLATILE; MODEL; LEAVES; PHOTOSYNTHESIS; TEMPERATURE; PROJECTIONS; MEMBRANES	Increases in the production of terpene- and phenolic-like compounds in plant species under abiotic stress conditions have been interpreted in physiological studies as a supplementary defense system due to their capacity to limit cell oxidation. From an ecological perspective however, these increases are only expected to confer competitive advantages if they do not imply a significant cost for the plant, that is, growth reduction. We investigated shifts of isoprene emissions, and to a lesser extent phenolic compound concentration, of Quercus pubescens Willd. from early leaf development to leaf senescence under optimal watering (control: C), mild and severe water stress (MS, SS). The impact of water stress was concomitantly assessed on plant physiological (chlorophyll fluorescence, stomatal conductance, net photosynthesis, water potential) functional (relative leaf water content, leaf mass per area ratio) and growth (aerial and root biomass) traits. Growth changes allowed to estimate the eventual costs related to the production of isoprene and phenolics. The total phenolic content was not modified under water stress whereas isoprene emissions were promoted under MS over the entire growing cycle despite the decline of P-n by 35%. Under SS, isoprene emissions remained similar to C all over the study despite the decline of Pn by 47% and were thereby clearly uncoupled to Pn leading to an overestimation of the isoprene emission factor by 44%. Under SS, maintenance of isoprene emissions and phenolic compound concentration resulted in very significant costs for the plants as growth rates were very significantly reduced. Under MS, increases of isoprene emission and maintenance of phenolic compound concentration resulted in moderate growth reduction. Hence, it is likely that investment in isoprene emissions confers Q. pubescens an important competitive advantage during moderate but not severe periods of water scarcity. Consequences of this response for air quality in North Mediterranean areas are also discussed.	[Genard-Zielinski, Anne-Cyrielle; Ormeno, Elena; Fernandez, Catherine] Avignon Univ, Aix Marseille Univ, Inst Mediterrane Biodiversite & Ecol Marine & Con, CNRS,IRD, F-84000 Avignon, France; [Genard-Zielinski, Anne-Cyrielle; Boissard, Christophe] Univ Versailles St Quentin En Yvelines, Lab Sci Climat & Environm LSCE IPSL, Unite Mixte CEA CNRS UVSQ, CEA,CNRS, Gif Sur Yvette, France	Avignon Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	Ormeno, E (corresponding author), Avignon Univ, Aix Marseille Univ, Inst Mediterrane Biodiversite & Ecol Marine & Con, CNRS,IRD, Technopole Arbois Mediterrane, F-84000 Avignon, France.	elena.ormeno-lafuente@imbe.fr	Ormeno, Elena/C-5887-2019; FERNANDEZ, Catherine/A-2556-2009	Ormeno, Elena/0000-0002-3265-5883; FERNANDEZ, Catherine/0000-0002-6868-4774	ADEME (Agence de l'environnement et de la maitrise de l'energie); region Provence-Alpes Cote d'Azur (PACA); European Union; French National Research Agency (ANR) [ANR-12-BSV7-0016-01]	ADEME (Agence de l'environnement et de la maitrise de l'energie); region Provence-Alpes Cote d'Azur (PACA)(Region Provence-Alpes-Cote d'Azur); European Union(European Commission); French National Research Agency (ANR)(French National Research Agency (ANR))	This research was supported by ADEME (Agence de l'environnement et de la maitrise de l'energie), the region Provence-Alpes Cote d'Azur (PACA) and the European Union and was funded by the French National Research Agency (ANR) through the SecPriMe2 project (ANR-12-BSV7-0016-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHERAR M, 1992, VEGETATIO, V100, P177; Affek HP, 2003, PLANT PHYSIOL, V131, P1727, DOI 10.1104/pp.102.012294; Atkinson R, 2000, ATMOS ENVIRON, V34, P2063, DOI 10.1016/S1352-2310(99)00460-4; Boberg F, 2012, NAT CLIM CHANGE, V2, P433, DOI 10.1038/NCLIMATE1454; Brilli F, 2007, NEW PHYTOL, V175, P244, DOI 10.1111/j.1469-8137.2007.02094.x; Bruggemann N, 2002, PLANT BIOLOGY, V4, P456, DOI 10.1055/s-2002-34128; Bussotti F, 2000, TREES-STRUCT FUNCT, V14, P361, DOI 10.1007/s004680000056; Claeys M, 2004, SCIENCE, V303, P1173, DOI 10.1126/science.1092805; Contran N, 2013, PLANT BIOLOGY, V15, P157, DOI 10.1111/j.1438-8677.2012.00627.x; ESTIARTE M, 1994, OECOLOGIA, V99, P387, DOI 10.1007/BF00627753; Fang CW, 1996, TREE PHYSIOL, V16, P441; Funk JL, 2004, PLANT CELL ENVIRON, V27, P747, DOI 10.1111/j.1365-3040.2004.01177.x; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Goulden ML, 1996, TREE PHYSIOL, V16, P417; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; GUENTHER AB, 1993, J GEOPHYS RES-ATMOS, V98, P12609, DOI 10.1029/93JD00527; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hernandez I, 2004, TREE PHYSIOL, V24, P1303, DOI 10.1093/treephys/24.11.1303; Hollosy F, 2002, MICRON, V33, P179, DOI 10.1016/S0968-4328(01)00011-7; Keenan T, 2009, ATMOS CHEM PHYS, V9, P4053, DOI 10.5194/acp-9-4053-2009; Kesselmeier J, 1999, J ATMOS CHEM, V33, P23, DOI 10.1023/A:1006127516791; Loreto F, 2001, PLANT PHYSIOL, V127, P1781, DOI 10.1104/pp.010497; Nardini A, 1999, NEW PHYTOL, V143, P485, DOI 10.1046/j.1469-8137.1999.00476.x; Niinemets U, 2010, TRENDS PLANT SCI, V15, P145, DOI 10.1016/j.tplants.2009.11.008; Ogaya R, 2003, FOREST ECOL MANAG, V180, P175, DOI 10.1016/S0378-1127(02)00598-4; Ormeno E, 2009, CHEMOSPHERE, V77, P94, DOI 10.1016/j.chemosphere.2009.05.014; Owen SM, 2002, ATMOS ENVIRON, V36, P3147, DOI 10.1016/S1352-2310(02)00235-2; Pegoraro E, 2006, GLOBAL CHANGE BIOL, V12, P456, DOI 10.1111/j.1365-2486.2006.01112.x; Pegoraro E, 2004, ATMOS ENVIRON, V38, P6149, DOI 10.1016/j.atmosenv.2004.07.028; Penuelas J, 2010, TRENDS PLANT SCI, V15, P133, DOI 10.1016/j.tplants.2009.12.005; Rodriguez-Calcerrada J, 2012, J EXPT BOT, V85, P36; Rosenstiel TN, 2004, PLANT BIOLOGY, V6, P12, DOI 10.1055/s-2003-44722; SHARKEY TD, 1993, OECOLOGIA, V95, P328, DOI 10.1007/BF00320984; Sharkey TD, 2008, ANN BOT-LONDON, V101, P5, DOI 10.1093/aob/mcm240; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Siwko ME, 2007, BBA-BIOMEMBRANES, V1768, P198, DOI 10.1016/j.bbamem.2006.09.023; Tani A, 2011, ATMOS ENVIRON, V45, P6261, DOI 10.1016/j.atmosenv.2011.08.003; TINGEY DT, 1981, PLANTA, V152, P565, DOI 10.1007/BF00380829; Velikova V, 2012, PLANT SIGNAL BEHAV, V7, P139, DOI 10.4161/psb.7.1.18521; Vickers CE, 2009, NAT CHEM BIOL, V5, P283, DOI 10.1038/nchembio.158; Zweifel R, 2009, J VEG SCI, V20, P442, DOI 10.1111/j.1654-1103.2009.05701.x	41	15	16	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112418	10.1371/journal.pone.0112418	http://dx.doi.org/10.1371/journal.pone.0112418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383554	Green Submitted, Green Published, gold			2022-12-27	WOS:000344816700060
J	Fischer, C; Lingsma, HF; Marang-van de Mheen, PJ; Kringos, DS; Klazinga, NS; Steyerberg, EW				Fischer, Claudia; Lingsma, Hester F.; Marang-van de Mheen, Perla J.; Kringos, Dionne S.; Klazinga, Niek S.; Steyerberg, Ewout W.			Is the Readmission Rate a Valid Quality Indicator? A Review of the Evidence	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; RISK-STANDARDIZED MORTALITY; PATIENT SAFETY INDICATORS; LENGTH-OF-STAY; HEART-FAILURE; HOSPITAL READMISSION; PERFORMANCE-MEASURES; CLINICAL-OUTCOMES; DISCHARGE INSTRUCTIONS; EMERGENCY READMISSION	Introduction: Hospital readmission rates are increasingly used for both quality improvement and cost control. However, the validity of readmission rates as a measure of quality of hospital care is not evident. We aimed to give an overview of the different methodological aspects in the definition and measurement of readmission rates that need to be considered when interpreting readmission rates as a reflection of quality of care. Methods: We conducted a systematic literature review, using the bibliographic databases Embase, Medline OvidSP, Web-of-Science, Cochrane central and PubMed for the period of January 2001 to May 2013. Results: The search resulted in 102 included papers. We found that definition of the context in which readmissions are used as a quality indicator is crucial. This context includes the patient group and the specific aspects of care of which the quality is aimed to be assessed. Methodological flaws like unreliable data and insufficient case-mix correction may confound the comparison of readmission rates between hospitals. Another problem occurs when the basic distinction between planned and unplanned readmissions cannot be made. Finally, the multi-faceted nature of quality of care and the correlation between readmissions and other outcomes limit the indicator's validity. Conclusions: Although readmission rates are a promising quality indicator, several methodological concerns identified in this study need to be addressed, especially when the indicator is intended for accountability or pay for performance. We recommend investing resources in accurate data registration, improved indicator description, and bundling outcome measures to provide a more complete picture of hospital care.	[Fischer, Claudia; Lingsma, Hester F.; Steyerberg, Ewout W.] Erasmus MC, Ctr Med Decis Making, Dept Publ Hlth, Rotterdam, Netherlands; [Marang-van de Mheen, Perla J.] Leiden Univ, Med Ctr, Dept Med Decis Making, Leiden, Netherlands; [Kringos, Dionne S.; Klazinga, Niek S.] Amsterdam Med Ctr, Dept Publ Hlth, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam	Fischer, C (corresponding author), Erasmus MC, Ctr Med Decis Making, Dept Publ Hlth, Rotterdam, Netherlands.	c.fischer@erasmusmc.nl	Kringos, Dionne/ABE-2290-2020; de Mheen, Perla J. Marang-van/I-2783-2015	Kringos, Dionne/0000-0003-2711-4713; de Mheen, Perla J. Marang-van/0000-0003-1439-0989; Fischer, Claudia/0000-0001-7574-8097	Dutch Health Care Authority (NZa)	Dutch Health Care Authority (NZa)	This research has been funding by the Dutch Health Care Authority (NZa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemo D, 2007, ANN ROY COLL SURG, V89, P363, DOI 10.1308/003588407X183409; Ahmed J, 2012, COLORECTAL DIS, V14, P1045, DOI 10.1111/j.1463-1318.2011.02856.x; Almoudaris AM, 2013, GUT, V62, P423, DOI 10.1136/gutjnl-2011-301489; Amin BY, 2012, NEUROSURGERY, V71, pE575, DOI 10.1227/01.neu.0000417785.91373.4d; Auerbach AD, 2010, J AM COLL SURGEONS, V211, P601, DOI 10.1016/j.jamcollsurg.2010.07.006; Auerbach AD, 2009, ANN INTERN MED, V150, P696, DOI 10.7326/0003-4819-150-10-200905190-00007; Axon RN, 2011, JAMA-J AM MED ASSOC, V305, P504, DOI 10.1001/jama.2011.72; Barbieri CE, 2007, J UROLOGY, V178, P1418, DOI 10.1016/j.juro.2007.05.156; Basu A, 2010, INT J HEALTH CARE Q, V23, P436, DOI 10.1108/09526861011037489; Ben-Assuli O, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-49; Benbassat J, 2013, ISR J HEALTH POLICY, V2, DOI 10.1186/2045-4015-2-1; Bernheim SM, 2010, CIRC-CARDIOVASC QUAL, V3, P459, DOI 10.1161/CIRCOUTCOMES.110.957613; Bianco A, 2012, PLOS ONE, V7; Bottle A, 2009, QUAL SAF HEALTH CARE, V18, P303, DOI 10.1136/qshc.2007.026096; Boulding W, 2011, AM J MANAG CARE, V17, P41; Brooke BS, 2012, J VASC SURG, V56, P556, DOI 10.1016/j.jvs.2012.03.260; Burke RE, 2013, J HOSP MED, V8, P102, DOI 10.1002/jhm.1990; Chan FWK, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-186; Chen Judy Y, 2012, J Diabetes Sci Technol, V6, P563; Chung ES, 2008, AM J MED QUAL, V23, P168, DOI 10.1177/1062860608315337; Correll PK, 2007, RESPIROLOGY, V12, P220, DOI 10.1111/j.1440-1843.2006.01039.x; Courtney EDJ, 2003, ANN ROY COLL SURG, V85, P75, DOI 10.1308/003588403321219803; Cram P, 2012, GERIATR ORTHOP SURG, V3, P17, DOI 10.1177/2151458511435723; Dallal RM, 2012, SURG ENDOSC, V26, P754, DOI 10.1007/s00464-011-1947-z; Demir E, 2008, IEEE T INF TECHNOL B, V12, P644, DOI 10.1109/TITB.2007.911311; Demir E, 2012, COMPUT METH PROG BIO, V108, P487, DOI 10.1016/j.cmpb.2011.03.003; Department of Health, 2008, EM READM RAT; Department of Health, 2010, OP FRAM; Desai AS, 2012, CIRCULATION, V126, P501, DOI 10.1161/CIRCULATIONAHA.112.125435; Dobrzanska L, 2006, J CLIN NURS, V15, P599, DOI 10.1111/j.1365-2702.2006.01333.x; Dunlay SM, 2012, ANN INTERN MED, V157, P11, DOI 10.7326/0003-4819-157-1-201207030-00004; Encinosa WE, 2008, HEALTH SERV RES, V43, P2067, DOI 10.1111/j.1475-6773.2008.00882.x; Fischer C, 2012, EUR J PUBLIC HEALTH, V22, P484, DOI 10.1093/eurpub/ckr165; Fonarow GC, 2007, JAMA-J AM MED ASSOC, V297, P61, DOI 10.1001/jama.297.1.61; Forster Alan J, 2012, Open Med, V6, pe75; Gawlas I, 2012, ANN SURG ONCOL, P1; Gheorghiade M, 2013, J AM COLL CARDIOL, V61, P391, DOI 10.1016/j.jacc.2012.09.038; Giamouzis G, 2011, J CARD FAIL, V17, P54, DOI 10.1016/j.cardfail.2010.08.010; Goldfield NI, 2008, HEALTH CARE FINANC R, V30, P75; Grocott MPW, 2010, CURR ANAESTH CRIT CA, V21, P129; Gu Q, 2014, HEALTH SERV RES, V49, P818, DOI 10.1111/1475-6773.12150; Halfon P, 2002, J CLIN EPIDEMIOL, V55, P573, DOI 10.1016/S0895-4356(01)00521-2; Halfon P, 2006, MED CARE, V44, P972, DOI 10.1097/01.mlr.0000228002.43688.c2; Hannan EL, 2011, JACC-CARDIOVASC INTE, V4, P569, DOI 10.1016/j.jcin.2011.01.010; Heggestad T, 2002, HEALTH SERV RES, V37, P647, DOI 10.1111/1475-6773.00042; Hernandez AF, 2010, AM HEART J, V159, P406, DOI 10.1016/j.ahj.2009.12.024; Holt PJE, 2010, EUR J VASC ENDOVASC, V39, P49, DOI 10.1016/j.ejvs.2009.10.003; Horwitz LI, 2012, J HOSP MED, V7, P690, DOI 10.1002/jhm.1965; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jensen PH, 2009, HEALTH ECON, V18, P1440, DOI 10.1002/hec.1435; Jha AK, 2009, NEW ENGL J MED, V361, P2637, DOI 10.1056/NEJMsa0904859; Jimenez-Puente A, 2004, INT J TECHNOL ASSESS, V20, P385, DOI 10.1017/S0266462304001230; Johnson Tricia, 2012, Qual Manag Health Care, V21, P68, DOI 10.1097/QMH.0b013e31824b9297; Joynt KE, 2011, ANN INTERN MED, V154, P94, DOI 10.7326/0003-4819-154-2-201101180-00008; Judge A, 2006, J PUBLIC HEALTH-UK, V28, P116, DOI 10.1093/pubmed/fdl003; Kaboli PJ, 2012, ANN INTERN MED, V157, P837, DOI 10.7326/0003-4819-157-12-201212180-00003; Kangovi S, 2011, JAMA-J AM MED ASSOC, V306, P1796, DOI 10.1001/jama.2011.1562; Kansagara D, 2011, J GEN INTERN MED, V26, pS125; Kent TS, 2011, J AM COLL SURGEONS, V213, P515, DOI 10.1016/j.jamcollsurg.2011.07.009; Kergoat MJ, 2012, J AM MED DIR ASSOC, V13, P459, DOI 10.1016/j.jamda.2011.11.004; Khawaja FJ, 2012, ARCH INTERN MED, V172, P112, DOI 10.1001/archinternmed.2011.569; Kiran RP, 2004, J AM COLL SURGEONS, V198, P877, DOI 10.1016/j.jamcollsurg.2004.01.036; Kociol RD, 2013, AM HEART J; Kramer AA, 2013, CRIT CARE MED, V41, P24, DOI 10.1097/CCM.0b013e3182657b8a; Krumholz HM, 2013, JAMA-J AM MED ASSOC, V309, P587, DOI 10.1001/jama.2013.333; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Lambrinou E, 2012, INT J NURS STUD, V49, P610, DOI 10.1016/j.ijnurstu.2011.11.002; Lau ACW, 2001, RESP MED, V95, P876, DOI 10.1053/rmed.2001.1180; Lindenauer PK, 2011, J HOSP MED, V6, P142, DOI 10.1002/jhm.890; Luthi JC, 2003, INT J QUAL HEALTH C, V15, P413, DOI 10.1093/intqhc/mzg055; Luthi JC, 2004, QUAL SAF HEALTH CARE, V13, P46, DOI 10.1136/qshc.2003.006999; Maeda JLK, 2010, J CARD FAIL, V16, P411, DOI 10.1016/j.cardfail.2010.01.005; Mansi IA, 2010, J NATL MED ASSOC, V102, P898, DOI 10.1016/S0027-9684(15)30708-2; Marang-van de Mheen PJ, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2008.031690; Marcin JP, 2004, CRIT CARE MED, V32, P1477, DOI 10.1097/01.CCM.0000127781.08985.03; Mattke S., 2006, OECD HLTH WORKING PA; Maurer PP, 2004, SWISS MED WKLY, V134, P606; Mayer EK, 2011, BJU INT, V108, pE258, DOI 10.1111/j.1464-410X.2010.10010.x; McConnell KJ, 2013, JAMA INTERN MED, V173, P684, DOI 10.1001/jamainternmed.2013.3577; McCormack R, 2013, J HEALTHC MANAG, V58, P64, DOI 10.1097/00115514-201301000-00011; Mokhtar S. A., 2012, Eastern Mediterranean Health Journal, V18, P474; Morse RB, 2011, JAMA-J AM MED ASSOC, V306, P1454, DOI 10.1001/jama.2011.1385; Nathwani D, 2002, CLIN INFECT DIS, V34, P318, DOI 10.1086/323186; Parker JP, 2003, MED CARE, V41, P407, DOI 10.1097/00005650-200303000-00009; Patterson ME, 2010, MED CARE, V48, P210, DOI 10.1097/MLR.0b013e3181ca3eb4; Polanczyk CA, 2001, J CARD FAIL, V7, P289, DOI 10.1054/jcaf.2001.28931; Ricciardi MJ, 2012, AM J CARDIOL, V110, P1389, DOI 10.1016/j.amjcard.2012.07.002; Roccaforte R, 2005, EUR J HEART FAIL, V7, P1133, DOI 10.1016/j.ejheart.2005.08.005; Rochefort MM, 2012, SURG ONCOL CLIN N AM, V21, P397, DOI 10.1016/j.soc.2012.03.004; Rosen AK, 2013, MED CARE, V51, P37, DOI 10.1097/MLR.0b013e318270c0f7; Rumball-Smith J, 2009, NZ MED J, V122; Rumball-Smith J, 2013, MED CARE, V51, P418, DOI 10.1097/MLR.0b013e31828d1275; Schiotz M, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-347; Schneider EB, 2012, J AM COLL SURGEONS, V214, P390, DOI 10.1016/j.jamcollsurg.2011.12.025; Schopfer DW, 2012, AM HEART J, V164, P80, DOI 10.1016/j.ahj.2012.04.017; Sellers MM, 2013, J AM COLL SURGEONS, V216, P420, DOI 10.1016/j.jamcollsurg.2012.11.013; Shahian DM, 2012, BMJ QUAL SAF, V21, P325, DOI 10.1136/bmjqs-2011-000615; Shepperd S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000313.pub4; Showalter JW, 2011, J GEN INTERN MED, V26, P718, DOI 10.1007/s11606-011-1712-y; Shulan M, 2013, HEALTH CARE MANAG SC, V16, P167, DOI 10.1007/s10729-013-9220-8; Spector WD, 2012, MED CARE, V50, P863, DOI 10.1097/MLR.0b013e31825f2840; Stefan MS, 2012, J GEN INTERN MED, P1; Stukel TA, 2010, MED CARE, V48, P157, DOI 10.1097/MLR.0b013e3181bd4da7; Tsai TC, 2013, NEW ENGL J MED, V369, P1134, DOI 10.1056/NEJMsa1303118; van Walraven C, 2012, J EVAL CLIN PRACT, V18, P1211, DOI 10.1111/j.1365-2753.2011.01773.x; van Walraven C, 2012, CAN MED ASSOC J, V184, pE810, DOI 10.1503/cmaj.120801; van Walraven C, 2012, J CLIN EPIDEMIOL, V65, P1124, DOI 10.1016/j.jclinepi.2012.04.001; van Walraven C, 2011, CAN MED ASSOC J, V183, pE391, DOI 10.1503/cmaj.101860; VanSuch M, 2006, QUAL SAF HEALTH CARE, V15, P414, DOI 10.1136/qshc.2005.017640; Wallmann R, 2013, INT J CARDIOL, V164, P193, DOI 10.1016/j.ijcard.2011.06.119; Weber RS, 2010, ARCH OTOLARYNGOL, V136, P1212, DOI 10.1001/archoto.2010.215; Wong FKY, 2011, SOC SCI MED, V73, P960, DOI 10.1016/j.socscimed.2011.06.036; Youn YJ, 2012, CIRC J, V76, P1151, DOI 10.1253/circj.CJ-11-1093	114	145	145	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112282	10.1371/journal.pone.0112282	http://dx.doi.org/10.1371/journal.pone.0112282			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT3WF	25379675	gold, Green Published, Green Submitted			2022-12-27	WOS:000344863100073
J	Ishida, M; Shimabukuro, M; Yagi, S; Nishimoto, S; Kozuka, C; Fukuda, D; Soeki, T; Masuzaki, H; Tsutsui, M; Sata, M				Ishida, Masayoshi; Shimabukuro, Michio; Yagi, Shusuke; Nishimoto, Sachiko; Kozuka, Chisayo; Fukuda, Daiju; Soeki, Takeshi; Masuzaki, Hiroaki; Tsutsui, Masato; Sata, Masataka			MicroRNA-378 Regulates Adiponectin Expression in Adipose Tissue: A New Plausible Mechanism	PLOS ONE			English	Article							METABOLIC DISEASE; GENE-EXPRESSION; ADIPOGENESIS; INFLAMMATION; ADIPOCYTES; PATHWAY; TARGET; CELLS	Aims: Mechanisms regulating adiponectin expression have not been fully clarified. MicroRNAs (miRNAs), small non-coding RNAs that regulate gene expression, are involved in biological processes, including obesity and insulin resistance. We evaluated whether the miRNA-378 pathway is involved in regulating adiponectin expression. Methods and Results: First, we determined a putative target site for miRNA-378 in the 3 prime untranslated region (3'UTR) of the adiponectin gene by in silico analysis. The levels of adiponectin mRNA and protein were decreased in 3T3-L1 cells overexpressing the mimic of miRNA-378. Luminescence activity in HEK293T cells expressing a renilla-luciferase-adiponectin-3'UTR sequence was inhibited by overexpressing the mimic of miRNA-378, and the decrease was reversed by adding the inhibitor of miRNA-378. Moreover, we confirmed the inhibitory effects of the mimic were cancelled in a deleted mutant of the miR-378 3'-UTR binding site. Addition of tumor necrosis factor-alpha (TNF alpha) led a upregulation of miR-378 and downregulation of adiponectin at mRNA and protein levels in 3T3-L1 cells. Level of miR-378 was higher and mRNA level of adiponectin was lower in diabetic ob/ob mice than those of normal C57BL/6 mice and levels of miR378 and adiponectin were negatively well correlated (r = -0.624, p = 0.004). Conclusions: We found that levels of miRNA-378 could modulate adiponectin expression via the 3'UTR sequence-binding site. Our findings warrant further investigations into the role of miRNAs in regulating the adiponectin expression.	[Ishida, Masayoshi; Yagi, Shusuke; Soeki, Takeshi; Sata, Masataka] Univ Tokushima, Grad Sch Hlth Biosci, Dept Cardiovasc Med, Tokushima 770, Japan; [Shimabukuro, Michio; Fukuda, Daiju] Univ Tokushima, Grad Sch Hlth Biosci, Dept Cardio Diabet Med, Tokushima 770, Japan; [Nishimoto, Sachiko] Univ Tokushima, Grad Sch Hlth Biosci, Dept Nutr & Metab, Tokushima 770, Japan; [Ishida, Masayoshi; Tsutsui, Masato] Univ Ryukyus, Grad Sch Med, Dept Pharmacol, Okinawa, Japan; [Kozuka, Chisayo; Masuzaki, Hiroaki] Univ Ryukyus, Grad Sch Med, Dept Internal Med 2, Div Endocrinol Diabet & Metab Hematol & Rheumatol, Okinawa, Japan	Tokushima University; Tokushima University; Tokushima University; University of the Ryukyus; University of the Ryukyus	Shimabukuro, M (corresponding author), Univ Tokushima, Grad Sch Hlth Biosci, Dept Cardio Diabet Med, Tokushima 770, Japan.	mshimabukuro-ur@umin.ac.jp	Fukuda, Daiju/AAO-6752-2021	Shimabukuro, Michio/0000-0001-7835-7665; Kozuka, Chisayo/0000-0002-9567-8361	Program for Promotion of Basic and Applied Researches for Innovations in Bio-Oriented Industry; Ministry of Education, Culture, Sports, Science and Technology [23591314]; Ministry of Health, Labour and Welfare (MHLW), Japan; Grants-in-Aid for Scientific Research [24591338] Funding Source: KAKEN	Program for Promotion of Basic and Applied Researches for Innovations in Bio-Oriented Industry; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare (MHLW), Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Program for Promotion of Basic and Applied Researches for Innovations in Bio-Oriented Industry; the Ministry of Education, Culture, Sports, Science and Technology (#23591314); and the Ministry of Health, Labour and Welfare (MHLW), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carrer M, 2012, P NATL ACAD SCI USA, V109, P15330, DOI 10.1073/pnas.1207605109; Dusserre E, 2000, BBA-MOL BASIS DIS, V1500, P88, DOI 10.1016/S0925-4439(99)00091-5; Eichner LJ, 2010, CELL METAB, V12, P352, DOI 10.1016/j.cmet.2010.09.002; Engeli S, 2003, DIABETES, V52, P942, DOI 10.2337/diabetes.52.4.942; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gerin I, 2010, AM J PHYSIOL-ENDOC M, V299, pE198, DOI 10.1152/ajpendo.00179.2010; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hiuge-Shimizu A, 2011, ARTERIOSCL THROM VAS, V31, P792, DOI 10.1161/ATVBAHA.110.221747; Kadowaki T, 2011, COLD SH Q B, V76, P257, DOI 10.1101/sqb.2012.76.010587; Kang M, 2013, MOL BIOL REP, V40, P5027, DOI 10.1007/s11033-013-2603-6; Knezevic I, 2012, J BIOL CHEM, V287, P12913, DOI 10.1074/jbc.M111.331751; Li HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071568; Liu ML, 2010, BIOCHEM J, V425, P41, DOI 10.1042/BJ20091045; Matsuzawa Y, 2006, NAT CLIN PRACT CARD, V3, P35, DOI 10.1038/ncpcardio0380; Muller G, 2002, INSULIN TARGET CELLS; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Perrini S, 2008, DIABETOLOGIA, V51, P155, DOI 10.1007/s00125-007-0841-7; Phillips SA, 2010, CURR OPIN PHARMACOL, V10, P676, DOI 10.1016/j.coph.2010.08.002; Rantalainen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027338; Santovito D, 2014, J CLIN ENDOCR METAB, V99, pE1681, DOI 10.1210/jc.2013-3843; Shimabukuro M, 2003, J CLIN ENDOCR METAB, V88, P3236, DOI 10.1210/jc.2002-021883; Spiegelman BM, 2013, DIABETES, V62, P1774, DOI 10.2337/db12-1665; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299	23	36	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111537	10.1371/journal.pone.0111537	http://dx.doi.org/10.1371/journal.pone.0111537			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379946	Green Published, Green Submitted, gold			2022-12-27	WOS:000344863100032
J	Petrella, LN				Petrella, Lisa N.			Natural Variants of C. elegans Demonstrate Defects in Both Sperm Function and Oogenesis at Elevated Temperatures	PLOS ONE			English	Article							MALE-STERILITY; CAENORHABDITIS-ELEGANS; CANALIZATION; DROSOPHILA; SPERMATOGENESIS; FERTILITY; GENETICS; POPULATIONS; PGL-1	The temperature sensitivity of the germ line is conserved from nematodes to mammals. Previous studies in C. briggsae and Drosophila showed that isolates originating from temperate latitudes lose fertility at a lower temperature than strains originating from tropical latitudes. In order to investigate these relationships in C. elegans, analysis of the fertility of 22 different wild-type isolates of C. elegans isolated from equatorial, tropical and temperate regions was undertaken. It was found that there are significant temperature, genotype and temperature 6 genotype effects on fertility but region of isolation showed no significant effect on differences in fertility. For most isolates 100% of the population maintained fertility from 20 degrees C to 26 degrees C, but there was a precipitous drop in the percentage of fertile hermaphrodites at 27 degrees C. In contrast, all isolates show a progressive decrease in brood size as temperature increases from 20 degrees C to 26 degrees C, followed by a brood size near zero at 27 degrees C. Temperature shift experiments were performed to better understand the causes of high temperature loss of fertility. Males up-shifted to high temperature maintained fertility, while males raised at high temperature lost fertility. Down-shifting males raised at high temperature generally did not restore fertility. This result differs from that observed in Drosophila and suggested that in C. elegans spermatogenesis or sperm function is irreversibly impaired in males that develop at high temperature. Mating and down-shifting experiments with hermaphrodites were performed to investigate the relative contributions of spermatogenic and oogenic defects to high temperature loss of fertility. It was found that the hermaphrodites of all isolates demonstrated loss in both spermatogenic and oogenic germ lines that differed in their relative contribution by isolate. These studies uncovered unexpectedly high variation in both the loss of fertility and problems with oocyte function in natural variants of C. elegans at high temperature.	[Petrella, Lisa N.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Petrella, Lisa N.] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA	University of California System; University of California Santa Cruz; Marquette University	Petrella, LN (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	lisa.petrella@marquette.edu			National Institutes of Health [1K99GM098436-01]; University of California, Santa Cruz; Marquette University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM098436] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, Santa Cruz(University of California System); Marquette University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health 1K99GM098436-01 to LNP, by University of California, Santa Cruz and by start-up funds to LNP from Marquette University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen EC, 2012, NAT GENET, V44, P285, DOI 10.1038/ng.1050; Anderson JL, 2007, J EXP BIOL, V210, P3107, DOI 10.1242/jeb.007351; Araripe LO, 2004, J THERM BIOL, V29, P73, DOI 10.1016/j.jtherbio.2003.11.006; Bilgir C, 2013, G3-GENES GENOM GENET, V3, P585, DOI 10.1534/g3.112.005165; BRENNER S, 1974, GENETICS, V77, P71; Bronikowski A, 2010, INTEGR COMP BIOL, V50, P880, DOI 10.1093/icb/icq132; CAMERON RDA, 1980, J REPROD FERTIL, V59, P173, DOI 10.1530/jrf.0.0590173; Chakir M, 2002, GENETICA, V114, P195, DOI 10.1023/A:1015154329762; Chatterjee I, 2013, EXP GERONTOL, V48, P1156, DOI 10.1016/j.exger.2013.07.014; Chen J, 2006, EXP GERONTOL, V41, P1059, DOI 10.1016/j.exger.2006.07.005; Conine CC, 2010, P NATL ACAD SCI USA, V107, P3588, DOI 10.1073/pnas.0911685107; David JR, 2005, J EVOLUTION BIOL, V18, P838, DOI 10.1111/j.1420-9101.2005.00914.x; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; Dolgin ES, 2008, HEREDITY, V100, P304, DOI 10.1038/sj.hdy.6801079; Dworkin I, 2005, EVOLUTION, V59, P1500; Felix MA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-59; Gibson G, 2000, BIOESSAYS, V22, P372, DOI 10.1002/(SICI)1521-1878(200004)22:4<372::AID-BIES7>3.0.CO;2-J; Gupta Bhagwati P, 2007, WormBook, P1; Harvey SC, 2007, J EXP ZOOL PART B, V308B, P409, DOI 10.1002/jez.b.21161; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Kim B, 2013, CELL MOL LIFE SCI, V70, P2623, DOI 10.1007/s00018-012-1165-4; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; McMullen PD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002338; Prasad A, 2011, EVOLUTION, V65, P52, DOI 10.1111/j.1558-5646.2010.01110.x; Ramler D, 2014, J EVOLUTION BIOL, V27, P497, DOI 10.1111/jeb.12311; Rohmer C, 2004, J EXP BIOL, V207, P2735, DOI 10.1242/jeb.01087; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wang C, 2007, J CLIN ENDOCR METAB, V92, P3292, DOI 10.1210/jc.2007-0367; Wong KSK, 2006, CELL RES, V16, P742, DOI 10.1038/sj.cr.7310090; Yaeram J, 2006, REPROD FERT DEVELOP, V18, P647, DOI 10.1071/RD05022	32	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112377	10.1371/journal.pone.0112377	http://dx.doi.org/10.1371/journal.pone.0112377			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380048	gold, Green Published, Green Submitted			2022-12-27	WOS:000344863100078
J	Sun, JF; Ke, BX; Huang, YH; He, DM; Li, XC; Liang, ZM; Ke, CW				Sun, Jiufeng; Ke, Bixia; Huang, Yanhui; He, Dongmei; Li, Xiaocui; Liang, Zhaoming; Ke, Changwen			The Molecular Epidemiological Characteristics and Genetic Diversity of Salmonella Typhimurium in Guangdong, China, 2007-2011	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; FLUOROQUINOLONE SUSCEPTIBILITY; EVOLUTIONARY RELATIONSHIPS; NONTYPHOID SALMONELLA; ENTERICA; SURVEILLANCE; CIPROFLOXACIN; SEROTYPES; STRAINS	Background: Salmonella enterica serovar Typhimurium is the most important serovar associated with human salmonellosis worldwide. Here we aimed to explore the molecular epidemiology and genetic characteristics of this serovar in Guangdong, China. Methodology: We evaluated the molecular epidemiology and genetic characteristics of 294 endemic Salmonella Typhimurium clinical isolates which were collected from 1977 to 2011 in Guangdong, China, and compared them with a global set of isolates of this serovar using epidemiological data and Multilocus Sequence Typing (MLST) analysis. Principal Finding: The 294 isolates were assigned to 13 Sequencing types (STs) by MLST, of which ST34 and ST19 were the most common in Guangdong. All the STs were further assigned to two eBurst Groups, eBG1 and eBG138. The eBG1 was the major group endemic in Guangdong. Nucleotide and amino acid variability were comparable for all seven MLST loci. Tajima's D test suggested positive selection in hisD and thrA genes (p<0.01), but positive selection was rejected for the five other genes (p>0.05). In addition, The Tajima's D test within each eBG using the global set of isolates showed positive selection in eBG1 and eBG138 (p<0.05), but was rejected in eBG243 (p>0.05). We also analyzed the phylogenetic structure of Salmonella Typhimurium from worldwide sources and found that certain STs are geographically restricted. ACSSuT was the predominant multidrug resistance pattern for this serovar. The resistant profiles ACSSuTTmNaG, ACSSuTTmNa and ACSuTTmNaG seem to be specific for ST34, and ASSuTNa for ST19. Conclusion: Here we presented a genotypic characterization of Salmonella Typhimurium isolates using MLST and found two major STs are endemic in Guangdong. Our analyses indicate that genetic selection may have shaped the Salmonella Typhimurium populations. However, further evaluation with additional isolates from various sources will be essential to reveal the scope of the epidemiological characteristics of Salmonella Typhimurium in Guangdong, China.	[Sun, Jiufeng] Guangdong Prov Ctr Dis Control & Prevent, Guangdong Prov Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Ke, Bixia; He, Dongmei; Li, Xiaocui; Liang, Zhaoming; Ke, Changwen] Guangdong Prov Ctr Dis Control & Prevent, Inst Microbiol, Guangzhou, Guangdong, Peoples R China; [Huang, Yanhui] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China	Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Southern Medical University - China	Ke, CW (corresponding author), Guangdong Prov Ctr Dis Control & Prevent, Inst Microbiol, Guangzhou, Guangdong, Peoples R China.	kecw2011@sina.com	sun, Jiufeng/CAG-6546-2022	sun, jiufeng/0000-0003-1047-929X	China-U.S. Collaborative Program on Emerging and Re-Emerging Infectious Diseases and the Medical Scientific Research Foundation in Guangdong [1U2GGH000018-01]; 12th five-year-major-projects of China's Ministry of Public Health [2012zx10004-213]; Science and Technology Planning Project of Guangdong Province Program [2012B060400012, 2013B060400012]	China-U.S. Collaborative Program on Emerging and Re-Emerging Infectious Diseases and the Medical Scientific Research Foundation in Guangdong; 12th five-year-major-projects of China's Ministry of Public Health; Science and Technology Planning Project of Guangdong Province Program	This project was supported by the China-U.S. Collaborative Program on Emerging and Re-Emerging Infectious Diseases and the Medical Scientific Research Foundation in Guangdong (1U2GGH000018-01), the 12th five-year-major-projects of China's Ministry of Public Health (2012zx10004-213), and Science and Technology Planning Project of Guangdong Province Program (2012B060400012; 2013B060400012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; Centers for Disease Control and Prevention, 2012, TRENDS FOODB ILLN US; CLSI, 2012, PERF STAND ANT SUSC; Cui SH, 2008, EMERG INFECT DIS, V14, P493, DOI 10.3201/eid1403.070857; Deng XL, 2012, FOODBORNE PATHOG DIS, V9, P305, DOI 10.1089/fpd.2011.1008; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Galanis E, 2006, EMERG INFECT DIS, V12, P381, DOI 10.3201/eid1203.050854; Godoy D, 2003, J CLIN MICROBIOL, V41, P2068, DOI 10.1128/JCM.41.5.2068-2079.2003; Gonzalez-Escalona N, 2008, J BACTERIOL, V190, P2831, DOI 10.1128/JB.01808-07; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; Hakanen A, 2001, EMERG INFECT DIS, V7, P996, DOI 10.3201/eid0706.010613; Harbottle H, 2006, J CLIN MICROBIOL, V44, P2449, DOI 10.1128/JCM.00019-06; He Dong-mei, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P424; Herikstad H, 2002, EPIDEMIOL INFECT, V129, P1, DOI 10.1017/S0950268802006842; Hu HH, 2006, GENETICS, V172, P743, DOI 10.1534/genetics.105.046466; Ke Bi-xia, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P789; Ke Bi-xia, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P1199; Ke BX, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-338; Lacher DW, 2007, J BACTERIOL, V189, P342, DOI 10.1128/JB.01472-06; Lee HY, 2009, ANTIMICROB AGENTS CH, V53, P2696, DOI 10.1128/AAC.01297-08; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lunguya O, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002103; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Mather AE, 2013, SCIENCE, V341, P1514, DOI 10.1126/science.1240578; Olsen SJ, 2001, J INFECT DIS, V183, P753, DOI 10.1086/318832; Sangal V, 2010, J BACTERIOL, V192, P6465, DOI 10.1128/JB.00969-10; Sukhnanand S, 2005, J CLIN MICROBIOL, V43, P3688, DOI 10.1128/JCM.43.8.3688-3698.2005; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tankouo-Sandjong B, 2007, J MICROBIOL METH, V69, P23, DOI 10.1016/j.mimet.2006.11.013; THAMPAPILLAI G, 1994, MOL BIOL EVOL, V11, P813; Torpdahl M, 2013, INT J FOOD MICROBIOL, V161, P69, DOI 10.1016/j.ijfoodmicro.2012.11.022; Wong MHY, 2013, ANTIMICROB AGENTS CH, V57, P4599, DOI 10.1128/AAC.01174-13; Xia SL, 2009, J CLIN MICROBIOL, V47, P401, DOI 10.1128/JCM.01099-08; Zhou ZM, 2014, P NATL ACAD SCI USA, V111, P12199, DOI 10.1073/pnas.1411012111; Zhou ZM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003471	39	21	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e113145	10.1371/journal.pone.0113145	http://dx.doi.org/10.1371/journal.pone.0113145			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380053	Green Published, Green Submitted, gold			2022-12-27	WOS:000344863100114
J	Thompson, IJT; Mann, ER; Stokes, MG; English, NR; Knight, SC; Williamson, D				Thompson, Iain J. T.; Mann, Elizabeth R.; Stokes, Margaret G.; English, Nicholas R.; Knight, Stella C.; Williamson, Diane			Specific Activation of Dendritic Cells Enhances Clearance of Bacillus anthracis following Infection	PLOS ONE			English	Article							MOUSE BONE-MARROW; VACCINE; IMMUNIZATION; PROTECTION; IMMUNITY; STRAIN; MICE	Dendritic cells are potent activators of the immune system and have a key role in linking innate and adaptive immune responses. In the current study we have used ex vivo pulsed bone marrow dendritic cells (BMDC) in a novel adoptive transfer strategy to protect against challenge with Bacillus anthracis, in a murine model. Pre-pulsing murine BMDC with either recombinant Protective Antigen (PA) or CpG significantly upregulated expression of the activation markers CD40, CD80, CD86 and MHC-II. Passive transfusion of mice with pulsed BMDC, concurrently with active immunisation with rPA in alum, significantly enhanced (p<0.001) PA-specific splenocyte responses seven days post-immunisation. Parallel studies using ex vivo DCs expanded from human peripheral blood and activated under the same conditions as the murine DC, demonstrated that human DCs had a PA dose-related significant increase in the markers CD40, CD80 and CCR7 and that the increases in CD40 and CD80 were maintained when the other activating components, CpG and HK B. anthracis were added to the rPA in culture. Mice vaccinated on a single occasion intra-muscularly with rPA and alum and concurrently transfused intra-dermally with pulsed BMDC, demonstrated 100% survival following lethal B. anthracis challenge and had significantly enhanced (p<0.05) bacterial clearance within 2 days, compared with mice vaccinated with rPA and alum alone.	[Thompson, Iain J. T.; Stokes, Margaret G.; Williamson, Diane] Def Sci & Technol Lab, Dept Biomed Sci, Salisbury SP4 0JQ, Wilts, England; [Mann, Elizabeth R.; English, Nicholas R.; Knight, Stella C.] Imperial Coll London, Antigen Presentat Res Grp, Harrow HA1 3UJ, Middx, England	Defence Science & Technology Laboratory; Imperial College London	Williamson, D (corresponding author), Def Sci & Technol Lab, Dept Biomed Sci, Salisbury SP4 0JQ, Wilts, England.	dewilliamson@dstl.gov.uk	Williamson, Ethel Diane/AAQ-8878-2020		United States Army Research Office; Defense Advanced Research Projects Agency (DARPA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007632] Funding Source: NIH RePORTER	United States Army Research Office; Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the United States Army Research Office and the Defense Advanced Research Projects Agency (DARPA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Do Y, 2010, EUR J IMMUNOL, V40, P2791, DOI 10.1002/eji.201040511; Elvin SJ, 2006, INFECT IMMUN, V74, P1706, DOI 10.1128/IAI.74.3.1706-1711.2006; Flick-Smith HC, 2005, MICROB PATHOGENESIS, V38, P33, DOI 10.1016/j.micpath.2004.10.007; Healey GD, 2005, INFECT IMMUN, V73, P5945, DOI 10.1128/IAI.73.9.5945-5951.2005; Holden NJ, 2008, CLIN EXP ALLERGY, V38, P1148, DOI 10.1111/j.1365-2222.2008.02997.x; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; IVINS BE, 1992, INFECT IMMUN, V60, P662, DOI 10.1128/IAI.60.2.662-668.1992; IVINS BE, 1988, EUR J EPIDEMIOL, V4, P12, DOI 10.1007/BF00152686; KNIGHT SC, 1986, IMMUNOLOGY, V57, P595; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; Okinaka R, 1999, J APPL MICROBIOL, V87, P261, DOI 10.1046/j.1365-2672.1999.00883.x; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Reuveny S, 2001, INFECT IMMUN, V69, P2888, DOI 10.1128/IAI.69.5.2888-2893.2001; TURNBULL PCB, 1991, VACCINE, V9, P533, DOI 10.1016/0264-410X(91)90237-Z; Welkos S, 2001, MICROBIOL-SGM, V147, P1677, DOI 10.1099/00221287-147-6-1677; WELKOS SL, 1988, MICROB PATHOGENESIS, V4, P53, DOI 10.1016/0882-4010(88)90048-4; WELKOS SL, 1986, INFECT IMMUN, V51, P795, DOI 10.1128/IAI.51.3.795-800.1986	20	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e109720	10.1371/journal.pone.0109720	http://dx.doi.org/10.1371/journal.pone.0109720			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380285	Green Published, Green Submitted, gold			2022-12-27	WOS:000344863100009
J	Yan, N; Yu, SZ; Hou, TS; Gu, GF; Zhang, HL; Zhao, S; He, SS				Yan, Ning; Yu, Shunzhi; Hou, Tiesheng; Gu, Guangfei; Zhang, Hailong; Zhao, Shan; He, Shisheng			Cervical Spondylotic Myelopathy Caused by Single-Level Vertebral Spontaneous Fusion	PLOS ONE			English	Article							ADJACENT SEGMENT DISEASE; LAMINOPLASTY; SPINE	Purpose: To evaluate the clinical features, imaging characteristics, surgical options, and clinical outcomes of patients with Cervical spondylotic myelopathy (CSM) caused by single-level vertebral spontaneous fusion (SLVSF). Methods: Sixteen consecutive patients with SLVSF who underwent anterior surgery were included in this study and 38 patients with CSM caused by spinal degeneration were enrolled as a control group. Demographic features, clinical presentations, imaging characteristics, surgery strategy, Nurick grade, Japanese Orthopedic Association (JOA) score, neck disability index (NDI), and complications were evaluated. Results: There were significant differences between the two groups in the mean age and the average duration of neck pain. There was no significant difference between the two groups in length of cervical spine. In the SLVSF group, 13 patients had upper segment translational instability and none had rotational instability. Pre- and postoperative Nurick grades were 2.94 +/- 0.77 and 2.19 +/- 0.54 in the SLVSF group, and 2.97 +/- 0.72 and 2.16 +/- 0.64 in the control group. Pre- and postoperative JOA scores were 9.25 +/- 2.02 and 11.69 +/- 1.62 in the SLVSF group, and 9.87 +/- 2.58 and 12.53 +/- 2.69 in the control group. Pre- and postoperative NDI values were 28.5 +/- 7.75 and 15.56 +/- 5.51 in the SLVSF group, and 16 +/- 6.13 and 11.29 +/- 4.58 in the control group. Conclusions: Patients with SLVSF have necks of normal lengths, which can be used to distinguish this disorder from Klippel-Feil syndrome. There are three main features of SLVSF: (1) hypoplasia at both of the spontaneously fused vertebral bodies; (2) a major pathological feature of translational instability of the upper vertebra to the fused level; and (3) severe neck pain. Anterior surgery has a good therapeutic effect for patients with cervical SLVSF.	[Yan, Ning; Yu, Shunzhi; Hou, Tiesheng; Gu, Guangfei; Zhang, Hailong; Zhao, Shan; He, Shisheng] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Orthoped Surg, Shanghai 200092, Peoples R China	Tongji University	Hou, TS (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Orthoped Surg, Shanghai 200092, Peoples R China.	itslxd@163.com						Bydon M, 2014, NEUROSURGERY, V74, P139, DOI 10.1227/NEU.0000000000000204; CHANDRARAJ S, 1987, J ANAT, V153, P55; Eubanks JD, 2013, ORTHOPEDICS, V36, pE1251, DOI 10.3928/01477447-20130920-15; Gilbert-Barness E, 2005, FETAL PEDIATR PATHOL, V24, P331, DOI 10.1080/15227950500503744; GRAY SW, 1964, SURG GYNECOL OBSTET, V118, P373; GUNDERSON CH, 1967, MEDICINE, V46, P491, DOI 10.1097/00005792-196711000-00003; Hashimoto M, 2010, EUR SPINE J, V19, P1702, DOI 10.1007/s00586-010-1427-5; Hirabayashi K, 1999, CLIN ORTHOP RELAT R, P35; Patil SJ, 2009, INDIAN J PEDIATR, V76, P417, DOI 10.1007/s12098-009-0017-1; RChappell BW, 1988, RADIOLOGY, V167, P282; Samartzis D, 2006, SPINE, V31, pE798, DOI 10.1097/01.brs.0000239222.36505.46; Toledano M, 2013, NEUROL CLIN, V31, P287, DOI 10.1016/j.ncl.2012.09.003; TORG JS, 1986, J BONE JOINT SURG AM, V68A, P1354, DOI 10.2106/00004623-198668090-00008; Tsuzuki N, 1993, Eur Spine J, V2, P197, DOI 10.1007/BF00299446; Wang SJ, 2011, EUR SPINE J, V20, P185, DOI 10.1007/s00586-010-1600-x; WHITE AA, 1975, CLIN ORTHOP RELAT R, P85, DOI 10.1097/00003086-197506000-00011; Yoshida M, 2002, SPINE, V27, P1414, DOI 10.1097/00007632-200207010-00008	17	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112423	10.1371/journal.pone.0112423	http://dx.doi.org/10.1371/journal.pone.0112423			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380388	Green Published, Green Submitted, gold			2022-12-27	WOS:000344863100089
J	Chen, SL; Shao, CH; Dong, TF; Chai, H; Xiong, XK; Sun, DY; Zhang, L; Yu, Y; Wang, P; Cheng, F				Chen, Shenglin; Shao, Cunhua; Dong, Tianfu; Chai, Hao; Xiong, Xinkui; Sun, Daoyi; Zhang, Long; Yu, Yue; Wang, Ping; Cheng, Feng			Transplantation of ATP7B-Transduced Bone Marrow Mesenchymal Stem Cells Decreases Copper Overload in Rats	PLOS ONE			English	Article							EVANS CINNAMON RATS; WILSONS-DISEASE; LIVER-TRANSPLANTATION; LENTIVIRAL VECTORS; ANIMAL-MODEL; LEC RAT; GROWTH-FACTOR; GENE-TRANSFER; HEPATOCYTES; DIFFERENTIATION	Background: Recent studies have demonstrated that transplantation of ATP7B-transduced hepatocytes ameliorates disease progression in LEC (Long-Evans Cinnamon) rats, a model of Wilson's disease (WD). However, the inability of transplanted cells to proliferate in a normal liver hampers long-term treatment. In the current study, we investigated whether transplantation of ATP7B-transduced bone marrow mesenchymal stem cells (BM-MSCs) could decrease copper overload in LEC rats. Materials and Methods: The livers of LEC rats were preconditioned with radiation (RT) and/or ischemia-reperfusion (IRP) before portal vein infusion of ATP7B-transduced MSCs (MSCsATP7B). The volumes of MSCsATP7B or saline injected as controls were identical. The expression of ATP7B was analyzed by real-time quantitative polymerase chain reaction (RT-PCR) at 4, 12 and 24 weeks post-transplantation. MSCATP7B repopulation, liver copper concentrations, serum ceruloplasmin levels, and alanine transaminase (ALT) and aspartate transaminase (AST) levels were also analyzed at each time-point post-transplantation. Results: IRP-plus-RT preconditioning was the most effective strategy for enhancing the engraftment and repopulation of transplanted MSCsATP7B. This strategy resulted in higher ATP7B expression and serum ceruloplasmin, and lower copper concentration in this doubly preconditioned group compared with the saline control group, the IRP group, and the RT group at all three time-points post-transplantation (p<0.05 for all). Moreover, 24 weeks post-transplantation, the levels of ALT and AST in the IRP group, the RT group, and the IRP-plus-RT group were all significantly decreased compared to those of the saline group (p<0.05 compared with the IRP group and RT group, p<0.01 compared with IRP-plus-RT group); ALT and AST levels were significantly lower in the IRP-plus-RT group compared to either the IRP group or the RT group (p<0.01 and p<0.05. respectively). Conclusions: These results demonstrate that transplantation of MSCsATP7B into IRP-plus-RT preconditioned LEC rats decreased copper overload and was associated with an increase in MSC engraftment and repopulation.	[Chen, Shenglin] Affiliated Wuhu 2 Peoples Hosp, Wannan Med Coll, Dept Hepatobiliary Surg Ward Gen Surg, Wuhu, Anhui, Peoples R China; [Shao, Cunhua] Dongying Peoples Hosp, Dept Hepatobiliary Surg, Dongying, Shandong, Peoples R China; [Dong, Tianfu; Chai, Hao; Xiong, Xinkui; Sun, Daoyi; Zhang, Long; Yu, Yue; Wang, Ping; Cheng, Feng] Nanjing Med Univ, Affiliated Hosp 1, Liver Transplantat Ctr, Nanjing, Jiangsu, Peoples R China; [Dong, Tianfu; Chai, Hao; Xiong, Xinkui; Sun, Daoyi; Zhang, Long; Yu, Yue; Wang, Ping; Cheng, Feng] Minist Publ Hlth, Key Lab Living Donor Liver Transplantat, Nanjing, Jiangsu, Peoples R China	Wannan Medical College; Nanjing Medical University	Wang, P (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Liver Transplantat Ctr, Nanjing, Jiangsu, Peoples R China.	wuwpzhy@163.com; docchengfeng@njmu.edu.cn			National Natural Science Foundation of China [81070324]; Research Foundation of the Department of Health of Jiangsu Province [200906, H201102]; "Summit of the Six Top Talents'' Program of Jiangsu Province [2009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Foundation of the Department of Health of Jiangsu Province; "Summit of the Six Top Talents'' Program of Jiangsu Province	This study was financially supported, in part, by the National Natural Science Foundation of China (Grant No. 81070324), the Research Foundation of the Department of Health of Jiangsu Province (Grant No. 200906, H201102) and "Summit of the Six Top Talents'' Program of Jiangsu Province (Grant No. 2009). All fundings mentioned above were received by Feng Cheng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2008, GENE THER, V15, P109, DOI 10.1038/sj.gt.3303067; Aurich I, 2007, GUT, V56, P405, DOI 10.1136/gut.2005.090050; Baccarani U, 2006, GROWTH FACTORS, V24, P107, DOI 10.1080/08977190600560636; Bartee MY, 2007, BIOMETALS, V20, P627, DOI 10.1007/s10534-006-9074-3; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bruder SP, 1998, CLIN ORTHOP RELAT R, pS247; Buchschacher GL, 2000, BLOOD, V95, P2499; Chen X, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-75; Enns GM, 2008, MOL GENET METAB, V95, P3, DOI 10.1016/j.ymgme.2008.06.001; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; FREDERIKS WM, 1982, EXP PATHOL-JENA, V22, P245, DOI 10.1016/S0232-1513(82)80015-7; Gao Y, 2010, ONCOGENE, V29, P2784, DOI 10.1038/onc.2010.38; Gollan John L., 1998, Journal of Hepatology, V28, P28, DOI 10.1016/S0168-8278(98)80373-5; Irani AN, 2001, MOL THER, V3, P302, DOI 10.1006/mthe.2001.0271; Kobayashi T, 2008, ARTHROSCOPY, V24, P69, DOI 10.1016/j.arthro.2007.08.017; Lemoli RM, 2006, STEM CELLS, V24, P2817, DOI 10.1634/stemcells.2006-0333; Malhi H, 2002, P NATL ACAD SCI USA, V99, P13114, DOI 10.1073/pnas.192365499; Malhi H, 2008, REGEN MED, V3, P165, DOI 10.2217/17460751.3.2.165; Medici V, 2005, LIVER TRANSPLANT, V11, P1056, DOI 10.1002/lt.20486; Meng Y, 2004, BBA-MOL BASIS DIS, V1690, P208, DOI 10.1016/j.bbadis.2004.06.022; Merle U, 2006, SCAND J GASTROENTERO, V41, P974, DOI 10.1080/00365520600554790; MURAMATSU Y, 1995, RES COMMUN MOL PATH, V89, P421; Murphy JM, 2002, ARTHRITIS RHEUM-US, V46, P704, DOI 10.1002/art.10118; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nussler A, 2006, J HEPATOL, V45, P144, DOI 10.1016/j.jhep.2006.04.002; Park SM, 2006, CELL TRANSPLANT, V15, P13, DOI 10.3727/000000006783982188; Pasha Z, 2008, CARDIOVASC RES, V77, P134, DOI 10.1093/cvr/cvm025; POLSON RJ, 1987, Q J MED, V64, P685; Sakai H, 2011, J VET MED SCI, V73, P299, DOI 10.1292/jvms.10-0256; Sato Y, 2005, BLOOD, V106, P756, DOI 10.1182/blood-2005-02-0572; Sauer V, 2012, LIVER TRANSPLANT, V18, P248, DOI 10.1002/lt.22466; Sauer V, 2010, BIOCHEM BIOPH RES CO, V395, P307, DOI 10.1016/j.bbrc.2010.03.158; SCHEINBERG IH, 1981, J RHEUMATOL, V8, P90; Shao CH, 2014, J SURG RES, V186, P408, DOI 10.1016/j.jss.2013.08.016; Solaiman F, 2000, MOL REPROD DEV, V56, P309, DOI 10.1002/(SICI)1098-2795(200006)56:2+&lt;309::AID-MRD22&gt;3.0.CO;2-Y; Terada K, 1998, J BIOL CHEM, V273, P1815, DOI 10.1074/jbc.273.3.1815; Wang N, 2008, INT J BIOCHEM CELL B, V40, P294, DOI 10.1016/j.biocel.2007.08.003; Wang X, 2002, AM J PATHOL, V161, P565, DOI 10.1016/S0002-9440(10)64212-5; Wertheim JA, 2011, AM J TRANSPLANT, V11, P1773, DOI 10.1111/j.1600-6143.2011.03587.x; WU JS, 1994, NAT GENET, V7, P541, DOI 10.1038/ng0894-541; Yagi K, 2008, YAKUGAKU ZASSHI, V128, P3, DOI 10.1248/yakushi.128.3; YAMAMOTO F, 1993, JPN J CANCER RES, V84, P508, DOI 10.1111/j.1349-7006.1993.tb00168.x; Yoshida Y, 1996, GASTROENTEROLOGY, V111, P1654, DOI 10.1016/S0016-5085(96)70029-X; Yu XB, 2003, MOL THER, V7, P827, DOI 10.1016/S1525-0016(03)00104-7; Yu Y, 2010, STEM CELLS DEV, V19, P903, DOI 10.1089/scd.2009.0254; Zhang H, 2012, ASIAN PAC J CANCER P, V13, P5799, DOI 10.7314/APJCP.2012.13.11.5799	46	7	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111425	10.1371/journal.pone.0111425	http://dx.doi.org/10.1371/journal.pone.0111425			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375371	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600039
J	Golden, S; Dukas, R				Golden, Shane; Dukas, Reuven			The Value of Patch-Choice Copying in Fruit Flies	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; MATE-CHOICE; SOCIAL INFORMATION; SEXUAL SELECTION; SITE SELECTION; BARK BEETLES; COLONIZATION BEHAVIOR; AGGREGATION PHEROMONE; POSTHARVEST DISEASES; SPATIAL AGGREGATION	Many animals copy the choices of others but the functional and mechanistic explanations for copying are still not fully resolved. We relied on novel behavioral protocols to quantify the value of patch-choice copying in fruit flies. In a titration experiment, we quantified how much nutritional value females were willing to trade for laying eggs on patches already occupied by larvae (social patches). Females were highly sensitive to nutritional quality, which was positively associated with their offspring success. Females, however, perceived social, low-nutrition patches (33% of the nutrients) as equally valuable as non-social, high-nutrition ones (100% of the nutrients). In follow-up experiments, we could not, however, either find informational benefits from copying others or detect what females' offspring may gain from developing with older larvae. Because patch-choice copying in fruit flies is a robust phenomenon in spite of potential costs due to competition, we suggest that it is beneficial in natural settings, where fruit flies encounter complex dynamics of microbial communities, which include, in addition to the preferred yeast species they feed on, numerous harmful fungi and bacteria. We suggest that microbial ecology underlies many cases of copying in nature.	[Golden, Shane; Dukas, Reuven] McMaster Univ, Dept Psychol Neurosci & Behav, Anim Behav Grp, Hamilton, ON, Canada	McMaster University	Dukas, R (corresponding author), McMaster Univ, Dept Psychol Neurosci & Behav, Anim Behav Grp, Hamilton, ON, Canada.	dukas@mcmaster.ca			Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; Ontario Innovation Trust	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Innovation Trust	This research has been funded by the Natural Sciences and Engineering Research Council of Canada, Canada Foundation for Innovation, and Ontario Innovation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AF, 2001, BEHAV ECOL SOCIOBIOL, V51, P33, DOI 10.1007/s002650100401; Allee W.C, 1931, ANIMAL AGGREGATION S; Alonzo SH, 2008, ANIM BEHAV, V75, P1715, DOI 10.1016/j.anbehav.2007.09.031; Arndt C, 1999, MICROBIOL-SGM, V145, P1989, DOI 10.1099/13500872-145-8-1989; ARNOLD W, 1988, J COMP PHYSIOL B, V158, P151, DOI 10.1007/BF01075828; Ashburner M., 1989, DROSOPHILA LAB HDB; ATKINSON WD, 1979, J ANIM ECOL, V48, P91, DOI 10.2307/4102; BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Battesti M, 2012, CURR BIOL, V22, P309, DOI 10.1016/j.cub.2011.12.050; Beauchamp G., 2014, SOCIAL PREDATION GRO; Becher PG, 2012, FUNCT ECOL, V26, P822, DOI 10.1111/j.1365-2435.2012.02006.x; BEGON M, 1982, GENET BIOL DROSOPHIL, P345; Betts MG, 2008, P ROY SOC B-BIOL SCI, V275, P2257, DOI 10.1098/rspb.2008.0217; Bodenstein D., 1950, BIOL DROSOPHILA, P275; BRIEGER G, 1970, Science (Washington D C), V167, P1262, DOI 10.1126/science.167.3922.1262; Burke CJ, 2011, CURR BIOL, V21, P746, DOI 10.1016/j.cub.2011.03.032; Carton Y., 1986, P347; Crowley S, 2012, J APPL MICROBIOL, V113, P1417, DOI 10.1111/jam.12012; Danchin E, 1997, TRENDS ECOL EVOL, V12, P342, DOI 10.1016/S0169-5347(97)01124-5; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Demain AL, 2000, ADV BIOCHEM ENG BIOT, V69, P1; DUGATKIN LA, 1992, AM NAT, V139, P1384, DOI 10.1086/285392; Dukas R, 2012, ANIM BEHAV, V84, P1427, DOI 10.1016/j.anbehav.2012.09.010; Durisko Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095495; Durisko Z, 2014, J EXP BIOL, V217, P1193, DOI 10.1242/jeb.097683; Durisko Z, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1398; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Fletcher RJ, 2008, BIOL LETTERS, V4, P482, DOI 10.1098/rsbl.2008.0306; Fleury F, 2004, GENETICA, V120, P181, DOI 10.1023/B:GENE.0000017640.78087.9e; Galef BG, 1998, ANIM BEHAV, V55, P545, DOI 10.1006/anbe.1997.0616; GRIMALDI D, 1984, ECOLOGY, V65, P1113, DOI 10.2307/1938319; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; IBMCorp, 2011, IBM SPSS STAT WIND V; Janisiewicz WJ, 2002, ANNU REV PHYTOPATHOL, V40, P411, DOI 10.1146/annurev.phyto.40.120401.130158; JANZEN DH, 1977, AM NAT, V111, P691, DOI 10.1086/283200; Kacsoh BZ, 2013, SCIENCE, V339, P947, DOI 10.1126/science.1229625; Keleman K, 2012, NATURE, V489, P145, DOI 10.1038/nature11345; KIRKPATRICK M, 1994, BEHAV ECOL SOCIOBIOL, V34, P443; KREBS JR, 1973, CAN J ZOOL, V51, P1275, DOI 10.1139/z73-181; Krijger CL, 2001, ECOL LETT, V4, P106, DOI 10.1046/j.1461-0248.2001.00200.x; Lacey LA, 2008, ANNU REV ENTOMOL, V53, P121, DOI 10.1146/annurev.ento.53.103106.093419; Masek P, 2010, P NATL ACAD SCI USA, V107, P14833, DOI 10.1073/pnas.1009318107; Mauch A, 2010, INT J FOOD MICROBIOL, V141, P116, DOI 10.1016/j.ijfoodmicro.2010.05.002; Paine TD, 1997, ANNU REV ENTOMOL, V42, P179, DOI 10.1146/annurev.ento.42.1.179; Prokopy RJ, 2001, ANNU REV ENTOMOL, V46, P631, DOI 10.1146/annurev.ento.46.1.631; Pulliam HR., 1984, BEHAVIOURAL ECOLOGY, P122; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; RAFFA KF, 1983, ECOL MONOGR, V53, P27, DOI 10.2307/1942586; Raitanen J, 2014, BEHAV ECOL, V25, P110, DOI 10.1093/beheco/art092; Roberts D. B., 1998, DROSOPHILA PRACTICAL; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Rohlfs M, 2005, MYCOLOGIA, V97, P996, DOI 10.3852/mycologia.97.5.996; Rohlfs M, 2005, ECOL ENTOMOL, V30, P556, DOI 10.1111/j.0307-6946.2005.00722.x; Rohlfs M, 2004, OECOLOGIA, V140, P654, DOI 10.1007/s00442-004-1629-9; Sarin S, 2009, P ROY SOC B-BIOL SCI, V276, P4323, DOI 10.1098/rspb.2009.1294; Schnurer J, 2005, TRENDS FOOD SCI TECH, V16, P70, DOI 10.1016/j.tifs.2004.02.014; Schwarz S, 2014, NATURWISSENSCHAFTEN, V101, P61, DOI 10.1007/s00114-013-1129-z; Sharma RR, 2009, BIOL CONTROL, V50, P205, DOI 10.1016/j.biocontrol.2009.05.001; SHORROCKS B, 1995, P ROY SOC B-BIOL SCI, V260, P305, DOI 10.1098/rspb.1995.0096; Sokolowski MB, 2010, NEURON, V65, P780, DOI 10.1016/j.neuron.2010.03.007; Stafford JW, 2012, J NEUROSCI, V32, P14767, DOI 10.1523/JNEUROSCI.1887-12.2012; STAMPS JA, 1987, AM NAT, V129, P629, DOI 10.1086/284663; Stamps JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042238; Stensmyr MC, 2012, CELL, V151, P1345, DOI 10.1016/j.cell.2012.09.046; Stokl J, 2010, CURR BIOL, V20, P1846, DOI 10.1016/j.cub.2010.09.033; Thorpe W, 1963, LEARNING INSTINCT AN, P56; Valone TJ, 2002, PHILOS T R SOC B, V357, P1549, DOI 10.1098/rstb.2002.1064; Venu I, 2014, J EXP BIOL, V217, P1346, DOI 10.1242/jeb.099648; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; WADE MJ, 1990, P NATL ACAD SCI USA, V87, P5749, DOI 10.1073/pnas.87.15.5749; WAITE RK, 1981, Z TIERPSYCHOL, V57, P15; Wertheim B, 2005, ANNU REV ENTOMOL, V50, P321, DOI 10.1146/annurev.ento.49.061802.123329; Wertheim B, 2002, ENTOMOL EXP APPL, V103, P61, DOI 10.1023/A:1019832101537; Wertheim B, 2002, ECOL ENTOMOL, V27, P608, DOI 10.1046/j.1365-2311.2002.00449.x; Willis CKR, 2007, BEHAV ECOL SOCIOBIOL, V62, P97, DOI 10.1007/s00265-007-0442-y; WOOD DL, 1982, ANNU REV ENTOMOL, V27, P411, DOI 10.1146/annurev.en.27.010182.002211; Yang CH, 2008, SCIENCE, V319, P1679, DOI 10.1126/science.1151842; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001	78	9	9	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112381	10.1371/journal.pone.0112381	http://dx.doi.org/10.1371/journal.pone.0112381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375776	gold, Green Submitted, Green Published			2022-12-27	WOS:000344402600140
J	Koltsova, SV; Shilov, B; Birulina, JG; Akimova, OA; Haloui, M; Kapilevich, LV; Gusakova, SV; Tremblay, J; Hamet, P; Orlov, SN				Koltsova, Svetlana V.; Shilov, Boris; Birulina, Julia G.; Akimova, Olga A.; Haloui, Mounsif; Kapilevich, Leonid V.; Gusakova, Svetlana V.; Tremblay, Johanne; Hamet, Pavel; Orlov, Sergei N.			Transcriptomic Changes Triggered by Hypoxia: Evidence for HIF-1 alpha -Independent, [Na+](i)/[K+](i)-Mediated, Excitation-Transcription Coupling	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; ENDOTHELIAL GROWTH-FACTOR; INDUCIBLE FACTOR; GENE-EXPRESSION; CARDIAC-GLYCOSIDES; CELL; CALCIUM; RECEPTOR; SODIUM; IDENTIFICATION	This study examines the relative impact of canonical hypoxia-inducible factor-1alpha-(HIF-1 alpha and Na-i(+)/K-i(+)-mediated signaling on transcriptomic changes evoked by hypoxia and glucose deprivation. Incubation of RASMC in ischemic conditions resulted in similar to 3-fold elevation of [Na+](i) and 2-fold reduction of [K+](i). Using global gene expression profiling we found that Na+, K+-ATPase inhibition by ouabain or K+-free medium in rat aortic vascular smooth muscle cells (RASMC) led to the differential expression of dozens of genes whose altered expression was previously detected in cells subjected to hypoxia and ischemia/reperfusion. For further investigations, we selected Cyp1a1, Fos, Atf3, Klf10, Ptgs2, Nr4a1, Per2 and Hes1, i. e. genes possessing the highest increments of expression under sustained Na+, K+-ATPase inhibition and whose implication in the pathogenesis of hypoxia was proved in previous studies. In ouabain-treated RASMC, low-Na+, high-K+ medium abolished amplification of the [Na+](i)/[K+](i) ratio as well as the increased expression of all tested genes. In cells subjected to hypoxia and glucose deprivation, dissipation of the transmembrane gradient of Na+ and K+ completely eliminated increment of Fos, Atf3, Ptgs2 and Per2 mRNAs and sharply diminished augmentation expression of Klf10, Edn1, Nr4a1 and Hes1. In contrast to low-Na+, high-K+ medium, RASMC transfection with Hif-1a siRNA attenuated increments of Vegfa, Edn1, Klf10 and Nr4a1 mRNAs triggered by hypoxia but did not impact Fos, Atf3, Ptgs2 and Per2 expression. Thus, our investigation demonstrates, for the first time, that Na-i(+)/K-i(+)-mediated, Hif-1 alpha-independent excitation-transcription coupling contributes to transcriptomic changes evoked in RASMC by hypoxia and glucose deprivation.	[Koltsova, Svetlana V.; Akimova, Olga A.; Orlov, Sergei N.] Moscow MV Lomonosov State Univ, Dept Biol, Moscow, Russia; [Koltsova, Svetlana V.; Haloui, Mounsif; Tremblay, Johanne; Hamet, Pavel; Orlov, Sergei N.] Ctr Hosp Univ Montreal, Ctr Rech, Dept Med, Montreal, PQ, Canada; [Shilov, Boris] Pirogov Russian Natl Res Med Univ, Dept Physiol, Moscow, Russia; [Birulina, Julia G.; Kapilevich, Leonid V.; Gusakova, Svetlana V.; Orlov, Sergei N.] Siberian State Med Univ, Dept Med Biol, Tomsk, Russia; [Kapilevich, Leonid V.] Tomsk State Univ, Dept Phys Educ, Tomsk 634050, Russia	Lomonosov Moscow State University; Universite de Montreal; Pirogov Russian National Research Medical University; Siberian State Medical University; Tomsk State University	Orlov, SN (corresponding author), Moscow MV Lomonosov State Univ, Dept Biol, Moscow, Russia.	sergeinorlov@yandex.ru	Orlov, Sergey N./T-3729-2018; Kapilevich, Leonid/AAU-3076-2020; Kapilevich, Leonid V./N-9196-2014; Kapilevich, Leonid V/J-1696-2016; Gusakova, Svetlana/R-8392-2016; Cossette, Suzanne/I-8008-2016; Gusakova, Svetlana/AAR-4165-2021; Julia, Birulina/S-2323-2016; Shilov, Boris/V-7642-2018	Kapilevich, Leonid/0000-0002-2316-576X; Julia, Birulina/0000-0003-1237-9786; Gusakova, Svetlana/0000-0001-5047-8668	Canadian Institutes of Health Research; Kidney Foundation of Canada; Russian Foundation for Fundamental Research; Ministry of Education and Science of the Russian Federation [8477, 8162]; Russian Science Foundation [14-15-00006] Funding Source: Russian Science Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; Russian Foundation for Fundamental Research(Russian Foundation for Basic Research (RFBR)); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by grants from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html), the Kidney Foundation of Canada (http://www.kidney.ca), the Russian Foundation for Fundamental Research (http://www.rfbr.ru/rffi/eng) and the Ministry of Education and Science of the Russian Federation (http://eng.mon.gov.ru, projects 8477 and 8162). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YJ, 2012, BMB REP, V45, P489, DOI 10.5483/BMBRep.2012.45.9.169; Akimova OA, 2005, J BIOL CHEM, V280, P832, DOI 10.1074/jbc.M411011200; Akimova OA, 2006, J BIOL CHEM, V281, P31317, DOI 10.1074/jbc.M602117200; Alarcon R, 1999, CANCER RES, V59, P6046; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Camacho M, 2011, J LIPID RES, V52, P720, DOI 10.1194/jlr.M011007; Castellano J, 2011, ARTERIOSCL THROM VAS, V31, P1411, DOI 10.1161/ATVBAHA.111.225490; Chakravarty A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-249; Chen F, 1999, CLIN CHEM, V45, P7; Coulon V, 2001, M S-MED SCI, V17, P969, DOI 10.4267/10608/1810; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; Eckle T, 2012, NAT MED, V18, P774, DOI 10.1038/nm.2728; Egger M, 2007, FASEB J, V21, P2906, DOI 10.1096/fj.06-7440com; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Greenstein AS, 2009, CIRCULATION, V119, P1661, DOI 10.1161/CIRCULATIONAHA.108.821181; Hamet P, 2006, METABOLISM, V55, pS7, DOI 10.1016/j.metabol.2006.07.006; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hausenloy DJ, 2009, ATHEROSCLEROSIS, V204, P334, DOI 10.1016/j.atherosclerosis.2008.10.029; Hu J, 1998, BIOCHEM BIOPH RES CO, V245, P894, DOI 10.1006/bbrc.1998.8543; Johnson AB, 2008, MUTAT RES-FUND MOL M, V640, P174, DOI 10.1016/j.mrfmmm.2008.01.001; Kallio PJ, 1997, P NATL ACAD SCI USA, V94, P5667, DOI 10.1073/pnas.94.11.5667; Kamphuis W, 2007, MOL VIS, V13, P1020; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kim BY, 2008, EXP MOL MED, V40, P71, DOI 10.3858/emm.2008.40.1.71; Kobayashi T, 2008, KIDNEY INT, V73, P1240, DOI 10.1038/ki.2008.74; Koltsova SV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038032; Koyanagi S, 2003, CANCER RES, V63, P7277; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lee JM, 2000, J CLIN INVEST, V106, P723, DOI 10.1172/JCI11003; Leonard MO, 2003, J BIOL CHEM, V278, P40296, DOI 10.1074/jbc.M302560200; Liu JA, 2010, BBA-MOL BASIS DIS, V1802, P1237, DOI 10.1016/j.bbadis.2010.01.013; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; Lu AG, 2003, J CEREBR BLOOD F MET, V23, P786, DOI 10.1097/01.WCB.0000062340.80057.06; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mazzatti D, 2012, ARCH PHYSIOL BIOCHEM, V118, P112, DOI 10.3109/13813455.2012.654611; MCDONALD TF, 1994, PHYSIOL REV, V74, P365, DOI 10.1152/physrev.1994.74.2.365; Murphy E, 2009, CIRC RES, V104, P292, DOI 10.1161/CIRCRESAHA.108.189050; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Nangaku M, 2007, J MOL MED, V85, P1325, DOI 10.1007/s00109-007-0278-y; Okamura Y, 2011, PHYSIOLOGY, V26, P6, DOI 10.1152/physiol.00035.2010; Ong LL, 2010, TISSUE ENG PART C-ME, V16, P1069, DOI [10.1089/ten.tec.2009.0641, 10.1089/ten.TEC.2009.0641]; Orlov SN, 2005, CELL CALCIUM, V38, P53, DOI 10.1016/j.ceca.2005.03.006; Orlov SN, 1996, AM J PHYSIOL-CELL PH, V270, pC1388, DOI 10.1152/ajpcell.1996.270.5.C1388; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Phillis JW, 2006, BRAIN RES REV, V52, P201, DOI 10.1016/j.brainresrev.2006.02.002; REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193; Schoner W, 2007, AM J PHYSIOL-CELL PH, V293, pC509, DOI 10.1152/ajpcell.00098.2007; Schults MA, 2010, J BIOL CHEM, V285, P14558, DOI 10.1074/jbc.M109.076323; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Sharp Frank R, 2004, NeuroRx, V1, P26, DOI 10.1602/neurorx.1.1.26; Tang Y, 2006, NEUROBIOL DIS, V21, P18, DOI 10.1016/j.nbd.2005.06.002; Taurin S, 2002, J PHYSIOL-LONDON, V543, P835, DOI 10.1113/jphysiol.2002.023259; Taylor CT, 2008, J PHYSIOL-LONDON, V586, P4055, DOI 10.1113/jphysiol.2008.157669; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; VENDER RL, 1994, CHEST, V106, P236, DOI 10.1378/chest.106.1.236; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Williams RS, 2000, J CLIN INVEST, V106, P813, DOI 10.1172/JCI11205; Wood IS, 2009, P NUTR SOC, V68, P370, DOI 10.1017/S0029665109990206; Yan SF, 1999, J BIOL CHEM, V274, P15030, DOI 10.1074/jbc.274.21.15030; Yang DHA, 2013, INT J BIOCHEM CELL B, V45, P419, DOI 10.1016/j.biocel.2012.11.007; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105; Zhang N, 2007, CARDIOVASC TOXICOL, V7, P282, DOI 10.1007/s12012-007-9007-6; Zhao H, 2012, CURR DRUG TARGETS, V13, P173, DOI 10.2174/138945012799201621; Zuloaga KL, 2011, AM J PHYSIOL-HEART C, V301, pH1882, DOI 10.1152/ajpheart.00446.2011	67	26	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e110597	10.1371/journal.pone.0110597	http://dx.doi.org/10.1371/journal.pone.0110597			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375852	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402600015
J	Price, JE; Phiri, L; Mulenga, D; Hewett, PC; Topp, SM; Shiliya, N; Hatzold, K				Price, Jessica E.; Phiri, Lyson; Mulenga, Drosin; Hewett, Paul C.; Topp, Stephanie M.; Shiliya, Nicholas; Hatzold, Karin			Behavior Change Pathways to Voluntary Medical Male Circumcision: Narrative Interviews with Circumcision Clients in Zambia	PLOS ONE			English	Article							TRANSTHEORETICAL MODEL; QUALITATIVE RESEARCH; HIV PREVENTION; ACCEPTABILITY; INFECTION; RISK; MEN	As an HIV prevention strategy, the scale-up of voluntary medical male circumcision (VMMC) is underway in 14 countries in Africa. For prevention impact, these countries must perform millions of circumcisions in adolescent and adult men before 2015. Although acceptability of VMMC in the region is well documented and service delivery efforts have proven successful, countries remain behind in meeting circumcision targets. A better understanding of men's VMMC-seeking behaviors and experiences is needed to improve communication and interventions to accelerate uptake. To this end, we conducted semi-structured interviews with 40 clients waiting for surgical circumcision at clinics in Zambia. Based on Stages of Change behavioral theory, men were asked to recount how they learned about adult circumcision, why they decided it was right for them, what they feared most, how they overcame their fears, and the steps they took to make it to the clinic that day. Thematic analysis across all cases allowed us to identify key behavior change triggers while within-case analysis elucidated variants of one predominant behavior change pattern. Major stages included: awareness and critical belief adjustment, norming pressures and personalization of advantages, a period of fear management and finally VMMC-seeking. Qualitative comparative analysis of ever-married and never-married men revealed important similarities and differences between the two groups. Unprompted, 17 of the men described one to four failed prior attempts to become circumcised. Experienced more frequently by older men, failed VMMC attempts were often due to service-side barriers. Findings highlight intervention opportunities to increase VMMC uptake. Reaching uncircumcised men via close male friends and female sex partners and tailoring messages to stage-specific concerns and needs would help accelerate men's movement through the behavior change process. Expanding service access is also needed to meet current demand. Improving clinic efficiencies and introducing time-saving procedures and advance scheduling options should be considered.	[Price, Jessica E.; Phiri, Lyson; Mulenga, Drosin] Populat Council, Zambia Off, Lusaka, Zambia; [Hewett, Paul C.] Populat Council, HIV Div, New York, NY USA; [Hewett, Paul C.] Populat Council, PGY Div, New York, NY USA; [Topp, Stephanie M.] Ctr Infect Dis Res, Lusaka, Zambia; [Topp, Stephanie M.] Univ Alabama Birmingham, Hlth Care Org & Policy Unit, Birmingham, AL USA; [Topp, Stephanie M.] Univ Melbourne, Nossol Inst Global Hlth, Melbourne, Vic, Australia; [Shiliya, Nicholas] Populat Serv Int Res Monitoring & Evaluat, Lusaka, Zambia; [Hatzold, Karin] Populat Serv Int, HIV, Harare, Zimbabwe; [Hatzold, Karin] Populat Serv Int, SRH, Harare, Zimbabwe	Population Council; Population Council; University of Alabama System; University of Alabama Birmingham; University of Melbourne	Price, JE (corresponding author), Populat Council, Zambia Off, Lusaka, Zambia.	ntaljess@gmail.com	Topp, Stephanie M/H-3923-2019	Topp, Stephanie M/0000-0002-3448-7983	Bill and Melinda Gates Foundation via the Population Services International Grant [3889]	Bill and Melinda Gates Foundation via the Population Services International Grant	The study was funded by the Bill and Melinda Gates Foundation via the Population Services International Grant #3889 to Population Council. Population Services International facilitated clinic access and reviewed the draft manuscripts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, UNAIDS REP GLOB AIDS; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Ayres L, 2003, QUAL HEALTH RES, V13, P871, DOI 10.1177/1049732303013006008; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Central Statistical Office Ministry of Health University of Zambia MEASURE Evaluation, 2010, ZAMB SEX BEH SURV 20; Cialdini R., 1993, PSYCHOL INFLUENCE; Di Noia J, 2012, AM J HEALTH PROMOT, V26, P381, DOI 10.4278/ajhp.100903-QUAN-302; Dray J, 2012, CLIN PSYCHOL REV, V32, P558, DOI 10.1016/j.cpr.2012.06.005; Everson ES, 2010, PATIENT EDUC COUNS, V78, P53, DOI 10.1016/j.pec.2009.05.004; Galukande Moses, 2012, Pan Afr Med J, V13, P88; Gasasira RA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-134; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gray RH, 2013, SEX TRANSM INFECT, V89, P345, DOI 10.1136/sextrans-2012-050595; Gummerson E, 2013, AIDS, V27, P2657, DOI 10.1097/01.aids.0000433235.55937.10; Herman-Roloff A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018299; Hogben M, 2008, SEX TRANSM DIS, V35, P1009, DOI 10.1097/OLQ.0b013e31818eb752; LUBORSKY MR, 1995, RES AGING, V17, P89, DOI 10.1177/0164027595171005; Luca NR, 2013, J HEALTH COMMUN, V18, P20, DOI 10.1080/10810730.2012.688243; Lukobo MD, 2007, AIDS CARE, V19, P471, DOI 10.1080/09540120601163250; Mahler HR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001131; Plotkin M, 2013, GLOB HEALTH-SCI PRAC, V1, P108, DOI 10.9745/GHSP-D-12-00037; Prochaska J, 2002, HLTH BEHAV THEORY RE, V3rd, P97; Reisenhofer S, 2013, PATIENT EDUC COUNS, V93, P536, DOI 10.1016/j.pec.2013.08.004; Sandelowski M, 2001, RES NURS HEALTH, V24, P230, DOI 10.1002/nur.1025; Sandelowski M, 1996, RES NURS HEALTH, V19, P525, DOI 10.1002/(SICI)1098-240X(199612)19:6<525::AID-NUR8>3.0.CO;2-Q; Tobian AAR, 2014, ANNU REV MED, V65, P293, DOI 10.1146/annurev-med-092412-090539; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; WHO/UNAIDS, 2011, JOINT STRAT ACT FRAM; Wouabe ED, 2013, SCOPING REPORT INTER	30	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111602	10.1371/journal.pone.0111602	http://dx.doi.org/10.1371/journal.pone.0111602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XM	25375790	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000344402600050
J	Xiong, XL; Zhong, AY; Xu, HJ				Xiong, Xiaolu; Zhong, Anyuan; Xu, Huajun			Effect of Cyanotoxins on the Hypothalamic-Pituitary-Gonadal Axis in Male Adult Mouse	PLOS ONE			English	Article							MICROCYSTIN-LR; REPRODUCTIVE-SYSTEM; SERTOLI-CELLS; IN-VITRO; SPERMATOGENESIS; HORMONE; MICE; RECEPTORS; RAT; TESTOSTERONE	Background: Microcystins LR (MC-LR) are hepatotoxic cyanotoxins that have been shown to induce reproductive toxicity, and Hypothalamic-Pituitary-Gonadal Axis (HPG) is responsible for the control of reproductive functions. However, few studies have been performed to evaluate the effects of MC-LR on HPG axis. This study aimed to investigate the MC-LR-induced toxicity in the reproductive system of mouse and focus on the HPG axis. Methods: Adult male C57BL/6 mice were exposed to various concentrations of MC-LR (0, 3.75, 7.50, 15.00 and 30.00 mu g/kg body weight per day) for 1 to 14 days, and it was found that exposure to different concentrations of MC-LR significantly disturbed sperm production in the mice testes in a dose- and time-dependent manner. To elucidate the associated possible mechanisms, the serum levels of testosterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH) were assessed. Meanwhile, PCR assays were employed to detect alterations in a series of genes involved in HPG axis, such as FSH, LH, gonadotropin-releasing hormone (GnRH) and their complement receptors. Furthermore, the effect of MC-LR on the viability and testosterone production of Leydig cells were tested in vitro. Results: MC-LR significantly impaired the spermatogenesis of mice possibly through the direct or indirect inhibition of GnRH synthesis at the hypothalamic level, which resulted in reduction of serum levels of LH that lead to suppression of testosterone production in the testis of mice. Conclusions: MC-LR may be a GnRH toxin that would disrupt the reproductive system of mice.	[Xiong, Xiaolu] Nanjing Med Univ, Drum Tower Hosp, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China; [Zhong, Anyuan] Soochow Univ, Affiliated Hosp 2, Dept Resp Dis, Suzhou, Peoples R China; [Xu, Huajun] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Otolaryngol Inst, Dept Otolaryngol, Shanghai 200030, Peoples R China	Nanjing Medical University; Nanjing University; Soochow University - China; Shanghai Jiao Tong University	Xu, HJ (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Otolaryngol Inst, Dept Otolaryngol, Shanghai 200030, Peoples R China.	sunnydayxu2010@163.com			National Natural Science Foundation of China [81200587]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was funded by the National Natural Science Foundation of China under the grant 81200587. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann JC, 1999, MOL ENDOCRINOL, V13, P812, DOI 10.1210/me.13.6.812; BAENZIGER JU, 1988, BIOCHIM BIOPHYS ACTA, V947, P287, DOI 10.1016/0304-4157(88)90012-3; Baker PJ, 2001, REPRODUCTION, V122, P227, DOI 10.1530/rep.0.1220227; Bernard DJ, 2010, FERTIL STERIL, V93, P2465, DOI 10.1016/j.fertnstert.2010.03.034; Bischoff K, 2001, VET HUM TOXICOL, V43, P294; Burger LL, 2004, J MOL ENDOCRINOL, V33, P559, DOI 10.1677/jme.1.01600; Campos A, 2010, INT J MOL SCI, V11, P268, DOI 10.3390/ijms11010268; CARA JF, 1988, ENDOCRINOLOGY, V123, P733, DOI 10.1210/endo-123-2-733; Chen J, 2009, TOXICOL SCI, V108, P81, DOI 10.1093/toxsci/kfp009; Chen Y, 2011, REPROD TOXICOL, V31, P551, DOI 10.1016/j.reprotox.2011.02.006; Ciccone NA, 2009, CURR OPIN ENDOCRINOL, V16, P321, DOI 10.1097/MED.0b013e32832d88fb; CONN PM, 1994, ANNU REV MED, V45, P391, DOI 10.1146/annurev.med.45.1.391; de Kretser DM, 1998, HUM REPROD, V13, P1; Dedes I, 2012, SYST BIOL REPROD MED, V58, P121, DOI 10.3109/19396368.2011.651555; Ding WX, 2003, FEMS MICROBIOL LETT, V220, P1, DOI 10.1016/S0378-1097(03)00100-9; Ding XS, 2006, TOXICON, V48, P973, DOI 10.1016/j.toxicon.2006.07.039; Feurstein D, 2009, TOXICOL APPL PHARM, V234, P247, DOI 10.1016/j.taap.2008.10.011; Fischer WJ, 2005, TOXICOL APPL PHARM, V203, P257, DOI 10.1016/j.taap.2004.08.012; Fischer WJ, 2000, TOXICOL APPL PHARM, V164, P73, DOI 10.1006/taap.1999.8861; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; Gupta N, 2003, TOXICOLOGY, V188, P285, DOI 10.1016/S0300-483X(03)00112-4; Haywood M, 2003, ENDOCRINOLOGY, V144, P509, DOI 10.1210/en.2002-220710; Heitman LH, 2008, MED RES REV, V28, P975, DOI 10.1002/med.20129; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; McLachlan RI, 1996, J ENDOCRINOL, V148, P1, DOI 10.1677/joe.0.1480001; Millar RP, 2005, ANIM REPROD SCI, V88, P5, DOI 10.1016/j.anireprosci.2005.05.032; Misrahi M, 1998, BAILLIERE CLIN ENDOC, V12, P35, DOI 10.1016/S0950-351X(98)80444-8; Roth MY, 2010, J ANDROL, V31, P138, DOI 10.2164/jandrol.109.008391; Segaloff Deborah L, 2012, Subcell Biochem, V63, P113, DOI 10.1007/978-94-007-4765-4_7; Shalev Eliezer, 2003, J Obstet Gynaecol Can, V25, P98; Sofikitis N, 2008, J STEROID BIOCHEM, V109, P323, DOI 10.1016/j.jsbmb.2008.03.004; Thackray VG, 2010, MOL CELL ENDOCRINOL, V314, P192, DOI 10.1016/j.mce.2009.09.003; Wang Q, 2008, TOXICON, V52, P721, DOI 10.1016/j.toxicon.2008.08.004; Wiegand C, 2005, TOXICOL APPL PHARM, V203, P201, DOI 10.1016/j.taap.2004.11.002; Zhang HJ, 2013, AQUAT TOXICOL, V126, P283, DOI 10.1016/j.aquatox.2012.09.017; Zhou Y, 2012, TOXICOL LETT, V212, P48, DOI 10.1016/j.toxlet.2012.05.001	36	14	15	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e106585	10.1371/journal.pone.0106585	http://dx.doi.org/10.1371/journal.pone.0106585			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375936	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600005
J	Liu, J; Nie, HR; Xu, ZL; Niu, X; Guo, SC; Yin, JH; Guo, F; Li, G; Wang, Y; Zhang, CQ				Liu, Ji; Nie, Huarong; Xu, Zhengliang; Niu, Xin; Guo, Shangchun; Yin, Junhui; Guo, Fei; Li, Gang; Wang, Yang; Zhang, Changqing			The Effect of 3D Nanofibrous Scaffolds on the Chondrogenesis of Induced Pluripotent Stem Cells and Their Application in Restoration of Cartilage Defects	PLOS ONE			English	Article							OSTEOCHONDRAL DEFECTS; CULTURE-CONDITIONS; DIFFERENTIATION; INDUCTION; TERATOMAS; KNEE	The discovery of induced pluripotent stem cells (iPSCs) rendered the reprogramming of terminally differentiated cells to primary stem cells with pluripotency possible and provided potential for the regeneration and restoration of cartilage defect. Chondrogenic differentiation of iPSCs is crucial for their application in cartilage tissue engineering. In this study we investigated the effect of 3D nanofibrous scaffolds on the chondrogenesis of iPSCs and articular cartilage defect restoration. Super-hydrophilic and durable mechanic polycaprolactone (PCL)/gelatin scaffolds were fabricated using two separate electrospinning processes. The morphological structure and mechanical properties of the scaffolds were characterized. The chondrogenesis of the iPSCs in vitro and the restoration of the cartilage defect was investigated using scanning electron microscopy (SEM), the Cell Counting Kit-8 (CCK-8), histological observation, RT-qPCR, and western blot analysis. iPSCs on the scaffolds expressed higher levels of chondrogenic markers than the control group. In an animal model, cartilage defects implanted with the scaffold-cell complex exhibited an enhanced gross appearance and histological improvements, higher cartilage-specific gene expression and protein levels, as well as subchondral bone regeneration. Therefore, we showed scaffolds with a 3D nanofibrous structure enhanced the chondrogenesis of iPSCs and that iPSC-containing scaffolds improved the restoration of cartilage defects to a greater degree than did scaffolds alone in vivo.	[Liu, Ji; Xu, Zhengliang; Niu, Xin; Guo, Shangchun; Yin, Junhui; Wang, Yang; Zhang, Changqing] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Sch Med, Dept Orthopaed Surg, Shanghai 200030, Peoples R China; [Nie, Huarong; Guo, Fei] Nanchang Univ, Sch Mat Sci & Engn, Inst Polymers, Nanchang, Peoples R China; [Li, Gang] Chinese Univ Hong Kong, Prince Wales Hosp, Sch Biomed Sci,,Stem Cells & Regenerat Program, Li Ka Shing Inst Hlth Sci,Dept Orthopaed & Trauma, Shatin, Hong Kong, Peoples R China	Shanghai Jiao Tong University; Nanchang University; Chinese University of Hong Kong; Prince of Wales Hospital	Wang, Y (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Sch Med, Dept Orthopaed Surg, Shanghai 200030, Peoples R China.	wangy63cn@126.com; zhangcq@sjtu.edu.cn	Li, Gang/J-7830-2018; Guo, Shang-Chun/M-6246-2018	Li, Gang/0000-0002-3981-2239; Guo, Shang-Chun/0000-0001-6285-6750; , Fei/0000-0003-2397-8629; zhang, changqing/0000-0002-7408-4126				BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; CANCEDDA R, 1995, INT REV CYTOL, V159, P265, DOI 10.1016/S0074-7696(08)62109-9; Carr AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008152; Chew SY, 2006, CURR PHARM DESIGN, V12, P4751, DOI 10.2174/138161206779026326; Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027; Clair Benjamin L, 2009, Foot Ankle Spec, V2, P179, DOI 10.1177/1938640009342272; Diekman BO, 2012, P NATL ACAD SCI USA, V109, P19172, DOI 10.1073/pnas.1210422109; Fecek C, 2008, TISSUE ENG PT A, V14, P1403, DOI [10.1089/ten.tea.2007.0293, 10.1089/tea.2007.0293]; Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007; Guha P, 2013, CELL STEM CELL, V12, P407, DOI 10.1016/j.stem.2013.01.006; Hoemann CD, 2010, AM J SPORT MED, V38, P1845, DOI 10.1177/0363546510369547; Jukes JM, 2008, TISSUE ENG PT A, V14, P135, DOI 10.1089/ten.a.2006.0397; Kawaguchi J, 2005, BONE, V36, P758, DOI 10.1016/j.bone.2004.07.019; Kim MS, 2010, MACROMOL BIOSCI, V10, P91, DOI 10.1002/mabi.200900168; Lee SJ, 2008, BIOMATERIALS, V29, P2891, DOI 10.1016/j.biomaterials.2008.03.032; Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Mano JF, 2007, J TISSUE ENG REGEN M, V1, P261, DOI 10.1002/term.37; Nakayama N, 2003, J CELL SCI, V116, P2015, DOI 10.1242/jcs.00417; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Payne KA, 2010, OSTEOARTHR CARTILAGE, V18, P705, DOI 10.1016/j.joca.2010.01.011; Qin DJ, 2008, J BIOL CHEM, V283, P33730, DOI 10.1074/jbc.M806788200; QUARTO R, 1995, CALCIFIED TISSUE INT, V56, P123, DOI 10.1007/BF00296343; Schnabel M, 2002, OSTEOARTHR CARTILAGE, V10, P62, DOI 10.1053/joca.2001.0482; Sharma B, 2004, ANN BIOMED ENG, V32, P148, DOI 10.1023/B:ABME.0000007799.60142.78; Spector M, 2006, SWISS MED WKLY, V136, P293; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tanaka H, 2004, J CELL BIOCHEM, V93, P454, DOI 10.1002/jcb.20171; Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6; Toh WS, 2007, STEM CELLS, V25, P950, DOI 10.1634/stemcells.2006-0326; Toh WS, 2009, J CELL MOL MED, V13, P3570, DOI 10.1111/j.1582-4934.2009.00762.x; Toh Wei Seong, 2007, V407, P333, DOI 10.1007/978-1-59745-536-7_23; Toh WS, 2005, GROWTH FACTORS, V23, P313, DOI 10.1080/08977190500252763; Vats A, 2006, TISSUE ENG, V12, P1687, DOI 10.1089/ten.2006.12.1687; Wakitani S, 2004, CELL TRANSPLANT, V13, P331, DOI 10.3727/000000004783983891; Wakitani S, 2003, RHEUMATOLOGY, V42, P162, DOI 10.1093/rheumatology/keg024; Yang PJ, 2009, TISSUE ENG PART B-RE, V15, P2; Yang XC, 2010, J BIOMED MATER RES A, V93A, P247, DOI 10.1002/jbm.a.32535; Zhang LM, 2010, BIOTECHNOL LETT, V32, P1339, DOI 10.1007/s10529-010-0293-x; zur Nieden NI, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-1	42	12	12	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111566	10.1371/journal.pone.0111566	http://dx.doi.org/10.1371/journal.pone.0111566			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389965	Green Published, gold			2022-12-27	WOS:000349144400024
J	Murakami, M; Oki, T				Murakami, Michio; Oki, Taikan			Estimated Dietary Intake of Radionuclides and Health Risks for the Citizens of Fukushima City, Tokyo, and Osaka after the 2011 Nuclear Accident	PLOS ONE			English	Article							POWER-PLANT ACCIDENT; CANCER INCIDENCE; ADULT RESIDENTS; RADIATION; RADIOCESIUM; POPULATION; PREFECTURE; DEPOSITION; TRANSPORT; JAPAN	The radionuclides released from the Fukushima Daiichi nuclear power plant in 2011 pose a health risk. In this study, we estimated the 1st-year average doses resulting from the intake of iodine 131 (I-131) and cesium 134 and 137 (Cs-134 and Cs-137) in drinking water and food ingested by citizens of Fukushima City (similar to 50 km from the nuclear power plant; outside the evacuation zone), Tokyo (similar to 230 km), and Osaka (similar to 580 km) after the accident. For citizens in Fukushima City, we considered two scenarios: Case 1, citizens consumed vegetables bought from markets; Case 2, citizens consumed vegetables grown locally (conservative scenario). The estimated effective doses of Cs-134 and Cs-137 agreed well with those estimated through market basket and food-duplicate surveys. The average thyroid equivalent doses due to ingestion of 131 I for adults were 840 mu Sv (Case 1) and 2700 mSv (Case 2) in Fukushima City, 370 mSv in Tokyo, and 16 mSv in Osaka. The average effective doses due to 134 Cs and 137 Cs were 19, 120, 6.1, and 1.9 mu Sv, respectively. The doses estimated in this study were much lower than values reported by the World Health Organization and the United Nations Scientific Committee on the Effects of Atomic Radiation, whose assessments lacked validation and full consideration of regional trade in foods, highlighting the importance of including regional trade. The 95th percentile effective doses were 2-3 times the average values. Lifetime attributable risks (LARs) of thyroid cancers due to ingestion were 2.3-39 X 10(-6) (Case 1) and 10-98 X 10(-6) (Case 2) in Fukushima City, 0.95-14 X 10(-6) in Tokyo, and 0.11-1.3 X 10(-6) in Osaka. The contributions of LARs of thyroid cancers due to ingestion were 7.5%-12% of all exposure (Case 1) and 12%-30% (Case 2) in Fukushima City.	[Murakami, Michio; Oki, Taikan] Univ Tokyo, Inst Ind Sci, Meguro, Tokyo, Japan; [Murakami, Michio; Oki, Taikan] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Murakami, M (corresponding author), Univ Tokyo, Inst Ind Sci, Meguro, Tokyo, Japan.	michio@iis.u-tokyo.ac.jp	Oki, Taikan/E-5778-2010	Oki, Taikan/0000-0003-4067-4678	"Core Research for Evolutionary Science and Technology (CREST)" grant from the Japan Science and Technology Agency	"Core Research for Evolutionary Science and Technology (CREST)" grant from the Japan Science and Technology Agency	This study was supported by a "Core Research for Evolutionary Science and Technology (CREST)" grant from the Japan Science and Technology Agency, http://www.jst.go.jp/kisoken/crest/en/index.html.MM and TO receive the funding. The funder had no role in study design, data collection and analysis, discussion to publish, or preparation of the manuscript.	Akahane K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01670; Amano H, 2012, J ENVIRON RADIOACTIV, V111, P42, DOI 10.1016/j.jenvrad.2011.10.019; [Anonymous], 2007, Ann ICRP, V37, P1, DOI 10.1016/j.icrp.2008.08.001; Brenner AV, 2011, ENVIRON HEALTH PERSP, V119, P933, DOI 10.1289/ehp.1002674; Center for Cancer Control and Information Services National Cancer Center Japan, 2013, CANC INC 1975 2008; Christoudias T, 2013, ATMOS CHEM PHYS, V13, P1425, DOI 10.5194/acp-13-1425-2013; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Evangeliou N, 2013, ENVIRON SCI TECHNOL, V47, P5803, DOI 10.1021/es400372u; Fukushima Prefecture, 2010, STAT FOREST IND FUKU; Harada KH, 2014, P NATL ACAD SCI USA, V111, pE914, DOI 10.1073/pnas.1315684111; Harada KH, 2013, ENVIRON SCI TECHNOL, V47, P2520, DOI 10.1021/es304128t; Hayano RS, 2013, P JPN ACAD B-PHYS, V89, P157, DOI 10.2183/pjab.89.157; International Commission on Radiological Protection (ICRP), 1983, ANN ICRP, V38, P11; Izumo Y, 2001, MINISTRY HLTH LABOUR; Japan Water Works Association, 2011, STAT TAP WAT 2009 FY; Kinoshita N, 2011, P NATL ACAD SCI USA, V108, P19526, DOI 10.1073/pnas.1111724108; Koizumi Akio, 2012, Environmental Health and Preventive Medicine, V17, P292, DOI 10.1007/s12199-011-0251-9; Kosaka K, 2012, WATER RES, V46, P4397, DOI 10.1016/j.watres.2012.05.055; Kuroda M, 2010, APPETITE, V54, P538, DOI 10.1016/j.appet.2010.02.010; Matsuda A, 2013, JPN J CLIN ONCOL, V43, P328, DOI 10.1093/jjco/hys233; Michio M, 2012, SEISAM KENKYU, V64, P359; Ministry of Agriculture Forestry and Fisheries, 2011, BAS DAT SPEC FOR PRO; Ministry of Agriculture Forestry and Fisheries, 2013, FOOD DEM SUPPL 2010; Ministry of Agriculture Forestry and Fisheries, 2010, STAT SURV MILK DAIR; Ministry of Agriculture Forestry and Fisheries, 2011, STAT SURV CULT ACR F; Ministry of Agriculture Forestry and Fisheries, 2011, STAT AN PROD DISTR 2; Ministry of Agriculture Forestry and Fisheries, 2011, CROP PROD STAT 2009; Ministry of Agriculture Forestry and Fisheries, 2012, CROP PROD STAT; Ministry of Agriculture Forestry and Fisheries, 2008, CENS AGR FOR 2005; Ministry of Agriculture Forestry and Fisheries, 2007, STAT SURV LIV 2006; Ministry of Agriculture Forestry and Fisheries, 2013, FISH AQ IND PROD STA; Ministry of Agriculture Forestry and Fisheries, 2013, CROP STAT 2011; Ministry of Health and Welfare, 2012, NAT HLTH NUTR SURV J; Mullenders L, 2009, NAT REV CANCER, V9, P596, DOI 10.1038/nrc2677; Murakami M, 2013, J JPN SOC WATER ENV, V36, P322; Murakami M, 2012, CHEMOSPHERE, V87, P1355, DOI 10.1016/j.chemosphere.2012.02.028; Nagataki S, 2014, CURR OPIN ENDOCRINOL, V21, P384, DOI 10.1097/MED.0000000000000098; Nakamura T, 1996, JPN J FOOD CHEM, V3, P141; National Research Council of the National Academies NRC, 2006, HLTH RISKS EXP LOW L; Nuclear Safety Commission of Japan, 1998, CONTR IND LEV ING FO; Ota T., 2009, JPN J HLTH PHYS, V44, P80, DOI DOI 10.5453/JHPS.44.80; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; RUSSELL WL, 1982, P NATL ACAD SCI-BIOL, V79, P542, DOI 10.1073/pnas.79.2.542; Statistics Bureau of Japan, 2011, NAT POP CENS 2010; Statistics Bureau of Japan, 2011, GEN MORT 2010; Sugiyama H, 2007, J HEALTH SCI, V53, P107, DOI 10.1248/jhs.53.107; Suzuki K, 2006, MEM OSAKA KYOIKU U S, V54, P27; Tsubokura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081909; United Nations Scientific Committee on the Effects of Atomic Radiation, 2014, SOURC EFF RISKS ION; United Nations Scientific Committee on the Effects of Atomic Radiation, 2008, ANN A EP STUD RAD CA, V1; Working Group on Radionuclides Pharmaceutical Affairs and Food Sanitation Council, 2011, EST CONTR RAD INT EX; Working Group on Radionuclides Pharmaceutical Affairs and Food Sanitation Council, 2011, REV NEW STAND RAD FO; World Health Organization, 2012, PREL DOS EST NUCL AC; World Health Organization, 2013, HLTH RISK ASS NUCL A; Yasutaka T, 2013, CHEMOSPHERE, V93, P1222, DOI 10.1016/j.chemosphere.2013.06.083; Yoshida-Ohuchi H, 2013, RADIAT PROT DOSIM, V154, P385, DOI 10.1093/rpd/ncs245	56	24	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112791	10.1371/journal.pone.0112791	http://dx.doi.org/10.1371/journal.pone.0112791			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390339	gold, Green Submitted, Green Published			2022-12-27	WOS:000349144400127
J	Stern, DI				Stern, David I.			High-Ranked Social Science Journal Articles Can Be Identified from Early Citation Information	PLOS ONE			English	Article							IMPACT FACTORS; SCIENTIFIC IMPACT; PUBLICATION; ECONOMICS; COUNTS; PREDICTION	Do citations accumulate too slowly in the social sciences to be used to assess the quality of recent articles? I investigate whether this is the case using citation data for all articles in economics and political science published in 2006 and indexed in the Web of Science. I find that citations in the first two years after publication explain more than half of the variation in cumulative citations received over a longer period. Journal impact factors improve the correlation between the predicted and actual future ranks of journal articles when using citation data from 2006 alone but the effect declines sharply thereafter. Finally, more than half of the papers in the top 20% in 2012 were already in the top 20% in the year of publication (2006).	Australian Natl Univ, Crawford Sch Publ Policy, Acton, ACT, Australia	Australian National University	Stern, DI (corresponding author), Australian Natl Univ, Crawford Sch Publ Policy, Acton, ACT, Australia.	david.stern@anu.edu.au	Stern, David I/B-4700-2009	Stern, David I/0000-0001-6595-4268				Adams J, 2005, SCIENTOMETRICS, V63, P567, DOI 10.1007/s11192-005-0228-9; Anderson DL, 2013, 313 U WAIK; Berk R, 2008, J QUANT CRIMINOL, V24, P269, DOI 10.1007/s10940-008-9048-4; Bertismas D, 2014, ALL SOC SCI ASS ANN; Bertocchi G, 2013, 7739 IZA; Bornmann L, 2014, J INFORMETR, V8, P175, DOI 10.1016/j.joi.2013.11.005; Bornmann L, 2013, J INFORMETR, V7, P933, DOI 10.1016/j.joi.2013.09.003; Bornmann L, 2011, ANNU REV INFORM SCI, V45, P199, DOI 10.1002/aris.2011.1440450112; BREUSCH TS, 1979, ECONOMETRICA, V47, P1287, DOI 10.2307/1911963; COLMAN AM, 1995, SCIENTOMETRICS, V32, P49, DOI 10.1007/BF02020188; Estima, 2010, RATS VERS 8 US GUID; Fu Lawrence D, 2008, AMIA Annu Symp Proc, P222; Harzing AW, 2013, SCIENTOMETRICS, V94, P23, DOI 10.1007/s11192-012-0738-1; Heffetz O., 2011, HDB SOCIAL EC, P69, DOI DOI 10.1016/B978-0-444-53187-2.00003-6; Hegarty P, 2012, PERSPECT PSYCHOL SCI, V7, P72, DOI 10.1177/1745691611429356; Hirsch JE, 2007, P NATL ACAD SCI USA, V104, P19193, DOI 10.1073/pnas.0707962104; Ibanez A, 2009, BIOINFORMATICS, V25, P3303, DOI 10.1093/bioinformatics/btp585; Laband DN, 2013, ECON J, V123, pF223, DOI 10.1111/ecoj.12067; Levitt JM, 2011, INFORM PROCESS MANAG, V47, P300, DOI 10.1016/j.ipm.2010.09.005; Lokker C, 2008, BMJ-BRIT MED J, V336, P655, DOI 10.1136/bmj.39482.526713.BE; Lovaglia MJ., 1991, AM SOCIOL, V22, P49, DOI [DOI 10.1007/BF02691867, 10.1007/BF02691867]; Lozano GA, 2012, J AM SOC INF SCI TEC, V63, P2140, DOI 10.1002/asi.22731; Mazloumian A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049246; McCabe MJ, REV EC STAT IN PRESS; McCullagh P, 1989, GEN LINEAR MODELS; Norris M, 2003, J DOC, V59, P709, DOI 10.1108/00220410310698734; Oppenheim, 1996, SERIALS, V9, P155, DOI 10.1629/09155; SEYFARTH RM, 1981, BEHAV BRAIN SCI, V4, P447, DOI 10.1017/S0140525X00009821; Sgroi D, 2013, ECON J, V123, pF255, DOI 10.1111/ecoj.12070; Stern DI, 2013, J ECON LIT, V51, P173, DOI 10.1257/jel.51.1.173; Stringer MJ, 2010, J AM SOC INF SCI TEC, V61, P1377, DOI 10.1002/asi.21335; Stringer MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001683; Sussmuth B, 2006, SCIENTOMETRICS, V66, P579, DOI 10.1007/s11192-006-0042-z; van Leeuwen T, 2012, SCIENTOMETRICS, V92, P443, DOI 10.1007/s11192-012-0677-x; Vanclay JK, 2012, SCIENTOMETRICS, V92, P211, DOI 10.1007/s11192-011-0561-0; Walters GD, 2006, SCIENTOMETRICS, V69, P499, DOI 10.1007/s11192-006-0166-1; Waltman L, 2011, SCIENTOMETRICS, V87, P467, DOI 10.1007/s11192-011-0354-5; Wang DS, 2013, SCIENCE, V342, P127, DOI 10.1126/science.1237825; Wang J, 2013, SCIENTOMETRICS, V94, P851, DOI 10.1007/s11192-012-0775-9; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934	40	37	38	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112520	10.1371/journal.pone.0112520	http://dx.doi.org/10.1371/journal.pone.0112520			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CP	25390035	Green Published, gold			2022-12-27	WOS:000349144400090
J	Company, N; Nadal, A; Ruiz, C; Pla, M				Company, Nuri; Nadal, Anna; Ruiz, Cristina; Pla, Maria			Production of Phytotoxic Cationic alpha-Helical Antimicrobial Peptides in Plant Cells Using Inducible Promoters	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; GENOME-WIDE ANALYSIS; STRESS-RESPONSE; TRANSCRIPTOME ANALYSIS; ABIOTIC STRESS; REPRODUCTIVE DEVELOPMENT; GENE-EXPRESSION; RICE; TOLERANCE; TOBACCO	Synthetic linear antimicrobial peptides with cationic alpha-helical structures, such as BP100, have potent and specific activities against economically important plant pathogenic bacteria. They are also recognized as valuable therapeutics and preservatives. However, highly active BP100 derivatives are often phytotoxic when expressed at high levels as recombinant peptides in plants. Here we demonstrate that production of recombinant phytotoxic peptides in transgenic plants is possible by strictly limiting transgene expression to certain tissues and conditions, and specifically that minimization of this expression during transformation and regeneration of transgenic plants is essential to obtain viable plant biofactories. On the basis of whole-genome transcriptomic data available online, we identified the Os.hsp82 promoter that fulfilled this requirement and was highly induced in response to heat shock. Using this strategy, we generated transgenic rice lines producing moderate yields of severely phytotoxic BP100 derivatives on exposure to high temperature. In addition, a threshold for gene expression in selected tissues and stages was experimentally established, below which the corresponding promoters should be suitable for driving the expression of recombinant phytotoxic proteins in genetically modified plants. In view of the growing transcriptomics data available, this approach is of interest to assist promoter selection for specific purposes.	[Company, Nuri; Nadal, Anna; Ruiz, Cristina; Pla, Maria] Univ Girona, Inst Food & Agr Technol, Girona, Spain	Universitat de Girona	Pla, M (corresponding author), Univ Girona, Inst Food & Agr Technol, Girona, Spain.	maria.pla@udg.edu	Nadal, Anna/K-3029-2017; Pla, Maria/K-5170-2017	Nadal, Anna/0000-0003-1917-9277; Pla, Maria/0000-0003-4382-5494	Spanish Ministerio de Economia y Competitividad [AGL2010-17181/AGR]; Generalitat de Catalunya	Spanish Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	This work was financially supported by the Spanish Ministerio de Economia y Competitividad (reference AGL2010-17181/AGR). The research group belongs to 2014SGR697, recognized by the Catalonian Government. N.C. and C.R. received fellowships from Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badosa E, 2007, PEPTIDES, V28, P2276, DOI 10.1016/j.peptides.2007.09.010; Badosa E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085515; BLUMENTHAL C, 1990, AUST J PLANT PHYSIOL, V17, P37, DOI 10.1071/PP9900037; Breitler JC, 2004, PLANT BIOTECHNOL J, V2, P417, DOI 10.1111/j.1467-7652.2004.00086.x; Cavallarin L, 1998, MOL PLANT MICROBE IN, V11, P218, DOI 10.1094/MPMI.1998.11.3.218; Chang PFL, 2007, PLANT SCI, V172, P64, DOI 10.1016/j.plantsci.2006.07.017; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; Civan P, 2009, GENOME, V52, P294, DOI 10.1139/G09-001; Company N, 2014, PLANT BIOTECHNOL J, V12, P81, DOI 10.1111/pbi.12119; Conley AJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-48; CORNELISSEN BJC, 1987, NUCLEIC ACIDS RES, V15, P6799, DOI 10.1093/nar/15.17.6799; Dai ZY, 2000, TRANSGENIC RES, V9, P43, DOI 10.1023/A:1008922404834; Dubey S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-648; Efeoglu B, 2009, GAZI U J SCI, V22, P67; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Ginzberg I, 2009, J EXP BOT, V60, P4411, DOI 10.1093/jxb/erp281; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; Hadiarto T, 2011, PLANT CELL REP, V30, P297, DOI 10.1007/s00299-010-0956-z; Ham D-J, 2013, MOL BIOL REP, P1; Hieno A, 2013, NUCLEIC ACIDS RES, P1; Hu WH, 2009, PLANT SCI, V176, P583, DOI 10.1016/j.plantsci.2009.01.016; Iba K, 2002, ANNU REV PLANT BIOL, V53, P225, DOI 10.1146/annurev.arplant.53.100201.160729; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jain M, 2009, FEBS J, V276, P3148, DOI 10.1111/j.1742-4658.2009.07033.x; Joensuu JJ, 2010, PLANT PHYSIOL, V152, P622, DOI 10.1104/pp.109.149021; Jung YJ, 2012, PLANT BIOTECHNOL REP, V6, P39, DOI 10.1007/s11816-011-0193-0; Kang K, 2011, PLANT J, V66, P247, DOI 10.1111/j.1365-313X.2011.04486.x; Khurana N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054418; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Larkindale J, 2008, PLANT PHYSIOL, V146, P748, DOI 10.1104/pp.107.112060; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Li YF, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-153; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Lopez-Garcia B, 2002, APPL ENVIRON MICROB, V68, P2453, DOI 10.1128/AEM.68.5.2453-2460.2002; Marcos JF, 2008, ANNU REV PHYTOPATHOL, V46, P273, DOI 10.1146/annurev.phyto.121307.094843; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Mittal D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040899; Monroc S, 2006, PEPTIDES, V27, P2567, DOI 10.1016/j.peptides.2006.04.019; Monroc S, 2006, PEPTIDES, V27, P2575, DOI 10.1016/j.peptides.2006.05.001; Montesinos E, 2008, CHEM BIODIVERS, V5, P1225, DOI 10.1002/cbdv.200890111; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nadal A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-159; Osusky M, 2000, NAT BIOTECHNOL, V18, P1162, DOI 10.1038/81145; Ouyang YD, 2009, PLANT MOL BIOL, V70, P341, DOI 10.1007/s11103-009-9477-y; Qin DD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-432; Qu AL, 2013, BIOCHEM BIOPH RES CO, V432, P203, DOI 10.1016/j.bbrc.2013.01.104; Rajasekaran K., 2012, SMALL WONDERS PEPTID; Ramessar Koreen, 2008, Phytochemistry Reviews, V7, P579, DOI 10.1007/s11101-008-9087-3; Rasche S., 2011, Open Biotechnology Journal, V5, P1; Rerksiri W, 2013, SCI WORLD J, DOI 10.1155/2013/397401; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Sallaud C, 2003, THEOR APPL GENET, V106, P1396, DOI 10.1007/s00122-002-1184-x; Sambrook J., 2001, MOL CLONING LAB MANU; Sarkar NK, 2014, PLANT MOL BIOL, V84, P125, DOI 10.1007/s11103-013-0123-3; Sarkar NK, 2013, CELL STRESS CHAPERON, V18, P427, DOI 10.1007/s12192-012-0395-6; Sarkar NK, 2013, CELL STRESS CHAPERON, V18, P321, DOI 10.1007/s12192-012-0384-9; Sarkar NK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-393; Sharma R, 2009, FEBS J, V276, P6301, DOI 10.1111/j.1742-4658.2009.07338.x; Siddique M, 2008, CELL STRESS CHAPERON, V13, P183, DOI 10.1007/s12192-008-0032-6; Singh A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-95; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Sun WN, 2002, BBA-GENE STRUCT EXPR, V1577, P1, DOI 10.1016/S0167-4781(02)00417-7; Todaka D, 2012, RICE, V5, DOI 10.1186/1939-8433-5-6; Torrent M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-5; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaquero C, 1999, P NATL ACAD SCI USA, V96, P11128, DOI 10.1073/pnas.96.20.11128; VIERLING E, 1991, ANNU REV PLANT PHYS, V42, P579, DOI 10.1146/annurev.pp.42.060191.003051; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Wakasa Y, 2013, BIOTECHNOL J, V8, P1133, DOI 10.1002/biot.201300065; Waters ER, 1996, J EXP BOT, V47, P325, DOI 10.1093/jxb/47.3.325; Yamakawa H, 2010, PLANT CELL PHYSIOL, V51, P795, DOI 10.1093/pcp/pcq034; Yamamoto YY, 2008, NUCLEIC ACIDS RES, V36, pD977, DOI 10.1093/nar/gkm785; Yamamoto YY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-67; YOUNG RA, 1989, CELL, V59, P5, DOI 10.1016/0092-8674(89)90861-1; Zhang XW, 2013, GENE, V530, P185, DOI 10.1016/j.gene.2013.08.048; Zheng LQ, 2009, PLANT PHYSIOL, V151, P262, DOI 10.1104/pp.109.141051	78	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e109990	10.1371/journal.pone.0109990	http://dx.doi.org/10.1371/journal.pone.0109990			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25387106	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400007
J	Lee, B; Zhou, X; Riching, K; Eliceiri, KW; Keely, PJ; Guelcher, SA; Weaver, AM; Jiang, Y				Lee, Byoungkoo; Zhou, Xin; Riching, Kristin; Eliceiri, Kevin W.; Keely, Patricia J.; Guelcher, Scott A.; Weaver, Alissa M.; Jiang, Yi			A Three-Dimensional Computational Model of Collagen Network Mechanics	PLOS ONE			English	Article							I COLLAGEN; EXTRACELLULAR-MATRIX; ELASTICITY; DYNAMICS; FIBRILS; DEFORMATION; RHEOLOGY	Extracellular matrix (ECM) strongly influences cellular behaviors, including cell proliferation, adhesion, and particularly migration. In cancer, the rigidity of the stromal collagen environment is thought to control tumor aggressiveness, and collagen alignment has been linked to tumor cell invasion. While the mechanical properties of collagen at both the single fiber scale and the bulk gel scale are quite well studied, how the fiber network responds to local stress or deformation, both structurally and mechanically, is poorly understood. This intermediate scale knowledge is important to understanding cell-ECM interactions and is the focus of this study. We have developed a three-dimensional elastic collagen fiber network model (bead-and-spring model) and studied fiber network behaviors for various biophysical conditions: collagen density, crosslinker strength, crosslinker density, and fiber orientation (random vs. prealigned). We found the best-fit crosslinker parameter values using shear simulation tests in a small strain region. Using this calibrated collagen model, we simulated both shear and tensile tests in a large linear strain region for different network geometry conditions. The results suggest that network geometry is a key determinant of the mechanical properties of the fiber network. We further demonstrated how the fiber network structure and mechanics evolves with a local formation, mimicking the effect of pulling by a pseudopod during cell migration. Our computational fiber network model is a step toward a full biomechanical model of cellular behaviors in various ECM conditions.	[Lee, Byoungkoo; Jiang, Yi] Georgia State Univ, Dept Math & Stat, Atlanta, GA 30303 USA; [Zhou, Xin] Chinese Acad Sci, Grad Univ, Sch Phys, Beijing, Peoples R China; [Riching, Kristin; Eliceiri, Kevin W.; Keely, Patricia J.] Univ Wisconsin, Lab Cell & Mol Biol, Lab Opt & Computat Instrumentat, Madison, WI USA; [Riching, Kristin; Eliceiri, Kevin W.; Keely, Patricia J.] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA; [Riching, Kristin; Keely, Patricia J.] Univ Wisconsin, Dept Cell & Regenerat Biol, Madison, WI USA; [Guelcher, Scott A.] Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN 37235 USA; [Weaver, Alissa M.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA	University System of Georgia; Georgia State University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Vanderbilt University; Vanderbilt University	Jiang, Y (corresponding author), Georgia State Univ, Dept Math & Stat, Atlanta, GA 30303 USA.	yjiang12@gsu.edu	Eliceiri, Kevin/ABD-4516-2020	Eliceiri, Kevin/0000-0001-8678-670X; Jiang, Yi/0000-0002-7519-6365	National Institutes of Health [5U01CA143069]; NATIONAL CANCER INSTITUTE [U01CA143069] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (www.nih.gov), 5U01CA143069. BL, KR, KWE, SAG, PJK, AW, and YJ received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004748; Arevalo RC, 2010, BIOPHYS J, V99, pL65, DOI 10.1016/j.bpj.2010.08.008; Bischofs IB, 2003, P NATL ACAD SCI USA, V100, P9274, DOI 10.1073/pnas.1233544100; Buehler MJ, 2008, J MECH BEHAV BIOMED, V1, P59, DOI 10.1016/j.jmbbm.2007.04.001; Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103; Buehler MJ, 2006, J MATER RES, V21, P1947, DOI 10.1557/JMR.2006.0236; Califano JP, 2008, CELL MOL BIOENG, V1, P122, DOI 10.1007/s12195-008-0022-x; Chandran PL, 2006, J BIOMECH ENG-T ASME, V128, P259, DOI 10.1115/1.2165699; Charulatha V, 2003, BIOMATERIALS, V24, P759, DOI 10.1016/S0142-9612(02)00412-X; Czirok A, 2006, CURR TOP DEV BIOL, V73, P237, DOI 10.1016/S0070-2153(05)73008-8; Duan X, 2006, BIOMATERIALS, V27, P4608, DOI 10.1016/j.biomaterials.2006.04.022; Dunn SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080516; Gautieri A, 2011, NANO LETT, V11, P757, DOI 10.1021/nl103943u; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Graham JS, 2004, EXP CELL RES, V299, P335, DOI 10.1016/j.yexcr.2004.05.022; Head DA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.061907; Huisman EM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.208103; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Kadler Karl, 2004, Birth Defects Res C Embryo Today, V72, P1, DOI 10.1002/bdrc.20002; Kraning-Rush CM, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015009; Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; LEVITT M, 1983, J MOL BIOL, V170, P723, DOI 10.1016/S0022-2836(83)80129-6; Lopez-Garcia MDC, 2010, BIO-MED MATER ENG, V20, P361, DOI 10.3233/BME-2010-0649; Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003; Munster S, 2013, P NATL ACAD SCI USA, V110, P12197, DOI 10.1073/pnas.1222787110; Nedelec F, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/427; Onck PR, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.178102; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Piechocka IK, 2011, BIOMACROMOLECULES, V12, P2797, DOI 10.1021/bm200553x; Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Riching KM, 2014, BIOPHYS J IN PRESS; Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904; Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471; Rubinstein M, 1997, MACROMOLECULES, V30, P8036, DOI 10.1021/ma970364k; Samani A, 2007, PHYS MED BIOL, V52, P1565, DOI 10.1088/0031-9155/52/6/002; Sandersius SA, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015002; SILVER FH, 1980, J BIOL CHEM, V255, P9427; Stein AM, 2011, COMPLEXITY, V16, P22, DOI 10.1002/cplx.20332; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Vader D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005902; van der Rijt JAJ, 2006, MACROMOL BIOSCI, V6, P697, DOI 10.1002/mabi.200600063; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Wozniak MA, 2005, BIOL PROCED ONLINE, V7, P144, DOI 10.1251/bpo112; Yang L, 2008, BIOPHYS J, V94, P2204, DOI 10.1529/biophysj.107.111013; Yang L, 2007, J BIOMED MATER RES A, V82A, P160, DOI 10.1002/jbm.a.31127; Zahalak GI, 2000, BIOPHYS J, V79, P2369, DOI 10.1016/S0006-3495(00)76482-4	51	47	48	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111896	10.1371/journal.pone.0111896	http://dx.doi.org/10.1371/journal.pone.0111896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386649	gold, Green Published, Green Submitted			2022-12-27	WOS:000345250400030
J	Bell, AJ; Gallagher, A; Mottram, T; Lake, A; Kane, EV; Lightfoot, T; Roman, E; Jarrett, RF				Bell, Adam J.; Gallagher, Alice; Mottram, Timothy; Lake, Annette; Kane, Eleanor V.; Lightfoot, Tracy; Roman, Eve; Jarrett, Ruth F.			Germ-Line Transmitted, Chromosomally Integrated HHV-6 and Classical Hodgkin Lymphoma	PLOS ONE			English	Article							HUMAN-HERPESVIRUS 6; BLOOD MONONUCLEAR-CELLS; BARR-VIRUS EBV; NO EVIDENCE; VARIANT-A; HUMAN-HERPESVIRUS-6; INFECTIONS; DISEASE; POPULATION; GENOME	A unique feature of both human herpesvirus 6A and B (HHV-6A and B) among human herpesviruses is their ability to integrate into chromosomal telomeres. In some individuals integrated viral genomes are present in the germ-line and result in the vertical transmission of HHV-6; however, little is known about the disease associations of germ-line transmitted, chromosomally integrated HHV-6 (ciHHV-6). Recent publications suggest that HHV-6 is associated with classical Hodgkin lymphoma (cHL). Here we examine the prevalence of ciHHV-6 in 936 cases of cHL and 563 controls by screening with a duplex TaqMan assay and confirming with droplet digital PCR. ciHHV-6 was detected in 10/563 (1.8%) controls and in all but one individual the virus was HHV-6B. Amongst cases 16/936 (1.7%) harboured ciHHV-6, thus demonstrating no association between ciHHV-6 and risk of cHL.	[Bell, Adam J.; Gallagher, Alice; Mottram, Timothy; Lake, Annette; Jarrett, Ruth F.] Univ Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland; [Kane, Eleanor V.; Lightfoot, Tracy; Roman, Eve] Univ York, Dept Hlth Sci, Epidemiol & Canc Stat Grp, York YO10 5DD, N Yorkshire, England	University of Glasgow; University of York - UK	Bell, AJ (corresponding author), Univ Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland.	a.bell.3@research.gla.ac.uk	Jarrett, Ruth F/A-5570-2012	Jarrett, Ruth/0000-0003-0390-3478; Kane, Eleanor/0000-0002-7438-9982; Roman, Eve/0000-0001-7603-3704; Mottram, Timothy/0000-0001-9013-3664	Medical Research Council [G0801822]; HHV-6 Foundation; MRC [G0801822] Funding Source: UKRI; Medical Research Council [1036080] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); HHV-6 Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council grant number G0801822, and a donation from the HHV-6 Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle SW, 1996, J CLIN MICROBIOL, V34, P3223, DOI 10.1128/JCM.34.12.3223-3225.1996; Ablashi D, 2014, ARCH VIROL, V159, P863, DOI 10.1007/s00705-013-1902-5; Alexander FE, 2000, BRIT J CANCER, V82, P1117, DOI 10.1054/bjoc.1999.1049; Alexander FE, 2003, INT J CANCER, V107, P298, DOI 10.1002/ijc.11156; Arbuckle JH, 2010, P NATL ACAD SCI USA, V107, P5563, DOI 10.1073/pnas.0913586107; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Bates M, 2009, J MED VIROL, V81, P779, DOI 10.1002/jmv.21455; Boutolleau D, 2006, J CLIN VIROL, V35, P257, DOI 10.1016/j.jcv.2005.08.002; Chang ET, 2004, CANCER EPIDEM BIOMAR, V13, P1361; Clark Duncan A, 2008, Herpes, V15, P28; Daibata M, 1999, BLOOD, V94, P1545, DOI 10.1182/blood.V94.5.1545.417a25_1545_1549; Daibata M, 2000, BLOOD, V95, P1108; DEWHURST S, 1993, J CLIN MICROBIOL, V31, P416, DOI 10.1128/JCM.31.2.416-418.1993; Gallagher A, 2003, INT J CANCER, V104, P624, DOI 10.1002/ijc.10979; Gallagher A, 2002, INT J CANCER, V101, P259, DOI 10.1002/ijc.10603; Geraudie B, 2012, J CLIN VIROL, V53, P151, DOI 10.1016/j.jcv.2011.10.017; Hall CB, 2006, J INFECT DIS, V193, P1063, DOI 10.1086/503434; Hall CB, 2004, J PEDIATR-US, V145, P472, DOI 10.1016/j.jpeds.2004.06.017; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Huang Y, 2014, NUCLEIC ACIDS RES, V42, P315, DOI 10.1093/nar/gkt840; Hubacek P, 2013, FOLIA MICROBIOL, V58, P87, DOI 10.1007/s12223-012-0180-z; Leibovitch EC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092328; Leong HN, 2007, J MED VIROL, V79, P45, DOI 10.1002/jmv.20760; LUPPI M, 1993, J MED VIROL, V40, P44, DOI 10.1002/jmv.1890400110; Nacheva EP, 2008, J MED VIROL, V80, P1952, DOI 10.1002/jmv.21299; Roberts CH, 2014, GENOME MED, V6, DOI 10.1186/gm537; Sedlak RH, 2014, CLIN CHEM, V60, P765, DOI 10.1373/clinchem.2013.217240; Siddon A, 2012, BRIT J HAEMATOL, V158, P635, DOI 10.1111/j.1365-2141.2012.09206.x; Strenger V, 2013, BRIT J HAEMATOL, V161, P594, DOI 10.1111/bjh.12257; Tavakoli NP, 2007, J CLIN MICROBIOL, V45, P3972, DOI 10.1128/JCM.01692-07; TORELLI G, 1995, J MED VIROL, V46, P178, DOI 10.1002/jmv.1890460303; Ward KN, 2005, J MED VIROL, V76, P563, DOI 10.1002/jmv.20399; Willett EV, 2007, EPIDEMIOLOGY, V18, P130, DOI 10.1097/01.ede.0000248899.47399.78; Zerr DM, 2005, NEW ENGL J MED, V352, P768, DOI 10.1056/NEJMoa042207	34	18	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112642	10.1371/journal.pone.0112642	http://dx.doi.org/10.1371/journal.pone.0112642			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384040	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000344816700086
J	Eichmiller, JJ; Bajer, PG; Sorensen, PW				Eichmiller, Jessica J.; Bajer, Przemyslaw G.; Sorensen, Peter W.			The Relationship between the Distribution of Common Carp and Their Environmental DNA in a Small Lake	PLOS ONE			English	Article							WATER; ABUNDANCE; CAPTURE; EDNA; BIODIVERSITY; EFFICIENCY	Although environmental DNA (eDNA) has been used to infer the presence of rare aquatic species, many facets of this technique remain unresolved. In particular, the relationship between eDNA and fish distribution is not known. We examined the relationship between the distribution of fish and their eDNA (detection rate and concentration) in a lake. A quantitative PCR (qPCR) assay for a region within the cytochrome b gene of the common carp (Cyprinus carpio or 'carp'), an ubiquitous invasive fish, was developed and used to measure eDNA in Lake Staring (MN, USA), in which both the density of carp and their distribution have been closely monitored for several years. Surface water, sub-surface water, and sediment were sampled from 22 locations in the lake, including areas frequently used by carp. In water, areas of high carp use had a higher rate of detection and concentration of eDNA, but there was no effect of fish use on sediment eDNA. The detection rate and concentration of eDNA in surface and sub-surface water were not significantly different (p >= 0.5), indicating that eDNA did not accumulate in surface water. The detection rate followed the trend: high-use water > low-use water > sediment. The concentration of eDNA in sediment samples that were above the limit of detection were several orders of magnitude greater than water on a per mass basis, but a poor limit of detection led to low detection rates. The patchy distribution of eDNA in the water of our study lake suggests that the mechanisms that remove eDNA from the water column, such as decay and sedimentation, are rapid. Taken together, these results indicate that effective eDNA sampling methods should be informed by fish distribution, as eDNA concentration was shown to vary dramatically between samples taken less than 100 m apart.	[Eichmiller, Jessica J.; Bajer, Przemyslaw G.; Sorensen, Peter W.] Univ Minnesota, Minnesota Aquat Invas Species Res Ctr, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Eichmiller, JJ (corresponding author), Univ Minnesota, Minnesota Aquat Invas Species Res Ctr, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA.	eich0146@umn.edu		Sorensen, Peter/0000-0003-0321-1279	Minnesota Environment and Natural Resources Trust Fund	Minnesota Environment and Natural Resources Trust Fund	Funding for this project was provided by the Minnesota Environment and Natural Resources Trust Fund as recommended by the Legislative-Citizen Commission on Minnesota Resources (LCCMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberg J. J., 2013, 20131080 US GEOL SUR; Bajer PG, 2011, FISHERIES MANAG ECOL, V18, P497, DOI 10.1111/j.1365-2400.2011.00805.x; Bajer PG, 2012, N AM J FISH MANAGE, V32, P817, DOI 10.1080/02755947.2012.690822; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Bayley PB, 2002, T AM FISH SOC, V131, P435, DOI 10.1577/1548-8659(2002)131<0435:CEOABE>2.0.CO;2; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; CHANG YS, 1994, J MOL EVOL, V38, P138, DOI 10.1007/BF00166161; CROSS DG, 1975, J FISH BIOL, V7, P349, DOI 10.1111/j.1095-8649.1975.tb04609.x; Darling John A, 2011, Environ Res, V111, P978, DOI 10.1016/j.envres.2011.02.001; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Dell'Anno A, 2004, APPL ENVIRON MICROB, V70, P4384, DOI 10.1128/AEM.70.7.4384-4386.2004; Domanico MJ, 1997, CAN J FISH AQUAT SCI, V54, P1865, DOI 10.1139/cjfas-54-8-1865; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Haugland RA, 2005, WATER RES, V39, P559, DOI 10.1016/j.watres.2004.11.011; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; Mahon AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058316; Mayden RL, 2007, J EXP ZOOL PART B, V308B, P642, DOI 10.1002/jez.b.21175; MESA MG, 1989, T AM FISH SOC, V118, P644, DOI 10.1577/1548-8659(1989)118<0644:EMADME>2.3.CO;2; Moyer GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103767; Mumy KL, 2004, J MICROBIOL METH, V57, P259, DOI 10.1016/j.mimet.2004.01.013; Olson ZH, 2012, WILDLIFE RES, V39, P629, DOI 10.1071/WR12114; Pietramellara G, 2009, BIOL FERT SOILS, V45, P219, DOI 10.1007/s00374-008-0345-8; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Simon M, 2002, AQUAT MICROB ECOL, V28, P175, DOI 10.3354/ame028175; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Tikel D, 1996, MOL ECOL, V5, P456, DOI 10.1111/j.1365-294X.1996.tb00337.x; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; U.S. Fish and Wildlife Service, 2013, QUAL ASS PROJ PLAN Q	35	110	119	10	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112611	10.1371/journal.pone.0112611	http://dx.doi.org/10.1371/journal.pone.0112611			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383965	Green Submitted, Green Published, gold			2022-12-27	WOS:000344816700084
J	Fink, DM; Connor, AL; Kelley, PM; Steele, MM; Hollingsworth, MA; Tempero, RM				Fink, Darci M.; Connor, Alicia L.; Kelley, Philip M.; Steele, Maria M.; Hollingsworth, Michael A.; Tempero, Richard M.			Nerve Growth Factor Regulates Neurolymphatic Remodeling during Corneal Inflammation and Resolution	PLOS ONE			English	Article							ARTERIAL DIFFERENTIATION; NEUROTROPHIC FACTORS; LYMPHATIC VESSELS; SIGNALING PATHWAY; TOPICAL TREATMENT; VEGF; EXPRESSION; NGF; INNERVATION; LYMPHANGIOGENESIS	The cellular and physiologic mechanisms that regulate the resolution of inflammation remain poorly defined despite their widespread importance in improving inflammatory disease outcomes. We studied the resolution of two cardinal signs of inflammation-pain and swelling-by investigating molecular mechanisms that regulate neural and lymphatic vessel remodeling during the resolution of corneal inflammation. A mouse model of corneal inflammation and wound recovery was developed to study this process in vivo. Administration of nerve growth factor (NGF) increased pain sensation and inhibited neural remodeling and lymphatic vessel regression processes during wound recovery. A complementary in vivo approach, the corneal micropocket assay, revealed that NGF-laden pellets stimulated lymphangiogenesis and increased protein levels of VEGF-C. Adult human dermal lymphatic endothelial cells did not express canonical NGF receptors TrkA and p75(NTR) or activate downstream MAPK-or Akt-pathway effectors in the presence of NGF, although NGF treatment increased their migratory and tubulogenesis capacities in vitro. Blockade of the VEGF-R2/R3 signaling pathway ablated NGF-mediated lymphangiogenesis in vivo. These findings suggest a hierarchical relationship with NGF functioning upstream of the VEGF family members, particularly VEGF-C, to stimulate lymphangiogenesis. Taken together, these studies show that NGF stimulates lymphangiogenesis and that NGF may act as a pathogenic factor that negatively regulates the normal neural and lymphatic vascular remodeling events that accompany wound recovery.	[Fink, Darci M.; Steele, Maria M.; Hollingsworth, Michael A.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Connor, Alicia L.; Kelley, Philip M.; Tempero, Richard M.] Boys Town Natl Res Hosp, Dept Genet, Omaha, NE 68131 USA; [Tempero, Richard M.] Boys Town Natl Res Hosp, Dept Otolaryngol, Omaha, NE 68131 USA	University of Nebraska System; University of Nebraska Medical Center; Boys Town National Research Hospital; Boys Town National Research Hospital	Tempero, RM (corresponding author), Boys Town Natl Res Hosp, Dept Genet, 555 North 30th St, Omaha, NE 68131 USA.	richard.tempero@boystown.org		Steele, Maria/0000-0003-0186-2633; Fink, Darci/0000-0002-7587-3063	National Institutes of Health; National Eye Institute [R01-EY021571]; National Institute of General Medical Sciences [5 P20 RR018788-08]; University of Nebraska Medical Center Office of Graduate Studies; NATIONAL CANCER INSTITUTE [P30CA036727, P50CA127297, U54CA163120, T32CA009476] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018788] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103471, P30GM110768] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Nebraska Medical Center Office of Graduate Studies; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the following: National Institutes of Health (www. nih. gov), National Eye Institute, R01-EY021571 (RT) and National Institutes of Health, National Institute of General Medical Sciences, 5 P20 RR018788-08 (RT). Fellowship support was provided by the University of Nebraska Medical Center Office of Graduate Studies (www. unmc. edu/gradstudies) (DF, MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875; Belmonte C, 2004, EXP EYE RES, V78, P513, DOI 10.1016/j.exer.2003.09.023; Blanco-Mezquita T, 2013, INVEST OPHTH VIS SCI, V54, P3880, DOI 10.1167/iovs.12-10816; Bock F, 2007, INVEST OPHTH VIS SCI, V48, P2545, DOI 10.1167/iovs.06-0570; Bock F, 2009, INVEST OPHTH VIS SCI, V50, P2095, DOI 10.1167/iovs.07-1129; Bonini S, 2000, OPHTHALMOLOGY, V107, P1347, DOI 10.1016/S0161-6420(00)00163-9; Bouvree K, 2012, CIRC RES, V111, P437, DOI 10.1161/CIRCRESAHA.112.269316; Buchler P, 2005, ANN SURG, V242, P791, DOI 10.1097/01.sla.0000189115.94847.f1; Calza L, 2001, P NATL ACAD SCI USA, V98, P4160, DOI 10.1073/pnas.051626998; Cao RH, 2004, CIRC RES, V94, P664, DOI 10.1161/01.RES.0000118600.91698.BB; Cellini M, 2006, OPHTHALMIC RES, V38, P177, DOI 10.1159/000092626; Chauvet S, 2013, CELL MOL LIFE SCI, V70, P1685, DOI 10.1007/s00018-013-1278-4; de Castro F, 1998, EUR J NEUROSCI, V10, P146, DOI 10.1046/j.1460-9568.1998.00037.x; Donaghy M, 2003, PRACTICAL NEUROLOGY, V3, P40, DOI DOI 10.1046/J.1474-7766.2003.00121.X; Entschladen F, 2008, SEMIN CANCER BIOL, V18, P171, DOI 10.1016/j.semcancer.2007.12.004; Entschladen F, 2006, MED HYPOTHESES, V67, P33, DOI 10.1016/j.mehy.2006.01.015; Esquenazi S, 2005, INVEST OPHTH VIS SCI, V46, P3121, DOI 10.1167/iovs.05-0241; Ferrari G, 2013, INVEST OPHTH VIS SCI, V54, P813, DOI 10.1167/iovs.11-8379; Gelfand MV, 2009, TRENDS CELL BIOL, V19, P99, DOI 10.1016/j.tcb.2009.01.001; Jee D, 2012, CURR EYE RES, V37, P408, DOI 10.3109/02713683.2011.632108; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Joo MJ, 2004, ARCH OPHTHALMOL-CHIC, V122, P1338, DOI 10.1001/archopht.122.9.1338; Kankaanpaa P, 2012, NAT METHODS, V9, P683, DOI [10.1038/NMETH.2047, 10.1038/nmeth.2047]; Kelley PM, 2013, AM J PATHOL, V182, P2418, DOI 10.1016/j.ajpath.2013.02.025; Kelley PM, 2011, LAB INVEST, V91, P1643, DOI 10.1038/labinvest.2011.121; Kim EC, 2010, INVEST OPHTH VIS SCI, V51, P4569, DOI 10.1167/iovs.09-4937; Lambiase A, 2000, ARCH OPHTHALMOL-CHIC, V118, P1446; Lambiase A, 1998, INVEST OPHTH VIS SCI, V39, P1272; Lambiase A, 2011, ARCH ITAL BIOL, V149, P283, DOI 10.4449/aib.v149i2.1363; Lambiase A, 2003, ARCH ITAL BIOL, V141, P141; Lambiase A, 1998, NEW ENGL J MED, V338, P1174, DOI 10.1056/NEJM199804233381702; Lambiase A, 2000, INVEST OPHTH VIS SCI, V41, P1063; Lambiase A, 2012, INVEST OPHTH VIS SCI, V53, P8280, DOI 10.1167/iovs.12-10593; Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144; Li WL, 2013, DEV CELL, V24, P359, DOI 10.1016/j.devcel.2013.01.009; Li ZJ, 2011, AM J PATHOL, V178, P1106, DOI 10.1016/j.ajpath.2010.12.001; Marfurt CF, 1998, EXP EYE RES, V66, P437, DOI 10.1006/exer.1997.0445; MARFURT CF, 1989, INVEST OPHTH VIS SCI, V30, P461; Mauro Cellini, 2007, J Med Case Rep, V1, P124, DOI 10.1186/1752-1947-1-124; McKenna CC, 2011, INVEST OPHTH VIS SCI, V52, P30, DOI 10.1167/iovs.10-5902; Melani M, 2010, ANNU REV CELL DEV BI, V26, P639, DOI 10.1146/annurev.cellbio.093008.093324; Mukouyama Y, 2002, CELL, V109, P693, DOI 10.1016/S0092-8674(02)00757-2; Mukouyama YS, 2005, DEVELOPMENT, V132, P941, DOI 10.1242/dev.01675; Muller LJ, 2003, EXP EYE RES, V76, P521, DOI 10.1016/S0014-4835(03)00050-2; Nakamura K, 2011, MOL CELL NEUROSCI, V46, P498, DOI 10.1016/j.mcn.2010.12.002; Oh SJ, 1997, DEV BIOL, V188, P96, DOI 10.1006/dbio.1997.8639; Quaegebeur A, 2011, NEURON, V71, P406, DOI 10.1016/j.neuron.2011.07.013; Rossi S, 2012, ARCH ITAL BIOL, V150, P15, DOI 10.4449/aib.v150i1.1382; Samii A, 1999, NEUROSCI LETT, V262, P159, DOI 10.1016/S0304-3940(99)00064-6; Saygili E, 2011, BIOCHEM BIOPH RES CO, V410, P62, DOI 10.1016/j.bbrc.2011.05.105; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seo K, 2001, J Vet Sci, V2, P125; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Sornelli F, 2010, MOL VIS, V16, P1439; Sweat RS, 2014, MICROCIRCULATION; Tan MH, 2006, CORNEA, V25, P352, DOI 10.1097/01.ico.0000176609.42838.df; Woo HM, 2005, EXP EYE RES, V80, P633, DOI 10.1016/j.exer.2004.11.013; You LT, 2000, INVEST OPHTH VIS SCI, V41, P692; Yu CQ, 2008, INVEST OPHTH VIS SCI, V49, P3870, DOI 10.1167/iovs.07-1418; ZANDER E, 1951, J ANAT, V85, P68	62	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112737	10.1371/journal.pone.0112737	http://dx.doi.org/10.1371/journal.pone.0112737			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383879	gold, Green Published, Green Submitted			2022-12-27	WOS:000344816700091
J	Maniscalco, JM; Springer, AM; Parker, P; Adkison, MD				Maniscalco, John M.; Springer, Alan M.; Parker, Pamela; Adkison, Milo D.			A Longitudinal Study of Steller Sea Lion Natality Rates in the Gulf of Alaska with Comparisons to Census Data	PLOS ONE			English	Article							ANTARCTIC FUR SEALS; EUMETOPIAS-JUBATUS; ROBUST DESIGN; REPRODUCTIVE-PERFORMANCE; ATTENDANCE PATTERNS; MODEL SELECTION; AGE STRUCTURE; POPULATIONS; HYPOTHESIS; PARAMETERS	Steller sea lion (Eumetopias jubatus) numbers in the Western Distinct Population Segment are beginning to recover following the dramatic decline that began in the 1970s and ended around the turn of the century. Low female reproductive rates (natality) may have contributed to the decline and remain an issue of concern for this population. During the 2000s we found high natality among Steller sea lions in the Gulf of Alaska indicating a healthy population. This study extends these previous estimates over an additional three years and tests for interannual variations and long-term trends. We further examine the proportions of pups to adult females observed on the rookery and nearby haulouts during the birthing season to assess whether census data can be used to estimate natality. Open robust design multistate models were built and tested using Program MARK to estimate survival, resighting, and state transition probabilities in addition to other parameters dependent on whether or not a female gave birth in the previous year. Natality was estimated at 70% with some evidence of interannual variation but a long-term increasing or decreasing trend was not supported by the data. Bootstrap and regression comparisons of census data with natality estimates revealed no correlation between the two methods suggesting that census data are not an appropriate proxy for natality in this species. Longitudinal studies of individual animals are an appropriate method for estimating vital rates in species with variable detection over time such as the Steller sea lion. This work indicates that natality remains high in this region and is consistent with a population in recovery.	[Maniscalco, John M.; Parker, Pamela] Alaska SeaLife Ctr, Dept Sci, Seward, AK 99664 USA; [Maniscalco, John M.; Springer, Alan M.; Adkison, Milo D.] Univ Alaska Fairbanks, Inst Marine Sci, Fairbanks, AK USA	University of Alaska System; University of Alaska Fairbanks	Maniscalco, JM (corresponding author), Alaska SeaLife Ctr, Dept Sci, Seward, AK 99664 USA.	johnm@alaskasealife.org			U.S. federal grant through the National Marine Fisheries Service - NOAA Award [NA09NMF4390169]	U.S. federal grant through the National Marine Fisheries Service - NOAA Award	This study was funded by U.S. federal grant appropriations through the National Marine Fisheries Service - NOAA Award NA09NMF4390169 (https://grantsonline.rdc.noaa.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1971, P 2 INT S INF THEOR, P267, DOI DOI 10.2307/2334537; BELL G, 1980, AM NAT, V116, P45, DOI 10.1086/283611; Boyce MS, 2006, TRENDS ECOL EVOL, V21, P141, DOI 10.1016/j.tree.2005.11.018; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Calkins Donald G., 1994, P119; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; Dabin W, 2004, CAN J ZOOL, V82, P1043, DOI 10.1139/Z04-079; DEMASTER D, 2002, AKSG0202 U AL SEA GR; DOIDGE DW, 1984, J ZOOL, V202, P449, DOI 10.1111/j.1469-7998.1984.tb05095.x; EBERHARDT LL, 1985, J WILDLIFE MANAGE, V49, P997, DOI 10.2307/3801386; Eberhardt LL, 2005, MAR MAMMAL SCI, V21, P728, DOI 10.1111/j.1748-7692.2005.tb01262.x; Fritz L, 2013, NMFSAFSC251 NOAA US; Fritz L, 2005, NMFSAFSC183 NOAA US; Gerber LR, 2001, MAMMAL REV, V31, P131, DOI 10.1046/j.1365-2907.2001.00081.x; Gibbens J, 2010, J MAMMAL, V91, P510, DOI 10.1644/08-MAMM-A-377.1; GILMARTIN W G, 1976, Journal of Wildlife Diseases, V12, P104; Hamel S, 2009, J ANIM ECOL, V78, P143, DOI 10.1111/j.1365-2656.2008.01459.x; Hastings KK, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00215.1; Holmes EE, 2007, ECOL APPL, V17, P2214, DOI 10.1890/07-0508.1; Holmes EE, 2003, CONSERV BIOL, V17, P1794, DOI 10.1111/j.1523-1739.2003.00191.x; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Jemison LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070167; Kaplan CC, 2008, MAR MAMMAL SCI, V24, P443, DOI 10.1111/j.1748-7692.2008.00203.x; KASTELEIN R A, 1991, Aquatic Mammals, V17, P91; Kendall WL, 2012, ECOLOGY, V93, P913, DOI 10.1890/11-1538.1; Kendall WL, 2002, ECOLOGY, V83, P3276; Kendall WL, 1997, ECOLOGY, V78, P563; Kendall WL, 2003, ECOLOGY, V84, P1058, DOI 10.1890/0012-9658(2003)084[1058:AMCMFM]2.0.CO;2; Kucey L, 2005, THESIS U BRIT COLUMB; Loughlin TR., 1998, BIOSPH CONSER NAT WI, V1, P91, DOI [10.20798/biospherecons.1.2_91, DOI 10.20798/BIOSPHERECONS.1.2_91]; LUNN NJ, 1994, J ANIM ECOL, V63, P827, DOI 10.2307/5260; Maniscalco JM, 2006, J MAMMAL, V87, P304, DOI 10.1644/05-MAMM-A-163R2.1; Maniscalco JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096328; Maniscalco JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010076; Maniscalco JM, 2009, MAR MAMMAL SCI, V25, P206, DOI 10.1111/j.1748-7692.2008.00247.x; Maniscalco John M., 2008, Aquatic Mammals, V34, P277, DOI 10.1578/AM.34.3.2008.277; Maschner HDG, 2014, FISH FISH, V15, P634, DOI 10.1111/faf.12038; McKenzie J, 2005, J MAMMAL, V86, P1237, DOI 10.1644/05-MAMM-A-085R.1; Melin SR, 2012, MAR MAMMAL SCI, V28, P751, DOI 10.1111/j.1748-7692.2011.00538.x; Milette LL, 2003, CAN J ZOOL, V81, P340, DOI 10.1139/Z03-008; National Research Council, 2003, DECL STELL SEA LION; Pitcher KW, 2007, FISH B-NOAA, V105, P102; PITCHER KW, 1981, J MAMMAL, V62, P599, DOI 10.2307/1380406; Pitcher KW, 1998, CAN J ZOOL, V76, P2075, DOI 10.1139/cjz-76-11-2075; Pitcher KW, 2001, J MAMMAL, V82, P1047, DOI 10.1644/1545-1542(2001)082<1047:SATVIT>2.0.CO;2; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; Taylor RL, 2012, ECOL MODEL, V243, P73, DOI 10.1016/j.ecolmodel.2012.06.013; TESTA JW, 1987, CAN J ZOOL, V65, P1091, DOI 10.1139/z87-173; Trites Andrew W., 2006, Aquatic Mammals, V32, P85, DOI 10.1578/AM.32.1.2006.85; Trites AW, 2003, MAMMAL REV, V33, P3, DOI 10.1046/j.1365-2907.2003.00009.x; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WITHROW DE, 1982, THESIS U WASHINGTON; Wolf N, 2008, ECOL APPL, V18, P1932, DOI 10.1890/07-1254.1; YORK AE, 1994, MAR MAMMAL SCI, V10, P38, DOI 10.1111/j.1748-7692.1994.tb00388.x	55	4	4	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e111523	10.1371/journal.pone.0111523	http://dx.doi.org/10.1371/journal.pone.0111523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383865	Green Submitted, Green Published, gold			2022-12-27	WOS:000344816700019
J	Montgomerie, AM; Chittleborough, CR; Taylor, AW				Montgomerie, Alicia M.; Chittleborough, Catherine R.; Taylor, Anne W.			Physical Inactivity and Incidence of Obesity among South Australian Adults	PLOS ONE			English	Article							WEIGHT-GAIN; BODY-COMPOSITION; LIFE-STYLE; OVERWEIGHT; VALIDITY; RISK; RELIABILITY; PREVENTION; HEALTH; TRENDS		[Montgomerie, Alicia M.; Taylor, Anne W.] Univ Adelaide, Sch Med, Discipline Med, Adelaide, SA, Australia; [Chittleborough, Catherine R.] Univ Adelaide, Discipline Publ Hlth, Sch Populat Hlth, Adelaide, SA, Australia	University of Adelaide; University of Adelaide	Montgomerie, AM (corresponding author), Univ Adelaide, Sch Med, Discipline Med, Adelaide, SA, Australia.	alicia.montgomerie@adelaide.edu.au	Chittleborough, Catherine/A-7436-2011; Taylor, Anne w/F-5708-2010	Chittleborough, Catherine/0000-0003-3196-7137; Taylor, Anne w/0000-0002-4422-7974				Adams RJ, 2003, THORAX, V58, P846, DOI 10.1136/thorax.58.10.846; AMPON RD, 2007, ASTHMA AUSTR FINDING; *AUSTR BUR STAT, 1995, AUSTR MEAS; Australian Bureau of Statistics, 2009, NAT HLTH SURV AUSTR; Australian Bureau of Statistics, 2012, NAT HLTH SURV PROF H; Australian Bureau of Statistics, 2012, NAT HLTH SURV 1 RES; Australian Bureau of Statistics, 2001, CENS POP HOUS SEL SO; Australian Bureau of Statistics, 2002, EST RES POP AG SEX 1; Australian Institute of Health and Welfare, 2001, HEART STROK VASC DIS; Australian Institute of Health and Welfare, 2004, HEART STROK VASC DIS; Australian Institute of Health and Welfare, 2012, NAT HLTH PRIOR AR; Australian Institute of Helth and Welfare, 2003, ACT AUSTR SURV GUID; Ball K, 2001, INT J OBESITY, V25, P914, DOI 10.1038/sj.ijo.0801622; BENNETT SA, 1994, MED J AUSTRALIA, V161, P519, DOI 10.5694/j.1326-5377.1994.tb127594.x; Bernstein MS, 2004, PREV MED, V38, P94, DOI 10.1016/j.ypmed.2003.09.032; Brien SE, 2007, CAN J PUBLIC HEALTH, V98, P121, DOI 10.1007/BF03404322; Brown WJ, 2008, AUST NZ J PUBL HEAL, V32, P535, DOI 10.1111/j.1753-6405.2008.00305.x; Brown WJ, 2004, J SCI MED SPORT, V7, P205, DOI 10.1016/S1440-2440(04)80010-0; Cameron AJ, 2003, MED J AUSTRALIA, V178, P427, DOI 10.5694/j.1326-5377.2003.tb05283.x; Carter KN, 2012, AUST NZ J PUBL HEAL, V36, P218, DOI 10.1111/j.1753-6405.2012.00867.x; CASEY VA, 1991, AM J CLIN NUTR, V53, P1493, DOI 10.1093/ajcn/53.6.1493; Chan CB, 2003, OBES RES, V11, P1563, DOI 10.1038/oby.2003.208; Commonwealth of Australia, 1999, NAT PHYS ACT GUID AD; Cooper AR, 2000, EUR J CLIN NUTR, V54, P887, DOI 10.1038/sj.ejcn.1601116; DiPietro L, 1999, MED SCI SPORT EXER, V31, pS542, DOI 10.1097/00005768-199911001-00009; Economics A, 2008, GROWING COST OBESITY; Erlichman J, 2002, Obes Rev, V3, P273, DOI 10.1046/j.1467-789X.2002.00078.x; Ewing R, 2003, AM J HEALTH PROMOT, V18, P47, DOI 10.4278/0890-1171-18.1.47; Fogelholm M, 2000, Obes Rev, V1, P95, DOI 10.1046/j.1467-789x.2000.00016.x; Grant Janet F, 2006, Epidemiol Perspect Innov, V3, P4, DOI 10.1186/1742-5573-3-4; Grant JF, 2009, INT J EPIDEMIOL, V38, P1479, DOI 10.1093/ije/dyn262; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Heesch KC, 2011, J SCI MED SPORT, V14, P233, DOI 10.1016/j.jsams.2010.11.004; Heitmann BL, 1997, AM J CLIN NUTR, V66, P672, DOI 10.1093/ajcn/66.3.672; Hill JO, 2005, J APPL PHYSIOL, V99, P765, DOI 10.1152/japplphysiol.00137.2005; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Klipstein-Grobusch K, 1998, EUR J CLIN NUTR, V52, P525, DOI 10.1038/sj.ejcn.1600601; Kovalchik S, 2009, PUBLIC HEALTH NUTR, V12, P1072, DOI 10.1017/S1368980008003728; Lafortune G, 2009, HLTH GLANC 2009 OECD; Lee IM, 2010, JAMA-J AM MED ASSOC, V303, P1173, DOI 10.1001/jama.2010.312; McLennan W., 1998, NATL NUTR SURVEY USE; NHMRC, 2009, AUSTR GUID RED HLTH; Nunez-Cordoba JM, 2013, AM J PREV MED, V44, P254, DOI 10.1016/j.amepre.2012.10.019; Pan LP, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-56; Pauwels R, 2001, EUR RESPIR J, V18, P901, DOI 10.1183/09031936.01.0027401; PERRY GS, 1995, EPIDEMIOLOGY, V6, P61, DOI 10.1097/00001648-199501000-00012; Petersen L, 2004, INT J OBESITY, V28, P105, DOI 10.1038/sj.ijo.0802548; Pink B, 2006, SOCIOECONOMIC INDEXE; Ponsonby AL, 2011, DIABETES CARE, V34, P1497, DOI 10.2337/dc10-2386; Pulsford RM, 2013, AM J PREV MED, V44, P132, DOI 10.1016/j.amepre.2012.10.009; Raguso CA, 2006, CLIN NUTR, V25, P573, DOI 10.1016/j.clnu.2005.10.013; Saris W H M, 2003, Obes Rev, V4, P101, DOI 10.1046/j.1467-789X.2003.00101.x; Scarborough P, 2011, BRIT J NUTR, V105, P1399, DOI 10.1017/S0007114510005076; Swinburn B, 2009, AM J CLIN NUTR, V90, P1453, DOI 10.3945/ajcn.2009.28595; Taylor AW, 2006, AUST NZ J PUBL HEAL, V30, P238, DOI 10.1111/j.1467-842X.2006.tb00864.x; Taylor AW, 2008, PUBLIC HLTH B SA, V5, P17; Thompson DL, 2004, MED SCI SPORT EXER, V36, P911, DOI 10.1249/01.MSS.0000126787.14165.B3; Unit PRaOS, 2002, 200220 UNIT PRAOS; Walls HL, 2012, J OBES, V2012, DOI 10.1155/2012/107989; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wareham NJ, 2005, P NUTR SOC, V64, P229, DOI 10.1079/PNS2005423; WHO, 2000, OB PREV MAN GLOB EP; WHO, 2003, DIET NUTR PREVENTION, V916; WHO, 1997, PREV MAN GLOB EP	65	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112693	10.1371/journal.pone.0112693	http://dx.doi.org/10.1371/journal.pone.0112693			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT3DP	25383626	Green Published, gold, Green Submitted			2022-12-27	WOS:000344816700088
J	Mariotti, V; Melissari, E; Iofrida, C; Righi, M; Di Russo, M; Donzelli, R; Saba, A; Frascarelli, S; Chiellini, G; Zucchi, R; Pellegrini, S				Mariotti, Veronica; Melissari, Erika; Iofrida, Caterina; Righi, Marco; Di Russo, Manuela; Donzelli, Riccardo; Saba, Alessandro; Frascarelli, Sabina; Chiellini, Grazia; Zucchi, Riccardo; Pellegrini, Silvia			Modulation of Gene Expression by 3-Iodothyronamine: Genetic Evidence for a Lipolytic Pattern	PLOS ONE			English	Article							LIPOPROTEIN LDL BINDING; ADAPTER PROTEIN ARH; RECEPTOR SR-BI; ADIPOSE-TISSUE; MESSENGER-RNA; SCAVENGER RECEPTOR; APOLIPOPROTEIN-D; THYROID-HORMONE; MALIC ENZYME; RAT-LIVER	3-Iodothyronamine (T(1)AM) is an endogenous biogenic amine, structurally related to thyroid hormone, which is regarded as a novel chemical messenger. The molecular mechanisms underlying T(1)AM effects are not known, but it is possible to envisage changes in gene expression, since delayed and long-lasting phenotypic effects have been reported, particularly with regard to the modulation of lipid metabolism and body weight. To test this hypothesis we analysed gene expression profiles in adipose tissue and liver of eight rats chronically treated with T(1)AM (10 mg/Kg twice a day for five days) as compared with eight untreated rats. In vivo T(1)AM administration produced significant transcriptional effects, since 378 genes were differentially expressed in adipose tissue, and 114 in liver. The reported changes in gene expression are expected to stimulate lipolysis and beta-oxidation, while inhibiting adipogenesis. T(1)AM also influenced the expression of several genes linked to lipoprotein metabolism suggesting that it may play an important role in the regulation of cholesterol homeostasis. No effect on the expression of genes linked to toxicity was observed. The assay of tissue T(1)AM showed that in treated animals its endogenous concentration increased by about one order of magnitude, without significant changes in tissue thyroid hormone concentration. Therefore, the effects that we observed might have physiological or pathophysiological importance. Our results provide the basis for the reported effectiveness of T(1)AM as a lipolytic agent and gain importance in view of a possible clinical use of T(1)AM in obesity and/or dyslipidaemia.	[Mariotti, Veronica; Melissari, Erika; Iofrida, Caterina; Righi, Marco; Di Russo, Manuela; Donzelli, Riccardo; Saba, Alessandro; Frascarelli, Sabina; Chiellini, Grazia; Zucchi, Riccardo; Pellegrini, Silvia] Univ Pisa, Dept Surg Med Mol Pathol & Crit Care, Pisa, Italy	University of Pisa	Pellegrini, S (corresponding author), Univ Pisa, Dept Surg Med Mol Pathol & Crit Care, Pisa, Italy.	silvia.pellegrini@med.unipi.it	Zucchi, Riccardo/AAC-8963-2022; PELLEGRINI, SILVIA/ABG-8822-2021; Saba, Alessandro/AAC-2147-2022; Chiellini, Grazia/AAC-5877-2022; Righi, Marco/B-1595-2016	PELLEGRINI, SILVIA/0000-0003-0556-0165; Saba, Alessandro/0000-0003-0611-5549; ZUCCHI, RICCARDO/0000-0002-6450-3788; Righi, Marco/0000-0002-1448-0960; Mariotti, Veronica/0000-0001-8148-7866				Achouri Y, 2005, BIOCHIMIE, V87, P1149, DOI 10.1016/j.biochi.2005.04.015; Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Baxter RC, 2009, TRENDS ENDOCRIN MET, V20, P499, DOI 10.1016/j.tem.2009.07.002; Beh CT, 2001, GENETICS, V157, P1117; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERLAN M, 1992, TRENDS PHARMACOL SCI, V13, P277, DOI 10.1016/0165-6147(92)90085-K; BLANCOVACA F, 1992, J LIPID RES, V33, P1785; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bon Gabriele Bittolo, 2008, G Ital Cardiol (Rome), V9, p23S; Braulke LJ, 2008, J COMP PHYSIOL B, V178, P167, DOI 10.1007/s00360-007-0208-x; BUBLITZ C, 1954, J BIOL CHEM, V211, P951; Bujalska IJ, 2006, J MOL ENDOCRINOL, V37, P327, DOI 10.1677/jme.1.02048; Chen Wenming, 2004, Chinese Medical Sciences Journal, V19, P6; Chiellini G, 2007, FASEB J, V21, P1597, DOI 10.1096/fj.06-7474com; Christiaens V, 2010, MOL CELL ENDOCRINOL, V318, P2, DOI 10.1016/j.mce.2009.08.006; Claudio P, 2002, GENOME BIOL, V3; Coleman RA, 2002, J NUTR, V132, P2123, DOI 10.1093/jn/132.8.2123; DARIMONT C, 1993, MOL CELL ENDOCRINOL, V98, P67, DOI 10.1016/0303-7207(93)90238-F; Dhillo WS, 2009, DIABETES OBES METAB, V11, P251, DOI 10.1111/j.1463-1326.2008.00935.x; Draghici S, 2003, NUCLEIC ACIDS RES, V31, P3775, DOI 10.1093/nar/gkg624; Fernandez-Alvarez A, 2010, J BIOL CHEM, V285, P11765, DOI 10.1074/jbc.M109.067447; Gachon F, 2011, P NATL ACAD SCI USA, V108, P4794, DOI 10.1073/pnas.1002862108; Galli E, 2012, J CLIN ENDOCR METAB, V97, pE69, DOI 10.1210/jc.2011-1115; Garitaonandia I, 2009, J RECEPT SIG TRANSD, V29, P67, DOI 10.1080/10799890902729456; Gill S, 2008, PROG LIPID RES, V47, P391, DOI 10.1016/j.plipres.2008.04.002; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; HAUNER H, 1989, J CLIN INVEST, V84, P1663, DOI 10.1172/JCI114345; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Hausman GJ, 2004, J ANIM SCI, V82, P925; Havel PJ, 2004, DIABETES, V53, pS143, DOI 10.2337/diabetes.53.2007.S143; Haviland JA, 2013, OBESITY, V21, P2538, DOI 10.1002/oby.20391; Igal RA, 1997, BIOCHEM J, V324, P529, DOI 10.1042/bj3240529; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; JUMP DB, 1990, MOL ENDOCRINOL, V4, P1655, DOI 10.1210/mend-4-11-1655; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; KATSURADA A, 1988, BIOCHIM BIOPHYS ACTA, V950, P113, DOI 10.1016/0167-4781(88)90003-6; Khatri P, 2002, GENOMICS, V79, P266, DOI 10.1006/geno.2002.6698; Kim JH, 2001, J BIOL CHEM, V276, P24667, DOI 10.1074/jbc.M010793200; Klieverik LP, 2009, J ENDOCRINOL, V201, P377, DOI 10.1677/JOE-09-0043; Konishi M, 2006, MOL CELL ENDOCRINOL, V249, P71, DOI 10.1016/j.mce.2006.01.010; KOVANEN PT, 1975, J LIPID RES, V16, P211; Krotkiewski M, 2002, EUR J PHARMACOL, V440, P85, DOI 10.1016/S0014-2999(02)01420-6; LaFave LT, 2006, ENDOCRINOLOGY, V147, P4044, DOI 10.1210/en.2006-0473; LAFONTAN M, 1995, ENDOCR REV, V16, P716, DOI 10.1210/er.16.6.716; Langin D, 2006, PHARMACOL RES, V53, P482, DOI 10.1016/j.phrs.2006.03.009; Lewin TM, 2001, J BIOL CHEM, V276, P24674, DOI 10.1074/jbc.M102036200; Li L, 2006, FUNCTIONS RAT ACYL C; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Llagostera E, 2009, FEBS LETT, V583, P2121, DOI 10.1016/j.febslet.2009.05.043; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; MAGNUSON MA, 1983, J BIOL CHEM, V258, P2712; MAHLEY RW, 1984, J LIPID RES, V25, P1277; Mannaerts GP, 2000, CELL BIOCHEM BIOPHYS, V32, P73, DOI 10.1385/CBB:32:1-3:73; Manni ME, 2013, BRIT J PHARMACOL, V168, P354, DOI 10.1111/j.1476-5381.2012.02137.x; Manni ME, 2012, BRIT J PHARMACOL, V166, P650, DOI 10.1111/j.1476-5381.2011.01823.x; MARIASH CN, 1984, BIOCHEM BIOPH RES CO, V123, P1122; MenendezHurtado A, 1997, BIOCHEM BIOPH RES CO, V234, P605, DOI 10.1006/bbrc.1997.6635; Michaely P, 2004, J BIOL CHEM, V279, P34023, DOI 10.1074/jbc.M405242200; Miyaoka Y, 2006, J BIOL CHEM, V281, P37913, DOI 10.1074/jbc.M606089200; Nanbu-Wakao R, 2002, MOL ENDOCRINOL, V16, P1565, DOI 10.1210/me.16.7.1565; NARKEWICZ MR, 1990, BIOCHEM J, V271, P585, DOI 10.1042/bj2710585; Nielsen TS, 2012, J CLIN ENDOCR METAB, V97, pE1348, DOI 10.1210/jc.2012-1159; Out R, 2004, J LIPID RES, V45, P2088, DOI 10.1194/jlr.M400191-JLR200; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Perdomo G, 2009, AGING-US, V1, P17; Pereira RC, 2000, AM J PHYSIOL-ENDOC M, V279, pE570, DOI 10.1152/ajpendo.2000.279.3.E570; Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7; Pucci E, 2000, INT J OBESITY, V24, pS109, DOI 10.1038/sj.ijo.0801292; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; Regard JB, 2007, J CLIN INVEST, V117, P4034, DOI 10.1172/JCI32994; Rehfeldt C, 2010, AM J PHYSIOL-ENDOC M, V299, pE287, DOI 10.1152/ajpendo.00492.2009; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799; Saba A, 2010, ENDOCRINOLOGY, V151, P5063, DOI 10.1210/en.2010-0491; Safran M, 2003, NUCLEIC ACIDS RES, V31, P142, DOI 10.1093/nar/gkg050; Sato Y, 2007, DIABETOLOGIA, V50, P481, DOI 10.1007/s00125-006-0480-4; Scanlan TS, 2004, NAT MED, V10, P638, DOI 10.1038/nm1051; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Sharma P, 2013, J BIOL CHEM, V288, P16321, DOI 10.1074/jbc.M112.445569; SHUGART EC, 1995, CELL GROWTH DIFFER, V6, P1541; Sirinian MI, 2005, J BIOL CHEM, V280, P38416, DOI 10.1074/jbc.M504343200; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Snead AN, 2007, ACS CHEM BIOL, V2, P390, DOI 10.1021/cb700057b; STEYRER E, 1988, BIOCHIM BIOPHYS ACTA, V958, P484, DOI 10.1016/0005-2760(88)90235-4; Sugiyama T, 2000, BIOCHEMISTRY-US, V39, P15817, DOI 10.1021/bi001583s; Takaishi K, 2004, P NATL ACAD SCI USA, V101, P7106, DOI 10.1073/pnas.0401715101; Trigatti B, 2000, CURR OPIN LIPIDOL, V11, P123, DOI 10.1097/00041433-200004000-00004; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varanasi U, 1996, J BIOL CHEM, V271, P2147, DOI 10.1074/jbc.271.4.2147; Viguerie N, 2002, J CLIN ENDOCR METAB, V87, P630, DOI 10.1210/jc.87.2.630; Wang Z, 2009, ENDOCR J, V56, P1019, DOI 10.1507/endocrj.K09E-178; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; WISE EM, 1964, P NATL ACAD SCI USA, V52, P1255, DOI 10.1073/pnas.52.5.1255; Wu SY, 2005, THYROID, V15, P943, DOI 10.1089/thy.2005.15.943; Xie Zheng-gao, 2009, Zhong Xi Yi Jie He Xue Bao, V7, P940, DOI 10.3736/jcim20091006; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Yu BL, 2010, OBES REV, V11, P560, DOI 10.1111/j.1467-789X.2009.00699.x; Zhang Y, 2010, ONCOGENE, V29, P5404, DOI 10.1038/onc.2010.270; Zucchi R, 2006, BRIT J PHARMACOL, V149, P967, DOI 10.1038/sj.bjp.0706948	102	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e106923	10.1371/journal.pone.0106923	http://dx.doi.org/10.1371/journal.pone.0106923			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379707	Green Published, gold, Green Submitted			2022-12-27	WOS:000344863100002
J	Saito, K; Ishikawa, M; Murayama, M; Urata, M; Senoo, Y; Toyoshima, K; Kumagai, Y; Maekawa, K; Saito, Y				Saito, Kosuke; Ishikawa, Masaki; Murayama, Mayumi; Urata, Masayo; Senoo, Yuya; Toyoshima, Katsuko; Kumagai, Yuji; Maekawa, Keiko; Saito, Yoshiro			Effects of Sex, Age, and Fasting Conditions on Plasma Lipidomic Profiles of Fasted Sprague-Dawley Rats	PLOS ONE			English	Article							MASS-SPECTROMETRIC ANALYSIS; HEPATIC LIPOGENESIS; LUNG-CANCER; SERUM; METABOLOMICS; EXPRESSION; REVEALS; DISEASE; WOMEN	Circulating lipid molecules reflect biological processes in the body and, thus, are useful tools for preclinical estimation of the efficacy and safety of newly developed drugs. However, background information on profiles of circulating lipid molecules in preclinical animal models is limited. Therefore, we examined the effects of multiple factors such as sex (fasted male vs. female), age (fasted 10 vs. 30 weeks old), and feeding conditions (feeding vs. fasting, 16 vs. 22 hr fasting, 10 AM vs. 4 PM blood collection), on the global profiles of lipid molecules in plasma from Sprague-Dawley rats by using a lipidomic approach. Our assay platform determined 262 lipid molecules (68 phospholipids, 20 sphingolipids, 138 neutral lipids, and 36 polyunsaturated fatty acids and their metabolites) in rat plasma. Multivariate discriminant analysis (orthogonal partial least squares discriminant analysis) and heat maps of statistically significant lipid molecules revealed that the plasma lipid profiles in rats are predominantly influenced by feeding conditions, followed by sex and age. In addition, the fasting duration (16 vs. 22 hr fasting) or the time of blood collection (10 AM vs. 4 PM blood collection) has limited or no contribution on the profiles of lipid molecules in rat plasma. Our results provide useful, fundamental information for exploring and validating biomarkers in future preclinical studies and may help to establish regulatory standards for such studies.	[Saito, Kosuke; Ishikawa, Masaki; Murayama, Mayumi; Urata, Masayo; Senoo, Yuya; Toyoshima, Katsuko; Maekawa, Keiko; Saito, Yoshiro] Natl Inst Hlth Sci, Div Med Safety Sci, Setagaya Ku, Tokyo, Japan; [Kumagai, Yuji] Kitasato Univ, Sch Med, Clin Res Ctr, Minami Ku, Sagamihara, Kanagawa 228, Japan	National Institute of Health Sciences - Japan; Kitasato University	Maekawa, K (corresponding author), Natl Inst Hlth Sci, Div Med Safety Sci, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo, Japan.	maekawa@nihs.go.jp	Saito, Kosuke/AAI-2878-2020		Health Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare [028]; Advanced Research for Products Mining Program from the National Institute of Biomedical Innovation of Japan [10-45]	Health Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare; Advanced Research for Products Mining Program from the National Institute of Biomedical Innovation of Japan	This work was supported by the Health Labour Sciences Research Grants (grant number 028) from the Ministry of Health, Labour and Welfare (http://www.mhlw.go.jp/), and by the Advanced Research for Products Mining Program (grant number 10-45) from the National Institute of Biomedical Innovation of Japan (http://www.nibio.go.jp/). YS received the fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia A, 2004, MOL ENDOCRINOL, V18, P747, DOI 10.1210/me.2003-0138; Alessandri JM, 2012, EUR J NUTR, V51, P199, DOI 10.1007/s00394-011-0208-1; DASHTI N, 1983, J LIPID RES, V24, P368; Demirkan A, 2013, J PSYCHIATR RES, V47, P357, DOI 10.1016/j.jpsychires.2012.11.001; Gonzalez-Covarrubias V, 2013, METABOLOMICS, V9, P337, DOI 10.1007/s11306-012-0450-4; Graessler J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006261; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Hewitt KN, 2003, ENDOCRINOLOGY, V144, P3895, DOI 10.1210/en.2003-0244; Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025; Hori S, 2011, LUNG CANCER, V74, P284, DOI 10.1016/j.lungcan.2011.02.008; Houjou T, 2005, RAPID COMMUN MASS SP, V19, P654, DOI 10.1002/rcm.1836; Ikeda A, 2012, BIOMED CHROMATOGR, V26, P548, DOI 10.1002/bmc.1671; Ishikawa M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091806; Ishikawa M, 2013, BIOL PHARM BULL, V36, P682; Kamp H, 2012, BIOANALYSIS, V4, P2291, DOI [10.4155/BIO.12.214, 10.4155/bio.12.214]; Kotronen A, 2010, OBESITY, V18, P937, DOI 10.1038/oby.2009.326; Liu JY, 2010, P NATL ACAD SCI USA, V107, P17017, DOI 10.1073/pnas.1011278107; Liu SH, 2013, NATURE, V502, P550, DOI 10.1038/nature12710; Menni C, 2013, METABOLOMICS, V9, P506, DOI 10.1007/s11306-012-0469-6; Nikkila Janne, 2008, Mol Syst Biol, V4, P197, DOI 10.1038/msb.2008.34; Pei WD, 2006, J ENDOCRINOL, V190, P261, DOI 10.1677/joe.1.06803; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Singh SS, 2006, CURR DRUG METAB, V7, P165, DOI 10.2174/138920006775541552; Sparvero LJ, 2010, J NEUROCHEM, V115, P1322, DOI 10.1111/j.1471-4159.2010.07055.x; Tajima Y, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-68; TSUCHIYA N, 1995, EXP ANIM TOKYO, V43, P671; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; Wedge DC, 2011, ANAL CHEM, V83, P6689, DOI 10.1021/ac2012224; Zivkovic AM, 2009, METABOLOMICS, V5, P507, DOI 10.1007/s11306-009-0174-2	30	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112266	10.1371/journal.pone.0112266	http://dx.doi.org/10.1371/journal.pone.0112266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375860	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402600123
J	Seebah, S; Fairfield, C; Ullrich, MS; Passow, U				Seebah, Shalin; Fairfield, Caitlin; Ullrich, Matthias S.; Passow, Uta			Aggregation and Sedimentation of Thalassiosira weissflogii (diatom) in a Warmer and More Acidified Future Ocean	PLOS ONE			English	Article							TRANSPARENT EXOPOLYMER PARTICLES; SINKING VELOCITY; EMILIANIA-HUXLEYI; ORGANIC-MATTER; GROWTH-RATE; CARBON; TEP; CO2; PHYTOPLANKTON; COAGULATION	Increasing Transparent Exopolymer Particle (TEP) formation during diatom blooms as a result of elevated temperature and pCO(2) have been suggested to result in enhanced aggregation and carbon flux, therewith potentially increasing the sequestration of carbon by the ocean. We present experimental results on TEP and aggregate formation by Thalassiosira weissflogii (diatom) in the presence or absence of bacteria under two temperature and three pCO(2) scenarios. During the aggregation phase of the experiment TEP formation was elevated at the higher temperature (20 degrees C vs. 15 degrees C), as predicted. However, in contrast to expectations based on the established relationship between TEP and aggregation, aggregation rates and sinking velocity of aggregates were depressed in warmer treatments, especially under ocean acidification conditions. If our experimental findings can be extrapolated to natural conditions, they would imply a reduction in carbon flux and potentially reduced carbon sequestration after diatom blooms in the future ocean.	[Seebah, Shalin; Ullrich, Matthias S.] Jacobs Univ Bremen, Mol Life Sci Res Ctr, D-28759 Bremen, Germany; [Fairfield, Caitlin; Passow, Uta] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA	Jacobs University; University of California System; University of California Santa Barbara	Passow, U (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA.	uta.passow@lifesci.ucsb.edu			National Science Foundation [OCE-0926711, OCE-1041038]; Helmholtz Graduate School for Polar and Marine Research; Jacobs University Bremen; Division Of Ocean Sciences [1041038] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Helmholtz Graduate School for Polar and Marine Research; Jacobs University Bremen; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by National Science Foundation grants OCE-0926711 & OCE-1041038 to UP and Helmholtz Graduate School for Polar and Marine Research and Jacobs University Bremen to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ALLDREDGE AL, 1993, DEEP-SEA RES PT I, V40, P1131, DOI 10.1016/0967-0637(93)90129-Q; Arrigo KR, 2007, NATURE, V450, P491, DOI 10.1038/450491a; Azetsu-Scott K, 2004, LIMNOL OCEANOGR, V49, P741, DOI 10.4319/lo.2004.49.3.0741; Bhaskar PV, 2005, FEMS MICROBIOL ECOL, V53, P255, DOI 10.1016/j.femsec.2004.12.013; Biermann A, 2010, BIOGEOSCIENCES, V7, P1017, DOI 10.5194/bg-7-1017-2010; Burd AB, 2009, ANNU REV MAR SCI, V1, P65, DOI 10.1146/annurev.marine.010908.163904; Claquin P, 2008, AQUAT MICROB ECOL, V51, P1, DOI 10.3354/ame01187; CLAYTON TD, 1993, DEEP-SEA RES PT I, V40, P2115, DOI 10.1016/0967-0637(93)90048-8; Cole, 1993, HDB METHODS AQUATIC, P117; CROCKER KM, 1995, MAR ECOL PROG SER, V117, P249, DOI 10.3354/meps117249; DECHO AW, 1990, OCEANOGR MAR BIOL, V28, P73; DECHO AW, 1995, SCI TOTAL ENVIRON, V165, P33, DOI 10.1016/0048-9697(95)04541-8; Dickson A. G., 2007, PICES SPEC PUB, V3, P1, DOI DOI 10.1159/000331784; Ding YX, 2009, TERR ATMOS OCEAN SCI, V20, P741, DOI 10.3319/TAO.2008.08.26.01(Oc); DURBIN EG, 1977, J PHYCOL, V13, P150, DOI 10.1111/j.1529-8817.1977.tb02904.x; Engel A, 1999, MAR ECOL PROG SER, V182, P69, DOI 10.3354/meps182069; Engel A, 2004, NATURE, V428, P929, DOI 10.1038/nature02453; Engel A, 2009, DEEP-SEA RES PT II, V56, P1408, DOI 10.1016/j.dsr2.2008.11.028; Engel A, 2009, DEEP-SEA RES PT II, V56, P1396, DOI 10.1016/j.dsr2.2008.11.027; Fangue NA, 2010, LIMNOL OCEANOGR-METH, V8, P441, DOI 10.4319/lom.2010.8.441; Frieder CA, 2012, BIOGEOSCIENCES, V9, P3917, DOI 10.5194/bg-9-3917-2012; Fukao T, 2012, J APPL PHYCOL, V24, P181, DOI 10.1007/s10811-011-9666-3; Gardes A, 2012, MAR ECOL PROG SER, V461, P1, DOI 10.3354/meps09894; Gardes A, 2011, ISME J, V5, P436, DOI 10.1038/ismej.2010.145; Gehlen M, 2007, BIOGEOSCIENCES, V4, P505, DOI 10.5194/bg-4-505-2007; Gehlen M, 2006, GEOPH RES ABSTR, V8, P3492; Grossart HP, 2006, ENVIRON MICROBIOL, V8, P1074, DOI 10.1111/j.1462-2920.2006.00999.x; Grossart HP, 2006, AQUAT MICROB ECOL, V42, P19, DOI 10.3354/ame042019; Guillard R.R.L., 1982, CULTURE MARINE INVER, P108; HEISSENBERGER A, 1994, MAR ECOL PROG SER, V111, P129, DOI 10.3354/meps111129; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Hoppe CJM, 2012, BIOGEOSCIENCES, V9, P2401, DOI 10.5194/bg-9-2401-2012; HOUGHTON J, 1995, SPECTROCHIM ACTA A, V51, P1391, DOI 10.1016/0584-8539(95)01485-3; Ishida Y, 2000, FISHERIES SCI, V66, P655, DOI 10.1046/j.1444-2906.2000.00105.x; Jackson GA, 1998, ENVIRON SCI TECHNOL, V32, P2805, DOI 10.1021/es980251w; JACKSON GA, 1990, DEEP-SEA RES, V37, P1197, DOI 10.1016/0198-0149(90)90038-W; JACKSON GA, 1995, DEEP-SEA RES PT II, V42, P215, DOI 10.1016/0967-0645(95)00015-I; Kaeppel EC, 2012, INT J SYST EVOL MICR, V62, P124, DOI 10.1099/ijs.0.030189-0; KESTER DR, 1967, LIMNOL OCEANOGR, V12, P176, DOI 10.4319/lo.1967.12.1.0176; KIORBOE T, 1994, J MAR RES, V52, P297, DOI 10.1357/0022240943077145; Lam PJ, 2007, DEEP-SEA RES PT II, V54, P601, DOI 10.1016/j.dsr2.2007.01.013; Lewis E., 1998, ORNLCDIAC105 US DEP; LOGAN BE, 1995, DEEP-SEA RES PT II, V42, P203, DOI 10.1016/0967-0645(95)00012-F; Mari X, 2008, BIOGEOSCIENCES, V5, P1023, DOI 10.5194/bg-5-1023-2008; Mejia LM, 2013, GEOCHIM COSMOCHIM AC, V123, P322, DOI 10.1016/j.gca.2013.06.011; Montagnes DJS, 2001, LIMNOL OCEANOGR, V46, P2008, DOI 10.4319/lo.2001.46.8.2008; MOPPER K, 1995, DEEP-SEA RES PT II, V42, P47, DOI 10.1016/0967-0645(95)00004-A; Moriceau B, 2007, MAR ECOL PROG SER, V333, P129, DOI 10.3354/meps333129; MYKLESTAD SM, 1995, SCI TOTAL ENVIRON, V165, P155, DOI 10.1016/0048-9697(95)04549-G; Passow U, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002579; Passow U, 1995, LIMNOL OCEANOGR, V40, P1326, DOI 10.4319/lo.1995.40.7.1326; Passow U, 2002, MAR ECOL PROG SER, V236, P1, DOI 10.3354/meps236001; Passow U, 2000, MAR ECOL PROG SER, V192, P1, DOI 10.3354/meps192001; PASSOW U, 1994, DEEP-SEA RES PT I, V41, P335, DOI 10.1016/0967-0637(94)90007-8; PASSOW U, 1995, DEEP-SEA RES PT II, V42, P99, DOI 10.1016/0967-0645(95)00006-C; Passow U, 2014, LIMNOL OCEANOGR, V59, P532, DOI 10.4319/lo.2014.59.2.0532; Passow U, 2012, MAR ECOL PROG SER, V470, P249, DOI 10.3354/meps09985; Passow U, 2012, MAR CHEM, V128, P72, DOI 10.1016/j.marchem.2011.10.004; Piontek J, 2009, AQUAT MICROB ECOL, V54, P305, DOI 10.3354/ame01273; Ploug H, 2010, LIMNOL OCEANOGR-METH, V8, P386, DOI 10.4319/lom.2010.8.386; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Raymont J.E.G., 1980, PLANKTON PRODUCTIVIT; Richardson TL, 1995, MAR ECOL PROG SER, V128, P77, DOI 10.3354/meps128077; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; ROY RN, 1993, MAR CHEM, V44, P249, DOI 10.1016/0304-4203(93)90207-5; SCHUSTER S, 1995, MAR ECOL PROG SER, V124, P227, DOI 10.3354/meps124227; Simon M, 2002, AQUAT MICROB ECOL, V28, P175, DOI 10.3354/ame028175; SMITH DC, 1995, DEEP-SEA RES PT II, V42, P75, DOI 10.1016/0967-0645(95)00005-B; Taucher J, 2014, GLOBAL BIOGEOCHEMICA, V28; Thornton DCO, 1998, MAR ECOL PROG SER, V174, P223, DOI 10.3354/meps174223; Venrick EL, 1998, MAR ECOL PROG SER, V167, P73, DOI 10.3354/meps167073; Verdugo P, 2012, ANNU REV MAR SCI, V4, P375, DOI 10.1146/annurev-marine-120709-142759; Verdugo P, 2010, DEEP-SEA RES PT II, V57, P1486, DOI 10.1016/j.dsr2.2010.03.002; Zeebe R. E., 2001, CO2 SEAWATER EQUILIB; Zhou J, 1998, LIMNOL OCEANOGR, V43, P1860	76	35	35	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112379	10.1371/journal.pone.0112379	http://dx.doi.org/10.1371/journal.pone.0112379			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375640	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402600139
J	Razavi, M; Shepard, DS; Suaya, JA; Stason, WB				Razavi, Moaven; Shepard, Donald S.; Suaya, Jose A.; Stason, William B.			Postoperative Staphylococcus aureus Infections in Medicare Beneficiaries	PLOS ONE			English	Article							RISK-FACTORS; MRSA	Staphylococcus aureus (S. aureus) infections are important because of their increasing frequency, resistance to antibiotics, and high associated rates of disabilities and deaths. We examined the incidence and correlates of S. aureus infections following 219,958 major surgical procedures in a 5% random sample of fee-for-service Medicare beneficiaries from 2004-2007. Of these surgical patients, 0.3% had S. aureus infections during the hospitalizations when index surgical procedures were performed; and 1.7% and 2.3%, respectively, were hospitalized with infections within 60 days or 180 days following admissions for index surgeries. S. aureus infections occurred within 180 days in 1.9% of patients following coronary artery bypass graft surgery, 2.3% following hip surgery, and 5.9% following gastric or esophageal surgery. Of patients first hospitalized with any major infection reported during the first 180 days after index surgery, 15% of infections were due to S. aureus, 18% to other documented organisms, and no specific organism was reported on claim forms in 67%. Patient-level predictors of S. aureus infections included transfer from skilled nursing facilities or chronic hospitals and comorbid conditions (e. g., diabetes, congestive heart failure, chronic obstructive pulmonary disease, and chronic renal disease). In a logarithmic regression, elective index admissions with S. aureus infection stayed 130% longer than comparable patients without that infection. Within 180 days of the index surgery, 23.9% of patients with S. aureus infection and 10.6% of patients without this infection had died. In a multivariate logistic regression of death within 180 days of admission for the index surgery with adjustment for demographics, co-morbidities, and other risks, S. aureus was associated with a 42% excess risk of death. Due to incomplete documentation of organisms in Medicare claims, these statistics may underestimate the magnitude of S. aureus infection. Nevertheless, this study generated a higher rate of S. aureus infections than previous studies.	[Razavi, Moaven; Shepard, Donald S.; Stason, William B.] Brandeis Univ, Heller Sch Social Policy & Management, Schneider Inst Hlth Policy, Waltham, MA 02453 USA; [Suaya, Jose A.] GlaxoSmithKline, Philadelphia, PA USA	Brandeis University; GlaxoSmithKline	Shepard, DS (corresponding author), Brandeis Univ, Heller Sch Social Policy & Management, Schneider Inst Hlth Policy, Waltham, MA 02453 USA.	shepard@brandeis.edu			GlaxoSmithKline Biologicals SA; GlaxoSmithKline	GlaxoSmithKline Biologicals SA(GlaxoSmithKline); GlaxoSmithKline(GlaxoSmithKline)	GlaxoSmithKline Biologicals SA funded this study/research. GlaxoSmithKline Biologicals SA also undertook all costs associated with the development and publication of this manuscript. GlaxoSmithKline provided support in the form of salary for author JAS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Brandeis University received funding from GlaxoSmithKline Biologicals SA to fund part of the cost of this study.	Anderson DJ, 2010, INFECT CONT HOSP EP, V31, P701, DOI 10.1086/653205; Awad SS, 2009, AM J SURG, V198, P607, DOI 10.1016/j.amjsurg.2009.07.010; Centers for Medicare and Medicaid Services (CMS), 2013, CHR COND DAT WAR MED; Fowler VG, 2005, CIRCULATION, V112, pI358, DOI 10.1161/CIRCULATIONAHA.104.525790; Fukuta Y, 2012, INFECT CONT HOSP EP, V33, P1219, DOI 10.1086/668420; Goyal N, 2012, J KNEE SURG, V25, P37, DOI 10.1055/s-0031-1286194; Gupta K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053674; Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3; Hortal J, 2009, INTENS CARE MED, V35, P1518, DOI 10.1007/s00134-009-1523-3; Huotari K, 2006, INFECT CONT HOSP EP, V27, P1324, DOI 10.1086/509840; Ramarathnam V, 2013, AM J INFECT CONTROL, V41, P625, DOI 10.1016/j.ajic.2012.08.005; Ray GT, 2012, J CLIN MICROBIOL, V50, P1950, DOI 10.1128/JCM.00134-12; Shams WE, 2004, ORTHOPEDICS, V27, P565; Tadros MA, 2013, AM J INFECT CONTROL, V41, P509, DOI 10.1016/j.ajic.2012.07.016; ter Gunne AFP, 2010, SPINE, V35, P1323, DOI 10.1097/BRS.0b013e3181bcde61; Vilchez F, 2011, CLIN MICROBIOL INFEC, V17, P439, DOI 10.1111/j.1469-0691.2010.03244.x; Wallace WC, 2000, AM SURGEON, V66, P874	17	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e110133	10.1371/journal.pone.0110133	http://dx.doi.org/10.1371/journal.pone.0110133			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389782	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400011
J	Zhang, JQ; Meng, SY; Rao, GY				Zhang, Jian-Qiang; Meng, Shi-Yong; Rao, Guang-Yuan			Phylogeography of Rhodiola kirilowii (Crassulaceae): A Story of Miocene Divergence and Quaternary Expansion	PLOS ONE			English	Article							QINGHAI-TIBETAN PLATEAU; CHLOROPLAST INTERGENIC REGIONS; GENETIC CONSEQUENCES; POPULATION-GROWTH; HABITAT FRAGMENTATION; RAPID RADIATION; TRNL-F; DNA; EVOLUTION; UPLIFT	The evolution and current distribution of the Sino-Tibetan flora have been greatly affected by historical geological events, such as the uplift of the Qinghai-Tibetan Plateau (QTP), and Quaternary climatic oscillations. Rhodiola kirilowii, a perennial herb with its distribution ranging from the southeastern QTP and the Hengduan Mountains (HM) to adjacent northern China and central Asia, provides an excellent model to examine and disentangle the effect of both geological orogeny and climatic oscillation on the evolutionary history of species with such distribution patterns. We here conducted a phylogeographic study using sequences of two chloroplast fragments (trnL-F and trnS-G) and internal transcribed spacers in 29 populations of R. kirilowii. A total of 25 plastid haplotypes and 12 ITS ribotypes were found. Molecular clock estimation revealed deep divergence between the central Asian populations and other populations from the HM and northern China; this split occurred ca. 2.84 million year ago. The majority of populations from the mountains of northern China were dominated by a single haplotype or ribotype, while populations of the HM harbored both high genetic diversity and high haplotype diversity. This distribution pattern indicates that HM was either a diversification center or a refugium for R. kirilowii during the Quaternary climatic oscillations. The present distribution of this species on mountains in northern China may have resulted from a rapid glacial population expansion from the HM. This expansion was confirmed by the mismatch distribution analysis and negative Tajima's D and Fu's FS values, and was dated to ca. 168 thousand years ago. High genetic diversity and population differentiation in both plastid and ITS sequences were revealed; these imply restricted gene flow between populations. A distinct isolation-by-distance pattern was suggested by the Mantel test. Our results show that in old lineages, populations may harbour divergent genetic forms that are sufficient to maintain or even increase overall genetic diversity despite fragmentation and low within-population variation.	[Zhang, Jian-Qiang; Meng, Shi-Yong; Rao, Guang-Yuan] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China	Peking University	Rao, GY (corresponding author), Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China.	rao@pku.edu.cn		Meng, Shiyong/0000-0002-6855-2990	National Natural Science Foundation of China [31470313]; China Scholarship Council [201206010113]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This research was supported by National Natural Science Foundation of China (Grant no. 31470313). JQZ has been supported by a scholarship for exchanging PhD candidates from the China Scholarship Council (No. 201206010113) for his studies at the Smithsonian Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2008, MOL ECOL, V17, P5177, DOI 10.1111/j.1365-294X.2008.03971.x; An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Boufford D. E., 2004, HOTSPOTS REVISITED E, P159; Boufford D. E., 2000, HOTSPOTS EARTHS BIOL, P338; CARSON HL, 1990, TRENDS ECOL EVOL, V5, P228, DOI 10.1016/0169-5347(90)90137-3; Chen ST, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-58; Chen SY, 2008, BOT J LINN SOC, V157, P125, DOI 10.1111/j.1095-8339.2008.00785.x; Cun YZ, 2010, MOL PHYLOGENET EVOL, V56, P972, DOI 10.1016/j.ympev.2010.05.007; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Frei ES, 2012, ALPINE BOT, V122, P23, DOI 10.1007/s00035-012-0103-2; Fu K. T., 2001, FLORA CHINA, V8, P202, DOI DOI 10.11646/PHYTOTAXA.292.2.5; Fu YX, 1997, GENETICS, V147, P915; Gao LM, 2007, MOL ECOL, V16, P4684, DOI 10.1111/j.1365-294X.2007.03537.x; Gao QB, 2012, BOT J LINN SOC, V168, P204, DOI 10.1111/j.1095-8339.2011.01193.x; Gao YD, 2013, MOL PHYLOGENET EVOL, V68, P443, DOI 10.1016/j.ympev.2013.04.026; Guo ZT, 2002, NATURE, V416, P159, DOI 10.1038/416159a; Hamilton MB, 1999, MOL ECOL, V8, P521; HARPENDING HC, 1994, HUM BIOL, V66, P591; HARRISON TM, 1992, SCIENCE, V255, P1663, DOI 10.1126/science.255.5052.1663; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hou Y, 2013, J HERED, V105, P101; Hou Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024497; Jia DR, 2012, NEW PHYTOL, V194, P1123, DOI 10.1111/j.1469-8137.2012.04115.x; Jia DR, 2011, BIOL J LINN SOC, V102, P37, DOI 10.1111/j.1095-8312.2010.01553.x; Li B.Y., 1987, J MT RES, V5, P74; Li BY., 1989, J MOUNTAIN RES, V7, P13; Li J., 1995, UPLIFT QINGHAI XIZAN; Li L, 2013, MOL ECOL, V22, P5237, DOI 10.1111/mec.12466; Li Y, 2011, MOL PHYLOGENET EVOL, V59, P412, DOI 10.1016/j.ympev.2011.01.009; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu J, 2013, NEW PHYTOL, V199, P1093, DOI 10.1111/nph.12336; Liu JQ, 2006, MOL PHYLOGENET EVOL, V38, P31, DOI 10.1016/j.ympev.2005.09.010; LIU KB, 1988, QUATERNARY SCI REV, V7, P1, DOI 10.1016/0277-3791(88)90089-3; Liu L, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085920, 10.1371/journal.pone.0088791]; Liu PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048970; Mayr E., 1942, P1; Mayuzumi S, 2004, SYST BOT, V29, P587, DOI 10.1600/0363644041744329; Meng HH, 2015, J SYST EVOL, V53, P33, DOI 10.1111/jse.12088; Meng LH, 2008, J SYST EVOL, V46, P32, DOI 10.3724/SP.J.1002.2008.07026; Meng LH, 2007, MOL ECOL, V16, P4128, DOI 10.1111/j.1365-294X.2007.03459.x; MOLNAR P, 1993, REV GEOPHYS, V31, P357, DOI 10.1029/93RG02030; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2006, NUCLEIC ACIDS RES, V34, pW700, DOI 10.1093/nar/gkl042; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schneider S, 1999, GENETICS, V152, P1079; Shi Y.F., 1998, UPLIFT ENV CHANGES Q; Shimono Y, 2009, AM J BOT, V96, P728, DOI 10.3732/ajb.0800242; SINGH JS, 1987, BOT REV, V53, P80, DOI 10.1007/BF02858183; Spicer RA, 2003, NATURE, V421, P622, DOI 10.1038/nature01356; Sun Hang, 2002, Acta Botanica Yunnanica, V24, P273; Sun YS, 2012, MOL PHYLOGENET EVOL, V63, P150, DOI 10.1016/j.ympev.2012.01.002; Swofford DL., 2003, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TAJIMA F, 1989, GENETICS, V123, P585; Tang L.Y., 1996, ACTA MICROPALAEONTOL, V44, P872; Tapponnier P, 2001, SCIENCE, V294, P1671, DOI 10.1126/science.105978; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang CS, 2008, P NATL ACAD SCI USA, V105, P4987, DOI 10.1073/pnas.0703595105; Wang LY, 2009, J INTEGR PLANT BIOL, V51, P698, DOI 10.1111/j.1744-7909.2009.00818.x; Wang LY, 2009, MOL ECOL, V18, P709, DOI 10.1111/j.1365-294X.2008.04055.x; Wang W, 1993, VASCULAR PLANTS HENG, V1; Wang W., 1994, VASCULAR PLANTS HENG, V2; Wang W.-T., 1992, ACTA PHYTOTAXONOMICA, V30, P97; WANG WT, 1992, ACTA PHYTOTAXON SIN, V30, P1, DOI DOI 10.4324/9780429500190-1; Wang YJ, 2007, ANN BOT-LONDON, V99, P311, DOI 10.1093/aob/mcl259; WILSON E O, 1992; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wu, 1980, VEGETATION CHINA; Wu ZY, 1987, FLORA XIZANGICA, P874; Wu ZY, 1988, J JPN BOT, V63, P1; Xu TT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-194; Yamane K, 2006, DNA RES, V13, P197, DOI 10.1093/dnares/dsl012; Yang FS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037196; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; YOUNG AG, 1993, HEREDITY, V71, P277, DOI 10.1038/hdy.1993.136; Zhang DF, 2000, ENVIRON GEOL, V39, P1352, DOI 10.1007/s002540000174; Zhang JQ, 2014, MOL PHYLOGENET EVOL, V77, P147, DOI 10.1016/j.ympev.2014.04.013; Zhang JQ, 2014, SYST BOT, V39, P441, DOI 10.1600/036364414X680753; Zhang Q, 2005, ACTA PHYTOTAXON SIN, V43, P503, DOI 10.1360/aps040148; Zhang TC, 2011, MOL PHYLOGENET EVOL, V60, P1, DOI 10.1016/j.ympev.2011.04.009; Zhang YH, 2010, MOL PHYLOGENET EVOL, V57, P1162, DOI 10.1016/j.ympev.2010.08.033; Zheng D, 1996, SCI CHINA SER D, V39, P410	97	20	20	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112923	10.1371/journal.pone.0112923	http://dx.doi.org/10.1371/journal.pone.0112923			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389750	Green Submitted, Green Published, gold			2022-12-27	WOS:000349144400143
J	Cai, M; Zhou, YH; Zhou, B; Lou, SJ				Cai, Ming; Zhou, Yuehui; Zhou, Bin; Lou, Shujie			Hypoxic Conditioned Medium from Rat Cerebral Cortical Cells Enhances the Proliferation and Differentiation of Neural Stem Cells Mainly through PI3-K/Akt Pathways	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; NEURONAL DIFFERENTIATION; EXPRESSION; NEUROGENESIS; OXYGEN; BDNF; VEGF; RECEPTORS; MIGRATION; ISCHEMIA	Purpose: To investigate the effects of hypoxic conditioned media from rat cerebral cortical cells on the proliferation and differentiation of neural stem cells (NSCs) in vitro, and to study the roles of PI3-K/Akt and JNK signal transduction pathways in these processes. Methods: Cerebral cortical cells from neonatal Sprague-Dawley rat were cultured under hypoxic and normoxic conditions; the supernatant was collected and named 'hypoxic conditioned medium' (HCM) and 'normoxic conditioned medium' (NCM), respectively. We detected the protein levels (by ELISA) of VEGF and BDNF in the conditioned media and mRNA levels (by RT-PCR) in cerebral cortical cells. The proliferation (number and size of neurospheres) and differentiation (proportion of neurons and astrocytes over total cells) of NSCs was assessed. LY294002 and SP600125, inhibitors of PI3-K/Akt and JNK, respectively, were applied, and the phosphorylation levels of PI3-K/Akt and JNK were measured by western blot. Results: The protein levels and mRNA expressions of VEGF and BDNF in 4% HCM and 1% HCM were both higher than that of those in NCM. The efficiency and speed of NSCs proliferation was enhanced in 4% HCM compared with 1% HCM. The highest percentage of neurons and lowest percentage of astrocytes was found in 4% HCM. However, the enhancement of NSCs proliferation and differentiation into neurons accelerated by 4% HCM was inhibited by LY294002 and SP600125, with LY294002 having a stronger inhibitory effect. The increased phosphorylation levels of PI3-K, Akt and JNK in 4% HCM were blocked by LY294002 and SP600125. Conclusions: 4% HCM could promote NSCs proliferation and differentiation into high percentage of neurons, these processes may be mainly through PI3-K/Akt pathways.	[Cai, Ming; Zhou, Yuehui; Lou, Shujie] Shanghai Univ Sport, Shanghai Key Lab Human Sport Competence Dev & Mai, Shanghai, Peoples R China; [Zhou, Bin] E Carolina Univ, Brody Sch Med, Dept Physiol, Greenville, NC USA	Shanghai University of Sport; University of North Carolina; East Carolina University	Lou, SJ (corresponding author), Shanghai Univ Sport, Shanghai Key Lab Human Sport Competence Dev & Mai, Shanghai, Peoples R China.	shujielou319@163.com			National Natural Science Foundation of China [30870349]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was funded by National Natural Science Foundation of China (No. 30870349). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Chanyshev B, 2012, MOL CELL BIOCHEM, V363, P167, DOI 10.1007/s11010-011-1169-7; Chavez-Valdez R, 2014, NEUROSCIENCE, V260, P106, DOI 10.1016/j.neuroscience.2013.12.023; Chen A, 2013, BIOMED REP, V1, P167, DOI 10.3892/br.2012.48; Dahl A, 2003, RAPID COMMUN MASS SP, V17, P2195, DOI 10.1002/rcm.1183; De Almodovar CR, 2009, PHYSIOL REV, V89, P607, DOI 10.1152/physrev.00031.2008; De Filippis L, 2011, CELL MOL LIFE SCI, V68, P2831, DOI 10.1007/s00018-011-0723-5; Demaurex N, 2009, NAT NEUROSCI, V12, P819, DOI 10.1038/nn0709-819; Fournier NM, 2012, NEUROPHARMACOLOGY, V63, P642, DOI 10.1016/j.neuropharm.2012.04.033; Gincberg G, 2012, BRIT MED BULL, V104, P7, DOI 10.1093/bmb/lds024; Go HS, 2009, NEUROIMMUNOMODULAT, V16, P365, DOI 10.1159/000228911; Greenberg DA, 2013, CELL MOL LIFE SCI, V70, P1753, DOI 10.1007/s00018-013-1282-8; Han Y, 2010, STEM CELLS, V28, P799, DOI 10.1002/stem.316; Helan M, 2014, J MOL CELL CARDIOL, V68, P89, DOI 10.1016/j.yjmcc.2014.01.006; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hogins J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025633; Horie N, 2008, CELL MOL NEUROBIOL, V28, P833, DOI 10.1007/s10571-007-9237-y; Hu JG, 2012, J MOL NEUROSCI, V46, P644, DOI 10.1007/s12031-011-9652-x; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Jun EK, 2014, INT J MOL SCI, V15, P605, DOI 10.3390/ijms15010605; Kaneko Y, 2003, OPHTHALMIC RES, V35, P268, DOI 10.1159/000072148; Kanzawa T, 2006, ONCOGENE, V25, P3638, DOI 10.1038/sj.onc.1209414; Lameu C, 2012, J BIOL CHEM, V287, P29690, DOI 10.1074/jbc.M111.338095; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022901; Licht T, 2013, CELL MOL LIFE SCI, V70, P1727, DOI 10.1007/s00018-013-1280-x; Lo Furno D, 2013, J CELL PHYSIOL, V228, P2109, DOI 10.1002/jcp.24386; Mani N, 2010, J NEUROSCI RES, V88, P248, DOI 10.1002/jnr.22197; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Margaritescu O, 2011, ROM J MORPHOL EMBRYO, V52, P1283; Miller GE, 2006, P NATL ACAD SCI USA, V103, P5496, DOI 10.1073/pnas.0506312103; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Otaegi G, 2006, J CELL SCI, V119, P2739, DOI 10.1242/jcs.03012; Pizzuti A, 2011, ARCH ITAL BIOL, V149, P113, DOI 10.4449/aib.v149i1.1266; Rodgers EE, 2002, INT J DEV NEUROSCI, V20, P187, DOI 10.1016/S0736-5748(02)00047-3; Samoilov M, 2014, ACTA HISTOCHEM, V116, P949, DOI 10.1016/j.acthis.2014.03.009; Santilli G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008575; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Spinella F, 2014, CARCINOGENESIS, V35, P840, DOI 10.1093/carcin/bgu018; Sun JQ, 2010, DEV DYNAM, V239, P2345, DOI 10.1002/dvdy.22377; Thomas K, 2005, CURR BIOL, V15, pR262, DOI 10.1016/j.cub.2005.03.023; Tonchev AB, 2011, ARCH ITAL BIOL, V149, P225, DOI 10.4449/aib.v149i2.1368; Uchida S, 2000, J NEUROSCI RES, V62, P585, DOI 10.1002/1097-4547(20001115)62:4<585::AID-JNR13>3.0.CO;2-U; Wada T, 2006, J NEUROSCI, V26, P6803, DOI 10.1523/JNEUROSCI.0526-06.2006; Wittko IM, 2009, J NEUROSCI, V29, P8704, DOI 10.1523/JNEUROSCI.5527-08.2009; Xu CS, 2013, SCI WORLD J, DOI 10.1155/2013/417413; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Ye PP, 2014, INT J MED SCI, V11, P17, DOI 10.7150/ijms.7329; Yung HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017894; Zhang K, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00005	49	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111938	10.1371/journal.pone.0111938	http://dx.doi.org/10.1371/journal.pone.0111938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386685	Green Published, Green Submitted, gold			2022-12-27	WOS:000345250400031
J	van Drongelen, J; de Vries, R; Lotgering, FK; Smits, P; Spaanderman, MEA				van Drongelen, Joris; de Vries, Rob; Lotgering, Frederik K.; Smits, Paul; Spaanderman, Marc E. A.			Functional Vascular Changes of the Kidney during Pregnancy in Animals: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							RENAL BLOOD-FLOW; NITRIC-OXIDE; ACUTE BLOCKADE; NATRIURETIC RESPONSE; MESENTERIC-ARTERIES; HEMODYNAMIC-CHANGES; ANGIOTENSIN-II; HYPERFILTRATION; VASODILATION; AUTOREGULATION	Renal vascular responses to pregnancy have frequently been studied, by investigating renal vascular resistance (RVR), renal flow, glomerular filtration rate (GFR), and renal artery responses to stimuli. Nonetheless, several questions remain: 1. Which vasodilator pathways are activated and to what extent do they affect RVR, renal flow and GFR across species, strains and gestational ages, 2. Are these changes dependent on renal artery adaptation, 3. At which cellular level does pregnancy affect the involved pathways? In an attempt to answer the questions raised, we performed a systematic review and meta-analysis on animal data. We included 37 studies (116 responses). At mid-gestation, RVR and GFR change to a similar degree across species and strains, accompanied by variable change in renal flow. At least in rats, changes depend on NO activation. At late gestation, changes in RVR, renal flow and GFR vary between species and strains. In rats, these changes are effectuated by sympathetic stimulation. Overall, renal artery responsiveness to stimuli is unaffected by pregnancy, except for Sprague Dawley rats in which pregnancy enhances renal artery vascular compliance and reduces renal artery myogenic reactivity. Our meta-analysis shows that: 1. Pregnancy changes RVR, renal flow and GFR dependent on NO-activation and sympathetic de-activation, but adjustments are different among species, strains and gestational ages; 2. These changes do not depend on adaptation of renal artery responsiveness; 3. It remains unknown at which cellular level pregnancy affects the pathways. Our meta-analysis suggests that renal changes during pregnancy in animals are qualitatively similar, even in comparison to humans, but quantitatively different.	[van Drongelen, Joris; Lotgering, Frederik K.; Spaanderman, Marc E. A.] Radboudumc, Dept Obstet & Gynecol, Nijmegen, Netherlands; [de Vries, Rob] Radboudumc, Systemat Review Ctr Lab Anim Experimentat, Nijmegen, Netherlands; [Smits, Paul] Radboudumc, Dept Pharmacol & Toxicol, Nijmegen, Netherlands; [Spaanderman, Marc E. A.] Maastricht Univ, Med Ctr, Res Sch GROW, Dept Obstet & Gynecol, Maastricht, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Maastricht University	van Drongelen, J (corresponding author), Radboudumc, Dept Obstet & Gynecol, Nijmegen, Netherlands.	joris.vandrongelen@radboudumc.nl	Lotgering, F.K./H-8069-2014; Smits, P.A.B.M./E-2889-2015					ANNIBALE DJ, 1989, AM J PHYSIOL, V256, pH1282, DOI 10.1152/ajpheart.1989.256.5.H1282; BAYLIS C, 1988, AM J PHYSIOL, V254, pF650, DOI 10.1152/ajprenal.1988.254.5.F650; BAYLIS C, 1986, AM J PHYSIOL, V250, pF308, DOI 10.1152/ajprenal.1986.250.2.F308; BAYLIS C, 1985, AM J PHYSIOL, V249, pF169, DOI 10.1152/ajprenal.1985.249.1.F169; BAYLIS C, 1995, HYPERTENS PREGNANCY, V14, P17, DOI 10.3109/10641959509058047; BAYLIS C, 1993, HYPERTENS PREGNANCY, V12, P93; Baylis C, 1998, CLIN PHYSL OBSTET, P263; Bobadilla RA, 2005, P W PHARMACOL SOC, V48, P49; Bobadilla RA, 2003, CAN J PHYSIOL PHARM, V81, P1, DOI 10.1139/Y02-168; Bobadilla RA, 2001, P W PHARMACOL SOC, V44, P43; Borenstein M, 2009, INTRO META ANAL; Busse R, 2002, TRENDS PHARMACOL SCI, V23, P374, DOI 10.1016/S0165-6147(02)02050-3; CHA SC, 1993, HYPERTENS PREGNANCY, V12, P71, DOI 10.3109/10641959309031054; CHA SC, 1993, AM J PHYSIOL, V265, pF278, DOI 10.1152/ajprenal.1993.265.2.F278; CHESLEY LC, 1965, AM J OBSTET GYNECOL, V91, P837, DOI 10.1016/0002-9378(65)90462-X; Chu ZM, 1997, BRIT J PHARMACOL, V122, P307, DOI 10.1038/sj.bjp.0701363; Conrad KP, 1999, AM J PHYSIOL-RENAL, V276, pF767, DOI 10.1152/ajprenal.1999.276.5.F767; CONRAD KP, 1989, AM J OBSTET GYNECOL, V161, P1065, DOI 10.1016/0002-9378(89)90785-0; DANIELSON LA, 1995, J CLIN INVEST, V96, P482, DOI 10.1172/JCI118059; Danielson LA, 1996, CIRC RES, V79, P1161, DOI 10.1161/01.RES.79.6.1161; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fan L, 1996, AM J PHYSIOL-REG I, V270, pR1132, DOI 10.1152/ajpregu.1996.270.5.R1132; Feletou M., 2011, THE ENDOTHELIUM 1, P19; FERRIS TF, 1983, J CLIN INVEST, V71, P809, DOI 10.1172/JCI110834; Gandley RE, 2001, AM J PHYSIOL-REG I, V280, pR1, DOI 10.1152/ajpregu.2001.280.1.R1; Gandley RE, 1997, AM J PHYSIOL-REG I, V273, pR22, DOI 10.1152/ajpregu.1997.273.1.R22; Greenberg SG, 1999, AM J PHYSIOL-REG I, V277, pR996, DOI 10.1152/ajpregu.1999.277.4.R996; GRIGGS KC, 1993, AM J PHYSIOL, V265, pF309, DOI 10.1152/ajprenal.1993.265.2.F309; Hines T, 2000, AM J PHYSIOL-REG I, V278, pR171, DOI 10.1152/ajpregu.2000.278.1.R171; HINES T, 1992, AM J PHYSIOL, V262, pR604, DOI 10.1152/ajpregu.1992.262.4.R604; Hooijmans CR, 2010, ATLA-ALTERN LAB ANIM, V38, P167, DOI 10.1177/026119291003800208; KIM TH, 1994, AM J PHYSIOL, V267, pH41, DOI 10.1152/ajpheart.1994.267.1.H41; Knight S, 2007, AM J PHYSIOL-RENAL, V292, pF655, DOI 10.1152/ajprenal.00309.2006; KUCZYNSKA-SICINSKA J, 1972, Polish Medical Journal (English Translation of Polskie Archiwum Medycyny Wewnetrznej), V11, P1113; MASILAMANI S, 1994, AM J PHYSIOL-REG I, V267, pR1611, DOI 10.1152/ajpregu.1994.267.6.R1611; McElvy S, 2001, AM J PHYSIOL-HEART C, V281, pH804, DOI 10.1152/ajpheart.2001.281.2.H804; MCLAUGHLIN MK, 1986, AM J OBSTET GYNECOL, V155, P1296, DOI 10.1016/0002-9378(86)90163-8; Morello F, 2009, CARDIOVASC RES, V82, P261, DOI 10.1093/cvr/cvn325; Novak J, 2001, J CLIN INVEST, V107, P1469, DOI 10.1172/JCI11975; Novak J, 1997, HYPERTENSION, V30, P580, DOI 10.1161/01.HYP.30.3.580; Ogueh O, 2011, HYPERTENS PREGNANCY, V30, P243, DOI 10.3109/10641955.2010.484079; OHNO M, 1993, CIRCULATION, V88, P193, DOI 10.1161/01.CIR.88.1.193; Omer S, 1999, J ENDOCRINOL, V161, P15, DOI 10.1677/joe.0.1610015; Parkington HC, 2004, PHARMACOL RES, V49, P509, DOI 10.1016/j.phrs.2003.11.012; PATEL KP, 1993, P SOC EXP BIOL MED, V203, P150; RECKELHOFF JF, 1992, AM J OBSTET GYNECOL, V166, P1546, DOI 10.1016/0002-9378(92)91632-K; Ren YL, 2009, PEDIATR NEPHROL, V24, P31, DOI 10.1007/s00467-008-0852-8; Sen AP, 1997, ARTIF CELL BLOOD SUB, V25, P275, DOI 10.3109/10731199709118917; Sladek SM, 1997, AM J PHYSIOL-REG I, V272, pR441, DOI 10.1152/ajpregu.1997.272.2.R441; Slangen BFM, 1996, AM J PHYSIOL-HEART C, V270, pH1779, DOI 10.1152/ajpheart.1996.270.5.H1779; Stanton BA, 1998, PHYSIOLOGY, P677; STURGISS SN, 1994, BAILLIERE CLIN OB GY, V8, P209, DOI 10.1016/S0950-3552(05)80319-0; van Drongelen J, 2012, AM J PHYSIOL-HEART C, V303, pH639, DOI 10.1152/ajpheart.00617.2011; van Drongelen J, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.020; van Eijndhoven HWF, 2007, REPROD SCI, V14, P771, DOI 10.1177/1933719107308335; van Eijndhoven HWF, 2003, J VASC RES, V40, P344, DOI 10.1159/000072698; Weber K, 2009, DIFFERENCES RAT STRA; WOODS LL, 1987, AM J PHYSIOL, V252, pR69, DOI 10.1152/ajpregu.1987.252.1.R69	59	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112084	10.1371/journal.pone.0112084	http://dx.doi.org/10.1371/journal.pone.0112084			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386682	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400038
J	Wernet, MF; Klovstad, M; Clandinin, TR				Wernet, Mathias F.; Klovstad, Martha; Clandinin, Thomas R.			A Drosophila Toolkit for the Visualization and Quantification of Viral Replication Launched from Transgenic Genomes	PLOS ONE			English	Article							SINDBIS-VIRUS; SUPERINFECTION EXCLUSION; GENE-EXPRESSION; DENGUE VIRUS; INTERFERENCE; PROTEIN; CELLS; RNAI; ALPHAVIRUSES; VECTORS	Arthropod RNA viruses pose a serious threat to human health, yet many aspects of their replication cycle remain incompletely understood. Here we describe a versatile Drosophila toolkit of transgenic, self-replicating genomes ('replicons') from Sindbis virus that allow rapid visualization and quantification of viral replication in vivo. We generated replicons expressing Luciferase for the quantification of viral replication, serving as useful new tools for large-scale genetic screens for identifying cellular pathways that influence viral replication. We also present a new binary system in which replication-deficient viral genomes can be activated 'in trans', through co-expression of an intact replicon contributing an RNA- dependent RNA polymerase. The utility of this toolkit for studying virus biology is demonstrated by the observation of stochastic exclusion between replicons expressing different fluorescent proteins, when co-expressed under control of the same cellular promoter. This process is analogous to 'superinfection exclusion' between virus particles in cell culture, a process that is incompletely understood. We show that viral polymerases strongly prefer to replicate the genome that encoded them, and that almost invariably only a single virus genome is stochastically chosen for replication in each cell. Our in vivo system now makes this process amenable to detailed genetic dissection. Thus, this toolkit allows the cell-type specific, quantitative study of viral replication in a genetic model organism, opening new avenues for molecular, genetic and pharmacological dissection of virus biology and tool development.	[Wernet, Mathias F.; Klovstad, Martha; Clandinin, Thomas R.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Clandinin, TR (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	trc@stanford.edu			Helen Hay Whitney Foundation; National Institutes of Health Director's Pioneer Award [DP1 OD003530]; National Institutes of Health of the United States of America [R21NS081507]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS081507] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003530] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; National Institutes of Health Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health of the United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by a post-doctoral fellowship from the Helen Hay Whitney Foundation (www. hhwf. org) to MFW; a National Institutes of Health Director's Pioneer Award (DP1 OD003530) to TRC; an R21NS081507 grant to TRC of the National Institutes of Health of the United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RH, 1985, J VIROL, V54, P351, DOI 10.1128/JVI.54.2.351-357.1985; Avadhanula V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000582; Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; BRAND AH, 1993, DEVELOPMENT, V118, P401; BREDENBEEK PJ, 1993, J VIROL, V67, P6439, DOI 10.1128/JVI.67.11.6439-6446.1993; Chao JA, 2005, NAT STRUCT MOL BIOL, V12, P952, DOI 10.1038/nsmb1005; Claus C, 2007, J GEN VIROL, V88, P2769, DOI 10.1099/vir.0.83092-0; Cleton N, 2012, J CLIN VIROL, V55, P191, DOI 10.1016/j.jcv.2012.07.004; Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007436; Coutinho-Abreu IV, 2010, PARASITOL INT, V59, P1, DOI 10.1016/j.parint.2009.10.002; den Boon JA, 2010, CELL HOST MICROBE, V8, P77, DOI 10.1016/j.chom.2010.06.010; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; DITTMAR D, 1982, J GEN VIROL, V59, P273, DOI 10.1099/0022-1317-59-2-273; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Folimonova SY, 2012, J VIROL, V86, P5554, DOI 10.1128/JVI.00310-12; Frolova E, 1997, J VIROL, V71, P248, DOI 10.1128/JVI.71.1.248-258.1997; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; GEIGENMULLERGNIRKE U, 1991, P NATL ACAD SCI USA, V88, P3253, DOI 10.1073/pnas.88.8.3253; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hardy RW, 2005, J VIROL, V79, P4630, DOI 10.1128/JVI.79.8.4630-4639.2005; Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114; Hopkins KC, 2013, GENE DEV, V27, P1511, DOI 10.1101/gad.215384.113; Huang ZJ, 2013, J VIROL, V87, P4272, DOI 10.1128/JVI.03360-12; Hubalek Z, 2008, PARASITOL RES, V103, pS29, DOI 10.1007/s00436-008-1064-7; JOHNSTON RE, 1974, J VIROL, V14, P1076, DOI 10.1128/JVI.14.5.1076-1082.1974; Karpf AR, 1997, J VIROL, V71, P7119, DOI 10.1128/JVI.71.9.7119-7123.1997; LAWSON ND, 1995, P NATL ACAD SCI USA, V92, P4477, DOI 10.1073/pnas.92.10.4477; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; LEMM JA, 1993, J VIROL, V67, P1916, DOI 10.1128/JVI.67.4.1916-1926.1993; LEVIS R, 1986, CELL, V44, P137, DOI 10.1016/0092-8674(86)90492-7; LEVIS R, 1990, J VIROL, V64, P1726, DOI 10.1128/JVI.64.4.1726-1733.1990; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Marshall JM, 2009, PLOS MED, V6, P164, DOI 10.1371/journal.pmed.1000020; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; Niklasson B., 1988, ARBOVIRUSES EPIDEMIO, VIV, P168; Noueiry AO, 2007, J VIROL, V81, P11992, DOI 10.1128/JVI.01358-07; O'Reilly EK, 1998, VIROLOGY, V252, P287, DOI 10.1006/viro.1998.9463; Olson KE, 2000, INSECT MOL BIOL, V9, P57, DOI 10.1046/j.1365-2583.2000.00162.x; Patel RK, 2012, J VIROL, V86, P3595, DOI 10.1128/JVI.06625-11; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Ryman KD, 2008, IMMUNOL REV, V225, P27, DOI 10.1111/j.1600-065X.2008.00670.x; Schlesinger, 1986, TOGAVIRIDAE FLAVIVIR, P35, DOI 10.1007/978-1-4757-0785-4_3; SCHLESINGER S, 1993, TRENDS BIOTECHNOL, V11, P18, DOI 10.1016/0167-7799(93)90070-P; Schlesinger S, 1999, CURR OPIN BIOTECH, V10, P434, DOI 10.1016/S0958-1669(99)00006-3; Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009; STOLLAR V, 1973, J VIROL, V11, P592, DOI 10.1128/JVI.11.4.592-595.1973; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Tscherne DM, 2007, J VIROL, V81, P3693, DOI 10.1128/JVI.01748-06; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; WEISS B, 1989, J VIROL, V63, P5310, DOI 10.1128/JVI.63.12.5310-5318.1989; Wernet MF, 2014, CURR BIOL, V24, pR107, DOI 10.1016/j.cub.2013.12.009; XIONG C, 1989, SCIENCE, V243, P1188, DOI 10.1126/science.2922607; Xu J, 2014, DEV COMP IMMUNOL, V42, P67, DOI 10.1016/j.dci.2013.05.002; Zhu YP, 2008, RNA BIOL, V5, P65, DOI 10.4161/rna.5.2.6044; Zou G, 2011, ANTIVIR RES, V91, P11, DOI 10.1016/j.antiviral.2011.05.001; Zou G, 2009, J VIROL, V83, P11765, DOI 10.1128/JVI.01205-09	59	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112092	10.1371/journal.pone.0112092	http://dx.doi.org/10.1371/journal.pone.0112092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386852	gold, Green Published, Green Submitted			2022-12-27	WOS:000345250400040
J	Huang, KC; Sun, W; Wu, Y; Chen, MJ; Mohlke, KL; Lange, LA; Li, Y				Huang, Kuan-Chieh; Sun, Wei; Wu, Ying; Chen, Mengjie; Mohlke, Karen L.; Lange, Leslie A.; Li, Yun			Association Studies with Imputed Variants Using Expectation-Maximization Likelihood-Ratio Tests	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENOTYPE IMPUTATION; AFRICAN-AMERICANS; GENETIC-VARIATION; LOCI; METAANALYSIS; UNCERTAINTY; HAPLOTYPES; SEQUENCE; TRAITS	Genotype imputation has become standard practice in modern genetic studies. As sequencing-based reference panels continue to grow, increasingly more markers are being well or better imputed but at the same time, even more markers with relatively low minor allele frequency are being imputed with low imputation quality. Here, we propose new methods that incorporate imputation uncertainty for downstream association analysis, with improved power and/or computational efficiency. We consider two scenarios: I) when posterior probabilities of all potential genotypes are estimated; and II) when only the one-dimensional summary statistic, imputed dosage, is available. For scenario I, we have developed an expectation-maximization likelihood-ratio test for association based on posterior probabilities. When only imputed dosages are available (scenario II), we first sample the genotype probabilities from its posterior distribution given the dosages, and then apply the EM-LRT on the sampled probabilities. Our simulations show that type I error of the proposed EM-LRT methods under both scenarios are protected. Compared with existing methods, EM-LRT-Prob (for scenario I) offers optimal statistical power across a wide spectrum of MAF and imputation quality. EM-LRT-Dose (for scenario II) achieves a similar level of statistical power as EM-LRT-Prob and, outperforms the standard Dosage method, especially for markers with relatively low MAF or imputation quality. Applications to two real data sets, the Cebu Longitudinal Health and Nutrition Survey study and the Women's Health Initiative Study, provide further support to the validity and efficiency of our proposed methods.	[Huang, Kuan-Chieh; Sun, Wei; Chen, Mengjie; Li, Yun] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27514 USA; [Sun, Wei; Wu, Ying; Chen, Mengjie; Mohlke, Karen L.; Lange, Leslie A.; Li, Yun] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Li, Yun] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Li, Y (corresponding author), Univ N Carolina, Dept Biostat, Chapel Hill, NC 27514 USA.	yunli@med.unc.edu			NIH [R01HG006292, R01HG006703, R01DA030976]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006292, R01HG006703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030976] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported by NIH funding R01HG006292, R01HG006703, and R01DA030976. This study makes use of GWAS data generated by WHI. A full data collection and analysis, decision to publish, or preparation of the manuscript. listing of WHI investigators can be found at: (https://www.whi.org/researchers/SitePages/WHI%20Investigators.aspx) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar EF, 2013, BIOMETRICS, V69, P427, DOI 10.1111/biom.12006; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Auer PL, 2012, AM J HUM GENET, V91, P794, DOI 10.1016/j.ajhg.2012.08.031; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Bizon C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-85; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Croteau-Chonka DC, 2012, HUM MOL GENET, V21, P463, DOI 10.1093/hmg/ddr480; Dastani Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002607; Duan Q, 2013, BIOINFORMATICS, V29, P2744, DOI 10.1093/bioinformatics/btt477; Duan Q, 2013, BIOINFORMATICS, V29, P528, DOI 10.1093/bioinformatics/bts724; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Fuchsberger C, 2012, 62 ANN M AM SOC HUM; Futema M, 2012, J MED GENET, V49, P644, DOI 10.1136/jmedgenet-2012-101189; Gao Xiaoyi, 2012, Frontiers in Genetics, V3, P117, DOI 10.3389/fgene.2012.00117; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jiao S, 2011, GENET EPIDEMIOL, V35, P597, DOI 10.1002/gepi.20608; Kang J, 2013, BIOINFORMATICS, V29, P799, DOI 10.1093/bioinformatics/btt041; Kutalik Z, 2011, BIOSTATISTICS, V12, P1, DOI 10.1093/biostatistics/kxq039; LANDER ES, 1989, GENETICS, V121, P185; Lange LA, 2010, HUM MOL GENET, V19, P2050, DOI 10.1093/hmg/ddq062; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lin DY, 2008, AM J HUM GENET, V82, P444, DOI 10.1016/j.ajhg.2007.11.004; Liu EY, 2013, GENET EPIDEMIOL, V37, P25, DOI 10.1002/gepi.21690; Liu EY, 2012, GENET EPIDEMIOL, V36, P107, DOI 10.1002/gepi.21603; Liu KL, 2013, HUM HERED, V75, P2, DOI 10.1159/000349974; Marchini J, 2013, 63 ANN M AM SOC HUM; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Pei YF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010827; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sanna S, 2012, 62 ANN M AM SOC HUM; Wu Y, 2010, HUM MOL GENET, V19, P4955, DOI 10.1093/hmg/ddq423; Zhang P, 2013, GENETICS, V195, P319, DOI 10.1534/genetics.113.154591; Zheng J, 2011, GENET EPIDEMIOL, V35, P102, DOI 10.1002/gepi.20552	42	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e110679	10.1371/journal.pone.0110679	http://dx.doi.org/10.1371/journal.pone.0110679			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383782	Green Published, Green Submitted, gold			2022-12-27	WOS:000344816700009
J	Joya, X; Garcia-Algar, O; Vall, O; Pujades, C				Joya, Xavier; Garcia-Algar, Oscar; Vall, Oriol; Pujades, Cristina			Transient Exposure to Ethanol during Zebrafish Embryogenesis Results in Defects in Neuronal Differentiation: An Alternative Model System to Study FASD	PLOS ONE			English	Article							FETAL ALCOHOL SYNDROME; SONIC HEDGEHOG; MOTOR-NEURONS; HINDBRAIN DEVELOPMENT; PRENATAL EXPOSURE; CRITICAL PERIODS; STEM-CELLS; IN-VIVO; EXPRESSION; PROTEIN	Background: The exposure of the human embryo to ethanol results in a spectrum of disorders involving multiple organ systems, including the impairment of the development of the central nervous system (CNS). In spite of the importance for human health, the molecular basis of prenatal ethanol exposure remains poorly understood, mainly to the difficulty of sample collection. Zebrafish is now emerging as a powerful organism for the modeling and the study of human diseases. In this work, we have assessed the sensitivity of specific subsets of neurons to ethanol exposure during embryogenesis and we have visualized the sensitive embryonic developmental periods for specific neuronal groups by the use of different transgenic zebrafish lines. Methodology/Principal Findings: In order to evaluate the teratogenic effects of acute ethanol exposure, we exposed zebrafish embryos to ethanol in a given time window and analyzed the effects in neurogenesis, neuronal differentiation and brain patterning. Zebrafish larvae exposed to ethanol displayed small eyes and/or a reduction of the body length, phenotypical features similar to the observed in children with prenatal exposure to ethanol. When neuronal populations were analyzed, we observed a clear reduction in the number of differentiated neurons in the spinal cord upon ethanol exposure. There was a decrease in the population of sensory neurons mainly due to a decrease in cell proliferation and subsequent apoptosis during neuronal differentiation, with no effect in motoneuron specification. Conclusion: Our investigation highlights that transient exposure to ethanol during early embryonic development affects neuronal differentiation although does not result in defects in early neurogenesis. These results establish the use of zebrafish embryos as an alternative research model to elucidate the molecular mechanism(s) of ethanol-induced developmental toxicity at very early stages of embryonic development.	[Joya, Xavier; Garcia-Algar, Oscar; Vall, Oriol] Inst Hosp Mar Invest Med, Unitat Recerca Infancia & Entorn, Barcelona, Spain; [Joya, Xavier; Garcia-Algar, Oscar; Vall, Oriol] Inst Carlos III, Programa RETICS, Red Salud Maternoinfantil & Desarrollo SAMID, Madrid, Spain; [Garcia-Algar, Oscar; Vall, Oriol] Univ Autonoma Barcelona, Dept Pediat Ginecol & Obstet & Med Prevent, Bellaterra, Spain; [Pujades, Cristina] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain	Autonomous University of Barcelona; Pompeu Fabra University	Pujades, C (corresponding author), Univ Pompeu Fabra, Dept Expt & Hlth Sci, Parc Recerca Biomed Barcelona, Barcelona, Spain.	cristina.pujades@upf.edu	Pujades, Cristina/F-7908-2014	Pujades, Cristina/0000-0001-6423-7451; GARCIA-ALGAR, OSCAR/0000-0001-5708-4362	Fondo de Investigaciones Sanitarias (FIS) [PI10/02593, PI13/01135]; Red de Salud Materno-Infantil y del Desarrollo (SAMID) from the Instituto Carlos III (Spain) [RD12/0026/0003]; Mutua Madrilena [AP150572014]; Neuroscience Program at IMIM (Institut Hospital del Mar d'Investigacions Mediques); Generalitat de Catalunya (Spain) [2009SGR1388, 2014SGR584]; Spanish Ministry of Economy and Competitiveness [BFU2012-31994]	Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III); Red de Salud Materno-Infantil y del Desarrollo (SAMID) from the Instituto Carlos III (Spain); Mutua Madrilena; Neuroscience Program at IMIM (Institut Hospital del Mar d'Investigacions Mediques); Generalitat de Catalunya (Spain)(Generalitat de Catalunya); Spanish Ministry of Economy and Competitiveness(Spanish Government)	This study was supported by grants from Fondo de Investigaciones Sanitarias (FIS) (PI10/02593; PI13/01135) and Red de Salud Materno-Infantil y del Desarrollo (SAMID) (RD12/0026/0003) from the Instituto Carlos III (Spain), a grant from Mutua Madrilena (AP150572014), intramural funding of the Neuroscience Program at IMIM (Institut Hospital del Mar d'Investigacions Mediques), partially supported by Generalitat de Catalunya (Spain) (2009SGR1388; 2014SGR584) and from Spanish Ministry of Economy and Competitiveness (BFU2012-31994). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL EL, 1986, LANCET, V2, P1222; Ahlgren SC, 2002, P NATL ACAD SCI USA, V99, P10476, DOI 10.1073/pnas.162356199; Ali Shaukat, 2011, PLoS One, V6, pe20037, DOI 10.1371/journal.pone.0020037; Aoto K, 2008, BIRTH DEFECTS RES A, V82, P224, DOI 10.1002/bdra.20447; Arenzana FJ, 2006, NEUROTOXICOL TERATOL, V28, P342, DOI 10.1016/j.ntt.2006.02.001; Astley SJ, 1996, J PEDIATR-US, V129, P33, DOI 10.1016/S0022-3476(96)70187-7; Benz J, 2009, PAED CHILD HEALT-CAN, V14, P231, DOI 10.1093/pch/14.4.231; Bilotta J, 2004, NEUROTOXICOL TERATOL, V26, P737, DOI 10.1016/j.ntt.2004.06.011; Blader P, 1998, DEV BIOL, V201, P185, DOI 10.1006/dbio.1998.8995; Calzolari S, 2014, EMBO J, V33, P686, DOI 10.1002/embj.201386003; Carvan MJ, 2004, NEUROTOXICOL TERATOL, V26, P757, DOI 10.1016/j.ntt.2004.06.016; Church MW, 1997, ALCOHOL CLIN EXP RES, V21, P495; CLARREN SK, 1978, J PEDIATR-US, V92, P64, DOI 10.1016/S0022-3476(78)80072-9; Coffey CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053991; Distel M, 2009, P NATL ACAD SCI USA, V106, P13365, DOI 10.1073/pnas.0903060106; Dlugos CA, 2003, PHARMACOL BIOCHEM BE, V74, P471, DOI 10.1016/S0091-3057(02)01026-2; DRISCOLL CD, 1990, NEUROTOXICOL TERATOL, V12, P231, DOI 10.1016/0892-0362(90)90094-S; Eberhart JK, 2008, NAT GENET, V40, P290, DOI 10.1038/ng.82; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; Flentke GR, 2014, ALCOHOL CLIN EXP RES, V38, P1255, DOI 10.1111/acer.12360; Gemma S, 2007, NEUROSCI BIOBEHAV R, V31, P221, DOI 10.1016/j.neubiorev.2006.06.018; Gerlai R, 2000, PHARMACOL BIOCHEM BE, V67, P773, DOI 10.1016/S0091-3057(00)00422-6; Giles S, 2008, REPROD TOXICOL, V25, P224, DOI 10.1016/j.reprotox.2007.11.014; GUERRI C, 1990, NEUROCHEM RES, V15, P559, DOI 10.1007/BF00966217; Guo S, 2004, GENES BRAIN BEHAV, V3, P63, DOI 10.1046/j.1601-183X.2003.00053.x; Heaton MB, 1999, DEV NEUROSCI-BASEL, V21, P444, DOI 10.1159/000017412; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; JONES KL, 1973, LANCET, V2, P999; Kalberg WO, 2006, ALCOHOL CLIN EXP RES, V30, P2037, DOI 10.1111/j.1530-0277.2006.00250.x; Kanungo J, 2009, BIOCHEM BIOPH RES CO, V386, P263, DOI 10.1016/j.bbrc.2009.06.038; Kashyap B, 2007, VISUAL NEUROSCI, V24, P409, DOI 10.1017/S0952523807070423; Kim CH, 1996, NEUROSCI LETT, V216, P109, DOI 10.1016/0304-3940(96)13021-4; Loucks EJ, 2009, BIRTH DEFECTS RES A, V85, P556, DOI 10.1002/bdra.20564; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Marrs JA, 2010, ALCOHOL, V44, P707, DOI 10.1016/j.alcohol.2009.03.004; McCarthy N, 2013, DEVELOPMENT, V140, P3254, DOI 10.1242/dev.094938; McGraw HF, 2008, J NEUROSCI, V28, P12558, DOI 10.1523/JNEUROSCI.2079-08.2008; Ogony JW, 2013, STEM CELLS DEV, V22, P2196, DOI 10.1089/scd.2012.0513; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; PENNINGTON SN, 1983, NEUROBEH TOXICOL TER, V5, P259; Pinto-Teixeira F, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00033; Pittman AJ, 2008, DEVELOPMENT, V135, P2865, DOI 10.1242/dev.025049; Reimers MJ, 2006, NEUROTOXICOL TERATOL, V28, P497, DOI 10.1016/j.ntt.2006.05.007; Reimers MJ, 2004, NEUROTOXICOL TERATOL, V26, P769, DOI 10.1016/j.ntt.2004.06.012; Sapede D, 2012, J NEUROSCI, V32, P16424, DOI 10.1523/JNEUROSCI.3686-12.2012; Sato T, 2006, GENESIS, V44, P136, DOI 10.1002/gene.20196; Simmons RW, 2002, ALCOHOL CLIN EXP RES, V26, P1412, DOI 10.1097/01.ALC.0000030563.14827.29; STAISEY NL, 1983, J STUD ALCOHOL, V44, P262, DOI 10.15288/jsa.1983.44.262; STREISSGUTH AP, 1980, SCIENCE, V209, P353, DOI 10.1126/science.6992275; Stromland K, 2002, ALCOHOL ALCOHOLISM, V37, P2, DOI 10.1093/alcalc/37.1.2; SULIK KK, 1981, SCIENCE, V214, P936, DOI 10.1126/science.6795717; SULIK KK, 1988, DEVELOPMENT, V103, P213; Swartz ME, 2014, ALCOHOL CLIN EXP RES, V38, P694, DOI 10.1111/acer.12286; Sylvain NJ, 2011, NEUROTOXICOL TERATOL, V33, P313, DOI 10.1016/j.ntt.2010.12.001; Sylvain NJ, 2010, NEUROTOXICOL TERATOL, V32, P472, DOI 10.1016/j.ntt.2010.03.001; Talens-Visconti R, 2011, STEM CELLS DEV, V20, P327, DOI 10.1089/scd.2010.0037; TANABE Y, 1995, CURR BIOL, V5, P651, DOI 10.1016/S0960-9822(95)00130-8; Tingling JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069560; Vangipuram SD, 2012, ALCOHOL CLIN EXP RES, V36, P788, DOI 10.1111/j.1530-0277.2011.01682.x; Veldman MB, 2008, PEDIATR RES, V64, P470, DOI 10.1203/PDR.0b013e318186e609; Zhang CJ, 2014, NEUROTOXICOL TERATOL, V44, P70, DOI 10.1016/j.ntt.2014.06.001; Zhang CJ, 2013, BIRTH DEFECTS RES A, V97, P8, DOI 10.1002/bdra.23099; Zhang CJ, 2011, BIRTH DEFECTS RES A, V91, P129, DOI 10.1002/bdra.20766; Zhou FC, 2011, ALCOHOL CLIN EXP RES, V35, P735, DOI 10.1111/j.1530-0277.2010.01391.x	65	29	29	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112851	10.1371/journal.pone.0112851	http://dx.doi.org/10.1371/journal.pone.0112851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383948	Green Published, Green Submitted, gold			2022-12-27	WOS:000344816700100
J	Muller, VD; Soares, RO; dos Santos, NN; Trabuco, AC; Cintra, AC; Figueiredo, LT; Caliri, A; Sampaio, SV; Aquino, VH				Muller, Vanessa Danielle; Soares, Ricardo Oliveira; dos Santos-Junior, Nilton Nascimento; Trabuco, Amanda Cristina; Cintra, Adelia Cristina; Figueiredo, Luiz Tadeu; Caliri, Antonio; Sampaio, Suely Vilela; Aquino, Victor Hugo			Phospholipase A(2) Isolated from the Venom of Crotalus durissus terrificus Inactivates Dengue virus and Other Enveloped Viruses by Disrupting the Viral Envelope	PLOS ONE			English	Article							PRODUCT-DERIVED COMPOUNDS; NATURAL-PRODUCTS; INTERFACIAL CATALYSIS; BIOLOGICAL-ACTIVITIES; GLOBAL DISTRIBUTION; CRYSTAL-STRUCTURE; PROTEIN; CROTOXIN; DYNAMICS; ENZYME	The Flaviviridae family includes several virus pathogens associated with human diseases worldwide. Within this family, Dengue virus is the most serious threat to public health, especially in tropical and sub-tropical regions of the world. Currently, there are no vaccines or specific antiviral drugs against Dengue virus or against most of the viruses of this family. Therefore, the development of vaccines and the discovery of therapeutic compounds against the medically most important flaviviruses remain a global public health priority. We previously showed that phospholipase A(2) isolated from the venom of Crotalus durissus terrificus was able to inhibit Dengue virus and Yellow fever virus infection in Vero cells. Here, we present evidence that phospholipase A(2) has a direct effect on Dengue virus particles, inducing a partial exposure of genomic RNA, which strongly suggests inhibition via the cleavage of glycerophospholipids at the virus lipid bilayer envelope. This cleavage might induce a disruption of the lipid bilayer that causes a destabilization of the E proteins on the virus surface, resulting in inactivation. We show by computational analysis that phospholipase A(2) might gain access to the Dengue virus lipid bilayer through the pores found on each of the twenty 3-fold vertices of the E protein shell on the virus surface. In addition, phospholipase A(2) is able to inactivate other enveloped viruses, highlighting its potential as a natural product lead for developing broad-spectrum antiviral drugs.	[Muller, Vanessa Danielle; dos Santos-Junior, Nilton Nascimento; Trabuco, Amanda Cristina; Aquino, Victor Hugo] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Virol Lab, Dept Anal Clin Toxicol & Bromatol, Sao Paulo, Brazil; [Cintra, Adelia Cristina; Sampaio, Suely Vilela] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Lab Toxinol, Dept Anal Clin Toxicol & Bromatol, Sao Paulo, Brazil; [Soares, Ricardo Oliveira; Caliri, Antonio] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Fis & Quim, Sao Paulo, Brazil; [Figueiredo, Luiz Tadeu] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Ctr Pesquisa Virol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Aquino, VH (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Virol Lab, Dept Anal Clin Toxicol & Bromatol, Sao Paulo, Brazil.	vhugo@fcfrp.usp.br	Muller, Vanessa/J-8722-2013; caliri, antonio/A-3963-2012; Vilela, Suely/D-7429-2012; Aquino, Victor Hugo/C-1922-2012; Oliveira dos Santos Soares, Ricardo/A-9748-2013; SANTOS-JUNIOR, NILTON NASCIMENTO/C-6439-2015	Vilela, Suely/0000-0003-3274-180X; Aquino, Victor Hugo/0000-0003-1910-0776; SANTOS-JUNIOR, NILTON NASCIMENTO/0000-0003-2155-032X; O. S. Soares, Ricardo/0000-0003-1549-8182; Trabuco, Amanda Cristina/0000-0003-1512-1561	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2005/54855-0, 2008/50617-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) grant 2005/54855-0 and 2008/50617-6. VHA, SVS and LTF hold a scholarship from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahyayauch H, 2005, BIOCHEMISTRY-US, V44, P11592, DOI 10.1021/bi050715k; Aquino VH, 2006, AM J TROP MED HYG, V75, P710, DOI 10.4269/ajtmh.2006.75.710; Bailey P, 2001, Emerg Med (Fremantle), V13, P28, DOI 10.1046/j.1442-2026.2001.00174.x; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BERG OG, 1991, BIOCHEMISTRY-US, V30, P7283, DOI 10.1021/bi00243a034; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Borkow G, 1999, BIOCHEM BIOPH RES CO, V264, P63, DOI 10.1006/bbrc.1999.1483; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Butler MS, 2008, NAT PROD REP, V25, P475, DOI 10.1039/b514294f; Butler MS, 2005, NAT PROD REP, V22, P162, DOI 10.1039/b402985m; Davidsen J, 2002, BBA-BIOMEMBRANES, V1564, P256, DOI 10.1016/S0005-2736(02)00461-3; de Paula RC, 2009, PROTEIN PEPTIDE LETT, V16, P899, DOI 10.2174/092986609788923365; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; DRAYTON HA, 1961, NATURE, V192, P896, DOI 10.1038/192896a0; EGBERTSON MS, 1994, J MED CHEM, V37, P2537, DOI 10.1021/jm00042a007; FAURE G, 1993, EUR J BIOCHEM, V214, P491, DOI 10.1111/j.1432-1033.1993.tb17946.x; Fenard D, 1999, J CLIN INVEST, V104, P611, DOI 10.1172/JCI6915; Fenard D, 2001, MOL PHARMACOL, V60, P341, DOI 10.1124/mol.60.2.341; FERREIRA SH, 1970, BIOCHEMISTRY-US, V9, P2583, DOI 10.1021/bi00815a005; Fletcher J.E., 1997, VENOM PHOSPHOLIPASE, pxii; FURUKAWA Y, 1976, BIOCHIM BIOPHYS ACTA, V453, P48, DOI 10.1016/0005-2795(76)90249-X; Ganesan A, 2008, CURR OPIN CHEM BIOL, V12, P306, DOI 10.1016/j.cbpa.2008.03.016; dos Santos HWG, 2008, J MED VIROL, V80, P1426, DOI 10.1002/jmv.21203; GRAINGER DW, 1990, BIOCHIM BIOPHYS ACTA, V1023, P365, DOI 10.1016/0005-2736(90)90128-B; Grandbois M, 1998, BIOPHYS J, V74, P2398, DOI 10.1016/S0006-3495(98)77948-2; Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6; HENDON RA, 1971, P NATL ACAD SCI USA, V68, P1560, DOI 10.1073/pnas.68.7.1560; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; HUANG HC, 1984, TOXICON, V22, P207, DOI 10.1016/0041-0101(84)90021-7; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; JAIN MK, 1991, BIOCHEMISTRY-US, V30, P7330, DOI 10.1021/bi00243a038; JAIN MK, 1983, BIOCHIM BIOPHYS ACTA, V736, P157, DOI 10.1016/0005-2736(83)90279-1; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaptein SJF, 2010, ANTIMICROB AGENTS CH, V54, P5269, DOI 10.1128/AAC.00686-10; KENSIL CR, 1985, LIPIDS, V20, P80, DOI 10.1007/BF02534212; Kim JO, 2007, J VIROL, V81, P1444, DOI 10.1128/JVI.01790-06; KING H, 1948, J CHEM SOC, P265, DOI 10.1039/jr9480000265; Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; KOHN A, 1967, VIROLOGY, V31, P385, DOI 10.1016/0042-6822(67)90183-3; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Lee CH, 1997, J PEPT RES, V50, P25; Letson GW, 2010, HUM VACCINES, V6, P802, DOI 10.4161/hv.6.10.13018; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Marchi-Salvador DP, 2008, PROTEINS, V72, P883, DOI 10.1002/prot.21980; Muller VDM, 2012, TOXICON, V59, P507, DOI 10.1016/j.toxicon.2011.05.021; Mitsuishi M, 2006, BIOCHEM J, V393, P97, DOI 10.1042/BJ20050781; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Mukherjee AK, 1997, CELL MOL LIFE SCI, V53, P152, DOI 10.1007/PL00000586; NAKASHIMA KI, 1995, P NATL ACAD SCI USA, V92, P5605, DOI 10.1073/pnas.92.12.5605; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Nozaki Y, 1967, METHOD ENZYMOL, V11, P715, DOI DOI 10.1016/S0076-6879(67)11088-4; ONDETTI MA, 1971, BIOCHEMISTRY-US, V10, P4033, DOI 10.1021/bi00798a004; Pan YH, 2001, BIOCHEMISTRY-US, V40, P609, DOI 10.1021/bi002514g; PARRINELLO M, 1980, PHYS REV LETT, V45, P1196, DOI 10.1103/PhysRevLett.45.1196; Petricevich VL, 2003, TOXICON, V42, P143, DOI 10.1016/S0041-0101(03)00124-7; Piggot TJ, 2012, J CHEM THEORY COMPUT, V8, P4593, DOI 10.1021/ct3003157; Ray D, 2006, DRUG DISCOV, V1, P45; Russo R.R., 2014, J VIROL ANTIVIR RES, V3, P1, DOI DOI 10.1371/JOURNAL.PONE.0112351; Samy RP, 2012, CURR MED CHEM, V19, P6150; SCARBOROUGH RM, 1991, J BIOL CHEM, V266, P9359; Soares ROS, 2013, BBA-PROTEINS PROTEOM, V1834, P221, DOI 10.1016/j.bbapap.2012.09.007; THWIN MM, 1995, TOXICON, V33, P63, DOI 10.1016/0041-0101(94)00133-S; TSAI IH, 1987, BIOCHIM BIOPHYS ACTA, V916, P94, DOI 10.1016/0167-4838(87)90215-9; VANDEENEN LLM, 1963, BIOCHIM BIOPHYS ACTA, V67, P295; VISHWANATH BS, 1988, TOXICON, V26, P713, DOI 10.1016/0041-0101(88)90278-4; Ward RJ, 1998, TOXICON, V36, P1623, DOI 10.1016/S0041-0101(98)00155-X; Wendt A, 2014, CLIN PHARMACOL-ADV A, V6, P1, DOI 10.2147/CPAA.S30338; WILSCHUT JC, 1979, FEBS LETT, V98, P181, DOI 10.1016/0014-5793(79)80179-9; Yasumura Y, 1963, NIHON RINSHO, V21, P15; Yeagle P. L., 2011, STRUCTURE BIOL MEMBR; Zhang Q, 2012, J BIOL CHEM, V287, P40525, DOI 10.1074/jbc.M112.384446; Zhang XCG, 2009, ANTIVIR RES, V83, P21, DOI 10.1016/j.antiviral.2009.02.204; Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110	83	40	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112351	10.1371/journal.pone.0112351	http://dx.doi.org/10.1371/journal.pone.0112351			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383618	Green Published, gold, Green Submitted			2022-12-27	WOS:000344816700052
J	Pathania, AS; Kumar, S; Guru, SK; Bhushan, S; Sharma, PR; Aithagani, SK; Singh, PP; Vishwakarma, RA; Kumar, A; Malik, F				Pathania, Anup S.; Kumar, Suresh; Guru, Santosh K.; Bhushan, Shashi; Sharma, Parduman R.; Aithagani, Sravan K.; Singh, Parvinder P.; Vishwakarma, Ram A.; Kumar, Ajay; Malik, Fayaz			The Synthetic Tryptanthrin Analogue Suppresses STAT3 Signaling and Induces Caspase Dependent Apoptosis via ERK Up Regulation in Human Leukemia HL-60 Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; BREAST-CANCER CELLS; NATURAL-PRODUCTS; SERINE PHOSPHORYLATION; EPITHELIAL-CELLS; DRUG DISCOVERY; DEATH; DEGRADATION; PROLIFERATION; SENSITIZATION	Tryptanthrin is a natural product which has been reported to have several medicinal properties. In this study, we tried to investigate the detailed molecular mechanism of its bromo analogue (TBr), a potent cytotoxic agent in the induction of cancer cell death. It was found that TBr primarily targets STAT3 and ERK signaling during the induction of apoptosis in several human leukemia cell lines. In HL-60 cells, TBr treatment caused early down regulation of p-STAT3 with concomitant up regulation of p-ERK which led to the activation of intrinsic and extrinsic pathways of apoptosis. The mechanism of TBr mediated inhibition of p-STAT3 was found to be due to the activation of ubiquitin dependent degradation of tyrosine 705 and serine 727 p-STAT3. As IL-6 is the main driver of the STAT3 pathway, the effect of TBr on cell death was subdued when treated in the combination with IL-6 in HL60 cells. Interestingly, PD98059 significantly reduced the apoptotic effects of TBr, thus showing the direct involvement of p-ERK in TBr mediated cell death. It was further shown that apoptotic protein Bax silencing in HL-60 cells resists TBr mediated ERK dependent apoptosis. In summary, for the first time we report the mechanism of TBr mediated cell death in human leukemia cell lines by targeting STAT3 and ERK pathways.	[Pathania, Anup S.; Kumar, Suresh; Guru, Santosh K.; Bhushan, Shashi; Sharma, Parduman R.; Kumar, Ajay; Malik, Fayaz] Indian Inst Integrat Med, Dept Canc Pharmacol, Jammu, Jammu & Kashmir, India; [Singh, Parvinder P.; Vishwakarma, Ram A.] Indian Inst Integrat Med, Div Med Chem, Jammu, Jammu & Kashmir, India; [Pathania, Anup S.; Kumar, Suresh; Aithagani, Sravan K.] Acad Sci & Innovat Res AcSIR, New Delhi, India; [Malik, Fayaz] Univ Michigan, Expt Breast Canc Res Lab, Ann Arbor, MI 48109 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM); Academy of Scientific & Innovative Research (AcSIR); University of Michigan System; University of Michigan	Kumar, A (corresponding author), Indian Inst Integrat Med, Dept Canc Pharmacol, Jammu, Jammu & Kashmir, India.	ajaykmahajan@hotmail.com; fmalik@iiim.ac.in	Guru, Santosh/AAR-1558-2021; KUMAR, AJAY/ABC-6109-2021	Guru, Santosh/0000-0002-9287-1836; KUMAR, AJAY/0000-0002-3889-3049; pathania, Anup/0000-0002-1517-2919; Malik, Fayaz/0000-0001-5475-6610	Indian institute of Integrative Medicine; Council of scientific and Industrial Research Canal road Jammu, Jammu and Kashmir, India [180001]	Indian institute of Integrative Medicine; Council of scientific and Industrial Research Canal road Jammu, Jammu and Kashmir, India	The authors received financial support from the Indian institute of Integrative Medicine; Council of scientific and Industrial Research Canal road Jammu, Jammu and Kashmir 180001, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin ARMR, 2009, J CLIN ONCOL, V27, P2712, DOI 10.1200/JCO.2008.20.6235; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Buettner R, 2002, CLIN CANCER RES, V8, P945; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Chan HL, 2009, CELL MOL IMMUNOL, V6, P335, DOI 10.1038/cmi.2009.44; Chin YW, 2006, AAPS J, V8, pE239, DOI 10.1007/BF02854894; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; Daino H, 2000, BLOOD, V95, P2577; Ding BB, 2008, BLOOD, V111, P1515, DOI 10.1182/blood-2007-04-087734; Hamblin T, 2006, LEUKEMIA RES, V30, P649, DOI 10.1016/j.leukres.2005.10.023; HONDA G, 1979, PLANTA MED, V37, P172, DOI 10.1055/s-0028-1097320; Ishihara T, 2000, EUR J PHARMACOL, V407, P197, DOI 10.1016/S0014-2999(00)00674-9; Kim YK, 2005, J APPL TOXICOL, V25, P374, DOI 10.1002/jat.1081; Kimoto T, 2001, PATHOL INT, V51, P315, DOI 10.1046/j.1440-1827.2001.01204.x; Krasilnikov M, 2003, ONCOGENE, V22, P4092, DOI 10.1038/sj.onc.1206598; Krivogorsky B, 2008, ANTIMICROB AGENTS CH, V52, P4466, DOI 10.1128/AAC.00903-08; Lim CP, 1999, J BIOL CHEM, V274, P31055, DOI 10.1074/jbc.274.43.31055; Lin TS, 2000, ONCOGENE, V19, P2496, DOI 10.1038/sj.onc.1203486; Lucas DM, 2010, CURR DRUG TARGETS, V11, P812; Miao S, 2011, INT J MOL SCI, V12, P3831, DOI 10.3390/ijms12063831; Mondal S, 2012, ANTI-CANCER AGENT ME, V12, P49, DOI 10.2174/187152012798764697; Morales-Prieto DM, 2013, SCI WORLD J, DOI 10.1155/2013/259845; Nabeyrat E, 2003, AM J PHYSIOL-LUNG C, V284, pL1112, DOI 10.1152/ajplung.00178.2002; Park BG, 2005, TOXICOLOGY, V215, P115, DOI 10.1016/j.tox.2005.07.003; Pathania AS, 2013, APOPTOSIS, V18, P1561, DOI 10.1007/s10495-013-0889-4; Perry E, 2004, ONCOGENE, V23, P8908, DOI 10.1038/sj.onc.1208149; Recio MC, 2006, PLANTA MED, V72, P539, DOI 10.1055/s-2006-931562; Scovill J, 2002, ANTIMICROB AGENTS CH, V46, P882, DOI 10.1128/AAC.46.3.882-883.2002; Spiekermann K, 2001, EUR J HAEMATOL, V67, P63, DOI 10.1034/j.1600-0609.2001.t01-1-00385.x; Takei Y, 2003, BIOL PHARM BULL, V26, P365, DOI 10.1248/bpb.26.365; Ulane CM, 2003, J VIROL, V77, P6385, DOI 10.1128/JVI.77.11.6385-6393.2003; Vainchenker W, 2013, ONCOGENE, V32, P2601, DOI 10.1038/onc.2012.347; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yu ST, 2007, BIOCHEM BIOPH RES CO, V358, P79, DOI 10.1016/j.bbrc.2007.04.107; Yu ST, 2009, ANTI-CANCER DRUG, V20, P382, DOI 10.1097/CAD.0b013e32832a2cd4; Zheng AP, 2007, ENDOCRINOLOGY, V148, P2764, DOI 10.1210/en.2006-1269	36	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e110411	10.1371/journal.pone.0110411	http://dx.doi.org/10.1371/journal.pone.0110411			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383546	Green Submitted, gold, Green Published			2022-12-27	WOS:000344816700006
J	Singh, P; Zheng, XL				Singh, Pavneet; Zheng, Xi-Long			Dual Regulation of Myocardin Expression by Tumor Necrosis Factor-alpha in Vascular Smooth Muscle Cells	PLOS ONE			English	Article							MESSENGER-RNA STABILITY; NF-KAPPA-B; TNF-ALPHA; GENE-EXPRESSION; ACTIVATION; PROLIFERATION; INDUCTION; ATHEROSCLEROSIS; DIFFERENTIATION; TRISTETRAPROLIN	De-differentiation of vascular smooth muscle cells (VSMCs) plays a critical role in the development of atherosclerosis, a chronic inflammatory disease involving various cytokines such as tumor necrosis factor-alpha (TNF alpha). Myocardin is a co-factor of serum response factor (SRF) and is considered to be the master regulator of VSMC differentiation. It binds to SRF and regulates the expression of contractile proteins in VSMCs. Myocardin is also known to inhibit VSMC proliferation by inhibiting the NF-kappa B pathway, whereas TNF alpha is known to activate the NF-kappa B pathway in VSMCs. NF-kappa B activation has also been shown to inhibit myocardin expression and smooth muscle contractile marker genes. However, it is not definitively known whether TNF alpha regulates the expression and activity of myocardin in VSMCs. The current study aimed to investigate the role of TNF alpha in regulating myocardin and VSMC function. Our studies showed that TNF alpha down-regulated myocardin expression and activity in cultured VSMCs by activating the NF-kappa B pathway, resulting in decreased VSMC contractility and increased VSMC proliferation. Surprisingly, we also found that TNF alpha prevented myocardin mRNA degradation, and resulted in a further significant increase in myocardin expression and activity in differentiated VSMCs. Both the NF-kappa B and p44/42 MAPK pathways were involved in TNF alpha regulation of myocardin, which further increased the contractility of VSMCs. These differential effects of TNF alpha on myocardin seemingly depended on whether VSMCs were in a differentiated or dedifferentiated state. Taken together, our results demonstrate that TNF alpha differentially regulates myocardin expression and activity, which may play a key role in regulating VSMC functions.	[Singh, Pavneet; Zheng, Xi-Long] Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, Smooth Muscle Res Grp,Libin Cardiovasc Inst Alber, Calgary, AB, Canada	Libin Cardiovascular Institute Of Alberta; University of Calgary	Zheng, XL (corresponding author), Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, Smooth Muscle Res Grp,Libin Cardiovasc Inst Alber, Calgary, AB, Canada.	xlzheng@ucalgary.ca		Zheng, Xi-Long/0000-0002-0889-1827	Canadian Institutes of Health Research [CIHR MOP-119511]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by the Canadian Institutes of Health Research (CIHR MOP-119511 to X.-L. Z.) (http://www.cihr-irsc.gc.ca/e/193.html). X.-L.Z. is the recipient of a Senior Scholar Award of Alberta Innovates - Health Solutions (AIHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MS, 2013, J CEREBR BLOOD F MET, V33, P1564, DOI 10.1038/jcbfm.2013.109; Armstrong SJ, 2008, NEUROSCI LETT, V439, P42, DOI 10.1016/j.neulet.2008.04.091; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Chen J, 2011, ARTERIOSCL THROM VAS, V31, P368, DOI 10.1161/ATVBAHA.110.218149; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Croft D, 1999, AM J PATHOL, V154, P1149, DOI 10.1016/S0002-9440(10)65367-9; Deleault KM, 2008, MOL IMMUNOL, V45, P13, DOI 10.1016/j.molimm.2007.05.017; Deptala A, 1998, CYTOMETRY, V33, P376, DOI 10.1002/(SICI)1097-0320(19981101)33:3<376::AID-CYTO13>3.0.CO;2-Q; Gordon D, 1987, AM J CARDIOL, V59, p44A; Goto K, 2009, J PHARMACOL SCI, V110, P437, DOI 10.1254/jphs.09081FP; Halayko AJ, 2001, J APPL PHYSIOL, V90, P358, DOI 10.1152/jappl.2001.90.1.358; Hao HY, 2003, ARTERIOSCL THROM VAS, V23, P1510, DOI 10.1161/01.ATV.0000090130.85752.ED; HAYES MP, 1995, CYTOKINE, V7, P427, DOI 10.1006/cyto.1995.0058; Henness S, 2006, AM J PHYSIOL-LUNG C, V290, pL1283, DOI 10.1152/ajplung.00367.2005; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Huang JH, 2008, J CLIN INVEST, V118, P515, DOI [10.1172/JC133304, 10.1172/JCI33304]; Huang ZF, 2000, BIOCHEM PHARMACOL, V59, P187, DOI 10.1016/S0006-2952(99)00312-3; Jiang YL, 2010, J CELL PHYSIOL, V225, P506, DOI 10.1002/jcp.22230; Jones Edward, 2007, J Inflamm (Lond), V4, P23, DOI 10.1186/1476-9255-4-23; Le Roy F, 2001, J BIOL CHEM, V276, P48473, DOI 10.1074/jbc.M107482200; Lee SJ, 2011, MOL MED REP, V4, P337, DOI 10.3892/mmr.2011.420; Li SH, 2001, CIRC RES, V89, P517, DOI 10.1161/hh1801.097165; LIBBY P, 1992, NOUV REV FR HEMATOL, V34, pS47; Masuda K, 2013, P NATL ACAD SCI USA, V110, P9409, DOI 10.1073/pnas.1307419110; NG SB, 1994, J BIOL CHEM, V269, P19021; Ohama T, 2007, AM J PHYSIOL-GASTR L, V292, pG1429, DOI 10.1152/ajpgi.00315.2006; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Perez-Ortin JE, 2013, J MOL BIOL, V425, P3750, DOI 10.1016/j.jmb.2013.02.029; POBER JS, 1990, PHYSIOL REV, V70, P427, DOI 10.1152/physrev.1990.70.2.427; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sachs A, 1990, CURR OPIN CELL BIOL, V2, P1092, DOI 10.1016/0955-0674(90)90161-7; Selzman CH, 1999, ANN THORAC SURG, V67, P1227, DOI 10.1016/S0003-4975(99)00252-0; Tang RH, 2008, P NATL ACAD SCI USA, V105, P3362, DOI 10.1073/pnas.0705842105; Taurin S, 2009, J BIOL CHEM, V284, P33789, DOI 10.1074/jbc.M109.048983; Tobe M, 2003, BIOORGAN MED CHEM, V11, P3869, DOI 10.1016/S0968-0896(03)00438-3; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Yin H, 2011, J CELL PHYSIOL, V226, P1897, DOI 10.1002/jcp.22519; Yoshida T, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000230	40	12	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112120	10.1371/journal.pone.0112120	http://dx.doi.org/10.1371/journal.pone.0112120			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384061	Green Published, gold, Green Submitted			2022-12-27	WOS:000344816700031
J	Kouvonen, A; Koskinen, A; Varje, P; Kokkinen, L; De Vogli, R; Vaananen, A				Kouvonen, Anne; Koskinen, Aki; Varje, Pekka; Kokkinen, Lauri; De Vogli, Roberto; Vaananen, Ari			National Trends in Main Causes of Hospitalization: A Multi-Cohort Register Study of the Finnish Working-Age Population, 1976-2010	PLOS ONE			English	Article							SEX-SPECIFIC TRENDS; DISEASE; HEALTH; RATES; MORTALITY; SCOTLAND; DECLINE; BREAST; BACK; RISK	Background: The health transition theory argues that societal changes produce proportional changes in causes of disability and death. The aim of this study was to identify long-term changes in main causes of hospitalization in working-age population within a nation that has experienced considerable societal change. Methodology: National trends in all-cause hospitalization and hospitalizations for the five main diagnostic categories were investigated in the data obtained from the Finnish Hospital Discharge Register. The seven-cohort sample covered the period from 1976 to 2010 and consisted of 3,769,356 randomly selected Finnish residents, each cohort representing 25% sample of population aged 18 to 64 years. Principal Findings: Over the period of 35 years, the risk of hospitalization for cardiovascular diseases and respiratory diseases decreased. Hospitalization for musculoskeletal diseases increased whereas mental and behavioral hospitalizations slightly decreased. The risk of cancer hospitalization decreased marginally in men, whereas in women an upward trend was observed. Conclusions/Significance: A considerable health transition related to hospitalizations and a shift in the utilization of health care services of working-age men and women took place in Finland between 1976 and 2010.	[Kouvonen, Anne] Univ Helsinki, Dept Social Res, Helsinki, Finland; [Kouvonen, Anne] Univ Social Sci & Humanities, Fac Wroclaw, Wroclaw, Poland; [Kouvonen, Anne] Queens Univ Belfast, UKCRC Ctr Excellence Publ Hlth Northern Ireland, Belfast, Antrim, North Ireland; [Koskinen, Aki; Varje, Pekka; Kokkinen, Lauri; Vaananen, Ari] Finnish Inst Occupat Hlth, Helsinki, Finland; [Koskinen, Aki; Varje, Pekka; Kokkinen, Lauri; Vaananen, Ari] Finnish Inst Occupat Hlth, Tampere, Finland; [Varje, Pekka] Univ Helsinki, Dept Philosophy Hist Culture & Art Studies, Helsinki, Finland; [De Vogli, Roberto] Univ Calif Davis, Sch Med, Dept Publ Hlth Sci, Davis, CA 95616 USA; [De Vogli, Roberto] UCL, Dept Epidemiol & Publ Hlth, London, England	University of Helsinki; SWPS University of Social Sciences & Humanities; Queens University Belfast; Finnish Institute of Occupational Health; Finnish Institute of Occupational Health; University of Helsinki; University of California System; University of California Davis; University of London; University College London	Kouvonen, A (corresponding author), Univ Helsinki, Dept Social Res, Helsinki, Finland.	anne.kouvonen@helsinki.fi	Kokkinen, Lauri PM/O-1295-2018	Kokkinen, Lauri PM/0000-0001-5827-6673; Kokkinen, Lauri/0000-0001-7654-3026; Kouvonen, Anne/0000-0001-6997-8312	Academy of Finland [67172]; Medical Research Council (MRC) [MR/K023241/1]; Economic and Social Research Council (ESRC) [ES/L007509/1, RES-070-27-0034]; Economic and Social Research Council [ES/L007509/1] Funding Source: researchfish; Medical Research Council [MR/K023241/1, MC_CF023241] Funding Source: researchfish; ESRC [ES/L007509/1] Funding Source: UKRI; MRC [MR/K023241/1] Funding Source: UKRI	Academy of Finland(Academy of Finland); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Academy of Finland (grant 67172). A. Kouvonen was supported by the Medical Research Council (MRC) (grant MR/K023241/1) and the Economic and Social Research Council (ESRC) (grant ES/L007509/1). R. De Vogli was supported by the Economic and Social Research Council (ESRC) (grant RES-070-27-0034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamgir H, 2006, OCCUP ENVIRON MED, V63, P290, DOI 10.1136/oem.2005.026047; Briffa T, 2011, HEART, V97, P400, DOI 10.1136/hrt.2010.210138; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Freburger JK, 2009, ARCH INTERN MED, V169, P251, DOI 10.1001/archinternmed.2008.543; Frenk J, 1991, Health Transit Rev, V1, P21; Galobardes B, 2006, ANN EPIDEMIOL, V16, P91, DOI 10.1016/j.annepidem.2005.06.053; Getahun D, 2005, J ASTHMA, V42, P373, DOI 10.1081/JAS-200062995; Haldeman GA, 1999, CONGESTIVE HEART FAI; Harper S, 2011, ANNU REV PUBL HEALTH, V32, P39, DOI 10.1146/annurev-publhealth-031210-101234; Hemminki E, 2008, MATURITAS, V61, P299, DOI 10.1016/j.maturitas.2008.09.022; Hjerppe R., 2006, ROAD PROSPERITY EC H; Hoeymans N, 2012, AM J PUBLIC HEALTH, V102, P163, DOI 10.2105/AJPH.2011.300296; Inglis SC, 2012, BRIT J SURG, V99, P680, DOI 10.1002/bjs.8686; Kauppinen T, 2013, ANN OCCUP HYG, V57, P593, DOI 10.1093/annhyg/mes090; Kela [Social Insurance Institution], 2012, STAT YB SOC INS I; Lee JM, 2010, J WOMENS HEALTH, V19, P2033, DOI 10.1089/jwh.2010.2029; Lehto A. M., 2008, TYOOLOJEN KOLME VUOS; Lewsey JD, 2009, CIRC-CARDIOVASC QUAL, V2, P475, DOI 10.1161/CIRCOUTCOMES.108.825968; Lincoln Andrew E, 2002, Work, V18, P99; Lindemann K, 2010, INT J CANCER, V127, P2661, DOI 10.1002/ijc.25267; Liu LJ, 2011, INT J CARDIOL, V149, P39, DOI 10.1016/j.ijcard.2009.11.037; Luepker RV, 2008, CIRCULATION, V117, P592, DOI 10.1161/CIRCULATIONAHA.107.747477; Lykkegaard J, 2012, RESP MED, V106, P549, DOI 10.1016/j.rmed.2011.11.001; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; Mattioli S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-374; McCallum AK, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-3; Mesle F, 2006, DEMOGRAPHY ANAL SYNT, P247; Moller B, 2005, EUR J CANCER PREV, V14, P117, DOI 10.1097/00008469-200504000-00007; Nedkoff LJ, 2011, CIRC-CARDIOVASC QUAL, V4, P557, DOI 10.1161/CIRCOUTCOMES.110.960005; Nowossadeck E, 2012, DTSCH ARZTEBL INT, V109, P151, DOI 10.3238/arztebl.2012.0151; Nurminen M, 2001, SCAND J WORK ENV HEA, V27, P161, DOI 10.5271/sjweh.605; Pukkala E., 2013, CANC IN FINLAND; Renehan AG, 2010, INT J CANCER, V126, P692, DOI 10.1002/ijc.24803; Schaufelberger M, 2004, EUR HEART J, V25, P300, DOI 10.1016/j.ehj.2003.12.012; Schmidt M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e356; Schnall P., 2009, UNHEALTHY WORK CAUSE; Straker LM, 2009, ERGONOMICS, V52, P1215, DOI 10.1080/00140130903039101; Sund R, 2012, SCAND J PUBLIC HEALT, V40, P505, DOI 10.1177/1403494812456637; Tan CE, 2012, CIRCULATION, V126, P2177, DOI 10.1161/CIRCULATIONAHA.112.121301; Teppo L, 1999, HLTH IN FINLAND; Thrasher JF, 2009, NICOTINE TOB RES, V11, P591, DOI 10.1093/ntr/ntp039; Towfighi A, 2011, AM J CARDIOL, V108, P1102, DOI 10.1016/j.amjcard.2011.05.046; Tuchsen F, 1996, J CLIN EPIDEMIOL, V49, P791, DOI 10.1016/0895-4356(95)00554-4; Tuchsen F, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001761; Ulmer H, 2007, J INTERN MED, V261, P566, DOI 10.1111/j.1365-2796.2007.01779.x; Vuorenkoski L., 2008, FINLAND HLTH SYSTEM; Wahlbeck K, 2011, BRIT J PSYCHIAT, V199, P453, DOI 10.1192/bjp.bp.110.085100; Wang OJ, 2012, AM J CARDIOL, V109, P1589, DOI 10.1016/j.amjcard.2012.01.381; Wearing SC, 2006, OBES REV, V7, P239, DOI 10.1111/j.1467-789X.2006.00251.x	51	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112314	10.1371/journal.pone.0112314	http://dx.doi.org/10.1371/journal.pone.0112314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT3WF	25379723	Green Published, Green Submitted, gold			2022-12-27	WOS:000344863100075
J	Ono, C; Yu, ZQ; Kasahara, Y; Kikuchi, Y; Ishii, N; Tomita, H				Ono, Chiaki; Yu, Zhiqian; Kasahara, Yoshiyuki; Kikuchi, Yoshie; Ishii, Naoto; Tomita, Hiroaki			Fluorescently Activated Cell Sorting Followed by Microarray Profiling of Helper T Cell Subtypes from Human Peripheral Blood	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; NETWORK ANALYSIS; IFN-GAMMA; DISEASE; CYTOKINES; TH1; CLASSIFICATION; BIOMARKER; PATTERNS; MARKERS	Background: Peripheral blood samples have been subjected to comprehensive gene expression profiling to identify biomarkers for a wide range of diseases. However, blood samples include red blood cells, white blood cells, and platelets. White blood cells comprise polymorphonuclear leukocytes, monocytes, and various types of lymphocytes. Blood is not distinguishable, irrespective of whether the expression profiles reflect alterations in (a) gene expression patterns in each cell type or (b) the proportion of cell types in blood. CD4(+) Th cells are classified into two functionally distinct subclasses, namely Th1 and Th2 cells, on the basis of the unique characteristics of their secreted cytokines and their roles in the immune system. Th1 and Th2 cells play an important role not only in the pathogenesis of human inflammatory, allergic, and autoimmune diseases, but also in diseases that are not considered to be immune or inflammatory disorders. However, analyses of minor cellular components such as CD4(+) cell subpopulations have not been performed, partly because of the limited number of these cells in collected samples. Methodology/Principal Findings: We describe fluorescently activated cell sorting followed by microarray (FACS-array) technology as a useful experimental strategy for characterizing the expression profiles of specific immune cells in the circulation. We performed reproducible gene expression profiling of Th1 and Th2, respectively. Our data suggest that this procedure provides reliable information on the gene expression profiles of certain small immune cell populations. Moreover, our data suggest that GZMK, GZMH, EOMES, IGFBP3, and STOM may be novel markers for distinguishing Th1 cells from Th2 cells, whereas IL17RB and CNTNAP1 can be Th2-specific markers. Conclusions/Significance: Our approach may help in identifying aberrations and novel therapeutic or diagnostic targets for diseases that affect Th1 or Th2 responses and elucidating the involvement of a subpopulation of immune cells in some diseases.	[Ono, Chiaki; Yu, Zhiqian; Kasahara, Yoshiyuki; Kikuchi, Yoshie; Tomita, Hiroaki] Tohoku Univ, Internal Res Inst Disaster Sci, Dept Disaster Psychiat, Sendai, Miyagi 980, Japan; [Ono, Chiaki; Yu, Zhiqian; Kasahara, Yoshiyuki; Kikuchi, Yoshie; Tomita, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Biol Psychiat, Sendai, Miyagi 980, Japan; [Ishii, Naoto] Tohoku Univ, Grad Sch Med, Dept Microbiol & Immunol, Sendai, Miyagi 980, Japan; [Ishii, Naoto; Tomita, Hiroaki] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University	Tomita, H (corresponding author), Tohoku Univ, Internal Res Inst Disaster Sci, Dept Disaster Psychiat, Sendai, Miyagi 980, Japan.	htomita@med.tohoku.ac.jp	yu, zhiqian/M-5041-2016	yu, zhiqian/0000-0002-4827-5922; Tomita, Hiroaki/0000-0003-2628-880X; Ishii, Naoto/0000-0002-0549-8245; Kasahara, Yoshiyuki/0000-0002-9508-2218; xing zhi, shi zhi/0000-0003-3289-5681	Health and Labour Sciences Research Grants [H19-kokoro-ippan-001]; Japan Research Foundation for Clinical Pharmacology; Intramural Research Grant for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry [21-9];  [24116007]	Health and Labour Sciences Research Grants(Ministry of Health, Labour and Welfare, Japan); Japan Research Foundation for Clinical Pharmacology; Intramural Research Grant for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry; 	This work was supported by a grant-in-aid for scientific research on innovative areas (No. 24116007), Health and Labour Sciences Research Grants research on psychiatric and neurological diseases and mental health (H19-kokoro-ippan-001), a grant-in-aid from the Japan Research Foundation for Clinical Pharmacology, and an Intramural Research Grant (No. 21-9) for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman PL, 1972, BIOL DATA BOOK FEDER; Arasappan D, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-65; Baatar D, 2007, J IMMUNOL, V178, P4891, DOI 10.4049/jimmunol.178.8.4891; Bade B, 2005, INT IMMUNOL, V17, P1419, DOI 10.1093/intimm/dxh320; Baine MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017014; Bansard C, 2011, RHEUMATOLOGY, V50, P283, DOI 10.1093/rheumatology/keq344; Beliakova-Bethell N, 2014, CYTOM PART A, V85A, P94, DOI 10.1002/cyto.a.22352; Burczynski ME, 2006, J MOL DIAGN, V8, P51, DOI 10.2353/jmoldx.2006.050079; Chen KD, 2011, NEUROBIOL DIS, V43, P698, DOI 10.1016/j.nbd.2011.05.023; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Dorner BG, 2002, P NATL ACAD SCI USA, V99, P6181, DOI 10.1073/pnas.092141999; Dorsam GP, 2010, MICROBIOL IMMUNOL, V54, P558, DOI 10.1111/j.1348-0421.2010.00242.x; Elenkov IJ, 1999, TRENDS ENDOCRIN MET, V10, P359, DOI 10.1016/S1043-2760(99)00188-5; Gardiner E, 2011, MOL PSYCHIAT; Giusti B, 2009, EUR J VASC ENDOVASC, V38, P104, DOI 10.1016/j.ejvs.2009.01.020; Grayson BL, 2011, GENES IMMUN, V12, P341, DOI 10.1038/gene.2011.13; Gurevich M, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-46; Hamalainen H, 2001, GENOME BIOL, V2; Haouas H, 2010, HEMATOLOGY, V15, P193, DOI 10.1179/102453310X12647083620769; Heizmann O, 2008, J TRAUMA, V65, P1374, DOI 10.1097/TA.0b013e31818b257d; Hirahara K, 2006, J IMMUNOL, V177, P4488, DOI 10.4049/jimmunol.177.7.4488; Kidd Parris, 2003, Altern Med Rev, V8, P223; Kondo T, 2006, CANCER SCI, V97, P780, DOI 10.1111/j.1349-7006.2006.00231.x; LILES WC, 1995, J INFECT DIS, V172, P1573, DOI 10.1093/infdis/172.6.1573; Liu Z, 2005, CLIN EXP ALLERGY, V35, P1581, DOI 10.1111/j.1365-2222.2005.02382.x; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Marsh ED, 2008, DEV NEUROBIOL, V68, P434, DOI 10.1002/dneu.20602; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Myint AM, 2005, J AFFECT DISORDERS, V88, P167, DOI 10.1016/j.jad.2005.07.008; Pavon L, 2006, J NEUROIMMUNOL, V172, P156, DOI 10.1016/j.jneuroim.2005.08.014; Riedel M, 2007, J PSYCHIATR RES, V41, P3, DOI 10.1016/j.jpsychires.2005.11.007; Romagnani S, 2004, J ALLERGY CLIN IMMUN, V113, P395, DOI 10.1016/j.jaci.2003.11.025; ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.iy.12.040194.001303; Rook GAW, 1997, LANCET, V349, P1831, DOI 10.1016/S0140-6736(97)01164-1; Saldanha-Araujo F, 2011, J CELL MOL MED; Sedelies KA, 2004, J BIOL CHEM, V279, P26581, DOI 10.1074/jbc.M312481200; Shehadeh LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009104; Staratschek-Jox A, 2009, EXPERT REV MOL DIAGN, V9, P271, DOI 10.1586/ERM.09.9; Stock P, 2009, J IMMUNOL, V182, P5116, DOI 10.4049/jimmunol.0804213; Suto A, 2006, J IMMUNOL, V177, P3721, DOI 10.4049/jimmunol.177.6.3721; Suzuki K, 2011, CLIN CANCER RES, V17, P5247, DOI 10.1158/1078-0432.CCR-10-2805; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takahashi M, 2010, SCHIZOPHR RES, V119, P210, DOI 10.1016/j.schres.2009.12.024; Takahashi N, 2008, EXP HEMATOL, V36, P1760, DOI 10.1016/j.exphem.2008.07.007; Takahashi R, 2009, J IMMUNOL, V182, P8071, DOI 10.4049/jimmunol.0804002; Wang H, CLIN EXP ALLERGY	46	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111405	10.1371/journal.pone.0111405	http://dx.doi.org/10.1371/journal.pone.0111405			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379667	Green Published, gold, Green Submitted			2022-12-27	WOS:000344863100028
J	Thierry, M; Pasquis, B; Acar, N; Gregoire, S; Febvret, V; Buteau, B; Gambert-Nicot, S; Bron, AM; Creuzot-Garcher, CP; Bretillon, L				Thierry, Magalie; Pasquis, Bruno; Acar, Niyazi; Gregoire, Stephane; Febvret, Valerie; Buteau, Benedicte; Gambert-Nicot, Segolene; Bron, Alain M.; Creuzot-Garcher, Catherine P.; Bretillon, Lionel			Metabolic Syndrome Triggered by High-Fructose Diet Favors Choroidal Neovascularization and Impairs Retinal Light Sensitivity in the Rat	PLOS ONE			English	Article							ELECTRORETINOGRAPHIC OSCILLATORY POTENTIALS; INDUCED INSULIN-RESISTANCE; FATTY-ACID PROFILE; MACULAR DEGENERATION; DIABETIC-RETINOPATHY; ANIMAL-MODELS; HEPATIC STEATOSIS; MOUSE; ASSOCIATION; ADIPOSITY	Diabetic retinopathy and age-related macular degeneration are the leading causes of blindness in Western populations. Although it is a matter of controversy, large-scale population-based studies have reported increased prevalence of age-related macular degeneration in patients with diabetes or diabetic retinopathy. We hypothesized that metabolic syndrome, one of the major risk factors for type 2 diabetes, would represent a favorable environment for the development of choroidal neovascularization, the main complication of age-related macular degeneration. The fructose-fed rat was used as a model for metabolic syndrome in which choroidal neovascularization was induced by laser photocoagulation. Male Brown Norway rats were fed for 1, 3, and 6 months with a standard equilibrated chow diet or a 60%-rich fructose diet (n = 24 per time point). The animals expectedly developed significant body adiposity (+17%), liver steatosis at 3 and 6 months, hyperleptinemia at 1 and 3 months (two-fold increase) and hyperinsulinemia at 3 and 6 months (up to two-fold increase), but remained normoglycemic and normolipemic. The fructose-fed animals exhibited partial loss of rod sensitivity to light stimulus and reduced amplitude of oscillatory potentials at 6 months. Fructose-fed rats developed significantly more choroidal neovascularization at 14 and 21 days post-laser photocoagulation after 1 and 3 months of diet compared to animals fed the control diet. These results were consistent with infiltration/activation of phagocytic cells and up-regulation of pro-angiogenic gene expression such as Vegf and Leptin in the retina. Our data therefore suggested that metabolic syndrome would exacerbate the development of choroidal neovascularization in our experimental model.	[Thierry, Magalie; Pasquis, Bruno; Acar, Niyazi; Gregoire, Stephane; Febvret, Valerie; Buteau, Benedicte; Gambert-Nicot, Segolene; Bron, Alain M.; Creuzot-Garcher, Catherine P.; Bretillon, Lionel] INRA, Ctr Sci Gout & Alimentat, Eye & Nutr Res Grp, UMR 1324, F-21034 Dijon, France; [Thierry, Magalie; Pasquis, Bruno; Acar, Niyazi; Gregoire, Stephane; Febvret, Valerie; Buteau, Benedicte; Gambert-Nicot, Segolene; Bron, Alain M.; Creuzot-Garcher, Catherine P.; Bretillon, Lionel] INRA, Ctr Sci Gout & Alimentat, UMR 6265, F-21034 Dijon, France; [Thierry, Magalie; Pasquis, Bruno; Acar, Niyazi; Gregoire, Stephane; Febvret, Valerie; Buteau, Benedicte; Gambert-Nicot, Segolene; Bron, Alain M.; Creuzot-Garcher, Catherine P.; Bretillon, Lionel] Univ Bourgogne, Ctr Sci Gout & Alimentat, Dijon, France; [Gambert-Nicot, Segolene] Univ Hosp, Dept Clin Chem, Dijon, France; [Bron, Alain M.; Creuzot-Garcher, Catherine P.] Univ Hosp, Dept Ophthalmol, Dijon, France	INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne	Bretillon, L (corresponding author), INRA, Ctr Sci Gout & Alimentat, Eye & Nutr Res Grp, UMR 1324, F-21034 Dijon, France.	lionel.bretillon@dijon.inra.fr	Bron, Alain/AAP-8010-2020	Bron, Alain/0000-0002-7265-931X; Bretillon, Lionel/0000-0002-6957-100X	Laboratoires Horus Pharma (Saint Laurent du Var, France); INRA-AlimH; CNRS; Universite de Bourgogne; Regional Council of Burgundy France (PARI Agrale 1); FEDER (European Funding for Regional Economic Development); French Government [ANR-11-LABX-0021-01-LipSTIC Labex]	Laboratoires Horus Pharma (Saint Laurent du Var, France); INRA-AlimH; CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Bourgogne; Regional Council of Burgundy France (PARI Agrale 1)(Region Bourgogne-Franche-Comte); FEDER (European Funding for Regional Economic Development); French Government	This work was supported by Laboratoires Horus Pharma (Saint Laurent du Var, France), INRA-AlimH, CNRS, Universite de Bourgogne, Regional Council of Burgundy France (PARI Agrale 1), FEDER (European Funding for Regional Economic Development), and French Government grant managed by the French National Research Agency (ANR) under the "Investissements d'Avenir'' program with reference ANR-11-LABX-0021-01-LipSTIC Labex. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackman R G, 1981, Methods Enzymol, V72, P205; Andreoli MF, 2010, LIPIDS, V45, P1035, DOI 10.1007/s11745-010-3466-4; Aung MH, 2013, INVEST OPHTH VIS SCI, V54, P1370, DOI 10.1167/iovs.12-10927; Beltran-Sanchez H, 2013, J AM COLL CARDIOL, V62, P697, DOI 10.1016/j.jacc.2013.05.064; BRESNICK GH, 1984, ARCH OPHTHALMOL-CHIC, V102, P1307, DOI 10.1001/archopht.1984.01040031057023; Bretillon L, 2008, INVEST OPHTH VIS SCI, V49, P1307, DOI 10.1167/iovs.07-0808; Bretillon L, 2008, EXP EYE RES, V87, P521, DOI 10.1016/j.exer.2008.08.010; Chiu CJ, 2011, PROG RETIN EYE RES, V30, P18, DOI 10.1016/j.preteyeres.2010.09.001; Cruz-Guilloty F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088201; Dekker MJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE685, DOI 10.1152/ajpendo.00283.2010; Du HJ, 2013, P NATL ACAD SCI USA, V110, P2377, DOI 10.1073/pnas.1221729110; Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911; Ferrannini E, 2011, MED CLIN N AM, V95, P327, DOI 10.1016/j.mcna.2010.11.005; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fourgeux C, 2014, BIOCHEM BIOPH RES CO, V446, P775, DOI 10.1016/j.bbrc.2014.01.118; Grossniklaus HE, 2010, PROG RETIN EYE RES, V29, P500, DOI 10.1016/j.preteyeres.2010.05.003; Hahn P, 2013, RETINA-J RET VIT DIS, V33, P911, DOI 10.1097/IAE.0b013e3182831248; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Hancock HA, 2004, INVEST OPHTH VIS SCI, V45, P1002, DOI 10.1167/iovs.03-1080; Holopigian K, 1997, INVEST OPHTH VIS SCI, V38, P2355; HWANG IS, 1989, AM J HYPERTENS, V2, P424, DOI 10.1093/ajh/2.6.424; HWANG IS, 1987, HYPERTENSION, V10, P512, DOI 10.1161/01.HYP.10.5.512; HYMAN LG, 1983, AM J EPIDEMIOL, V118, P213, DOI 10.1093/oxfordjournals.aje.a113629; Jaissle GB, 2001, INVEST OPHTH VIS SCI, V42, P506; Jesmin S, 2013, THROMB HAEMOSTASIS, V109, P696, DOI 10.1160/TH12-09-0654; JUEN S, 1990, ARCH OPHTHALMOL-CHIC, V108, P372, DOI 10.1001/archopht.1990.01070050070033; Jurgens H, 2005, OBES RES, V13, P1146, DOI 10.1038/oby.2005.136; KAHN HA, 1977, AM J EPIDEMIOL, V106, P33, DOI 10.1093/oxfordjournals.aje.a112429; Klein R, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12789; LACHAPELLE P, 1989, DOC OPHTHALMOL, V73, P327, DOI 10.1007/BF00154488; Lutty GA, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12979; Maugeri A, 2000, AM J HUM GENET, V67, P960, DOI 10.1086/303079; Milton RC, 2005, OPHTHALMOLOGY, V112, P533, DOI 10.1016/j.ophtha.2004.10.047; Mishra S, 2013, J NUTR METAB, V2013, DOI 10.1155/2013/327079; Mitchell P, 1999, AUST NZ J OPHTHALMOL, V27, P197, DOI 10.1046/j.1440-1606.1999.00211.x; MORRISON WR, 1964, J LIPID RES, V5, P600; Nagai Y, 2002, AM J PHYSIOL-ENDOC M, V282, pE1180, DOI 10.1152/ajpendo.00471.2001; Omarova S, 2012, J CLIN INVEST, V122, P3012, DOI 10.1172/JCI63816; Park SH, 2003, DIABETOLOGIA, V46, P1260, DOI 10.1007/s00125-003-1177-6; Reaven G, 2005, CIRCULATION, V112, P3030, DOI 10.1161/CIRCULATIONAHA.105.504670; Rees DA, 2005, DIABETIC MED, V22, P359, DOI 10.1111/j.1464-5491.2005.01499.x; Robinson R, 2012, DIS MODEL MECH, V5, P444, DOI 10.1242/dmm.009597; SEBEDIO JL, 1987, J CHROMATOGR, V405, P371, DOI 10.1016/S0021-9673(01)81779-9; Seeliger MW, 2001, NAT GENET, V29, P70, DOI 10.1038/ng712; Shirao Y, 1998, PROG RETIN EYE RES, V17, P59, DOI 10.1016/S1350-9462(97)00005-0; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Suganami E, 2004, DIABETES, V53, P2443, DOI 10.2337/diabetes.53.9.2443; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; Tarr Joanna M, 2013, ISRN Ophthalmol, V2013, P343560, DOI 10.1155/2013/343560; Tinsley FC, 2004, OBES RES, V12, P150, DOI 10.1038/oby.2004.20; TOBEY TA, 1982, METABOLISM, V31, P608, DOI 10.1016/0026-0495(82)90100-7; Topouzis F, 2009, BRIT J OPHTHALMOL, V93, P1037, DOI 10.1136/bjo.2008.146316; Vadala M, 2002, ACTA OPHTHALMOL SCAN, V80, P305, DOI 10.1034/j.1600-0420.2002.800314.x; Vernay M, 2013, INT J PUBLIC HEALTH, V58, P855, DOI 10.1007/s00038-013-0501-2; WACHTMEISTER L, 1978, INVEST OPHTH VIS SCI, V17, P1176; Wu XL, 2011, J AGR FOOD CHEM, V59, P747, DOI 10.1021/jf1038426; ZAVARONI I, 1980, METABOLISM, V29, P970, DOI 10.1016/0026-0495(80)90041-4	59	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112450	10.1371/journal.pone.0112450	http://dx.doi.org/10.1371/journal.pone.0112450			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380250	Green Published, Green Submitted, gold			2022-12-27	WOS:000344863100097
J	Burns, RT; Pechenik, JA; Biggers, WJ; Scavo, G; Lehman, C				Burns, Robert T.; Pechenik, Jan A.; Biggers, William J.; Scavo, Gia; Lehman, Christopher			The B Vitamins Nicotinamide (B-3) and Riboflavin (B-2) Stimulate Metamorphosis in Larvae of the Deposit-Feeding Polychaete Capitella teleta: Implications for a Sensory Ligand-Gated Ion Channel	PLOS ONE			English	Article							URCHIN HOLOPNEUSTES-PURPURASCENS; HORMONE-ACTIVE COMPOUNDS; SP-I ANNELIDA; NITRIC-OXIDE; DELAYED METAMORPHOSIS; SETTLEMENT CUE; CHEMICAL CUES; SEA; SEROTONIN; SEDIMENT	Marine sediments can contain B vitamins, presumably incorporated from settled, decaying phytoplankton and microorganisms associated with decomposition. Because B vitamins may be advantageous for the energetically intensive processes of metamorphosis, post-metamorphic growth, and reproduction, we tested several B vitamins to determine if they would stimulate larvae of the deposit-feeding polychaete Capitella teleta to settle and metamorphose. Nicotinamide and riboflavin individually stimulated larvae of Capitella teleta to settle and metamorphose, generally within 1-2 hours at nicotinamide concentrations as low as 3 mu M and riboflavin concentrations as low as 50 mu M. More than 80% of the larvae metamorphosed within 30 minutes at a nicotinamide concentration of 7 mu M. The pyridine channel agonist pyrazinecarboxamide also stimulated metamorphosis at very low concentrations. In contrast, neither lumichrome, thiamine HCl, pyridoxine HCl, nor vitamin B-12 stimulated larvae of Capitella teleta to metamorphose at concentrations as high as 500 mu M. Larvae also did not metamorphose in response to either nicotinamide or pyrazinecarboxamide in calcium-free seawater or with the addition of 4-acetylpyridine, a competitive inhibitor of the pyridine receptor. Together, these results suggest that larvae of Capitella teleta are responding to nicotinamide and riboflavin via a chemosensory pyridine receptor similar to that previously reported to be present on crayfish chela and involved with food recognition. Our data are the first to implicate B vitamins as possible natural chemical settlement cues for marine invertebrate larvae.	[Burns, Robert T.; Pechenik, Jan A.] Tufts Univ, Dept Biol, Medford, MA 02155 USA; [Biggers, William J.; Scavo, Gia; Lehman, Christopher] Wilkes Univ, Dept Biol, Wilkes Barre, PA 18766 USA	Tufts University; Wilkes University	Burns, RT (corresponding author), Tufts Univ, Dept Biol, Medford, MA 02155 USA.	robert.burns@tufts.edu			Howard Hughes Medical Institute; Wilkes University Mentoring Task Force grant; Wilkes University; Tufts FRAC	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Wilkes University Mentoring Task Force grant; Wilkes University; Tufts FRAC	This work was supported in part by funding from the Howard Hughes Medical Institute to the Biology Department of Wilkes University and Wilkes University Mentoring Task Force grant to WB, GS, and CL. Wilkes University and Tufts FRAC funded the publication of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTNER H, 1986, CELL TISSUE RES, V244, P537; BALOUN AJ, 1984, BIOL BULL, V167, P124, DOI 10.2307/1541342; Biggers WJ, 2012, INVERTEBR REPROD DEV, V56, P1, DOI 10.1080/07924259.2011.588006; Biggers WJ, 1999, BIOL BULL, V196, P187, DOI 10.2307/1542564; BIGGERS WJ, 1992, INVERTEBR REPROD DEV, V22, P39, DOI 10.1080/07924259.1992.9672255; Bishop CD, 2001, BIOL BULL, V201, P394, DOI 10.2307/1543617; Bishop CD, 2001, J EXP ZOOL, V289, P374, DOI 10.1002/jez.1019; Bishop CD, 2008, EVOL DEV, V10, P288, DOI 10.1111/j.1525-142X.2008.00238.x; Blake JA, 2009, ZOOSYMPOSIA, V2, P25, DOI 10.11646/zoosymposia.2.1.6; Brown MR, 1999, J APPL PHYCOL, V11, P247, DOI 10.1023/A:1008075903578; BUTMAN CA, 1988, NATURE, V333, P771, DOI 10.1038/333771a0; CARR WES, 1987, ENVIRON HEALTH PERSP, V71, P31, DOI 10.2307/3430411; Cohen RA, 1999, J EXP MAR BIOL ECOL, V240, P1, DOI 10.1016/S0022-0981(99)00047-7; Comes S, 2007, DEV BIOL, V306, P772, DOI 10.1016/j.ydbio.2007.04.016; DUBILIER N, 1988, BIOL BULL, V174, P30, DOI 10.2307/1541756; ECKELBARGER KJ, 1987, B BIOL SOC WASH, V7, P62; Giovannoni SJ, 2012, P NATL ACAD SCI USA, V109, P13888, DOI 10.1073/pnas.1211722109; GOTTHOLD ML, 1974, COMP BIOCHEM PHYSIOL, V48, P307, DOI 10.1016/0305-0491(74)90208-9; GRASSLE JP, 1976, SCIENCE, V192, P567, DOI 10.1126/science.1257794; GREMARE A, 1988, J EXP MAR BIOL ECOL, V123, P147, DOI 10.1016/0022-0981(88)90166-9; Hadfield MG, 2001, CRC MAR SCI, P431; HATT H, 1987, NEUROSCI LETT, V73, P137, DOI 10.1016/0304-3940(87)90007-3; HATT H, 1985, CHEM SENSES, V10, P317, DOI 10.1093/chemse/10.3.317; HATT H, 1984, J COMP PHYSIOL, V154, P855, DOI 10.1007/BF00610686; KATO T, 1975, EXPERIENTIA, V31, P433, DOI 10.1007/BF02026361; Launay JM, 1996, J BIOL CHEM, V271, P3141, DOI 10.1074/jbc.271.6.3141; Leise EM, 2001, AM ZOOL, V41, P258, DOI 10.1668/0003-1569(2001)041[0258:SANORM]2.0.CO;2; Lindsay SM, 2009, ZOOSYMPOSIA, V2, P339, DOI 10.11646/zoosymposia.2.1.24; MARSH AG, 1990, MAR ECOL PROG SER, V67, P301, DOI 10.3354/meps067301; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; Meunier N, 2009, CHEM SENSES, V34, P441, DOI 10.1093/chemse/bjp019; Mitra S, 2012, APPL BIOCHEM BIOTECH, V166, P1991, DOI 10.1007/s12010-012-9626-7; OHWADA K, 1972, Marine Chemistry, V1, P61, DOI 10.1016/0304-4203(72)90007-2; Panzeca C, 2009, ESTUAR COAST SHELF S, V85, P223, DOI 10.1016/j.ecss.2009.08.016; PAWLIK JR, 1992, OCEANOGR MAR BIOL, V30, P273; PAWLIK JR, 1986, J EXP MAR BIOL ECOL, V102, P301, DOI 10.1016/0022-0981(86)90183-8; PECHENIK JA, 1991, J EXP MAR BIOL ECOL, V151, P17, DOI 10.1016/0022-0981(91)90012-L; PECHENIK JA, 1990, OPHELIA, V32, P63, DOI 10.1080/00785236.1990.10422025; Pechenik JA, 2007, BIOL BULL-US, V213, P160, DOI 10.2307/25066632; Pellegrino M, 2009, J EXP BIOL, V212, P1973, DOI 10.1242/jeb.023036; Ricker T, 2011, INTEGR COMP BIOL, V51, pE243; Rittschof D, 1998, BIOFOULING, V12, P31, DOI 10.1080/08927019809378344; Sanudo-Wilhelmy SA, 2012, P NATL ACAD SCI USA, V109, P14041, DOI 10.1073/pnas.1208755109; SIMS GK, 1992, APPL ENVIRON MICROB, V58, P3423, DOI 10.1128/AEM.58.10.3423-3425.1992; Swanson RL, 2006, MAR ECOL PROG SER, V314, P1, DOI 10.3354/meps314001; Swanson RL, 2012, MAR BIOL, V159, P915, DOI 10.1007/s00227-011-1869-2; Swanson RL, 2004, BIOL BULL-US, V206, P161, DOI 10.2307/1543640; Thiyagarajan V, 2005, J EXP MAR BIOL ECOL, V323, P70, DOI 10.1016/j.jembe.2005.03.001; Tsukamoto S, 1999, EUR J BIOCHEM, V264, P785, DOI 10.1046/j.1432-1327.1999.00642.x; TSUTSUMI H, 1990, MAR ECOL PROG SER, V63, P157, DOI 10.3354/meps063157; WOODIN SA, 1991, AM ZOOL, V31, P797	51	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e109535	10.1371/journal.pone.0109535	http://dx.doi.org/10.1371/journal.pone.0109535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390040	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400006
J	Park, B; Jung, KW; Oh, CM; Choi, KS; Suh, M; Jun, JK				Park, Boyoung; Jung, Kyu-Won; Oh, Chang-Mo; Choi, Kui Son; Suh, Mina; Jun, Jae Kwan			Factors Associated with Alcohol Consumption in Hepatitis B Carriers: A Nationwide Study in the Republic of Korea	PLOS ONE			English	Article							RISK-FACTORS; HEPATOCELLULAR-CARCINOMA; LIVER-CANCER; SOCIOECONOMIC-STATUS; VIRAL-HEPATITIS; DISEASE; INEQUALITIES; RELIABILITY; EDUCATION; SYNERGISM	This study was conducted to investigate the prevalence of alcohol consumption and identify the sociodemographic factors associated with alcohol consumption among individuals with hepatitis B virus(HBV) infection. We used data from the Korean National Health and Nutrition Examination Surveys, a nationwide survey conducted between 2007 and 2011. "Monthly alcohol consumption'' was defined as having consumed alcohol at least once per month during the past year, and "high-risk alcohol consumption'' was defined as having consumed alcohol twice or more per week and, for males, having consumed at least 60 g of alcohol on one occasion or, for females, having consumed at least 40 g of alcohol on more than one occasion. The prevalence of monthly alcohol consumption was 53.2%, and that of high-risk alcohol consumption was 11.8% among HBV carriers. Less education was associated with both monthly and high-risk alcohol consumption(OR = 1.75 [95% CI = 1.02-3.02] for monthly alcohol consumption among those with less than a high school education; OR = 2.48 [95% CI = 1.19-5.17] for high-risk alcohol consumption among those with less than a high school education and OR = 2.02 [95% CI = 1.12-3.64] among those with a high school education). Additionally, smoking and being male increased the risk of alcohol consumption, and older age and having a normal body mass index decreased the risk. HBV carriers who were less educated, overweight, and smokers were more likely to consume alcohol or meet criteria for high-risk drinking. Health policies and intervention programs aimed at promoting a generally healthy lifestyle in HBV carriers should consider educational inequalities and alcohol consumption.	[Park, Boyoung; Jung, Kyu-Won; Oh, Chang-Mo; Choi, Kui Son; Suh, Mina; Jun, Jae Kwan] Natl Canc Ctr, Natl Canc Control Inst, Goyang Si, South Korea	National Cancer Center - Korea (NCC)	Jun, JK (corresponding author), Natl Canc Ctr, Natl Canc Control Inst, Goyang Si, South Korea.	jkjun@ncc.re.kr			National Cancer Center of Korea [1310232]	National Cancer Center of Korea	This study was supported by a Grant-in-Aid for Cancer Research and Control from the National Cancer Center of Korea (#1310232). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2004, BMJ-BRIT MED J, V329, P1080, DOI 10.1136/bmj.329.7474.1080; Bialecki ES, 2005, EUR J GASTROEN HEPAT, V17, P485, DOI 10.1097/00042737-200505000-00003; Bowlin SJ, 1996, J CLIN EPIDEMIOL, V49, P511, DOI 10.1016/0895-4356(96)00010-8; BROWNSON RC, 1994, EPIDEMIOLOGY, V5, P545; Chae Hee Bok, 2009, Korean J Hepatol, V15 Suppl 6, pS13, DOI 10.3350/kjhep.2009.15.S6.S13; Chan HLY, 2011, J GASTROEN HEPATOL, V26, P131, DOI 10.1111/j.1440-1746.2010.06544.x; Cho ER, 2010, CANCER EPIDEMIOL, V34, P713, DOI 10.1016/j.canep.2010.09.003; Chuang SC, 2010, CANCER EPIDEM BIOMAR, V19, P1261, DOI 10.1158/1055-9965.EPI-09-1297; Donato F, 2002, AM J EPIDEMIOL, V155, P323, DOI 10.1093/aje/155.4.323; Ekholm O, 2008, EUR J CLIN NUTR, V62, P286, DOI 10.1038/sj.ejcn.1602728; Fattovich G, 2008, J HEPATOL, V48, P335, DOI 10.1016/j.jhep.2007.11.011; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fong C. W., 2007, SMJ Singapore Medical Journal, V48, P1091; Grant JD, 2012, ALCOHOL CLIN EXP RES, V36, P1412, DOI 10.1111/j.1530-0277.2012.01752.x; Hassan MM, 2002, HEPATOLOGY, V36, P1206, DOI 10.1053/jhep.2002.36780; Huerta MC, 2010, SOC SCI MED, V71, P143, DOI 10.1016/j.socscimed.2010.03.022; KCDC, 2005, 4 KOR NAT HLTH NUTR; Khang YH, 2004, INT J EPIDEMIOL, V33, P299, DOI 10.1093/ije/dyg244; Koh K., 2000, HLTH WELFARE POLICY, V6, P77; Korean Association for the Study of Liver, 2011, TREATM GUID CHRON HE; Lee EH, 2010, ASIAN PAC J CANCER P, V11, P1305; Liaw YF, 2009, J HEPATOL, V51, P403, DOI 10.1016/j.jhep.2009.04.003; Noh DK, 2012, ASIAN PAC J CANCER P, V13, P731, DOI 10.7314/APJCP.2012.13.2.731; Park B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068315; Park B, 2012, VACCINE, V30, P5844, DOI 10.1016/j.vaccine.2012.07.022; Schroder H, 2004, EUR J NUTR, V43, P77, DOI 10.1007/s00394-004-0443-9; Stockwell T, 2004, ADDICTION, V99, P1024, DOI 10.1111/j.1360-0443.2004.00815.x; Stroffolini T, 2010, LIVER INT, V30, P867, DOI 10.1111/j.1478-3231.2010.02261.x; TENCONI MT, 1992, EUR J EPIDEMIOL, V8, P763, DOI 10.1007/BF00145317; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Woitas-Slubowska Donata, 2010, Central European Journal of Public Health, V18, P179; World Health Organization, 2000, INT GUID MON ALC CON; Yuan JM, 2004, CANCER, V101, P1009, DOI 10.1002/cncr.20427; Zakhari S, 2013, J GASTROEN HEPATOL, V28, P18, DOI 10.1111/jgh.12207; Zanetti AR, 2008, VACCINE, V26, P6266, DOI 10.1016/j.vaccine.2008.09.056	36	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e110144	10.1371/journal.pone.0110144	http://dx.doi.org/10.1371/journal.pone.0110144			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25387237	Green Submitted, gold, Green Published			2022-12-27	WOS:000345250400008
J	Zhang, CH; Walters, D; Kovacs, JM				Zhang, Chunhua; Walters, Dan; Kovacs, John M.			Applications of Low Altitude Remote Sensing in Agriculture upon Farmers' Requests- A Case Study in Northeastern Ontario, Canada	PLOS ONE			English	Article							MULTITEMPORAL POLARIMETRIC RADARSAT-2; QUICKBIRD SATELLITE IMAGERY; UNMANNED AERIAL VEHICLE; PRECISION AGRICULTURE; HYPERSPECTRAL IMAGERY; MANAGEMENT ZONES; YIELD; AIRBORNE; PLATFORM; TRENDS	With the growth of the low altitude remote sensing (LARS) industry in recent years, their practical application in precision agriculture seems all the more possible. However, only a few scientists have reported using LARS to monitor crop conditions. Moreover, there have been concerns regarding the feasibility of such systems for producers given the issues related to the post-processing of images, technical expertise, and timely delivery of information. The purpose of this study is to showcase actual requests by farmers to monitor crop conditions in their fields using an unmanned aerial vehicle (UAV). Working in collaboration with farmers in northeastern Ontario, we use optical and near-infrared imagery to monitor fertilizer trials, conduct crop scouting and map field tile drainage. We demonstrate that LARS imagery has many practical applications. However, several obstacles remain, including the costs associated with both the LARS system and the image processing software, the extent of professional training required to operate the LARS and to process the imagery, and the influence from local weather conditions (e. g. clouds, wind) on image acquisition all need to be considered. Consequently, at present a feasible solution for producers might be the use of LARS service provided by private consultants or in collaboration with LARS scientific research teams.	[Zhang, Chunhua] Algoma Univ, Dept Geog & Geol, Sault Ste Marie, ON, Canada; [Walters, Dan; Kovacs, John M.] Nipissing Univ, Dept Geog, North Bay, ON, Canada	Algoma University; Nipissing University	Zhang, CH (corresponding author), Algoma Univ, Dept Geog & Geol, Sault Ste Marie, ON, Canada.	chunhua.zhang@algomau.ca	Kovacs, John/B-3641-2008; Zhang, Chunhua/O-6602-2014	Kovacs, John/0000-0002-0520-3996; Zhang, Chunhua/0000-0001-6685-0137	Northern Ontario Heritage Fund Corporation of Canada [920161]	Northern Ontario Heritage Fund Corporation of Canada	Funding for this project was provided by a grant (project #920161) awarded to John M. Kovacs and Dan Walters from the Northern Ontario Heritage Fund Corporation of Canada (http://nohfc.ca/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berni JAJ, 2009, IEEE T GEOSCI REMOTE, V47, P722, DOI 10.1109/TGRS.2008.2010457; Blackmore S, 2000, COMPUT ELECTRON AGR, V26, P37, DOI 10.1016/S0168-1699(99)00075-7; Blackmore S, 2003, BIOSYST ENG, V84, P455, DOI 10.1016/S1537-5110(03)00038-2; Blann KL, 2009, CRIT REV ENV SCI TEC, V39, P909, DOI 10.1080/10643380801977966; Cable JW, 2014, REMOTE SENS-BASEL, V6, P2343, DOI 10.3390/rs6032343; Cable JW, 2014, REMOTE SENS-BASEL, V6, P2372, DOI 10.3390/rs6032372; Chang JY, 2003, AGRON J, V95, P1447, DOI 10.2134/agronj2003.1447; DeTar WR, 2008, T ASABE, V51, P463, DOI 10.13031/2013.24388; Diker K., 2004, Precision Agriculture, V5, P435, DOI 10.1007/s11119-004-5318-9; Flowers M, 2005, AGRON J, V97, P968, DOI 10.2134/agronj2004.0224; Godwin RJ, 2003, BIOSYST ENG, V84, P533, DOI 10.1016/S1537-5110(02)00282-9; Gomez-Candon D, 2011, PRECIS AGRIC, V12, P876, DOI 10.1007/s11119-011-9228-3; Honkavaara E, 2013, REMOTE SENS-BASEL, V5, P5006, DOI 10.3390/rs5105006; Hunt E. R., 2008, P 17 WT PEC MEM REM, V17, P18; Hunt E. Raymond Jr, 2005, Precision Agriculture, V6, P359, DOI 10.1007/s11119-005-2324-5; Hunt ER, 2010, REMOTE SENS-BASEL, V2, P290, DOI 10.3390/rs2010290; Inman D, 2008, AGRON J, V100, P60, DOI 10.2134/agronj2007.0020; Inoue Y, 2000, INT J REMOTE SENS, V21, P379, DOI 10.1080/014311600210894; Keener H. M., 2000, Land application of agricultural, industrial, and municipal by-products, P315; Lelong CCD, 1998, REMOTE SENS ENVIRON, V66, P179, DOI 10.1016/S0034-4257(98)00049-2; Link J, 2013, COMPUT ELECTRON AGR, V94, P20, DOI 10.1016/j.compag.2013.03.003; Lopez-Lozano R, 2009, AGR FOREST METEOROL, V149, P1307, DOI 10.1016/j.agrformet.2009.03.001; Mamo M, 1998, J PROD AGRIC, V11, P469, DOI 10.2134/jpa1998.0469; Pena JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077151; McSorley R, 1996, J NEMATOL, V28, P655; Primicerio J, 2012, PRECIS AGRIC, V13, P517, DOI 10.1007/s11119-012-9257-6; Ryo S, 2007, BIOSYST ENG, V96, P301; Seelan SK, 2003, REMOTE SENS ENVIRON, V88, P157, DOI 10.1016/j.rse.2003.04.007; Shanahan JF, 2001, AGRON J, V93, P583, DOI 10.2134/agronj2001.933583x; Spaling H, 1995, AGR ECOSYST ENVIRON, V53, P299; SPARKS AN, 1979, FLA ENTOMOL, V62, P82, DOI 10.2307/3494083; Stratton ML, 1998, BOOK SOIL P, P43; Swain KC, 2010, T ASABE, V53, P21; Swain KC, 2007, J APPL REMOTE SENS, V1, DOI 10.1117/1.2824287; Torres-Sanchez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058210; WIEGAND CL, 1994, REMOTE SENS ENVIRON, V49, P212, DOI 10.1016/0034-4257(94)90017-5; Wilson JM, 2014, TLS-TIMES LIT SUPPL, P6; Yang C, 2006, T ASABE, V49, P1599, DOI 10.13031/2013.22034; Yang C, 2004, T ASAE, V47, P915, DOI 10.13031/2013.16111; Yang C, 2000, T ASAE, V43, P1927, DOI 10.13031/2013.3098; Yang Chenghai, 2004, Precision Agriculture, V5, P445, DOI 10.1007/s11119-004-5319-8; Yang CH, 2006, PRECIS AGRIC, V7, P33, DOI 10.1007/s11119-005-6788-0; Yang CH, 2013, P IEEE, V101, P582, DOI 10.1109/JPROC.2012.2196249; Yang Chenghai, 1999, Precision Agriculture, V1, P67, DOI 10.1023/A:1009917617316; Zarco-Tejada PJ, 2013, AGR FOREST METEOROL, V171, P281, DOI 10.1016/j.agrformet.2012.12.013; Zarco-Tejada PJ, 2012, REMOTE SENS ENVIRON, V117, P322, DOI 10.1016/j.rse.2011.10.007; Zhang CH, 2012, PRECIS AGRIC, V13, P693, DOI 10.1007/s11119-012-9274-5; ZUCKER L. A, 1998, OHIO STATE U EXTENSI, V871- 98	48	49	53	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112894	10.1371/journal.pone.0112894	http://dx.doi.org/10.1371/journal.pone.0112894			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386696	Green Submitted, gold, Green Published			2022-12-27	WOS:000345250400101
J	Agollah, GD; Gonzalez-Garay, ML; Rasmussen, JC; Tan, IC; Aldrich, MB; Darne, C; Fife, CE; Guilliod, R; Maus, EA; King, PD; Sevick-Muraca, EM				Agollah, Germaine D.; Gonzalez-Garay, Manuel L.; Rasmussen, John C.; Tan, I-Chih; Aldrich, Melissa B.; Darne, Chinmay; Fife, Caroline E.; Guilliod, Renie; Maus, Erik A.; King, Philip D.; Sevick-Muraca, Eva M.			Evidence for SH2 Domain-Containing 5 '-Inositol Phosphatase-2 (SHIP2) Contributing to a Lymphatic Dysfunction	PLOS ONE			English	Article							5'-PHOSPHATASE-2 GENE POLYMORPHISMS; NEAR-INFRARED FLUORESCENCE; SECONDARY LYMPHEDEMA; TRANSCRIPTION FACTOR; FACTOR-RECEPTOR; BREAST-CANCER; B-CELLS; MUTATIONS; GROWTH; LYMPHANGIOGENESIS	The lymphatic vasculature plays a critical role in a number of disease conditions of increasing prevalence, such as autoimmune disorders, obesity, blood vascular diseases, and cancer metastases. Yet, unlike the blood vasculature, the tools available to interrogate the molecular basis of lymphatic dysfunction/disease have been lacking. More recently, investigators have reported that dysregulation of the PI3K pathway is involved in syndromic human diseases that involve abnormal lymphatic vasculatures, but there have been few compelling results that show the direct association of this molecular pathway with lymphatic dysfunction in humans. Using near-infrared fluorescence lymphatic imaging (NIRFLI) to phenotype and next generation sequencing (NGS) for unbiased genetic discovery in a family with non-syndromic lymphatic disease, we discovered a rare, novel mutation in INPPL1 that encodes the protein SHIP2, which is a negative regulator of the PI3K pathway, to be associated with lymphatic dysfunction in the family. In vitro interrogation shows that SHIP2 is directly associated with impairment of normal lymphatic endothelial cell (LEC) behavior and that SHIP2 associates with receptors that are associated in lymphedema, implicating its direct involvement in the lymphatic vasculature.	[Agollah, Germaine D.; Rasmussen, John C.; Tan, I-Chih; Aldrich, Melissa B.; Darne, Chinmay; Sevick-Muraca, Eva M.] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Ctr Mol Imaging, Houston, TX 77030 USA; [Agollah, Germaine D.] Univ Texas MD Anderson Canc Ctr, Univ Texas Grad Sch Biomed Sci Houston, Houston, TX 77030 USA; [Gonzalez-Garay, Manuel L.] Brown Fdn Inst Mol Med, Ctr Mol Imaging, Div Genom & Bioinformat, Houston, TX USA; [Fife, Caroline E.; Guilliod, Renie; Maus, Erik A.] Mem Hermann Hosp Ctr Lymphedema Management, Houston, TX USA; [King, Philip D.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Michigan System; University of Michigan	Sevick-Muraca, EM (corresponding author), Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Ctr Mol Imaging, Houston, TX 77030 USA.	Eva.Sevick@uth.tmc.edu	Sevick-Muraca, Eva M/A-4152-2017	Sevick-Muraca, Eva M/0000-0002-8152-4847; Gonzalez-Garay, Manuel/0000-0003-3412-0353; Rasmussen, John/0000-0002-0557-6899	National Institutes of Health (NIH) [R01 HL092923, R01 CA128919, U54 CA136404]; Texas Star Award (EMS-M) [R01 HL096498]; Schissler Foundation Fellowship for Translational Studies of Common Human Diseases; Cancer Prevention and Research Institute of Texas (CPRIT) [RP110776]; NATIONAL CANCER INSTITUTE [U54CA136404, R01CA128919] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092923, R01HL096498] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Star Award (EMS-M); Schissler Foundation Fellowship for Translational Studies of Common Human Diseases; Cancer Prevention and Research Institute of Texas (CPRIT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in parts by the National Institutes of Health (NIH) grants R01 HL092923, R01 CA128919, U54 CA136404 and The Texas Star Award (EMS-M) and R01 HL096498 (PDK). GDA acknowledges support from The Schissler Foundation Fellowship for Translational Studies of Common Human Diseases. Flow cytometry measurements were supported in part through a Cancer Prevention and Research Institute of Texas (CPRIT) instrumentation grant (RP110776). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alders M, 2013, MOL SYNDROMOL, V4, P107, DOI [10.1159/000342486, 10.1159/000354097]; Alders M, 2009, NAT GENET, V41, P1272, DOI 10.1038/ng.484; Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Below JE, 2013, AM J HUM GENET, V92, P137, DOI 10.1016/j.ajhg.2012.11.011; Brouillard P, 2014, J CLIN INVEST, V124, P898, DOI 10.1172/JCI71614; Burrows PE, 2013, P NATL ACAD SCI USA, V110, P8621, DOI 10.1073/pnas.1222722110; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Clement S, 2001, NATURE, V409, P92, DOI 10.1038/35051094; Cormier JN, 2010, CANCER-AM CANCER SOC, V116, P5138, DOI 10.1002/cncr.25458; Coso S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039558; Deneubourg L, 2010, ADV ENZYME REGUL, V50, P262, DOI 10.1016/j.advenzreg.2009.10.009; Deng Y, 2013, J CLIN INVEST, V123, P1202, DOI 10.1172/JCI63034; Fang JM, 2000, AM J HUM GENET, V67, P1382, DOI 10.1086/316915; Ferrell RE, 2010, AM J HUM GENET, V86, P943, DOI 10.1016/j.ajhg.2010.04.010; Finegold DN, 2012, CLIN CANCER RES, V18, P2382, DOI 10.1158/1078-0432.CCR-11-2303; Finegold David N., 2008, Lymphatic Research and Biology, V6, P65, DOI 10.1089/lrb.2008.1524; Giuriato S, 2003, BIOCHEM J, V376, P199, DOI 10.1042/BJ20030581; Gordon K, 2013, CIRC RES, V112, P956, DOI 10.1161/CIRCRESAHA.113.300350; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Hoey SEH, 2008, CLIN EXP DERMATOL, V33, P234, DOI 10.1111/j.1365-2230.2007.02601.x; Huber C, 2013, AM J HUM GENET, V92, P144, DOI 10.1016/j.ajhg.2012.11.015; Ichise T, 2010, DEVELOPMENT, V137, P1003, DOI 10.1242/dev.043489; Irrthum A, 2003, AM J HUM GENET, V72, P1470, DOI 10.1086/375614; Ishida S, 2006, PANCREAS, V33, P63, DOI 10.1097/01.mpa.0000222317.82231.16; Kagawa S, 2005, J CLIN ENDOCR METAB, V90, P2911, DOI 10.1210/jc.2004-1724; Kaisaki PJ, 2004, DIABETES, V53, P1900, DOI 10.2337/diabetes.53.7.1900; Kajiya K, 2005, EMBO J, V24, P2885, DOI 10.1038/sj.emboj.7600763; Karkkainen MJ, 2000, NAT GENET, V25, P153, DOI 10.1038/75997; Karpanen T, 2008, ANNU REV PATHOL-MECH, V3, P367, DOI 10.1146/annurev.pathol.3.121806.151515; Koch A, 2005, ONCOGENE, V24, P3436, DOI 10.1038/sj.onc.1208558; Kurek KC, 2012, AM J HUM GENET, V90, P1108, DOI 10.1016/j.ajhg.2012.05.006; Lapinski PE, 2012, J CLIN INVEST, V122, P733, DOI 10.1172/JCI46116; Lin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052021; Liu XW, 2012, NAT IMMUNOL, V13, P457, DOI 10.1038/ni.2258; Mihara M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038182; Mihara M, 2012, ANN VASC SURG, V26, DOI 10.1016/j.avsg.2011.08.007; Moro L, 2007, INT J ONCOL, V30, P217, DOI 10.3892/ijo.30.1.217; Mortimer PS, 2014, J CLIN INVEST, V124, P915, DOI 10.1172/JCI71608; Mouta-Bellum C, 2009, DEV DYNAM, V238, P2670, DOI 10.1002/dvdy.22078; Ostergaard P, 2012, AM J HUM GENET, V90, P356, DOI 10.1016/j.ajhg.2011.12.018; Ostergaard P, 2011, NAT GENET, V43, P929, DOI 10.1038/ng.923; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Prasad NK, 2008, CARCINOGENESIS, V29, P25, DOI 10.1093/carcin/bgm213; Prasad NK, 2005, J BIOL CHEM, V280, P13129, DOI 10.1074/jbc.M410289200; Rasmussen JC, 2010, TRANSL ONCOL, V3, P362, DOI 10.1593/tlo.10190; Rasmussen JC, 2009, CURR OPIN BIOTECH, V20, P74, DOI 10.1016/j.copbio.2009.01.009; Readinger JA, 2009, IMMUNOL REV, V228, P93, DOI 10.1111/j.1600-065X.2008.00757.x; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Saito Y, 2006, CIRCULATION, V114, P1177, DOI 10.1161/CIRCULATIONAHA.105.602953; Sevick-Muraca EM, 2013, TRENDS CARDIOVASC ME; Sevick-Muraca EM, 2014, J CLIN INVEST, V124, P905, DOI 10.1172/JCI71612; Sleeman MW, 2005, NAT MED, V11, P199, DOI 10.1038/nm1178; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Suwa A, 2010, EXPERT OPIN THER TAR, V14, P727, DOI 10.1517/14728222.2010.492780; Tamir I, 2000, IMMUNITY, V12, P347, DOI 10.1016/S1074-7613(00)80187-9; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tridandapani S, 1997, IMMUNOL TODAY, V18, P424, DOI 10.1016/S0167-5699(97)01112-2; Zhou F, 2010, AM J PATHOL, V177, P2124, DOI 10.2353/ajpath.2010.091301; Zhou XP, 2000, HUM MOL GENET, V9, P765, DOI 10.1093/hmg/9.5.765	59	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112548	10.1371/journal.pone.0112548	http://dx.doi.org/10.1371/journal.pone.0112548			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383712	Green Submitted, Green Published, gold			2022-12-27	WOS:000344816700080
J	Fernandes, KA; Kittelmann, S; Rogers, CW; Gee, EK; Bolwell, CF; Bermingham, EN; Thomas, DG				Fernandes, Karlette A.; Kittelmann, Sandra; Rogers, Christopher W.; Gee, Erica K.; Bolwell, Charlotte F.; Bermingham, Emma N.; Thomas, David G.			Faecal Microbiota of Forage-Fed Horses in New Zealand and the Population Dynamics of Microbial Communities following Dietary Change	PLOS ONE			English	Article							HAY-GRAIN RATIOS; CILIATE COMPOSITION; GASTROINTESTINAL-TRACT; EQUUS-CABALLUS; PASSAGE RATE; DIVERSITY; DISORDERS; DIGESTIBILITY; DIGESTION; LINNAEUS	The effects of abrupt dietary transition on the faecal microbiota of forage-fed horses over a 3-week period were investigated. Yearling Thoroughbred fillies reared as a cohort were exclusively fed on either an ensiled conserved forage-grain diet ("Group A''; n = 6) or pasture ("Group B''; n = 6) for three weeks prior to the study. After the Day 0 faecal samples were collected, horses of Group A were abruptly transitioned to pasture. Both groups continued to graze similar pasture for three weeks, with faecal samples collected at 4-day intervals. DNA was isolated from the faeces and microbial 16S and 18S rRNA gene amplicons were generated and analysed by pyrosequencing. The faecal bacterial communities of both groups of horses were highly diverse (Simpson's index of diversity >0.8), with differences between the two groups on Day 0 (P<0.017 adjusted for multiple comparisons). There were differences between Groups A and B in the relative abundances of four genera, BF311 (family Bacteroidaceae; P = 0.003), CF231 (family Paraprevotellaceae; P = 0.004), and currently unclassified members within the order Clostridiales (P = 0.003) and within the family Lachnospiraceae (P = 0.006). The bacterial community of Group A horses became similar to Group B within four days of feeding on pasture, whereas the structure of the archaeal community remained constant pre- and post-dietary change. The community structure of the faecal microbiota (bacteria, archaea and ciliate protozoa) of pasture-fed horses was also identified. The initial differences observed appeared to be linked to recent dietary history, with the bacterial community of the forage-fed horses responding rapidly to abrupt dietary change.	[Fernandes, Karlette A.; Rogers, Christopher W.; Gee, Erica K.; Bolwell, Charlotte F.; Thomas, David G.] Massey Univ, Coll Sci, Inst Vet Anim & Biomed Sci, Palmerston North 4442, New Zealand; [Kittelmann, Sandra; Bermingham, Emma N.] AgResearch Ltd, Grasslands Res Ctr, Palmerston North 4442, New Zealand	Massey University; AgResearch - New Zealand	Fernandes, KA (corresponding author), Massey Univ, Coll Sci, Inst Vet Anim & Biomed Sci, Palmerston North 4442, New Zealand.	k.a.fernandes@massey.ac.nz	Rogers, Chris W./D-9812-2012; Bolwell, Charlotte/AGZ-4348-2022; Gee, Erica/Y-1999-2018	Rogers, Chris W./0000-0002-4253-1825; Bolwell, Charlotte/0000-0001-9995-8232; Kittelmann, Sandra/0000-0002-6019-9854; Bermingham, Emma/0000-0003-0952-5260; Gee, Erica/0000-0001-5218-6589	Massey University; AgResearch CORE [A17976]; Ministry of Business Innovation and Employment: Science and Innovation Group	Massey University; AgResearch CORE; Ministry of Business Innovation and Employment: Science and Innovation Group	This study was funded by the Massey University Internal Research Funding (DGT) and AgResearch CORE (A17976) funds (ENB). An educational fellowship from the Ministry of Business Innovation and Employment: Science and Innovation Group (www.msi.govt.nz) and a Massey University Doctoral Scholarship (www.massey.ac.nz) provided financial assistance for the duration of the doctoral study (KAF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Jassim RAM, 2009, VET CLIN N AM-EQUINE, V25, P199, DOI 10.1016/j.cveq.2009.04.005; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Biddle AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077599; Bishop L, 2013, THESIS MASSEY U PALM; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Costa MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041484; Costa Marcio C., 2012, Animal Health Research Reviews, V13, P121, DOI 10.1017/S1466252312000035; CYMBALUK NF, 1990, CAN J ANIM SCI, V70, P601, DOI 10.4141/cjas90-072; de Fombelle A, 2001, J EQUINE VET SCI, V21, P439, DOI 10.1016/S0737-0806(01)70018-4; Dougal K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077660; Dougal K, 2012, FEMS MICROBIOL ECOL, V82, P642, DOI 10.1111/j.1574-6941.2012.01441.x; Drogoul C, 2001, J EQUINE VET SCI, V21, P487, DOI 10.1016/S0737-0806(01)70211-0; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elliott J, 2006, J NUTR, V136, p2103S, DOI 10.1093/jn/136.7.2103S; ESTY WW, 1986, ANN STAT, V14, P1257, DOI 10.1214/aos/1176350066; Fernando SC, 2010, APPL ENVIRON MICROB, V76, P7482, DOI 10.1128/AEM.00388-10; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; GLINSKY MJ, 1976, J ANIM SCI, V42, P1465, DOI 10.2527/jas1976.4261465x; Gocmen B, 2012, TURK J ZOOL, V36, P163, DOI 10.3906/zoo-1003-141; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Gurelli G, 2012, EUR J PROTISTOL, V48, P215, DOI 10.1016/j.ejop.2012.01.002; Gurelli G, 2011, EUR J PROTISTOL, V47, P245, DOI 10.1016/j.ejop.2011.04.005; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hastie PM, 2008, BRIT J NUTR, V100, P561, DOI 10.1017/S0007114508968227; HENNEKE DR, 1983, EQUINE VET J, V15, P371, DOI 10.1111/j.2042-3306.1983.tb01826.x; Hirst R.L., 2011, THESIS MASSEY U PALM; Hoskin SO, 2004, NEW ZEAL VET J, V52, P332, DOI 10.1080/00480169.2004.36449; JANIS C, 1976, EVOLUTION, V30, P757, DOI 10.1111/j.1558-5646.1976.tb00957.x; Janssen PH, 2008, APPL ENVIRON MICROB, V74, P3619, DOI 10.1128/AEM.02812-07; Julliand V, 2006, LIVEST SCI, V100, P44, DOI 10.1016/j.livprodsci.2005.11.001; Julliand V, 2001, J EQUINE VET SCI, V21, P543, DOI 10.1016/S0737-0806(01)70159-1; Kittelmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047879; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Lee CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044224; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Litherland AJ, 2002, NZ SOC ANIMAL PRODUC; Lueders T, 2004, ENVIRON MICROBIOL, V6, P73, DOI 10.1046/j.1462-2920.2003.00536.x; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Milinovich GJ, 2006, ENVIRON MICROBIOL, V8, P885, DOI 10.1111/j.1462-2920.2005.00975.x; MOORE BE, 1993, J ANIM SCI, V71, P3350, DOI 10.2527/1993.71123350x; Muller CE, 2008, LIVEST SCI, V119, P116, DOI 10.1016/j.livsci.2008.03.007; Murray J, 2010, ADV ANIMAL BIOSCIENC, V1, P365; O' Donnell MM, 2013, LETT APPL MICROBIOL, V57, P492, DOI 10.1111/lam.12137; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rogers CW, 2007, NEW ZEAL VET J, V55, P302, DOI 10.1080/00480169.2007.36785; Rogers CW, 2004, NZ SOC ANIMAL PRODUC; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Spellerberg IF, 2003, GLOBAL ECOL BIOGEOGR, V12, P177, DOI 10.1046/j.1466-822X.2003.00015.x; St-Pierre B, 2013, ANIMAL, V7, P49, DOI 10.1017/S1751731112000912; Steelman SM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-231; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van den Berg M, 2013, J EQUINE VET SCI, V33, P215, DOI 10.1016/j.jevs.2012.06.004; Van Weyenberg S, 2006, LIVEST SCI, V99, P3, DOI 10.1016/j.livprodsci.2005.04.008; Vermorel M, 1997, LIVEST PROD SCI, V47, P261, DOI 10.1016/S0301-6226(96)01410-8; Willing B, 2009, EQUINE VET J, V41, P908, DOI 10.2746/042516409X447806; Yamano H, 2008, ANIM SCI J, V79, P234, DOI 10.1111/j.1740-0929.2008.00522.x	58	87	90	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112846	10.1371/journal.pone.0112846	http://dx.doi.org/10.1371/journal.pone.0112846			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383707	gold, Green Published, Green Submitted			2022-12-27	WOS:000344816700098
J	Guo, G; Wang, L; Liu, HX; Randall, T				Guo, Guang; Wang, Lin; Liu, Hexuan; Randall, Thomas			Genomic Assortative Mating in Marriages in the United States	PLOS ONE			English	Article							BIOLOGICAL PATHWAYS; 5 DECADES; HEIGHT; LOCI; ASSOCIATION; DISORDERS; C6ORF217; VARIANTS; TRENDS; ADULT	Assortative mating in phenotype in human marriages has been widely observed. Using genome-wide genotype data from the Framingham Heart study (FHS; number of married couples = 989) and Health Retirement Survey (HRS; number of married couples = 3,474), this study investigates genomic assortative mating in human marriages. Two types of genomic marital correlations are calculated. The first is a correlation specific to a single married couple "averaged'' over all available autosomal single-nucleotide polymorphism (SNPs). In FHS, the average married-couple correlation is 0.0018 with p=3x10(-5); in HRS, it is 0.0017 with p=7.13x10(-13). The marital correlation among the positively assorting SNPs is 0.001 (p=.0043) in FHS and 0.015 (p=1.66x10(-24)) in HRS. The sizes of these estimates in FHS and HRS are consistent with what are suggested by the distribution of the allelic combination. The study also estimated SNP-specific correlation "averaged'' over all married couples. Suggestive evidence is reported. Future studies need to consider a more general form of genomic assortment, in which different allelic forms in homologous genes and non-homologous genes result in the same phenotype.	[Guo, Guang; Liu, Hexuan] Univ N Carolina, Dept Sociol, Chapel Hill, NC 27599 USA; [Guo, Guang; Liu, Hexuan] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA; [Guo, Guang] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Wang, Lin] Duke Univ, Ctr Child & Family Policy, Durham, NC USA; [Randall, Thomas] NIEHS, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Guo, G (corresponding author), Univ N Carolina, Dept Sociol, Chapel Hill, NC 27599 USA.	guang_guo@unc.edu			National Institutes of Health [RC1 DA029425-01]; NATIONAL INSTITUTE ON DRUG ABUSE [RC1DA029425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding provided by Challenge Grant RC1 DA029425-01, National Institutes of Health, http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Amann-Zalcenstein D, 2006, EUR J HUM GENET, V14, P1111, DOI 10.1038/sj.ejhg.5201675; Cherlin CJ, 2009, MARRIAGE GO ROUND ST; Domingue BW, 2014, P NATL ACAD SCI USA, V111, P7996, DOI 10.1073/pnas.1321426111; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Goldstein H., 2011, MULTILEVEL STAT MODE, V4th; HEATH AC, 1985, BEHAV GENET, V15, P15, DOI 10.1007/BF01071929; Hindorff L., 2013, CATALOG PUBLISHED GE; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; LEWONTIN R, 1968, EUGEN QUART, V15, P141, DOI 10.1080/19485565.1968.9987764; Ma JW, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046096, 10.1371/journal.pone.0041560]; MARE RD, 1991, AM SOCIOL REV, V56, P15, DOI 10.2307/2095670; MERIKANGAS KR, 1982, ARCH GEN PSYCHIAT, V39, P1173; NIELSEN J, 1964, BRIT J PSYCHIAT, V110, P683, DOI 10.1192/bjp.110.468.683; Pawlowski B, 2000, NATURE, V403, P156, DOI 10.1038/35003107; Pearson Karl, 1903, BIOMETRIKA, V2, P481; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Qian ZC, 1998, DEMOGRAPHY, V35, P279, DOI 10.2307/3004036; Qian ZC, 2007, AM SOCIOL REV, V72, P68, DOI 10.1177/000312240707200104; RAMSOY NR, 1966, AM SOCIOL REV, V31, P773, DOI 10.2307/2091657; Risch N, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r132; Salonen JT, 2007, AM J HUM GENET, V81, P338, DOI 10.1086/520599; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Schwartz CR, 2005, DEMOGRAPHY, V42, P621, DOI 10.1353/dem.2005.0036; Searle S.R., 1971, LINEAR MODELS; Silventoinen K, 2000, AM J PUBLIC HEALTH, V90, P627, DOI 10.2105/AJPH.90.4.627; Slonimsky A, 2010, SCHIZOPHR RES, V120, P159, DOI 10.1016/j.schres.2010.03.041; Smits J, 2009, SOC FORCES, V88, P227; Speakman JR, 2007, AM J CLIN NUTR, V86, P316, DOI 10.1093/ajcn/86.2.316; THIESSEN D, 1980, ETHOL SOCIOBIOL, V1, P111, DOI 10.1016/0162-3095(80)90003-5; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Torche F, 2010, DEMOGRAPHY, V47, P481; VANDENBERG SG, 1972, BEHAV GENET, V2, P127, DOI 10.1007/BF01065686; Volkening K, 2010, AMYOTROPH LATERAL SC, V11, P97, DOI 10.3109/17482960902995584; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; Wright S, 1921, GENETICS, V6, P144	37	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112322	10.1371/journal.pone.0112322	http://dx.doi.org/10.1371/journal.pone.0112322			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384046	Green Published, gold, Green Submitted			2022-12-27	WOS:000344816700049
J	Li, XZ; Rui, JP; Xiong, JB; Li, JB; He, ZL; Zhou, JZ; Yannarell, AC; Mackie, RI				Li, Xiangzhen; Rui, Junpeng; Xiong, Jingbo; Li, Jiabao; He, Zhili; Zhou, Jizhong; Yannarell, Anthony C.; Mackie, Roderick I.			Functional Potential of Soil Microbial Communities in the Maize Rhizosphere	PLOS ONE			English	Article							ZEA-MAYS; DIVERSITY; GROWTH; BT	Microbial communities in the rhizosphere make significant contributions to crop health and nutrient cycling. However, their ability to perform important biogeochemical processes remains uncharacterized. Here, we identified important functional genes that characterize the rhizosphere microbial community to understand metabolic capabilities in the maize rhizosphere using the GeoChip-based functional gene array method. Significant differences in functional gene structure were apparent between rhizosphere and bulk soil microbial communities. Approximately half of the detected gene families were significantly (p<0.05) increased in the rhizosphere. Based on the detected gyrB genes, Gammaproteobacteria, Betaproteobacteria, Firmicutes, Bacteroidetes and Cyanobacteria were most enriched in the rhizosphere compared to those in the bulk soil. The rhizosphere niche also supported greater functional diversity in catabolic pathways. The maize rhizosphere had significantly enriched genes involved in carbon fixation and degradation (especially for hemicelluloses, aromatics and lignin), nitrogen fixation, ammonification, denitrification, polyphosphate biosynthesis and degradation, sulfur reduction and oxidation. This research demonstrates that the maize rhizosphere is a hotspot of genes, mostly originating from dominant soil microbial groups such as Proteobacteria, providing functional capacity for the transformation of labile and recalcitrant organic C, N, P and S compounds.	[Li, Xiangzhen; Mackie, Roderick I.] Univ Illinois, Energy Biosci Inst, Urbana, IL 61820 USA; [Li, Xiangzhen; Li, Jiabao] Chinese Acad Sci, Chengdu Inst Biol, Environm Microbiol Key Lab Sichuan Prov, Key Lab Environm & Appl Microbiol,CAS, Chengdu, Sichuan, Peoples R China; [Rui, Junpeng] Chinese Acad Sci, Chengdu Inst Biol, Ecol Restorat Biodivers Conservat Key Lab Sichuan, Key Lab Mt Ecol Restorat & Bioresource Utilizat,C, Beijing 100864, Sichuan, Peoples R China; [Xiong, Jingbo] Sch Marine Sci, Ningbo, Zhejiang, Peoples R China; [He, Zhili; Zhou, Jizhong] Univ Oklahoma, Inst Environm Genom, Norman, OK 73019 USA; [He, Zhili; Zhou, Jizhong] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA; [Yannarell, Anthony C.] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL USA; [Mackie, Roderick I.] Univ Illinois, Dept Anim Sci, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Mackie, RI (corresponding author), Univ Illinois, Energy Biosci Inst, Urbana, IL 61820 USA.	r-mackie@illinois.edu	吴, 昊/AAB-1620-2020; He, Zhili/C-2879-2012; Liu, Jia-Bao/C-7850-2015; li, jia/GVT-7587-2022; Yannarell, Anthony/AAA-1720-2019	He, Zhili/0000-0001-8225-7333; Liu, Jia-Bao/0000-0002-9620-7692; 	Energy Biosciences Institute, Environmental Impact and Sustainability of Feedstock Production Program at the University of Illinois, Urbana; National Natural Science Foundation of China [41371268, 41301272]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB15010000]	Energy Biosciences Institute, Environmental Impact and Sustainability of Feedstock Production Program at the University of Illinois, Urbana; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was funded by the Energy Biosciences Institute, Environmental Impact and Sustainability of Feedstock Production Program at the University of Illinois, Urbana (http://www.energybiosciencesinstitute.org/program_project/environmental-impact-and-sustainability-feedstock-production). The author RJ was also supported from the National Natural Science Foundation of China (41371268, 41301272) (http://www.nsfc.gov.cn/publish/portal1/), Strategic Priority Research Program of the Chinese Academy of Sciences (XDB15010000) (http://english.cas.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aira M, 2010, SOIL BIOL BIOCHEM, V42, P2276, DOI 10.1016/j.soilbio.2010.08.029; ASMAR F, 1995, PLANT SOIL, V172, P117, DOI 10.1007/BF00020865; Bonkowski M, 2000, EUR J SOIL BIOL, V36, P135, DOI 10.1016/S1164-5563(00)01059-1; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; COOK RJ, 1995, P NATL ACAD SCI USA, V92, P4197, DOI 10.1073/pnas.92.10.4197; Dohrmann AB, 2013, ISME J, V7, P37, DOI 10.1038/ismej.2012.77; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Velasco AGV, 2013, APPL SOIL ECOL, V68, P46, DOI 10.1016/j.apsoil.2013.03.010; HANWAY JJ, 1963, AGRON J, V55, P487, DOI 10.2134/agronj1963.00021962005500050024x; He ZL, 2012, CURR OPIN BIOTECH, V23, P460, DOI 10.1016/j.copbio.2011.12.021; He ZL, 2010, ISME J, V4, P1167, DOI 10.1038/ismej.2010.46; Kersten P, 2007, FUNGAL GENET BIOL, V44, P77, DOI 10.1016/j.fgb.2006.07.007; Li XZ, 2014, SOIL BIOL BIOCHEM, V68, P392, DOI 10.1016/j.soilbio.2013.10.017; Mahmood T, 1997, BIOL FERT SOILS, V24, P323, DOI 10.1007/s003740050251; Marschner P, 2004, PLANT SOIL, V261, P199, DOI 10.1023/B:PLSO.0000035569.80747.c5; Mendes LW, 2014, ISME J, V8, P1577, DOI 10.1038/ismej.2014.17; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Philippot L, 2002, APPL ENVIRON MICROB, V68, P6121, DOI 10.1128/AEM.68.12.6121-6128.2002; Singh BK, 2004, TRENDS MICROBIOL, V12, P386, DOI 10.1016/j.tim.2004.06.008; Wang HB, 2011, J PROTEOME RES, V10, P932, DOI 10.1021/pr100981r; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	22	98	107	12	185	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112609	10.1371/journal.pone.0112609	http://dx.doi.org/10.1371/journal.pone.0112609			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383887	Green Submitted, Green Published, gold			2022-12-27	WOS:000344816700083
J	Linder, B; Hirmer, A; Gal, A; Ruther, K; Bolz, HJ; Winkler, C; Laggerbauer, B; Fischer, U				Linder, Bastian; Hirmer, Anja; Gal, Andreas; Ruether, Klaus; Bolz, Hanno Joern; Winkler, Christoph; Laggerbauer, Bernhard; Fischer, Utz			Identification of a PRPF4 Loss-of-Function Variant That Abrogates U4/U6.U5 Tri-snRNP Integration and Is Associated with Retinitis Pigmentosa	PLOS ONE			English	Article							SPLICING FACTOR GENES; DEVELOPMENTAL DISORDER; RECYCLING FACTOR; MUTATIONS; RNA; PROTEIN; SPLICEOSOME; CYCLOPHILIN; EXPRESSIVITY; COMPONENT	Pre-mRNA splicing by the spliceosome is an essential step in the maturation of nearly all human mRNAs. Mutations in six spliceosomal proteins, PRPF3, PRPF4, PRPF6, PRPF8, PRPF31 and SNRNP200, cause retinitis pigmentosa (RP), a disease characterized by progressive photoreceptor degeneration. All splicing factors linked to RP are constituents of the U4/U6. U5 tri-snRNP subunit of the spliceosome, suggesting that the compromised function of this particle may lead to RP. Here, we report the identification of the p.R192H variant of the tri-snRNP factor PRPF4 in a patient with RP. The mutation affects a highly conserved arginine residue that is crucial for PRPF4 function. Introduction of a corresponding mutation into the zebrafish homolog of PRPF4 resulted in a complete loss of function in vivo. A series of biochemical experiments suggested that p.R192H disrupts the binding interface between PRPF4 and its interactor PRPF3. This interferes with the ability of PRPF4 to integrate into the tri-snRNP, as shown in a human cell line and in zebrafish embryos. These data suggest that the p.R192H variant of PRPF4 represents a functional null allele. The resulting haploinsufficiency of PRPF4 compromises the function of the tri-snRNP, reinforcing the notion that this spliceosomal particle is of crucial importance in the physiology of the retina.	[Linder, Bastian; Hirmer, Anja; Laggerbauer, Bernhard; Fischer, Utz] Univ Wurzburg, Dept Biochem, D-97070 Wurzburg, Germany; [Gal, Andreas] Univ Med Ctr Hamburg Eppendorf, Dept Human Genet, Hamburg, Germany; [Ruether, Klaus] St Gertrauden Hosp, Dept Ophthalmol, Berlin, Germany; [Bolz, Hanno Joern] Univ Hosp Cologne, Inst Human Genet, Cologne, Germany; [Bolz, Hanno Joern] Bioscientia Ctr Human Genet, Ingelheim, Germany; [Winkler, Christoph] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	University of Wurzburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Cologne; National University of Singapore	Fischer, U (corresponding author), Univ Wurzburg, Dept Biochem, D-97070 Wurzburg, Germany.	utz.fischer@biozentrum.uni-wuerzburg.de	Linder, Bastian/W-4923-2019; Winkler, Christoph/G-4822-2012; Fischer, Utz/A-4090-2016; Fischer, Utz/AAT-8422-2020; Linder, Bastian/G-5111-2012	Linder, Bastian/0000-0003-1203-3136; Fischer, Utz/0000-0002-1465-6591; Fischer, Utz/0000-0002-1465-6591; Winkler, Christoph/0000-0003-4688-6241	German Research Foundation (DFG); Academic Research Fund (AcRF) grant of the Ministry of Education, Singapore [T207B3107]; German ProRetina Foundation; Graduiertenkolleg GK [1048]; University of Wuerzburg in the funding programme Open Access Publishing	German Research Foundation (DFG)(German Research Foundation (DFG)); Academic Research Fund (AcRF) grant of the Ministry of Education, Singapore(Ministry of Education, Singapore); German ProRetina Foundation; Graduiertenkolleg GK(German Research Foundation (DFG)); University of Wuerzburg in the funding programme Open Access Publishing	This work was supported by German Research Foundation (DFG) grants to U. Fischer and an Academic Research Fund (AcRF) grant (T207B3107) of the Ministry of Education, Singapore to C. Winkler. B. Linder and A. Hirmer received fellowships from the German ProRetina Foundation and the Graduiertenkolleg GK 1048, respectively. This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ayadi L, 1998, J MOL BIOL, V284, P673, DOI 10.1006/jmbi.1998.2183; Bell M, 2002, EMBO J, V21, P2724, DOI 10.1093/emboj/21.11.2724; Benaglio P, 2014, MOL VIS, V20, P843; Bonnal S, 2008, MOL CELL, V32, P81, DOI 10.1016/j.molcel.2008.08.008; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Chakarova CF, 2002, HUM MOL GENET, V11, P87, DOI 10.1093/hmg/11.1.87; Chen X, 2014, HUM MOL GENET, V23, P2926, DOI 10.1093/hmg/ddu005; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Cvackova Z, 2014, HUM MUTAT, V35, P308, DOI 10.1002/humu.22481; Edery P, 2011, SCIENCE, V332, P240, DOI 10.1126/science.1202205; EVANS K, 1995, BRIT J OPHTHALMOL, V79, P841, DOI 10.1136/bjo.79.9.841; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Galej Wojciech P, 2013, Nature, V493, P638, DOI 10.1038/nature11843; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; He HL, 2011, SCIENCE, V332, P238, DOI 10.1126/science.1200587; Horowitz DS, 1997, RNA, V3, P1374; Horowitz DS, 2002, EMBO J, V21, P470, DOI 10.1093/emboj/21.3.470; HU J, 1994, NUCLEIC ACIDS RES, V22, P1724, DOI 10.1093/nar/22.9.1724; Huranova M, 2009, HUM MOL GENET, V18, P2014, DOI 10.1093/hmg/ddp125; Jia YC, 2012, CELL, V148, P296, DOI 10.1016/j.cell.2011.11.057; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Linder B, 2008, HUM MOL GENET, V17, P3236, DOI 10.1093/hmg/ddn219; Linder B, 2011, HUM MOL GENET, V20, P368, DOI 10.1093/hmg/ddq473; Maubaret CG, 2011, INVEST OPHTH VIS SCI, V52, P9304, DOI 10.1167/iovs.11-8372; McKie AB, 2001, HUM MOL GENET, V10, P1555, DOI 10.1093/hmg/10.15.1555; Mordes D, 2006, MOL VIS, V12, P1259; Nag A, 2012, RNA BIOL, V9, P0; Pasternack SM, 2013, AM J HUM GENET, V92, P81, DOI 10.1016/j.ajhg.2012.10.022; Raghunathan PL, 1998, SCIENCE, V279, P857, DOI 10.1126/science.279.5352.857; Tanackovic G, 2011, AM J HUM GENET, V88, P643, DOI 10.1016/j.ajhg.2011.04.008; Tanackovic G, 2011, HUM MOL GENET, V20, P2116, DOI 10.1093/hmg/ddr094; Teigelkamp S, 1998, RNA, V4, P127; Trede NS, 2007, P NATL ACAD SCI USA, V104, P6608, DOI 10.1073/pnas.0701919104; Vaclavik V, 2010, MOL VIS, V16, P467; Venturini G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003040; Vithana EN, 2001, MOL CELL, V8, P375, DOI 10.1016/S1097-2765(01)00305-7; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Zhao C, 2009, AM J HUM GENET, V85, P617, DOI 10.1016/j.ajhg.2009.09.020	40	28	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e111754	10.1371/journal.pone.0111754	http://dx.doi.org/10.1371/journal.pone.0111754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383878	Green Published, gold, Green Submitted			2022-12-27	WOS:000344816700020
J	Liu, Y; Wen, J; Chen, J; Xu, CY; Hu, YL; Zhou, YH				Liu, Yong; Wen, Jian; Chen, Jie; Xu, Chenyu; Hu, Yali; Zhou, Yi-Hua			Rare Detection of Occult Hepatitis B Virus Infection in Children of Mothers with Positive Hepatitis B Surface Antigen	PLOS ONE			English	Article							RETRACTED ARTICLE. SEE; HBV INFECTION; VACCINATION; PREVALENCE; ADULTS; KOREA; DNA; PCR	The prevalence of occult Hepatitis B virus (HBV) infection in children was considerably varied from 0.1-64% in different reports. In this study we aimed to investigate the prevalence of occult HBV infection among the children born to mothers with positive hepatitis B surface antigen (HBsAg) in Jiangsu, China. Serum samples were collected from 210 children of 207 mothers with positive HBsAg. HBV serological markers were detected by ELISA and HBV DNA was detected by nested PCR. Homology comparison of HBV sequences recovered from the child and mother was used to define the infection. Three children (1.43%) were positive for HBsAg, in whom the HBV pre S and S gene sequence in each child was identical to that in her mother. Of the 207 HBsAg-negative children, nine displayed HBV DNA positive by two nested PCR assays using primers derived from S and C genes. However, the sequence alignment showed that the sequences in each child were considerably different from those in his/her mother. Therefore, the sequences amplified from the children were very likely resultant from the cross-contaminations. Furthermore, the nine children with 'positive HBV DNA' were all negative for anti-HBc, and one had anti-HBs 3.42 mIU/ml and eight others had anti-HBs from 72 to >1000 mIU/ml, indicating that the nine children were less likely infected with HBV. Therefore, none of the 207 HBsAg-negative children of HBV-infected mothers was found to have occult HBV infection. We conclude that the prevalence of occult HBV infection in vaccinated children born to HBsAg positive mothers should be extremely low. We recommend that homology comparison of sequences recovered from the child and mother be used to define the occult HBV infection in children born to HBV infected mothers.	[Liu, Yong; Zhou, Yi-Hua] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Lab Med, Nanjing 210008, Jiangsu, Peoples R China; [Wen, Jian; Xu, Chenyu] Zhenjiang Fourth Peoples Hosp, Dept Obstet & Gynecol, Zhenjiang, Jiangsu, Peoples R China; [Chen, Jie; Hu, Yali] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Obstet & Gynecol, Nanjing 210008, Jiangsu, Peoples R China; [Zhou, Yi-Hua] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Infect Dis, Nanjing 210008, Jiangsu, Peoples R China; [Liu, Yong; Hu, Yali; Zhou, Yi-Hua] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing University	Zhou, YH (corresponding author), Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Lab Med, Nanjing 210008, Jiangsu, Peoples R China.	yzh20061111@yahoo.com			Nanjing Medical Science and Technique Development Foundation [QRX11024]; Key Laboratory from Department of Health, Jiangsu Province, China [XK201102]	Nanjing Medical Science and Technique Development Foundation; Key Laboratory from Department of Health, Jiangsu Province, China	This study was supported by Nanjing Medical Science and Technique Development Foundation (QRX11024) and by a Research Grant (XK201102) for the Key Laboratory from the Department of Health, Jiangsu Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizaki H, 1998, HEPATOLOGY, V27, P621, DOI 10.1002/hep.510270242; Chakvetadze C, 2011, VACCINE, V29, P2846, DOI 10.1016/j.vaccine.2011.01.101; Chen SJ, 2012, VIRUS RES, V163, P197, DOI 10.1016/j.virusres.2011.09.029; Duckmanton L, 1999, VIRUS RES, V64, P137, DOI 10.1016/S0168-1702(99)00088-X; Duckmanton L, 2001, VIRUS RES, V81, P167, DOI 10.1016/S0168-1702(01)00372-0; Elrashidy H, 2014, HUM VACCIN IMMUNOTHE, P10; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; He JK, 2006, J CLIN MICROBIOL, V44, P1208, DOI 10.1128/JCM.44.3.1208.2006; He JK, 2002, J CLIN MICROBIOL, V40, P4493, DOI 10.1128/JCM.40.12.4493-4498.2002; Kim SM, 2007, J INFECTION, V54, P185, DOI 10.1016/j.jinf.2006.02.002; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Liu Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-193; Lopez-Rios F, 2004, LANCET, V364, P1157, DOI 10.1016/S0140-6736(04)17102-X; Mu SC, 2009, J HEPATOL, V50, P264, DOI 10.1016/j.jhep.2008.09.017; Ni YH, 2012, J HEPATOL, V57, P730, DOI 10.1016/j.jhep.2012.05.021; Pande C, 2013, J VIRAL HEPATITIS, V20, P801, DOI 10.1111/jvh.12102; Raimondo G, 2008, J HEPATOL, V49, P652, DOI 10.1016/j.jhep.2008.07.014; Shahmoradi S, 2012, J HEPATOL, V57, P515, DOI 10.1016/j.jhep.2012.04.021; Song EY, 2009, INTERVIROLOGY, V52, P57, DOI 10.1159/000214633; Su HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070768; Vilchez RA, 2002, LANCET, V359, P817, DOI 10.1016/S0140-6736(02)07950-3; Xu LB, 2010, VACCINE, V28, P5986, DOI 10.1016/j.vaccine.2010.06.106; Zhou YH, 2009, CHINESE MED J-PEKING, V122, P98, DOI 10.3760/cma.j.issn.0366-6999.2009.01.018	24	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112803	10.1371/journal.pone.0112803	http://dx.doi.org/10.1371/journal.pone.0112803			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383543	Green Published, gold, Green Submitted			2022-12-27	WOS:000344816700096
J	Crowley, SJ; Van Reen, E; LeBourgeois, MK; Acebo, C; Tarokh, L; Seifer, R; Barker, DH; Carskadon, MA				Crowley, Stephanie J.; Van Reen, Eliza; LeBourgeois, Monique K.; Acebo, Christine; Tarokh, Leila; Seifer, Ronald; Barker, David H.; Carskadon, Mary A.			A Longitudinal Assessment of Sleep Timing, Circadian Phase, and Phase Angle of Entrainment across Human Adolescence	PLOS ONE			English	Article							RESPONSE CURVE; SOCIAL JETLAG; YOUNG ADULTHOOD; DELAYED PHASE; SCHOOL; PATTERNS; TIME; SEX; HABITS; BED	The aim of this descriptive analysis was to examine sleep timing, circadian phase, and phase angle of entrainment across adolescence in a longitudinal study design. Ninety-four adolescents participated; 38 (21 boys) were 9-10 years ("younger cohort") and 56 (30 boys) were 15-16 years ("older cohort") at the baseline assessment. Participants completed a baseline and then follow-up assessments approximately every six months for 2.5 years. At each assessment, participants wore a wrist actigraph for at least one week at home to measure self-selected sleep timing before salivary dim light melatonin onset (DLMO) phase - a marker of the circadian timing system - was measured in the laboratory. Weekday and weekend sleep onset and offset and weekend-weekday differences were derived from actigraphy. Phase angles were the time durations from DLMO to weekday sleep onset and offset times. Each cohort showed later sleep onset (weekend and weekday), later weekend sleep offset, and later DLMO with age. Weekday sleep offset shifted earlier with age in the younger cohort and later in the older cohort after age 17. Weekend-weekday sleep offset differences increased with age in the younger cohort and decreased in the older cohort after age 17. DLMO to sleep offset phase angle narrowed with age in the younger cohort and became broader in the older cohort. The older cohort had a wider sleep onset phase angle compared to the younger cohort; however, an age-related phase angle increase was seen in the younger cohort only. Individual differences were seen in these developmental trajectories. This descriptive study indicated that circadian phase and self-selected sleep delayed across adolescence, though school-day sleep offset advanced until no longer in high school, whereupon offset was later. Phase angle changes are described as an interaction of developmental changes in sleep regulation interacting with psychosocial factors (e.g., bedtime autonomy).	[Crowley, Stephanie J.] Rush Univ, Med Ctr, Dept Behav Sci, Biol Rhythms Res Lab, Chicago, IL 60612 USA; [Van Reen, Eliza; Acebo, Christine; Tarokh, Leila; Seifer, Ronald; Barker, David H.; Carskadon, Mary A.] Brown Univ, Warren Alpert Med Sch, Dept Psychiat & Human Behav, EP Bradley Hosp Sleep Res Lab, Providence, RI 02912 USA; [LeBourgeois, Monique K.] Univ Colorado, Dept Integrat Physiol, Sleep & Dev Lab, Boulder, CO 80309 USA; [Seifer, Ronald; Barker, David H.] Bradley Hasbro Childrens Res Ctr, Providence, RI USA; [Tarokh, Leila] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Tarokh, Leila] Univ Bern, Univ Hosp Child & Adolescent Psychiat, Bern, Switzerland; [Carskadon, Mary A.] Univ S Australia, Ctr Sleep Res, Adelaide, SA 5001, Australia	Rush University; Brown University; University of Colorado System; University of Colorado Boulder; University of Zurich; University of Bern; University Hospital of Bern; University of South Australia	Crowley, SJ (corresponding author), Rush Univ, Med Ctr, Dept Behav Sci, Biol Rhythms Res Lab, Chicago, IL 60612 USA.	Stephanie_J_Crowley@Rush.edu		Seifer, Ronald/0000-0003-4879-2839; Crowley, Stephanie/0000-0003-2057-9876	National Institutes of Health [AA 13252]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by a grant from the National Institutes of Health (AA 13252) to MAC. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Institute of Alcohol Abuse and Alcoholism. The National Institute of Alcohol Abuse and Alcoholism and the National Institutes of Health had no involvement in designing the study, data collection, data analysis and interpretation, writing of the manuscript, nor in the decision to submit the manuscript for publication. The authors alone are responsible for the content and writing of the paper.	Acebo C, 1999, SLEEP, V22, P95, DOI 10.1093/sleep/22.1.95; ANDRADE MMM, 1993, J ADOLESCENT HEALTH, V14, P401, DOI 10.1016/S1054-139X(08)80016-X; Boergers J, 2014, J DEV BEHAV PEDIATR, V35, P11, DOI 10.1097/DBP.0000000000000018; Burgess HJ, 2013, APPL ERGON, V44, P109, DOI 10.1016/j.apergo.2012.05.007; Burgess HJ, 2005, J SLEEP RES, V14, P229, DOI 10.1111/j.1365-2869.2005.00470.x; Cain SW, 2010, J BIOL RHYTHM, V25, P288, DOI 10.1177/0748730410374943; Campbell IG, 2011, SLEEP, V34, P83, DOI 10.1093/sleep/34.1.83; CARSKADON M A, 1990, Pediatrician, V17, P5; CARSKADON MA, 1993, SLEEP, V16, P258, DOI 10.1093/sleep/16.3.258; Carskadon MA, 2004, ANN NY ACAD SCI, V1021, P276, DOI 10.1196/annals.1308.032; Carskadon MA, 1998, SLEEP, V21, P871, DOI 10.1093/sleep/21.8.871; Carskadon MA, 1997, J BIOL RHYTHM, V12, P278, DOI 10.1177/074873049701200309; Carskadon MA., ALCOHOL DRUGS DRIV, V5/6, P317; Crowley SJ, 2007, SLEEP MED, V8, P602, DOI 10.1016/j.sleep.2006.12.002; Crowley SJ, 2006, SLEEP, V29, P1632, DOI 10.1093/sleep/29.12.1632; Duffy JF, 2011, P NATL ACAD SCI USA, V108, P15602, DOI 10.1073/pnas.1010666108; Fredriksen K, 2004, CHILD DEV, V75, P84, DOI 10.1111/j.1467-8624.2004.00655.x; Frey S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005217; Giannotti F, 2002, J SLEEP RES, V11, P191, DOI 10.1046/j.1365-2869.2002.00302.x; Gradisar M, 2013, J CLIN SLEEP MED, V9, P1291, DOI 10.5664/jcsm.3272; Hagenauer MH, 2009, DEV NEUROSCI-BASEL, V31, P276, DOI 10.1159/000216538; Iglowstein I, 2003, PEDIATRICS, V111, P302, DOI 10.1542/peds.111.2.302; Jenni OG, 2005, SLEEP, V28, P1446, DOI 10.1093/sleep/28.11.1446; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; Kraemer HC, 2000, AM J PSYCHIAT, V157, P163, DOI 10.1176/appi.ajp.157.2.163; Kripke Daniel F, 2007, J Circadian Rhythms, V5, P4, DOI 10.1186/1740-3391-5-4; Laberge L, 2001, J SLEEP RES, V10, P59, DOI 10.1046/j.1365-2869.2001.00242.x; LeBourgeois MK, 2013, J BIOL RHYTHM, V28, P322, DOI 10.1177/0748730413506543; Levandovski R, 2011, CHRONOBIOL INT, V28, P771, DOI 10.3109/07420528.2011.602445; Loessl B, 2008, CHILD CARE HLTH DEV, V34, P549, DOI 10.1111/j.1365-2214.2008.00845.x; Lund HG, 2010, J ADOLESCENT HEALTH, V46, P124, DOI 10.1016/j.jadohealth.2009.06.016; Martin SK, 2002, CHRONOBIOL INT, V19, P695, DOI 10.1081/CBI-120006080; Maslowsky J, 2014, J ADOLESCENT HEALTH, V54, P691, DOI 10.1016/j.jadohealth.2013.10.201; MINORS DS, 1991, NEUROSCI LETT, V133, P36, DOI 10.1016/0304-3940(91)90051-T; National Sleep Foundation, 2014, SLEEP AM POLL SLEEP; National Sleep Foundation, 2006, SLEEP AM POLL; O'Brien Erin M, 2005, Behav Sleep Med, V3, P113, DOI 10.1207/s15402010bsm0303_1; Olds T, 2010, SLEEP MED REV, V14, P371, DOI 10.1016/j.smrv.2009.12.002; Randler C, 2008, CHRONOBIOL INT, V25, P565, DOI 10.1080/07420520802257794; Revell VL, 2012, J PHYSIOL-LONDON, V590, P4859, DOI 10.1113/jphysiol.2012.235416; Roenneberg T, 2004, CURR BIOL, V14, pR1038, DOI 10.1016/j.cub.2004.11.039; Roenneberg T, 2012, CURR BIOL, V22, P939, DOI 10.1016/j.cub.2012.03.038; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; Sadeh A, 2009, SLEEP, V32, P1602, DOI 10.1093/sleep/32.12.1602; SMITH CS, 1989, J APPL PSYCHOL, V74, P728, DOI 10.1037/0021-9010.74.5.728; St Hilaire MA, 2012, J PHYSIOL-LONDON, V590, P3035, DOI 10.1113/jphysiol.2012.227892; STRAUCH I, 1988, SLEEP, V11, P378, DOI 10.1093/sleep/11.4.378; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; Tarokh L, 2012, NEUROSCIENCE, V216, P167, DOI 10.1016/j.neuroscience.2012.04.055; Taylor A, 2008, SLEEP BIOL RHYTHMS, V6, P172, DOI 10.1111/j.1479-8425.2008.00356.x; Taylor DJ, 2005, J SLEEP RES, V14, P239, DOI 10.1111/j.1365-2869.2005.00467.x; Thorleifsdottir B, 2002, J PSYCHOSOM RES, V53, P529, DOI 10.1016/S0022-3999(02)00444-0; Urner M, 2009, CHRONOBIOL INT, V26, P1222, DOI 10.1080/07420520903244600; Van den Bulck J, 2004, SLEEP, V27, P101, DOI 10.1093/sleep/27.1.101; Van Reen E, 2013, J BIOL RHYTHM, V28, P425, DOI 10.1177/0748730413511771; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; Wolfson Amy R, 2007, Behav Sleep Med, V5, P194; Wolfson AR, 2003, SLEEP, V26, P213, DOI 10.1093/sleep/26.2.213; Wolfson AR, 1998, CHILD DEV, V69, P875, DOI 10.2307/1132351; Yang CK, 2005, PEDIATRICS, V115, P250, DOI 10.1542/peds.2004-0815G; Yang CM, 2001, SLEEP, V24, P272, DOI 10.1093/sleep/24.3.272; Yang CM, 2001, PSYCHOL HEALTH, V16, P715, DOI 10.1080/08870440108405869	62	145	148	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112199	10.1371/journal.pone.0112199	http://dx.doi.org/10.1371/journal.pone.0112199			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT3WF	25380248	Green Published, Green Accepted, gold			2022-12-27	WOS:000344863100062
J	Kern, J; Drutel, R; Leanhart, S; Bogacz, M; Pacholczyk, R				Kern, Joanna; Drutel, Robert; Leanhart, Silvia; Bogacz, Marek; Pacholczyk, Rafal			Reduction of T Cell Receptor Diversity in NOD Mice Prevents Development of Type 1 Diabetes but Not Sjogren's Syndrome	PLOS ONE			English	Article							SALIVARY-GLAND; CLASS-II; AUTOIMMUNE EXOCRINOPATHY; POSTTRANSLATIONAL MODIFICATIONS; INSULIN PEPTIDE; MOUSE MODEL; ALPHA-BETA; REPERTOIRE; MHC; SELECTION	Non-obese diabetic (NOD) mice are well-established models of independently developing spontaneous autoimmune diseases, Sjogren's syndrome (SS) and type 1 diabetes (T1D). The key determining factor for T1D is the strong association with particular MHCII molecule and recognition by diabetogenic T cell receptor (TCR) of an insulin peptide presented in the context of I-A(g7) molecule. For SS the association with MHCII polymorphism is weaker and TCR diversity involved in the onset of the autoimmune phase of SS remains poorly understood. To compare the impact of TCR diversity reduction on the development of both diseases we generated two lines of TCR transgenic NOD mice. One line expresses transgenic TCR beta chain originated from a pathogenically irrelevant TCR, and the second line additionally expresses transgenic TCR alpha(mini) locus. Analysis of TCR sequences on NOD background reveals lower TCR diversity on Treg cells not only in the thymus, but also in the periphery. This reduction in diversity does not affect conventional CD4(+) T cells, as compared to the TCRmini repertoire on B6 background. Interestingly, neither transgenic TCR beta nor TCRmini mice develop diabetes, which we show is due to lack of insulin B:9-23 specific T cells in the periphery. Conversely SS develops in both lines, with full glandular infiltration, production of autoantibodies and hyposalivation. It shows that SS development is not as sensitive to limited availability of TCR specificities as T1D, which suggests wider range of possible TCR/peptide/MHC interactions driving autoimmunity in SS.	[Kern, Joanna; Drutel, Robert; Leanhart, Silvia; Bogacz, Marek; Pacholczyk, Rafal] Georgia Regents Univ, Ctr Biotechnol & Genom Med, Augusta, GA 30901 USA	University System of Georgia; Augusta University	Pacholczyk, R (corresponding author), Georgia Regents Univ, Ctr Biotechnol & Genom Med, Augusta, GA 30901 USA.	rpacholczyk@gru.du			National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI081798]; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081798] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by grants from National Institute of Allergy and Infectious Diseases of the National Institutes of Health (R01AI081798) and Juvenile Diabetes Research Foundation (RP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	ADELMAN MA, 1969, REV ECON STAT, V51, P99, DOI 10.2307/1926955; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Anderton SM, 2004, CURR OPIN IMMUNOL, V16, P753, DOI 10.1016/j.coi.2004.09.001; Arakaki R, 2003, ARTHRITIS RHEUM-US, V48, P3603, DOI 10.1002/art.11352; ATKINSON JC, 1992, ARTHRITIS RHEUM, V35, P1368, DOI 10.1002/art.1780351119; Baker FJ, 2002, P NATL ACAD SCI USA, V99, P9374, DOI 10.1073/pnas.142284899; Berglund JP, 2008, MOL IMMUNOL, V45, P3059, DOI 10.1016/j.molimm.2008.03.009; Brayer JB, 2001, SCAND J IMMUNOL, V54, P133, DOI 10.1046/j.1365-3083.2001.00958.x; Burek CL, 2007, J IMMUNOL, V178; CarrascoMarin E, 1996, J IMMUNOL, V156, P450; Cha S, 2002, ARTHRITIS RHEUM-US, V46, P1390, DOI 10.1002/art.10258; Cha S, 2002, CRIT REV ORAL BIOL M, V13, P5, DOI 10.1177/154411130201300103; Chaparro RJ, 2010, EXPERT REV CLIN IMMU, V6, P939, DOI [10.1586/eci.10.68, 10.1586/ECI.10.68]; D'Alise AM, 2008, P NATL ACAD SCI USA, V105, P19857, DOI 10.1073/pnas.0810713105; DWYER E, 1993, J CLIN INVEST, V92, P495, DOI 10.1172/JCI116593; Engelhard VH, 2006, CURR OPIN IMMUNOL, V18, P92, DOI 10.1016/j.coi.2005.11.015; Ferreira C, 2009, P NATL ACAD SCI USA, V106, P8320, DOI 10.1073/pnas.0808493106; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; FOX RI, 1992, RHEUM DIS CLIN N AM, V18, P517; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Gao JH, 2006, J AUTOIMMUN, V26, P90, DOI 10.1016/j.jaut.2005.11.004; Gottenberg JE, 2003, ARTHRITIS RHEUM, V48, P2240, DOI 10.1002/art.11103; Haneji N, 1997, SCIENCE, V276, P604, DOI 10.1126/science.276.5312.604; HARADA M, 1984, DIABETOLOGIA, V27, P604, DOI 10.1007/BF00276978; Iizuka M, 2010, J AUTOIMMUN, V35, P383, DOI 10.1016/j.jaut.2010.08.004; JOST L, 2010, DIVERSITY-BASEL, V2, P207, DOI [DOI 10.3390/d2020207, 10.3390/d2020207]; Kishimoto H, 2001, NAT IMMUNOL, V2, P1025, DOI 10.1038/ni726; Kisielow J, 2011, BLOOD, V118, P6591, DOI 10.1182/blood-2011-05-352732; Kraj P, 2001, J IMMUNOL, V166, P2251, DOI 10.4049/jimmunol.166.4.2251; Lavoie TN, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/549107; Lessard CJ, 2013, NAT GENET, V45, P1284, DOI 10.1038/ng.2792; LI XP, 1993, DIABETES, V42, P1166, DOI 10.2337/diabetes.42.8.1166; Lindqvist AKB, 2005, SCAND J IMMUNOL, V61, P119, DOI 10.1111/j.0300-9475.2005.01550.x; LIPES MA, 1993, SCIENCE, V259, P1165, DOI 10.1126/science.8267690; Lutsiak MEC, 2005, BLOOD, V105, P2862, DOI 10.1182/blood-2004-06-2410; Manoussakis MN, 2004, ARTHRITIS RHEUM-US, V50, P882, DOI 10.1002/art.20093; Marrack P, 2012, COLD SPRING HARBOR P, V2; Marrero I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076546; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Matsumoto I, 1999, INT J MOL MED, V3, P485; Matsumoto I, 1999, INT J MOL MED, V4, P519; Michels AW, 2011, J IMMUNOL, V187, P5921, DOI 10.4049/jimmunol.1100746; Mingueneau M, 2012, J EXP MED, V209, P623, DOI 10.1084/jem.20112593; Mohan JF, 2011, J EXP MED, V208, P2375, DOI 10.1084/jem.20111502; MOUTSOPOULOS HM, 1986, ANN RHEUM DIS, V45, P677, DOI 10.1136/ard.45.8.677; Naito Y, 2006, ANN RHEUM DIS, V65, P269, DOI 10.1136/ard.2005.039065; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Nakayama M, 2012, DIABETES, V61, P857, DOI 10.2337/db11-1113; Nguyen CQ, 2009, OCUL SURF, V7, P11, DOI 10.1016/S1542-0124(12)70289-6; Pacholczyk R, 2002, J IMMUNOL, V168, P613, DOI 10.4049/jimmunol.168.2.613; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Pivetta B, 1999, J RHEUMATOL, V26, P1101; Robinson CP, 1998, ARTHRITIS RHEUM, V41, P150, DOI 10.1002/1529-0131(199801)41:1<150::AID-ART18>3.0.CO;2-T; Serreze DV, 2001, DIABETES, V50, P1992, DOI 10.2337/diabetes.50.9.1992; Simone E, 1997, P NATL ACAD SCI USA, V94, P2518, DOI 10.1073/pnas.94.6.2518; Singh N, 2012, J AUTOIMMUN, V39, P229, DOI 10.1016/j.jaut.2012.05.019; Skarstein K, 1995, AUTOIMMUNITY, V22, P9, DOI 10.3109/08916939508995294; Stadinski BD, 2010, P NATL ACAD SCI USA, V107, P10978, DOI 10.1073/pnas.1006545107; SUMIDA T, 1992, J CLIN INVEST, V89, P681, DOI 10.1172/JCI115635; Sumida T, 2014, J AUTOIMMUN; Sumida T, 2010, AUTOIMMUN REV, V9, P615, DOI 10.1016/j.autrev.2010.05.008; Takada K, 2005, J BIOL CHEM, V280, P3982, DOI 10.1074/jbc.M410157200; WICKER LS, 1992, J EXP MED, V176, P67, DOI 10.1084/jem.176.1.67; Winer S, 2002, LANCET, V360, P1063, DOI 10.1016/S0140-6736(02)11144-5; YONAHA F, 1992, ARTHRITIS RHEUM, V35, P1362, DOI 10.1002/art.1780351118; Zhang L, 2009, J AUTOIMMUN, V33, P42, DOI 10.1016/j.jaut.2009.02.003	67	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112467	10.1371/journal.pone.0112467	http://dx.doi.org/10.1371/journal.pone.0112467			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379761	Green Published, gold			2022-12-27	WOS:000344863100103
J	Koy, T; Zange, J; Rittweger, J; Pohle-Frohlich, R; Hackenbroch, M; Eysel, P; Ganse, B				Koy, Timmo; Zange, Jochen; Rittweger, Joern; Pohle-Froehlich, Regina; Hackenbroch, Matthias; Eysel, Peer; Ganse, Bergita			Assessment of Lumbar Intervertebral Disc Glycosaminoglycan Content by Gadolinium-Enhanced MRI before and after 21-Days of Head-Down-Tilt Bedrest	PLOS ONE			English	Article							LOW-BACK-PAIN; NUCLEUS PULPOSUS; BED REST; CARTILAGE; RECOVERY; SYSTEM; RISK	During spaceflight, it has been shown that intervertebral discs (IVDs) increase in height, causing elongation of the spine up to several centimeters. Astronauts frequently report dull lower back pain that is most likely of discogenic origin and may result from IVD expansion. It is unknown whether disc volume solely increases by water influx, or if the content of glycosaminoglycans also changes in microgravity. Aim of this pilot study was to investigate effects of the spaceflight analog of bedrest on the glycosaminoglycan content of human lumbar IVDs. Five healthy, non-smoking, male human subjects of European descent were immobilized in 6 degrees head-down-tilt bedrest for 21 days. Subjects remained in bed 24 h a day with at least one shoulder on the mattress. Magnetic Resonance Imaging (MRI) scans were taken according to the delayed gadolinium-enhanced magnetic resonance imaging (dGEMRIC) protocol before and after bedrest. The outcome measures were T-1 and Delta T-1. Scans were performed before and after administration of the contrast agent Gd-DOTA, and differences between T-1-values of both scans (Delta T-1) were computed. Delta T-1 is the longitudinal relaxation time in the tissue and inversely related to the glycosaminoglycan-content. For data analysis, IVDs L1/2 to L4/5 were semi-automatically segmented. Zones were defined and analyzed separately. Results show a highly significant decrease in Delta T-1 (p < 0.001) after bedrest in all IVDs, and in all areas of the IVDs. The Delta T-1-decrease was most prominent in the nucleus pulposus and in L4/5, and was expressed slightly more in the posterior than anterior IVD. Unexpected negative Delta T-1-values were found in Pfirrmann-grade 2-discs after bedrest. Significantly lower T-1 before contrast agent application was found after bedrest compared to before bedrest. According to the dGEMRIC-literature, the decrease in Delta T-1 may be interpreted as an increase in glycosaminoglycans in healthy IVDs during bedrest. This interpretation seems contradictory to previous findings in IVD unloading.	[Koy, Timmo; Eysel, Peer] Univ Cologne, Dept Orthopaed & Trauma Surg, D-50931 Cologne, Germany; [Zange, Jochen; Rittweger, Joern; Ganse, Bergita] German Aerosp Ctr DLR, Inst Aerosp Med, Dept Space Physiol, Cologne, Germany; [Pohle-Froehlich, Regina] Hsch Niederrhein, Inst Pattern Recognit, Krefeld, Germany; [Hackenbroch, Matthias] Univ Cologne, Dept Radiol, D-50931 Cologne, Germany; [Eysel, Peer] Univ Cologne, Fac Med, CCMB, D-50931 Cologne, Germany; [Ganse, Bergita] Rhein Westfal TH Aachen, Dept Orthopaed, Aachen, Germany	University of Cologne; Helmholtz Association; German Aerospace Centre (DLR); University of Cologne; University of Cologne; RWTH Aachen University	Ganse, B (corresponding author), German Aerosp Ctr DLR, Inst Aerosp Med, Dept Space Physiol, Cologne, Germany.	bergita.ganse@dlr.de	Rittweger, Jörn/A-4308-2009	Rittweger, Jörn/0000-0002-2223-8963; Ganse, Bergita/0000-0002-9512-2910; Zange, Jochen/0000-0003-1822-0952	European Space Agency, "Microgravity Applications Program'' [21381/07/NL/VJ]; German Aerospace Center (DLR Space Program)	European Space Agency, "Microgravity Applications Program''; German Aerospace Center (DLR Space Program)	The NUC-study took place in the Institute of Aerospace Medicine of the German Aerospace Center, Cologne, Germany, and was funded by the European Space Agency (www.esa.int) as part of the "Microgravity Applications Program'' (contract number: 21381/07/NL/VJ) and by institutional funding of the German Aerospace Center (DLR Space Program) (www.dlr.de). The funders had influence on the study design, but had no role in data collection, analysis, decision to publish, or preparation of the manuscript.	Auvinen JP, 2010, EUR SPINE J, V19, P641, DOI 10.1007/s00586-009-1215-2; Belavy DL, 2012, SPINE, V37, P1245, DOI 10.1097/BRS.0b013e3182354d84; Belavy DL, 2011, J APPL PHYSIOL, V111, P1304, DOI 10.1152/japplphysiol.00695.2011; Bittersohl B, 2009, MAGN RESON MED, V62, P1362, DOI 10.1002/mrm.22166; Brisby H, 2006, J BONE JOINT SURG AM, V88A, P68, DOI 10.2106/JBJS.E.01282; Ciavarro C, 2012, J MAGN RESON IMAGING, V35, P1145, DOI 10.1002/jmri.23525; D'Aprile P, 2007, EUR RADIOL, V17, P523, DOI 10.1007/s00330-006-0324-0; Frings-Meuthen P, 2013, J MUSCULOSKEL NEURON, V13, P45; Hanley EN, 2010, J BONE JOINT SURG AM, V92A, P1293, DOI 10.2106/JBJS.I.01439; Hunter CJ, 2004, J ANAT, V205, P357, DOI 10.1111/j.0021-8782.2004.00352.x; HUTCHINSON KJ, 1995, AVIAT SPACE ENVIR MD, V66, P256; Hutton WC, 2002, SPINE, V27, P1286, DOI 10.1097/00007632-200206150-00008; Johnston SL, 2010, AVIAT SPACE ENVIR MD, V81, P566, DOI 10.3357/ASEM.2427.2010; Kelsen J, 2012, CYTOKINE, V59, P403, DOI 10.1016/j.cyto.2012.04.032; Kerstman EL, 2012, AVIAT SPACE ENVIR MD, V83, P2, DOI 10.3357/ASEM.2876.2012; Lotz JC, 1998, SPINE, V23, P2493, DOI 10.1097/00007632-199812010-00004; Mamisch TC, 2008, MAGN RESON MED, V60, P768, DOI 10.1002/mrm.21726; Niinimaki JL, 2006, J MAGN RESON IMAGING, V24, P796, DOI 10.1002/jmri.20693; PAAJANEN H, 1994, J ORTHOPAED RES, V12, P509, DOI 10.1002/jor.1100120407; Perry J, 2006, AM J NEURORADIOL, V27, P337; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Pope MH, 2002, ANNU REV BIOMED ENG, V4, P49, DOI 10.1146/annurev.bioeng.4.092101.122107; Sayson JV, 2008, AVIAT SPACE ENVIR MD, V79, P365, DOI 10.3357/ASEM.1994.2008; Sinha Raj K, 2002, Spine J, V2, P239, DOI 10.1016/S1529-9430(02)00197-3; Tibiletti M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076697; Vaga S, 2008, MAGN RESON MED, V59, P85, DOI 10.1002/mrm.21433; Vaga S, 2009, EUR SPINE J, V18, pS40, DOI 10.1007/s00586-009-0996-7; Vaga S, 2009, J MAGN RESON IMAGING, V29, P1443, DOI 10.1002/jmri.21774; WING PC, 1991, ORTHOP CLIN N AM, V22, P255; Zilkens C, 2009, ORTHOPADE, V38, P591, DOI 10.1007/s00132-009-1441-7; Zilkens C, 2010, J PEDIATR ORTHOPED, V30, P147, DOI 10.1097/BPO.0b013e3181cf13e6	31	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112104	10.1371/journal.pone.0112104	http://dx.doi.org/10.1371/journal.pone.0112104			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380233	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000344863100053
J	Palma, P; Cano, C; Conde-Muino, R; Comino, A; Bueno, P; Ferron, JA; Cuadros, M				Palma, Pablo; Cano, Carlos; Conde-Muino, Raquel; Comino, Ana; Bueno, Pablo; Ferron, J. Antonio; Cuadros, Marta			Expression Profiling of Rectal Tumors Defines Response to Neoadjuvant Treatment Related Genes	PLOS ONE			English	Article							C-MYC; PREOPERATIVE CHEMORADIOTHERAPY; PATHOLOGICAL RESPONSE; MICROARRAY ANALYSIS; CODING REGION; CANCER; PREDICTION; MUTATIONS; CHEMORADIATION; 5-FLUOROURACIL	To date, no effective method exists that predicts the response to preoperative chemoradiation (CRT) in locally advanced rectal cancer (LARC). Nevertheless, identification of patients who have a higher likelihood of responding to preoperative CRT could be crucial in decreasing treatment morbidity and avoiding expensive and time-consuming treatments. The aim of this study was to identify signatures or molecular markers related to response to pre-operative CRT in LARC. We analyzed the gene expression profiles of 26 pre-treatment biopsies of LARC (10 responders and 16 non-responders) without metastasis using Human WG CodeLink microarray platform. Two hundred and fifty seven genes were differentially over-expressed in the responder patient subgroup. Ingenuity Pathway Analysis revealed a significant ratio of differentially expressed genes related to cancer, cellular growth and proliferation pathways, and c-Myc network. We demonstrated that high Gng4, c-Myc, Pola1, and Rrm1 mRNA expression levels was a significant prognostic factor for response to treatment in LARC patients (p, 0.05). Using this gene set, we were able to establish a new model for predicting the response to CRT in rectal cancer with a sensitivity of 60% and 100% specificity. Our results reflect the value of gene expression profiling to gain insight about the molecular pathways involved in the response to treatment of LARC patients. These findings could be clinically relevant and support the use of mRNA levels when aiming to identify patients who respond to CRT therapy.	[Palma, Pablo; Conde-Muino, Raquel; Ferron, J. Antonio] Virgen de las Nieves Hosp HUVN, Div Colon & Rectal Surg, Granada, Spain; [Cano, Carlos] Univ Granada, Dept Comp Sci & Artificial Intelligence, Granada, Spain; [Comino, Ana; Bueno, Pablo; Ferron, J. Antonio] Virgen de las Nieves Hosp HUVN, Dept Surg Res, Granada, Spain; [Cuadros, Marta] Univ Granada, Junta De Andalucia, Pfizer, Ctr Genom & Oncol Res,GENYO, Granada, Spain	University of Granada; Pfizer; University of Granada	Cuadros, M (corresponding author), Univ Granada, Dept Biochem & Mol Biol & Immunol 3, Granada, Spain.	mcuadros@ugr.es	Gutierrez, Carlos Cano/ABH-2343-2020; Cuadros, Marta/K-1576-2014	Cuadros, Marta/0000-0002-8329-4854; Conde Muino, Raquel/0000-0002-9163-9410; Palma, Pablo/0000-0003-1084-5982	Fundacion Investigacion Biomedica Mutua Madrilena; Consejeria de Innovacion y Ciencia (Proyecto de Excelencia) de la Junta de Andalucia; Junta de Andalucia [CTS2200, PI-0710-2013]; Programa Estatal I+D+i MINECO [TIN2013-41990-R]; GREIB of University of Granada [PYR_2010-02, 2010_05]	Fundacion Investigacion Biomedica Mutua Madrilena; Consejeria de Innovacion y Ciencia (Proyecto de Excelencia) de la Junta de Andalucia; Junta de Andalucia(Junta de Andalucia); Programa Estatal I+D+i MINECO; GREIB of University of Granada	This investigation was supported by the Fundacion Investigacion Biomedica Mutua Madrilena and Consejeria de Innovacion y Ciencia (Proyecto de Excelencia) de la Junta de Andalucia. MC, CC and AB were supported by projects CTS2200 and PI-0710-2013 of Junta de Andalucia, TIN2013-41990-R of Programa Estatal I+D+i MINECO, and GREIB PYR_2010-02 and 2010_05 of University of Granada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamodt R, 2009, GASTROENT RES PRACT, V2009, DOI 10.1155/2009/285830; Akiyoshi T, 2012, SURG TODAY, V42, P713, DOI 10.1007/s00595-012-0223-8; Arango D, 2001, CANCER RES, V61, P4910; BHATIA K, 1994, BLOOD, V84, P883; BHATIA K, 1993, NAT GENET, V5, P56, DOI 10.1038/ng0993-56; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brettingham-Moore KH, 2011, CLIN CANCER RES, V17, P3039, DOI 10.1158/1078-0432.CCR-10-2915; CLARK HM, 1994, CANCER RES, V54, P3383; Dang CV, 1999, MOL CELL BIOL, V19, P1; Gantt GA, 2014, COLORECTAL DIS, V16, P57, DOI 10.1111/codi.12395; Ghadimi BM, 2005, J CLIN ONCOL, V23, P1826, DOI 10.1200/JCO.2005.00.406; Glynne-Jones R, 2011, DRUGS, V71, P1153, DOI 10.2165/11591330-000000000-00000; Horisberger K, 2008, INT J COLORECTAL DIS, V23, P257, DOI 10.1007/s00384-007-0408-6; Kim IJ, 2007, DIS COLON RECTUM, V50, P1342, DOI 10.1007/s10350-007-277-7; Lin MS, 2011, HEPATO-GASTROENTEROL, V58, P1937, DOI 10.5754/hge11262; MANDARD AM, 1994, CANCER, V73, P2680, DOI 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C; Nishioka M, 2011, CANCER GENOM PROTEOM, V8, P87; Ojima E, 2007, J GASTROENTEROL, V42, P730, DOI 10.1007/s00535-007-2089-x; Palma P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074034; Palma P, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-119; Pascal LE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-246; POTTER M, 1992, CARCINOGENESIS, V13, P1681, DOI 10.1093/carcin/13.10.1681; Prendergast GC, 1999, ONCOGENE, V18, P2967, DOI 10.1038/sj.onc.1202727; Rimkus C, 2008, CLIN GASTROENTEROL H, V6, P53, DOI 10.1016/j.cgh.2007.10.022; Saigusa S, 2012, ONCOL REP, V28, P855, DOI 10.3892/or.2012.1863; Sasaki K, 2012, ANTI-CANCER DRUG, V23, P675, DOI 10.1097/CAD.0b013e328353f8c7; Scarpati GD, 2012, INT J RADIAT ONCOL, V83, P1113, DOI 10.1016/j.ijrobp.2011.09.030; SMITH DR, 1993, BRIT J CANCER, V68, P407, DOI 10.1038/bjc.1993.350; Snipstad K, 2010, MOL ONCOL, V4, P52, DOI 10.1016/j.molonc.2009.11.002; van de Wiel MA, 2005, CANCER RES, V65, P10208, DOI 10.1158/0008-5472.CAN-05-0760; Watanabe T, 2006, CANCER RES, V66, P3370, DOI 10.1158/0008-5472.CAN-05-3834; YANO T, 1993, ONCOGENE, V8, P2741	32	27	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112189	10.1371/journal.pone.0112189	http://dx.doi.org/10.1371/journal.pone.0112189			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380052	Green Published, Green Submitted, gold			2022-12-27	WOS:000344863100060
J	Adler, J; Parmryd, I				Adler, Jeremy; Parmryd, Ingela			Quantifying Colocalization: Thresholding, Void Voxels and the H-coef	PLOS ONE			English	Article							IMAGE; PROTEINS; COEFFICIENT	A critical step in the analysis of images is identifying the area of interest e. g. nuclei. When the nuclei are brighter than the remainder of the image an intensity can be chosen to identify the nuclei. Intensity thresholding is complicated by variations in the intensity of individual nuclei and their intensity relative to their surroundings. To compensate thresholds can be based on local rather than global intensities. By testing local thresholding methods we found that the local mean performed poorly while the Phansalkar method and a new method based on identifying the local background were superior. A new colocalization coefficient, the H-coef, highlights a number of controversial issues. (i) Are molecular interactions measurable (ii) whether to include voxels without fluorophores in calculations, and (iii) the meaning of negative correlations. Negative correlations can arise biologically (a) because the two fluorophores are in different places or (b) when high intensities of one fluorophore coincide with low intensities of a second. The cases are distinct and we argue that it is only relevant to measure correlation using pixels that contain both fluorophores and, when the fluorophores are in different places, to just report the lack of co-occurrence and omit these uninformative negative correlation. The H-coef could report molecular interactions in a homogenous medium. But biology is not homogenous and distributions also reflect physico-chemical properties, targeted delivery and retention. The H-coef actually measures a mix of correlation and co-occurrence, which makes its interpretation problematic and in the absence of a convincing demonstration we advise caution, favouring separate measurements of correlation and of co-occurrence.	[Adler, Jeremy] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden; [Parmryd, Ingela] Uppsala Univ, Dept Med Cell Biol, Sci Life Lab, Uppsala, Sweden	Uppsala University; Uppsala University	Parmryd, I (corresponding author), Uppsala Univ, Dept Med Cell Biol, Sci Life Lab, Uppsala, Sweden.	ingela.parmryd@mcb.uu.se		Parmryd, Ingela/0000-0003-4834-3611	Magnus Bergvall's Foundation; Signhild Engkvist's Foundation; O. E. and Edla Johansson's Foundation	Magnus Bergvall's Foundation; Signhild Engkvist's Foundation; O. E. and Edla Johansson's Foundation	IP recieved funding from Magnus Bergvall's Foundation (http://www.magnbergvallsstiftelse.nu), Signhild Engkvist's Foundation (http://www.engkviststiftelserna.se/index.php/om-signhild-engkvists-stiftelse) and O. E. and Edla Johansson's Foundation (http://www.stiftelsen.rago.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2008, J MICROSC-OXFORD, V230, P121, DOI 10.1111/j.1365-2818.2008.01967.x; Adler J, 2007, J MICROSC-OXFORD, V227, P83, DOI 10.1111/j.1365-2818.2007.01788.x; Adler Jeremy, 2013, Methods Mol Biol, V931, P97, DOI 10.1007/978-1-62703-056-4_5; Adler J, 2010, CYTOM PART A, V77A, P733, DOI 10.1002/cyto.a.20896; Agnati LF, 2005, J HISTOCHEM CYTOCHEM, V53, P941, DOI 10.1369/jhc.4A6355.2005; Barlow AL, 2010, MICROSC MICROANAL, V16, P710, DOI 10.1017/S143192761009389X; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; BLYTH CR, 1972, J AM STAT ASSOC, V67, P364, DOI 10.2307/2284382; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Galton F., 1888, P R SOC LONDON, V45, P135, DOI [DOI 10.1098/RSPL.1888.0082, 10.1098/rspl.1888.0082]; Glynn MW, 2006, NAT PROTOC, V1, P1287, DOI 10.1038/nprot.2006.220; Herce HD, 2013, J MICROSC-OXFORD, V249, P184, DOI 10.1111/jmi.12008; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; McDonald JH, 2013, J MICROSC-OXFORD, V252, P295, DOI 10.1111/jmi.12093; Meijering E, 2012, IEEE SIGNAL PROC MAG, V29, P140, DOI 10.1109/MSP.2012.2204190; Parmryd I, 2013, FEBS J, V280, P2775, DOI 10.1111/febs.12209; PFANNER N, 1988, EUR J BIOCHEM, V175, P205, DOI 10.1111/j.1432-1033.1988.tb14185.x; Phansalkar Neerad, 2011, 2011 International Conference on Communications and Signal Processing (ICCSP), P218, DOI 10.1109/ICCSP.2011.5739305; Rappaz B., 2013, CURR PROTOC CELL BIO; Sauvola J, 2000, PATTERN RECOGN, V33, P225, DOI 10.1016/S0031-3203(99)00055-2; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Tsarouhas V, 2014, J CELL SCI, V127, P1829, DOI 10.1242/jcs.143016; WAGNER P, 1990, FEBS LETT, V275, P1, DOI 10.1016/0014-5793(90)81425-N; Wilcox RR, 2001, INT J SELECT ASSESS, V9, P195, DOI 10.1111/1468-2389.00172; Wu Y, 2012, INTERDISCIP SCI, V4, P27, DOI 10.1007/s12539-012-0117-x; Wu Y, 2010, BIOPHYS J, V98, P493, DOI 10.1016/j.bpj.2009.10.037	28	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111983	10.1371/journal.pone.0111983	http://dx.doi.org/10.1371/journal.pone.0111983			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375829	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600086
J	Legagneux, P; Suffice, P; Messier, JS; Lelievre, F; Tremblay, JA; Maisonneuve, C; Saint-Louis, R; Bety, J				Legagneux, Pierre; Suffice, Pauline; Messier, Jean-Sebastien; Lelievre, Frederick; Tremblay, Junior A.; Maisonneuve, Charles; Saint-Louis, Richard; Bety, Joel			High Risk of Lead Contamination for Scavengers in an Area with High Moose Hunting Success	PLOS ONE			English	Article							ISOTOPE RATIOS; CALIFORNIA CONDORS; BULLET FRAGMENTS; EXPOSURE; AMMUNITION; BIRDS; SHOT; INGESTION; DEER; PREDATORS	Top predators and scavengers are vulnerable to pollutants, particularly those accumulated along the food chain. Lead accumulation can induce severe disorders and alter survival both in mammals (including humans) and in birds. A potential source of lead poisoning in wild animals, and especially in scavengers, results from the consumption of ammunition residues in the tissues of big game killed by hunters. For two consecutive years we quantified the level lead exposure in individuals of a sentinel scavenger species, the common raven (Corvus corax), captured during the moose (Alces alces) hunting season in eastern Quebec, Canada. The source of the lead contamination was also determined using stable isotope analyses. Finally, we identified the different scavenger species that could potentially be exposed to lead by installing automatic cameras targeting moose gut piles. Blood lead concentration in ravens increased over time, indicating lead accumulation over the moose- hunting season. Using a contamination threshold of 100 mg. L 21, more than 50% of individuals were lead- contaminated during the moose hunting period. Lead concentration was twice as high in one year compared to the other, matching the number of rifle- shot moose in the area. Non-contaminated birds exhibited no ammunition isotope signatures. The isotope signature of the lead detected in contaminated ravens tended towards the signature from lead ammunition. We also found that black bears (Ursus americanus), golden eagles and bald eagles (Aquila chrysaetos and Haliaeetus leucocephalus, two species of conservation concern) scavenged heavily on moose viscera left by hunters. Our unequivocal results agree with other studies and further motivate the use of non-toxic ammunition for big game hunting.	[Legagneux, Pierre; Suffice, Pauline; Messier, Jean-Sebastien; Saint-Louis, Richard; Bety, Joel] Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ, Canada; [Legagneux, Pierre; Suffice, Pauline; Messier, Jean-Sebastien; Saint-Louis, Richard; Bety, Joel] Univ Quebec, Ctr Etudes Nord, Rimouski, PQ, Canada; [Lelievre, Frederick; Maisonneuve, Charles] Minist Dev Durable Environm Faune & Parcs, Quebec City, PQ, Canada; [Tremblay, Junior A.] Environm Canada, Sci & Technol Branch, Quebec City, PQ, Canada	University of Quebec; University of Quebec; Environment & Climate Change Canada	Legagneux, P (corresponding author), Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ, Canada.	legagneux@gmail.com	Tremblay, Junior A./AAX-7353-2020	Tremblay, Junior A./0000-0003-4930-0939; Bety, Joel/0000-0002-8775-6411; Legagneux, Pierre/0000-0002-6366-0554	Ministere du Developpement Durable, de l'Environnement, de la Faune et des Parcs; Fondation de la faune du Quebec; Universite ' du Quebec a Rimouski	Ministere du Developpement Durable, de l'Environnement, de la Faune et des Parcs; Fondation de la faune du Quebec; Universite ' du Quebec a Rimouski	This study was supported by the Ministere du Developpement Durable, de l'Environnement, de la Faune et des Parcs; the Fondation de la faune du Quebec (Programme "Protection, mise en valeur et amenagement des habitats fauniques", and Programme "Faune en danger"), and the Universite ' du Quebec a Rimouski. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery D, 2009, REGULATION LEAD BASE, P161; Aznar JC, 2008, ENVIRON POLLUT, V156, P76, DOI 10.1016/j.envpol.2007.12.037; Bedrosian B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051978; Bellrose FC, 1959, B ILL NAT HIST SURV, V27; Beschta RL, 2009, BIOL CONSERV, V142, P2401, DOI 10.1016/j.biocon.2009.06.015; Burger J, 2000, J TOXICOL ENV HEAL B, V3, P59, DOI 10.1080/109374000281096; Burger J, 2004, ECOTOX ENVIRON SAFE, V57, P136, DOI 10.1016/S0147-6513(03)00035-6; Cade TJ, 2007, J WILDLIFE MANAGE, V71, P2125, DOI 10.2193/2007-084; Carson EA, 2000, J FORENSIC SCI, V45, P515; Church ME, 2006, ENVIRON SCI TECHNOL, V40, P6143, DOI 10.1021/es060765s; Clark AJ, 2003, ECOTOXICOLOGY, V12, P23, DOI 10.1023/A:1022576510445; Couture A, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.18591; Craighead D, 2008, J WILDLIFE MANAGE, V72, P240, DOI 10.2193/2007-120; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Finkelstein ME, 2012, P NATL ACAD SCI USA, V109, P11449, DOI 10.1073/pnas.1203141109; Fisher IJ, 2006, BIOL CONSERV, V131, P421, DOI 10.1016/j.biocon.2006.02.018; Gordon JN, 2002, BRIT J CLIN PHARMACO, V53, P451, DOI 10.1046/j.1365-2125.2002.01580.x; GRASMAN KA, 1995, ARCH ENVIRON CON TOX, V28, P161, DOI 10.1007/BF00217611; Grund Marrett D., 2010, Human-Wildlife Interactions, V4, P257; HEINRICH B, 1988, BEHAV ECOL SOCIOBIOL, V23, P141, DOI 10.1007/BF00300349; Hunt WG, 2006, WILDLIFE SOC B, V34, P167, DOI 10.2193/0091-7648(2006)34[167:BFIDRI]2.0.CO;2; Hunt WG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005330; Kelly TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017656; Kendall RJ, 1996, ENVIRON TOXICOL CHEM, V15, P4, DOI 10.1002/etc.5620150103; Knott Jeff, 2009, Conservation Evidence, V6, P71; Krone O., 2009, INGESTION LEAD SPENT; Lambertucci SA, 2011, BIOL CONSERV, V144, P1464, DOI 10.1016/j.biocon.2011.01.015; Lambertucci SA, 2010, ENVIRON SCI TECHNOL, V44, P7759, DOI 10.1021/es102667c; Levesque B, 2003, OCCUP ENVIRON MED, V60, P693, DOI 10.1136/oem.60.9.693; Lindboe M, 2012, FOOD ADDIT CONTAM A, V29, P1052, DOI 10.1080/19440049.2012.680201; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; Needleman H, 2004, ANNU REV MED, V55, P209, DOI 10.1146/annurev.med.55.091902.103653; Pain Deborah J., 2009, P99, DOI 10.4080/ilsa.2009.0108; Pain DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010315; PAIN DJ, 1993, IBIS, V135, P379, DOI 10.1111/j.1474-919X.1993.tb02109.x; PAIN DJ, 1988, B ENVIRON CONTAM TOX, V40, P159, DOI 10.1007/BF01881033; PAIN DJ, 1990, ENVIRON POLLUT, V66, P273, DOI 10.1016/0269-7491(90)90007-Y; Pariseau J, 2009, MAR POLLUT BULL, V58, P503, DOI 10.1016/j.marpolbul.2008.12.011; Pauli JN, 2007, J WILDLIFE MANAGE, V71, P103, DOI 10.2193/2005-620; Rogers TA, 2012, J WILDLIFE MANAGE, V76, P575, DOI 10.1002/jwmg.277; Scheuhammer AM, 2003, ENVIRON TOXICOL CHEM, V22, P2585, DOI 10.1897/02-361; Scheuhammer AM, 1998, ECOTOXICOLOGY, V7, P37, DOI 10.1023/A:1008855617453; SCHEUHAMMER AM, 1987, ENVIRON POLLUT, V46, P263, DOI 10.1016/0269-7491(87)90173-4; Scheuhammer AM, 1996, ECOTOXICOLOGY, V5, P279, DOI 10.1007/BF00119051; Schmitz OJ, 2006, ECOLOGY, V87, P1432, DOI 10.1890/0012-9658(2006)87[1432:PHLEOE]2.0.CO;2; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Stauber E, 2010, J AVIAN MED SURG, V24, P279, DOI 10.1647/2009-006.1; Thomas VG, 2009, SCI TOTAL ENVIRON, V407, P3494, DOI 10.1016/j.scitotenv.2009.02.003; Tsuji LJS, 2008, SCI TOTAL ENVIRON, V393, P291, DOI 10.1016/j.scitotenv.2008.01.022; Wayland M, 1999, ENVIRON POLLUT, V104, P341, DOI 10.1016/S0269-7491(98)00201-2; White C, 2005, ECOLOGY, V86, P1057, DOI 10.1890/03-3185; Wilmers CC, 2003, J ANIM ECOL, V72, P909, DOI 10.1046/j.1365-2656.2003.00766.x	52	37	38	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111546	10.1371/journal.pone.0111546	http://dx.doi.org/10.1371/journal.pone.0111546			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389754	gold, Green Published			2022-12-27	WOS:000349144400023
J	Dahlberg, CJ; Ehrlen, J; Hylander, K				Dahlberg, C. Johan; Ehrlen, Johan; Hylander, Kristoffer			Performance of Forest Bryophytes with Different Geographical Distributions Transplanted across a Topographically Heterogeneous Landscape	PLOS ONE			English	Article							SOLAR-RADIATION; SPECIES DISTRIBUTION; DISTRIBUTION MODELS; POPULATION-GROWTH; COMPLEX TERRAIN; RANGE-LIMIT; CLIMATE; EDGE; TEMPERATURE; TOLERANCE	Most species distribution models assume a close link between climatic conditions and species distributions. Yet, we know little about the link between species' geographical distributions and the sensitivity of performance to local environmental factors. We studied the performance of three bryophyte species transplanted at south- and north-facing slopes in a boreal forest landscape in Sweden. At the same sites, we measured both air and ground temperature. We hypothesized that the two southerly distributed species Eurhynchium angustirete and Herzogiella seligeri perform better on south- facing slopes and in warm conditions, and that the northerly distributed species Barbilophozia lycopodioides perform better on north-facing slopes and in relatively cool conditions. The northern, but not the two southern species, showed the predicted relationship with slope aspect. However, the performance of one of the two southern species was still enhanced by warm temperatures. An important reason for the inconsistent results can be that microclimatic gradients across landscapes are complex and influenced by many climate-forcing factors. Therefore, comparing only north- and south-facing slopes might not capture the complexity of microclimatic gradients. Population growth rates and potential distributions are the integrated results of all vital rates. Still, the study of selected vital rates constitutes an important first step to understand the relationship between population growth rates and geographical distributions and is essential to better predict how climate change influences species distributions.	[Dahlberg, C. Johan; Ehrlen, Johan; Hylander, Kristoffer] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden	Stockholm University	Dahlberg, CJ (corresponding author), Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden.	johan.dahlberg@su.se	Dahlberg, Carl Johan/AAA-4465-2022	Dahlberg, Carl Johan/0000-0003-0271-3306; Ehrlen, Johan/0000-0001-8539-8967	Strategic Research Programme EkoKlim	Strategic Research Programme EkoKlim	This work was supported by Strategic Research Programme EkoKlim (http://www.zoologi.su.se/ekoklim). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahti T., 1968, Annales Botanici Fennici, Helsinki, V5, P168; Andersson G, 1912, NORRLANDSKA FLORANS; Angert AL, 2005, EVOLUTION, V59, P1671, DOI 10.1111/j.0014-3820.2005.tb01817.x; ARNOLD SJ, 1983, AM ZOOL, V23, P347, DOI 10.1093/icb/23.2.347; Artdatabanken SLU, 2011, ARTPORTALEN RAPPORTS; Ashcroft MB, 2012, INT J CLIMATOL, V32, P2134, DOI 10.1002/joc.2428; Astrom M, 2007, ECOLOGY, V88, P749, DOI 10.1890/06-0613; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Bennie J, 2006, J ECOL, V94, P355, DOI 10.1111/j.1365-2745.2006.01104.x; Breckle S.W, 2002, WALTERS VEGETATION E; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Crandall-Stotler B., 2009, BRYOPHYTE BIOL, P1; Crozier LG, 2004, OECOLOGIA, V141, P148, DOI 10.1007/s00442-004-1634-z; Dahlgren JP, 2010, ECOL LETT, V13, pE7, DOI 10.1111/j.1461-0248.2010.01460.x; Damsholt K, 2002, ILLUSTRATED FLORA NO; DAVISON AW, 1977, J ECOL, V65, P523, DOI 10.2307/2259498; Despland E, 1997, AM J BOT, V84, P928, DOI 10.2307/2446283; Dobrowski SZ, 2011, GLOBAL CHANGE BIOL, V17, P1022, DOI 10.1111/j.1365-2486.2010.02263.x; ERIKSSON O, 1988, J ECOL, V76, P522, DOI 10.2307/2260610; Esseen Per-Anders, 1997, Ecological Bulletins, V46, P16; Frahm Jan-Peter, 2001, Lindbergia, V26, P97; FRANK IE, 1993, TECHNOMETRICS, V35, P109, DOI 10.2307/1269656; Fridley JD, 2009, J APPL METEOROL CLIM, V48, P1033, DOI 10.1175/2008JAMC2084.1; Fu PD, 2002, COMPUT ELECTRON AGR, V37, P25, DOI 10.1016/S0168-1699(02)00115-1; Gaston KJ, 2009, P R SOC B, V276, P1395, DOI 10.1098/rspb.2008.1480; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Geiger R., 2003, CLIMATE NEAR GROUND; Gilman SE, 2006, OECOLOGIA, V148, P270, DOI 10.1007/s00442-006-0372-9; Gimenez-Benavides L, 2008, ECOGRAPHY, V31, P731, DOI 10.1111/j.0906-7590.2008.05509.x; Goffinet B., 2009, BRYOPHYTE BIOL, V2, P55, DOI DOI 10.1017/CBO9780511754807.003; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hagglund B., 1982, HANDLEDNING BONITERI; Hampe A, 2005, OECOLOGIA, V143, P377, DOI 10.1007/s00442-004-1811-0; Hampe A, 2011, ANNU REV ECOL EVOL S, V42, P313, DOI 10.1146/annurev-ecolsys-102710-145015; Hiesey W., 1971, EXPT STUDIES NATURE; Hill MO, 2006, J BRYOL, V28, P198, DOI 10.1179/174328206X119998; Huang SL, 2008, PHYS GEOGR, V29, P158, DOI 10.2747/0272-3646.29.2.158; Hutchinson G.E., 1978, INTRO POPULATION ECO; Hylander K, 2005, ECOL APPL, V15, P674, DOI 10.1890/04-0570; Hylander K, 2005, J APPL ECOL, V42, P518, DOI 10.1111/j.1365-2664.2005.01033.x; Kurschner H, 1999, CRYPTOGAM BRYOL, V20, P17, DOI 10.1016/S1290-0796(99)80004-2; Lomolino MV, 2006, BIOGEOGRAPHY; Lonnell N, 2014, ECOGRAPHY, V37, P591, DOI 10.1111/j.1600-0587.2013.00530.x; MAGUIRE B, 1973, AM NAT, V107, P213, DOI 10.1086/282827; Mossberg B, 2012, NYA NORDISKA FLORAN; Mrascner JW, 1990, ANGERINANRANDS HORA; NAULT A, 1993, J ECOL, V81, P101, DOI 10.2307/2261228; Normand S, 2009, GLOBAL ECOL BIOGEOGR, V18, P437, DOI 10.1111/j.1466-8238.2009.00451.x; OKLAND RH, 1995, J ECOL, V83, P697, DOI 10.2307/2261637; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; PROCTOR M. C. F., 2009, BRYOPHYTE BIOL, P237; Proctor MCF., 2011, BRYOPHYTE ECOLOGY CL, P35, DOI [10.1017/CBO9780511779701.004, DOI 10.1111/J.1442-9993.2012.02409.X]; R Core Team, 2021, R LANGUAGE ENV STAT; RADCLIFFE JE, 1981, NEW ZEAL J AGR RES, V24, P55, DOI 10.1080/00288233.1981.10420871; Ribbing J, 2007, J PHARMACOKINET PHAR, V34, P485, DOI 10.1007/s10928-007-9057-1; RORISON IH, 1986, PLANT CELL ENVIRON, V9, P49, DOI 10.1111/1365-3040.ep11612961; Sanford E, 2006, ECOLOGY, V87, P2882, DOI 10.1890/0012-9658(2006)87[2882:LTGFAT]2.0.CO;2; Schmalholz M, 2011, ECOGRAPHY, V34, P637, DOI 10.1111/j.1600-0587.2010.06652.x; Sibly RM, 2002, PHILOS T R SOC B, V357, P1153, DOI 10.1098/rstb.2002.1117; Skov F, 2004, ECOGRAPHY, V27, P366, DOI 10.1111/j.0906-7590.2004.03823.x; Slack N.G., 2011, BRYOPHYTE ECOLOGY CL, P3; Soderstrom L, 1981, WAHLENBERGIA, V7, P141; Svenning JC, 2013, AM J BOT, V100, P1266, DOI 10.3732/ajb.1200469; Swedish Meteorological and Hydrological Institute, 2013, KLIM DAT DAT MED NOR; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tuhkanen S., 1980, CLIMATIC PARAMETERS; Van der Veken S, 2007, J ECOL, V95, P343, DOI 10.1111/j.1365-2745.2006.01208.x; Van der Veken S, 2012, BASIC APPL ECOL, V13, P10, DOI 10.1016/j.baae.2011.10.007; Vanderpoorten A, 2009, INTRODUCTION TO BRYOPHYTES, P1, DOI 10.1017/CBO9780511626838; Vercauteren N, 2013, J APPL METEOROL CLIM, V52, P1208, DOI 10.1175/JAMC-D-12-0115.1; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Wood AJ, 2007, BRYOLOGIST, V110, P163, DOI 10.1639/0007-2745(2007)110[163:IENFIB]2.0.CO;2; Zimmermann NE, 2009, P NATL ACAD SCI USA, V106, P19723, DOI 10.1073/pnas.0901643106	73	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112943	10.1371/journal.pone.0112943	http://dx.doi.org/10.1371/journal.pone.0112943			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25387233	gold, Green Published, Green Submitted			2022-12-27	WOS:000345250400106
J	Noveski, P; Madjunkova, S; Mircevska, M; Plaseski, T; Filipovski, V; Plaseska-Karanfilska, D				Noveski, Predrag; Madjunkova, Svetlana; Mircevska, Marija; Plaseski, Toso; Filipovski, Vanja; Plaseska-Karanfilska, Dijana			SNaPshot Assay for the Detection of the Most Common CFTR Mutations in Infertile Men	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS MUTATIONS; SPERM FERTILIZING-CAPACITY; VAS-DEFERENS; CONGENITAL ABSENCE; GENE-MUTATIONS; HEALTHY-MEN; FREQUENCY; FAILURE; QUALITY	Congenital bilateral absence of vas deferens (CBAVD) is the most common CFTR-related disorder (CFTR-RD) that explains about 1-2% of the male infertility cases. Controversial data have been published regarding the involvement of CFTR mutations in infertile men with non-obstructive azoospermia and oligozoospermia. Here, we describe single base extension (SNaPshot) assay for detection of 11 common CFTR mutations: F508del, G542X, N1303K, 621+1G->T, G551D, R553X, R1162X, W1282X, R117H, 2184insA and 1717-1G->A and IVS8polyT variants. The assay was validated on 50 previously genotyped samples and was used to screen a total of 369 infertile men with different impairment of spermatogenesis and 136 fertile controls. Our results show that double heterozygosity of cystic fibrosis (CF) and CFTR-related disorder (CFTR-RD) mutations are found in a high percentage (22.7%) of infertile men with obstructive azoospermia, but not in other studied groups of infertile men. The SNaPshot assay described here is an inexpensive, fast and robust method for primary screening of the most common CFTR mutations both in patients with classical CF and CFTR-RD. It can contribute to better understanding of the role of CFTR mutations in impaired spermatogenesis, ultimately leading to improved management of infertile men.	[Noveski, Predrag; Madjunkova, Svetlana; Mircevska, Marija; Plaseska-Karanfilska, Dijana] Macedonian Acad Sci & Arts, Res Ctr Genet Engn & Biotechnol Georgi D Efremov, Skopje, Macedonia; [Madjunkova, Svetlana] Hosp Sick Children, Div Clin Pharmacol & Toxicol, Toronto, ON M5G 1X8, Canada; [Plaseski, Toso] Clin Endocrinol & Metab Disorders, Fac Med, Skopje, Macedonia; [Filipovski, Vanja] Clin Hosp Acibadem Sistina, Skopje, Macedonia	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Plaseska-Karanfilska, D (corresponding author), Macedonian Acad Sci & Arts, Res Ctr Genet Engn & Biotechnol Georgi D Efremov, Skopje, Macedonia.	dijana@manu.edu.mk	Karanfilska, Dijana Plaseska/P-6096-2018; Madjunkova, Svetlana/AAV-2941-2020	Karanfilska, Dijana Plaseska/0000-0001-8877-2416; Madjunkova, Svetlana/0000-0001-8233-6621; Noveski, Predrag/0000-0002-3882-9821	ICGEB-Trieste [CRP/MAC09-01]	ICGEB-Trieste	This study was supported by grant CRP/MAC09-01 from ICGEB-Trieste (to DPK). Web: http://www.icgeb.org/research-grants.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanasovska B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048167; Bustamante-Aragones A, 2008, J CYST FIBROS, V7, P505, DOI 10.1016/j.jcf.2008.05.006; Casals T, 2000, HUM REPROD, V15, P1476, DOI 10.1093/humrep/15.7.1476; Chan HC, 2009, J PHYSIOL-LONDON, V587, P2187, DOI 10.1113/jphysiol.2008.164970; Chen H, 2012, HUM REPROD UPDATE, V18, P703, DOI 10.1093/humupd/dms027; Chen J, 2012, HUM REPROD, V27, P2585, DOI 10.1093/humrep/des254; Claustres M, 2000, HUM MUTAT, V16, P143, DOI 10.1002/1098-1004(200008)16:2<143::AID-HUMU7>3.0.CO;2-J; Claustres M, 2005, REPROD BIOMED ONLINE, V10, P14, DOI 10.1016/S1472-6483(10)60801-2; Costa C, 2008, CLIN CHEM, V54, P1564, DOI 10.1373/clinchem.2008.103259; Cuppens H, 1998, J CLIN INVEST, V101, P487, DOI 10.1172/JCI639; De Braekeleer M, 1996, MOL HUM REPROD, V2, P669, DOI 10.1093/molehr/2.9.669; Dequeker E, 2009, EUR J HUM GENET, V17, P51, DOI 10.1038/ejhg.2008.136; Dork T, 1997, HUM GENET, V100, P365, DOI 10.1007/s004390050518; Groman JD, 2004, AM J HUM GENET, V74, P176, DOI 10.1086/381001; Jakubiczka S, 1999, HUM REPROD, V14, P1833, DOI 10.1093/humrep/14.7.1833; KAZAZIAN HH, 1994, HUM MUTAT, V4, P167; Koceva S, 2001, BALK J MED GENET, V4, P47; Kolettis PN, 2003, AM FAM PHYSICIAN, V67, P2165; Li CY, 2010, HUM REPROD, V25, P317, DOI 10.1093/humrep/dep406; Madjunkova S, 2012, GENET TEST MOL BIOMA, V16, P259, DOI 10.1089/gtmb.2011.0173; Mak V, 2000, HUM REPROD, V15, P436, DOI 10.1093/humrep/15.2.436; Noveski P, 2009, BALKAN J MED GENETIC, V12; Pallares-Ruiz N, 1999, HUM REPROD, V14, P3035, DOI 10.1093/humrep/14.12.3035; PATRIZIO P, 1993, HUM REPROD, V8, P215, DOI 10.1093/oxfordjournals.humrep.a138025; Petreska L, 1998, CLIN GENET, V54, P203; Plaseski T, 2012, J ANDROL, V33, P675, DOI 10.2164/jandrol.111.013995; Poongothai J, 2009, SINGAP MED J, V50, P336; Rowntree RK, 2003, ANN HUM GENET, V67, P471, DOI 10.1046/j.1469-1809.2003.00028.x; Ruan YC, 2012, J PHYSIOL-LONDON, V590, P4209, DOI 10.1113/jphysiol.2012.230581; Schulz S, 2006, FERTIL STERIL, V85, P135, DOI 10.1016/j.fertnstert.2005.07.1282; Tuerlings JHAM, 1998, FERTIL STERIL, V69, P899, DOI 10.1016/S0015-0282(98)00050-8; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Visser L, 2010, REPRODUCTION, V139, P303, DOI 10.1530/REP-09-0229; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Wong PYD, 1998, MOL HUM REPROD, V4, P107, DOI 10.1093/molehr/4.2.107; Xu WM, 2007, P NATL ACAD SCI USA, V104, P9816, DOI 10.1073/pnas.0609253104; Xu WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019120; Yu JM, 2012, HUM REPROD, V27, P25, DOI 10.1093/humrep/der377; Yu JM, 2011, MOL HUM REPROD, V17, P594, DOI 10.1093/molehr/gar019; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021	41	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112498	10.1371/journal.pone.0112498	http://dx.doi.org/10.1371/journal.pone.0112498			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386751	gold, Green Published, Green Submitted			2022-12-27	WOS:000345250400067
J	Reolon, LA; Martello, CL; Schrank, IS; Ferreira, HB				Reolon, Luciano Antonio; Martello, Carolina Lumertz; Schrank, Irene Silveira; Ferreira, Henrique Bunselmeyer			Survey of Surface Proteins from the Pathogenic Mycoplasma hyopneumoniae Strain 7448 Using a Biotin Cell Surface Labeling Approach	PLOS ONE			English	Article							PLASMINOGEN-BINDING PROTEINS; CILIUM ADHESIN; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; IMMUNOGENIC PROTEINS; ENZOOTIC PNEUMONIA; PORCINE CILIA; SWINE; HEPARIN; IDENTIFICATION; FIBRONECTIN	The characterization of the repertoire of proteins exposed on the cell surface by Mycoplasma hyopneumoniae (M. hyopneumoniae), the etiological agent of enzootic pneumonia in pigs, is critical to understand physiological processes associated with bacterial infection capacity, survival and pathogenesis. Previous in silico studies predicted that about a third of the genes in the M. hyopneumoniae genome code for surface proteins, but so far, just a few of them have experimental confirmation of their expression and surface localization. In this work, M. hyopneumoniae surface proteins were labeled in intact cells with biotin, and affinity-captured biotin-labeled proteins were identified by a gel-based liquid chromatographytandem mass spectrometry approach. A total of 20 gel slices were separately analyzed by mass spectrometry, resulting in 165 protein identifications corresponding to 59 different protein species. The identified surface exposed proteins better defined the set of M. hyopneumoniae proteins exposed to the host and added confidence to in silico predictions. Several proteins potentially related to pathogenesis, were identified, including known adhesins and also hypothetical proteins with adhesin-like topologies, consisting of a transmembrane helix and a large tail exposed at the cell surface. The results provided a better picture of the M. hyopneumoniae cell surface that will help in the understanding of processes important for bacterial pathogenesis. Considering the experimental demonstration of surface exposure, adhesion-like topology predictions and absence of orthologs in the closely related, non-pathogenic species Mycoplasma flocculare, several proteins could be proposed as potential targets for the development of drugs, vaccines and/or immunodiagnostic tests for enzootic pneumonia.	[Martello, Carolina Lumertz; Ferreira, Henrique Bunselmeyer] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Lab Genom Estrutural & Func, Porto Alegre, RS, Brazil; [Reolon, Luciano Antonio; Schrank, Irene Silveira] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Lab Microrganismos Diazotrof, Porto Alegre, RS, Brazil; [Reolon, Luciano Antonio; Schrank, Irene Silveira; Ferreira, Henrique Bunselmeyer] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Programa Posgrad Biol Celular & Mol, Porto Alegre, RS, Brazil; [Schrank, Irene Silveira; Ferreira, Henrique Bunselmeyer] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Biol Mol & Biotecnol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Ferreira, HB (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotecnol, Lab Genom Estrutural & Func, Porto Alegre, RS, Brazil.	Henrique@cbiot.ufrgs.br	Ferreira, Henrique B/H-4189-2012	Ferreira, Henrique B/0000-0003-3611-6040	MCT/CNPq; FAPERGS	MCT/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERGS(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS))	This work was funding from MCT/CNPq and FAPERGS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Hearn M, 2008, INFECT IMMUN, V76, P170, DOI 10.1128/IAI.01913-06; Alvarez RA, 2003, MOL MICROBIOL, V48, P1417, DOI 10.1046/j.1365-2958.2003.03518.x; AMASS SF, 1994, J AM VET MED ASSOC, V204, P102; Bogema DR, 2012, MBIO, V3, DOI 10.1128/mBio.00282-11; Bogema DR, 2011, J BIOL CHEM, V286, P41217, DOI 10.1074/jbc.M111.226084; Burnett TA, 2006, MOL MICROBIOL, V60, P669, DOI 10.1111/j.1365-2958.2006.05139.x; Cacciotto C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-225; Chitlaru T, 2007, INFECT IMMUN, V75, P2841, DOI 10.1128/IAI.02029-06; Chou SY, 1997, BIOCHEM MOL BIOL INT, V41, P821; Cordwell SJ, 2006, CURR OPIN MICROBIOL, V9, P320, DOI 10.1016/j.mib.2006.04.008; Corona L, 2013, VET MICROBIOL, V167, P434, DOI 10.1016/j.vetmic.2013.08.024; Cullen PA, 2005, INFECT IMMUN, V73, P4853, DOI 10.1128/IAI.73.8.4853-4863.2005; DEBEY MC, 1994, INFECT IMMUN, V62, P5312, DOI 10.1128/IAI.62.12.5312-5318.1994; Deutscher AT, 2012, J PROTEOME RES, V11, P1924, DOI 10.1021/pr201115v; Deutscher AT, 2010, MOL MICROBIOL, V78, P444, DOI 10.1111/j.1365-2958.2010.07345.x; Djordjevic SP, 2004, INFECT IMMUN, V72, P2791, DOI 10.1128/IAI.72.5.2791-2802.2004; Fadiel A, 2007, FRONT BIOSCI-LANDMRK, V12, P2020, DOI 10.2741/2207; FREY J, 1994, MICROB PATHOGENESIS, V17, P313, DOI 10.1006/mpat.1994.1077; Hall RE, 1999, MICROB PATHOGENESIS, V27, P145, DOI 10.1006/mpat.1999.0293; Hopfe M, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-46; Jenkins C, 2008, J BACTERIOL, V190, P2206, DOI 10.1128/JB.01685-07; Jenkins C, 2007, MICROBIOL-SGM, V153, P1455, DOI 10.1099/mic.0.2006/004937-0; Kobisch M, 1996, REV SCI TECH OIE, V15, P1569, DOI 10.20506/rst.15.4.983; Krasteva I, 2014, VET MICROBIOL, V168, P116, DOI 10.1016/j.vetmic.2013.10.025; Krause DC, 1996, MOL MICROBIOL, V20, P247, DOI 10.1111/j.1365-2958.1996.tb02613.x; Maes D, 2008, VET MICROBIOL, V126, P297, DOI 10.1016/j.vetmic.2007.09.008; Maes D, 1996, VET QUART, V18, P104, DOI 10.1080/01652176.1996.9694628; Matic JN, 2003, GENE, V319, P99, DOI 10.1016/S0378-1119(03)00798-4; MOWBRAY SL, 1992, J MOL BIOL, V225, P155, DOI 10.1016/0022-2836(92)91033-L; Piersma SR, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-17; Pinto PM, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-45; Pinto PM, 2007, VET MICROBIOL, V121, P83, DOI 10.1016/j.vetmic.2006.11.018; Raymond BBA, 2013, J PROTEOME RES, V12, P5891, DOI 10.1021/pr400903s; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Rottem S, 2003, PHYSIOL REV, V83, P417, DOI 10.1152/physrev.00030.2002; Seidler NW, 2013, ADV EXP MED BIOL, V985, P149, DOI 10.1007/978-94-007-4716-6_5; Seymour LM, 2012, CELL MICROBIOL, V14, P81, DOI 10.1111/j.1462-5822.2011.01702.x; Seymour LM, 2010, J BIOL CHEM, V285, P33971, DOI 10.1074/jbc.M110.104463; Siqueira FM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-175; Tacchi JL, 2014, J PROTEOME RES, V13, P2920, DOI 10.1021/pr500087c; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Terao Y, 2006, J BIOL CHEM, V281, P14215, DOI 10.1074/jbc.M513408200; Thacker EL, 1999, J CLIN MICROBIOL, V37, P620, DOI 10.1128/JCM.37.3.620-627.1999; Thomas C, 2013, MICROBIOL-SGM, V159, P352, DOI 10.1099/mic.0.061184-0; Vasconcelos ATR, 2005, J BACTERIOL, V187, P5568, DOI 10.1128/JB.187.16.5568-5577.2005; Wilton J, 2009, MOL MICROBIOL, V71, P566, DOI 10.1111/j.1365-2958.2008.06546.x; Xolalpa W, 2007, PROTEOMICS, V7, P3332, DOI 10.1002/pmic.200600876; You Xiao-xing, 2006, J Zhejiang Univ Sci B, V7, P342, DOI 10.1631/jzus.2006.B0342; Yu J, 1999, MICROBES INFECT, V1, P1221, DOI 10.1016/S1286-4579(99)00239-7; ZHANG QJ, 1994, INFECT IMMUN, V62, P1616, DOI 10.1128/IAI.62.5.1616-1622.1994; ZIELINSKI GC, 1993, AM J VET RES, V54, P1262	51	18	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112596	10.1371/journal.pone.0112596	http://dx.doi.org/10.1371/journal.pone.0112596			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386928	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400070
J	Takahashi, K; Matafonov, A; Sumarriva, K; Ito, H; Lauhan, C; Zemel, D; Tsuboi, N; Chen, J; Reynolds, A; Takahashi, T				Takahashi, Keiko; Matafonov, Anton; Sumarriva, Katherine; Ito, Hideyuki; Lauhan, Colette; Zemel, Dana; Tsuboi, Nobuo; Chen, Jin; Reynolds, Albert; Takahashi, Takamune			CD148 Tyrosine Phosphatase Promotes Cadherin Cell Adhesion	PLOS ONE			English	Article							ACTIN CYTOSKELETON; BETA-CATENIN; P120 CATENIN; PHOSPHOINOSITIDE 3-KINASE; SIGNAL-TRANSDUCTION; ADHERENS JUNCTIONS; ENDOTHELIAL-CELLS; RAC1 ACTIVATION; ETA SUPPRESSES; GROWTH-FACTOR	CD148 is a transmembrane tyrosine phosphatase that is expressed at cell junctions. Recent studies have shown that CD148 associates with the cadherin/catenin complex and p120 catenin (p120) may serve as a substrate. However, the role of CD148 in cadherin cell-cell adhesion remains unknown. Therefore, here we addressed this issue using a series of stable cells and cell-based assays. Wild-type (WT) and catalytically inactive (CS) CD148 were introduced to A431D (lacking classical cadherins), A431D/E-cadherin WT (expressing wild-type E-cadherin), and A431D/E-cadherin 764AAA (expressing p120-uncoupled E-cadherin mutant) cells. The effects of CD148 in cadherin adhesion were assessed by Ca2+ switch and cell aggregation assays. Phosphorylation of E-cadherin/catenin complex and Rho family GTPase activities were also examined. Although CD148 introduction did not alter the expression levels and complex formation of E-cadherin, p120, and beta-catenin, CD148 WT, but not CS, promoted cadherin contacts and strengthened cell-cell adhesion in A431D/E-cadherin WT cells. This effect was accompanied by an increase in Rac1, but not RhoA and Cdc42, activity and largely diminished by Rac1 inhibition. Further, we demonstrate that CD148 reduces the tyrosine phosphorylation of p120 and beta-catenin; causes the dephosphorylation of Y529 suppressive tyrosine residue in Src, a well-known CD148 site, increasing Src activity and enhancing the phosphorylation of Y228 (a Src kinase site) in p120, in E-cadherin contacts. Consistent with these findings, CD148 dephosphorylated both p120 and beta-catenin in vitro. The shRNA-mediated CD148 knockdown in A431 cells showed opposite effects. CD148 showed no effects in A431D and A431D/E-cadherin 764AAA cells. In aggregate, these findings provide the first evidence that CD148 promotes E-cadherin adhesion by regulating Rac1 activity concomitant with modulation of p120, beta-catenin, and Src tyrosine phosphorylation. This effect requires E-cadherin and p120 association.	[Takahashi, Keiko; Matafonov, Anton; Sumarriva, Katherine; Ito, Hideyuki; Lauhan, Colette; Zemel, Dana; Tsuboi, Nobuo; Chen, Jin; Takahashi, Takamune] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Chen, Jin; Reynolds, Albert; Takahashi, Takamune] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University	Takahashi, T (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA.	takamune.takahashi@vanderbilt.edu		Chen, Jin/0000-0002-5557-2079; Peters, Katherine/0000-0002-8872-9271	National Institute of Diabetes and Digestive and Kidney Disease grant (NIDDK) [DK38517, DK97332]; National Institutes of Health National Heart, Lung, and Blood Institute (NHLBI) [HL109715]; NATIONAL CANCER INSTITUTE [R01CA177681] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL109715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097332, P30DK020593, R01DK038517] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Disease grant (NIDDK); National Institutes of Health National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institute of Diabetes and Digestive and Kidney Disease grant (NIDDK) DK38517 and DK97332 (to TT) (http://www.niddk.nih.gov/Pages/default.aspx); National Institutes of Health National Heart, Lung, and Blood Institute (NHLBI) HL109715 to TT) (http://www.nhlbi.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alema S, 2007, BBA-MOL CELL RES, V1773, P47, DOI 10.1016/j.bbamcr.2006.06.001; Autschbach F, 1999, TISSUE ANTIGENS, V54, P485, DOI 10.1034/j.1399-0039.1999.540506.x; Baker JE, 2001, MOL CELL BIOL, V21, P2393, DOI 10.1128/MCB.21.7.2393-2403.2001; Balavenkatraman KK, 2006, ONCOGENE, V25, P6319, DOI 10.1038/sj.onc.1209647; Braga VMM, 1999, MOL BIOL CELL, V10, P9, DOI 10.1091/mbc.10.1.9; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Castano J, 2007, MOL CELL BIOL, V27, P1745, DOI 10.1128/MCB.01974-06; Chabot C, 2009, MOL CELL BIOL, V29, P241, DOI 10.1128/MCB.01374-08; Chu YS, 2004, J CELL BIOL, V167, P1183, DOI 10.1083/jcb.200403043; Daniel JM, 1997, BIOESSAYS, V19, P883, DOI 10.1002/bies.950191008; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; de la Fuente-Garcia MA, 1998, BLOOD, V91, P2800, DOI 10.1182/blood.V91.8.2800.2800_2800_2809; Fukuyama T, 2006, ONCOGENE, V25, P8, DOI 10.1038/sj.onc.1209010; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; Giampietro C, 2012, BLOOD, V119, P2159, DOI 10.1182/blood-2011-09-381012; Goodwin M, 2003, J BIOL CHEM, V278, P20533, DOI 10.1074/jbc.M213171200; GRAZIA LM, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Holsinger LJ, 2002, ONCOGENE, V21, P7067, DOI 10.1038/sj.onc.1205858; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Iuliano R, 2003, CANCER RES, V63, P882; KANNER SB, 1991, MOL CELL BIOL, V11, P713, DOI 10.1128/MCB.11.2.713; Katsumoto TR, 2013, J CLIN INVEST, V123, P2037, DOI 10.1172/JCI66397; Lambert M, 2002, J CELL BIOL, V157, P469, DOI 10.1083/jcb.200107104; Le Pera I, 2005, ONCOGENE, V24, P3187, DOI 10.1038/sj.onc.1208510; Lewis JE, 1997, J CELL BIOL, V136, P919, DOI 10.1083/jcb.136.4.919; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Mariner DJ, 2001, J BIOL CHEM, V276, P28006, DOI 10.1074/jbc.M102443200; Massa A, 2004, ANN NY ACAD SCI, V1030, P264, DOI 10.1196/annals.1329.033; Miyashita Y, 2007, J BIOL CHEM, V282, P11540, DOI 10.1074/jbc.M608351200; Mukherjee M, 2012, EMBO J, V31, P1308, DOI 10.1038/emboj.2011.496; Nakagawa M, 2001, J CELL SCI, V114, P1829; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Oas RG, 2013, MOL BIOL CELL, V24, P704, DOI 10.1091/mbc.E12-06-0471; OSTMAN A, 1994, P NATL ACAD SCI USA, V91, P9680, DOI 10.1073/pnas.91.21.9680; Palka HL, 2003, J BIOL CHEM, V278, P5728, DOI 10.1074/jbc.M210656200; Pang JH, 2005, J BIOL CHEM, V280, P3043, DOI 10.1074/jbc.M412148200; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Reynolds AB, 2014, ONCOGENE, V33, P4537, DOI 10.1038/onc.2013.416; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P629, DOI 10.1128/MCB.9.2.629; Ruivenkamp CAL, 2002, NAT GENET, V31, P295, DOI 10.1038/ng903; Sacco F, 2009, J BIOL CHEM, V284, P22048, DOI 10.1074/jbc.M109.002758; Smith AL, 2012, MOL BIOL CELL, V23, P99, DOI 10.1091/mbc.E11-06-0497; Spring K, 2012, BLOOD, V120, P2745, DOI 10.1182/blood-2011-12-398040; Takahashi K, 2012, P NATL ACAD SCI USA, V109, P1985, DOI 10.1073/pnas.1106171109; Takahashi T, 1999, J AM SOC NEPHROL, V10, P2135; Takahashi T, 2006, BLOOD, V108, P1234, DOI 10.1182/blood-2005-10-4296; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Tarcic G, 2009, CURR BIOL, V19, P1788, DOI 10.1016/j.cub.2009.09.048; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Timmerman I, 2012, MOL BIOL CELL, V23, P4212, DOI 10.1091/mbc.E12-01-0038; Trapasso F, 2004, CARCINOGENESIS, V25, P2107, DOI 10.1093/carcin/bgh224; Trapasso F, 2000, MOL CELL BIOL, V20, P9236, DOI 10.1128/MCB.20.24.9236-9246.2000; Tsuboi N, 2008, BIOCHEM J, V413, P193, DOI 10.1042/BJ20071317; Valls G, 2012, J CELL SCI, V125, P5288, DOI 10.1242/jcs.101030; Watanabe T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003020; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Xu YR, 1997, J BIOL CHEM, V272, P13463, DOI 10.1074/jbc.272.21.13463; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Zebda N, 2013, J BIOL CHEM, V288, P18290, DOI 10.1074/jbc.M112.432757; Zhang L, 1997, EXP CELL RES, V235, P62, DOI 10.1006/excr.1997.3659	61	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112753	10.1371/journal.pone.0112753	http://dx.doi.org/10.1371/journal.pone.0112753			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386896	gold, Green Published, Green Submitted			2022-12-27	WOS:000345250400090
J	Byun, YS; Tibrewal, S; Kim, E; Yco, L; Sarkar, J; Ivanir, Y; Liu, CY; Sano, CM; Jain, S				Byun, Yong-Soo; Tibrewal, Sapna; Kim, Eunjae; Yco, Lisette; Sarkar, Joy; Ivanir, Yair; Liu, Chia-Yang; Sano, Cecile M.; Jain, Sandeep			Keratocytes Derived from Spheroid Culture of Corneal Stromal Cells Resemble Tissue Resident Keratocytes	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ALDEHYDE DEHYDROGENASE; EXTRACELLULAR-MATRIX; PROTEIN EXPRESSION; NERVE REGENERATION; EPITHELIAL-CELLS; COLLAGEN XVIII; MOUSE CORNEA; PHENOTYPE; FIBROBLASTS	Purpose: Corneal stromal cells transform to precursor cells in spheroid culture. We determined whether keratocytes derived from spheroid culture of murine corneal stromal cells resemble tissue resident keratocytes. Methods: Spheroid culture was performed by seeding dissociated stromal cells onto ultra-low attachment plates containing serum-free mesenchymal stem cell culture medium. Spheroids were characterized with phenotype specific markers and stemness transcription factor genes. Spheroids and adherent cells in culture were induced to differentiate to keratocytes using keratocyte induction medium (KIM) and compared with tissue resident keratocytes. Results: Stromal cells formed spheroids in ultra-low attachment plates, but not in polystyrene tissue culture dishes. Keratocan expression and abundance was significantly higher in spheroids as compared to adherent cells whereas alpha-smooth muscle actin (alpha-SMA) was significantly lower. As compared to adherent culture-derived cells, the expressions of keratocan, aldehyde dehydrogenase (ALDH3A1) and alpha-SMA in spheroid-derived cells approximated much more closely the levels of these genes in tissue resident keratocytes. Of the stemness genes, Nanog and Oct4 were upregulated in the spheroids. Conclusion: Stemness transcription factor genes are upregulated in spheroids. Keratocytes derived from spheroids resemble tissue resident keratocytes, thus increasing manifolds the quantity of these cells for in-vitro experiments.	[Byun, Yong-Soo; Tibrewal, Sapna; Kim, Eunjae; Yco, Lisette; Sarkar, Joy; Ivanir, Yair; Sano, Cecile M.; Jain, Sandeep] Univ Illinois, Dept Ophthalmol & Visual Sci, Coll Med, Corneal Neurobiol Lab, Chicago, IL 60607 USA; [Byun, Yong-Soo] Catholic Univ Korea, Coll Med, Dept Ophthalmol & Visual Sci, Catholic Inst Visual Sci, Seoul, South Korea; [Yco, Lisette] Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA; [Liu, Chia-Yang] Univ Cincinnati, Coll Med, Dept Ophthalmol, Cincinnati, OH USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Catholic University of Korea; University of Hawaii System; University of Hawaii Manoa; University System of Ohio; University of Cincinnati	Jain, S (corresponding author), Univ Illinois, Dept Ophthalmol & Visual Sci, Coll Med, Corneal Neurobiol Lab, Chicago, IL 60607 USA.	jains@uic.edu		Byun, Yong-Soo/0000-0002-7264-0723; Liu, Chia-yang/0000-0002-8398-5516	National Eye Institute (NEI) [R01EY023656, P30EY001792]; Midwest Eye Banks; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY001792, R01EY023656] Funding Source: NIH RePORTER	National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Midwest Eye Banks; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute (NEI) Grant R01EY023656 (SJ), NEI core grant P30EY001792, Midwest Eye Banks (SJ), and Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azar DT, 2010, CORNEA, V29, P321, DOI 10.1097/ICO.0b013e3181b1165d; Beales MP, 1999, INVEST OPHTH VIS SCI, V40, P1658; Blanco-Mezquita JT, 2011, INVEST OPHTH VIS SCI, V52, P8505, DOI 10.1167/iovs.11-8194; Chang JYF, 2013, STEM CELL RES, V11, P990, DOI 10.1016/j.scr.2013.06.008; Chang TT, 2009, TISSUE ENG PT A, V15, P559, DOI 10.1089/ten.tea.2007.0434; Chase LG, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt8; Chaudhary S, 2012, CORNEA, V31, P1460, DOI 10.1097/ICO.0b013e318247b60e; Chien Y, 2012, BIOMATERIALS, V33, P8003, DOI 10.1016/j.biomaterials.2012.07.029; Du YD, 2005, STEM CELLS, V23, P1266, DOI 10.1634/stemcells.2004-0256; Ellenberg D, 2010, PROG RETIN EYE RES, V29, P208, DOI 10.1016/j.preteyeres.2010.01.002; Funderburgh ML, 2008, MOL VIS, V14, P308; Gao C, 2002, MOL CANCER RES, V1, P12; GARANA RMR, 1992, INVEST OPHTH VIS SCI, V33, P3271; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Horswill MA, 2008, EXP EYE RES, V86, P586, DOI 10.1016/j.exer.2008.01.003; Jester JV, 2005, INVEST OPHTH VIS SCI, V46, P2369, DOI 10.1167/iovs.04-1225; Jester JV, 2003, EXP EYE RES, V77, P581, DOI 10.1016/S0014-4835(03)00188-X; Kawakita T, 2004, INVEST OPHTH VIS SCI, V45, P3507, DOI 10.1167/iovs.04-0266; Kawakita T, 2008, J CELL MOL MED, V12, P1303, DOI 10.1111/j.1582-4934.2008.00297.x; Lai JY, 2012, ACTA BIOMATER, V8, P1068, DOI 10.1016/j.actbio.2011.11.012; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Maltseva O, 2001, INVEST OPHTH VIS SCI, V42, P2490; Masur SK, 1996, P NATL ACAD SCI USA, V93, P4219, DOI 10.1073/pnas.93.9.4219; Mimura T, 2008, MOL VIS, V14, P197; Mohan RR, 2003, EXP EYE RES, V76, P71, DOI 10.1016/S0014-4835(02)00251-8; Namavari A, 2012, INVEST OPHTH VIS SCI, V53, P4575, DOI 10.1167/iovs.12-9760; Netto MV, 2006, J REFRACT SURG, V22, P562; Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697; Olschlager V, 2009, ARZNEIMITTEL-FORSCH, V59, P146, DOI 10.1055/s-0031-1296378; Pei Y, 2006, EXP EYE RES, V83, P1063, DOI 10.1016/j.exer.2006.05.011; Ryan DG, 2003, INVEST OPHTH VIS SCI, V44, P4255, DOI 10.1167/iovs.03-0578; Sakimoto T, 2008, FEBS LETT, V582, P3674, DOI 10.1016/j.febslet.2008.09.052; Scott SG, 2011, EXP EYE RES, V93, P898, DOI 10.1016/j.exer.2011.10.004; Shaheen BS, 2014, SURV OPHTHALMOL, V59, P263, DOI 10.1016/j.survophthal.2013.09.002; Sommer CA, 2013, J CELL PHYSIOL, V228, P267, DOI 10.1002/jcp.24155; Song BJ, 2011, J PROTEOMICS, V74, P2691, DOI 10.1016/j.jprot.2011.05.013; Stramer BM, 2003, INVEST OPHTH VIS SCI, V44, P4237, DOI 10.1167/iovs.02-1188; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Weiswald LB, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-106; Wilson SE, 1997, J REFRACT SURG, V13, P171; Wilson SE, 1996, EXP EYE RES, V62, P325, DOI 10.1006/exer.1996.0038; Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8; YANOFF M, 1977, INVEST OPHTH VIS SCI, V16, P269; Yeh SI, 2010, CURR EYE RES, V35, P799, DOI 10.3109/02713683.2010.494239; Yoshida S, 2005, INVEST OPHTH VIS SCI, V46, P1653, DOI 10.1167/iovs.04-1405; Yoshida S, 2006, STEM CELLS, V24, P2714, DOI 10.1634/stemcells.2006-0156; Young RD, 2009, INVEST OPHTH VIS SCI, V50, P4155, DOI 10.1167/iovs.09-3561	48	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112781	10.1371/journal.pone.0112781	http://dx.doi.org/10.1371/journal.pone.0112781			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384043	gold, Green Published, Green Submitted			2022-12-27	WOS:000344816700095
J	Koblizek, V; Pecen, L; Zatloukal, J; Kocianova, J; Plutinsky, M; Kolek, V; Novotna, B; Kocova, E; Pracharova, S; Tichopad, A				Koblizek, Vladimir; Pecen, Ladislav; Zatloukal, Jaromir; Kocianova, Jana; Plutinsky, Marek; Kolek, Vitezslav; Novotna, Barbora; Kocova, Eva; Pracharova, Sarka; Tichopad, Ales			Real-Life GOLD 2011 Implementation: The Management of COPD Lacks Correct Classification and Adequate Treatment	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; GUIDELINE DEVELOPMENT.; COORDINATING EFFORTS; THORACIC-SOCIETY; PHYSICIANS; RECOMMENDATIONS; PREVALENCE; DIAGNOSIS	Chronic obstructive pulmonary disease (COPD) is a serious, yet preventable and treatable, disease. The success of its treatment relies largely on the proper implementation of recommendations, such as the recently released Global Strategy for Diagnosis, Management, and Prevention of COPD (GOLD 2011, of late December 2011). The primary objective of this study was to examine the extent to which GOLD 2011 is being used correctly among Czech respiratory specialists, in particular with regard to the correct classification of patients. The secondary objective was to explore what effect an erroneous classification has on inadequate use of inhaled corticosteroids (ICS). In order to achieve these goals, a multicenter, cross-sectional study was conducted, consisting of a general questionnaire and patient-specific forms. A subjective classification into the GOLD 2011 categories was examined, and then compared with the objectively computed one. Based on 1,355 patient forms, a discrepancy between the subjective and objective classifications was found in 32.8% of cases. The most common reason for incorrect classification was an error in the assessment of symptoms, which resulted in underestimation in 23.9% of cases, and overestimation in 8.9% of the patients' records examined. The specialists seeing more than 120 patients per month were most likely to misclassify their condition, and were found to have done so in 36.7% of all patients seen. While examining the subjectively driven ICS prescription, it was found that 19.5% of patients received ICS not according to guideline recommendations, while in 12.2% of cases the ICS were omitted, contrary to guideline recommendations. Furthermore, with consideration to the objectively-computed classification, it was discovered that 15.4% of patients received ICS unnecessarily, whereas in 15.8% of cases, ICS were erroneously omitted. It was therefore concluded that Czech specialists tend either to under-prescribe or overuse inhaled corticosteroids.	[Koblizek, Vladimir; Novotna, Barbora; Kocova, Eva; Pracharova, Sarka] Charles Univ Prague, Fac Med Hradec Kralove, Dept Pulm, Hradec Kralove, Czech Republic; [Koblizek, Vladimir; Novotna, Barbora; Kocova, Eva; Pracharova, Sarka] Univ Hosp Hradec Kralove, Hradec Kralove, Czech Republic; [Pecen, Ladislav; Tichopad, Ales] CEEOR Inst, Prague, Czech Republic; [Zatloukal, Jaromir; Kolek, Vitezslav] Palacky Univ Olomouc, Fac Med & Dent, Dept Resp Med & TB, Ostrava, Czech Republic; [Zatloukal, Jaromir; Kolek, Vitezslav] Univ Hosp Olomouc, Ostrava, Czech Republic; [Kocianova, Jana] Chest Clin, Ostrava, Czech Republic; [Plutinsky, Marek] Masaryk Univ, Fac Med, Dept Resp Med & TB, Brno, Czech Republic; [Plutinsky, Marek] Univ Hosp Brno, Brno, Czech Republic	Charles University Prague; University Hospital Hradec Kralove; University Hospital Hradec Kralove; Palacky University Olomouc; University Hospital Olomouc; Masaryk University Brno; University Hospital Brno	Tichopad, A (corresponding author), CEEOR Inst, Prague, Czech Republic.	tichopad@ceeor.com	Koblizek, Vladimir/AAC-5374-2019; Kocova, Eva/N-1702-2017; Pecen, Ladislav/G-7057-2014; Plutinsky, Marek/ABF-2366-2020	Kocova, Eva/0000-0002-1185-7697; Plutinsky, Marek/0000-0003-1723-3794; Koblizek, Vladimir/0000-0002-2446-2790	Boehringer Ingelheim; Czech Ministry of Health [00179906]	Boehringer Ingelheim(Boehringer Ingelheim); Czech Ministry of Health(Ministry of Health, Czech Republic)	The study was funded by Boehringer Ingelheim. The study was awarded the Czech Ministry of Health grant, number of reference: DRO(UHHK, 00179906). Boehringer Ingelheim has contributed to the study design by providing the outline for data input requested, conceiving the preliminary version of the doctors' questionnaire and supervising the study conduct throughout its course. The Czech Ministry of Health did not intervene in the study design or its conduct, except for its compliance assessment and registration. The funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellamy David, 2006, Prim Care Respir J, V15, P48, DOI 10.1016/j.pcrj.2005.11.003; Bridevaux PO, 2010, EUR RESPIR J, V36, P1259, DOI 10.1183/09031936.00004110; Buist AS, 2008, INT J TUBERC LUNG D, V12, P703; Burgers Jako S, 2012, Proc Am Thorac Soc, V9, P304, DOI 10.1513/pats.201208-067ST; Caballero A, 2008, CHEST, V133, P343, DOI 10.1378/chest.07-1361; Decramer M, 2013, ACTA CLIN BELG, V68, P325, DOI 10.2143/ACB.3403; Desalu OO, 2013, PRIM CARE RESP J, V22, P79, DOI 10.4104/pcrj.2013.00014; Dong Y. H., 2014, CHEST; Ford ES, 2014, COPD; Glaab T, 2006, INT J CHRONIC OBSTR, V3, P141; Glaab T, 2012, INT J CHRONIC OBSTR, V7, P101, DOI 10.2147/COPD.S27887; Global Initiative for Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; Grimshaw Jeremy M, 2012, Proc Am Thorac Soc, V9, P298, DOI 10.1513/pats.201208-066ST; Gupta Dheeraj, 2013, Lung India, V30, P228, DOI 10.4103/0970-2113.116248; Hoonhorst SJM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087443; Kew KM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010844.pub2; Kew KM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010115.pub2; Koblizek V, 2013, BIOMED PAP, V157, P189, DOI 10.5507/bp.2013.039; Lee H, 2013, AM FAM PHYSICIAN, V88, P655; Lucas AEM, 2008, FAM PRACT, V25, P86, DOI 10.1093/fampra/cmn006; Maio S, 2014, CURR MED RES OPIN; Maly M., 2013, Studia Pneumologica et Phthiseologica, V73, P128; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Miravitlles M, 2014, ARCH BRONCONEUMOL, V50, P1, DOI 10.1016/S0300-2896(14)70070-5; Miravitlles M, 2009, RESP MED, V103, P714, DOI 10.1016/j.rmed.2008.11.019; Montanari Ugo, 2013, Recenti Progressi in Medicina, V104, P23, DOI 10.1701/1226.13591; National Institute of Health and Care Excellence, CHRON OBSTR PULM DIS; O'Donnell DE, 2007, CAN RESPIR J, V14, p5B, DOI 10.1155/2007/830570; Parker DR, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-56; Poznanska Anna, 2011, Przegl Epidemiol, V65, P483; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; Roche N, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-56; Sarc I, 2011, J EVAL CLIN PRACT, V17, P737, DOI 10.1111/j.1365-2753.2010.01617.x; Schunemann Holger J, 2012, Proc Am Thorac Soc, V9, P215, DOI 10.1513/pats.201208-053ST; Smidth M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-385; Valipour A, 2014, PHENOTYPES COPD CENT; Vestbo J, 2014, RESP MED, V108, P729, DOI 10.1016/j.rmed.2014.03.002; White P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075221; WHO, WHO EUR DET MORT DAT; Wilt Timothy J, 2012, Proc Am Thorac Soc, V9, P243, DOI 10.1513/pats.201208-058ST; World Health Organisation, BURD COPD; Yawn Barbara P, 2012, Proc Am Thorac Soc, V9, P219, DOI 10.1513/pats.201208-054ST	42	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111078	10.1371/journal.pone.0111078	http://dx.doi.org/10.1371/journal.pone.0111078			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380287	Green Published, gold, Green Submitted			2022-12-27	WOS:000344863100018
J	Lou, J; Ren, MW; Wang, H				Lou, Jing; Ren, Mingwu; Wang, Huan			Regional Principal Color Based Saliency Detection	PLOS ONE			English	Article							VISUAL-ATTENTION; OBJECT DETECTION; EXTRACTION; FEATURES	Saliency detection is widely used in many visual applications like image segmentation, object recognition and classification. In this paper, we will introduce a new method to detect salient objects in natural images. The approach is based on a regional principal color contrast modal, which incorporates low-level and medium-level visual cues. The method allows a simple computation of color features and two categories of spatial relationships to a saliency map, achieving higher F-measure rates. At the same time, we present an interpolation approach to evaluate resulting curves, and analyze parameters selection. Our method enables the effective computation of arbitrary resolution images. Experimental results on a saliency database show that our approach produces high quality saliency maps and performs favorably against ten saliency detection algorithms.	[Lou, Jing; Ren, Mingwu; Wang, Huan] Nanjing Univ Sci & Technol, Sch Comp Sci & Engn, Nanjing, Jiangsu, Peoples R China	Nanjing University of Science & Technology	Ren, MW (corresponding author), Nanjing Univ Sci & Technol, Sch Comp Sci & Engn, Nanjing, Jiangsu, Peoples R China.	renmingwu@sina.com	Lou, Jing/B-3258-2011	Lou, Jing/0000-0001-8502-7429	National Natural Science Foundation of China (NSFC) [61231014, 60875010]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (NSFC, Grant nos. 61231014, 60875010) (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta R, 2008, LECT NOTES COMPUT SC, V5008, P66; Achanta R, 2009, PROC CVPR IEEE, P1597, DOI 10.1109/CVPRW.2009.5206596; Alexe B, 2010, PROC CVPR IEEE, P73, DOI 10.1109/CVPR.2010.5540226; Chen TC, 2009, PROC EUR SOLID-STATE, P1; Felzenszwalb PF, 2004, INT J COMPUT VISION, V59, P167, DOI 10.1023/B:VISI.0000022288.19776.77; Goferman S, 2010, PROC CVPR IEEE, P2376, DOI 10.1109/CVPR.2010.5539929; Han JW, 2006, IEEE T CIRC SYST VID, V16, P141, DOI 10.1109/TCSVT.2005.859028; Heckbert P., 1982, Computer Graphics, V16, P297, DOI 10.1145/965145.801294; Hiremath P.S., 2008, INT J IMAGE PROCESS, V2, P10; Hou XD, 2007, PROC CVPR IEEE, P2280; Huang H, 2010, COMPUT GRAPH FORUM, V29, P2055, DOI 10.1111/j.1467-8659.2010.01792.x; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Jiang HZ, 2013, PROC CVPR IEEE, P2083, DOI 10.1109/CVPR.2013.271; Judd T, 2009, IEEE I CONF COMP VIS, P2106, DOI 10.1109/ICCV.2009.5459462; Kai-Yueh Chang, 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P2129, DOI 10.1109/CVPR.2011.5995415; Klein DA, 2011, IEEE I CONF COMP VIS, P2214, DOI 10.1109/ICCV.2011.6126499; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Li HL, 2011, IEEE T IMAGE PROCESS, V20, P3365, DOI 10.1109/TIP.2011.2156803; Li J, 2013, IEEE T PATTERN ANAL, V35, P996, DOI 10.1109/TPAMI.2012.147; Liu T, 2007, PROC CVPR IEEE, P596; [马儒宁 Ma Runing], 2012, [自动化学报, Acta Automatica Sinica], V38, P870; Ma Y.-F, 2003, P 11 ACM INT C MULTI, P374; Min Chen, 2011, IEEE INFOCOM 2011 - IEEE Conference on Computer Communications. Workshops, P409, DOI 10.1109/INFCOMW.2011.5928847; Perona, 2007, ADV NEURAL INFORM PR, P545, DOI DOI 10.7551/MITPRESS/7503.003.0073; Riche N, 2012, IEEE IMAGE PROC, P641, DOI 10.1109/ICIP.2012.6466941; Rother C, 2004, ACM T GRAPHIC, V23, P309, DOI 10.1145/1015706.1015720; Russell B., 2006, COMP VIS PATT REC 20, V2, P1605, DOI DOI 10.1109/CVPR.2006.326; Rutishauser U, 2004, PROC CVPR IEEE, P37; Sharma G, 2012, PROC CVPR IEEE, P3506, DOI 10.1109/CVPR.2012.6248093; Shen XH, 2012, PROC CVPR IEEE, P853, DOI 10.1109/CVPR.2012.6247758; Siagian C, 2007, IEEE T PATTERN ANAL, V29, P300, DOI 10.1109/TPAMI.2007.40; Tang KT, 2011, IEEE IMAGE PROC; Tatler BW, 2007, J VISION, V7, DOI 10.1167/7.14.4; Torralba A, 2006, PSYCHOL REV, V113, P766, DOI 10.1037/0033-295X.113.4.766; Torralba A, 2011, PROC CVPR IEEE, P1521, DOI 10.1109/CVPR.2011.5995347; Wan X, 1996, P SOC PHOTO-OPT INS, V2670, P8, DOI 10.1117/12.234782; Wang P, 2012, PROC CVPR IEEE, P3194, DOI 10.1109/CVPR.2012.6248054; Xie YL, 2013, IEEE T IMAGE PROCESS, V22, P1689, DOI 10.1109/TIP.2012.2216276; Yan Q, 2013, PROC CVPR IEEE, P1155, DOI 10.1109/CVPR.2013.153; Zhai Y., 2006, PROC14TH ACM INT C M, DOI DOI 10.1145/1180639.1180824	40	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112475	10.1371/journal.pone.0112475	http://dx.doi.org/10.1371/journal.pone.0112475			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379960	Green Published, Green Submitted, gold			2022-12-27	WOS:000344863100105
J	Nemes, K; Gellert, A; Balazs, E; Salanki, K				Nemes, Katalin; Gellert, Akos; Balazs, Ervin; Salanki, Katalin			Alanine Scanning of Cucumber Mosaic Virus (CMV) 2B Protein Identifies Different Positions for Cell-To-Cell Movement and Gene Silencing Suppressor Activity	PLOS ONE			English	Article							ARABIDOPSIS ARGONAUTE1; RNA-BINDING; I-TASSER; ACCUMULATION; EXPRESSION; VIRULENCE; RESISTANCE; 2B-PROTEIN; INHIBITION; INDUCTION	The multifunctional 2b protein of CMV has a role in the long distance and local movement of the virus, in symptom formation, in evasion of defense mediated by salicylic acid as well as in suppression of RNA silencing. The role of conserved amino acid sequence domains were analyzed previously in the protein function, but comprehensive analysis of this protein was not carried out until recently. We have analyzed all over the 2b protein by alanine scanning mutagenesis changing three consecutive amino acids (aa) to alanine. We have identified eight aa triplets as key determinants of the 2b protein function in virus infection. Four of them (KKQ/22-24/AAA, QNR/31-33/AAA, RER/34-36/AAA, SPS/40-42/AAA) overlap with previously determined regions indispensable in gene silencing suppressor function. We have identified two additional triplets necessary for the suppressor function of the 2b protein (LPF/55-57/AAA, NVE/10-12/AAA), and two other positions were required for cell-to-cell movement of the virus (MEL/1-3/AAA, RHV/70-72/AAA), which are not essential for suppressor activity.	[Nemes, Katalin; Salanki, Katalin] Hungarian Acad Sci, Agr Res Ctr, Inst Plant Protect, Budapest, Hungary; [Nemes, Katalin] Corvinus Univ Budapest, Dept Plant Pathol, Budapest, Hungary; [Gellert, Akos; Balazs, Ervin] Hungarian Acad Sci, Agr Res Ctr, Inst Agr, Dept Appl Genom, Budapest, Hungary; [Salanki, Katalin] Agr Biotechnol Ctr, Godollo, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Corvinus University Budapest; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research	Salanki, K (corresponding author), Hungarian Acad Sci, Agr Res Ctr, Inst Plant Protect, Budapest, Hungary.	salanki.katalin@agrar.mta.hu	Salanki, Katalin/AAY-1834-2021	Salanki, Katalin/0000-0002-0128-4338	Hungarian Scientific Research Fund [OTKA-K75168, OTKA-K109482]; Hungarian Academy of Sciences	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This project was funded by the Hungarian Scientific Research Fund OTKA-K75168 and OTKA-K109482. Akos Gellert was the recipient of Janos Bolyai fellowship from the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAULCOMBE DC, 1995, PLANT J, V7, P1045, DOI 10.1046/j.1365-313X.1995.07061045.x; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; Chen HY, 2008, EMBO REP, V9, P754, DOI 10.1038/embor.2008.118; Csorba T, 2009, ADV VIRUS RES, V75, P35, DOI 10.1016/S0065-3527(09)07502-2; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Diaz-Pendon JA, 2007, PLANT CELL, V19, P2053, DOI 10.1105/tpc.106.047449; DING SW, 1995, EMBO J, V14, P5762, DOI 10.1002/j.1460-2075.1995.tb00265.x; DING SW, 1994, VIROLOGY, V198, P593, DOI 10.1006/viro.1994.1071; Diveki Z, 2004, MOL PLANT MICROBE IN, V17, P837, DOI 10.1094/MPMI.2004.17.8.837; Donaire L, 2009, VIROLOGY, V392, P203, DOI 10.1016/j.virol.2009.07.005; Du ZY, 2014, J VIROL, V88, P5228, DOI 10.1128/JVI.00284-14; Duan CG, 2012, PLANT CELL, V24, P259, DOI 10.1105/tpc.111.092718; Gellert A, 2012, J MOL GRAPH MODEL, V38, P446, DOI 10.1016/j.jmgm.2012.08.005; Gonzalez I, 2012, RNA, V18, P771, DOI 10.1261/rna.031260.111; Gonzalez I, 2010, MOL PLANT MICROBE IN, V23, P294, DOI 10.1094/MPMI-23-3-0294; Goto K, 2007, PLANT CELL PHYSIOL, V48, P1050, DOI 10.1093/pcp/pcm074; Guo HS, 2002, EMBO J, V21, P398, DOI 10.1093/emboj/21.3.398; Ham BK, 1999, MOL CELLS, V9, P548; Hamera S, 2012, PLANT J, V69, P104, DOI 10.1111/j.1365-313X.2011.04774.x; Harvey JJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014639; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huppert E, 2002, J VIROL, V76, P3554, DOI 10.1128/JVI.76.7.3554-3557.2002; Ji LH, 2001, MOL PLANT MICROBE IN, V14, P715, DOI 10.1094/MPMI.2001.14.6.715; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; Lewsey M, 2009, MOL PLANT MICROBE IN, V22, P642, DOI 10.1094/MPMI-22-6-0642; Lewsey MG, 2010, PLANT SIGNAL BEHAV, V5, P705, DOI 10.4161/psb.5.6.11643; Lewsey MG, 2010, MOL PLANT MICROBE IN, V23, P835, DOI 10.1094/MPMI-23-7-0835; Lucy AP, 2000, EMBO J, V19, P1672, DOI 10.1093/emboj/19.7.1672; Mayers CN, 2000, J GEN VIROL, V81, P219, DOI 10.1099/0022-1317-81-1-219; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Netsu O, 2008, ARCH VIROL, V153, P1731, DOI 10.1007/s00705-008-0166-y; PALUKAITIS P, 1992, ADV VIRUS RES, V41, P281, DOI 10.1016/B978-0-12-394314-9.00013-0; Qi XP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004971; Qu J, 2007, J VIROL, V81, P6690, DOI 10.1128/JVI.02457-06; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scholthof HB, 2011, PLANT PHYSIOL, V156, P1548, DOI 10.1104/pp.111.178764; Shi BJ, 2003, MOL PLANT MICROBE IN, V16, P261, DOI 10.1094/MPMI.2003.16.3.261; Shi BJ, 1997, J GEN VIROL, V78, P505, DOI 10.1099/0022-1317-78-3-505; Soards AJ, 2002, MOL PLANT MICROBE IN, V15, P647, DOI 10.1094/MPMI.2002.15.7.647; Sueda K, 2010, FEBS LETT, V584, P945, DOI 10.1016/j.febslet.2010.01.033; Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wang XB, 2011, PLANT CELL, V23, P1625, DOI 10.1105/tpc.110.082305; Wang YZ, 2004, J GEN VIROL, V85, P3135, DOI 10.1099/vir.0.80250-0; WHITE JL, 1989, J VIROL METHODS, V23, P83, DOI 10.1016/0166-0934(89)90122-5; Ye J, 2009, FEBS LETT, V583, P101, DOI 10.1016/j.febslet.2008.11.031; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhou T, 2014, J GEN VIROL, V95, P1408, DOI 10.1099/vir.0.063461-0	52	14	15	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112095	10.1371/journal.pone.0112095	http://dx.doi.org/10.1371/journal.pone.0112095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380036	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000344863100051
J	Wu, J; Zhang, YS; Mu, ZC				Wu, Jing; Zhang, Yusen; Mu, Zengchao			Predicting Nucleosome Positioning Based on Geometrically Transformed Tsallis Entropy	PLOS ONE			English	Article							SEQUENCE; YEAST; OCCUPANCY	As the fundamental unit of eukaryotic chromatin structure, nucleosome plays critical roles in gene expression and regulation by controlling physical access to transcription factors. In this paper, based on the geometrically transformed Tsallis entropy and two index-vectors, a valid nucleosome positioning information model is developed to describe the distribution of A/T-riched and G/C-riched dimeric and trimeric motifs along the DNA duplex. When applied to train the support vector machine, the model achieves high AUCs across five organisms, which have significantly outperformed the previous studies. Besides, we adopt the concept of relative distance to describe the probability of arbitrary DNA sequence covered by nucleosome. Thus, the average nucleosome occupancy profile over the S.cerevisiae genome is calculated. With our peak detection model, the isolated nucleosomes along genome sequence are located. When compared with some published results, it shows that our model is effective for nucleosome positioning. The index-vector component n(WWW)/n(W) is identified to be an important influencing factor of nucleosome organizations.	[Wu, Jing; Zhang, Yusen; Mu, Zengchao] Shandong Univ, Sch Math & Stat, Weihai, Peoples R China	Shandong University	Zhang, YS (corresponding author), Shandong Univ, Sch Math & Stat, Weihai, Peoples R China.	zhangys@sdu.edu.cn	Zhang, Yusen/R-8508-2017; Zhang, Yusen/R-6097-2019	Zhang, Yusen/0000-0003-3842-1153; Zhang, Yusen/0000-0003-3842-1153	Shandong Natural Science Foundation [ZR2010AM020]	Shandong Natural Science Foundation(Natural Science Foundation of Shandong Province)	This work was supported by the Shandong Natural Science Foundation (ZR2010AM020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chung HR, 2009, J MOL BIOL, V386, P1411, DOI 10.1016/j.jmb.2008.11.049; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Gan YL, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-49; Gupta S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000134; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Miele V, 2008, NUCLEIC ACIDS RES, V36, P3746, DOI 10.1093/nar/gkn262; Morozov AV, 2009, NUCLEIC ACIDS RES, V37, P4707, DOI 10.1093/nar/gkp475; Nandy A, 2003, CHEM PHYS LETT, V368, P102, DOI 10.1016/S0009-2614(02)01830-4; Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007; Polishko A, 2012, BIOINFORMATICS, V28, pI242, DOI 10.1093/bioinformatics/bts206; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Tanaka Yoshiaki, 2009, Genome Inform, V23, P169; Tillo D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-442; Tolstorukov MY, 2007, J MOL BIOL, V371, P725, DOI 10.1016/j.jmb.2007.05.048; Trifonov EN, 1997, MOL BIOL+, V31, P647; TSALLIS C, 1988, J STAT PHYS, V52, P479, DOI 10.1007/BF01016429; Vapnik V., 1998, STAT LEARNING THEORY, V3, DOI DOI 10.1007/978-1-4419-1428-6_5864; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Yuan GC, 2008, PLOS COMPUT BIOL, V4, DOI [10.1371/journal.pcbi.0040013, 10.1371/journal.pcbi.0040013.eor]; Yuan GC, 2009, J COMPUT BIOL, V16, P341, DOI 10.1089/cmb.2008.18TT; Zhang YS, 2011, MATCH-COMMUN MATH CO, V65, P477; Zhang YS, 2011, J BIOMOL STRUCT DYN, V28, P557, DOI 10.1080/07391102.2011.10508595; Zhang ZQ, 2012, MATCH-COMMUN MATH CO, V68, P639; Zhang ZQ, 2012, J BIOMOL STRUCT DYN, V29, P1081, DOI 10.1080/073911012010525032	29	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e109395	10.1371/journal.pone.0109395	http://dx.doi.org/10.1371/journal.pone.0109395			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380134	Green Published, Green Submitted, gold			2022-12-27	WOS:000344863100007
J	Du, Y; Gao, YH; Meng, FG; Liu, SJ; Fan, ZP; Wu, JH; Sun, DJ				Du, Yang; Gao, Yanhui; Meng, Fangang; Liu, Shoujun; Fan, Zhipeng; Wu, Junhua; Sun, Dianjun			Iodine Deficiency and Excess Coexist in China and Induce Thyroid Dysfunction and Disease: A Cross-Sectional Study	PLOS ONE			English	Article							DRINKING-WATER; ENDEMIC GOITER; CHILDREN; EPIDEMIOLOGY; PREVALENCE; GESTATION; PREGNANCY; NUTRITION; NODULES; REGIONS	Background: In spite of the salt iodization, iodine deficiency disorders (IDD) have not been sustainably eliminated in China. There are coastal areas with low iodized salt coverage rates (iodine nutrition is inadequate) and other areas with excessive amounts of iodine in the drinking water. Objective: This study aimed to clarify the association of iodine deficiencies resulting from a low coverage rate of iodized salt, excess iodine intake from drinking water with thyroid function and disease in adults. Design: A cross-sectional study was conducted in adults in different iodine nutrition areas in three provinces in China. Results: The prevalence of thyroid nodules was 15.52%, 8.66% and 22.17% in the iodine excess, sufficient and deficient groups, respectively. The prevalence of subclinical hypothyroidism was 20.09%, 10.41%, and 2.25% in the excess, sufficient and deficient iodine groups, respectively. The prevalence of subclinical hyperthyroidism and overt hyperthyroidism in the iodine deficient group was higher than that in the iodine excess group (chi(2) = 9.302, p = 0.002) and iodine sufficient group (chi(2) = 7.553, p = 0.006). Thyroid-stimulating hormone (TSH) was significantly correlated with excess iodine intake (beta = 1.764, P = 0.001) and deficient iodine intake (beta = -1.219, P = 0.028). Conclusions: Thyroid nodules are more likely to be present in the iodine excess and deficient areas than in the iodine sufficient areas. Subclinical hyperthyroidism and overt hyperthyroidism are more likely to be prevalent in the iodine deficient areas than in the iodine excess or sufficient areas. Subclinical hypothyroidism is more likely to be prevalent in the high iodine intake areas than in the iodine deficient or sufficient areas. Median TSH may be deemed as an alternative indicator for monitoring the iodine nutrition status of the adult population in iodine excess and deficient areas.	[Sun, Dianjun] Harbin Med Univ, Chinese Ctr Dis Control & Prevent, Ctr Endem Dis Control, Key Lab Etiol & Epidemiol,Educ Bur Heilongjiang P, Harbin 23618504, Peoples R China; Minist Hlth, Harbin 23618504, Peoples R China	Chinese Center for Disease Control & Prevention; Harbin Medical University	Sun, DJ (corresponding author), Harbin Med Univ, Chinese Ctr Dis Control & Prevent, Ctr Endem Dis Control, Key Lab Etiol & Epidemiol,Educ Bur Heilongjiang P, Harbin 23618504, Peoples R China.	hrbmusdj@163.com			Special Fund for National Health Scientific Research in the Public Interest by the Ministry of Health of China [201202012]	Special Fund for National Health Scientific Research in the Public Interest by the Ministry of Health of China	This study was supported by the Special Fund for National Health Scientific Research in the Public Interest by the Ministry of Health of China (No. 201202012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2014, J FAM COMMUNITY MED, V21, P48, DOI 10.4103/2230-8229.128783; Andersen S, 2009, MATURITAS, V64, P126, DOI 10.1016/j.maturitas.2009.08.007; Andersson M, 2010, BEST PRACT RES CL EN, V24, P1, DOI 10.1016/j.beem.2009.08.005; Chen ZX, 2013, AM J CLIN NUTR, V98, P684, DOI 10.3945/ajcn.112.054353; Eltom A, 2001, CLIN ENDOCRINOL, V55, P485, DOI 10.1046/j.1365-2265.2001.01368.x; Evans C, 2014, CLIN ENDOCRINOL, V81, P606, DOI 10.1111/cen.12474; GUTEKUNST R, 1986, ACTA ENDOCRINOL-COP, V112, P494, DOI 10.1530/acta.0.1120494; Henjum S, 2010, PUBLIC HEALTH NUTR, V13, P1472, DOI 10.1017/S1368980010000650; Jin Y, 2006, GBT575052006; Kapil U, 2014, PUBLIC HEALTH NUTR, V17, P1971, DOI 10.1017/S1368980014000226; LI M, 1987, LANCET, V2, P257; Liu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089608; Liu S, 2007, 2762007 WS; Lu Ying-li, 2005, J Zhejiang Univ Sci B, V6, P1200, DOI 10.1631/jzus.2005.B1200; Lv SM, 2014, BRIT J NUTR, V111, P86, DOI 10.1017/S0007114513001906; Lv SM, 2012, PUBLIC HEALTH NUTR, V15, P1168, DOI 10.1017/S1368980012000146; Matthys B, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-50; Medani AMMH, 2013, PUBLIC HEALTH NUTR, V16, P1586, DOI 10.1017/S1368980012004685; Mesele M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-130; Mitka M, 2013, JAMA-J AM MED ASSOC, V309, P2428, DOI 10.1001/jama.2013.7239; Pearce EN, 2013, THYROID, V23, P523, DOI 10.1089/thy.2013.0128; Pearce EN, 2012, J TRACE ELEM MED BIO, V26, P131, DOI 10.1016/j.jtemb.2012.04.005; Roti E, 2001, THYROID, V11, P493, DOI 10.1089/105072501300176453; Sang ZN, 2013, J NUTR, V143, P2038, DOI 10.3945/jn.113.179135; Sang ZN, 2012, J CLIN ENDOCR METAB, V97, pE1363, DOI 10.1210/jc.2011-3438; Shen HM, 2011, BRIT J NUTR, V106, P243, DOI 10.1017/S0007114511000055; Sukkhojaiwaratkul D, 2014, J PERINATOL, V34, P594, DOI 10.1038/jp.2014.62; Szabolcs I, 1997, CLIN ENDOCRINOL, V47, P87, DOI 10.1046/j.1365-2265.1997.2271040.x; Takahashi T, 1999, INT J EPIDEMIOL, V28, P742, DOI 10.1093/ije/28.4.742; Teng WP, 2006, NEW ENGL J MED, V354, P2783, DOI 10.1056/NEJMoa054022; Tong YK, 2012, 1302572012 GBT; WHO UNICEF ICCIDD, 2007, ASS IOD DEF DIS MON; Yan YQ, 2006, 1072006 WST; Yu X, 2008, J ENDOCRINOL INVEST, V31, P243, DOI 10.1007/BF03345597; Zama SY, 2013, J CLIN DIAGN RES, V7, P2807, DOI 10.7860/JCDR/2013/6878.3702; Zimmermann MB, 2008, LANCET, V372, P1251, DOI 10.1016/S0140-6736(08)61005-3; Zimmermann MB, 2013, ENDOCR PRACT, V19, P839, DOI 10.4158/EP13180.RA; Zimmermann MB, 2012, PAEDIATR PERINAT EP, V26, P108, DOI 10.1111/j.1365-3016.2012.01275.x; Zimmermann MB, 2009, ENDOCR REV, V30, P376, DOI 10.1210/er.2009-0011; Zou SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040718	40	49	61	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111937	10.1371/journal.pone.0111937	http://dx.doi.org/10.1371/journal.pone.0111937			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375854	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402600077
J	Kalani, K; Kushwaha, V; Sharma, P; Verma, R; Srivastava, M; Khan, F; Murthy, PK; Srivastava, SK				Kalani, Komal; Kushwaha, Vikas; Sharma, Pooja; Verma, Richa; Srivastava, Mukesh; Khan, Feroz; Murthy, P. K.; Srivastava, Santosh Kumar			In Vitro, In Silico and In Vivo Studies of Ursolic Acid as an Anti-Filarial Agent	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; MASTOMYS-NATALENSIS; BRUGIA-MALAYI; SYSTEMS; TOXICITY; PARASITE; LEAVES; ASSAY	As part of our drug discovery program for anti-filarial agents from Indian medicinal plants, leaves of Eucalyptus tereticornis were chemically investigated, which resulted in the isolation and characterization of an anti-filarial agent, ursolic acid (UA) as a major constituent. Antifilarial activity of UA against the human lymphatic filarial parasite Brugia malayi using in vitro and in vivo assays, and in silico docking search on glutathione-s-transferase (GST) parasitic enzyme were carried out. The UA was lethal to microfilariae (mf; LC100: 50; IC50: 8.84 mu M) and female adult worms (LC100: 100; IC50: 35.36 mu M) as observed by motility assay; it exerted 86% inhibition in MTT reduction potential of the adult parasites. The selectivity index (SI) of UA for the parasites was found safe. This was supported by the molecular docking studies, which showed adequate docking (LibDock) scores for UA (-8.6) with respect to the standard antifilarial drugs, ivermectin (IVM -8.4) and diethylcarbamazine (DEC-C -4.6) on glutathione-s-transferase enzyme. Further, in silico pharmacokinetic and drug-likeness studies showed that UA possesses drug-like properties. Furthermore, UA was evaluated in vivo in B. malayi-M. coucha model (natural infection), which showed 54% macrofilaricidal activity, 56% female worm sterility and almost unchanged microfilaraemia maintained throughout observation period with no adverse effect on the host. Thus, in conclusion in vitro, in silico and in vivo results indicate that UA is a promising, inexpensive, widely available natural lead, which can be designed and developed into a macrofilaricidal drug. To the best of our knowledge this is the first ever report on the anti-filarial potential of UA from E. tereticornis, which is in full agreement with the Thomson Reuter's 'Metadrug' tool screening predictions.	[Kalani, Komal; Srivastava, Santosh Kumar] CSIR, Cent Inst Med & Aromat Plants, Dept Med Chem, Lucknow 226015, Uttar Pradesh, India; [Kushwaha, Vikas; Verma, Richa; Murthy, P. K.] CSIR, Cent Drug Res Inst, Div Parasitol, Lucknow 226001, Uttar Pradesh, India; [Sharma, Pooja; Khan, Feroz] CSIR, Cent Inst Med & Aromat Plants, Metab & Struct Biol Dept, Lucknow 226015, Uttar Pradesh, India; [Srivastava, Mukesh] CSIR, Cent Drug Res Inst, Biometry Sect, Lucknow 226001, Uttar Pradesh, India; [Kalani, Komal; Khan, Feroz; Srivastava, Santosh Kumar] Anusandhan Bhawan, Acad Sci & Innovat Res AcSIR, New Delhi 110001, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Academy of Scientific & Innovative Research (AcSIR)	Murthy, PK (corresponding author), CSIR, Cent Drug Res Inst, Div Parasitol, Lucknow 226001, Uttar Pradesh, India.	drpkmurthy@gmail.com; skscimap@gmail.com	Khan, Feroz/AHC-3474-2022; Kushwaha, Vikas/AAA-6987-2021	Khan, Feroz/0000-0002-2704-5925; Kushwaha, Vikas/0000-0003-4365-5720	CSIR-network project [BSC-0121]; CSIR-SPLENDID	CSIR-network project(Council of Scientific & Industrial Research (CSIR) - India); CSIR-SPLENDID	The funding sources are CSIR-network project BSC-0121 and CSIR-SPLENDID and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azeez S, 2012, J MOL MODEL, V18, P151, DOI 10.1007/s00894-011-1035-2; BROPHY PM, 1994, EXP PARASITOL, V79, P89, DOI 10.1006/expr.1994.1067; Bugrim A, 2004, DRUG DISCOV TODAY, V9, P127, DOI 10.1016/S1359-6446(03)02971-4; Burkot T R, 2006, Filaria J, V5, P10, DOI 10.1186/1475-2883-5-10; CHATTERJEE RK, 1992, DRUG DEVELOP RES, V26, P67, DOI 10.1002/ddr.430260106; Dadzie Yankum, 2003, Filaria J, V2, P2, DOI 10.1186/1475-2883-2-2; Gaur RL, 2007, PARASITOLOGY, V134, P537, DOI 10.1017/S0031182006001612; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; HUBER W, 1993, ACTA TROP, V55, P257, DOI 10.1016/0001-706X(93)90083-N; Kalani K, 2014, CURR TOP MED CHEM, V14, P1005, DOI 10.2174/1568026614666140324121606; Kalani K, 2013, BIOORG MED CHEM LETT, V23, P2566, DOI 10.1016/j.bmcl.2013.02.115; Kalani K, 2012, J MOL MODEL, V18, P3389, DOI 10.1007/s00894-011-1327-6; Kushwaha V, 2011, CHRON YOUNG SCI, P202, DOI DOI 10.4103/2229-5186.93025; Lakshmi V, 2010, ACTA TROP, V116, P127, DOI 10.1016/j.actatropica.2010.06.006; LAMMLER G, 1977, TROPENMED PARASITOL, V28, P205; Lanham A, 2013, AM J INFECT DIS MICR, V1, P5; Maurya A, 2012, J BRAZIL CHEM SOC, V23, P468, DOI 10.1590/S0103-50532012000300013; Molyneux DH, 2002, ANN TROP MED PARASIT, V96, pS15, DOI 10.1179/000349802125002374; Molyneux DH, 2003, TRENDS PARASITOL, V19, P516, DOI 10.1016/j.pt.2003.09.004; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murthy PK, 1999, CURR SCI INDIA, V77, P1084; Murthy PK, 1997, FOLIA PARASIT, V44, P302; MURTHY PK, 1983, INDIAN J MED RES, V77, P623; Murthy PK, 2011, PLANTA MED, V77, P647, DOI 10.1055/s-0030-1250452; Ottesen EA, 2000, TROP MED INT HEALTH, V5, P591, DOI 10.1046/j.1365-3156.2000.00620.x; PAGE B, 1993, INT J ONCOL, V3, P473; Sashidhara KV, 2014, EUR J MED CHEM, V81, P473, DOI 10.1016/j.ejmech.2014.05.029; Sommer A, 2001, INFECT IMMUN, V69, P7718, DOI 10.1128/IAI.69.12.7718-7728.2001; WHO, 2006, WEEKLY EPIDEMIOLOGIC; WHO, 2012, WEEKLY EPIDEMIOLOGIC; World Health Organization, 2005, WEEKLY EPIDEMIOLOGIC; Yadav D, 2013, PHYTOMEDICINE, V20, P124, DOI 10.1016/j.phymed.2012.10.017	32	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111244	10.1371/journal.pone.0111244	http://dx.doi.org/10.1371/journal.pone.0111244			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375886	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600032
J	Sahu, RP; Rezania, S; Ocana, JA; DaSilva-Arnold, SC; Bradish, JR; Richey, JD; Warren, SJ; Rashid, B; Travers, JB; Konger, RL				Sahu, Ravi P.; Rezania, Samin; Ocana, Jesus A.; DaSilva-Arnold, Sonia C.; Bradish, Joshua R.; Richey, Justin D.; Warren, Simon J.; Rashid, Badri; Travers, Jeffrey B.; Konger, Raymond L.			Topical Application of a Platelet Activating Factor Receptor Agonist Suppresses Phorbol Ester-Induced Acute and Chronic Inflammation and Has Cancer Chemopreventive Activity in Mouse Skin	PLOS ONE			English	Article							MAST-CELLS; HYPERSENSITIVITY REACTIONS; CONTACT HYPERSENSITIVITY; INDUCED APOPTOSIS; PHOSPHOLIPASE-C; FACTOR PAF; MICE; AUGMENTATION; EXPRESSION; MEDIATORS	Platelet activating factor (PAF) has long been associated with acute edema and inflammatory responses. PAF acts by binding to a specific G-protein coupled receptor (PAF-R, Ptafr). However, the role of chronic PAF-R activation on sustained inflammatory responses has been largely ignored. We recently demonstrated that mice lacking the PAF-R (Ptafr-/- mice) exhibit increased cutaneous tumorigenesis in response to a two-stage chemical carcinogenesis protocol. Ptafr-/- mice also exhibited increased chronic inflammation in response to phorbol ester application. In this present study, we demonstrate that topical application of the non-hydrolysable PAF mimetic (carbamoyl-PAF (CPAF)), exerts a potent, dose-dependent, and short-lived edema response in WT mice, but not Ptafr-/- mice or mice deficient in c-Kit (c-Kit(W-sh/W-sh) mice). Using an ear inflammation model, co-administration of topical CPAF treatment resulted in a paradoxical decrease in both acute ear thickness changes associated with a single PMA application, as well as the sustained inflammation associated with chronic repetitive PMA applications. Moreover, mice treated topically with CPAF also exhibited a significant reduction in chemical carcinogenesis. The ability of CPAF to suppress acute and chronic inflammatory changes in response to PMA application(s) was PAF-R dependent, as CPAF had no effect on basal or PMA-induced inflammation in Ptafr-/- mice. Moreover, c-Kit appears to be necessary for the anti-inflammatory effects of CPAF, as CPAF had no observable effect in c-Kit(W-sh/W-sh) mice. These data provide additional evidence that PAF-R activation exerts complex immunomodulatory effects in a model of chronic inflammation that is relevant to neoplastic development.	[Sahu, Ravi P.; Rezania, Samin; DaSilva-Arnold, Sonia C.; Bradish, Joshua R.; Richey, Justin D.; Warren, Simon J.; Rashid, Badri; Konger, Raymond L.] Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Ocana, Jesus A.; DaSilva-Arnold, Sonia C.; Travers, Jeffrey B.; Konger, Raymond L.] Indiana Univ, Sch Med, Dept Dermatol, Indianapolis, IN 46202 USA; [Travers, Jeffrey B.] Richard L Roudebush Vet Adm Med Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Konger, RL (corresponding author), Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA.	rkonger@iupui.edu	Sahu, Ravi Prakash/AFQ-3359-2022	Sahu, Ravi Prakash/0000-0003-3857-9073; DaSilva-Arnold, Sonia/0000-0003-2721-4626; Ocana, Jesus/0000-0003-3124-9282; Travers, Jeffrey/0000-0001-7232-1039	National Institutes of Health [R01 HL062996, R21 ES017497, R21 ES020965]; Veterans Administration (VA Merit) [510BX000853]; Prevent Cancer Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES017497, R21ES020965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration (VA Merit)(US Department of Veterans Affairs); Prevent Cancer Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health (www.nih.gov) (R01 HL062996, R21 ES017497, and R21 ES020965), the Veterans Administration (www.research.va.gov/funding)(VA Merit 510BX000853), and the Prevent Cancer Foundation (www.preventcancer.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin K, 2012, RESP MED, V106, P9, DOI 10.1016/j.rmed.2011.09.007; BOYER JL, 1994, J BIOL CHEM, V269, P2814; Bulger EM, 2000, CRIT CARE MED, V28, pN27, DOI 10.1097/00003246-200004001-00004; CANTWELL ME, 1987, AGENTS ACTIONS, V20, P165, DOI 10.1007/BF02074658; Ch'ng S, 2006, MODERN PATHOL, V19, P149, DOI 10.1038/modpathol.3800474; Chacon-Salinas R, 2013, J LEUKOCYTE BIOL; Chang DZ, 2011, CLIN CANCER RES, V17, P7015, DOI 10.1158/1078-0432.CCR-11-0607; CHURUKIAN C J, 1981, Journal of Histotechnology, V4, P85; Collington SJ, 2011, TRENDS IMMUNOL, V32, P478, DOI 10.1016/j.it.2011.08.002; Darst M, 2004, J IMMUNOL, V172, P6330, DOI 10.4049/jimmunol.172.10.6330; de Oliveira SI, 2006, PROSTAG OTH LIPID M, V80, P62, DOI 10.1016/j.prostaglandins.2006.04.002; de Vries VC, 2010, CURR OPIN IMMUNOL, V22, P643, DOI 10.1016/j.coi.2010.08.015; DEYOUNG LM, 1989, AGENTS ACTIONS, V26, P335; Dougan M, 2008, J EXP MED, V205, P267, DOI 10.1084/jem.20080136; Dupre DJ, 2003, J BIOL CHEM, V278, P48228, DOI 10.1074/jbc.M304082200; Dy LC, 1999, J BIOL CHEM, V274, P26917, DOI 10.1074/jbc.274.38.26917; Dyer KD, 2010, J IMMUNOL, V184, P6327, DOI 10.4049/jimmunol.0904043; Frenzel L, 2013, JOINT BONE SPINE, V80, P141, DOI 10.1016/j.jbspin.2012.08.013; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; Gebhardt C, 2008, J EXP MED, V205, P275, DOI 10.1084/jem.20070679; Gounaris E, 2007, P NATL ACAD SCI USA, V104, P19977, DOI 10.1073/pnas.0704620104; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatton JL, 2007, J INVEST DERMATOL, V127, P1507, DOI 10.1038/sj.jid.5700746; HEIMAN AS, 1985, J IMMUNOL, V134, P548; Kajiwara N, 2010, J ALLERGY CLIN IMMUN, V125, P1137, DOI 10.1016/j.jaci.2010.01.056; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Konger RL, 2008, PROSTAG OTH LIPID M, V87, P1, DOI 10.1016/j.prostaglandins.2008.04.002; Konger RL, 2002, AM J PATHOL, V161, P2065, DOI 10.1016/S0002-9440(10)64485-9; Krause K, 2013, ALLERGY, V68, P256, DOI 10.1111/all.12083; Kripke ML, 2013, J INVEST DERMATOL, V133, P27, DOI 10.1038/jid.2012.234; Li T, 2003, J BIOL CHEM, V278, P16614, DOI 10.1074/jbc.M211287200; Marathe GK, 2000, FREE RADICAL BIO MED, V28, P1762, DOI 10.1016/S0891-5849(00)00234-3; Marathe GK, 2005, J BIOL CHEM, V280, P35448, DOI 10.1074/jbc.M503811200; Michel A, 2013, J IMMUNOL, V190, P5534, DOI 10.4049/jimmunol.1203355; Muehlmann LA, 2012, RES VET SCI, V93, P393, DOI 10.1016/j.rvsc.2011.07.008; Nilsson G, 2000, IMMUNOLOGY, V99, P314, DOI 10.1046/j.1365-2567.2000.00972.x; Norval M, 2006, PROG BIOPHYS MOL BIO, V92, P108, DOI 10.1016/j.pbiomolbio.2006.02.009; PARK DG, 1993, J BIOL CHEM, V268, P4573; Rabenhorst A, 2012, BLOOD, V120, P2042, DOI 10.1182/blood-2012-03-415638; RAO TS, 1993, INFLAMMATION, V17, P723, DOI 10.1007/BF00920477; Rios FJ, 2013, MEDIAT INFLAMM, V2013, P8, DOI DOI 10.1155/2013/198193; Rios FJO, 2011, CELL PHYSIOL BIOCHEM, V27, P363, DOI 10.1159/000327962; Sahu RP, 2013, J IMMUNOL, V190, P2447, DOI 10.4049/jimmunol.1202699; Sahu RP, 2012, INT J CANCER, V131, pE1055, DOI 10.1002/ijc.27562; Sahu RP, 2012, CARCINOGENESIS, V33, P1360, DOI 10.1093/carcin/bgs152; Sahu RP, 2012, PHOTOCHEM PHOTOBIOL, V88, P490, DOI 10.1111/j.1751-1097.2011.01071.x; Sahu RP, 2012, CARCINOGENESIS, V33, P694, DOI 10.1093/carcin/bgr322; Sarchio SNE, 2012, EXP DERMATOL, V21, P241, DOI 10.1111/j.1600-0625.2012.01438.x; Siebenhaar F, 2014, EXP DERMATOL, V23, P159, DOI 10.1111/exd.12328; Sinnamon MJ, 2008, CARCINOGENESIS, V29, P880, DOI 10.1093/carcin/bgn040; Sreevidya CS, 2008, CANCER RES, V68, P3978, DOI 10.1158/0008-5472.CAN-07-6132; St John AL, 2013, J IMMUNOL, V190, P4458, DOI 10.4049/jimmunol.1203420; Stafforini DM, 2003, CRIT REV CL LAB SCI, V40, P643, DOI 10.1080/714037693; Tanaka T, 2013, SEMIN IMMUNOPATHOL, V35, P245, DOI 10.1007/s00281-012-0343-7; TANOOKA H, 1982, J NATL CANCER I, V69, P1305; TRAVERS JB, 1995, J INVEST DERMATOL, V105, P816, DOI 10.1111/1523-1747.ep12326581; Waskow C, 2007, BLOOD, V109, P5363, DOI 10.1182/blood-2006-08-039131; Yao YX, 2009, J IMMUNOL, V182, P2842, DOI 10.4049/jimmunol.0802689; Zhang QW, 2008, J INVEST DERMATOL, V128, P1780, DOI 10.1038/sj.jid.5701251; Zhang QW, 2005, J CLIN INVEST, V115, P2855, DOI 10.1172/JCI25429	62	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111608	10.1371/journal.pone.0111608	http://dx.doi.org/10.1371/journal.pone.0111608			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375862	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600051
J	Vahtera, V; Edgecombe, GD				Vahtera, Varpu; Edgecombe, Gregory D.			First Molecular Data and the Phylogenetic Position of the Millipede-Like Centipede Edentistoma octosulcatum Tomosvary, 1882 (Chilopoda: Scolopendromorpha: Scolopendridae)	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MORPHOLOGY; BLOCKS	Edentistoma octosulcatum Tomosvary, 1882, is a rare, superficially millipede-like centipede known only from Borneo and the Philippines. It is unique within the order Scolopendromorpha for its slow gait, robust tergites, and highly modified gizzard and mandible morphology. Not much is known about the biology of the species but it has been speculated to be arboreal with a possibly vegetarian diet. Until now its phylogenetic position within the subfamily Otostigminae has been based only on morphological characters, being variably ranked as a monotypic tribe (Arrhabdotini) or classified with the Southeast Asian genus Sterropristes Attems, 1934. The first molecular data for E. octosulcatum sourced from a newly collected specimen from Sarawak were analysed with and without morphology. Parsimony analysis of 122 morphological characters together with two nuclear and two mitochondrial loci resolves Edentistoma as sister group to three Indo-Australian species of Rhysida, this clade in turn grouping with Ethmostigmus, whereas maximum likelihood and parsimony analyses of the molecular data on their own ally Edentistoma with species of Otostigmus. A position of Edentistoma within Otostigmini (rather than being its sister group as predicted by the Arrhabdotini hypothesis) is consistently retrieved under different analytical conditions, but support values within the subfamily remain low for most nodes. The species exhibits strong pushing behaviour, suggestive of burrowing habits. Evidence against a suggested vegetarian diet is provided by observation of E. octosulcatum feeding on millipedes in the genus Trachelomegalus.	[Vahtera, Varpu] Univ Turku, Dept Biol, Zool Museum, SF-20500 Turku, Finland; [Vahtera, Varpu] Univ Helsinki, Zool Unit, Finnish Museum Nat Hist, Helsinki, Finland; [Edgecombe, Gregory D.] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England	University of Turku; University of Helsinki; Natural History Museum London	Vahtera, V (corresponding author), Univ Turku, Dept Biol, Zool Museum, SF-20500 Turku, Finland.	varpu.vahtera@utu.fi		Edgecombe, Gregory/0000-0002-9591-8011; Vahtera, Varpu/0000-0002-6710-6358	University of Helsinki, Finland	University of Helsinki, Finland	Funding for the field and laboratory work as well as VV's personal salary was provided by University of Helsinki, Finland, postdoctoral research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attems CG, 1930, MYRUAPODA 2 SCOLOPEN; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgecombe GD, 2011, TREATISE ZOOLOGY ANA, V1, P392, DOI DOI 10.1163/9789004188266_; Edgecombe GD, 2012, ZOOL J LINN SOC-LOND, V166, P768, DOI 10.1111/j.1096-3642.2012.00860.x; Edgecombe Gregory D., 2009, Soil Organisms, V81, P295; Edgecombe GD, 2008, CLADISTICS, V24, P872, DOI 10.1111/j.1096-0031.2008.00220.x; Farris JS, 1996, CLADISTICS, V12, P99, DOI 10.1111/j.1096-0031.1996.tb00196.x; Hazebroek HP, 2002, GUIDE GUNUNG MULU NA; Joshi J, 2011, MOL PHYLOGENET EVOL, V60, P287, DOI 10.1016/j.ympev.2011.04.024; Koch Markus, 2010, International Journal of Myriapodology, V3, P51, DOI 10.1163/187525410X12578602960344; Koch M, 2009, ZOOL SCR, V38, P269, DOI 10.1111/j.1463-6409.2008.00372.x; LEWIS J G E, 1981, Entomologist's Monthly Magazine, V117, P245; Lewis J. G. E., 1981, BIOL CENTIPEDES; Manton S. M., 1965, Journal of the Linnean Society London Zoology, V46, P251; Miller M.A., 2010, P GAT COMP ENV WORKS; MINELLI A, 2006, CHILOBASE WEB RESOUR; Muadsub S, 2012, ZOOTAXA, P35; Schileyko AA, 1997, ENTOMOL SCAND, P33; Schileyko Arkadiy A., 1992, Arthropoda Selecta, V1, P5; Stamatakis A, 2014, BIOINFORMATICS; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Vahtera V, 2013, INVERTEBR SYST, V27, P578, DOI 10.1071/IS13035; Vahtera V, 2012, ZOOMORPHOLOGY, V131, P225, DOI 10.1007/s00435-012-0157-0; Vahtera V, 2012, CLADISTICS, V28, P4, DOI 10.1111/j.1096-0031.2011.00361.x; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Wheeler W, 1996, CLADISTICS, V12, P1, DOI 10.1111/j.1096-0031.1996.tb00189.x; Wheeler WC, 2014, POY VERSION 5 PHYLOG	29	7	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112461	10.1371/journal.pone.0112461	http://dx.doi.org/10.1371/journal.pone.0112461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389773	Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400083
J	Wang, WY; Komatsu, K; Huang, YX; Wu, J; Zhang, WH; Lee, JY; Miyata, M; Xu, HD; Li, JD				Wang, Wenzhuo Y.; Komatsu, Kensei; Huang, Yuxian; Wu, Jing; Zhang, Wenhong; Lee, Ji-Yun; Miyata, Masanori; Xu, Haidong; Li, Jian-Dong			CYLD Negatively Regulates Nontypeable Haemophilus influenzae-Induced IL-8 Expression via Phosphatase MKP-1-Dependent Inhibition of ERK	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-SUPPRESSOR CYLD; STREPTOCOCCUS-PNEUMONIAE; SIGNALING PATHWAYS; IMMUNE-RESPONSE; KINASE PATHWAY; UP-REGULATION; OTITIS-MEDIA; INFLAMMATION; PROTEIN	Nontypeable Haemophilus influenzae (NTHi), a Gram-negative bacterium, is the primary cause of otitis media in children and the exacerbation of chronic obstructive pulmonary disease in adults. A hallmark of both diseases is an overactive inflammatory response, including the upregulation of chemokines, such as interleukin-8 (IL-8). An appropriate inflammatory response is essential for eradicating pathogens. However, excessive inflammation can cause host tissue damage. Therefore, expression of IL-8 must be tightly regulated. We previously reported that NTHi induces IL-8 expression in an ERK-dependent manner. We also have shown that the deubiquitinase cylindromatosis (CYLD) suppresses NTHi-induced inflammation. However, the underlying molecular mechanism of how CYLD negatively regulates ERK-mediated IL-8 production is largely unknown. Here, we examine both human lung epithelial A549 cells and lung of Cyld(-/-) mice to show that CYLD specifically targets the activation of ERK. Interestingly, CYLD enhances NTHi-induced upregulation of another negative regulator, MAP Kinase Phosphatase-1 (MKP-1), which, in turn, leads to reduced ERK activation and subsequent suppression of IL-8. Taken together, the CYLD suppression of ERK-dependent IL-8 via MKP-1 may bring novel insights into the tight regulation of inflammatory responses and also lead to innovative therapeutic strategies for controlling these responses by targeting key negative regulators of inflammation.	[Wang, Wenzhuo Y.; Komatsu, Kensei; Lee, Ji-Yun; Miyata, Masanori; Xu, Haidong; Li, Jian-Dong] Georgia State Univ, Ctr Inflammat Immun & Infect, Inst Biomed Sci, Atlanta, GA 30303 USA; [Wang, Wenzhuo Y.] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Huang, Yuxian; Wu, Jing; Zhang, Wenhong] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China; [Huang, Yuxian] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Viral Hepatitis, Shanghai 200433, Peoples R China	University System of Georgia; Georgia State University; University of Rochester; Fudan University; Fudan University	Huang, YX (corresponding author), Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China.	yxhuang@fudan.edu.cn; jdli@gsu.edu	Wu, Jing/GQI-1843-2022; Komatsu, Kensei/AAO-6492-2021	Wu, Jing/0000-0002-1224-0912; Li, Jian-Dong/0000-0002-5593-050X; Komatsu, Kensei/0000-0001-7418-3805	National Institutes of Health [DC005843, DC004562, GM107529]; National Natural Science Foundation of China [30972635]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004562, R01DC013833, R01DC005843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from National Institutes of Health (http://www.nih.gov) DC005843, DC004562 and GM107529 to J. D. L., and National Natural Science Foundation of China (http://www.nsfc.gov.cn) 30972635 to Y. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SM, 2006, BIOCHEM SOC T, V34, P1018, DOI 10.1042/BST0341018; [Anonymous], BIOESSAYS, V34, P142; Arguedas A, 2010, INT J PEDIATR OTORHI, V74, P1419, DOI 10.1016/j.ijporl.2010.09.022; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Chartrand SA, 1998, PEDIATR ANN, V27, P86, DOI 10.3928/0090-4481-19980201-06; Comalada M, 2012, EUR J IMMUNOL, V42, P1938, DOI 10.1002/eji.201242441; de Oliveira S, 2013, J IMMUNOL, V190, P4349, DOI 10.4049/jimmunol.1203266; Foxwell AR, 1998, MICROBIOL MOL BIOL R, V62, P294, DOI 10.1128/MMBR.62.2.294-308.1998; Gates GA, 1996, OTOLARYNG HEAD NECK, V114, P525, DOI 10.1016/S0194-5998(96)70243-7; Ito M, 2010, INT J PEDIATR OTORHI, V74, P901, DOI 10.1016/j.ijporl.2010.05.008; Jono H, 2004, J BIOL CHEM, V279, P36171, DOI 10.1074/jbc.M406638200; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Koga T, 2008, J BIOL CHEM, V283, P12546, DOI 10.1074/jbc.M710518200; Komatsu K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2674; Komatsu K, 2008, BIOCHEM BIOPH RES CO, V377, P763, DOI 10.1016/j.bbrc.2008.10.091; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lee J, 2012, J BIOL CHEM, V287, P22799, DOI 10.1074/jbc.M111.337378; Lim JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001032; Lim JH, 2007, IMMUNITY, V27, P349, DOI 10.1016/j.immuni.2007.07.011; Lim JH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1776; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Ludwig S, 2009, J ANTIMICROB CHEMOTH, V64, P1, DOI 10.1093/jac/dkp161; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; McCullough SD, 2014, AM J RESP CELL MOL B; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Minino Arialdi M, 2002, Natl Vital Stat Rep, V50, P1; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Pannem RR, 2014, CARCINOGENESIS, V35, P461, DOI 10.1093/carcin/bgt335; Poulikakos PI, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001948; Reiley W, 2004, J BIOL CHEM, V279, P55161, DOI 10.1074/jbc.M411049200; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rubinstein AL, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-34; Sakai A, 2007, FEBS J, V274, P3655, DOI 10.1111/j.1742-4658.2007.05899.x; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; Shuto T, 2001, P NATL ACAD SCI USA, V98, P8774, DOI 10.1073/pnas.151236098; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Wancket LM, 2012, LIFE SCI, V90, P237, DOI 10.1016/j.lfs.2011.11.017; Wang BN, 2003, INFECT IMMUN, V71, P5523, DOI 10.1128/IAI.71.10.5523-5530.2003; Wang BN, 2002, J BIOL CHEM, V277, P949, DOI 10.1074/jbc.M107484200; Wang WZY, 2012, CELL MOL IMMUNOL, V9, P131, DOI 10.1038/cmi.2011.65; Yoshida H, 2005, J BIOL CHEM, V280, P41111, DOI 10.1074/jbc.M509526200	44	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112516	10.1371/journal.pone.0112516	http://dx.doi.org/10.1371/journal.pone.0112516			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389768	Green Submitted, Green Published, gold			2022-12-27	WOS:000349144400089
J	Saare, M; Rekker, K; Laisk-Podar, T; Soritsa, D; Roost, AM; Simm, J; Velthut-Meikas, A; Samuel, K; Metsalu, T; Karro, H; Soritsa, A; Salumets, A; Peters, M				Saare, Merli; Rekker, Kadri; Laisk-Podar, Triin; Soritsa, Deniss; Roost, Anne Mari; Simm, Jaak; Velthut-Meikas, Agne; Samuel, Kuelli; Metsalu, Tauno; Karro, Helle; Soritsa, Andrei; Salumets, Andres; Peters, Maire			High-Throughput Sequencing Approach Uncovers the miRNome of Peritoneal Endometriotic Lesions and Adjacent Healthy Tissues	PLOS ONE			English	Article							GENE-EXPRESSION DATA; MESENCHYMAL TRANSITION; MICRORNA EXPRESSION; MIR-200 FAMILY; INFERTILE WOMEN; CANCER-CELLS; E-CADHERIN; LAPAROSCOPY; ZEB1; PATHOGENESIS	Accumulating data have shown the involvement of microRNAs (miRNAs) in endometriosis pathogenesis. In this study, we used a novel approach to determine the endometriotic lesion-specific miRNAs by high-throughput small RNA sequencing of paired samples of peritoneal endometriotic lesions and matched healthy surrounding tissues together with eutopic endometria of the same patients. We found five miRNAs specific to epithelial cells - miR-34c, miR-449a, miR-200a, miR-200b and miR-141 showing significantly higher expression in peritoneal endometriotic lesions compared to healthy peritoneal tissues. We also determined the expression levels of miR-200 family target genes E-cadherin, ZEB1 and ZEB2 and found that the expression level of E-cadherin was significantly higher in endometriotic lesions compared to healthy tissues. Further evaluation verified that studied miRNAs could be used as diagnostic markers for confirming the presence of endometrial cells in endometriotic lesion biopsy samples. Furthermore, we demonstrated that the miRNA profile of peritoneal endometriotic lesion biopsies is largely masked by the surrounding peritoneal tissue, challenging the discovery of an accurate lesion-specific miRNA profile. Taken together, our findings indicate that only particular miRNAs with a significantly higher expression in endometriotic cells can be detected from lesion biopsies, and can serve as diagnostic markers for endometriosis.	[Saare, Merli; Rekker, Kadri; Laisk-Podar, Triin; Soritsa, Deniss; Roost, Anne Mari; Velthut-Meikas, Agne; Samuel, Kuelli; Salumets, Andres; Peters, Maire] Competence Ctr Reprod Med & Biol, Tartu, Estonia; [Saare, Merli; Rekker, Kadri; Laisk-Podar, Triin; Karro, Helle; Salumets, Andres; Peters, Maire] Univ Tartu, Dept Obstet & Gynecol, EE-50090 Tartu, Estonia; [Saare, Merli; Salumets, Andres] Univ Tartu, Inst Bio & Translat Med, EE-50090 Tartu, Estonia; [Soritsa, Deniss; Karro, Helle] Tartu Univ Hosp, Womens Clin, Tartu, Estonia; [Soritsa, Deniss; Soritsa, Andrei] Elite Clin, Tartu, Estonia; [Simm, Jaak] Katholieke Univ Leuven, STADIUS Ctr Dynam Syst Signal Proc & Data Analyt, Dept Elect Engn ESAT, Leuven, Belgium; [Simm, Jaak] iMinds Med IT, Leuven, Belgium; [Simm, Jaak; Velthut-Meikas, Agne] Tallinn Univ Technol, Ctr Biol Integrated Syst, EE-19086 Tallinn, Estonia; [Metsalu, Tauno] Univ Tartu, Inst Comp Sci, EE-50090 Tartu, Estonia	University of Tartu; University of Tartu; KU Leuven; IMEC; Tallinn University of Technology; University of Tartu	Saare, M (corresponding author), Competence Ctr Reprod Med & Biol, Tartu, Estonia.	merli.saare@ut.ee	Velthut-Meikas, Agne/N-3522-2019; Velthut-Meikas, Agne/F-3530-2017; Saare, Merli/J-2559-2015; Salumets, Andres/J-2278-2015; Karro, Helle/AAL-2191-2020; Peters, Maire/J-2310-2015; Laisk, Triin/J-2290-2015	Velthut-Meikas, Agne/0000-0003-1927-9016; Velthut-Meikas, Agne/0000-0003-1927-9016; Salumets, Andres/0000-0002-1251-8160; Peters, Maire/0000-0003-2063-242X; Laisk-Podar, Triin/0000-0003-1501-9030	Estonian Ministry of Education and Research [SF0180044s09]; Enterprise Estonia [EU30020]; Eureka's EUROSTARS programme (NOTED) [EU41564]; FP7 Marie Curie Industry-Academia Partnerships and Pathways grant (SARM) [EU324509]	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Enterprise Estonia; Eureka's EUROSTARS programme (NOTED); FP7 Marie Curie Industry-Academia Partnerships and Pathways grant (SARM)	This research was funded by grant SF0180044s09 from the Estonian Ministry of Education and Research, Enterprise Estonia, grant no EU30020, Eureka's EUROSTARS programme grant (NOTED, EU41564), and FP7 Marie Curie Industry-Academia Partnerships and Pathways grant (SARM, EU324509). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmae S, 2013, REPROD SCI, V20, P308, DOI 10.1177/1933719112453507; Balasch J, 1996, HUM REPROD, V11, P387, DOI 10.1093/HUMREP/11.2.387; Banno K, 2013, INT J CLIN ONCOL, V18, P186, DOI 10.1007/s10147-013-0526-9; Bartley J, 2014, ARCH GYNECOL OBSTET, V289, P871, DOI 10.1007/s00404-013-3040-4; Braza-Boils A, 2014, HUM REPROD, V29, P978, DOI 10.1093/humrep/deu019; Burney RO, 2009, MOL HUM REPROD, V15, P625, DOI 10.1093/molehr/gap068; Canis M, 1997, FERTIL STERIL, V67, P817; Creighton CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009637; Dai YH, 2012, DIGEST DIS SCI, V57, P1253, DOI 10.1007/s10620-012-2042-6; Davalos V, 2012, ONCOGENE, V31, P2062, DOI 10.1038/onc.2011.383; Filigheddu N, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/369549; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gilabert-Estelles J, 2012, CURR MED CHEM, V19, P2406, DOI 10.2174/092986712800269362; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hawkins SM, 2011, MOL ENDOCRINOL, V25, P821, DOI 10.1210/me.2010-0371; Hill L, 2013, INT J CANCER, V132, P745, DOI 10.1002/ijc.27708; Hsu CY, 2014, J PATHOL, V232, P330, DOI 10.1002/path.4295; Hu JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045965; Khan KN, 2014, HUM REPROD, V29, P462, DOI 10.1093/humrep/det438; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kuokkanen S, 2010, BIOL REPROD, V82, P791, DOI 10.1095/biolreprod.109.081059; Laudanski P, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-78; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lize M, 2011, CELL CYCLE, V10, P2874, DOI 10.4161/cc.10.17.17181; Luo WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064759; Matsuzaki S, 2012, HUM REPROD, V27, P712, DOI 10.1093/humrep/der442; MOEN MH, 1992, ACTA OBSTET GYN SCAN, V71, P337, DOI 10.3109/00016349209021069; NISOLLE M, 1990, FERTIL STERIL, V53, P984; Ohira T, 2003, P NATL ACAD SCI USA, V100, P10429, DOI 10.1073/pnas.1734137100; Pan Q, 2007, MOL HUM REPROD, V13, P797, DOI 10.1093/molehr/gam063; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Ramon LA, 2011, HUM REPROD, V26, P1082, DOI 10.1093/humrep/der025; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Romero-Perez L, 2013, MODERN PATHOLOGY OFF; Sha AG, 2011, FERTIL STERIL, V96, P150, DOI 10.1016/j.fertnstert.2011.04.072; Shi XY, 2014, INT J MOL MED, V33, P59, DOI 10.3892/ijmm.2013.1536; Spoelstra NS, 2006, CANCER RES, V66, P3893, DOI 10.1158/0008-5472.CAN-05-2881; Stegmann BJ, 2008, FERTIL STERIL, V89, P1632, DOI 10.1016/j.fertnstert.2007.05.042; Stratton P, 2003, FERTIL STERIL, V79, P1078, DOI 10.1016/S0015-0282(03)00155-9; Teague EMCO, 2010, HUM REPROD UPDATE, V16, P142, DOI 10.1093/humupd/dmp034; Teague EMCO, 2009, MOL ENDOCRINOL, V23, P265, DOI 10.1210/me.2008-0387; Toloubeydokhti T, 2008, REPROD SCI, V15, P993, DOI 10.1177/1933719108324132; Torres A, 2013, GYNECOL ONCOL, V130, P588, DOI 10.1016/j.ygyno.2013.06.026; Torres A, 2013, INT J CANCER, V132, P1633, DOI 10.1002/ijc.27840; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Velthut-Meikas A, 2013, MOL ENDOCRINOL, V27, P1128, DOI 10.1210/me.2013-1058; Vrba L, 2011, GENOME RES, V21, P2026, DOI 10.1101/gr.123935.111; Wanyonyi SZ, 2011, INT J GYNECOL OBSTET, V115, P273, DOI 10.1016/j.ijgo.2011.07.022	49	29	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112630	10.1371/journal.pone.0112630	http://dx.doi.org/10.1371/journal.pone.0112630			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386850	Green Submitted, gold, Green Published			2022-12-27	WOS:000345250400075
J	Underhill, K; Morrow, KM; Colleran, CM; Holcomb, R; Operario, D; Calabrese, SK; Galarraga, O; Mayer, KH				Underhill, Kristen; Morrow, Kathleen M.; Colleran, Christopher M.; Holcomb, Richard; Operario, Don; Calabrese, Sarah K.; Galarraga, Omar; Mayer, Kenneth H.			Access to Healthcare, HIV/STI Testing, and Preferred Pre-Exposure Prophylaxis Providers among Men Who Have Sex with Men and Men Who Engage in Street-Based Sex Work in the US	PLOS ONE			English	Article							HIV PREVENTION; ANTIRETROVIRAL PROPHYLAXIS; INTERIM GUIDANCE; YOUNG MEN; QUALITATIVE RESEARCH; PREP ACCEPTABILITY; LIMITED KNOWLEDGE; UNITED-STATES; BISEXUAL MEN; CONDOM-USE	Background: Pre-exposure prophylaxis (PrEP) is a promising strategy for HIV prevention among men who have sex with men (MSM) and men who engage in sex work. But access will require routine HIV testing and contacts with healthcare providers. This study investigated men's healthcare and HIV testing experiences to inform PrEP implementation. Methods: We conducted 8 focus groups (n = 38) in 2012 and 56 in-depth qualitative interviews in 2013-14 with male sex workers (MSWs) (n = 31) and other MSM (n = 25) in Providence, RI. MSWs primarily met clients in street-based sex work venues. Facilitators asked participants about access to healthcare and HIV/STI testing, healthcare needs, and preferred PrEP providers. Results: MSWs primarily accessed care in emergency rooms (ERs), substance use clinics, correctional institutions, and walk-in clinics. Rates of HIV testing were high, but MSWs reported low access to other STI testing, low insurance coverage, and unmet healthcare needs including primary care, substance use treatment, and mental health services. MSM not engaging in sex work were more likely to report access to primary and specialist care. Rates of HIV testing among these MSM were slightly lower, but they reported more STI testing, more insurance coverage, and fewer unmet needs. Preferred PrEP providers for both groups included primary care physicians, infectious disease specialists, and psychiatrists. MSWs were also willing to access PrEP in substance use treatment and ER settings. Conclusions: PrEP outreach efforts for MSWs and other MSM should engage diverse providers in many settings, including mental health and substance use treatment, ERs, needle exchanges, correctional institutions, and HIV testing centers. Access to PrEP will require financial assistance, but can build on existing healthcare contacts for both populations.	[Underhill, Kristen] Yale Univ, Yale Law Sch, Yale Ctr Interdisciplinary Res AIDS, New Haven, CT 06520 USA; [Morrow, Kathleen M.; Colleran, Christopher M.] Miriam Hosp, Centers Behav & Prevent Med, Providence, RI 02906 USA; [Holcomb, Richard] Project Weber, Providence, RI USA; [Operario, Don; Galarraga, Omar] Brown Univ, Sch Publ Hlth, Providence, RI 02912 USA; [Calabrese, Sarah K.] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Mayer, Kenneth H.] Fenway Hlth, Fenway Inst, Boston, MA USA	Yale University; Lifespan Health Rhode Island; Miriam Hospital; Brown University; Yale University; Fenway Health	Underhill, K (corresponding author), Yale Univ, Yale Law Sch, Yale Ctr Interdisciplinary Res AIDS, New Haven, CT 06520 USA.	kristen.underhill@yale.edu	Galarraga, Omar/N-1622-2019	Galarraga, Omar/0000-0002-9985-9266	National Institute of Mental Health [5K01MH093273]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R25HD045810, K24HD062645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020031, K01MH093273, K01MH103080, P30MH062294] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the National Institute of Mental Health, #5K01MH093273 (PI: Underhill). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, NVIVO 9; [Anonymous], MMWR; Awad GH, 2004, AIDS EDUC PREV, V16, P115, DOI 10.1521/aeap.16.2.115.29397; Bacon O, 2006, SEX TRANSM DIS, V33, P228, DOI 10.1097/01.olq.0000204914.91923.ad; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Ballester-Arnal R, 2014, CURR HIV-AIDS REP, V11, P72, DOI 10.1007/s11904-013-0195-3; Baral SD, 2014, LANCET; Bernstein KT, 2008, ARCH INTERN MED, V168, P1458, DOI 10.1001/archinte.168.13.1458; Beyrer C, 2012, LANCET, V380, P424, DOI 10.1016/S0140-6736(12)61022-8; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brooks RA, 2012, AIDS PATIENT CARE ST, V26, P87, DOI 10.1089/apc.2011.0283; Brooks RA, 2011, AIDS CARE, V23, P1136, DOI 10.1080/09540121.2011.554528; Brunsberg SA, 2012, SEX RES SOC POLICY, V9, P125, DOI 10.1007/s13178-012-0085-2; Bush S, 2014, 9 INT C HIV TREATM P; CDC, 2010, PREL RES 1 SAF STUD; CDC, 2011, CDC FACT SHEET HIV A; Centers for Disease Control and Prevention, 2021, PREEXP PROPH PREV HI; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cohan D, 2006, SEX TRANSM INFECT, V82, P418, DOI 10.1136/sti.2006.020628; Cohen RA, 2014, HLTH INSURANCE COVER; Denzin N.K., 2005, HDB QUALITATIVE RES, P1, DOI DOI 10.1017/CBO9781107415324.004; Edelstein Z, 2014, 9 INT C HIV TREATM P, P494; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Food and Drug Administration, 2012, TRUV PREP FACT SHEET; Galea JT, 2011, INT J STD AIDS, V22, P256, DOI 10.1258/ijsa.2009.009255; Gilead Sciences Inc, 2013, TRUVADA PREEXP PROPH; Gilead Sciences Inc, 2012, TRUV RISK EV MIT STR; Golub SA, 2013, AIDS PATIENT CARE ST, V27, P248, DOI 10.1089/apc.2012.0419; Golub SA, 2010, JAIDS-J ACQ IMM DEF, V54, P548, DOI 10.1097/QAI.0b013e3181e19a54; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grov C, 2014, SEX RES SOC POLICY, V11, P176, DOI 10.1007/s13178-014-0151-z; Holt M, 2014, SEX HEALTH, V11, P166, DOI 10.1071/SH13060; Horberg M, 2013, AM J PREV MED, V44, pS125, DOI 10.1016/j.amepre.2012.09.039; Horstmann E, 2010, CLIN INFECT DIS, V50, P752, DOI 10.1086/649933; Hosek SG, 2013, JAIDS-J ACQ IMM DEF, V62, P447, DOI 10.1097/QAI.0b013e3182801081; Kaiser Family Foundation, 2014, AV SINGL PREM ENR EM; Kaiser Family Foundation, 2014, AV PERS MONTHL PREM; Kempf M.C., 2020, WEEXPAND PREP DEMONS; Koblin BA, 2011, JAIDS-J ACQ IMM DEF, V58, P319, DOI 10.1097/QAI.0b013e31822b76d2; Koester KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071546; Krakower D, 2014, AIDS BEHAV, V18, P1712, DOI 10.1007/s10461-014-0839-3; Krakower DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033119; Lankenau SE, 2005, INT J DRUG POLICY, V16, P10, DOI 10.1016/j.drugpo.2004.07.006; Liu A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001613; Liu AY, 2008, JAIDS-J ACQ IMM DEF, V47, P241, DOI 10.1097/QAI.0b013e31815e4041; Mansergh G, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001286; McKinnon LR, 2014, SEX TRANSM INFECT, V90, P237, DOI 10.1136/sextrans-2013-051310; McKirnan DJ, 2013, HEALTH EDUC BEHAV, V40, P32, DOI 10.1177/1090198111436340; Mera RM, 2013, 53 INT C ANT AG CHEM; Mimiaga MJ, 2007, SEX TRANSM DIS, V34, P113, DOI 10.1097/01.olq.0000225327.13214.bf; Mimiaga MJ, 2009, J URBAN HEALTH, V86, P54, DOI 10.1007/s11524-008-9316-5; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P77, DOI 10.1097/QAI.0b013e31818d5a27; Newman PA, 2004, AM J PUBLIC HEALTH, V94, P1998, DOI 10.2105/AJPH.94.11.1998; Oster Alexandra M., 2011, Morbidity and Mortality Weekly Report, V60, P694; Patel V, 2014, 9 INT C HIV TREATM P; Ponterotto JG, 2005, J COUNS PSYCHOL, V52, P126, DOI 10.1037/0022-0167.52.2.126; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Rietmeijer CA, 1998, SEX TRANSM DIS, V25, P353, DOI 10.1097/00007435-199808000-00006; Sanchez Travis, 2006, Morbidity and Mortality Weekly Report, V55, P1; Santos GM, 2013, JAIDS-J ACQ IMM DEF, V63, pE167, DOI 10.1097/QAI.0b013e318294de80; Scott J, 2005, J INTERPERS VIOLENCE, V20, P320, DOI 10.1177/0886260504270334; Smith D. K., 2012, Morbidity and Mortality Weekly Report, V61, P586; Smith DK, 2013, MMWR-MORBID MORTAL W, V62, P463; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Underhill K, 2012, AM PUBL HLTH ASS 140; Underhill K, 2014, AM PUBL HLTH ASS 142; Underhill K, 2012, 19 INT AIDS C WASH D; Underhill K, 2014, 2014 NAT STD PREV C; Underhill K, 2014, 9 INT C HIV TREATM P; Underhill K, 2014, AIDS BEHAV, V18, P241, DOI 10.1007/s10461-013-0498-9; Underhill K, 2012, AM J LAW MED, V38, P607, DOI 10.1177/009885881203800402; Underhill K, 2010, JAIDS-J ACQ IMM DEF, V55, P8, DOI 10.1097/QAI.0b013e3181e8efe4; Williams ML, 2006, AIDS EDUC PREV, V18, P204, DOI 10.1521/aeap.2006.18.3.204; Wingood GM, 2013, JAIDS-J ACQ IMM DEF, V63, pS95, DOI 10.1097/QAI.0b013e3182920126; Wolitski RJ, 2011, AIDS BEHAV, V15, pS9, DOI 10.1007/s10461-011-9901-6; Young I, 2014, AIDS BEHAV, V18, P195, DOI 10.1007/s10461-013-0560-7	76	56	56	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112425	10.1371/journal.pone.0112425	http://dx.doi.org/10.1371/journal.pone.0112425			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT9MC	25386746	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400060
J	Camilo, LM; Avila, MB; Cruz, LFS; Ribeiro, GCM; Spieth, PM; Reske, AA; Amato, M; Giannella-Neto, A; Zin, WA; Carvalho, AR				Camilo, Luciana M.; Avila, Mariana B.; Cruz, Luis Felipe S.; Ribeiro, Gabriel C. M.; Spieth, Peter M.; Reske, Andreas A.; Amato, Marcelo; Giannella-Neto, Antonio; Zin, Walter A.; Carvalho, Alysson R.			Positive End-Expiratory Pressure and Variable Ventilation in Lung-Healthy Rats under General Anesthesia	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; LEFT-VENTRICULAR PERFORMANCE; PROTECTIVE MECHANICAL VENTILATION; TIDAL VOLUMES; GAS-EXCHANGE; ATELECTASIS FORMATION; ARTERIAL OXYGENATION; ABDOMINAL-SURGERY; PORCINE MODEL; INJURY	Objectives: Variable ventilation (VV) seems to improve respiratory function in acute lung injury and may be combined with positive end-expiratory pressure (PEEP) in order to protect the lungs even in healthy subjects. We hypothesized that VV in combination with moderate levels of PEEP reduce the deterioration of pulmonary function related to general anesthesia. Hence, we aimed at evaluating the alveolar stability and lung protection of the combination of VV at different PEEP levels. Design: Randomized experimental study. Setting: Animal research facility. Subjects: Forty-nine male Wistar rats (200-270 g). Interventions: Animals were ventilated during 2 hours with protective low tidal volume (VT) in volume control ventilation (VCV) or VV and PEEP adjusted at the level of minimum respiratory system elastance (Ers), obtained during a decremental PEEP trial subsequent to a recruitment maneuver, and 2 cmH(2)O above or below of this level. Measurements and Main Results: Ers, gas exchange and hemodynamic variables were measured. Cytokines were determined in lung homogenate and plasma samples and left lung was used for histologic analysis and diffuse alveolar damage scoring. A progressive time-dependent increase in Ers was observed independent on ventilatory mode or PEEP level. Despite of that, the rate of increase of Ers and lung tissue IL-1 beta concentration were significantly lower in VV than in VCV at the level of the PEEP of minimum Ers. A significant increase in lung tissue cytokines (IL-6, IL-1 beta, CINC-1 and TNFalpha) as well as a ventral to dorsal and cranial to caudal reduction in aeration was observed in all ventilated rats with no significant differences among groups. Conclusions: VV combined with PEEP adjusted at the level of the PEEP of minimal Ers seemed to better prevent anesthesia-induced atelectasis and might improve lung protection throughout general anesthesia.	[Camilo, Luciana M.; Avila, Mariana B.; Cruz, Luis Felipe S.; Zin, Walter A.; Carvalho, Alysson R.] Univ Fed Rio de Janeiro, Carlos Chagas Filho Inst Biophys, Lab Resp Physiol, BR-21941901 Rio De Janeiro, Brazil; [Ribeiro, Gabriel C. M.; Carvalho, Alysson R.] Univ Fed Rio de Janeiro, Alberto Luis Coimbra Inst Postgrad & Res Engn, Biomed Engn Program, Lab Pulm Engn, Rio De Janeiro, Brazil; [Spieth, Peter M.] Tech Univ Dresden, Dept Anesthesiol & Intens Care Med, Pulm Engn Grp, Dresden, Germany; [Reske, Andreas A.] Univ Leipzig, Dept Anesthesiol & Intens Care Med, D-04109 Leipzig, Germany; [Amato, Marcelo] Univ Sao Paulo, Hosp Clin, Div Pulm, Cardio Pulm Dept, Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Technische Universitat Dresden; Leipzig University; Universidade de Sao Paulo	Carvalho, AR (corresponding author), Univ Fed Rio de Janeiro, Carlos Chagas Filho Inst Biophys, Lab Resp Physiol, BR-21941901 Rio De Janeiro, Brazil.	acarvalho@biof.ufrj.br	Carvalho, Alysson/AAF-1022-2019; Spieth, Peter/C-2928-2011; Avila, Mariana/ABH-1358-2021; CAMILO, LUCIANA MOISES/W-7144-2019; Ribeiro, Gabriel Motta/AAG-7479-2020; Reske, Andreas W/E-8141-2010; Zin, Walter A/H-8220-2013	Ribeiro, Gabriel Motta/0000-0001-5982-8863; Reske, Andreas W/0000-0002-2759-0245; Zin, Walter A/0000-0001-8226-9123; Spieth, Peter/0000-0003-3953-3253; Carvalho, Alysson/0000-0003-2708-7735	Brazilian Council for Scientific and Technological Development (CNPq); Carlos Chagas Filho Rio de Janeiro State Research Supporting Foundation (FAPERJ)	Brazilian Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlos Chagas Filho Rio de Janeiro State Research Supporting Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	The work was supported by grants from the Brazilian Council for Scientific and Technological Development (CNPq) and Carlos Chagas Filho Rio de Janeiro State Research Supporting Foundation (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellardine CL, 2006, CRIT CARE MED, V34, P439, DOI 10.1097/01.CCM.0000196208.01682.87; Bilek AM, 2003, J APPL PHYSIOL, V94, P770, DOI 10.1152/japplphysiol.00764.2002; Boker A, 2004, ANESTHESIOLOGY, V100, P608, DOI 10.1097/00000542-200403000-00022; Boker A, 2002, AM J RESP CRIT CARE, V165, P456, DOI 10.1164/ajrccm.165.4.2108006; Carvalho AR, 2013, ANESTH ANALG, V116, P677, DOI 10.1213/ANE.0b013e318254230b; Carvalho ARS, 2006, CRIT CARE, V10, DOI 10.1186/cc5030; Do Anesthesia H, 2013, ANESTHESIOLOGY; Duggan M, 2005, ANESTHESIOLOGY, V102, P838, DOI 10.1097/00000542-200504000-00021; Duggan M, 2007, CURR OPIN ANESTHESIO, V20, P37, DOI 10.1097/ACO.0b013e328011d7e5; Frank JA, 2008, THORAX, V63, P147, DOI 10.1136/thx.2007.079608; Futier E, 2013, NEW ENGL J MED, V369, P428, DOI 10.1056/NEJMoa1301082; Hedenstierna G, 2000, J CLIN MONITOR COMP, V16, P329, DOI 10.1023/A:1011491231934; Hedenstierna G, 2000, Minerva Anestesiol, V66, P293; Hedenstierna G, 2012, COMPR PHYSIOL, V2, P69, DOI 10.1002/cphy.c080111; HUEMER G, 1994, CHEST, V106, P67, DOI 10.1378/chest.106.1.67; Huh D, 2007, P NATL ACAD SCI USA, V104, P18886, DOI 10.1073/pnas.0610868104; Imberger G, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007922.pub2; Jaber S, 2012, ANAESTHESIA, V67, P999, DOI 10.1111/j.1365-2044.2012.07218.x; JARDIN F, 1981, NEW ENGL J MED, V304, P387, DOI 10.1056/NEJM198102123040703; Kowalski S, 2013, CAN J ANESTH, V60, P502, DOI 10.1007/s12630-013-9899-5; Krebs J, 2011, RESP PHYSIOL NEUROBI, V178, P323, DOI 10.1016/j.resp.2011.07.006; Kumar A, 1973, Crit Care Med, V1, P181, DOI 10.1097/00003246-197307000-00001; LUTCH JS, 1972, ANN INTERN MED, V76, P193, DOI 10.7326/0003-4819-76-2-193; Ma BS, 2011, J APPL PHYSIOL, V110, P1319, DOI 10.1152/japplphysiol.01364.2010; MEAD J, 1970, J APPL PHYSIOL, V28, P596, DOI 10.1152/jappl.1970.28.5.596; Mead J, 1959, J APPL PHYSL; Mutch WAC, 2000, BRIT J ANAESTH, V84, P197, DOI 10.1093/oxfordjournals.bja.a013403; Mutch WAC, 2000, CRIT CARE MED, V28, P2457, DOI 10.1097/00003246-200007000-00045; NEIDHART PP, 1988, INTENS CARE MED, V14, P471; Neumann P, 1998, J APPL PHYSIOL, V85, P1533, DOI 10.1152/jappl.1998.85.4.1533; Ng CSH, 2009, CRIT CARE, V13, DOI 10.1186/cc7719; Pecchiari M, 2013, ANESTHESIOLOGY; ROBOTHAM JL, 1980, AM REV RESPIR DIS, V121, P677; Rothen HU, 1999, BRIT J ANAESTH, V82, P551, DOI 10.1093/bja/82.4.551; Rothen HU, 1998, BRIT J ANAESTH, V81, P681, DOI 10.1093/bja/81.5.681; Rouby JJ, 2007, CRIT CARE, V11, DOI 10.1186/cc6183; Rusca M, 2003, ANESTH ANALG, V97, P1835, DOI 10.1213/01.ANE.0000087042.02266.F6; SANTOS RLB, 1992, J APPL PHYSIOL, V72, P1985, DOI 10.1152/jappl.1992.72.5.1985; SEEGER W, 1993, EUR RESPIR J, V6, P971; Severgnini P, 2013, ANESTHESIOLOGY, V118, P1307, DOI 10.1097/ALN.0b013e31829102de; Shimabukuro DW, 2009, ANESTHESIOLOGY, V110, P214, DOI 10.1097/ALN.0b013e3181945b63; Spieth PM, 2007, INTENS CARE MED, V33, P308, DOI 10.1007/s00134-006-0428-7; Spieth PM, 2009, AM J RESP CRIT CARE, V179, P684, DOI 10.1164/rccm.200806-975OC; Suki B, 1998, NATURE, V393, P127, DOI 10.1038/30130; SUTER PM, 1975, NEW ENGL J MED, V292, P284, DOI 10.1056/NEJM197502062920604; Thammanomai A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053934; TOBIN MJ, 1983, CHEST, V84, P286, DOI 10.1378/chest.84.3.286; Vassilakopoulos T, 2008, CRIT CARE MED, V36, P1009, DOI 10.1097/CCM.0B013E3181650592; Vlahakis NE, 2000, J APPL PHYSIOL, V89, P2490, DOI 10.1152/jappl.2000.89.6.2490; WALLIS TW, 1983, J APPL PHYSIOL, V54, P1039, DOI 10.1152/jappl.1983.54.4.1039; Wolff G, 1992, POLYMORPHOUS VENTILA, P235; Wolthuis EK, 2009, CRIT CARE, V13, DOI 10.1186/cc7688; Wu JB, 2013, J IMMUNOL, V190, P3590, DOI 10.4049/jimmunol.1200860	53	12	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e110817	10.1371/journal.pone.0110817	http://dx.doi.org/10.1371/journal.pone.0110817			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383882	Green Published, Green Submitted, gold			2022-12-27	WOS:000344816700011
J	Selvik, LKM; Rao, S; Steigedal, TS; Haltbakk, I; Misund, K; Bruland, T; Prestvik, WS; Laegreid, A; Thommesen, L				Selvik, Linn-Karina M.; Rao, Shalini; Steigedal, Tonje S.; Haltbakk, Ildri; Misund, Kristine; Bruland, Torunn; Prestvik, Wenche S.; Laegreid, Astrid; Thommesen, Liv			Salt-Inducible Kinase 1 (SIK1) Is Induced by Gastrin and Inhibits Migration of Gastric Adenocarcinoma Cells	PLOS ONE			English	Article							C-FOS GENE; ADRENOCORTICAL TUMOR-CELLS; BREAST-CANCER; MOLECULAR MECHANISMS; SIGNALING PATHWAYS; EPITHELIAL-CELLS; CLASS IIHDAC; AGS CELLS; EXPRESSION; TRANSCRIPTION	Salt-inducible kinase 1 (SIK1/Snf1lk) belongs to the AMP-activated protein kinase (AMPK) family of kinases, all of which play major roles in regulating metabolism and cell growth. Recent studies have shown that reduced levels of SIK1 are associated with poor outcome in cancers, and that this involves an invasive cellular phenotype with increased metastatic potential. However, the molecular mechanism(s) regulated by SIK1 in cancer cells is not well explored. The peptide hormone gastrin regulates cellular processes involved in oncogenesis, including proliferation, apoptosis, migration and invasion. The aim of this study was to examine the role of SIK1 in gastrin responsive adenocarcinoma cell lines AR42J, AGS-G(R) and MKN45. We show that gastrin, known to signal through the Gq/G(11)-coupled CCK2 receptor, induces SIK1 expression in adenocarcinoma cells, and that transcriptional activation of SIK1 is negatively regulated by the Inducible cAMP early repressor (ICER). We demonstrate that gastrin-mediated signalling induces phosphorylation of Liver Kinase 1B (LKB1) Ser-428 and SIK1 Thr-182. Ectopic expression of SIK1 increases gastrin-induced phosphorylation of histone deacetylase 4 (HDAC4) and enhances gastrin-induced transcription of c-fos and CRE-, SRE-, AP1-and NF-kappa B-driven luciferase reporter plasmids. We also show that gastrin induces phosphorylation and nuclear export of HDACs. Next we find that siRNA mediated knockdown of SIK1 increases migration of the gastric adenocarcinoma cell line AGS-G(R). Evidence provided here demonstrates that SIK1 is regulated by gastrin and influences gastrin elicited signalling in gastric adenocarcinoma cells. The results from the present study are relevant for the understanding of molecular mechanisms involved in gastric adenocarcinomas.	[Selvik, Linn-Karina M.; Rao, Shalini; Steigedal, Tonje S.; Haltbakk, Ildri; Misund, Kristine; Bruland, Torunn; Laegreid, Astrid] Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Trondheim, Norway; [Selvik, Linn-Karina M.; Rao, Shalini; Prestvik, Wenche S.; Thommesen, Liv] Sor Trondelag Univ Coll, Dept Technol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Thommesen, L (corresponding author), Sor Trondelag Univ Coll, Dept Technol, Trondheim, Norway.	Liv.Thommesen@ntnu.no	Bluland, Torunn/AAT-5730-2021	Steigedal, Tonje S./0000-0002-8427-0117; Bruland, Torunn/0000-0002-1568-2476	Norwegian Cancer Association; Cancer Fund at St. Olavs Hospital, Trondheim, Norway	Norwegian Cancer Association; Cancer Fund at St. Olavs Hospital, Trondheim, Norway	This work was supported by the Norwegian Cancer Association and the Cancer Fund at St. Olavs Hospital, Trondheim, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Cheng HL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000369; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Finsterwald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054545; Fjeldbo CS, 2012, AM J PHYSIOL-GASTR L, V302, pG21, DOI 10.1152/ajpgi.00197.2011; Fu A, 2008, CELL CYCLE, V7, P3823, DOI 10.4161/cc.7.24.7241; Kanyo R, 2009, ENDOCRINOLOGY; Kato H, 2004, J BIOL CHEM, V279, P41966, DOI 10.1074/jbc.M406320200; Katoh Y, 2004, EUR J BIOCHEM, V271, P4307, DOI 10.1111/j.1432-1033.2004.04372.x; Khan ZE, 2003, GASTROENTEROLOGY, V125, P510, DOI 10.1016/S0016-5085(03)00908-9; Kinoshita Y, 1998, GASTROENTEROLOGY, V115, P93, DOI 10.1016/S0016-5085(98)70369-5; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kowanetz M, 2008, J CELL BIOL, V182, P655, DOI 10.1083/jcb.200804107; Li SA, 2009, J NEUROSCI, V29, P2334, DOI 10.1523/JNEUROSCI.2296-08.2009; Lin XZ, 2001, MOL ENDOCRINOL, V15, P1264, DOI 10.1210/me.15.8.1264; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Martin M, 2007, ONCOGENE, V26, P5450, DOI 10.1038/sj.onc.1210613; Mirouse V, 2007, J CELL BIOL, V177, P387, DOI 10.1083/jcb.200702053; Misund K, 2007, J CELL BIOCHEM, V101, P1532, DOI 10.1002/jcb.21267; Misund K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076234; Mousses S, 2003, GENOME RES, V13, P2341, DOI 10.1101/gr.1478703; Murphy DJ, 1999, MOL CELL BIOL, V19, P2724; Noble PJM, 2003, AM J PHYSIOL-GASTR L, V284, pG75, DOI 10.1152/ajpgi.00300.2002; Norsett KG, 2011, AM J PHYSIOL-GASTR L, V301, pG446, DOI 10.1152/ajpgi.00527.2010; Pan XF, 2005, BIOCHEM BIOPH RES CO, V337, P1052, DOI 10.1016/j.bbrc.2005.09.155; Selvik LKM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-429; Seternes OM, 1998, BBA-GENE STRUCT EXPR, V1395, P345, DOI 10.1016/S0167-4781(97)00189-9; SEVA C, 1994, REGUL PEPTIDES, V52, P31, DOI 10.1016/0167-0115(94)90018-3; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Song P, 2008, J BIOL CHEM, V283, P12446, DOI 10.1074/jbc.M708208200; Steigedal TS, 2007, AM J PHYSIOL-GASTR L, V292, pG1062, DOI 10.1152/ajpgi.00287.2006; Steigedal TS, 2013, IN VITRO CELL DEV-AN, V49, P162, DOI 10.1007/s11626-013-9588-2; Takemori H, 2002, J BIOL CHEM, V277, P42334, DOI 10.1074/jbc.M204602200; Takemori H, 2009, ENDOCR J, V56, P121, DOI 10.1507/endocrj.K08E-173; Thommesen L, 2000, J BIOL CHEM, V275, P4244, DOI 10.1074/jbc.275.6.4244; Thommesen L, 2001, AM J PHYSIOL-ENDOC M, V281, pE1316, DOI 10.1152/ajpendo.2001.281.6.E1316; Todisco A, 2001, AM J PHYSIOL-GASTR L, V280, pG298, DOI 10.1152/ajpgi.2001.280.2.G298; Todisco A, 1997, AM J PHYSIOL-GASTR L, V273, pG891, DOI 10.1152/ajpgi.1997.273.4.G891; Tomita H, 2011, GASTROENTEROLOGY, V140, P879, DOI 10.1053/j.gastro.2010.11.037; van der Linden AM, 2007, EMBO J, V26, P358, DOI 10.1038/sj.emboj.7601479; Varro A, 2002, GASTROENTEROLOGY, V123, P271, DOI 10.1053/gast.2002.34162; Varro A, 2002, GUT, V50, P827, DOI 10.1136/gut.50.6.827; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Watson F, 2001, J BIOL CHEM, V276, P7661, DOI 10.1074/jbc.M006697200; WHALEY PD, 1995, ENDOCRINOLOGY, V136, P3046, DOI 10.1210/en.136.7.3046; Wroblewski LE, 2002, BIOCHEM J, V365, P873, DOI 10.1042/BJ20020068; ZHOU QJ, 1995, J VIROL, V69, P4323, DOI 10.1128/JVI.69.7.4323-4330.1995; Zhuang ZG, 2006, MOL CANCER RES, V4, P843, DOI 10.1158/1541-7786.MCR-06-0118; Zhuang Zhi-Gang, 2007, Zhonghua Yi Xue Za Zhi, V87, P81	51	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112485	10.1371/journal.pone.0112485	http://dx.doi.org/10.1371/journal.pone.0112485			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384047	Green Published, gold, Green Submitted			2022-12-27	WOS:000344816700068
J	Faria, D; Pesquita, C; Santos, E; Cruz, IF; Couto, FM				Faria, Daniel; Pesquita, Catia; Santos, Emanuel; Cruz, Isabel F.; Couto, Francisco M.			Automatic Background Knowledge Selection for Matching Biomedical Ontologies	PLOS ONE			English	Article							SYSTEM	Ontology matching is a growing field of research that is of critical importance for the semantic web initiative. The use of background knowledge for ontology matching is often a key factor for success, particularly in complex and lexically rich domains such as the life sciences. However, in most ontology matching systems, the background knowledge sources are either predefined by the system or have to be provided by the user. In this paper, we present a novel methodology for automatically selecting background knowledge sources for any given ontologies to match. This methodology measures the usefulness of each background knowledge source by assessing the fraction of classes mapped through it over those mapped directly, which we call the mapping gain. We implemented this methodology in the AgreementMakerLight ontology matching framework, and evaluate it using the benchmark biomedical ontology matching tasks from the Ontology Alignment Evaluation Initiative (OAEI) 2013. In each matching problem, our methodology consistently identified the sources of background knowledge that led to the highest improvements over the baseline alignment (i.e., without background knowledge). Furthermore, our proposed mapping gain parameter is strongly correlated with the F-measure of the produced alignments, thus making it a good estimator for ontology matching techniques based on background knowledge.	[Faria, Daniel; Pesquita, Catia; Couto, Francisco M.] Univ Lisbon, LASIGE, Fac Ciencias, P-1699 Lisbon, Portugal; [Pesquita, Catia; Santos, Emanuel; Couto, Francisco M.] Univ Lisbon, Fac Ciencias, Dept Informat, P-1699 Lisbon, Portugal; [Cruz, Isabel F.] Univ Illinois, Dept Comp Sci, ADVIS Lab, Chicago, IL USA	Universidade de Lisboa; Universidade de Lisboa; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Faria, D (corresponding author), Univ Lisbon, LASIGE, Fac Ciencias, P-1699 Lisbon, Portugal.	dfaria@lasige.di.fc.ul.pt	Couto, Francisco M/A-4066-2010; Pesquita, Catia/O-8883-2015	Couto, Francisco M/0000-0003-0627-1496; Pesquita, Catia/0000-0002-1847-9393; Faria, Daniel/0000-0003-1511-277X	Fundacao para a Ciencia e Tecnologia through the SOMER project [PTDC/EIA-EIA/119119/2010]; European Commission through the BiobankCloud project under the Seventh Framework Programme [317871]; National Science Foundation [CCF-1331800, IIS-1213013, IIS-1143926, IIS-0812258]; Institute for Policy and Civic Engagement of the University of Illinois at Chicago; Civic Engagement of the University of Illinois at Chicago; Direct For Computer & Info Scie & Enginr [0812258, 1213013] Funding Source: National Science Foundation; Division of Computing and Communication Foundations [1331800] Funding Source: National Science Foundation; Div Of Information & Intelligent Systems [1143926] Funding Source: National Science Foundation	Fundacao para a Ciencia e Tecnologia through the SOMER project; European Commission through the BiobankCloud project under the Seventh Framework Programme; National Science Foundation(National Science Foundation (NSF)); Institute for Policy and Civic Engagement of the University of Illinois at Chicago; Civic Engagement of the University of Illinois at Chicago; Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	DF, CP, ES and FMC were supported by the 'Fundacao para a Ciencia e Tecnologia' (http://www.fct.pt/) through the SOMER project (PTDC/EIA-EIA/119119/2010) and the multi-annual funding program to LASIGE, and by the European Commission (http://ec.europa.eu) through the BiobankCloud project under the Seventh Framework Programme (grant #317871). IFC was supported by the National Science Foundation (http://www.nsf.gov/) through awards CCF-1331800, IIS-1213013, IIS-1143926 and IIS-0812258, and by a Civic Engagement Research Fund Award from the Institute for Policy and Civic Engagement of the University of Illinois at Chicago (http://www.uic.edu/cuppa/ipce/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksovski Z, 2006, ISWC INT WORKSH ONT; Bernstein P, 2007, MODEL MANAGEMENT 2 0; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Bodenreider O, 2006, BRIEF BIOINFORM, V7, P256, DOI 10.1093/bib/bbl027; Cruz IF, 2003, IEEE INTELL SYST, V18, P66, DOI 10.1109/MIS.2003.1193659; Cruz IF, 2011, ISWC INT WORKSH ONT; Cruz IF, 2009, PROC VLDB ENDOW, V2, P1586, DOI 10.14778/1687553.1687598; David J, 2006, CIKM, V2006, P830, DOI DOI 10.1145/1183614.1183752; DuyHoa Ngo, 2012, Knowledge Engineering and Knowledge Management. 18th International Conference, EKAW 2012. Proceedings, P421, DOI 10.1007/978-3-642-33876-2_38; Euzenat J., 2007, ONTOLOGY MATCHING; Faria D, 2013, ISWC INT WORKSH ONT; Faria D, 2013, LECT NOTES COMPUT SC, V8185, P527, DOI 10.1007/978-3-642-41030-7_38; Gracia J, 2007, ISWC INT WORKSH ONT; Grau BC, 2013, ISEC INT WORKSH ONT; Gross A, 2012, ISWC INT WORKSH ONT; Gross Anika, 2011, P INT C BIOM ONT, P109; Hartung M, 2012, WORKSH SEM INT MED I; Jain P, 2010, LECT NOTES COMPUT SC, V6496, P402, DOI 10.1007/978-3-642-17746-0_26; Jean-Mary YR, 2009, ISWC INT WORKSH ONT; Jimenez-Ruiz E, 2011, P 4 INT WORKSH SEM W, P45, DOI DOI 10.1145/2166896.2166911; Jimenez-Ruiz E, 2012, ISWC INT WORKSH ONT; Kirsten T, 2011, J BIOMED SEMANT, V2, DOI 10.1186/2041-1480-2-6; Kocbek S, 2012, SWAT4LS 2012; Lambrix P, 2006, J WEB SEMANT, V4, P196, DOI 10.1016/j.websem.2006.05.003; Mascardi V, 2010, IEEE T KNOWL DATA EN, V22, P609, DOI 10.1109/TKDE.2009.154; Ngo D, 2013, ISWC INT WORKSH ONT; Noy NF, 2009, NUCLEIC ACIDS RES, V37, pW170, DOI 10.1093/nar/gkp440; Pesquita C, 2013, LECT NOTES COMPUT SC, V8218, P526, DOI 10.1007/978-3-642-41335-3_33; Quix C, 2011, SWIM 2011; Rubin DL, 2008, BRIEF BIOINFORM, V9, P75, DOI 10.1093/bib/bbm059; Shvaiko P, 2001, IEEE T KNOWLEDGE DAT, V25; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Vazirani V., 2001, APPROXIMATION ALGORI; Wijaya D, 2013, PROCEEDINGS OF THE 22ND ACM INTERNATIONAL CONFERENCE ON INFORMATION & KNOWLEDGE MANAGEMENT (CIKM'13), P589, DOI 10.1145/2505515.2505559; Zhang Songmao, 2005, AMIA Annu Symp Proc, P864	35	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111226	10.1371/journal.pone.0111226	http://dx.doi.org/10.1371/journal.pone.0111226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379899	Green Published, gold, Green Submitted			2022-12-27	WOS:000344863100023
J	Hermont, AP; Oliveira, PAD; Martins, CC; Paiva, SM; Pordeus, IA; Auad, SM				Hermont, Ana Paula; Oliveira, Patricia A. D.; Martins, Carolina C.; Paiva, Saul M.; Pordeus, Isabela A.; Auad, Sheyla M.			Tooth Erosion and Eating Disorders: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							ANOREXIA-NERVOSA; DENTAL EROSION; ORAL-HEALTH; BULIMIA; COMPLICATIONS; PREVENTION; MANAGEMENT; BIAS	Background: Eating disorders are associated with the highest rates of morbidity and mortality of any mental disorders among adolescents. The failure to recognize their early signs can compromise a patient's recovery and long-term prognosis. Tooth erosion has been reported as an oral manifestation that might help in the early detection of eating disorders. Objectives: The aim of this systematic review and meta-analysis was to search for scientific evidence regarding the following clinical question: Do eating disorders increase the risk of tooth erosion? Methods: An electronic search addressing eating disorders and tooth erosion was conducted in eight databases. Two independent reviewers selected studies, abstracted information and assessed its quality. Data were abstracted for meta-analysis comparing tooth erosion in control patients (without eating disorders) vs. patients with eating disorders; and patients with eating disorder risk behavior vs. patients without such risk behavior. Combined odds ratios (ORs) and a 95% confidence interval (CI) were obtained. Results: Twenty-three papers were included in the qualitative synthesis and assessed by a modified version of the Newcastle-Ottawa Scale. Fourteen papers were included in the meta-analysis. Patients with eating disorders had more risk of tooth erosion (OR = 12.4, 95% CI = 4.1-37.5). Patients with eating disorders who self-induced vomiting had more risk of tooth erosion than those patients who did not self-induce vomiting (OR = 19.6, 95% CI = 5.6-68.8). Patients with risk behavior of eating disorder had more risk of tooth erosion than patients without such risk behavior (Summary OR = 11.6, 95% CI = 3.241.7). Conclusion: The scientific evidence suggests a causal relationship between tooth erosion and eating disorders and purging practices. Nevertheless, there is a lack of scientific evidence to fulfill the basic criteria of causation between the risk behavior for eating disorders and tooth erosion.	[Hermont, Ana Paula; Oliveira, Patricia A. D.; Martins, Carolina C.; Paiva, Saul M.; Pordeus, Isabela A.; Auad, Sheyla M.] Univ Fed Minas Gerais, Fac Dent, Dept Pediat Dent & Orthodont, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais	Martins, CC (corresponding author), Univ Fed Minas Gerais, Fac Dent, Dept Pediat Dent & Orthodont, Belo Horizonte, MG, Brazil.	carolcm10@hotmail.com	Martins, Carolina/AFD-8433-2022; Martins, Carolina Castro/O-2514-2014; Auad, Sheyla/T-7290-2019; Paiva, Saul Martins/H-5757-2012; PORDEUS, ISABELA A/B-1570-2013	Martins, Carolina/0000-0001-9072-3226; Martins, Carolina Castro/0000-0001-9072-3226; Paiva, Saul Martins/0000-0002-3968-1638; PORDEUS, ISABELA A/0000-0002-5902-7481; Auad, Sheyla/0000-0002-4572-6425	Brazilian Coordination of Higher Education (CAPES); State of Minas Gerais Research Foundation (FAPEMIG); National Council for Scientific and Technological Development (CNPq); Pro-Reitoria de Pesquisa da UFMG (PRPq/ UFMG)	Brazilian Coordination of Higher Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); State of Minas Gerais Research Foundation (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Pro-Reitoria de Pesquisa da UFMG (PRPq/ UFMG)	This study was supported by the Brazilian Coordination of Higher Education (CAPES), State of Minas Gerais Research Foundation (FAPEMIG), the National Council for Scientific and Technological Development (CNPq) and Pro-Reitoria de Pesquisa da UFMG (PRPq/ UFMG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso C, 2001, REV ASS ODONTOL ARGE, V89, P390; Biljana M, 1999, STUD HEALTH TECHNOL, V68, P323; Borenstein M., 2009, INTRO METAANALYSIS; Cohn LD, 2003, PSYCHOL METHODS, V8, P243, DOI 10.1037/1082-989X.8.3.243; Dynesen AW, 2008, ORAL SURG ORAL MED O, V106, P696, DOI 10.1016/j.tripleo.2008.07.003; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Emodi-Perlman A, 2008, J OROFAC PAIN, V22, P201; Ganss C, 2012, AM J DENT, V25, P351; Greenwood A M, 1988, J Ir Dent Assoc, V34, P26; HELLSTROM I, 1977, SCAND J DENT RES, V85, P71; Hermont AP, 2013, INT J EAT DISORDER, V46, P677, DOI 10.1002/eat.22132; Herpertz-Dahlmann B, 2009, CHILD ADOL PSYCH CL, V18, P31, DOI 10.1016/j.chc.2008.07.005; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; HOWAT PM, 1990, J AM DIET ASSOC, V90, P1099; HURST PS, 1977, POSTGRAD MED J, V53, P298, DOI 10.1136/pgmj.53.620.298; JARVINEN VK, 1991, J DENT RES, V70, P942, DOI 10.1177/00220345910700060601; Johansson AK, 2012, EUR J ORAL SCI, V120, P61, DOI 10.1111/j.1600-0722.2011.00922.x; JONES RRH, 1989, J DENT RES, V68, P1275, DOI 10.1177/00220345890680081201; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Lifante-Oliva C, 2008, Int J Dent Hyg, V6, P119, DOI 10.1111/j.1601-5037.2008.00296.x; Micali N, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002646; MILOSEVIC A, 1989, BRIT DENT J, V167, P66, DOI 10.1038/sj.bdj.4806915; Mirtz Timothy A, 2009, Chiropr Osteopat, V17, P13, DOI 10.1186/1746-1340-17-13; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; O'Sullivan E, 2008, INT J PAEDIATR DENT, V18, P29, DOI 10.1111/j.1365-263X.2008.00936.x; Ohm R, 1999, EUR J ORAL SCI, V107, P157, DOI 10.1046/j.0909-8836.1999.eos1070301.x; Pierce CA, 2008, ORGAN RES METHODS, V11, P188, DOI 10.1177/1094428106296641; ROBB ND, 1995, BRIT DENT J, V178, P171, DOI 10.1038/sj.bdj.4808695; ROBERTS MW, 1987, J AM DENT ASSOC, V115, P407, DOI 10.14219/jada.archive.1987.0262; Rosen DS, 2010, PEDIATRICS, V126, P1240, DOI 10.1542/peds.2010-2821; Rytomaa I, 1998, ACTA ODONTOL SCAND, V56, P36, DOI 10.1080/000163598423045; Shaughnessy BE, 2008, J CLIN PEDIATR DENT, V33, P87, DOI 10.17796/jcpd.33.2.d0kwj02t525t8177; SIMMONS MS, 1986, AM J PSYCHIAT, V143, P783; Sivolella S, 2000, Minerva Stomatol, V49, P119; TOUYZ SW, 1993, INT J EAT DISORDER, V14, P341, DOI 10.1002/1098-108X(199311)14:3&lt;341::AID-EAT2260140312&gt;3.0.CO;2-X; Ximenes R, 2010, INT J EAT DISORDER, V43, P59, DOI 10.1002/eat.20660	37	58	58	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111123	10.1371/journal.pone.0111123	http://dx.doi.org/10.1371/journal.pone.0111123			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379668	Green Published, Green Submitted, gold			2022-12-27	WOS:000344863100019
J	Mano, T; Suzuki, T; Tsuji, S; Iwata, A				Mano, Tatsuo; Suzuki, Takayoshi; Tsuji, Shoji; Iwata, Atsushi			Differential Effect of HDAC3 on Cytoplasmic and Nuclear Huntingtin Aggregates	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; HISTONE DEACETYLASE INHIBITORS; TRANSGENIC MOUSE MODEL; AUTOPHAGIC DEGRADATION; MUTANT HUNTINGTIN; MOTOR DEFICITS; DISEASE MICE; TRANSCRIPTION; PROTEIN; IMPAIRMENT	Histone deacetylases (HDACs) are potential therapeutic targets of polyglutamine (pQ) diseases including Huntington's disease (HD) that may function to correct aberrant transcriptional deactivation caused by mutant pQ proteins. HDAC3 is a unique class 1 HDAC found in both the cytoplasm and in the nucleus. However, the precise functions of HDAC3 in the two cellular compartments are only vaguely known. HDAC3 directly binds to huntingtin (Htt) with short pQ and this interaction is important for suppressing neurotoxicity induced by HDAC3. With long pQ Htt, the interaction with HDAC3 is inhibited, and this supposedly promotes neuronal death, indicating that HDAC3 would be a good therapeutic target for HD. However, the knockout of one HDAC3 allele did not show any efficacy in reducing neurodegenerative symptoms in a mouse model of HD. Therefore, the role of HDAC3 in the pathogenesis of HD has yet to be fully elucidated. We attempted to resolve this issue by focusing on the different roles of HDAC3 on cytoplasmic and nuclear Htt aggregates. In addition to supporting the previous findings, we found that HDAC3 preferentially binds to nuclear Htt over cytoplasmic ones. Specific HDAC3 inhibitors increased the total amount of Htt aggregates by increasing the amount of nuclear aggregates. Both cytoplasmic and nuclear Htt aggregates were able to suppress endogenous HDAC3 activity, which led to decreased nuclear proteasome activity. Therefore, we concluded that Htt aggregates impair nuclear proteasome activity through the inhibition of HDAC3. Our findings provide new insights regarding cross-compartment proteasome regulation.	[Mano, Tatsuo; Tsuji, Shoji; Iwata, Atsushi] Univ Tokyo, Grad Sch Med, Dept Neurol, Tokyo, Japan; [Suzuki, Takayoshi] Kyoto Prefectural Univ Med, Dept Grad Sch Med Sci, Kyoto, Japan; [Suzuki, Takayoshi; Iwata, Atsushi] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Saitama, Japan	University of Tokyo; Kyoto Prefectural University of Medicine; Japan Science & Technology Agency (JST)	Iwata, A (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neurol, Tokyo, Japan.	Iwata-tky@umin.ac.jp	Iwata, Atsushi/AAH-8924-2019; Iwata, Atsushi/A-9598-2013	Iwata, Atsushi/0000-0001-7308-5314; Iwata, Atsushi/0000-0001-7308-5314	Kakenhi (JSPS, Tokyo, Japan) [KB: 24390220]; JST PRESTO (Kawaguchi, Saitama); Cell Science Research Foundation (Osaka, Japan); Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care (Tokyo, Japan); Takeda Science Foundation (Osaka, Japan); Janssen Pharmaceutical K.K. (Tokyo, Japan); Eisai Co. (Tokyo, Japan)	Kakenhi (JSPS, Tokyo, Japan); JST PRESTO (Kawaguchi, Saitama); Cell Science Research Foundation (Osaka, Japan); Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care (Tokyo, Japan); Takeda Science Foundation (Osaka, Japan)(Takeda Science Foundation (TSF)); Janssen Pharmaceutical K.K. (Tokyo, Japan); Eisai Co. (Tokyo, Japan)	This study was supported by Kakenhi (KB: 24390220, JSPS, Tokyo, Japan), JST PRESTO (Kawaguchi, Saitama), the Cell Science Research Foundation (Osaka, Japan), the Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care (Tokyo, Japan), the Takeda Science Foundation (Osaka, Japan), Janssen Pharmaceutical K.K. (Tokyo, Japan), and Eisai Co. (Tokyo, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; Bardai FH, 2013, J NEUROSCI, V33, P11833, DOI 10.1523/JNEUROSCI.5831-12.2013; Bardai FH, 2011, J NEUROSCI, V31, P1746, DOI 10.1523/JNEUROSCI.5704-10.2011; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Benn CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005747; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bobrowska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020696; Boutell JM, 1999, HUM MOL GENET, V8, P1647, DOI 10.1093/hmg/8.9.1647; Broide RS, 2007, J MOL NEUROSCI, V31, P47, DOI 10.1007/BF02686117; Cho Y, 2013, CELL, V155, P894, DOI 10.1016/j.cell.2013.10.004; Duncan CE, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-42; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Gardian G, 2005, J BIOL CHEM, V280, P556, DOI 10.1074/jbc.M410210200; Hathorn T, 2011, NEUROBIOL DIS, V41, P43, DOI 10.1016/j.nbd.2010.08.017; Hipp MS, 2012, J CELL BIOL, V196, P573, DOI 10.1083/jcb.201110093; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Iwata A, 2009, J BIOL CHEM, V284, P9796, DOI 10.1074/jbc.M809739200; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Jia HQ, 2012, HUM MOL GENET, V21, P5280, DOI 10.1093/hmg/dds379; Jia HQ, 2012, NEUROBIOL DIS, V46, P351, DOI 10.1016/j.nbd.2012.01.016; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Mielcarek M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001717; Moumne L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031080; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Pallos J, 2008, HUM MOL GENET, V17, P3767, DOI 10.1093/hmg/ddn273; Sadri-Vakili G, 2006, NAT CLIN PRACT NEURO, V2, P330, DOI 10.1038/ncpneuro0199; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Suzuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068669; Thomas EA, 2008, P NATL ACAD SCI USA, V105, P15564, DOI 10.1073/pnas.0804249105; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200	36	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111277	10.1371/journal.pone.0111277	http://dx.doi.org/10.1371/journal.pone.0111277			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380050	gold, Green Published, Green Submitted			2022-12-27	WOS:000344863100024
J	Morisaki, T; Yashiro, M; Kakehashi, A; Inagaki, A; Kinoshita, H; Fukuoka, T; Kasashima, H; Masuda, G; Sakurai, K; Kubo, N; Muguruma, K; Ohira, M; Wanibuchi, H; Hirakawa, K				Morisaki, Tamami; Yashiro, Masakazu; Kakehashi, Anna; Inagaki, Azusa; Kinoshita, Haruhito; Fukuoka, Tatsunari; Kasashima, Hiroaki; Masuda, Go; Sakurai, Katsunobu; Kubo, Naoshi; Muguruma, Kazuya; Ohira, Masaichi; Wanibuchi, Hideki; Hirakawa, Kosei			Comparative Proteomics Analysis of Gastric Cancer Stem Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GENE-EXPRESSION PROFILES; PANCREATIC-CANCER; TUMOR-CELLS; PROTEIN; IDENTIFICATION; P53; PERITONEUM; CARCINOMA; INTERACTS	Cancer stem cells (CSCs) are responsible for cancer progression, metastasis, and recurrence. To date, the specific markers of CSCs remain undiscovered. The aim of this study was to identify novel biomarkers of gastric CSCs for clinical diagnosis using proteomics technology. CSC-like SP cells, OCUM-12/SP cells, OCUM-2MD3/SP cells, and their parent OCUM-12 cells and OCUM-2MD3 cells were used in this study. Protein lysates from each cell line were analyzed using QSTAR Elite Liquid Chromatography with Tandem Mass Spectrometry, coupled with isobaric tags for relative and absolute quantitation technology. Candidate proteins detected by proteomics technology were validated by immunohistochemical analysis of 300 gastric cancers. Based on the results of LC-MS/MS, eight proteins, including RBBP6, GLG1, VPS13A, DCTPP1, HSPA9, HSPA4, ALDOA, and KRT18, were up-regulated in both OCUM-12/SP cells and OCUM-2MD3/SP cells when compared to their corresponding parent cells. RT-PCR analysis indicated that the expression level of RBBP6, HSPA4, DCTPP1, HSPA9, VPS13A, ALDOA, GLG1, and CK18 was high in OCUM-12/SP and OCUM-2MD3/SP, in compared with the control of parent OCUM-12 and OCUM-2MD3. These proteins were significantly associated with advanced invasion depth, lymph node metastasis, distant metastasis, or advanced clinical stage. RBBP6, DCTPP1, HSPA4, and ALDOA expression in particular were significantly associated with a poor prognosis in the 300 gastric cancer patients. RBBP6 was determined to be an independent prognostic factor. The motility-stimulating ability of OCUM-12/SP cells and OCUM-2MD3/SP cells was inhibited by RBBP6 siRNA. These findings might suggest that the eight proteins, RBBP6, GLG1, VPS13A, DCTPP1, HSPA9, HSPA4, ALDOA, and KRT18, utilizing comparative proteomics analysis, were perceived to be potential CSC markers of gastric cancer. Of the eight candidate proteins, RBBP6 was suggested to be a promising prognostic biomarker and a therapeutic target for gastric cancer.	[Morisaki, Tamami; Yashiro, Masakazu; Kinoshita, Haruhito; Fukuoka, Tatsunari; Kasashima, Hiroaki; Masuda, Go; Sakurai, Katsunobu; Kubo, Naoshi; Muguruma, Kazuya; Ohira, Masaichi; Hirakawa, Kosei] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 558, Japan; [Yashiro, Masakazu] Osaka City Univ, Grad Sch Med, Oncol Inst Geriatr & Med Sci, Osaka 558, Japan; [Kakehashi, Anna; Inagaki, Azusa; Wanibuchi, Hideki] Osaka City Univ, Grad Sch Med, Dept Pathol, Osaka 558, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University	Yashiro, M (corresponding author), Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 558, Japan.	m9312510@med.osaka-cu.ac.jp	Kakehashi, Anna/ABF-2986-2020	Kakehashi, Anna/0000-0003-1149-1450	KAKENHI [22390262, 23390329, 26293307]; National Cancer Center Research and Development Fund [23-A-9]; Priority Research Fund of Osaka City University; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Priority Research Fund of Osaka City University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study is partially funded by KAKENHI (Grant-in-Aid for Scientific Research, Nos. 22390262, 23390329, and 26293307), by the National Cancer Center Research and Development Fund (23-A-9), and by Priority Research Fund of Osaka City University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; An CH, 2012, HUM PATHOL, V43, P40, DOI 10.1016/j.humpath.2010.03.015; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Chen S, 2013, J CELL BIOCHEM, V114, P2795, DOI 10.1002/jcb.24626; Chibi M, 2008, J MOL BIOL, V384, P908, DOI 10.1016/j.jmb.2008.09.060; Chung Kyukwang, 2012, Osaka City Med J, V58, P13; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Crnogorac-Jurcevic T, 2001, ONCOGENE, V20, P7437, DOI 10.1038/sj.onc.1204935; Devarajan E, 2012, INT J CANCER, V131, P1023, DOI 10.1002/ijc.26493; Du S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085804; Fortier AM, 2013, J BIOL CHEM, V288, P11555, DOI 10.1074/jbc.M112.428920; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Gestl EE, 2012, BIOCHEM BIOPH RES CO, V423, P411, DOI 10.1016/j.bbrc.2012.05.139; Giampieri R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072843; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; Hasegawa T, 2013, INT J CANC; Hippo Y, 2001, CANCER RES, V61, P889; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kajita E, 2001, MECH DEVELOP, V102, P283, DOI 10.1016/S0925-4773(01)00324-0; Kakehashi A, 2013, TOXICOL APPL PHARM, V273, P390, DOI 10.1016/j.taap.2013.09.016; Kakehashi A, 2011, TOXICOL SCI, V119, P61, DOI 10.1093/toxsci/kfq307; Kato Y, 2010, BRIT J CANCER, V102, P898, DOI 10.1038/sj.bjc.6605543; Kibriya MG, 2009, BREAST CANCER RES TR, V114, P463, DOI 10.1007/s10549-008-0039-9; Kuramitsu Y, 2010, ANTICANCER RES, V30, P4459; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li L, 2007, P NATL ACAD SCI USA, V104, P7951, DOI 10.1073/pnas.0701916104; Liu JM, 2013, INT J ONCOL, V42, P453, DOI 10.3892/ijo.2012.1720; Midgley CA, 1997, ONCOGENE, V15, P1179, DOI 10.1038/sj.onc.1201459; Nimmanapalli R, 2008, BRIT J HAEMATOL, V142, P551, DOI 10.1111/j.1365-2141.2008.07217.x; Nishii T, 2009, CANCER SCI, V100, P1397, DOI 10.1111/j.1349-7006.2009.01211.x; Peng CM, 2013, ONCOL REP, V29, P2431, DOI 10.3892/or.2013.2399; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Pugh DJR, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-1; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Scott RE, 2005, J CELL PHYSIOL, V204, P99, DOI 10.1002/jcp.20263; Shimizu T, 2013, J GASTROENTEROL; Simons A, 1997, ONCOGENE, V14, P145, DOI 10.1038/sj.onc.1200825; Stojnev S, 2014, GASTRIC CANCER, V17, P13, DOI 10.1007/s10120-013-0254-x; Takaishi S, 2008, J CLIN ONCOL, V26, P2876, DOI 10.1200/JCO.2007.15.2603; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Wei L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3042; Wen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059154; Wu CY, 2010, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-1; Yamaguchi F, 2003, INT J ONCOL, V22, P1045; Yashiro M, 2013, BRIT J CANCER, V109, P2619, DOI 10.1038/bjc.2013.638; Yashiro M, 1996, CLIN EXP METASTAS, V14, P43, DOI 10.1007/BF00157685; Yenari MA, 2005, ANN NY ACAD SCI, V1053, P74, DOI 10.1196/annals.1344.007; Yoshitake Y, 2004, CLIN CANCER RES, V10, P6437, DOI 10.1158/1078-0432.CCR-04-0841; Zhang Y, 2013, Eur J Histochem, V57, pe29, DOI 10.4081/ejh.2013.e29; Zhong MA, 2011, MOL MED REP, V4, P805, DOI 10.3892/mmr.2011.528	56	34	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e110736	10.1371/journal.pone.0110736	http://dx.doi.org/10.1371/journal.pone.0110736			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379943	gold, Green Submitted, Green Published			2022-12-27	WOS:000344863100014
J	Pinol, RA; Jameson, H; Popratiloff, A; Lee, NH; Mendelowitz, D				Pinol, Ramon A.; Jameson, Heather; Popratiloff, Anastas; Lee, Norman H.; Mendelowitz, David			Visualization of Oxytocin Release that Mediates Paired Pulse Facilitation in Hypothalamic Pathways to Brainstem Autonomic Neurons	PLOS ONE			English	Article							PARASYMPATHETIC CARDIAC NEURONS; LONG-TERM POTENTIATION; DORSAL MOTOR NUCLEUS; PARAVENTRICULAR NUCLEUS; HEART-FAILURE; SPINAL-CORD; VASOPRESSIN; TRANSMISSION; INHIBITION; RATIONALE	Recent work has shown that oxytocin is involved in more than lactation and uterine contraction. The paraventricular nucleus of the hypothalamus (PVN) contains neuroendocrine neurons that control the release of hormones, including vasopressin and oxytocin. Other populations of PVN neurons do not release hormones, but rather project to and release neurotransmitters onto other neurons in the CNS involved in fluid retention, thermoregulation, sexual behavior and responses to stress. Activation of oxytocin receptors can be cardioprotective and reduces the adverse cardiovascular consequences of anxiety and stress, yet how oxytocin can affect heart rate and cardiac function is unknown. While anatomical work has shown the presence of peptides, including oxytocin, in the projections from the PVN to parasympathetic nuclei, electrophysiological studies to date have only demonstrated release of glutamate and activation of fast ligand gated receptors in these pathways. In this study, using rats, we directly show, using sniffer CHO cells that express oxytocin receptors and the Ca2+ indicator R-GECO, that optogenetic activation of channelrhodopsin-2 (ChR2) expressing PVN fibers in the brainstem activates oxytocin receptors in the dorsomotor nucleus of the vagus (DMNV). We also demonstrate that while a single photoactivation of PVN terminals only activates glutamatergic receptors in brainstem cardiac vagal neurons (CVNs), neurons that dominate the neural control of heart rate, both the paired pulse facilitation, and sustained enhancement of glutamate release in this pathway is mediated by activation of oxytocin receptors. Our results provide direct evidence that a pathway from the PVN likely releases oxytocin and enhances short-term plasticity of this critical autonomic connection.	[Pinol, Ramon A.; Jameson, Heather; Lee, Norman H.; Mendelowitz, David] George Washington Univ, Dept Physiol & Pharmacol, Washington, DC 20052 USA; [Pinol, Ramon A.; Jameson, Heather] George Washington Univ, Inst Biomed Sci, Washington, DC USA; [Popratiloff, Anastas] George Washington Univ, Ctr Microscopy & Image Anal, Washington, DC USA	George Washington University; George Washington University; George Washington University	Mendelowitz, D (corresponding author), George Washington Univ, Dept Physiol & Pharmacol, Washington, DC 20052 USA.	dmendel@gwu.edu		Pinol, Ramon/0000-0002-8877-8444	National Institutes of Health [HL49965, HL59895, HL72006]; National Institute of Child Health and Human Development [P30 HD040677]; Mental Retardation and Developmental Disabilities Research Center at Children's National Medical Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD040677] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072006, R01HL049965, R29HL049965, R01HL059895] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Mental Retardation and Developmental Disabilities Research Center at Children's National Medical Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by National Institutes of Health grants HL49965, HL59895 and HL72006 to D.M; National Institute of Child Health and Human Development, P30 HD040677, Mental Retardation and Developmental Disabilities Research Center at Children's National Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouairi E, 2006, J NEUROPHYSIOL, V96, P3266, DOI 10.1152/jn.00590.2006; Breton JD, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-19; Coleman CG, 2010, J NEUROSCI, V30, P12103, DOI 10.1523/JNEUROSCI.3367-10.2010; De Ferrari GM, 2014, EUR J HEART FAIL, V16, P692, DOI 10.1002/ejhf.80; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; ECKBERG DL, 1971, NEW ENGL J MED, V285, P877, DOI 10.1056/NEJM197110142851602; Fang LY, 2008, NEUROSCI LETT, V438, P133, DOI 10.1016/j.neulet.2007.12.070; Gamer M, 2012, PSYCHONEUROENDOCRINO, V37, P87, DOI 10.1016/j.psyneuen.2011.05.007; Geerling JC, 2010, J COMP NEUROL, V518, P1460, DOI 10.1002/cne.22283; da Silva AQG, 2011, BRAIN RES, V1368, P231, DOI 10.1016/j.brainres.2010.10.087; de Oliveira DCG, 2012, HUM PSYCHOPHARM CLIN, V27, P378, DOI 10.1002/hup.2237; Goncharuk VD, 2011, J COMP NEUROL, V519, P93, DOI 10.1002/cne.22507; Grippo AJ, 2012, STRESS, V15, P149, DOI 10.3109/10253890.2011.605486; Grippo AJ, 2009, PSYCHONEUROENDOCRINO, V34, P1542, DOI 10.1016/j.psyneuen.2009.05.017; Hauptman PJ, 2012, AM HEART J, V163, P954, DOI 10.1016/j.ahj.2012.03.021; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; Kamendi H, 2006, HYPERTENSION, V48, P1137, DOI 10.1161/01.HYP.0000246493.00385.94; Kc P, 2010, RESP PHYSIOL NEUROBI, V174, P55, DOI 10.1016/j.resp.2010.08.001; LAROVERE MT, 1988, CIRCULATION, V78, P816, DOI 10.1161/01.CIR.78.4.816; Lin YT, 2012, J NEUROSCI, V32, P15476, DOI 10.1523/JNEUROSCI.2429-12.2012; Mastitskaya S, 2012, CARDIOVASC RES; McCall C, 2012, NAT NEUROSCI, V15, P681, DOI 10.1038/nn.3084; Mendelowitz D, 1996, AM J PHYSIOL-HEART C, V271, pH2609, DOI 10.1152/ajpheart.1996.271.6.H2609; Ninan I, 2011, J NEUROCHEM, V119, P324, DOI 10.1111/j.1471-4159.2011.07430.x; Norman GJ, 2011, BIOL PSYCHOL, V86, P174, DOI 10.1016/j.biopsycho.2010.11.006; Pinol RA, 2012, J NEUROSCI METH, V210, P238, DOI 10.1016/j.jneumeth.2012.07.022; Pyner S, 2009, J CHEM NEUROANAT, V38, P197, DOI 10.1016/j.jchemneu.2009.03.005; RARDON DP, 1983, J AM COLL CARDIOL, V2, P1200, DOI 10.1016/S0735-1097(83)80351-9; Regehr WG, 2009, NEURON, V63, P154, DOI 10.1016/j.neuron.2009.06.021; Rinaman L, 1998, J COMP NEUROL, V399, P101, DOI 10.1002/(SICI)1096-9861(19980914)399:1<101::AID-CNE8>3.0.CO;2-5; SAPER CB, 1976, BRAIN RES, V117, P305, DOI 10.1016/0006-8993(76)90738-1; SAWCHENKO PE, 1982, J COMP NEUROL, V205, P260, DOI 10.1002/cne.902050306; Stoop R, 2012, NEURON, V76, P142, DOI 10.1016/j.neuron.2012.09.025; STORNETTA RL, 1987, J AUTONOM NERV SYST, V20, P121, DOI 10.1016/0165-1838(87)90109-3; TOWNEND JN, 1995, LANCET, V345, P937, DOI 10.1016/S0140-6736(95)90694-0; VANOLI E, 1991, CIRC RES, V68, P1471, DOI 10.1161/01.RES.68.5.1471; Wang J, 2002, NEUROSCIENCE, V111, P699, DOI 10.1016/S0306-4522(02)00046-5; WAXMAN MB, 1977, CIRCULATION, V56, P385, DOI 10.1161/01.CIR.56.3.385; WHITESCARVER SA, 1990, AM J PHYSIOL, V259, pR76, DOI 10.1152/ajpregu.1990.259.1.R76; Yang Z, 2001, BRAIN RES, V908, P99, DOI 10.1016/S0006-8993(01)02593-8; Yang Z, 2009, AUTON NEUROSCI-BASIC, V147, P80, DOI 10.1016/j.autneu.2009.01.013; Zhang XG, 2002, J NEUROPHYSIOL, V88, P49, DOI 10.1152/jn.2002.88.1.49; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	45	36	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112138	10.1371/journal.pone.0112138	http://dx.doi.org/10.1371/journal.pone.0112138			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379676	Green Submitted, gold, Green Published			2022-12-27	WOS:000344863100055
J	Vrijsen, JN; Speckens, A; Arias-Vasquez, A; Franke, B; Becker, ES; van Oostrom, I				Vrijsen, Janna N.; Speckens, Anne; Arias-Vasquez, Alejandro; Franke, Barbara; Becker, Eni S.; van Oostrom, Iris			No Evidence for the Association between a Polymorphism in the PCLO Depression Candidate Gene with Memory Bias in Remitted Depressed Patients and Healthy Individuals	PLOS ONE			English	Article							STRUCTURED CLINICAL INTERVIEW; GENOME-WIDE ASSOCIATION; COGNITIVE VULNERABILITY; MAJOR DEPRESSION; EMOTIONAL FACES; LIFE EVENTS; ATTENTION; MOOD; SEROTONIN; REAPPRAISAL	The PCLO rs2522833 candidate polymorphism for depression has been associated to monoaminergic neurotransmission. In healthy and currently depressed individuals, the polymorphism has been found to affect activation of brain areas during memory processing, but no direct association of PCLO with memory bias was found. We hypothesized that the absence of this association might have been obscured by current depressive symptoms or genetically driven individual differences in reactivity to stressful events. Experiencing stressful childhood events fosters dysfunctional assumptions that are related to cognitive biases, and may modulate the predisposition for depression via epigenetic effects. The association between PCLO and memory bias, as well as interaction between PCLO and childhood events was studied in patients remitted from depression (N = 299), as well as a sample of healthy individuals (N = 157). The participants performed an emotional verbal memory task after a sad mood induction. Childhood trauma and adversity were measured with a questionnaire. The Genotype main effect, and Genotype by Childhood Events interaction were analyzed for memory bias in both samples. PCLO risk allele carrying remitted depressed patients did not show more negatively biased memory than non-risk allele carriers, not even patients with stressful childhood events. A similar pattern of results was found in healthy individuals. Memory bias may not be strongly associated with the PCLO rs2522833 polymorphism. We did not find any support for the PCLO-childhood events interaction, but the power of our study was insufficient to exclude this possibility.	[Vrijsen, Janna N.; Speckens, Anne; Arias-Vasquez, Alejandro; Franke, Barbara; van Oostrom, Iris] Radboud Univ Nijmegen, Med Ctr, Dept Psychiat, NL-6525 ED Nijmegen, Netherlands; [Arias-Vasquez, Alejandro; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Arias-Vasquez, Alejandro] Radboud Univ Nijmegen, Med Ctr, Dept Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands; [Arias-Vasquez, Alejandro; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Becker, Eni S.] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Vrijsen, JN (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Psychiat, NL-6525 ED Nijmegen, Netherlands.	Janna.Vrijsen@radboudumc.nl	Vasquez, A. Arias/L-4175-2015; Franke, Barbara/D-4836-2009; Speckens, Anne/H-8093-2014; Oostrom, I./L-4559-2015; Vasquez, Alejandro Arias/E-4762-2012; Becker, Eni S/A-2668-2010; Vrijsen, Janna N/L-4736-2015	Franke, Barbara/0000-0003-4375-6572; Speckens, Anne/0000-0001-5266-1554; Vasquez, Alejandro Arias/0000-0002-4786-0169; Becker, Eni S/0000-0003-3524-426X; Vrijsen, Janna N/0000-0002-7081-9893	department of Psychiatry of the Radboud University Medical Centre	department of Psychiatry of the Radboud University Medical Centre	The study was funded by the department of Psychiatry of the Radboud University Medical Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], 1958, STANDARD PROGR MATRI; Aragam N, 2011, J AFFECT DISORDERS, V133, P516, DOI 10.1016/j.jad.2011.04.054; Beck AT, 2008, AM J PSYCHIAT, V165, P969, DOI 10.1176/appi.ajp.2008.08050721; Beck AT, 1996, PSYCHOL ASSESS; Betts MJ, 2007, BIOINFORMATICS GENET, P289; Bhagwagar Z, 2008, PSYCHOL MED, V38, P307, DOI 10.1017/S0033291707001250; Bochdanovits Z, 2009, MOL PSYCHIATR, V14, P650, DOI 10.1038/mp.2009.37; Bockting CLH, 2006, J CLIN PSYCHIAT, V67, P747, DOI 10.4088/JCP.v67n0508; BOWER GH, 1981, AM PSYCHOL, V36, P129, DOI 10.1037/0003-066X.36.2.129; Bradley M. M., 1999, C1 U FLOR CTR RES PS, V30, P25; BREWIN CR, 1993, PSYCHOL BULL, V113, P82, DOI 10.1037/0033-2909.113.1.82; BRUGHA TS, 1990, ACTA PSYCHIAT SCAND, V82, P77, DOI 10.1111/j.1600-0447.1990.tb01360.x; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; De Raedt R, 2010, COGN AFFECT BEHAV NE, V10, P50, DOI 10.3758/CABN.10.1.50; DENNY EB, 1992, J ABNORM PSYCHOL, V101, P575, DOI 10.1037/0021-843X.101.3.575; Ellwart T, 2003, DEPRESS ANXIETY, V17, P197, DOI 10.1002/da.10102; Firk C, 2007, J PSYCHOPHARMACOL, V21, P538, DOI 10.1177/0269881106075588; First M.B., 2014, STRUCTURED CLIN INTE; Fitzgerald DA, 2011, NEUROIMAGE, V56, P1783, DOI 10.1016/j.neuroimage.2011.02.061; Fox E, 2009, P R SOC B, V276, P1747, DOI 10.1098/rspb.2008.1788; Franke B, 2009, HUM GENET, V126, P13, DOI 10.1007/s00439-009-0663-4; Gerritsen L, 2012, MOL PSYCHIATR, V17, P597, DOI 10.1038/mp.2011.51; Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P386, DOI 10.1037/0021-843x.113.3.386; Gupta Rashmi, 2012, Front Psychiatry, V3, P99, DOI 10.3389/fpsyt.2012.00099; Hek K, 2010, HUM MOL GENET, V19, P731, DOI 10.1093/hmg/ddp529; Joormann J, 2007, J ABNORM PSYCHOL, V116, P80, DOI 10.1037/0021-843X.116.1.80; Kanai T, 2003, PSYCHOL MED, V33, P839, DOI 10.1017/S0033291703007827; Kendler KS, 2010, MOL PSYCHIATR, V15, P789, DOI 10.1038/mp.2010.8; Klein AA, 2013, ADDICT BEHAV, V38, P1687, DOI 10.1016/j.addbeh.2012.10.006; Kuehner C, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.11; LeMoult J, 2012, COGNITIVE THER RES, V36, P47, DOI 10.1007/s10608-010-9322-2; Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916; MATT GE, 1992, CLIN PSYCHOL REV, V12, P227, DOI 10.1016/0272-7358(92)90116-P; McCabe SB, 2000, COGNITIVE THER RES, V24, P427, DOI 10.1023/A:1005579719849; Minelli A, 2012, J AFFECT DISORDERS, V139, P250, DOI 10.1016/j.jad.2012.01.028; Pergamin-Hight L, 2012, BIOL PSYCHIAT, V71, P373, DOI 10.1016/j.biopsych.2011.10.030; Perry BD, 1995, INFANT MENT HEALTH J, V16, P271, DOI 10.1002/1097-0355(199524)16:4<271::AID-IMHJ2280160404>3.0.CO;2-B; Phaf RH, 2006, TECHNICAL REPORT; Ridout N, 2009, BEHAV RES THER, V47, P851, DOI 10.1016/j.brat.2009.06.013; ROGERS TB, 1977, J PERS SOC PSYCHOL, V35, P677, DOI 10.1037/0022-3514.35.9.677; Schott BH, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.10; Schuhmacher A, 2011, INT J NEUROPSYCHOPH, V14, P237, DOI 10.1017/S1461145710000854; Shyn SI, 2010, PSYCHIAT CLIN N AM, V33, P125, DOI 10.1016/j.psc.2009.10.004; SKRE I, 1991, ACTA PSYCHIAT SCAND, V84, P167, DOI 10.1111/j.1600-0447.1991.tb03123.x; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Teasdale JD, 1988, COGNITION EMOTION, V2, P247, DOI 10.1080/02699938808410927; van Oostrom I, 2012, BIOL PSYCHOL, V89, P214, DOI 10.1016/j.biopsycho.2011.10.012; van Tol MJ, 2012, BIOL PSYCHIAT, V71, P593, DOI 10.1016/j.biopsych.2011.11.016; Verbeek EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079921; Vogel S, 2014, PSYCHONEUROENDOCRINO, V40, P181, DOI 10.1016/j.psyneuen.2013.11.010; Vrijsen JN, 2014, GENES BRAIN BEHAV, V13, P508, DOI 10.1111/gbb.12129; Vrijsen JN, 2014, COGNITIVE THER RES, V38, P334, DOI 10.1007/s10608-013-9590-8; Vrijsen JN, 2014, PSYCHIAT RES, V217, P134, DOI 10.1016/j.psychres.2014.02.033; WATKINS PC, 1992, J ABNORM PSYCHOL, V101, P581, DOI 10.1037/0021-843X.101.3.581; Watson DE, 2005, INT J TOXICOL, V24, P139, DOI 10.1080/10915810590948299; Williams J. M., 1996, REMEMBERING OUR STUD; Williams JMG, 2007, PSYCHOL BULL, V133, P122, DOI 10.1037/0033-2909.133.1.122; WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630; Williams LM, 2010, NEUROIMAGE, V53, P918, DOI 10.1016/j.neuroimage.2010.01.084; Wingenfeld K, 2013, PSYCHOPATHOLOGY, V46, P22, DOI 10.1159/000338609; Woudstra S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.29; Woudstra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061494	67	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112153	10.1371/journal.pone.0112153	http://dx.doi.org/10.1371/journal.pone.0112153			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379724	gold, Green Published, Green Submitted			2022-12-27	WOS:000344863100057
J	Bordiuk, OL; Smith, K; Morin, PJ; Semenov, MV				Bordiuk, Olivia L.; Smith, Karen; Morin, Peter J.; Semenov, Mikhail V.			Cell Proliferation and Neurogenesis in Adult Mouse Brain	PLOS ONE			English	Article							NEWLY GENERATED NEURONS; HIPPOCAMPAL NEUROGENESIS; GANGLIONIC EMINENCE; PATTERN SEPARATION; MAMMALIAN BRAIN; NERVOUS-SYSTEM; INTERNEURONS; DOUBLECORTIN; EXPRESSION; CORTEX	Neurogenesis, the formation of new neurons, can be observed in the adult brain of many mammalian species, including humans. Despite significant progress in our understanding of adult neurogenesis, we are still missing data about the extent and location of production of neural precursors in the adult mammalian brain. We used 5-ethynyl-2'-deoxyuridine (EdU) to map the location of proliferating cells throughout the entire adult mouse brain and found that neurogenesis occurs at two locations in the mouse brain. The larger one we define as the main proliferative zone (MPZ), and the smaller one corresponds to the subgranular zone of the hippocampus. The MPZ can be divided into three parts. The caudate migratory stream (CMS) occupies the middle part of the MPZ. The cable of proliferating cells emanating from the most anterior part of the CMS toward the olfactory bulbs forms the rostral migratory stream. The thin layer of proliferating cells extending posteriorly from the CMS forms the midlayer. We have not found any additional aggregations of proliferating cells in the adult mouse brain that could suggest the existence of other major neurogenic zones in the adult mouse brain.	[Bordiuk, Olivia L.; Smith, Karen; Morin, Peter J.; Semenov, Mikhail V.] Edith Nourse Rogers Mem Vet Hosp, New England Geriatr Res Educ & Clin Ctr, Bedford Div, Bedford, MA 01730 USA	Geriatric Research Education & Clinical Center	Semenov, MV (corresponding author), Edith Nourse Rogers Mem Vet Hosp, New England Geriatr Res Educ & Clin Ctr, Bedford Div, Bedford, MA 01730 USA.	mikhail.semenov@va.gov			Janet and Edward Gildea Charitable Foundation; Department of Veterans Affairs	Janet and Edward Gildea Charitable Foundation; Department of Veterans Affairs(US Department of Veterans Affairs)	This study was supported by the Janet and Edward Gildea Charitable Foundation and in part by the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Andrews WD, 2007, J ANAT, V211, P188, DOI 10.1111/j.1469-7580.2007.00750.x; Bernier PJ, 2002, P NATL ACAD SCI USA, V99, P11464, DOI 10.1073/pnas.172403999; Braun SMG, 2014, DEVELOPMENT, V141, P1983, DOI 10.1242/dev.104596; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Cameron HA, 2008, BIOL PSYCHIAT, V63, P650, DOI 10.1016/j.biopsych.2007.09.023; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Del Bigio MR, 2011, BRAIN, V134, P1344, DOI 10.1093/brain/awr052; Feliciano DM, 2013, TRENDS NEUROSCI, V36, P51, DOI 10.1016/j.tins.2012.09.004; Gatome CW, 2010, BRAIN BEHAV EVOLUT, V76, P116, DOI 10.1159/000320210; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Haan N, 2013, J NEUROSCI, V33, P6170, DOI 10.1523/JNEUROSCI.2437-12.2013; Ihrie RA, 2011, NEURON, V70, P674, DOI 10.1016/j.neuron.2011.05.004; Kim WR, 2011, DEV GROWTH DIFFER, V53, P225, DOI 10.1111/j.1440-169X.2010.01226.x; Kim WR, 2011, EUR J NEUROSCI, V33, P599, DOI 10.1111/j.1460-9568.2010.07557.x; Kostovic I, 2009, SEMIN PERINATOL, V33, P220, DOI 10.1053/j.semperi.2009.04.003; Lee DA, 2012, NAT NEUROSCI, V15, P700, DOI 10.1038/nn.3079; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Luzzati F, 2003, P NATL ACAD SCI USA, V100, P13036, DOI 10.1073/pnas.1735482100; Ma T, 2012, CEREB CORTEX, V22, P2120, DOI 10.1093/cercor/bhr296; McNay DEG, 2012, J CLIN INVEST, V122, P142, DOI 10.1172/JCI43134; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; MORSHEAD CM, 1992, J NEUROSCI, V12, P249; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Ohira R, 2002, MOL GENET METAB, V77, P179, DOI 10.1016/S1096-7192(02)00126-9; Peng HC, 2010, NAT BIOTECHNOL, V28, P348, DOI 10.1038/nbt.1612; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Rudolph J, 2010, CELL ADHES MIGR, V4, P400, DOI 10.4161/cam.4.3.11640; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; SCHUZ A, 1989, J COMP NEUROL, V286, P442, DOI 10.1002/cne.902860404; Seri B, 2006, CEREB CORTEX, V16, pI103, DOI 10.1093/cercor/bhk027; Shapiro LA, 2007, BRAIN STRUCT FUNCT, V212, P133, DOI 10.1007/s00429-007-0151-3; Sousa-Ferreira L, 2014, TRENDS ENDOCRIN MET, V25, P80, DOI 10.1016/j.tem.2013.10.005; Takemura NU, 2005, NEUROSCIENCE, V134, P121, DOI 10.1016/j.neuroscience.2005.04.033; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Walker TL, 2007, J NEUROSCI, V27, P3734, DOI 10.1523/JNEUROSCI.5060-06.2007; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Zeng CB, 2010, BRAIN RES, V1319, P21, DOI 10.1016/j.brainres.2009.12.092	42	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111453	10.1371/journal.pone.0111453	http://dx.doi.org/10.1371/journal.pone.0111453			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375658	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402600040
J	Kelker, MS; Berry, C; Evans, SL; Pai, R; McCaskill, DG; Wang, NX; Russell, JC; Baker, MD; Yang, C; Pflugrath, JW; Wade, M; Wess, TJ; Narva, KE				Kelker, Matthew S.; Berry, Colin; Evans, Steven L.; Pai, Reetal; McCaskill, David G.; Wang, Nick X.; Russell, Joshua C.; Baker, Matthew D.; Yang, Cheng; Pflugrath, J. W.; Wade, Matthew; Wess, Tim J.; Narva, Kenneth E.			Structural and Biophysical Characterization of Bacillus thuringiensis Insecticidal Proteins Cry34Ab1 and Cry35Ab1	PLOS ONE			English	Article							SPHAERICUS BINARY TOXIN; WESTERN CORN-ROOTWORM; MOBILITY-MASS-SPECTROMETRY; PORE-FORMING TOXIN; CRYSTAL-STRUCTURE; EQUINATOXIN-II; LYSINIBACILLUS-SPHAERICUS; SOLUBLE FORM; PURIFICATION; COMPONENTS	Bacillus thuringiensis strains are well known for the production of insecticidal proteins upon sporulation and these proteins are deposited in parasporal crystalline inclusions. The majority of these insect-specific toxins exhibit three domains in the mature toxin sequence. However, other Cry toxins are structurally and evolutionarily unrelated to this three-domain family and little is known of their three dimensional structures, limiting our understanding of their mechanisms of action and our ability to engineer the proteins to enhance their function. Among the non-three domain Cry toxins, the Cry34Ab1 and Cry35Ab1 proteins from B. thuringiensis strain PS149B1 are required to act together to produce toxicity to the western corn rootworm (WCR) Diabrotica virgifera virgifera Le Conte via a pore forming mechanism of action. Cry34Ab1 is a protein of similar to 14 kDa with features of the aegerolysin family (Pfam06355) of proteins that have known membrane disrupting activity, while Cry35Ab1 is a similar to 44 kDa member of the toxin_10 family (Pfam05431) that includes other insecticidal proteins such as the binary toxin BinA/BinB. The Cry34Ab1/Cry35Ab1 proteins represent an important seed trait technology having been developed as insect resistance traits in commercialized corn hybrids for control of WCR. The structures of Cry34Ab1 and Cry35Ab1 have been elucidated to 2.15 angstrom and 1.80 angstrom resolution, respectively. The solution structures of the toxins were further studied by small angle X-ray scattering and native electrospray ion mobility mass spectrometry. We present here the first published structure from the aegerolysin protein domain family and the structural comparisons of Cry34Ab1 and Cry35Ab1 with other pore forming toxins.	[Kelker, Matthew S.; Evans, Steven L.; Pai, Reetal; McCaskill, David G.; Wang, Nick X.; Russell, Joshua C.; Narva, Kenneth E.] LLC, Dow AgroSci, Indianapolis, IN 46285 USA; [Berry, Colin; Baker, Matthew D.] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Yang, Cheng; Pflugrath, J. W.] Rigaku Americas Corp, The Woodlands, TX USA; [Wess, Tim J.; Narva, Kenneth E.] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff CF10 3AX, S Glam, Wales	Cardiff University; Rigaku Corporation; Cardiff University	Kelker, MS (corresponding author), LLC, Dow AgroSci, Indianapolis, IN 46285 USA.	mskelker@dow.com	Berry, Colin/A-4338-2010; Russell, Joshua C/G-6985-2015; Baker, Matthew/B-4850-2011	Berry, Colin/0000-0002-9943-548X; Russell, Joshua C/0000-0002-4193-9204; Baker, Matthew/0000-0001-6950-204X; McCaskill, David/0000-0001-6244-3067; Narva, Kenneth/0000-0001-8094-6418; Plummer, Beverley/0000-0002-6559-7237	E.I. DuPont de Nemours & Co., The Dow Chemical Company; Northwestern University; U.S. DOE [DE-AC02-06CH11357]; NIGMS [P41-GM103311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	E.I. DuPont de Nemours & Co., The Dow Chemical Company; Northwestern University; U.S. DOE(United States Department of Energy (DOE)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Portions of this work were performed at the DuPont-Northwestern-Dow Collaborative Access Team (DND-CAT) located at Sector 5 of the Advanced Photon Source (APS). DND-CAT is supported by E.I. DuPont de Nemours & Co., The Dow Chemical Company and Northwestern University. Use of the APS, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under Contract No. DE-AC02-06CH11357. Molecular graphics and analyses were performed with the UCSF Chimera package. Chimera was developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIGMS P41-GM103311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba T, 2006, PROTEINS, V63, P243, DOI 10.1002/prot.20843; Akiba T, 2009, J MOL BIOL, V386, P121, DOI 10.1016/j.jmb.2008.12.002; Alvarez C, 2009, TOXICON, V54, P1135, DOI 10.1016/j.toxicon.2009.02.022; [Anonymous], 2012, US EPA CURRENT PREVI; Athanasiadis A, 2001, STRUCTURE, V9, P341, DOI 10.1016/S0969-2126(01)00592-5; Baum JA, 2004, APPL ENVIRON MICROB, V70, P4889, DOI 10.1128/AEM.70.8.4889-4898.2004; Berne S, 2009, PROTEIN SCI, V18, P694, DOI 10.1002/pro.85; Berry C, 2012, J INVERTEBR PATHOL, V109, P1, DOI 10.1016/j.jip.2011.11.008; Birck C, 2004, J MOL BIOL, V344, P1409, DOI 10.1016/j.jmb.2004.10.007; Boonyos P, 2010, BMB REP, V43, P23, DOI 10.5483/BMBRep.2010.43.1.023; BROADWELL AH, 1987, APPL ENVIRON MICROB, V53, P1333, DOI 10.1128/AEM.53.6.1333-1337.1987; Bush MF, 2010, ANAL CHEM, V82, P9557, DOI 10.1021/ac1022953; Campuzano I, 2012, ANAL CHEM, V84, P1026, DOI 10.1021/ac202625t; de Maagd RA, 2003, ANNU REV GENET, V37, P409, DOI 10.1146/annurev.genet.37.110801.143042; DeLano WL, 2006, PYMOL V 0 99RC6; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Donovan WP, 2000, BACILLUS THURINGIENS; Ellis RT, 2002, APPL ENVIRON MICROB, V68, P1137, DOI 10.1128/AEM.68.3.1137-1145.2002; Eswar N., 2006, COMP PROTEIN STRUCTU; Gao Y, 2004, J AGR FOOD CHEM, V52, P8057, DOI 10.1021/jf048744+; Herman RA, 2002, J ECON ENTOMOL, V95, P635, DOI 10.1603/0022-0493-95.3.635; Hinds MG, 2002, J MOL BIOL, V315, P1219, DOI 10.1006/jmbi.2001.5321; Hire RS, 2009, J INVERTEBR PATHOL, V101, P106, DOI 10.1016/j.jip.2009.03.005; Jones GW, 2007, FASEB J, V21, P4112, DOI 10.1096/fj.07-8913com; Jones RT, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-141; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jurneczko E, 2011, ANALYST, V136, P20, DOI 10.1039/c0an00373e; Kale A, 2013, INSECT BIOCHEM MOLEC, V43, P1045, DOI 10.1016/j.ibmb.2013.07.011; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Konijnenberg A, 2013, BBA-PROTEINS PROTEOM, V1834, P1239, DOI 10.1016/j.bbapap.2012.11.013; Kristan KC, 2009, TOXICON, V54, P1125, DOI 10.1016/j.toxicon.2009.02.026; Kunthic T, 2011, BMB REP, V44, P674, DOI 10.5483/BMBRep.2011.44.10.674; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LI H, 2013, PLOS ONE, V8; Mancheno JM, 2003, STRUCTURE, V11, P1319, DOI 10.1016/j.str.2003.09.019; Masson L, 2004, BIOCHEMISTRY-US, V43, P12349, DOI 10.1021/bi048946z; Mechaly AE, 2009, ACTA CRYSTALLOGR F, V65, P357, DOI 10.1107/S1744309109007064; Melo F, 2002, PROTEIN SCI, V11, P430, DOI 10.1002/pro.110430; Mesleh MF, 1996, J PHYS CHEM-US, V100, P16082, DOI 10.1021/jp961623v; Moellenbeck DJ, 2001, NAT BIOTECHNOL, V19, P668, DOI 10.1038/90282; Narva KE, 2014, ADV INSECT PHYSL; Narva KE, 2013, ADV BIOCHEM ENG BIOT, V136, P135, DOI 10.1007/10_2013_195; NIELSENLEROUX C, 1992, EUR J BIOCHEM, V210, P585, DOI 10.1111/j.1432-1033.1992.tb17458.x; Ottmann C, 2009, P NATL ACAD SCI USA, V106, P10359, DOI 10.1073/pnas.0902362106; Palma L, 2014, TOXINS, V6, P1490, DOI 10.3390/toxins6051490; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Promdonkoy B, 2008, CURR MICROBIOL, V56, P334, DOI 10.1007/s00284-007-9065-9; Revina LP, 2005, CAN J MICROBIOL, V51, P141, DOI 10.1139/w04-121; Rojko N, 2013, J BIOL CHEM, V288, P23704, DOI 10.1074/jbc.M113.481572; Rossjohn J, 1997, EMBO J, V16, P3426, DOI 10.1093/emboj/16.12.3426; RUPAR MJ, 2003, NUCL ACIDS ENCODING; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schnepf HE, 2005, APPL ENVIRON MICROB, V71, P1765, DOI 10.1128/AEM.71.4.1765-1774.2005; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Shvartsburg AA, 1996, CHEM PHYS LETT, V261, P86, DOI 10.1016/0009-2614(96)00941-4; Squires C.H., 2004, BIOPROCESS INT, V2004, P54; Srisucharitpanit K, 2014, PROTEINS; Srisucharitpanit K, 2012, PROTEIN EXPRES PURIF, V82, P368, DOI 10.1016/j.pep.2012.02.009; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Xu CC, 2014, TOXINS, V6, P2732, DOI 10.3390/toxins6092732; Yanagihara I, 2010, J BIOL CHEM, V285, P16267, DOI 10.1074/jbc.M109.074526	65	50	54	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112555	10.1371/journal.pone.0112555	http://dx.doi.org/10.1371/journal.pone.0112555			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390338	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000349144400097
J	Kwon, MS; Vorobyev, V; Moe, D; Parkkola, R; Hamalainen, H				Kwon, Myoung Soo; Vorobyev, Victor; Moe, Dagfinn; Parkkola, Riitta; Hamalainen, Heikki			Brain Structural Correlates of Risk-Taking Behavior and Effects of Peer Influence in Adolescents	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; IMAGE REGISTRATION; MATURATION; ENGAGEMENT; PASSENGERS; CHILDHOOD; CHILDREN	Adolescents are characterized by impulsive risky behavior, particularly in the presence of peers. We discriminated high and low risk-taking male adolescents aged 18-19 years by assessing their propensity for risky behavior and vulnerability to peer influence with personality tests, and compared structural differences in gray and white matter of the brain with voxel-based morphometry (VBM) and diffusion tensor imaging (DTI), respectively. We also compared the brain structures according to the participants' actual risk-taking behavior in a simulated driving task with two different social conditions making up a peer competition situation. There was a discrepancy between the self-reported personality test results and risky driving behavior (running through an intersection with traffic lights turning yellow, chancing a collision with another vehicle). Comparison between high and low risk-taking adolescents according to personality test results revealed no significant difference in gray matter volume and white matter integrity. However, comparison according to actual risk-taking behavior during task performance revealed significantly higher white matter integrity in the high risk-taking group, suggesting that increased risky behavior during adolescence is not necessarily attributed to the immature brain as conventional wisdom says.	[Kwon, Myoung Soo; Vorobyev, Victor; Hamalainen, Heikki] Univ Turku, Ctr Cognit Neurosci, Dept Psychol, Turku, Finland; [Moe, Dagfinn] SINTEF Technol & Soc, Dept Transport Res, Trondheim, Norway; [Parkkola, Riitta] Tampere Univ Hosp, Dept Radiol, Tampere, Finland	University of Turku; SINTEF; Tampere University; Tampere University Hospital	Kwon, MS (corresponding author), Univ Turku, Ctr Cognit Neurosci, Dept Psychol, Turku, Finland.	mskwon@utu.fi	Vorobyev, Vitaly/H-9799-2018; Kwon, Myoung Soo/C-3922-2008; Parkkola, Riitta/AAZ-1341-2020	Vorobyev, Vitaly/0000-0002-6660-868X; Moe, Dagfinn/0000-0002-3277-4882	Norwegian Public Roads Administration (NPRA); Finnish Transport Safety Agency (Trafi)	Norwegian Public Roads Administration (NPRA); Finnish Transport Safety Agency (Trafi)	This study was supported by the Norwegian Public Roads Administration (NPRA, http://www.vegvesen.no/): HH; Finnish Transport Safety Agency (Trafi, http://www.trafi.fi/): HH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluja A, 2010, J PERS ASSESS, V92, P416, DOI 10.1080/00223891.2010.497406; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Berns GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006773; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Casey BJ, 2008, DEV REV, V28, P62, DOI [10.1016/j.dr.2007.08.003, 10.1196/annals.1440.010]; Casey BJ, 2011, J RES ADOLESCENCE, V21, P21, DOI 10.1111/j.1532-7795.2010.00712.x; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; Caviness VS, 1996, CEREB CORTEX, V6, P726, DOI 10.1093/cercor/6.5.726; Chassin L., 2009, HDB ADOLESCENT PSYCH, V1, P723, DOI DOI 10.1002/9780470479193.ADLPSY001022; Chein J, 2011, DEVELOPMENTAL SCI, V14, pF1, DOI 10.1111/j.1467-7687.2010.01035.x; Crone EA, 2012, NAT REV NEUROSCI, V13, P636, DOI 10.1038/nrn3313; Epstein R, 2007, SCI AM MIND, V18, P56; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Gardner M, 2005, DEV PSYCHOL, V41, P625, DOI 10.1037/0012-1649.41.4.625; Geier CF, 2013, HORM BEHAV, V64, P333, DOI 10.1016/j.yhbeh.2013.02.008; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giedd JN, 1996, CEREB CORTEX, V6, P551, DOI 10.1093/cercor/6.4.551; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Jacobus J, 2013, PSYCHOL ADDICT BEHAV, V27, P431, DOI 10.1037/a0028235; JERNIGAN TL, 1991, BRAIN, V114, P2037, DOI 10.1093/brain/114.5.2037; Luna B, 2010, BRAIN COGNITION, V72, P101, DOI 10.1016/j.bandc.2009.08.005; Marengo D, 2012, TRANSPORT RES F-TRAF, V15, P480, DOI 10.1016/j.trf.2012.04.001; Mirman JH, 2012, J ADOLESCENT HEALTH, V50, P634, DOI 10.1016/j.jadohealth.2011.10.256; Mishra S, 2011, PERS INDIV DIFFER, V50, P869, DOI 10.1016/j.paid.2010.11.037; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; Mohammadi S, 2013, MAGN RESON MED, V70, P358, DOI 10.1002/mrm.24467; Mohammadi S, 2010, MAGN RESON MED, V64, P1047, DOI 10.1002/mrm.22501; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; O'Brien L, 2011, J RES ADOLESCENCE, V21, P747, DOI 10.1111/j.1532-7795.2011.00738.x; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Pluim JPW, 2000, IEEE T MED IMAGING, V19, P809, DOI 10.1109/42.876307; Reiss AL, 1996, BRAIN, V119, P1763, DOI 10.1093/brain/119.5.1763; Ridgway GR, 2009, NEUROIMAGE, V44, P99, DOI 10.1016/j.neuroimage.2008.08.045; Romer D, 2011, DEVELOPMENTAL SCI, V14, P1119, DOI 10.1111/j.1467-7687.2011.01061.x; Romer D, 2010, DEV PSYCHOBIOL, V52, P263, DOI 10.1002/dev.20442; Schneider S, 2012, AM J PSYCHIAT, V169, P39, DOI 10.1176/appi.ajp.2011.11030489; Silveri MM, 2006, MAGN RESON IMAGING, V24, P833, DOI 10.1016/j.mri.2006.03.012; Simons-Morton B, 2005, ACCIDENT ANAL PREV, V37, P973, DOI 10.1016/j.aap.2005.04.014; Smith AR, 2013, HORM BEHAV, V64, P323, DOI 10.1016/j.yhbeh.2013.03.006; Somerville LH, 2010, BRAIN COGNITION, V72, P124, DOI 10.1016/j.bandc.2009.07.003; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Steinberg L, 2007, DEV PSYCHOL, V43, P1531, DOI 10.1037/0012-1649.43.6.1531; Van Leijenhorst L, 2010, NEUROIMAGE, V51, P345, DOI 10.1016/j.neuroimage.2010.02.038; Williams JM, 1999, J ADOLESCENCE, V22, P157, DOI 10.1006/jado.1998.0208; Zimring F.E., 1998, AM YOUTH VIOLENCE; Zuckerman M., 1994, BEHAV EXPRESSIONS BI	51	36	36	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112780	10.1371/journal.pone.0112780	http://dx.doi.org/10.1371/journal.pone.0112780			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389976	gold, Green Published			2022-12-27	WOS:000349144400126
J	Sanchez-Pages, S; Rodriguez-Ruiz, C; Turiegano, E				Sanchez-Pages, Santiago; Rodriguez-Ruiz, Claudia; Turiegano, Enrique			Facial Masculinity: How the Choice of Measurement Method Enables to Detect Its Influence on Behaviour	PLOS ONE			English	Article							SEXUAL-DIMORPHISM; PERCEIVED ATTRACTIVENESS; GEOMETRIC MORPHOMETRICS; COMPETITIVE AROUSAL; TESTOSTERONE LEVELS; MENSTRUAL-CYCLE; FACES; SYMMETRY; PREFERENCES; COOPERATION	Recent research has explored the relationship between facial masculinity, human male behaviour and males' perceived features (i.e. attractiveness). The methods of measurement of facial masculinity employed in the literature are quite diverse. In the present paper, we use several methods of measuring facial masculinity to study the effect of this feature on risk attitudes and trustworthiness. We employ two strategic interactions to measure these two traits, a first-price auction and a trust game. We find that facial width-to-height ratio is the best predictor of trustworthiness, and that measures of masculinity which use Geometric Morphometrics are the best suited to link masculinity and bidding behaviour. However, we observe that the link between masculinity and bidding in the first-price auction might be driven by competitiveness and not by risk aversion only. Finally, we test the relationship between facial measures of masculinity and perceived masculinity. As a conclusion, we suggest that researchers in the field should measure masculinity using one of these methods in order to obtain comparable results. We also encourage researchers to revise the existing literature on this topic following these measurement methods.	[Sanchez-Pages, Santiago] Univ Barcelona, Dept Teor Econ, Barcelona, Spain; [Sanchez-Pages, Santiago] Edinburgh Sch Econ, Edinburgh, Midlothian, Scotland; [Rodriguez-Ruiz, Claudia; Turiegano, Enrique] Univ Barcelona, Dept Teor Econ, Barcelona, Spain	University of Barcelona; University of Edinburgh; University of Barcelona	Turiegano, E (corresponding author), Univ Barcelona, Dept Teor Econ, Barcelona, Spain.	enrique.turiegano@uam.es	Turiegano, Enrique/M-8679-2013; Rodriguez-Ruiz, Claudia/A-7914-2015	Turiegano, Enrique/0000-0003-4620-7894; Rodriguez-Ruiz, Claudia/0000-0002-2284-1682				Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Apicella CL, 2008, EVOL HUM BEHAV, V29, P384, DOI 10.1016/j.evolhumbehav.2008.07.001; Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Bhasin S, 2003, GROWTH HORM IGF RES, V13, pS63, DOI 10.1016/S1096-6374(03)00058-3; Boothroyd LG, 2013, EVOL PSYCHOL-US, V11, P1044, DOI 10.1177/147470491301100508; Burriss RP, 2007, ARCH SEX BEHAV, V36, P377, DOI 10.1007/s10508-006-9136-1; Campo S, 2011, REV ECON STUD, V78, P112, DOI 10.1093/restud/rdq001; Carre JM, 2008, P ROY SOC B-BIOL SCI, V275, P2651, DOI 10.1098/rspb.2008.0873; Coates JM, 2008, P NATL ACAD SCI USA, V105, P6167, DOI 10.1073/pnas.0704025105; Coetzee V, 2010, PERCEPTION, V39, P51, DOI 10.1068/p6560; Danel D, 2007, J COMP PSYCHOL, V121, P221, DOI 10.1037/0735-7036.121.2.221; Dave C, 2010, J RISK UNCERTAINTY, V41, P219, DOI 10.1007/s11166-010-9103-z; DeBruine LM, 2006, P ROY SOC B-BIOL SCI, V273, P1355, DOI 10.1098/rspb.2005.3445; Doyen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029081; Edelstein RS, 2010, HORM BEHAV, V57, P230, DOI 10.1016/j.yhbeh.2009.11.007; Eisenegger C, 2011, TRENDS COGN SCI, V15, P263, DOI 10.1016/j.tics.2011.04.008; Enlow D.H., 1996, ESSENTIAL FACIAL GRO, V1; Fink B, 2005, P ROY SOC B-BIOL SCI, V272, P1995, DOI 10.1098/rspb.2005.3179; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Gangestad SW, 2010, EVOL HUM BEHAV, V31, P412, DOI 10.1016/j.evolhumbehav.2010.06.001; Gangestad SW, 2003, EVOL HUM BEHAV, V24, P231, DOI 10.1016/S1090-5138(03)00017-5; Garbarino E, 2011, J RISK UNCERTAINTY, V42, P1, DOI 10.1007/s11166-010-9109-6; Geniole SN, 2013, EVOL PSYCHOL-US, V11, P1027; Gomez-Valdes J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052317; Hampson E, 2008, ARCH SEX BEHAV, V37, P133, DOI 10.1007/s10508-007-9263-3; Harrison C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067494; Haselhuhn MP, 2012, P ROY SOC B-BIOL SCI, V279, P571, DOI 10.1098/rspb.2011.1193; Hines M, 2006, EUR J ENDOCRINOL, V155, pS115, DOI 10.1530/eje.1.02236; Honekopp J, 2011, PERS INDIV DIFFER, V51, P381, DOI 10.1016/j.paid.2010.05.003; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Huizenga HM, 2012, ORGAN BEHAV HUM DEC, V117, P332, DOI 10.1016/j.obhdp.2011.11.010; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Johnston VS, 2006, TRENDS COGN SCI, V10, P9, DOI 10.1016/j.tics.2005.11.003; Johnston VS, 2001, EVOL HUM BEHAV, V22, P251, DOI 10.1016/S1090-5138(01)00066-6; Jones BC, 2008, ARCH SEX BEHAV, V37, P78, DOI 10.1007/s10508-007-9268-y; Josephs RA, 2006, J PERS SOC PSYCHOL, V90, P999, DOI 10.1037/0022-3514.90.6.999; Kagel JC, 1995, HDB EXPT EC, V1, P501; Koehler N, 2004, P ROY SOC B-BIOL SCI, V271, pS296, DOI 10.1098/rsbl.2004.0163; Kramer RSS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042705; KRISHNA V., 2002, AUCTION THEORY; Ku G, 2005, ORGAN BEHAV HUM DEC, V96, P89, DOI 10.1016/j.obhdp.2004.10.001; Lefevre CE, 2013, EVOL HUM BEHAV, V34, P273, DOI 10.1016/j.evolhumbehav.2013.03.005; Lefevre CE, 2012, EVOL HUM BEHAV, V33, P623, DOI 10.1016/j.evolhumbehav.2012.03.002; Little AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002106; Macapagal Kathryn R, 2011, J Soc Evol Cult Psychol, V5, P92; Malhotra D, 2010, ORGAN BEHAV HUM DEC, V111, P139, DOI 10.1016/j.obhdp.2009.11.005; McClure SM, 2011, DECISION MAKING AFFE, P63; MILGROM PR, 1982, ECONOMETRICA, V50, P1089, DOI 10.2307/1911865; Moore FR, 2011, P ROY SOC B-BIOL SCI, V278, P774, DOI 10.1098/rspb.2010.1678; Ozener B, 2012, EVOL HUM BEHAV, V33, P169, DOI 10.1016/j.evolhumbehav.2011.08.001; Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P528, DOI 10.1177/1745691612465253; Pearson M, 2013, GAME ECON BEHAV, V78, P1, DOI 10.1016/j.geb.2012.10.008; Pearson M, 2012, EXP ECON, V15, P510, DOI 10.1007/s10683-011-9311-7; Penton-Voak IS, 2001, P ROY SOC B-BIOL SCI, V268, P1617, DOI 10.1098/rspb.2001.1703; Penton-Voak IS, 2004, EVOL HUM BEHAV, V25, P229, DOI 10.1016/j.evolhumbehav.2004.04.003; Peters M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004138; Pound N, 2009, P ROY SOC B-BIOL SCI, V276, P153, DOI 10.1098/rspb.2008.0990; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rhodes G, 2003, P ROY SOC B-BIOL SCI, V270, pS93, DOI 10.1098/rsbl.2003.0023; Roberti JW, 2004, J RES PERS, V38, P256, DOI 10.1016/S0092-6566(03)00067-9; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Roney JR, 2006, P ROY SOC B-BIOL SCI, V273, P2169, DOI 10.1098/rspb.2006.3569; Rubinow DR, 1996, AM J PSYCHIAT, V153, P974; Rupp HA, 2007, HORM BEHAV, V52, P581, DOI 10.1016/j.yhbeh.2007.07.015; Sanchez-Pages S, 2013, BEHAVIOUR, V150, P713, DOI 10.1163/1568539X-00003077; Sanchez-Pages S, 2010, PHYSIOL BEHAV, V99, P355, DOI 10.1016/j.physbeh.2009.11.013; Schaefer K, 2006, AM J PHYS ANTHROPOL, V129, P132, DOI 10.1002/ajpa.20224; Scheib JE, 1999, P ROY SOC B-BIOL SCI, V266, P1913, DOI 10.1098/rspb.1999.0866; Schipper B, 2012, WORKING PAPERS U CAL; Schulz KM, 2009, HORM BEHAV, V55, P597, DOI 10.1016/j.yhbeh.2009.03.010; Scott IML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013585; SCUTT D, 1996, SYMMETRY OVULATION W, V11, P2477; Shanks DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056515; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Slice DE, 2007, ANNU REV ANTHROPOL, V36, P261, DOI 10.1146/annurev.anthro.34.081804.120613; Stanton SJ, 2011, PSYCHOL SCI, V22, P447, DOI 10.1177/0956797611401752; Stephen ID, 2012, EVOL HUM BEHAV, V33, P260, DOI 10.1016/j.evolhumbehav.2011.10.003; Stirrat M, 2012, PSYCHOL SCI, V23, P718, DOI 10.1177/0956797611435133; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; Thompson AE, 2013, CANADIAN J HUMAN SEX, V22, P5, DOI DOI 10.3138/cjhs.929; van den Bos W, 2008, JUDGM DECIS MAK, V3, P483; van den Bos W, 2013, J NEUROSCI, V33, P2137, DOI 10.1523/JNEUROSCI.3095-12.2013; Van Dongen S., 2012, SEX HORMONES, P293; van't Wout M, 2008, COGNITION, V108, P796, DOI 10.1016/j.cognition.2008.07.002; Veldhuis JD, 2005, ENDOCR REV, V26, P114, DOI 10.1210/er.2003-0038; Verdonck A, 1999, EUR J ORTHODONT, V21, P137, DOI 10.1093/ejo/21.2.137; Weston EM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000710; Windhager S, 2011, AM J HUM BIOL, V23, P805, DOI 10.1002/ajhb.21219; Yong E, 2012, NATURE, V485, P298, DOI 10.1038/485298a; Zar, 2011, BIOSTAT ANAL; Zheng ZG, 2011, P NATL ACAD SCI USA, V108, P16289, DOI 10.1073/pnas.1108312108; Zitzmann M, 2001, EUR J ENDOCRINOL, V144, P183, DOI 10.1530/eje.0.1440183	96	17	17	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112157	10.1371/journal.pone.0112157	http://dx.doi.org/10.1371/journal.pone.0112157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CP	25389770	Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400059
J	D'Souza, JW; Reddy, S; Goldsmith, LE; Shchaveleva, I; Marks, JD; Litwin, S; Robinson, MK				D'Souza, Jimson W.; Reddy, Smitha; Goldsmith, Lisa E.; Shchaveleva, Irina; Marks, James D.; Litwin, Samuel; Robinson, Matthew K.			Combining Anti-ERBB3 Antibodies Specific for Domain I and Domain III Enhances the Anti-Tumor Activity over the Individual Monoclonal Antibodies	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; METASTATIC BREAST-CANCER; FACTOR RECEPTOR; EXTRACELLULAR DOMAINS; TYROSINE KINASE; LIGAND-BINDING; TUMOR-GROWTH; CELL-LINES; HER3; ERBB3	Background: Inappropriate signaling through the epidermal growth factor receptor family (EGFR1/ERBB1, ERBB2/HER2, ERBB3/HER3, and ERBB4/HER4) of receptor tyrosine kinases leads to unregulated activation of multiple downstream signaling pathways that are linked to cancer formation and progression. In particular, ERBB3 plays a critical role in linking ERBB signaling to the phosphoinositide 3-kinase and Akt signaling pathway and increased levels of ERBB3-dependent signaling is also increasingly recognized as a mechanism for acquired resistance to ERBB-targeted therapies. Methods: We had previously reported the isolation of a panel of anti-ERBB3 single-chain Fv antibodies through use of phage-display technology. In the current study scFv specific for domain I (F4) and domain III (A5) were converted into human IgG1 formats and analyzed for efficacy. Results: Treatment of cells with an oligoclonal mixture of the A5/F4 IgGs appeared more effective at blocking both ligand-induced and ligand-independent signaling through ERBB3 than either single IgG alone. This correlated with improved ability to inhibit the cell growth both as a single agent and in combination with other ERBB-targeted therapies. Treatment of NCI-N87 tumor xenografts with the A5/F4 oligoclonal led to a statistically significant decrease in tumor growth rate that was further enhanced in combination with trastuzumab. Conclusion: These results suggest that an oligoclonal antibody mixture may be a more effective approach to downregulate ERBB3-dependent signaling.	[D'Souza, Jimson W.; Reddy, Smitha; Goldsmith, Lisa E.; Shchaveleva, Irina; Robinson, Matthew K.] Fox Chase Canc Ctr, Mol Therapeut Program, Philadelphia, PA 19111 USA; [Litwin, Samuel] Fox Chase Canc Ctr, Biostat & Bioinformat Facil, Philadelphia, PA 19111 USA; [Marks, James D.] Univ Calif San Francisco, Dept Anesthesia & Pharmaceut Chem, San Francisco, CA 94143 USA	Fox Chase Cancer Center; Fox Chase Cancer Center; University of California System; University of California San Francisco	Robinson, MK (corresponding author), Fox Chase Canc Ctr, Mol Therapeut Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	matthew.robinson@fccc.edu			American Cancer Society [MRSG-08-018-01-CDD]; NIH [CA09035, CA06927, P50 CA00588207]; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by American Cancer Society Grant MRSG-08-018-01-CDD (MKR), NIH post-doctoral training grant CA09035 (S.R., L.E.G.), NIH CORE Grant CA06927, and P50 CA00588207 (J.D.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIMANDI M, 1995, ONCOGENE, V10, P1813; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Baselga J, 2010, J CLIN ONCOL, V28, P1138, DOI 10.1200/JCO.2009.24.2024; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Ben-Kasus T, 2009, P NATL ACAD SCI USA, V106, P3294, DOI 10.1073/pnas.0812059106; Blackburn E, 2012, BREAST CANCER RES TR, V134, P53, DOI 10.1007/s10549-011-1908-1; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Campbell MR, 2010, CLIN CANCER RES, V16, P1373, DOI 10.1158/1078-0432.CCR-09-1218; Friedman LM, 2005, P NATL ACAD SCI USA, V102, P1915, DOI 10.1073/pnas.0409610102; Garrett JT, 2013, CLIN CANCER RES, V19, P610, DOI 10.1158/1078-0432.CCR-12-2024; Garrett JT, 2011, P NATL ACAD SCI USA, V108, P5021, DOI 10.1073/pnas.1016140108; Garrett JT, 2013, CANC RES; Gostring L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040023; Hettmann T, 2010, U3 1287 AMG 888 FULL; Horak E, 2005, CANCER BIOTHER RADIO, V20, P603, DOI 10.1089/cbr.2005.20.603; Hsieh AC, 2007, BRIT J CANCER, V97, P453, DOI 10.1038/sj.bjc.6603910; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Jaiswal BS, 2013, CANCER CELL, V23, P603, DOI 10.1016/j.ccr.2013.04.012; Kani K, 2005, BIOCHEMISTRY-US, V44, P15842, DOI 10.1021/bi0515220; Lazrek Y, 2013, NEOPLASIA, V15, P335, DOI 10.1593/neo.121960; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Lemmon MA, 1997, EMBO J, V16, P281, DOI 10.1093/emboj/16.2.281; McDonagh CF, 2012, MOL CANCER THER, V11, P582, DOI 10.1158/1535-7163.MCT-11-0820; Menendez JA, 2006, J CLIN ONCOL, V24, P3735, DOI 10.1200/JCO.2005.04.3489; Motoyama AB, 2002, CANCER RES, V62, P3151; North B, 2011, J MOL BIOL, V406, P228, DOI 10.1016/j.jmb.2010.10.030; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; Ramakrishnan MS, 2009, MABS-AUSTIN, V1, P41, DOI 10.4161/mabs.1.1.7509; Robinson MK, 2008, BRIT J CANCER, V99, P1415, DOI 10.1038/sj.bjc.6604700; Robinson MK, 2011, CANC PRINCIPLES PRAC, P499; Rudnick SI, 2011, CANCER RES, V71, P2250, DOI 10.1158/0008-5472.CAN-10-2277; Sala G, 2012, ONCOGENE, V31, P1275, DOI 10.1038/onc.2011.322; Schaefer G, 2011, CANCER CELL, V20, P472, DOI 10.1016/j.ccr.2011.09.003; Schmiedel J, 2008, CANCER CELL, V13, P365, DOI 10.1016/j.ccr.2008.02.019; Schoeberl B, 2010, CANCER RES, V70, P2485, DOI 10.1158/0008-5472.CAN-09-3145; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; SOLTOFF SP, 1994, MOL CELL BIOL, V14, P3550, DOI 10.1128/MCB.14.6.3550; Spangler JB, 2010, P NATL ACAD SCI USA, V107, P13252, DOI 10.1073/pnas.0913476107; Talavera A, 2009, CANCER RES, V69, P5851, DOI 10.1158/0008-5472.CAN-08-4518; Tang Y, 2007, J IMMUNOL, V179, P2815, DOI 10.4049/jimmunol.179.5.2815; van der Horst EH, 2005, INT J CANCER, V115, P519, DOI 10.1002/ijc.20867; Wakankar AA, 2010, BIOCONJUGATE CHEM, V21, P1588, DOI 10.1021/bc900434c; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Zhang K, 1996, J BIOL CHEM, V271, P3884	44	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112376	10.1371/journal.pone.0112376	http://dx.doi.org/10.1371/journal.pone.0112376			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386657	gold, Green Published, Green Submitted			2022-12-27	WOS:000345250400058
J	Lang, SJ; Bischoff, M; Bohringer, D; Seitz, B; Reinhard, T				Lang, Stefan J.; Bischoff, Mona; Boehringer, Daniel; Seitz, Berthold; Reinhard, Thomas			Analysis of the Changes in Keratoplasty Indications and Preferred Techniques	PLOS ONE			English	Article							MEMBRANE ENDOTHELIAL KERATOPLASTY; POSTERIOR LAMELLAR KERATOPLASTY; PENETRATING KERATOPLASTY; FEMTOSECOND LASER; EXCIMER-LASER; TISSUE-TRANSPLANTATION; SURGICAL TECHNIQUE; CORNEAL BUTTONS; DEEP; BIOTECHNOLOGY	Background: Recently, novel techniques introduced to the field of corneal surgery, e. g. Descemet membrane endothelial keratoplasty (DMEK) and corneal crosslinking, extended the therapeutic options. Additionally contact lens fitting has developed new alternatives. We herein investigated, whether these techniques have affected volume and spectrum of indications of keratoplasties in both a center more specialized in treating Fuchs' dystrophy (center 1) and a second center that is more specialized in treating keratoconus (center 2). Methods: We retrospectively reviewed the waiting lists for indication, transplantation technique and the patients' travel distances to the hospital at both centers. Results: We reviewed a total of 3778 procedures. Fuchs' dystrophy increased at center 1 from 17% (42) to 44% (150) and from 13% (27) to 23% (62) at center 2. In center 1, DMEK increased from zero percent in 2010 to 51% in 2013. In center 2, DMEK was not performed until 2013. The percentage of patients with keratoconus slightly decreased from 15% (36) in 2009 vs. 12% (40) in 2013 in center 1. The respective percentages in center 2 were 28% (57) and 19% (51). In both centers, the patients' travel distances increased. Conclusions: The results from center 1 suggest that DMEK might increase the total number of keratoplasties. The increase in travel distance suggests that this cannot be fully attributed to recruiting the less advanced patients from the hospital proximity. The increase is rather due to more referrals from other regions. The decrease of keratoconus patients in both centers is surprising and may be attributed to optimized contact lens fitting or even to the effect corneal crosslinking procedure.	[Lang, Stefan J.; Boehringer, Daniel; Reinhard, Thomas] Univ Freiburg, Ctr Eye, D-79106 Freiburg, Germany; [Bischoff, Mona; Seitz, Berthold] Univ Saarland, Med Ctr, Dept Ophthalmol, Homburg, Germany	University of Freiburg; Saarland University	Lang, SJ (corresponding author), Univ Freiburg, Ctr Eye, Hugstetter Str 55, D-79106 Freiburg, Germany.	stefan.lang@uniklinik-freiburg.de	Seitz, Berthold/AAB-8546-2019; Lang, Stefan J./I-5169-2019	Seitz, Berthold/0000-0001-9701-8204; Lang, Stefan J./0000-0002-5324-7002				Anwar M, 2002, CORNEA, V21, P374, DOI 10.1097/00003226-200205000-00009; ARENTSEN JJ, 1976, AM J OPHTHALMOL, V81, P313, DOI 10.1016/0002-9394(76)90246-4; Bahar I, 2008, CORNEA, V27, P209, DOI 10.1097/ICO.0b013e31815b7d50; Birnbaum F, 2013, GRAEF ARCH CLIN EXP, V251, P95, DOI 10.1007/s00417-012-2054-0; CHAU GK, 1992, BRIT J OPHTHALMOL, V76, P646, DOI 10.1136/bjo.76.11.646; Cursiefen C, 1998, CORNEA, V17, P468, DOI 10.1097/00003226-199809000-00002; DAMJI KF, 1990, CAN J OPHTHALMOL, V25, P243; Galvis V, 2013, OPEN OPHTHALMOL J, V7, P30, DOI 10.2174/1874364101307010030; Gorovoy MS, 2006, CORNEA, V25, P886, DOI 10.1097/01.ico.0000214224.90743.01; Heinzelmann S, 2013, GRAEF ARCH CLIN EXP, V251, P1979, DOI 10.1007/s00417-013-2359-7; Heinzelmann S, 2014, CORNEA, V33, P644, DOI 10.1097/ICO.0000000000000106; Ignacio TS, 2006, CORNEA, V25, P336, DOI 10.1097/01.ico.0000179739.31196.e8; Jones DT, 1998, INVEST OPHTHAMOL VIS; Kang PC, 2005, CORNEA, V24, P801, DOI 10.1097/01.ico.0000157407.43699.22; Lang G K, 1988, Fortschr Ophthalmol, V85, P255; Lang G K, 1989, Fortschr Ophthalmol, V86, P437; LANG GK, 1989, OPHTHALMIC SURG LAS, V20, P262; Levinger E, 2014, CORNEA, V33, P481, DOI 10.1097/ICO.0000000000000080; Melles GRJ, 2006, CORNEA, V25, P987, DOI 10.1097/01.ico.0000248385.16896.34; Melles GRJ, 1998, CORNEA, V17, P618, DOI 10.1097/00003226-199811000-00010; Melles GRJ, 2000, CORNEA, V19, P427, DOI 10.1097/00003226-200007000-00004; Pahor D, 2007, KLIN MONATSBL AUGENH, V224, P110, DOI 10.1055/s-2007-962962; Price FW, 2005, J REFRACT SURG, V21, P339; Reinshagen H, 2014, KLIN MONATSBL AUGENH, V231, P262, DOI 10.1055/s-0033-1360354; Reinshagen H, 2012, KLIN MONATSBL AUGENH, V229, P554, DOI 10.1055/s-0031-1299354; Schulze R, 2009, AM J OPHTHALMOL, V147, P755, DOI 10.1016/j.ajo.2008.12.019; Seitz B, 2004, OPHTHALMOLOGE, V101, P478, DOI 10.1007/s00347-003-0900-5; Seitz B, 1999, OPHTHALMOLOGY, V106, P1156, DOI 10.1016/S0161-6420(99)90265-8; SMITH RE, 1980, ARCH OPHTHALMOL-CHIC, V98, P1226, DOI 10.1001/archopht.1980.01020040078009; Terry MA, 2000, CORNEA, V19, P611, DOI 10.1097/00003226-200009000-00006; TILLETT CW, 1956, AM J OPHTHALMOL, V41, P530, DOI 10.1016/0002-9394(56)91269-7; Tourtas T, 2012, AM J OPHTHALMOL, V153, P1082, DOI 10.1016/j.ajo.2011.12.012; Wang J, 2013, GRAEF ARCH CLIN EXP, V251, P797, DOI 10.1007/s00417-012-2117-2; Zirm E K, 1989, Refract Corneal Surg, V5, P258	34	40	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112696	10.1371/journal.pone.0112696	http://dx.doi.org/10.1371/journal.pone.0112696			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386909	Green Submitted, Green Published, gold			2022-12-27	WOS:000345250400083
J	Vicente-Dolera, N; Troadec, C; Moya, M; del Rio-Celestino, M; Pomares-Viciana, T; Bendahmane, A; Pico, B; Roman, B; Gomez, P				Vicente-Dolera, Nelly; Troadec, Christelle; Moya, Manuel; del Rio-Celestino, Mercedes; Pomares-Viciana, Teresa; Bendahmane, Abdelhafid; Pico, Belen; Roman, Belen; Gomez, Pedro			First TILLING Platform in Cucurbita pepo: A New Mutant Resource for Gene Function and Crop Improvement	PLOS ONE			English	Article							INDUCED MUTATIONS; DISCOVERY; POPULATION; TOOL	Although the availability of genetic and genomic resources for Cucurbita pepo has increased significantly, functional genomic resources are still limited for this crop. In this direction, we have developed a high throughput reverse genetic tool: the first TILLING (Targeting Induced Local Lesions IN Genomes) resource for this species. Additionally, we have used this resource to demonstrate that the previous EMS mutant population we developed has the highest mutation density compared with other cucurbits mutant populations. The overall mutation density in this first C. pepo TILLING platform was estimated to be 1/133 Kb by screening five additional genes. In total, 58 mutations confirmed by sequencing were identified in the five targeted genes, thirteen of which were predicted to have an impact on the function of the protein. The genotype/phenotype correlation was studied in a peroxidase gene, revealing that the phenotype of seedling homozygous for one of the isolated mutant alleles was albino. These results indicate that the TILLING approach in this species was successful at providing new mutations and can address the major challenge of linking sequence information to biological function and also the identification of novel variation for crop breeding.	[Vicente-Dolera, Nelly; Moya, Manuel; del Rio-Celestino, Mercedes; Pomares-Viciana, Teresa; Gomez, Pedro] IFAPA Ctr La Mojonera, La Mojonera, Almeria, Spain; [Troadec, Christelle; Bendahmane, Abdelhafid] INRA URGV, UMR1165, Unite Rech Genom Vegetale, Saclay Plant Sci, Evry, France; [Pico, Belen] Univ Politecn Valencia, Inst Conservat & Breeding Agr Biodivers COMAV UPV, Valencia 46022, Spain; [Roman, Belen] IFAPA Ctr Alameda del Obispo, Cordoba 14004, Spain	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Universitat Politecnica de Valencia	Gomez, P (corresponding author), IFAPA Ctr La Mojonera, Camino San Nicolas 1, La Mojonera, Almeria, Spain.	pedro.gomez.j@juntadeandalucia.es	Del Río Celestino, Mercedes/C-3815-2016; Román, Belén/V-9092-2018; Román, Belén/ABG-8794-2020; PICO, BELEN/K-6517-2014	Del Río Celestino, Mercedes/0000-0001-9130-2669; Román, Belén/0000-0003-3796-5546; Román, Belén/0000-0003-3796-5546; PICO, BELEN/0000-0001-7761-990X; Bendahmane, Abdelhafid/0000-0003-3246-868X; TROADEC, Christelle/0000-0003-1927-7352	Spanish Project INIA (Instituto Nacional de Investigacion y Tecnologia Agraria y Almentaria) [RTA2011-00044C02-01]; ANR MELODY [ANR-11-BSV7-0024]; European Research Council (ERCSEXYPARTH); FEDER; FSE funds; Andalusian Institute of Agronomy Research IFAPA	Spanish Project INIA (Instituto Nacional de Investigacion y Tecnologia Agraria y Almentaria); ANR MELODY(French National Research Agency (ANR)); European Research Council (ERCSEXYPARTH)(European Research Council (ERC)); FEDER(European Commission); FSE funds; Andalusian Institute of Agronomy Research IFAPA	Financial support was provided by the Spanish Project INIA (Instituto Nacional de Investigacion y Tecnologia Agraria y Almentaria) RTA2011-00044C02-01, the ANR MELODY (ANR-11-BSV7-0024), the European Research Council (ERCSEXYPARTH), FEDER, and FSE funds. NVD has been awarded a grant by the Andalusian Institute of Agronomy Research IFAPA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanca J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-104; Boualem A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097963; Campa A., 1991, PEROXIDASES CHEM BIO, P25; Carpin S, 2001, PLANT CELL, V13, P511, DOI 10.1105/tpc.13.3.511; Carpin S, 1999, PLANT PHYSIOL, V120, P1; Chantreau M, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-159; Colbert T, 2001, PLANT PHYSIOL, V126, P480, DOI 10.1104/pp.126.2.480; Cosio C, 2009, PLANTA, V229, P823, DOI 10.1007/s00425-008-0876-0; Dahmani-Mardas F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015776; Dalmais M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r43; Dong CM, 2009, PLANT GENOME-US, V2, P39, DOI 10.3835/plantgenome2008.10.0012; Elias Rana, 2009, BMC Res Notes, V2, P141, DOI 10.1186/1756-0500-2-141; Esteras C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-80; Gady ALF, 2012, MOL BREEDING, V29, P801, DOI 10.1007/s11032-011-9591-9; Gilchrist E, 2010, BRIEF FUNCT GENOMICS, V9, P103, DOI 10.1093/bfgp/elp059; Gonzalez Mireia, 2011, BMC Res Notes, V4, P289, DOI 10.1186/1756-0500-4-289; Greene EA, 2003, GENETICS, V164, P731; Kumar APK, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-38; Kurowska M, 2011, J APPL GENET, V52, P371, DOI 10.1007/s13353-011-0061-1; MARKIEWICZ P, 1994, J MOL BIOL, V240, P421, DOI 10.1006/jmbi.1994.1458; Martin B, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-147; McCallum CM, 2000, PLANT PHYSIOL, V123, P439, DOI 10.1104/pp.123.2.439; Minoia Silvia, 2010, BMC Res Notes, V3, P69, DOI 10.1186/1756-0500-3-69; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Obrero A, 2013, J AGR FOOD CHEM, V61, P6393, DOI 10.1021/jf4004576; Paris HS, 2003, THEOR APPL GENET, V106, P971, DOI 10.1007/S00122-002-1157-0; Parry MAJ, 2009, J EXP BOT, V60, P2817, DOI 10.1093/jxb/erp189; Rawat N, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-205; Rigola D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004761; Schuller DJ, 1996, STRUCTURE, V4, P311, DOI 10.1016/S0969-2126(96)00035-4; Sisko M, 2003, PLANT SCI, V165, P663, DOI 10.1016/S0168-9452(03)00256-5; Stephenson P, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-62; Suzuki T, 2008, MOL GENET GENOMICS, V279, P213, DOI 10.1007/s00438-007-0293-2; Taylor NE, 2003, NUCLEIC ACIDS RES, V31, P3808, DOI 10.1093/nar/gkg574; Till BJ, 2003, METH MOL B, V236, P205; Triques K, 2007, PLANT J, V51, P1116, DOI 10.1111/j.1365-313X.2007.03201.x; Uauy C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-115; Vicente-Dolera N, 2014, SCI HORTIC-AMSTERDAM, V169, P14, DOI 10.1016/j.scienta.2014.01.045; Wang TL, 2012, PLANT BIOTECHNOL J, V10, P761, DOI 10.1111/j.1467-7652.2012.00708.x; Welinder KG, 2002, EUR J BIOCHEM, V269, P6063, DOI 10.1046/j.1432-1033.2002.03311.x; Whitwood W. N., 1978, Cucurbit Genetics Cooperative, P34; Wienholds E, 2003, GENOME RES, V13, P2700, DOI 10.1101/gr.1725103	42	20	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112743	10.1371/journal.pone.0112743	http://dx.doi.org/10.1371/journal.pone.0112743			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386735	Green Submitted, Green Published, gold			2022-12-27	WOS:000345250400088
J	Zhou, CY; Li, G; Zhou, JJ; Han, N; Liu, ZH; Yin, J				Zhou, Chengyan; Li, Gang; Zhou, Jingjing; Han, Na; Liu, Zhihui; Yin, Jun			miR-107 Activates ATR/Chk1 Pathway and Suppress Cervical Cancer Invasion by Targeting MCL1	PLOS ONE			English	Article							MICRORNA; MIRNAS	MicroRNAs (miRNAs) are a class of single-stranded, non-coding RNAs of about 22 nucleotides in length. Increasing evidence implicates miRNAs may function as oncogenes or tumor suppressors. Here we showed that miR-107 directly targeted MCL1 and activated ATR/Chk1 pathway to inhibit proliferation, migration and invasiveness of cervical cancer cells. Moreover, we found that MCL1 was frequently up-regulated in cervical cancer, and knockdown of MCL1 markedly inhibited cancer cell proliferation, migration and invasion, whereas ectopic expression of MCL1 significantly enhances these properties. The restoration of MCL1 expression can counteract the effect of miR-107 on the cancer cells. Together, miR-107 is a new regulator of MCL1, and both miR-107 and MCL1 play important roles in the pathogenesis of cervical cancer. We have therefore identified a mechanism for ATR/Chk1 pathway which involves an increase in miR-107 leading to a decrease in MCL1. Correspondingly, our results revealed that miR-107 affected ATR/Chk1 signalling and gene expression, and implicated miR-107 as a therapeutic target in human cervical cancer. We also demonstrated that taxol attenuated migration and invasion in cervical cancer cells by activating the miR-107, in which miR-107 play an important role in regulating the expression of MCL1. Elucidation of this discovered MCL1 was directly regulated by miR-107 will greatly enhance our understanding of the mechanisms responsible for cervical cancer and will provide an additional arm for the development of anticancer therapies.	[Zhou, Chengyan; Zhou, Jingjing; Han, Na; Liu, Zhihui; Yin, Jun] Shenyang Pharmaceut Univ, Sch Tradit Chinese Mat Med, Key Lab Northeast Authent Mat Res & Dev Liaoning, Dev & Utilizat Key Lab Northeast Plant Mat, Shenyang 110016, Peoples R China; [Li, Gang] Harbin Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Harbin 150081, Peoples R China	Shenyang Pharmaceutical University; Harbin Medical University	Yin, J (corresponding author), Shenyang Pharmaceut Univ, Sch Tradit Chinese Mat Med, Key Lab Northeast Authent Mat Res & Dev Liaoning, Dev & Utilizat Key Lab Northeast Plant Mat, Wenhua Rd 103, Shenyang 110016, Peoples R China.	junyin_good@163.com			National High Technology Research and Development Program of China (863 program) [2010AA023002]; National 12th Five-Year Scientific and Technical Support Program of China [2012BAI02B02]	National High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); National 12th Five-Year Scientific and Technical Support Program of China	This work was funded by National High Technology Research and Development Program of China (863 program) (2010AA023002) and the National 12th Five-Year Scientific and Technical Support Program of China (2012BAI02B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen L, 2013, CELL MOL NEUROBIOL, V33, P651, DOI 10.1007/s10571-013-9927-6; Chen PS, 2011, J CLIN INVEST, V121, P3442, DOI 10.1172/JCI45390; Hosaka K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3129; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Kanellopoulou C, 2009, P NATL ACAD SCI USA, V106, P1122, DOI 10.1073/pnas.0812210106; Kawahara Y, 2012, P NATL ACAD SCI USA, V109, P3347, DOI 10.1073/pnas.1112427109; Lamprecht B, 2010, NAT MED, V16, P571, DOI 10.1038/nm.2129; Lin CW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2876; Liu J, 2008, CANCER RES, V68, P8871, DOI 10.1158/0008-5472.CAN-08-1972; Oakes SR, 2012, P NATL ACAD SCI USA, V109, P2766, DOI 10.1073/pnas.1104778108; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Pietrosiuk Agnieszka, 2004, Acta Pol Pharm, V61, P379; Polytarchou C, 2012, P NATL ACAD SCI USA, V109, P14470, DOI 10.1073/pnas.1212811109; Rob L, 2010, LANCET ONCOL, V11, P292, DOI 10.1016/S1470-2045(09)70191-3; Siciliano V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3364; Tai WT, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.18; Tan CL, 2013, SCIENCE, V342, P1254, DOI 10.1126/science.1244193; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Wahl AF, 1996, NAT MED, V2, P72, DOI 10.1038/nm0196-72; Xin JX, 2013, ONCOL LETT, V6, P1025, DOI 10.3892/ol.2013.1473; Xu GL, 2013, NAT MED, V19, P1141, DOI 10.1038/nm.3287; Xue XC, 2014, EUR J IMMUNOL, V44, P673, DOI 10.1002/eji.201343717; Zhang HS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1555	23	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111860	10.1371/journal.pone.0111860	http://dx.doi.org/10.1371/journal.pone.0111860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386925	gold, Green Published, Green Submitted			2022-12-27	WOS:000345250400028
J	Li, XL; Sluijter, M; Doorduijn, EM; Kale, SP; McFerrin, H; Liu, YY; Li, Y; Mottamal, M; Yao, X; Du, FK; Gu, BH; Hoang, K; Nguyen, YH; Taylor, N; Stephens, CR; van Hall, T; Zhang, QJ				Li, Xiao-Lin; Sluijter, Marjolein; Doorduijn, Elien M.; Kale, Shubha P.; McFerrin, Harris; Liu, Yong-Yu; Li, Yan; Mottamal, Madhusoodanan; Yao, Xin; Du, Fengkun; Gu, Baihan; Hoang, Kim; Nguyen, Yen H.; Taylor, Nichelle; Stephens, Chelsea R.; van Hall, Thorbald; Zhang, Qian-Jin			Limited Density of an Antigen Presented by RMA-S Cells Requires B7-1/CD28 Signaling to Enhance T-Cell Immunity at the Effector Phase	PLOS ONE			English	Article							CANCER; CD80; COSTIMULATION; EXPRESSION; RECEPTOR; TAP; ACTIVATION; INDUCTION; ANTIBODY; THERAPY	The association of B7-1/CD28 between antigen presenting cells (APCs) and T-cells provides a second signal to proliferate and activate T-cell immunity at the induction phase. Many reports indicate that tumor cells transfected with B7-1 induced augmented antitumor immunity at the induction phase by mimicking APC function; however, the function of B7-1 on antitumor immunity at the effector phase is unknown. Here, we report direct evidence of enhanced T-cell antitumor immunity at the effector phase by the B7-1 molecule. Our experiments in vivo and in vitro indicated that reactivity of antigen-specific monoclonal and polyclonal T-cell effectors against a Lass5 epitope presented by RMA-S cells is increased when the cells expressed B7-1. Use of either anti-B7-1 or anti-CD28 antibodies to block the B7-1/CD28 association reduced reactivity of the T effectors against B7-1 positive RMA-S cells. Transfection of Lass5 cDNA into or pulse of Lass5 peptide onto B7-1 positive RMA-S cells overcomes the requirement of the B7-1/CD28 signal for T effector response. To our knowledge, the data offers, for the first time, strong evidence that supports the requirement of B7-1/CD28 secondary signal at the effector phase of antitumor T-cell immunity being dependent on the density of an antigenic peptide.	[Li, Xiao-Lin; Kale, Shubha P.; McFerrin, Harris; Li, Yan; Mottamal, Madhusoodanan; Yao, Xin; Du, Fengkun; Gu, Baihan; Hoang, Kim; Nguyen, Yen H.; Taylor, Nichelle; Stephens, Chelsea R.; Zhang, Qian-Jin] Xavier Univ, Dept Biol, New Orleans, LA 70125 USA; [Sluijter, Marjolein; Doorduijn, Elien M.; van Hall, Thorbald] Leiden Univ, Med Ctr, Leiden, Netherlands; [Liu, Yong-Yu] Univ Louisiana Monroe, Dept Basic Pharmaceut Sci, Monroe, LA USA; [Li, Yan] Hebei Univ, Coll Chem & Environm Sci, Baoding, Hebei Province, Peoples R China	Xavier University of Louisiana; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Louisiana System; University of Louisiana Monroe; Hebei University	Zhang, QJ (corresponding author), Xavier Univ, Dept Biol, New Orleans, LA 70125 USA.	qzhang2@xula.edu	van Hall, Thorbald/Y-5651-2018	van Hall, Thorbald/0000-0002-9115-558X; Liu, Yong-Yu/0000-0002-7968-0162	NIH (RCMI) [8G12MD007595]; Louisiana Cancer Research Consortium (LCRC); Xavier University's Center for Undergraduate Research (CUR); Dutch Cancer Society [UL2010-4785]; NIGMS [P20GM103424]; Louisiana Board of Regents Eminent Alumni Scholars Program, Kellogg Professorship IV in the Arts and Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103424] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007595] Funding Source: NIH RePORTER	NIH (RCMI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Cancer Research Consortium (LCRC); Xavier University's Center for Undergraduate Research (CUR); Dutch Cancer Society(KWF Kankerbestrijding); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Louisiana Board of Regents Eminent Alumni Scholars Program, Kellogg Professorship IV in the Arts and Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by funding from NIH (RCMI, 8G12MD007595), Louisiana Cancer Research Consortium (LCRC) and Xavier University's Center for Undergraduate Research (CUR) to Dr. Qian-Jin Zhang. Dr. Thorbald van Hallwas supported by Dutch Cancer Society (UL2010-4785). Dr. Harris McFerrin was supported by funding from the NIGMS (P20GM103424). This study was also supported by funding from Louisiana Board of Regents Eminent Alumni Scholars Program, Kellogg Professorship IV in the Arts and Sciences to Dr. Shubha P. Kale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anikeeva N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041466; Bai XF, 2001, J IMMUNOL, V167, P3936, DOI 10.4049/jimmunol.167.7.3936; Bixby DL, 1998, INT J CANCER, V78, P685, DOI 10.1002/(SICI)1097-0215(19981209)78:6<685::AID-IJC4>3.3.CO;2-3; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; Boussiotis VA, 1996, IMMUNOL REV, V153, P5, DOI 10.1111/j.1600-065X.1996.tb00918.x; Boyerinas B, 2012, INT J CANCER, V130, P1787, DOI 10.1002/ijc.26190; Bueler H, 1996, MOL MED, V2, P545, DOI 10.1007/BF03401639; Chambers BJ, 1996, IMMUNITY, V5, P311, DOI 10.1016/S1074-7613(00)80257-5; CHEN LP, 1992, CELL, V71, P1093, DOI 10.1016/S0092-8674(05)80059-5; Cochran JR, 2001, TRENDS BIOCHEM SCI, V26, P304, DOI 10.1016/S0968-0004(01)01815-1; Dolfi DV, 2011, J IMMUNOL, V186, P4599, DOI 10.4049/jimmunol.1001972; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Germain RN, 1997, CURR BIOL, V7, pR640, DOI 10.1016/S0960-9822(06)00323-X; Hufford MM, 2011, J EXP MED, V208, P167, DOI 10.1084/jem.20101850; Kaufmann AM, 1997, CANCER GENE THER, V4, P377; Kelly JM, 2002, J IMMUNOL, V168, P4472, DOI 10.4049/jimmunol.168.9.4472; LEVITSKY HI, 1994, J EXP MED, V179, P1215, DOI 10.1084/jem.179.4.1215; Li XL, 2009, IMMUNOLOGY, V128, P420, DOI 10.1111/j.1365-2567.2009.03127.x; Li XL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006385; Ly LV, 2013, J IMMUNOL, V190, P489, DOI 10.4049/jimmunol.1200135; Oliveira CC, 2011, EUR J IMMUNOL, V41, P3114, DOI 10.1002/eji.201141836; RAZIWOLF Z, 1992, P NATL ACAD SCI USA, V89, P4210, DOI 10.1073/pnas.89.9.4210; Ritz U, 2001, MOL MED, V7, P149, DOI 10.1007/BF03401948; ROBEY E, 1995, IMMUNOL TODAY, V16, P306, DOI 10.1016/0167-5699(95)80140-5; Seliger B, 1997, IMMUNOL TODAY, V18, P292, DOI 10.1016/S0167-5699(97)01052-9; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351; van Hall T, 2006, NAT MED, V12, P417, DOI 10.1038/nm1381; van Hall T, 2000, J EXP MED, V192, P483, DOI 10.1084/jem.192.4.483; VanGool SW, 1996, IMMUNOL REV, V153, P47; Wolpert EZ, 1997, P NATL ACAD SCI USA, V94, P11496, DOI 10.1073/pnas.94.21.11496; Wu Y, 1997, J EXP MED, V185, P1327, DOI 10.1084/jem.185.7.1327; Yu XZ, 2000, J IMMUNOL, V164, P4564, DOI 10.4049/jimmunol.164.9.4564; Zang XX, 2007, CLIN CANCER RES, V13, P5271, DOI 10.1158/1078-0432.CCR-07-1030	34	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e108192	10.1371/journal.pone.0108192	http://dx.doi.org/10.1371/journal.pone.0108192			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383875	Green Submitted, Green Published, gold			2022-12-27	WOS:000344816700002
J	Mbondji-Wonje, C; Ragupathy, V; Zhao, JQ; Nanfack, A; Lee, S; Torimiro, J; Nyambi, P; Hewlett, IK				Mbondji-Wonje, Christelle; Ragupathy, Viswanath; Zhao, Jiangqin; Nanfack, Aubin; Lee, Sherwin; Torimiro, Judith; Nyambi, Phillipe; Hewlett, Indira K.			Genotypic Prediction of Tropism of Highly Diverse HIV-1 Strains from Cameroon	PLOS ONE			English	Article							VIRUS TYPE-1 GP120; GENETIC DIVERSITY; INTERSUBTYPE RECOMBINANTS; BLOOD-DONORS; V3 LOOP; CCR5; PREVALENCE; CRF02-AG; SUBTYPES; CXCR4	Background: The use of CCR5 antagonists involves determination of HIV-1 tropism prior to initiation of treatment. HIV-1 tropism can be assessed either by phenotypic or genotypic methods. Genotypic methods are extensively used for tropism prediction. However, their validation in predicting tropism of viral isolates belonging to group M non-B subtypes remains challenging. In Cameroon, the genetic diversity of HIV-1 strains is the broadest reported worldwide. To facilitate the integration of CCR5 antagonists into clinical practice in this region, there is a need to evaluate the performance of genotypic methods for predicting tropism of highly diverse group M HIV-1 strains. Methods: Tropism of diverse HIV-1 strains isolated from PBMCs from Cameroon was determined using the GHOST cell assay. Prediction, based on V3 sequences from matched plasma samples, was determined using bioinformatics algorithms and rules based on position 11/25 and net charge applied independently or combined according to Delobel's and Garrido's rules. Performance of genotypic methods was evaluated by comparing prediction generated with tropism assigned by the phenotypic assay. Results: Specificity for predicting R5-tropic virus was high, ranging from 83.7% to 97.7% depending on the genotypic methods used. Sensitivity for X4-tropic viruses was fairly low, ranging from 33.3% to 50%. In our study, overall, genotypic methods were less able to accurately predict X4-tropic virus belonging to subtype CRF02_AG. In addition, it was found that of the methods we used the Garrido rule has the highest sensitivity rate of over 50% with a specificity of 93%. Conclusion: Our study demonstrated that overall, genotypic methods were less sensitive for accurate prediction of HIV-1 tropism in settings where diverse HIV-1 strains co-circulate. Our data suggest that further optimization of genotypic methods is needed and that larger studies to determine their utility for tropism prediction of diverse HIV-1 strains may be warranted.	[Mbondji-Wonje, Christelle; Ragupathy, Viswanath; Zhao, Jiangqin; Lee, Sherwin; Hewlett, Indira K.] Ctr Biol Evaluat & Res, Div Emerging & Transmiss Transmitted Dis, Mol Virol Lab, Off Blood Review & Res,Food & Drug Adm, Silver Spring, MD 20993 USA; [Mbondji-Wonje, Christelle] Univ Douala, Fac Med Pharm & Biomed Sci, Douala, Cameroon; [Nanfack, Aubin; Torimiro, Judith] Chantal Biya Int Reference Ctr, Yaounde, Cameroon; [Nanfack, Aubin] NYU, Sch Med, Dept Pathol, New York, NY USA	US Food & Drug Administration (FDA); New York University	Mbondji-Wonje, C (corresponding author), Ctr Biol Evaluat & Res, Div Emerging & Transmiss Transmitted Dis, Mol Virol Lab, Off Blood Review & Res,Food & Drug Adm, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA.	christelle.mbondji@fda.hhs.gov	mbondji, christelle/Q-3145-2019; Ragupathy, Viswanath/ABA-3444-2021	mbondji, christelle/0000-0001-7222-9849; Zhao, Jiangqin/0000-0003-4672-0735	National Heart, Lung and Blood Institute [BY1-HB-5026-01]; Center for Biologics Evaluation and Research intramural funding program (CBER/FDA)	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Center for Biologics Evaluation and Research intramural funding program (CBER/FDA)	For this work the authors received the funding support of the National Heart, Lung and Blood Institute for funding part of this work through the Inter-Agency Agreement BY1-HB-5026-01, www.nhlbi.nih.gov; and of the Center for Biologics Evaluation and Research intramural funding program (CBER/FDA), www.fda.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer J, 2009, AIDS, V23, P1209, DOI 10.1097/QAD.0b013e32832b4399; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Brennan CA, 2008, JAIDS-J ACQ IMM DEF, V49, P432, DOI 10.1097/QAI.0b013e31818a6561; Briggs D, 2000, SURF INTERFACE ANAL, V29, P1; Carr JK, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-39; CHEINGSONGPOPOV R, 1994, AIDS RES HUM RETROV, V10, P1379, DOI 10.1089/aid.1994.10.1379; Cooper DA, 2010, J INFECT DIS, V201, P803, DOI 10.1086/650697; Delgado E, 2012, J ANTIMICROB CHEMOTH, V67, P25, DOI 10.1093/jac/dkr438; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Esbjornsson J, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-23; Ghaffari G, 2005, J VIROL, V79, P13250, DOI 10.1128/JVI.79.21.13250-13261.2005; Gorry Paul R, 2011, Curr HIV/AIDS Rep, V8, P45, DOI 10.1007/s11904-010-0069-x; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Huang W, 2008, J VIROL, V82, P5584, DOI 10.1128/JVI.02676-07; Hung CS, 1999, J VIROL, V73, P8216, DOI 10.1128/JVI.73.10.8216-8226.1999; Koup RA, 2001, CURR PROTOC IMMUNOL; Labrosse B, 2001, J VIROL, V75, P5457, DOI 10.1128/JVI.75.12.5457-5464.2001; Lai A, 2010, HIV MED, V11, P593, DOI 10.1111/j.1468-1293.2010.00832.x; Lee MK, 1999, VIROLOGY, V257, P290, DOI 10.1006/viro.1999.9686; Lihana RW, 2012, AIDS REV, V14, P83; Machuca A, 2007, JAIDS-J ACQ IMM DEF, V45, P361, DOI 10.1097/QAI.0b013e318053754c; MOORE J, 1993, NATURE, V361, P309, DOI 10.1038/361309b0; Mulinge M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060566; Nadai Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001420; NKENGASONG JN, 1994, AIDS, V8, P1405, DOI 10.1097/00002030-199410000-00006; Nyambi P, 2002, AIDS, V16, P295, DOI 10.1097/00002030-200201250-00022; Paraskevis D, 1999, J HUMAN VIROL, V2, P339; PAU CP, 1994, AIDS RES HUM RETROV, V10, P1369, DOI 10.1089/aid.1994.10.1369; Peeters M, 2003, AIDS, V17, P2547, DOI 10.1097/00002030-200312050-00002; Pollakis G, 2001, J BIOL CHEM, V276, P13433, DOI 10.1074/jbc.M009779200; Poveda E, 2012, AIDS REV, V14, P208; Powell R, 2010, VIRUSES-BASEL, V2, P639, DOI 10.3390/v2020639; Ragupathy V, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-185; Ragupathy Viswanath, 2009, AIDS Res Ther, V6, P27, DOI 10.1186/1742-6405-6-27; Raymond S, 2008, AIDS, V22, pF11, DOI 10.1097/QAD.0b013e32830ebcd4; Raymond S, 2013, J CLIN MICROBIOL, V51, P564, DOI 10.1128/JCM.02328-12; Raymond S, 2009, J CLIN MICROBIOL, V47, P2292, DOI 10.1128/JCM.02439-08; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Seclen E, 2010, J ANTIMICROB CHEMOTH, V65, P1486, DOI 10.1093/jac/dkq137; Swenson LC, 2013, ANTIMICROB AGENTS CH, V57, P6122, DOI 10.1128/AAC.01534-13; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torimiro JN, 2009, NEW MICROBIOL, V32, P325; Tsibris AMN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005683; Vandekerckhove LPR, 2011, LANCET INFECT DIS, V11, P394, DOI 10.1016/S1473-3099(10)70319-4; Vergne L, 2003, VIROLOGY, V310, P254, DOI 10.1016/S0042-6822(03)00167-3; Weidle PJ, 2000, J INFECT DIS, V181, P470, DOI 10.1086/315253; Wheeler WH, 2010, AIDS, V24, P1203, DOI 10.1097/QAD.0b013e3283388742	48	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112434	10.1371/journal.pone.0112434	http://dx.doi.org/10.1371/journal.pone.0112434			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379669	Green Published, Green Submitted, gold			2022-12-27	WOS:000344863100091
J	Probst, M; Hoeller, C; Ferenci, P; Staettermayer, AF; Beinhardt, S; Pehamberger, H; Kittler, H; Grabmeier-Pfistershammer, K				Probst, Martin; Hoeller, Christoph; Ferenci, Peter; Staettermayer, Albert F.; Beinhardt, Sandra; Pehamberger, Hubert; Kittler, Harald; Grabmeier-Pfistershammer, Katharina			IL28B Polymorphism Cannot Predict Response to Interferon Alpha Treatment in Patients with Melanoma	PLOS ONE			English	Article							COOPERATIVE-ONCOLOGY-GROUP; HIGH-RISK MELANOMA; HEPATITIS-C VIRUS; ADJUVANT THERAPY; GENETIC-VARIATION; DOSE INTERFERON-ALPHA-2B; TRIAL; EXPRESSION; GENOTYPE; STAGE	Background: Recent genome-wide association studies revealed the rs12979860 single nucleotide polymorphism (SNP) of the IL28B gene (CC genotype) to be the strongest pre-therapeutic predictor of therapy response to interferon alpha in patients with chronic hepatitis C infection. The favorable CC genotype is associated with significantly higher rates of sustained virologic response. No data exist on the role of IL28B polymorphism in interferon therapy of diseases other than viral hepatitis. Methods: A retrospective study involving 106 patients with melanoma who received low-or high-dose interferon therapy was performed. The CC and non-CC genotype of IL28B rs12979860 SNP were correlated with progression-free and overall survival. Results: 44 (41.5%) patients were CC and 62 (58.5%) non-CC. There was no statistically significant difference in age at diagnosis, melanoma type or localization, Breslow level or AJCC stage between CC and non-CC patients. During the observation period (6.43 +/- 4.66 years) disease progression occurred in 36 (34%) patients after 5.5 +/- 4.3 years. 43.2% (19) of patients with CC and 27.4% (17) of patients with non-CC genotype were affected (p = 0.091). Disease progression was more frequent in patients on high dose interferon therapy and with a worse AJCC stage. Conclusion: In contrast to classical risk factors like tumor thickness and clinical stage, IL28B polymorphism was not associated with progression-free or overall survival in patients with melanoma treated with interferon alpha.	[Probst, Martin; Grabmeier-Pfistershammer, Katharina] Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, Vienna, Austria; [Hoeller, Christoph; Pehamberger, Hubert; Kittler, Harald] Med Univ Vienna, Dept Dermatol, Div Gen Dermatol, Vienna, Austria; [Ferenci, Peter; Staettermayer, Albert F.; Beinhardt, Sandra] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Kittler, H (corresponding author), Med Univ Vienna, Dept Dermatol, Div Gen Dermatol, Vienna, Austria.	harald.kittler@meduniwien.ac.at; katharina.pfistershammer@meduniwien.ac.at	Kittler, Harald/K-7574-2013; Kittler, Harald/AAK-1502-2020	Stattermayer, Albert/0000-0003-0737-4091; KITTLER, HARALD/0000-0002-0051-8016; Grabmeier-Pfistershammer, Katharina/0000-0003-0665-5414				Ascierto PA, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-76; Ascierto PA, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-62; Beinhardt S, 2012, GASTROENTEROLOGY, V142, P78, DOI 10.1053/j.gastro.2011.09.039; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Grob JJ, 1998, LANCET, V351, P1905, DOI 10.1016/S0140-6736(97)12445-X; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Ives NJ, 2007, J CLIN ONCOL, V25, P5426, DOI 10.1200/JCO.2007.12.0253; Jilg N., 2013, HEPATOLOGY; Kaufman HL, 2013, NAT REV CLIN ONCOL, V10, P588, DOI 10.1038/nrclinonc.2013.153; Kirkwood JM, 2000, J CLIN ONCOL, V18, P2444, DOI 10.1200/JCO.2000.18.12.2444; Kirkwood JM, 1996, J CLIN ONCOL, V14, P7, DOI 10.1200/JCO.1996.14.1.7; Kirkwood JM, 2004, CLIN CANCER RES, V10, P1670, DOI 10.1158/1078-0432.CCR-1103-3; Kirkwood JM, 2002, CANCER-AM CANCER SOC, V95, P1101, DOI 10.1002/cncr.10775; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Mocellin S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008955.pub2; Mocellin S, 2010, JNCI-J NATL CANCER I, V102, P493, DOI 10.1093/jnci/djq009; Naggie S, 2012, HEPATOLOGY, V56, P444, DOI 10.1002/hep.25647; Pehamberger H, 1998, J CLIN ONCOL, V16, P1425, DOI 10.1200/JCO.1998.16.4.1425; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Slominski A, 2009, INT J CANCER, V124, P1470, DOI 10.1002/ijc.24005; Slominski AT, 2014, MAYO CLIN PROC, V89, P429, DOI 10.1016/j.mayocp.2014.02.009; Stattermayer AF, 2014, ALIMENT PHARM THER, V39, P104, DOI 10.1111/apt.12547; Stattermayer AF, 2011, CLIN GASTROENTEROL H, V9, P344, DOI 10.1016/j.cgh.2010.07.019; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas E, 2012, GASTROENTEROLOGY, V142, P978, DOI 10.1053/j.gastro.2011.12.055; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Wang WJ, 2008, CANCER IMMUNOL IMMUN, V57, P1315, DOI 10.1007/s00262-008-0466-9; Wang WJ, 2007, CLIN CANCER RES, V13, P1523, DOI 10.1158/1078-0432.CCR-06-1387; Weber F, 2007, WORLD J GASTROENTERO, V13, P4818, DOI 10.3748/wjg.v13.i36.4818	34	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112613	10.1371/journal.pone.0112613	http://dx.doi.org/10.1371/journal.pone.0112613			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389973	gold, Green Submitted, Green Published			2022-12-27	WOS:000349144400108
J	Goulas, T; Cuppari, A; Garcia-Castellanos, R; Snipas, S; Glockshuber, R; Arolas, JL; Gomis-Ruth, FX				Goulas, Theodoros; Cuppari, Anna; Garcia-Castellanos, Raquel; Snipas, Scott; Glockshuber, Rudi; Arolas, Joan L.; Gomis-Rueth, F. Xavier			The pCri System: A Vector Collection for Recombinant Protein Expression and Purification	PLOS ONE			English	Article							HIGH CELL-DENSITY; ESCHERICHIA-COLI; MEMBRANE-PROTEINS; MESSENGER-RNA; MOLECULAR CHAPERONES; SECONDARY STRUCTURE; BINDING-PROTEIN; PICHIA-PASTORIS; FUSION; PREDICTION	A major bottleneck in structural, biochemical and biophysical studies of proteins is the need for large amounts of pure homogenous material, which is generally obtained by recombinant overexpression. Here we introduce a vector collection, the pCri System, for cytoplasmic and periplasmic/extracellular expression of heterologous proteins that allows the simultaneous assessment of prokaryotic and eukaryotic host cells (Escherichia coli, Bacillus subtilis, and Pichia pastoris). By using a single polymerase chain reaction product, genes of interest can be directionally cloned in all vectors within four different rare restriction sites at the 5' end and multiple cloning sites at the 3' end. In this way, a number of different fusion tags but also signal peptides can be incorporated at the N- and C-terminus of proteins, facilitating their expression, solubility and subsequent detection and purification. Fusion tags can be efficiently removed by treatment with site-specific peptidases, such as tobacco etch virus proteinase, thrombin, or sentrin specific peptidase 1, which leave only a few extra residues at the N- terminus of the protein. The combination of different expression systems in concert with the cloning approach in vectors that can fuse various tags makes the pCri System a valuable tool for high throughput studies.	[Goulas, Theodoros; Cuppari, Anna; Garcia-Castellanos, Raquel; Arolas, Joan L.; Gomis-Rueth, F. Xavier] CSIC, Mol Biol Inst Barcelona, Proteolysis Lab, Barcelona, Spain; [Snipas, Scott] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Glockshuber, Rudi] ETH, Inst Mol Biol & Biophys, Dept Biol, CH-8093 Zurich, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Sanford Burnham Prebys Medical Discovery Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Goulas, T (corresponding author), CSIC, Mol Biol Inst Barcelona, Proteolysis Lab, Barcelona Sci Pk,Helix Bldg, Barcelona, Spain.	thgcri@ibmb.csic.es; fxgr@ibmb.csic.es	Goulas, Theodoros/H-1951-2015	Goulas, Theodoros/0000-0002-6938-5493; Lopez Arolas, Joan/0000-0002-4198-5016; Garcia-Castellanos, Raquel/0000-0001-6225-5373; Gomis-Ruth, F. Xavier/0000-0002-6848-6874; Cuppari, Anna/0000-0002-7763-5747	European, Spanish, and Catalan agencies [FP7-HEALTH-2010-261460, FP7-PEOPLE-2011- ITN-290246, FP7-HEALTH-2012-306029-2, BFU2012-32862, CSD2006-00015, 2014SGR9]	European, Spanish, and Catalan agencies	This study was supported in part by grants from European, Spanish, and Catalan agencies (FP7-HEALTH-2010-261460 "Gums& Joints''; FP7-PEOPLE-2011- ITN-290246 "RAPID''; FP7-HEALTH-2012-306029-2 "TRIGGER''; BFU2012-32862; CSD2006-00015; and 2014SGR9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo I, 2011, GLYCOBIOLOGY, V21, P1349, DOI 10.1093/glycob/cwr074; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Arolas JL, 2011, ANGEW CHEM INT EDIT, V50, P10357, DOI 10.1002/anie.201103262; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Babu MM, 2002, BIOINFORMATICS, V18, P641, DOI 10.1093/bioinformatics/18.4.641; BANEYX F, 1992, ANN NY ACAD SCI, V665, P301, DOI 10.1111/j.1749-6632.1992.tb42593.x; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Butt TR, 2005, PROTEIN EXPRES PURIF, V43, P1, DOI 10.1016/j.pep.2005.03.016; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cregg JM, 2000, MOL BIOTECHNOL, V16, P23, DOI 10.1385/MB:16:1:23; Daly R, 2005, J MOL RECOGNIT, V18, P119, DOI 10.1002/jmr.687; de Marco A, 2007, NAT PROTOC, V2, P2632, DOI 10.1038/nprot.2007.400; de Marco A, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-26; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Drag M, 2008, IUBMB LIFE, V60, P734, DOI 10.1002/iub.113; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Dvir H, 2009, PROTEIN EXPRES PURIF, V68, P28, DOI 10.1016/j.pep.2009.06.007; Esposito D, 2006, CURR OPIN BIOTECH, V17, P353, DOI 10.1016/j.copbio.2006.06.003; Fuhrmann M, 2004, PLANT MOL BIOL, V55, P869, DOI 10.1007/s11103-004-2150-6; Goulas T, 2011, P NATL ACAD SCI USA, V108, P1856, DOI 10.1073/pnas.1012173108; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; HALL MN, 1982, NATURE, V295, P616, DOI 10.1038/295616a0; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harper S, 2011, METHODS MOL BIOL, V681, P259, DOI 10.1007/978-1-60761-913-0_14; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hayat S, 2012, BIOINFORMATICS, V28, P516, DOI 10.1093/bioinformatics/btr710; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Kefala Georgia, 2007, Journal of Structural and Functional Genomics, V8, P167, DOI 10.1007/s10969-007-9033-4; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lund PA, 2001, ADV MICROB PHYSIOL, V44, P93, DOI 10.1016/S0065-2911(01)44012-4; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; Marrero A, 2006, J MOL BIOL, V361, P506, DOI 10.1016/j.jmb.2006.06.046; Maskos K, 2003, J MOL BIOL, V325, P495, DOI 10.1016/S0022-2836(02)01248-2; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; McNulty DE, 2003, PROTEIN EXPRES PURIF, V27, P365, DOI 10.1016/S1046-5928(02)00610-1; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Nallamsetty S, 2006, PROTEIN EXPRES PURIF, V45, P175, DOI 10.1016/j.pep.2005.06.012; Nallamsetty S, 2007, NAT PROTOC, V2, P383, DOI 10.1038/nprot.2007.50; NEWBURY SF, 1987, CELL, V48, P297, DOI 10.1016/0092-8674(87)90433-8; Peroutka RJ, 2011, METHODS MOL BIOL, V705, P15, DOI 10.1007/978-1-61737-967-3_2; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; POOLE ES, 1995, EMBO J, V14, P151, DOI 10.1002/j.1460-2075.1995.tb06985.x; Porro D, 2005, MOL BIOTECHNOL, V31, P245, DOI 10.1385/MB:31:3:245; Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219; Reverter D, 1997, FEBS LETT, V420, P7, DOI 10.1016/S0014-5793(97)01476-2; Reverter David, 2009, V497, P225, DOI 10.1007/978-1-59745-566-4_15; Roosild TP, 2005, SCIENCE, V307, P1317, DOI 10.1126/science.1106392; Sambrook J., 2001, MOL CLONING LAB MANU; Sanglas L, 2009, P NATL ACAD SCI USA, V106, P1743, DOI 10.1073/pnas.0812623106; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Schwarz D, 2007, NAT PROTOC, V2, P2945, DOI 10.1038/nprot.2007.426; Shiloach J, 2005, BIOTECHNOL ADV, V23, P345, DOI 10.1016/j.biotechadv.2005.04.004; SIMONEN M, 1993, MICROBIOL REV, V57, P109, DOI 10.1128/MMBR.57.1.109-137.1993; Smyth DR, 2003, PROTEIN SCI, V12, P1313, DOI 10.1110/ps.0243403; Sorensen HP, 2005, J BIOTECHNOL, V115, P113, DOI 10.1016/j.jbiotec.2004.08.004; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; STUDIER FW, 1991, J MOL BIOL, V219, P37, DOI 10.1016/0022-2836(91)90855-Z; Trang TPP, 2012, J BIOTECHNOL, V157, P167, DOI 10.1016/j.jbiotec.2011.10.006; Vergis JM, 2011, PROTEIN EXPRES PURIF, V78, P139, DOI 10.1016/j.pep.2011.04.011; Vincze T, 2003, NUCLEIC ACIDS RES, V31, P3688, DOI 10.1093/nar/gkg526; Waugh DS, 2005, TRENDS BIOTECHNOL, V23, P316, DOI 10.1016/j.tibtech.2005.03.012; Westers L, 2004, BBA-MOL CELL RES, V1694, P299, DOI 10.1016/j.bbamcr.2004.02.011; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; YEE L, 1992, BIO-TECHNOL, V10, P1550, DOI 10.1038/nbt1292-1550; Zhou FF, 2006, NAT PROTOC, V1, P1318, DOI 10.1038/nprot.2006.209	79	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112643	10.1371/journal.pone.0112643	http://dx.doi.org/10.1371/journal.pone.0112643			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386923	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400076
J	Kim, TH; Lee, JH				Kim, Tae-Hyoung; Lee, Jae-Hyeok			Serum Uric Acid and Nigral Iron Deposition in Parkinson's Disease: A Pilot Study	PLOS ONE			English	Article							HUMAN BRAIN; ANTIOXIDANT; METABOLISM; URATE	Background: Uric acid (UA) is an endogenous antioxidant which is known to reduce oxidative stress and also chelate iron ion. Recent studies have provided evidence that UA may play a neuroprotective role in Parkinson's disease (PD). However, it is unknown whether UA relates to nigral iron deposition, which is a characteristic pathophysiological alteration in PD. The aim of this study was to determine the potential relationship of these two markers in patients with PD. Methods: A total of 30 patients of PD and 25 age-and gender-matched healthy controls underwent 3-Tesla MRI and laboratory tests including serum UA levels. We assessed iron levels by measuring phase shift values using susceptibility-weighted image. Mean phase shift values of the substantia nigra (SN), red nucleus, head of the caudate nucleus, globus pallidus, putamen, thalamus, and frontal white matter were calculated and correlated with serum UA levels. Results: Serum UA levels were significantly decreased in the PD patients than in the controls. Phase shift values in bilateral SN were significantly increased in the PD patients than in the controls. There was no significant correlation between serum UA levels and nigral phase shift values. Conclusions: As previous studies, low serum UA level and increased nigral iron content in the PD was reconfirmed in this study. However, we failed to find the relationship between these two markers. Our data suggest that serum UA may not be important determinant of nigral iron deposition in PD.	[Kim, Tae-Hyoung; Lee, Jae-Hyeok] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Dept Neurol, Yangsan, South Korea	Pusan National University; Pusan National University Hospital	Lee, JH (corresponding author), Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Dept Neurol, Yangsan, South Korea.	jhlee.neuro@pusan.ac.kr			Pusan National University Yangsan Hospital	Pusan National University Yangsan Hospital(Pusan National University)	This study was supported by Pusan National University Yangsan Hospital (2014). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg D, 2006, MOVEMENT DISORD, V21, P1299, DOI 10.1002/mds.21020; Bowman GL, 2010, J ALZHEIMERS DIS, V19, P1331, DOI 10.3233/JAD-2010-1330; CHURCH WH, 1994, BRAIN RES BULL, V33, P419, DOI 10.1016/0361-9230(94)90285-2; Cipriani S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037331; Constantinescu R, 2013, ACTA NEUROL SCAND, V127, pe8, DOI 10.1111/ane.12012; Crichton RR, 2011, J NEURAL TRANSM, V118, P301, DOI 10.1007/s00702-010-0470-z; DAVIES KJA, 1986, BIOCHEM J, V235, P747, DOI 10.1042/bj2350747; Du GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035397; Duan W, 2002, J NEUROCHEM, V80, P101, DOI 10.1046/j.0022-3042.2001.00676.x; Groger A, 2012, J NEURAL TRANSM, V119, P1523, DOI 10.1007/s00702-012-0873-0; Haacke EM, 2007, J MAGN RESON IMAGING, V26, P256, DOI 10.1002/jmri.22987; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Huang XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022854; Jin LR, 2011, BRAIN, V134, P50, DOI 10.1093/brain/awq319; Kutzing MK, 2008, J PHARMACOL EXP THER, V324, P1, DOI 10.1124/jpet.107.129031; Li W, 2011, NEUROIMAGE, V55, P1645, DOI 10.1016/j.neuroimage.2010.11.088; Mounsey Ross B, 2012, Int J Cell Biol, V2012, P983245, DOI 10.1155/2012/983245; Pfefferbaum A, 2009, NEUROIMAGE, V47, P493, DOI 10.1016/j.neuroimage.2009.05.006; Schlesinger I, 2008, MOVEMENT DISORD, V23, P1653, DOI 10.1002/mds.22139; Schwarzschild MA, 2008, ARCH NEUROL-CHICAGO, V65, P716, DOI 10.1001/archneur.2008.65.6.nct70003; Shen L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003620; Sian-Hulsmann J, 2011, J NEUROCHEM, V118, P939, DOI 10.1111/j.1471-4159.2010.07132.x; Toncev G, 2002, EUR J NEUROL, V9, P221, DOI 10.1046/j.1468-1331.2002.00384.x; Yan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031748; Zhang JQ, 2010, BRAIN RES, V1330, P124, DOI 10.1016/j.brainres.2010.03.036; Zoccolella S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040608	26	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112512	10.1371/journal.pone.0112512	http://dx.doi.org/10.1371/journal.pone.0112512			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386854	gold, Green Published, Green Submitted			2022-12-27	WOS:000345250400068
J	Legrand, M; De Berardinis, B; Gaggin, HK; Magrini, L; Belcher, A; Zancla, B; Femia, A; Simon, M; Motiwala, S; Sambhare, R; Di Somma, S; Mebazaa, A; Vaidya, VS; Januzzi, JL				Legrand, Matthieu; De Berardinis, Benedetta; Gaggin, Hanna K.; Magrini, Laura; Belcher, Arianna; Zancla, Benedetta; Femia, Alexandra; Simon, Mandy; Motiwala, Shweta; Sambhare, Rasika; Di Somma, Salvatore; Mebazaa, Alexandre; Vaidya, Vishal S.; Januzzi, James L., Jr.		Global Res Acute Conditions Team G	Evidence of Uncoupling between Renal Dysfunction and Injury in Cardiorenal Syndrome: Insights from the BIONICS Study	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; ACUTE KIDNEY INJURY; DECOMPENSATED HEART-FAILURE; CARDIAC-FAILURE; NGAL; BIOMARKERS	Objective: The objective of the study was to assess urinary biomarkers of renal injury for their individual or collective ability to predict Worsening renal function (WRF) in patients with acutely decompensated heart failure (ADHF). Methods: In a prospective, blinded international study, 87 emergency department (ED) patients with ADHF were evaluated with biomarkers of cardiac stretch (B type natriuretic peptide [BNP] and its amino terminal equivalent [NT-proBNP], ST2), biomarkers of renal function (creatinine, estimated glomerular filtration rate [eGFR]) and biomarkers of renal injury (plasma neutrophil gelatinase associated lipocalin [pNGAL], urine kidney injury molecule-1 [KIM-1], urine N-acetyl-beta-D-glucosaminidase [NAG], urine Cystatin C, urine fibrinogen). The primary endpoint was WRF. Results: 26% developed WRF; baseline characteristics of subjects who developed WRF were generally comparable to those who did not. Biomarkers of renal function and urine biomarkers of renal injury were not correlated, while urine biomarkers of renal injury correlated between each other. Biomarker concentrations were similar between patients with and without WRF except for baseline BNP. Although plasma NGAL was associated with the combined endpoint, none of the biomarker showed predictive accuracy for WRF. Conclusions: In ED patients with ADHF, urine biomarkers of renal injury did not predict WRF. Our data suggest that a weak association exists between renal dysfunction and renal injury in this setting.	[Legrand, Matthieu; Mebazaa, Alexandre] Grp Hosp St Louis Lariboisiere, AP HP, Dept Anesthesiol, F-75475 Paris, France; [Legrand, Matthieu; Mebazaa, Alexandre] Grp Hosp St Louis Lariboisiere, AP HP, Burn Unit, F-75475 Paris, France; [Legrand, Matthieu; Mebazaa, Alexandre] Univ Paris Diderot, Paris, France; [Legrand, Matthieu; Femia, Alexandra; Mebazaa, Alexandre] INSERM, U942, F-75475 Paris, France; [De Berardinis, Benedetta; Magrini, Laura; Zancla, Benedetta; Di Somma, Salvatore] Univ Roma La Sapienza, StAndrea Hosp, Dept Med Surg Sci & Translat Med, I-00185 Rome, Italy; [Gaggin, Hanna K.; Belcher, Arianna; Simon, Mandy; Motiwala, Shweta; Januzzi, James L., Jr.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA USA; [Sambhare, Rasika; Vaidya, Vishal S.] Harvard Univ, Sch Med, Boston, MA USA; [Sambhare, Rasika; Vaidya, Vishal S.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Legrand, M (corresponding author), Grp Hosp St Louis Lariboisiere, AP HP, Dept Anesthesiol, F-75475 Paris, France.	matthieu.m.legrand@gmail.com	Januzzi, James/Y-2436-2019	Mebazaa, Alexandre/0000-0001-8715-7753	Astute; bioporto; BRAHMS; Roche Diagnostics; Siemens; Critical Diagnostics; BG Medicine; Singulex; Thermo Fisher; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017543] Funding Source: NIH RePORTER	Astute; bioporto; BRAHMS; Roche Diagnostics; Siemens(Siemens AG); Critical Diagnostics; BG Medicine; Singulex; Thermo Fisher; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors have read the journal's policy and the authors of this manuscript have the following competing interests: Dr. Legrand consulted for Alere (lecture fees) and received support for research from Astute, bioporto and BRAHMS. Dr. Mebazaa served as board member for Critical Diagnostics, The Medicine Company, Cardiorentis, and Bayer and lectured for Alere, Bayer, Edwards Life Sciences, The Medicines Company, Novartis, Orion, Servier, Thermofisher, and Vifor Pharma. Dr. Januzzi received support for participation in review activities from Radiometer. His institution received grant support from Roche Diagnostics, Siemens, Critical Diagnostics, BG Medicine, Singulex, and Thermo Fisher. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Aghel A, 2010, J CARD FAIL, V16, P49, DOI 10.1016/j.cardfail.2009.07.003; Ahmad T, 2014, JACC HEART FAIL S, P2213; Alvelos M, 2011, CLIN J AM SOC NEPHRO, V6, P476, DOI 10.2215/CJN.06140710; Bart BA, 2012, NEW ENGL J MED, V367, P2296, DOI 10.1056/NEJMoa1210357; Breidthardt T, 2012, CRIT CARE, V16, DOI 10.1186/cc10600; Damman K, 2007, J CARD FAIL, V13, P599, DOI 10.1016/j.cardfail.2007.04.008; Damman K, 2011, J AM COLL CARDIOL, V57, P2233, DOI 10.1016/j.jacc.2010.10.065; Damman K, 2010, HEART, V96, P1297, DOI 10.1136/hrt.2010.194878; Felker GM, 2011, NEW ENGL J MED, V364, P797, DOI 10.1056/NEJMoa1005419; Haase M, 2011, J AM COLL CARDIOL, V57, P1752, DOI 10.1016/j.jacc.2010.11.051; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; Hoffmann D, 2012, AM J PATHOL, V181, P818, DOI 10.1016/j.ajpath.2012.06.004; Jungbauer CG, 2011, EUR J HEART FAIL, V13, P1104, DOI 10.1093/eurjhf/hfr102; Lassus JPE, 2010, EUR HEART J, V31, P2791, DOI 10.1093/eurheartj/ehq293; Legrand M, 2014, CRIT CARE MED, V42, P2109, DOI 10.1097/CCM.0000000000000404; Legrand M, 2013, INTENS CARE MED, V39, P1861, DOI 10.1007/s00134-013-3061-2; Legrand M, 2013, ANESTHESIOLOGY, V118, P1446, DOI 10.1097/ALN.0b013e3182923e8a; Macdonald S, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-8; Maisel AS, 2011, EUR J HEART FAIL, V13, P846, DOI 10.1093/eurjhf/hfr087; Park M, 2013, BIOMARK INSIGHTS, V8, P15, DOI 10.4137/BMI.S11479; Ronco C, 2012, J AM COLL CARDIOL, V60, P1031, DOI 10.1016/j.jacc.2012.01.077; Royakkers AANM, 2011, INTENS CARE MED, V37, P493, DOI 10.1007/s00134-010-2087-y; Shrestha K, 2012, AM J CARDIOL, V110, P1329, DOI 10.1016/j.amjcard.2012.06.035; van Kimmenade RRJ, 2012, CLIN CHEM, V58, P127, DOI 10.1373/clinchem.2011.165720; Zamora E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051234	25	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112313	10.1371/journal.pone.0112313	http://dx.doi.org/10.1371/journal.pone.0112313			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386851	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400054
J	Maugars, G; Dufour, S; Cohen-Tannoudji, J; Querat, B				Maugars, Gersende; Dufour, Sylvie; Cohen-Tannoudji, Joelle; Querat, Bruno			Multiple Thyrotropin beta-Subunit and Thyrotropin Receptor-Related Genes Arose during Vertebrate Evolution	PLOS ONE			English	Article							THYROID-STIMULATING HORMONE; GLYCOPROTEIN HORMONE; SEASONAL-CHANGES; FUNCTIONAL-CHARACTERIZATION; MOLECULAR CHARACTERIZATION; TSH RECEPTOR; JAPANESE EEL; EXPRESSION; TELEOST; FISH	Thyroid-stimulating hormone (TSH) is composed of a specific beta subunit and an alpha subunit that is shared with the two pituitary gonadotropins. The three beta subunits derive from a common ancestral gene through two genome duplications (1R and 2R) that took place before the radiation of vertebrates. Analysis of genomic data from phylogenetically relevant species allowed us to identify an additional Tsh beta subunit-related gene that was generated through 2R. This gene, named Tsh beta 2, present in cartilaginous fish, little skate and elephant shark, and in early lobe-finned fish, coelacanth and lungfish, was lost in ray-finned fish and tetrapods. The absence of a second type of TSH receptor (Tshr) gene in these species suggests that both TSHs act through the same receptor. A novel Tsh beta sister gene, named Tsh beta 3, was generated through the third genomic duplication (3R) that occurred early in the teleost lineage. Tsh beta 3 is present in most teleost groups but was lostin tedraodontiforms. The 3R also generated a second Tshr, named Tshr beta. Interestingly, the new Tshr beta was translocated from its original chromosomic position after the emergence of eels and was then maintained in its new position. Tshr beta was lost in tetraodontiforms and in ostariophysians including zebrafish although the latter species have two TSHs, suggesting that TSHR beta may be dispensable. The tissue distribution of duplicated Tsh beta s and Tshrs was studied in the European eel. The endocrine thyrotropic function in the eel would be essentially mediated by the classical Tsh beta and Tshra, which are mainly expressed in the pituitary and thyroid, respectively. Tsh beta 3 and Tshr beta showed a similar distribution pattern in the brain, pituitary, ovary and adipose tissue, suggesting a possible paracrine/autocrine mode of action in these non-thyroidal tissues. Further studies will be needed to determine the binding specificity of the two receptors and how these two TSH systems are interrelated.	[Maugars, Gersende; Dufour, Sylvie] Univ Paris 04, Museum Natl Hist Nat, Biol Aquat Organisms & Ecosyst BOREA, Paris, France; [Maugars, Gersende; Dufour, Sylvie] Univ Paris 06, Paris, France; [Maugars, Gersende; Dufour, Sylvie] Univ Caen Basse Normandie, Caen, France; [Maugars, Gersende; Dufour, Sylvie] CNRS, Unite Mixte Rech UMR 7208, Paris, France; [Maugars, Gersende; Dufour, Sylvie] Inst Rech Dev IRD 207, Paris, France; [Cohen-Tannoudji, Joelle; Querat, Bruno] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Cohen-Tannoudji, Joelle; Querat, Bruno] CNRS, UMR 8251, Paris, France; [Cohen-Tannoudji, Joelle; Querat, Bruno] INSERM, Physiol Axe Gonadotrope U1133, Paris, France	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Universite de Caen Normandie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Querat, B (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Paris, France.	bruno.querat@univ-paris-diderot.fr	Quérat, Bruno/L-1843-2017	Quérat, Bruno/0000-0002-6765-1057; Maugars, Gersende/0000-0002-2090-6585				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amemiya CT, 2013, NATURE, V496, P311, DOI 10.1038/nature12027; Amores A, 2011, GENETICS, V188, P799, DOI 10.1534/genetics.111.127324; Angers B, 2002, J MOL EVOL, V54, P501, DOI 10.1007/s00239-001-0041-x; Aroua S, 2012, GEN COMP ENDOCR, V175, P82, DOI 10.1016/j.ygcen.2011.10.002; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; Bodo E, 2010, ENDOCRINOLOGY, V151, P1633, DOI 10.1210/en.2009-0306; Chauvigne F, 2010, BIOL REPROD, V82, P1088, DOI 10.1095/biolreprod.109.082289; Chen JN, 2014, MOL PHYLOGENET EVOL, V70, P152, DOI 10.1016/j.ympev.2013.09.002; Choi JK, 2007, GENETICS, V175, P1607, DOI 10.1534/genetics.106.069047; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; Davies TF, 2005, J CLIN INVEST, V115, P1972, DOI 10.1172/JCI26031; de Jesus EGT, 1998, GEN COMP ENDOCR, V112, P10, DOI 10.1006/gcen.1998.7103; Denver RJ, 2013, CURR TOP DEV BIOL, V103, P195, DOI 10.1016/B978-0-12-385979-2.00007-1; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dethleffsen K, 2003, MOL CELL NEUROSCI, V24, P380, DOI 10.1016/S1044-7431(03)00195-7; Dos Santos S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-332; Dos Santos S, 2009, ENDOCRINOLOGY, V150, P3815, DOI 10.1210/en.2008-1743; Duarte-Guterman P, 2014, GEN COMP ENDOCR, V203, P69, DOI 10.1016/j.ygcen.2014.03.015; Faircloth BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065923; Goto-Kazeto R, 2003, FISH PHYSIOL BIOCHEM, V28, P339, DOI 10.1023/B:FISH.0000030578.25321.8f; Harewood L, 2010, GENOME RES, V20, P554, DOI 10.1101/gr.103622.109; Henkel CV, 2012, GENE, V511, P195, DOI 10.1016/j.gene.2012.09.064; Henkel CV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032231; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Hurles M, 2004, PLOS BIOL, V2, P900, DOI 10.1371/journal.pbio.0020206; INUI Y, 1985, GEN COMP ENDOCR, V60, P450, DOI 10.1016/0016-6480(85)90080-2; Kano S, 2010, INTEGR COMP BIOL, V50; Kitano J, 2010, CURR BIOL, V20, P2124, DOI 10.1016/j.cub.2010.10.050; Klein JR, 2003, AUTOIMMUNITY, V36, P417, DOI 10.1080/08916930310001603019; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Krassas GE, 2010, ENDOCR REV, V31, P702, DOI 10.1210/er.2009-0041; Krause G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052920; Kumar RS, 2000, MOL CELL ENDOCRINOL, V167, P1, DOI 10.1016/S0303-7207(00)00304-X; Lema SC, 2009, J ENDOCRINOL, V202, P43, DOI 10.1677/JOE-08-0472; Levavi-Sivan B, 2010, GEN COMP ENDOCR, V165, P412, DOI 10.1016/j.ygcen.2009.07.019; Liang D, 2013, MOL BIOL EVOL, V30, P1803, DOI 10.1093/molbev/mst072; Lu SM, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-17; MacKenzie DS, 2009, GEN COMP ENDOCR, V161, P83, DOI 10.1016/j.ygcen.2008.12.010; Manchado M, 2008, GEN COMP ENDOCR, V155, P447, DOI 10.1016/j.ygcen.2007.07.011; Nakane Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3108; Oba Y, 2000, BIOCHEM BIOPH RES CO, V276, P258, DOI 10.1006/bbrc.2000.3410; Pasquier J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048931; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Ponce M, 2010, GEN COMP ENDOCR, V168, P431, DOI 10.1016/j.ygcen.2010.05.012; Querat B, 2000, BIOL REPROD, V63, P222, DOI 10.1095/biolreprod63.1.222; Querat B, 2004, BIOL REPROD, V70, P356, DOI 10.1095/biolreprod.103.022004; Rocha A, 2007, GEN COMP ENDOCR, V152, P89, DOI 10.1016/j.ygcen.2007.03.001; Rousseau Karine, 2012, P167; Stavreus Evers Anneli, 2012, Front Endocrinol (Lausanne), V3, P50, DOI 10.3389/fendo.2012.00050; Sudo R, 2014, J EXP ZOOL PART A, V321, P357, DOI 10.1002/jez.1861; Szkudlinski MW, 2002, PHYSIOL REV, V82, P473, DOI 10.1152/physrev.00031.2001; Tata JR, 1997, ADV DEV BIOL, V7, P37; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Vischer HF, 2003, J MOL ENDOCRINOL, V30, P227, DOI 10.1677/jme.0.0300227; Wang Y, 2004, MOL CELL ENDOCRINOL, V220, P77, DOI 10.1016/j.mce.2004.03.007; Williams GR, 2011, ANN ENDOCRINOL-PARIS, V72, P68, DOI 10.1016/j.ando.2011.03.006; Williams R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086088; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097	61	26	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111361	10.1371/journal.pone.0111361	http://dx.doi.org/10.1371/journal.pone.0111361			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386660	gold, Green Published, Green Submitted			2022-12-27	WOS:000345250400016
J	Shi, XH; Wang, SL; Zhang, YM; Wang, YC; Yang, Z; Zhou, X; Lei, ZY; Fan, DL				Shi, Xiao-hua; Wang, Shao-liang; Zhang, Yi-ming; Wang, Yi-cheng; Yang, Zhi; Zhou, Xin; Lei, Ze-yuan; Fan, Dong-li			Hydroxyapatite-Coated Sillicone Rubber Enhanced Cell Adhesion and It May Be through the Interaction of EF1 beta and gamma-Actin	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; SILICONE BREAST IMPLANTS; IN-VITRO; BONE-FORMATION; THIN-FILMS; SURFACE; ELONGATION; DEPOSITION; BINDING; LASER	Silicone rubber (SR) is a common soft tissue filler material used in plastic surgery. However, it presents a poor surface for cellular adhesion and suffers from poor biocompatibility. In contrast, hydroxyapatite (HA), a prominent component of animal bone and teeth, can promote improved cell compatibility, but HA is an unsuitable filler material because of the brittleness in mechanism. In this study, using a simple and economical method, two sizes of HA was applied to coat on SR to counteract the poor biocompatibility of SR. Surface and mechanical properties of SR and HA/SRs confirmed that coating with HA changes the surface topology and material properties. Analysis of cell proliferation and adhesion as well as measurement of the expression levels of adhesion related molecules indicated that HA-coated SR significantly increased cell compatibility. Furthermore, mass spectrometry proved that the biocompatibility improvement may be related to elongation factor 1-beta (EF1 beta)/gamma-actin adjusted cytoskeletal rearrangement.	[Shi, Xiao-hua; Wang, Shao-liang; Zhang, Yi-ming; Zhou, Xin; Lei, Ze-yuan; Fan, Dong-li] Third Mil Med Univ, Xinqiao Hosp, Dept Plast & Cosmet Surg, Chongqing 400037, Peoples R China; [Wang, Yi-cheng] Chongqing Armed Police Corps Hosp, Dept Plast & Cosmet Surg, Chongqing 400061, Peoples R China; [Yang, Zhi] Hainan Branch PLA Gen Hosp, Dept War Trauma Care, Sanya 572013, Hainan, Peoples R China	Army Medical University	Fan, DL (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Plast & Cosmet Surg, Chongqing 400037, Peoples R China.	fdltmmu@sina.com		Zhou, Xin/0000-0002-9324-4308	National Natural Science Foundation of China [81372075]; Third Military Medical University [2012XZH05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Third Military Medical University	This work was funded by a grant from National Natural Science Foundation of China (81372075) (http://www.nsfc.gov.cn/publish/portal0/default.htm), and a grant for Transformation of Scientific and Technological Achievements from Third Military Medical University (2012XZH05) (http://www.tmmu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryington MS, 2013, DENT MATER, V29, P514, DOI 10.1016/j.dental.2013.02.004; Carr-Schmid A, 1999, MOL CELL BIOL, V19, P5257; Chandanshive BB, 2013, MAT SCI ENG C-MATER, V33, P2981, DOI 10.1016/j.msec.2013.03.022; Citeau A, 2005, BIOMATERIALS, V26, P157, DOI 10.1016/j.biomaterials.2004.02.033; Thanh DTM, 2013, MAT SCI ENG C-MATER, V33, P2037, DOI 10.1016/j.msec.2013.01.018; Dunne CF, 2014, J BIOMATER APPL, V28, P767, DOI 10.1177/0885328213480534; Franco-Cea A, 2010, DEV BIOL, V345, P64, DOI 10.1016/j.ydbio.2010.06.027; Furukawa R, 2001, BBA-GEN SUBJECTS, V1527, P130, DOI 10.1016/S0304-4165(01)00157-X; Hauser J, 2009, J MATER SCI-MATER M, V20, P2541, DOI 10.1007/s10856-009-3826-x; HIRAGA K, 1993, FEBS LETT, V316, P165, DOI 10.1016/0014-5793(93)81208-H; Iskandar ME, 2013, J BIOMED MATER RES A, V101, P2340, DOI 10.1002/jbm.a.34530; Johnson I, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/37/375103; Kim BS, 2013, J BIOMED MATER RES B, V101, P1302, DOI 10.1002/jbm.b.32943; Koshino T, 2001, BIOMATERIALS, V22, P1579, DOI 10.1016/S0142-9612(00)00318-5; Le Sourd F, 2006, BBA-GENE STRUCT EXPR, V1759, P13, DOI 10.1016/j.bbaexp.2006.02.003; LEWIS DH, 1980, J PROSTHET DENT, V43, P426, DOI 10.1016/0022-3913(80)90215-2; Nelea V, 2004, APPL SURF SCI, V228, P346, DOI 10.1016/j.apsusc.2004.01.029; Park YJ, 2013, J CRANIOFAC SURG, V24, P632, DOI 10.1097/SCS.0b013e318270fb23; Peng F, 2013, J BIOMATER APPL, V27, P641, DOI 10.1177/0885328211419873; Pittman YR, 2009, J BIOL CHEM, V284, P4739, DOI 10.1074/jbc.M807945200; Puskas JE, 2012, WIRES NANOMED NANOBI, V4, P153, DOI 10.1002/wnan.164; Rojaee R, 2013, MAT SCI ENG C-MATER, V33, P3817, DOI 10.1016/j.msec.2013.05.014; Ruan Hongjiang, 2011, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V25, P668; Siggelkow W, 2004, INT J ARTIF ORGANS, V27, P1100, DOI 10.1177/039139880402701214; Sisti KE, 2013, INT J PERIODONT REST, V33, P689, DOI 10.11607/prd.1151; Stankiewicz JA., 2010, OPER TECH OTOLARYNGO, V21, P147, DOI 10.1016/j.otot.2010.07.001; Tan F, 2012, BIOTECHNOL ADV, V30, P352, DOI 10.1016/j.biotechadv.2011.07.008; Thian ES, 2005, BIOMATERIALS, V26, P2947, DOI 10.1016/j.biomaterials.2004.07.058; van der Houwen EB, 2013, J MECH BEHAV BIOMED, V28, P47, DOI 10.1016/j.jmbbm.2013.07.002; VANNOORT R, 1979, J MATER SCI, V14, P197, DOI 10.1007/BF01028344; Wang SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098320; Yang Z, 2012, SPRAY PAINTING EQUIP; Zeplin PH, 2010, PLAST RECONSTR SURG, V126, P266, DOI 10.1097/PRS.0b013e3181dbc313; Zhang YM, 2009, AESTHET PLAST SURG, V33, P760, DOI 10.1007/s00266-009-9363-7	34	6	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111503	10.1371/journal.pone.0111503	http://dx.doi.org/10.1371/journal.pone.0111503			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386892	Green Submitted, Green Published, gold			2022-12-27	WOS:000345250400019
J	Chang, HH; Chiang, YW; Lin, TK; Lin, GL; Lin, YY; Kau, JH; Huang, HH; Hsu, HL; Wang, JH; Sun, DS				Chang, Hsin-Hou; Chiang, Ya-Wen; Lin, Ting-Kai; Lin, Guan-Ling; Lin, You-Yen; Kau, Jyh-Hwa; Huang, Hsin-Hsien; Hsu, Hui-Ling; Wang, Jen-Hung; Sun, Der-Shan			Erythrocytic Mobilization Enhanced by the Granulocyte Colony-Stimulating Factor Is Associated with Reduced Anthrax-Lethal-Toxin-Induced Mortality in Mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; HEMATOPOIETIC GROWTH-FACTORS; G-CSF; MYELODYSPLASTIC SYNDROMES; ERYTHROPOIETIN; ANEMIA; COMBINATION; APOPTOSIS; ISCHEMIA; ANTIBODY	Anthrax lethal toxin (LT), one of the primary virulence factors of Bacillus anthracis, causes anthrax-like symptoms and death in animals. Experiments have indicated that levels of erythrocytopenia and hypoxic stress are associated with disease severity after administering LT. In this study, the granulocyte colony-stimulating factor (G-CSF) was used as a therapeutic agent to ameliorate anthrax-LT- and spore-induced mortality in C57BL/6J mice. We demonstrated that G-CSF promoted the mobilization of mature erythrocytes to peripheral blood, resulting in a significantly faster recovery from erythrocytopenia. In addition, combined treatment using G-CSF and erythropoietin tended to ameliorate B. anthracis-spore-elicited mortality in mice. Although specific treatments against LT-mediated pathogenesis remain elusive, these results may be useful in developing feasible strategies to treat anthrax.	[Chang, Hsin-Hou; Chiang, Ya-Wen; Lin, Ting-Kai; Sun, Der-Shan] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Chang, Hsin-Hou; Lin, Guan-Ling; Lin, You-Yen; Sun, Der-Shan] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Kau, Jyh-Hwa] Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei, Taiwan; [Huang, Hsin-Hsien; Hsu, Hui-Ling] Natl Def Med Ctr, Inst Prevent Med, Taipei, Taiwan; [Wang, Jen-Hung] Tzu Chi Gen Hosp, Dept Med Res, Hualien, Taiwan	Tzu Chi University; Tzu Chi University; National Defense Medical Center; National Defense Medical Center; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital	Sun, DS (corresponding author), Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan.	dssun@mail.tcu.edu.tw	Chang, Hsin-Hou/B-6225-2012	Chang, Hsin-Hou/0000-0002-8731-3485	National Science Council [NSC 96-2311-B-320-005-MY3, NSC 99-2311-B-320-003-MY3]; Tzu-Chi University [610400130]	National Science Council(Ministry of Science and Technology, Taiwan); Tzu-Chi University	This work was supported by grants of National Science Council http://web1.nsc.gov.tw/mp.aspx (NSC 96-2311-B-320-005-MY3 and NSC 99-2311-B-320-003-MY3) and Tzu-Chi University http://www.tcu.edu.tw/ (610400130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2012, J CEREBR BLOOD F MET, V32, P1317, DOI 10.1038/jcbfm.2011.187; Alileche A, 2005, PLOS PATHOG, V1, P150, DOI 10.1371/journal.ppat.0010019; Baldo MP, 2011, CELL PHYSIOL BIOCHEM, V28, P33, DOI 10.1159/000331711; Bardwell AJ, 2004, BIOCHEM J, V378, P569, DOI 10.1042/BJ20031382; Bessho M, 1997, EUR J HAEMATOL, V58, P265; Brossier F, 2001, TOXICON, V39, P1747, DOI 10.1016/S0041-0101(01)00161-1; Chang HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071718; Chen PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059512; Chen WF, 2008, NEUROSCIENCE, V153, P31, DOI 10.1016/j.neuroscience.2008.01.062; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Comer JE, 2005, INFECT IMMUN, V73, P8275, DOI 10.1128/IAI.73.12.8275-8281.2005; DEBILI N, 1995, BLOOD, V86, P2516; Fang H, 2006, J IMMUNOL, V176, P6155, DOI 10.4049/jimmunol.176.10.6155; Fisher JW, 2003, EXP BIOL MED, V228, P1; Gaia S, 2006, J HEPATOL, V45, P13, DOI 10.1016/j.jhep.2006.02.018; Greenberg PL, 2009, BLOOD, V114, P2393, DOI 10.1182/blood-2009-03-211797; Hagemann C, 2001, CELL SIGNAL, V13, P863, DOI 10.1016/S0898-6568(01)00220-0; Harkness JE, 1995, CLIN PROCEDURES BIOL, P93; Hellstrom-Lindberg E, 2003, BRIT J HAEMATOL, V120, P1037, DOI 10.1046/j.1365-2141.2003.04153.x; HellstromLindberg E, 1997, BRIT J HAEMATOL, V99, P344, DOI 10.1046/j.1365-2141.1997.4013211.x; Hubel K, 2002, J INFECT DIS, V185, P1490, DOI 10.1086/340221; Jadersten M, 2005, BLOOD, V106, P803, DOI 10.1182/blood-2004-10-3872; Kassam A, 2005, CELL MICROBIOL, V7, P281, DOI 10.1111/j.1462-5822.2004.00458.x; Kau JH, 2005, J INFECT DIS, V192, P1465, DOI 10.1086/491477; Kau JH, 2002, CURR MICROBIOL, V44, P106, DOI 10.1007/s00284-001-0059-8; Kau JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014289; Kikuta T, 2000, EXP HEMATOL, V28, P311, DOI 10.1016/S0301-472X(99)00151-4; Kina T, 2000, BRIT J HAEMATOL, V109, P280, DOI 10.1046/j.1365-2141.2000.02037.x; Liu SH, 2013, NATURE, V501, P63, DOI 10.1038/nature12510; Metcalf D, 2008, BLOOD, V111, P485, DOI 10.1182/blood-2007-03-079681; Moayeri M, 2004, CURR OPIN MICROBIOL, V7, P19, DOI 10.1016/j.mib.2003.12.001; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; MORSTYN G, 1988, CANCER RES, V48, P5624; Mourez M, 2004, Rev Physiol Biochem Pharmacol, V152, P135; Muehlbauer SM, 2007, CELL CYCLE, V6, P758, DOI 10.4161/cc.6.6.3991; Negrin RS, 1996, BLOOD, V87, P4076, DOI 10.1182/blood.V87.10.4076.bloodjournal87104076; NIJHOF W, 1994, ANN NY ACAD SCI, V718, P312; OGAWA M, 1976, BLOOD, V48, P407; Page AV, 2011, INFECT DIS CLIN N AM, V25, P803, DOI 10.1016/j.idc.2011.07.007; PARK K, 1991, Osaka City Medical Journal, V37, P123; Rainey GJA, 2004, NAT REV MICROBIOL, V2, P721, DOI 10.1038/nrmicro977; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rankin SM, 2012, IMMUNOL LETT, V145, P47, DOI 10.1016/j.imlet.2012.04.009; Remacha AF, 1996, BONE MARROW TRANSPL, V17, P163; Sarma NJ, 2010, J VIS EXP; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; TROWBRIDGE IS, 1982, J CELL PHYSIOL, V112, P403, DOI 10.1002/jcp.1041120314; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wadhwa M, 2008, THROMB HAEMOSTASIS, V99, P863, DOI 10.1160/TH07-11-0703; Xiao BG, 2007, J CELL MOL MED, V11, P1272, DOI 10.1111/j.1582-4934.2007.00101.x	51	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e111149	10.1371/journal.pone.0111149	http://dx.doi.org/10.1371/journal.pone.0111149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384016	Green Published, Green Submitted, gold			2022-12-27	WOS:000344816700013
J	Kauppi, PE; Posch, M; Pirinen, P				Kauppi, Pekka E.; Posch, Maximilian; Pirinen, Pentti			Large Impacts of Climatic Warming on Growth of Boreal Forests since 1960	PLOS ONE			English	Article							CARBON SINK; SENSITIVITY; ECOSYSTEMS; MANAGEMENT; TEMPERATE; FEEDBACKS; CO2	Boreal forests are sensitive to climatic warming, because low temperatures hold back ecosystem processes, such as the mobilization of nitrogen in soils. A greening of the boreal landscape has been observed using remote sensing, and the seasonal amplitude of CO2 in the northern hemisphere has increased, indicating warming effects on ecosystem productivity. However, field observations on responses of ecosystem productivity have been lacking on a large sub-biome scale. Here we report a significant increase in the annual growth of boreal forests in Finland in response to climatic warming, especially since 1990. This finding is obtained by linking meteorological records and forest inventory data on an area between 60 degrees and 70 degrees northern latitude. An additional increase in growth has occurred in response to changes in other drivers, such as forest management, nitrogen deposition and/or CO2 concentration. A similar warming impact can be expected in the entire boreal zone, where warming takes place. Given the large size of the boreal biome - more than ten million km 2 - important climate feedbacks are at stake, such as the future carbon balance, transpiration and albedo.	[Kauppi, Pekka E.] Univ Helsinki, Dept Environm Sci, Helsinki, Finland; [Kauppi, Pekka E.] Finnish Forest Res Inst METLA, Vantaa, Finland; [Posch, Maximilian] Natl Inst Publ Hlth & Environm RIVM, Coordinat Ctr Effects, Bilthoven, Netherlands; [Pirinen, Pentti] Finnish Meteorol Inst, Climate Serv Ctr, FIN-00101 Helsinki, Finland	University of Helsinki; Natural Resources Institute Finland (Luke); Netherlands National Institute for Public Health & the Environment; Finnish Meteorological Institute	Kauppi, PE (corresponding author), Univ Helsinki, Dept Environm Sci, Helsinki, Finland.	pekka.kauppi@helsinki.fi						Betts RA, 2000, NATURE, V408, P187, DOI 10.1038/35041545; Bintanja R, 2014, NATURE, V509, P479, DOI 10.1038/nature13259; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; FINLAY KW, 1963, AUST J AGR RES, V14, P742, DOI 10.1071/AR9630742; FOLEY JA, 1994, NATURE, V371, P52, DOI 10.1038/371052a0; Frost GV, 2014, GLOBAL CHANGE BIOL, V20, P1264, DOI 10.1111/gcb.12406; Goulden ML, 1998, SCIENCE, V279, P214, DOI 10.1126/science.279.5348.214; Graven HD, 2013, SCIENCE, V341, P1085, DOI 10.1126/science.1239207; Hartmann DL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P159; Hember RA, 2012, GLOBAL CHANGE BIOL, V18, P2026, DOI 10.1111/j.1365-2486.2012.02669.x; Henttonen H, 1991, 12 U JYVASKYLA DEP S; Huikari O, 1984, FOLIA FORESTALIA, V590, P76; Hyvonen R, 2007, NEW PHYTOL, V173, P463, DOI 10.1111/j.1469-8137.2007.01967.x; KAUPPI P, 1985, CLIMATIC CHANGE, V7, P45, DOI 10.1007/BF00139440; Kauppi P., 1988, The impact of climatic variations on agriculture. Volume 1: Assessment in cool temperate and cold regions., P183; Lukes P, 2014, REMOTE SENS ENVIRON, V152, P526, DOI 10.1016/j.rse.2014.06.023; Luyssaert S, 2014, NAT CLIM CHANGE, V4, P389, DOI [10.1038/nclimate2196, 10.1038/NCLIMATE2196]; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; MIKOLA P., 1950, COMMUN INST FOREST FENNIAE, V38, P1; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Peng Y, 2014, BIOGEOSCIENCES, V11, P635, DOI 10.5194/bg-11-635-2014; Swann AL, 2010, P NATL ACAD SCI USA, V107, P1295, DOI 10.1073/pnas.0913846107; Tomppo E, 2011, MANAG FOR ECOSYST, V21, P1; Venalainen A, 2002, PHYS CHEM EARTH, V27, P1045, DOI 10.1016/S1474-7065(02)00140-7; Ylitalo, 2013, FINNISH STAT YB FORE	26	85	87	7	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e111340	10.1371/journal.pone.0111340	http://dx.doi.org/10.1371/journal.pone.0111340			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383552	Green Published, Green Submitted, gold			2022-12-27	WOS:000344816700015
J	Kim, J; Yin, T; Yin, M; Zhang, W; Shinozaki, K; Selak, MA; Pappan, KL; Lampe, JW; Becker, LB				Kim, Junhwan; Yin, Tai; Yin, Ming; Zhang, Wei; Shinozaki, Koichiro; Selak, Mary A.; Pappan, Kirk L.; Lampe, Joshua W.; Becker, Lance B.			Examination of Physiological Function and Biochemical Disorders in a Rat Model of Prolonged Asphyxia-Induced Cardiac Arrest followed by Cardio Pulmonary Bypass Resuscitation	PLOS ONE			English	Article							GLOBAL BRAIN ISCHEMIA; CELL INJURY; CARDIOPULMONARY BYPASS; LIPID-METABOLISM; HEART; PHOSPHOLIPIDS; REPERFUSION; DEATH; ACCUMULATION; DYSFUNCTION	Background: Cardiac arrest induces whole body ischemia, which causes damage to multiple organs particularly the heart and the brain. There is clinical and preclinical evidence that neurological injury is responsible for high mortality and morbidity of patients even after successful cardiopulmonary resuscitation. A better understanding of the metabolic alterations in the brain during ischemia will enable the development of better targeted resuscitation protocols that repair the ischemic damage and minimize the additional damage caused by reperfusion. Method: A validated whole body model of rodent arrest followed by resuscitation was utilized; animals were randomized into three groups: control, 30 minute asphyxial arrest, or 30 minutes asphyxial arrest followed by 60 min cardiopulmonary bypass (CPB) resuscitation. Blood gases and hemodynamics were monitored during the procedures. An untargeted metabolic survey of heart and brain tissues following cardiac arrest and after CPB resuscitation was conducted to better define the alterations associated with each condition. Results: After 30 min cardiac arrest and 60 min CPB, the rats exhibited no observable brain function and weakened heart function in a physiological assessment. Heart and brain tissues harvested following 30 min ischemia had significant changes in the concentration of metabolites in lipid and carbohydrate metabolism. In addition, the brain had increased lysophospholipid content. CPB resuscitation significantly normalized metabolite concentrations in the heart tissue, but not in the brain tissue. Conclusion: The observation that metabolic alterations are seen primarily during cardiac arrest suggests that the events of ischemia are the major cause of neurological damage in our rat model of asphyxia-CPB resuscitation. Impaired glycolysis and increased lysophospholipids observed only in the brain suggest that altered energy metabolism and phospholipid degradation may be a central mechanism in unresuscitatable brain damage.	[Kim, Junhwan; Yin, Tai; Yin, Ming; Zhang, Wei; Shinozaki, Koichiro; Selak, Mary A.; Lampe, Joshua W.; Becker, Lance B.] Univ Penn, Dept Emergency Med, Ctr Resuscitat Sci, Philadelphia, PA 19104 USA; [Pappan, Kirk L.] Metabolon Inc, Durham, NC USA	University of Pennsylvania; Pennsylvania Medicine; Metabolon	Kim, J (corresponding author), Univ Penn, Dept Emergency Med, Ctr Resuscitat Sci, Philadelphia, PA 19104 USA.	junhwan.kim@uphs.upenn.edu	Yin, Ming/ABA-8766-2020; Pappan, Kirk/AAV-5946-2021	Yin, Ming/0000-0003-4585-8732; Kim, Junhwan/0000-0002-1162-8616; Pappan, Kirk/0000-0002-2341-8798; Lampe, Joshua/0000-0001-6036-535X	National Institutes of Health [HL067630]; Metabolon, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067630] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Metabolon, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant HL067630. Metabolon, Inc., provided support in the form of a salary for author KLP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Adibhatla RM, 2006, FREE RADICAL BIO MED, V40, P376, DOI 10.1016/j.freeradbiomed.2005.08.044; Allen BS, 2012, EUR J CARDIO-THORAC, V41, P1155, DOI 10.1093/ejcts/ezr318; Allen BS, 2012, EUR J CARDIO-THORAC, V41, P1132, DOI 10.1093/ejcts/ezr315; ARNSDORF MF, 1981, CIRC RES, V49, P16, DOI 10.1161/01.RES.49.1.16; Bonventre JV, 1999, J AM SOC NEPHROL, V10, P404; Boutilier RG, 2001, J EXP BIOL, V204, P3171; BUJA LM, 1991, TRENDS CARDIOVAS MED, V1, P40, DOI 10.1016/1050-1738(91)90058-M; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; Chen YS, 2008, CRIT CARE MED, V36, P2529, DOI 10.1097/CCM.0b013e318183f491; CHIEN KR, 1978, J BIOL CHEM, V253, P4809; CHIEN KR, 1984, CIRC RES, V54, P313, DOI 10.1161/01.RES.54.3.313; De Windt LJ, 1998, MOL CELL BIOCHEM, V180, P65, DOI 10.1023/A:1006886906105; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; FARBER JL, 1981, AM J PATHOL, V102, P271; GROSS RW, 1992, TRENDS CARDIOVAS MED, V2, P115, DOI 10.1016/1050-1738(92)90016-L; Han F, 2010, RESUSCITATION, V81, P93, DOI 10.1016/j.resuscitation.2009.09.018; HEUSER D, 1985, BRIT J ANAESTH, V57, P23, DOI 10.1093/bja/57.1.23; KATZ L, 1995, J CEREBR BLOOD F MET, V15, P1032, DOI 10.1038/jcbfm.1995.129; Kristian T, 2004, CELL CALCIUM, V36, P221, DOI 10.1016/j.ceca.2004.02.016; Kubasiak LA, 2002, P NATL ACAD SCI USA, V99, P12825, DOI 10.1073/pnas.202474099; Liachenko S, 1998, STROKE, V29, P1229, DOI 10.1161/01.STR.29.6.1229; Liam BL, 1998, J THORAC CARDIOV SUR, V115, P1203, DOI 10.1016/S0022-5223(98)70422-2; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Madl Christian, 2004, Curr Opin Crit Care, V10, P213, DOI 10.1097/01.ccx.0000127542.32890.fa; MAN RYK, 1988, BRIT J PHARMACOL, V93, P412, DOI 10.1111/j.1476-5381.1988.tb11448.x; Mongardon N, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-45; Morimura N, 2011, RESUSCITATION, V82, P10, DOI 10.1016/j.resuscitation.2010.08.032; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; NEELY JR, 1974, ANNU REV PHYSIOL, V36, P413, DOI 10.1146/annurev.ph.36.030174.002213; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Nichol G, 2006, RESUSCITATION, V70, P381, DOI 10.1016/j.resuscitation.2006.01.018; Nieman DC, 2013, J PROTEOME RES, V12, P4577, DOI 10.1021/pr400717j; OPIE LH, 1990, CARDIOVASC DRUG THER, V4, P777, DOI 10.1007/BF00051275; PETRICH ER, 1996, EXS, V76, P115; Purdon AD, 2002, NEUROCHEM RES, V27, P1641, DOI 10.1023/A:1021635027211; Rau TF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047877, 10.1371/journal.pone.0040881]; Shin TG, 2011, CRIT CARE MED, V39, P1, DOI 10.1097/CCM.0b013e3181feb339; SIESJO BK, 1981, J CEREBR BLOOD F MET, V1, P155, DOI 10.1038/jcbfm.1981.18; Starkov AA, 2004, CELL CALCIUM, V36, P257, DOI 10.1016/j.ceca.2004.02.012; STEENBERGEN C, 1984, J MOL CELL CARDIOL, V16, P605, DOI 10.1016/S0022-2828(84)80625-2; Stub D, 2011, CIRCULATION, V123, P1428, DOI 10.1161/CIRCULATIONAHA.110.988725; SUN DD, 1994, J NEUROCHEM, V62, P1921; van der Vusse G J, 1996, EXS, V76, P175; VANDERVUSSE GJ, 1992, PHYSIOL REV, V72, P881, DOI 10.1152/physrev.1992.72.4.881; Wang HYJ, 2010, RAPID COMMUN MASS SP, V24, P2057, DOI 10.1002/rcm.4620; Xie JL, 1997, CIRCULATION, V96, P683	48	18	18	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112012	10.1371/journal.pone.0112012	http://dx.doi.org/10.1371/journal.pone.0112012			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383962	gold, Green Published, Green Submitted			2022-12-27	WOS:000344816700028
J	Kirkpatrick, RM; McGue, M; Iacono, WG; Miller, MB; Basu, S				Kirkpatrick, Robert M.; McGue, Matt; Iacono, William G.; Miller, Michael B.; Basu, Saonli			Results of a "GWAS Plus:" General Cognitive Ability Is Substantially Heritable and Massively Polygenic	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMMON SNPS EXPLAIN; LARGE PROPORTION; TWIN; INTELLIGENCE; STRATIFICATION; GENETICS; FAMILY; DNA	We carried out a genome-wide association study (GWAS) for general cognitive ability (GCA) plus three other analyses of GWAS data that aggregate the effects of multiple single-nucleotide polymorphisms (SNPs) in various ways. Our multigenerational sample comprised 7,100 Caucasian participants, drawn from two longitudinal family studies, who had been assessed with an age-appropriate IQ test and had provided DNA samples passing quality screens. We conducted the GWAS across similar to 2.5 million SNPs (both typed and imputed), using a generalized least-squares method appropriate for the different family structures present in our sample, and subsequently conducted gene-based association tests. We also conducted polygenic prediction analyses under five-fold cross-validation, using two different schemes of weighting SNPs. Using parametric bootstrapping, we assessed the performance of this prediction procedure under the null. Finally, we estimated the proportion of variance attributable to all genotyped SNPs as random effects with software GCTA. The study is limited chiefly by its power to detect realistic single-SNP or single-gene effects, none of which reached genome-wide significance, though some genomic inflation was evident from the GWAS. Unit SNP weights performed about as well as least-squares regression weights under cross-validation, but the performance of both increased as more SNPs were included in calculating the polygenic score. Estimates from GCTA were 35% of phenotypic variance at the recommended biological-relatedness ceiling. Taken together, our results concur with other recent studies: they support a substantial heritability of GCA, arising from a very large number of causal SNPs, each of very small effect. We place our study in the context of the literature-both contemporary and historical-and provide accessible explication of our statistical methods.	[Kirkpatrick, Robert M.; McGue, Matt; Iacono, William G.; Miller, Michael B.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Basu, Saonli] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Kirkpatrick, RM (corresponding author), Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA.	rkirkpatrick2@vcu.edu		Basu, Saonli/0000-0003-1200-4546	NIH [AA09367, AA11886, DA05147, DA13240, DA024417, MH066140, R25DA026119]; University of Minnesota Graduate School; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA009367, R01AA009367, R01AA011886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013240, U01DA024417, R25DA026119, R01DA005147, R37DA005147, R01DA024417] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota Graduate School(University of Minnesota System); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The reported research was made possible by NIH grants AA09367, AA11886, DA05147, DA13240, DA024417, and MH066140. While conducting the reported analyses and drafting the manuscript, the first author was supported by a Doctoral Dissertation Fellowship from the University of Minnesota Graduate School, and while finalizing the manuscript for publication, was supported by NIH grant R25DA026119. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Benjamin DJ, 2012, P NATL ACAD SCI USA, V109, P8026, DOI 10.1073/pnas.1120666109; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benyamin B, 2014, MOL PSYCHIATR, V19, P253, DOI 10.1038/mp.2012.184; Bouchard TJ, 2004, CURR DIR PSYCHOL SCI, V13, P148, DOI 10.1111/j.0963-7214.2004.00295.x; Bouchard TJ, 2003, J NEUROBIOL, V54, P4, DOI 10.1002/neu.10160; BOUCHARD TJ, 1981, SCIENCE, V212, P1055, DOI 10.1126/science.7195071; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; BUSE A, 1973, AM STAT, V27, P106, DOI 10.2307/2683631; Butcher LM, 2008, GENES BRAIN BEHAV, V7, P435, DOI 10.1111/j.1601-183X.2007.00368.x; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Chabris CF, 2012, PSYCHOL SCI, V23, P1314, DOI 10.1177/0956797611435528; Dana J, 2004, J EDUC BEHAV STAT, V29, P317, DOI 10.3102/10769986029003317; Daniels J, 1998, AM J HUM GENET, V62, P1189, DOI 10.1086/301816; Davies G, 2011, MOL PSYCHIATR, V16, P996, DOI 10.1038/mp.2011.85; Davis OSP, 2010, BEHAV GENET, V40, P759, DOI 10.1007/s10519-010-9350-4; Deary IJ, 2006, EUR J HUM GENET, V14, P690, DOI 10.1038/sj.ejhg.5201588; Deary IJ, 2012, ANNU REV PSYCHOL, V63, P453, DOI 10.1146/annurev-psych-120710-100353; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; FLYNN JR, 1987, PSYCHOL BULL, V101, P171, DOI 10.1037/0033-2909.101.2.171; FLYNN JR, 1984, PSYCHOL BULL, V95, P29, DOI 10.1037/0033-2909.95.1.29; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Gibson G, 2010, NAT GENET, V42, P558, DOI 10.1038/ng0710-558; Gottfredson LS, 2003, SCIENTIFIC STUDY OF GENERAL INTELLIGENCE: TRIBUTE TO ARTHUR R. J ENSEN, P293, DOI 10.1016/B978-008043793-4/50053-2; Herrnstein R J, 1994, BELL CURVE; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Iacono WG, 1999, DEV PSYCHOPATHOL, V11, P869, DOI 10.1017/S0954579499002369; Iacono WG, 2002, TWIN RES, V5, P482, DOI 10.1375/twin.5.5.482; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Jensen A.R., 1998, G FACTOR SCI MENTAL; Keyes MA, 2009, TWIN RES HUM GENET, V12, P489, DOI 10.1375/twin.12.5.489; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Li X, 2011, HUM HERED, V71, P67, DOI 10.1159/000324839; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; McCulloch CE, 2011, BIOMETRICS, V67, P270, DOI 10.1111/j.1541-0420.2010.01435.x; Mcgue M, 2007, BEHAV GENET, V37, P449, DOI 10.1007/s10519-007-9142-7; Miller MB, 2012, TWIN RES HUM GENET, V15, P767, DOI 10.1017/thg.2012.62; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Pan Y, 2011, PROG NEURO-PSYCHOPH, V35, P154, DOI 10.1016/j.pnpbp.2010.10.016; Payton A, 2006, GENES BRAIN BEHAV, V5, P44, DOI 10.1111/j.1601-183X.2006.00194.x; Plomin R, 2003, SCI STUDY GEN INTELL, P275; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rijsdijk FV, 2002, BEHAV GENET, V32, P199, DOI 10.1023/A:1016021128949; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sattler J. M., 1974, ASSESSMENT CHILDREN; Turkheimer E, 2011, RES HUM DEV, V8, P227, DOI 10.1080/15427609.2011.625321; Visscher PM, 2008, NAT GENET, V40, P489, DOI 10.1038/ng0508-489; Visscher PM, 2010, TWIN RES HUM GENET, V13, P517, DOI 10.1375/twin.13.6.517; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	60	25	26	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112390	10.1371/journal.pone.0112390	http://dx.doi.org/10.1371/journal.pone.0112390			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383866	Green Submitted, gold, Green Published			2022-12-27	WOS:000344816700055
J	Priplatova, L; Sebankova, B; Flegr, J				Priplatova, Lenka; Sebankova, Blanka; Flegr, Jaroslav			Contrasting Effect of Prepulse Signals on Performance of Toxoplasma-Infected and Toxoplasma-Free Subjects in an Acoustic Reaction Times Test	PLOS ONE			English	Article							STARTLE GATING DEFICITS; LATENT TOXOPLASMOSIS; PERSONALITY PROFILE; FATAL ATTRACTION; GONDII INFECTION; DECREASED LEVEL; ANIMAL BEHAVIOR; NOVELTY SEEKING; SCHIZOPHRENIA; DOPAMINE	Background: About 30% of people on Earth have latent toxoplasmosis. Infected subjects do not express any clinical symptoms, however, they carry dormant stages of parasite Toxoplasma for the rest of their life. This form of toxoplasmosis is mostly considered harmless, however, recent studies showed its specific effects on physiology, behaviour and its associations with various diseases, including psychiatric disorders such as schizophrenia. Individuals who suffer from schizophrenia have about 2.7 times higher prevalence of Toxoplasma-seropositivity than controls, which suggests that some traits characteristic of schizophrenic patients, including the sex difference in schizophrenia onset, decrease of grey matter density in specific brain areas and modification of prepulse inhibition of startle reaction could in fact be caused by toxoplasmosis for those patients who are Toxoplasma-seropositive. Methodology/Principal Findings: We measured the effect of prepulse inhibition/facilitation of the startle reaction on reaction times. The students, 170 women and 66 men, were asked to react as quickly as possible to a startling acoustic signal by pressing a computer mouse button. Some of the startling signals were without the prepulse, some were 20 msec. preceded by a short (20 msec.) prepulse signal of lower intensity. Toxoplasma-seropositive subjects had longer reaction times than the controls. Acoustic prepulse shorted the reaction times in all subjects. This effect of prepulse on reaction times was stronger in male subjects and increased with the duration of infection, suggesting that it represented a cumulative effect of latent toxoplasmosis, rather than a fading out after effect of past acute toxoplasmosis. Conclusions: Different sensitivity of Toxoplasma-seropositive and Toxoplasma-seronegative subjects on effect of prepulses on reaction times (the toxoplasmosis-prepulse interaction) suggested, but of course did not prove, that the alternations of prepulse inhibition of startle reaction observed in schizophrenia patients probably joined the list of schizophrenia symptoms that are in fact caused by latent toxoplasmosis.	[Priplatova, Lenka; Sebankova, Blanka; Flegr, Jaroslav] Charles Univ Prague, Fac Sci, Dept Philosophy & Hist Sci, Prague, Czech Republic	Charles University Prague	Flegr, J (corresponding author), Charles Univ Prague, Fac Sci, Dept Philosophy & Hist Sci, Prague, Czech Republic.	flegr@cesnet.cz	Šebánková, Blanka/GQH-0803-2022; Flegr, Jaroslav/A-1564-2008; Flegr, Jaroslav/AAG-7568-2021	Flegr, Jaroslav/0000-0002-0822-0126; Flegr, Jaroslav/0000-0002-0822-0126; Priplatova, Lenka/0000-0002-2860-3853	Charles University of Prague [GAUK 18810, UNCE 204004]; Grand Agency of the Czech Republic [P303/11/1398]	Charles University of Prague; Grand Agency of the Czech Republic	The authors' work was supported by the Charles University of Prague (GAUK 18810, grant UNCE 204004) and the Grand Agency of the Czech Republic (Grant No. P303/11/1398). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berdoy M, 2000, P ROY SOC B-BIOL SCI, V267, P1591, DOI 10.1098/rspb.2000.1182; Braff DL, 1999, AM J PSYCHIAT, V156, P596; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Cadenhead KS, 2000, AM J PSYCHIAT, V157, P1660, DOI 10.1176/appi.ajp.157.10.1660; Filion DL, 1998, BIOL PSYCHOL, V47, P1, DOI 10.1016/S0301-0511(97)00020-3; Flegr J, 2003, BIOL PSYCHOL, V63, P253, DOI 10.1016/S0301-0511(03)00075-9; FLEGR J, 1994, FOLIA PARASIT, V41, P122; Flegr J, 2008, PARASITOLOGY, V135, P427, DOI 10.1017/S0031182007004064; Flegr J, 1999, FOLIA PARASIT, V46, P22; Flegr J, 2005, FOLIA PARASIT, V52, P199, DOI 10.14411/fp.2005.026; Flegr J, 2013, PLOS ONE, V8; Flegr J, 2008, NEUROENDOCRINOL LETT, V29, P475; Flegr J, 2013, TRENDS PARASITOL, V29, P156, DOI 10.1016/j.pt.2013.01.007; Flegr J, 2013, J EXP BIOL, V216, P127, DOI 10.1242/jeb.073635; Flegr J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001389; Flegr J, 2010, FOLIA PARASIT, V57, P143, DOI 10.14411/fp.2010.018; Flegr J, 2010, FOLIA PARASIT, V57, P81, DOI 10.14411/fp.2010.010; FOSS JA, 1989, HUM FACTORS, V31, P319, DOI 10.1177/001872088903100306; Gaskell EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004801; Gatkowska J, 2013, EXP PARASITOL, V133, P1, DOI 10.1016/j.exppara.2012.10.005; GRILLON C, 1992, BIOL PSYCHIAT, V32, P939, DOI 10.1016/0006-3223(92)90183-Z; Havlicek J, 2001, PARASITOLOGY, V122, P515, DOI 10.1017/S0031182001007624; Hodkova H, 2007, PARASITOLOGY, V134, P1329, DOI 10.1017/S0031182007002673; Holub D, 2013, ACTA PSYCHIAT SCAND, V127, P227, DOI 10.1111/acps.12031; Holub D, 2006, PSYCHIATRIE, V10, P66; Horacek J, 2012, WORLD J BIOL PSYCHIA; Horacek J, 2012, WORLD J BIOL PSYCHIA, V13, P501, DOI 10.3109/15622975.2011.573809; House PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023277; Kankova S, 2011, EXP PARASITOL, V128, P181, DOI 10.1016/j.exppara.2011.03.014; Kodym P, 2007, CLIN MICROBIOL INFEC, V13, P40, DOI 10.1111/j.1469-0691.2006.01564.x; Kumari V, 2000, ARCH GEN PSYCHIAT, V57, P609, DOI 10.1001/archpsyc.57.6.609; Lindova J, 2010, FOLIA PARASIT, V57, P136, DOI 10.14411/fp.2010.017; Maslovat D, 2012, NEUROSCI LETT, V513, P243, DOI 10.1016/j.neulet.2012.02.052; McConkey GA, 2013, J EXP BIOL, V216, P113, DOI 10.1242/jeb.074153; Nikam SS, 2008, CURR OPIN INVEST DR, V9, P37; Novotna M, 2008, PARASITOLOGY, V135, P1253, DOI 10.1017/S003118200800485X; Pearce BD, 2013, SCHIZOPHR RES, V150, P258, DOI 10.1016/j.schres.2013.07.028; Prandovszky E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023866; Rupp CI, 2010, CURR OPIN PSYCHIATR, V23, P97, DOI 10.1097/YCO.0b013e328336643f; Saklayen SS, 2004, J PHARMACOL EXP THER, V311, P342, DOI 10.1124/jpet.104.067991; Siegel S, 1988, NONPARAMETRIC STAT B, Vxxiii; Skallova A, 2006, PARASITOLOGY, V133, P525, DOI 10.1017/S0031182006000886; Skallova A, 2005, NEUROENDOCRINOL LETT, V26, P480; Strobl JS, 2012, J PARASITOL, V98, P1296, DOI 10.1645/GE-2760.1; Sun XJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-241; Swerdlow NR, 2006, ARCH GEN PSYCHIAT, V63, P1325, DOI 10.1001/archpsyc.63.12.1325; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Torrey EF, 2007, SCHIZOPHRENIA BULL, V33, P729, DOI 10.1093/schbul/sbl050; Torrey EF, 2007, SCHIZOPHRENIA BULL, V33, P727, DOI 10.1093/schbul/sbm026; Torrey EF, 2012, SCHIZOPHRENIA BULL, V38, P642, DOI 10.1093/schbul/sbs043; Turetsky BI, 2009, AM J PSYCHIAT, V166, P226, DOI 10.1176/appi.ajp.2008.07071210; Valls-Sole J, 1999, EXP BRAIN RES, V129, P49, DOI 10.1007/s002210050935; Valls-Sole J, 2008, EXP BRAIN RES, V187, P497, DOI 10.1007/s00221-008-1402-0; VALLSSOLE J, 1995, NEUROSCI LETT, V195, P97, DOI 10.1016/0304-3940(94)11790-P; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Vyas A, 2013, J EXP BIOL, V216, P120, DOI 10.1242/jeb.072983; Wang HL, 2006, ACTA PSYCHIAT SCAND, V114, P40, DOI 10.1111/j.1600-0447.2006.00780.x; Webster JP, 2007, SCHIZOPHRENIA BULL, V33, P752, DOI 10.1093/schbul/sbl073; Webster JP, 2013, J EXP BIOL, V216, P99, DOI 10.1242/jeb.074716; Willner P, 1997, INT CLIN PSYCHOPHARM, V12, P297, DOI 10.1097/00004850-199711000-00002; Xiao JC, 2013, MICROBES INFECT, V15, P74, DOI 10.1016/j.micinf.2012.10.016; Yolken RH, 2009, PARASITE IMMUNOL, V31, P706, DOI 10.1111/j.1365-3024.2009.01131.x; Zhou P, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-165	63	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112771	10.1371/journal.pone.0112771	http://dx.doi.org/10.1371/journal.pone.0112771			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384036	gold, Green Submitted, Green Published			2022-12-27	WOS:000344816700094
J	Rigby, P; Pizarro, O; Williams, SB				Rigby, Paul; Pizarro, Oscar; Williams, Stefan B.			Estimation of Clustering Parameters Using Gaussian Process Regression	PLOS ONE			English	Article							LINE TRANSECT SURVEYS; SPATIAL METHODS	We propose a method for estimating the clustering parameters in a Neyman-Scott Poisson process using Gaussian process regression. It is assumed that the underlying process has been observed within a number of quadrats, and from this sparse information the distribution is modelled as a Gaussian process. The clustering parameters are then estimated numerically by fitting to the covariance structure of the model. It is shown that the proposed method is resilient to any sampling regime. The method is applied to simulated two-dimensional clustered populations and the results are compared to a related method from the literature.	[Rigby, Paul] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Pizarro, Oscar; Williams, Stefan B.] Univ Sydney, Australian Ctr Field Robot, Sydney, NSW 2006, Australia	Australian Institute of Marine Science; University of Sydney	Rigby, P (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	p.rigby@aims.gov.au	Williams, Stefan/AAE-4376-2020	Williams, Stefan/0000-0001-9416-5639; Pizarro, Oscar/0000-0001-6612-2738	Australian Research Council (ARC); New South Wales State Government; Integrated Marine Observing System (IMOS) through the National Collaborative Research Infrastructure Strategy; Integrated Marine Observing System (IMOS) through the Super Science Initiative	Australian Research Council (ARC)(Australian Research Council); New South Wales State Government; Integrated Marine Observing System (IMOS) through the National Collaborative Research Infrastructure Strategy; Integrated Marine Observing System (IMOS) through the Super Science Initiative	This work is funded by the Australian Research Council (ARC), the New South Wales State Government, and the Integrated Marine Observing System (IMOS) through the National Collaborative Research Infrastructure Strategy and the Super Science Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrin M, 2003, BIOMETRICS, V59, P186, DOI 10.1111/1541-0420.00022; Aldrin M, 2002, TECHNICAL REPORT; Cowling A, 1998, BIOMETRICS, V54, P828, DOI 10.2307/2533837; Cressie N, 1991, STAT SPATIAL DATA; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; DUNNING JB, 1995, ECOL APPL, V5, P3, DOI 10.2307/1942045; Hagen G, 1995, DEV MAR BIO, V4, P27; Hanski Ilkka, 1997, P5, DOI 10.1016/B978-012323445-2/50003-1; HOLMES EE, 1994, ECOLOGY, V75, P17, DOI 10.2307/1939378; Holmes KW, 2006, TECHNICAL REPORT; Matern B, 1971, STAT ECOLOGY, V1, P195; Matheron G., 1963, ECON GEOL, V58, P1246, DOI [DOI 10.2113/GSECONGEO.58.8.1246, 10.2113/gsecongeo.58.8.1246]; Okubo A, 1980, DIFFUSION ECOLOGICA; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Von Mises R., 1964, MATH THEORY PROBABIL; Wu BM, 2006, J PHYTOPATHOL, V154, P349, DOI 10.1111/j.1439-0434.2006.01105.x	17	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e111522	10.1371/journal.pone.0111522	http://dx.doi.org/10.1371/journal.pone.0111522			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383766	Green Published, Green Submitted, gold			2022-12-27	WOS:000344816700018
J	Teleki, I; Szasz, AM; Maros, ME; Gyorffy, B; Kulka, J; Meggyeshazi, N; Kiszner, G; Balla, P; Samu, A; Krenacs, T				Teleki, Ivett; Szasz, Attila Marcell; Maros, Mate Elod; Gyorffy, Balazs; Kulka, Janina; Meggyeshazi, Nora; Kiszner, Gergo; Balla, Peter; Samu, Aliz; Krenacs, Tibor			Correlations of Differentially Expressed Gap Junction Connexins Cx26, Cx30, Cx32, Cx43 and Cx46 with Breast Cancer Progression and Prognosis	PLOS ONE			English	Article							INTERCELLULAR COMMUNICATION; DOWN-REGULATION; MAMMARY-GLAND; DEVELOPMENTAL EXPRESSION; MICROARRAY DATA; ESTROGEN; CELL; PROTEINS; PHENOTYPE; CHANNELS	Background and Aims: Connexins and their cell membrane channels contribute to the control of cell proliferation and compartmental functions in breast glands and their deregulation is linked to breast carcinogenesis. Our aim was to correlate connexin expression with tumor progression and prognosis in primary breast cancers. Materials and Methods: Meta-analysis of connexin isotype expression data of 1809 and 1899 breast cancers from the Affymetrix and Illumina array platforms, respectively, was performed. Expressed connexins were also monitored at the protein level in tissue microarrays of 127 patients equally representing all tumor grades, using immunofluorescence and multilayer, multichannel digital microscopy. Prognostic correlations were plotted in Kaplan-Meier curves and tested using the log-rank test and cox-regression analysis in univariate and multivariate models. Results: The expression of GJA1/Cx43, GJA3/Cx46 and GJB2/Cx26 and, for the first time, GJA6/Cx30 and GJB1/Cx32 was revealed both in normal human mammary glands and breast carcinomas. Within their subfamilies these connexins can form homo- and heterocellular epithelial channels. In cancer, the array datasets cross-validated each other's prognostic results. In line with the significant correlations found at mRNA level, elevated Cx43 protein levels were linked with significantly improved breast cancer outcome, offering Cx43 protein detection as an independent prognostic marker stronger than vascular invasion or necrosis. As a contrary, elevated Cx30 mRNA and protein levels were associated with a reduced disease outcome offering Cx30 protein detection as an independent prognostic marker outperforming mitotic index and necrosis. Elevated versus low Cx43 protein levels allowed the stratification of grade 2 tumors into good and poor relapse free survival subgroups, respectively. Also, elevated versus low Cx30 levels stratified grade 3 patients into poor and good overall survival subgroups, respectively. Conclusion: Differential expression of Cx43 and Cx30 may serve as potential positive and negative prognostic markers, respectively, for a clinically relevant stratification of breast cancers.	[Teleki, Ivett; Maros, Mate Elod; Meggyeshazi, Nora; Kiszner, Gergo; Balla, Peter; Samu, Aliz; Krenacs, Tibor] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary; [Szasz, Attila Marcell; Kulka, Janina] Semmelweis Univ, Dept Pathol 2, H-1085 Budapest, Hungary; [Gyorffy, Balazs] MTA TTK Lendulet Canc Biomarker Res Grp, Budapest, Hungary; [Gyorffy, Balazs] Semmelweis Univ, Dept Pediat 2, H-1085 Budapest, Hungary; [Gyorffy, Balazs] MTA SE Pediat & Nephrol Res Grp, Budapest, Hungary; [Krenacs, Tibor] MTA SE Tumor Progress Res Grp, Budapest, Hungary	Semmelweis University; Semmelweis University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Semmelweis University; Semmelweis University	Krenacs, T (corresponding author), Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary.	krenacst@gmail.com	Gyorffy, Balazs/AAA-9135-2021; Maros, Máté E./ABB-3203-2021; Kulka, Janina/K-5703-2017	Gyorffy, Balazs/0000-0002-5772-3766; Maros, Máté E./0000-0002-1589-8699; Kulka, Janina/0000-0003-1530-6646	MTA TKI of the Hungarian Academy of Sciences; OTKA [K108655]; European Union; European Social Fund [TAMOP-4.2.4.A/2-11-1-2012-0001]; State of Hungary	MTA TKI of the Hungarian Academy of Sciences; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Union(European Commission); European Social Fund(European Social Fund (ESF)); State of Hungary	This work was supported by MTA TKI of the Hungarian Academy of Sciences and OTKA K108655. AMS was supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP-4.2.4.A/2-11-1-2012-0001 'National Excellence Program.' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen J, 2000, ENVIRON HEALTH PERSP, V108, P811, DOI 10.2307/3454311; Axelsen LN, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00130; Banerjee D, 2011, J BIOL CHEM, V286, P24519, DOI 10.1074/jbc.M110.217208; Banerjee D, 2010, INT J CANCER, V127, P839, DOI 10.1002/ijc.25107; Baselga J, 2006, ONCOLOGIST, V11, P4, DOI 10.1634/theoncologist.11-90001-4; Boswell BA, 2009, EXP EYE RES, V88, P919, DOI 10.1016/j.exer.2008.11.031; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chen VC, 2012, J PROTEOME RES, V11, P6134, DOI 10.1021/pr300790h; Conklin C, 2007, CANCER LETT, V255, P284, DOI 10.1016/j.canlet.2007.05.001; Cronier L, 2009, ANTIOXID REDOX SIGN, V11, P323, DOI 10.1089/ars.2008.2153; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Czyz J, 2008, CELL MOL BIOL LETT, V13, P92, DOI 10.2478/s11658-007-0039-5; Falk MM, 2014, FEBS LETT, V588, P1221, DOI 10.1016/j.febslet.2014.01.031; Groenendijk FH, 2014, MOL ONCOL; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Harbeck N, 2014, CANCER TREAT REV, V40, P434, DOI 10.1016/j.ctrv.2013.09.014; Helguero LA, 2005, ONCOGENE, V24, P6605, DOI 10.1038/sj.onc.1208807; Hirschi KK, 1996, CELL GROWTH DIFFER, V7, P861; Jamieson S, 1998, J PATHOL, V184, P37, DOI 10.1002/(SICI)1096-9896(199801)184:1<37::AID-PATH966>3.0.CO;2-D; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kalra J, 2006, CARCINOGENESIS, V27, P2528, DOI 10.1093/carcin/bgl110; Kanczuga-Koda L, 2006, J CLIN PATHOL, V59, P429, DOI 10.1136/jcp.2005.029272; Kanczuga-Koda Luiza, 2007, Folia Histochem Cytobiol, V45 Suppl 1, pS175; Kapoor P, 2004, INT J CANCER, V111, P693, DOI 10.1002/ijc.20318; Koval M, 2014, FEBS LETT, V588, P1193, DOI 10.1016/j.febslet.2014.02.025; Laird DW, 2010, TRENDS CELL BIOL, V20, P92, DOI 10.1016/j.tcb.2009.11.001; Laird DW, 1999, CANCER RES, V59, P4104; LEE SW, 1992, J CELL BIOL, V118, P1213, DOI 10.1083/jcb.118.5.1213; Leithe Edward, 2006, Critical Reviews in Oncogenesis, V12, P225; Lesniewicz T, 2009, INT J GYNECOL CANCER, V19, P1253, DOI 10.1111/IGC.0b013e3181a40618; Lin VCL, 2001, CLIN CANCER RES, V7, P2880; Liu XL, 2010, INT J MOL MED, V25, P709, DOI 10.3892/ijmm_00000395; Locke D, 1998, J PATHOL, V186, P343; Locke D, 2000, J CELL PHYSIOL, V183, P228; Marotti JD, 2010, MODERN PATHOL, V23, P197, DOI 10.1038/modpathol.2009.158; McLachlan E, 2007, J MEMBRANE BIOL, V218, P107, DOI 10.1007/s00232-007-9052-x; Mesnil M, 2005, BBA-BIOMEMBRANES, V1719, P125, DOI 10.1016/j.bbamem.2005.11.004; Mesnil M, 2002, BIOL CELL, V94, P493, DOI 10.1016/S0248-4900(02)00025-4; Monaghan P, 1996, EXP CELL RES, V223, P29, DOI 10.1006/excr.1996.0055; Naus CC, 2010, NAT REV CANCER, V10, P435, DOI 10.1038/nrc2841; Neijssen J, 2005, NATURE, V434, P83, DOI 10.1038/nature03290; Ng CKY, 2012, EXPERT REV ANTICANC, V12, P1021, DOI [10.1586/ERA.12.85, 10.1586/era.12.85]; Nielsen MS, 2012, COMPR PHYSIOL, V2, P1981, DOI 10.1002/cphy.c110051; Nomura S, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-79; Orthmann-Murphy JL, 2007, J NEUROSCI, V27, P13949, DOI 10.1523/JNEUROSCI.3395-07.2007; Oyamada M, 2005, BBA-BIOMEMBRANES, V1719, P6, DOI 10.1016/j.bbamem.2005.11.002; Plante I, 2011, ONCOGENE, V30, P1681, DOI 10.1038/onc.2010.551; Plante I, 2010, BIOL REPROD, V82, P837, DOI 10.1095/biolreprod.109.081406; Pollmann MA, 2005, BREAST CANCER RES, V7, pR522, DOI 10.1186/bcr1042; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Rakha EA, 2010, BREAST CANCER RES TR, V120, P293, DOI 10.1007/s10549-010-0746-x; Rash JE, 2005, J NEUROCYTOL, V34, P307, DOI 10.1007/s11068-005-8360-2; Renoir JM, 2013, BIOCHEM PHARMACOL, V85, P449, DOI 10.1016/j.bcp.2012.10.018; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Saez JC, 2014, FEBS LETT, V588, P1205, DOI 10.1016/j.febslet.2014.03.004; Saito T, 2004, ONCOGENE, V23, P1109, DOI 10.1038/sj.onc.1207215; Saunders MM, 2001, CANCER RES, V61, P1765; Shao Q, 2005, CANCER RES, V65, P2705, DOI 10.1158/0008-5472.CAN-04-2367; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Stoletov K, 2013, J CELL SCI, V126, P904, DOI 10.1242/jcs.112748; Su V, 2014, FEBS LETT, V588, P1212, DOI 10.1016/j.febslet.2014.01.013; Szasz AM, 2011, CANCER SCI, V102, P2248, DOI 10.1111/j.1349-7006.2011.02085.x; Talhouk RS, 2005, CELL TISSUE RES, V319, P49, DOI 10.1007/s00441-004-0915-5; Teleki I, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-50; TOMASETTO C, 1993, J CELL BIOL, V122, P157, DOI 10.1083/jcb.122.1.157; Vinken M, 2009, BBA-REV CANCER, V1795, P53, DOI 10.1016/j.bbcan.2008.08.002; Yum SW, 2007, AM J PHYSIOL-CELL PH, V293, pC1032, DOI 10.1152/ajpcell.00011.2007; Zhou JZ, 2014, FEBS LETT, V588, P1186, DOI 10.1016/j.febslet.2014.01.001	69	58	59	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112541	10.1371/journal.pone.0112541	http://dx.doi.org/10.1371/journal.pone.0112541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383624	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000344816700079
J	Wolfram, S; Nejstgaard, JC; Pohnert, G				Wolfram, Stefanie; Nejstgaard, Jens C.; Pohnert, Georg			Accumulation of Polyunsaturated Aldehydes in the Gonads of the Copepod Acartia tonsa Revealed by Tailored Fluorescent Probes	PLOS ONE			English	Article							CALANUS-HELGOLANDICUS; ALPHA,BETA,GAMMA,DELTA-UNSATURATED ALDEHYDES; HERBIVOROUS COPEPOD; DIATOMS; REPRODUCTION; RECRUITMENT; OXYLIPINS; ADDUCTS; GROWTH	Polyunsaturated aldehydes (PUAs) are released by several diatom species during predation. Besides other attributed activities, these oxylipins can interfere with the reproduction of copepods, important predators of diatoms. While intensive research has been carried out to document the effects of PUAs on copepod reproduction, little is known about the underlying mechanistic aspects of PUA action. Especially PUA uptake and accumulation in copepods has not been addressed to date. To investigate how PUAs are taken up and interfere with the reproduction in copepods we developed a fluorescent probe containing the alpha,beta,gamma,delta-unsaturated aldehyde structure element that is essential for the activity of PUAs as well as a set of control probes. We developed incubation and monitoring procedures for adult females of the calanoid copepod Acartia tonsa and show that the PUA derived fluorescent molecular probe selectively accumulates in the gonads of this copepod. In contrast, a saturated aldehyde derived probe of an inactive parent molecule was enriched in the lipid sac. This leads to a model for PUAs' teratogenic mode of action involving accumulation and covalent interaction with nucleophilic moieties in the copepod reproductive tissue. The teratogenic effect of PUAs can therefore be explained by a selective targeting of the molecules into the reproductive tissue of the herbivores, while more lipophilic but otherwise strongly related structures end up in lipid bodies.	[Wolfram, Stefanie; Pohnert, Georg] Univ Jena, Inst Inorgan & Analyt Chem, Jena, Germany; [Nejstgaard, Jens C.] Skidaway Inst Oceanog, Savannah, GA 31411 USA; [Nejstgaard, Jens C.] Leibniz Inst Freshwater Ecol & Inland Fisheries I, Dept Expt Limnol, Dept Expt Limnol 3, Stechlin, Germany	Friedrich Schiller University of Jena; University System of Georgia; University of Georgia; Skidaway Institute of Oceanography; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Nejstgaard, JC (corresponding author), Skidaway Inst Oceanog, Savannah, GA 31411 USA.	nejstgaard@igb-berlin.de; Georg.Pohnert@uni-jena.de	Nejstgaard, Jens/ABB-8903-2020; Pohnert, Georg/D-3721-2013	Nejstgaard, Jens/0000-0003-1236-0647; Pohnert, Georg/0000-0003-2351-6336	Lichtenberg Professorship Volkswagen Foundation; Stipend Studienstiftung des Deutschen Volkes; Skidaway Institute of Oceanography	Lichtenberg Professorship Volkswagen Foundation; Stipend Studienstiftung des Deutschen Volkes; Skidaway Institute of Oceanography	This work was supported by Lichtenberg Professorship Volkswagen Foundation and a Stipend Studienstiftung des Deutschen Volkes and by start-up grants from Skidaway Institute of Oceanography. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph S, 2004, J EXP BIOL, V207, P2935, DOI 10.1242/jeb.01105; Adolph S, 2003, TETRAHEDRON, V59, P3003, DOI 10.1016/S0040-4020(03)00382-X; Barglow KT, 2007, NAT METHODS, V4, P822, DOI 10.1038/NMETH1092; Buttino I, 2008, J EXP BIOL, V211, P1426, DOI 10.1242/jeb.015859; Caldwell GS, 2009, MAR DRUGS, V7, P367, DOI 10.3390/md7030367; Carvalho VM, 2000, CHEM RES TOXICOL, V13, P397, DOI 10.1021/tx9901682; Dutz J, 2008, LIMNOL OCEANOGR, V53, P225, DOI 10.4319/lo.2008.53.1.0225; Gonzalez G, 2013, ANIMAL DIVERSITY WEB; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Ianora A, 1996, MAR BIOL, V125, P279, DOI 10.1007/BF00346308; Ianora A, 2004, NATURE, V429, P403, DOI 10.1038/nature02526; Ianora A, 2003, PHYCOLOGIA, V42, P351, DOI 10.2216/i0031-8884-42-4-351.1; Ianora A, 2010, ECOTOXICOLOGY, V19, P493, DOI 10.1007/s10646-009-0434-y; Jonasdottir SH, 1996, MAR BIOL, V125, P743, DOI 10.1007/BF00349257; Jonasdottir SH, 2011, MAR BIOL, V158, P1943, DOI 10.1007/s00227-011-1705-8; KIORBOE T, 1987, J PLANKTON RES, V9, P525, DOI 10.1093/plankt/9.3.525; Koski M, 2008, MAR BIOL, V154, P719, DOI 10.1007/s00227-008-0965-4; Lee RF, 2006, MAR ECOL PROG SER, V307, P273, DOI 10.3354/meps307273; Loureiro APM, 2000, CHEM RES TOXICOL, V13, P601, DOI 10.1021/tx000004h; Loureiro APM, 2004, CHEM RES TOXICOL, V17, P641, DOI 10.1021/tx034225+; Mauchline J., 1998, ADV MARINE BIOL, V33; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; Paffenhofer GA, 2005, MAR ECOL PROG SER, V286, P293, DOI 10.3354/meps286293; Paffenhofer GA, 2002, MAR ECOL PROG SER, V227, P305, DOI 10.3354/meps227305; Pohnert G, 2005, CHEMBIOCHEM, V6, P946, DOI 10.1002/cbic.200400348; Pohnert G, 2000, ANGEW CHEM INT EDIT, V39, P4352, DOI 10.1002/1521-3773(20001201)39:23<4352::AID-ANIE4352>3.0.CO;2-U; Poulet SA, 2007, MAR BIOL, V152, P415, DOI 10.1007/s00227-007-0701-5; Poulet SA, 2006, MAR ECOL PROG SER, V308, P129, DOI 10.3354/meps308129; Poulet SA, 1995, MAR ECOL PROG SER, V129, P85, DOI 10.3354/meps129085; Sigolo CAO, 2007, CHEM RES TOXICOL, V20, P1099, DOI 10.1021/tx700111v; Sommer U, 2009, OECOLOGIA, V159, P207, DOI 10.1007/s00442-008-1193-9; Walter TC, 2014, WORMS ACARTIA ACANTH; Wichard T, 2008, PROG OCEANOGR, V77, P30, DOI 10.1016/j.pocean.2008.03.002; Wichard T, 2007, CHEMBIOCHEM, V8, P1146, DOI 10.1002/cbic.200700053; Yang Z, 2011, J PLANKTON RES, V33, P665, DOI 10.1093/plankt/fbq112; Young SC, 2010, ENVIRON MOL MUTAGEN, V51, P315, DOI 10.1002/em.20550; Zhu XC, 2010, CHEM RES TOXICOL, V23, P467, DOI 10.1021/tx900379a	37	8	8	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112522	10.1371/journal.pone.0112522	http://dx.doi.org/10.1371/journal.pone.0112522			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383890	Green Published, Green Submitted, gold			2022-12-27	WOS:000344816700074
J	Berglund, A; Ekelund, M; Fletcher, MA; Nyman, L				Berglund, Anders; Ekelund, Mats; Fletcher, Mark A.; Nyman, Lars			All-Cause Pneumonia Hospitalizations in Children < 2 Years Old in Sweden, 1998 to 2012: Impact of Pneumococcal Conjugate Vaccine Introduction	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; CHILDHOOD IMMUNIZATION; ADMISSIONS; SCHEDULE; ENGLAND; DECLINE; TRENDS; PCV7	Background: In late 2007, some Swedish County Councils started 7-valent pneumococcal conjugate vaccine (PCV7) implementation for children, and PCV7 was included in the national immunization program in 2009. By 2010, both PCV10 and PCV13 were licensed, and the selection of vaccine was subject to County Councils tenders. This study investigated the impact of the order of PCV introduction into vaccination programs on the incidence of all-cause pneumonia hospitalizations in children <2 years-old. Methods: Using population-based data from the publicly available National Inpatient Registry, the incidence of inpatient pneumonia (ICD-10 J12-J18) hospitalizations by County Councils among children <2 years old was identified between 1998 and 2012. Incidence rate ratios (IRR; 95% CI) were calculated during the nationwide implementation of PCV7 and then between County Councils, as based on the higher-valent vaccine chosen for a program. Results: There was a lower risk of all-cause pneumonia hospitalization among <2 year-old children following the introduction of PCV7, as compared to the pre-PCV7 period (0.77; 0.63-0.93). A decreased risk of all-cause pneumonia was also observed in the County Councils that followed the order PCV7 then PCV13 (0.82; 0.66-1.01), while no trend was observed in County Councils with a program in the order PCV7 then PCV10 (1.03; 0.82-1.30). When comparing the higher-valent vaccines, there was a 21% (0.79; 0.66-0.96) lower risk for childhood pneumonia hospitalization in County Councils finally using PCV13 as compared to the experience in County Councils that ultimately adopted PCV10. Conclusions: Among children <2 years-old, all-cause pneumonia hospitalizations were significantly reduced by 23% one to two years after introduction of PCV7 vaccination in Sweden. In those County Councils that next introduced PCV13, a further decline in all-cause pneumonia hospitalization was observed, in contrast to those County Councils that followed with PCV10; this 21% lower risk for childhood pneumonia hospitalization was statistically significant.	[Berglund, Anders; Ekelund, Mats; Nyman, Lars] Pfizer Inc, Sollentuna, Sweden; [Fletcher, Mark A.] Pfizer Inc, Paris, France	Pfizer; Pfizer	Berglund, A (corresponding author), Pfizer Inc, Sollentuna, Sweden.	anders.berglund@pfizer.com			Pfizer Inc	Pfizer Inc(Pfizer)	The present study was performed and funded in full by Pfizer Inc.	Afonso ET, 2013, EMERG INFECT DIS, V19, P589, DOI 10.3201/eid1904.121198; Angoulvant F, 2014, CLIN INFECT DIS, V58, P918, DOI 10.1093/cid/ciu006; [Anonymous], IMM SURV ASS MON; Becker-Dreps S, 2014, PEDIATR INFECT DIS J, V33, P637, DOI 10.1097/INF.0000000000000269; Cleveland R.B., 1990, J OFF STAT, V6, P3; Durando P, 2009, VACCINE, V27, P3459, DOI 10.1016/j.vaccine.2009.01.052; European Medicines Agency, 2013, EUR PUBL ASS REP; Fitzwater SP, 2012, PEDIATR INFECT DIS J, V31, P501, DOI 10.1097/INF.0b013e31824de9f6; Frees E.W., 2004, LONGITUDINAL PANEL D, DOI 10.1198/jasa.2006.s88; Griffin MR, 2013, NEW ENGL J MED, V369, P155, DOI 10.1056/NEJMoa1209165; Grijalva CG, 2007, LANCET, V369, P1179, DOI 10.1016/S0140-6736(07)60564-9; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Hortal M, 2012, VACCINE, V30, P4934, DOI 10.1016/j.vaccine.2012.05.054; Jardine A, 2010, PEDIATR INFECT DIS J, V29, P607, DOI 10.1097/INF.0b013e3181d7d09c; Koshy E, 2010, THORAX, V65, P770, DOI 10.1136/thx.2010.137802; Lee GE, 2010, PEDIATRICS, V126, P204, DOI 10.1542/peds.2009-3109; Loo JD, 2014, PEDIATR INFECT DIS J, V33, pS140, DOI 10.1097/INF.0000000000000082; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; McIntosh K, 2002, NEW ENGL J MED, V346, P429, DOI 10.1056/NEJMra011994; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Patrzalek M, 2010, EUR J CLIN MICROBIOL, V29, P787, DOI 10.1007/s10096-010-0928-9; Rozenbaum MH, 2011, EXPERT REV VACCINES, V10, P187, DOI [10.1586/erv.10.163, 10.1586/ERV.10.163]; Simonsen L, 2011, MBIO, V2, DOI 10.1128/mBio.00309-10; Statistics Sweden, 2012, STAT DAT DEM CHAR SW; Swedish Association of Local Authorities and Regions, 2012, STAT DAT MUN COUNT C; Swedish Institute for Communicable Disease Control, 2013, ANN EP REP 2012; The National Board of Health and Welfare, 2012, STAT DAT DIAGN INP C; Wardlaw T, 2006, LANCET, V368, P1048, DOI 10.1016/S0140-6736(06)69334-3; WHO Publication, 2012, VACCINE, V30, P4717, DOI 10.1016/j.vaccine.2012.04.093; Zhou FJ, 2007, ARCH PEDIAT ADOL MED, V161, P1162, DOI 10.1001/archpedi.161.12.1162	30	37	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112211	10.1371/journal.pone.0112211	http://dx.doi.org/10.1371/journal.pone.0112211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379659	gold, Green Published, Green Submitted			2022-12-27	WOS:000344863100064
J	Olthof, ED; Versleijen, MW; Huisman-de Waal, G; Feuth, T; Kievit, W; Wanten, GJA				Olthof, Evelyn D.; Versleijen, Michelle W.; Huisman-de Waal, Getty; Feuth, Ton; Kievit, Wietske; Wanten, Geert J. A.			Taurolidine Lock Is Superior to Heparin Lock in the Prevention of Catheter Related Bloodstream Infections and Occlusions	PLOS ONE			English	Article							HOME PARENTERAL-NUTRITION; CENTRAL VENOUS CATHETERS; ADULT PATIENTS; CITRATE; EFFICACY; CANCER; SEPSIS; TRIAL	Background and Aims: Patients on home parenteral nutrition (HPN) are at risk for catheter-related complications; mainly infections and occlusions. We have previously shown in HPN patients presenting with catheter sepsis that catheter locking with taurolidine dramatically reduced re-infections when compared with heparin. Our HPN population therefore switched from heparin to taurolidine in 2008. The aim of the present study was to compare long-term effects of this catheter lock strategy on the occurrence of catheter-related bloodstream infections and occlusions in HPN patients. Methods: Data of catheter-related complications were retrospectively collected from 212 patients who received HPN between January 2000 and November 2011, comprising 545 and 200 catheters during catheter lock therapy with heparin and taurolidine, respectively. We evaluated catheter-related bloodstream infection and occlusion incidence rates using Poisson-normal regression analysis. Incidence rate ratios were calculated by dividing incidence rates of heparin by those of taurolidine, adjusting for underlying disease, use of anticoagulants or immune suppressives, frequency of HPN/fluid administration, composition of infusion fluids, and duration of HPN/fluid use before catheter creation. Results: Bloodstream infection incidence rates were 1.1/year for heparin and 0.2/year for taurolidine locked catheters. Occlusion incidence rates were 0.2/year for heparin and 0.1/year for taurolidine locked catheters. Adjusted incidence ratios of heparin compared to taurolidine were 5.9 (95% confidence interval, 3.9-8.7) for bloodstream infections and 1.9 (95% confidence interval, 1.1-3.1) for occlusions. Conclusions: Given that no other procedural changes than the catheter lock strategy were implemented during the observation period, these data strongly suggest that taurolidine decreases catheter-related bloodstream infections and occlusions in HPN patients compared with heparin.	[Olthof, Evelyn D.; Huisman-de Waal, Getty; Wanten, Geert J. A.] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, Intestinal Failure Unit, NL-6525 ED Nijmegen, Netherlands; [Versleijen, Michelle W.] Netherlands Canc Inst Antoni Van Leeuwenhoek, Dept Nucl Med, Amsterdam, Netherlands; [Huisman-de Waal, Getty] Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare, NL-6525 ED Nijmegen, Netherlands; [Feuth, Ton; Kievit, Wietske] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Netherlands Cancer Institute; Radboud University Nijmegen; Radboud University Nijmegen	Wanten, GJA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, Intestinal Failure Unit, NL-6525 ED Nijmegen, Netherlands.	Geert.Wanten@radboudumc.nl	Wanten, G.J.A./L-4742-2015; Huisman, Getty/D-9871-2015; Kievit, Wietske/A-5666-2015		Geistlich Pharma (Wolhusen Switzerland)	Geistlich Pharma (Wolhusen Switzerland)	This study was supported by a research grant from: Geistlich Pharma (Wolhusen Switzerland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Amin AH, 2013, J VASC ACCESS, V14, P379, DOI 10.5301/jva.5000168; Betjes MGH, 2004, NEPHROL DIAL TRANSPL, V19, P1546, DOI 10.1093/ndt/gfh014; Bisseling TM, 2010, CLIN NUTR, V29, P464, DOI 10.1016/j.clnu.2009.12.005; Bozzetti F, 2002, CLIN NUTR, V21, P475, DOI 10.1054/clnu.2002.0578; Bradshaw JH, 2008, J PEDIATR GASTR NUTR, V47, P179, DOI 10.1097/MPG.0b013e318162c428; Caruso F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008927; Chu HP, 2012, J PEDIAT GASTROENTER; Dreesen M, 2013, CLIN NUTR, V32, P16, DOI 10.1016/j.clnu.2012.08.004; Dumichen MJ, 2012, J HOSP INFECT, V80, P304, DOI 10.1016/j.jhin.2012.01.003; Ge X, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004084.pub3; Handrup MM, 2013, PEDIATR BLOOD CANCER, V60, P1292, DOI 10.1002/pbc.24482; Jurewitsch B, 2005, CLIN NUTR, V24, P462, DOI 10.1016/j.clnu.2005.02.001; Jurewitsch B, 1998, JPEN-PARENTER ENTER, V22, P242, DOI 10.1177/0148607198022004242; Kaptanoglui L, 2008, EUR J PHARMACOL, V578, P238, DOI 10.1016/j.ejphar.2007.08.035; Koldehoff A, 2004, INT J ANTIMICROB AG, V24, P491, DOI 10.1016/j.ijantimicag.2004.06.006; Lai NM, 2013, COCHRANE DB SYST REV, V6; Liu YX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0079417, 10.1371/journal.pone.0082678, 10.1371/journal.pone.0061031, 10.1371/journal.pone.0072930, 10.1371/journal.pone.0055221, 10.1371/journal.pone.0075318, 10.1371/journal.pone.0080097]; NOSNER K, 1994, CHIR GASTROENTEROL, V10, P80, DOI 10.1159/000178454; OKEEFE SJD, 1994, JPEN-PARENTER ENTER, V18, P256, DOI 10.1177/0148607194018003256; Olthof ED, 2013, UNITED EUROPEAN GAST, V32, pS97; Pittiruti M, 2009, CLIN NUTR, V28, P365, DOI 10.1016/j.clnu.2009.03.015; Simon A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-102; Solomon LR, 2010, AM J KIDNEY DIS, V55, P1060, DOI 10.1053/j.ajkd.2009.11.025; Tacconelli E, 2009, J HOSP INFECT, V72, P97, DOI 10.1016/j.jhin.2008.12.012; Timsit JF, 1998, CHEST, V114, P207, DOI 10.1378/chest.114.1.207; Tokars JI, 1999, ANN INTERN MED, V131, P340, DOI 10.7326/0003-4819-131-5-199909070-00004; Versleijen MWJ, 2009, GASTROENTEROLOGY, V136, P1577, DOI 10.1053/j.gastro.2009.02.005; Wanten G, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1447; Wanten GJA, 2007, AM J CLIN NUTR, V85, P1171; Yoshida K, 2008, INT ARCH ALLERGY IMM, V146, P169, DOI 10.1159/000113522; Zwiech R, 2013, AM J THER	31	44	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111216	10.1371/journal.pone.0111216	http://dx.doi.org/10.1371/journal.pone.0111216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379781	Green Published, gold			2022-12-27	WOS:000344863100022
J	Zhao, J; Li, SP; He, XY; Liu, L; Wang, KL				Zhao, Jie; Li, Shengping; He, Xunyang; Liu, Lu; Wang, Kelin			The Soil Biota Composition along a Progressive Succession of Secondary Vegetation in a Karst Area	PLOS ONE			English	Article							FATTY-ACID PROFILES; MICROBIAL COMMUNITIES; UNDERSTORY REMOVAL; FOREST RECOVERY; DIVERSITY; CARBON; PLANT; NEMATODES; REGION; GRASSLAND	Karst ecosystems are fragile and are in many regions degraded by anthropogenic activities. Current management of degraded karst areas focuses on aboveground vegetation succession or recovery and aims at establishing a forest ecosystem. Whether progressive succession of vegetation in karst areas is accompanied by establishment of soil biota is poorly understood. In the present study, soil microbial and nematode communities, as well as soil physico-chemical properties were studied along a progressive succession of secondary vegetation (from grassland to shrubland to forest) in a karst area in southwest China. Microbial biomass, nematode density, ratio of fungal to bacterial biomass, nematode structure index, and nematode enrichment index decreased with the secondary succession in the plant community. Overall, the results indicated a pattern of declines in soil biota abundance and food web complexity that was associated with a decrease in soil pH and a decrease in soil organic carbon content with the progressive secondary succession of the plant community. Our findings suggest that soil biota amendment is necessary during karst ecosystem restoration and establishment and management of grasslands may be feasible in karst areas.	[Zhao, Jie; Li, Shengping; He, Xunyang; Liu, Lu; Wang, Kelin] Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agroecol Proc Subtrop Reg, Changsha, Hunan, Peoples R China; [Zhao, Jie; Li, Shengping; He, Xunyang; Liu, Lu; Wang, Kelin] Chinese Acad Sci, Huanjiang Observat & Res Stn Karst Ecosyst, Huanjiang, Guangxi, Peoples R China; [Li, Shengping; Liu, Lu] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, KL (corresponding author), Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agroecol Proc Subtrop Reg, Changsha, Hunan, Peoples R China.	kelin@isa.ac.cn			Chinese Academy of Sciences Action Plan for the Development of Western China [KZCX2-XB3-10]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2010BAE00739-02]; CAS; NSFC [31300448]	Chinese Academy of Sciences Action Plan for the Development of Western China(Chinese Academy of Sciences); National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); CAS(Chinese Academy of Sciences); NSFC(National Natural Science Foundation of China (NSFC))	This study was supported by the Chinese Academy of Sciences Action Plan for the Development of Western China (KZCX2-XB3-10), the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2010BAE00739-02) given to Kelin Wang. The study was also supported by a Western Light Program from CAS and a NSFC program (31300448) given to Jie Zhao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison VJ, 2005, SOIL SCI SOC AM J, V69, P1412, DOI 10.2136/sssaj2004.0252; Baath E, 2003, SOIL BIOL BIOCHEM, V35, P955, DOI 10.1016/S0038-0717(03)00154-8; Bardgett RD, 2005, TRENDS ECOL EVOL, V20, P634, DOI 10.1016/j.tree.2005.08.005; Barker K. R., 1985, ADV TREATISE MELOIDO, VII; Bongers T, 1998, APPL SOIL ECOL, V10, P239, DOI 10.1016/S0929-1393(98)00123-1; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; Chabrerie O, 2003, APPL SOIL ECOL, V24, P43, DOI 10.1016/S0929-1393(03)00062-3; Chen D, 2013, J ECOLOGY; De Deyn GB, 2003, NATURE, V422, P711, DOI 10.1038/nature01548; Dmowska E, 2006, EUR J SOIL BIOL, V42, pS164, DOI 10.1016/j.ejsobi.2006.07.005; Evrendilek F, 2004, J ARID ENVIRON, V59, P743, DOI 10.1016/j.jaridenv.2004.03.002; Ferris H, 2001, APPL SOIL ECOL, V18, P13, DOI 10.1016/S0929-1393(01)00152-4; FRECKMAN DW, 1988, AGR ECOSYST ENVIRON, V24, P195, DOI 10.1016/0167-8809(88)90066-7; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Frostegard A, 2011, SOIL BIOL BIOCHEM, V43, P1621, DOI 10.1016/j.soilbio.2010.11.021; Guo Ke, 2011, Chinese Journal of Plant Ecology, V35, P991, DOI 10.3724/SP.J.1258.2011.00991; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Holtkamp R, 2008, APPL SOIL ECOL, V39, P23, DOI 10.1016/j.apsoil.2007.11.002; Joergensen RG, 2008, SOIL BIOL BIOCHEM, V40, P2977, DOI 10.1016/j.soilbio.2008.08.017; KIEFT TL, 1994, APPL ENVIRON MICROB, V60, P3292, DOI 10.1128/AEM.60.9.3292-3299.1994; Latinne AS., 2011, INT C ENV SUPP FOOD, P176; Leps J, 2003, MULTIVARIATE ANAL EC; Liang WJ, 2009, SOIL BIOL BIOCHEM, V41, P883, DOI 10.1016/j.soilbio.2008.06.018; Liu G, 1996, ANAL SOIL PHYS CHEM; Matlaga DP, 2013, J APPL ECOL, V50, P479, DOI 10.1111/1365-2664.12057; Neher DA, 2001, J NEMATOL, V33, P161; Parise M, 2009, ENVIRON GEOL, V58, P235, DOI 10.1007/s00254-008-1608-2; Pate E, 2000, APPL SOIL ECOL, V14, P5, DOI 10.1016/S0929-1393(99)00051-7; Qi XK, 2013, ECOL ENG, V54, P245, DOI 10.1016/j.ecoleng.2013.01.002; Querejeta JI, 2007, OECOLOGIA, V152, P26, DOI 10.1007/s00442-006-0629-3; Raty M, 2003, BIOL FERT SOILS, V38, P52, DOI 10.1007/s00374-003-0614-5; Rivera LW, 1998, FOREST ECOL MANAG, V108, P63, DOI 10.1016/S0378-1127(97)00349-6; Rivera LW, 2000, PLANT ECOL, V148, P115, DOI 10.1023/A:1009825211430; ROBERTSON GP, 1981, ECOLOGY, V62, P376, DOI 10.2307/1936712; Rousk J, 2010, SOIL BIOL BIOCHEM, V42, P516, DOI 10.1016/j.soilbio.2009.11.026; Rousk J, 2009, APPL ENVIRON MICROB, V75, P1589, DOI 10.1128/AEM.02775-08; Schipper LA, 2001, SOIL BIOL BIOCHEM, V33, P2093, DOI 10.1016/S0038-0717(01)00142-0; Schmitt A, 2011, SOIL BIOL BIOCHEM, V43, P478, DOI 10.1016/j.soilbio.2010.09.037; Smith RS, 2003, J APPL ECOL, V40, P51, DOI 10.1046/j.1365-2664.2003.00780.x; Tuyet D, 2001, ACTA GEOL SIN-ENGL, V75, P325; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Viketoft M, 2013, SOIL BIOL BIOCHEM, V62, P92, DOI 10.1016/j.soilbio.2013.03.012; Walker L.R., 1999, ECOSYSTEMS DISTURBED; Walker LR, 2010, J ECOL, V98, P725, DOI 10.1111/j.1365-2745.2010.01664.x; Wang KeLin, 2008, Research of Agricultural Modernization, V29, P641; WARDLE DA, 1993, FUNCT ECOL, V7, P346, DOI 10.2307/2390215; WASILEWSKA L, 1979, Polish Ecological Studies, V5, P97; Xiong YM, 2008, PLANT SOIL, V304, P179, DOI 10.1007/s11104-007-9536-6; YEATES GW, 1993, J NEMATOL, V25, P315; Yeates GW, 1999, AGR ECOSYST ENVIRON, V74, P113, DOI 10.1016/S0167-8809(99)00033-X; Yu L.F., 1998, J MOUNTAIN AGR BIOL, V17, P71; Yuan DX, 2002, GEOLOGY GEOHYDROLOGY, P15; ZAK DR, 1990, BIOGEOCHEMISTRY, V11, P111, DOI 10.1007/BF00002062; [曾馥平 ZENG FuPing], 2007, [生态学报, Acta Ecologica Sinica], V27, P5110, DOI 10.1016/S1872-2032(08)60016-5; Zhang PJ, 2006, ENVIRON GEOL, V51, P609, DOI 10.1007/s00254-006-0356-4; [张信宝 ZHANG Xin-bao], 2009, [地球与环境, Earth and Environment], V37, P337; Zhao J, 2014, APPL SOIL ECOL, V75, P134, DOI 10.1016/j.apsoil.2013.10.011; Zhao J, 2013, FOREST ECOL MANAG, V310, P80, DOI 10.1016/j.foreco.2013.08.013; Zhao J, 2013, APPL SOIL ECOL, V64, P135, DOI 10.1016/j.apsoil.2012.11.008; Zhao J, 2013, ECOL INDIC, V24, P236, DOI 10.1016/j.ecolind.2012.06.012; Zhao J, 2012, SOIL BIOL BIOCHEM, V49, P78, DOI 10.1016/j.soilbio.2012.02.020; Zhu HH, 2012, EUR J SOIL BIOL, V51, P1, DOI 10.1016/j.ejsobi.2012.03.003	62	18	21	6	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112436	10.1371/journal.pone.0112436	http://dx.doi.org/10.1371/journal.pone.0112436			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379741	Green Published, gold, Green Submitted			2022-12-27	WOS:000344863100092
J	Cao, B; Qi, YF; Yang, Y; Liu, XC; Xu, D; Guo, W; Zhan, Y; Xiong, ZG; Zhang, A; Wang, AR; Fu, XQ; Zhang, HT; Zhao, LJ; Gu, JK; Dong, Y				Cao, Bo; Qi, Yanfeng; Yang, Yan; Liu, Xichun; Xu, Duo; Guo, Wei; Zhan, Yang; Xiong, Zhenggang; Zhang, Allen; Wang, Alun R.; Fu, Xueqi; Zhang, Haitao; Zhao, Lijing; Gu, Jingkai; Dong, Yan			20(S)-Protopanaxadiol Inhibition of Progression and Growth of Castration-Resistant Prostate Cancer	PLOS ONE			English	Article							TRUNCATED ANDROGEN RECEPTOR; DE-NOVO STEROIDOGENESIS; FULL-LENGTH; SPLICE VARIANTS; TUMOR-GROWTH; CELLS; ANTIANDROGEN; SUPPRESSION; EXPRESSION; MECHANISM	Castration-resistant progression of prostate cancer after androgen deprivation therapies remains the most critical challenge in the clinical management of prostate cancer. Resurgent androgen receptor (AR) activity is an established driver of castration-resistant progression, and upregulation of the full-length AR (AR-FL) and constitutively-active AR splice variants (AR-Vs) has been implicated to contribute to the resurgent AR activity. We reported previously that ginsenoside 20(S)-protopanaxadiol-aglycone (PPD) can reduce the abundance of both AR-FL and AR-Vs. In the present study, we further showed that the effect of PPD on AR expression and target genes was independent of androgen. PPD treatment resulted in a suppression of ligand-independent AR transactivation. Moreover, PPD delayed castration-resistant regrowth of LNCaP xenograft tumors after androgen deprivation and inhibited the growth of castration-resistant 22Rv1 xenograft tumors with endogenous expression of AR-FL and AR-Vs. This was accompanied by a decline in serum prostate-specific antigen levels as well as a decrease in AR levels and mitoses in the tumors. Notably, the 22Rv1 xenograft tumors were resistant to growth inhibition by the next-generation anti-androgen enzalutamide. The present study represents the first to show the preclinical efficacy of PPD in inhibiting castration-resistant progression and growth of prostate cancer. The findings provide a rationale for further developing PPD or its analogues for prostate cancer therapy.	[Cao, Bo; Yang, Yan; Xu, Duo; Guo, Wei; Fu, Xueqi; Gu, Jingkai; Dong, Yan] Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China; [Cao, Bo; Qi, Yanfeng; Zhan, Yang; Zhang, Allen; Dong, Yan] Tulane Univ, Sch Med, Dept Struct & Cellular Biol, Tulane Canc Ctr, New Orleans, LA 70112 USA; [Liu, Xichun; Xiong, Zhenggang; Wang, Alun R.; Zhang, Haitao] Tulane Univ, Sch Med, Dept Pathol & Lab Med, Tulane Canc Ctr, New Orleans, LA 70112 USA; [Zhao, Lijing] Jilin Univ, Coll Basic Med Sci, Changchun 130023, Peoples R China; [Dong, Yan] Jilin Univ, Natl Engn Lab AIDS Vaccine, Changchun 130023, Peoples R China	Jilin University; Tulane University; Tulane University; Jilin University; Jilin University	Zhao, LJ (corresponding author), Jilin Univ, Coll Basic Med Sci, Changchun 130023, Peoples R China.	zhao_lj@jlu.edu.cn; gujk@jlu.edu.cn; ydong@tulane.edu		Zhang, Allen/0000-0002-5780-9121; Dong, Yan/0000-0003-1622-5354	National Cancer Institute of the National Institutes of Health [R01CA188609]; Department of Defense [W81XWH-12-1-0112, W81XWH-12-1-0275]; National Natural Science Foundation of China [81272851, 30973587, 81102383, 81302206, 81430087]; Louisiana Board-of-Regents Grant [LEQSF(2012-15)-RD-A-25]; Louisiana Cancer Research Consortium Fund; Tulane Cancer Center Developmental Fund; Tulane University School of Medicine; NATIONAL CANCER INSTITUTE [R01CA188609] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Louisiana Board-of-Regents Grant; Louisiana Cancer Research Consortium Fund; Tulane Cancer Center Developmental Fund; Tulane University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute of the National Institutes of Health grant R01CA188609, Department of Defense grants W81XWH-12-1-0112 and W81XWH-12-1-0275, National Natural Science Foundation of China Projects 81272851, 30973587, 81102383, 81302206, and 81430087, Louisiana Board-of-Regents Grant LEQSF(2012-15)-RD-A-25, Louisiana Cancer Research Consortium Fund, Tulane Cancer Center Developmental Fund, and Tulane University School of Medicine Pilot Fund and Bridge Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao B, 2014, ONCOTARGET, V5, P1646, DOI 10.18632/oncotarget.1802; Cao B, 2013, INT J CANCER, V132, P1277, DOI 10.1002/ijc.27754; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Cheng H, 2006, CANCER RES, V66, P10613, DOI 10.1158/0008-5472.CAN-06-0028; Culig Z, 1998, PROSTATE, V35, P63, DOI 10.1002/(SICI)1097-0045(19980401)35:1<63::AID-PROS9>3.0.CO;2-I; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Dong Y, 2004, CANCER RES, V64, P19, DOI 10.1158/0008-5472.CAN-03-2789; Dong Y, 2003, CANCER RES, V63, P52; Dong Y, 2005, MOL CANCER THER, V4, P1047, DOI 10.1158/1535-7163.MCT-05-0124; Egan A, 2014, CANCER TREAT REV, V40, P426, DOI 10.1016/j.ctrv.2013.09.011; Fizazi K, 2012, LANCET ONCOL, V13, P983, DOI 10.1016/S1470-2045(12)70379-0; Freedland SJ, 2011, CANCER-AM CANCER SOC, V117, P1123, DOI 10.1002/cncr.25477; GLEAVE ME, 1992, CANCER RES, V52, P1598; Gregory CW, 2004, J BIOL CHEM, V279, P7119, DOI 10.1074/jbc.M307649200; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Hara T, 2003, CANCER RES, V63, P149; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; Hu R, 2012, CANCER RES, V72, P3457, DOI 10.1158/0008-5472.CAN-11-3892; Hu R, 2011, PROSTATE, V71, P1656, DOI 10.1002/pros.21382; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Jackson JK, 2000, CANCER RES, V60, P4146; Kim HG, 2011, FOOD CHEM TOXICOL, V49, P2229, DOI 10.1016/j.fct.2011.06.020; Knudsen KE, 2009, CLIN CANCER RES, V15, P4792, DOI 10.1158/1078-0432.CCR-08-2660; Koivisto P, 1997, CANCER RES, V57, P314; Lamont KR, 2011, MOL ENDOCRINOL, V25, P897, DOI 10.1210/me.2010-0469; Lamoureux F, 2011, CLIN CANCER RES, V17, P2301, DOI 10.1158/1078-0432.CCR-10-3077; Lee NH, 2012, J ALTERN COMPLEM MED, V18, P1061, DOI 10.1089/acm.2011.0591; Li J, 2011, MOL CANCER THER, V10, P1346, DOI 10.1158/1535-7163.MCT-10-0985; Li XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031213; Li Y., 2012, CANCER RES, V73, P483; Liu LL, 2014, ONCOGENE, V33, P3140, DOI 10.1038/onc.2013.284; Locke JA, 2008, CANCER RES, V68, P6407, DOI 10.1158/0008-5472.CAN-07-5997; Lubik AA, 2011, CANCER RES, V71, P5754, DOI 10.1158/0008-5472.CAN-10-2470; Mashima T, 2010, MOL PHARMACOL, V78, P846, DOI 10.1124/mol.110.064790; Miyake H, 2000, CANCER RES, V60, P3058; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Mostaghel EA, 2011, CLIN CANCER RES, V17, P5913, DOI 10.1158/1078-0432.CCR-11-0728; Nadiminty N, 2013, MOL CANCER THER, V12, P1629, DOI 10.1158/1535-7163.MCT-13-0027; Narizhneva NV, 2009, CELL CYCLE, V8, P4155, DOI 10.4161/cc.8.24.10316; O'Hara M, 1998, ARCH FAM MED, V7, P523, DOI 10.1001/archfami.7.6.523; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Snoek R, 2009, CLIN CANCER RES, V15, P39, DOI 10.1158/1078-0432.CCR-08-1726; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Tepper CG, 2002, CANCER RES, V62, P6606; Toren P, 2015, EUR UROL, V67, P986, DOI 10.1016/j.eururo.2014.08.006; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Tsuta K, 2011, AM J CLIN PATHOL, V136, P252, DOI 10.1309/AJCPDXFOPXGEF0RP; VELDSCHOLTE J, 1992, J STEROID BIOCHEM, V41, P665, DOI 10.1016/0960-0760(92)90401-4; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wafa LA, 2012, INT J CANCER, V130, P2835, DOI 10.1002/ijc.26287; Waltering KK, 2009, CANCER RES, V69, P8141, DOI 10.1158/0008-5472.CAN-09-0919; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Yamashita S, 2012, NEOPLASIA, V14, P74, DOI 10.1593/neo.111436; Yeh SY, 1996, P NATL ACAD SCI USA, V93, P5517, DOI 10.1073/pnas.93.11.5517; Yoshida T, 2005, CANCER RES, V65, P9611, DOI 10.1158/0008-5472.CAN-05-0817; Yuan CS, 2010, J GINSENG RES, V34, P160, DOI 10.5142/jgr.2010.34.3.160; Zengerling F, 2012, INT J MOL SCI, V13, P11530, DOI 10.3390/ijms130911530; Zhan Y, 2013, INT J CANCER, V133, P2225, DOI 10.1002/ijc.28202; Zhao XY, 2000, NAT MED, V6, P703, DOI 10.1038/76287	61	38	40	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111201	10.1371/journal.pone.0111201	http://dx.doi.org/10.1371/journal.pone.0111201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375370	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402600029
J	Hata, M; Miyamoto, K; Oishi, A; Makiyama, Y; Gotoh, N; Kimura, Y; Akagi, T; Yoshimura, N				Hata, Masayuki; Miyamoto, Kazuaki; Oishi, Akio; Makiyama, Yukiko; Gotoh, Norimoto; Kimura, Yugo; Akagi, Tadamichi; Yoshimura, Nagahisa			Comparison of Optic Disc Morphology of Optic Nerve Atrophy between Compressive Optic Neuropathy and Glaucomatous Optic Neuropathy	PLOS ONE			English	Article							NORMAL-TENSION GLAUCOMA; OPEN-ANGLE GLAUCOMA; LAMINA-CRIBROSA THICKNESS; COHERENCE TOMOGRAPHY; CHOROIDAL THICKNESS; DEPTH; EXCAVATION; EYES; LOCATION; DAMAGE	Objectives: To compare the optic nerve head (ONH) structure between compressive optic neuropathy (CON) and glaucomatous optic neuropathy (GON), and to determine whether selected ONH quantitative parameters effectively discriminate between GON and CON, especially CON cases presenting with a glaucoma-like disc. Methods: We prospectively assessed 34 patients with CON, 34 age-matched patients with moderate or severe GON, and 34 age-matched healthy control subjects. The quantitative parameters of ONH structure were compared using the Heidelberg Retina Tomograph 2 (HRT2) and Spectralis optical coherence tomography with an enhanced depth imaging method. Results: The mean and maximum cup depths of CON were significantly smaller than those with GON (P<0.001 and P<0.001, respectively). The distance between Bruch's membrane opening and anterior surface of the lamina cribrosa (BMO-anterior LC) of CON was also significantly smaller than that of glaucoma but was similar to that of the healthy group (P, 0.001 and P = 0.47, respectively). Based on Moorfields regression analysis of the glaucoma classification of HRT2, 15 eyes with CON were classified with a glaucoma-like disc. The cup/disc area ratio did not differ between cases of CON with a glaucoma-like disc and cases of GON (P = 0.16), but the BMO-anterior LC and mean and maximum cup depths of CON cases with a glaucoma-like disc were smaller than those in GON (P = 0.005, P = 0.003, and P = 0.001, respectively). Conclusions: Measurements of the cup depths and the LC depth had good ability to differentiate between CON with a glaucoma-like disc and glaucoma. There was no laminar remodeling detected by laminar surface position in the patients with CON compared to those with GON.	[Hata, Masayuki; Miyamoto, Kazuaki; Oishi, Akio; Makiyama, Yukiko; Gotoh, Norimoto; Kimura, Yugo; Akagi, Tadamichi; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan	Kyoto University	Hata, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan.	trj74h6@kuhp.kyoto-u.ac.jp	Oishi, Akio/AAE-9996-2020	Oishi, Akio/0000-0002-0977-9458				Ahmed IIK, 2002, J GLAUCOMA, V11, P279, DOI 10.1097/00061198-200208000-00002; Anderson DR, 1997, CLIN NEUROSCI, V4, P274; Bellezza AJ, 2003, INVEST OPHTH VIS SCI, V44, P623, DOI 10.1167/iovs.01-1282; BIANCHIMARZOLI S, 1995, OPHTHALMOLOGY, V102, P436; BLAZAR HA, 1950, ARCH OPHTHALMOL-CHIC, V44, P499; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Downs JC, 2011, EXP EYE RES, V93, P133, DOI 10.1016/j.exer.2010.08.004; Fatehee N, 2011, BRIT J OPHTHALMOL, V95, P585, DOI 10.1136/bjo.2010.188441; Fontana L, 1998, CURR EYE RES, V17, P363, DOI 10.1080/02713689808951216; Fournier AV, 2001, OPHTHALMOLOGY, V108, P1595, DOI 10.1016/S0161-6420(01)00696-0; Furlanetto RL, 2013, INVEST OPHTH VIS SCI, V54, P4836, DOI 10.1167/iovs.12-11530; Greenfield DS, 1998, OPHTHALMOLOGY, V105, P1866, DOI 10.1016/S0161-6420(98)91031-4; HAYREH SS, 1974, BRIT J OPHTHALMOL, V58, P863, DOI 10.1136/bjo.58.10.863; Hernandez MR, 1997, ARCH OPHTHALMOL-CHIC, V115, P389, DOI 10.1001/archopht.1997.01100150391013; Hirooka K, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-29; Inoue R, 2009, OPHTHALMOLOGY, V116, P214, DOI 10.1016/j.ophtha.2008.09.008; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Johnstone J, 2014, INVEST OPHTH VIS SCI, V55, P2004, DOI 10.1167/iovs.13-12937; Jonas JB, 1997, OPHTHALMOLOGY, V104, P1934, DOI 10.1016/S0161-6420(97)30004-9; KUPERSMITH MJ, 1984, ANN OPHTHALMOL, V16, P948; Lee EJ, 2011, AM J OPHTHALMOL, V152, P87, DOI 10.1016/j.ajo.2011.01.024; Mashima Y, 2003, GRAEF ARCH CLIN EXP, V241, P75, DOI 10.1007/s00417-002-0598-0; Nagai-Kusuhara A, 2008, EYE, V22, P1154, DOI 10.1038/sj.eye.6702871; ORTIZ RG, 1992, AM J OPHTHALMOL, V113, P561, DOI 10.1016/S0002-9394(14)74730-0; Park HYL, 2013, OPHTHALMOLOGY, V120, P745, DOI 10.1016/j.ophtha.2012.09.051; Park HYL, 2012, OPHTHALMOLOGY, V119, P10, DOI 10.1016/j.ophtha.2011.07.033; Park SC, 2012, OPHTHALMOLOGY, V119, P3, DOI 10.1016/j.ophtha.2011.07.012; PORTNEY GL, 1977, AM J OPHTHALMOL, V84, P98, DOI 10.1016/0002-9394(77)90332-4; PRUETT RC, 1973, AM J OPHTHALMOL, V76, P229, DOI 10.1016/0002-9394(73)90166-9; QUIGLEY H, 1977, T AM ACAD OPHTHALMOL, V83, P755; QUIGLEY HA, 1979, OPHTHALMOLOGY, V86, P1803; QUIGLEY HA, 1976, INVEST OPHTH VISUAL, V15, P606; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P137; QUIGLEY HA, 1983, AM J OPHTHALMOL, V95, P673, DOI 10.1016/0002-9394(83)90389-6; Rebolleda G, 2009, EYE, V23, P890, DOI 10.1038/eye.2008.117; Seo JH, 2014, INVEST OPHTH VIS SCI, V55, P1241, DOI 10.1167/iovs.13-12536; SHIOSE Y, 1991, JPN J OPHTHALMOL, V35, P133; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Tezel G, 2004, BRIT J OPHTHALMOL, V88, P251, DOI 10.1136/bjo.2003.019281; TROBE JD, 1980, ARCH OPHTHALMOL-CHIC, V98, P1046	40	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112403	10.1371/journal.pone.0112403	http://dx.doi.org/10.1371/journal.pone.0112403			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375855	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600141
J	Maitra, D; Ali, I; Abdulridha, RM; Shaeib, F; Khan, SN; Saed, GM; Pennathur, S; Abu-Soud, HM				Maitra, Dhiman; Ali, Iyad; Abdulridha, Rasha M.; Shaeib, Faten; Khan, Sana N.; Saed, Ghassan M.; Pennathur, Subramaniam; Abu-Soud, Husam M.			Kinetic Studies on the Reaction between Dicyanocobinamide and Hypochlorous Acid	PLOS ONE			English	Article							COBALAMIN PRECURSOR COBINAMIDE; FREE IRON RELEASE; CRYSTAL-STRUCTURE; MOLECULAR-STRUCTURE; CYANOGEN CHLORIDE; HEPTAMETHYL ESTER; HEME DESTRUCTION; WARFARE AGENTS; CORRIN RING; CYANIDE	Hypochlorous acid (HOCl) is a potent oxidant generated by myeloperoxidase (MPO), which is an abundant enzyme used for defense against microbes. We examined the potential role of HOCl in corrin ring destruction and subsequent formation of cyanogen chloride (CNCl) from dicyanocobinamide ((CN)(2)-Cbi). Stopped-flow analysis revealed that the reaction consists of at least three observable steps, including at least two sequential transient intermediates prior to corrin ring destruction. The first two steps were attributed to sequential replacement of the two cyanide ligands with hypochlorite, while the third step was the destruction of the corrin ring. The formation of (OCl)(CN)-Cbi and its conversion to (OCl)(2)-Cbi was fitted to a first order rate equation with second order rate constants of 0.002 and 0.0002 mu M-1 s(-1), respectively. The significantly lower rate of the second step compared to the first suggests that the replacement of the first cyanide molecule by hypochlorite causes an alteration in the ligand trans effects changing the affinity and/or accessibility of Co toward hypochlorite. Plots of the apparent rate constants as a function of HOCl concentration for all the three steps were linear with Y-intercepts close to zero, indicating that HOCl binds in an irreversible one-step mechanism. Collectively, these results illustrate functional differences in the corrin ring environments toward binding of diatomic ligands.	[Maitra, Dhiman; Ali, Iyad; Abdulridha, Rasha M.; Shaeib, Faten; Khan, Sana N.; Saed, Ghassan M.; Abu-Soud, Husam M.] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, CS Mott Ctr Human Growth & Dev, Detroit, MI 48201 USA; [Ali, Iyad] An Najah Natl Univ, Fac Med & Hlth Sci, Dept Biochem & Genet, Nablus, Israel; [Pennathur, Subramaniam] Univ Michigan, Sch Med, Dept Internal Med, Div Nephrol, Ann Arbor, MI 48109 USA; [Abu-Soud, Husam M.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, CS Mott Ctr Human Growth & Dev, Detroit, MI 48201 USA	Wayne State University; An Najah National University; University of Michigan System; University of Michigan; Wayne State University	Abu-Soud, HM (corresponding author), Wayne State Univ, Sch Med, Dept Obstet & Gynecol, CS Mott Ctr Human Growth & Dev, Detroit, MI 48201 USA.	habusoud@med.wayne.edu		Ali, Iyad/0000-0002-3921-6859; , dhiman/0000-0002-8775-2963	National Institutes of Health [RO1HL066367, R01HL094230]; Children's Hospital of Michigan; Molecular Phenotyping Core of the Michigan Nutrition and Obesity Research Center [DK089503]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094230, R01HL066367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Michigan; Molecular Phenotyping Core of the Michigan Nutrition and Obesity Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health grant RO1HL066367 and R01HL094230, the Children's Hospital of Michigan, and the Molecular Phenotyping Core of the Michigan Nutrition and Obesity Research Center (DK089503). Dr. Iyad. A. Ali is a Fulbright Senior Research Scholar in Dr. H. M. A-S laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Soud HM, 2012, FREE RADICAL BIO MED, V52, P616, DOI 10.1016/j.freeradbiomed.2011.10.496; ALDRIDGE WN, 1951, BIOCHEM J, V48, P271, DOI 10.1042/bj0480271; BALDWIN DA, 1983, J CHEM SOC DALTON, P217, DOI 10.1039/dt9830000217; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; Brennan RJ, 1999, ANN EMERG MED, V34, P191, DOI 10.1016/S0196-0644(99)70229-5; BRESCIANIPAHOR N, 1982, J CHEM SOC DALTON, P1009, DOI 10.1039/dt9820001009; Broderick KE, 2007, EXP BIOL MED, V232, P789; Broderick KE, 2006, EXP BIOL MED, V231, P641; Broderick KE, 2005, J BIOL CHEM, V280, P8678, DOI 10.1074/jbc.M410498200; Brown KL, 2005, CHEM REV, V105, P2075, DOI 10.1021/cr030720z; Brown KL, 1997, INORG CHEM, V36, P3666, DOI 10.1021/ic9615077; Chemaly SM, 2011, INORG CHEM, V50, P8700, DOI 10.1021/ic200285k; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; Eitenmiller R.R, 2008, VITAMIN ANAL HLTH FO, V2nd; Fletcher NM, 2011, CANCER BIOMARK, V10, P267, DOI 10.3233/CBM-2012-0255; Goud AP, 2008, FREE RADICAL BIO MED, V44, P1295, DOI 10.1016/j.freeradbiomed.2007.11.014; Gruber K, 2011, CHEM SOC REV, V40, P4346, DOI 10.1039/c1cs15118e; Gumus G, 2000, TALANTA, V53, P305, DOI 10.1016/S0039-9140(00)00485-9; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; HODGKIN DC, 1955, NATURE, V176, P325, DOI 10.1038/176325a0; HUTTEMANN TJ, 1965, INORG CHEM, V4, P950, DOI 10.1021/ic50029a005; KAMIYA K, 1982, J CHEM SOC PERK T 1, P2279, DOI 10.1039/p19820002279; KETTLE AJ, 1994, METHOD ENZYMOL, V233, P502; Kettle AJ, 2014, BBA-GEN SUBJECTS, V1840, P781, DOI 10.1016/j.bbagen.2013.07.004; KRASNER SW, 1989, J AM WATER WORKS ASS, V81, P41; KRAUTLER B, 1994, INORG CHEM, V33, P4128; LUNDQUIST P, 1985, CLIN CHEM, V31, P591; Ma J, 2012, ANAL CHIM ACTA, V736, P78, DOI 10.1016/j.aca.2012.05.028; Ma JA, 2010, ANAL CHIM ACTA, V673, P117, DOI 10.1016/j.aca.2010.05.042; Maitra D, 2013, FREE RADICAL BIO MED, V63, P90, DOI 10.1016/j.freeradbiomed.2013.04.009; Maitra D, 2011, FREE RADICAL BIO MED, V51, P374, DOI 10.1016/j.freeradbiomed.2011.04.011; Maitra D, 2011, FREE RADICAL BIO MED, V51, P364, DOI 10.1016/j.freeradbiomed.2011.03.040; MALECH HL, 1987, NEW ENGL J MED, V317, P687, DOI 10.1056/NEJM198709103171107; MARKWELL AJ, 1987, J CHEM SOC DALTON, P1349, DOI 10.1039/dt9870001349; Matthews JH, 1997, BLOOD, V89, P4600, DOI 10.1182/blood.V89.12.4600; Na CZ, 2006, ENVIRON SCI TECHNOL, V40, P1469, DOI 10.1021/es0512273; Nicholls SJ, 2009, J LIPID RES, V50, pS346, DOI 10.1194/jlr.R800086-JLR200; Pattison DI, 2006, CURR MED CHEM, V13, P3271, DOI 10.2174/092986706778773095; Pennathur S, 2007, ANTIOXID REDOX SIGN, V9, P955, DOI 10.1089/ars.2007.1595; Pullar JM, 2000, IUBMB LIFE, V50, P259, DOI 10.1080/15216540051080958; Randaccio L, 1998, INORG CHEM, V37, P5390, DOI 10.1021/ic980181u; Saini Y, 2010, TOXICOL SCI, V116, P673, DOI 10.1093/toxsci/kfq155; Schneider Z, 1987, COMPREHENSIVE B; Sharina I, 2012, J PHARMACOL EXP THER, V340, P723, DOI 10.1124/jpet.111.186957; Souza CEA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027641; Szinicz L, 2005, TOXICOLOGY, V214, P167, DOI 10.1016/j.tox.2005.06.011; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Vivekanadan-Giri A, 2008, REV ENDOCR METAB DIS, V9, P275, DOI 10.1007/s11154-008-9093-1; Wang L, 2007, J Burns Wounds, V6, pe5; Weinberg JB, 2009, FREE RADICAL BIO MED, V46, P1626, DOI 10.1016/j.freeradbiomed.2009.03.017; Weinberg JB, 1998, BIOCHEM BIOPH RES CO, V246, P393, DOI 10.1006/bbrc.1998.8629; WEISS SJ, 1982, J CLIN INVEST, V70, P598, DOI 10.1172/JCI110652; Zhou K, 2011, EUR J INORG CHEM, P53, DOI 10.1002/ejic.201001146	53	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e110595	10.1371/journal.pone.0110595	http://dx.doi.org/10.1371/journal.pone.0110595			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375773	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600014
J	Simon-Santamaria, J; Rinaldo, CH; Kardas, P; Li, RM; Malovic, I; Elvevold, K; McCourt, P; Smedsrod, B; Hirsch, HH; Sorensen, KK				Simon-Santamaria, Jaione; Rinaldo, Christine Hanssen; Kardas, Piotr; Li, Ruomei; Malovic, Ivana; Elvevold, Kjetil; McCourt, Peter; Smedsrod, Bard; Hirsch, Hans H.; Sorensen, Karen Kristine			Efficient Uptake of Blood-Borne BK and JC Polyomavirus-Like Particles in Endothelial Cells of Liver Sinusoids and Renal Vasa Recta	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RECEPTOR-MEDIATED ENDOCYTOSIS; GLYCATION END-PRODUCTS; MANNOSE RECEPTOR; SCAVENGER-RECEPTOR; HYALURONAN RECEPTOR; PROTEIN VP1; VIRUS; EXPRESSION; CLEARANCE	Liver sinusoidal endothelial cells (LSECs) are specialized scavenger cells that mediate high-capacity clearance of soluble waste macromolecules and colloid material, including blood-borne adenovirus. To explore if LSECs function as a sink for other viruses in blood, we studied the fate of virus-like particles (VLPs) of two ubiquitous human DNA viruses, BK and JC polyomavirus, in mice. Like complete virions, VLPs specifically bind to receptors and enter cells, but unlike complete virions, they cannot replicate. I-125-labeled VLPs were used to assess blood decay, organ-, and hepatocellular distribution of ligand, and non-labeled VLPs to examine cellular uptake by immunohisto- and -cytochemistry. BK- and JC-VLPs rapidly distributed to liver, with lesser uptake in kidney and spleen. Liver uptake was predominantly in LSECs. Blood half-life (similar to 1 min), and tissue distribution of JC-VLPs and two JC-VLP-mutants (L55F and S269F) that lack sialic acid binding affinity, were similar, indicating involvement of non-sialic acid receptors in cellular uptake. Liver uptake was not mediated by scavenger receptors. In spleen, the VLPs localized to the red pulp marginal zone reticuloendothelium, and in kidney to the endothelial lining of vasa recta segments, and the transitional epithelium of renal pelvis. Most VLP-positive vessels in renal medulla did not express PV-1/Meca 32, suggesting location to the non-fenestrated part of vasa recta. The endothelial cells of these vessels also efficiently endocytosed a scavenger receptor ligand, formaldehyde-denatured albumin, suggesting high endocytic activity compared to other renal endothelia. We conclude that LSECs very effectively cleared a large fraction of blood-borne BK- and JC-VLPs, indicating a central role of these cells in early removal of polyomavirus from the circulation. In addition, we report the novel finding that a subpopulation of endothelial cells in kidney, the main organ of polyomavirus persistence, showed selective and rapid uptake of VLPs, suggesting a role in viremic organ tropism.	[Simon-Santamaria, Jaione; Li, Ruomei; Malovic, Ivana; Elvevold, Kjetil; McCourt, Peter; Smedsrod, Bard; Sorensen, Karen Kristine] UiT Arctic Univ Norway, Dept Med Biol, Tromso, Norway; [Rinaldo, Christine Hanssen] Univ Hosp North Norway, Dept Microbiol & Infect Control, Tromso, Norway; [Rinaldo, Christine Hanssen] UiT Arctic Univ Norway, Dept Clin Med, Tromso, Norway; [Kardas, Piotr; Hirsch, Hans H.] Univ Basel, Dept Biomed, Basel, Switzerland; [Hirsch, Hans H.] Univ Basel Hosp, Div Infect Dis, CH-4031 Basel, Switzerland; [Hirsch, Hans H.] Univ Basel Hosp, Div Hosp Epidemiol, CH-4031 Basel, Switzerland	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University of Basel; University of Basel; University of Basel	Sorensen, KK (corresponding author), UiT Arctic Univ Norway, Dept Med Biol, Tromso, Norway.	karen.sorensen@uit.no	McCourt, Peter/B-3043-2009; Rinaldo, Christine Hanssen/AAX-1762-2020	McCourt, Peter/0000-0001-5072-4590; Malovic, Ivana/0000-0001-8390-7617; Hirsch, Hans H./0000-0003-0883-0423	Tromso Research Foundation (Tromso, Norway); University of Basel (Basel, Switzerland)	Tromso Research Foundation (Tromso, Norway); University of Basel (Basel, Switzerland)	The work was supported by a grant from The Tromso Research Foundation (Tromso, Norway) to BS, and an institutional grant of the University of Basel (Basel, Switzerland) to HHH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany R, 2000, J GEN VIROL, V81, P2605, DOI 10.1099/0022-1317-81-11-2605; Asumendi A, 1996, HEPATOLOGY, V23, P1521, DOI 10.1002/hep.510230632; BLOMHOFF R, 1984, BIOCHEM J, V218, P81, DOI 10.1042/bj2180081; Bodaghi S, 2009, J CLIN MICROBIOL, V47, P2577, DOI 10.1128/JCM.00030-09; Brinkman-Van der Linden ECM, 2002, ANAL BIOCHEM, V303, P98, DOI 10.1006/abio.2001.5539; Drachenberg CB, 2007, TRANSPLANTATION, V84, P323, DOI 10.1097/01.tp.0000269706.59977.a5; Egli A, 2009, J INFECT DIS, V199, P837, DOI 10.1086/597126; Elvevold K, 2008, AM J PHYSIOL-GASTR L, V294, pG391, DOI 10.1152/ajpgi.00167.2007; Elvevold K, 2008, HEPATOLOGY, V48, P2007, DOI 10.1002/hep.22527; Elvevold Kjetil H, 2004, Comp Hepatol, V3, P4, DOI 10.1186/1476-5926-3-4; ESBACH S, 1993, HEPATOLOGY, V18, P537, DOI 10.1016/0270-9139(93)90352-N; Fang CY, 2010, VIROLOGY, V402, P164, DOI 10.1016/j.virol.2010.03.029; Ferenczy MW, 2012, CLIN MICROBIOL REV, V25, P471, DOI 10.1128/CMR.05031-11; Funk GA, 2007, LANCET INFECT DIS, V7, P460, DOI 10.1016/S1473-3099(07)70159-7; Ganesan LP, 2012, J IMMUNOL, V189, P4981, DOI 10.4049/jimmunol.1202017; Ganesan LP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002281; Goldmann C, 1999, J VIROL, V73, P4465, DOI 10.1128/JVI.73.5.4465-4469.1999; Gorelik L, 2011, J INFECT DIS, V204, P103, DOI 10.1093/infdis/jir198; Gosert R, 2010, J VIROL, V84, P10448, DOI 10.1128/JVI.00614-10; Green NK, 2004, GENE THER, V11, P1256, DOI 10.1038/sj.gt.3302295; Hansen B, 2005, EXP CELL RES, V303, P160, DOI 10.1016/j.yexcr.2004.09.017; Hansen B, 2002, MOL CELL BIOCHEM, V229, P63, DOI 10.1023/A:1017919800347; Hellevik T, 1996, EXP CELL RES, V223, P39, DOI 10.1006/excr.1996.0056; Hirsch HH, 2013, AM J TRANSPLANT, V13, P179, DOI 10.1111/ajt.12110; Hirsch HH, 2013, APMIS, V121, P685, DOI 10.1111/apm.12128; Hirsch HH, 2005, CLIN INFECT DIS, V41, P354, DOI 10.1086/431488; Hosel M, 2012, HEPATOLOGY, V55, P287, DOI 10.1002/hep.24625; INCHLEY CJ, 1969, CLIN EXP IMMUNOL, V5, P173; Jacobs F, 2010, AM J PATHOL, V176, P14, DOI 10.2353/ajpath.2010.090136; Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691; Kjeken R, 2001, CELL TISSUE RES, V304, P221, DOI 10.1007/s004410100348; Lalor PF, 2006, WORLD J GASTROENTERO, V12, P5429, DOI 10.3748/wjg.v12.i34.5429; Lau SK, 2004, AM J CLIN PATHOL, V122, P794, DOI 10.1309/QHD6YFN81KQXUUH6; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Li RM, 2011, AM J PHYSIOL-GASTR L, V300, pG71, DOI 10.1152/ajpgi.00215.2010; Li Y, 2009, MOL CELL BIOCHEM, V327, P183, DOI 10.1007/s11010-009-0056-y; MAGNUSSON S, 1989, BIOCHEM J, V257, P651, DOI 10.1042/bj2570651; Malerod L, 2002, CELL TISSUE RES, V307, P173, DOI 10.1007/s00441-001-0476-9; Malovic I, 2007, HEPATOLOGY, V45, P1454, DOI 10.1002/hep.21639; Martens JH, 2006, J PATHOL, V208, P574, DOI 10.1002/path.1921; Martin-Armas M, 2006, J HEPATOL, V44, P939, DOI 10.1016/j.jhep.2005.09.020; Martinez Inigo, 2008, Comp Hepatol, V7, P4, DOI 10.1186/1476-5926-7-4; McCourt PAG, 1999, HEPATOLOGY, V30, P1276, DOI 10.1002/hep.510300521; MELKKO J, 1994, J EXP MED, V179, P405, DOI 10.1084/jem.179.2.405; MIMS CA, 1959, BRIT J EXP PATHOL, V40, P543; Mousavi SA, 2007, HEPATOLOGY, V46, P871, DOI 10.1002/hep.21748; Napper CE, 2006, BIOCHEM J, V395, P579, DOI 10.1042/BJ20052027; Neu U, 2009, VIROLOGY, V384, P389, DOI 10.1016/j.virol.2008.12.021; Neu U, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003688; Neu U, 2010, CELL HOST MICROBE, V8, P309, DOI 10.1016/j.chom.2010.09.004; Olofsson S, 2005, ANN MED, V37, P154, DOI 10.1080/07853890510007340; Pannabecker TL, 2007, AM J PHYSIOL-RENAL, V293, pF696, DOI 10.1152/ajprenal.00231.2007; Petrogiannis-Haliotis T, 2001, NEW ENGL J MED, V345, P1250, DOI 10.1056/NEJMoa010319; Politz O, 2002, BIOCHEM J, V362, P155, DOI 10.1042/0264-6021:3620155; Rinaldo CH, 2003, VIRUS RES, V93, P181, DOI 10.1016/S0168-1702(03)00096-0; Seckert CK, 2009, J VIROL, V83, P8869, DOI 10.1128/JVI.00870-09; Seternes T, 2002, P NATL ACAD SCI USA, V99, P7594, DOI 10.1073/pnas.102173299; SKOGH T, 1985, IMMUNOLOGY, V55, P585; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; SMEDSROD B, 1990, BIOCHEM J, V271, P345, DOI 10.1042/bj2710345; Smedsrod B, 1997, BIOCHEM J, V322, P567, DOI 10.1042/bj3220567; Smedsrod B, 2012, PROTOCOL PREPARATION; Sorensen KK, 2012, AM J PHYSIOL-REG I, V303, pR1217, DOI 10.1152/ajpregu.00686.2011; Stan RV, 1999, P NATL ACAD SCI USA, V96, P13203, DOI 10.1073/pnas.96.23.13203; Suzuki S, 2001, VIROLOGY, V286, P100, DOI 10.1006/viro.2001.0972; Svistounov D, 2013, EXP GERONTOL, V48, P549, DOI 10.1016/j.exger.2013.03.005; Tan CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064313; Tsai B, 2010, CURR TOP MICROBIOL, V343, P177, DOI 10.1007/82_2010_38; Uhrig A, 2005, J LEUKOCYTE BIOL, V77, P626, DOI 10.1189/jlb.0604332; VALLBRACHT A, 1993, AM J PATHOL, V143, P29; VANBERKEL TJC, 1991, J BIOL CHEM, V266, P2282; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Wu J, 2010, IMMUNOLOGY, V129, P363, DOI 10.1111/j.1365-2567.2009.03179.x; Xie GH, 2010, AM J PHYSIOL-GASTR L, V299, pG1204, DOI 10.1152/ajpgi.00302.2010; Zhang LQ, 1999, J VIROL, V73, P855, DOI 10.1128/JVI.73.1.855-860.1999	75	30	30	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111762	10.1371/journal.pone.0111762	http://dx.doi.org/10.1371/journal.pone.0111762			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375646	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600059
J	Gromov, P; Espinoza, JA; Talman, ML; Honma, N; Kroman, N; Wielenga, VT; Moreira, JMA; Gromova, I				Gromov, Pavel; Espinoza, Jaime A.; Talman, Maj-Lis; Honma, Naoko; Kroman, Niels; Wielenga, Vera Timmermans; Moreira, Jose M. A.; Gromova, Irina			FABP7 and HMGCS2 Are Novel Protein Markers for Apocrine Differentiation Categorizing Apocrine Carcinoma of the Breast	PLOS ONE			English	Article							RECEPTOR-NEGATIVE TUMORS; ANDROGEN RECEPTOR; EXPRESSION; CANCER; ESTROGEN; METABOLISM; LESIONS; EGFR; OVEREXPRESSION; TRANSCRIPTION	Apocrine carcinoma of the breast is a distinctive malignancy with unique morphological and molecular features, generally characterized by being negative for estrogen and progesterone receptors, and thus not electable for endocrine therapy. Despite the fact that they are morphologically distinct from other breast lesions, no standard molecular criteria are currently available for their diagnosis. Using gel-based proteomics in combination with mass spectrometry and immunohistochemistry we have identified two novel markers, HMGCS2 and FABP7 that categorize the entire breast apocrine differentiation spectrum from benign metaplasia and cysts to invasive stages. Expression of HMGCS2 and FABP7 is strongly associated with apocrine differentiation; their expression is retained by most invasive apocrine carcinomas (IAC) showing positive immunoreactivity in 100% and 78% of apocrine carcinomas, respectively, as compared to non-apocrine tumors (16.7% and 6.8%). The nuclear localization of FABP7 in tumor cells was shown to be associated with more aggressive stages of apocrine carcinomas. In addition, when added to the panel of apocrine biomarkers previously reported by our group: 15-PGDH, HMGCR and ACSM1, together they provide a signature that may represent a golden molecular standard for defining the apocrine phenotype in the breast. Moreover, we show that combining HMGCS2 to the steroidal profile (HMGCS2+/ Androgen Receptor (AR)+/Estrogen Receptor(ER)-/Progesteron Receptor (PR)-identifies IACs with a greater sensitivity (79%) as compared with the steroidal profile (AR+/ER-/PR-) alone (54%). We have also presented a detailed immunohistochemical analysis of breast apocrine lesions with a panel of antibodies against proteins which correspond to 10 genes selected from published transcriptomic signatures that currently characterize molecular apocrine subtype and shown that except for melanophilin that is overexpressed in benign apocrine lesions, these proteins were not specific for morphological apocrine differentiation in breast.	[Gromov, Pavel; Gromova, Irina] Danish Canc Soc, Res Ctr, Genome Integr Unit, Copenhagen, Denmark; [Espinoza, Jaime A.] Pontificia Univ Catolica Chile, Sch Med, Ctr Invest Translat Oncol, Dept Pathol, Santiago, Chile; [Talman, Maj-Lis; Wielenga, Vera Timmermans] Copenhagen Univ Hosp, Dept Pathol, Ctr Diagnost Invest, Copenhagen, Denmark; [Honma, Naoko] Tokyo Metropolitan Inst Gerontol, Res Team Geriatr Pathol, Tokyo, Japan; [Kroman, Niels] Copenhagen Univ Hosp, Dept Breast Surg, Copenhagen, Denmark; [Moreira, Jose M. A.] Univ Copenhagen, Fac Med & Hlth Sci, Dept Vet Dis Biol, Sect Mol Dis Biol, Copenhagen, Denmark; [Moreira, Jose M. A.] Univ Copenhagen, Fac Med & Hlth Sci, Dept Vet Dis Biol, Sinodanish Breast Canc Res Ctr, Copenhagen, Denmark	Danish Cancer Society; Pontificia Universidad Catolica de Chile; University of Copenhagen; Tokyo Metropolitan Institute of Gerontology; University of Copenhagen; University of Copenhagen; University of Copenhagen	Gromov, P (corresponding author), Danish Canc Soc, Res Ctr, Genome Integr Unit, Copenhagen, Denmark.	psg@cancer.dk		Espinoza, Jaime/0000-0002-0731-2715; Gromova, Irina/0000-0003-4357-5958; Moreira, Jose/0000-0002-9944-1214	Danish Cancer Society; John and Birthe Meyer Foundation; Kai Lange and Gundhild Kai Lange Fond; Lisa and Gudmund JArgensens Fond; Marketing Department at the Danish Cancer Society	Danish Cancer Society(Danish Cancer Society); John and Birthe Meyer Foundation; Kai Lange and Gundhild Kai Lange Fond; Lisa and Gudmund JArgensens Fond; Marketing Department at the Danish Cancer Society	This work was supported by grants from the Danish Cancer Society, the John and Birthe Meyer Foundation, the Kai Lange and Gundhild Kai Lange Fond, and the Lisa and Gudmund JArgensens Fond. The ear-marked support of the Marketing Department at the Danish Cancer Society through their fundraising activities on behalf of DCTB is greatly appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshareeda AT, 2012, BREAST CANCER RES TR, V134, P519, DOI 10.1007/s10549-012-2083-8; BARTEK J, 1990, HISTOCHEM J, V22, P537, DOI 10.1007/BF01005976; Cabezon T, 2013, MOL CELL PROTEOMICS, V12, P381, DOI 10.1074/mcp.M112.019786; Celis JE, 2006, MOL CELL PROTEOMICS, V5, P462, DOI 10.1074/mcp.M500348-MCP200; CELIS JE, 2006, CELL BIOL LAB HDB, P165; Celis JE, 2008, MOL CELL PROTEOMICS, V7, P1795, DOI 10.1074/mcp.R800011-MCP200; Celis JE, 2007, MOL ONCOL, V1, P97, DOI 10.1016/j.molonc.2007.02.005; Celis JE, 2006, FEBS LETT, V580, P2935, DOI 10.1016/j.febslet.2006.03.080; Celis JE, 2009, MOL ONCOL, V3, P220, DOI 10.1016/j.molonc.2009.01.005; Celis JE, 2007, MOL ONCOL, V1, P1, DOI 10.1016/j.molonc.2007.02.003; Chia KM, 2011, NEOPLASIA, V13, P154, DOI 10.1593/neo.101324; Collins LC, 2011, MODERN PATHOL, V24, P924, DOI 10.1038/modpathol.2011.54; De Longueville F, 2005, INT J ONCOL, V27, P881; Dellapasqua S, 2013, CLIN BREAST CANCER, V13, P95, DOI 10.1016/j.clbc.2012.11.004; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; Edwards TL, 2012, CANCER PREV RES, V5, P855, DOI 10.1158/1940-6207.CAPR-11-0459; Elayat G, 2009, BREAST J, V15, P475, DOI 10.1111/j.1524-4741.2009.00762.x; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Garay JP, 2012, AM J CANCER RES, V2, P434; Gasparini P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088525; Gatalica Z, 1997, PATHOL RES PRACT, V193, P753, DOI 10.1016/S0344-0338(97)80053-2; GIRARD J, 1992, PHYSIOL REV, V72, P507, DOI 10.1152/physrev.1992.72.2.507; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Grimsrud PA, 2012, CELL METAB, V16, P672, DOI 10.1016/j.cmet.2012.10.004; Gromov P, 2008, MOL ONCOL, V2, P368, DOI 10.1016/j.molonc.2008.09.003; Gromov P, 2010, MOL ONCOL, V4, P65, DOI 10.1016/j.molonc.2009.11.003; Gromova I., 2006, CELL BIOL LAB HDB, P219, DOI DOI 10.1016/B978-012164730-8/50212-4; Guedj M, 2012, ONCOGENE, V31, P1196, DOI 10.1038/onc.2011.301; Honma N, 2007, HISTOPATHOLOGY, V50, P425, DOI 10.1111/j.1365-2559.2007.02636.x; Honma N, 2005, HISTOPATHOLOGY, V47, P195, DOI 10.1111/j.1365-2559.2005.02181.x; Honma N, 2006, APMIS, V114, P712, DOI 10.1111/j.1600-0463.2006.apm_434.x; Iggo RD, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3036; Japaze H, 2005, BREAST, V14, P3, DOI 10.1016/j.breast.2004.06.003; Kaloshi G, 2007, J NEURO-ONCOL, V84, P245, DOI 10.1007/s11060-007-9377-4; Kostiuk MA, 2010, FASEB J, V24, P1914, DOI 10.1096/fj.09-149765; Lakhani SR, 2012, WHO CLASSIFICATION T; Lakis S, 2014, BREAST, V23, P234, DOI 10.1016/j.breast.2014.02.013; Lehmann-Che J, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3421; Liang Y, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-97; Martinez-Outschoorn UE, 2012, CELL CYCLE, V11, P3964, DOI 10.4161/cc.22137; Martinez-Outschoorn UE, 2012, CELL CYCLE, V11, P3956, DOI 10.4161/cc.22136; Moinfar F, 2003, CANCER-AM CANCER SOC, V98, P703, DOI 10.1002/cncr.11532; Moll R, 1998, Subcell Biochem, V31, P205; Moreira JMA, 2005, MOL CELL PROTEOMICS, V4, P555, DOI 10.1074/mcp.M400205-MCP200; Naderi A, 2008, NEOPLASIA, V10, P542, DOI 10.1593/neo.08274; Niemeier LA, 2010, MODERN PATHOL, V23, P205, DOI 10.1038/modpathol.2009.159; O'Malley FP, 2008, HISTOPATHOLOGY, V52, P3, DOI 10.1111/j.1365-2559.2007.02888.x; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Page DL, 2005, BREAST, V14, P1, DOI 10.1016/j.breast.2004.06.002; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Robinson JLL, 2011, EMBO J, V30, P3019, DOI 10.1038/emboj.2011.216; Rogowska-Wrzesinska A, 2013, J PROTEOMICS, V88, P4, DOI 10.1016/j.jprot.2013.01.010; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Safarpour D, 2014, AM J CANCER RES, V4, P353; Sanga S, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-59; Sapp Michelle, 2003, Breast J, V9, P335, DOI 10.1046/j.1524-4741.2003.09422.x; Sasahara M, 2014, ANTICANCER RES, V34, P1261; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sckolnick M, 2013, J BIOL CHEM, V288, P29313, DOI 10.1074/jbc.M113.476929; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smathers Rebecca L., 2011, Human Genomics, V5, P170; Tanaka K, 2008, BREAST J, V14, P164, DOI 10.1111/j.1524-4741.2007.00548.x; Tang XY, 2010, PATHOL RES PRACT, V206, P98, DOI 10.1016/j.prp.2009.06.010; Tsutsumi Y, 2012, JPN J CLIN ONCOL, V42, P375, DOI 10.1093/jjco/hys034; Vainio P, 2011, AM J PATHOL, V178, P525, DOI 10.1016/j.ajpath.2010.10.002; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Vranic S, 2013, HISTOL HISTOPATHOL, V28, P1393, DOI 10.14670/HH-28.1393; Vranic S, 2011, ONCOL LETT, V2, P1131, DOI 10.3892/ol.2011.375; Vranic S, 2010, MODERN PATHOL, V23, P644, DOI 10.1038/modpathol.2010.50; Wang J, 2013, CANCER PREV RES, V6, P321, DOI 10.1158/1940-6207.CAPR-12-0304; Wells CA, 2007, J CLIN PATHOL, V60, P1313, DOI 10.1136/jcp.2006.040626; Yeganeh B, 2014, PHARM THER; Zhang H, 2010, BREAST CANCER RES TR, V121, P41, DOI 10.1007/s10549-009-0450-x	73	17	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112024	10.1371/journal.pone.0112024	http://dx.doi.org/10.1371/journal.pone.0112024			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389781	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400047
J	Okuliarova, M; Kankova, Z; Bertin, A; Leterrier, C; Mostl, E; Zeman, M				Okuliarova, Monika; Kankova, Zuzana; Bertin, Aline; Leterrier, Christine; Mostl, Erich; Zeman, Michal			Maternally Derived Egg Hormones, Antibodies and Antimicrobial Proteins: Common and Different Pathways of Maternal Effects in Japanese Quail	PLOS ONE			English	Article							COTURNIX-COTURNIX-JAPONICA; YOLK TESTOSTERONE LEVELS; IMMUNE FUNCTION; DIVERGENT SELECTION; GREY PARTRIDGE; INNATE IMMUNITY; BARN SWALLOW; CHICKS; GROWTH; ANDROGENS	Avian eggs contain a variety of maternally-derived substances that can influence the development and performance of offspring. The levels of these egg compounds vary in relation to environmental and genetic factors, but little is known about whether there are correlative links between maternal substances in the egg underlying common and different pathways of maternal effects. In the present study, we investigated genetically determined variability and mutually adjusted deposition of sex hormones (testosterone-T, androstenedione-A(4) and progesterone-P-4), antibodies (IgY) and antimicrobial proteins (lysozyme) in eggs of Japanese quail (Coturnix japonica). We used different genetic lines that were independently selected for yolk T concentrations, duration of tonic immobility and social reinstatement behaviour, since both selections for behavioural traits (fearfulness and social motivation, respectively) produced considerable correlative responses in yolk androgen levels. A higher selection potential was found for increased rather than decreased yolk T concentrations, suggesting that there is a physiological minimum in egg T levels. Line differences in yolk IgY concentrations were manifested within each selection experiment, but no consistent inter-line pattern between yolk IgY and T was revealed. On the other hand, a consistent inverse inter-line pattern was recorded between yolk IgY and P-4 in both selections for behavioural traits. In addition, selections for contrasting fearfulness and social motivation were associated with changes in albumen lysozyme concentrations and an inverse inter-line pattern between the deposition of yolk IgY and albumen lysozyme was found in lines selected for the level of social motivation. Thus, our results demonstrate genetically-driven changes in deposition of yolk T, P-4, antibodies and albumen lysozyme in the egg. This genetic variability can partially explain mutually adjusted maternal deposition of sex hormones and immune-competent molecules but the inconsistent pattern of inter-line differences across all selections indicates that there are other underlying mechanisms, which require further studies.	[Okuliarova, Monika; Kankova, Zuzana; Zeman, Michal] Comenius Univ, Fac Nat Sci, Dept Anim Physiol & Ethol, Bratislava, Slovakia; [Bertin, Aline; Leterrier, Christine] Univ Tours, IFCE, INRA Val Loire, CNRS,UMR 7247,UMR Physiol Reprod & Comportements, Nouzilly, France; [Mostl, Erich] Univ Vet Med, Dept Biomed Sci, Vienna, Austria; [Zeman, Michal] Slovak Acad Sci, Inst Anim Biochem & Genet, Ivanka Pri Dunaji, Slovakia	Comenius University Bratislava; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Universite de Tours; University of Veterinary Medicine Vienna; Slovak Academy of Sciences	Okuliarova, M (corresponding author), Comenius Univ, Fac Nat Sci, Dept Anim Physiol & Ethol, Bratislava, Slovakia.	okuliarova@fns.uniba.sk	Okuliarova, Monika/S-4622-2017; Zeman, Michal/S-4175-2017; Zeman, M/L-2392-2019; Leterrier, Christine/AAY-7201-2020	Okuliarova, Monika/0000-0002-9186-7341; Zeman, M/0000-0002-2712-6805; 	Slovak Research and Development Agency [APVV 0047-10]; Scientific Grant Agency of the Ministry of Education of the Slovak Republic; Slovak Academy of Sciences (VEGA) [1/0686/12]	Slovak Research and Development Agency(Slovak Research and Development Agency); Scientific Grant Agency of the Ministry of Education of the Slovak Republic; Slovak Academy of Sciences (VEGA)(Vedecka grantova agentura MSVVaS SR a SAV (VEGA))	This study was supported by the Slovak Research and Development Agency (APVV 0047-10) and the Scientific Grant Agency of the Ministry of Education of the Slovak Republic and of the Slovak Academy of Sciences (VEGA 1/0686/12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertin A, 2009, BEHAVIOUR, V146, P757, DOI 10.1163/156853909X446190; BOARD RG, 1974, BIOL REV, V49, P15, DOI 10.1111/j.1469-185X.1974.tb01297.x; Bonisoli-Alquati A, 2010, BEHAV ECOL SOCIOBIOL, V64, P845, DOI 10.1007/s00265-010-0901-8; Buechler K, 2002, J ANIM ECOL, V71, P247, DOI 10.1046/j.1365-2656.2002.00591.x; Carmichael NL, 1998, APPL ANIM BEHAV SCI, V58, P353, DOI 10.1016/S0168-1591(97)00151-2; Cucco M, 2006, CAN J ZOOL, V84, P72, DOI 10.1139/Z05-179; Cucco M, 2008, GEN COMP ENDOCR, V156, P418, DOI 10.1016/j.ygcen.2007.12.010; Cucco M, 2007, COMP BIOCHEM PHYS A, V147, P1038, DOI 10.1016/j.cbpa.2007.03.014; Egbert JR, 2013, GEN COMP ENDOCR, V183, P53, DOI 10.1016/j.ygcen.2012.12.001; Faure JM, 2006, ARCH GEFLUGELKD, V70, P216; Gasparini J, 2007, J EVOLUTION BIOL, V20, P874, DOI 10.1111/j.1420-9101.2007.01315.x; Gil D, 1999, SCIENCE, V286, P126, DOI 10.1126/science.286.5437.126; Gil D, 2007, J EXP ZOOL PART A, V307A, P91, DOI 10.1002/jez.a.340; Grindstaff JL, 2008, J EXP BIOL, V211, P654, DOI 10.1242/jeb.012344; Grindstaff JL, 2003, P ROY SOC B-BIOL SCI, V270, P2309, DOI 10.1098/rspb.2003.2485; Groothuis TGG, 2006, J EVOLUTION BIOL, V19, P1304, DOI 10.1111/j.1420-9101.2005.01072.x; Groothuis TGG, 2005, BIOL LETTERS, V1, P78, DOI 10.1098/rsbl.2004.0233; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Groothuis TGG, 2008, PHILOS T R SOC B, V363, P1647, DOI 10.1098/rstb.2007.0007; Guesdon V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023941; Hamal KR, 2006, POULTRY SCI, V85, P1364, DOI 10.1093/ps/85.8.1364; Hargitai R, 2009, BEHAV ECOL SOCIOBIOL, V63, P869, DOI 10.1007/s00265-009-0727-4; JONES RB, 1991, J COMP PSYCHOL, V105, P15, DOI 10.1037/0735-7036.105.1.15; Kankova Z, 2012, J EXP BIOL, V215, P617, DOI 10.1242/jeb.064030; Lennie Terry A, 2004, Biol Res Nurs, V5, P255, DOI 10.1177/1099800404263014; McGraw KJ, 2005, NATURWISSENSCHAFTEN, V92, P375, DOI 10.1007/s00114-005-0003-z; MILLS AD, 1991, J COMP PSYCHOL, V105, P25, DOI 10.1037/0735-7036.105.1.25; Morosinotto C, 2013, J AVIAN BIOL, V44, P427, DOI 10.1111/j.1600-048X.2013.00084.x; Mostl E, 2001, WIEN TIERARZTL MONAT, V88, P62; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Muller W, 2012, GEN COMP ENDOCR, V175, P337, DOI 10.1016/j.ygcen.2011.11.034; Muller W, 2005, P ROY SOC B-BIOL SCI, V272, P1971, DOI 10.1098/rspb.2005.3178; Muller W, 2004, FUNCT ECOL, V18, P719, DOI 10.1111/j.0269-8463.2004.00902.x; Muller W, 2007, AM NAT, V169, pE84, DOI 10.1086/511962; Navara KJ, 2006, PHYSIOL BIOCHEM ZOOL, V79, P550, DOI 10.1086/501054; Okuliarova M, 2011, CONSEQUENCES DIVERGE, P39; Okuliarova M, 2011, COMP BIOCHEM PHYS A, V160, P81, DOI 10.1016/j.cbpa.2011.05.012; Okuliarova M, 2011, AM NAT, V177, P824, DOI 10.1086/659996; Okuliarova M, 2009, COMP BIOCHEM PHYS A, V154, P530, DOI 10.1016/j.cbpa.2009.08.012; OSSERMAN EF, 1966, J EXP MED, V124, P921, DOI 10.1084/jem.124.5.921; PALME R, 1993, P 5 S AN STER, P111; Peluc SI, 2012, J COMP PHYSIOL B, V182, P687, DOI 10.1007/s00360-011-0638-3; Pihlaja M, 2006, J ANIM ECOL, V75, P1154, DOI 10.1111/j.1365-2656.2006.01136.x; Pilz KM, 2004, FUNCT ECOL, V18, P58, DOI 10.1111/j.1365-2435.2004.00811.x; Pitala N, 2009, J AVIAN BIOL, V40, P225, DOI 10.1111/j.1600-048X.2009.04452.x; Postma E, 2013, OECOLOGIA; Rutkowska J, 2005, HORM BEHAV, V47, P585, DOI 10.1016/j.yhbeh.2004.12.006; Ruuskanen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025360; Saino N, 2002, P ROY SOC B-BIOL SCI, V269, P1005, DOI 10.1098/rspb.2002.1992; Saino N, 2002, J EVOLUTION BIOL, V15, P735, DOI 10.1046/j.1420-9101.2002.00448.x; Saino N, 2003, P ROY SOC B-BIOL SCI, V270, P2485, DOI 10.1098/rspb.2003.2534; Sandell MI, 2009, J EXP BIOL, V212, P815, DOI 10.1242/jeb.022111; Schweitzer C, 2009, DEV PSYCHOBIOL, V51, P311, DOI 10.1002/dev.20370; Sellier N, 2007, BRIT POULTRY SCI, V48, P559, DOI 10.1080/00071660701592367; Shawkey MD, 2008, BEHAV ECOL, V19, P920, DOI 10.1093/beheco/arn019; Swierczewska Ewa, 2003, Animal Science Papers and Reports, V21, P63; Tobler M, 2010, BEHAV ECOL SOCIOBIOL, V64, P717, DOI 10.1007/s00265-009-0889-0; Tschirren B, 2005, J ANIM ECOL, V74, P675, DOI 10.1111/j.1365-2656.2005.00963.x; Tschirren B, 2004, P ROY SOC B-BIOL SCI, V271, P1371, DOI 10.1098/rspb.2004.2730; Tschirren B, 2009, AM NAT, V174, P557, DOI 10.1086/605379; von Engelhardt N, 2011, HORMONES AND REPRODUCTION OF VERTEBRATES, VOL 4: BIRDS, P91; ZEMAN M, 1986, BRIT POULTRY SCI, V27, P261, DOI 10.1080/00071668608416879	62	9	9	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112817	10.1371/journal.pone.0112817	http://dx.doi.org/10.1371/journal.pone.0112817			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390303	Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400133
J	Tagar, E; Sundaram, M; Condliffe, K; Matatiyo, B; Chimbwandira, F; Chilima, B; Mwanamanga, R; Moyo, C; Chitah, BM; Nyemazi, JP; Assefa, Y; Pillay, Y; Mayer, S; Shear, L; Dain, M; Hurley, R; Kumar, R; McCarthy, T; Batra, P; Gwinnell, D; Diamond, S; Over, M				Tagar, Elya; Sundaram, Maaya; Condliffe, Kate; Matatiyo, Blackson; Chimbwandira, Frank; Chilima, Ben; Mwanamanga, Robert; Moyo, Crispin; Chitah, Bona Mukosha; Nyemazi, Jean Pierre; Assefa, Yibeltal; Pillay, Yogan; Mayer, Sam; Shear, Lauren; Dain, Mary; Hurley, Raphael; Kumar, Ritu; McCarthy, Thomas; Batra, Parul; Gwinnell, Dan; Diamond, Samantha; Over, Mead			Multi-Country Analysis of Treatment Costs for HIV/AIDS (MATCH): Facility-Level ART Unit Cost Analysis in Ethiopia, Malawi, Rwanda, South Africa and Zambia	PLOS ONE			English	Article							HIV	Background: Today's uncertain HIV funding landscape threatens to slow progress towards treatment goals. Understanding the costs of antiretroviral therapy (ART) will be essential for governments to make informed policy decisions about the pace of scale-up under the 2013 WHO HIV Treatment Guidelines, which increase the number of people eligible for treatment from 17.6 million to 28.6 million. The study presented here is one of the largest of its kind and the first to describe the facility-level cost of ART in a random sample of facilities in Ethiopia, Malawi, Rwanda, South Africa and Zambia. Methods & Findings: In 2010-2011, comprehensive data on one year of facility-level ART costs and patient outcomes were collected from 161 facilities, selected using stratified random sampling. Overall, facility-level ART costs were significantly lower than expected in four of the five countries, with a simple average of $208 per patient-year (ppy) across Ethiopia, Malawi, Rwanda and Zambia. Costs were higher in South Africa, at $682 ppy. This included medications, laboratory services, direct and indirect personnel, patient support, equipment and administrative services. Facilities demonstrated the ability to retain patients alive and on treatment at these costs, although outcomes for established patients (2-8% annual loss to follow-up or death) were better than outcomes for new patients in their first year of ART (77-95% alive and on treatment). Conclusions: This study illustrated that the facility-level costs of ART are lower than previously understood in these five countries. While limitations must be considered, and costs will vary across countries, this suggests that expanded treatment coverage may be affordable. Further research is needed to understand investment costs of treatment scale-up, non-facility costs and opportunities for more efficient resource allocation.	[Tagar, Elya; Sundaram, Maaya; Condliffe, Kate; Mayer, Sam; Batra, Parul; Gwinnell, Dan; Diamond, Samantha] HIV, Clinton Hlth Access Initiat, TB & Hlth Financing, Boston, MA 02127 USA; [Matatiyo, Blackson] Natl AIDS Commiss, Lilongwe, Malawi; [Chimbwandira, Frank] Minist Hlth, Dept HIV & AIDS, Lilongwe, Malawi; [Chilima, Ben] Minist Hlth, Commun Hlth Sci Unit, Lilongwe, Malawi; [Mwanamanga, Robert] Minist Hlth, Dept Planning & Policy Dev, Lilongwe, Malawi; [Moyo, Crispin] Minist Hlth, Natl ART Program, Lusaka, Zambia; [Chitah, Bona Mukosha] Univ Zambia, Dept Econ, Lusaka, Zambia; [Nyemazi, Jean Pierre] Minist Hlth, Monitoring & Evaluat Div, Kigali, Rwanda; [Assefa, Yibeltal] Fed HIV AIDS Prevent & Control Off, Addis Ababa, Ethiopia; [Pillay, Yogan] HIV AIDS, TB & MCWH, Natl Dept Hlth, Pretoria, South Africa; [Shear, Lauren] HIV, TB & Hlth Financing, Clinton Hlth Access Initiat, Lilongwe, Malawi; [Dain, Mary] HIV, TB & Hlth Financing, Clinton Hlth Access Initiat, Kigali, Rwanda; [Hurley, Raphael] HIV, TB & Hlth Financing, Clinton Hlth Access Initiat, Addis Ababa, Ethiopia; [Kumar, Ritu] HIV, TB & Hlth Financing, Clinton Hlth Access Initiat, Lusaka, Zambia; [McCarthy, Thomas] HIV, TB & Hlth Financing, Clinton Hlth Access Initiat, Pretoria, South Africa; [Over, Mead] Ctr Global Dev, Washington, DC USA	University of Zambia	Tagar, E (corresponding author), HIV, Clinton Hlth Access Initiat, TB & Hlth Financing, Boston, MA 02127 USA.	etagar@clintonhealthaccess.org	Assefa, Yibeltal/N-5984-2016; Assefa, Yibeltal/ABI-8057-2020	Assefa, Yibeltal/0000-0003-2393-1492; Assefa, Yibeltal/0000-0003-2393-1492	Bill and Melinda Gates Foundation [WO5, 19419]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The funder for this work was the Bill and Melinda Gates Foundation (www.gatesfoundation.org) through the following grant: WO5, Contract 19419. The funders provided technical input into the study design, data collection and analysis. They provided limited and non-binding comments on the manuscript. The study team held 2 meetings with a technical advisory group, specifically the 28th of September 2010 and 12-13 of December 2011, to provide technical guidance for study design and review of preliminary findings.	[Anonymous], 2013, 2013 REP COSTS TREAT; [Anonymous], 2013, ANT MED LOW MIDDL IN; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Galarraga O, 2011, PHARMACOECONOMICS, V29, P579, DOI 10.2165/11586120-000000000-00000; Marseille E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051993; Menzies NA, 2011, AIDS, V25, P1753, DOI 10.1097/QAD.0b013e3283463eec; Rosen S, 2006, 9 BOST U SCH PUBL HL; Suthar AB, 2012, B WORLD HEALTH ORGAN, V90, P128, DOI 10.2471/BLT.11.093260; UNAIDS, 2004, ACC HIV TREATM CAR F; UNAIDS, 2010, GLOB REP UNAIDS REP; UNAIDS, 2014, THE GAP REP; WHO UNICEF & UNAIDS., 2011, UN ACC, P1	12	61	61	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e108304	10.1371/journal.pone.0108304	http://dx.doi.org/10.1371/journal.pone.0108304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389777	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400005
J	Piekarski, A; Khaldi, S; Greene, E; Lassiter, K; Mason, JG; Anthony, N; Bottje, W; Dridi, S				Piekarski, Alissa; Khaldi, Stephanie; Greene, Elizabeth; Lassiter, Kentu; Mason, James G.; Anthony, Nicholas; Bottje, Walter; Dridi, Sami			Tissue Distribution, Gender-and Genotype-Dependent Expression of Autophagy-Related Genes in Avian Species	PLOS ONE			English	Article							BLOOD CORTICOSTERONE RESPONSE; MULTIPLE SEQUENCE ALIGNMENT; JAPANESE-QUAIL; REGULATES AUTOPHAGY; MOLECULAR MACHINERY; MEDIATED AUTOPHAGY; PROTEINS; DISEASE; COMPLEX; TARGETS	As a result of the genetic selection of broiler (meat-type breeders) chickens for enhanced growth rate and lower feed conversion ratio, it has become necessary to restrict feed intake. When broilers are fed ad libitum, they would become obese and suffer from several health-related problems. A vital adaptation to starvation is autophagy, a self-eating mechanism for recycling cellular constituents. The autophagy pathway has witnessed dramatic growth in the last few years and extensively studied in yeast and mammals however, there is a paucity of information in avian (non-mammalian) species. Here we characterized several genes involved in autophagosome initiation and elongation in Red Jungle fowl (Gallus gallus) and Japanese quail (coturnix coturnix Japonica). Both complexes are ubiquitously expressed in chicken and quail tissues (liver, leg and breast muscle, brain, gizzard, intestine, heart, lung, kidney, adipose tissue, ovary and testis). Alignment analysis showed high similarity (50.7 to 91.5%) between chicken autophagy-related genes and their mammalian orthologs. Phylogenetic analysis demonstrated that the evolutionary relationship between autophagy genes is consistent with the consensus view of vertebrate evolution. Interestingly, the expression of autophagy-related genes is tissue- and gender-dependent. Furthermore, using two experimental male quail lines divergently selected over 40 generations for low (resistant, R) or high (sensitive, S) stress response, we found that the expression of most studied genes are higher in R compared to S line. Together our results indicate that the autophagy pathway is a key molecular signature exhibited gender specific differences and likely plays an important role in response to stress in avian species.	[Piekarski, Alissa; Khaldi, Stephanie; Greene, Elizabeth; Lassiter, Kentu; Mason, James G.; Anthony, Nicholas; Bottje, Walter; Dridi, Sami] Univ Arkansas, Ctr Excellence Poultry Sci, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville	Dridi, S (corresponding author), Univ Arkansas, Ctr Excellence Poultry Sci, Fayetteville, AR 72701 USA.	dridi@uark.edu	Dridi, Sami/Q-8207-2019		Arkansas state Start-up funding; Arkansas Bioscience 339 Institute (ABI) equipment grant;  [FY2012-15]	Arkansas state Start-up funding; Arkansas Bioscience 339 Institute (ABI) equipment grant; 	This study was supported by Arkansas state Start-up funding (to SD) and Arkansas Bioscience 339 Institute (ABI) equipment grant (to SD) and FY2012-15 (to WB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; Coto-Montes A, 2009, J ANDROL, V30, P113, DOI 10.2164/jandrol.108.005355; Davis KA, 2008, POULTRY SCI, V87, P1303, DOI 10.3382/ps.2008-00083; Du L, 2009, J BIOL CHEM, V284, P2383, DOI 10.1074/jbc.M804396200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Bolanos JMG, 2014, ANIM REPROD SCI, V145, P40, DOI 10.1016/j.anireprosci.2014.01.001; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hasson SA, 2013, NATURE, V504, P291, DOI 10.1038/nature12748; Hemelaar J, 2003, J BIOL CHEM, V278, P51841, DOI 10.1074/jbc.M308762200; Huff GR, 2013, POULTRY SCI, V92, P603, DOI 10.3382/ps.2012-02518; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kimura S, 2008, CELL STRUCT FUNCT, V33, P109, DOI 10.1247/csf.08005; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Malik SA, 2011, CELL CYCLE, V10, P2917, DOI 10.4161/cc.10.17.17067; Massey AC, 2006, CURR TOP DEV BIOL, V73, P205, DOI 10.1016/S0070-2153(05)73007-6; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Rodriguez A, 2012, DIABETOLOGIA, V55, P3038, DOI 10.1007/s00125-012-2671-5; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Satterlee DG, 2006, POULTRY SCI, V85, P404, DOI 10.1093/ps/85.3.404; SATTERLEE DG, 1990, COMP BIOCHEM PHYS A, V95, P401, DOI 10.1016/0300-9629(90)90239-O; SATTERLEE DG, 1988, POULTRY SCI, V67, P25, DOI 10.3382/ps.0670025; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Slupecka M, 2014, DOMEST ANIM ENDOCRIN, V46, P12, DOI 10.1016/j.domaniend.2013.09.007; Sobolewska A, 2009, EUR J CELL BIOL, V88, P117, DOI 10.1016/j.ejcb.2008.09.004; Straface E, 2009, FEBS LETT, V583, P3448, DOI 10.1016/j.febslet.2009.09.052; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tasdemir E, 2007, CELL CYCLE, V6, P2263, DOI 10.4161/cc.6.18.4681; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vega-Naredo I, 2009, AUTOPHAGY, V5, P1004, DOI 10.4161/auto.5.7.9610; Wang MJ, 2008, CIRCULATION, V118, pS38, DOI 10.1161/CIRCULATIONAHA.107.756890; Xia XC, 2010, J BONE MINER RES, V25, P2479, DOI 10.1002/jbmr.160; Yang DS, 2011, BRAIN, V134, P258, DOI 10.1093/brain/awq341; Yansong W., 2014, J CELL PHYSL; Yoon S, 2010, AUTOPHAGY, V6, P1125, DOI 10.4161/auto.6.8.13547; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765	61	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112449	10.1371/journal.pone.0112449	http://dx.doi.org/10.1371/journal.pone.0112449			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386921	Green Submitted, Green Published, gold			2022-12-27	WOS:000345250400063
J	Tembuyser, L; Tack, V; Zwaenepoel, K; Pauwels, P; Miller, K; Bubendorf, L; Kerr, K; Schuuring, E; Thunnissen, E; Dequeker, EMC				Tembuyser, Lien; Tack, Veronique; Zwaenepoel, Karen; Pauwels, Patrick; Miller, Keith; Bubendorf, Lukas; Kerr, Keith; Schuuring, Ed; Thunnissen, Erik; Dequeker, Elisabeth M. C.			The Relevance of External Quality Assessment for Molecular Testing for ALK Positive Non-Small Cell Lung Cancer: Results from Two Pilot Rounds Show Room for Optimization	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; IMMUNOHISTOCHEMISTRY; IDENTIFICATION; GUIDELINE; GENE; EGFR; ADENOCARCINOMAS; REARRANGEMENTS; BIOMARKERS; MUTATION	Background and Purpose: Molecular profiling should be performed on all advanced non-small cell lung cancer with non-squamous histology to allow treatment selection. Currently, this should include EGFR mutation testing and testing for ALK rearrangements. ROS1 is another emerging target. ALK rearrangement status is a critical biomarker to predict response to tyrosine kinase inhibitors such as crizotinib. To promote high quality testing in non-small cell lung cancer, the European Society of Pathology has introduced an external quality assessment scheme. This article summarizes the results of the first two pilot rounds organized in 2012-2013. Materials and Methods: Tissue microarray slides consisting of cell-lines and resection specimens were distributed with the request for routine ALK testing using IHC or FISH. Participation in ALK FISH testing included the interpretation of four digital FISH images. Results: Data from 173 different laboratories was obtained. Results demonstrate decreased error rates in the second round for both ALK FISH and ALK IHC, although the error rates were still high and the need for external quality assessment in laboratories performing ALK testing is evident. Error rates obtained by FISH were lower than by IHC. The lowest error rates were observed for the interpretation of digital FISH images. Conclusion: There was a large variety in FISH enumeration practices. Based on the results from this study, recommendations for the methodology, analysis, interpretation and result reporting were issued. External quality assessment is a crucial element to improve the quality of molecular testing.	[Tembuyser, Lien; Tack, Veronique; Dequeker, Elisabeth M. C.] KU Leuven Univ Leuven, Biomed Qual Assurance Res Unit, Dept Publ Hlth & Primary Care, Leuven, Belgium; [Zwaenepoel, Karen; Pauwels, Patrick] Univ Antwerp Hosp, Dept Pathol, Edegem, Belgium; [Miller, Keith] UK NEQAS ICC & ISH, London, England; [Bubendorf, Lukas] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland; [Kerr, Keith] Aberdeen Royal Infirm, Dept Pathol, Aberdeen, Scotland; [Schuuring, Ed] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Thunnissen, Erik] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands	KU Leuven; University of Antwerp; University of Basel; University of Aberdeen; University of Groningen; Vrije Universiteit Amsterdam	Dequeker, EMC (corresponding author), KU Leuven Univ Leuven, Biomed Qual Assurance Res Unit, Dept Publ Hlth & Primary Care, Leuven, Belgium.	els.dequeker@med.kuleuven.be	Bubendorf, Lukas/G-5299-2015; Bubendorfl, Lukas/H-5880-2011	Bubendorf, Lukas/0000-0001-5970-1803; Tack, Veronique/0000-0001-8464-9541	Pfizer [ZL520506]	Pfizer(Pfizer)	This work was supported by an unrestricted grant from Pfizer: grant number ZL520506, www.pfizer.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackhall FH, 2014, J CLIN ONCOL, V32, P2780, DOI 10.1200/JCO.2013.54.5921; Cabillic F, 2014, J THORAC ONCOL, V9, P295, DOI 10.1097/JTO.0000000000000072; Cagle PT, 2013, ARCH PATHOL LAB MED, V137, P1191, DOI 10.5858/arpa.2013-0319-CR; Camidge DR, 2010, CLIN CANCER RES, V16, P5581, DOI 10.1158/1078-0432.CCR-10-0851; Choi YL, 2008, CANCER RES, V68, P4971, DOI 10.1158/0008-5472.CAN-07-6158; Conklin CMJ, 2013, J THORAC ONCOL, V8, P45, DOI 10.1097/JTO.0b013e318274a83e; Crystal AS, 2012, CLIN CANCER RES, V18, P4479, DOI 10.1158/1078-0432.CCR-12-1952; Dacic S, 2013, J CLIN PATHOL, V66, P870, DOI 10.1136/jclinpath-2012-201336; Deans ZC, 2013, J CLIN PATHOL, V66, P319, DOI 10.1136/jclinpath-2012-201227; Garrido P, 2012, CLIN TRANSL ONCOL, V14, P338, DOI 10.1007/s12094-012-0806-2; Gulley ML, 2007, ARCH PATHOL LAB MED, V131, P852; Han XH, 2013, VIRCHOWS ARCH, V463, P583, DOI 10.1007/s00428-013-1472-7; Heuckmann JM, 2012, CLIN CANCER RES, V18, P4682, DOI 10.1158/1078-0432.CCR-11-3260; International Organization for Standardization, 2012, 15189 ISO; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lindeman NI, 2013, J MOL DIAGN, V15, P415, DOI 10.1016/j.jmoldx.2013.03.001; Mescam-Mancini L, 2014, LUNG CANCER, V83, P168, DOI 10.1016/j.lungcan.2013.11.019; Mino-Kenudson M, 2011, ARCH PATHOL LAB MED, V135, P655, DOI 10.1043/2011-0029-RAI.1; Mino-Kenudson M, 2010, CLIN CANCER RES, V16, P1561, DOI 10.1158/1078-0432.CCR-09-2845; Nordic Immunohistochemical Quality Control, 2013, LUNG AN LYMPH KIN AS; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Ruschoff J, 2010, VIRCHOWS ARCH, V457, P299, DOI 10.1007/s00428-010-0952-2; Sasaki T, 2011, CLIN CANCER RES, V17, P7213, DOI 10.1158/1078-0432.CCR-11-1404; Selinger CI, 2013, MODERN PATHOL, V26, P1545, DOI 10.1038/modpathol.2013.87; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stinchcombe TE, 2008, ONCOLOGIST, V13, P933, DOI 10.1634/theoncologist.2008-0019; Takeuchi K, 2009, CLIN CANCER RES, V15, P3143, DOI 10.1158/1078-0432.CCR-08-3248; Tembuyser L, 2014, J MOL DIAGN, V16, P371, DOI 10.1016/j.jmoldx.2014.01.003; Thunnissen E, 2014, VIRCHOWS ARCH, V464, P347, DOI 10.1007/s00428-014-1535-4; Thunnissen E, 2012, VIRCHOWS ARCH, V461, P245, DOI 10.1007/s00428-012-1281-4; Thunnissen E, 2011, J CLIN PATHOL, V64, P884, DOI 10.1136/jclinpath-2011-200163; van Krieken JH, 2013, VIRCHOWS ARCH, V462, P27, DOI 10.1007/s00428-012-1354-4; Yoshida A, 2011, J THORAC ONCOL, V6, P1677, DOI 10.1097/JTO.0b013e3182286d25; Zwaenepoel K, 2014, HISTOPATHOL IN PRESS	37	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112159	10.1371/journal.pone.0112159	http://dx.doi.org/10.1371/journal.pone.0112159			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386659	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400044
J	Zhang, J; Sun, GQ; Sun, XD; Hou, Q; Li, MT; Huang, BX; Wang, HY; Jin, Z				Zhang, Juan; Sun, Gui-Quan; Sun, Xiang-Dong; Hou, Qiang; Li, Mingtao; Huang, Baoxu; Wang, Haiyan; Jin, Zhen			Prediction and Control of Brucellosis Transmission of Dairy Cattle in Zhejiang Province, China	PLOS ONE			English	Article							BOVINE BRUCELLOSIS; MODEL; EPIDEMIOLOGY; CONTROL/ERADICATION; MONGOLIA; DISEASE; REGION; INDIA; OVINE; HERDS	Brucellosis is a bacterial disease caused by brucella; mainly spread by direct contact transmission through the brucella carriers, or indirect contact transmission by the environment containing large quantities of bacteria discharged by the infected individuals. At the beginning of 21st century, the epidemic among dairy cows in Zhejiang province, began to come back and has become a localized prevalent epidemic. Combining the pathology of brucellosis, the reported positive data characteristics, and the feeding method in Zhejiang province, this paper establishes an SEIV dynamic model to excavate the internal transmission dynamics, fit the real disease situation, predict brucellosis tendency and assess control measures in dairy cows. By careful analysis, we give some quantitative results as follows. (1) The external input of dairy cows from northern areas may lead to high fluctuation of the number of the infectious cows in Zhejiang province that can reach several hundreds. In this case, the disease cannot be controlled and the infection situation cannot easily be predicted. Thus, this paper encourages cows farms to insist on self-supplying production of the dairy cows. (2) The effect of transmission rate of brucella in environment to dairy cattle on brucellosis spreading is greater than transmission rate of the infectious dairy cattle to susceptible cattle. The prevalence of the epidemic is mainly aroused by environment transmission. (3) Under certain circumstances, the epidemic will become a periodic phenomenon. (4) For Zhejiang province, besides measures that have already been adopted, sterilization times of the infected regions is suggested as twice a week, and should be combined with management of the birth rate of dairy cows to control brucellosis spread.	[Zhang, Juan] North Univ China, Sch Mech Engn, Taiyuan, Shanxi, Peoples R China; [Zhang, Juan; Sun, Gui-Quan; Li, Mingtao; Jin, Zhen] Shanxi Univ, Complex Syst Res Ctr, Taiyuan, Shanxi, Peoples R China; [Sun, Gui-Quan] Fudan Univ, Sch Math Sci, Shanghai 200433, Peoples R China; [Sun, Xiang-Dong; Huang, Baoxu] China Anim Hlth & Epidemiol Ctr, Lab Anim Epidemiol Surveillance, Qingdao, Shandong, Peoples R China; [Hou, Qiang] North Univ China, Dept Math, Taiyuan, Shanxi, Peoples R China; [Wang, Haiyan] Arizona State Univ, Sch Math & Nat Sci, Phoenix, AZ USA	North University of China; Shanxi University; Fudan University; China Animal Health & Epidemiology Center; North University of China; Arizona State University; Arizona State University-Downtown Phoenix	Jin, Z (corresponding author), Shanxi Univ, Complex Syst Res Ctr, Taiyuan, Shanxi, Peoples R China.	jinzhn@263.net	jin, zhen/B-6563-2015; Sun, Gui-Quan/Y-3606-2019; Sun, Gui-Quan/AAE-7769-2019	jin, zhen/0000-0002-9763-707X; Sun, Gui-Quan/0000-0002-1831-1603; Wang, Haiyan/0000-0002-5204-967X	National Natural Science Foundation of China [11171314, 11147015, 11301490]; Natural Science Foundation of Shan'Xi Province [2012021002-1]; specialized research fund for the doctoral program of higher education (preferential development) [20121420130001]; China Postdoctoral Science Foundation [2012M520814]; Shanghai Postdoctoral Science Foundation [13R21410100, IDRC104519-010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shan'Xi Province(Natural Science Foundation of Shanxi Province); specialized research fund for the doctoral program of higher education (preferential development); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This research is supported by the National Natural Science Foundation of China under grants (11171314, 11147015, and 11301490), Natural Science Foundation of Shan'Xi Province grant no. 2012021002-1, The specialized research fund for the doctoral program of higher education (preferential development) no. 20121420130001, China Postdoctoral Science Foundation under grant no. 2012M520814, and Shanghai Postdoctoral Science Foundation under grant no. 13R21410100 and IDRC104519-010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainseba Bedr'Eddine, 2010, Journal of Biological Dynamics, V4, P2, DOI 10.1080/17513750903171688; ALTON GG, 1987, TROP ANIM HEALTH PRO, V19, P65, DOI 10.1007/BF02297320; Benkirane A, 2006, SMALL RUMINANT RES, V62, P19, DOI 10.1016/j.smallrumres.2005.07.032; BERCOVICH Z, 1992, PREV VET MED, V13, P277, DOI 10.1016/0167-5877(92)90042-E; Bercovich Z, 1998, VET QUART, V20, P81, DOI 10.1080/01652176.1998.9694845; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; England T, 2004, PREV VET MED, V63, P63, DOI 10.1016/j.prevetmed.2004.01.009; Fang Xie, 2009, Journal of Agricultural and Resource Economics, V34, P11; GONZALEZGUZMAN J, 1994, J MATH BIOL, V33, P211, DOI 10.1007/BF00160180; Hou Q, 2013, MATH BIOSCI, V242, P51, DOI 10.1016/j.mbs.2012.11.012; Jiao J., 2009, ANIM HUSB FEED SCI, V30, P170; Keeling M.J., 2008, MODELING INFECT DIS; Liu JP, 2009, PROGR VET MED, V30, P121; MacMillan A, 1990, CONVENTIONAL SEROLOG, P131; MacMillan A., 1994, CATTLE PRACT, V2, P469; Renukaradhya GJ, 2002, VET MICROBIOL, V90, P183, DOI 10.1016/S0378-1135(02)00253-5; Sandip R, 2011, PLOS NEGLECT TROP D, V5, pe1259; Shang DQ, 2002, VET MICROBIOL, V90, P165, DOI 10.1016/S0378-1135(02)00252-3; Sharp Merck, 2011, MERCK VET MAN BRUC C; Smits HL, 2005, INDIAN J MED RES, V122, P375; STEMSHORN BW, 1985, CAN J COMP MED, V49, P391; The Chinese Ministry of Agriculture, 2001, CHIN AN IND YB; Xu W., 2007, CHIN RURAL HLTH SERV, V27, P209; Zinsstag J, 2005, PREV VET MED, V69, P77, DOI 10.1016/j.prevetmed.2005.01.017; 徐卫民, 2009, [中华预防医学杂志, Chinese Journal of Preventive Medicine], V43, P746	25	78	82	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e108592	10.1371/journal.pone.0108592	http://dx.doi.org/10.1371/journal.pone.0108592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386963	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400001
J	Ho, ES; Kuchie, J; Duffy, S				Ho, Eric S.; Kuchie, Joan; Duffy, Siobain			Bioinformatic Analysis Reveals Genome Size Reduction and the Emergence of Tyrosine Phosphorylation Site in the Movement Protein of New World Bipartite Begomoviruses	PLOS ONE			English	Article							LEAF CURL VIRUS; MONOPARTITE BEGOMOVIRUS; MOLECULAR-BIOLOGY; TOMATO; GEMINIVIRUSES; EVOLUTION; RATES; DATAMONKEY; DISEASE; TOOLS	Begomovirus (genus Begomovirus, family Geminiviridae) infection is devastating to a wide variety of agricultural crops including tomato, squash, and cassava. Thus, understanding the replication and adaptation of begomoviruses has important translational value in alleviating substantial economic loss, particularly in developing countries. The bipartite genome of begomoviruses prevalent in the New World and their counterparts in the Old World share a high degree of genome homology except for a partially overlapping reading frame encoding the pre-coat protein (PCP, or AV2). PCP contributes to the essential functions of intercellular movement and suppression of host RNA silencing, but it is only present in the Old World viruses. In this study, we analyzed a set of non-redundant bipartite begomovirus genomes originating from the Old World (N = 28) and the New World (N = 65). Our bioinformatic analysis suggests similar to 120 nucleotides were deleted from PCP's proximal promoter region that may have contributed to its loss in the New World viruses. Consequently, genomes of the New World viruses are smaller than the Old World counterparts, possibly compensating for the loss of the intercellular movement functions of PCP. Additionally, we detected substantial purifying selection on a portion of the New World DNA-B movement protein (MP, or BC1). Further analysis of the New World MP gene revealed the emergence of a putative tyrosine phosphorylation site, which likely explains the increased purifying selection in that region. These findings provide important information about the strategies adopted by bipartite begomoviruses in adapting to new environment and suggest future in planta experiments.	[Ho, Eric S.] Lafayette Coll, Dept Biol, Easton, PA 18042 USA; [Kuchie, Joan] New Jersey City Univ, Jersey City, NJ USA; [Duffy, Siobain] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA	Lafayette College; Rutgers State University New Brunswick	Ho, ES (corresponding author), Lafayette Coll, Dept Biol, Easton, PA 18042 USA.	hoe@lafayette.edu	Duffy, Siobain/A-9104-2009	Duffy, Siobain/0000-0003-0753-223X; Ho, Eric/0000-0002-0713-9545	NIH [K12 GM093854-01]; New Jersey City University; RiSE program at Rutgers; NSF [DEB 1026095]; BMGF/DFID [OPP1052391]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM093854] Funding Source: NIH RePORTER; Direct For Biological Sciences [1026095] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey City University; RiSE program at Rutgers; NSF(National Science Foundation (NSF)); BMGF/DFID; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	ESH is supported by NIH K12 GM093854-01. JK is supported by New Jersey City University and the RiSE program at Rutgers. SD is supported by NSF DEB 1026095 and BMGF/DFID OPP1052391. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Modena NA, 2008, VIRUS RES, V137, P16, DOI 10.1016/j.virusres.2008.04.007; Briddon RW, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-97; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Duffy S, 2009, J GEN VIROL, V90, P1539, DOI 10.1099/vir.0.009266-0; Gilbertson RL, 2003, PLANT CELL, V15, P2578, DOI 10.1105/tpc.015057; Glick E, 2008, P NATL ACAD SCI USA, V105, P157, DOI 10.1073/pnas.0709036105; Ha C, 2008, J GEN VIROL, V89, P312, DOI 10.1099/vir.0.83236-0; King A. M. Q, 2012, VIRUS TAXONOMY; Kleinow T, 2008, VIRUS RES, V131, P86, DOI 10.1016/j.virusres.2007.08.011; Melgarejo TA, 2013, J VIROL, V87, P5397, DOI 10.1128/JVI.00234-13; Monjane AL, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-252; Nault LR, 1997, ANN ENTOMOL SOC AM, V90, P521, DOI 10.1093/aesa/90.5.521; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; PADIDAM M, 1995, J GEN VIROL, V76, P249, DOI 10.1099/0022-1317-76-2-249; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Priyadarshini CGP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026929; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rocha CS, 2013, J VIROL, V87, P5784, DOI 10.1128/JVI.00155-13; Rojas MR, 2005, ANNU REV PHYTOPATHOL, V43, P361, DOI 10.1146/annurev.phyto.43.040204.135939; Rojas MR, 2001, VIROLOGY, V291, P110, DOI 10.1006/viro.2001.1194; Rothenstein D, 2007, VIROLOGY, V359, P137, DOI 10.1016/j.virol.2006.09.014; RYBICKI EP, 1994, ARCH VIROL, V139, P49, DOI 10.1007/BF01309454; Seal SE, 2006, ADV VIRUS RES, V67, P297, DOI 10.1016/S0065-3527(06)67008-5; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Team RDC, 2012, R LANG ENV STAT COMP; Tonukari NJ, 2000, PLANT CELL, V12, P237, DOI 10.1105/tpc.12.2.237; Xu XZ, 2008, J ZHEJIANG UNIV-SC B, V9, P667, DOI 10.1631/jzus.B0820005; Zhang WM, 2014, J ECON ENTOMOL, V107, P98, DOI 10.1603/EC13348	35	12	13	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e111957	10.1371/journal.pone.0111957	http://dx.doi.org/10.1371/journal.pone.0111957			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383632	gold, Green Published, Green Submitted			2022-12-27	WOS:000344816700025
J	Seladi-Schulman, J; Campbell, PJ; Suppiah, S; Steel, J; Lowen, AC				Seladi-Schulman, Jill; Campbell, Patricia J.; Suppiah, Suganthi; Steel, John; Lowen, Anice C.			Filament-Producing Mutants of Influenza A/Puerto Rico/8/1934 (H1N1) Virus Have Higher Neuraminidase Activities than the Spherical Wild-Type	PLOS ONE			English	Article							A VIRUS; PARTICLE FORMATION; VIRAL MORPHOLOGY; M SEGMENT; IN-VIVO; HEMAGGLUTININ; M1; CONTACT; STRAINS; VIRIONS	Influenza virus exhibits two morphologies-spherical and filamentous. Strains that have been grown extensively in laboratory substrates are comprised predominantly of spherical virions while clinical or low passage isolates produce a mixture of spheres and filamentous virions of varying lengths. The filamentous morphology can be lost upon continued passage in embryonated chicken eggs, a common laboratory substrate for influenza viruses. The fact that the filamentous morphology is maintained in nature but lost in favor of a spherical morphology in ovo suggests that filaments confer a selective advantage within the infected host that is not necessary for growth in laboratory substrates. Indeed, we have recently shown that filament-producing variant viruses are selected upon passage of the spherical laboratory strain A/Puerto Rico/8/1934 (H1N1) [PR8] in guinea pigs. Toward determining the nature of the selective advantage conferred by filaments, we sought to identify functional differences between spherical and filamentous particles. We compared the wildtype PR8 virus to two previously characterized recombinant PR8 viruses in which single point mutations within M1 confer a filamentous morphology. Our results indicate that these filamentous PR8 mutants have higher neuraminidase activities than the spherical PR8 virus. Conversely, no differences were observed in HAU:PFU or HAU:RNA ratios, binding avidity, sensitivity to immune serum in hemagglutination inhibition assays, or virion stability at elevated temperatures. Based on these results, we propose that the pleomorphic nature of influenza virus particles is important for the optimization of neuraminidase functions in vivo.	[Seladi-Schulman, Jill; Campbell, Patricia J.; Suppiah, Suganthi; Steel, John; Lowen, Anice C.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Emory University	Lowen, AC (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	anice.lowen@emory.edu			National Institutes of Health/National Institute of Allergy and Infectious Disease under Centers for Excellence in Influenza Research and Surveillance (CEIRS) [HHSN266200700006C]	National Institutes of Health/National Institute of Allergy and Infectious Disease under Centers for Excellence in Influenza Research and Surveillance (CEIRS)	This work was funded by the National Institutes of Health/National Institute of Allergy and Infectious Disease under Centers for Excellence in Influenza Research and Surveillance (CEIRS) contract number HHSN266200700006C (http://www.niaid.nih.gov/labsandresources/resources/ceirs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADA GL, 1958, J GEN MICROBIOL, V19, P40, DOI 10.1099/00221287-19-1-40; Bialas KM, 2014, J VIROL, V88, P2227, DOI 10.1128/JVI.03354-13; Bourmakina SV, 2003, J GEN VIROL, V84, P517, DOI 10.1099/vir.0.18803-0; Bouvier NM, 2008, J VIROL, V82, P10052, DOI 10.1128/JVI.01226-08; Burleigh LM, 2005, J VIROL, V79, P1262, DOI 10.1128/JVI.79.2.1262-1270.2005; Calder LJ, 2010, P NATL ACAD SCI USA, V107, P10685, DOI 10.1073/pnas.1002123107; Campbell PJ, 2014, J VIROL, V88, P3802, DOI 10.1128/JVI.03607-13; CHOPPIN PW, 1960, J EXP MED, V112, P945, DOI 10.1084/jem.112.5.945; Chou YY, 2011, J VIROL, V85, P11235, DOI 10.1128/JVI.05794-11; CHU CM, 1949, LANCET, V256, P602; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Elleman CJ, 2004, VIROLOGY, V321, P144, DOI 10.1016/j.virol.2003.12.009; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Gong LI, 2013, ELIFE, V2, DOI 10.7554/eLife.00631; Harris A, 2006, P NATL ACAD SCI USA, V103, P19123, DOI 10.1073/pnas.0607614103; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jin H, 1997, EMBO J, V16, P1236, DOI 10.1093/emboj/16.6.1236; KILBOURNE ED, 1960, J EXP MED, V111, P387, DOI 10.1084/jem.111.3.387; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; Mitnaul LJ, 1996, J VIROL, V70, P873, DOI 10.1128/JVI.70.2.873-879.1996; MOSLEY VM, 1946, NATURE, V157, P263, DOI 10.1038/157263a0; MURTI KG, 1986, VIROLOGY, V149, P36, DOI 10.1016/0042-6822(86)90084-X; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; Quinlivan M, 2005, J VIROL, V79, P8431, DOI 10.1128/JVI.79.13.8431-8439.2005; Roberts PC, 1998, P NATL ACAD SCI USA, V95, P5746, DOI 10.1073/pnas.95.10.5746; Roberts PC, 1998, VIROLOGY, V240, P127, DOI 10.1006/viro.1997.8916; Seladi-Schulman J, 2013, J VIROL, V87, P13343, DOI 10.1128/JVI.02004-13; SMIRNOV YA, 1991, ARCH VIROL, V118, P279, DOI 10.1007/BF01314038; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Vijayakrishnan S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003413; Webster R, 2002, WHO MANUAL ANIMAL IN	34	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112462	10.1371/journal.pone.0112462	http://dx.doi.org/10.1371/journal.pone.0112462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383873	Green Published, gold, Green Submitted			2022-12-27	WOS:000344816700064
J	Alves-Silva, AP; Barros, LAC; Chaul, JCM; Pompolo, SD				Alves-Silva, Ana Paula; Campos Barros, Luisa Antonia; Mario Chaul, Julio Cezar; Pompolo, Silvia das Gracas			The First Cytogenetic Data on Strumigenys louisianae Roger, 1863 (Formicidae: Myrmicinae: Dacetini): The Lowest Chromosome Number in the Hymenoptera of the Neotropical Region	PLOS ONE			English	Article							NEW-SPECIES HYMENOPTERA; KARYOTYPIC EVOLUTION; INDIAN MUNTJAC; ANT; DIVERSIFICATION; FUSIONS; GENERA; APIDAE; BANDS	In the present study, the first cytogenetic data was obtained for the ant species Strumigenys louisianae, from a genus possessing no previous cytogenetic data for the Neotropical region. The chromosome number observed was 2n = 4, all possessing metacentric morphology. Blocks rich in GC base pairs were observed in the interstitial region of the short arm of the largest chromosome pair, which may indicate that this region corresponds to the NORs. The referred species presented the lowest chromosome number observed for the subfamily Myrmicinae and for the Hymenoptera found in the Neotropical region. Observation of a low chromosome number karyotype has been described in Myrmecia croslandi, in which the occurrence of tandem fusions accounts for the most probable rearrangement for its formation. The accumulation of cytogenetic data may carry crucial information to ensure deeper understanding of the systematics of the tribe Dacetini.	[Alves-Silva, Ana Paula; Campos Barros, Luisa Antonia; Pompolo, Silvia das Gracas] Univ Fed Vicosa, Dept Biol Geral, Lab Citogenet Insetos, Vicosa, MG, Brazil; [Alves-Silva, Ana Paula; Campos Barros, Luisa Antonia] Univ Fed Vicosa, Programa Posgrad Genet & Melhoramento, Vicosa, MG, Brazil; [Mario Chaul, Julio Cezar] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Vicosa	Alves-Silva, AP (corresponding author), Univ Fed Vicosa, Dept Biol Geral, Lab Citogenet Insetos, Vicosa, MG, Brazil.	anapaula-ssdd@hotmail.com	Barros, Luísa A.C./A-4106-2017		Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Pesquisa (CNPq); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG); Fundacao de Amparo a Pesquisa da Bahia (FAPESB) [RED0012/2012]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao de Amparo a Pesquisa da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB))	The authors wish to thank the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Pesquisa (CNPq) for the grants provided to APAS and LACB, respectively. This study was supported by Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG) and Fundacao de Amparo a Pesquisa da Bahia (FAPESB - RED0012/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azorsa F, 2008, ZOOTAXA, P27, DOI 10.11646/zootaxa.1749.1.3; de Souza ALB, 2011, ANN SOC ENTOMOL FR, V47, P510, DOI 10.1080/00379271.2011.10697742; Bolton B, 1999, J NAT HIST, V33, P1639, DOI 10.1080/002229399299798; BOLTON B, 1984, SYST ENTOMOL, V9, P373, DOI 10.1111/j.1365-3113.1984.tb00516.x; Bolton B., 2014, ANTCAT ONLINE CATALO; Bolton Barry, 2000, Memoirs of the American Entomological Institute (Gainesville), V65, P1; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Brito RM, 2003, GENET MOL BIOL, V26, P53, DOI 10.1590/S1415-47572003000100009; Barros LAC, 2010, SOCIOBIOLOGY, V56, P57; Cardoso DC, 2012, COMP CYTOGENET, V6, P107, DOI 10.3897/CompCytogen.v6i2.2397; Cardoso DC, 2014, PLOS ONE, V9; CROZIER RH, 1977, ANNU REV ENTOMOL, V22, P263, DOI 10.1146/annurev.en.22.010177.001403; Fernandez F, 2004, BIOTA COLOMBIANA, V5, P3; Mariano CDF, 2008, INSECT CONSERV DIVER, V1, P161, DOI 10.1111/j.1752-4598.2008.00022.x; HIRAI H, 1994, CHROMOSOMA, V103, P171, DOI 10.1007/s004120050021; Imai H.T., 1983, ANNU REP NAT I GENET, V34, P66; IMAI HT, 1975, CHROMOSOMA, V51, P391, DOI 10.1007/BF00326325; IMAI HT, 1989, CHROMOSOMA, V98, P456, DOI 10.1007/BF00292792; IMAI HT, 1994, JPN J GENET, V69, P137, DOI 10.1266/jjg.69.137; IMAI HT, 1988, JPN J GENET, V63, P159, DOI 10.1266/jjg.63.159; IMAI HT, 1991, JPN J GENET, V66, P635, DOI 10.1266/jjg.66.635; IMAI HT, 1977, CHROMOSOMA, V59, P341, DOI 10.1007/BF00327974; Imai HT, 2001, J THEOR BIOL, V210, P475, DOI 10.1006/jtbi.2001.2327; Imai HT, 1985, ANN REP NATL I GENET, V35, P46; LEE C, 1993, CYTOGENET CELL GENET, V63, P156, DOI 10.1159/000133525; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; LIN CC, 1991, CHROMOSOMA, V101, P19, DOI 10.1007/BF00360682; Longino JT, 2013, ZOOTAXA, V3616, P301, DOI 10.11646/zootaxa.3616.4.1; Longino John T., 2006, Myrmecologische Nachrichten, V8, P131; Lopes DM, 2008, GENET MOL BIOL, V31, P49, DOI 10.1590/S1415-47572008000100010; Lorite P, 1997, HEREDITY, V78, P578, DOI 10.1038/hdy.1997.96; Lorite P, 2010, MYRMECOL NEWS, V13, P89; Moreau CS, 2013, EVOLUTION, V67, P2240, DOI 10.1111/evo.12105; Murakami Takahiro, 1998, Chromosome Science, V2, P135; Galvis JP, 2009, REV COLOMB ENTOMOL, V35, P245; Rocha MP, 2002, HEREDITAS, V136, P19, DOI 10.1034/j.1601-5223.2002.1360104.x; SCHWEIZER D, 1980, CYTOGENET CELL GENET, V27, P190, DOI 10.1159/000131482; Sosa-Calvo J, 2010, J HYMENOPT RES, V19, P12; TAYLOR RW, 1991, J AUST ENTOMOL SOC, V30, P288; Urbani Cesare Baroni, 2007, Annali del Museo Civico di Storia Naturale Giacomo Doria, V99, P1; Urbani Cesare Baroni, 1994, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V198, P1; WURSTER DH, 1970, SCIENCE, V168, P1364, DOI 10.1126/science.168.3937.1364	42	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111706	10.1371/journal.pone.0111706	http://dx.doi.org/10.1371/journal.pone.0111706			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379715	gold, Green Published, Green Submitted			2022-12-27	WOS:000344863100038
J	Sassenrath, C; Sassenberg, K; Ray, DG; Scheiter, K; Jarodzka, H				Sassenrath, Claudia; Sassenberg, Kai; Ray, Devin G.; Scheiter, Katharina; Jarodzka, Halszka			A Motivational Determinant of Facial Emotion Recognition: Regulatory Focus Affects Recognition of Emotions in Faces	PLOS ONE			English	Article							INTERPERSONAL SENSITIVITY; INDIVIDUAL-DIFFERENCES; FEAR RECOGNITION; GOAL ATTAINMENT; PERFORMANCE; AVOIDANCE; IMPACT; FIT; PERSPECTIVE; EXPRESSION	Two studies examined an unexplored motivational determinant of facial emotion recognition: observer regulatory focus. It was predicted that a promotion focus would enhance facial emotion recognition relative to a prevention focus because the attentional strategies associated with promotion focus enhance performance on well-learned or innate tasks - such as facial emotion recognition. In Study 1, a promotion or a prevention focus was experimentally induced and better facial emotion recognition was observed in a promotion focus compared to a prevention focus. In Study 2, individual differences in chronic regulatory focus were assessed and attention allocation was measured using eye tracking during the facial emotion recognition task. Results indicated that the positive relation between a promotion focus and facial emotion recognition is mediated by shorter fixation duration on the face which reflects a pattern of attention allocation matched to the eager strategy in a promotion focus ( i.e., striving to make hits). A prevention focus did not have an impact neither on perceptual processing nor on facial emotion recognition. Taken together, these findings demonstrate important mechanisms and consequences of observer motivational orientation for facial emotion recognition.	[Sassenrath, Claudia; Sassenberg, Kai; Scheiter, Katharina] Knowledge Media Res Ctr, Social Proc Lab, Tubingen, Germany; [Sassenrath, Claudia] Univ Ulm, Dept Social Psychol, D-89069 Ulm, Germany; [Sassenberg, Kai; Scheiter, Katharina] Univ Tubingen, Dept Psychol, Tubingen, Germany; [Ray, Devin G.] Univ Aberdeen, Sch Psychol, Aberdeen, Scotland; [Jarodzka, Halszka] Open Univ Nederland, Ctr Learning Sci & Technol, Heerlen, Netherlands	Eberhard Karls University of Tubingen; Leibniz Institut fur Wissensmedien; Ulm University; Eberhard Karls University of Tubingen; University of Aberdeen; Open University Netherlands	Sassenrath, C (corresponding author), Knowledge Media Res Ctr, Social Proc Lab, Tubingen, Germany.	c.sassenrath@iwm-kmrc.de	Scheiter, Katharina/Q-2458-2018; Scheiter, Katharina/AAA-7429-2020; Sassenberg, Kai/D-3048-2011	Scheiter, Katharina/0000-0002-9397-7544; Scheiter, Katharina/0000-0002-9397-7544; Sassenberg, Kai/0000-0001-6579-8250	Netherlands Organization for Scientific Research (NWO) [452-07-006]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The research was supported by The Netherlands Organization for Scientific Research (NWO, project 452-07-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington J, 2006, SCHIZOPHR RES, V85, P142, DOI 10.1016/j.schres.2006.03.028; Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Beilock SL, 2002, J EXP PSYCHOL-APPL, V8, P6, DOI 10.1037/1076-898X.8.1.6; Beilock SL, 2001, J EXP PSYCHOL GEN, V130, P701, DOI 10.1037/0096-3445.130.4.701; Bombari D, 2013, Q J EXP PSYCHOL, V66, P2426, DOI 10.1080/17470218.2013.789065; Bombari D, 2009, PERCEPTION, V38, P1508, DOI 10.1068/p6117; Calder AJ, 2000, J EXP PSYCHOL HUMAN, V26, P527, DOI 10.1037/0096-1523.26.2.527; Camacho CJ, 2003, J PERS SOC PSYCHOL, V84, P498, DOI 10.1037/0022-3514.84.3.498; Cassia VM, 2002, COGNITIVE DEV, V17, P1219; Corden B, 2006, J COGNITIVE NEUROSCI, V18, P889, DOI 10.1162/jocn.2006.18.6.889; Crowe E, 1997, ORGAN BEHAV HUM DEC, V69, P117, DOI 10.1006/obhd.1996.2675; Curby KM, 2012, COGNITION EMOTION, V26, P93, DOI 10.1080/02699931.2011.555752; De Dreu CKW, 2008, J PERS SOC PSYCHOL, V94, P739, DOI 10.1037/0022-3514.94.5.739; Dodson CS, 1997, MEM COGNITION, V25, P129, DOI 10.3758/BF03201107; EKMAN P, 1992, PSYCHOL REV, V99, P550, DOI 10.1037/0033-295X.99.3.550; Elfenbein HA, 2007, EMOTION, V7, P131, DOI 10.1037/1528-3542.7.1.131; Engelberg E, 2004, CYBERPSYCHOL BEHAV, V7, P41, DOI 10.1089/109493104322820101; Faddegon K, 2008, EUR J SOC PSYCHOL, V38, P880, DOI 10.1002/ejsp.483; Forster J, 1998, J PERS SOC PSYCHOL, V75, P1115, DOI 10.1037/0022-3514.75.5.1115; Forster J, 2005, PSYCHOL SCI, V16, P631, DOI 10.1111/j.1467-9280.2005.01586.x; Forster J, 2003, ORGAN BEHAV HUM DEC, V90, P148, DOI 10.1016/S0749-5978(02)00509-5; Forster J, 2001, J EXP SOC PSYCHOL, V37, P253, DOI 10.1006/jesp.2000.1455; Friedman RS, 2010, PSYCHOL BULL, V136, P875, DOI 10.1037/a0020495; Friedman RS, 2000, J PERS SOC PSYCHOL, V79, P477, DOI 10.1037//0022-3514.79.4.477; Galinsky AD, 2006, PSYCHOL SCI, V17, P1068, DOI 10.1111/j.1467-9280.2006.01824.x; Greving H, 2014, BIASED REFLECTION IN; Hall JA, 2004, EMOTION, V4, P201, DOI 10.1037/1528-3542.4.2.201; Hall JK, 2010, COGNITION EMOTION, V24, P629, DOI 10.1080/02699930902906882; Hall JA, 2009, J NONVERBAL BEHAV, V33, P149, DOI 10.1007/s10919-009-0070-5; Hamstra MRW, 2014, J EXP SOC PSYCHOL, V51, P34, DOI 10.1016/j.jesp.2013.11.003; Henderson JM, 2007, CURR DIR PSYCHOL SCI, V16, P219, DOI 10.1111/j.1467-8721.2007.00507.x; Hendriks MCP, 2006, COGNITION EMOTION, V20, P878, DOI 10.1080/02699930500450218; Higgins ET, 1997, J PERS SOC PSYCHOL, V72, P515, DOI 10.1037/0022-3514.72.3.515; Higgins ET, 1997, AM PSYCHOL, V52, P1280, DOI 10.1037/0003-066X.52.12.1280; Higgins ET, 2001, EUR J SOC PSYCHOL, V31, P3, DOI 10.1002/ejsp.27; Higgins ET, 2004, HDB SELF REGULATION, P171; Holmqvist K., 2011, EYE TRACKING COMPREH; Horstmann G, 2003, EMOTION, V3, P150, DOI 10.1037/1528-3542.3.2.150; Huttermann S, 2014, COGN EMOT IN PRESS; Johnston PJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00026; JUST MA, 1980, PSYCHOL REV, V87, P329, DOI 10.1037/0033-295X.87.4.329; Kafetsios K, 2013, J NONVERBAL BEHAV, V37, P191, DOI 10.1007/s10919-013-0149-x; Lee AY, 2000, J PERS SOC PSYCHOL, V78, P1122, DOI 10.1037//0022-3514.78.6.1122; Leppanen JM, 2007, VIS COGN, V15, P468, DOI 10.1080/13506280600765333; Lockwood P, 2002, J PERS SOC PSYCHOL, V83, P854, DOI 10.1037//0022-3514.83.4.854; Mackinnon A, 1999, PERS INDIV DIFFER, V27, P405, DOI 10.1016/S0191-8869(98)00251-7; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Macrae CN, 2002, PSYCHOL SCI, V13, P194, DOI 10.1111/1467-9280.00436; Manor BR, 1999, BIOL PSYCHIAT, V46, P963, DOI 10.1016/S0006-3223(99)00038-4; Mast MS, 2009, J PERS SOC PSYCHOL, V97, P835, DOI 10.1037/a0016234; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; McGlade N, 2008, BRIT J PSYCHIAT, V193, P77, DOI 10.1192/bjp.bp.107.044198; MCKELVIE SJ, 1995, BRIT J SOC PSYCHOL, V34, P325, DOI 10.1111/j.2044-8309.1995.tb01067.x; Miller M, 2011, J ATTEN DISORD, V15, P452, DOI 10.1177/1087054710368636; NOWICKI S, 1993, J SOC PSYCHOL, V133, P749, DOI 10.1080/00224545.1993.9713934; Ozcelik E, 2010, COMPUT HUM BEHAV, V26, P110, DOI 10.1016/j.chb.2009.09.001; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; PURCELL DG, 1986, B PSYCHONOMIC SOC, V24, P118; Ratcliff R, 2004, PSYCHOL REV, V111, P333, DOI 10.1037/0033-295X.111.2.333; Reissland N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024081; Righetti F, 2011, J PERS SOC PSYCHOL, V101, P720, DOI 10.1037/a0023592; Righetti F, 2010, J EXP SOC PSYCHOL, V46, P972, DOI 10.1016/j.jesp.2010.06.001; Rubin RS, 2005, ACAD MANAGE J, V48, P845, DOI 10.2307/20159701; Sassenberg K, 2003, J EXP SOC PSYCHOL, V39, P48, DOI 10.1016/S0022-1031(02)00519-X; Sassenberg K, 2014, COGN EMOT IN PRESS; Sassenberg K, 2008, EUR REV SOC PSYCHOL, V19, P126, DOI 10.1080/10463280802201894; Sassenberg K, 2007, J PERS SOC PSYCHOL, V92, P249, DOI 10.1037/0022-3514.92.2.249; Sassenberg K, 2013, SOC PSYCHOL-GERMANY, V44, P4, DOI 10.1027/1864-9335/a000095; Sassenberg K, 2012, J EXP SOC PSYCHOL, V48, P550, DOI 10.1016/j.jesp.2011.11.008; Sassenrath C, 2014, SOC PSYCHOL PERS SCI, V5, P18, DOI 10.1177/1948550613486672; Schmid PC, 2011, SWISS J PSYCHOL, V70, P223, DOI 10.1024/1421-0185/a000060; Scholer A. A., 2011, HDB SELF REGULATION; Seibt B, 2004, J PERS SOC PSYCHOL, V87, P38, DOI 10.1037/0022-3514.87.1.38; Seidel EM, 2010, J EXP PSYCHOL HUMAN, V36, P500, DOI 10.1037/a0018169; Shah J, 1997, J PERS SOC PSYCHOL, V73, P447, DOI 10.1037/0022-3514.73.3.447; Sonnby-Borgstrom M, 2003, J NONVERBAL BEHAV, V27, P3, DOI 10.1023/A:1023608506243; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Srinivasan N, 2011, Q J EXP PSYCHOL, V64, P425, DOI 10.1080/17470218.2011.552981; Stel M, 2008, PSYCHOL SCI, V19, P984, DOI 10.1111/j.1467-9280.2008.02188.x; Stoecker JJ, 1998, J EXP CHILD PSYCHOL, V71, P63, DOI 10.1006/jecp.1998.2460; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Tatler B.W., 2008, J EYE MOVEMENT RES, P1; Thomas G, 2008, J PERS SOC PSYCHOL, V95, P1165, DOI 10.1037/a0013067; Touryan SR, 2007, SOC NEUROSCI-UK, V2, P14, DOI 10.1080/17470910601046829; Wang RS, 2012, PSYCHOL SCI, V23, P169, DOI 10.1177/0956797611420575; Winterheld HA, 2011, J PERS SOC PSYCHOL, V101, P935, DOI 10.1037/a0025012; Woltin KA, 2011, J EXP SOC PSYCHOL, V47, P418, DOI 10.1016/j.jesp.2010.11.006; Wu SL, 2007, PSYCHOL SCI, V18, P600, DOI 10.1111/j.1467-9280.2007.01946.x	88	4	4	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112383	10.1371/journal.pone.0112383	http://dx.doi.org/10.1371/journal.pone.0112383			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT3WF	25380247	Green Published, gold, Green Submitted			2022-12-27	WOS:000344863100080
J	Cano, I; Selivanov, V; Gomez-Cabrero, D; Tegner, J; Roca, J; Wagner, PD; Cascante, M				Cano, Isaac; Selivanov, Vitaly; Gomez-Cabrero, David; Tegner, Jesper; Roca, Josep; Wagner, Peter D.; Cascante, Marta			Oxygen Pathway Modeling Estimates High Reactive Oxygen Species Production above the Highest Permanent Human Habitation	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; SIMULATED ALTITUDE; O-2 TRANSPORT; COPD PATIENTS; MUSCLE; EXERCISE; BLOOD; VENTILATION	The production of reactive oxygen species (ROS) from the inner mitochondrial membrane is one of many fundamental processes governing the balance between health and disease. It is well known that ROS are necessary signaling molecules in gene expression, yet when expressed at high levels, ROS may cause oxidative stress and cell damage. Both hypoxia and hyperoxia may alter ROS production by changing mitochondrial Po-2 (PmO2). Because PmO2 depends on the balance between O-2 transport and utilization, we formulated an integrative mathematical model of O-2 transport and utilization in skeletal muscle to predict conditions to cause abnormally high ROS generation. Simulations using data from healthy subjects during maximal exercise at sea level reveal little mitochondrial ROS production. However, altitude triggers high mitochondrial ROS production in muscle regions with high metabolic capacity but limited O-2 delivery. This altitude roughly coincides with the highest location of permanent human habitation. Above 25,000 ft., more than 90% of exercising muscle is predicted to produce abnormally high levels of ROS, corresponding to the "death zone'' in mountaineering.	[Cano, Isaac; Roca, Josep] Hosp Clin Barcelona, Ctr Resp Diagnoses, Barcelona, Catalonia, Spain; [Cano, Isaac; Roca, Josep] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Catalonia, Spain; [Cano, Isaac; Roca, Josep] Ctr Invest Biomed Red Enfermedades Respiratoria, Barcelona, Catalonia, Spain; [Cano, Isaac; Roca, Josep] Univ Barcelona, Barcelona, Catalonia, Spain; [Selivanov, Vitaly; Cascante, Marta] Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Barcelona, Catalonia, Spain; [Selivanov, Vitaly; Cascante, Marta] Inst Biomed IBUB, Barcelona, Catalonia, Spain; [Gomez-Cabrero, David; Tegner, Jesper] Karolinska Inst, Ctr Mol Med, Unit Computat Med, Stockholm, Sweden; [Gomez-Cabrero, David; Tegner, Jesper] Karoliska Univ Hosp, Dept Med, Stockholm, Sweden; [Wagner, Peter D.] Univ Calif San Diego, Div Physiol Pulm & Crit Care Med, San Diego, CA 92103 USA	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; University of Barcelona; University of Barcelona; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of California System; University of California San Diego	Cascante, M (corresponding author), Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Barcelona, Catalonia, Spain.	martacascante@ub.edu	Roca, Josep/J-2583-2015; Cano, Isaac/D-1732-2019; CASCANTE, MARTA/AAG-4355-2022; tegner, jesper N/R-5095-2017; Gomez-Cabrero, David/O-9879-2019; Cano, Isaac/M-8507-2019; CASCANTE, MARTA/AFK-5991-2022	Roca, Josep/0000-0003-4768-8722; Cano, Isaac/0000-0003-2938-7459; CASCANTE, MARTA/0000-0002-2062-4633; tegner, jesper N/0000-0002-9568-5588; Gomez-Cabrero, David/0000-0003-4186-3788; Cano, Isaac/0000-0003-2938-7459; CASCANTE, MARTA/0000-0002-2062-4633; Selivanov, Vitaly/0000-0002-7937-9249	European Commission [270086 (2011-2014)]; AGAUR [2009SGR1308, 2009SGR911]; "ICREA Academia prize", Spanish Government; European Union FEDER funds [SAF2011-25726]; NIH [P01 HL091830]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL091830] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); "ICREA Academia prize", Spanish Government(ICREA); European Union FEDER funds(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research has been carried out under the Synergy-COPD research grant, funded by the Seventh Frame-work Program of the European Commission as a Collaborative Project with contract no. 270086 (2011-2014), AGAUR (2009SGR1308 and 2009SGR911), "ICREA Academia prize'' (MC), Spanish Government and the European Union FEDER funds (SAF2011-25726) and NIH P01 HL091830. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey DM, 2004, AM J PHYSIOL-HEART C, V287, pH1689, DOI 10.1152/ajpheart.00148.2004; BALDWIN JE, 1981, NATURE, V291, P381, DOI 10.1038/291381a0; Berkelhamer SK, 2013, FREE RADICAL BIO MED, V61, P51, DOI 10.1016/j.freeradbiomed.2013.03.003; BRISCOE WA, 1959, J APPL PHYSIOL, V14, P291, DOI 10.1152/jappl.1959.14.3.291; Cano I, 2013, RESP PHYSIOL NEUROBI, V189, P477, DOI 10.1016/j.resp.2013.08.020; Cherniack NS, 2004, J APPL PHYSIOL, V96, P352, DOI 10.1152/japplphysiol.00755.2003; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Dejours P., 1966, RESPIRATION, DOI DOI 10.1044/1092-4388(2007/044); Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Gnaiger E, 1998, J EXP BIOL, V201, P1129; Gore A, 2010, J IMMUNOTOXICOL, V7, P239, DOI 10.3109/1547691X.2010.492254; Gough DR, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.96; Hare JM, 2004, NEW ENGL J MED, V351, P2112, DOI 10.1056/NEJMe048269; Joanny P, 2001, RESUSCITATION, V49, P307, DOI 10.1016/S0300-9572(00)00373-7; Kang MA, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.134; Koch LG, 2008, J PHYSIOL-LONDON, V586, P83, DOI 10.1113/jphysiol.2007.144709; Koechlin C, 2005, THORAX, V60, P834, DOI 10.1136/thx.2004.037531; Magalhaes J, 2004, AVIAT SPACE ENVIR MD, V75, P16; Meyer A, 2013, EXP PHYSIOL, V98, P1063, DOI 10.1113/expphysiol.2012.069468; Mik EG, 2013, ANESTH ANALG, V117, P834, DOI 10.1213/ANE.0b013e31828f29da; Oshikawa J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010189; Powers SK, 2011, FREE RADICAL BIO MED, V51, P942, DOI 10.1016/j.freeradbiomed.2010.12.009; Puente-Maestu L, 2009, AM J RESP CELL MOL, V40, P746, DOI 10.1165/rcmb.2008-0289OC; Rabinovich RA, 2007, EUR RESPIR J, V29, P643, DOI 10.1183/09031936.00086306; Raymond J, 2006, SCIENCE, V311, P1764, DOI 10.1126/science.1118439; RICHARDSON RS, 1995, J CLIN INVEST, V96, P1916, DOI 10.1172/JCI118237; Rodriguez DA, 2012, FREE RADICAL BIO MED, V52, P88, DOI 10.1016/j.freeradbiomed.2011.09.022; Scandurra FM, 2010, ADV EXP MED BIOL, V662, P7, DOI 10.1007/978-1-4419-1241-1_2; Schumacker Paul T, 2011, Proc Am Thorac Soc, V8, P477, DOI 10.1513/pats.201103-032MW; Selivanov VA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002700; Selivanov VA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001115; Selivanov VA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000619; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Singel DJ, 2004, NATURE, V430, P297, DOI 10.1038/430297a; Sinha S, 2009, EUR J APPL PHYSIOL, V106, P807, DOI 10.1007/s00421-009-1082-x; SUTTON JR, 1988, J APPL PHYSIOL, V64, P1309, DOI 10.1152/jappl.1988.64.4.1309; Tran TK, 1999, NMR BIOMED, V12, P26, DOI 10.1002/(SICI)1099-1492(199902)12:1<26::AID-NBM563>3.0.CO;2-9; Turan N, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002129; Wagner PD, 1996, ANNU REV PHYSIOL, V58, P21, DOI 10.1146/annurev.physiol.58.1.21; WAGNER PD, 1974, J CLIN INVEST, V54, P54, DOI 10.1172/JCI107750; WAGNER PD, 1987, AM REV RESPIR DIS, V136, P605, DOI 10.1164/ajrccm/136.3.605; WAGNER PD, 1993, RESP PHYSIOL, V93, P221, DOI 10.1016/0034-5687(93)90007-W; Waypa GB, 2010, CIRC RES, V106, P526, DOI 10.1161/CIRCRESAHA.109.206334; WEIBEL ER, 1981, RESP PHYSIOL, V44, P151, DOI 10.1016/0034-5687(81)90081-5; Weibel ER, 1984, PATHWAY OXYGEN STRUC; WELCH HG, 1982, MED SCI SPORT EXER, V14, P253, DOI 10.1249/00005768-198204000-00001; WEST JB, 1960, J APPL PHYSIOL, V15, P405, DOI 10.1152/jappl.1960.15.3.405; West JB, 2002, HIGH ALT MED BIOL, V3, P401, DOI 10.1089/15270290260512882; WILSON DF, 1977, AM J PHYSIOL, V233, pC135, DOI 10.1152/ajpcell.1977.233.5.C135; WILSON GD, 1975, MED SCI SPORT EXER, V7, P48	50	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111068	10.1371/journal.pone.0111068	http://dx.doi.org/10.1371/journal.pone.0111068			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375931	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600024
J	Garin, N; Olaya, B; Moneta, MV; Miret, M; Lobo, A; Ayuso-Mateos, JL; Haro, JM				Garin, Noe; Olaya, Beatriz; Victoria Moneta, Maria; Miret, Marta; Lobo, Antonio; Luis Ayuso-Mateos, Jose; Maria Haro, Josep			Impact of Multimorbidity on Disability and Quality of Life in the Spanish Older Population	PLOS ONE			English	Article							MULTIPLE CHRONIC CONDITIONS; WORLD-HEALTH-ORGANIZATION; GENDER-DIFFERENCES; FUNCTIONAL DISABILITY; CHRONIC DISEASE; PRIMARY-CARE; ANGINA-PECTORIS; RISK-FACTORS; SYMPTOMS; COPD	Background: Population aging is closely related to high prevalence of chronic conditions in developed countries. In this context, health care policies aim to increase life span cost-effectively while maintaining quality of life and functional ability. There is still, however, a need for further understanding of how chronic conditions affect these health aspects. The aim of this paper is to assess the individual and combined impact of chronic physical and mental conditions on quality of life and disability in Spain, and secondly to show gender trends. Methods: Cross-sectional data were collected from the COURAGE study. A total of 3,625 participants over 50 years old from Spain were included. Crude and adjusted multiple linear regressions were conducted to detect associations between individual chronic conditions and disability, and between chronic conditions and quality of life. Separate models were used to assess the influence of the number of diseases on the same variables. Additional analogous regressions were performed for males and females. Results: All chronic conditions except hypertension were statistically associated with poor results in quality of life and disability. Depression, anxiety and stroke were found to have the greatest impact on outcomes. The number of chronic conditions was associated with substantially lower quality of life [beta for 4+ diseases: -18.10 (-20.95,-15.25)] and greater disability [beta for 4+ diseases: 27.64 (24.99,30.29]. In general, women suffered from higher rates of multimorbidity and poorer results in quality of life and disability. Conclusions: Chronic conditions impact greatly on quality of life and disability in the older Spanish population, especially when co-occurring diseases are added. Multimorbidity considerations should be a priority in the development of future health policies focused on quality of life and disability. Further studies would benefit from an expanded selection of diseases. Policies should also deal with gender idiosyncrasy in certain cases.	[Garin, Noe; Olaya, Beatriz; Victoria Moneta, Maria; Maria Haro, Josep] Univ Barcelona, Res Unit, Parc Sanitari St Joan de Deu, Barcelona, Spain; [Garin, Noe; Olaya, Beatriz; Maria Haro, Josep] Esplugues Llobregat, Fdn St Joan de Deu, Barcelona, Spain; [Garin, Noe; Olaya, Beatriz; Miret, Marta; Lobo, Antonio; Luis Ayuso-Mateos, Jose; Maria Haro, Josep] Ctr Invest Biomed Red Salud Mental CIBERSAM, Inst Salud Carlos III, Madrid, Spain; [Miret, Marta; Luis Ayuso-Mateos, Jose] Univ Autonoma Madrid, Dept Psychiat, Madrid, Spain; [Miret, Marta; Luis Ayuso-Mateos, Jose] Hosp Univ Princesa, Dept Psychiat, Inst Invest Sanitaria Princesa IP, Madrid, Spain; [Lobo, Antonio] Univ Zaragoza, Dept Psychiat, Zaragoza, Spain; [Lobo, Antonio] Inst Invest Sanitaria Aragon, Zaragoza, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; Autonomous University of Madrid; University of Zaragoza	Haro, JM (corresponding author), Univ Barcelona, Res Unit, Parc Sanitari St Joan de Deu, Barcelona, Spain.	jmharo@pssjd.org	Miret, Marta/C-6103-2019; Olaya, Beatriz/AAB-1952-2020; Haro, Josep Maria/D-1423-2011	Miret, Marta/0000-0003-3252-854X; Olaya, Beatriz/0000-0003-2046-3929; Haro, Josep Maria/0000-0002-3984-277X; Lobo, Antonio/0000-0002-9098-655X; Ayuso-Mateos, Jose Luis/0000-0002-7544-826X; Garin, Noe/0000-0002-1559-9453	European Community [223071]; Spanish Ministry of Education, Culture and Sport [FPU12/05661]; Instituto de Salud Carlos III [PS09/00295, PS09/01845]; Spanish Ministry of Science and Innovation's ACIPromociona [ACI2009-1010]; Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III; Instituto de Salud Carlos III, Spain [CD12/00429]	European Community(European Commission); Spanish Ministry of Education, Culture and Sport; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Science and Innovation's ACIPromociona(Ministry of Science and Innovation, Spain (MICINN)); Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III(Instituto de Salud Carlos III); Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III)	The research leading to these results has received funding from the European Community's Seventh Framework Program (FP7/2007-2013) under grant agreement number 223071 (COURAGE in Europe) and the Spanish Ministry of Education, Culture and Sport (FPU12/05661). Additional support was provided by funds from the Instituto de Salud Carlos III-FIS research grant numbers PS09/00295 and PS09/01845, from the Spanish Ministry of Science and Innovation's ACIPromociona (ACI2009-1010). The study was supported by the Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III. This article is part of a PhD program developed in the Public Health Department of the Universitat de Barcelona, Spain. B.O. is grateful to the Sara Borrell postdoctoral program (reference CD12/00429) supported by the Instituto de Salud Carlos III, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre TD, 2012, ARCH GERONTOL GERIAT, V55, P431, DOI 10.1016/j.archger.2012.04.001; Alfonso Silguero Sergio A, 2014, Rev Esp Geriatr Gerontol, V49, P51, DOI 10.1016/j.regg.2013.05.007; Alves L, 2010, ARQ BRAS CARDIOL, V95, P179, DOI 10.1590/S0066-782X2010005000075; American Optometric Association, 2004, OPT CLIN PRACT GUID; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], GLOB STRAT DIAGN MAN; Assari S, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-3; Barile JP, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120282; Basu S, 2013, AM J EPIDEMIOL, V178, P1620, DOI 10.1093/aje/kwt191; Bauer UE, 2014, LANCET, V384, P45, DOI 10.1016/S0140-6736(14)60648-6; Belanger A, 2002, J WOMEN AGING, V14, P61, DOI 10.1300/J074v14n01_05; Borras X, 2012, REV ESP CARDIOL, V65, P734, DOI 10.1016/j.rec.2012.03.010; Bourdel-Marchasson I, 2007, DIABETES METAB, V33, pS66, DOI 10.1016/S1262-3636(07)80058-9; Boutron I, 2008, OSTEOARTHR CARTILAGE, V16, P1024, DOI 10.1016/j.joca.2008.01.001; Boyd CM, 2010, PUBLIC HEALTH REV, V32, P451, DOI 10.1007/BF03391611; BRETTSCHNEIDER C, 2013, PLOS ONE, V0008; Chakrabarty D, 2010, Ghana Med J, V44, P150; Chen HY, 2011, PREV CHRONIC DIS, V8; Cohen HJ, 1997, J GERONTOL A-BIOL, V52, pM201, DOI 10.1093/gerona/52A.4.M201; Dragomirecka E, 2008, CLIN PSYCHOL PSYCHOT, V15, P193, DOI 10.1002/cpp.571; Dumitru Luminita, 2013, Maedica (Bucur), V8, P206; Erickson SR, 2004, PHARMACOTHERAPY, V24, P344, DOI 10.1592/phco.24.4.344.33177; ETTINGER WH, 1994, J CLIN EPIDEMIOL, V47, P809, DOI 10.1016/0895-4356(94)90178-3; European Commission, 2006, DEM FUT EUR CHALL OP; European Union, 2012, HLTH POL FOR ANSW DG; Caballero FF, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-177; Formiga F, 2013, EUR J INTERN MED, V24, P40, DOI 10.1016/j.ejim.2012.11.003; Fortin M, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-52; Fu JJ, 2014, RESPIRATION, V87, P63, DOI 10.1159/000352053; Garin N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084794; Global Initiative for Asthma, 2012, GLOB STRAT ASTHM MAN; Griffith L, 2010, AGE AGEING, V39, P738, DOI 10.1093/ageing/afq105; Hardin M, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-127; Heyworth ITM, 2009, BRIT J GEN PRACT, V59, P833, DOI 10.3399/bjgp09X453990; Hinton R, 2002, AM FAM PHYSICIAN, V65, P841; Hunger M, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-53; Hunter DJ, 2014, INT J RHEUM DIS, V17, P149, DOI 10.1111/1756-185X.12232; Jayasinghe UW, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-102; Jespersen L, 2013, EUR HEART J, V34, P3294, DOI 10.1093/eurheartj/eht395; Johansson R, 2013, PEERJ, V1, DOI 10.7717/peerj.98; Jones PW, 2011, RESP MED, V105, P57, DOI 10.1016/j.rmed.2010.09.004; Karimi Saied, 2013, Mater Sociomed, V25, P158, DOI 10.5455/msm.2013.25.158-162; Kauppi P, 2011, J ASTHMA, V48, P279, DOI 10.3109/02770903.2011.555576; Kim Il Ho, 2011, J Prev Med Public Health, V44, P32, DOI 10.3961/jpmph.2011.44.1.32; Kim Seong Il, 2006, Korean J Ophthalmol, V20, P201; Kirchberger I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030556; Kirchengast S, 2008, GENDER MED, V5, P270, DOI 10.1016/j.genm.2008.07.001; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; Lawson KD, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-67; Lehnert T, 2011, MED CARE RES REV, V68, P387, DOI 10.1177/1077558711399580; Leonardi M, 2014, CLIN PSYCHOL PSYCHOT, V21, P193, DOI 10.1002/cpp.1856; Liu CJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002759.pub2; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Martin LG, 2010, HEALTH AFFAIR, V29, P725, DOI 10.1377/hlthaff.2008.0746; McDaid O, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002571; Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P1180, DOI 10.1001/archpsyc.64.10.1180; Murtagh KN, 2004, AM J PUBLIC HEALTH, V94, P1406, DOI 10.2105/AJPH.94.8.1406; Nagl A, 2012, Z GERONTOL GERIATR, V45, P146, DOI 10.1007/s00391-011-0266-2; Nakawah MO, 2013, J AM BOARD FAM MED, V26, P470, DOI 10.3122/jabfm.2013.04.120256; Okochi J, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-55; Ose D, 2009, DIABETES CARE, V32, P1594, DOI 10.2337/dc08-2223; Ozminkowski RJ, 2012, INT J GERIATR PSYCH, V27, P948, DOI 10.1002/gps.2806; Palazzo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044994; Parekh AK, 2011, PUBLIC HEALTH REP, V126, P460, DOI 10.1177/003335491112600403; Parekh AK, 2010, JAMA-J AM MED ASSOC, V303, P1303, DOI 10.1001/jama.2010.381; Rodrigues MAP, 2009, CAD SAUDE PUBLICA, V25, pS464, DOI 10.1590/S0102-311X2009001500011; Power M, 1998, SOC SCI MED, V46, P1569, DOI 10.1016/s0277-9536(98)00009-4; Prados-Torres A, 2014, J CLIN EPIDEMIOL, V67, P254, DOI 10.1016/j.jclinepi.2013.09.021; Prados-Torres A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032190; Raman R, 2010, INVEST OPHTH VIS SCI, V51, P6253, DOI 10.1167/iovs.10-5414; Regidor E, 2014, J EPIDEMIOL COMMUN H, V68, P280, DOI 10.1136/jech-2013-202944; Rosenzweig JRC, 2004, RESP MED, V98, P1157, DOI 10.1016/j.rmed.2004.04.001; Ruiz-Cantero MT, 2007, J EPIDEMIOL COMMUN H, V61, P46, DOI 10.1136/jech.2007.062034; Schmitz N, 2007, PSYCHOSOM MED, V69, P332, DOI 10.1097/PSY.0b013e31804259e0; Snider JT, 2012, COPD, V9, P513, DOI 10.3109/15412555.2012.696159; Sprangers MAG, 2000, J CLIN EPIDEMIOL, V53, P895, DOI 10.1016/S0895-4356(00)00204-3; Stein J D, 2002, J Clin Hypertens (Greenwich), V4, P181, DOI 10.1111/j.1524-6175.2002.00970.x; Suissa S, 2012, THORAX, V67, P957, DOI 10.1136/thoraxjnl-2011-201518; Tan ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065958; Tas U, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-22; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; United Nations, 2013, WORLD POP AG 2013; United Nations, 2012, POP AG DEV 2012 WALL; Valderrama-Gama E, 2002, J GERONTOL A-BIOL, V57, pM716, DOI 10.1093/gerona/57.11.M716; Violan C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-251; Wang R, 2009, PUBLIC HEALTH, V123, P534, DOI 10.1016/j.puhe.2009.06.009; Watson HJ, 2011, COMPR PSYCHIAT, V52, P265, DOI 10.1016/j.comppsych.2010.07.006; Wee HL, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-93; WHO, 2007, GLOB AG FRIENDL CIT; Wong E, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-47; World Health Organization, 2011, NONCOMMUNICABLE DIS; World Health Organization, 2014, WHO DIS; World Health Organization, 2014, WHO PROC TRANSL AD I; Yount KM, 2010, SOC SCI MED, V71, P1418, DOI 10.1016/j.socscimed.2010.06.046; Zygmuntowicz M, 2012, POL ARCH MED WEWN, V122, P333, DOI 10.20452/pamw.1345	96	95	97	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111498	10.1371/journal.pone.0111498	http://dx.doi.org/10.1371/journal.pone.0111498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XM	25375890	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600042
J	Gleim, ER; Conner, LM; Berghaus, RD; Levin, ML; Zemtsova, GE; Yabsley, MJ				Gleim, Elizabeth R.; Conner, L. Mike; Berghaus, Roy D.; Levin, Michael L.; Zemtsova, Galina E.; Yabsley, Michael J.			The Phenology of Ticks and the Effects of Long-Term Prescribed Burning on Tick Population Dynamics in Southwestern Georgia and Northwestern Florida	PLOS ONE			English	Article							AMBLYOMMA-AMERICANUM ACARI; IXODES-SCAPULARIS ACARI; GULF-COAST TICK; LYME-DISEASE; MACULATUM ACARI; CLIMATE-CHANGE; HABITAT TYPE; FIRE; ABUNDANCE; IXODIDAE	Some tick populations have increased dramatically in the past several decades leading to an increase in the incidence and emergence of tick-borne diseases. Management strategies that can effectively reduce tick populations while better understanding regional tick phenology is needed. One promising management strategy is prescribed burning. However, the efficacy of prescribed burning as a mechanism for tick control is unclear because past studies have provided conflicting data, likely due to a failure of some studies to simulate operational management scenarios and/or account for other predictors of tick abundance. Therefore, our study was conducted to increase knowledge of tick population dynamics relative to long-term prescribed fire management. Furthermore, we targeted a region, southwestern Georgia and northwestern Florida (USA), in which little is known regarding tick dynamics so that basic phenology could be determined. Twenty-one plots with varying burn regimes (burned surrounded by burned [BB], burned surrounded by unburned [BUB], unburned surrounded by burned [UBB], and unburned surrounded by unburned [UBUB]) were sampled monthly for two years while simultaneously collecting data on variables that can affect tick abundance (e.g., host abundance, vegetation structure, and micro- and macro-climatic conditions). In total, 47,185 ticks were collected, of which, 99% were Amblyomma americanum, 0.7% were Ixodes scapularis, and fewer numbers of Amblyomma maculatum, Ixodes brunneus, and Dermacentor variabilis. Monthly seasonality trends were similar between 2010 and 2011. Long-term prescribed burning consistently and significantly reduced tick counts (overall and specifically for A. americanum and I. scapularis) regardless of the burn regimes and variables evaluated. Tick species composition varied according to burn regime with A. americanum dominating at UBUB, A. maculatum at BB, I. scapularis at UBB, and a more even composition at BUB. These data indicate that regular prescribed burning is an effective tool for reducing tick populations and ultimately may reduce risk of tick-borne disease.	[Gleim, Elizabeth R.; Yabsley, Michael J.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Gleim, Elizabeth R.; Yabsley, Michael J.] Univ Georgia, Coll Vet Med, Southeastern Cooperat Wildlife Dis Study, Athens, GA 30602 USA; [Gleim, Elizabeth R.; Conner, L. Mike] Joseph W Jones Ecol Res Ctr Ichauway, Wildlife Lab, Newton, GA USA; [Berghaus, Roy D.] Univ Georgia, Coll Vet Med, Dept Populat Hlth, Athens, GA 30602 USA; [Levin, Michael L.; Zemtsova, Galina E.] Ctr Dis Control & Prevent, Rickettsial Zoonoses Branch, Atlanta, GA USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Centers for Disease Control & Prevention - USA	Gleim, ER (corresponding author), Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA.	egleim@gmail.com	Berghaus, Roy/GPX-7566-2022	Berghaus, Roy/0000-0002-8813-3056; Yabsley, Michael/0000-0003-2452-5015; Gleim, Elizabeth/0000-0001-9380-4689	Centers for Disease Control and Prevention/University of Georgia (UGA) [8212]; Joseph W. Jones Ecological Research Center at Ichauway; Warnell School of Forestry and Natural Resources (UGA); Southeastern Cooperative Wildlife Disease Study (SCWDS) (UGA)	Centers for Disease Control and Prevention/University of Georgia (UGA); Joseph W. Jones Ecological Research Center at Ichauway; Warnell School of Forestry and Natural Resources (UGA); Southeastern Cooperative Wildlife Disease Study (SCWDS) (UGA)	This work was funded by the Centers for Disease Control and Prevention/University of Georgia (UGA) collaborative grant, (http://www.cdc.gov/od/science/technology/innovation/seeds.htm) (8212, Ecosystem Health and Human Health: Understanding the Ecological Effects of Prescribed Fire Regimes on the Distribution and Population Dynamics of Tick-borne Zoonoses, MJY, ERG, LMC, and MLL). Additional funding was provided by the Joseph W. Jones Ecological Research Center at Ichauway, Warnell School of Forestry and Natural Resources (UGA), and the Southeastern Cooperative Wildlife Disease Study (SCWDS) (UGA) through the Federal Aid to Wildlife Restoration Act (50 Stat. 917) and through SCWDS sponsorship from fish and wildlife agencies of member states. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; Allan BF, 2009, J MED ENTOMOL, V46, P1030, DOI 10.1603/033.046.0509; Apperson CS, 2008, VECTOR-BORNE ZOONOT, V8, P597, DOI 10.1089/vbz.2007.0271; Bacon Rendi Murphree, 2008, Morbidity and Mortality Weekly Report, V57, P1; Bailey JK, 2002, ECOLOGY, V83, P1701, DOI 10.1890/0012-9658(2002)083[1701:IAFAAE]2.0.CO;2; BARBOUR AG, 1993, SCIENCE, V260, P1610, DOI 10.1126/science.8503006; Barker RW, 2004, J MED ENTOMOL, V41, P170, DOI 10.1603/0022-2585-41.2.170; BLACK WC, 1994, P NATL ACAD SCI USA, V91, P10034, DOI 10.1073/pnas.91.21.10034; Brunner JL, 2008, ECOLOGY, V89, P2259, DOI 10.1890/07-0665.1; Cilek JE, 2000, J MED ENTOMOL, V37, P439, DOI 10.1603/0022-2585(2000)037[0439:SDAAOT]2.0.CO;2; Cooley R. A., 1944, JOUR PARASITOL, V30, P77, DOI 10.2307/3272571; Cully JF, 1999, J RANGE MANAGE, V52, P139, DOI 10.2307/4003507; DANIELS TJ, 1995, J MED ENTOMOL, V32, P5, DOI 10.1093/jmedent/32.1.5; DAUBENMIRE R., 1959, NORTHWEST SCI, V33, P43; DAVIDSON WR, 1994, J MED ENTOMOL, V31, P72, DOI 10.1093/jmedent/31.1.72; DREW ML, 1985, J WILDLIFE DIS, V21, P313, DOI 10.7589/0090-3558-21.3.313; Fernandes PM, 2003, INT J WILDLAND FIRE, V12, P117, DOI 10.1071/WF02042; Frater H., 2011, THESIS IOWA STATE U; Gleim ER, 2013, J MED ENTOMOL, V50, P270, DOI 10.1603/ME12168; Goddard J, 2005, J MED ENTOMOL, V42, P176, DOI 10.1603/0022-2585(2005)042[0176:OODASA]2.0.CO;2; Goodin DG, 2006, GLOBAL ECOL BIOGEOGR, V15, P519, DOI 10.1111/j.1466-822x.2006.00244.x; Haines Terry K., 2001, Southern Journal of Applied Forestry, V25, P149; HOBBS NT, 1984, J WILDLIFE MANAGE, V48, P551, DOI 10.2307/3801188; HOCH AL, 1972, J MED ENTOMOL, V9, P446, DOI 10.1093/jmedent/9.5.446; JACOBSON HA, 1979, J WILDLIFE DIS, V15, P43, DOI 10.7589/0090-3558-15.1.43; KEIRANS JE, 1989, J MED ENTOMOL, V26, P435, DOI 10.1093/jmedent/26.5.435; Keirans JE, 1998, J MED ENTOMOL, V35, P489, DOI 10.1093/jmedent/35.4.489; Kirkman LK, 2001, AM J BOT, V88, P2119, DOI 10.2307/3558437; Knapp EE, 2005, FOREST ECOL MANAG, V208, P383, DOI 10.1016/j.foreco.2005.01.016; Landers JL, 1995, GFC84004 FLOR GAM FR; LEMMON PAUL E., 1956, FOREST SCI, V2, P314; MAEDA K, 1987, NEW ENGL J MED, V316, P853, DOI 10.1056/NEJM198704023161406; Masters R.E., 2007, GEN TECHNICAL REPORT, P35; MATHER TN, 1993, J MED ENTOMOL, V30, P642, DOI 10.1093/jmedent/30.3.642; NEEDHAM GR, 1991, ANNU REV ENTOMOL, V36, P659, DOI 10.1146/annurev.en.36.010191.003303; Ogden NH, 2006, INT J PARASITOL, V36, P63, DOI 10.1016/j.ijpara.2005.08.016; Ogden NH, 2009, CAN MED ASSOC J, V180, P1221, DOI 10.1503/cmaj.080148; Oorebeek M, 2008, PARASITOL RES, V103, P871, DOI 10.1007/s00436-008-1071-8; Paddock CD, 2007, CURR TOP MICROBIOL, V315, P289; Paddock CD, 2004, CLIN INFECT DIS, V38, P805, DOI 10.1086/381894; Padgett KA, 2009, J MED ENTOMOL, V46, P1138, DOI 10.1603/033.046.0522; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; PIESMAN J, 1987, AM J EPIDEMIOL, V126, P1187, DOI 10.1093/oxfordjournals.aje.a114757; Polito VJ, 2012, THESIS OKLAHOMA STAT; REGO FC, 1991, FOREST ECOL MANAG, V41, P21, DOI 10.1016/0378-1127(91)90117-E; Schulze TL, 2001, ENVIRON ENTOMOL, V30, P568, DOI 10.1603/0046-225X-30.3.568; SEMTNER PJ, 1971, J MED ENTOMOL, V8, P329, DOI 10.1093/jmedent/8.3.329; Sparks JC, 1998, J VEG SCI, V9, P133, DOI 10.2307/3237231; Stafford KC, 1998, J MED ENTOMOL, V35, P510, DOI 10.1093/jmedent/35.4.510; StataCorp, 2009, STAT STAT SOFTW REL; Stromdahl EY, 2012, ZOONOSES PUBLIC HLTH, V59, P48, DOI 10.1111/j.1863-2378.2012.01475.x; Teel PD, 1998, J MED ENTOMOL, V35, P483, DOI 10.1093/jmedent/35.4.483; Thomas RJ, 2009, EXPERT REV ANTI-INFE, V7, P709, DOI [10.1586/eri.09.44, 10.1586/ERI.09.44]; TOWNE G, 1984, J RANGE MANAGE, V37, P392, DOI 10.2307/3899622; Willis D, 2012, J VECTOR ECOL, V37, P373, DOI 10.1111/j.1948-7134.2012.00241.x; WILSON ML, 1986, J ECON ENTOMOL, V79, P693, DOI 10.1093/jee/79.3.693; Zemtsova GE, 2014, J MED ENTOM IN PRESS	58	37	38	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112174	10.1371/journal.pone.0112174	http://dx.doi.org/10.1371/journal.pone.0112174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375797	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600112
J	Zhu, D; Li, RT; Liu, X; Sun, MZ; Wu, J; Zhang, N; Zhu, YM				Zhu, Dan; Li, Rongtian; Liu, Xin; Sun, Mingzhe; Wu, Jing; Zhang, Ning; Zhu, Yanming			The Positive Regulatory Roles of the TIFY10 Proteins in Plant Responses to Alkaline Stress	PLOS ONE			English	Article							BHLH TRANSCRIPTION FACTORS; INDUCED GENE-EXPRESSION; NADP-MALIC ENZYME; GLYCINE-SOJA; JASMONATE; JAZ; TOLERANCE; SALT; REPRESSOR; ZIM	The TIFY family is a novel plant-specific protein family, and is characterized by a conserved TIFY motif ( TIFF/YXG). Our previous studies indicated the potential roles of TIFY10/11 proteins in plant responses to alkaline stress. In the current study, we focused on the regulatory roles and possible physiological and molecular basis of the TIFY10 proteins in plant responses to alkaline stress. We demonstrated the positive function of TIFY10s in alkaline responses by using the AtTIFY10a and AtTIFY10b knockout Arabidopsis, as evidenced by the relatively lower germination rates of attify10a and attify10b mutant seeds under alkaline stress. We also revealed that ectopic expression of GsTIFY10a in Medicago sativa promoted plant growth, and increased the NADP-ME activity, citric acid content and free proline content but decreased the MDA content of transgenic plants under alkaline stress. Furthermore, expression levels of the stress responsive genes including NADP-ME, CS, H+-ppase and P5CS were also up-regulated in GsTIFY10a transgenic plants under alkaline stress. Interestingly, GsTIFY10a overexpression increased the jasmonate content of the transgenic alfalfa. In addition, we showed that neither GsTIFY10a nor GsTIFY10e exhibited transcriptional activity in yeast cells. However, through Y2H and BiFc assays, we demonstrated that GsTIFY10a, not GsTIFY10e, could form homodimers in yeast cells and in living plant cells. As expected, we also demonstrated that GsTIFY10a and GsTIFY10e could heterodimerize with each other in both yeast and plant cells. Taken together, our results provided direct evidence supporting the positive regulatory roles of the TIFY10 proteins in plant responses to alkaline stress.	[Zhu, Dan; Liu, Xin] Qingdao Agr Univ, Coll Life Sci, Qingdao, Peoples R China; [Li, Rongtian] Heilongjiang Univ, Coll Heilongjiang Prov, Key Lab Mol Biol, Harbin, Peoples R China; [Sun, Mingzhe; Wu, Jing; Zhang, Ning; Zhu, Yanming] Northeast Agr Univ, Plant Bioengn Lab, Harbin, Peoples R China	Qingdao Agricultural University; Heilongjiang University; Northeast Agricultural University - China	Zhu, YM (corresponding author), Northeast Agr Univ, Plant Bioengn Lab, Harbin, Peoples R China.	ymzhu@neau.edu.cn		Sun, Mingzhe/0000-0001-7557-623X; , chenchao/0000-0002-1865-7751	Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program [2011TD005]; National Natural Science Foundation of China [31171578]; National Major Project for Cultivation of Transgenic Crops [2011ZX08004-002]	Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Project for Cultivation of Transgenic Crops	This work was supported by Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program (grant no. 2011TD005 to YMZ), National Natural Science Foundation of China (grant no. 31171578 to YMZ), National Major Project for Cultivation of Transgenic Crops (grant no. 2011ZX08004-002 to YMZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bai YH, 2011, GENOMICS, V98, P128, DOI 10.1016/j.ygeno.2011.05.002; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bogino P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079614; Chen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083227; Chini A, 2009, PLANT J, V59, P77, DOI 10.1111/j.1365-313X.2009.03852.x; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Chung HS, 2009, PLANT CELL, V21, P131, DOI 10.1105/tpc.108.064097; delaFuente JM, 1997, SCIENCE, V276, P1566, DOI 10.1126/science.276.5318.1566; Demianski AJ, 2012, MOL PLANT PATHOL, V13, P46, DOI 10.1111/j.1364-3703.2011.00727.x; EDWARDS GE, 1992, PHYTOCHEMISTRY, V31, P1845, DOI 10.1016/0031-9422(92)80322-6; Fernandez-Calvo P, 2011, PLANT CELL, V23, P701, DOI 10.1105/tpc.110.080788; Fonseca S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086182; Ge Y, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-153; GEER BW, 1979, BIOCHEM GENET, V17, P867, DOI 10.1007/BF00504309; Grunewald W, 2009, EMBO REP, V10, P923, DOI 10.1038/embor.2009.103; Guan QM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003755; Hakata M, 2012, BIOSCI BIOTECH BIOCH, V76, P2129, DOI 10.1271/bbb.120545; Han X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050868; Hu YR, 2013, PLANT CELL, V25, P2907, DOI 10.1105/tpc.113.112631; Ishiga Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075728; Ismail A, 2012, J EXP BOT, V63, P2127, DOI 10.1093/jxb/err426; Jiang SS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003715; Li WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082725; Liu JP, 1997, PLANT PHYSIOL, V114, P591, DOI 10.1104/pp.114.2.591; Liu JT, 2011, J GENET GENOMICS, V38, P307, DOI 10.1016/j.jgg.2011.05.006; Melotto M, 2008, PLANT J, V55, P979, DOI 10.1111/j.1365-313X.2008.03566.x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Niu YJ, 2011, J EXP BOT, V62, P2143, DOI 10.1093/jxb/erq408; Oh Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057868; PEEVER TL, 1989, PLANT PHYSIOL, V90, P867, DOI 10.1104/pp.90.3.867; Qi T, 2014, PLANT CELL, V26, P16; Robson F, 2010, PLANT CELL, V22, P1143, DOI 10.1105/tpc.109.067728; Seo JS, 2011, PLANT J, V65, P907, DOI 10.1111/j.1365-313X.2010.04477.x; Seo JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055482; Shi YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088282; Shikata M, 2004, J EXP BOT, V55, P631, DOI 10.1093/jxb/erh078; Siberil Y, 2001, EUR J BIOCHEM, V268, P5655, DOI 10.1046/j.0014-2956.2001.02552.x; Song SJ, 2011, J MECH SCI TECHNOL, V25, P3; Song SS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003653; Sun MZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089578; Sun XL, 2012, J PLANT RES, V125, P429, DOI 10.1007/s10265-011-0448-4; Sun YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053632; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Toda Y, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.26256; Toda Y, 2013, PLANT CELL, V25, P1709, DOI 10.1105/tpc.113.112052; Tong ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088310; Van der Does D, 2013, PLANT CELL, V25, P744, DOI 10.1105/tpc.112.108548; Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037817; Weltmeier F, 2009, PLANT MOL BIOL, V69, P107, DOI 10.1007/s11103-008-9410-9; White DWR, 2006, P NATL ACAD SCI USA, V103, P13238, DOI 10.1073/pnas.0604349103; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Withers J, 2012, P NATL ACAD SCI USA, V109, P20148, DOI 10.1073/pnas.1210054109; Xiong HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092913; Xu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059703; Xu WF, 2013, PLANT PHYSIOL, V163, P1817, DOI 10.1104/pp.113.224758; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708; Yang CW, 2008, PHOTOSYNTHETICA, V46, P107, DOI [10.1007/s11099-008-0018-8, 10.1007/s11099-008-0047-3]; Ye HY, 2009, PLANT MOL BIOL, V71, P291, DOI 10.1007/s11103-009-9524-8; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084750; Zhu D, 2013, PLANT CELL REP, V32, P263, DOI 10.1007/s00299-012-1360-7; Zhu D, 2012, BIOCHEM BIOPH RES CO, V426, P273, DOI 10.1016/j.bbrc.2012.08.086; Zhu Dan, 2012, Yichuan, V34, P230, DOI 10.3724/SP.J.1005.2012.00230; Zhu D, 2011, PLANT MOL BIOL, V77, P285, DOI 10.1007/s11103-011-9810-0	66	27	34	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111984	10.1371/journal.pone.0111984	http://dx.doi.org/10.1371/journal.pone.0111984			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375909	gold, Green Submitted, Green Published			2022-12-27	WOS:000344402600087
J	Lerner, N; Beit-Yannai, E				Lerner, Natalie; Beit-Yannai, Elie			Cross-Talk between Ciliary Epithelium and Trabecular Meshwork Cells In-Vitro: A New Insight into Glaucoma	PLOS ONE			English	Article							AQUEOUS-HUMOR SECRETION; NECROSIS-FACTOR-ALPHA; OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; MATRIX METALLOPROTEINASES; GENE-EXPRESSION; OKADAIC ACID; MAP KINASES; ACTIVATION; INDUCTION	Purpose: It is assumed that the non-pigmented ciliary epithelium plays a role in regulating intraocular pressure via its neuroendocrine activities. To test this hypothesis, we investigated the effect on a human trabecular meshwork (TM) cell line (NTM) of co-culture with a human non-pigmented ciliary epithelium cell line (ODM-2). Methods: The cellular cross-talk between ODM-2 and NTM cells was studied in a co-culture system in which the two cell types were co-cultured for 5 to 60 min or 2, 4 and 8 h and then removed from the co-culture and analyzed. Analyses of the ERK and p38 mitogen-activated protein kinase (MAPK) pathways and of the activity of TM phosphatases and matrix metalloproteins (MMPs) were performed. Acid and alkaline phosphatase activity was determined by the DiFMUP (6, 8-difluoro-4-methylumbelliferyl phosphate) assay. MMP levels were determined by gelatin zymography. Results: Exposure of NTM cells to ODM-2 cells led to the activation of the MAPK signal transduction pathways in NTM cells within 5 min of co-culture. Phosphorylation of ERK1/ERK2 and p38 peaked at 10 and 15 min and then decreased over time. Interaction between ODM-2 and NTM cells promoted the expression of MMP-9 in the NTM cells after 4 h of co-culture. Conclusions: Our findings provide support for the hypothesis that crosstalk does indeed take place between ODM-2 and NTM cells. Future studies should be designed to determine the relationship between the MMP system, MAPK kinases and phosphatases. Manipulation of these signaling molecules and the related NTM signal transduction pathways may provide targets for developing improved treatments for glaucoma.	[Lerner, Natalie; Beit-Yannai, Elie] Ben Gurion Univ Negev, Dept Clin Biochem & Pharmacol, IL-84105 Beer Sheva, Israel	Ben Gurion University	Beit-Yannai, E (corresponding author), Ben Gurion Univ Negev, Dept Clin Biochem & Pharmacol, IL-84105 Beer Sheva, Israel.	bye@bgu.ac.il		Beit-Yannai, Elie/0000-0001-9347-822X				ALEXANDER JP, 1991, INVEST OPHTH VIS SCI, V32, P172; Aslan M, 2008, FREE RADICAL BIO MED, V45, P367, DOI 10.1016/j.freeradbiomed.2008.04.026; Beit-Yannai E, 2007, MED HYPOTHESES, V68, P299, DOI 10.1016/j.mehy.2006.05.067; Borkenstein A, 2013, MOL VIS, V19, P2306; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradley JMB, 1998, INVEST OPHTH VIS SCI, V39, P2649; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chang EE, 2012, OPHTHALMOLOGY, V119, P979, DOI 10.1016/j.ophtha.2011.11.003; Coca-Prados M, 2007, PROG RETIN EYE RES, V26, P239, DOI 10.1016/j.preteyeres.2007.01.002; COCAPRADOS M, 1986, P NATL ACAD SCI USA, V83, P8754, DOI 10.1073/pnas.83.22.8754; Dahlmann-Noor AH, 2010, DRUG DISCOV TODAY, V15, P287, DOI 10.1016/j.drudis.2010.02.007; De Groef L, 2013, INVEST OPHTH VIS SCI, V54, P7756, DOI 10.1167/iovs.13-13088; Garcia L, 2002, FEBS LETT, V523, P90, DOI 10.1016/S0014-5793(02)02950-2; GHOSH S, 1991, J CELL PHYSIOL, V149, P184, DOI 10.1002/jcp.1041490203; Goel M, 2010, OPEN OPHTHALMOL J, V4, P52, DOI 10.2174/1874364101004010052; Halliwell B, 2011, TRENDS PHARMACOL SCI, V32, P125, DOI 10.1016/j.tips.2010.12.002; Hashimoto A, 2005, BRAIN RES, V1033, P210, DOI 10.1016/j.brainres.2004.11.031; HOLLADAY K, 1992, MOL CARCINOGEN, V5, P16, DOI 10.1002/mc.2940050106; Hosseini M, 2006, INVEST OPHTH VIS SCI, V47, P1469, DOI 10.1167/iovs.05-0451; Huang Ping, 2009, J Ocul Biol Dis Infor, V2, P98; Inoue T, 2013, PROG RETIN EYE RES, V37, P1, DOI 10.1016/j.preteyeres.2013.05.002; Johnson TV, 2013, CURR OPIN PHARMACOL, V13, P78, DOI 10.1016/j.coph.2012.08.003; Kumar M, 2009, J IMMUNOL, V182, P2439, DOI 10.4049/jimmunol.0803357; Latarya G, 2012, INVEST OPHTH VIS SCI, V53, P1679, DOI 10.1167/iovs.11-9120; Li DQ, 2006, EXP EYE RES, V82, P588, DOI 10.1016/j.exer.2005.08.019; Liacini A, 2002, MATRIX BIOL, V21, P251, DOI 10.1016/S0945-053X(02)00007-0; Loeser RF, 2008, CURR OPIN RHEUMATOL, V20, P581, DOI 10.1097/BOR.0b013e3283090463; Marchenko ND, 2004, INT J BIOCHEM CELL B, V36, P942, DOI 10.1016/j.biocel.2003.12.007; MARTINVASALLO P, 1989, J CELL PHYSIOL, V141, P243, DOI 10.1002/jcp.1041410203; McKinnon Stuart J, 2008, Am J Manag Care, V14, pS20; Oh DJ, 2013, INVEST OPHTH VIS SCI, V54, P3309, DOI 10.1167/iovs.12-11362; PANG IH, 1994, CURR EYE RES, V13, P51, DOI 10.3109/02713689409042398; Pufe T, 2004, J PATHOL, V202, P367, DOI 10.1002/path.1527; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rao PV, 2014, J OCUL PHARMACOL TH, V30, P181, DOI 10.1089/jop.2013.0194; Rhim E.-M., 2011, J KOREAN ACAD CONSER, V36, P26, DOI [10.5395/JKACD.2011.36.1.26, DOI 10.5395/JKACD.2011.36.1.26]; Rietz A, 2012, BRIT J PHARMACOL, V166, P1225, DOI 10.1111/j.1476-5381.2012.01917.x; Sanchez-Sanchez F, 2007, J BIOL CHEM, V282, P27810, DOI 10.1074/jbc.M609608200; Sanka K, 2007, INVEST OPHTH VIS SCI, V48, P2105, DOI 10.1167/iovs.06-1089; Sawada H, 2010, INVEST OPHTH VIS SCI, V51, P903, DOI 10.1167/iovs.09-4247; Sehgal I, 1998, CANCER RES, V58, P4288; Shmulevich A, 2009, CURR EYE RES, V34, P466, DOI 10.1080/02713680902916090; Stamer WD, 2011, J PROTEOMICS, V74, P796, DOI 10.1016/j.jprot.2011.02.024; Strouthidis NG, 2013, CURR OPIN PHARMACOL, V13, P83, DOI 10.1016/j.coph.2012.09.001; Takai Y, 2012, INVEST OPHTH VIS SCI, V53, P241, DOI 10.1167/iovs.11-8434; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Wang SK, 2014, CLIN OPHTHALMOL, V8, P883, DOI 10.2147/OPTH.S41000; WESTERMARCK J, 1994, CELL GROWTH DIFFER, V5, P1205; Wiederholt M, 1998, INVEST OPHTH VIS SCI, V39, P1012; Zhang X, 2006, EXP EYE RES, V82, P968, DOI 10.1016/j.exer.2005.11.001	50	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112259	10.1371/journal.pone.0112259	http://dx.doi.org/10.1371/journal.pone.0112259			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389776	Green Published, Green Submitted, gold			2022-12-27	WOS:000349144400065
J	Oneil, ST; Rahn, KC; Bump, JK				Oneil, Shawn T.; Rahn, Kasey C.; Bump, Joseph K.			Habitat Capacity for Cougar Recolonization in the Upper Great Lakes Region	PLOS ONE			English	Article							PUMA-CONCOLOR; MOUNTAIN LIONS; BLACK-HILLS; DISPERSAL; LANDSCAPE; MOVEMENTS; DYNAMICS; PATTERNS; SPACE; LYNX	Background: Recent findings indicate that cougars (Puma concolor) are expanding their range into the midwestern United States. Confirmed reports of cougar in Michigan, Minnesota, and Wisconsin have increased dramatically in frequency during the last five years, leading to speculation that cougars may re-establish in the Upper Great Lakes (UGL) region, USA. Recent work showed favorable cougar habitat in northeastern Minnesota, suggesting that the northern forested regions of Michigan and Wisconsin may have similar potential. Recolonization of cougars in the UGL states would have important ecological, social, and political impacts that will require effective management. Methodology/Principal Findings: Using Geographic Information Systems (GIS), we extended a cougar habitat model to Michigan and Wisconsin and incorporated primary prey densities to estimate the capacity of the region to support cougars. Results suggest that approximately 39% (>58,000 km(2)) of the study area could support cougars, and that there is potential for a population of approximately 500 or more animals. An exploratory validation of this habitat model revealed strong association with 58 verified cougar locations occurring in the study area between 2008 and 2013. Conclusions/Significance: Spatially explicit information derived from this study could potentially lead to estimation of a viable population, delineation of possible cougar-human conflict areas, and the targeting of site locations for current monitoring. Understanding predator-prey interactions, interspecific competition, and human-wildlife relationships is becoming increasingly critical as top carnivores continue to recolonize the UGL region.	[Oneil, Shawn T.; Rahn, Kasey C.; Bump, Joseph K.] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA	Michigan Technological University	Bump, JK (corresponding author), Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA.	jkbump@mtu.edu		O'Neil, Shawn/0000-0002-0899-5220	School of Forest Resources and Environmental Science Ecosystem Science Center at Michigan Technological University	School of Forest Resources and Environmental Science Ecosystem Science Center at Michigan Technological University	This project was funded and supported by the School of Forest Resources and Environmental Science Ecosystem Science Center at Michigan Technological University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Charles R. Jr, 2010, P41; Anderson EM, 2006, P E COUG C 28 APR 20; BEIER P, 1995, J WILDLIFE MANAGE, V59, P228, DOI 10.2307/3808935; BEIER P, 1995, J MAMMAL, V76, P1056, DOI 10.2307/1382599; Beier Paul, 2010, P177; Beyer DE, 2009, RECOVERY OF GRAY WOLVES IN THE GREAT LAKES REGION OF THE UNITED STATES, P65, DOI 10.1007/978-0-387-85952-1_5; Bolgiano C., 2005, E COUGAR HIST ACCOUN; Boyce MS, 1999, TRENDS ECOL EVOL, V14, P268, DOI 10.1016/S0169-5347(99)01593-1; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Clark DW, 2002, SOUTHEAST NAT, V1, P269, DOI 10.1656/1528-7092(2002)001[0269:ASORAO]2.0.CO;2; Conkin JA, 2013, J WILDLIFE MANAGE, V77, P931, DOI 10.1002/jwmg.560; Corona Research I, 2006, PUBL OP PERC MOUNT L; Cougar Management Guidelines Working Group, 2005, COUG MAN GUID; Davenport Mae A., 2010, Human Dimensions of Wildlife, V15, P373, DOI 10.1080/10871209.2010.507564; DelGiudice GD, 2009, RECOVERY OF GRAY WOLVES IN THE GREAT LAKES REGION OF THE UNITED STATES, P155, DOI 10.1007/978-0-387-85952-1_10; Dickson BG, 2005, J WILDLIFE MANAGE, V69, P264, DOI 10.2193/0022-541X(2005)069&lt;0264:IOVTAR&gt;2.0.CO;2; Donovan ML, 2004, MICHIGAN GAP ANAL FI; Fecske DM, 2008, N DAKOTA MOUNTAIN LI, P92; Geist V., 1998, DEER WORLD THEIR EVO; Glick HB, 2014, ECOL MODEL, V285, P78, DOI 10.1016/j.ecolmodel.2014.02.005; HALLS L, 1984, WHITE TAILED DEER EC; Hastie T, 2013, ECOGRAPHY, V36, P864, DOI 10.1111/j.1600-0587.2013.00321.x; Henaux V, 2011, METHODS ECOL EVOL, V2, P489, DOI 10.1111/j.2041-210X.2011.00107.x; Johnson CJ, 2006, J WILDLIFE MANAGE, V70, P347, DOI 10.2193/0022-541X(2006)70[347:RSFBOU]2.0.CO;2; Johnson Kirk, 2002, Endangered Species Update, V19, P27; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Kertson BN, 2011, ECOL APPL, V21, P2866, DOI 10.1890/11-0947.1; Lambert CMS, 2006, J WILDLIFE MANAGE, V70, P246, DOI 10.2193/0022-541X(2006)70[246:CPDAVI]2.0.CO;2; LaRue MA, 2007, PREDICTING POTENTIAL; Larue MA, 2008, ECOL MODEL, V212, P372, DOI 10.1016/j.ecolmodel.2007.10.036; Larue MA, 2012, J WILDLIFE MANAGE, V76, P1364, DOI 10.1002/jwmg.396; Larue MA, 2011, ECOL MODEL, V222, P897, DOI 10.1016/j.ecolmodel.2010.11.017; Laundre JW, 2013, ORYX, V47, P96, DOI 10.1017/S0030605311001475; Laundre John W., 2010, P76; Linden DW, 2011, WILDLIFE SOC B, V35, P20, DOI 10.1002/wsb.3; Logan Kenneth A., 2010, P105; McDonald L, 2013, J ANIM ECOL, V82, P1120, DOI 10.1111/1365-2656.12145; Michigan Department of Natural Resources, 2013, CLICK MAP PROP 2006; Mladenoff DJ, 1997, BIOSCIENCE, V47, P21, DOI 10.2307/1313003; Murphy Kerry, 2010, P118; Murray BD, 2013, ECOLOGY, V94, P1317, DOI 10.1890/12-1582.1; Northrup JM, 2013, ECOLOGY, V94, P1456, DOI 10.1890/12-1688.1; Palomares F, 2000, CONSERV BIOL, V14, P809, DOI 10.1046/j.1523-1739.2000.98539.x; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; Potvin MJ, 2005, J WILDLIFE MANAGE, V69, P1660, DOI 10.2193/0022-541X(2005)69[1660:MAHAFW]2.0.CO;2; Quigley Howard, 2010, P59; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rosatte R, 2011, CAN FIELD NAT, V125, P116, DOI 10.22621/cfn.v125i2.1194; Ruth Toni K., 2010, P163; Saaty TL., 1980, ANAL HIERARCHY PROCE; Smallwood KS, 1997, ENVIRON CONSERV, V24, P283, DOI 10.1017/S0376892997000362; Smith JB, 2014, J WILDLIFE MANAGE, V78, P930, DOI 10.1002/jwmg.718; Sweanor Linda L., 2010, P190; Sweanor LL, 2000, CONSERV BIOL, V14, P798, DOI 10.1046/j.1523-1739.2000.99079.x; Teichman KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074663; Thompson DJ, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00028.1; Thompson DJ, 2005, J WILDLIFE MANAGE, V69, P818, DOI 10.2193/0022-541X(2005)069[0818:LDBASM]2.0.CO;2; Treves A, 2013, CONSERV BIOL, V27, P315, DOI 10.1111/cobi.12009; Treves A, 2009, J APPL ECOL, V46, P1350, DOI 10.1111/j.1365-2664.2009.01729.x; U.S. Fish and Wildlife Service, 1982, E COUG REC PLAN; VERME LJ, 1989, J MAMMAL, V70, P438, DOI 10.2307/1381538; Vucetich J., 2014, OXFORD HDB ANIMAL ST; Washington Department of Fish and Wildlife, 2008, WASH DEP FISH WILDL; Wiedenhoeft JE, 2009, WISCONSIN WILDLIFE S, V19, P83; Wiedenhoeft JE, 2011, WISCONSIN WILDLIFE S, V21, P99; Wiedenhoeft JE, 2012, RARE MAMMAL OBSERVAT; Wiedenhoeft JE, 2010, WISCONSIN WILDLIFE S, V20, P103; Wiedenhoeft JE, 2013, WISCONSIN WILDLIFE S, V23, P93; Wilmers CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060590; Wilson S, 2010, WEST N AM NATURALIST, V70, P238, DOI 10.3398/064.070.0211; Wisconsin Cougar Working Group, 2010, WISC COUG R IN PRESS; Wisconsin Department of Natural Resources, 2013, EST FALL DEER POP 20; Wisconsin Department of Natural Resources, 2013, COURG WISC; Wydeven AP, 2009, RECOVERY OF GRAY WOLVES IN THE GREAT LAKES REGION OF THE UNITED STATES, P87, DOI 10.1007/978-0-387-85952-1_6	75	7	8	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112565	10.1371/journal.pone.0112565	http://dx.doi.org/10.1371/journal.pone.0112565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389761	gold, Green Published, Green Submitted			2022-12-27	WOS:000349144400101
J	Rudat, C; Grieskamp, T; Rohr, C; Airik, R; Wrede, C; Hegermann, J; Herrmann, BG; Schuster-Gossler, K; Kispert, A				Rudat, Carsten; Grieskamp, Thomas; Roehr, Christian; Airik, Rannar; Wrede, Christoph; Hegermann, Jan; Herrmann, Bernhard G.; Schuster-Gossler, Karin; Kispert, Andreas			Upk3b Is Dispensable for Development and Integrity of Urothelium and Mesothelium	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; IDENTIFICATION; LINEAGE; FIBROBLASTS; PROGENITORS; MEMBRANE; PLAQUES; MARKER; TBX18; FATE	The mesothelium, the lining of the coelomic cavities, and the urothelium, the inner lining of the urinary drainage system, are highly specialized epithelia that protect the underlying tissues from mechanical stress and seal them from the overlying fluid space. The development of these epithelia from simple precursors and the molecular characteristics of the mature tissues are poorly analyzed. Here, we show that uroplakin 3B (Upk3b), which encodes an integral membrane protein of the tetraspanin superfamily, is specifically expressed both in development as well as under homeostatic conditions in adult mice in the mesothelia of the body cavities, i.e., the epicardium and pericardium, the pleura and the peritoneum, and in the urothelium of the urinary tract. To analyze Upk3b function, we generated a creERT2 knock-in allele by homologous recombination in embryonic stem cells. We show that Upk3b creERT2 represents a null allele despite the lack of creERT2 expression from the mutated locus. Morphological, histological and molecular analyses of Upk3b-deficient mice did not detect changes in differentiation or integrity of the urothelium and the mesothelia that cover internal organs. Upk3b is coexpressed with the closely related Upk3a gene in the urothelium but not in the mesothelium, leaving the possibility of a functional redundancy between the two genes in the urothelium only.	[Rudat, Carsten; Grieskamp, Thomas; Roehr, Christian; Airik, Rannar; Schuster-Gossler, Karin; Kispert, Andreas] Hannover Med Sch, Inst Mol Biol, D-30623 Hannover, Germany; [Wrede, Christoph; Hegermann, Jan] Hannover Med Sch, Inst Funct & Appl Anat, D-30623 Hannover, Germany; [Herrmann, Bernhard G.] Max Planck Inst Mol Genet, D-14195 Berlin, Germany	Hannover Medical School; Hannover Medical School; Max Planck Society	Kispert, A (corresponding author), Hannover Med Sch, Inst Mol Biol, D-30623 Hannover, Germany.	kispert.andreas@mh-hannover.de	Airik, Rannar/AAS-7810-2021	Airik, Rannar/0000-0002-7055-6325	German Research Foundation; Hannover Medical School [KFO136]	German Research Foundation(German Research Foundation (DFG)); Hannover Medical School	This work was supported by grants from the German Research Foundation (DFG) for the Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy) to C.W., J.H. and A.K. and by a grant for the Clinical Research Group KFO136 to A.K. at Hannover Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airik R, 2007, KIDNEY INT, V72, P1459, DOI 10.1038/sj.ki.5002589; Asahina K, 2011, HEPATOLOGY, V53, P983, DOI 10.1002/hep.24119; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Christoffels VM, 2009, NATURE, V458, pE8, DOI 10.1038/nature07916; Deng FM, 2002, J CELL BIOL, V159, P685, DOI 10.1083/jcb.200204102; Dettman RW, 1998, DEV BIOL, V193, P169, DOI 10.1006/dbio.1997.8801; Duan JZ, 2012, EMBO J, V31, P429, DOI 10.1038/emboj.2011.418; Greulich F, 2013, J DEV BIOL, V1, P32, DOI 10.3390/jdb1010032; Grieskamp T, 2011, CIRC RES, V108, P813, DOI 10.1161/CIRCRESAHA.110.228809; Hoogaars WMH, 2007, GENE DEV, V21, P1098, DOI 10.1101/gad.416007; Hu CCA, 2005, MOL BIOL CELL, V16, P3937, DOI 10.1091/mbc.E05-02-0136; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Kanamori-Katayama M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025391; Kong XT, 2004, J CELL BIOL, V167, P1195, DOI 10.1083/jcb.200406025; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; Min GW, 2006, J CELL BIOL, V173, P975, DOI 10.1083/jcb.200602086; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Norden J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045100; Que JW, 2008, P NATL ACAD SCI USA, V105, P16626, DOI 10.1073/pnas.0808649105; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rinkevich Y, 2012, NAT CELL BIOL, V14, P1251, DOI 10.1038/ncb2610; Rudat C, 2012, CIRC RES, V111, P165, DOI 10.1161/CIRCRESAHA.112.273946; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shelton EL, 2013, J TISSUE ENG REGEN M, V7, P421, DOI 10.1002/term.528; STAEHELIN LA, 1972, J CELL BIOL, V53, P73, DOI 10.1083/jcb.53.1.73; van Wijk B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044692; Wilm B, 2005, DEVELOPMENT, V132, P5317, DOI 10.1242/dev.02141; Winters NI, 2014, DEV BIOL, V391, P125, DOI 10.1016/j.ydbio.2014.04.003; Winters NI, 2012, DEVELOPMENT, V139, P2926, DOI 10.1242/dev.082396; Yung S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/484167; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou B, 2011, J CELL MOL MED, V15, P2781, DOI 10.1111/j.1582-4934.2011.01450.x	35	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112112	10.1371/journal.pone.0112112	http://dx.doi.org/10.1371/journal.pone.0112112			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389758	Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400053
J	Aghcheh, RK; Nemeth, Z; Atanasova, L; Fekete, E; Paholcsek, M; Sandor, E; Aquino, B; Druzhinina, IS; Karaffa, L; Kubicek, CP				Aghcheh, Razieh Karimi; Nemeth, Zoltan; Atanasova, Lea; Fekete, Erzsebet; Paholcsek, Melinda; Sandor, Erzsebet; Aquino, Benigno; Druzhinina, Irina S.; Karaffa, Levente; Kubicek, Christian P.			The VELVET A Orthologue VEL1 of Trichoderma reesei Regulates Fungal Development and Is Essential for Cellulase Gene Expression	PLOS ONE			English	Article							BIOMASS-DEGRADING ENZYMES; ASPERGILLUS-NIDULANS; SECONDARY METABOLISM; PENICILLIUM-CHRYSOGENUM; SEXUAL DEVELOPMENT; FILAMENTOUS FUNGI; VEA GENE; PROTEIN; LACTOSE; COMPLEX	Trichoderma reesei is the industrial producer of cellulases and hemicellulases for biorefinery processes. Their expression is obligatorily dependent on the function of the protein methyltransferase LAE1. The Aspergillus nidulans orthologue of LAE1 - LaeA - is part of the VELVET protein complex consisting of LaeA, VeA and VelB that regulates secondary metabolism and sexual as well as asexual reproduction. Here we have therefore investigated the function of VEL1, the T. reesei orthologue of A. nidulans VeA. Deletion of the T. reesei vel1 locus causes a complete and light-independent loss of conidiation, and impairs formation of perithecia. Deletion of vel1 also alters hyphal morphology towards hyperbranching and formation of thicker filaments, and with consequently reduced growth rates. Growth on lactose as a sole carbon source, however, is even more strongly reduced and growth on cellulose as a sole carbon source eliminated. Consistent with these findings, deletion of vel1 completely impaired the expression of cellulases, xylanases and the cellulase regulator XYR1 on lactose as a cellulase inducing carbon source, but also in resting mycelia with sophorose as inducer. Our data show that in T. reesei VEL1 controls sexual and asexual development, and this effect is independent of light. VEL1 is also essential for cellulase gene expression, which is consistent with the assumption that their regulation by LAE1 occurs by the VELVET complex.	[Aghcheh, Razieh Karimi; Atanasova, Lea; Aquino, Benigno; Druzhinina, Irina S.; Kubicek, Christian P.] Vienna Univ Technol, Inst Chem Engn, Res Div Biotechnol & Microbiol, Microbiol Grp, A-1060 Vienna, Austria; [Nemeth, Zoltan; Fekete, Erzsebet; Karaffa, Levente] Univ Debrecen, Fac Sci & Technol, Dept Biochem Engn, H-4032 Debrecen, Hungary; [Paholcsek, Melinda] Univ Debrecen, Fac Med, Dept Human Genet, H-4032 Debrecen, Hungary; [Sandor, Erzsebet] Inst Food Sci, Fac Agr & Food Sci & Environm Management, H-4032 Debrecen, Hungary; [Druzhinina, Irina S.] Vienna Univ Technol, Inst Chem Engn, Austrian Ctr Ind Biotechnol, A-1060 Vienna, Austria; [Kubicek, Christian P.] Austrian Ctr Ind Biotechnol, A-8010 Graz, Austria	Technische Universitat Wien; University of Debrecen; University of Debrecen; Austrian Centre of Industrial Biotechnology; Technische Universitat Wien; Austrian Centre of Industrial Biotechnology	Kubicek, CP (corresponding author), Vienna Univ Technol, Inst Chem Engn, Res Div Biotechnol & Microbiol, Microbiol Grp, A-1060 Vienna, Austria.	christian.kubicek@gmail.com	Paholcsek, Melinda/AAR-4464-2020; Atanasova, Lea/AAK-4479-2021; Druzhinina, Irina S./AAK-7054-2021; Karaffa, Erzsébet/A-3547-2016	Atanasova, Lea/0000-0002-1751-277X; Druzhinina, Irina S./0000-0003-2821-5268; Karaffa, Erzsebet/0000-0001-8356-1716; Karimi Aghcheh, Razieh/0000-0003-0027-1030	Austrian Science Foundation [P 21266, I 1249]; EU; European Social Fund [TA MOP-4.2.2.A-11/1/KONV-2012-0043, TAMOP-4.2.4.A/2-11/1-2012-0001]; Hungarian Scientific Research Fund (OTKA) [K1006600]; Austrian Science Fund (FWF) [I 1249] Funding Source: researchfish	Austrian Science Foundation(Austrian Science Fund (FWF)); EU(European Commission); European Social Fund(European Social Fund (ESF)); Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by grants of the Austrian Science Foundation (to CPK; P 21266 and I 1249), by the EU and co-financed by the European Social Fund under the project ENVIKUT (TA MOP-4.2.2.A-11/1/KONV-2012-0043), and also by the Hungarian Scientific Research Fund (OTKA Grant K1006600). LK is a recipient of a Bolyai Janos Research Scholarship. MP was supported by the EU and Hungary, co-financed by the European Social Fund in the framework of the TAMOP-4.2.4.A/2-11/1-2012-0001 'National Excellence Program.' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akel E, 2009, EUKARYOT CELL, V8, P1837, DOI 10.1128/EC.00162-09; Amaike S, 2009, EUKARYOT CELL, V8, P1051, DOI 10.1128/EC.00088-09; Arvas M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-616; Ausubel F. M., 1999, SHORT PROTOCOLS MOL; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Bayram O, 2008, FUNGAL GENET BIOL, V45, P127, DOI 10.1016/j.fgb.2007.06.001; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; Bischof R, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-127; Bok JW, 2006, MOL MICROBIOL, V61, P1636, DOI 10.1111/j.1365-2958.2006.05330.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Busch S, 2007, P NATL ACAD SCI USA, V104, P8089, DOI 10.1073/pnas.0702108104; Calvo AM, 2008, FUNGAL GENET BIOL, V45, P1053, DOI 10.1016/j.fgb.2008.03.014; Chen CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044969; Chettri P, 2012, FUNGAL GENET BIOL, V49, P141, DOI 10.1016/j.fgb.2011.11.009; Dhingra S, 2012, EUKARYOT CELL, V11, P1531, DOI 10.1128/EC.00222-12; Dreyer J, 2007, APPL ENVIRON MICROB, V73, P3412, DOI 10.1128/AEM.00129-07; Duran RM, 2014, APPL MICROBIOL BIOT, V98, P5081, DOI 10.1007/s00253-014-5598-6; Fischer R, 2008, SCIENCE, V320, P1430, DOI 10.1126/science.1160123; Foreman PK, 2003, J BIOL CHEM, V278, P31988, DOI 10.1074/jbc.M304750200; Ghassemi S, 2014, MOL MICROBIOL; Guangtao Z, 2009, J BIOTECHNOL, V139, P146, DOI 10.1016/j.jbiotec.2008.10.007; Hakkinen M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-134; Hoff B, 2010, EUKARYOT CELL, V9, P1236, DOI 10.1128/EC.00077-10; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Ivanova C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062631; Jiang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028291; Kamerewerd J, 2011, MICROBIOL-SGM, V157, P3036, DOI 10.1099/mic.0.051896-0; Karaffa L, 2013, APPL MICROBIOL BIOT, V97, P5447, DOI 10.1007/s00253-012-4667-y; Karimi-Aghcheh R, 2013, G3-GENES GENOM GENET, V3, P369, DOI 10.1534/g3.112.005140; Kim HS, 2002, FUNGAL GENET BIOL, V37, P72, DOI 10.1016/S1087-1845(02)00029-4; Kim HJ, 2014, FUNGAL GENET BIOL, V66, P33, DOI 10.1016/j.fgb.2014.02.011; Kubicek C. P, 2012, FUNGI LIGNOCELLULOSE; Kubicek CP, 2013, J BIOTECHNOL, V163, P133, DOI 10.1016/j.jbiotec.2012.05.020; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Laskowski-Peak MC, 2012, FUNGAL GENET BIOL, V49, P838, DOI 10.1016/j.fgb.2012.07.001; Le Crom S, 2009, P NATL ACAD SCI USA, V106, P16151, DOI 10.1073/pnas.0905848106; MACH RL, 1994, CURR GENET, V25, P567, DOI 10.1007/BF00351679; MANDELS M, 1978, PROCESS BIOCHEM, V13, P6; Merhej J, 2012, MOL PLANT PATHOL, V13, P363, DOI 10.1111/j.1364-3703.2011.00755.x; Metz B, 2011, EUKARYOT CELL, V10, P1527, DOI 10.1128/EC.05014-11; Mukherjee PK, 2010, APPL ENVIRON MICROB, V76, P2345, DOI 10.1128/AEM.02391-09; Myung K, 2012, PLANT PATHOL, V61, P152, DOI 10.1111/j.1365-3059.2011.02504.x; Park HS, 2012, MOL MICROBIOL, V86, P937, DOI 10.1111/mmi.12032; Patananan AN, 2013, J BIOL CHEM, V288, P14032, DOI 10.1074/jbc.M113.465765; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Purschwitz J, 2009, MOL GENET GENOMICS, V281, P35, DOI 10.1007/s00438-008-0390-x; RECHSTEINER M, 1987, TRENDS BIOCHEM SCI, V12, P390; Reyes-Dominguez Y, 2010, MOL MICROBIOL, V76, P1376, DOI 10.1111/j.1365-2958.2010.07051.x; Ries L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-541; Sarikaya-Bayram O, 2014, DEV CELL, V29, P406, DOI 10.1016/j.devcel.2014.03.020; Seiboth B, 2007, MOL MICROBIOL, V66, P890, DOI 10.1111/j.1365-2958.2007.05953.x; Seiboth Bernhard, 2007, Fungal Biology Reviews, V21, P42, DOI 10.1016/j.fbr.2007.02.006; Seiboth Bernhard, 2012, Subcell Biochem, V64, P367, DOI 10.1007/978-94-007-5055-5_18; Seiboth B, 2012, MOL MICROBIOL, V84, P1150, DOI 10.1111/j.1365-2958.2012.08083.x; Seidl V, 2009, P NATL ACAD SCI USA, V106, P13909, DOI 10.1073/pnas.0904936106; STERNBERG D, 1979, J BACTERIOL, V139, P761, DOI 10.1128/JB.139.3.761-769.1979; Stinnett SM, 2007, MOL MICROBIOL, V63, P242, DOI 10.1111/j.1365-2958.2006.05506.x; Tisch D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-613; Uzbas F, 2012, APPL MICROBIOL BIOT, V93, P1601, DOI 10.1007/s00253-011-3674-8; Vitikainen M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-441; Wiemann P, 2010, MOL MICROBIOL, V77, P972, DOI 10.1111/j.1365-2958.2010.07263.x; Yager L N, 1992, Biotechnology, V23, P19; Yang QQ, 2013, FUNGAL GENET BIOL, V50, P63, DOI 10.1016/j.fgb.2012.10.003; Yu JH, 2005, ANNU REV PHYTOPATHOL, V43, P437, DOI 10.1146/annurev.phyto.43.040204.140214	64	64	66	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112799	10.1371/journal.pone.0112799	http://dx.doi.org/10.1371/journal.pone.0112799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386652	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400093
J	Atkinson, SJ; Cvijanovich, NZ; Thomas, NJ; Allen, GL; Anas, N; Bigham, MT; Hall, M; Freishtat, RJ; Sen, A; Meyer, K; Checchia, PA; Shanley, TP; Nowak, J; Quasney, M; Weiss, SL; Banschbach, S; Beckman, E; Howard, K; Frank, E; Harmon, K; Lahni, P; Lindsell, CJ; Wong, HR				Atkinson, Sarah J.; Cvijanovich, Natalie Z.; Thomas, Neal J.; Allen, Geoffrey L.; Anas, Nick; Bigham, Michael T.; Hall, Mark; Freishtat, Robert J.; Sen, Anita; Meyer, Keith; Checchia, Paul A.; Shanley, Thomas P.; Nowak, Jeffrey; Quasney, Michael; Weiss, Scott L.; Banschbach, Sharon; Beckman, Eileen; Howard, Kelli; Frank, Erin; Harmon, Kelli; Lahni, Patrick; Lindsell, Christopher J.; Wong, Hector R.			Corticosteroids and Pediatric Septic Shock Outcomes: A Risk Stratified Analysis	PLOS ONE			English	Article							SEVERE SEPSIS; STEROIDS; HYDROCORTISONE; THERAPY	Background: The potential benefits of corticosteroids for septic shock may depend on initial mortality risk. Objective: We determined associations between corticosteroids and outcomes in children with septic shock who were stratified by initial mortality risk. Methods: We conducted a retrospective analysis of an ongoing, multi-center pediatric septic shock clinical and biological database. Using a validated biomarker-based stratification tool (PERSEVERE), 496 subjects were stratified into three initial mortality risk strata (low, intermediate, and high). Subjects receiving corticosteroids during the initial 7 days of admission (n = 252) were compared to subjects who did not receive corticosteroids (n = 244). Logistic regression was used to model the effects of corticosteroids on 28-day mortality and complicated course, defined as death within 28 days or persistence of two or more organ failures at 7 days. Results: Subjects who received corticosteroids had greater organ failure burden, higher illness severity, higher mortality, and a greater requirement for vasoactive medications, compared to subjects who did not receive corticosteroids. PERSEVERE-based mortality risk did not differ between the two groups. For the entire cohort, corticosteroids were associated with increased risk of mortality (OR 2.3, 95% CI 1.3-4.0, p = 0.004) and a complicated course (OR 1.7, 95% CI 1.1-2.5, p = 0.012). Within each PERSEVERE-based stratum, corticosteroid administration was not associated with improved outcomes. Similarly, corticosteroid administration was not associated with improved outcomes among patients with no comorbidities, nor in groups of patients stratified by PRISM. Conclusions: Risk stratified analysis failed to demonstrate any benefit from corticosteroids in this pediatric septic shock cohort.	[Atkinson, Sarah J.; Banschbach, Sharon; Beckman, Eileen; Howard, Kelli; Frank, Erin; Harmon, Kelli; Lahni, Patrick; Wong, Hector R.] Cincinnati Childrens Hosp Med Ctr, Div Crit Care Med, Cincinnati, OH 45229 USA; [Atkinson, Sarah J.; Banschbach, Sharon; Beckman, Eileen; Howard, Kelli; Frank, Erin; Harmon, Kelli; Lahni, Patrick; Wong, Hector R.] Cincinnati Childrens Res Fdn, Cincinnati, OH USA; [Atkinson, Sarah J.] Univ Cincinnati, Dept Surg, Cincinnati, OH 45267 USA; [Cvijanovich, Natalie Z.] UCSF Benioff Childrens Hosp Oakland, Oakland, CA USA; [Thomas, Neal J.] Penn State Hershey Childrens Hosp, Hershey, PA USA; [Allen, Geoffrey L.] Childrens Mercy Hosp, Kansas City, MO 64108 USA; [Anas, Nick] Childrens Hosp Orange Cty, Orange, CA 92668 USA; [Bigham, Michael T.] Akron Childrens Hosp, Akron, OH USA; [Hall, Mark] Nationwide Childrens Hosp, Columbus, OH USA; [Freishtat, Robert J.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Sen, Anita] Columbia Univ, Med Ctr, Morgan Stanley Childrens Hosp, New York, NY USA; [Meyer, Keith] Miami Childrens Hosp, Miami, FL USA; [Checchia, Paul A.] Texas Childrens Hosp, Houston, TX 77030 USA; [Shanley, Thomas P.; Quasney, Michael] Univ Michigan, CS Mott Childrens Hosp, Ann Arbor, MI 48109 USA; [Nowak, Jeffrey] Childrens Hosp & Clin Minnesota, Minneapolis, MN USA; [Weiss, Scott L.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Lindsell, Christopher J.] Univ Cincinnati, Coll Med, Dept Emergency Med, Cincinnati, OH USA; [Wong, Hector R.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Children's Mercy Hospital; Childrens Hospital of Orange County; Akron Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Children's National Health System; Columbia University; NewYork-Presbyterian Hospital; Morgan Stanley Children's Hospital; Baylor College of Medicine; University of Michigan System; University of Michigan; Children's Hospitals & Clinics of Minnesota; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Wong, HR (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Crit Care Med, Cincinnati, OH 45229 USA.	hector.wong@cchmc.org	Hall, Mark/E-3193-2011	Thomas, Neal/0000-0002-7991-7510; Meyer, Keith/0000-0001-7354-5552; Weiss, Scott/0000-0002-7040-3281; Wong, Hector/0000-0001-7989-1173; Freishtat, Robert/0000-0002-7411-2342; Shanley, Thomas/0000-0001-8936-377X	National Institutes of Health [RO1GM064619, RO1GM099773, R01GM108025, T32GM008478]; Institutional Clinical and Translational Science [NIH/NCRR 8UL1 TR000077]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD047349] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008478, R01GM108025, R01GM099773, R01GM064619] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Clinical and Translational Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health grants RO1GM064619, RO1GM099773, and R01GM108025, and supported in part by an Institutional Clinical and Translational Science Award, NIH/NCRR 8UL1 TR000077. Dr. Atkinson is supported by a training grant from the National Institutes of Health, T32GM008478. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulebda K, 2014, CRIT CARE MED, V42, P397, DOI 10.1097/CCM.0b013e3182a64607; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Annane D, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-7; Brierley J, 2009, CRIT CARE MED, V37, P666, DOI 10.1097/CCM.0b013e31819323c6; Casserly B, 2012, INTENS CARE MED, V38, P1946, DOI 10.1007/s00134-012-2720-z; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Hanna W, 2013, CRIT CARE CLIN, V29, P203, DOI 10.1016/j.ccc.2012.11.003; Kaplan JM, 2011, PEDIATR CRIT CARE ME, V12, P165, DOI 10.1097/PCC.0b013e3181e28876; Katsenos CS, 2014, CRIT CARE MED, V42, P1651, DOI 10.1097/CCM.0000000000000318; Markovitz Barry P, 2005, Pediatr Crit Care Med, V6, P270, DOI 10.1097/01.PCC.0000160596.31238.72; McIntyre LA, 2007, CRIT CARE, V11, DOI 10.1186/cc5962; Menon K, 2013, PEDIATR CRIT CARE ME, V14, P462, DOI 10.1097/PCC.0b013e31828a7287; Menon K, 2013, PEDIATR CRIT CARE ME, V14, P474, DOI 10.1097/PCC.0b013e31828a8125; Menon K, 2010, AM J RESP CRIT CARE, V182, P246, DOI 10.1164/rccm.200911-1738OC; Mickiewicz B, 2013, AM J RESP CRIT CARE, V187, P967, DOI 10.1164/rccm.201209-1726OC; Patel GP, 2012, AM J RESP CRIT CARE, V185, P133, DOI 10.1164/rccm.201011-1897CI; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Wong HR, 2008, AM J RESP CRIT CARE, V178, P276, DOI 10.1164/rccm.200801-131OC; Wong HR, 2007, PHYSIOL GENOMICS, V30, P146, DOI 10.1152/physiolgenomics.00024.2007; Wong HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092121; Wong HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086242; Wong HR, 2013, PEDIATR RES, V73, P564, DOI 10.1038/pr.2013.11; Wong HR, 2012, CRIT CARE, V16, DOI 10.1186/cc11652; Zimmerman JJ, 2011, PEDIATR CRIT CARE ME, V12, P2, DOI 10.1097/PCC.0b013e3181d903f6; [No title captured]; [No title captured]; [No title captured]	28	44	47	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112702	10.1371/journal.pone.0112702	http://dx.doi.org/10.1371/journal.pone.0112702			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386653	Green Published, Green Submitted, gold			2022-12-27	WOS:000345250400086
J	Feehily, C; Finnerty, A; Casey, PG; Hill, C; Gahan, CGM; O'Byrne, CP; Karatzas, KAG				Feehily, Conor; Finnerty, Aiden; Casey, Pat G.; Hill, Colin; Gahan, Cormac G. M.; O'Byrne, Conor P.; Karatzas, Kimon-Andreas G.			Divergent Evolution of the Activity and Regulation of the Glutamate Decarboxylase Systems in Listeria monocytogenes EGD-e and 10403S: Roles in Virulence and Acid Tolerance	PLOS ONE			English	Article							ORAL INFECTION; RESISTANCE; IDENTIFICATION; EXPRESSION; STRESS; GROWTH; PH; INHIBITION; SURVIVAL; STRAINS	The glutamate decarboxylase (GAD) system has been shown to be important for the survival of Listeria monocytogenes in low pH environments. The bacterium can use this faculty to maintain pH homeostasis under acidic conditions. The accepted model for the GAD system proposes that the antiport of glutamate into the bacterial cell in exchange for c-aminobutyric acid (GABA) is coupled to an intracellular decarboxylation reaction of glutamate into GABA that consumes protons and therefore facilitates pH homeostasis. Most strains of L. monocytogenes possess three decarboxylase genes (gadD1, D2 & D3) and two antiporter genes (gadT1 & gadT2). Here, we confirm that the gadD3 encodes a glutamate decarboxylase dedicated to the intracellular GAD system (GAD(i)), which produces GABA from cytoplasmic glutamate in the absence of antiport activity. We also compare the functionality of the GAD system between two commonly studied reference strains, EGD-e and 10403S with differences in terms of acid resistance. Through functional genomics we show that EGD-e is unable to export GABA and relies exclusively in the GADi system, which is driven primarily by GadD3 in this strain. In contrast 10403S relies upon GadD2 to maintain both an intracellular and extracellular GAD system (GAD(i)/GAD(e)). Through experiments with a murinised variant of EGD-e (EGDm) in mice, we found that the GAD system plays a significant role in the overall virulence of this strain. Double mutants lacking either gadD1D3 or gadD2D3 of the GAD system displayed reduced acid tolerance and were significantly affected in their ability to cause infection following oral inoculation. Since EGDm exploits GAD(i) but not GAD(e) the results indicate that the GAD(i) system makes a contribution to virulence within the mouse. Furthermore, we also provide evidence that there might be a separate line of evolution in the GAD system between two commonly used reference strains.	[Feehily, Conor; Finnerty, Aiden; O'Byrne, Conor P.] Natl Univ Ireland, Coll Sci, Sch Nat Sci, Bacterial Stress Response Grp, Galway, Ireland; [Casey, Pat G.; Hill, Colin; Gahan, Cormac G. M.] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Casey, Pat G.; Hill, Colin; Gahan, Cormac G. M.] Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland; [Karatzas, Kimon-Andreas G.] Univ Reading, Reading, Berks, England	Ollscoil na Gaillimhe-University of Galway; University College Cork; University College Cork; University of Reading	O'Byrne, CP (corresponding author), Natl Univ Ireland, Coll Sci, Sch Nat Sci, Bacterial Stress Response Grp, Galway, Ireland.	k.karatzas@reading.ac.uk	Gahan, Cormac G/AAE-9346-2019; Hill, Colin/A-5611-2012	Gahan, Cormac G/0000-0003-2385-8192; Hill, Colin/0000-0002-8527-1445; O'Byrne, Conor/0000-0001-6228-4676; Feehily, Conor/0000-0002-1253-7353; karatzas, kimon Andreas G/0000-0002-5533-4038	Science Foundation Ireland Starting Investigator Research Grant (SIRG) [09/SIRG/B1570]; Marie Curie European Reintegration Grant (ERG) [265154]; National University of Ireland Galway; Science Foundation Ireland [SFI/12/RC/2273, 12/RC/2273]	Science Foundation Ireland Starting Investigator Research Grant (SIRG)(Science Foundation Ireland); Marie Curie European Reintegration Grant (ERG)(European Commission); National University of Ireland Galway; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	CF, CPOB and KAGK were supported by a Science Foundation Ireland Starting Investigator Research Grant (SIRG; 09/SIRG/B1570), a Marie Curie European Reintegration Grant (ERG 265154) and by the National University of Ireland Galway. PGC, CH and CGMG are supported by Science Foundation Ireland in the form of a centre grant (Alimentary Pharmabiotic Centre; Grant Numbers SFI/12/RC/2273 and 12/RC/2273). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram F, 2008, APPL ENVIRON MICROB, V74, P6848, DOI 10.1128/AEM.00442-08; Archambaud C, 2012, P NATL ACAD SCI USA, V109, P16684, DOI 10.1073/pnas.1212809109; Becavin C, 2014, MBIO, V5, DOI 10.1128/mBio.00969-14; Chatterjee SS, 2006, INFECT IMMUN, V74, P1323, DOI 10.1128/IAI.74.2.1323-1338.2006; COLE MB, 1990, J APPL BACTERIOL, V69, P63, DOI 10.1111/j.1365-2672.1990.tb02912.x; Cotter PD, 2005, APPL ENVIRON MICROB, V71, P2832, DOI 10.1128/AEM.71.6.2832-2839.2005; Cotter PD, 2001, MOL MICROBIOL, V40, P465, DOI 10.1046/j.1365-2958.2001.02398.x; Cotter PD, 2000, INT J FOOD MICROBIOL, V60, P137, DOI 10.1016/S0168-1605(00)00305-6; Davis MJ, 1996, MICROBIOL-UK, V142, P2975, DOI 10.1099/13500872-142-10-2975; DECHASTELLIER C, 1994, INFECT IMMUN, V62, P543, DOI 10.1128/IAI.62.2.543-553.1994; Feehily C, 2013, APPL ENVIRON MICROB, V79, P74, DOI 10.1128/AEM.02184-12; Glaser P, 2001, SCIENCE, V294, P849; Heavin SB, 2009, LETT APPL MICROBIOL, V49, P179, DOI 10.1111/j.1472-765X.2009.02634.x; Hersh BM, 1996, J BACTERIOL, V178, P3978, DOI 10.1128/jb.178.13.3978-3981.1996; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Joseph B, 2006, J BACTERIOL, V188, P556, DOI 10.1128/JB.188.2.556-568.2006; Karatzas KAG, 2003, MOL MICROBIOL, V49, P1227, DOI 10.1046/j.1365-2958.2003.03636.x; Karatzas KAG, 2012, APPL ENVIRON MICROB, V78, P3571, DOI 10.1128/AEM.00227-12; Karatzas KAG, 2010, APPL ENVIRON MICROB, V76, P3529, DOI 10.1128/AEM.03063-09; McConnell EL, 2008, J PHARM PHARMACOL, V60, P63, DOI 10.1211/jpp.60.1.0008; Monk IR, 2008, APPL ENVIRON MICROB, V74, P3921, DOI 10.1128/AEM.00314-08; Monk IR, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-318; O'Byrne CP, 2011, J MICROBIOL METH, V84, P137, DOI 10.1016/j.mimet.2010.10.017; Occhialini A, 2012, J INFECT DIS, V206, P1424, DOI 10.1093/infdis/jis522; Ryan S, 2009, ENVIRON MICROBIOL, V11, P432, DOI 10.1111/j.1462-2920.2008.01782.x; SMITH K, 1992, BIOCHIMIE, V74, P705, DOI 10.1016/0300-9084(92)90143-3; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Tsai MF, 2013, P NATL ACAD SCI USA, V110, P5898, DOI 10.1073/pnas.1301444110; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Utratna M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/641647; Utratna M, 2011, APPL ENVIRON MICROB, V77, P7841, DOI 10.1128/AEM.05732-11; WALKER SJ, 1990, J APPL BACTERIOL, V68, P157, DOI 10.1111/j.1365-2672.1990.tb02561.x; Wemekamp-Kamphuis HH, 2004, APPL ENVIRON MICROB, V70, P3457, DOI 10.1128/AEM.70.6.3457-3466.2004; YOUNG KM, 1993, J APPL BACTERIOL, V74, P515	34	24	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112649	10.1371/journal.pone.0112649	http://dx.doi.org/10.1371/journal.pone.0112649			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386947	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000345250400078
J	Glen, P; Chasse, M; Doyle, MA; Nasr, A; Fergusson, DA				Glen, Peter; Chasse, Michael; Doyle, Mary-Anne; Nasr, Ahmed; Fergusson, Dean A.			Partial versus Complete Fundoplication for the Correction of Pediatric GERD: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; VERTICAL GASTRIC PLICATION; NISSEN FUNDOPLICATION; SURGICAL-TREATMENT; ANTIREFLUX SURGERY; BOIX-OCHOA; CHILDREN; GASTROPEXY	Backgroud: There is no consensus as to what extent of "wrap'' is required in a fundoplication for correction of gastroesophageal reflux disease (GERD). Objective: To evaluate if a complete (360 degree) or partial fundoplication gives better control of GERD. Methods: A systematic search of MEDLINE and Scopus identified interventional and observational studies of fundoplication in children. Screening identified those comparing techniques. The primary outcome was recurrence of GERD following surgery. Dysphagia and complications were secondary outcomes of interest. Meta-analysis was performed when appropriate. Study quality was assessed using the Cochrane Risk of Bias Tool. Results: 2289 abstracts were screened, yielding 2 randomized controlled trials (RCTs) and 12 retrospective cohort studies. The RCTs were pooled. There was no difference in surgical success between partial and complete fundoplication, OR 1.33 [0.67,2.66]. In the 12 cohort studies, 3 (25%) used an objective assessment of the surgery, one of which showed improved outcomes with complete fundoplication. Twenty-five different complications were reported; common were dysphagia and gas-bloat syndrome. Overall study quality was poor. Conclusions: The comparison of partial fundoplication with complete fundoplication warrants further study. The evidence does not demonstrate superiority of one technique. The lack of high quality RCTs and the methodological heterogeneity of observational studies limits a powerful meta-analysis.	[Glen, Peter] Univ Ottawa, Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Chasse, Michael; Fergusson, Dean A.] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Doyle, Mary-Anne] Ottawa Hosp, Dept Med, Ottawa, ON, Canada; [Nasr, Ahmed] Childrens Hosp Eastern Ontario, Div Gen Surg, Ottawa, ON K1H 8L1, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Children's Hospital of Eastern Ontario	Glen, P (corresponding author), Univ Ottawa, Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.	pglen@toh.on.ca	Chassé, Michaël/L-7906-2017; Chassé, Michaël/Y-7820-2019	Chassé, Michaël/0000-0001-7075-1924; Fergusson, Dean/0000-0002-3389-2485				Allal H, 2001, J PEDIATR SURG, V36, P921, DOI 10.1053/jpsu.2001.23975; BOIXOCHOA J, 1986, J PEDIATR SURG, V21, P1032, DOI 10.1016/0022-3468(86)90002-3; Broeders JAJL, 2010, BRIT J SURG, V97, P1318, DOI 10.1002/bjs.7174; Ceriati E, 1998, LANGENBECK ARCH SURG, V383, P317, DOI 10.1007/s004230050139; Cohen Z, 1999, EUR J PEDIATR SURG, V9, P289, DOI 10.1055/s-2008-1072265; Curry JI, 2003, J PEDIATR SURG, V38, P556, DOI 10.1053/jpsu.2003.50121; Durante AP, 2007, SAO PAULO MED J, V125, P15, DOI 10.1590/S1516-31802007000100004; Georgeson K E, 1998, Semin Laparosc Surg, V5, P25; GERD, 2009, J LAPAROENDOSC ADV S, V19, px; Goessler A, 2007, ACTA PAEDIATR, V96, P87, DOI 10.1111/j.1651-2227.2006.00005.x; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kane TD, 2009, J PEDIATR SURG, V44, P1034, DOI 10.1016/j.jpedsurg.2009.01.050; KAZEROONI NL, 1994, J PEDIATR SURG, V29, P677, DOI 10.1016/0022-3468(94)90739-0; KRUPP S, 1966, ANN SURG, V164, P927; Kubiak R, 2011, ANN SURG, V253, P44, DOI 10.1097/SLA.0b013e3181fc98a0; Levin DN, 2011, J PEDIATR SURG, V46, P854, DOI 10.1016/j.jpedsurg.2011.02.018; Ma SJ, 2012, ANZ J SURG, V82, P17, DOI 10.1111/j.1445-2197.2010.05637.x; Mauritz FA, 2013, J GASTROINTEST SURG, V17, P1883, DOI 10.1007/s11605-013-2305-3; Mauritz FA, 2011, J GASTROINTEST SURG, V15, P1872, DOI 10.1007/s11605-011-1644-1; NISSEN R, 1961, AM J DIG DIS, V6, P954, DOI 10.1007/BF02231426; NISSEN R, 1956, Schweiz Med Wochenschr, V86, P590; Reeves S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002213.pub2; Siddiqui MRS, 2011, PEDIATR SURG INT, V27, P359, DOI 10.1007/s00383-010-2698-y; Stefanidis D, 2010, SURG ENDOSC, V24, P1872; Strecker-McGraw MK, 1998, J PEDIATR SURG, V33, P1623, DOI 10.1016/S0022-3468(98)90594-2; Subramaniam R, 2000, J PEDIATR SURG, V35, P1214, DOI 10.1053/jpsu.2000.8729; TAYLOR TV, 1989, ANN ROY COLL SURG, V71, P31; THAL AP, 1965, SURG GYNECOL OBSTETR, V120, P1225; TOUPET A, 1963, Mem Acad Chir (Paris), V89, P384; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Valentine JC, 2013, RES SYNTH METHODS, V4, P26, DOI 10.1002/jrsm.1064; Vandenplas Y, 2009, J PEDIATR GASTR NUTR, V49, P498, DOI 10.1097/MPG.0b013e3181b7f563; VANDERZEE DC, 1994, PEDIATR SURG INT, V9, P334, DOI 10.1007/BF01685994; Wagener S, 2007, J PEDIATR SURG, V42, P1098, DOI 10.1016/j.jpedsurg.2007.01.047; WATSON A, 1991, BRIT J SURG, V78, P1088, DOI 10.1002/bjs.1800780918; Weber TR, 1999, ARCH SURG-CHICAGO, V134, P717, DOI 10.1001/archsurg.134.7.717	37	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112417	10.1371/journal.pone.0112417	http://dx.doi.org/10.1371/journal.pone.0112417			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386679	Green Published, Green Submitted, gold			2022-12-27	WOS:000345250400059
J	Lossl, P; Kolbel, K; Tanzler, D; Nannemann, D; Ihling, CH; Keller, MV; Schneider, M; Zaucke, F; Meiler, J; Sinz, A				Loessl, Philip; Koelbel, Knut; Taenzler, Dirk; Nannemann, David; Ihling, Christian H.; Keller, Manuel V.; Schneider, Marian; Zaucke, Frank; Meiler, Jens; Sinz, Andrea			Analysis of Nidogen-1/Laminin gamma 1 Interaction by Cross-Linking, Mass Spectrometry, and Computational Modeling Reveals Multiple Binding Modes	PLOS ONE			English	Article							LAMININ-NIDOGEN COMPLEX; PROTEIN SECONDARY STRUCTURE; BASEMENT-MEMBRANE PROTEIN; STRUCTURE PREDICTION; 1 CHAIN; IDENTIFICATION; DOMAINS; CHAPERONIN; FRAGMENTS; DATABASE	We describe the detailed structural investigation of nidogen-1/laminin gamma 1 complexes using full-length nidogen-1 and a number of laminin gamma 1 variants. The interactions of nidogen-1 with laminin variants gamma 1 LEb2-4, gamma 1 LEb2-4 N836D, gamma 1 short arm, and gamma 1 short arm N836D were investigated by applying a combination of (photo-) chemical cross-linking, high-resolution mass spectrometry, and computational modeling. In addition, surface plasmon resonance and ELISA studies were used to determine kinetic constants of the nidogen-1/laminin gamma 1 interaction. Two complementary cross-linking strategies were pursued to analyze solution structures of laminin gamma 1 variants and nidogen-1. The majority of distance information was obtained with the homobifunctional amine-reactive cross-linker bis(sulfosuccinimidyl) glutarate. In a second approach, UV-induced cross-linking was performed after incorporation of the diazirine-containing unnatural amino acids photo-leucine and photo-methionine into laminin gamma 1 LEb2-4, laminin gamma 1 short arm, and nidogen-1. Our results indicate that Asn-836 within laminin gamma 1 LEb3 domain is not essential for complex formation. Cross-links between laminin gamma 1 short arm and nidogen-1 were found in all protein regions, evidencing several additional contact regions apart from the known interaction site. Computational modeling based on the cross-linking constraints indicates the existence of a conformational ensemble of both the individual proteins and the nidogen-1/laminin gamma 1 complex. This finding implies different modes of interaction resulting in several distinct protein-protein interfaces.	[Loessl, Philip; Koelbel, Knut; Taenzler, Dirk; Ihling, Christian H.; Sinz, Andrea] Univ Halle Wittenberg, Inst Pharm, Dept Pharmaceut Chem & Bioanalyt, D-06108 Halle, Saale, Germany; [Nannemann, David; Meiler, Jens] Vanderbilt Univ, Dept Chem, Nashville, TN USA; [Nannemann, David; Meiler, Jens] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37235 USA; [Keller, Manuel V.; Zaucke, Frank] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Schneider, Marian] Univ Halle Wittenberg, Inst Biochem & Biotechnol, Res Grp Artificial Binding Prot, D-06108 Halle, Saale, Germany	Martin Luther University Halle Wittenberg; Vanderbilt University; Vanderbilt University; University of Cologne; Martin Luther University Halle Wittenberg	Sinz, A (corresponding author), Univ Halle Wittenberg, Inst Pharm, Dept Pharmaceut Chem & Bioanalyt, D-06108 Halle, Saale, Germany.	andrea.sinz@pharmazie.uni-halle.de	Zaucke, Frank/E-2077-2012; Zaucke, Frank/AAT-2688-2021	Meiler, Jens/0000-0001-8945-193X; Lossl, Philip/0000-0001-5062-7723; Nannemann, David/0000-0002-4946-3263	BMBF project; DFG [Si 867/13-1, 15-1, 16-1]; BMBF [Pro-Net-T3]; region of Saxony-Anhalt; NIH [R01 GM080403, R01 MH090192, R01 GM099842, R01 DK097376]; NSF [CHE 1305874]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080403, R01GM099842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090192] Funding Source: NIH RePORTER	BMBF project(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); region of Saxony-Anhalt; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	KK is funded by the BMBF project. AS acknowledges financial support from the DFG (projects Si 867/13-1, 15-1, and 16-1), the BMBF (Pro-Net-T3), and the region of Saxony-Anhalt. JM is funded through NIH (R01 GM080403, R01 MH090192, R01 GM099842, and R01 DK097376) and NSF (CHE 1305874). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; AUMAILLEY M, 1989, EUR J BIOCHEM, V184, P241, DOI 10.1111/j.1432-1033.1989.tb15013.x; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Baumgartner R, 1996, J MOL BIOL, V257, P658, DOI 10.1006/jmbi.1996.0192; Bechtel M, 2012, FASEB J, V26, P3637, DOI 10.1096/fj.11-194597; BECK K, 1990, FASEB J, V4, P148, DOI 10.1096/fasebj.4.2.2404817; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; BOREK F, 1961, NATURE, V191, P1293, DOI 10.1038/1911293a0; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Butler JE, 2000, METHODS, V22, P4, DOI 10.1006/meth.2000.1031; Carafoli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042473; CARLIN B, 1981, J BIOL CHEM, V256, P5209; Combs SA, 2013, NAT PROTOC, V8, P1277, DOI 10.1038/nprot.2013.074; DZIADEK M, 1985, EMBO J, V4, P2513, DOI 10.1002/j.1460-2075.1985.tb03964.x; FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x; GERL M, 1991, EUR J BIOCHEM, V202, P167, DOI 10.1111/j.1432-1033.1991.tb16358.x; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Gront D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023294; Guo X, 2008, ANAL CHEM, V80, P951, DOI 10.1021/ac701636w; Herzog F, 2012, SCIENCE, V337, P1348, DOI 10.1126/science.1221483; Ho MSP, 2008, MICROSC RES TECHNIQ, V71, P387, DOI 10.1002/jemt.20567; Hohenester E, 2013, CELL ADHES MIGR, V7, P56, DOI 10.4161/cam.21831; Hussain SA, 2011, EMBO REP, V12, P276, DOI 10.1038/embor.2011.3; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; Kahraman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073411; Kalisman N, 2012, P NATL ACAD SCI USA, V109, P2884, DOI 10.1073/pnas.1119472109; Kalkhof S, 2010, PROTEINS, V78, P3409, DOI 10.1002/prot.22848; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kolbel K, 2012, ANGEW CHEM INT EDIT, V51, P12602, DOI 10.1002/anie.201205308; Kohfeldt E, 1998, J MOL BIOL, V282, P99, DOI 10.1006/jmbi.1998.2004; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Lange OF, 2012, PROTEINS, V80, P884, DOI 10.1002/prot.23245; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leitner A, 2012, STRUCTURE, V20, P814, DOI 10.1016/j.str.2012.03.007; Leitner A, 2010, MOL CELL PROTEOMICS, V9, P1634, DOI 10.1074/mcp.R000001-MCP201; Leman JK, 2013, PROTEINS, V81, P1127, DOI 10.1002/prot.24258; Lossl P, 2014, METH MOL BIOL UNPUB; MANN K, 1988, EUR J BIOCHEM, V178, P71, DOI 10.1111/j.1432-1033.1988.tb14430.x; MAYER U, 1993, EMBO J, V12, P1879, DOI 10.1002/j.1460-2075.1993.tb05836.x; Merkley ED, 2014, PROTEIN SCI, V23, P747, DOI 10.1002/pro.2458; Miosge N, 2002, MATRIX BIOL, V21, P611, DOI 10.1016/S0945-053X(02)00070-7; Muller MQ, 2010, ANAL CHEM, V82, P6958, DOI 10.1021/ac101241t; Ortiz AR, 2002, PROTEIN SCI, V11, P2606, DOI 10.1110/ps.0215902; Patel TR, 2014, MATRIX BIOL, V33, P60, DOI 10.1016/j.matbio.2013.07.009; PAULSSON M, 1987, EUR J BIOCHEM, V166, P11, DOI 10.1111/j.1432-1033.1987.tb13476.x; Poschl E, 1996, EMBO J, V15, P5154, DOI 10.1002/j.1460-2075.1996.tb00899.x; Rappsilber J, 2011, J STRUCT BIOL, V173, P530, DOI 10.1016/j.jsb.2010.10.014; Ries A, 2001, EUR J BIOCHEM, V268, P5119, DOI 10.1046/j.0014-2956.2001.02437.x; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/nmeth.1192, 10.1038/NMETH.1192]; Salmivirta K, 2002, EXP CELL RES, V279, P188, DOI 10.1006/excr.2002.5611; SASAKI M, 1987, J BIOL CHEM, V262, P17111; Sasaki T, 2004, J CELL BIOL, V164, P959, DOI 10.1083/jcb.200401058; Schaks S, 2012, BIOMACROMOLECULAR MA, P1; Sinz A, 2014, EXPERT REV PROTEOMIC, V16, P1; Sinz A, 2006, MASS SPECTROM REV, V25, P663, DOI 10.1002/mas.20082; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stetefeld J, 1996, J MOL BIOL, V257, P644, DOI 10.1006/jmbi.1996.0191; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; Takagi J, 2003, NATURE, V424, P969, DOI 10.1038/nature01873; TIMPL R, 1979, J BIOL CHEM, V254, P9933; TIMPL R, 1983, EUR J BIOCHEM, V137, P455, DOI 10.1111/j.1432-1033.1983.tb07849.x; Tunggal P, 2000, MICROSC RES TECHNIQ, V51, P214, DOI 10.1002/1097-0029(20001101)51:3<214::AID-JEMT2>3.0.CO;2-J; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; YURCHENCO PD, 1994, CURR OPIN CELL BIOL, V6, P674, DOI 10.1016/0955-0674(94)90093-0; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	70	33	35	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112886	10.1371/journal.pone.0112886	http://dx.doi.org/10.1371/journal.pone.0112886			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25387007	Green Submitted, gold, Green Published			2022-12-27	WOS:000345250400099
J	Mehra, T; Grozinger, G; Mann, S; Guenova, E; Moos, R; Rocken, M; Claussen, CD; Dummer, R; Clasen, S; Naumann, A; Garbe, C				Mehra, Tarun; Groezinger, Gerd; Mann, Steven; Guenova, Emmanuella; Moos, Rudolf; Roecken, Martin; Claussen, Claus Detlef; Dummer, Reinhard; Clasen, Stephan; Naumann, Aline; Garbe, Claus			Primary Localization and Tumor Thickness as Prognostic Factors of Survival in Patients with Mucosal Melanoma	PLOS ONE			English	Article							POSTOPERATIVE RADIOTHERAPY; HEAD	Background: Data on survival with mucosal melanoma and on prognostic factors of are scarce. It is still unclear if the disease course allows for mucosal melanoma to be treated as primary cutaneous melanoma or if differences in overall survival patterns require adapted therapeutic approaches. Furthermore, this investigation is the first to present 10-year survival rates for mucosal melanomas of different anatomical localizations. Methodology: 116 cases from Sep 10 1984 until Feb 15 2011 retrieved from the Comprehensive Cancer Center and of the Central Register of the German Dermatologic Society databases in Tubingen were included in our analysis. We recorded anatomical location and tumor thickness, and estimated overall survival at 2, 5 and 10 years and the mean overall survival time. Survival times were analyzed with the Kaplan-Meier method. The log-rank test was used to compare survival times by localizations and by T-stages. Principal Findings: We found a median overall survival time of 80.9 months, with an overall 2-year survival of 71.7%, 5-year survival of 55.8% and 10-year survival of 38.3%. The 10-year survival rates for patients with T-1, T-2, T-3 or T-4 stage tumors were 100.0%, 77.9%, 66.3% and 10.6% respectively. 10-year survival of patients with melanomas of the vulva was 64.5% in comparison to 22.3% of patients with non-vulva mucosal melanomas. Conclusion: Survival times differed significantly between patients with melanomas of the vulva compared to the rest (p = 0.0006). It also depends on T-stage at the time of diagnosis (p<0.0001).	[Mehra, Tarun; Roecken, Martin; Garbe, Claus] Univ Tubingen, Dept Dermatol, Tubingen, Germany; [Groezinger, Gerd; Mann, Steven; Claussen, Claus Detlef; Clasen, Stephan] Univ Tubingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany; [Guenova, Emmanuella; Dummer, Reinhard] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland; [Mehra, Tarun; Moos, Rudolf] Univ Spital Zurich, Med Directorate, Zurich, Switzerland; [Naumann, Aline] Univ Tubingen, Inst Clin Epidemiol & Appl Biometry, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Eberhard Karls University of Tubingen	Mehra, T (corresponding author), Univ Tubingen, Dept Dermatol, Tubingen, Germany.	tarun.mehra@usz.ch	Guenova, Emmanuella/G-7441-2017; Garbe, Claus/ABH-2128-2021	Guenova, Emmanuella/0000-0001-5478-8735; Garbe, Claus/0000-0001-8530-780X; Rocken, Martin/0000-0003-3795-7001	Deutsche Forschungsgemeinschaft [GU1271/2-1]; Eberhard-Karls-University-Hospital of Tubingen in Germany; UniversitatsSpital Zurich, Switzerland	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Eberhard-Karls-University-Hospital of Tubingen in Germany; UniversitatsSpital Zurich, Switzerland	This work was partially supported by the Deutsche Forschungsgemeinschaft (Grant number GU1271/2-1) for EG. The Deutsche Forschungsgemeinschaft did not participate in the design or analysis of the study, nor did participate in any form in the drafting of the manuscript. The additional Funding was provided by the Eberhard-Karls-University-Hospital of Tubingen in Germany (salaries and publication costs) as well as the UniversitatsSpital Zurich, Switzerland (salaries). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Bauer CGJ, 2012, DERMATOLOGY, P1885; Benlyazid A, 2010, ARCH OTOLARYNGOL, V136, P1219, DOI 10.1001/archoto.2010.217; Chang AE, 1998, CANCER, V83, P1664, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G; GARBE C, 1995, CANCER-AM CANCER SOC, V75, P2484, DOI 10.1002/1097-0142(19950515)75:10<2484::AID-CNCR2820751014>3.0.CO;2-U; IVERSEN K, 1980, AM J SURG, V139, P660, DOI 10.1016/0002-9610(80)90358-X; Jethanamest D, 2011, ANN SURG ONCOL, V18, P2748, DOI 10.1245/s10434-011-1685-4; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kim HS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-167; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Meleti M, 2008, HEAD NECK-J SCI SPEC, V30, P1543, DOI 10.1002/hed.20901; Pflugfelder A, 2013, J DTSCH DERMATOL GES, V11, P3; R Development Core Team, 2014, R LANG ENV STAT COMP; Ross M. I., 2009, CUTANEOUS MELANOMA, P337; SAS Institute Inc, 1989, JMP VERS 10 0	15	16	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112535	10.1371/journal.pone.0112535	http://dx.doi.org/10.1371/journal.pone.0112535			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383553	Green Published, Green Accepted, gold			2022-12-27	WOS:000344816700078
J	Wu, QQ; Zhang, JZ; Shi, J; Ge, ML; Li, XX; Shao, YQ; Yao, JF; Zheng, YZ				Wu, Qingqing; Zhang, Jizhou; Shi, Jun; Ge, Meili; Li, Xingxin; Shao, Yingqi; Yao, Jianfeng; Zheng, Yizhou			Increased Bone Marrow (BM) Plasma Level of Soluble CD30 and Correlations with BM Plasma Level of Interferon (IFN)-gamma, CD4/CD8 T-Cell Ratio and Disease Severity in Aplastic Anemia	PLOS ONE			English	Article							BRENTUXIMAB VEDOTIN SGN-35; VERSUS-HOST-DISEASE; IFN-GAMMA; IMMUNOSUPPRESSIVE THERAPY; NEGATIVE SELECTION; FLOW-CYTOMETRY; SERUM-LEVELS; TNF-ALPHA; EXPRESSION; LYMPHOMA	Idiopathic aplastic anemia (AA) is an immune-mediated bone marrow failure syndrome. Immune abnormalities such as decreased lymphocyte counts, inverted CD4/CD8 T-cell ratio and increased IFN-gamma-producing T cells have been found in AA. CD30, a surface protein belonging to the tumor necrosis factor receptor family and releasing from cell surface as a soluble form (sCD30) after activation, marks a subset of activated T cells secreting IFN-gamma when exposed to allogeneic antigens. Our study found elevated BM plasma levels of sCD30 in patients with SAA, which were closely correlated with disease severity, including absolute lymphocyte count (ALC) and absolute netrophil count (ANC). We also noted that sCD30 levels were positively correlated with plasma IFN-gamma levels and CD4/CD8 T-cell ratio in patients with SAA. In order to explain these phenomena, we stimulated T cells with alloantigen in vitro and found that CD30(+) T cells were the major source of IFN-gamma, and induced CD30(+) T cells from patients with SAA produced significantly more IFN-gamma than that from healthy individuals. In addition, increased proportion of CD8(+) T cells in AA showed enhanced allogeneic response by the fact that they expressed more CD30 during allogeneic stimulation. sCD30 levels decreased in patients responded to immunosuppressive therapy. In conclusion, elevated BM plasma levels of sCD30 reflected the enhanced CD30(+) T cell-mediated immune response in SAA. CD30 as a molecular marker that transiently expresses on IFN-gamma-producing T cells, may participate in mediating bone marrow failure in AA, which also can facilitate our understanding of AA pathogenesis to identify new therapeutic targets.	[Wu, Qingqing; Zhang, Jizhou; Shi, Jun; Ge, Meili; Li, Xingxin; Shao, Yingqi; Yao, Jianfeng; Zheng, Yizhou] Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, Severe Aplast Anemia Studying Program, State Key Lab Expt Hematol, 288 Nanjing Rd, Tianjin 300020, Peoples R China; [Wu, Qingqing; Zhang, Jizhou; Shi, Jun; Ge, Meili; Li, Xingxin; Shao, Yingqi; Yao, Jianfeng; Zheng, Yizhou] Peking Union Med Coll, Tianjin 300020, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zheng, YZ (corresponding author), Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, Severe Aplast Anemia Studying Program, State Key Lab Expt Hematol, 288 Nanjing Rd, Tianjin 300020, Peoples R China.	zheng_yizhou@hotmail.com	Wu, Qingqing/AFU-3222-2022	Wu, Qingqing/0000-0002-1566-1253	National Public Health Grant Research Foundation of China [201202017]; Fundamental Research Funds for the Central Universities of China [2012N05]; National Basic Research Program [2010CB945204]; National Natural Science Foundation of China (NNSFC) [81330015]; NNSFC [81300388]	National Public Health Grant Research Foundation of China; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China (NNSFC)(National Natural Science Foundation of China (NSFC)); NNSFC(National Natural Science Foundation of China (NSFC))	This study was supported by the National Public Health Grant Research Foundation of China (no. 201202017) to Y.Z., http://www.nhfpc.gov.cn/zhuzhan/index.shtml; the Fundamental Research Funds for the Central Universities of China (no. 2012N05) to Y.Z., http://www.moe.gov.cn/; the National Basic Research Program (2010CB945204) to Y.Z., http://www.nsfc.gov.cn/; the National Natural Science Foundation of China (NNSFC, no. 81330015) to Z.H., http://www.nsfc.gov.cn/; and the NNSFC (no. 81300388) to M.G., http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALZONA M, 1994, J IMMUNOL, V153, P2861; Amakawa R, 1996, CELL, V84, P551, DOI 10.1016/S0092-8674(00)81031-4; Berro AI, 2004, J IMMUNOL, V173, P2174, DOI 10.4049/jimmunol.173.3.2174; Brodsky RA, 2005, LANCET, V365, P1647, DOI 10.1016/S0140-6736(05)66515-4; CALIGARISCAPPIO F, 1995, CLIN EXP RHEUMATOL, V13, P339; CAMITTA BM, 1979, BLOOD, V53, P504; Chan KW, 2002, J IMMUNOL, V169, P1784, DOI 10.4049/jimmunol.169.4.1784; Chen JC, 2007, J IMMUNOL, V178, P4159, DOI 10.4049/jimmunol.178.7.4159; Chen YB, 2012, BLOOD, V120, P691, DOI 10.1182/blood-2012-03-415422; Chiarle R, 1999, J IMMUNOL, V163, P194; Couriel D, 2004, CANCER-AM CANCER SOC, V101, P1936, DOI 10.1002/cncr.20613; Dummer W, 1997, BRIT J DERMATOL, V137, P185, DOI 10.1046/j.1365-2133.1997.18031887.x; ELLIS TM, 1993, J IMMUNOL, V151, P2380; Fanale MA, 2012, CLIN CANCER RES, V18, P248, DOI 10.1158/1078-0432.CCR-11-1425; Gerli R, 1995, CLIN EXP IMMUNOL, V102, P547; Goto M, 2013, BRIT J HAEMATOL, V160, P359, DOI 10.1111/bjh.12116; Hansen HP, 2000, J IMMUNOL, V165, P6703, DOI 10.4049/jimmunol.165.12.6703; Hirano N, 2005, BRIT J HAEMATOL, V128, P221, DOI 10.1111/j.1365-2141.2004.05317.x; Hirano N, 2003, BLOOD, V102, P4567, DOI 10.1182/blood-2002-11-3409; Hubel K, 2010, TRANSPL IMMUNOL, V23, P215, DOI 10.1016/j.trim.2010.07.001; Marsh JCW, 2009, BRIT J HAEMATOL, V147, P43, DOI 10.1111/j.1365-2141.2009.07842.x; Martinez OM, 1998, TRANSPLANTATION, V65, P1240, DOI 10.1097/00007890-199805150-00016; Mir SS, 2000, BLOOD, V96, P4307; Pro B, 2012, J CLIN ONCOL, V30, P2190, DOI 10.1200/JCO.2011.38.0402; Rezaei N, 2008, J CLIN IMMUNOL, V28, P78, DOI 10.1007/s10875-007-9135-6; Risitano AM, 2004, LANCET, V364, P355, DOI 10.1016/S0140-6736(04)16724-X; Risitano AM, 2002, BLOOD, V100, P178, DOI 10.1182/blood-2002-01-0236; Saraiva M, 2002, J EXP MED, V196, P829, DOI 10.1084/jem.20020319; Sasse S, 2013, LEUKEMIA LYMPHOMA, V54, P2144, DOI 10.3109/10428194.2013.775434; Scheinberg P, 2009, BRIT J HAEMATOL, V144, P206, DOI 10.1111/j.1365-2141.2008.07450.x; Schlaf G, 2007, HISTOL HISTOPATHOL, V22, P1269, DOI 10.14670/HH-22.1269; Sloand E, 2002, BLOOD, V100, P1185, DOI 10.1182/blood-2002-01-0035; Takamatsu H, 2009, J IMMUNOL, V182, P703, DOI 10.4049/jimmunol.182.1.703; Telford WG, 1997, CELL IMMUNOL, V182, P125, DOI 10.1006/cimm.1997.1228; Velasquez SY, 2013, TRANSPLANTATION, V96, P154, DOI 10.1097/TP.0b013e318296fd69; Younes A, 2010, NEW ENGL J MED, V363, P1812, DOI 10.1056/NEJMoa1002965; Young NS, 2008, CURR OPIN HEMATOL, V15, P162, DOI 10.1097/MOH.0b013e3282fa7470; Zeiser R, 2007, BLOOD, V109, P2225, DOI 10.1182/blood-2006-07-038455; Zeng WH, 2001, J CLIN INVEST, V108, P765, DOI 10.1172/JCI12687; ZOUMBOS NC, 1984, BRIT J HAEMATOL, V58, P95, DOI 10.1111/j.1365-2141.1984.tb06063.x	40	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e110787	10.1371/journal.pone.0110787	http://dx.doi.org/10.1371/journal.pone.0110787			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383872	Green Submitted, gold, Green Published			2022-12-27	WOS:000344816700010
J	Lan, N; Luo, GY; Yang, XQ; Cheng, YY; Zhang, Y; Wang, XY; Wang, X; Xie, T; Li, GP; Liu, ZG; Zhong, NS				Lan, Nan; Luo, Guangyan; Yang, Xiaoqiong; Cheng, Yuanyuan; Zhang, Yun; Wang, Xiaoyun; Wang, Xing; Xie, Tao; Li, Guoping; Liu, Zhigang; Zhong, Nanshan			25-Hydroxyvitamin D3-Deficiency Enhances Oxidative Stress and Corticosteroid Resistance in Severe Asthma Exacerbation	PLOS ONE			English	Article							VITAMIN-D STATUS; OBSTRUCTIVE PULMONARY-DISEASE; DNA-DAMAGE; MOLECULAR-MECHANISMS; AIRWAY INFLAMMATION; ANTIOXIDANT STATUS; EPITHELIAL-CELLS; LUNG-FUNCTION; TNF-ALPHA; CHILDREN	Oxidative stress plays a significant role in exacerbation of asthma. The role of vitamin D in oxidative stress and asthma exacerbation remains unclear. We aimed to determine the relationship between vitamin D status and oxidative stress in asthma exacerbation. Severe asthma exacerbation patients with 25-hydroxyvitamin D3-deficiency (V-D deficiency) or 25-hydroxyvitamin D-sufficiency (V-D sufficiency) were enrolled. Severe asthma exacerbation with V-D-deficiency showed lower forced expiratory volume in one second (FEV1) compared to that with V-D-sufficiency. V-D-deficiency intensified ROS release and DNA damage and increased TNF-alpha, OGG1 and NF kappa B expression and NF kappa B phosphorylation in severe asthma exacerbation. Supplemental vitamin D3 significantly increased the rates of FEV1 change and decreased ROS and DNA damage in V-D-deficiency. Vitamin D3 inhibited LPS-induced ROS and DNA damage and were associated with a decline in TNF-alpha and NF kappa B in epithelial cells. H2O2 reduces nuclear translocation of glucocorticoid receptors in airway epithelial cell lines. V-D pretreatment enhanced the dexamethasone-induced nuclear translocation of glucocorticoid receptors in airway epithelial cell lines and monocytes from 25-hydroxyvitamin D3-deficiency asthma patients. These findings indicate that V-D deficiency aggravates oxidative stress and DNA damage, suggesting a possible mechanism for corticosteroid resistance in severe asthma exacerbation.	[Lan, Nan; Yang, Xiaoqiong; Cheng, Yuanyuan; Zhang, Yun; Wang, Xiaoyun; Wang, Xing; Xie, Tao; Li, Guoping] Luzhou Med Coll, Affiliated Hosp, Inflammat & Allerg Dis Res Unit, Luzhou 646000, Sichuan, Peoples R China; [Luo, Guangyan] Luzhou Med Coll, Hyg Sect, Luzhou 646000, Sichuan, Peoples R China; [Li, Guoping; Liu, Zhigang] Shenzhen Univ, Sch Med, State Key Lab Resp Dis Allergy, Shenzhen 518060, Guangdong, Peoples R China; [Zhong, Nanshan] Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou 510120, Guangdong, Peoples R China	Southwest Medical University; Southwest Medical University; Shenzhen University; State Key Laboratory of Respiratory Disease; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Li, GP (corresponding author), Luzhou Med Coll, Affiliated Hosp, Inflammat & Allerg Dis Res Unit, Luzhou 646000, Sichuan, Peoples R China.	lzlgp@163.com; lzg195910@126.com; nanshan@vip.163.com			Chinese National Science Foundation [81170032]	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC))	This project was supported by Chinese National Science Foundation Grant 81170032. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2012, ANN THORAC MED, V7, P226, DOI 10.4103/1817-1737.102182; Asaba K, 2004, ENDOCRINOLOGY, V145, P39, DOI 10.1210/en.2003-0375; Berry DJ, 2011, BRIT J NUTR, V106, P1433, DOI 10.1017/S0007114511001991; Bousquet J, 2010, J ALLERGY CLIN IMMUN, V126, P926, DOI 10.1016/j.jaci.2010.07.019; Bozzetto S, 2012, ALLERGY, V67, P10, DOI 10.1111/j.1398-9995.2011.02711.x; Brehm JM, 2012, AM J RESP CRIT CARE, V186, P140, DOI 10.1164/rccm.201203-0431OC; Brightling C, 2008, J ALLERGY CLIN IMMUN, V121, P5, DOI 10.1016/j.jaci.2007.10.028; Chung KF, 2010, ANN NY ACAD SCI, V1203, P85, DOI 10.1111/j.1749-6632.2010.05600.x; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Codoner-Franch P, 2012, J PEDIATR-US, V161, P848, DOI 10.1016/j.jpeds.2012.04.046; Di Rosa M, 2012, CELL IMMUNOL, V280, P36, DOI 10.1016/j.cellimm.2012.10.009; Dunstan JA, 2006, CLIN EXP ALLERGY, V36, P993, DOI 10.1111/j.1365-2222.2006.02539.x; Fedirko V, 2010, CANCER EPIDEM BIOMAR, V19, P280, DOI 10.1158/1055-9965.EPI-09-0448; Finklea JD, 2011, ADV NUTR, V2, P244, DOI 10.3945/an.111.000398; Goleva E, 2008, J ALLERGY CLIN IMMUN, V122, P550, DOI 10.1016/j.jaci.2008.07.007; Goleva E, 2013, AM J RESP CRIT CARE, V188, P1193, DOI 10.1164/rccm.201304-0775OC; Gupta GK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042789; Hamden K, 2009, J NUTR SCI VITAMINOL, V55, P215, DOI 10.3177/jnsv.55.215; Hansdottir S, 2011, VITAM HORM, V86, P217, DOI 10.1016/B978-0-12-386960-9.00009-5; He XJ, 2012, MOLECULES, V17, P3155, DOI 10.3390/molecules17033155; Huang CH, 2013, PHYTOMEDICINE, V20, P303, DOI 10.1016/j.phymed.2012.11.004; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; Janssen-Heininger Y, 2005, AM J PATHOL, V166, P649, DOI 10.1016/S0002-9440(10)62286-9; Katsoulis K, 2003, J ASTHMA, V40, P847, DOI 10.1081/JAS-120023575; Knaapen AM, 2002, MOL CELL BIOCHEM, V234, P143, DOI 10.1023/A:1015997001657; Kox M, 2013, CLIN EXP IMMUNOL, V171, P231, DOI 10.1111/cei.12006; Kratzer E, 2012, AM J RESP CELL MOL, V47, P688, DOI 10.1165/rcmb.2012-0161OC; Li GP, 2012, FREE RADICAL BIO MED, V52, P392, DOI 10.1016/j.freeradbiomed.2011.10.490; Liu AH, 2002, J ALLERGY CLIN IMMUN, V109, P379, DOI 10.1067/mai.2002.122157; Marotta F, 2012, J BIOL REG HOMEOS AG, V26, P285; Meng Z, 2013, ACTA PHARMACOL SIN, V34, P901, DOI 10.1038/aps.2013.24; Milara J, 2011, CLIN EXP ALLERGY, V41, P535, DOI 10.1111/j.1365-2222.2011.03715.x; Nanzer AM, 2013, J ALLERGY CLIN IMMUN, V132, P297, DOI 10.1016/j.jaci.2013.03.037; Okamoto T, 2004, AM J PHYSIOL-LUNG C, V286, pL198, DOI 10.1152/ajplung.00136.2003; Papiris S, 2002, CRIT CARE, V6, P30; Peden DB, 2011, IMMUNOL REV, V242, P91, DOI 10.1111/j.1600-065X.2011.01035.x; Peng XJ, 2010, J CELL BIOCHEM, V110, P1324, DOI 10.1002/jcb.22646; Renz H, 2002, EUR RESPIR J, V19, P158, DOI 10.1183/09031936.02.00254202; Rosanna D, 2012, CURR PHARM DESIGN, V18, P3889, DOI 10.2174/138161212802083716; Sevin CM, 2010, CLIN EXP ALLERGY, V40, P1142, DOI 10.1111/j.1365-2222.2010.03563.x; Shermatov K, 2012, INDIAN PEDIATR, V49, P958, DOI 10.1007/s13312-012-0250-y; To Y, 2010, AM J RESP CRIT CARE, V182, P897, DOI 10.1164/rccm.200906-0937OC; Tse SM, 2012, J ALLERGY CLIN IMMUN, V130, P53, DOI 10.1016/j.jaci.2012.04.005; Williams LK, 2011, J ALLERGY CLIN IMMUN, V128, P1185, DOI 10.1016/j.jaci.2011.09.011; Wu AC, 2012, AM J RESP CRIT CARE, V186, P508, DOI 10.1164/rccm.201202-0351OC; Zhang QL, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-35; Zhang Y, 2014, J ALLERGY CLIN IMMUN, V133, P1744, DOI 10.1016/j.jaci.2013.12.004	47	59	61	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111599	10.1371/journal.pone.0111599	http://dx.doi.org/10.1371/journal.pone.0111599			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380286	Green Published, Green Submitted, gold			2022-12-27	WOS:000344863100036
J	Lee, TC; Lee, TH; Huang, YH; Chang, NK; Lin, YJ; Chien, PWC; Yang, WH; Lin, MHC				Lee, Tao-Chen; Lee, Tsung-Han; Huang, Yu-Hua; Chang, Nyuk-Kong; Lin, Yu-Jun; Chien, Pei-Wen Chang; Yang, Wei-Hsun; Lin, Martin Hsiu-Chu			Comparison of Surface Markers between Human and Rabbit Mesenchymal Stem Cells	PLOS ONE			English	Article							BONE-MARROW; ADIPOSE-TISSUE; STROMAL CELLS	This study investigated whether there are marked differences in surface markers between rabbit and human mesenchymal stem cells (MSCs). Murine and rabbit MSCs have been reported to be CD90-negative. Rat MSCs have been reported to be CD71-negative. Our previous study also shows that rabbit MSCs are CD29-negative. However, human MSCs are generally considered to be CD29-, CD71-, and CD90-positive. Therefore, the surface markers of human MSCs might differ from those of other species. Rabbit bone marrow MSCs were obtained that had a multi-differentiation potential. The phenotype of these cells was studied using flow cytometry antibodies for 25 rabbit surface markers, namely, CD13, CD14, CD29, CD31, CD34, CD44, CD45, CD49d, CD49f, CD51, CD54, CD59, CD71, CD73, CD90, CD105, CD106, CD133, CD166, MHC I, MHC II, alpha-smooth muscle actin (alpha-SMA), cytokeratin, desmin, and vimentin. The phenotype of commercially available human MSCs was similarly studied using antibodies for human surface markers. CD14, CD31, CD34, CD45, CD49d, CD49f, CD51, CD54, CD71, CD106, CD133, MHC II, and cytokeratin were absent from both rabbit and human MSCs, while CD44, alpha-SMA, and vimentin were present on both cell lines. CD13, CD29, CD59, CD73, CD90, CD105, CD166, and MHC I were present on human MSCs, but not on rabbit MSCs. However, desmin was present on rabbit MSCs, but not on human MSCs. In total, the surface expression of nine markers differed between human and rabbit MSCs, whereas the surface expression of 16 markers was the same in the two cell lines.	[Lee, Tao-Chen; Yang, Wei-Hsun; Lin, Martin Hsiu-Chu] Chiayi Chang Gung Mem Hosp, Dept Neurosurg, Chiayi, Taiwan; [Lee, Tao-Chen; Yang, Wei-Hsun; Lin, Martin Hsiu-Chu] Chang Gung Univ, Coll Med, Chiayi, Taiwan; [Lee, Tsung-Han; Huang, Yu-Hua; Lin, Yu-Jun; Chien, Pei-Wen Chang] Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Lee, Tsung-Han; Huang, Yu-Hua; Chang, Nyuk-Kong; Lin, Yu-Jun; Chien, Pei-Wen Chang] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Chang, Nyuk-Kong] Kaohsiung Chang Gung Mem Hosp, Dept Ctr Lab Anim, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Lee, TC (corresponding author), Chiayi Chang Gung Mem Hosp, Dept Neurosurg, Chiayi, Taiwan.	leetc@cgmh.org.tw			National Science Council of Taiwan [NSC100-2314-B-182A-011-MY2]; Chang Gung Memorial Hospital, Taiwan [CMRPG6C0481]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This article was sponsored by National Science Council of Taiwan, grant numbers: NSC100-2314-B-182A-011-MY2 (Website: http://web1.nsc.gov.tw/) and Chang Gung Memorial Hospital, Taiwan, grant numbers: CMRPG6C0481 (Website: http://jiawww.cgmh.org.tw/intr/c01s60/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco JF, 2010, SPINE, V35, P2259, DOI 10.1097/BRS.0b013e3181cb8828; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5; Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138; Halfon S, 2011, STEM CELLS DEV, V20, P53, DOI 10.1089/scd.2010.0040; Martinez-Lorenzo MJ, 2009, J ORTHOP RES, V27, P1499, DOI 10.1002/jor.20898; Karaoz E, 2009, HISTOCHEM CELL BIOL, V132, P533, DOI 10.1007/s00418-009-0629-6; Kassem M, 2004, CLONING STEM CELLS, V6, P369, DOI 10.1089/clo.2004.6.369; Lapi Simone, 2008, BMC Res Notes, V1, P53, DOI 10.1186/1756-0500-1-53; Lee Tsung-Han, 2013, BMC Res Notes, V6, P528, DOI 10.1186/1756-0500-6-528; P Mafi, 2011, Open Orthop J, V5, P253, DOI 10.2174/1874325001105010253; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Screven R, 2014, VET IMMUNOL IMMUNOP, V161, P21, DOI 10.1016/j.vetimm.2014.06.002; Stich S, 2008, EUR J CELL BIOL, V87, P365, DOI 10.1016/j.ejcb.2008.03.009	15	49	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111390	10.1371/journal.pone.0111390	http://dx.doi.org/10.1371/journal.pone.0111390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380245	Green Submitted, Green Published, gold			2022-12-27	WOS:000344863100026
J	He, LW; Shi, R; Jiang, L; Zeng, Y; Ma, WL; Zhou, JY				He, Li-Wen; Shi, Rong; Jiang, Lei; Zeng, Ye; Ma, Wen-Li; Zhou, Jue-Yu			XRCC1 Gene Polymorphisms and Glioma Risk in Chinese Population: A Meta-Analysis	PLOS ONE			English	Article							DNA-REPAIR GENES; BASE EXCISION-REPAIR; ASSOCIATION; SUSCEPTIBILITY; CANCER; EPIDEMIOLOGY; VARIANTS	Background: Three extensively investigated polymorphisms (Arg399Gln, Arg194Trp, and Arg280His) in the X-ray repair cross-complementing group 1 (XRCC1) gene have been implicated in risk for glioma. However, the results from different studies remain inconsistent. To clarify these conflicts, we performed a quantitative synthesis of the evidence to elucidate these associations in the Chinese population. Methods: Data were extracted from PubMed and EMBASE, with the last search up to August 21, 2014. Meta-analysis was performed by critically reviewing 8 studies for Arg399Gln (3062 cases and 3362 controls), 8 studies for Arg194Trp (3419 cases and 3680 controls), and 5 studies for Arg280His (2234 cases and 2380 controls). All of the statistical analyses were performed using the software program, STATA (version 11.0). Results: Our analysis suggested that both Arg399Gln and Arg194Trp polymorphisms were significantly associated with increased risk of glioma (for Arg399Gln polymorphism: Gln/Gln vs. Arg/Arg, OR = 1.82, 95% CI = 1.46-2.27, P = 0.000; Arg/Gln vs. Arg/Arg, OR = 1.25, 95% CI = 1.10-1.42, P = 0.001 and for Arg194Trp polymorphism: recessive model, OR = 1.78, 95% CI = 1.44-2.19, P = 0.000), whereas the Arg280His polymorphism had no influence on the susceptibility to glioma in a Chinese population. Conclusions: This meta-analysis suggests that there may be no association between the Arg280His polymorphism and glioma risk, whereas the Arg399Gln/Arg194Trp polymorphisms may contribute to genetic susceptibility to glioma in the Chinese population. Nevertheless, large-scale, well-designed and population-based studies are needed to further evaluate gene-gene and gene-environment interactions, as well as to measure the combined effects of these XRCC1 variants on glioma risk.	[He, Li-Wen; Shi, Rong; Ma, Wen-Li; Zhou, Jue-Yu] Southern Med Univ, Inst Genet Engn, Guangzhou, Guangdong, Peoples R China; [He, Li-Wen] Southern Med Univ, Zhujiang Hosp, Guangzhou, Guangdong, Peoples R China; [Jiang, Lei] Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Zeng, Ye] Southern Med Univ, Nanfang Hosp, Dept Stomatol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Naval Medical University; Southern Medical University - China	Zhou, JY (corresponding author), Southern Med Univ, Inst Genet Engn, Guangzhou, Guangdong, Peoples R China.	zhoujueyu@126.com			National Natural Science Foundation of China [81201565, 81101536]; Program of the Pearl River Young Talents of Science and Technology in Guangzhou, China [2013J2200042]; Natural Science Foundation of Guangdong Province, China [S2012010009404, S2012010009294]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20124433120001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of the Pearl River Young Talents of Science and Technology in Guangzhou, China; Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (81201565, 81101536), Program of the Pearl River Young Talents of Science and Technology in Guangzhou, China (2013J2200042), Natural Science Foundation of Guangdong Province, China (S2012010009404, S2012010009294) and Specialized Research Fund for the Doctoral Program of Higher Education of China (20124433120001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Attia J, 2003, J CLIN EPIDEMIOL, V56, P297, DOI 10.1016/S0895-4356(03)00011-8; Bethke L, 2008, HUM MOL GENET, V17, P800, DOI 10.1093/hmg/ddm351; Caldecott KW, 1995, NUCLEIC ACIDS RES, V23, P4836, DOI 10.1093/nar/23.23.4836; Camargo MC, 2006, CANCER EPIDEM BIOMAR, V15, P1674, DOI 10.1158/1055-9965.EPI-06-0189; Campalans A, 2005, DNA REPAIR, V4, P826, DOI 10.1016/j.dnarep.2005.04.014; Cengiz SL, 2008, NEUROSCIENCES, V13, P227; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Felini MJ, 2007, NEUROEPIDEMIOLOGY, V29, P55, DOI 10.1159/000108919; Gao K, 2014, GENET MOL RES, V13, P1203, DOI 10.4238/2014.February.27.5; Gao LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020157; Goodenberger ML, 2012, CANCER GENET-NY, V205, P613, DOI 10.1016/j.cancergen.2012.10.009; Gu J, 2009, NEUROTHERAPEUTICS, V6, P427, DOI 10.1016/j.nurt.2009.05.001; Hamajima Nobuyuki, 2002, Asian Pac J Cancer Prev, V3, P197; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hu XD, 2011, J COMB OPTIM, V21, P1, DOI 10.1007/s10878-010-9361-3; Jiang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055597; Jin X, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068617, 10.1371/journal.pone.0078071]; Karahalil B, 2012, HUM EXP TOXICOL, V31, P981, DOI 10.1177/0960327112444476; Kiuru A, 2008, J NEURO-ONCOL, V88, P135, DOI 10.1007/s11060-008-9556-y; Li MJ, 2013, J NEURO-ONCOL, V111, P221, DOI 10.1007/s11060-012-1022-1; Liu HB, 2012, ASIAN PAC J CANCER P, V13, P4905, DOI 10.7314/APJCP.2012.13.10.4905; Liu J, 2011, MOD PREV MED, V38, P3340; Liu YH, 2009, CANCER EPIDEM BIOMAR, V18, P204, DOI 10.1158/1055-9965.EPI-08-0632; Luo KQ, 2013, ASIAN PAC J CANCER P, V14, P449, DOI 10.7314/APJCP.2013.14.1.449; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mao C, 2010, BREAST CANCER RES TR, V121, P245, DOI 10.1007/s10549-009-0605-9; Martinez Ramon, 2012, J Signal Transduct, V2012, P519807, DOI 10.1155/2012/519807; Minelli C, 2008, INT J EPIDEMIOL, V37, P136, DOI 10.1093/ije/dym234; Monaco R, 2007, PROTEIN J, V26, P541, DOI 10.1007/s10930-007-9095-y; Moullan N, 2003, CANCER EPIDEM BIOMAR, V12, P1168; Ostrom QT, 2011, CURR NEUROL NEUROSCI, V11, P329, DOI 10.1007/s11910-011-0189-8; Pan WR, 2013, INT J MOL SCI, V14, P3314, DOI 10.3390/ijms14023314; Rajaraman P, 2010, NEURO-ONCOLOGY, V12, P37, DOI 10.1093/neuonc/nop012; Ricard D, 2012, LANCET, V379, P1984, DOI 10.1016/S0140-6736(11)61346-9; Rodriguez-Hernandez I, 2013, GENE; Salanti G, 2005, EUR J HUM GENET, V13, P840, DOI 10.1038/sj.ejhg.5201410; Schwartzbaum JA, 2006, NAT CLIN PRACT NEURO, V2, P494, DOI 10.1038/ncpneuro0289; Shen MR, 1998, CANCER RES, V58, P604; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; SICILIANO MJ, 1986, MUTAT RES, V174, P303, DOI 10.1016/0165-7992(86)90051-5; Sun JY, 2012, ASIAN PAC J CANCER P, V13, P4783, DOI 10.7314/APJCP.2012.13.9.4783; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Wang DH, 2012, GENE, V509, P223, DOI 10.1016/j.gene.2012.08.023; Wang LE, 2004, CANCER RES, V64, P5560, DOI 10.1158/0008-5472.CAN-03-2181; Wei XT, 2013, MOL BIOL REP, V40, P567, DOI 10.1007/s11033-012-2093-y; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Xu G, 2013, TUMOUR BIOL J INT SO; Yang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063827; Yosunkaya E, 2010, BRIT J NEUROSURG, V24, P561, DOI 10.3109/02688697.2010.489655; Yu Z, 1999, ENVIRON MOL MUTAGEN, V33, P3, DOI 10.1002/(SICI)1098-2280(1999)33:1<3::AID-EM2>3.0.CO;2-L; Zhang HJ, 2013, TUMOR BIOL, V34, P3003, DOI 10.1007/s13277-013-0865-1; Zhang L, 2013, PAK J MED SCI, V29, P37, DOI 10.12669/pjms.291.2694; Zhang L, 2012, EXP THER MED, V4, P1057, DOI 10.3892/etm.2012.716; Zhou LQ, 2011, ASIAN PAC J CANCER P, V12, P2547; Zhu W, 2013, TUMOUR BIOL J INT SO	59	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111981	10.1371/journal.pone.0111981	http://dx.doi.org/10.1371/journal.pone.0111981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375625	Green Submitted, gold, Green Published			2022-12-27	WOS:000344402600084
J	Shane, MS; Weywadt, CR				Shane, Matthew S.; Weywadt, Christina R.			Voluntary Modulation of Anterior Cingulate Response to Negative Feedback	PLOS ONE			English	Article							MEDIAL-FRONTAL-CORTEX; REAL-TIME FMRI; EMOTION REGULATION; ELECTROPHYSIOLOGICAL RESPONSES; CHILDREN; PSYCHOPATHOLOGY; ACTIVATION; BEHAVIOR; CONTEXT; REWARD	Anterior cingulate and medial frontal cortex (dACC/mFC) response to negative feedback represents the actions of a generalized error-monitoring system critical for the management of goal-directed behavior. Magnitude of dACC/mFC response to negative feedback correlates with levels of post-feedback behavioral change, and with proficiency of operant learning processes. With this in mind, it follows that an ability to alter dACC/mFC response to negative feedback may lead to representative changes in operant learning proficiency. To this end, the present study investigated the extent to which healthy individuals would show modulation of their dACC/mFC response when instructed to try to either maximize or minimize their neural response to the presentation of contingent negative feedback. Participants performed multiple runs of a standard time-estimation task, during which they received feedback regarding their ability to accurately estimate a one-second duration. On Watch runs, participants were simply instructed to try to estimate as closely as possible the one second duration. On Increase and Decrease runs, participants performed the same task, but were instructed to "try to increase [decrease] their brain's response every time they received negative feedback''. Results indicated that participants showed changes in dACC/mFC response under these differing instructional conditions: dACC/mFC activity following negative feedback was higher in the Increase condition, and dACC activity trended lower in the Decrease condition, compared to the Watch condition. Moreover, dACC activity correlated with post-feedback performance adjustments, and these adjustments were highest in the Increase condition. Potential implications for neuromodulation and facilitated learning are discussed.	[Shane, Matthew S.] Univ Ontario, Inst Technol, Oshawa, ON, Canada; [Shane, Matthew S.] Mind Res Network, Albuquerque, NM USA; [Weywadt, Christina R.] Univ New Mexico, Albuquerque, NM 87131 USA	Ontario Tech University; Lovelace Respiratory Research Institute; University of New Mexico	Shane, MS (corresponding author), Univ Ontario, Inst Technol, Oshawa, ON, Canada.	matthew.shane@uoit.ca			Mind Research Network; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026932] Funding Source: NIH RePORTER	Mind Research Network; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project has been supported by an internal award by The Mind Research Network to MSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calhoun VD, 2004, NEUROIMAGE, V22, P252, DOI 10.1016/j.neuroimage.2003.12.029; Clark VP, 2012, NEUROIMAGE, V59, P117, DOI 10.1016/j.neuroimage.2010.11.036; Dan-Glauser ES, 2013, EMOTION, V13, P832, DOI 10.1037/a0032672; Davidson RJ, 2000, PSYCHOL BULL, V126, P890, DOI 10.1037/0033-2909.126.6.890; deCharms RC, 2005, P NATL ACAD SCI USA, V102, P18626, DOI 10.1073/pnas.0505210102; Erk S, 2010, J NEUROSCI, V30, P15726, DOI 10.1523/JNEUROSCI.1856-10.2010; Freire L, 2001, NEUROIMAGE, V14, P709, DOI 10.1006/nimg.2001.0869; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Gehring WJ, 2002, SCIENCE, V296, P1611; Groom MJ, 2013, J CHILD PSYCHOL PSYC, V54, P836, DOI 10.1111/jcpp.12069; Gross JJ, 2011, EMOT REV, V3, P8, DOI 10.1177/1754073910380974; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Hajcak G, 2003, BIOL PSYCHOL, V64, P77, DOI 10.1016/S0301-0511(03)00103-0; Hall JR, 2007, PSYCHOL SCI, V18, P326, DOI 10.1111/j.1467-9280.2007.01899.x; Harmer CJ, 2001, NAT NEUROSCI, V4, P17, DOI 10.1038/82854; Holroyd CB, 2004, PSYCHOPHYSIOLOGY, V41, P245, DOI 10.1111/j.1469-8986.2004.00152.x; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Holroyd CB, 2006, BRAIN RES, V1105, P93, DOI 10.1016/j.brainres.2005.12.015; Ichikawa N, 2011, COGN AFFECT BEHAV NE, V11, P354, DOI 10.3758/s13415-011-0028-z; Lewis MD, 2008, DEV PSYCHOPATHOL, V20, P913, DOI 10.1017/S0954579408000448; Luu P, 2003, PSYCHOL SCI, V14, P47, DOI 10.1111/1467-9280.01417; Luu P, 2001, CLIN NEUROPHYSIOL, V112, P1295, DOI 10.1016/S1388-2457(01)00559-4; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Moser JS, 2015, J CLIN CHILD ADOLESC, V44, P329, DOI 10.1080/15374416.2013.865191; Nieuwenhuis S, 2004, CEREB CORTEX, V14, P741, DOI 10.1093/cercor/bhh034; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Posse S, 2003, NEUROIMAGE, V18, P760, DOI 10.1016/S1053-8119(03)00004-1; Schneider W., 2002, E PRIME USERS GUIDE; Silvers J., 2013, OXFORD HDB COGNITIVE, V2; Swick D, 2004, COGNITIVE NEUROSCIEN, P393; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; van Duijvenvoorde ACK, 2008, J NEUROSCI, V28, P9495, DOI 10.1523/JNEUROSCI.1485-08.2008; Volkow ND, 2010, NEUROIMAGE, V49, P2536, DOI 10.1016/j.neuroimage.2009.10.088; Wessing I, 2013, NEUROIMAGE, V81, P15, DOI 10.1016/j.neuroimage.2013.04.117; Williams NR, 2014, ACAD PSYCHIATR, V38, P168, DOI 10.1007/s40596-014-0050-x; Wrase J, 2007, NEUROIMAGE, V36, P1253, DOI 10.1016/j.neuroimage.2007.04.001; Zanolie K, 2008, NEUROPSYCHOLOGIA, V46, P117, DOI 10.1016/j.neuropsychologia.2007.08.009; Zotev V, 2014, NEUROIMAGE, V85, P985, DOI 10.1016/j.neuroimage.2013.04.126	40	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e107322	10.1371/journal.pone.0107322	http://dx.doi.org/10.1371/journal.pone.0107322			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS6XM	25376010	Green Submitted, gold, Green Published			2022-12-27	WOS:000344402600006
J	Chen, JC; Yang, ST; Lin, CY; Hsu, CJ; Tsai, CH; Su, JL; Tang, CH				Chen, Jui-Chieh; Yang, Shu-Ting; Lin, Chih-Yang; Hsu, Chin-Jung; Tsai, Chun-Hao; Su, Jen-Liang; Tang, Chih-Hsin			BMP-7 Enhances Cell Migration and alpha v beta 3 Integrin Expression via a c-Src-Dependent Pathway in Human Chondrosarcoma Cells	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-7; METASTATIC PROSTATE-CANCER; CLINICAL-SIGNIFICANCE; GASTRIC-CANCER; UP-REGULATION; INVASION; CARCINOMA; APOPTOSIS; PI3K/AKT; TUMOR	Bone morphogenic protein (BMP)-7 is a member of the transforming growth factor (TGF)-beta superfamily, which is originally identified based on its ability to induce cartilage and bone formation. In recent years, BMP-7 is also defined as a potent promoter of cell motility, invasion, and metastasis. However, there is little knowledge of the role of BMP-7 and its cellular function in chondrosarcoma cells. In the present study, we investigated the biological impact of BMP-7 on cell motility using transwell assay. In addition, the intracellular signaling pathways were also investigated by pharmacological and genetic approaches. Our results demonstrated that treatment with exogenous BMP-7 markedly increased cell migration by activating c-Src/PI3K/Akt/IKK/NF-kappa B signaling pathway, resulting in the transactivation of alpha v beta 3 integrin expression. Indeed, abrogation of signaling activation, by chemical inhibition or expression of a kinase dead form of the protein attenuated BMP-7-induced expression of integrin alpha v beta 3 and cell migration. These findings may provide a useful tool for diagnostic/prognostic purposes and even therapeutically in late-stage chondrosarcoma as an anti-metastatic agent.	[Chen, Jui-Chieh] Natl Chiayi Univ, Dept Biochem Sci & Technol, Chiayi, Taiwan; [Chen, Jui-Chieh; Lin, Chih-Yang; Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chen, Jui-Chieh; Su, Jen-Liang] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan, Miaoli County, Taiwan; [Yang, Shu-Ting] China Med Univ, Sch Pharm, Taichung, Taiwan; [Hsu, Chin-Jung] China Med Univ, Coll Chinese Med, Sch Chinese Med, Taichung, Taiwan; [Hsu, Chin-Jung; Tsai, Chun-Hao] China Med Univ Hosp, Dept Orthoped Surg, Taichung, Taiwan; [Tsai, Chun-Hao] China Med Univ, Dept Med, Taichung, Taiwan; [Tsai, Chun-Hao] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Su, Jen-Liang; Tang, Chih-Hsin] Asia Univ, Coll Hlth Sci, Dept Biotechnol, Taichung, Taiwan; [Su, Jen-Liang] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan; [Su, Jen-Liang] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Sch Med, Dept Pharmacol, Taichung, Taiwan	National Chiayi University; China Medical University Taiwan; National Health Research Institutes - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan	Su, JL (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan, Miaoli County, Taiwan.	jlsu@nhri.org.tw; chtang@mail.cmu.edu.tw	é, çå/HCH-5712-2022; Tang, Chih Hsin/O-5212-2015; Tsai, Chun-Hao/H-3140-2013	Tang, Chih Hsin/0000-0002-7113-8352; Tsai, Chun-Hao/0000-0002-4428-3132	National Science Council of Taiwan [MOST 103-2628-B-039-002-MY3]; China Medical University Hospital [DMR-103-059]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); China Medical University Hospital	This work was supported by grants from the National Science Council of Taiwan (MOST 103-2628-B-039-002-MY3) and China Medical University Hospital (DMR-103-059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarmo EL, 2008, ANN ONCOL, V19, P308, DOI 10.1093/annonc/mdm453; Alarmo EL, 2009, CANCER LETT, V275, P35, DOI 10.1016/j.canlet.2008.09.028; Aoki M, 2011, BRIT J CANCER, V104, P714, DOI 10.1038/sj.bjc.6606075; Araujo J, 2009, INT J CANCER, V124, P1, DOI 10.1002/ijc.23998; Asahina I, 1996, EXP CELL RES, V222, P38, DOI 10.1006/excr.1996.0005; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Boeuf S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-488; Breen MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072407; Buijs JT, 2009, CANCER LETT, V273, P177, DOI 10.1016/j.canlet.2008.05.044; Chen JC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/396839; Feeley BT, 2005, J BONE MINER RES, V20, P2189, DOI 10.1359/JBMR.050802; Fong YC, 2008, J CELL PHYSIOL, V217, P846, DOI 10.1002/jcp.21568; Ganapathy V, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-122; Ganguly KK, 2013, CELL ADHES MIGR, V7, P251, DOI 10.4161/cam.23840; Ghert MA, 2002, J ORTHOP RES, V20, P834, DOI 10.1016/S0736-0266(01)00172-3; Goodman SL, 2012, TRENDS PHARMACOL SCI, V33, P405, DOI 10.1016/j.tips.2012.04.002; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; Guo W, 1999, CLIN ORTHOP RELAT R, P175; Hao JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090748; Kang MH, 2011, EXP CELL RES, V317, P1746, DOI 10.1016/j.yexcr.2011.04.006; Katsuno Y, 2008, ONCOGENE, V27, P6322, DOI 10.1038/onc.2008.232; Kazuo M, 2008, ANN SURG ONCOL, V15, P1530, DOI 10.1245/s10434-007-9746-4; Korpal M, 2010, EUR J CANCER, V46, P1232, DOI 10.1016/j.ejca.2010.02.040; Li W, 2013, TUMOR BIOL, V34, P669, DOI 10.1007/s13277-012-0594-x; Liu YN, 2012, INT J MOL MED, V29, P1016, DOI 10.3892/ijmm.2012.948; Maegdefrau U, 2012, EXP MOL PATHOL, V92, P74, DOI 10.1016/j.yexmp.2011.10.004; Masuda H, 2003, PROSTATE, V54, P268, DOI 10.1002/pros.10193; Megumi K, 2012, ANN SURG ONCOL, V19, P2066, DOI 10.1245/s10434-011-2024-5; Melisi D, 2008, MOL CANCER THER, V7, P829, DOI 10.1158/1535-7163.MCT-07-0337; Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080; Ristiniemi J, 2007, J BONE JOINT SURG BR, V89B, P265, DOI 10.1302/0301-620X.89B2.18230; Rothhammer Tania, 2007, Cancer Biomarkers, V3, P111; Scully SP, 2000, CLIN ORTHOP RELAT R, P291; Shimizu T, 2012, BIOCHEM BIOPH RES CO, V417, P869, DOI 10.1016/j.bbrc.2011.12.064; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Tang CH, 2012, BIOMEDICINE-TAIWAN, V2, P92, DOI 10.1016/j.biomed.2012.01.001; Wang ZH, 2013, CELL BIOCHEM BIOPHYS, V67, P567, DOI 10.1007/s12013-013-9543-6; Weber KL, 1998, J ORTHOPAED RES, V16, P8, DOI 10.1002/jor.1100160103; Wong WKP, 2005, AM J RESP CELL MOL, V33, P438, DOI 10.1165/rcmb.2005-0103OC; Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530; Xu GH, 2013, DIGEST DIS SCI, V58, P1871, DOI 10.1007/s10620-013-2611-3; Ye L, 2011, FRONT BIOSCI-LANDMRK, V16, P865, DOI 10.2741/3725; Yeh YY, 2008, BIOCHEM PHARMACOL, V75, P1292, DOI 10.1016/j.bcp.2007.11.017; Yin MC, 2012, BIOMEDICINE-TAIWAN, V2, P2, DOI 10.1016/j.biomed.2011.12.001	44	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112636	10.1371/journal.pone.0112636	http://dx.doi.org/10.1371/journal.pone.0112636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390068	gold, Green Published, Green Submitted			2022-12-27	WOS:000349144400114
J	Miranda-Dominguez, O; Mills, BD; Carpenter, SD; Grant, KA; Kroenke, CD; Nigg, JT; Fair, DA				Miranda-Dominguez, Oscar; Mills, Brian D.; Carpenter, Samuel D.; Grant, Kathleen A.; Kroenke, Christopher D.; Nigg, Joel T.; Fair, Damien A.			Connectotyping: Model Based Fingerprinting of the Functional Connectome	PLOS ONE			English	Article							RESTING-STATE NETWORKS; PREFRONTAL CORTEX; HUMAN BRAIN; CONNECTIVITY; EVOLUTION; MONKEYS; MOTION; AREAS	A better characterization of how an individual's brain is functionally organized will likely bring dramatic advances to many fields of study. Here we show a model-based approach toward characterizing resting state functional connectivity MRI (rs-fcMRI) that is capable of identifying a so-called "connectotype'', or functional fingerprint in individual participants. The approach rests on a simple linear model that proposes the activity of a given brain region can be described by the weighted sum of its functional neighboring regions. The resulting coefficients correspond to a personalized model-based connectivity matrix that is capable of predicting the timeseries of each subject. Importantly, the model itself is subject specific and has the ability to predict an individual at a later date using a limited number of non-sequential frames. While we show that there is a significant amount of shared variance between models across subjects, the model's ability to discriminate an individual is driven by unique connections in higher order control regions in frontal and parietal cortices. Furthermore, we show that the connectotype is present in non-human primates as well, highlighting the translational potential of the approach.	[Miranda-Dominguez, Oscar; Mills, Brian D.; Carpenter, Samuel D.; Grant, Kathleen A.; Kroenke, Christopher D.; Nigg, Joel T.; Fair, Damien A.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Kroenke, Christopher D.; Fair, Damien A.] Oregon Hlth & Sci Univ, Adv Imaging Res Ctr, Portland, OR 97201 USA; [Kroenke, Christopher D.] Oregon Natl Primate Res Ctr, Div Neurosci, Beaverton, OR USA; [Kroenke, Christopher D.; Nigg, Joel T.; Fair, Damien A.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University	Miranda-Dominguez, O (corresponding author), Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA.	miran045@umn.edu; faird@ohsu.edu	Miranda-Dominguez, Oscar/A-7412-2019	Miranda-Dominguez, Oscar/0000-0002-3622-0166	McDonnell Foundation Collaborative Activity Award [220020256]; Oregon Clinical and Translational Institute (OCTRI); Programa de Profesores en el Extranjero (PEX); Tecnologico de Monterrey [OD 11092, AA109431, AA13510, 1R01MH86654];  [R01 MH096773];  [K99/R00 MH091238]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086654, R01MH099064, K99MH091238, R01MH096773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P60AA010760, U01AA013510] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007262] Funding Source: NIH RePORTER	McDonnell Foundation Collaborative Activity Award; Oregon Clinical and Translational Institute (OCTRI); Programa de Profesores en el Extranjero (PEX); Tecnologico de Monterrey; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by R01 MH096773 (Fair), K99/R00 MH091238 (Fair), McDonnell Foundation Collaborative Activity Award 220020256 (Petersen, PI, and Fair, site PI), Oregon Clinical and Translational Institute (OCTRI) (Fair), Programa de Profesores en el Extranjero (PEX), Tecnologico de Monterrey OD 11092 (Grant), AA109431 (Grant), AA13510 (Grant), and 1R01MH86654 (Nigg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna C, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00062; Astafiev SV, 2003, J NEUROSCI, V23, P4689; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BIEDERMAN J, 1992, ARCH GEN PSYCHIAT, V49, P728; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Chu C, 2011, MEASURING CONSISTENC, P41; Craddock RC, 2013, NEUROIMAGE, V82, P127, DOI 10.1016/j.neuroimage.2013.05.072; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Denys K, 2004, J COGNITIVE NEUROSCI, V16, P1505, DOI 10.1162/0898929042568505; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; Fair DA, 2013, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00080; Fair DA, 2012, P NATL ACAD SCI USA, V109, P6769, DOI 10.1073/pnas.1115365109; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; First M.B., 2016, STRUCTURED CLIN INTE; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friston KJ, 2009, PLOS BIOL, V7, P220, DOI 10.1371/journal.pbio.1000033; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Friston KJ, 1993, HUM BRAIN MAPP, V1, P69, DOI DOI 10.1002/HBM.460010108; Frith CD, 1995, HUM BRAIN MAPP, V3, P153, DOI 10.1002/hbm.460030209; Gates KM, 2012, NEUROIMAGE, V63, P310, DOI 10.1016/j.neuroimage.2012.06.026; Hansen P. C., 1994, Numerical Algorithms, V6, P1, DOI 10.1007/BF02149761; HANSEN PC, 1987, BIT, V27, P534, DOI 10.1007/BF01937276; Iyer SP, 2013, NEUROIMAGE, V75, P165, DOI 10.1016/j.neuroimage.2013.02.054; Kaas JH, 2006, CURR BIOL, V16, pR910, DOI 10.1016/j.cub.2006.09.057; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Markov NT, 2012, WEIGHTED DIRECTED IN; Markram H, 2006, NAT REV NEUROSCI, V7, P153, DOI 10.1038/nrn1848; Miranda-Dominguez O, 2014, J NEUROSCI, V34, P5552, DOI 10.1523/JNEUROSCI.4229-13.2014; Mueller S, 2013, NEURON, V77, P586, DOI 10.1016/j.neuron.2012.12.028; Orban GA, 2004, TRENDS COGN SCI, V8, P315, DOI 10.1016/j.tics.2004.05.009; Paxinos G., 1999, RHESUS MONKEY BRAIN, DOI DOI 10.1016/J.CEJA.2021.100223; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Robertson G, 2006, WIDE RANGE ACHIEVEME; Ryali S, 2012, NEUROIMAGE, V59, P3852, DOI 10.1016/j.neuroimage.2011.11.054; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Seung S., 2012, CONNECTOME BRAINS WI; Smaers JB, 2011, BRAIN BEHAV EVOLUT, V77, P67, DOI 10.1159/000323671; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; van Essen D. C., 2004, VISUAL NEUROSCI, V1, P507; Van Essen DC, 2007, NEURON, V56, P209, DOI 10.1016/j.neuron.2007.10.015; Van Essen DC, 2004, NEUROIMAGE, V23, pS97, DOI 10.1016/j.neuroimage.2004.07.024; Varoquaux G., 2010, ARXIV10085071; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	50	110	110	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111048	10.1371/journal.pone.0111048	http://dx.doi.org/10.1371/journal.pone.0111048			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386919	Green Published, Green Submitted, gold			2022-12-27	WOS:000345250400013
J	Montero, M; de la Fuente, S; Fonteriz, RI; Moreno, A; Alvarez, J				Montero, Mayte; de la Fuente, Sergio; Fonteriz, Rosalba I.; Moreno, Alfredo; Alvarez, Javier			Effects of Long-Term Feeding of the Polyphenols Resveratrol and Kaempferol in Obese Mice	PLOS ONE			English	Article							PROBE LEVEL DATA; LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; PLANT FLAVONOIDS; RAT ADIPOCYTES; GINKGO-BILOBA; ACTIVATION; PREVENTION; CANCER; DIET	The effect of the intake of antioxidant polyphenols such as resveratrol and others on survival and different parameters of life quality has been a matter of debate in the last years. We have studied here the effects of the polyphenols resveratrol and kaempferol added to the diet in a murine model undergoing long-term hypercaloric diet. Using 50 mice for each condition, we have monitored weight, survival, biochemical parameters such as blood glucose, insulin, cholesterol, triglycerides and aspartate aminotransferase, neuromuscular coordination measured with the rotarod test and morphological aspect of stained sections of liver and heart histological samples. Our data show that mice fed since they are 3-months-old with hypercaloric diet supplemented with any of these polyphenols reduced their weight by about 5-7% with respect to the controls fed only with hypercaloric diet. We also observed that mice fed with any of the polyphenols had reduced levels of glucose, insulin and cholesterol, and better marks in the rotarod test, but only after 1 year of treatment, that is, during senescence. No effect was observed in the rest of the parameters studied. Furthermore, although treatment with hypercaloric diets induced large changes in the pattern of gene expression in liver, we found no significant changes in gene expression induced by the presence of any of the polyphenols. Thus, our data indicate that addition of resveratrol or kaempferol to mice food produces an initial decrease in weight in mice subjected to hypercaloric diet, but beneficial effects in other parameters such as blood glucose, insulin and cholesterol, and neuromuscular coordination, only appear after prolonged treatments.	[Alvarez, Javier] Univ Valladolid, Fac Med, IBGM, Dept Bioquim & Biol Mol & Fisiol, Valladolid, Spain; CSIC, Valladolid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Consejo Superior de Investigaciones Cientificas (CSIC)	Alvarez, J (corresponding author), Univ Valladolid, Fac Med, IBGM, Dept Bioquim & Biol Mol & Fisiol, Valladolid, Spain.	jalvarez@ibgm.uva.es	Alvarez, Javier/K-8210-2014; Montero, Mayte/K-8212-2014; Fonteriz, Rosalba I/L-1212-2014; Fonteriz, Rosalba/ABE-3175-2021	Alvarez, Javier/0000-0003-0636-5521; Montero, Mayte/0000-0001-7702-6653; Fonteriz, Rosalba I/0000-0001-8349-6264; Fonteriz, Rosalba/0000-0001-8349-6264; Moreno, Alfredo/0000-0002-7444-5198; De la Fuente, Sergio/0000-0001-7823-063X; , Sergio/0000-0002-8021-2390	Ministerio de Ciencia e Innovacion [BFU2008-01871, BFU 2011-25763]; Junta de Castilla y Leon [VA029A12, GR105]; Spanish Government	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Spanish Government(Spanish GovernmentEuropean Commission)	This work was supported by grants from Ministerio de Ciencia e Innovacion [BFU2008-01871 and BFU 2011-25763; (http://www.idi.mineco.gob.es/portal/site/MICINN/)] and from Junta de Castilla y Leon [VA029A12-1 and GR105, (http://www.educa.jcyl.es/educacyl/cm/universidad)]. Sergio de la Fuente had an FPI (Formacion de Personal Investigador) fellowship from the Spanish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Birt DF, 2001, PHARMACOL THERAPEUT, V90, P157, DOI 10.1016/S0163-7258(01)00137-1; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Canto C, 2011, NATURE, V477, P411; Couzin-Frankel J, 2011, SCIENCE, V334, P1194, DOI 10.1126/science.334.6060.1194; Da-Silva WS, 2007, DIABETES, V56, P767, DOI 10.2337/db06-1488; Do GM, 2011, MOL NUTR FOOD RES, V55, pS173, DOI 10.1002/mnfr.201100064; Garcia-Mediavilla V, 2007, EUR J PHARMACOL, V557, P221, DOI 10.1016/j.ejphar.2006.11.014; Gates MA, 2007, INT J CANCER, V121, P2225, DOI 10.1002/ijc.22790; Grassi D, 2005, HYPERTENSION, V46, P398, DOI 10.1161/01.HYP.0000174990.46027.70; Havsteen BH, 2002, PHARMACOL THERAPEUT, V96, P67, DOI 10.1016/S0163-7258(02)00298-X; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jarolim S, 2004, FEMS YEAST RES, V5, P169, DOI 10.1016/j.femsyr.2004.06.015; KUPPUSAMY UR, 1994, BIOCHEM PHARMACOL, V47, P521, DOI 10.1016/0006-2952(94)90184-8; KUPPUSAMY UR, 1992, BIOCHEM PHARMACOL, V44, P1307, DOI 10.1016/0006-2952(92)90531-M; LALONDE R, 1995, NEUROSCI RES, V22, P423, DOI 10.1016/0168-0102(95)00916-H; Lee YE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050412; Lombard DB, 2011, NATURE, V477, P410, DOI 10.1038/477410a; Luo Y, 2002, P NATL ACAD SCI USA, V99, P12197, DOI 10.1073/pnas.182425199; Manach C, 2005, CURR OPIN LIPIDOL, V16, P77, DOI 10.1097/00041433-200502000-00013; Middleton E, 2000, PHARMACOL REV, V52, P673; Montero M, 2004, BIOCHEM J, V384, P19, DOI 10.1042/BJ20040990; Nestel P, 2003, CURR OPIN LIPIDOL, V14, P3, DOI 10.1097/00041433-200302000-00002; Poulsen MM, 2013, DIABETES, V62, P1186, DOI 10.2337/db12-0975; Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096; Shiotsuki H, 2010, J NEUROSCI METH, V189, P180, DOI 10.1016/j.jneumeth.2010.03.026; Shockley KR, 2009, PHYSIOL GENOMICS, V39, P172, DOI 10.1152/physiolgenomics.90350.2008; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Watanabe CMH, 2001, P NATL ACAD SCI USA, V98, P6577, DOI 10.1073/pnas.111126298; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Yu SF, 2006, BIOL PHARM BULL, V29, P2510, DOI 10.1248/bpb.29.2510	37	11	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112825	10.1371/journal.pone.0112825	http://dx.doi.org/10.1371/journal.pone.0112825			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386805	gold, Green Published, Green Submitted			2022-12-27	WOS:000345250400095
J	Raffetseder, J; Pienaar, E; Blomgran, R; Eklund, D; Brodin, VP; Andersson, H; Welin, A; Lerm, M				Raffetseder, Johanna; Pienaar, Elsje; Blomgran, Robert; Eklund, Daniel; Brodin, Veronika Patcha; Andersson, Henrik; Welin, Amanda; Lerm, Maria			Replication Rates of Mycobacterium tuberculosis in Human Macrophages Do Not Correlate with Mycobacterial Antibiotic Susceptibility	PLOS ONE			English	Article							IN-VITRO; LATENT TUBERCULOSIS; INFECTED MICE; PERSISTENCE; OXYGEN; MODEL; ACID; DRUG; PYRAZINAMIDE; GRANULOMAS	The standard treatment of tuberculosis (TB) takes six to nine months to complete and this lengthy therapy contributes to the emergence of drug-resistant TB. TB is caused by Mycobacterium tuberculosis (Mtb) and the ability of this bacterium to switch to a dormant phenotype has been suggested to be responsible for the slow clearance during treatment. A recent study showed that the replication rate of a non-virulent mycobacterium, Mycobacterium smegmatis, did not correlate with antibiotic susceptibility. However, the question whether this observation also holds true for Mtb remains unanswered. Here, in order to mimic physiological conditions of TB infection, we established a protocol based on long-term infection of primary human macrophages, featuring Mtb replicating at different rates inside the cells. During conditions that restricted Mtb replication, the bacterial phenotype was associated with reduced acid-fastness. However, these phenotypically altered bacteria were as sensitive to isoniazid, pyrazinamide and ethambutol as intracellularly replicating Mtb. In support of the recent findings with M. smegmatis, we conclude that replication rates of Mtb do not correlate with antibiotic tolerance.	[Raffetseder, Johanna; Pienaar, Elsje; Blomgran, Robert; Eklund, Daniel; Brodin, Veronika Patcha; Andersson, Henrik; Welin, Amanda; Lerm, Maria] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Microbiol & Mol Med, SE-58185 Linkoping, Sweden	Linkoping University	Lerm, M (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Microbiol & Mol Med, SE-58185 Linkoping, Sweden.	maria.lerm@liu.se	Lerm, Maria/AAM-8705-2020; Lerm, Maria/AAA-1780-2020	Lerm, Maria/0000-0002-5092-9892; Andersson, Henrik/0000-0002-6020-5177; Eklund, Daniel/0000-0002-6045-4800; Raffetseder, Johanna/0000-0001-8871-2560; Blomgran, Robert/0000-0002-2767-8175	Bill & Melinda Gates Foundation; Swedish Research Council [2009-3821, 2012-3349]; Swedish International Development Cooperation Agency; Swedish Heart-Lung Foundation; King Oscar II Foundation; Carl Trygger Foundation; Clas Groschinsky Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Cooperation Agency; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); King Oscar II Foundation; Carl Trygger Foundation; Clas Groschinsky Foundation	The project was funded by the Bill & Melinda Gates Foundation (www.gatesfoundation.org), the Swedish Research Council (grant numbers 2009-3821 and 2012-3349, www.vr.se), the Swedish International Development Cooperation Agency (www.sida.se), the Swedish Heart-Lung Foundation (www.hjart-lungfonden.se), King Oscar II Foundation, Carl Trygger Foundation (www.carltryggersstiftelse.se), and the Clas Groschinsky Foundation (www.groschinsky.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; Aly S, 2006, J PATHOL, V210, P298, DOI 10.1002/path.2055; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Caceres N, 2009, TUBERCULOSIS, V89, P175, DOI 10.1016/j.tube.2008.11.001; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; DHILLON J, 1989, ANTIMICROB AGENTS CH, V33, P1255, DOI 10.1128/AAC.33.8.1255; Eklund D, 2010, CLIN VACCINE IMMUNOL, V17, P513, DOI 10.1128/CVI.00446-09; Estrella JL, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00067; Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075; Garton NJ, 2002, MICROBIOL-SGM, V148, P2951, DOI 10.1099/00221287-148-10-2951; Gill WP, 2009, NAT MED, V15, P211, DOI 10.1038/nm.1915; Helaine S, 2014, SCIENCE, V343, P204, DOI 10.1126/science.1244705; Hernandez-Pando R, 2000, LANCET, V356, P2133, DOI 10.1016/S0140-6736(00)03493-0; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412; Magliozzo RS, 1996, J AM CHEM SOC, V118, P11303, DOI 10.1021/ja962047j; MCCUNE RM, 1956, J EXP MED, V104, P763, DOI 10.1084/jem.104.5.763; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Rastogi N, 1996, CURR MICROBIOL, V33, P167, DOI 10.1007/s002849900095; Rohde KH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002769; Santi I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3470; Schon T, 2013, J INTERN MED, V273, P368, DOI 10.1111/joim.12031; Seiler P, 2003, J INFECT DIS, V188, P1326, DOI 10.1086/378563; SHERMAN DR, 1995, P NATL ACAD SCI USA, V92, P6625, DOI 10.1073/pnas.92.14.6625; Snewin VA, 1999, INFECT IMMUN, V67, P4586, DOI 10.1128/IAI.67.9.4586-4593.1999; Tailleux L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001403; Tsai MC, 2006, CELL MICROBIOL, V8, P218, DOI 10.1111/j.1462-5822.2005.00612.x; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Vogt G, 2011, J CLIN INVEST, V121, P3889, DOI 10.1172/JCI57235; Wakamoto Y, 2013, SCIENCE, V339, P91, DOI 10.1126/science.1229858; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Welin A, 2011, J INNATE IMMUN, V3, P508, DOI 10.1159/000325297; Welin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020302; YOUATT JEAN, 1960, AUSTRALIAN JOUR EXPTL BIOL AND MED SCI, V38, P331, DOI 10.1038/icb.1960.35; Young DB, 2009, TRENDS MICROBIOL, V17, P183, DOI 10.1016/j.tim.2009.02.005; Zabinski RF, 1997, J AM CHEM SOC, V119, P2331, DOI 10.1021/ja9639731; Zhang Y, 1999, J BACTERIOL, V181, P2044, DOI 10.1128/JB.181.7.2044-2049.1999; Zumla A, 2011, TROP MED INT HEALTH, V16, P79, DOI 10.1111/j.1365-3156.2010.02665.x	42	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112426	10.1371/journal.pone.0112426	http://dx.doi.org/10.1371/journal.pone.0112426			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386849	Green Submitted, Green Published, gold			2022-12-27	WOS:000345250400061
J	Sparks, ME; Shelby, KS; Kuhar, D; Gundersen-Rindal, DE				Sparks, Michael E.; Shelby, Kent S.; Kuhar, Daniel; Gundersen-Rindal, Dawn E.			Transcriptome of the Invasive Brown Marmorated Stink Bug, Halyomorpha halys (Stal) (Heteroptera: Pentatomidae)	PLOS ONE			English	Article							HEMIPTERA-PENTATOMIDAE; AGGREGATION PHEROMONE; RHODNIUS-PROLIXUS; DESERT LOCUST; PROTEIN; RECOGNITION; SCAVENGER; FUNGI; BLAST; SUITE	Halyomorpha halys (Stal) (Heteroptera: Pentatomidae), the brown marmorated stink bug, is an invasive agricultural and nuisance pest rapidly expanding its incidence in North America. This voracious pest poses a significant threat to rural and urban agriculture, especially to specialty crops such as apples, grapes and ornamentals, as well as staple crops including soybean and corn. The object of this study was to generate transcript sequence resources for H. halys. RNA-seq libraries derived from distinct developmental stages and sexes were sequenced and assembled into 248,569 putatively unique transcripts (PUTs). PUTs were segmented into three disjoint tiers of varying reliability, with 4,794 classified as gold tier (highest quality), 16,878 as silver, and 14,357 as bronze. The gold-tier PUTs associated with 2,580 distinct non-redundant protein sequences from the NCBI NR database-1,785 of these (69%) mapped to annotated UniProtKB database proteins, from which 1,273 unique Pfam families and 459 unique Molecular Function GO terms were encountered. Of the silver tier's 6,527 PUTs associated with unique proteins, 4,193 mapped to UniProtKB (64%), from which 1,941 and 640 unique Pfam and Molecular Function GO terms were extracted. H. halys PUTs related to important life processes like immunity, endocrinology, reproduction, development, behavior, neurotransmission, neurotoxicity, olfaction, and small RNA pathways were validated through quantitative Real-Time PCR (qRT-PCR) for differential expression during distinct life stages (eggs, 2nd instar nymphs, 4th instar nymphs, female adults, male adults). PUTs similar to hypothetical proteins identified in symbiont microbes, including Pantoea and Nosema species, were more abundantly expressed in adults versus nymphs. These comprehensive H. halys transcriptomic resources can be utilized to aid development of novel control methodologies to disrupt life processes; to conduct reverse genetic screens to determine host gene function; and to design environmentally unobtrusive means to control host populations or target specific H. halys life stages, such as molecular biopesticides.	[Sparks, Michael E.; Kuhar, Daniel; Gundersen-Rindal, Dawn E.] USDA ARS, Invas Insect Biocontrol & Behav Lab, Beltsville, MD 20705 USA; [Shelby, Kent S.] USDA ARS, Biol Control Insects Res Lab, Columbia, MO 65205 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Gundersen-Rindal, DE (corresponding author), USDA ARS, Invas Insect Biocontrol & Behav Lab, Beltsville, MD 20705 USA.	dawn.gundersen-rindal@ars.usda.gov	; Shelby, Kent/E-1605-2011	Sparks, Michael/0000-0001-6251-8559; Shelby, Kent/0000-0001-9859-3497				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bansal R, 2014, ENVIRON ENTOMOL, V43, P617, DOI 10.1603/EN13341; Blander JM, 2012, NAT REV IMMUNOL, V12, P215, DOI 10.1038/nri3167; Broderick Nichole A., 2009, P13; Deffarari MS, 2013, BIOCHIM BIOPHYS ACTA, V1840, P396; Eleftherianos I, 2009, INSECT MOL BIOL, V18, P507, DOI 10.1111/j.1365-2583.2009.00899.x; Engels W., 1990, Advances in Invertebrate Reproduction, V5, P495; Garcia ES, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-33; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gouli V, 2012, PEST MANAG SCI, V68, P155, DOI 10.1002/ps.2310; Grabherr M. G., 2011, NAT BIOTECHNOL, V8, P469; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Hrassnigg N, 2005, APIDOLOGIE, V36, P255, DOI 10.1051/apido:2005015; Hunter W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001160; Jiang H, 2011, INVERTEBRATE IMMUNIT, P163; Kanost MR, 2008, INSECT IMMUNOLOGY, P69, DOI 10.1016/B978-012373976-6.50006-9; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khrimian A, 2014, J NAT PROD, V77, P1708, DOI 10.1021/np5003753; Leskey T. C., 2012, Outlooks on Pest Management, V23, P218, DOI 10.1564/23oct07; Matouskova P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086033; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; OZAWA M, 1993, J BIOL CHEM, V268, P699; Paluzzi JPV, 2012, PEPTIDES, V34, P127, DOI 10.1016/j.peptides.2011.10.025; Firmino AAP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085079; Renwick J, 2007, DEV COMP IMMUNOL, V31, P347, DOI 10.1016/j.dci.2006.06.007; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schmidt O, 2010, ANNU REV ENTOMOL, V55, P485, DOI 10.1146/annurev.ento.54.110807.090618; Singh NK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0083963, 10.1371/journal.pone.0073005]; Sparks ME, 2013, GENOME ANNOUNCEMENTS, V1; Sparks ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061190; Taylor CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090312; The Uniprot Consortium, 2012, NUCLEIC ACIDS RES, V41, pD43; van Kretschmar JBD, 2012, BELTW COTT C, P1090; Weber DC, 2014, J ECON ENTOMOL, V107, P1061, DOI 10.1603/EC13502; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Wynant N, 2014, INSECT MOL BIOL, V23, P320, DOI 10.1111/imb.12083; Wynant N, 2014, J INSECT PHYSIOL, V64, P7, DOI 10.1016/j.jinsphys.2014.02.010; Xiong YH, 2013, INT J BIOL SCI, V9, P370, DOI 10.7150/ijbs.5929; Xu JW, 2014, BIOL INVASIONS, V16, P153, DOI 10.1007/s10530-013-0510-3; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhang H, 2013, BIOCHEM BIOPH RES CO, V442, P105, DOI 10.1016/j.bbrc.2013.11.025; Zhu GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031246	42	35	37	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111646	10.1371/journal.pone.0111646	http://dx.doi.org/10.1371/journal.pone.0111646			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386688	Green Published, Green Submitted, gold			2022-12-27	WOS:000345250400024
J	Wang, XL; Wang, L; Wang, J; Jin, P; Liu, HX; Zheng, YH				Wang, Xiaoli; Wang, Lei; Wang, Jing; Jin, Peng; Liu, Hongxia; Zheng, Yonghua			Bacillus cereus AR156-Induced Resistance to Colletotrichum acutatum Is Associated with Priming of Defense Responses in Loquat Fruit	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; POSTHARVEST DISEASES; SYSTEMIC RESISTANCE; ROT	The effectiveness of a biocontrol agent Bacillus cereus AR156 for control of anthracnose rot caused by Colletotrichum acutatum in harvested loquat fruit and the possible mechanisms of its action have been investigated. Treatment of fruit with B. cereus AR156 resulted in lower disease incidence and smaller lesion diameters compared with that of untreated fruit. The treatment enhanced activities of defense-related enzymes including chitinase, beta-1, 3-glucanase, phenylalanine ammonialyase, peroxidase and polyphenoloxidase, and promoted accumulation of H2O2. Total phenolic content and 2,2-diphenyl-1-picrylhydrazyl radical scavenging activity were also increased by treatment. Transcripts of three defense-related genes were enhanced only in fruit undergoing both B. cereus AR156 treatment and C. acutatum inoculation compared with those receiving either intervention alone. These results suggest that the disease resistance against C. acutatum in loquat fruit is enhanced by B. cereus AR156 and that the induced resistance is associated with induction and priming of defense responses in the fruit.	[Wang, Xiaoli; Wang, Lei; Wang, Jing; Jin, Peng; Zheng, Yonghua] Nanjing Agr Univ, Coll Food Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Wang, Xiaoli] Huaiyin Inst Technol, Coll Life Sci & Chem Engn, Huaian, Jiangsu, Peoples R China; [Liu, Hongxia] Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Huaiyin Institute of Technology; Nanjing Agricultural University	Zheng, YH (corresponding author), Nanjing Agr Univ, Coll Food Sci & Technol, Nanjing, Jiangsu, Peoples R China.	zhengyh@njau.edu.cn			National Natural Science Foundation of China [31172003]; Special Fund for Agro-scientific Research in the Public Interest of China [201003073]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest of China	This work was supported by the National Natural Science Foundation of China (31172003) and the Special Fund for Agro-scientific Research in the Public Interest of China (201003073). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES FB, 1971, PLANT PHYSIOL, V47, P129, DOI 10.1104/pp.47.1.129; Ahn IP, 2011, MOL CELLS, V32, P7, DOI 10.1007/s10059-011-2209-6; Arrebola E, 2010, CROP PROT, V29, P369, DOI 10.1016/j.cropro.2009.08.001; Assis JS, 2001, POSTHARVEST BIOL TEC, V23, P33, DOI 10.1016/S0925-5214(01)00100-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao SF, 2008, J HORTIC SCI BIOTECH, V83, P816, DOI 10.1080/14620316.2008.11512466; Chan ZL, 2005, POSTHARVEST BIOL TEC, V36, P215, DOI 10.1016/j.postharvbio.2005.01.001; CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chen YF, 2005, ANN BOT-LONDON, V95, P901, DOI 10.1093/aob/mci100; Conrath U, 2002, TRENDS PLANT SCI, V7, P210, DOI 10.1016/S1360-1385(02)02244-6; Conrath U, 2011, TRENDS PLANT SCI, V16, P524, DOI 10.1016/j.tplants.2011.06.004; Ferreira RB, 2007, MOL PLANT PATHOL, V8, P677, DOI 10.1111/J.1364-3703.2007.00419.X; Gonzalez EM, 1999, J AGR FOOD CHEM, V47, P4068, DOI 10.1021/jf981325q; Guo JH, 2007, U S Patent, Patent No. [200710021376.0, 2007100213760]; HAHLBROCK K, 1989, ANNU REV PLANT PHYS, V40, P347, DOI 10.1146/annurev.pp.40.060189.002023; Janisiewicz WJ, 2002, ANNU REV PHYTOPATHOL, V40, P411, DOI 10.1146/annurev.phyto.40.120401.130158; Jia ZH, 2010, BIOCHEM BIOPH RES CO, V396, P522, DOI 10.1016/j.bbrc.2010.04.131; Kinkema M, 2000, PLANT CELL, V12, P2339, DOI 10.1105/tpc.12.12.2339; KOCHBA J, 1977, PLANT CELL PHYSIOL, V18, P463, DOI 10.1093/oxfordjournals.pcp.a075455; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Larrauri JA, 1998, J AGR FOOD CHEM, V46, P2694, DOI 10.1021/jf980017p; Liu HX, 2005, POSTHARVEST BIOL TEC, V35, P263, DOI 10.1016/j.postharvbio.2004.08.006; Niu DD, 2011, MOL PLANT MICROBE IN, V24, P533, DOI 10.1094/MPMI-09-10-0213; Patterson BD, 2004, ANAL BIOCHEM, V139, P487; Rao MV, 1996, PLANT PHYSIOL, V110, P125, DOI 10.1104/pp.110.1.125; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Sharma RR, 2009, BIOL CONTROL, V50, P205, DOI 10.1016/j.biocontrol.2009.05.001; Shoresh M, 2005, PHYTOPATHOLOGY, V95, P76, DOI 10.1094/PHYTO-95-0076; SLINKARD K, 1977, AM J ENOL VITICULT, V28, P49; Taheri P, 2010, J PLANT PHYSIOL, V167, P201, DOI 10.1016/j.jplph.2009.08.003; Verhagen BWM, 2010, J EXP BOT, V61, P249, DOI 10.1093/jxb/erp295; Vicente AR, 2006, POSTHARVEST BIOL TEC, V40, P116, DOI 10.1016/j.postharvbio.2005.12.012; Wang CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052565; Wang KT, 2011, J PHYTOPATHOL, V159, P417, DOI 10.1111/j.1439-0434.2010.01782.x; Wang XL, 2013, FOOD CHEM, V136, P400, DOI 10.1016/j.foodchem.2012.09.032; Zhang SJ, 2009, J INTEGR PLANT BIOL, V51, P167, DOI 10.1111/j.1744-7909.2008.00763.x; Zhou XH, 2011, J FOOD SCI, V76, pM254, DOI 10.1111/j.1750-3841.2011.02160.x	38	7	8	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112494	10.1371/journal.pone.0112494	http://dx.doi.org/10.1371/journal.pone.0112494			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386680	Green Published, Green Submitted, gold			2022-12-27	WOS:000345250400066
J	Yu, WY; Jiang, LH; Zheng, Y; Hu, XP; Luo, JH; Yang, W				Yu, Wenyue; Jiang, Lin-Hua; Zheng, Yang; Hu, Xupang; Luo, Jianhong; Yang, Wei			Inactivation of TRPM2 Channels by Extracellular Divalent Copper	PLOS ONE			English	Article							HEAVY-METALS; ION-CHANNEL; PORE REGION; OUTER PORE; ACIDIC PH; ZINC; INHIBITION; RECEPTORS; CALCIUM; IDENTIFICATION	Cu2+ is an essential metal ion that plays a critical role in the regulation of a number of ion channels and receptors in addition to acting as a cofactor in a variety of enzymes. Here, we showed that human melastatin transient receptor potential 2 (hTRPM2) channel is sensitive to inhibition by extracellular Cu2+. Cu2+ at concentrations as low as 3 mM inhibited the hTRPM2 channel completely and irreversibly upon washing or using Cu2+ chelators, suggesting channel inactivation. The Cu2+-induced inactivation was similar when the channels conducted inward or outward currents, indicating the permeating ions had little effect on Cu2+-induced inactivation. Furthermore, Cu2+ had no effect on singe channel conductance. Alanine substitution bysite-directed mutagenesis of His995 in the pore-forming region strongly attenuated Cu2+-induced channel inactivation, and mutation of several other pore residues to alanine altered the kinetics of channel inactivation by Cu2+. In addition, while introduction of the P1018L mutation is known to result in channel inactivation, exposure to Cu2+ accelerated the inactivation of this mutant channel. In contrast with the hTRPM2, the mouse TRPM2 (mTRPM2) channel, which contains glutamine at the position equivalent to His995, was insensitive to Cu2+. Replacement of His995 with glutamine in the hTRPM2 conferred loss of Cu2+-induced channel inactivation. Taken together, these results suggest that Cu2+ inactivates the hTRPM2 channel by interacting with the outer pore region. Our results also indicate that the amino acid residue difference in this region gives rise to species-dependent effect by Cu2+ on the human and mouse TRPM2 channels.	[Yu, Wenyue; Zheng, Yang; Hu, Xupang; Luo, Jianhong; Yang, Wei] Zhejiang Univ, Sch Med, Zhejiang Prov Key Lab Neurobiol, Key Lab Med Neurobiol,Minist Hlth China,Dept Neur, Hangzhou 310003, Zhejiang, Peoples R China; [Jiang, Lin-Hua] Xinxiang Med Univ, Dept Physiol & Neurobiol, Xinxiang, Henan Province, Peoples R China; [Jiang, Lin-Hua] Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds, W Yorkshire, England	Zhejiang University; Xinxiang Medical University; University of Leeds	Luo, JH (corresponding author), Zhejiang Univ, Sch Med, Zhejiang Prov Key Lab Neurobiol, Key Lab Med Neurobiol,Minist Hlth China,Dept Neur, Hangzhou 310003, Zhejiang, Peoples R China.	luojianhong@zju.edu.cn; yangwei@zju.edu.cn	Luo, jian/HGE-7331-2022; Jiang, Lin-Hua/AAU-1078-2020; Jiang, Lin-Hua/D-2030-2010	Jiang, Lin-Hua/0000-0001-6398-0411; Jiang, Lin-Hua/0000-0001-6398-0411	National Basic Research Program of China [2013CB910204, 2014CB910300, 2010CB912002]; Natural Science Foundation of China [81371302, 31471118]; Zhejiang Province Qianjiang Talent Project [2012R10037]; Zhejiang University [2012FZA7014]; University of Leeds-Zhejiang University Strategic Collaboration Award	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Province Qianjiang Talent Project; Zhejiang University; University of Leeds-Zhejiang University Strategic Collaboration Award	This work was supported by National Basic Research Program of China (2013CB910204), Natural Science Foundation of China (81371302), Zhejiang Province Qianjiang Talent Project (2012R10037), and Zhejiang University basic research fund (2012FZA7014) to WY; University of Leeds-Zhejiang University Strategic Collaboration Award and Natural Science Foundation of China (31471118) to LHJ; and National Basic Research Program of China (2014CB910300 and 2010CB912002) to JHL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja A, 2014, J TRACE ELEM MED BIO; Cao X, 2014, J GEN PHYSIOL, V143, P75, DOI 10.1085/jgp.201311025; CHELLY J, 1993, NAT GENET, V5, P317, DOI 10.1038/ng1293-317; Chen JX, 2011, J BIOL CHEM, V286, P27436, DOI 10.1074/jbc.M111.232058; Coddou C, 2007, J BIOL CHEM, V282, P36879, DOI 10.1074/jbc.M706925200; Desai V, 2008, AM J CLIN NUTR, V88, p855S, DOI 10.1093/ajcn/88.3.855S; Di AK, 2012, NAT IMMUNOL, V13, P29, DOI 10.1038/ni.2171; Ding XQ, 2010, ADV EXP MED BIOL, V664, P245, DOI 10.1007/978-1-4419-1399-9_28; Du JY, 2009, J GEN PHYSIOL, V134, P471, DOI 10.1085/jgp.200910254; Ellingsen DG, 2007, BIOMARKERS, V12, P497, DOI 10.1080/13547500701366496; Gavazzo P, 2000, J GEN PHYSIOL, V116, P311, DOI 10.1085/jgp.116.3.311; Gu QH, 2010, J APPL PHYSIOL, V108, P891, DOI 10.1152/japplphysiol.01371.2009; Haraguchi K, 2012, J NEUROSCI, V32, P3931, DOI 10.1523/JNEUROSCI.4703-11.2012; Hermosura MC, 2008, P NATL ACAD SCI USA, V105, P18029, DOI 10.1073/pnas.0808218105; Jiang LH, 2010, EXPERT OPIN THER TAR, V14, P973, DOI 10.1517/14728222.2010.510135; KISS T, 1994, PHARMACOL REV, V46, P245; Kocer G, 2013, BIOL TRACE ELEM RES, V153, P251, DOI 10.1007/s12011-013-9659-y; Laszlo C, 2009, J GEN PHYSIOL, V133, P189, DOI 10.1085/jgp.200810109; Liu X, 2008, MOL PHARMACOL, V73, P252, DOI 10.1124/mol.107.039651; Ma ZM, 2008, J GEN PHYSIOL, V131, P483, DOI 10.1085/jgp.200809980; Massullo P, 2006, SEMIN CELL DEV BIOL, V17, P654, DOI 10.1016/j.semcdb.2006.11.006; McGee TP, 2013, J NEUROSCI, V33, P13431, DOI 10.1523/JNEUROSCI.1908-13.2013; McHugh D, 2003, J BIOL CHEM, V278, P11002, DOI 10.1074/jbc.M210810200; Mei ZZ, 2006, AM J PHYSIOL-CELL PH, V291, pC1022, DOI 10.1152/ajpcell.00606.2005; Nilius Bernd, 2007, Bull Mem Acad R Med Belg, V162, P244; Orfanelli U, 2008, CELL RES, V18, P1128, DOI 10.1038/cr.2008.296; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Restrepo-Angulo I, 2010, J APPL TOXICOL, V30, P497, DOI 10.1002/jat.1556; Riera CE, 2007, AM J PHYSIOL-REG I, V293, pR626, DOI 10.1152/ajpregu.00286.2007; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Squitti R, 2012, J TRACE ELEM MED BIO, V26, P93, DOI 10.1016/j.jtemb.2012.04.012; Sumoza-Toledo A, 2011, J PHYSIOL-LONDON, V589, P1515, DOI 10.1113/jphysiol.2010.201855; Tisato F, 2010, MED RES REV, V30, P708, DOI 10.1002/med.20174; Toth B, 2012, P NATL ACAD SCI USA, V109, P13440, DOI 10.1073/pnas.1204702109; Uchida K, 2011, ISLETS, V3, P209, DOI 10.4161/isl.3.4.16130; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725; Yang Wei, 2013, Methods Mol Biol, V998, P257, DOI 10.1007/978-1-62703-351-0_20; Yang W, 2011, J BIOL CHEM, V286, P23789, DOI 10.1074/jbc.M111.247478; Yang W, 2010, J BIOL CHEM, V285, P30411, DOI 10.1074/jbc.M110.139774; Zeng B, 2012, BIOCHEM BIOPH RES CO, V424, P279, DOI 10.1016/j.bbrc.2012.06.107; Zou J, 2011, PFLUG ARCH EUR J PHY, V462, P293, DOI 10.1007/s00424-011-0957-y	41	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112071	10.1371/journal.pone.0112071	http://dx.doi.org/10.1371/journal.pone.0112071			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386648	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000345250400037
J	Zhou, R; Wang, SS; Shi, CZ; Wang, WX; Zhao, H; Liu, R; Chen, LM; Zhou, B				Zhou, Rui; Wang, Shanshan; Shi, Chanzhen; Wang, Wenxin; Zhao, Heng; Liu, Rui; Chen, Limin; Zhou, Bin			Study on the Traffic Air Pollution inside and outside a Road Tunnel in Shanghai, China	PLOS ONE			English	Article							PARTICULATE MATTER PM2.5; EMISSIONS; VEHICLES; IMPACT	To investigate the vehicle induced air pollution situations both inside and outside the tunnel, the field measurement of the pollutants concentrations and its diurnal variations was performed inside and outside the Xiangyin tunnel in Shanghai from 13: 00 on April 24th to 13: 00 on April 25th, 2013. The highest hourly average concentrations of pollutants were quantified that CO, NO, NO2 and NOX inside the tunnel were 13.223 mg/m(3), 1.829 mg/m(3), 0.291 mg/m(3) and 3.029 mg/m(3), respectively, while the lowest ones were 3.086 mg/m(3), 0.344 mg/m(3), 0.080 mg/m(3) and 0.619 mg/m(3). Moreover, the concentrations of pollutants were higher during the daytime, and lower at night, which is relevant to the traffic conditions inside the tunnel. Pollutants concentrations inside the tunnel were much higher than those outside the tunnel. Then in a case of slow wind, the effect of wind is much smaller than the impact of pollution sources. Additionally, the PM2.5 concentrations climbed to the peak sharply (468.45 mu g/m(3)) during the morning rush hours. The concentrations of organic carbon (OC) and elemental carbon (EC) in PM2.5 inside the tunnel were 37.09-99.06 mu g/m(3) and 22.69-137.99 mu g/m(3), respectively. Besides, the OC/EC ratio ranged from 0.72 to 2.19 with an average value of 1.34. Compared with the results of other tunnel experiments in Guangzhou and Shenzhen, China, it could be inferred that the proportion of HDVs through the Xiangyin tunnel is relatively lower.	[Zhou, Rui; Shi, Chanzhen; Wang, Wenxin; Zhao, Heng; Liu, Rui; Chen, Limin; Zhou, Bin] Fudan Univ, Dept Environm Sci & Engn, Shanghai Key Lab Atmospher Particle Pollut & Prev, Shanghai 200433, Peoples R China; [Wang, Shanshan] Shanghai Univ Sci & Technol, Sch Environm & Architecture, Shanghai 200093, Peoples R China; [Zhou, Bin] Fudan Univ, Fudan Tyndall Ctr, Shanghai 200433, Peoples R China	Fudan University; University of Shanghai for Science & Technology; Fudan University	Wang, SS (corresponding author), Shanghai Univ Sci & Technol, Sch Environm & Architecture, Shanghai 200093, Peoples R China.	shanshan.wang@usst.edu.cn; binzhou@fudan.edu.cn	wang, wenxin/HGD-7043-2022	Wang, Shanshan/0000-0003-2590-9563	National Natural Science Foundation of China [21277029, 40975076, 41365010]; Science and Technology Commission of Shanghai Municipality [12231201001, 12DJ1400102]; China Meteorological Administration [GYHY201106045-8]; Shanghai Environmental Protection Bureau [2013-76, 2013-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); China Meteorological Administration; Shanghai Environmental Protection Bureau	This work was partially supported by the National Natural Science Foundation of China under grant No. 21277029, 40975076, 41365010, Science and Technology Commission of Shanghai Municipality (Grant: 12231201001, 12DJ1400102), and China Meteorological Administration (Grant: GYHY201106045-8). The authors are thankful for the great help from Shanghai Environmental Protection Bureau (Grant: 2013-76, 2013-03) and Design Institute of Urban Transport and Underground Space. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancelet T, 2011, ATMOS ENVIRON, V45, P4463, DOI 10.1016/j.atmosenv.2011.05.032; Beelen R, 2008, EPIDEMIOLOGY, V19, P702, DOI 10.1097/EDE.0b013e318181b3ca; Beevers SD, 2005, ATMOS ENVIRON, V39, P1, DOI 10.1016/j.atmosenv.2004.10.001; Brito J, 2013, ATMOS CHEM PHYS DISC, V13, P20839, DOI DOI 10.5194/ACPD-13-20839-2013; Chen CH, 2009, BIOMED ENVIRON SCI, V22, P210, DOI 10.1016/S0895-3988(09)60047-7; [程兴宏 CHENG Xinghong], 2007, [安全与环境学报, Journal of Safety and Environment], V7, P77; Cheng Y, 2006, ATMOS ENVIRON, V40, P4235, DOI 10.1016/j.atmosenv.2006.04.002; Cowie CT, 2012, ENVIRON SCI TECHNOL, V46, P2918, DOI 10.1021/es202686r; El Haddad I, 2009, ATMOS ENVIRON, V43, P6190, DOI 10.1016/j.atmosenv.2009.09.001; Gillies JA, 2001, ENVIRON SCI TECHNOL, V35, P1054, DOI 10.1021/es991320p; Grieshop AP, 2006, ATMOS ENVIRON, V40, pS287, DOI 10.1016/j.atmosenv.2006.03.064; Handler M, 2008, ATMOS ENVIRON, V42, P2173, DOI 10.1016/j.atmosenv.2007.11.054; He LY, 2008, ENVIRON SCI TECHNOL, V42, P4461, DOI 10.1021/es7022658; [刘川 Liu Chuan], 2012, [环境科学与技术, Enuivonmental Science and Technology], V35, P150; McKillup, 2006, STAT EXPLAINED INTRO, P44; Pio C, 2011, ATMOS ENVIRON, V45, P6121, DOI 10.1016/j.atmosenv.2011.08.045; Sandra S, 2007, ELEMENTARY STAT USIN, P166; Tian LW, 2011, CONTAM CONTR, V6, P30; Wang HK, 2008, SCI TOTAL ENVIRON, V398, P60, DOI 10.1016/j.scitotenv.2008.01.038; Wang J., 2009, CHINESE J UNDERGROUN, V5, P196; [薛佳平 Xue Jiaping], 2010, [环境科学研究, Research of Environmental Sciences], V23, P613; Yang F, 2004, TRANSPORT RES REC, P77; Yang L, 2011, THESIS TSINGHUA U; Zhao HJ, 2013, ATMOS POLLUT RES, V4, P427, DOI 10.5094/APR.2013.049; Zhu CS, 2010, ATMOS ENVIRON, V44, P2668, DOI 10.1016/j.atmosenv.2010.04.042	25	31	31	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112195	10.1371/journal.pone.0112195	http://dx.doi.org/10.1371/journal.pone.0112195			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386920	Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400048
J	Di Clemente, R; Chiarotti, GL; Cristelli, M; Tacchella, A; Pietronero, L				Di Clemente, Riccardo; Chiarotti, Guido L.; Cristelli, Matthieu; Tacchella, Andrea; Pietronero, Luciano			Diversification versus Specialization in Complex Ecosystems	PLOS ONE			English	Article								By analyzing the distribution of revenues across the production sectors of quoted firms we suggest a novel dimension that drives the firms diversification process at country level. Data show a non trivial macro regional clustering of the diversification process, which underlines the relevance of geopolitical environments in determining the microscopic dynamics of economic entities. These findings demonstrate the possibility of singling out in complex ecosystems those micro-features that emerge at macro-levels, which could be of particular relevance for decision-makers in selecting the appropriate parameters to be acted upon in order to achieve desirable results. The understanding of this micro-macro information exchange is further deepened through the introduction of a simplified dynamic model.	[Di Clemente, Riccardo] IMT Inst Adv Studies Lucca, Lucca, Italy; [Di Clemente, Riccardo; Chiarotti, Guido L.; Cristelli, Matthieu; Tacchella, Andrea; Pietronero, Luciano] UOS Sapienza, CNR, Ist Sistemi Complessi, Rome, Italy; [Tacchella, Andrea; Pietronero, Luciano] Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy; [Pietronero, Luciano] London Inst Math Sci, London, England	IMT School for Advanced Studies Lucca; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); Sapienza University Rome	Di Clemente, R (corresponding author), IMT Inst Adv Studies Lucca, Lucca, Italy.	riccardo.diclemente@isc.cnr.it	Di Clemente, Riccardo/N-9471-2014; Pietronero, Luciano/O-4473-2018	Di Clemente, Riccardo/0000-0001-8005-6351; Pietronero, Luciano/0000-0001-6424-8863; Tacchella, Andrea/0000-0003-3940-9404	Italian PNR project "CRISIS-Lab"; EU Project "GROWTHCOM" [611272]	Italian PNR project "CRISIS-Lab"; EU Project "GROWTHCOM"	M. C., A. T. and G. L. C. are funded by Italian PNR project "CRISIS-Lab"; R. D. C. is funded by EU Project nr. 611272 "GROWTHCOM". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, IND METH GLOB FIX IN; [Anonymous], 2013, DAT COLL; ANSOFF HI, 1957, HARVARD BUS REV, V35, P113; Bianco M, 1999, EUR ECON REV, V43, P1057, DOI 10.1016/S0014-2921(98)00114-7; Campa JM, 2002, J FINANC, V57, P1731, DOI 10.1111/1540-6261.00476; CHU YJ, 1965, SCI SINICA, V14, P1396; CRACRAFT J, 1985, ANN MO BOT GARD, V72, P794, DOI 10.2307/2399222; Cristelli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070726; Faccio M, 2002, J FINANC ECON, V65, P365, DOI 10.1016/S0304-405X(02)00146-0; Fauver L, 2003, J FINANC QUANT ANAL, V38, P135, DOI 10.2307/4126767; Garlaschelli D, 2003, NATURE, V423, P165, DOI 10.1038/nature01604; GOMEZMEJIA LR, 1992, STRATEGIC MANAGE J, V13, P381, DOI 10.1002/smj.4250130506; Haldane AG, 2011, NATURE, V469, DOI 10.1038/nature09659; Hidalgo CA, 2009, P NATL ACAD SCI USA, V106, P10570, DOI 10.1073/pnas.0900943106; Khanna T, 2000, J FINANC, V55, P867, DOI 10.1111/0022-1082.00229; KNOLL AH, 1999, SCIENCE, V284, P2129, DOI DOI 10.1126/SCIENCE.284.5423.2129; Shleifer A, 1997, J FINANC, V52, P737, DOI 10.1111/j.1540-6261.1997.tb04820.x; Tacchella A, 2013, J ECON DYN CONTROL, V37, P1683, DOI 10.1016/j.jedc.2013.04.006; Tacchella A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00723; WALKER I, 1972, Acta Biotheoretica, V21, P203, DOI 10.1007/BF01557179	21	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112525	10.1371/journal.pone.0112525	http://dx.doi.org/10.1371/journal.pone.0112525			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT3DP	25384059	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000344816700076
J	Macrae, FL; Evans, HL; Bridge, KI; Johnson, A; Scott, DJA; Ariens, RAS				Macrae, Fraser L.; Evans, Hannah Lee; Bridge, Katherine I.; Johnson, Anne; Scott, D. Julian A.; Ariens, Robert A. S.			Common FXIII and Fibrinogen Polymorphisms in Abdominal Aortic Aneurysms	PLOS ONE			English	Article							FACTOR-XIII GENE; ALPHA THR312ALA POLYMORPHISM; INTRALUMINAL THROMBUS; COAGULATION-FACTOR; PLASMA-FIBRINOGEN; MURAL THROMBUS; OLDER-ADULTS; RISK-FACTORS; B-SUBUNIT; ASSOCIATION	Introduction: Abdominal aortic aneurysms (AAA) are characterized by a progressive dilatation of the abdominal aorta, and are associated with a high risk of rupture once the dilatation exceeds 55 mm in diameter. A large proportion of AAA develops an intraluminal thrombus, which contributes to hypoxia, inflammation and tissue degradation. We have previously shown that patients with AAA produce clots with altered structure which is more resistant to fibrinolysis. The aim of this study was to investigate genetic polymorphisms of FXIII and fibrinogen in AAA to identify how changes to these proteins may play a role in the development of AAA. Methods: Subjects of Western/European descent, >= 55 years of age (520 AAA patients and 449 controls) were genotyped for five polymorphisms (FXIII-A Val34Leu, FXIII-B His95Arg, FXIII-B Splice Variant (intron K nt29576C-G), Fib-A Thr312Ala and Fib-B Arg448Lys) by RT-PCR. Data were analysed by chi(2) test and CubeX. Results: The FXIII-B Arg95 allele associated with AAA (Relative risk - 1.240, CI 1.093-1.407, P = 0.006). There was no association between FXIII-A Val34Leu, FXIII-B Splice Variant, Fib-A Thr312Ala or Fib-B Arg448Lys and AAA. FXIII-B His95Arg and FXIII-B Splice variant (intron K nt29576C-G) were in negative linkage disequilibrium (D' = -0.609, p = 0.011). Discussion: The FXIII-B Arg95 variant is associated with an increased risk of AAA. These data suggest a possible role for FXIII in AAA pathogenesis.	[Macrae, Fraser L.; Evans, Hannah Lee; Bridge, Katherine I.; Johnson, Anne; Scott, D. Julian A.; Ariens, Robert A. S.] Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, Div Cardiovasc & Diabet Res, Leeds Inst Cardiovasc & Metab Med, Leeds, W Yorkshire, England; [Bridge, Katherine I.; Johnson, Anne; Scott, D. Julian A.] Gen Infirm, Leeds Vasc Inst, Leeds LS1 3EX, W Yorkshire, England	University of Leeds; Leeds General Infirmary	Ariens, RAS (corresponding author), Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, Div Cardiovasc & Diabet Res, Leeds Inst Cardiovasc & Metab Med, Leeds, W Yorkshire, England.	r.a.s.ariens@leeds.ac.uk	Macrae, Fraser/AAN-8377-2021	Ariens, Robert/0000-0002-6310-5745; Macrae, Fraser/0000-0002-7092-0422	Garfield Weston trust; British Heart Foundation [FS/12/26/29395]; British Heart Foundation [RG/13/3/30104] Funding Source: researchfish	Garfield Weston trust; British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	RASA and DJAS were supported by The Garfield Weston trust into diseases of the Heart. KIB was supported by The British Heart Foundation Clinical Research Training Fellowship, FS/12/26/29395. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajjan R, 2008, BLOOD, V111, P643, DOI 10.1182/blood-2007-05-091231; Al-Barjas HS, 2006, ANGIOLOGY, V57, P607, DOI 10.1177/0003319706293132; Alcorn HG, 1996, ARTERIOSCL THROM VAS, V16, P963, DOI 10.1161/01.ATV.16.8.963; Ariens RAS, 2000, BLOOD, V96, P988, DOI 10.1182/blood.V96.3.988.015k57_988_995; BOARD PG, 1993, BLOOD REV, V7, P229, DOI 10.1016/0268-960X(93)90010-2; Carrell TWG, 2006, VASCULAR, V14, P9, DOI 10.2310/6670.2006.00008; Catto AJ, 1999, BLOOD, V93, P906, DOI 10.1182/blood.V93.3.906.403k24_906_908; Dardik R, 2006, J THROMB HAEMOST, V4, P19, DOI 10.1111/j.1538-7836.2005.01473.x; de Willige SU, 2009, BLOOD, V114, P3994, DOI 10.1182/blood-2009-05-217968; Elbaz A, 2000, BLOOD, V95, P586, DOI 10.1182/blood.V95.2.586; Folkesson M, 2007, THROMB HAEMOSTASIS, V98, P427, DOI 10.1160/TH06-11-0638; Fontaine V, 2002, AM J PATHOL, V161, P1701, DOI 10.1016/S0002-9440(10)64447-1; Franco RF, 2000, HAEMATOLOGICA, V85, P67; Franco RF, 1999, THROMB HAEMOSTASIS, V81, P676; Gaunt TR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-428; Golledge J, 2006, EUR J VASC ENDOVASC, V31, P237, DOI 10.1016/j.ejvs.2005.10.032; HARTER LP, 1982, J ULTRAS MED, V1, P315; Henderson EL, 1999, CIRCULATION, V99, P96, DOI 10.1161/01.CIR.99.1.96; Houard X, 2007, J PATHOL, V212, P20, DOI 10.1002/path.2148; Ichinose A, 2012, INT J HEMATOL, V95, P362, DOI 10.1007/s12185-012-1064-3; Iwata H, 2009, J THROMB HAEMOST, V7, P1084, DOI 10.1111/j.1538-7836.2009.03443.x; Jagadesham VP, 2008, TRENDS MOL MED, V14, P522, DOI 10.1016/j.molmed.2008.09.008; Kain K, 2002, AM J EPIDEMIOL, V156, P174, DOI 10.1093/aje/kwf017; Katona E, 2014, BLOOD, V123, P1757, DOI 10.1182/blood-2013-10-533596; Kazi M, 2003, J VASC SURG, V38, P1283, DOI 10.1016/S0741-5214(03)00791-2; Kohler HP, 1998, THROMB HAEMOSTASIS, V79, P8, DOI 10.1055/s-0037-1614250; Komanasin N, 2005, J THROMB HAEMOST, V3, P2487, DOI 10.1111/j.1538-7836.2005.01624.x; Ladenvall C, 2009, J NEUROSURG, V110, P475, DOI 10.3171/2008.7.JNS08272; Lim BCB, 2003, LANCET, V361, P1424, DOI 10.1016/S0140-6736(03)13135-2; LopezCandales A, 1997, AM J PATHOL, V150, P993; Lord ST, 2011, ARTERIOSCL THROM VAS, V31, P494, DOI 10.1161/ATVBAHA.110.213389; Lunetta KL, 2008, CIRCULATION, V118, P96, DOI 10.1161/CIRCULATIONAHA.107.700401; MIKKOLA H, 1994, BLOOD, V84, P517; Muszbek L, 2011, PHYSIOL REV, V91, P931, DOI 10.1152/physrev.00016.2010; Newman AB, 2001, ANN INTERN MED, V134, P182, DOI 10.7326/0003-4819-134-3-200102060-00008; Parry DJ, 2009, BRIT J SURG, V96, P870, DOI 10.1002/bjs.6632; Parry DJ, 2010, J VASC SURG, V52, P145, DOI 10.1016/j.jvs.2010.02.279; Patel A, 2008, EUR J VASC ENDOVASC, V36, P20, DOI 10.1016/j.ejvs.2008.01.014; Rasmussen-Torvik LJ, 2007, THROMB RES, V121, P1, DOI 10.1016/j.thromres.2007.02.008; Ruigrok YM, 2010, ACTA NEUROCHIR, V152, P257, DOI 10.1007/s00701-009-0505-0; Ryan AW, 2009, EUR J HUM GENET, V17, P219, DOI 10.1038/ejhg.2008.137; SCHWARTZ ML, 1973, J BIOL CHEM, V248, P1395; Scott DJA, 2011, ARTERIOSCL THROM VAS, V31, P3004, DOI 10.1161/ATVBAHA.111.236786; Singh K, 2001, AM J EPIDEMIOL, V154, P236, DOI 10.1093/aje/154.3.236; Standeven KF, 2003, CIRCULATION, V107, P2326, DOI 10.1161/01.CIR.0000066690.89407.CE; Suntharalingam J, 2008, EUR RESPIR J, V31, P736, DOI 10.1183/09031936.00055107; Thompson RW, 1997, CORONARY ARTERY DIS, V8, P623, DOI 10.1097/00019501-199710000-00005; van der Bom JG, 1998, ARTERIOSCL THROM VAS, V18, P621, DOI 10.1161/01.ATV.18.4.621; Vardulaki KA, 1998, BRIT J SURG, V85, P1674; Vorp DA, 2001, J VASC SURG, V34, P291, DOI 10.1067/mva.2001.114813; Wartiovaara U, 1999, ATHEROSCLEROSIS, V142, P295, DOI 10.1016/S0021-9150(98)00241-X	51	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112407	10.1371/journal.pone.0112407	http://dx.doi.org/10.1371/journal.pone.0112407			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384012	gold, Green Submitted, Green Published			2022-12-27	WOS:000344816700057
J	AbdulHameed, MDM; Tawa, GJ; Kumar, K; Ippolito, DL; Lewis, JA; Stallings, JD; Wallqvist, A				AbdulHameed, Mohamed Diwan M.; Tawa, Gregory J.; Kumar, Kamal; Ippolito, Danielle L.; Lewis, John A.; Stallings, Jonathan D.; Wallqvist, Anders			Systems Level Analysis and Identification of Pathways and Networks Associated with Liver Fibrosis	PLOS ONE			English	Article							GENE-EXPRESSION; HEART-FAILURE; MECHANISMS; DATABASE; BIOINFORMATICS; BIOMARKERS; DISEASE; TOXICOGENOMICS; BIOCONDUCTOR; FIBROGENESIS	Toxic liver injury causes necrosis and fibrosis, which may lead to cirrhosis and liver failure. Despite recent progress in understanding the mechanism of liver fibrosis, our knowledge of the molecular-level details of this disease is still incomplete. The elucidation of networks and pathways associated with liver fibrosis can provide insight into the underlying molecular mechanisms of the disease, as well as identify potential diagnostic or prognostic biomarkers. Towards this end, we analyzed rat gene expression data from a range of chemical exposures that produced observable periportal liver fibrosis as documented in DrugMatrix, a publicly available toxicogenomics database. We identified genes relevant to liver fibrosis using standard differential expression and co-expression analyses, and then used these genes in pathway enrichment and protein-protein interaction (PPI) network analyses. We identified a PPI network module associated with liver fibrosis that includes known liver fibrosis-relevant genes, such as tissue inhibitor of metalloproteinase-1, galectin-3, connective tissue growth factor, and lipocalin-2. We also identified several new genes, such as perilipin-3, legumain, and myocilin, which were associated with liver fibrosis. We further analyzed the expression pattern of the genes in the PPI network module across a wide range of 640 chemical exposure conditions in DrugMatrix and identified early indications of liver fibrosis for carbon tetrachloride and lipopolysaccharide exposures. Although it is well known that carbon tetrachloride and lipopolysaccharide can cause liver fibrosis, our network analysis was able to link these compounds to potential fibrotic damage before histopathological changes associated with liver fibrosis appeared. These results demonstrated that our approach is capable of identifying early-stage indicators of liver fibrosis and underscore its potential to aid in predictive toxicity, biomarker identification, and to generally identify disease-relevant pathways.	[AbdulHameed, Mohamed Diwan M.; Tawa, Gregory J.; Kumar, Kamal; Wallqvist, Anders] US Army Med Res & Mat Command, Telemed & Adv Technol Res Ctr, High Performance Comp Software Applicat Inst, Dept Def Biotechnol, Ft Detrick, MD 21702 USA; [Ippolito, Danielle L.; Lewis, John A.; Stallings, Jonathan D.] US Army Ctr Environm Hlth Res, Ft Detrick, MD USA	United States Department of Defense; United States Army	Wallqvist, A (corresponding author), US Army Med Res & Mat Command, Telemed & Adv Technol Res Ctr, High Performance Comp Software Applicat Inst, Dept Def Biotechnol, Ft Detrick, MD 21702 USA.	awallqvist@bhsai.org	AbdulHameed, Mohamed Diwan M/O-3088-2015; wallqvist, anders/W-2584-2019; Stallings, Jonathan D/H-7779-2013	AbdulHameed, Mohamed Diwan M/0000-0003-1483-4084; wallqvist, anders/0000-0002-9775-7469; Stallings, Jonathan D/0000-0002-6430-5888; Kumar, Kamal/0000-0002-9470-6682	Military Operational Medicine Research Program; U.S. Army's Network Science Initiative, U.S. Army Medical Research and Materiel Command (USAMRMC); U.S. Department of Energy; USAMRMC	Military Operational Medicine Research Program(United States Department of DefenseUnited States ArmyUnited States Army Medical Research & Development Command (USAMRDC)); U.S. Army's Network Science Initiative, U.S. Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); U.S. Department of Energy(United States Department of Energy (DOE)); USAMRMC(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	The authors were supported by the Military Operational Medicine Research Program and the U.S. Army's Network Science Initiative, U.S. Army Medical Research and Materiel Command (USAMRMC, http://mrmc.amedd.army.mil), Ft. Detrick, MD. This research was supported in part by an appointment to the Postgraduate Research Participation Program at the U.S. Army Center for Environmental Health Research (USACEHR, http://usacehr.amedd.army.mil) administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and USAMRMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2011, J GASTROEN HEPATOL, V26, P802, DOI 10.1111/j.1440-1746.2010.06612.x; Affo S, 2013, GUT, V62, P452, DOI 10.1136/gutjnl-2011-301146; Afshari CA, 2011, TOXICOL SCI, V120, pS225, DOI 10.1093/toxsci/kfq373; Alcaraz N, 2012, INTEGR BIOL-UK, V4, P756, DOI 10.1039/c2ib00133k; Azuaje F, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-60; Azuaje FJ, 2012, CIRC-CARDIOVASC GENE, V5, P360, DOI 10.1161/CIRCGENETICS.112.962977; Baranova A, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-91; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Baumbach J, 2012, PROCEEDINGS OF THE FOURTEENTH INTERNATIONAL CONFERENCE ON GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P169, DOI 10.1145/2330163.2330188; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Brenner David A, 2009, Trans Am Clin Climatol Assoc, V120, P361; Camargo A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001347; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Davis AP, 2013, NUCLEIC ACIDS RES, V41, pD1104, DOI 10.1093/nar/gks994; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Feala JD, 2013, J NEUROTRAUM, V30, P1101, DOI 10.1089/neu.2012.2631; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Ganter B, 2006, PHARMACOGENOMICS, V7, P1025, DOI 10.2217/14622416.7.7.1025; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Gentleman R, 2013, GENEFILTER METHODS F; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hartung T, 2011, ALTEX-ALTERN ANIM EX, V28, P83, DOI 10.14573/altex.2011.2.083; Heinloth AN, 2007, TOXICOL PATHOL, V35, P276, DOI 10.1080/01926230601178207; Henderson NC, 2006, P NATL ACAD SCI USA, V103, P5060, DOI 10.1073/pnas.0511167103; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Huan JL, 2014, GENE, V533, P346, DOI 10.1016/j.gene.2013.08.027; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-288; Ikeda K, 1998, AM J PATHOL, V153, P1695, DOI 10.1016/S0002-9440(10)65683-0; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kim MJ, 2012, ENVIRON HEALTH PERSP, V120, P508, DOI 10.1289/ehp.1104282; Kisseleva T, 2008, EXP BIOL MED, V233, P109, DOI 10.3181/0707-MR-190; Kitada T, 2000, J HEPATOL, V33, P751, DOI 10.1016/S0168-8278(00)80306-2; Koukoulis GK, 2001, HUM PATHOL, V32, P1356, DOI 10.1053/hupa.2001.29675; Krishnan A, 2012, LAB INVEST, V92, P1712, DOI 10.1038/labinvest.2012.121; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lehne B, 2012, PHARMACOGENOMICS, V13, P1967, DOI [10.2217/pgs.12.170, 10.2217/PGS.12.170]; Li L, 2012, LIVER INT, V32, P1093, DOI 10.1111/j.1478-3231.2012.02809.x; Liedtke C, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-19; Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002; Mallat A, 2013, AM J PHYSIOL-CELL PH, V305, pC789, DOI 10.1152/ajpcell.00230.2013; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Moreno M, 2010, HEPATOLOGY, V51, P974, DOI 10.1002/hep.23421; Morita Y, 2007, FEBS LETT, V581, P1417, DOI 10.1016/j.febslet.2007.02.064; Mukhopadhyay P, 2014, HEPATOLOGY, V59, P1998, DOI 10.1002/hep.26763; Nam D, 2008, BRIEF BIOINFORM, V9, P189, DOI 10.1093/bib/bbn001; Nose F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071542; Okayama T, 2008, BBA-MOL BASIS DIS, V1782, P542, DOI 10.1016/j.bbadis.2008.06.006; Okumura T, 2011, J PHYSIOL BIOCHEM, V67, P629, DOI 10.1007/s13105-011-0110-6; Page S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056009; Pan KH, 2005, P NATL ACAD SCI USA, V102, P8961, DOI 10.1073/pnas.0502674102; Pan YM, 2014, J CHEM INF MODEL, V54, P407, DOI 10.1021/ci4005354; Qiu LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073591; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reiss DJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-154; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028; Sebastiani G, 2012, CLIN CHEM LAB MED, V50, P595, DOI 10.1515/cclm-2011-0850; Shen HW, 2009, PHYSICA A, V388, P1706, DOI 10.1016/j.physa.2008.12.021; Shi ZA, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-74; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tamm ER, 2002, PROG RETIN EYE RES, V21, P395, DOI 10.1016/S1350-9462(02)00010-1; Tawa GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107230; Tugues S, 2007, HEPATOLOGY, V46, P1919, DOI 10.1002/hep.21921; ULITSKY I, 2010, PLOS ONE, V0005; Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011; Vinuela A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012145; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xiao Y, 2012, GENE, V499, P332, DOI 10.1016/j.gene.2012.03.039; Yu CG, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-143; Yu XP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-79; Zhang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024680; Zhang LP, 1999, J HEPATOL, V31, P703, DOI 10.1016/S0168-8278(99)80351-1; Zhu WL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006288	84	41	43	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112193	10.1371/journal.pone.0112193	http://dx.doi.org/10.1371/journal.pone.0112193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380136	Green Published, gold, Green Submitted			2022-12-27	WOS:000344863100061
J	Ros-Santaella, JL; Dominguez-Rebolledo, AE; Garde, JJ				Luis Ros-Santaella, Jose; Efren Dominguez-Rebolledo, Alvaro; Julian Garde, Jose			Sperm Flagellum Volume Determines Freezability in Red Deer Spermatozoa	PLOS ONE			English	Article							PLASMA-MEMBRANE INTEGRITY; BOAR SPERM; FUNCTIONAL-SIGNIFICANCE; EPIDIDYMAL SPERMATOZOA; NATURAL-POPULATIONS; ANIMAL VARIABILITY; LIPID-PEROXIDATION; COOLING RATE; CRYOPRESERVATION; MOTILITY	The factors affecting the inter-individual differences in sperm freezability is a major line of research in spermatology. Poor sperm freezability is mainly characterised by a low sperm velocity, which in turn is associated with low fertility rates in most animal species. Studies concerning the implications of sperm morphometry on freezability are quite limited, and most of them are based on sperm head size regardless of the structural parts of the flagellum, which provides sperm motility. Here, for the first time, we determined the volumes of the flagellum structures in fresh epididymal red deer spermatozoa using a stereological method under phase contrast microscopy. Sperm samples from thirty-three stags were frozen and classified as good freezers (GF) or bad freezers (BF) at two hours post-thawing using three sperm kinetic parameters which are strongly correlated with fertility in this species. Fourteen stags were clearly identified as GF, whereas nineteen were BF. No significant difference in sperm head size between the two groups was found. On the contrary, the GF exhibited a lower principal piece volume than the BF (6.13 mm 3 vs 6.61 mm 3, respectively, p = 0.006). The volume of the flagellum structures showed a strong negative relationship with post-thawing sperm velocity. For instance, the volume of the sperm principal piece was negatively correlated with sperm velocity at two hours post-thawing (r = 20.60; p<0.001). Our results clearly show that a higher volume of the sperm principal piece results in poor freezability, and highlights the key role of flagellum size in sperm cryopreservation success.	[Luis Ros-Santaella, Jose; Julian Garde, Jose] CSIC UCLM JCCM, Inst Invest Recursos Cineget IREC, SaBio, Albacete, Spain; [Luis Ros-Santaella, Jose] Czech Univ Life Sci, Fac Trop AgriSci, Dept Anim Sci & Food Proc, Prague, Czech Republic; [Efren Dominguez-Rebolledo, Alvaro] INIFAP, Mococha, Yucatan, Mexico	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Czech University of Life Sciences Prague	Ros-Santaella, JL (corresponding author), CSIC UCLM JCCM, Inst Invest Recursos Cineget IREC, SaBio, Campus Univ, Albacete, Spain.	joseluis.ros@irec.csic.es	Ros-Santaella, José Luis/F-9890-2019; Garde, Julian J/O-5607-2015; López-Brea, José Julián Garde/AAE-5894-2019	Ros-Santaella, José Luis/0000-0002-4186-7730; Garde, Julian J/0000-0002-3667-6518; López-Brea, José Julián Garde/0000-0002-3667-6518; Dominguez Rebolledo, Alvaro Efren/0000-0002-1444-3844	Czech University of Life Sciences, Prague, Czech Republic [99830/1181/1822, CIGA 20145001]; I3P program (Spanish National Research Council, CSIC, Spain)	Czech University of Life Sciences, Prague, Czech Republic; I3P program (Spanish National Research Council, CSIC, Spain)	JLRS was supported by I3P program (Spanish National Research Council, CSIC, Spain), post-doctoral fellowship no. 99830/1181/1822 (Czech University of Life Sciences, Prague, Czech Republic), and by the project CIGA 20145001 (Czech University of Life Sciences, Prague, Czech Republic). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2005, J ZOOL, V267, P135, DOI 10.1017/S0952836905007284; Anderson MJ, 2002, NATURE, V416, P496, DOI 10.1038/416496a; Anel-Lopez L, 2012, ANIM REPROD SCI, V135, P37, DOI 10.1016/j.anireprosci.2012.09.001; Billard R, 2000, AQUAC RES, V31, P283, DOI 10.1046/j.1365-2109.2000.00423.x; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P1759, DOI 10.1098/rspb.1999.0843; Bohonak A. J., 2004, RMA SOFTWARE REDUCED; Bollwein H, 2008, REPROD DOMEST ANIM, V43, P189, DOI 10.1111/j.1439-0531.2007.00876.x; Brouwers JF, 2005, THERIOGENOLOGY, V63, P458, DOI 10.1016/j.theriogenology.2004.09.046; Budaev SV, 2010, ETHOLOGY, V116, P472, DOI 10.1111/j.1439-0310.2010.01758.x; Comizzoli P, 2001, THERIOGENOLOGY, V56, P261, DOI 10.1016/S0093-691X(01)00561-1; Correa LM, 2007, BIOL REPROD, V77, P942, DOI 10.1095/biolreprod.107.060533; Cremades T, 2005, J ANDROL, V26, P610, DOI 10.2164/jandrol.05028; Curry MR, 1996, BIOL REPROD, V55, P1325, DOI 10.1095/biolreprod55.6.1325; Del Olmo E, 2013, ANIM REPROD SCI, V138, P102, DOI 10.1016/j.anireprosci.2013.02.007; Devireddy RV, 2002, REPRODUCTION, V124, P643, DOI 10.1530/reprod/124.5.643; Domes U., 2001, Animal Reproduction Science, V68, P329; Dominguez-Rebolledo AE, 2010, REPROD FERT DEVELOP, V22, P856, DOI 10.1071/RD09197; Felipe-Perez YE, 2012, CRYOBIOLOGY, V64, P103, DOI 10.1016/j.cryobiol.2011.12.004; Esteso MC, 2006, J ANDROL, V27, P662, DOI 10.2164/jandrol.106.000489; FAWCETT DW, 1975, DEV BIOL, V44, P394, DOI 10.1016/0012-1606(75)90411-X; Fernandez-Santos MR, 2006, THERIOGENOLOGY, V66, P1931, DOI 10.1016/j.theriogenology.2006.05.012; FULCHER KD, 1995, MOL REPROD DEV, V42, P415, DOI 10.1002/mrd.1080420407; Gage MJG, 2004, CURR BIOL, V14, P44, DOI 10.1016/j.cub.2003.12.028; Garde JJ, 2006, REPROD DOMEST ANIM, V41, P93, DOI 10.1111/j.1439-0531.2006.00773.x; Garde JJ, 1998, ARCH ANDROLOGY, V41, P195, DOI 10.3109/01485019808994891; Holt WV, 2005, THERIOGENOLOGY, V63, P370, DOI 10.1016/j.theriogenology.2004.09.018; HOLT WV, 1989, HUM REPROD, V4, P292, DOI 10.1093/oxfordjournals.humrep.a136891; HOLT WV, 1994, BIOL REPROD, V51, P414, DOI 10.1095/biolreprod51.3.414; HOLT WV, 1984, J EXP ZOOL, V230, P473, DOI 10.1002/jez.1402300316; Holt WV, 2000, ANIM REPROD SCI, V62, P3, DOI 10.1016/S0378-4320(00)00152-4; Hossain AM, 2001, J ANDROL, V22, P119; KEATES RAB, 1980, BIOCHEM BIOPH RES CO, V97, P1163, DOI 10.1016/0006-291X(80)91497-7; LINDEMANN CB, 1992, J CELL SCI, V102, P249; Garcia BM, 2012, THERIOGENOLOGY, V77, P1280, DOI 10.1016/j.theriogenology.2011.10.033; Malo AF, 2005, BIOL REPROD, V72, P822, DOI 10.1095/biolreprod.104.036368; Malo AF, 2006, BIOL LETTERS, V2, P246, DOI 10.1098/rsbl.2006.0449; McClean RV, 2007, CRYOBIOLOGY, V54, P271, DOI 10.1016/j.cryobiol.2007.03.004; Medrano A, 2002, REPRODUCTION, V123, P315, DOI 10.1530/rep.0.1230315; Nagy S, 1999, THERIOGENOLOGY, V52, P1153, DOI 10.1016/S0093-691X(99)00207-1; Nunez-Martinez I., 2006, J ANDROL, V27, P596; Parapanov RN, 2009, ANIM REPROD SCI, V114, P269, DOI 10.1016/j.anireprosci.2008.09.013; PARKS JE, 1992, THERIOGENOLOGY, V38, P209, DOI 10.1016/0093-691X(92)90231-F; Pena FJ, 2005, J ANDROL, V26, P716, DOI 10.2164/jandrol.05030; Petrunkina AM, 2004, REPRODUCTION, V128, P829, DOI 10.1530/rep.1.00296; Petrunkina AM, 2004, REPRODUCTION, V127, P105, DOI 10.1530/rep.1.00047; Petrunkina AM, 2004, THERIOGENOLOGY, V61, P35, DOI 10.1016/S0093-691X(03)00184-5; Ramanujan S., 1914, Q J MATH, V45, p[350, 23]; Ramm SA, 2010, BIOL LETTERS, V6, P219, DOI 10.1098/rsbl.2009.0635; Saacke RG, 1972, P 4 TECH C ART INS R, P2; Sanchez L, 2005, LECT NOTES COMPUT SC, V3691, P88; Schlingmann K, 2007, J ANDROL, V28, P706, DOI 10.2164/jandrol.106.001669; Thurston LM, 2002, BIOL REPROD, V66, P545, DOI 10.1095/biolreprod66.3.545; Turner RM, 2006, REPROD FERT DEVELOP, V18, P25, DOI 10.1071/RD05120; Tuset VM, 2008, THERIOGENOLOGY, V69, P1033, DOI 10.1016/j.theriogenology.2008.01.012; Voordouw MJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-214; Watson PF, 1995, REPROD FERT DEVELOP, V7, P871, DOI 10.1071/RD9950871; Watson PF, 2000, ANIM REPROD SCI, V60, P481, DOI 10.1016/S0378-4320(00)00099-3; WOOLLEY DM, 1978, J REPROD FERTIL, V53, P389; Zhu WJ, 2000, ASIAN J ANDROL, V2, P135	59	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112382	10.1371/journal.pone.0112382	http://dx.doi.org/10.1371/journal.pone.0112382			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380133	gold, Green Submitted, Green Published			2022-12-27	WOS:000344863100079
J	Peters, LP; Carvalho, G; Martins, PF; Dourado, MN; Vilhena, MB; Pileggi, M; Azevedo, RA				Peters, Leila Priscila; Carvalho, Giselle; Martins, Paula Fabiane; Dourado, Manuella Nobrega; Vilhena, Milca Bartz; Pileggi, Marcos; Azevedo, Ricardo Antunes			Differential Responses of the Antioxidant System of Ametryn and Clomazone Tolerant Bacteria	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; 16S RIBOSOMAL-RNA; DEGRADING BACTERIA; SOIL BACTERIUM; GLUTATHIONE; HERBICIDE; TRANSFERASE; SUPEROXIDE; CATALASE; BIODEGRADATION	The herbicides ametryn and clomazone are widely used in sugarcane cultivation, and following microbial degradation are considered as soil and water contaminants. The exposure of microorganisms to pesticides can result in oxidative damage due to an increase in the production of reactive oxygen species (ROS). This study investigated the response of the antioxidant systems of two bacterial strains tolerant to the herbicides ametryn and clomazone. Bacteria were isolated from soil with a long history of ametryn and clomazone application. Comparative analyses based on 16S rRNA gene sequences revealed that strain CC07 is phylogenetically related to Pseudomonas aeruginosa and strain 4C07 to P. fulva. The two bacterial strains were grown for 14 h in the presence of separate and combined herbicides. Lipid peroxidation, reduced glutathione content (GSH) and antioxidant enzymes activities were evaluated. The overall results indicated that strain 4C07 formed an efficient mechanism to maintain the cellular redox balance by producing reactive oxygen species (ROS) and subsequently scavenging ROS in the presence of the herbicides. The growth of bacterium strain 4C07 was inhibited in the presence of clomazone alone, or in combination with ametryn, but increased glutathione reductase (GR) and glutathione S-transferase (GST) activities, and a higher GSH concentration were detected. Meanwhile, reduced superoxide dismutase (SOD), catalase (CAT) and GST activities and a lower concentration of GSH were detected in the bacterium strain CC07, which was able to achieve better growth in the presence of the herbicides. The results suggest that the two bacterial strains tolerate the ametryn and clomazone herbicides with distinctly different responses of the antioxidant systems.	[Peters, Leila Priscila; Carvalho, Giselle; Martins, Paula Fabiane; Dourado, Manuella Nobrega; Vilhena, Milca Bartz; Azevedo, Ricardo Antunes] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Dept Genet, Piracicaba, Brazil; [Pileggi, Marcos] Univ Estadual Ponta Grossa, Dept Biol Estrut Mol & Genet, Ponta Grossa, Brazil	Universidade de Sao Paulo; Universidade Estadual de Ponta Grossa	Azevedo, RA (corresponding author), Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Dept Genet, Piracicaba, Brazil.	raa@usp.br	Azevedo, Ricardo Antunes/F-8863-2011; Dourado, Manuella N/P-2337-2018; Pileggi, Marcos/B-8651-2012; Pileggi, Marcos/H-2695-2017; Carvalho, Giselle/AAO-9818-2020	Azevedo, Ricardo Antunes/0000-0001-7316-125X; Dourado, Manuella N/0000-0002-2152-0246; Pileggi, Marcos/0000-0003-1633-8295; Pileggi, Marcos/0000-0003-1633-8295; Carvalho, Giselle/0000-0001-5161-7340; Peters, Leila Priscila/0000-0002-9469-5290	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [09/54676-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by grant 09/54676-0 from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo to RAA. The authors thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (RAA and MBV) and the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (LPP, PFM, GC and MND) for the fellowship and scholarships granted. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allocati N, 2009, FEBS J, V276, P58, DOI 10.1111/j.1742-4658.2008.06743.x; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Andrade SRB, 2010, PLANTA DANINHA, V28, P655, DOI 10.1590/S0100-83582010000300023; Araujo WL, 2002, APPL ENVIRON MICROB, V68, P4906, DOI 10.1128/AEM.68.10.4906-4914.2002; Azevedo RA, 1998, PHYSIOL PLANTARUM, V104, P280, DOI 10.1034/j.1399-3054.1998.1040217.x; Boaretto LF, 2014, PLANT PHYSIOL BIOCH, V74, P165, DOI 10.1016/j.plaphy.2013.11.016; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camargo O.A., 2009, B TECNICO, V106, P77; Carlomagno M, 2010, J AGR FOOD CHEM, V58, P4367, DOI 10.1021/jf9043259; Carvalho RF, 2011, SCI AGR, V68, P598, DOI 10.1590/S0103-90162011000500014; Cia MC, 2012, ANN APPL BIOL, V161, P313, DOI 10.1111/j.1744-7348.2012.00575.x; Cumming JP, 2002, WEED SCI, V50, P405, DOI 10.1614/0043-1745(2002)050[0405:CDIFTT]2.0.CO;2; Costa JSD, 2011, ECOTOX ENVIRON SAFE, V74, P2020, DOI 10.1016/j.ecoenv.2011.06.017; Dwivedi S, 2011, J HAZARD MATER, V185, P938, DOI 10.1016/j.jhazmat.2010.09.110; Ferhatoglu Y, 2006, PESTIC BIOCHEM PHYS, V85, P7, DOI 10.1016/j.pestbp.2005.10.002; Ferhatoglu Y, 2005, PESTIC BIOCHEM PHYS, V81, P59, DOI 10.1016/j.pestbp.2004.09.002; Foyer CH, 1997, PHYSIOL PLANTARUM, V100, P241, DOI 10.1034/j.1399-3054.1997.1000205.x; Garcia JS, 2006, J AGR FOOD CHEM, V54, P8623, DOI 10.1021/jf061593l; Garcia-Cruz U, 2010, J HAZARD MATER, V179, P591, DOI 10.1016/j.jhazmat.2010.03.044; Ghelfi A, 2011, ANN APPL BIOL, V159, P267, DOI 10.1111/j.1744-7348.2011.00491.x; Gomes RA, 2006, PLANT PHYSIOL BIOCH, V44, P420, DOI 10.1016/j.plaphy.2006.06.002; Gomes-Junior RA, 2007, FUNCT PLANT BIOL, V34, P449, DOI 10.1071/FP07010; Gomes-Junior RA, 2006, CHEMOSPHERE, V65, P1330, DOI 10.1016/j.chemosphere.2006.04.056; Goulielmos GN, 2003, BIOCHEM BIOPH RES CO, V308, P433, DOI 10.1016/S0006-291X(03)01422-0; Gratao PL, 2008, ANN APPL BIOL, V153, P321, DOI 10.1111/j.1744-7348.2008.00299.x; Gratao PL, 2005, FUNCT PLANT BIOL, V32, P481, DOI 10.1071/FP05016; Gratao PL, 2012, PLANT PHYSIOL BIOCH, V56, P79, DOI 10.1016/j.plaphy.2012.04.009; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; Hultberg M, 1998, CURR MICROBIOL, V37, P301, DOI 10.1007/s002849900382; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Juraske R, 2007, ENVIRON INT, V33, P886, DOI 10.1016/j.envint.2007.04.005; Konstantinidis KT, 2005, J BACTERIOL, V187, P6258, DOI 10.1128/JB.187.18.6258-6264.2005; Labrou NE, 2005, PLANTA, V222, P91, DOI 10.1007/s00425-005-1520-x; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lin XY, 2009, ECOTOX ENVIRON SAFE, V72, P1899, DOI 10.1016/j.ecoenv.2009.04.016; Lu ZM, 2004, J ENVIRON SCI HEAL B, V39, P431, DOI 10.1081/PFC-120035928; Lu ZM, 2009, ECOTOX ENVIRON SAFE, V72, P136, DOI 10.1016/j.ecoenv.2008.01.009; Lushchak VI, 2001, BIOCHEMISTRY-MOSCOW+, V66, P476, DOI 10.1023/A:1010294415625; Lushchak VI, 2011, COMP BIOCHEM PHYS C, V153, P175, DOI 10.1016/j.cbpc.2010.10.004; Martins PF, 2011, PROCESS BIOCHEM, V46, P1186, DOI 10.1016/j.procbio.2011.02.014; Martins PF, 2007, BRAZ ARCH BIOL TECHN, V50, P153, DOI 10.1590/S1516-89132007000100019; Masip L, 2006, ANTIOXID REDOX SIGN, V8, P753, DOI 10.1089/ars.2006.8.753; Matsue Y, 2010, J ANTIBIOT, V63, P583, DOI 10.1038/ja.2010.100; Mattos MLT, 1996, DECH MONOG, V133, P623; McKnight US, 2012, SCI TOTAL ENVIRON, V427, P319, DOI 10.1016/j.scitotenv.2012.04.011; MERVOSH TL, 1995, J AGR FOOD CHEM, V43, P537, DOI 10.1021/jf00050a052; Mishra K, 2012, ECOTOX ENVIRON SAFE, V76, P215, DOI 10.1016/j.ecoenv.2011.09.014; Mongkolsuk S, 2005, J IND MICROBIOL BIOT, V32, P687, DOI 10.1007/s10295-005-0036-5; Monquero PA, 2008, PLANTA DANINHA, V26, P685, DOI 10.1590/S0100-83582008000300025; Monteiro CC, 2012, AN ACAD BRAS CIENC, V84, P573, DOI 10.1590/S0001-37652012005000022; Monteiro CC, 2011, ENVIRON EXP BOT, V71, P306, DOI 10.1016/j.envexpbot.2010.12.020; Navaratna D, 2012, BIORESOURCE TECHNOL, V113, P181, DOI 10.1016/j.biortech.2011.12.018; Nie ZJ, 2011, J AGR FOOD CHEM, V59, P6040, DOI 10.1021/jf200397t; Pileggi M, 2012, CHEMOSPHERE, V86, P1127, DOI 10.1016/j.chemosphere.2011.12.041; Pimentel David, 2009, P83, DOI 10.1007/978-1-4020-8992-3_3; Ramu S, 2014, J ENVIRON SCI HEAL B, V49, P23, DOI 10.1080/03601234.2013.836868; Ryan KC, 2010, J BIOL INORG CHEM, V15, P795, DOI 10.1007/s00775-010-0645-y; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sangali S, 2000, J APPL MICROBIOL, V89, P735, DOI 10.1046/j.1365-2672.2000.01173.x; Shao TJ, 2010, ECOTOXICOLOGY, V19, P1117, DOI 10.1007/s10646-010-0494-z; Smirnova GV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P1199, DOI 10.1007/s10541-005-0248-3; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tejada M, 2011, ECOTOX ENVIRON SAFE, V74, P2075, DOI 10.1016/j.ecoenv.2011.07.005; Tironi SP, 2009, PLANTA DANINHA, V27, P995, DOI 10.1590/S0100-83582009000500013; Vercraene-Eairmal M, 2010, CHEMOSPHERE, V81, P837, DOI 10.1016/j.chemosphere.2010.08.014; Veremeenko EG, 2010, MICROBIOLOGY+, V79, P439, DOI 10.1134/S0026261710040041; Viegas CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037140; Vieira VC, 2010, ACTA SCI-AGRON, V32, P255, DOI 10.4025/actasciagron.v32i2.3841; Yasuor H, 2008, PEST MANAG SCI, V64, P1031, DOI 10.1002/ps.1604; ZABLOTOWICZ RM, 1995, APPL ENVIRON MICROB, V61, P1054, DOI 10.1128/AEM.61.3.1054-1060.1995; Zeng HW, 2010, ANN MICROBIOL, V60, P701, DOI 10.1007/s13213-010-0116-2; Zhang Y, 2012, J HAZARD MATER, V229, P434, DOI 10.1016/j.jhazmat.2012.05.054	73	31	33	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112271	10.1371/journal.pone.0112271	http://dx.doi.org/10.1371/journal.pone.0112271			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380132	Green Published, Green Submitted, gold			2022-12-27	WOS:000344863100070
J	Xu, HC; Zhong, JC; Yu, GH; Wu, J; Jiang, HL; Yang, LY				Xu, Huacheng; Zhong, Jicheng; Yu, Guanghui; Wu, Jun; Jiang, Helong; Yang, Liuyan			Further Insights into Metal-DOM Interaction: Consideration of Both Fluorescent and Non-Fluorescent Substances	PLOS ONE			English	Article							EXTRACELLULAR POLYMERIC SUBSTANCES; DISSOLVED ORGANIC-MATTER; EXCITATION-EMISSION MATRIX; PARALLEL FACTOR-ANALYSIS; HEAVY-METALS; FULVIC-ACID; FRESH-WATER; MICROCYSTIS-AERUGINOSA; CYANOBACTERIAL BLOOMS; AMENDED SOILS	Information on metal binding with fluorescent substances has been widely studied. By contrast, information on metal binding with non-fluorescent substances remains lacking despite the dominance of these substances in aquatic systems. In this study, the metal binding properties of both fluorescent and non-fluorescent substances were investigated by using metal titration combined with two-dimensional correlation spectroscopy (2D-COS) analysis. The organic matters in the eutrophic algae-rich lake, including natural organic matters (NOM) and algae-induced extracellular polymeric substances (EPS), both contained fluorescent and non-fluorescent substances. The peaks in the one-dimensional spectra strongly overlapped, while 2D-COS can decompose the overlapped peaks and thus enhanced the spectral resolution. Moreover, 2D FTIR COS demonstrated that the binding susceptibility of organic ligands in both NOM and algal EPS matrices followed the order: 3400>1380>1650 cm(-1), indicative the significant contribution of non-fluorescent ligands in metal binding. The modified Stern-Volmer equation also revealed a substantial metal binding potential for the non-fluorescent substances (logK(M): 3.57 similar to 4.92). As for the effects of organic ligands on metal binding, EPS was characterized with higher binding ability than NOM for both fluorescent and non-fluorescent ligands. Algae-induced EPS and the non-fluorescent substances in eutrophic algae-rich lakes should not be overlooked because of their high metal binding potential.	[Xu, Huacheng; Yang, Liuyan] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resources Reuse, Nanjing, Jiangsu, Peoples R China; [Xu, Huacheng; Zhong, Jicheng; Yu, Guanghui; Jiang, Helong] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China; [Yu, Guanghui] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China; [Wu, Jun] Chinese Acad Sci, Inst Soil Sci, Key Lab Soil Environm & Pollut Remediat, Nanjing, Jiangsu, Peoples R China	Nanjing University; Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Nanjing Agricultural University; Chinese Academy of Sciences; Institute of Soil Science, CAS	Xu, HC (corresponding author), Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resources Reuse, Xianlin Campus, Nanjing, Jiangsu, Peoples R China.	hcxu@niglas.ac.cn; yangly@nju.edu.cn	liu, yang/HHY-8583-2022; yang, liu/GVU-8760-2022; Yu, Guanghui/H-4968-2013; Jiang, Helong/H-2709-2015	Yu, Guanghui/0000-0002-5699-779X; Jiang, He-Long/0000-0001-5528-423X; Xu, Huacheng/0000-0003-1724-6720	National Natural Science Foundation of China [51209192, 51379199, 41301241]; Natural Science Foundation of Jiangsu province, China [BK2012501]; China Postdoctoral Science Foundation [2013M540438]; Jiangsu Planned Projects for Postdoctoral Research Funds [1301007A]; State Key Laboratory of Pollution Control and Resource Reuse Foundation [PCRRF13011]; State Key Laboratory of Lake Science and Environment, Chinese Academy of Sciences [2012SKL007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu province, China(Natural Science Foundation of Jiangsu Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jiangsu Planned Projects for Postdoctoral Research Funds; State Key Laboratory of Pollution Control and Resource Reuse Foundation; State Key Laboratory of Lake Science and Environment, Chinese Academy of Sciences	This work was funded by the National Natural Science Foundation of China (51209192, 51379199 and 41301241), the Natural Science Foundation of Jiangsu province, China (BK2012501), the China Postdoctoral Science Foundation (2013M540438), the Jiangsu Planned Projects for Postdoctoral Research Funds (1301007A), the State Key Laboratory of Pollution Control and Resource Reuse Foundation (PCRRF13011), and the State Key Laboratory of Lake Science and Environment, Chinese Academy of Sciences (2012SKL007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla HAN, 2010, ENVIRON SCI TECHNOL, V44, P8044, DOI 10.1021/es100898x; CABANISS SE, 1992, ENVIRON SCI TECHNOL, V26, P1133, DOI 10.1021/es50002a018; Chai XL, 2012, J HAZARD MATER, V209, P59, DOI 10.1016/j.jhazmat.2011.12.077; Ghatak H., 2004, Wetlands Ecology and Management, V12, P145, DOI 10.1023/B:WETL.0000034068.68049.a3; Hays MD, 2004, ANAL CHEM, V76, P848, DOI 10.1021/ac0344135; Hernandez D, 2006, ENVIRON POLLUT, V143, P212, DOI 10.1016/j.envpol.2005.11.038; Hur J, 2011, THESCIENTIFICWORLDJO, V11, P1865, DOI 10.1100/2011/640598; Hur J, 2011, CHEMOSPHERE, V83, P1603, DOI 10.1016/j.chemosphere.2011.01.004; Landry C, 2012, ENVIRON SCI TECHNOL, V46, P1700, DOI 10.1021/es203711v; Lee BM, 2013, CHEMOSPHERE, V90, P237, DOI 10.1016/j.chemosphere.2012.06.060; Leenheer JA, 2003, ENVIRON SCI TECHNOL, V37, p18A, DOI 10.1021/es032333c; Li XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065949; Liu LZ, 2014, J ENVIRON SCI, V26, P1725, DOI 10.1016/j.jes.2014.06.013; McIntyre AM, 2013, CHEMOSPHERE, V90, P620, DOI 10.1016/j.chemosphere.2012.08.057; Noda I., 2004, 2 DIMENSIONAL CORREL; Ohno T, 2008, ENVIRON SCI TECHNOL, V42, P186, DOI 10.1021/es071855f; Paerl HW, 2012, WATER RES, V46, P1349, DOI 10.1016/j.watres.2011.08.002; Pan XL, 2010, COLLOID SURFACE B, V80, P103, DOI 10.1016/j.colsurfb.2010.05.002; Plaza C, 2006, ENVIRON SCI TECHNOL, V40, P917, DOI 10.1021/es051687w; Qin BQ, 2010, ENVIRON MANAGE, V45, P105, DOI 10.1007/s00267-009-9393-6; Qu FS, 2012, WATER RES, V46, P2881, DOI 10.1016/j.watres.2012.02.045; SAAR RA, 1980, ANAL CHEM, V52, P2095, DOI 10.1021/ac50063a025; Shen J, 2007, HYDROBIOLOGIA, V581, P141, DOI 10.1007/s10750-006-0523-3; Sheng GP, 2013, WATER RES, V47, P607, DOI 10.1016/j.watres.2012.10.037; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076633; Wu J, 2012, ENVIRON POLLUT, V162, P63, DOI 10.1016/j.envpol.2011.10.017; Xu HC, 2013, J HAZARD MATER, V263, P412, DOI 10.1016/j.jhazmat.2013.09.042; Xu HC, 2013, ECOTOX ENVIRON SAFE, V98, P266, DOI 10.1016/j.ecoenv.2013.09.008; Xu HC, 2013, WATER RES, V47, P6506, DOI 10.1016/j.watres.2013.08.021; Xu HC, 2013, CHEMOSPHERE, V93, P75, DOI 10.1016/j.chemosphere.2013.04.077; Xu HC, 2013, WATER RES, V47, P2005, DOI 10.1016/j.watres.2013.01.019; Yamashita Y, 2008, ENVIRON SCI TECHNOL, V42, P7374, DOI 10.1021/es801357h; Yao X, 2011, CHEMOSPHERE, V82, P145, DOI 10.1016/j.chemosphere.2010.10.049; Yu GH, 2012, ENVIRON SCI TECHNOL, V46, P6102, DOI 10.1021/es3002212; Zhang DY, 2010, J HAZARD MATER, V175, P359, DOI 10.1016/j.jhazmat.2009.10.011; Zhang YL, 2011, WATER RES, V45, P5110, DOI 10.1016/j.watres.2011.07.014	36	14	16	3	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112272	10.1371/journal.pone.0112272	http://dx.doi.org/10.1371/journal.pone.0112272			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380246	Green Submitted, Green Published, gold			2022-12-27	WOS:000344863100071
J	Chen, PL; Wu, CJ; Tsai, PJ; Tang, HJ; Chuang, YC; Lee, NY; Lee, CC; Li, CW; Li, MC; Chen, CC; Tsai, HW; Ou, CC; Chen, CS; Ko, WC				Chen, Po-Lin; Wu, Chi-Jung; Tsai, Pei-Jane; Tang, Hung-Jen; Chuang, Yin-Ching; Lee, Nan-Yao; Lee, Ching-Chi; Li, Chia-Wen; Li, Ming-Chi; Chen, Chi-Chung; Tsai, Hung-Wen; Ou, Chun-Chun; Chen, Chang-Shi; Ko, Wen-Chien			Virulence Diversity among Bacteremic Aeromonas Isolates: Ex Vivo, Animal, and Clinical Evidences	PLOS ONE			English	Article							HEMOLYTIC TOXIN GENES; SALMONELLA BACTEREMIA; NECROTIZING FASCIITIS; SOFT-TISSUE; HYDROPHILA; INFECTIONS; STRAINS; CAVIAE; AQUARIORUM; AEROLYSIN	Background: The objective of this study was to compare virulence among different Aeromonas species causing bloodstream infections. Methodology/Principal Findings: Nine of four species of Aeromonas blood isolates, including A. dhakensis, A. hydrophila, A. veronii and A. caviae were randomly selected for analysis. The species was identified by the DNA sequence matching of rpoD. Clinically, the patients with A. dhakensis bacteremia had a higher sepsis-related mortality rate than those with other species (37.5% vs. 0%, P = 0.028). Virulence of different Aeromonas species were tested in C. elegans, mouse fibroblast C2C12 cell line and BALB/c mice models. C. elegans fed with A. dhakensis and A. caviae had the lowest and highest survival rates compared with other species, respectively (all P values <0.0001). A. dhakensis isolates also exhibited more cytotoxicity in C2C12 cell line (all P values <0.0001). Fourteen-day survival rate of mice intramuscularly inoculated with A. dhakensis was lower than that of other species (all P values <0.0001). Hemolytic activity and several virulence factor genes were rarely detected in the A. caviae isolates. Conclusions/Significance: Clinical data, ex vivo experiments, and animal studies suggest there is virulence variation among clinically important Aeromonas species.	[Chen, Po-Lin; Lee, Nan-Yao; Lee, Ching-Chi; Li, Chia-Wen; Li, Ming-Chi; Ou, Chun-Chun; Ko, Wen-Chien] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan; [Tsai, Hung-Wen] Natl Cheng Kung Univ Hosp, Dept Pathol, Tainan 70428, Taiwan; [Chen, Po-Lin; Wu, Chi-Jung] Natl Cheng Kung Univ, Coll Med, Grad Inst Clin Med, Tainan 70101, Taiwan; [Tsai, Pei-Jane] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan; [Chen, Chang-Shi] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 70101, Taiwan; [Ko, Wen-Chien] Natl Cheng Kung Univ, Coll Med, Dept Med, Tainan 70101, Taiwan; [Wu, Chi-Jung] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Taipei, Taiwan; [Tsai, Pei-Jane] Natl Cheng Kung Univ, Res Ctr Infect Dis & Signaling, Tainan 70101, Taiwan; [Tang, Hung-Jen; Chuang, Yin-Ching] Chi Mei Med Ctr, Dept Med, Tainan, Taiwan; [Chuang, Yin-Ching; Chen, Chi-Chung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Chuang, Yin-Ching] Chi Mei Med Ctr, Dept Clin Pathol, Tainan, Taiwan; [Tang, Hung-Jen] Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Health Research Institutes - Taiwan; National Cheng Kung University; Chi Mei Hospital; Chi Mei Hospital; Chi Mei Hospital; Chia Nan University of Pharmacy & Science	Chen, CS (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 70101, Taiwan.	cschen@mail.ncku.edu.tw; winston3415@gmail.com	Ko, Wen-Chien/ABG-4316-2020; Chen, Chang-Shi/B-9251-2009; chen, chen/GRY-7085-2022; Li, Ming-Chi/AAF-5731-2020; CHEN, CHEN/HDM-6657-2022; Tsai, Pei-Jane/G-3563-2011; Wu, Chi-Jung/F-8364-2011	Ko, Wen-Chien/0000-0001-7497-149X; Chen, Chang-Shi/0000-0002-8201-3635; 	National Science Council; National Cheng Kung University Hospital; National Health Research Institutes; Ministry of Health and Welfare, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); National Cheng Kung University Hospital; National Health Research Institutes(National Health Research Institutes, Japan); Ministry of Health and Welfare, Taiwan	The study was supported by the grants from, National Science Council, National Cheng Kung University Hospital, National Health Research Institutes, and Ministry of Health and Welfare (A Landmark Project to Promote Innovation & Competitiveness of Clinical Trials by the Excellent Clinical Trial and Research Center), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera-Arreola MG, 2007, CAN J MICROBIOL, V53, P877, DOI 10.1139/W07-051; Aravena-Roman M, 2011, J CLIN MICROBIOL, V49, P3006, DOI 10.1128/JCM.00472-11; Bogaerts A, 2010, DEV COMP IMMUNOL, V34, P690, DOI 10.1016/j.dci.2010.02.003; CHAKRABORTY T, 1987, INFECT IMMUN, V55, P2274, DOI 10.1128/IAI.55.9.2274-2280.1987; Chao CM, 2013, EUR J CLIN MICROBIOL, V32, P543, DOI 10.1007/s10096-012-1771-y; Chao CM, 2013, EUR J CLIN MICROBIOL, V32, P245, DOI 10.1007/s10096-012-1736-1; Chao CM, 2013, J MICROBIOL IMMUNOL, V46, P144, DOI 10.1016/j.jmii.2013.02.006; Chen PL, 2007, J INTERN MED, V261, P91, DOI 10.1111/j.1365-2796.2006.01748.x; Chen PL, 2013, CLIN MICROBIOL INFEC; Chow JW, 1999, INT J ANTIMICROB AG, V11, P7, DOI 10.1016/S0924-8579(98)00060-0; Chuang HC, 2011, J KOREAN MED SCI, V26, P1415, DOI 10.3346/jkms.2011.26.11.1415; Daly KA, 2011, TISSUE ENG PART C-ME, V17, P631, DOI 10.1089/ten.tec.2010.0699; Emekdas G, 2006, INT J FOOD MICROBIOL, V107, P310, DOI 10.1016/j.ijfoodmicro.2005.10.012; GOLD WL, 1993, CLIN INFECT DIS, V16, P69, DOI 10.1093/clinids/16.1.69; Grim CJ, 2014, APPL ENVIRON MICROB, V80, P4162, DOI 10.1128/AEM.00486-14; Heuzenroeder MW, 1999, FEMS MICROBIOL LETT, V174, P131, DOI 10.1016/S0378-1097(99)00130-5; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Figueras MJ, 2009, J CLIN MICROBIOL, V47, P3742, DOI 10.1128/JCM.02216-08; KELLY KA, 1993, CLIN INFECT DIS, V16, P574, DOI 10.1093/clind/16.4.574; Kimura M, 2013, SCAND J INFECT DIS, V45, P304, DOI 10.3109/00365548.2012.737474; Ko WC, 2000, J INFECTION, V40, P267, DOI 10.1053/jinf.2000.0654; KO WC, 1995, CLIN INFECT DIS, V20, P1298, DOI 10.1093/clinids/20.5.1298; Lee CC, 2008, DIAGN MICR INFEC DIS, V62, P219, DOI 10.1016/j.diagmicrobio.2008.05.016; Lee NY, 2012, ANTIMICROB AGENTS CH, V56, P2888, DOI 10.1128/AAC.06301-11; Martino ME, 2011, APPL ENVIRON MICROB, V77, P4986, DOI 10.1128/AEM.00708-11; Morinaga Y, 2013, DIAGN MICR INFEC DIS, V76, P106, DOI 10.1016/j.diagmicrobio.2013.01.019; Osman K, 2012, WORLD J MICROB BIOT, V28, P1863, DOI 10.1007/s11274-011-0915-z; Papadakis V, 2012, J MICROBIOL IMMUNOL, V45, P154, DOI 10.1016/j.jmii.2011.09.008; Parker JL, 2011, J INFECTION, V62, P109, DOI 10.1016/j.jinf.2010.12.003; Rimola A, 2000, J HEPATOL, V32, P142, DOI 10.1016/S0168-8278(00)80201-9; Santos JA, 1999, APPL ENVIRON MICROB, V65, P5612; Soler L, 2004, INT J SYST EVOL MICR, V54, P1511, DOI 10.1099/ijs.0.03048-0; Tang HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091642; Van der Burg BLSB, 2006, J BONE JOINT SURG AM, V88A, P1357, DOI 10.2106/00004623-200606000-00028; Wang CY, 2009, J MICROBIOL IMMUNOL, V42, P510; Wang GH, 2003, J CLIN MICROBIOL, V41, P1048, DOI 10.1128/JCM.41.3.1048-1054.2003; Wong CYF, 1998, MICROBIOL-SGM, V144, P291, DOI 10.1099/00221287-144-2-291; Wu CJ, 2014, J MICROBIOL IMMUNOL, V47, P145, DOI 10.1016/j.jmii.2012.08.019; Wu CJ, 2012, J BACTERIOL, V194, P4114, DOI 10.1128/JB.00621-12; Yi SW, 2013, VET MICROBIOL, V164, P195, DOI 10.1016/j.vetmic.2013.02.006	40	30	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111213	10.1371/journal.pone.0111213	http://dx.doi.org/10.1371/journal.pone.0111213			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375798	Green Published, Green Submitted, gold			2022-12-27	WOS:000344402600031
J	Fu, DL; Chong, T; Li, HC; Zhang, HB; Wang, ZM				Fu, Delai; Chong, Tie; Li, Hecheng; Zhang, Huibo; Wang, Ziming			Docetaxel Inhibits Urethral Stricture Formation, an Initial Study in Rabbit Model	PLOS ONE			English	Article							PACLITAXEL AMELIORATES FIBROSIS; HALOFUGINONE; PREVENTION; RECURRENCE; BINDING	Introduction: Urethral stricture, a frequent source of lower urinary tract disorders in men, is still a difficult problem for urologists. Based the anti-restenosis effect of paclitaxel on coronary artery, the role of docetaxel, a semi-synthetic analogue of paclitaxel, in limiting urethral stricture formation was studied. Methods: Forty adult New Zealand male rabbits were involved in this study, which were randomly assigned into 3 groups, namely a high dose docetaxel (D-H, 0.1 mg/d), a low dose docetaxel (D-L, 0.01 mg/d) and a control (C) group, with 16, 16, 8 rabbits in each group, respectively. All animals underwent a 10 mm-long circumferential electrocoagulation of the bulbar urethra with a 13Fr pediatric resectoscope. Drugs were given by urethral irrigation daily and continuous for 28 days. Stricture formation was assessed by retrograde urethrography and videourethroscopy. Urethra pathology was evaluated by hematoxylin and eosin staining and Sirius red staining. Results: At the end of this study, 15, 14 and 7 rabbits remained for evaluation in D-H, D-L and C group, respectively. Urethral diameters in D-H, D-L and C group were (7.17 +/- 1.63) mm, (6.55 +/- 0.62) mm, (3.23 +/- 1.36) mm, with a normal urethral diameter of (9.08 +/- 1.29) mm. Lumen reduction in D-H, D-L and C group were (36.93 +/- 11.58)%, (48.03 +/- 7.89)% and (84.66 +/- 14.95)%, respectively. Statistically difference could be found between every two groups (p<0.05) both in urethral diameters and in lumen reduction, except for compare of urethral diameters between D-H and D-L group. Histological examination confirmed mass fibrous tissue and collagen content at the stricture sit in C group, whereas less in docetaxel treated rabbits. Conclusions: Docetaxel could limit urethral stricture formation, which may be due to inhibition of fibrous tissue and collagen expression. Docetaxel may become a new choice in the prevention of urethral stricture formation.	[Fu, Delai; Chong, Tie; Li, Hecheng; Wang, Ziming] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Urol, Sch Med, Xian 710049, Shaanxi, Peoples R China; [Zhang, Huibo] Shaanxi Tradit Chinese Med Collage, Affiliated Hosp, Dept Urol, Xianyang, Shaanxi, Peoples R China	Xi'an Jiaotong University; Shaanxi University of Chinese Medicine	Li, HC (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Urol, Sch Med, Xian 710049, Shaanxi, Peoples R China.	lhch029@aliyun.com			Fund for National Key Disciplines of the authors' hospital	Fund for National Key Disciplines of the authors' hospital	This study was supported by the Fund for National Key Disciplines of the authors' hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen HL, 2003, UROL RES, V31, P363, DOI 10.1007/s00240-003-0333-2; Andersen HL, 2003, UROL RES, V31, P25, DOI 10.1007/s00240-003-0296-3; Buey RM, 2005, CHEM BIOL, V12, P1269, DOI 10.1016/j.chembiol.2005.09.010; Chong T, 2011, J PHARMACOL EXP THER, V338, P47, DOI 10.1124/jpet.110.178624; Dong CM, 2000, MOL CELL, V5, P27, DOI 10.1016/S1097-2765(00)80400-1; Esmaeli B, 2006, J CLIN ONCOL, V24, P3619, DOI 10.1200/JCO.2005.04.4453; Greenwell TJ, 2004, J UROLOGY, V172, P275, DOI 10.1097/01.ju.0000132156.76403.8f; Jaidane M, 2003, J UROLOGY, V170, P2049, DOI 10.1097/01.ju.0000091262.01493.e3; Khera M, 2004, J UROLOGY, V172, P574, DOI 10.1097/01.ju.0000130652.27541.22; Kupfer I, 2003, J AM ACAD DERMATOL, V48, P279, DOI 10.1067/mjd.2003.30; Langston JP, 2009, J UROLOGY, V181, P2161, DOI 10.1016/j.juro.2009.01.044; Liu XL, 2005, PLOS MED, V2, P1334, DOI 10.1371/journal.pmed.0020354; Lumen N, 2009, J UROLOGY, V182, P983, DOI 10.1016/j.juro.2009.05.023; Mazdak H, 2007, EUR UROL, V51, P1089, DOI 10.1016/j.eururo.2006.11.038; Meria P, 1999, UROLOGY, V53, P1054, DOI 10.1016/S0090-4295(98)00642-6; Nagler A, 2000, J UROLOGY, V164, P1776, DOI 10.1016/S0022-5347(05)67105-4; Ostoros G, 2006, INT J GYNECOL CANCER, V16, P391, DOI 10.1111/j.1525-1438.2006.00222.x; Qi Z, 2007, CHINESE MED J, V120, P533; Sciarra A, 2005, UROLOGY, V66, P1218, DOI 10.1016/j.urology.2005.06.090; Suk KT, 2007, GASTROINTEST ENDOSC, V66, P798, DOI 10.1016/j.gie.2007.05.037; Sun L, 2011, J PATHOL, V225, P364, DOI 10.1002/path.2961; Waxman SW, 2006, LANCET, V367, P1379, DOI 10.1016/S0140-6736(06)68592-9; Zhang DS, 2010, LAB INVEST, V90, P436, DOI 10.1038/labinvest.2009.149; Zhou J, 2010, WORLD J GASTROENTERO, V16, P3330, DOI 10.3748/wjg.v16.i26.3330; Zhou XC, 2010, CHINESE MED J-PEKING, V123, P2405, DOI 10.3760/cma.j.issn.0366-6999.2010.17.022	25	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112097	10.1371/journal.pone.0112097	http://dx.doi.org/10.1371/journal.pone.0112097			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375859	Green Submitted, Green Published, gold			2022-12-27	WOS:000344402600104
J	Gunal-Sadik, G; Paszkowski-Rogacz, M; Singaravelu, K; Beyer, A; Buchholz, F; Jessberger, R				Guenal-Sadik, Gamze; Paszkowski-Rogacz, Maciej; Singaravelu, Kalaimathy; Beyer, Andreas; Buchholz, Frank; Jessberger, Rolf			Stage-Specific Binding Profiles of Cohesin in Resting and Activated B Lymphocytes Suggest a Role for Cohesin in Immunoglobulin Class Switching and Maturation	PLOS ONE			English	Article							3' REGULATORY REGION; PLASMA-CELL DIFFERENTIATION; GENE-EXPRESSION; IGH LOCUS; V(D)J RECOMBINATION; CTCF; ARCHITECTURE; ELEMENTS; IDENTIFICATION; REARRANGEMENT	The immunoglobulin heavy chain locus (Igh) features higher-order chromosomal interactions to facilitate stage-specific assembly of the Ig molecule. Cohesin, a ring-like protein complex required for sister chromatid cohesion, shapes chromosome architecture and chromatin interactions important for transcriptional regulation and often acts together with CTCF. Cohesin is likely involved in B cell activation and Ig class switch recombination. Hence, binding profiles of cohesin in resting mature murine splenic B lymphocytes and at two stages after cell activation were elucidated by chromatin immunoprecipitation and deep sequencing. Comparative genomic analysis revealed cohesin extensively changes its binding to transcriptional control elements after 48 h of stimulation with LPS/IL-4. Cohesin was clearly underrepresented at switch regions regardless of their activation status, suggesting that switch regions need to be cohesin-poor. Specific binding changes of cohesin at B-cell specific gene loci Pax5 and Blimp-1 indicate new cohesin-dependent regulatory pathways. Together with conserved cohesin/CTCF sites at the Igh 3'RR, a prominent cohesin/CTCF binding site was revealed near the 3' end of C alpha where PolII localizes to 3' enhancers. Our study shows that cohesin likely regulates B cell activation and maturation, including Ig class switching.	[Guenal-Sadik, Gamze; Jessberger, Rolf] Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst Physiol Chem, Dresden, Germany; [Paszkowski-Rogacz, Maciej; Buchholz, Frank] Tech Univ Dresden, Univ Hosp, Dept Med Syst Biol, Dresden, Germany; [Paszkowski-Rogacz, Maciej; Buchholz, Frank] Tech Univ Dresden, Med Fac Carl Gustav Carus, Dresden, Germany; [Singaravelu, Kalaimathy; Beyer, Andreas] Tech Univ Dresden, Ctr Biotechnol, Dresden, Germany; [Beyer, Andreas] Univ Cologne, CECAD, D-50931 Cologne, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; University of Cologne	Jessberger, R (corresponding author), Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst Physiol Chem, Dresden, Germany.	Rolf.Jessberger@tu-dresden.de	Buchholz, Frank/B-4700-2017; Sadık, Gamze Günal/AAX-9664-2020; Beyer, Andreas/AAQ-5519-2020	Buchholz, Frank/0000-0002-4577-3344; Beyer, Andreas/0000-0002-3891-2123; Gunal Sadik, Gamze/0000-0003-0610-0726	TUD "Support-the-best'' program; EU [SyBoSS FP7-242129]; DFG [SFB655]	TUD "Support-the-best'' program; EU(European Commission); DFG(German Research Foundation (DFG))	This work was supported by the SFB655 (DFG) to RJ and FB, the TUD "Support-the-best'' program to FB, and by the EU (SyBoSS FP7-242129) to AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chatterjee S, 2011, J BIOL CHEM, V286, P29303, DOI 10.1074/jbc.M111.243543; Chaumeil J, 2012, CURR OPIN IMMUNOL, V24, P153, DOI 10.1016/j.coi.2012.01.003; Decker T, 2009, IMMUNITY, V30, P508, DOI 10.1016/j.immuni.2009.01.012; Degner SC, 2011, P NATL ACAD SCI USA, V108, P9566, DOI 10.1073/pnas.1019391108; Degner SC, 2009, J IMMUNOL, V182, P44, DOI 10.4049/jimmunol.182.1.44; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Enervald E, 2013, J EXP MED, V210, P2503, DOI 10.1084/jem.20130168; Feeney KM, 2010, BIOCHEM J, V428, P147, DOI 10.1042/BJ20100151; Guo CY, 2011, CELL, V147, P332, DOI 10.1016/j.cell.2011.08.049; Guo CG, 2011, NATURE, V477, P424, DOI 10.1038/nature10495; Gyory I, 2012, GENE DEV, V26, P668, DOI 10.1101/gad.187328.112; Haering CH, 2012, EXP CELL RES, V318, P1386, DOI 10.1016/j.yexcr.2012.03.016; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Jessberger R, 2009, EMBO J, V28, P2491, DOI 10.1038/emboj.2009.217; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Jyonouchi S, 2013, PEDIATRICS, V132, pE484, DOI 10.1542/peds.2012-3815; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Meffre E, 2000, NAT IMMUNOL, V1, P379, DOI 10.1038/80816; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Nera KP, 2006, IMMUNITY, V24, P283, DOI 10.1016/j.immuni.2006.02.003; Nitzsche A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019470; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pawlitzky I, 2006, J IMMUNOL, V176, P6839, DOI 10.4049/jimmunol.176.11.6839; Peric-Hupkes D, 2008, CELL, V132, P925, DOI 10.1016/j.cell.2008.03.001; Perlot T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013992; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Rouaud P, 2012, J BIOL CHEM, V287, P8356, DOI 10.1074/jbc.M112.341024; Schliephake DE, 1996, EUR J IMMUNOL, V26, P268, DOI 10.1002/eji.1830260142; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Seitan VC, 2011, NATURE, V476, P467, DOI 10.1038/nature10312; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Shintomi K, 2010, CHROMOSOMA, V119, P459, DOI 10.1007/s00412-010-0271-z; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Thomas-Claudepierre AS, 2013, J EXP MED, V210, P2495, DOI 10.1084/jem.20130166; Vincent-Fabert C, 2010, BLOOD, V116, P1895, DOI 10.1182/blood-2010-01-264689; Volpi SA, 2012, J IMMUNOL, V188, P2556, DOI 10.4049/jimmunol.1102763; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wuerffe R, 2007, IMMUNITY, V27, P711, DOI 10.1016/j.immuni.2007.09.007; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964	42	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111748	10.1371/journal.pone.0111748	http://dx.doi.org/10.1371/journal.pone.0111748			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375358	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402600058
J	Kuo, CC; Luu, P; Morgan, KK; Dow, M; Davey, C; Song, J; Malony, AD; Tucker, DM				Kuo, Ching-Chang; Luu, Phan; Morgan, Kyle K.; Dow, Mark; Davey, Colin; Song, Jasmine; Malony, Allen D.; Tucker, Don M.			Localizing Movement-Related Primary Sensorimotor Cortices with Multi-Band EEG Frequency Changes and Functional MRI	PLOS ONE			English	Article							SOMATOSENSORY CORTEX; FINGER MOVEMENTS; OSCILLATIONS; FMRI; RHYTHMS; SYNCHRONIZATION; REPRESENTATION; LOCALIZATION; STIMULATION; ACTIVATION	Electroencephalographic (EEG) oscillations in multiple frequency bands can be observed during functional activity of the cerebral cortex. An important question is whether activity of focal areas of cortex, such as during finger movements, is tracked by focal oscillatory EEG changes. Although a number of studies have compared EEG changes to functional MRI hemodynamic responses, we can find no previous research that relates the fMRI hemodynamic activity to localization of the multiple EEG frequency changes observed in motor tasks. In the present study, five participants performed similar thumb and finger movement tasks in parallel EEG and functional MRI studies. We examined changes in five frequency bands (from 5-120 Hz) and localized them using 256 dense-array EEG (dEEG) recordings and high-resolution individual head models. These localizations were compared with fMRI localizations in the same participants. Results showed that beta-band (14-30 Hz) desynchronizations (power decreases) were the most robust effects, appearing in all individuals, consistently localized to the hand region of the primary motor cortex, and consistently aligned with fMRI localizations.	[Kuo, Ching-Chang; Luu, Phan; Morgan, Kyle K.; Davey, Colin; Song, Jasmine; Tucker, Don M.] Elect Geodes Inc, Eugene, OR USA; [Kuo, Ching-Chang; Malony, Allen D.; Tucker, Don M.] Univ Oregon, NeuroInformat Ctr, Eugene, OR 97403 USA; [Luu, Phan; Morgan, Kyle K.; Dow, Mark; Tucker, Don M.] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; [Malony, Allen D.] Univ Oregon, Dept Comp & Informat Sci, Eugene, OR 97403 USA	University of Oregon; University of Oregon; University of Oregon	Kuo, CC (corresponding author), Elect Geodes Inc, Eugene, OR USA.	bkuo@egi.com			Department of Defense, Telemedicine Advanced Technology Research Center (TATRC); Electrical Geodesics, Inc.	Department of Defense, Telemedicine Advanced Technology Research Center (TATRC); Electrical Geodesics, Inc.	This work was supported by a contract from the Department of Defense, Telemedicine Advanced Technology Research Center (TATRC). Electrical Geodesics, Inc., provided support in the form of salaries for authors CCK, PL, KKM, CD, JS, and DMT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmadian P, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00124; Bai XX, 2007, NEUROIMAGE, V35, P598, DOI 10.1016/j.neuroimage.2006.12.026; Ball T, 2008, NEUROIMAGE, V41, P302, DOI 10.1016/j.neuroimage.2008.02.032; Brittain JS, 2014, NEUROIMAGE, V85, P637, DOI 10.1016/j.neuroimage.2013.05.084; Cheyne DO, 2013, EXP NEUROL, V245, P27, DOI 10.1016/j.expneurol.2012.08.030; Darvas F, 2010, NEUROIMAGE, V49, P930, DOI 10.1016/j.neuroimage.2009.08.041; Darvas F, 2013, J CLIN NEUROPHYSIOL, V30, P299, DOI 10.1097/WNP.0b013e3182872f40; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Donner TH, 2009, CURR BIOL, V19, P1581, DOI 10.1016/j.cub.2009.07.066; Eichelbaum S, 2014, NEUROIMAGE, V101, P513, DOI 10.1016/j.neuroimage.2014.04.085; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Gaetz W, 2006, NEUROIMAGE, V30, P899, DOI 10.1016/j.neuroimage.2005.10.009; Gaetz W, 2013, NEUROIMAGE, V74, P245, DOI 10.1016/j.neuroimage.2013.02.013; Gelnar PA, 1998, NEUROIMAGE, V7, P261, DOI 10.1006/nimg.1998.0341; Gerloff C, 1998, ELECTROMYOGR MOTOR C, V109, P444, DOI 10.1016/S0924-980X(98)00045-9; Hammond DK, 2013, IEEE T MED IMAGING, V32, P1952, DOI 10.1109/TMI.2013.2271486; Hari R, 2006, PROG BRAIN RES, V159, P253, DOI 10.1016/S0079-6123(06)59017-X; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; KAAS JH, 1993, ANN ANAT, V175, P509, DOI 10.1016/S0940-9602(11)80212-8; Kilavik BE, 2013, EXP NEUROL, V245, P15, DOI 10.1016/j.expneurol.2012.09.014; Koelewijn T, 2008, NEUROIMAGE, V40, P767, DOI 10.1016/j.neuroimage.2007.12.018; Lew E., 2012, FRONT NEUROENG, V5, P13, DOI [10.3389/fneng.2012.00013, DOI 10.3389/FNENG.2012.00013]; Li K, 2007, THESIS U OREGON EUGE; Lin FH, 2006, HUM BRAIN MAPP, V27, P1, DOI 10.1002/hbm.20155; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Luu P, 2004, CLIN NEUROPHYSIOL, V115, P1821, DOI 10.1016/j.clinph.2004.03.031; Luu P, 2001, CLIN NEUROPHYSIOL, V112, P1295, DOI 10.1016/S1388-2457(01)00559-4; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mazziotta J, 2001, J AM MED INFORM ASSN, V8, P401, DOI 10.1136/jamia.2001.0080401; Michel CM, 2012, NEUROIMAGE, V61, P371, DOI 10.1016/j.neuroimage.2011.12.039; Miller KJ, 2009, J NEUROSCI, V29, P3132, DOI 10.1523/JNEUROSCI.5506-08.2009; Miller KJ, 2007, J NEUROSCI, V27, P2424, DOI 10.1523/JNEUROSCI.3886-06.2007; Miller KJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002655; Miller KJ, 2010, P NATL ACAD SCI USA, V107, P4430, DOI 10.1073/pnas.0913697107; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3968, DOI 10.1152/jn.1996.76.6.3968; Muthukumaraswamy SD, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00138; Neuper C, 2009, CLIN NEUROPHYSIOL, V120, P239, DOI 10.1016/j.clinph.2008.11.015; Ojemann GA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00034; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Parkes LM, 2006, NEUROIMAGE, V29, P685, DOI 10.1016/j.neuroimage.2005.08.018; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Roach BJ, 2008, SCHIZOPHRENIA BULL, V34, P907, DOI 10.1093/schbul/sbn093; Russell GS, 2005, CLIN NEUROPHYSIOL, V116, P1130, DOI 10.1016/j.clinph.2004.12.022; Salman A, 2005, LECT NOTES COMPUT SC, V3514, P631; Salman A, 2013, NEXT GENERATION HUMA, P234; Salmelin R, 1995, NEUROIMAGE, V2, P237, DOI 10.1006/nimg.1995.1031; Scheeringa R, 2011, NEURON, V69, P572, DOI 10.1016/j.neuron.2010.11.044; Seeber M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00485; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Song J, 2014, SENSOR DENSITY HEAD, P620; Song J, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00055; Srinivasan R, 1998, BEHAV RES METH INS C, V30, P8, DOI 10.3758/BF03209412; TANJI J, 1981, J NEUROPHYSIOL, V45, P467, DOI 10.1152/jn.1981.45.3.467; Waldert S, 2009, J PHYSIOL-PARIS, V103, P244, DOI 10.1016/j.jphysparis.2009.08.007; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; Yuan H, 2010, NEUROIMAGE, V49, P2596, DOI 10.1016/j.neuroimage.2009.10.028	60	17	18	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112103	10.1371/journal.pone.0112103	http://dx.doi.org/10.1371/journal.pone.0112103			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375957	gold, Green Submitted, Green Published			2022-12-27	WOS:000344402600105
J	Puttkammer, N; Zeliadt, S; Balan, JG; Baseman, J; Destine, R; Domercant, JW; France, G; Hyppolite, N; Pelletier, V; Raphael, NA; Sherr, K; Yuhas, K; Barnhart, S				Puttkammer, Nancy; Zeliadt, Steven; Balan, Jean Gabriel; Baseman, Janet; Destine, Rodney; Domercant, Jean Wysler; France, Garilus; Hyppolite, Nathaelf; Pelletier, Valerie; Raphael, Nernst Atwood; Sherr, Kenneth; Yuhas, Krista; Barnhart, Scott			Development of an Electronic Medical Record Based Alert for Risk of HIV Treatment Failure in a Low-Resource Setting	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY ADHERENCE; CLINICAL DECISION-SUPPORT; PHARMACY; CARE; RECOMMENDATIONS; DEFINITIONS; OUTCOMES; SYSTEM; ADULTS	Background: The adoption of electronic medical record systems in resource-limited settings can help clinicians monitor patients' adherence to HIV antiretroviral therapy (ART) and identify patients at risk of future ART failure, allowing resources to be targeted to those most at risk. Methods: Among adult patients enrolled on ART from 2005-2013 at two large, public-sector hospitals in Haiti, ART failure was assessed after 6-12 months on treatment, based on the World Health Organization's immunologic and clinical criteria. We identified models for predicting ART failure based on ART adherence measures and other patient characteristics. We assessed performance of candidate models using area under the receiver operating curve, and validated results using a randomly-split data sample. The selected prediction model was used to generate a risk score, and its ability to differentiate ART failure risk over a 42-month follow-up period was tested using stratified Kaplan Meier survival curves. Results: Among 923 patients with CD4 results available during the period 6-12 months after ART initiation, 196 (21.2%) met ART failure criteria. The pharmacy-based proportion of days covered (PDC) measure performed best among five possible ART adherence measures at predicting ART failure. Average PDC during the first 6 months on ART was 79.0% among cases of ART failure and 88.6% among cases of non-failure (p<0.01). When additional information including sex, baseline CD4, and duration of enrollment in HIV care prior to ART initiation were added to PDC, the risk score differentiated between those who did and did not meet failure criteria over 42 months following ART initiation. Conclusions: Pharmacy data are most useful for new ART adherence alerts within iSante. Such alerts offer potential to help clinicians identify patients at high risk of ART failure so that they can be targeted with adherence support interventions, before ART failure occurs.	[Puttkammer, Nancy; Barnhart, Scott] Univ Washington, Int Training & Educ Ctr Hlth, Dept Global Hlth, Seattle, WA 98195 USA; [Puttkammer, Nancy; Zeliadt, Steven] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Balan, Jean Gabriel; Destine, Rodney; Hyppolite, Nathaelf; Raphael, Nernst Atwood] Int Training & Educ Ctr Health Haiti, Port Au Prince, Haiti; [Baseman, Janet] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Domercant, Jean Wysler; Pelletier, Valerie] Ctr Dis Control & Prevent, Div Global HIV AIDS, Port Au Prince, Haiti; [France, Garilus] Minist Publ Hlth & Populat, Populat Div, Port Au Prince, Haiti; [Sherr, Kenneth] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Yuhas, Krista] Univ Washington, Ctr AIDS Res, Dept Global Hlth, Seattle, WA 98195 USA; [Barnhart, Scott] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Puttkammer, N (corresponding author), Univ Washington, Int Training & Educ Ctr Hlth, Dept Global Hlth, Seattle, WA 98195 USA.			Raphael, Nernst-Atwood/0000-0002-6229-9584	President's Emergency Plan for AIDS Relief (PEPFAR) through the Health Resources and Services Administration [U91HA0680]; United States Centers for Disease Control and Prevention [5U2GGH000549-03]; University of Washington Center for AIDS Research (CFAR); National Institutes of Health (NIH) (National Institute of Allergy and Infectious Diseases) [P30AI027757]; National Institutes of Health (NIH) (National Cancer Institute) [P30AI027757]; National Institutes of Health (NIH) (National Institute of Mental Health) [P30AI027757]; National Institutes of Health (NIH) (National Institute on Drug Abuse) [P30AI027757]; National Institutes of Health (NIH) (National Institute of Child Health and Human Development) [P30AI027757]; National Institutes of Health (NIH) (National Heart, Lung, and Blood Institute) [P30AI027757]; National Institutes of Health (NIH) (National Institute on Aging) [P30AI027757]; National Institutes of Health (NIH) (National Institute of General Medical Sciences) [P30AI027757]; National Institutes of Health (NIH) (National Institute of Diabetes and Digestive and Kidney Diseases) [P30AI027757]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	President's Emergency Plan for AIDS Relief (PEPFAR) through the Health Resources and Services Administration; United States Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); University of Washington Center for AIDS Research (CFAR); National Institutes of Health (NIH) (National Institute of Allergy and Infectious Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH) (National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH) (National Institute of Mental Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health (NIH) (National Institute on Drug Abuse)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Health (NIH) (National Institute of Child Health and Human Development)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health (NIH) (National Heart, Lung, and Blood Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health (NIH) (National Institute on Aging)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health (NIH) (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health (NIH) (National Institute of Diabetes and Digestive and Kidney Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Health Resources and Services Administration, under award number U91HA0680, and the United States Centers for Disease Control and Prevention, under award number 5U2GGH000549-03, to the International Training and Education Center for Health (I-TECH) at the University of Washington. This research was also funded in part by a 2012 developmental grant from the University of Washington Center for AIDS Research (CFAR), a National Institutes of Health (NIH) funded program under award number P30AI027757 which is supported by the following NIH Institutes and Centers (National Institute of Allergy and Infectious Diseases, National Cancer Institute, National Institute of Mental Health, National Institute on Drug Abuse, National Institute of Child Health and Human Development, National Heart, Lung, and Blood Institute, National Institute on Aging, National Institute of General Medical Sciences, National Institute of Diabetes and Digestive and Kidney Diseases). Two authors are employees of the United States Centers for Disease Control and Prevention. However, the findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention, the National Institutes of Health, or the Health Resources and Services Administration. The other funders for this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Amico K Rivet, 2013, J Int Assoc Provid AIDS Care, V12, P128, DOI 10.1177/1545109712459041; Balan JG, 2013, COMMUNICATION; Bisson GP, 2008, PLOS MED, V5, P777, DOI 10.1371/journal.pmed.0050109; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cayemittes M, 2013, ENQUETE MORTALITE MO; Chaiyachati K, 2011, AIDS PATIENT CARE ST, V25, P163, DOI 10.1089/apc.2010.0257; Charles M, 2008, B WORLD HEALTH ORGAN, V86, P970, DOI 10.2471/BLT.07.050120; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Chu LH., SAS MACROPROGRAM CAL; Damiani G, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-2; Fan VS, 2002, J CLIN EPIDEMIOL, V55, P371, DOI 10.1016/S0895-4356(01)00493-0; Garfield S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-149; Giordano TP, 2004, HIV CLIN TRIALS, V5, P74, DOI 10.1310/JFXH-G3X2-EYM6-D6UG; Gsponer T, 2012, AIDS, V26, P57, DOI 10.1097/QAD.0b013e32834e1b5f; Hess LM, 2006, ANN PHARMACOTHER, V40, P1280, DOI 10.1345/aph.1H018; Hosmer DW., 2007, APPL SURVIVAL ANAL; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Keiser O, 2009, TROP MED INT HEALTH, V14, P1220, DOI 10.1111/j.1365-3156.2009.02338.x; Koenig SP, 2012, JAIDS-J ACQ IMM DEF, V59, pE60, DOI 10.1097/QAI.0b013e318245d3c1; Kunutsor S, 2010, JAIDS-J ACQ IMM DEF, V55, P221, DOI 10.1097/QAI.0b013e3181e255ec; Liu HH, 2001, ANN INTERN MED, V134, P968, DOI 10.7326/0003-4819-134-10-200105150-00011; Lober William B, 2008, AMIA Annu Symp Proc, P434; Matheson AI, 2012, INT J MED INFORM, V81, P244, DOI 10.1016/j.ijmedinf.2012.01.011; McMahon JH, 2013, AIDS BEHAV, V17, P2253, DOI 10.1007/s10461-013-0436-x; McMahon JH, 2011, CLIN INFECT DIS, V52, P493, DOI 10.1093/cid/ciq167; Mee P, 2008, AIDS, V22, P1971, DOI 10.1097/QAD.0b013e32830e4cd8; MSPP/PNLS, 2012, DECL ENG VIH SIDA RA; Oluoch T, 2012, INT J MED INFORM, V81, pE83, DOI 10.1016/j.ijmedinf.2012.07.010; Pearson SA, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-154; Pepe M. S., 2003, STAT EVALUATION MED; Pepe MS, 2009, STATA J, V9, P1; Plews I, 2010, CONSTRUCTING APPL RI; Puttkammer N, 2013, USING ELECT MED RECO; Puttkammer N, 2013, INTERNAL REPORT; Raebel MA, 2013, MED CARE, V51, pS11, DOI 10.1097/MLR.0b013e31829b1d2a; Robbins GK, 2012, ANN INTERN MED, V157, P757, DOI 10.7326/0003-4819-157-11-201212040-00003; Robbins GK, 2010, CLIN INFECT DIS, V50, P779, DOI 10.1086/650537; Simoni JM, 2006, AIDS BEHAV, V10, P227, DOI 10.1007/s10461-006-9078-6; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419; van Oosterhout JJG, 2009, TROP MED INT HEALTH, V14, P856, DOI 10.1111/j.1365-3156.2009.02309.x; Wand H, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000005; Were MC, 2011, J AM MED INFORM ASSN, V18, P150, DOI 10.1136/jamia.2010.005520	44	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112261	10.1371/journal.pone.0112261	http://dx.doi.org/10.1371/journal.pone.0112261			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CP	25390044	gold, Green Published			2022-12-27	WOS:000349144400066
J	Correia, M; Thiagarajan, V; Coutinho, I; Gajula, GP; Petersen, SB; Neves-Petersen, MT				Correia, Manuel; Thiagarajan, Viruthachalam; Coutinho, Isabel; Gajula, Gnana Prakash; Petersen, Steffen B.; Neves-Petersen, Maria Teresa			Modulating the Structure of EGFR with UV Light: New Possibilities in Cancer Therapy	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; EXCITED-STATE CHEMISTRY; AROMATIC-AMINO-ACIDS; RECEPTOR EXTRACELLULAR DOMAIN; VITAMIN-D; ULTRAVIOLET-IRRADIATION; SIGNAL-TRANSDUCTION; OXIDATION-PRODUCTS; CRYSTAL-STRUCTURE; DECAY KINETICS	The epidermal growth factor receptor (EGFR) is a member of the ErbB family of receptor tyrosine kinases. EGFR is activated upon binding to e. g. epidermal growth factor (EGF), leading to cell survival, proliferation and migration. EGFR overactivation is associated with tumor progression. We have previously shown that low dose UVB illumination of cancer cells overexpressing EGFR prior to adding EGF halted the EGFR signaling pathway. We here show that UVB illumination of the extracellular domain of EGFR (sEGFR) induces protein conformational changes, disulphide bridge breakage and formation of tryptophan and tyrosine photoproducts such as dityrosine, N-formylkynurenine and kynurenine. Fluorescence spectroscopy, circular dichroism and thermal studies confirm the occurrence of conformational changes. An immunoassay has confirmed that UVB light induces structural changes in the EGF binding site. A monoclonal antibody which competes with EGF for binding sEGFR was used. We report clear evidence that UVB light induces structural changes in EGFR that impairs the correct binding of an EGFR specific antibody that competes with EGF for binding EGFR, confirming that the 3D structure of the EGFR binding domain suffered conformational changes upon UV illumination. The irradiance used is in the same order of magnitude as the integrated intensity in the solar UVB range. The new photonic technology disables a key receptor and is most likely applicable to the treatment of various types of cancer, alone or in combination with other therapies.	[Correia, Manuel] Aalborg Univ, Dept Phys & Nanotechnol, Aalborg, Denmark; [Thiagarajan, Viruthachalam; Coutinho, Isabel; Gajula, Gnana Prakash; Neves-Petersen, Maria Teresa] Int Iberian Nanotechnol Lab INL, Dept Nanomed, BioPhoton Grp, Braga, Portugal; [Thiagarajan, Viruthachalam] Bharathidasan Univ, Sch Chem, Tiruchirappalli, Tamil Nadu, India; [Petersen, Steffen B.] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark; [Petersen, Steffen B.] SUNY Buffalo, Inst Lasers Photon & Biophoton, Buffalo, NY 14260 USA	Aalborg University; International Iberian Nanotechnology Laboratory; Bharathidasan University; Aalborg University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Neves-Petersen, MT (corresponding author), Int Iberian Nanotechnol Lab INL, Dept Nanomed, BioPhoton Grp, Braga, Portugal.	nevespetersen@gmail.com	Viruthachalam, Thiagarajan/I-2503-2013; INL, Citations/K-3436-2015; Petersen, Steffen b/E-8727-2015; Coutinho, Isabel/J-4165-2016	INL, Citations/0000-0002-3745-5100; Petersen, Steffen b/0000-0002-0739-2751; Thiagarajan, Viruthachalam/0000-0003-4197-2255; Correia, Manuel/0000-0001-7619-2780	"Fundaco para a Ciencia e Tecnologia" (FCT) [SFRH/BD/61012/2009]; "Programa Operacional Potencial Humano" (POPH); European Social Fund ("Fundo Social Europeu", FSE)	"Fundaco para a Ciencia e Tecnologia" (FCT); "Programa Operacional Potencial Humano" (POPH); European Social Fund ("Fundo Social Europeu", FSE)(European Social Fund (ESF))	MC acknowledges the support from "Fundaco para a Ciencia e Tecnologia" (FCT) for the PhD grant (SFRH/BD/61012/2009) supported by "Programa Operacional Potencial Humano" (POPH) in the framework of "Quadro de Referencia Estrategica Nacional" (QREN) and co-financed by the European Social Fund ("Fundo Social Europeu", FSE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2011, J BIOL CHEM, V286, P26178, DOI 10.1074/jbc.M111.240630; Banwell CM, 2003, RECENT RESULTS CANC, V164, P83; BENT DV, 1975, J AM CHEM SOC, V97, P2599, DOI 10.1021/ja00843a002; BENT DV, 1975, J AM CHEM SOC, V97, P2606, DOI 10.1021/ja00843a003; BENT DV, 1975, J AM CHEM SOC, V97, P2612, DOI 10.1021/ja00843a004; Budiyanto A, 2003, J INVEST DERMATOL, V121, P1088, DOI 10.1046/j.1523-1747.2003.12529.x; Cao C, 2008, CELL SIGNAL, V20, P1830, DOI 10.1016/j.cellsig.2008.06.010; Casanova ML, 2002, CANCER RES, V62, P3402; Correia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050733; Correia M, 2012, J FLUORESC, V22, P323, DOI 10.1007/s10895-011-0963-7; CREED D, 1984, PHOTOCHEM PHOTOBIOL, V39, P537; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Finley EL, 1997, PHOTOCHEM PHOTOBIOL, V66, P635, DOI 10.1111/j.1751-1097.1997.tb03200.x; Finley EL, 1998, PROTEIN SCI, V7, P2391, DOI 10.1002/pro.5560071116; FUKUNAGA Y, 1982, J BIOCHEM-TOKYO, V92, P129, DOI 10.1093/oxfordjournals.jbchem.a133909; Garland CF, 2006, AM J PUBLIC HEALTH, V96, P252, DOI 10.2105/AJPH.2004.045260; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Giulivi C, 2003, AMINO ACIDS, V25, P227, DOI 10.1007/s00726-003-0013-0; Gorham ED, 2005, J STEROID BIOCHEM, V97, P179, DOI 10.1016/j.jsbmb.2005.06.018; Grant WB, 2002, CANCER-AM CANCER SOC, V94, P1867, DOI 10.1002/cncr.10427; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Han W, 2012, CANCER LETT, V318, P124, DOI 10.1016/j.canlet.2012.01.011; HOFFMAN MZ, 1972, J AM CHEM SOC, V94, P7950, DOI 10.1021/ja00778a002; Huang RP, 1996, J CELL BIOL, V133, P211, DOI 10.1083/jcb.133.1.211; Jacob JS, 1996, J BIOL CHEM, V271, P19950, DOI 10.1074/jbc.271.33.19950; JONES CA, 1987, RADIAT RES, V110, P244, DOI 10.2307/3576902; Kaskel P, 2001, BRIT J DERMATOL, V145, P602, DOI 10.1046/j.1365-2133.2001.04432.x; Kawaguchi J, 2012, ONCOL REP, V27, P935, DOI 10.3892/or.2011.1612; KAWAMOTO T, 1992, IN VITRO CELL DEV-AN, V28A, P782; Kerwin BA, 2007, J PHARM SCI-US, V96, P1468, DOI 10.1002/jps.20815; Kiguchi K, 1998, MOL CARCINOGEN, V22, P73, DOI 10.1002/(SICI)1098-2744(199806)22:2<73::AID-MC2>3.0.CO;2-L; Kim YN, 2002, EXP CELL RES, V280, P134, DOI 10.1006/excr.2002.5623; LI Z, 1989, BIOPHYS J, V56, P361, DOI 10.1016/S0006-3495(89)82682-7; Liu P, 2012, P NATL ACAD SCI USA, V109, P10861, DOI 10.1073/pnas.1201114109; Macdonald J, 2006, BBA-MOL CELL RES, V1763, P870, DOI 10.1016/j.bbamcr.2006.05.002; Malencik DA, 2003, AMINO ACIDS, V25, P233, DOI 10.1007/s00726-003-0014-z; MALENCIK DA, 1987, BIOCHEMISTRY-US, V26, P695, DOI 10.1021/bi00377a006; Moan J., 2001, RAD HOME OUTDOORS WO, P69; Neves-Petersen MT, 2009, BIOPHYS J, V97, P211, DOI 10.1016/j.bpj.2009.01.065; Neves-Petersen MT, 2006, PROTEIN SCI, V15, P343, DOI 10.1110/ps.051885306; Neves-Petersen MT, 2002, PROTEIN SCI, V11, P588, DOI 10.1110/ps.06002; Newton-Bishop JA, 2011, EUR J CANCER, V47, P732, DOI 10.1016/j.ejca.2010.10.008; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Nilsen LTN, 2011, PHOTOCH PHOTOBIO SCI, V10, P1129, DOI 10.1039/c1pp05029j; Noonberg SB, 2000, DRUGS, V59, P753, DOI 10.2165/00003495-200059040-00003; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Olsen BB, 2007, INT J ONCOL, V30, P181; Petersen MTN, 1999, PROTEIN ENG, V12, P535, DOI 10.1093/protein/12.7.535; PIRIE A, 1971, BIOCHEM J, V125, P203, DOI 10.1042/bj1250203; Pukkala E, 2009, ACTA ONCOL, V48, P646, DOI 10.1080/02841860902913546; Riener CK, 2002, ANAL BIOANAL CHEM, V373, P266, DOI 10.1007/s00216-002-1347-2; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Segrelles C, 2002, ONCOGENE, V21, P53, DOI 10.1038/sj.onc.1205032; Sibilia M, 2000, CELL, V102, P211, DOI 10.1016/S0092-8674(00)00026-X; Suzuki S, 2005, CANCER-AM CANCER SOC, V103, P1265, DOI 10.1002/cncr.20909; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Teresa M., 2012, MOL PHOTOCHEM VAR AS, V37947, P1, DOI [10.5772/37947, DOI 10.5772/37947]; Wan YS, 2001, INT J ONCOL, V18, P461; Webb AR, 2006, PHOTOCHEM PHOTOBIOL, V82, P1697, DOI 10.1562/2006-09-01-RA-670; Xu YR, 2006, AM J PATHOL, V169, P823, DOI 10.2353/ajpath.2006.050449; Yarden Y, 2001, EUR J CANCER, V37, pS3; Zhang YG, 2001, DNA CELL BIOL, V20, P769, DOI 10.1089/104454901753438589	63	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111617	10.1371/journal.pone.0111617	http://dx.doi.org/10.1371/journal.pone.0111617			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386651	Green Published, Green Submitted, gold			2022-12-27	WOS:000345250400023
J	Gillis, LG; Ziegler, AD; van Oevelen, D; Cathalot, C; Herman, PMJ; Wolters, JW; Bouma, TJ				Gillis, Lucy G.; Ziegler, Alan D.; van Oevelen, Dick; Cathalot, Cecile; Herman, Peter M. J.; Wolters, Jan W.; Bouma, Tjeerd J.			Tiny Is Mighty: Seagrass Beds Have a Large Role in the Export of Organic Material in the Tropical Coastal Zone	PLOS ONE			English	Article							POSIDONIA-OCEANICA; MATTER; PARTICULATE; NUTRIENT; CARBON; NITROGEN; RETENTION; TRANSPORT; SEDIMENTS; DYNAMICS	Ecosystems in the tropical coastal zone exchange particulate organic matter (POM) with adjacent systems, but differences in this function among ecosystems remain poorly quantified. Seagrass beds are often a relatively small section of this coastal zone, but have a potentially much larger ecological influence than suggested by their surface area. Using stable isotopes as tracers of oceanic, terrestrial, mangrove and seagrass sources, we investigated the origin of particulate organic matter in nine mangrove bays around the island of Phuket (Thailand). We used a linear mixing model based on bulk organic carbon, total nitrogen and delta C-13 and delta N-15 and found that oceanic sources dominated suspended particulate organic matter samples along the mangrove-seagrass-ocean gradient. Sediment trap samples showed contributions from four sources oceanic, mangrove forest/terrestrial and seagrass beds where oceanic had the strongest contribution and seagrass beds the smallest. Based on ecosystem area, however, the contribution of suspended particulate organic matter derived from seagrass beds was disproportionally high, relative to the entire area occupied by mangrove forests, the catchment area (terrestrial) and seagrass beds. The contribution from mangrove forests was approximately equal to their surface area, whereas terrestrial contributions to suspended organic matter under contributed compared to their relative catchment area. Interestingly, mangrove forest contribution at 0 m on the transects showed a positive relationship with the exposed frontal width of the mangrove, indicating that mangrove forest exposure to hydrodynamic energy may be a controlling factor in mangrove outwelling. However we found no relationship between seagrass bed contribution and any physical factors, which we measured. Our results indicate that although seagrass beds occupy a relatively small area of the coastal zone, their role in the export of organic matter is disproportional and should be considered in coastal management especially with respect to their importance as a nutrient source for other ecosystems and organisms.	[Gillis, Lucy G.; Herman, Peter M. J.; Bouma, Tjeerd J.] Royal Netherlands Inst Sea Res NIOZ, Spatial Ecol Dept, Yerseke, Zealand, Netherlands; [Ziegler, Alan D.] Natl Univ Singapore, Dept Geog, Singapore 117548, Singapore; [van Oevelen, Dick] Royal Netherlands Inst Sea Res NIOZ, Ecosyst Studies Dept, Yerseke, Zealand, Netherlands; [Cathalot, Cecile] IFREMER, Lab Environm Profond, Polouzane, Brittany, France; [Wolters, Jan W.] Univ Antwerp, Dept Biol, B-2020 Antwerp, Flanders, Belgium	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); National University of Singapore; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Ifremer; University of Antwerp	Gillis, LG (corresponding author), Royal Netherlands Inst Sea Res NIOZ, Spatial Ecol Dept, Yerseke, Zealand, Netherlands.	lucygwen.gillis@nioz.nl	Gillis, Lucy Gwen/I-5313-2017; Herman, Peter M.J./A-9018-2011; , dr dr/AAA-5406-2022; ZIEGLER, ALAN/A-5463-2012	Gillis, Lucy Gwen/0000-0002-3901-2258; Herman, Peter M.J./0000-0003-2188-6341; ZIEGLER, ALAN/0000-0001-5305-2136; Cathalot, Cecile/0000-0002-0868-7201; Bouma, Tjeerd/0000-0001-7824-7546	Ecoshape, Building with Nature (SDWI/Eco-Shape/Building with Nature grant) [R-303-001-020-414]	Ecoshape, Building with Nature (SDWI/Eco-Shape/Building with Nature grant)	This research was funded by Ecoshape, Building with Nature (SDWI/Eco-Shape/Building with Nature grant R-303-001-020-414). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONGI DM, 1990, ESTUAR COAST SHELF S, V31, P581, DOI 10.1016/0272-7714(90)90014-I; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bouillon S, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003052; Bouillon S, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000325; Burkholder JM, 2007, J EXP MAR BIOL ECOL, V350, P46, DOI 10.1016/j.jembe.2007.06.024; CLINE J D, 1975, Marine Chemistry, V3, P271, DOI 10.1016/0304-4203(75)90009-2; Dittmar T, 2001, ESTUAR COAST SHELF S, V52, P249, DOI 10.1006/ecss.2000.0743; Evrard V, 2005, MAR ECOL PROG SER, V295, P49, DOI 10.3354/meps295049; FONSECA MS, 1992, ESTUAR COAST SHELF S, V35, P565, DOI 10.1016/S0272-7714(05)80039-3; Forward RB, 2001, OCEANOGR MAR BIOL, V39, P305; Gattuso JP, 1998, ANNU REV ECOL SYST, V29, P405, DOI 10.1146/annurev.ecolsys.29.1.405; Gillis LG, 2014, MAR ECOL PROG SER, V498, P95, DOI 10.3354/meps10615; Heck KL, 2006, J EXP MAR BIOL ECOL, V330, P420, DOI 10.1016/j.jembe.2005.12.044; Hemminga MA, 1999, AQUAT BOT, V65, P141, DOI 10.1016/S0304-3770(99)00037-6; HEMMINGA MA, 1994, MAR ECOL PROG SER, V106, P291, DOI 10.3354/meps106291; Hendriks IE, 2008, MAR ECOL PROG SER, V356, P163, DOI 10.3354/meps07316; Hunsinger GB, 2010, LIMNOL OCEANOGR, V55, P1653, DOI 10.4319/lo.2010.55.4.1653; Infantes E, 2009, BOT MAR, V52, P419, DOI 10.1515/BOT.2009.050; Kimirei IA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066320; Koch EW, 2001, GLOBAL SEAGRASS RESEARCH METHODS, P325, DOI 10.1016/B978-044450891-1/50018-9; Krumme U, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P271, DOI 10.1007/978-90-481-2406-0_8; Krusche AV, 2002, WATER RES, V36, P2743, DOI 10.1016/S0043-1354(01)00495-X; Kuramoto T., 2001, J OCEANOGR, V57, P421, DOI DOI 10.1023/A:1021232132755; Lai S, 2013, CORAL REEFS, V32, P1061, DOI 10.1007/s00338-013-1062-9; LEE SY, 1995, HYDROBIOLOGIA, V295, P203, DOI 10.1007/BF00029127; Limpsaichol P, 1998, 1992 COMMUNITY BASED, P85; McConnachie JL, 2006, GEOMORPHOLOGY, V79, P13, DOI 10.1016/j.geomorph.2005.09.011; Meksumpun S, 2005, CONT SHELF RES, V25, P1905, DOI 10.1016/j.csr.2005.04.009; NIEUWENHUIZE J, 1994, MAR CHEM, V45, P217, DOI 10.1016/0304-4203(94)90005-1; Odum E.P., 1968, P 2 SEA GRANT C, P63; Perez M, 2007, J EXP MAR BIOL ECOL, V344, P149, DOI 10.1016/j.jembe.2006.12.020; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Phillips DL, 2002, OECOLOGIA, V130, P114, DOI 10.1007/s004420100786; R Core Team, 2012, R LANG ENV STAT COMP; Schindler Wildhaber Y, 2012, BIOGEOSCIENCES, V9, P1985, DOI 10.5194/bg-9-1985-2012; Terrados J, 2000, J EXP MAR BIOL ECOL, V243, P45, DOI 10.1016/S0022-0981(99)00110-0; Thimdee W, 2003, WETLANDS, V23, P729, DOI 10.1672/0277-5212(2003)023[0729:SAFOOM]2.0.CO;2; Todd PA, 2010, BIODIVERS CONSERV, V19, P1063, DOI 10.1007/s10531-010-9778-0; Van Engeland T, 2011, MAR ECOL PROG SER, V427, P71, DOI 10.3354/meps09054; van Oevelen D, 2010, ECOSYSTEMS, V13, P32, DOI 10.1007/s10021-009-9297-6; Vonk JA, 2008, LIMNOL OCEANOGR, V53, P542, DOI 10.4319/lo.2008.53.2.0542; Wilkie L, 2012, AQUAT BOT, V102, P15, DOI 10.1016/j.aquabot.2012.04.004; Woodroffe C, 1992, TROPICAL MANGROVE EC, P7, DOI DOI 10.1029/CE041P0007	43	18	18	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111847	10.1371/journal.pone.0111847	http://dx.doi.org/10.1371/journal.pone.0111847			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386853	Green Published, gold			2022-12-27	WOS:000345250400026
J	Yang, WZ; Qi, Y; Fu, JZ				Yang, Weizhao; Qi, Yin; Fu, Jinzhong			Exploring the Genetic Basis of Adaptation to High Elevations in Reptiles: A Comparative Transcriptome Analysis of Two Toad-Headed Agamas (Genus Phrynocephalus)	PLOS ONE			English	Article							GENOME REVEALS; SEQUENCE; LIFE; EVOLUTION; SELECTION; ALIGNMENT; HYPOXIA; EXPRESSION; INSIGHTS; PROGRAM	High elevation adaptation offers an excellent study system to understand the genetic basis of adaptive evolution. We acquired transcriptome sequences of two closely related lizards, Phrynocephalus przewalskii from low elevations and P. vlangalii from high elevations. Within a phylogenetic framework, we compared their genomic data along with green anole, chicken and Chinese softshell turtle, and identified candidate genes and functional categories that are potentially linked to adaptation to high elevation environments. More than 100 million sequence reads were generated for each species via Illumina sequencing. A de novo assembly produced 70,919 and 62,118 transcripts for P. przewalskii and P. vlangalii, respectively. Based on a well-established reptile phylogeny, we detected 143 positively selected genes (PSGs) along the P. vlangalii lineage from the 7,012 putative orthologs using a branch-site model. Furthermore, ten GO categories and one KEGG pathway that are over-represented by PSGs were recognized. In addition, 58 GO categories were revealed to have elevated evolutionary rates along the P. vlangalii lineage relative to P. przewalskii. These functional analyses further filter out PSGs that are most likely involved in the adaptation process to high elevations. Among them, ADAM17, MD, and HSP90B1 likely contributed to response to hypoxia, and POLK likely contributed to DNA repair. Many other candidate genes involved in gene expression and metabolism were also identified. Genome-wide scan for candidate genes may serve as the first step to explore the genetic basis of high elevation adaptation. Detailed comparative study and functional verification are needed to solidify any conclusions. High elevation adaptation requires coordinated changes in multiple genes that involve various physiological and biochemical pathways; we hope that our genetic studies will provide useful directions for future physiological or molecular studies in reptiles as well as other poikilothermic species.	[Yang, Weizhao; Qi, Yin; Fu, Jinzhong] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China; [Yang, Weizhao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Fu, Jinzhong] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Guelph	Fu, JZ (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China.	jfu@uoguelph.ca			Key Laboratory of Mountain Ecological Restoration and Bioresource Utilization (CAS); Ecological Restoration & Biodiversity Conservation Key Laboratory of Sichuan Province; 100 Talents Programme of Sichuan Province [Y1D3011]; Chinese Academy of Sciences Knowledge Innovation Program [Y1C2021203]; NSERC Discovery Program (Canada)	Key Laboratory of Mountain Ecological Restoration and Bioresource Utilization (CAS); Ecological Restoration & Biodiversity Conservation Key Laboratory of Sichuan Province; 100 Talents Programme of Sichuan Province; Chinese Academy of Sciences Knowledge Innovation Program(Knowledge Innovation Program of the Chinese Academy of SciencesChinese Academy of Sciences); NSERC Discovery Program (Canada)	This work is supported by the Key Laboratory of Mountain Ecological Restoration and Bioresource Utilization (CAS), the Ecological Restoration & Biodiversity Conservation Key Laboratory of Sichuan Province, the 100 Talents Programme of Sichuan Province (Y1D3011), the Chinese Academy of Sciences Knowledge Innovation Program (grant Y1C2021203), and the NSERC Discovery Program (Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bavoux C, 2005, BIOCHIMIE, V87, P637, DOI 10.1016/j.biochi.2005.02.007; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Bi K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-403; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Blumthaler M, 1997, J PHOTOCH PHOTOBIO B, V39, P130, DOI 10.1016/S1011-1344(96)00018-8; Castoe TA, 2013, P NATL ACAD SCI USA, V110, P20645, DOI 10.1073/pnas.1314475110; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cheviron ZA, 2012, HEREDITY, V108, P354, DOI 10.1038/hdy.2011.85; Chiari Y, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-65; Fraser J, 2006, P NATL ACAD SCI USA, V103, P2977, DOI 10.1073/pnas.0508270103; Ge RL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2860; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Gruenheit N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-92; Guo XG, 2007, MOL PHYLOGENET EVOL, V45, P643, DOI 10.1016/j.ympev.2007.06.013; Habib T, 1998, J BIOL CHEM, V273, P18605, DOI 10.1074/jbc.273.29.18605; He JZ, 2013, J EXP ZOOL PART A, V319A, P117, DOI 10.1002/jez.1776; HOLM S, 1979, SCAND J STAT, V6, P65; Hua Fang-fang, 2012, Chinese Journal of Pathology, V41, P466, DOI 10.3760/cma.j.issn.0529-5807.2012.07.008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huey R.B., 1982, Biology of Reptilia, V12, P25; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Koh MY, 2008, TRENDS BIOCHEM SCI, V33, P526, DOI 10.1016/j.tibs.2008.08.002; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li WH, 2005, NATURE, V437, P50, DOI 10.1038/437050a; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; McGowen MR, 2012, P ROY SOC B-BIOL SCI, V279, P3643, DOI 10.1098/rspb.2012.0869; Merx Marc W., 2001, FASEB Journal, V15, P1077; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Qiu Q, 2012, NAT GENET, V44, P946, DOI 10.1038/ng.2343; Qu YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3071; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Rose Michael R., 2001, P17; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; Scheinfeldt LB, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-133; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Srour N, 2003, FEBS LETT, V554, P275, DOI 10.1016/S0014-5793(03)01159-1; Storz JF, 2010, J EXP BIOL, V213, P4125, DOI 10.1242/jeb.048181; Sun YB, 2013, GENOME BIOL EVOL, V5, P130, DOI 10.1093/gbe/evs123; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Svobodova AR, 2012, ARCH DERMATOL RES, V304, P407, DOI 10.1007/s00403-012-1212-x; Vonk FJ, 2013, P NATL ACAD SCI USA, V110, P20651, DOI 10.1073/pnas.1314702110; Wang Z, 2013, NAT GENET, V45, P701, DOI 10.1038/ng.2615; Yang WZ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-588; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhao E.M., 1999, FAUNA SINICA REPTILI; Zhou J, 2003, MOL BIOL CELL, V14, P2216, DOI 10.1091/mbc.E02-09-0598	59	28	33	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112218	10.1371/journal.pone.0112218	http://dx.doi.org/10.1371/journal.pone.0112218			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386640	gold, Green Published			2022-12-27	WOS:000345250400051
J	Lee, LC; Tu, CH; Chen, LF; Shen, HD; Chao, HT; Lin, MW; Hsieh, JC				Lee, Lin-Chien; Tu, Cheng-Hao; Chen, Li-Fen; Shen, Horng-Der; Chao, Hsiang-Tai; Lin, Ming-Wei; Hsieh, Jen-Chuen			Association of Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism with Primary Dysmenorrhea	PLOS ONE			English	Article							MENSTRUAL-CYCLE; MOOD DISORDERS; NONDYSMENORRHEIC WOMEN; FIBROMYALGIA SYNDROME; OXYTOCIN RECEPTOR; YOUNG-WOMEN; PAIN; BDNF; ANXIETY; STRESS	Primary dysmenorrhea (PDM), the most prevalent menstrual cycle-related problem in women of reproductive age, is associated with negative moods. Whether the menstrual pain and negative moods have a genetic basis remains unknown. Brain-derived neurotrophic factor (BDNF) plays a key role in the production of central sensitization and contributes to chronic pain conditions. BDNF has also been implicated in stress-related mood disorders. We screened and genotyped the BDNF Val66Met polymorphism (rs6265) in 99 Taiwanese (Asian) PDMs (20-30 years old) and 101 age-matched healthy female controls. We found that there was a significantly higher frequency of the Met allele of the BDNF Val66Met polymorphism in the PDM group. Furthermore, BDNF Met/Met homozygosity had a significantly stronger association with PDM compared with Val carrier status. Subsequent behavioral/hormonal assessments of sub-groups (PDMs = 78, controls = 81; eligible for longitudinal multimodal neuroimaging battery studies) revealed that the BDNF Met/Met homozygous PDMs exhibited a higher menstrual pain score (sensory dimension) and a more anxious mood than the Val carrier PDMs during the menstrual phase. Although preliminary, our study suggests that the BDNF Val66Met polymorphism is associated with PDM in Taiwanese (Asian) people, and BDNF Met/Met homozygosity may be associated with an increased risk of PDM. Our data also suggest the BDNF Val66Met polymorphism as a possible regulator of menstrual pain and pain-related emotions in PDM. Absence of thermal hypersensitivity may connote an ethnic attribution. The presentation of our findings calls for further genetic and neuroscientific investigations of PDM.	[Lee, Lin-Chien; Tu, Cheng-Hao; Chen, Li-Fen; Hsieh, Jen-Chuen] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Lee, Lin-Chien] Cheng Hsin Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Lee, Lin-Chien; Tu, Cheng-Hao; Chen, Li-Fen; Hsieh, Jen-Chuen] Taipei Vet Gen Hosp, Dept Med Res, Div Clin Res, Integrated Brain Res Unit, Taipei, Taiwan; [Tu, Cheng-Hao] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Shen, Horng-Der; Lin, Ming-Wei] Taipei Vet Gen Hosp, Dept Med Res, Basic Res Div, Taipei, Taiwan; [Chao, Hsiang-Tai] Taipei Vet Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Chao, Hsiang-Tai] Natl Yang Ming Univ, Fac Med, Sch Med, Dept Obstet & Gynecol, Taipei 112, Taiwan; [Lin, Ming-Wei] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; Cheng Hsin General Hospital; Taipei Veterans General Hospital; Taipei City Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Lin, MW (corresponding author), Taipei Vet Gen Hosp, Dept Med Res, Basic Res Div, Taipei, Taiwan.	mwlin@ym.edu.tw; jchsieh@ym.edu.tw	Tu, Cheng-Hao/GOE-4336-2022	Tu, Cheng-Hao/0000-0002-7695-5570	Taipei Veterans General Hospital [V100D-001, V100D-001-1, V100D-001-2, V100E3-002, V101E3-002, V102E3002]; Cheng-Hsin General Hospital [101-33]; National Science Council [NSC 100-2314-B-010-006-MY3, NSC 100-2629-B-010-001, NSC 101-2629-B-010-001, NSC 1012911-I-009-101, NSC 102-2629-B-010-001]; Yen Tjing Ling Medical Foundation [CI-100-5]; Top University Plan of the Ministry of Education for National Yang-Ming University	Taipei Veterans General Hospital(Taipei Veterans General Hospital); Cheng-Hsin General Hospital; National Science Council(Ministry of Science and Technology, Taiwan); Yen Tjing Ling Medical Foundation; Top University Plan of the Ministry of Education for National Yang-Ming University	This research was supported by the Taipei Veterans General Hospital (V100D-001, V100D-001-1, V100D-001-2, V100E3-002, V101E3-002, and V102E3002),Cheng-Hsin General Hospital (101-33), National Science Council (NSC 100-2314-B-010-006-MY3, NSC 100-2629-B-010-001, NSC 101-2629-B-010-001, NSC 1012911-I-009-101, and NSC 102-2629-B-010-001), Yen Tjing Ling Medical Foundation (CI-100-5), and The Aim for the Top University Plan of the Ministry of Education for National Yang-Ming University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu JI, 2000, HUM REPROD UPDATE, V6, P200, DOI 10.1093/humupd/6.2.200; AKERLUND M, 1994, ANN NY ACAD SCI, V734, P47, DOI 10.1111/j.1749-6632.1994.tb21735.x; Akerlund M, 2006, EXPERT OPIN THER TAR, V10, P423, DOI 10.1517/14728222.10.3.423; Alonso C, 2001, HEALTH PSYCHOL, V20, P411, DOI 10.1037/0278-6133.20.6.411; AMODEI N, 1989, J BEHAV MED, V12, P373, DOI 10.1007/BF00844930; Bajaj P, 2002, CLIN J PAIN, V18, P180, DOI 10.1097/00002508-200205000-00007; Barnard K, 2003, J WOMENS HEALTH, V12, P911, DOI 10.1089/154099903770948140; Bath KG, 2012, BIOL PSYCHIAT, V72, P499, DOI 10.1016/j.biopsych.2012.03.032; Beck A., 1993, MANUAL BECK ANXIETY; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Berkley KJ, 2011, PAIN, V152, P1940, DOI 10.1016/j.pain.2011.04.013; Berkley KJ, 2013, PAIN, V1, P1; Blurton-Jones M, 2004, J COMP NEUROL, V468, P347, DOI 10.1002/cne.10989; Brinkert W, 2007, PAIN, V132, pS46, DOI 10.1016/j.pain.2006.12.011; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Choi MJ, 2006, BRAIN RES, V1118, P176, DOI 10.1016/j.brainres.2006.08.012; Davis A R, 2001, J Pediatr Adolesc Gynecol, V14, P3, DOI 10.1016/S1083-3188(00)00076-0; Di Lorenzo C, 2012, J PAIN, V13, P866, DOI 10.1016/j.jpain.2012.05.014; Dorn LD, 2009, J ADOLESCENT HEALTH, V44, P237, DOI 10.1016/j.jadohealth.2008.07.018; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Duric V, 2006, J PAIN, V7, P544, DOI 10.1016/j.jpain.2006.01.458; Fedorowicz Z, 2012, COCHRANE DB SYST REV, V5; French L, 2005, AM FAM PHYSICIAN, V71, P285; Frustaci A, 2008, NEUROPSYCHOBIOLOGY, V58, P163, DOI 10.1159/000182892; Gatt JM, 2009, MOL PSYCHIATR, V14, P681, DOI 10.1038/mp.2008.143; Giamberardino MA, 1997, PAIN, V71, P187, DOI 10.1016/S0304-3959(97)03362-9; Giamberardino MA, 2010, PAIN, V151, P307, DOI 10.1016/j.pain.2010.06.023; Granot M, 2001, OBSTET GYNECOL, V98, P407, DOI 10.1016/S0029-7844(01)01465-X; Groves JO, 2007, MOL PSYCHIATR, V12, P1079, DOI 10.1038/sj.mp.4002075; Guo SW, 2013, FERTIL STERIL, V99, P231, DOI 10.1016/j.fertnstert.2012.08.038; Haas L, 2010, NEUROCHEM RES, V35, P830, DOI 10.1007/s11064-010-0129-z; HAPIDOU EG, 1988, PAIN, V34, P277, DOI 10.1016/0304-3959(88)90123-6; Hariri AR, 2006, BIOL PSYCHIAT, V59, P888, DOI 10.1016/j.biopsych.2005.11.005; HOLDEN RR, 1988, J CONSULT CLIN PSYCH, V56, P766, DOI 10.1037/0022-006X.56.5.766; Hong CJ, 2003, NEUROPSYCHOBIOLOGY, V48, P186, DOI 10.1159/000074636; Huennerkopf R, 2007, NEUROPSYCHOPHARMACOL, V32, P2552, DOI 10.1038/sj.npp.1301383; Hwang JP, 2006, NEUROBIOL AGING, V27, P1834, DOI 10.1016/j.neurobiolaging.2005.10.013; Hwang RJ, 2008, HORM BEHAV, V54, P28, DOI 10.1016/j.yhbeh.2007.11.007; Hwang RJ, 2009, HORM BEHAV, V55, P203, DOI 10.1016/j.yhbeh.2008.10.008; Ignacio ZM, 2014, NEUROSCIENCE, V275, P455, DOI 10.1016/j.neuroscience.2014.06.036; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lommatzsch M, 2005, NEUROBIOL AGING, V26, P115, DOI 10.1016/j.neurobiolaging.2004.03.002; Ma HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055200; Martinowich K, 2008, NEUROPSYCHOPHARMACOL, V33, P73, DOI 10.1038/sj.npp.1301571; Merighi A, 2008, PROG NEUROBIOL, V85, P297, DOI 10.1016/j.pneurobio.2008.04.004; Montag C, 2010, PSYCHIAT RES, V179, P86, DOI 10.1016/j.psychres.2008.08.005; Nugraha B, 2012, RHEUMATOL INT, V32, P2593, DOI 10.1007/s00296-011-2348-2; Obata K, 2006, NEUROSCI RES, V55, P1, DOI 10.1016/j.neures.2006.01.005; Petryshen TL, 2010, MOL PSYCHIATR, V15, P810, DOI 10.1038/mp.2009.24; Quartana PJ, 2009, EXPERT REV NEUROTHER, V9, P745, DOI 10.1586/ERN.09.34; Ren K, 2007, MOL NEUROBIOL, V35, P224, DOI 10.1007/s12035-007-0028-8; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; Sarchielli P, 2007, J PAIN, V8, P737, DOI 10.1016/j.jpain.2007.05.002; Sherman JJ, 2006, AM J PHYSIOL-REG I, V291, pR245, DOI 10.1152/ajpregu.00920.2005; Solum DT, 2002, J NEUROSCI, V22, P2650, DOI 10.1523/JNEUROSCI.22-07-02650.2002; Spencer JL, 2010, P NATL ACAD SCI USA, V107, P4395, DOI 10.1073/pnas.0915105107; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Sun RF, 2011, NEUROSCI LETT, V489, P34, DOI 10.1016/j.neulet.2010.11.061; SUNDELL G, 1990, BRIT J OBSTET GYNAEC, V97, P588, DOI 10.1111/j.1471-0528.1990.tb02545.x; Tu CH, 2013, PAIN, V154, P1718, DOI 10.1016/j.pain.2013.05.022; Tu CH, 2009, NEUROIMAGE, V47, P28, DOI 10.1016/j.neuroimage.2009.03.080; Tzafettas John, 2006, Pediatr Endocrinol Rev, V3 Suppl 1, P160; Verhagen M, 2010, MOL PSYCHIATR, V15, P260, DOI 10.1038/mp.2008.109; Vincent K, 2011, PAIN, V152, P1966, DOI 10.1016/j.pain.2011.03.029; Vossen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013641; Ware J., 1993, SF 36 HLTH SURVEY MA; Westling AM, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.020; Yu H, 2012, J NEUROSCI, V32, P4092, DOI 10.1523/JNEUROSCI.5048-11.2012; Yu YB, 2012, GUT, V61, P685, DOI 10.1136/gutjnl-2011-300265; Zhang HP, 2006, AM J MED GENET B, V141B, P387, DOI 10.1002/ajmg.b.30332	71	30	32	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112766	10.1371/journal.pone.0112766	http://dx.doi.org/10.1371/journal.pone.0112766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383981	Green Published, Green Submitted, gold			2022-12-27	WOS:000344816700093
J	Li, RW; Giarrizzo, JG; Wu, ST; Li, WZ; Duringer, JM; Craig, AM				Li, Robert W.; Giarrizzo, Juan Gabriel; Wu, Sitao; Li, Weizhong; Duringer, Jennifer M.; Craig, A. Morrie			Metagenomic Insights into the RDX-Degrading Potential of the Ovine Rumen Microbiome	PLOS ONE			English	Article							HEXAHYDRO-1,3,5-TRINITRO-1,3,5-TRIAZINE RDX; CLOSTRIDIUM-KLUYVERI; DEGRADATION; BIOTRANSFORMATION; CYTOCHROME-P450; BIODEGRADATION; TRANSFORMATION; GORDONIA; CLONING; GENES	The manufacturing processes of royal demolition explosive (RDX), or hexahydro-1,3,5-trinitro-1,3,5-triazine, have resulted in serious water contamination. As a potential carcinogen, RDX can cause a broad range of harmful effects to humans and animals. The ovine rumen is capable of rapid degradation of nitroaromatic compounds, including RDX. While ruminal RDX-degrading bacteria have been identified, the genes and pathways responsible for RDX degradation in the rumen have yet to be characterized. In this study, we characterized the metabolic potential of the ovine rumen using metagenomic approaches. Sequences homologous to at least five RDX-degrading genes cloned from environmental samples (diaA, xenA, xenB, xplA, and xplB) were present in the ovine rumen microbiome. Among them, diaA was the most abundant, likely reflective of the predominance of the genus Clostridium in the ovine rumen. At least ten genera known to harbor RDX-degrading microorganisms were detectable. Metagenomic sequences were also annotated using public databases, such as Pfam, COG, and KEGG. Five of the six Pfam protein families known to be responsible for RDX degradation in environmental samples were identified in the ovine rumen. However, increased substrate availability did not appear to enhance the proliferation of RDX-degrading bacteria and alter the microbial composition of the ovine rumen. This implies that the RDX-degrading capacity of the ovine rumen microbiome is likely regulated at the transcription level. Our results provide metagenomic insights into the RDX-degrading potential of the ovine rumen, and they will facilitate the development of novel and economic bioremediation strategies.	[Li, Robert W.] ARS, USDA, Agr Res Serv, Anim Genom & Improvement Lab, Beltsville, MD 20705 USA; [Giarrizzo, Juan Gabriel; Craig, A. Morrie] Oregon State Univ, Coll Vet Med, Corvallis, OR 97331 USA; [Wu, Sitao; Li, Weizhong] Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92093 USA; [Duringer, Jennifer M.] Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA	United States Department of Agriculture (USDA); Oregon State University; University of California System; University of California San Diego; Oregon State University	Li, RW (corresponding author), ARS, USDA, Agr Res Serv, Anim Genom & Improvement Lab, Beltsville, MD 20705 USA.	Robert.Li@ars.usda.gov; a.morrie.craig@oregonstate.edu	Li, Weizhong/A-9735-2008	Li, Weizhong/0000-0003-1804-9403; Craig, Morrie/0000-0001-8566-8875	Oregon Agricultural Experiment Station [ORE00871]; United States Department of Agriculture Agricultural Research Service [1245-32000-093-00D]	Oregon Agricultural Experiment Station; United States Department of Agriculture Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was supported by the Oregon Agricultural Experiment Station (Project ORE00871) and United States Department of Agriculture Agricultural Research Service (Project 1245-32000-093-00D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andeer PF, 2009, APPL ENVIRON MICROB, V75, P3258, DOI 10.1128/AEM.02396-08; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bernstein A, 2013, ENVIRON SCI TECHNOL, V47, P479, DOI 10.1021/es302691g; Bhushan B, 2003, APPL ENVIRON MICROB, V69, P1347, DOI 10.1128/AEM.69.3.1347-1351.2003; Bhushan B, 2002, BIOCHEM BIOPH RES CO, V296, P779, DOI 10.1016/S0006-291X(02)00874-4; Blehert DS, 1999, J BACTERIOL, V181, P6254, DOI 10.1128/JB.181.20.6254-6263.1999; Castro-Carrera T, 2014, J DAIRY SCI, V97, P1661, DOI 10.3168/jds.2013-7243; Chakraborty S, 2008, BIOSCI BIOTECH BIOCH, V72, P735, DOI 10.1271/bbb.70606; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; De Lorme M, 2009, CURR MICROBIOL, V58, P81, DOI 10.1007/s00284-008-9281-y; Eaton HL, 2013, APPL MICROBIOL BIOT, V97, P3699, DOI 10.1007/s00253-012-4172-3; Eaton HL, 2011, MICROB ECOL, V62, P274, DOI 10.1007/s00248-011-9809-8; Eaton HL, 2014, FEMS MICROBIOL LETT, V350, P34, DOI 10.1111/1574-6968.12316; Ellison MJ, 2014, DNA RES, V21, P115, DOI 10.1093/dnares/dst044; Fuller ME, 2009, APPL MICROBIOL BIOT, V84, P535, DOI 10.1007/s00253-009-2024-6; Giarrizzo JG, 2013, J CHROMATOGR B, V925, P70, DOI 10.1016/j.jchromb.2013.02.033; Halasz A, 2012, ENVIRON SCI TECHNOL, V46, P7245, DOI 10.1021/es3011964; Hawari J, 2000, APPL MICROBIOL BIOT, V54, P605, DOI 10.1007/s002530000445; Hayete B, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P127; Indest KJ, 2013, APPL ENVIRON MICROB, V79, P1746, DOI 10.1128/AEM.03905-12; Indest KJ, 2010, APPL ENVIRON MICROB, V76, P6329, DOI 10.1128/AEM.01217-10; Jackson RG, 2007, P NATL ACAD SCI USA, V104, P16822, DOI 10.1073/pnas.0705110104; Ju KS, 2010, MICROBIOL MOL BIOL R, V74, P250, DOI 10.1128/MMBR.00006-10; Khan MI, 2012, J MICROBIOL BIOTECHN, V22, P1311, DOI 10.4014/jmb.1203.04002; Kittelmann Sandra, 2013, PLoS One, V8, pe47879, DOI 10.1371/journal.pone.0047879; Kitts CL, 2000, CAN J MICROBIOL, V46, P278, DOI 10.1139/cjm-46-3-278; Li RW, 2012, INFECT IMMUN, V80, P2150, DOI 10.1128/IAI.00141-12; Li RW, 2012, ENVIRON MICROBIOL, V14, P129, DOI 10.1111/j.1462-2920.2011.02543.x; Li RG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037127, 10.1371/journal.pone.0029392, 10.1371/journal.pone.0051897]; Livermore JA, 2013, ENVIRON SCI TECHNOL, V47, P7672, DOI 10.1021/es4012788; Namiki Toshiaki, 2012, Nucleic Acids Res, V40, pe155, DOI 10.1093/nar/gks678; Niu BF, 2011, BIOINFORMATICS, V27, P1704, DOI 10.1093/bioinformatics/btr252; Omoniyi LA, 2014, J APPL MICROBIOL, V116, P1094, DOI 10.1111/jam.12450; Perumbakkam S, 2012, CURR MICROBIOL, V65, P195, DOI 10.1007/s00284-012-0144-1; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Rodgers JD, 2001, WATER RES, V35, P2101, DOI 10.1016/S0043-1354(00)00505-4; Rylott EL, 2011, BBA-PROTEINS PROTEOM, V1814, P230, DOI 10.1016/j.bbapap.2010.07.004; Rylott EL, 2009, TRENDS BIOTECHNOL, V27, P73, DOI 10.1016/j.tibtech.2008.11.001; Seth-Smith HMB, 2002, APPL ENVIRON MICROB, V68, P4764, DOI 10.1128/AEM.68.10.4764-4771.2002; Shi W, 2014, GENOME RES; Talmage Sylvia S., 1999, Reviews of Environmental Contamination and Toxicology, V161, P1; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Thompson KT, 2005, APPL ENVIRON MICROB, V71, P8265, DOI 10.1128/AEM.71.12.8265-8272.2005; Weimer PJ, 2012, APPL MICROBIOL BIOT, V94, P461, DOI 10.1007/s00253-011-3751-z; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wilke A, 2013, METHOD ENZYMOL, V531, P487, DOI 10.1016/B978-0-12-407863-5.00022-8; Williams AGB, 2005, ENVIRON SCI TECHNOL, V39, P5183, DOI 10.1021/es0490525; Wu ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035470	48	12	12	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e110505	10.1371/journal.pone.0110505	http://dx.doi.org/10.1371/journal.pone.0110505			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383623	Green Published, Green Submitted, gold			2022-12-27	WOS:000344816700007
J	Carlos, C; Castro, DBA; Ottoboni, LMM				Carlos, Camila; Assumpcao Castro, Daniel Bedo; Ottoboni, Laura M. M.			Comparative Metagenomic Analysis of Coral Microbial Communities Using a Reference-Independent Approach	PLOS ONE			English	Article							SECRETION SYSTEMS; WEB SERVER; MARINE; DIVERSITY; SEQUENCES; BACTERIA; NETWORK	By comparing the SEED and Pfam functional profiles of metagenomes of two Brazilian coral species with 29 datasets that are publicly available, we were able to identify some functions, such as protein secretion systems, that are overrepresented in the metagenomes of corals and may play a role in the establishment and maintenance of bacteria-coral associations. However, only a small percentage of the reads of these metagenomes could be annotated by these reference databases, which may lead to a strong bias in the comparative studies. For this reason, we have searched for identical sequences (99% of nucleotide identity) among these metagenomes in order to perform a reference-independent comparative analysis, and we were able to identify groups of microbial communities that may be under similar selective pressures. The identification of sequences shared among the metagenomes was found to be even better for the identification of groups of communities with similar niche requirements than the traditional analysis of functional profiles. This approach is not only helpful for the investigation of similarities between microbial communities with high proportion of unknown reads, but also enables an indirect overview of gene exchange between communities.	[Carlos, Camila; Assumpcao Castro, Daniel Bedo; Ottoboni, Laura M. M.] State Univ Campinas UNICAMP, Ctr Mol Biol & Genet Engn CBMEG, Campinas, SP, Brazil	Universidade Estadual de Campinas	Ottoboni, LMM (corresponding author), State Univ Campinas UNICAMP, Ctr Mol Biol & Genet Engn CBMEG, Campinas, SP, Brazil.	ottoboni@unicamp.br	Carlos, Camila/Q-8327-2016; Carlos, Camila/Q-3742-2019	Carlos, Camila/0000-0002-4574-1270; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2010/50247-4, 2010/02325-6]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo: 2010/50247-4; and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo: 2010/02325-6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Barret M, 2013, ENV MICROBIOL REP, V5, P117, DOI 10.1111/j.1758-2229.2012.00394.x; Bondarev V, 2013, ENVIRON MICROBIOL, V15, P2095, DOI 10.1111/1462-2920.12123; Breitbart M, 2004, FEMS MICROBIOL LETT, V236, P249, DOI 10.1016/j.femsle.2004.05.042; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Burke C, 2011, P NATL ACAD SCI USA, V108, P14288, DOI 10.1073/pnas.1101591108; Carlos C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01624; Charles H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029096; Delwart E, 2012, VIRUS RES, V164, P114, DOI 10.1016/j.virusres.2011.11.021; Dutilh BE, 2012, BIOINFORMATICS, V28, P3225, DOI 10.1093/bioinformatics/bts613; FATH MJ, 1989, J BACTERIOL, V171, P3158, DOI 10.1128/jb.171.6.3158-3161.1989; Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761; Garcia GD, 2013, MICROB ECOL, V65, P1076, DOI 10.1007/s00248-012-0161-4; Gardebrecht A, 2012, ISME J, V6, P766, DOI 10.1038/ismej.2011.137; Gophna U, 2003, GENE, V312, P151, DOI 10.1016/S0378-1119(03)00612-7; Hadjifrangiskou M, 2012, J BACTERIOL, V194, P6195, DOI 10.1128/JB.01012-12; Kav AB, 2012, P NATL ACAD SCI USA, V109, P5452, DOI 10.1073/pnas.1116410109; Kloesges T, 2011, MOL BIOL EVOL, V28, P1057, DOI 10.1093/molbev/msq297; Krupovic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019893; Labonte JM, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00404; Lingner T, 2011, NUCLEIC ACIDS RES, V39, pW518, DOI 10.1093/nar/gkr388; McCallum H, 2003, ECOL LETT, V6, P1062, DOI 10.1046/j.1461-0248.2003.00545.x; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Muniesa M, 2013, FUTURE MICROBIOL, V8, P739, DOI 10.2217/fmb.13.32; Qu A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002945; Rohwer F, 2009, NATURE, V459, P207, DOI 10.1038/nature08060; Roux S, 2011, BIOINFORMATICS, V27, P3074, DOI 10.1093/bioinformatics/btr519; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schmieder R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-341; Schottner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032093; Schottner S, 2009, ISME J, V3, P756, DOI 10.1038/ismej.2009.15; Sharp KH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010898; Short CM, 2005, APPL ENVIRON MICROB, V71, P480, DOI 10.1128/AEM.71.1.480-486.2005; Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571; Szalay-Beko M, 2012, BIOINFORMATICS, V28, P2202, DOI 10.1093/bioinformatics/bts352; Tamminen M, 2012, MOL BIOL EVOL, V29, P1225, DOI 10.1093/molbev/msr292; Teeling H, 2012, BRIEF BIOINFORM, V13, P728, DOI 10.1093/bib/bbs039; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; Trindade-Silva AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039905; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Upreti RK, 2003, PROTEOMICS, V3, P363, DOI 10.1002/pmic.200390052; Wegley L, 2007, ENVIRON MICROBIOL, V9, P2707, DOI 10.1111/j.1462-2920.2007.01383.x; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Yip ES, 2005, MOL MICROBIOL, V57, P1485, DOI 10.1111/j.1365-2958.2005.04784.x	45	8	9	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111626	10.1371/journal.pone.0111626	http://dx.doi.org/10.1371/journal.pone.0111626			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379670	gold, Green Published, Green Submitted			2022-12-27	WOS:000344863100037
J	Chen, L; Choyke, PL; Wang, NY; Clarke, R; Bhujwalla, ZM; Hillman, EMC; Wang, G; Wang, Y				Chen, Li; Choyke, Peter L.; Wang, Niya; Clarke, Robert; Bhujwalla, Zaver M.; Hillman, Elizabeth M. C.; Wang, Ge; Wang, Yue			Unsupervised Deconvolution of Dynamic Imaging Reveals Intratumor Vascular Heterogeneity and Repopulation Dynamics	PLOS ONE			English	Article							TUMOR HETEROGENEITY; BREAST-CANCER; MRI; KINETICS	With the existence of biologically distinctive malignant cells originated within the same tumor, intratumor functional heterogeneity is present in many cancers and is often manifested by the intermingled vascular compartments with distinct pharmacokinetics. However, intratumor vascular heterogeneity cannot be resolved directly by most in vivo dynamic imaging. We developed multi-tissue compartment modeling (MTCM), a completely unsupervised method of deconvoluting dynamic imaging series from heterogeneous tumors that can improve vascular characterization in many biological contexts. Applying MTCM to dynamic contrast-enhanced magnetic resonance imaging of breast cancers revealed characteristic intratumor vascular heterogeneity and therapeutic responses that were otherwise undetectable. MTCM is readily applicable to other dynamic imaging modalities for studying intratumor functional and phenotypic heterogeneity, together with a variety of foreseeable applications in the clinic.	[Chen, Li] NCI, Genet Branch, NIH, Bethesda, MD 20892 USA; [Choyke, Peter L.] NCI, Mol Imaging Program, NIH, Bethesda, MD 20892 USA; [Chen, Li; Wang, Niya; Wang, Yue] Virginia Polytech Inst & State Univ, Dept Elect & Comp Engn, Arlington, VA 22203 USA; [Clarke, Robert] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; [Bhujwalla, Zaver M.] Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Baltimore, MD 21205 USA; [Hillman, Elizabeth M. C.] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Wang, Ge] Rensselaer Polytech Inst, Biomed Imaging Ctr, Dept Biomed Engn, Troy, NY 12180 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Virginia Polytechnic Institute & State University; Georgetown University; Johns Hopkins University; Columbia University; Rensselaer Polytechnic Institute	Wang, Y (corresponding author), Virginia Polytech Inst & State Univ, Dept Elect & Comp Engn, Arlington, VA 22203 USA.	yuewang@vt.edu	Wang, Ge/AAH-8592-2020; Hillman, Elizabeth M C/B-9854-2009; Clarke, Robert/A-6485-2008	Wang, Ge/0000-0002-2656-7705; Clarke, Robert/0000-0002-9278-0854; Hillman, Elizabeth M. C./0000-0001-5511-1451	National Institutes of Health [EB000830, NS29525, CA149147]; NATIONAL CANCER INSTITUTE [ZIABC010714, U54CA149147, U01CA184902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB000830, R33EB000830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the National Institutes of Health under Grants EB000830, NS29525, and CA149147. The funder's URL is http://www.nih.gov/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedard PL, 2013, NATURE, V501, P355, DOI 10.1038/nature12627; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Cong WX, 2014, APPL OPTICS, V53, P5672, DOI 10.1364/AO.53.005672; Cong WX, 2014, OPT EXPRESS, V22, P5572, DOI 10.1364/OE.22.005572; Costouros Nick G, 2002, Mol Imaging, V1, P301, DOI 10.1162/153535002760235481; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Hillman EMC, 2007, NAT PHOTONICS, V1, P526, DOI 10.1038/nphoton.2007.146; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kim E, 2012, ANN BIOMED ENG, V40, P2425, DOI 10.1007/s10439-012-0585-5; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Li KL, 2005, J MAGN RESON IMAGING, V22, P511, DOI 10.1002/jmri.20387; Li X, 2013, MAGN RESON MED; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; McDonald DM, 2003, NAT MED, V9, P713, DOI 10.1038/nm0603-713; O'Connor JPB, 2011, BRIT J CANCER, V105, P139, DOI 10.1038/bjc.2011.191; O'Connor JPB, 2012, NAT REV CLIN ONCOL, V9, P167, DOI 10.1038/nrclinonc.2012.2; Padhani AR, 2003, BRIT J RADIOL, V76, pS60, DOI 10.1259/bjr/15334380; Port RE, 1999, JMRI-J MAGN RESON IM, V10, P233; Segal E, 2007, NAT BIOTECHNOL, V25, P675, DOI 10.1038/nbt1306; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shibata D, 2012, SCIENCE, V336, P304, DOI 10.1126/science.1222361; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Wang C, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.2.025003; Wang FY, 2010, IEEE T PATTERN ANAL, V32, P875, DOI 10.1109/TPAMI.2009.72; Wang Y, 2001, IEEE T INF TECHNOL B, V5, P150, DOI 10.1109/4233.924805; Wang Y, 2002, P IEEE INT S BIOM IM, P178; WAX M, 1985, IEEE T ACOUST SPEECH, V33, P387, DOI 10.1109/TASSP.1985.1164557; Yankeelov TE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005686; Yuan YY, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004330; Zhou Y, 1997, IEEE T NUCL SCI, V44, P2522, DOI 10.1109/23.656461	33	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112143	10.1371/journal.pone.0112143	http://dx.doi.org/10.1371/journal.pone.0112143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379705	Green Published, gold, Green Submitted			2022-12-27	WOS:000344863100056
J	Humphreys, KJ; McKinnon, RA; Michael, MZ				Humphreys, Karen J.; McKinnon, Ross A.; Michael, Michael Z.			miR-18a Inhibits CDC42 and Plays a Tumour Suppressor Role in Colorectal Cancer Cells	PLOS ONE			English	Article							POSTTRANSCRIPTIONAL REGULATION; TERTIARY STRUCTURE; MIR-17-92 CLUSTER; EXPRESSION; MICRORNA; ADENOCARCINOMA; GTPASES; TARGET; GENE; RHO	The miR-17-92 cluster of microRNAs is elevated in colorectal cancer, and has a causative role in cancer development. Of the six miR-17-92 cluster members, miR-19a and b in particular are key promoters of cancer development and cell proliferation, while preliminary evidence suggests that miR-18a may act in opposition to other cluster members to decrease cell proliferation. It was hypothesised that miR-18a may have a homeostatic function in helping to contain the oncogenic effect of the entire miR-17-92 cluster, and that elevated miR-17-92 cluster activity without a corresponding increase in miR-18a may promote colorectal tumour progression. In colorectal cancer samples and corresponding normal colorectal mucosa, miR-18a displayed lower overall expression than other miR-17-92 cluster members. miR-18a was shown to have an opposing role to other miR-17-92 cluster members, in particular the key oncogenic miRNAs, miR-19a and b. Transfection of HCT116 and LIM1215 colorectal cancer cell lines with miR-18a mimics decreased proliferation, while a miR-18a inhibitor increased proliferation. miR-18a was also responsible for decreasing cell migration, altering cell morphology, inducing G1/S phase cell cycle arrest, increasing apoptosis, and enhancing the action of a pro-apoptotic agent. CDC42, a mediator of the PI3K pathway, was identified as a novel miR-18a target. Overexpression of miR-18a reduced CDC42 expression, and a luciferase assay confirmed that miR-18a directly targets the 3'UTR of CDC42. miR-18a mimics had a similar effect on proliferation as a small molecule inhibitor of CDC42. Inhibition of CDC42 expression is likely to be a key mechanism by which miR-18a impairs cancer cell growth, with a target protector experiment revealing miR-18a influences proliferation via direct inhibition of CDC42. Inhibition of CCND1 by miR-18a may also assist in this growth-suppression effect. The homeostatic function of miR-18a within the miR-17-92 cluster in colorectal cancer cells may be achieved through suppression of CDC42 and the PI3K pathway.	[Humphreys, Karen J.; McKinnon, Ross A.; Michael, Michael Z.] Flinders Univ S Australia, Flinders Med Ctr, Flinders Ctr Innovat Canc, Sch Med, Adelaide, SA 5001, Australia	Flinders Medical Centre; Flinders University South Australia	Michael, MZ (corresponding author), Flinders Univ S Australia, Flinders Med Ctr, Flinders Ctr Innovat Canc, Sch Med, Adelaide, SA 5001, Australia.	michael.michael@flinders.edu.au	McKinnon, Ross Allan/B-9340-2009	McKinnon, Ross Allan/0000-0002-3725-793X; Michael, Michael/0000-0001-5954-7105	Flinders Centre for Innovation in Cancer Research Grant; Cancer Council SA's Beat Cancer Project; State Government of South Australia through the Department of Health	Flinders Centre for Innovation in Cancer Research Grant; Cancer Council SA's Beat Cancer Project(Cancer Council South Australia); State Government of South Australia through the Department of Health	The study was funded by a Flinders Centre for Innovation in Cancer Research Grant. This study was produced with the financial and other support of Cancer Council SA's Beat Cancer Project on behalf of its donors and the State Government of South Australia through the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader Andreas G., 2012, Frontiers in Genetics, V3, P120, DOI 10.3389/fgene.2012.00120; Carlin LM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001729; Castellano L, 2009, P NATL ACAD SCI USA, V106, P15732, DOI 10.1073/pnas.0906947106; Chakraborty S, 2012, RNA, V18, P1014, DOI 10.1261/rna.031039.111; Chaulk SG, 2011, RNA BIOL, V8, P1105, DOI 10.4161/rna.8.6.17410; Chen HY, 2013, EMBO MOL MED, V5, P723, DOI 10.1002/emmm.201202140; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Daly K, 2006, DNA CELL BIOL, V25, P49, DOI 10.1089/dna.2006.25.49; Dar AA, 2013, JNCI-J NATL CANCER I, V105, P433, DOI 10.1093/jnci/djt003; Del Pulgar TG, 2008, INT J ONCOL, V33, P185; Diosdado B, 2009, BRIT J CANCER, V101, P707, DOI 10.1038/sj.bjc.6605037; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Ellenbroek SIJ, 2007, CLIN EXP METASTAS, V24, P657, DOI 10.1007/s10585-007-9119-1; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fujiya M, 2013, ONCOGENE; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Guil S, 2009, INT J BIOCHEM CELL B, V41, P87, DOI 10.1016/j.biocel.2008.09.005; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hong L, 2013, J BIOL CHEM, V288, P8531, DOI 10.1074/jbc.M112.435941; Humphreys KJ, 2013, MOL CARCINOGEN, V52, P459, DOI 10.1002/mc.21879; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Iacomino G, 2001, BIOCHEM BIOPH RES CO, V285, P1280, DOI 10.1006/bbrc.2001.5323; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jin HY, 2013, EMBO J, V32, P2377, DOI 10.1038/emboj.2013.178; Kahlert C, 2011, CANCER SCI, V102, P1799, DOI 10.1111/j.1349-7006.2011.02023.x; Kang SG, 2013, NAT IMMUNOL, V14, P849, DOI 10.1038/ni.2648; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luo ZH, 2013, CARCINOGENESIS, V34, P415, DOI 10.1093/carcin/bgs329; Ma J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066275; Mariadason JM, 2000, CANCER RES, V60, P4561; Marques CA, 2008, BLOOD, V111, P1413, DOI 10.1182/blood-2007-05-089458; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Olive V, 2013, ELIFE, V2, DOI 10.7554/eLife.00822; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Pothula S, 2013, INVEST OPHTH VIS SCI, V54, P5343, DOI 10.1167/iovs.13-11955; Pullamsetti SS, 2012, AM J RESP CRIT CARE, V185, P409, DOI 10.1164/rccm.201106-1093OC; Rao E, 2012, LEUKEMIA, V26, P1064, DOI 10.1038/leu.2011.305; Reymond N, 2012, J CELL BIOL, V199, P653, DOI 10.1083/jcb.201205169; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Sakamori R, 2014, CANC RES; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Stengel KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037317; Tao J, 2012, MOL MED REP, V5, P167, DOI 10.3892/mmr.2011.591; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yu G, 2012, J SURG ONCOL, V106, P232, DOI 10.1002/jso.22138	57	69	75	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112288	10.1371/journal.pone.0112288	http://dx.doi.org/10.1371/journal.pone.0112288			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379703	Green Submitted, Green Published, gold			2022-12-27	WOS:000344863100074
J	Njihia, TN; Jaramillo, J; Murungi, L; Mwenda, D; Orindi, B; Poehling, HM; Torto, B				Njihia, Teresiah Nyambura; Jaramillo, Juliana; Murungi, Lucy; Mwenda, Dickson; Orindi, Benedict; Poehling, Hans-Michael; Torto, Baldwyn			Spiroacetals in the Colonization Behaviour of the Coffee Berry Borer: A 'Push-Pull' System	PLOS ONE			English	Article							MOUNTAIN PINE-BEETLE; HYPOTHENEMUS-HAMPEI COLEOPTERA; DENDROCTONUS-PONDEROSAE HOPKINS; BARK BEETLE; IPS-TYPOGRAPHUS; CURCULIONIDAE SCOLYTINAE; PHEROMONE PRODUCTION; FIELD RESPONSE; VOLATILES; SEMIOCHEMICALS	Coffee berries are known to release several volatile organic compounds, among which is the spiroacetal, conophthorin, an attractant for the coffee berry borer Hypothenemus hampei. Elucidating the effects of other spiroacetals released by coffee berries is critical to understanding their chemo-ecological roles in the host discrimination and colonization process of the coffee berry borer, and also for their potential use in the management of this pest. Here, we show that the coffee berry spiroacetals frontalin and 1,6-dioxaspiro [4.5] decane (referred thereafter as brocain), are also used as semiochemicals by the coffee berry borer for host colonization. Bioassays and chemical analyses showed that crowding coffee berry borers from 2 to 6 females per berry, reduced borer fecundity, which appeared to correlate with a decrease in the emission rates of conophthorin and frontalin over time. In contrast, the level of brocain did not vary significantly between borer-uninfested and infested berries. Brocain was attractive at lower doses, but repellent at higher doses while frontalin alone or in a blend was critical for avoidance. Field assays with a commercial attractant comprising a mixture of ethanol and methanol (1:1), combined with frontalin, confirmed the repellent effect of this compound by disrupting capture rates of H. hampei females by 77% in a coffee plantation. Overall, our results suggest that the levels of frontalin and conophthorin released by coffee berries determine the host colonization behaviour of H. hampei, possibly through a 'push-pull' system, whereby frontalin acts as the 'push' (repellent) and conophthorin acting as the 'pull' (attractant). Furthermore, our results reveal the potential use of frontalin as a repellent for management of this coffee pest.	[Njihia, Teresiah Nyambura; Jaramillo, Juliana; Murungi, Lucy; Mwenda, Dickson; Orindi, Benedict; Torto, Baldwyn] Int Ctr Insect Physiol & Ecol Icipe, Nairobi, Kenya; [Njihia, Teresiah Nyambura; Murungi, Lucy] Jomo Kenyatta Univ Agr & Technol, Dept Hort, Nairobi, Kenya; [Jaramillo, Juliana; Poehling, Hans-Michael] Leibniz Univ Hannover, Inst Hort Prod Syst Plant Protect, D-30167 Hannover, Germany	International Centre of Insect Physiology & Ecology (ICIPE); Jomo Kenyatta University of Agriculture & Technology; Leibniz University Hannover	Jaramillo, J (corresponding author), Int Ctr Insect Physiol & Ecol Icipe, Nairobi, Kenya.	jjaramillos@gmail.com		Orindi, Benedict/0000-0002-4601-7890; Njihia, Teresiah/0000-0002-8982-2259	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	This research was funded by the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEDARD WD, 1980, J CHEM ECOL, V6, P997, DOI 10.1007/BF00994657; Blomquist GJ, 2010, INSECT BIOCHEM MOLEC, V40, P699, DOI 10.1016/j.ibmb.2010.07.013; Borden JH, 1998, CHEMOECOLOGY, V8, P69, DOI 10.1007/PL00001806; BRUN LO, 1994, B ENTOMOL RES, V84, P175, DOI 10.1017/S0007485300039651; Bustillo A. E., 1998, HYPOTHENEMUS HAMPEI; Byers JA, 1998, NATURWISSENSCHAFTEN, V85, P557, DOI 10.1007/s001140050551; BYERS JA, 1989, HOLARCTIC ECOL, V12, P466; BYERS JA, 1984, ENVIRON ENTOMOL, V13, P1191, DOI 10.1093/ee/13.5.1191; CORBET SA, 1971, NATURE, V232, P481, DOI 10.1038/232481b0; Dallara PL, 2000, CAN ENTOMOL, V132, P889, DOI 10.4039/Ent132889-6; Damon A, 2000, B ENTOMOL RES, V90, P453, DOI 10.1017/S0007485300000584; GONGORA C, 2001, C SOC COL ENT, V28, P47; Huber DPW, 1999, J CHEM ECOL, V25, P805, DOI 10.1023/A:1020892700653; Huber DPW, 2001, J CHEM ECOL, V27, P217, DOI 10.1023/A:1005668019434; Jactel H., 2003, Integrated Pest Management Reviews, V6, P197, DOI 10.1023/A:1025775419193; Jaramillo J, 2006, B ENTOMOL RES, V96, P223, DOI 10.1079/BER2006434; Jaramillo J, 2009, ENTOMOL EXP APPL, V130, P275, DOI 10.1111/j.1570-7458.2008.00820.x; Jaramillo Juliana, 2013, PLoS ONE, V8, P1, DOI 10.1371/journal.pone.0074277; Kraker JD, 1988, COFFEE BERRY BORER H; Liu ZD, 2013, CHEM SENSES, V38, P485, DOI 10.1093/chemse/bjt019; Mejia M. J. W., 2002, Revista Colombiana de Entomologia, V28, P167; Mendesil E, 2009, J CHEM ECOL, V35, P944, DOI 10.1007/s10886-009-9685-6; Morewood WD, 2003, J CHEM ECOL, V29, P2115, DOI 10.1023/A:1025690519818; Nufio CR, 2001, ENTOMOL EXP APPL, V99, P273, DOI 10.1023/A:1019204817341; PAYNE TL, 1978, ENVIRON ENTOMOL, V7, P578, DOI 10.1093/ee/7.4.578; Pureswaran DS, 2004, CHEMOECOLOGY, V14, P67, DOI 10.1007/s00049-003-0260-2; Pureswaran DS, 2000, CHEMOECOLOGY, V10, P153, DOI 10.1007/PL00001818; R Development Core Team, 2014, R VERS 3 1 0 LANG EN; RAFFA KF, 1983, CAN ENTOMOL, V115, P723, DOI 10.4039/Ent115723-7; ROITBERG BD, 1991, OIKOS, V61, P389, DOI 10.2307/3545246; RUDINSKY JA, 1974, ENVIRON ENTOMOL, V3, P90, DOI 10.1093/ee/3.1.90; Ruiz-Cardenas R, 2010, SCI AGR, V67, P658, DOI 10.1590/S0103-90162010000600007; RYKER LC, 1982, J CHEM ECOL, V8, P1399, DOI 10.1007/BF01403103; SAS Institute, 1999, SAS STAT US GUID; SCHLYTER F, 1987, J CHEM ECOL, V13, P1503, DOI 10.1007/BF01012294; Stelinski Lukasz L., 2009, Communicative & Integrative Biology, V2, P391; Strom BL, 2013, ENVIRON ENTOMOL, V42, P323, DOI 10.1603/EN12300; Strom BL, 1999, ECOL APPL, V9, P1028, DOI 10.1890/1051-0761(1999)009[1028:VASDOH]2.0.CO;2; SZENTESI A, 1981, ENTOMOL EXP APPL, V30, P219, DOI 10.1007/BF00347701; Vega FE, 2011, J ECON ENTOMOL, V104, P87, DOI 10.1603/EC10353; Vega Fernando E., 2009, Terrestrial Arthropod Reviews, V2, P129; VITE JP, 1985, NATURWISSENSCHAFTEN, V72, P99, DOI 10.1007/BF00508146; Zhang QH, 1999, J CHEM ECOL, V25, P2847, DOI 10.1023/A:1020816011131; ZHANG QH, 1992, J APPL ECOL, V29, P672, DOI 10.2307/2404475	46	18	19	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111316	10.1371/journal.pone.0111316	http://dx.doi.org/10.1371/journal.pone.0111316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380135	Green Published, gold			2022-12-27	WOS:000344863100025
J	O'Rourke, JP; Daly, SM; Triplett, KD; Peabody, D; Chackerian, B; Hall, PR				O'Rourke, John P.; Daly, Seth M.; Triplett, Kathleen D.; Peabody, David; Chackerian, Bryce; Hall, Pamela R.			Development of a Mimotope Vaccine Targeting the Staphylococcus aureus Quorum Sensing Pathway	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; ALPHA-HEMOLYSIN; VIRULENCE DETERMINANTS; MONOCLONAL-ANTIBODIES; IMMUNOGENIC DISPLAY; BACTERIOPHAGE PP7; DIVERSE PEPTIDES; SKIN INFECTION; TOXIN; IDENTIFICATION	A major hurdle in vaccine development is the difficulty in identifying relevant target epitopes and then presenting them to the immune system in a context that mimics their native conformation. We have engineered novel virus-like-particle (VLP) technology that is able to display complex libraries of random peptide sequences on a surface-exposed loop in the coat protein without disruption of protein folding or VLP assembly. This technology allows us to use the same VLP particle for both affinity selection and immunization, integrating the power of epitope discovery and epitope mimicry of traditional phage display with the high immunogenicity of VLPs. Previously, we showed that using affinity selection with our VLP platform identifies linear epitopes of monoclonal antibodies and subsequent immunization generates the proper antibody response. To test if our technology could identify immunologic mimotopes, we used affinity selection on a monoclonal antibody (AP4-24H11) that recognizes the Staphylococcus aureus autoinducing peptide 4 (AIP4). AIP4 is a secreted eight amino acid, cyclized peptide produced from the S. aureus accessory gene regulator (agrIV) quorum-sensing operon. The agr system coordinates density dependent changes in gene expression, leading to the upregulation of a host of virulence factors, and passive transfer of AP4-24H11 protects against S. aureus agrIV-dependent pathogenicity. In this report, we identified a set of peptides displayed on VLPs that bound with high specificity to AP4-24H11. Importantly, similar to passive transfer with AP4-24H11, immunization with a subset of these VLPs protected against pathogenicity in a mouse model of S. aureus dermonecrosis. These data are proof of principle that by performing affinity selection on neutralizing antibodies, our VLP technology can identify peptide mimics of non-linear epitopes and that these mimotope based VLP vaccines provide protection against pathogens in relevant animal models.	[O'Rourke, John P.; Peabody, David; Chackerian, Bryce] Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Daly, Seth M.; Triplett, Kathleen D.; Hall, Pamela R.] Univ New Mexico, Sch Med, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico	O'Rourke, JP (corresponding author), Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA.	jorourkejr@salud.unm.edu; phall@salud.unm.edu	Daly, Seth/H-6395-2019; Hall, Pamela/O-5402-2016	Daly, Seth/0000-0002-3532-8810; Hall, Pamela/0000-0003-2367-3382	NIH [R01 AI083305, RO1 AI091917]; University of New Mexico Biology of Infectious Diseases and Inflammation Training Grant [T32-AI007538]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083305, R01AI091917, T32AI007538] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of New Mexico Biology of Infectious Diseases and Inflammation Training Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JPO and BC were supported by NIH grant R01 AI083305. SMD was supported by the University of New Mexico Biology of Infectious Diseases and Inflammation Training Grant (T32-AI007538). PH was supported by NIH grant RO1 AI091917. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038567; Berube BJ, 2013, TOXINS, V5, P1140, DOI 10.3390/toxins5061140; BHAKDI S, 1989, INFECT IMMUN, V57, P3512, DOI 10.1128/IAI.57.11.3512-3519.1989; Bose JL, 2014, INFECT IMMUN, V82, P1813, DOI 10.1128/IAI.01655-13; Brady CS, 2000, TISSUE ANTIGENS, V55, P401, DOI 10.1034/j.1399-0039.2000.550502.x; Caldeira JC, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-22; Caldeira Jerri C., 2007, Journal of Nanobiotechnology, V5, P10, DOI 10.1186/1477-3155-5-10; Caldeira JD, 2010, VACCINE, V28, P4384, DOI 10.1016/j.vaccine.2010.04.049; Chackerian B, 2007, EXPERT REV VACCINES, V6, P381, DOI 10.1586/14760584.6.3.381; Chackerian B, 2011, J MOL BIOL, V409, P225, DOI 10.1016/j.jmb.2011.03.072; Cheung GYC, 2012, EXPERT OPIN THER TAR, V16, P601, DOI 10.1517/14728222.2012.682573; Cheung GYC, 2011, INFECT IMMUN, V79, P1927, DOI 10.1128/IAI.00046-11; Cho JS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003047; Craven RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007446; Folettit D, 2013, J MOL BIOL, V425, P1641, DOI 10.1016/j.jmb.2013.02.008; Fowler VG, 2014, CLIN MICROBIOL INFEC, V20, P66, DOI 10.1111/1469-0691.12570; Hall PR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003166; Hua L, 2014, ANTIMICROB AGENTS CH, V58, P1108, DOI 10.1128/AAC.02190-13; Inoshima N, 2012, J INVEST DERMATOL, V132, P1513, DOI 10.1038/jid.2011.462; Jennings GT, 2008, BIOL CHEM; Kaufmann GF, 2008, EXPERT OPIN BIOL TH, V8, P719, DOI 10.1517/14712598.8.6.719 ; Kaufmann GF, 2011, METHODS MOL BIOL, V692, P299, DOI 10.1007/978-1-60761-971-0_22; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Kirchdoerfer RN, 2011, J BIOL CHEM, V286, P17351, DOI 10.1074/jbc.M111.231258; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; Malachowa Natalia, 2013, Methods Mol Biol, V1031, P109, DOI 10.1007/978-1-62703-481-4_14; Malone CL, 2009, J MICROBIOL METH, V77, P251, DOI 10.1016/j.mimet.2009.02.011; Mihailova M, 2006, VACCINE, V24, P4369, DOI 10.1016/j.vaccine.2006.02.051; Montgomery CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015177; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Park J, 2007, CHEM BIOL, V14, P1119, DOI 10.1016/j.chembiol.2007.08.013; Peabody DS, 2008, J MOL BIOL, V380, P252, DOI 10.1016/j.jmb.2008.04.049; Peterson MM, 2008, CELL HOST MICROBE, V4, P555, DOI 10.1016/j.chom.2008.10.001; Pynnonen M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002104; Ragle BE, 2009, INFECT IMMUN, V77, P2712, DOI 10.1128/IAI.00115-09; Rothfork JM, 2004, P NATL ACAD SCI USA, V101, P13867, DOI 10.1073/pnas.0402996101; Schlievert PM, 2007, BIOCHEMISTRY-US, V46, P14349, DOI 10.1021/bi701202w; Sully EK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004174; Tissot AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009809; Tkaczyk C, 2012, CLIN VACCINE IMMUNOL, V19, P377, DOI 10.1128/CVI.05589-11; Tumban E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023310; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wright JS, 2005, P NATL ACAD SCI USA, V102, P1691, DOI 10.1073/pnas.0407661102	46	20	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111198	10.1371/journal.pone.0111198	http://dx.doi.org/10.1371/journal.pone.0111198			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379726	Green Submitted, Green Published, gold			2022-12-27	WOS:000344863100021
J	Oyen, J; Diamantopoulos, AP; Haugeberg, G				Oyen, Jannike; Diamantopoulos, Andreas P.; Haugeberg, Glenn			Mortality after Distal Radius Fracture in Men and Women Aged 50 Years and Older in Southern Norway	PLOS ONE			English	Article							OSTEOPOROTIC FRACTURES; HIP FRACTURE; ELDERLY-MEN; RISK-FACTOR; EPIDEMIOLOGY; FOREARM	Increased mortality rates in patients sustaining hip and vertebral fractures are well documented; however in distal radius fracture patients the results are conflicting. The aim of this study was to examine short-and long-term mortality in distal radius fracture patient in comparison with the background population. Patients aged >= 50 years with distal radius fracture living in Southern Norway who suffered a fracture in the two year period 2004 and 2005 were included in the study. The mortality risk of the standard Norwegian population was used to calculate the standardized mortality ratio (SMR). The number of distal radius fractures was 883 (166 men and 717 women). Mean age was 69 years (men 65 years and women 70 years). After one year the overall mortality rate was 3.4% (men 5.4% and women 2.9%) and after five years 4.6% (men 4.0% and women 4.8%). The SMR for men and women compared to the Norwegian population for the first year was 1.6 (95% confidence interval (CI): 0.6, 2.7) and 0.9 (95% CI: 0.4, 1.2), respectively, and after five years 1.7 (95% CI: 0.3, 3.0) and 2.0 (95% CI: 1.2, 2.7). Stratified on age groups (50-70 and >70 years) an increased SMR was only seen in female patients aged > 70 years five years after the fracture (SMR: 1.9, 95% CI: 1.1, 2.6). In conclusion, increased SMR was found in female patients aged > 70 years five years after the distal radius fracture, but not in men or in women younger than 70 years.	[Oyen, Jannike] Natl Inst Nutr & Seafood Res, Bergen, Norway; [Diamantopoulos, Andreas P.; Haugeberg, Glenn] Hosp Southern Norway, Dept Rheumatol, Kristiansand, Norway; [Haugeberg, Glenn] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Oyen, J (corresponding author), Natl Inst Nutr & Seafood Res, Bergen, Norway.	jannike.oyen@nifes.no	Øyen, Jannike/G-4156-2017; Øyen, Jannike/H-9857-2018	Øyen, Jannike/0000-0002-5590-5136; Øyen, Jannike/0000-0002-5590-5136	Competence Development Fund of Southern Norway; Hospital of Southern Norway Trust	Competence Development Fund of Southern Norway; Hospital of Southern Norway Trust	This work was supported and funded by the Competence Development Fund of Southern Norway and Hospital of Southern Norway Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cauley JA, 2000, OSTEOPOROSIS INT, V11, P556, DOI 10.1007/s001980070075; CUMMINGS SR, 1985, EPIDEMIOL REV, V7, P178, DOI 10.1093/oxfordjournals.epirev.a036281; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Diamantopoulos AP, 2013, CLIN INTERV AGING, V8, P817, DOI 10.2147/CIA.S45468; Diamantopoulos AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043367; Diamantopoulos AP, 2012, AGE AGEING, V41, P86, DOI 10.1093/ageing/afr114; Endres HG, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-87; Gronskag AB, 2012, OSTEOPOROSIS INT, V23, P1807, DOI 10.1007/s00198-011-1811-y; HOVE LM, 1995, SCAND J PLAST RECONS, V29, P263, DOI 10.3109/02844319509050137; Johnell O, 2004, OSTEOPOROSIS INT, V15, P38, DOI 10.1007/s00198-003-1490-4; Lofthus CM, 2008, OSTEOPOROSIS INT, V19, P781, DOI 10.1007/s00198-007-0499-5; MALLMIN H, 1993, CALCIFIED TISSUE INT, V52, P269, DOI 10.1007/BF00296650; McLellan AR, 2003, OSTEOPOROSIS INT, V14, P1028, DOI 10.1007/s00198-003-1507-z; Omsland TK, 2014, MORTALITY FOLLOWING; Oyen J, 2010, OSTEOPOROSIS INT, V21, P1257, DOI 10.1007/s00198-009-1068-x; Oyen J, 2010, OSTEOPOROSIS INT, V21, P1247, DOI 10.1007/s00198-009-1065-0; Oyen J, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-67; Oyen J, 2011, J BONE JOINT SURG AM, V93A, P348, DOI 10.2106/JBJS.J.00303; Oyen J, 2011, BONE, V48, P1140, DOI 10.1016/j.bone.2011.01.021; Rozental TD, 2002, J HAND SURG-AM, V27A, P948, DOI 10.1053/jhsu.2002.36995; Shortt NL, 2005, J ORTHOP TRAUMA, V19, P396, DOI 10.1097/01.bot.0000155311.04886.7e; Statistics, NORW ALD DODSF MENN	22	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112098	10.1371/journal.pone.0112098	http://dx.doi.org/10.1371/journal.pone.0112098			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380128	Green Published, Green Submitted, gold			2022-12-27	WOS:000344863100052
J	Maiwald, B; Lobsien, D; Kahn, T; Stumpp, P				Maiwald, Bettina; Lobsien, Donald; Kahn, Thomas; Stumpp, Patrick			Is 3-Tesla Gd-EOB-DTPA-Enhanced MRI with Diffusion-Weighted Imaging Superior to 64-Slice Contrast-Enhanced CT for the Diagnosis of Hepatocellular Carcinoma?	PLOS ONE			English	Article							FOCAL LIVER-LESIONS; CLINICAL-EVALUATION; MULTIDETECTOR CT; ADDITIONAL VALUE; B-VALUE; MANAGEMENT; AGENT; TRANSPLANTATION; SENSITIVITY; METASTASES	Objectives: To compare 64-slice contrast-enhanced computed tomography (CT) with 3-Tesla magnetic resonance imaging (MRI) using Gd-EOB-DTPA for the diagnosis of hepatocellular carcinoma (HCC) and evaluate the utility of diffusion-weighted imaging (DWI) in this setting. Methods: 3-phase-liver-CT was performed in fifty patients (42 male, 8 female) with suspected or proven HCC. The patients were subjected to a 3-Tesla-MRI-examination with Gd-EOB-DTPA and diffusion weighted imaging (DWI) at b-values of 0, 50 and 400 s/mm(2). The apparent diffusion coefficient (ADC)-value was determined for each lesion detected in DWI. The histopathological report after resection or biopsy of a lesion served as the gold standard, and a surrogate of follow-up or complementary imaging techniques in combination with clinical and paraclinical parameters was used in unresected lesions. Diagnostic accuracy, sensitivity, specificity, and positive and negative predictive values were evaluated for each technique. Results: MRI detected slightly more lesions that were considered suspicious for HCC per patient compared to CT (2.7 versus 2.3, respectively). ADC-measurements in HCC showed notably heterogeneous values with a median of 1.2 +/- 0.5x10(-3) mm(2)/s (range from 0.07 +/- 0.1 to 3.0 +/- 0.1x10(-3) mm(2)/s). MRI showed similar diagnostic accuracy, sensitivity, and positive and negative predictive values compared to CT (AUC 0.837, sensitivity 92%, PPV 80% and NPV 90% for MRI vs. AUC 0.798, sensitivity 85%, PPV 79% and NPV 82% for CT; not significant). Specificity was 75% for both techniques. Conclusions: Our study did not show a statistically significant difference in detection in detection of HCC between MRI and CT. Gd-EOB-DTPA-enhanced MRI tended to detect more lesions per patient compared to contrast-enhanced CT; therefore, we would recommend this modality as the first-choice imaging method for the detection of HCC and therapeutic decisions. However, contrast-enhanced CT was not inferior in our study, so that it can be a useful image modality for follow-up examinations.	[Maiwald, Bettina; Lobsien, Donald; Kahn, Thomas; Stumpp, Patrick] Univ Leipzig, Dept Diagnost & Intervent Radiol, D-04109 Leipzig, Germany	Leipzig University	Maiwald, B (corresponding author), Univ Leipzig, Dept Diagnost & Intervent Radiol, D-04109 Leipzig, Germany.	bettina.maiwald@medizin.uni-leipzig.de			Bayer Vital, Leverkusen, Germany	Bayer Vital, Leverkusen, Germany(Bayer AG)	This work was supported by a research grant from Bayer Vital, Leverkusen, Germany. This was used to buy contrast media for the MRI-examination. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the author received specific funding for this work. www.bayerpharma.com.	Ahn SS, 2010, RADIOLOGY, V255, P459, DOI 10.1148/radiol.10091388; Akai H, 2011, EUR J RADIOL, V80, P310, DOI 10.1016/j.ejrad.2010.07.026; Bruegel M, 2008, EUR RADIOL, V18, P477, DOI 10.1007/s00330-007-0785-9; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Cauchy F, 2012, LANGENBECK ARCH SURG, V397, P681, DOI 10.1007/s00423-012-0911-2; Chan Rs, 2011, Biomed Imaging Interv J, V7, pe12, DOI 10.2349/biij.7.2.e12; Chiu FY, 2005, J COMPUT ASSIST TOMO, V29, P176, DOI 10.1097/01.rct.0000157472.98277.5c; Choi JS, 2010, EUR RADIOL, V20, P1052, DOI 10.1007/s00330-009-1651-8; Chung J, 2011, MAGN RESON IMAGING, V29, P1235, DOI 10.1016/j.mri.2011.07.025; CLEMENT O, 1992, INVEST RADIOL, V27, P612; Di Martino M, 2010, RADIOLOGY, V256, P806, DOI 10.1148/radiol.10091334; El-Serag HB, 2007, HEPATOL RES, V37, pS88, DOI 10.1111/j.1872-034X.2007.00168.x; Goshima S, 2008, J MAGN RESON IMAGING, V28, P691, DOI 10.1002/jmri.21467; HAMM B, 1995, RADIOLOGY, V195, P785, DOI 10.1148/radiology.195.3.7754011; Haradome H, 2011, J MAGN RESON IMAGING, V34, P69, DOI 10.1002/jmri.22588; Hollingsworth KG, 2006, NMR BIOMED, V19, P231, DOI 10.1002/nbm.1028; Holzapfel K, 2012, ABDOM IMAGING, V37, P74, DOI 10.1007/s00261-011-9758-1; Holzapfel K, 2010, EUR J RADIOL, V76, P89, DOI 10.1016/j.ejrad.2009.05.014; Huppertz A, 2005, RADIOLOGY, V234, P468, DOI 10.1148/radiol.2342040278; Huppertz A, 2004, RADIOLOGY, V230, P266, DOI 10.1148/radiol.2301020269; Kim MJ, 2006, AM J ROENTGENOL, V187, P198, DOI 10.2214/AJR.05.0257; Kim T, 1995, AM J ROENTGENOL, V173, P393; Kim YK, 2012, INVEST RADIOL, V47, P159, DOI 10.1097/RLI.0b013e31823a1495; Kim YK, 2009, J COMPUT ASSIST TOMO, V33, P844, DOI 10.1097/RCT.0b013e3181a7e3c7; Kinner S, 2012, EUR J RADIOL, V81, pE625, DOI 10.1016/j.ejrad.2011.12.042; Koike N, 2009, WORLD J GASTROENTERO, V15, P5805, DOI 10.3748/wjg.15.5805; Kudo M, 2007, ONCOLOGY-BASEL, V72, P2, DOI 10.1159/000111702; Kudo M, 2010, J GASTROEN HEPATOL, V25, P439, DOI 10.1111/j.1440-1746.2009.06207.x; Lee CH, 2012, EUR J RADIOL, V81, pE605, DOI 10.1016/j.ejrad.2011.12.033; Lee JH, 2012, BRIT J RADIOL, V85, pE573, DOI 10.1259/bjr/86767895; Llovet JM, 2005, J GASTROENTEROL, V40, P225, DOI 10.1007/s00535-005-1566-3; Low RN, 2007, LANCET ONCOL, V8, P525, DOI 10.1016/S1470-2045(07)70170-5; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Mazzaferro V, 2011, LIVER TRANSPLANT, V17, pS44, DOI 10.1002/lt.22365; MOTEKI T, 1995, JMRI-J MAGN RESON IM, V5, P187, DOI 10.1002/jmri.1880050214; Motosugi U, 2009, EUR RADIOL, V19, P2623, DOI 10.1007/s00330-009-1467-6; Nasu K, 2006, RADIOLOGY, V239, P122, DOI 10.1148/radiol.2383041384; Park MS, 2012, HEPATOLOGY, V56, P140, DOI 10.1002/hep.25681; Pitton MB, 2009, WORLD J GASTROENTERO, V15, P6044, DOI 10.3748/wjg.15.6044; Reimer P, 1996, RADIOLOGY, V199, P177, DOI 10.1148/radiology.199.1.8633143; Rempp H, 2011, ABDOM IMAGING, V36, P635, DOI 10.1007/s00261-011-9749-2; Sano K, 2011, RADIOLOGY, V261, P834, DOI 10.1148/radiol.11101840; SCHUHMANNGIAMPIERI G, 1992, RADIOLOGY, V183, P59, DOI 10.1148/radiology.183.1.1549695; Takahara T, 2012, J MAGN RESON IMAGING, V35, P1266, DOI 10.1002/jmri.22857; Tanimoto A, 2009, EUR RADIOL, V19, pS975, DOI 10.1007/s00330-009-1624-y; Tannapfel A, 2003, CHIR GASTROENTEROL, V19, P225, DOI 10.1159/000074007; Vandecaveye V, 2009, EUR RADIOL, V19, P2456, DOI 10.1007/s00330-009-1431-5; WEINMANN HJ, 1991, MAGNET RESON MED, V22, P233, DOI 10.1002/mrm.1910220214; Yu JS, 2011, MAGN RESON IMAGING, V29, P985, DOI 10.1016/j.mri.2011.04.010; Zech CJ, 2009, DIGEST DIS, V27, P114, DOI 10.1159/000218343	50	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111935	10.1371/journal.pone.0111935	http://dx.doi.org/10.1371/journal.pone.0111935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375778	Green Published, gold			2022-12-27	WOS:000344402600076
J	Patrick, WS; Cope, J				Patrick, Wesley S.; Cope, Jason			Examining the 10-Year Rebuilding Dilemma for US Fish Stocks	PLOS ONE			English	Article							FISHERIES MANAGEMENT; CLIMATE-CHANGE; RECOVERY; IMPACTS; RESTORATION; UNCERTAINTY; STRATEGIES; TARGETS; COD	Worldwide, fishery managers strive to maintain fish stocks at or above levels that produce maximum sustainable yields, and to rebuild overexploited stocks that can no longer support such yields. In the United States, rebuilding overexploited stocks is a contentious issue, where most stocks are mandated to rebuild in as short a time as possible, and in a time period not to exceed 10 years. Opponents of such mandates and related guidance argue that rebuilding requirements are arbitrary, and create discontinuities in the time and fishing effort allowed for stocks to rebuild due to differences in productivity. Proponents, however, highlight how these mandates and guidance were needed to curtail the continued overexploitation of these stocks by setting firm deadlines on rebuilding. Here we evaluate the statements made by opponents and proponents of the 10-year rebuilding mandate and related guidance to determine whether such points are technically accurate using a simple population dynamics model and a database of U.S. fish stocks to parameterize the model. We also offer solutions to many of the issues surrounding this mandate and its implementation by recommending some fishing mortality based frameworks, which meet the intent of the 10-year rebuilding requirement while also providing more flexibility.	[Patrick, Wesley S.] Natl Marine Fisheries Serv, Off Sustainable Fisheries, Silver Spring, MD 20910 USA; [Cope, Jason] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Seattle, WA 98112 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Patrick, WS (corresponding author), Natl Marine Fisheries Serv, Off Sustainable Fisheries, Silver Spring, MD 20910 USA.	Wesley.Patrick@noaa.gov						[Anonymous], 1989, FED REGISTER, V54, P30826; [Anonymous], [No title captured]; Bell JD, 2006, FISH RES, V80, P1, DOI 10.1016/j.fishres.2006.03.008; Berkson J., 2011, NMFSSEFSC616 NOAA; Brodziak J, 2005, CAN J FISH AQUAT SCI, V62, P544, DOI 10.1139/F04-199; Caddy JF, 2001, OCEAN COAST MANAGE, V44, P653, DOI 10.1016/S0964-5691(01)00074-6; Cadrin SX, 1997, FISH B-NOAA, V95, P445; Carmichael J., 2011, NAT SSC WORKSH ABC C; Caswell, 2000, MATRIX POPULATION MO; Clark CW, 2005, J ENVIRON ECON MANAG, V50, P47, DOI 10.1016/j.jeem.2004.11.002; Collie J, 2013, ECOL APPL, V23, P374, DOI 10.1890/12-0877.1; Costello C, 2012, SCIENCE, V338, P517, DOI 10.1126/science.1223389; Curtis R., 2007, FISHERIES BUYBACKS; Federal Register, 1998, FED REGISTER, V63, P24212; FishBase, 2013, EST LIF HIST KEY FAC; Guenette S, 2000, B MAR SCI, V66, P831; Hasselman DJ, 2012, MAR COAST FISH, V4, P174, DOI 10.1080/19425120.2012.675968; Hilborn R, 2012, CONSERV BIOL, V26, DOI 10.1111/j.1523-1739.2011.01800.x; Hollowed AB, 2011, ICES J MAR SCI, V68, P984, DOI 10.1093/icesjms/fsr085; Hsieh CH, 2005, NATURE, V435, P336, DOI 10.1038/nature03553; Jacob S, 2009, FISHERIES, V34, P228, DOI 10.1577/1548-8446-34.5.228; Jacobson LD, 2002, FISH B-NOAA, V100, P519; Jensen OP, 2012, THEOR ECOL-NETH, V5, P3, DOI 10.1007/s12080-011-0146-9; Kasperski S, 2013, P NATL ACAD SCI USA, V110, P2076, DOI 10.1073/pnas.1212278110; Lande Russell, 2001, Conservation Biology Series (Cambridge), V6, P67; Longhurst AR., 2010, MISMANAGEMENT MARINE; MACE PM, 1994, CAN J FISH AQUAT SCI, V51, P110, DOI 10.1139/f94-013; Methot RD, 2014, ICES J MAR SCI, V71, P183, DOI 10.1093/icesjms/fst119; Milazzo MJ, 2012, REV FISH BIOL FISHER, V22, P273, DOI 10.1007/s11160-011-9219-5; Murawski SA, 2010, ICES J MAR SCI, V67, P1830, DOI 10.1093/icesjms/fsq125; Myers RA, 1999, CAN J FISH AQUAT SCI, V56, P2404, DOI 10.1139/cjfas-56-12-2404; Myers RA, 1997, FISH B-NOAA, V95, P762; Neubauer P, 2013, SCIENCE, V340, P347, DOI 10.1126/science.1230441; New Zealand Ministry of Fisheries, 2014, OP GUID NZ HARV STRA; NMFS (National Marine Fisheries Service), 2013, STAT US FISH; NRC (National Research Council), 2013, EV EFF FISH STOCK RE; Pacific Fishery Management Council, 2012, TERMS REF GROUNDF CO; Patrick WS, 2013, OCEAN COAST MANAGE, V71, P64, DOI 10.1016/j.ocecoaman.2012.11.002; Patrick WS, 2013, MAR POLICY, V38, P470, DOI 10.1016/j.marpol.2012.07.007; Pauly D, 2007, AMBIO, V36, P290, DOI 10.1579/0044-7447(2007)36[290:TSAUPD]2.0.CO;2; Punt AE, 2003, FISH B-NOAA, V101, P860; Punt AE, 2012, FISH RES, V134, P113, DOI 10.1016/j.fishres.2012.08.014; Punt AE, 2011, FISH RES, V109, P320, DOI 10.1016/j.fishres.2011.02.019; Ralston S, 2011, FISH B-NOAA, V109, P217; Restrepo V.R., 1998, NOAA TECHNICAL MEMOR, V56; Restrepo VR, 1999, ICES J MAR SCI, V56, P846, DOI 10.1006/jmsc.1999.0546; Rosenberg AA, 2006, FRONT ECOL ENVIRON, V4, P303, DOI 10.1890/1540-9295(2006)4[303:RUFPAP]2.0.CO;2; Safina C, 2005, SCIENCE, V309, P707, DOI 10.1126/science.1113725; Sewell B, 2013, R1301A NAT RES DEF C; Smith T. D., 1994, SCALING FISHERIES SC; Stewart I.J., 2009, REBUILDING ANAL CANA; Thompson Grant G., 1993, Canadian Special Publication of Fisheries and Aquatic Sciences, V120, P303; Thorson JT, 2014, ECOL APPL, V24, P217, DOI 10.1890/12-1855.1; Williams RN, 1999, FISHERIES, V24, P10, DOI 10.1577/1548-8446(1999)024<0010:RTTRSI>2.0.CO;2; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	55	9	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112232	10.1371/journal.pone.0112232	http://dx.doi.org/10.1371/journal.pone.0112232			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375788	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600122
J	Peng, DM; Wang, XJ; Zhao, CY; Wu, XR; Jiang, FQ; Chen, PX				Peng, Dongmei; Wang, Xiujun; Zhao, Chenyi; Wu, Xingren; Jiang, Fengqing; Chen, Pengxiang			Characterizing Air Temperature Changes in the Tarim Basin over 1960-2012	PLOS ONE			English	Article							DETRENDED FLUCTUATION ANALYSIS; CLIMATE-CHANGE; RIVER-BASIN; WATER-RESOURCES; NORTHWEST CHINA; TRENDS; SURFACE; XINJIANG; PRECIPITATION; VARIABILITY	There has been evidence of warming rate varying largely over space and between seasons. However, little has been done to evaluate the spatial and temporal variability of air temperature in the Tarim Basin, northwest China. In this study, we collected daily air temperature from 19 meteorological stations for the period of 1960-2012, and analyzed annual mean temperature (AMT), the annual minimum (T-min) and maximum temperature (T-max), and mean temperatures of all twelve months and four seasons and their anomalies. Trend analyses, standard deviation of the detrended anomaly (SDDA) and correlations were carried out to characterize the spatial and temporal variability of various mean air temperatures. Our data showed that increasing trend was much greater in the T-min (0.55 degrees C/10a) than in the AMT (0.25 degrees C/10a) and T-max (0.12 degrees C/10a), and the fluctuation followed the same order. There were large spatial variations in the increasing trends of both AMT (from -0.09 to 0.43 degrees C/10a) and T-min (from 0.15 to 1.12 degrees C/10a). Correlation analyses indicated that AMT had a significantly linear relationship with T-min and the mean temperatures of four seasons. There were also pronounced changes in the monthly air temperature from November to March at decadal time scale. The seasonality (i.e., summer and winter difference) of air temperature was stronger during the period of 1960-1979 than over the recent three decades. Our preliminary analyses indicated that local environmental conditions (such as elevation) might be partly responsible for the spatial variability, and large scale climate phenomena might have influences on the temporal variability of air temperature in the Tarim Basin. In particular, there was a significant correlation between index of El Nino-Southern Oscillation (ENSO) and air temperature of May (P = 0.004), and between the index of Pacific Decadal Oscillation (PDO) and air temperature of July (P = 0.026) over the interannual to decadal time scales.	[Peng, Dongmei; Wang, Xiujun; Zhao, Chenyi; Jiang, Fengqing] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Xinjiang, Peoples R China; [Peng, Dongmei] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Wang, Xiujun] Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA; [Wu, Xingren] Natl Ocean & Atmospher Adm, Natl Ctr Environm Predict, IM Syst Grp, College Pk, MD USA; [Wu, Xingren] Natl Ocean & Atmospher Adm, Natl Ctr Environm Predict, Environm Modeling Ctr, College Pk, MD USA; [Chen, Pengxiang] Xinjiang Meteorol Observ, Urumqi, Xinjiang, Peoples R China; [Peng, Dongmei] Informat Ctr Xinjiang Xingnong Net, Urumqi, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University System of Maryland; University of Maryland College Park; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Wang, XJ (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Xinjiang, Peoples R China.	wwang@essic.umd.edu	Wang, Xiujun/F-2641-2010	Wang, Xiujun/0000-0002-2859-8011	Chinese National Basic Research Key Project [2010cb951001]; National Natural Science Foundation [41171095]; National Science & Technology Pillar Program [2013BAC10B01]	Chinese National Basic Research Key Project; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Science & Technology Pillar Program	This research was supported by the Chinese National Basic Research Key Project (No. 2010cb951001), National Natural Science Foundation (No. 41171095), and National Science & Technology Pillar Program (No. 2013BAC10B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Brown SJ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2006JD008091; Chen SY, 2010, J ARID LAND, V2, P87, DOI 10.3724/SP.J.1227.2010.00087; [陈亚宁 CHEN Ya ning], 2008, [冰川冻土, Journal of Glaciology and Geocryology], V30, P921; Chen YN, 2007, J ENVIRON SCI-CHINA, V19, P488, DOI 10.1016/S1001-0742(07)60082-5; Chen YN, 2009, QUATERN INT, V208, P53, DOI 10.1016/j.quaint.2008.11.011; Ding YH, 2007, ADV ATMOS SCI, V24, P954, DOI 10.1007/s00376-007-0954-4; Hansen J, 2002, SCIENCE, V295, P275; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; Hao XM, 2008, WATER RESOUR MANAG, V22, P1159, DOI 10.1007/s11269-007-9218-4; Holmes JA, 2009, QUATERN INT, V194, P91, DOI 10.1016/j.quaint.2007.10.013; Hu ZZ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003651; Jones PD, 2003, J CLIMATE, V16, P206, DOI 10.1175/1520-0442(2003)016<0206:HALSSA>2.0.CO;2; Jones PD, 1999, REV GEOPHYS, V37, P173, DOI 10.1029/1999RG900002; KARL TR, 1993, B AM METEOROL SOC, V74, P1007, DOI 10.1175/1520-0477(1993)074<1007:ANPORG>2.0.CO;2; Kiraly A, 2005, METEOROL ATMOS PHYS, V88, P119, DOI 10.1007/s00703-004-0078-7; Li B, 2012, J GEOPHYS RES-ATMOS, P117; Li B, 2012, THEORETICAL APPL CLI, P1; Li BF, 2013, FRESEN ENVIRON BULL, V22, P362; Li QH, 2011, J GEOGR SCI, V21, P1007, DOI 10.1007/s11442-011-0896-8; Li Z, 2009, ATMOS OCEAN SCI LETT, V2, P237, DOI 10.1080/16742834.2009.11446802; Liu BH, 2004, J CLIMATE, V17, P4453, DOI 10.1175/3230.1; Liu XD, 2009, GLOBAL PLANET CHANGE, V68, P164, DOI 10.1016/j.gloplacha.2009.03.017; Liu Z, 2007, J CHINA HYDROLOGY, V5; Luterbacher J, 2004, SCIENCE, V303, P1499, DOI 10.1126/science.1093877; Pepin N, 2002, INT J CLIMATOL, V22, P311, DOI 10.1002/joc.740; Pepin NC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034026; Pepin NC, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005047; Qian W, 2006, METEOROL ATMOS PHYS, V93, P1, DOI 10.1007/s00703-005-0163-6; [任国玉 REN GuoYu], 2005, [气候与环境研究, Climatic and environmental research], V10, P717; Solomon S., 2007, PHYS SCI BASIS WORKI; Tabari H, 2011, GLOBAL PLANET CHANGE, V79, P1, DOI 10.1016/j.gloplacha.2011.07.008; Talkner P, 2000, PHYS REV E, V62, P150, DOI 10.1103/PhysRevE.62.150; Tao H, 2011, J HYDROL, V400, P1, DOI 10.1016/j.jhydrol.2011.01.016; Turkes M, 2004, THEOR APPL CLIMATOL, V77, P195, DOI 10.1007/s00704-003-0024-5; Vuille M, 2000, GEOPHYS RES LETT, V27, P3885, DOI 10.1029/2000GL011871; Wang GY, 2010, ENVIRON EARTH SCI, V59, P1759, DOI 10.1007/s12665-009-0158-6; Wang J, 2008, J DESERT RES, V4, P723; Wang SW, 2004, ADV ATMOS SCI, V21, P307, DOI 10.1007/BF02915560; Wang SW, 2000, GEOPHYS RES LETT, V27, P2581, DOI 10.1029/1999GL010825; Wei F., 2008, ADV CLIM CHANG RES, V4, P8; Woo SH, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016929; Wu SH, 2007, J GEOGR SCI, V17, P141, DOI 10.1007/s11442-007-0141-7; Xu CC, 2008, ENVIRON GEOL, V53, P1465, DOI 10.1007/s00254-007-0755-1; Xu JH, 2010, HYDROL PROCESS, V24, P136, DOI 10.1002/hyp.7484; Xu JH, 2009, CHINESE GEOGR SCI, V19, P306, DOI 10.1007/s11769-009-0306-7; Xu ZX, 2010, J ARID ENVIRON, V74, P256, DOI 10.1016/j.jaridenv.2009.08.014; Xu ZX, 2004, WATER RESOUR MANAG, V18, P439, DOI 10.1023/B:WARM.0000049142.95583.98; You QL, 2011, CLIM DYNAM, V36, P2399, DOI 10.1007/s00382-009-0735-0; Zhang J., 2002, RES XINJIANG CLIMATE; Zhang Y, 2012, NAT HAZARD EARTH SYS, V12, P1327, DOI 10.5194/nhess-12-1327-2012; Zhao P, 2011, J CLIMATE, V24, P4793, DOI 10.1175/JCLI-D-11-00054.1; Zhou HC, 2011, ELECTRON J QUAL THEO, P1	53	7	7	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e112231	10.1371/journal.pone.0112231	http://dx.doi.org/10.1371/journal.pone.0112231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375648	gold, Green Published, Green Submitted			2022-12-27	WOS:000344402600121
J	Chrastil, ER; Warren, WH				Chrastil, Elizabeth R.; Warren, William H.			From Cognitive Maps to Cognitive Graphs	PLOS ONE			English	Article							TRAVERSED DISTANCE; PATH-INTEGRATION; SPATIAL ABILITY; CAUDATE-NUCLEUS; MEMORY; NAVIGATION; HUMANS; SYSTEMS; ENVIRONMENT; HIPPOCAMPUS	We investigate the structure of spatial knowledge that spontaneously develops during free exploration of a novel environment. We present evidence that this structure is similar to a labeled graph: a network of topological connections between places, labeled with local metric information. In contrast to route knowledge, we find that the most frequent routes and detours to target locations had not been traveled during learning. Contrary to purely topological knowledge, participants typically traveled the shortest metric distance to a target, rather than topologically equivalent but longer paths. The results are consistent with the proposal that people learn a labeled graph of their environment.	[Chrastil, Elizabeth R.; Warren, William H.] Brown Univ, Providence, RI 02912 USA; [Chrastil, Elizabeth R.] Boston Univ, Ctr Memory & Brain, Dept Psychol & Brain Sci, Boston, MA 02215 USA	Brown University; Boston University	Chrastil, ER (corresponding author), Brown Univ, Providence, RI 02912 USA.	chrastil@bu.edu	Warren, William H./AAX-7781-2021	Chrastil, Elizabeth/0000-0003-2544-0152	National Science Foundation [BCS-0843940]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation award BCS-0843940 (nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIRD JC, 1982, GEOGR ANAL, V14, P204; Bohbot VD, 2002, PHYSIOL RES, V51, pS49; BYRNE RW, 1979, Q J EXP PSYCHOL, V31, P147, DOI 10.1080/14640747908400714; CADWALLADER M, 1979, ENVIRON BEHAV, V11, P559, DOI 10.1177/0013916579114007; CHOWN E, 1995, COGNITIVE SCI, V19, P1, DOI 10.1207/s15516709cog1901_1; Chrastil ER, 2013, J EXP PSYCHOL LEARN, V39, P1520, DOI 10.1037/a0032382; Foo P, 2005, J EXP PSYCHOL LEARN, V31, P195, DOI 10.1037/0278-7393.31.2.195; Foo P, 2007, PSYCHOL RES-PSYCH FO, V71, P240, DOI 10.1007/s00426-006-0080-4; Gallistel C. R., 1990, ORG LEARNING; Hartley T, 2003, NEURON, V37, P877, DOI 10.1016/S0896-6273(03)00095-3; Hegarty M, 2002, INTELLIGENCE, V30, P425, DOI 10.1016/S0160-2896(02)00116-2; HIRTLE SC, 1985, MEM COGNITION, V13, P208, DOI 10.3758/BF03197683; Iaria G, 2003, J NEUROSCI, V23, P5945; KOSSLYN SM, 1974, CHILD DEV, V45, P707, DOI 10.2307/1127837; Kozhevnikov M, 2001, MEM COGNITION, V29, P745, DOI 10.3758/BF03200477; Kubie JL, 2009, HIPPOCAMPUS, V19, P456, DOI 10.1002/hipo.20532; Kuipers B, 2003, ENVIRON BEHAV, V35, P81, DOI 10.1177/0013916502238866; Mallot HA, 2009, IMAGE VISION COMPUT, V27, P1658, DOI 10.1016/j.imavis.2008.09.001; McNamara TP, 1997, COGNITIVE PSYCHOL, V34, P160, DOI 10.1006/cogp.1997.0669; MCNAMARA TP, 1986, COGNITIVE PSYCHOL, V18, P87, DOI 10.1016/0010-0285(86)90016-2; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Meilinger T, 2008, LECT NOTES ARTIF INT, V5248, P344, DOI 10.1007/978-3-540-87601-4_25; MONEY JOHN, 1966, J MED GENET, V3, P47, DOI 10.1136/jmg.3.1.47; Packard MG, 1996, NEUROBIOL LEARN MEM, V65, P65, DOI 10.1006/nlme.1996.0007; Richardson AR, 2007, HUM FACTORS, V49, P507, DOI 10.1518/001872007X200139; SADALLA EK, 1980, ENVIRON BEHAV, V12, P65, DOI 10.1177/0013916580121005; SADALLA EK, 1980, ENVIRON BEHAV, V12, P167, DOI 10.1177/0013916580122003; Shelton AL, 2001, COGNITIVE PSYCHOL, V43, P274, DOI 10.1006/cogp.2001.0758; Thrun S., 2008, ROBOTICS COGNITIVE A; Trullier O, 1997, PROG NEUROBIOL, V51, P483, DOI 10.1016/S0301-0082(96)00060-3; Tutte W.T., 1984, GRAPH THEORY; TVERSKY B, 1981, COGNITIVE PSYCHOL, V13, P407, DOI 10.1016/0010-0285(81)90016-5; Tversky B, 1993, LECT NOTES COMPUTER, V716, P14; Wagner M, 2008, COGN STUD, V15, P6; Werner S, 2000, LECT NOTES ARTIF INT, V1849, P295; Wolbers T, 2010, TRENDS COGN SCI, V14, P138, DOI 10.1016/j.tics.2010.01.001; Zacks J. M., 2000, Spatial Cognition and Computation, V2, P315, DOI 10.1023/A:1015584100204	37	65	65	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112544	10.1371/journal.pone.0112544	http://dx.doi.org/10.1371/journal.pone.0112544			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CP	25389769	Green Published, gold			2022-12-27	WOS:000349144400095
J	Berman, Y; Shapira, Y; Ben-Jacob, E				Berman, Yonatan; Shapira, Yoash; Ben-Jacob, Eshel			Unraveling Hidden Order in the Dynamics of Developed and Emerging Markets	PLOS ONE			English	Article							PRICES; EFFICIENCY; MODEL; TIME	The characterization of asset price returns is an important subject in modern finance. Traditionally, the dynamics of stock returns are assumed to lack any temporal order. Here we present an analysis of the autocovariance of stock market indices and unravel temporal order in several major stock markets. We also demonstrate a fundamental difference between developed and emerging markets in the past decade - emerging markets are marked by positive order in contrast to developed markets whose dynamics are marked by weakly negative order. In addition, the reaction to financial crises was found to be reversed among developed and emerging markets, presenting large positive/negative autocovariance spikes following the onset of these crises. Notably, the Chinese market shows neutral or no order while being regarded as an emerging market. These findings show that despite the coupling between international markets and global trading, major differences exist between different markets, and demonstrate that the autocovariance of markets is correlated with their stability, as well as with their state of development.	[Berman, Yonatan; Shapira, Yoash; Ben-Jacob, Eshel] Tel Aviv Univ, Raymond & Beverly Sackler Fac Exact Sci, Sch Phys & Astron, IL-69978 Tel Aviv, Israel	Tel Aviv University	Ben-Jacob, E (corresponding author), Tel Aviv Univ, Raymond & Beverly Sackler Fac Exact Sci, Sch Phys & Astron, IL-69978 Tel Aviv, Israel.	eshelbj@gmail.com		Berman, Yonatan/0000-0001-6969-271X	Tauber Family Foundation; Maguy-Glass Chair in Physics of Complex System at the Tel-Aviv University	Tauber Family Foundation; Maguy-Glass Chair in Physics of Complex System at the Tel-Aviv University	This research has been supported in part by the Tauber Family Foundation (http://www.tauberfoundation.org) - EBJ - and the Maguy-Glass Chair in Physics of Complex System at the Tel-Aviv University - YB, EBJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou A., 1997, APPL FINANC EC, V7, P361, DOI [DOI 10.1080/096031097333475, 10.1080/096031097333475]; Bekaert G., 2002, EMERG MARK REV, V3, P429, DOI DOI 10.1016/S1566-0141(02)00045-6; Bikhchandani S, 2001, IMF STAFF PAPERS, V47, P279; BLACK F, 1973, J POLIT ECON, V81, P637, DOI 10.1086/260062; Blitz D, 2012, EMERG MARK REV, V13, P149, DOI 10.1016/j.ememar.2012.01.004; BOLLERSLEV T, 1988, J POLIT ECON, V96, P116, DOI 10.1086/261527; Bradley JV., 1968, DISTRIBUTION FREE ST; CAMPBELL JY, 1988, J FINANC, V43, P661, DOI 10.2307/2328190; Chaboud A, 2013, J FINANCE IN PRESS; Colander D, 2009, CRIT REV, V21, P249, DOI 10.1080/08913810902934109; Cont R, 2013, MATH FINANC, V23, P718, DOI 10.1111/j.1467-9965.2011.00510.x; ENGLE RF, 1982, ECONOMETRICA, V50, P987, DOI 10.2307/1912773; FAMA EF, 1970, J FINANC, V25, P383, DOI 10.2307/2325486; Filimonov V, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.056108; Griffin JM, 2010, REV FINANC STUD, V23, P3225, DOI 10.1093/rfs/hhq044; HARVEY CR, 1995, REV FINANC STUD, V8, P773, DOI 10.1093/rfs/8.3.773; Hendershott T, 2011, J FINANC, V66, P1, DOI 10.1111/j.1540-6261.2010.01624.x; Hoskisson RE, 2000, ACAD MANAGE J, V43, P249, DOI 10.2307/1556394; Huang BN, 1995, APPL FINAN EC, V5, P251, DOI DOI 10.1080/758536875; Johansen A, 1999, CONDMAT9907270 ARXIV; Jung WS, 2008, PHYSICA A, V387, P537, DOI 10.1016/j.physa.2007.09.022; Kedia BL, 2006, NEW HORIZ INT BUS, P46; Kenett DY, 2013, SCI REP-UK, V3, DOI 10.1038/srep02110; Kenett DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031144; Lane PR, 2012, J ECON PERSPECT, V26, P49, DOI 10.1257/jep.26.3.49; Lemperiere Y, 2014, ARXIVEPRINTS14043274; Levy H., 2000, MICROSCOPIC SIMULATI; Levy M, 1997, PHYSICA A, V242, P90, DOI 10.1016/S0378-4371(97)00217-3; Lim KP, 2011, J ECON SURV, V25, P69, DOI 10.1111/j.1467-6419.2009.00611.x; Lo AW, 1988, REV FINANC STUD, V1, P41, DOI 10.1093/rfs/1.1.41; Lo AW, 2011, WALL STREET; Lux T, 1999, NATURE, V397, P498, DOI 10.1038/17290; Lux T, 2009, HANDB FINANC, P161, DOI 10.1016/B978-012374258-2.50007-5; Lux T, 2009, NAT PHYS, V5, P2, DOI 10.1038/nphys1163; Malkiel B. G., 2007, RANDOM WALK WALL STR; MANTEGNA RN, 1994, PHYS REV LETT, V73, P2946, DOI 10.1103/PhysRevLett.73.2946; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; Morck R, 2000, J FINANC ECON, V58, P215, DOI 10.1016/S0304-405X(00)00071-4; Plerou V, 2001, QUANT FINANC, V1, P262, DOI 10.1088/1469-7688/1/2/308; Preis T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00752; Preis T, 2011, PHYS WORLD, V24, P29; Preis T, 2011, P NATL ACAD SCI USA, V108, P7674, DOI 10.1073/pnas.1019484108; Shapira Y, 2011, AIP ADV, V1, DOI 10.1063/1.3598412; Shapira Y, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/5/053040; SHARPE WF, 1964, J FINANC, V19, P425, DOI 10.2307/2977928; Shiller R., 2008, SUBPRIME SOLUTION; Sizemore C, 2013, FORBES; Song DM, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.026108; Sornette D, 2003, PHYS REP, V378, P1, DOI 10.1016/S0370-1573(02)00634-8; Sornette D., 2010, BRUSSELS EC REV CAHI, V53, P201; Sornette D, 2009, WHY STOCK MARKETS CR; Sornette D, 2010, ECONOPHYSICS APPROACHES TO LARGE-SCALE BUSINESS DATA AND FINANCIAL CRISIS, P101, DOI 10.1007/978-4-431-53853-0_6; Tarasov A, 2012, J INT ECON, V86, P284, DOI 10.1016/j.jinteco.2011.10.006; The World Bank, 2014, GDP GROWTH ANN; Tsekov R, 2013, CHINESE PHYS LETT, V30, DOI 10.1088/0256-307X/30/8/088901; Urrutia J.L., 1995, J FINANC RES, V18, P299, DOI DOI 10.1111/J.1475-6803.1995.TB00568.X; Yu L, 2005, BASKET SECURITIES PR; Zunino L, 2010, PHYSICA A, V389, P1891, DOI 10.1016/j.physa.2010.01.007	58	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112427	10.1371/journal.pone.0112427	http://dx.doi.org/10.1371/journal.pone.0112427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT3DP	25383630	Green Published, gold, Green Submitted			2022-12-27	WOS:000344816700061
J	Berthet, N; Falguieres, M; Filippone, C; Bertolus, C; Bole-Feysot, C; Brisse, S; Gessain, A; Heard, I; Favre, M				Berthet, Nicolas; Falguieres, Michael; Filippone, Claudia; Bertolus, Chloe; Bole-Feysot, Christine; Brisse, Sylvain; Gessain, Antoine; Heard, Isabelle; Favre, Michel			Resequencing Microarray Technology for Genotyping Human Papillomavirus in Cervical Smears	PLOS ONE			English	Article							DNA MICROARRAYS; VIRUSES; CANCER; DESIGN	There are more than 40 human papillomaviruses (HPVs) belonging to the alpha genus that cause sexually transmitted infections; these infections are among the most frequent and can lead to condylomas and anogenital intra-epithelial neoplasia. At least 18 of these viruses are causative agents of anogenital carcinomas. We evaluated the performance of a resequencing microarray for the detection and genotyping of alpha HPV of clinical significance using cloned HPV DNA. To reduce the number of HPV genotypes tiled on microarray, we used reconstructed ancestral sequences (RASs) as they are more closely related to the various genotypes than the current genotypes are among themselves. The performance of this approach was tested by genotyping with a set of 40 cervical smears already genotyped using the commercial PapilloCheck kit. The results of the two tests were concordant for 70% (28/40) of the samples and compatible for 30% (12/40). Our findings indicate that RASs were able to detect and identify one or several HPV in clinical samples. Associating RASs with homonym sequences improved the genotyping of HPV present in cases of multiple infection. In conclusion, we demonstrate the diagnostic potential of resequencing technology for genotyping of HPV, and illustrate its value both for epidemiological studies and for monitoring the distribution of HPV in the post-vaccination era.	[Berthet, Nicolas; Filippone, Claudia; Gessain, Antoine] Inst Pasteur, F-75724 Paris 15, France; [Berthet, Nicolas; Filippone, Claudia; Gessain, Antoine] CNRS, UMR 3569, F-75724 Paris 15, France; [Falguieres, Michael; Heard, Isabelle; Favre, Michel] Inst Pasteur, Ctr Natl Reference Papillomavirus, F-75724 Paris 15, France; [Bertolus, Chloe] Hop La Pitie Salpetriere, AP HP, Serv Chirurg Maxillofaciale & Stomatol, F-75013 Paris, France; [Bertolus, Chloe] Univ Paris 06, CIMI Paris, UMRS CR7, INSERM U1135, F-75005 Paris, France; [Bole-Feysot, Christine] Hop Necker Enfants Malad, Inst Malad Genet Plateforme Genom, F-75743 Paris 15, France; [Brisse, Sylvain] Inst Pasteur, Plate Forme Genotypage Pathogenes & Sante Publ, F-75724 Paris 15, France; [Heard, Isabelle] Univ Paris 06, Grp Hosp Pitie Salpetriere, Paris 13, France; [Favre, Michel] Inst Pasteur, Unite Genet Papillomavirus & Canc Humain, F-75724 Paris 15, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Berthet, N (corresponding author), CIRMF, Dept Zoonose & Malad Emergentes, BP769, Franceville, Gabon.	nicolas.berthet@ird.fr	Brisse, Sylvain/M-8723-2013; Berthet, Nicolas/J-9373-2012	Brisse, Sylvain/0000-0002-2516-2108; 	Programme Transversal de Recherche DEVA - Institut Pasteur (Paris, France) [246]; Fondation Total-Institut Pasteur; Academie Nationale de Medecine; French Institut National du Cancer [2011-1VADS 03-IP1]	Programme Transversal de Recherche DEVA - Institut Pasteur (Paris, France); Fondation Total-Institut Pasteur; Academie Nationale de Medecine; French Institut National du Cancer(Institut National du Cancer (INCA) France)	This program was supported by the Programme Transversal de Recherche DEVA No. 246 financed by the Institut Pasteur (Paris, France), sponsored by the Fondation Total-Institut Pasteur and the Elisabeth Taub award from the Academie Nationale de Medecine. This study was funded by the French Institut National du Cancer (Canceropole 2011-1VADS 03-IP1). The funders had no role in study design, data analysis or preparation of the manuscript.	Albrecht V, 2006, J VIROL METHODS, V137, P236, DOI 10.1016/j.jviromet.2006.06.023; Berthet N, 2012, J CLIN VIROL; Berthet N, 2008, MICROB BIOTECHNOL, V1, P79, DOI 10.1111/j.1751-7915.2007.00012.x; Berthet N, 2011, LANCET, V378, P1354, DOI 10.1016/S0140-6736(11)61142-2; Berthet N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015243; Berthet N, 2010, NAT BIOTECHNOL, V28, P25, DOI 10.1038/nbt0110-25; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Chen ZG, 2007, VIROLOGY, V360, P447, DOI 10.1016/j.virol.2006.10.022; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Dacheux L, 2010, J VIROL, V84, P9557, DOI 10.1128/JVI.00771-10; de Villiers EM, 2013, VIROLOGY, V445, P2, DOI 10.1016/j.virol.2013.04.023; Filippone C, 2012, CLIN MICROBIOLOGY IN; Heard I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079372; Leclercq I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-586; Lin ZH, 2005, PATHOL INT, V55, P491, DOI 10.1111/j.1440-1827.2005.01858.x; Mendoza JA, 2006, J VIROL, V80, P12420, DOI 10.1128/JVI.02576-05; Mighty KK, 2014, RECENT RESULTS CANC, V193, P135, DOI 10.1007/978-3-642-38965-8_8; Saslow D, 2012, AM J CLIN PATHOL, V137, P516, DOI [10.1309/AJCPTGD94EVRSJCG, 10.3322/caac.21139]; Schmitz M, 2009, J CLIN VIROL, V44, P302, DOI 10.1016/j.jcv.2009.01.006; Wang Z, 2006, EMERG INFECT DIS, V12, P638, DOI 10.3201/eid1204.051441; Wang Z, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-577; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	22	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e109301	10.1371/journal.pone.0109301	http://dx.doi.org/10.1371/journal.pone.0109301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383888	Green Published, gold, Green Submitted			2022-12-27	WOS:000344816700003
J	Blonder, B; Sloat, L; Enquist, BJ; McGill, B				Blonder, Benjamin; Sloat, Lindsey; Enquist, Brian J.; McGill, Brian			Separating Macroecological Pattern and Process: Comparing Ecological, Economic, and Geological Systems	PLOS ONE			English	Article							UNIVERSAL SPECIES-AREA; ABUNDANCE DISTRIBUTIONS; COMMUNITY STRUCTURE; STOCHASTIC-THEORY; TROPICAL FORESTS; BETA-DIVERSITY; BIODIVERSITY; MODELS; SCALES; GROWTH	Theories of biodiversity rest on several macroecological patterns describing the relationship between species abundance and diversity. A central problem is that all theories make similar predictions for these patterns despite disparate assumptions. A troubling implication is that these patterns may not reflect anything unique about organizational principles of biology or the functioning of ecological systems. To test this, we analyze five datasets from ecological, economic, and geological systems that describe the distribution of objects across categories in the United States. At the level of functional form ('first-order effects'), these patterns are not unique to ecological systems, indicating they may reveal little about biological process. However, we show that mechanism can be better revealed in the scale-dependency of first-order patterns ('second-order effects'). These results provide a roadmap for biodiversity theory to move beyond traditional patterns, and also suggest ways in which macroecological theory can constrain the dynamics of economic systems.	[Blonder, Benjamin] Univ Arizona, Sky Sch, Tucson, AZ 85721 USA; [Sloat, Lindsey; Enquist, Brian J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Enquist, Brian J.] Santa Fe Inst, Santa Fe, NM 87501 USA; [McGill, Brian] Univ Maine, Sch Biol & Ecol, Orono, ME USA	University of Arizona; University of Arizona; The Santa Fe Institute; University of Maine System; University of Maine Orono	Blonder, B (corresponding author), Univ Arizona, Sky Sch, Tucson, AZ 85721 USA.	bblonder@gmail.com	Enquist, Brian J/B-6436-2008; McGill, Brian J/A-3476-2008	Enquist, Brian J/0000-0002-6124-7096; McGill, Brian J/0000-0002-0850-1913; Sloat, Lindsey/0000-0002-2986-9725	National Science Foundation [EPS-0904155]; National Center for Ecological Analysis and Synthesis	National Science Foundation(National Science Foundation (NSF)); National Center for Ecological Analysis and Synthesis	BB was supported by a National Science Foundation pre-doctoral fellowship. LS was supported by the National Center for Ecological Analysis and Synthesis. BJE was supported by a National Science Foundation Advancing Theory in Biology grant. BJM was funded by a National Science Foundation Experimental Program to Stimulate Competitive Research grant EPS-0904155 at the University of Maine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 2001, ECOL LETT, V4, P1, DOI 10.1046/j.1461-0248.2001.00194.x; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Brown JH, 2011, BIOSCIENCE, V61, P19, DOI 10.1525/bio.2011.61.1.7; Chave J, 2002, AM NAT, V159, P1, DOI 10.1086/324112; Chave J, 2002, THEOR POPUL BIOL, V62, P153, DOI 10.1006/tpbi.2002.1597; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Decker EH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000934; GASTON KJ, 1993, OIKOS, V66, P172, DOI 10.2307/3545211; GAUCH HG, 1972, ECOLOGY, V53, P446, DOI 10.2307/1934231; Haldane AG, 2011, NATURE, V469, DOI 10.1038/nature09659; Harte J, 2008, ECOLOGY, V89, P2700, DOI 10.1890/07-1369.1; Harte J, 2013, AM NAT, V181, P282, DOI 10.1086/668821; Harte J, 2009, ECOL LETT, V12, P789, DOI 10.1111/j.1461-0248.2009.01328.x; He FL, 2000, AM NAT, V156, P553, DOI 10.1086/303403; Holyoak M, 2006, ECOLOGY, V87, P1370, DOI 10.1890/0012-9658(2006)87[1370:REEWNC]2.0.CO;2; Hubbell Stephen P., 2001, V32, pi; MACARTHUR R, 1960, AM NAT, V94, P25, DOI 10.1086/282106; MacArthur R. H., 1969, Biological Journal of the Linnean Society, V1, P19, DOI 10.1111/j.1095-8312.1969.tb01809.x; MACARTHUR RH, 1965, BIOL REV, V40, P510, DOI 10.1111/j.1469-185X.1965.tb00815.x; Martiny JBH, 2011, P NATL ACAD SCI USA, V108, P7850, DOI 10.1073/pnas.1016308108; May R.M., 1975, ECOLOGY EVOLUTION CO; McGill B, 2003, OIKOS, V102, P679, DOI 10.1034/j.1600-0706.2003.12617.x; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; McGill BJ, 2011, AM J BOT, V98, P481, DOI 10.3732/ajb.1000509; McGill BJ, 2010, SCIENCE, V328, P575, DOI 10.1126/science.1188528; McGill BJ, 2010, ECOL LETT, V13, P627, DOI 10.1111/j.1461-0248.2010.01449.x; McGill BJ, 2010, OIKOS, V119, P591, DOI 10.1111/j.1600-0706.2009.17771.x; McKane A, 2000, PHYS REV E, V62, P8466, DOI 10.1103/PhysRevE.62.8466; Morlon H, 2008, ECOL LETT, V11, P904, DOI 10.1111/j.1461-0248.2008.01202.x; Nekola JC, 2007, ECOL LETT, V10, P188, DOI 10.1111/j.1461-0248.2006.01003.x; Plotkin JB, 2000, J THEOR BIOL, V207, P81, DOI 10.1006/jtbi.2000.2158; PRESTON FW, 1962, ECOLOGY, V43, P185, DOI 10.2307/1931976; PRESTON FW, 1960, ECOLOGY, V41, P611, DOI 10.2307/1931793; Pueyo S, 2006, OIKOS, V112, P392, DOI 10.1111/j.0030-1299.2006.14188.x; Rosindell J, 2013, OIKOS, V122, P1101, DOI 10.1111/j.1600-0706.2012.20751.x; Rosindell J, 2009, ECOLOGY, V90, P1743, DOI 10.1890/08-0661.1; Stanley MHR, 1996, NATURE, V379, P804, DOI 10.1038/379804a0; Storch D, 2008, FOLIA GEOBOT, V43, P329, DOI 10.1007/s12224-008-9015-8; Storch D, 2012, NATURE, V488, P78, DOI 10.1038/nature11226; SUGIHARA G, 1980, AM NAT, V116, P770, DOI 10.1086/283669; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Wiens JJ, 2011, Q REV BIOL, V86, P75, DOI 10.1086/659883	44	6	6	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112850	10.1371/journal.pone.0112850	http://dx.doi.org/10.1371/journal.pone.0112850			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383874	Green Published, Green Submitted, gold			2022-12-27	WOS:000344816700099
J	Ganguly, A; Chakravorty, R; Sarkar, A; Mandal, DK; Haldar, P; Ramos-Elorduy, J; Moreno, JMP				Ganguly, Arijit; Chakravorty, Ranita; Sarkar, Angshuman; Mandal, Dipak K.; Haldar, Parimalendu; Ramos-Elorduy, Julieta; Pino Moreno, Jose Manuel			A Preliminary Study on Oxya fuscovittata (Marschall) as an Alternative Nutrient Supplement in the Diets of Poecillia sphenops (Valenciennes)	PLOS ONE			English	Article								Growth of the ornamental fish industry is being hindered by the scarcity of low cost feed; hence alternative protein supplements should be explored. In this context the present study aims to evaluate whether the grasshopper Oxya fuscovittata could be used as a supplement for fish meal in the diets of Poecillia sphenops, which is one of the most common ornamental fishes worldwide. The present work is divided into three phases: In the first phase proximate composition of the grasshopper is obtained and five diets are prepared where fish meal is gradually replaced by Oxya meal and named as control, D1, D2, D3 and D4. All the diets are formulated on iso-nitrogenous basis where the protein percentage is fixed at 400 g/kg. The second phase deals with feeding trial and in the third phase all the data of the feeding trial are subjected to a linear model. The feeding trial shows that the control, D1 and D2 fed fishes have almost similar results. The linear model proves that the variation in the indices are mainly due to replacement of fish meal by Oxya meal, not due to the variations of rice husk and mustard oil cake that are also used to formulate the diets of the present study. From the results two Oxya supplemented diets, i.e. D1 and D2 are proved to be almost equivalent to the control diet. Hence it is concluded that Oxya meal is able to replace 25% to 50% of fish meal from the diets of P. sphenops.	[Ganguly, Arijit; Chakravorty, Ranita; Mandal, Dipak K.; Haldar, Parimalendu] Visva Bharati Univ, Dept Zool, Santini Ketan, W Bengal, India; [Sarkar, Angshuman] Visva Bharati Univ, Dept Stat, Santini Ketan, W Bengal, India; [Ramos-Elorduy, Julieta; Pino Moreno, Jose Manuel] Univ Nacl Autonoma Mexico, Dept Zool, Mexico City 04510, DF, Mexico	Visva Bharati University; Visva Bharati University; Universidad Nacional Autonoma de Mexico	Moreno, JMP (corresponding author), Univ Nacl Autonoma Mexico, Dept Zool, Mexico City 04510, DF, Mexico.	jpino@ib.unam.mx		Mandal, Dipak Kumar/0000-0002-2492-7180				AKAND AM, 1991, ASIAN FISH SOC SPEC, V5, P93; Anand H., 2008, J ENV SOCIOBIOL, V5, P181; Aoac, 1997, OFFICIAL METHODS ANA, DOI DOI 10.1016/0165-9936(90)87098-7; APHA, 1999, STANDARD METHODS EXA; Arockiaraj A. Jesu, 1999, Acta Zoologica Taiwanica, V10, P103; Bahnasawy M., 2009, EGYPT J AQUAT BIOL F, V13, P1; Bailey M, 2001, ULTIMATE AQUARIUM; Cowey C.B., 1979, FISH PHYSIOL, P1; De Silva SS, 1998, FISH NUTR AQUACULTUR; Fernando A.A., 1991, Asian Fisheries Science, V4, P99; Furuichi M., 1982, Bulletin of the Japanese Society of Scientific Fisheries, V48, P945; Guillaume Jean, 1997, Advances in World Aquaculture, V6, P26; Hasan MR, 1990, P 2 AS FISH FOR, P275; Hossain M. H., 2003, International Journal of Poultry Science, V2, P159; Kalita P, 2007, FOOD CHEM, V103, P204, DOI 10.1016/j.foodchem.2006.08.007; LAGLER KF, 1956, FRESHWATER FISHERY B; Lawrence C, 2007, AQUACULTURE, V269, P1, DOI 10.1016/j.aquaculture.2007.04.077; Martinez HH, 2008, CIENC PESQ, V16, P25; Mohanta KN, 2011, TECHNICAL B ICAR RES, V27; Moyle P. B., 1996, FISHES INTRO ICHTHYO; National Research Council (NRC), 1983, NUTR REQ WARM WAT FI; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Nyirenda J, 2000, NAGA ICLARM Q, V23, P13; Parker R, 2011, AQUACULTURE SCI; Shim Kim Fah, 1986, Journal of Aquariculture & Aquatic Sciences, V4, P79; Sogbesan AO, 2008, TURK J FISH AQUAT SC, V8, P149; Sogbesan OA, 2006, NIGERIAN J FISHERIES, V2, P358; Timmerman CM, 2004, J FISH BIOL, V65, P635, DOI 10.1111/j.0022-1112.2004.00474.x; Van Huis A, 2013, EDIBLE INSECTS FUTUR; Wade JW, 1992, J AQUATIC SCI, V7, P59; Xiaoming C, 2010, FOREST INSECTS FOOD, P85	31	5	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e111848	10.1371/journal.pone.0111848	http://dx.doi.org/10.1371/journal.pone.0111848			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383946	gold, Green Published, Green Submitted			2022-12-27	WOS:000344816700021
J	Malentacchi, F; Pazzagli, M; Simi, L; Orlando, C; Wyrich, R; Gunther, K; Verderio, P; Pizzamiglio, S; Ciniselli, CM; Zhang, H; Korenkova, V; Rainen, L; Bar, T; Kubista, M; Gelmini, S				Malentacchi, Francesca; Pazzagli, Mario; Simi, Lisa; Orlando, Claudio; Wyrich, Ralf; Guenther, Kalle; Verderio, Paolo; Pizzamiglio, Sara; Ciniselli, Chiara Maura; Zhang, Hui; Korenkova, Vlasta; Rainen, Lynne; Bar, Tzachi; Kubista, Mikael; Gelmini, Stefania			SPIDIA-RNA: Second External Quality Assessment for the Pre-Analytical Phase of Blood Samples Used for RNA Based Analyses	PLOS ONE			English	Article							WHOLE-BLOOD; QUANTITATIVE PCR; EXPRESSION; QUANTIFICATION; DNA	One purpose of the EC funded project, SPIDIA, is to develop evidence-based quality guidelines for the pre-analytical handling of blood samples for RNA molecular testing. To this end, two pan-European External Quality Assessments (EQAs) were implemented. Here we report the results of the second SPIDIA-RNA EQA. This second study included modifications in the protocol related to the blood collection process, the shipping conditions and pre-analytical specimen handling for participants. Participating laboratories received two identical proficiency blood specimens collected in tubes with or without an RNA stabilizer. For pre-defined specimen storage times and temperatures, laboratories were asked to perform RNA extraction from whole blood according to their usual procedure and to return extracted RNA to the SPIDIA facility for further analysis. These RNA samples were evaluated for purity, yield, integrity, stability, presence of interfering substances, and gene expression levels for the validated markers of RNA stability: FOS, IL1B, IL8, GAPDH, FOSB and TNFRSF10c. Analysis of the gene expression results of FOS, IL8, FOSB, and TNFRSF10c, however, indicated that the levels of these transcripts were significantly affected by blood collection tube type and storage temperature. These results demonstrated that only blood collection tubes containing a cellular RNA stabilizer allowed reliable gene expression analysis within 48 h from blood collection for all the genes investigated. The results of these two EQAs have been proposed for use in the development of a Technical Specification by the European Committee for Standardization.	[Malentacchi, Francesca; Pazzagli, Mario; Simi, Lisa; Orlando, Claudio; Gelmini, Stefania] Univ Florence, Dept Biomed Expt & Clin Sci, Florence, Italy; [Wyrich, Ralf; Guenther, Kalle] Qiagen GmbH, Hilden, Germany; [Verderio, Paolo; Pizzamiglio, Sara; Ciniselli, Chiara Maura] Fdn Ist Ricovero & Cura Carattere Sci IRCCS, Unit Med Stat Biometry & Bioinformat, Ist Nazl Tumori, Milan, Italy; [Zhang, Hui] DiaGenic ASA, Oslo, Norway; [Korenkova, Vlasta; Kubista, Mikael] Acad Sci Czech Republic, Inst Biotechnol, Prague, Czech Republic; [Rainen, Lynne] Becton Dickinson, Franklin Lakes, NJ USA; [Bar, Tzachi] Labonnet Ltd, St Ramat Hasharon, Israel; [Kubista, Mikael] TATAA Bioctr AB, Gothenburg, Sweden	University of Florence; QIAGEN GmbH; Fondazione IRCCS Istituto Nazionale Tumori Milan; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Becton Dickinson	Malentacchi, F (corresponding author), Univ Florence, Dept Biomed Expt & Clin Sci, Florence, Italy.	francesca.malentacchi@gmail.com	Kubista, Mikael/A-5689-2008; Ciniselli, Chiara M/C-4518-2017; Korenková, Vlasta/G-6401-2014; GELMINI, STEFANIA/K-8387-2018; Pizzamiglio, Sara/C-1061-2017; Verderio, Paolo/B-5034-2017	Kubista, Mikael/0000-0002-2940-352X; Ciniselli, Chiara M/0000-0003-4488-885X; GELMINI, STEFANIA/0000-0002-4718-0833; Pizzamiglio, Sara/0000-0002-7759-0550; Verderio, Paolo/0000-0002-9231-1281; Korenkova, Vlasta/0000-0002-6289-5175; Pazzagli, Mario/0000-0003-3673-691X; Bar, Tzachi/0000-0001-7315-0710	European Union (FP7. Title "SPIDIA: Standardization and improvement of generic pre-analytical tools and procedures for in vitro diagnostic'') [222916]	European Union (FP7. Title "SPIDIA: Standardization and improvement of generic pre-analytical tools and procedures for in vitro diagnostic'')	The SPIDIA RNA study has been supported by European Union (FP7. Title "SPIDIA: Standardization and improvement of generic pre-analytical tools and procedures for in vitro diagnostic'', Grant agreement no. 222916). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Gunther K, 2012, CLIN CHIM ACTA, V413, P779, DOI 10.1016/j.cca.2012.01.015; Hartel C, 2001, J IMMUNOL METHODS, V249, P63, DOI 10.1016/S0022-1759(00)00334-3; Iglewicz B, 1993, DETECT HANDLE OUTLIE, V16; Kim SJ, 2007, CLIN CHEM, V53, P1038, DOI 10.1373/clinchem.2006.078436; Laurell H, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1259; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madej RM, 2005, MM14A CLSI, V25, P1; Malentacchi F, 2013, CLIN CHIM ACTA, V424, P274, DOI 10.1016/j.cca.2013.05.012; McCulloch CE, 2001, GEN LINEAR MIXED MOD, P281; Nussbaumer C, 2006, FORENSIC SCI INT, V157, P181, DOI 10.1016/j.forsciint.2005.10.009; Ovstebo R, 2007, CLIN CHEM LAB MED, V45, P171, DOI 10.1515/CCLM.2007.035; Pahl A, 2002, BLOOD, V100, P1094, DOI 10.1182/blood-2002-03-0813; Pazzagli M, 2013, METHODS, V59, P20, DOI 10.1016/j.ymeth.2012.10.007; Rainen L, 2002, CLIN CHEM, V48, P1883; Tichopad A, 2010, METHODS, V50, P308, DOI 10.1016/j.ymeth.2010.01.028	19	23	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112293	10.1371/journal.pone.0112293	http://dx.doi.org/10.1371/journal.pone.0112293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384019	Green Published, gold, Green Submitted			2022-12-27	WOS:000344816700048
J	Montagner, IM; Merlo, A; Zuccolotto, G; Renier, D; Campisi, M; Pasut, G; Zanovello, P; Rosato, A				Montagner, Isabella Monia; Merlo, Anna; Zuccolotto, Gaia; Renier, Davide; Campisi, Monica; Pasut, Gianfranco; Zanovello, Paola; Rosato, Antonio			Peritoneal Tumor Carcinomatosis: Pharmacological Targeting with Hyaluronan-Based Bioconjugates Overcomes Therapeutic Indications of Current Drugs	PLOS ONE			English	Article							CYTOREDUCTIVE SURGERY; GASTRIC-CANCER; FUTURE-DIRECTIONS; HYDROSOLUBLE BIOCONJUGATE; LOCOREGIONAL TREATMENT; PACLITAXEL; DELIVERY; ACID; IDENTIFICATION; RECEPTOR	Peritoneal carcinomatosis still lacks reliable therapeutic options. We aimed at testing a drug delivery strategy allowing a controlled release of cytotoxic molecules and selective targeting of tumor cells. We comparatively assessed the efficacy of a loco-regional intraperitoneal treatment in immunocompromised mice with bioconjugates formed by chemical linking of paclitaxel or SN-38 to hyaluronan, against three models of peritoneal carcinomatosis derived from human colorectal, gastric and esophageal tumor cell xenografts. In vitro, bioconjugates were selectively internalized through mechanisms largely dependent on interaction with the CD44 receptor and caveolin-mediated endocytosis, which led to accumulation of compounds into lysosomes of tumor cells. Moreover, they inhibited tumor growth comparably to free drugs. In vivo, efficacy of bioconjugates or free drugs against luciferase-transduced tumor cells was assessed by bioluminescence optical imaging, and by recording mice survival. The intraperitoneal administration of bioconjugates in tumor-bearing mice exerted overlapping or improved therapeutic efficacy compared with unconjugated drugs. Overall, drug conjugation to hyaluronan significantly improved the profiles of in vivo tolerability and widened the field of application of existing drugs, over their formal approval or current use. Therefore, this approach can be envisaged as a promising therapeutic strategy for locoregional treatment of peritoneal carcinomatosis.	[Montagner, Isabella Monia; Merlo, Anna; Zanovello, Paola; Rosato, Antonio] Veneto Inst Oncol IOV IRCCS, Padua, Italy; [Zuccolotto, Gaia] Univ Padua, Dept Med, Padua, Italy; [Renier, Davide; Campisi, Monica] Fidia Farmaceutici SpA, Abano Terme, Italy; [Pasut, Gianfranco] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy; [Zanovello, Paola; Rosato, Antonio] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy	IRCCS Istituto Oncologico Veneto (IOV); University of Padua; University of Padua; University of Padua	Rosato, A (corresponding author), Veneto Inst Oncol IOV IRCCS, Padua, Italy.	antonio.rosato@unipd.it	Rosato, Antonio/E-8626-2010; Montagner, Isabella Monia/AAI-2317-2019; Pasut, Gianfranco/I-5944-2012; montagner, isabella monia/K-1653-2016; ZUCCOLOTTO, GAIA/K-1654-2016; Merlo, Anna/FCK-4327-2022	Rosato, Antonio/0000-0002-5263-8386; Montagner, Isabella Monia/0000-0002-5778-2221; Pasut, Gianfranco/0000-0002-8754-0899; montagner, isabella monia/0000-0002-5778-2221; ZUCCOLOTTO, GAIA/0000-0002-2002-8807; Merlo, Anna/0000-0002-2741-9624; Zanovello, Paola/0000-0002-9996-2669	Italian Association for Cancer Research (AIRC) [IG-13121, 10016]	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Italian Association for Cancer Research (AIRC, IG-13121; and Special Program Molecular Clinical Oncology 5 per mille ID 10016 to AR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	al-Shammaa HAH, 2008, WORLD J GASTROENTERO, V14, P1159, DOI 10.3748/wjg.14.1159; Aoyagi Keishiro, 2013, World J Crit Care Med, V2, P48, DOI 10.5492/wjccm.v2.i4.48; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Authier N, 2001, NEUROTOX RES, V3, P301, DOI 10.1007/BF03033269; Banzato A, 2008, CLIN CANCER RES, V14, P3598, DOI 10.1158/1078-0432.CCR-07-2019; Bassi PF, 2011, J UROLOGY, V185, P445, DOI 10.1016/j.juro.2010.09.073; Bozzetti F, 2008, J SURG ONCOL, V98, P273, DOI 10.1002/jso.21052; Brucher BLDM, 2012, CANCER INVEST, V30, P209, DOI 10.3109/07357907.2012.654871; Clementi C, 2011, MOL PHARMACEUT, V8, P1063, DOI 10.1021/mp2001445; Coccolini F, 2013, WORLD J GASTROENTERO, V19, P6979, DOI 10.3748/wjg.v19.i41.6979; Contreras-Ruiz L, 2011, MOL VIS, V17, P279; Correa P, 2013, GASTROENTEROL CLIN N, V42, P211, DOI 10.1016/j.gtc.2013.01.002; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; De Smet L, 2013, SCI WORLD J, DOI 10.1155/2013/720858; Dodds HM, 1998, J PHARMACOL EXP THER, V286, P578; Dong ZK, 2013, J APPL POLYM SCI, V130, P927, DOI 10.1002/app.39247; Duncan R, 2013, ADV DRUG DELIVER REV, V65, P60, DOI 10.1016/j.addr.2012.08.012; Elias D, 2012, SURG ONCOL CLIN N AM, V21, P611, DOI 10.1016/j.soc.2012.07.014; Elias D, 2010, J CLIN ONCOL, V28, P63, DOI 10.1200/JCO.2009.23.9285; Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B; Faryammanesh R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093173; Gelderblom H, 2001, EUR J CANCER, V37, P1590, DOI 10.1016/S0959-8049(01)00171-X; Gill RS, 2011, J SURG ONCOL, V104, P692, DOI 10.1002/jso.22017; Glockzin G, 2012, SURG ONCOL CLIN N AM, V21, P625, DOI 10.1016/j.soc.2012.07.002; Glockzin G, 2009, WORLD J SURG ONCOL, V7, DOI 10.1186/1477-7819-7-5; Gros SJ, 2010, ANTICANCER RES, V30, P3933; Isacke CM, 2002, INT J BIOCHEM CELL B, V34, P718, DOI 10.1016/S1357-2725(01)00166-2; Jaganathan SK, 2013, WORLD J GASTROENTERO, V19, P7726, DOI 10.3748/wjg.v19.i43.7726; Jain JP, 2008, EXPERT OPIN DRUG DEL, V5, P889, DOI [10.1517/17425247.5.8.889, 10.1517/17425247.5.8.889 ]; Keyaerts M, 2008, EUR J NUCL MED MOL I, V35, P999, DOI 10.1007/s00259-007-0664-2; Konigsrainer I, 2012, WORLD J GASTROENTERO, V18, P5317, DOI 10.3748/wjg.v18.i38.5317; Kumar Shalini Sree, 2014, Gastrointest Cancer Res, V7, P23; Larson N, 2013, INT J PHARMACEUT, V454, P435, DOI 10.1016/j.ijpharm.2013.06.046; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Liao YH, 2005, DRUG DELIV, V12, P327, DOI 10.1080/10717540590952555; Lu Z, 2010, FUTURE ONCOL, V6, P1625, DOI 10.2217/FON.10.100; Montagner IM, 2013, UROL ONCOL-SEMIN ORI, V31, P1261, DOI 10.1016/j.urolonc.2012.01.005; Nakamura H, 2014, J CONTROL RELEASE, V174, P81, DOI 10.1016/j.jconrel.2013.11.011; Northfelt DW, 2012, AM J CLIN ONCOL; Oommen OP, 2013, MACROMOL BIOSCI; Passot G, 2013, EUR J SURG ONCOL; Patnaik A, 2013, CANCER CHEMOTH PHARM, V71, P1499, DOI 10.1007/s00280-013-2149-2; Pucciarelli S, 2003, BRIT J SURG, V90, P66, DOI 10.1002/bjs.4006; Rosato A, 2006, UROL ONCOL-SEMIN ORI, V24, P207, DOI 10.1016/j.urolonc.2005.08.020; Schweigert M, 2013, NAT REV GASTRO HEPAT, V10, P230, DOI 10.1038/nrgastro.2012.236; Serafino A, 2011, CURR CANCER DRUG TAR, V11, P572, DOI 10.2174/156800911795655976; Smit JK, 2013, RADIOTHER ONCOL, V107, P434, DOI 10.1016/j.radonc.2013.03.027; Sorbi C, 2009, CARBOHYD RES, V344, P91, DOI 10.1016/j.carres.2008.09.021; Sugahara S, 2007, J CONTROL RELEASE, V117, P40, DOI 10.1016/j.jconrel.2006.10.009; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Varshosaz J, 2012, EXPERT OPIN DRUG DEL, V9, P509, DOI 10.1517/17425247.2012.673580; Walker AS, 2014, J CANCER, V5, P44, DOI 10.7150/jca.7809; Yuan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031802; Zhao JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021419; Zhou B, 2003, GLYCOBIOLOGY, V13, P339, DOI 10.1093/glycob/cwg029	55	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112240	10.1371/journal.pone.0112240	http://dx.doi.org/10.1371/journal.pone.0112240			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383653	Green Submitted, Green Published, gold			2022-12-27	WOS:000344816700043
J	Rosca, EV; Penet, MF; Mori, N; Koskimaki, JE; Lee, E; Pandey, NB; Bhujwalla, ZM; Popel, AS				Rosca, Elena V.; Penet, Marie-France; Mori, Noriko; Koskimaki, Jacob E.; Lee, Esak; Pandey, Niranjan B.; Bhujwalla, Zaver M.; Popel, Aleksander S.			A Biomimetic Collagen Derived Peptide Exhibits Anti-Angiogenic Activity in Triple Negative Breast Cancer	PLOS ONE			English	Article							TUMOR-GROWTH; IV COLLAGEN; BEVACIZUMAB; INTEGRIN; IDENTIFICATION; VASCULATURE; COOPERATION; MECHANISM; VEGFR2; AGENT	We investigated the application of a mimetic 20 amino acid peptide derived from type IV collagen for treatment of breast cancer. We showed that the peptide induced a decrease of proliferation, adhesion, and migration of endothelial and tumor cells in vitro. We also observed an inhibition of triple negative MDA-MB-231 xenograft growth by 75% relative to control when administered intraperitoneally for 27 days at 10 mg/kg. We monitored in vivo the changes in vascular properties throughout the treatment using MRI and found that the vascular volume and permeability surface area product decreased significantly. The treatment also resulted in an increase of caspase-3 activity and in a reduction of microvascular density. The multiple mode of action of this peptide, i.e., anti-angiogenic, and anti-tumorigenic, makes it a viable candidate as a therapeutic agent as a monotherapy or in combination with other compounds.	[Rosca, Elena V.; Koskimaki, Jacob E.; Lee, Esak; Pandey, Niranjan B.; Popel, Aleksander S.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Penet, Marie-France; Mori, Noriko; Bhujwalla, Zaver M.] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, In Vivo Cellular & Mol Imaging Ctr Program,Div Ca, Baltimore, MD 21205 USA; [Bhujwalla, Zaver M.; Popel, Aleksander S.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Bhujwalla, Zaver M.; Popel, Aleksander S.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Rosca, EV (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	e.v.rosca@gmail.com	Penet, Marie-France/AGZ-6991-2022; Popel, Aleksander S/A-6724-2009; Lee, Esak/AAC-6403-2020	Lee, Esak/0000-0002-5328-6677; Popel, Aleksander/0000-0002-6706-9235	National Institutes of Health [R01CA138264, R21CA152473, R01CA136576, P50CA103175]; Safeway Foundation; NATIONAL CANCER INSTITUTE [R01CA138264, R21CA152473, R01CA136576, P50CA103175] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Safeway Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health grants R01CA138264, R21CA152473, R01CA136576 and P50CA103175 and the Safeway Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backer MV, 2012, THERANOSTICS, V2, P502, DOI 10.7150/thno.3623; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Bhujwalla ZM, 2003, CLIN CANCER RES, V9, P355; Braghiroli MI, 2012, EXPERT REV ANTICANC, V12, P567, DOI [10.1586/ERA.12.13, 10.1586/era.12.13]; Mena AC, 2010, ANTI-CANCER DRUG, V21, pS3, DOI 10.1097/01.cad.0000361534.44052.c5; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Glunde K, 2009, NMR BIOMED, V22, P92, DOI 10.1002/nbm.1269; Goel S, 2012, P NATL ACAD SCI USA, V109, pE1214, DOI 10.1073/pnas.1203794109; Imoukhuede PI, 2014, CANCER MED-US, V3, P225, DOI 10.1002/cam4.188; Ivaska J, 2011, ANNU REV CELL DEV BI, V27, P291, DOI 10.1146/annurev-cellbio-092910-154017; Karagiannis ED, 2008, P NATL ACAD SCI USA, V105, P13775, DOI 10.1073/pnas.0803241105; Karagiannis ED, 2007, BIOCHEM BIOPH RES CO, V354, P434, DOI 10.1016/j.bbrc.2006.12.231; Koskimaki JE, 2009, NEOPLASIA, V11, P1285, DOI 10.1593/neo.09620; Koskimaki JE, BMC CANC, V10, P29; Lakshmikanthan S, 2011, BLOOD, V118, P2015, DOI 10.1182/blood-2011-04-349282; Manegold C, 2012, INVEST NEW DRUGS; Montenegro CF, 2012, BIOCHIMIE, V94, P1812, DOI 10.1016/j.biochi.2012.04.020; Nabors LB, 2010, ARCH NEUROL-CHICAGO, V67, P313, DOI 10.1001/archneurol.2010.16; OGAN MD, 1987, INVEST RADIOL, V22, P665, DOI 10.1097/00004424-198708000-00008; Pathak AP, 2010, ADV GENET, V69, P1, DOI 10.1016/S0065-2660(10)69010-4; Pathak AP, 2008, ANGIOGENESIS, V11, P321, DOI 10.1007/s10456-008-9119-z; Preusser M, 2012, ONCOLOGIST, V17, pE13, DOI 10.1634/theoncologist.2012-0115; Raatschen HJ, 2008, RADIOLOGY, V247, P391, DOI 10.1148/radiol.2472070363; Rivera CG, 2011, J MED CHEM, V54, P6492, DOI 10.1021/jm200114f; Rosca EV, 2012, CHEM BIOL DRUG DES, V80, P27, DOI 10.1111/j.1747-0285.2012.01376.x; Rosca EV, 2011, CURR PHARM BIOTECHNO, V12, P1101; Rose S, 2011, CANCER DISCOV, V1, DOI 10.1158/2159-8290.CD-ND112311OL-08; Shojaei F, 2012, CANCER LETT, V320, P130, DOI 10.1016/j.canlet.2012.03.008; Somanath PR, 2009, ANGIOGENESIS, V12, P177, DOI 10.1007/s10456-009-9141-9; van der Veldt AAM, 2012, NEW ENGL J MED, V366, P1637, DOI 10.1056/NEJMc1202229; West XZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031071	33	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e111901	10.1371/journal.pone.0111901	http://dx.doi.org/10.1371/journal.pone.0111901			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384034	Green Published, Green Submitted, gold			2022-12-27	WOS:000344816700023
J	Short, DPG; Gurung, S; Hu, XP; Inderbitzin, P; Subbarao, KV				Short, Dylan P. G.; Gurung, Suraj; Hu, Xiaoping; Inderbitzin, Patrik; Subbarao, Krishna V.			Maintenance of Sex-Related Genes and the Co-Occurrence of Both Mating Types in Verticillium dahliae	PLOS ONE			English	Article							AMINO-ACID SITES; GENOME SEQUENCE; NEUROSPORA-CRASSA; CRYPTOCOCCUS-NEOFORMANS; MOLECULAR-ORGANIZATION; PURIFYING SELECTION; FUNGAL PATHOGENS; ASPERGILLUS; EVOLUTION; RECOMBINATION	Verticillium dahliae is a cosmopolitan, soilborne fungus that causes a significant wilt disease on a wide variety of plant hosts including economically important crops, ornamentals, and timber species. Clonal expansion through asexual reproduction plays a vital role in recurring plant epidemics caused by this pathogen. The recent discovery of recombination between clonal lineages and preliminary investigations of the meiotic gene inventory of V. dahliae suggest that cryptic sex appears to be rare in this species. Here we expanded on previous findings on the sexual nature of V. dahliae. Only 1% of isolates in a global collection of 1120 phytopathogenic V. dahliae isolates contained the MAT1-1 idiomorph, whereas 99% contained MAT1-2. Nine unique multilocus microsatellite types comprised isolates of both mating types, eight of which were collected from the same substrate at the same time. Orthologs of 88 previously characterized sex-related genes from fungal model systems in the Ascoymycota were identified in the genome of V. dahliae, out of 93 genes investigated. Results of RT-PCR experiments using both mating types revealed that 10 arbitrarily chosen sex-related genes, including MAT1-1-1 and MAT1-21, were constitutively expressed in V. dahliae cultures grown under laboratory conditions. Ratios of non-synonymous (amino-acid altering) to synonymous (silent) substitutions in V. dahliae MAT1-1-1 and MAT1-2-1 sequences were indistinguishable from the ratios observed in the MAT genes of sexual fungi in the Pezizomycotina. Patterns consistent with strong purifying selection were also observed in 18 other arbitrarily chosen V. dahliae sex-related genes, relative to the patterns in orthologs from fungi with known sexual stages. This study builds upon recent findings from other laboratories and mounts further evidence for an ancestral or cryptic sexual stage in V. dahliae.	[Short, Dylan P. G.; Gurung, Suraj; Inderbitzin, Patrik; Subbarao, Krishna V.] Univ Calif Davis, Dept Plant Pathol, Salinas, CA 93901 USA; [Hu, Xiaoping] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Hu, Xiaoping] Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China	University of California System; University of California Davis; Northwest A&F University - China; Northwest A&F University - China	Subbarao, KV (corresponding author), Univ Calif Davis, Dept Plant Pathol, Salinas, CA 93901 USA.	kvsubbarao@ucdavis.edu	Subbarao, Krishna/X-3870-2019	Subbarao, Krishna/0000-0002-2075-1835	USDA-NIFA-SCRI [2010-51181-21069]; California Leafy Greens Research Board	USDA-NIFA-SCRI; California Leafy Greens Research Board	Funding for this study was provided by USDA-NIFA-SCRI grant no. 2010-51181-21069 and the California Leafy Greens Research Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2009, MOL ECOL RESOUR, V9, P1460, DOI 10.1111/j.1755-0998.2009.02759.x; Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Amyotte SG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-314; Atallah ZK, 2010, FUNGAL GENET BIOL, V47, P416, DOI 10.1016/j.fgb.2010.02.003; Berbee ML, 2003, MYCOL RES, V107, P169, DOI 10.1017/S0953756203007263; Bidard F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021476; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; Butler G, 2010, CLIN MICROBIOL REV, V23, P140, DOI 10.1128/CMR.00053-09; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Clarke DL, 2001, MOL MICROBIOL, V40, P200, DOI 10.1046/j.1365-2958.2001.02375.x; Clutterbuck AJ, 1996, J GENET, V75, P281, DOI 10.1007/BF02966308; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; de Jonge R, 2013, GENOME RES, V23, P1271, DOI 10.1101/gr.152660.112; de Jonge R, 2012, P NATL ACAD SCI USA, V109, P5110, DOI 10.1073/pnas.1119623109; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Debuchy R, 2006, MYCOTA, P293, DOI DOI 10.1007/3-540-28135-5_15; Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259; Doron-Faigenboim A, 2007, MOL BIOL EVOL, V24, P388, DOI 10.1093/molbev/msl175; Dyer PS, 2012, FEMS MICROBIOL REV, V36, P165, DOI 10.1111/j.1574-6976.2011.00308.x; Dyer PS, 2011, CURR OPIN MICROBIOL, V14, P649, DOI 10.1016/j.mib.2011.10.001; Dyer PS, 2003, MICROBIOL-SGM, V149, P2301, DOI 10.1099/mic.0.C0119-0; Espagne E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r77; Freitag M, 2002, P NATL ACAD SCI USA, V99, P8802, DOI 10.1073/pnas.132212899; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Goddard MR, 2005, NATURE, V434, P636, DOI 10.1038/nature03405; Goodwin SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002070; Grossetete S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-81; Gurung S, 2014, PHYTOPATHOLOGY, V104, P641, DOI 10.1094/PHYTO-10-13-0282-R; Gurung S, 2013, FUNGAL GENET BIOL, V52, P32, DOI 10.1016/j.fgb.2013.01.003; Henk DA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002851; Inderbitzin P, 2014, GENOMICS PLANT ASS F; Inderbitzin P, 2014, PHYTOPATHOLOGY, V104, P564, DOI 10.1094/PHYTO-11-13-0315-IA; Inderbitzin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028341; Inderbitzin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018260; JOAQUIM TR, 1991, PHYTOPATHOLOGY, V81, P552, DOI 10.1094/Phyto-81-552; Kabir Z, 2004, PLANT DIS, V88, P49, DOI 10.1094/PDIS.2004.88.1.49; KISTLER HC, 1992, ANNU REV PHYTOPATHOL, V30, P131, DOI 10.1146/annurev.py.30.090192.001023; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602, DOI 10.1128/IAI.60.2.602-605.1992; Lockhart SR, 2005, GENETICS, V169, P1883, DOI 10.1534/genetics.104.038737; Malcolm GM, 2013, PHYTOPATHOLOGY, V103, P538, DOI 10.1094/PHYTO-08-12-0192-LE; Martinez D, 2008, NAT BIOTECHNOL, V26, P1193, DOI 10.1038/nbt1008-1193a; Maruthachalam K, 2010, PHYTOPATHOLOGY, V100, P1222, DOI 10.1094/PHYTO-04-10-0122; Massingham T, 2005, GENETICS, V169, P1753, DOI 10.1534/genetics.104.032144; METZENBERG RL, 1990, BIOESSAYS, V12, P53, DOI 10.1002/bies.950120202; Milgroom MG, 1996, ANNU REV PHYTOPATHOL, V34, P457, DOI 10.1146/annurev.phyto.34.1.457; Milgroom MG, 2013, 11 INT VERT S GOTT 2; Milgroom MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106740; Nierman WC, 2006, NATURE, V439, P502, DOI 10.1038/nature04572; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; O'Gorman CM, 2009, NATURE, V457, P471, DOI 10.1038/nature07528; Ohm RA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003037; Otto SP, 2009, AM NAT, V174, pS1, DOI 10.1086/599084; Paoletti M, 2005, CURR BIOL, V15, P1242, DOI 10.1016/j.cub.2005.05.045; Pasqualotto AC, 2007, J CLIN MICROBIOL, V45, P522, DOI 10.1128/JCM.02136-06; Pegg GF, 2002, VERTICILLUM WILTS, DOI [DOI 10.1079/9780851995298.0000, 10.1079/9780851995298.0000]; Poggeler S, 2011, FUNGAL BIOL-UK, V115, P615, DOI 10.1016/j.funbio.2011.03.003; Puhalla J, 1983, PHYTOPATHOLOGY, V73, P1; Ramesh MA, 2005, CURR BIOL, V15, P185, DOI 10.1016/j.cub.2005.01.003; Ropars J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049665; Saleh D, 2012, MOL ECOL, V21, P1330, DOI 10.1111/j.1365-294X.2012.05469.x; Schardl C. L., 2012, Epichloae, endophytes of cool season grasses: implications, utilization and biology. Proceedings of the 7th International Symposium on Fungal Endophytes of Grasses, Lexington, Kentucky, USA, 28 June to 1 July 2010, P59; Schurko AM, 2008, BIOESSAYS, V30, P579, DOI 10.1002/bies.20764; Shittu HO, 2009, PLANTA, V229, P415, DOI 10.1007/s00425-008-0840-z; Short DPG, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-91; Short DPG, 2013, FUNGAL GENET BIOL, V53, P59, DOI 10.1016/j.fgb.2013.01.004; Smith JM, 1998, MOL BIOL EVOL, V15, P590, DOI 10.1093/oxfordjournals.molbev.a025960; Staats M, 2012, EUKARYOT CELL, V11, P1413, DOI 10.1128/EC.00164-12; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; TIBAYRENC M, 1991, P NATL ACAD SCI USA, V88, P5129, DOI 10.1073/pnas.88.12.5129; TURGEON BG, 1995, CAN J BOT, V73, pS778, DOI 10.1139/b95-322; Turgeon G, 2000, FUNGAL GENET BIOL, V31, P1, DOI 10.1006/fgbi.2000.1227; Usami T, 2008, PHYSIOL MOL PLANT P, V73, P133, DOI 10.1016/j.pmpp.2009.04.002; Usami T, 2009, J GEN PLANT PATHOL, V75, P422, DOI 10.1007/s10327-009-0197-6; van den Berg MA, 2008, NAT BIOTECHNOL, V26, P1161, DOI 10.1038/nbt.1498; Weismann A., 1889, ESSAYS HEREDITY KIND; WILHELM S, 1955, PHYTOPATHOLOGY, V45, P180; Wong WSW, 2004, GENETICS, V167, P949, DOI 10.1534/genetics.102.010959; Yang ZH, 2000, GENETICS, V155, P431; Yun SH, 2000, FUNGAL GENET BIOL, V31, P7, DOI 10.1006/fgbi.2000.1226; Zhan JS, 2007, FUNGAL GENET BIOL, V44, P339, DOI 10.1016/j.fgb.2006.10.008	85	35	37	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112145	10.1371/journal.pone.0112145	http://dx.doi.org/10.1371/journal.pone.0112145			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383550	Green Submitted, Green Published, gold			2022-12-27	WOS:000344816700033
J	Drewes, YM; Blom, JW; Assendelft, WJJ; Stijnen, T; den Elzen, WPJ; Gussekloo, J				Drewes, Yvonne M.; Blom, Jeanet W.; Assendelft, Willem J. J.; Stijnen, Theo; den Elzen, Wendy P. J.; Gussekloo, Jacobijn			Variability in Vulnerability Assessment of Older People by Individual General Practitioners: A Cross-Sectional Study	PLOS ONE			English	Article							FRAILTY; DISABILITY; ADULTS	Background: In clinical practice, GPs appeared to have an internalized concept of "vulnerability.'' This study investigates the variability between general practitioners (GPs) in their vulnerability-assessment of older persons. Methods: Seventy-seven GPs categorized their 75-plus patients (n = 11392) into non-vulnerable, possibly vulnerable, and vulnerable patients. GPs personal and practice characteristics were collected. From a sample of 2828 patients the following domains were recorded: sociodemographic, functional [instrumental activities in daily living (IADL), basic activities in daily living (BADL)], somatic (number of diseases, polypharmacy), psychological (Mini-Mental State Examination, 15-item Geriatric Depression Scale; GDS-15) and social (De Jong-Gierveld Loneliness Scale; DJG). Variability in GPs' assessment of vulnerability was tested with mixed effects logistic regression. P-values for variability (p(var)) were calculated by the log-likelihood ratio test. Results: Participating GPs assessed the vulnerability of 10,361 patients. The median percentage of vulnerable patients was 32.0% (IQR 19.5 to 40.1%). From the somatic and psychological domains, GPs uniformly took into account the patient characteristics 'total number of diseases' (OR 1.7, 90% range = 0, p(var) = 1), 'polypharmacy' (OR 2.3, 90% range = 0, p(var) = 1) and 'GDS-15' (OR 1.6, 90% range = 0, p(var) = 1). GPs vary in the way they assessed their patients' vulnerability in the functional domain (IADL: median OR 2.8, 90% range 1.6, p(var)<0.001, BADL: median OR 2.4, 90% range 2.9, p(var)<0.001) and the social domain (DJG: median OR 1.2, 90% range = 1.2, p(var)<0.001). Conclusions: GPs seem to share a medical concept of vulnerability, since they take somatic and psychological characteristics uniformly into account in the vulnerability-assessment of older persons. In the functional and social domains, however, variability was found. Vulnerability assessment by GPs might be a promising instrument to select older people for geriatric care if more uniformity could be achieved.	[Drewes, Yvonne M.; Blom, Jeanet W.; Assendelft, Willem J. J.; den Elzen, Wendy P. J.; Gussekloo, Jacobijn] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands; [Assendelft, Willem J. J.] Radboud Univ Nijmegen, Med Ctr, Dept Primary Community Care, NL-6525 ED Nijmegen, Netherlands; [Stijnen, Theo] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Drewes, YM (corresponding author), Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands.	y.m.drewes@lumc.nl	assendelft, willem/AAW-1854-2021; Assendelft, W.J.J./H-8008-2014; Gussekloo, Jacobijn/ABE-3879-2021	assendelft, willem/0000-0002-2966-3778; Assendelft, W.J.J./0000-0002-2966-3778; Gussekloo, Jacobijn/0000-0001-7186-8278; den Elzen, Wendy/0000-0002-6774-4077	ZonMw, the Netherlands, Organization for Health Research and Development [311060201]	ZonMw, the Netherlands, Organization for Health Research and Development(Netherlands Organization for Health Research and DevelopmentNetherlands Government)	This study was funded by ZonMw, the Netherlands, Organization for Health Research and Development, ZonMw number 311060201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bootsma-van der Wiel A, 2001, J AM GERIATR SOC, V49, P909; Daniels R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-69; DATH P, 1994, FAM PRACT, V11, P260, DOI 10.1093/fampra/11.3.260; DEJONGGIERVELD J, 1985, APPL PSYCH MEAS, V9, P289, DOI 10.1177/014662168500900307; Drewes Y M, 2012, BR J GEN PRACT, V62604, P765; Drewes YM, 2012, J AM GERIATR SOC, V60, P42, DOI 10.1111/j.1532-5415.2011.03775.x; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Gobbens RJJ, 2010, J AM MED DIR ASSOC, V11, P344, DOI 10.1016/j.jamda.2009.11.003; HENDEE WR, 1990, ARCH INTERN MED, V150, P2459; Hertogh C MPM, 1996, CLIN REHABIL, V10, P135; Hoogendijk EO, 2013, AGE AGEING, V42, P262, DOI 10.1093/ageing/afs163; Kempen GIJM, 1996, SOC SCI MED, V43, P1601, DOI 10.1016/S0277-9536(96)00057-3; Peters LL, 2012, J AM MED DIR ASSOC, V13, P546, DOI 10.1016/j.jamda.2012.04.007; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P738, DOI 10.1093/gerona/62.7.738; Saliba D, 2001, J AM GERIATR SOC, V49, P1691, DOI 10.1046/j.1532-5415.2001.49281.x; Schuurmans H, 2004, J GERONTOL A-BIOL, V59, P962; Slaets JPJ, 2006, MED CLIN N AM, V90, P593, DOI 10.1016/j.mcna.2006.05.008; Tijhuis MAR, 1999, AGE AGEING, V28, P491, DOI 10.1093/ageing/28.5.491; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; van Ravesteijn H, 2008, AUST FAM PHYSICIAN, V37, P973	22	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e108666	10.1371/journal.pone.0108666	http://dx.doi.org/10.1371/journal.pone.0108666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT3WF	25379778	Green Submitted, Green Published, gold			2022-12-27	WOS:000344863100004
J	Panico, L; Stuart, B; Bartley, M; Kelly, Y				Panico, Lidia; Stuart, Beth; Bartley, Mel; Kelly, Yvonne			Asthma Trajectories in Early Childhood: Identifying Modifiable Factors	PLOS ONE			English	Article							LOW SOCIOECONOMIC-STATUS; 1ST 6 YEARS; WHEEZING DISORDERS; RESPIRATORY SYMPTOMS; PHENOTYPES; CHILDREN; RISK; PREVALENCE; ATTENDANCE; ALLERGIES	Background: There are conflicting views as to whether childhood wheezing represents several discreet entities or a single but variable disease. Classification has centered on phenotypes often derived using subjective criteria, small samples, and/or with little data for young children. This is particularly problematic as asthmatic features appear to be entrenched by age 6/7. In this paper we aim to: identify longitudinal trajectories of wheeze and other atopic symptoms in early childhood; characterize the resulting trajectories by the socio-economic background of children; and identify potentially modifiable processes in infancy correlated with these trajectories. Data and Methods: The Millennium Cohort Study is a large, representative birth cohort of British children born in 2000-2002. Our analytical sample includes 11,632 children with data on key variables (wheeze in the last year; ever hay-fever and/or eczema) reported by the main carers at age 3, 5 and 7 using a validated tool, the International Study of Asthma and Allergies in Childhood module. We employ longitudinal Latent Class Analysis, a clustering methodology which identifies classes underlying the observed population heterogeneity. Results: Our model distinguished four latent trajectories: a trajectory with both low levels of wheeze and other atopic symptoms (54% of the sample); a trajectory with low levels of wheeze but high prevalence of other atopic symptoms (29%); a trajectory with high prevalence of both wheeze and other atopic symptoms (9%); and a trajectory with high levels of wheeze but low levels of other atopic symptoms (8%). These groups differed in terms of socio-economic markers and potential intervenable factors, including household damp and breastfeeding initiation. Conclusion: Using data-driven techniques, we derived four trajectories of asthmatic symptoms in early childhood in a large, population based sample. These groups differ in terms of their socio-economic profiles. We identified correlated intervenable pathways in infancy, including household damp and breastfeeding initiation.	[Panico, Lidia] Inst Natl Etud Demog, F-75675 Paris, France; [Stuart, Beth] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Bartley, Mel; Kelly, Yvonne] UCL, Int Ctr Lifecourse Studies, Dept Epidemiol & Populat Hlth, London, England	University of Southampton; University of London; University College London	Panico, L (corresponding author), Inst Natl Etud Demog, F-75675 Paris, France.	lidia.panico@ined.fr		Stuart, Beth/0000-0001-5432-7437; Kelly, Yvonne/0000-0002-2936-3994	Economic and Social Research Council (ESRC), UK; ESRC International Centre for Lifecourse Studies in Society and Health [RES-596-28-0001]; ESRC [ES/J019119/1] Funding Source: UKRI; Economic and Social Research Council [ES/J019119/1] Funding Source: researchfish	Economic and Social Research Council (ESRC), UK(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC International Centre for Lifecourse Studies in Society and Health(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The Millennium Cohort Study is funded by the Economic and Social Research Council (ESRC), UK. This work was partly funded by the ESRC International Centre for Lifecourse Studies in Society and Health (RES-596-28-0001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almqvist C, 2005, CLIN EXP ALLERGY, V35, P612, DOI 10.1111/j.1365-2222.2005.02243.x; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Biemer PP, 2010, LATENT CLASS ANAL SU; Burr ML, 2006, THORAX, V61, P296, DOI 10.1136/thx.2005.045682; Cane R, 2001, BMC Fam Pract, V2, P4, DOI 10.1186/1471-2296-2-4; Dex S., 2005, CHILDREN 21 CENTURY; Elphick HE, 2000, EUR RESPIR J, V16, P593, DOI 10.1034/j.1399-3003.2000.16d04.x; Elphick HE, 2001, ARCH DIS CHILD, V84, P35, DOI 10.1136/adc.84.1.35; Font-Ribera L, 2009, EUR RESPIR J, V34, P1304, DOI 10.1183/09031936.00180608; Fuller E, 2006, CHILDRENS HLTH HLTH; Hedlund U, 2006, EUR RESPIR J, V28, P303, DOI 10.1183/09031936.06.00108105; Hegewald MJ, 2007, CHEST, V132, P1608, DOI 10.1378/chest.07-1405; Henderson J, 2008, THORAX, V63, P974, DOI 10.1136/thx.2007.093187; Kanervisto M, 2011, RESP MED, V105, P1140, DOI 10.1016/j.rmed.2011.03.008; Kozyrskyj AL, 2010, AM J PUBLIC HEALTH, V100, P540, DOI 10.2105/AJPH.2008.150771; Kuehni CE, 2001, LANCET, V357, P1821, DOI 10.1016/S0140-6736(00)04958-8; Leermakers ETM, 2013, EUR J CLIN NUTR, V67, P353, DOI 10.1038/ejcn.2013.36; Magidson J., 2004, SAGE HDB QUANTITATIV, P175; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Martinez FD, 2002, PEDIATRICS, V109, P362; Martinez Fernando D, 2009, Proc Am Thorac Soc, V6, P272, DOI 10.1513/pats.200808-092RM; MCCLEMENTS LD, 1977, J PUBLIC ECON, V8, P191, DOI 10.1016/0047-2727(77)90018-4; McLachlan G., 2000, WILEY SER PROB STAT; Midodzi WK, 2008, RESPIROLOGY, V13, P537, DOI 10.1111/j.1440-1843.2008.01284.x; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Oswald H, 1997, PEDIATR PULM, V23, P14, DOI 10.1002/(SICI)1099-0496(199701)23:1<14::AID-PPUL2>3.0.CO;2-P; Panico L, 2007, INT J EPIDEMIOL, V36, P1093, DOI 10.1093/ije/dym089; Pearce N, 2007, THORAX, V62, P758, DOI 10.1136/thx.2006.070169; Pedersen SE, 2011, PEDIATR PULM, V46, P1, DOI 10.1002/ppul.21321; Plewis I., 2007, INT J SOC RES METHOD, V10, P325, DOI [DOI 10.1080/13645570701676955, 10.1080/13645570701676955]; Plewis I., 2007, MILLENNIUM COHORT ST; Rusconi Franca, 2005, Epidemiol Prev, V29, P47; Savenije OE, 2011, J ALLERGY CLIN IMMUN, V127, P1505, DOI 10.1016/j.jaci.2011.02.002; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Shiue I, 2013, ALLERGY, V68, P392, DOI 10.1111/all.12091; SOYSETH V, 1995, CHEST, V107, P389, DOI 10.1378/chest.107.2.389; Speer CP, 1998, EUR RESPIR J, V12, p13S; Spycher BD, 2008, EUR RESPIR J, V31, P974, DOI 10.1183/09031936.00153507; Spycher BD, 2010, CLIN EXP ALLERGY, V40, P1130, DOI 10.1111/j.1365-2222.2010.03541.x; Spycher BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008533; StataCorp, 2009, STAT REL 2; Stein RT, 1999, AM J EPIDEMIOL, V149, P1030; Storr CL, 2004, NICOTINE TOB RES, V6, P533, DOI 10.1080/14622200410001696493; Strina A, 2014, EMERG THEMES EPIDEMI, V11, DOI 10.1186/1742-7622-11-5; Taussig LM, 2003, J ALLERGY CLIN IMMUN, V111, P661, DOI 10.1067/mai.2003.162; Vermunt JK, 1997, LEM GEN PROGRAM ANAL; von Mutius E, 2011, J ALLERGY CLIN IMMUN, V127, P1513, DOI 10.1016/j.jaci.2011.04.026; Williams DR, 2009, PEDIATRICS, V123, pS174, DOI 10.1542/peds.2008-2233H	49	39	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111922	10.1371/journal.pone.0111922	http://dx.doi.org/10.1371/journal.pone.0111922			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379671	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000344863100046
J	Chu, ZH; Lin, H; Liang, XH; Huang, RF; Zhan, Q; Jiang, JW; Zhou, XL				Chu, Zhaohui; Lin, Hao; Liang, Xiaohua; Huang, Ruofan; Zhan, Qiong; Jiang, Jingwei; Zhou, Xinli			Clinicopathologic Characteristics of Typical Medullary Breast Carcinoma: A Retrospective Study of 117 Cases	PLOS ONE			English	Article							DUCTAL CARCINOMA; RISK-FACTORS; CANCER; BASAL; SURVIVAL; FEATURES	Purpose: This study analyzed the clinicopathologic characteristics of typical medullary breast carcinoma (TMBC) in a cohort of Chinese patients. Methods: We conducted a retrospective review of clinical data including general information, pathologic results, treatment regimens, and patient survival in cases of TMBC diagnosed between February 2004 and April 2011. Results: A total of 117 patients were enrolled, with a median age of 52 years (range, 28,92 years). Stage I and II disease accounted for 31.6% and 61.6% of the cases, respectively. Hormonal receptor negative disease (estrogen receptor negative, 68.4%; progestogen receptor negative, 86.3%) was more prevalent in this population. Human epidermal growth factor receptor-2 (HER-2) positivity was 20.5%, while equivocal and HER-2 negative cases represented 16.2% and 63.2% of the cohort. The triple-negative, luminal, and HER-2 overexpressing subtypes constituted 44.4%, 31.6%, and 15.4% of the cases, respectively. The various TMBC subtypes showed no differences regarding tumor size, rates of lymph node(s) metastasis, TNM staging, treatment regimens, and 2-year recurrence rates. However, patients with triple-negative disease were more likely to be younger, when compared to those with luminal disease (P = 0.002). At a median follow-up of 56 months (range, 2-112 months), the 2-year disease-free survival and overall survival rates were 99.1% and 98.2%, respectively. Conclusion: Early stage disease dominated the study cohort, and at two years after surgery, recurrence was extremely low. The heterogeneity of molecular subtypes was clearly shown, and no apparent differences were found among the clinicopathologic characteristics of the triple-negative, luminal, and HER-2 overexpressing subtypes.	[Chu, Zhaohui; Lin, Hao; Liang, Xiaohua; Huang, Ruofan; Zhan, Qiong; Jiang, Jingwei; Zhou, Xinli] Fudan Univ, Huashan Hosp, Dept Oncol, Shanghai 200040, Peoples R China; [Chu, Zhaohui; Lin, Hao; Liang, Xiaohua; Huang, Ruofan; Zhan, Qiong; Jiang, Jingwei; Zhou, Xinli] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Zhou, XL (corresponding author), Fudan Univ, Huashan Hosp, Dept Oncol, Shanghai 200040, Peoples R China.	xinlizhou11@gmail.com			Fudan University, Shanghai, China	Fudan University, Shanghai, China	The author(s) received autonomous scientific research projects funding from Fudan University, Shanghai, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, WHO CLASSIFICATION T; Bertucci F, 2006, CANCER RES, V66, P4636, DOI 10.1158/0008-5472.CAN-06-0031; Cao AY, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-91; Chandrika, 2012, J CANCER RES THER, V8, P129, DOI 10.4103/0973-1482.95193; Dendale R, 2003, INT J BIOL MARKER, V18, P99, DOI 10.1177/172460080301800202; Eisinger F, 1998, CANCER RES, V58, P1588; Flucke U, 2010, HISTOPATHOLOGY, V56, P852, DOI 10.1111/j.1365-2559.2010.03555.x; Foschini MP, 2009, PATHOLOGY, V41, P48, DOI 10.1080/00313020802563528; Gnant M, 2011, BREAST CARE, V6, P136, DOI 10.1159/000328054; Huober J, 2012, ANN ONCOL, V23, P2843, DOI 10.1093/annonc/mds105; Jacquemier J, 2005, J PATHOL, V207, P260, DOI 10.1002/path.1845; Jensen ML, 1997, HISTOPATHOLOGY, V30, P523; Martinez SR, 2011, MED ONCOL, V28, P738, DOI 10.1007/s12032-010-9526-z; Orlando L, 2005, ANN ONCOL, V16, P1094, DOI 10.1093/annonc/mdi213; Pedersen L, 1995, EUR J CANCER, V31A, P2289, DOI 10.1016/0959-8049(95)00408-4; PERTSCHUK LP, 1990, CANCER, V66, P1663, DOI 10.1002/1097-0142(19901015)66:8<1663::AID-CNCR2820660802>3.0.CO;2-C; Pillai SKK, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-18; Pintens S, 2009, J CLIN PATHOL, V62, P624, DOI 10.1136/jcp.2008.061358; Rakha EA, 2006, J PATHOL, V208, P495, DOI 10.1002/path.1916; RAPIN V, 1988, CANCER, V61, P2503, DOI 10.1002/1097-0142(19880615)61:12<2503::AID-CNCR2820611219>3.0.CO;2-3; REINFUSS M, 1995, J SURG ONCOL, V60, P89, DOI 10.1002/jso.2930600205; RIDOLFI RL, 1977, CANCER, V40, P1365, DOI 10.1002/1097-0142(197710)40:4<1365::AID-CNCR2820400402>3.0.CO;2-N; ROSEN PP, 1995, CANCER, V75, P1320, DOI 10.1002/1097-0142(19950315)75:6<1320::AID-CNCR2820750614>3.0.CO;2-C; Vincent-Salomon A, 2007, BREAST CANCER RES, V24, P9; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Xue C, 2012, CANCER SCI, V103, P1679, DOI 10.1111/j.1349-7006.2012.02339.x	26	14	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111493	10.1371/journal.pone.0111493	http://dx.doi.org/10.1371/journal.pone.0111493			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375803	gold, Green Submitted, Green Published			2022-12-27	WOS:000344402600041
J	Arora, R; Bhushan, S; Kumar, R; Mannan, R; Kaur, P; Singh, AP; Singh, B; Vig, AP; Sharma, D; Arora, S				Arora, Rohit; Bhushan, Sakshi; Kumar, Rakesh; Mannan, Rahul; Kaur, Pardeep; Singh, Amrit Pal; Singh, Bikram; Vig, Adarsh P.; Sharma, Deepika; Arora, Saroj			Hepatic Dysfunction Induced by 7, 12-Dimethylbenz(alpha) anthracene and Its Obviation with Erucin Using Enzymatic and Histological Changes as Indicators	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; OXIDATIVE STRESS; RAT-LIVER; DMBA; ISOTHIOCYANATES; CANCER; SULFORAPHANE; BINDING; CHEMOPREVENTION; PRODUCTS	The toxicity induced by 7, 12-dimethylbenz(alpha) anthracene (DMBA) has been widely delineated by a number of researchers. This potent chemical damages many internal organs including liver, by inducing the production of reactive oxygen species, DNA-adduct formation and affecting the activities of phase I, II, antioxidant and serum enzymes. Glucosinolate hydrolytic products like isothiocyanates (ITCs) are well known for inhibiting the DNA-adduct formation and modulating phase I, II enzymes. Sulforaphane is ITC, currently under phase trials, is readily metabolized and inter-converted into erucin upon ingestion. We isolated erucin from Eruca sativa (Mill.) Thell. evaluated its hepatoprotective role in DMBA induced toxicity in male wistar rats. The rats were subjected to hepatic damage by five day regular intraperitoneal doses of DMBA. At the end of the protocol, the rats were euthanized, their blood was collected and livers were processed. The liver homogenate was analyzed for phase I (NADPH-cytochrome P450 reductase, NADH-cytochrome b5 reductase, cytochrome P450, cytochrome P420 and cytochrome b5), phase II (DT diaphorase, glutathione-S-transferase and gamma-glutamyl transpeptidase) and antioxidant enzymes (superoxide dismutase, catalase, guaiacol peroxidise, ascorbate peroxidise, glutathione reductase and lactate dehydrogenase). The level of thiobarbituric acid reactive substances, lipid hydroperoxides, conjugated dienes and reduced glutathione in the liver homogenate was also analyzed. The serum was also analyzed for markers indicating hepatic damage (alkaline phosphatase, serum glutamic oxaloacetic transaminase, serum glutamic pyruvic transaminase, direct bilirubin and total bilirubin). Erucin provided significant protection against DMBA induced damage by modulating the phase I, II and antioxidant enzymes. The histological evaluation of liver tissue was also conducted, which showed the hepatoprotective role of erucin.	[Arora, Rohit; Bhushan, Sakshi; Kumar, Rakesh; Kaur, Pardeep; Vig, Adarsh P.; Arora, Saroj] Guru Nanak Dev Univ, Dept Bot & Environm Sci, Amritsar, Punjab, India; [Mannan, Rahul] Sri Guru Ram Inst Med Sci & Res, Amritsar, Punjab, India; [Singh, Amrit Pal] Guru Nanak Dev Univ, Dept Pharmaceut Sci, Amritsar, Punjab, India; [Singh, Bikram; Sharma, Deepika] Inst Himalayan Bioresource & Technol, CSIR, Nat Plant Prod Div, Palampur, Himachal Prades, India	Guru Nanak Dev University; Guru Nanak Dev University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT)	Arora, S (corresponding author), Guru Nanak Dev Univ, Dept Bot & Environm Sci, Amritsar, Punjab, India.	sarojarora.gndu@gmail.com	Kumar, Rakesh/ABD-1065-2020; Arora, Saroj/AAV-3682-2021; Kaur, Pardeep/N-7224-2019; Arora, Rohit/AAF-8162-2020; Vig, Adarsh Pal/AAI-1312-2020; Mannan, Rahul/AAQ-2608-2021; Singh, Amrit Pal/ABI-8109-2020	Kumar, Rakesh/0000-0001-7664-0803; Arora, Saroj/0000-0002-4086-5653; Kaur, Pardeep/0000-0001-7350-7839; Vig, Adarsh Pal/0000-0003-1419-2501; Mannan, Rahul/0000-0002-6642-0468; Singh, Amrit Pal/0000-0002-7658-241X; Arora, Rohit/0000-0001-6447-5628; SHARMA, DEEPIKA/0000-0001-7627-6458	Department of Science and Technology (DST) & University Grants Commission (UGC), New Delhi; Guru Nanak Dev University, Amritsar	Department of Science and Technology (DST) & University Grants Commission (UGC), New Delhi; Guru Nanak Dev University, Amritsar	The authors thank financial support of Department of Science and Technology (DST) & University Grants Commission (UGC), New Delhi and Guru Nanak Dev University, Amritsar. Authors are thankful to UPE (under the university with potential for excellence), BSR and CPEPA programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Agca CA, 2012, PHARM BIOL, V50, P1513, DOI 10.3109/13880209.2012.688057; Ahmed HA, 2006, J EGYPT SOC TOXICOL, V35, P97; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Anzenbacherova E, 2008, PHYSIOL RES, V57, P761, DOI 10.33549/physiolres.931319; Arora R, 2014, J FOOD SCI, V79, pC1964, DOI 10.1111/1750-3841.12579; ASADA K, 1992, PHYSIOL PLANTARUM, V85, P235, DOI 10.1111/j.1399-3054.1992.tb04728.x; Blazevic I, 2009, FOOD CHEM, V113, P96, DOI 10.1016/j.foodchem.2008.07.029; Boghori M, 2014, J ORAL BIOL CRANIOFA; Carlberg I, 1975, METHOD ENZYMOL, P484; Chatterjee M, 2010, CHEM-BIOL INTERACT, V188, P102, DOI 10.1016/j.cbi.2010.06.007; Cho HJ, 2013, INT J MOL SCI, V14, P20564, DOI 10.3390/ijms141020564; Choi SJ, 2003, J BIOCHEM MOL BIOL, V36, P332; Clarke JD, 2008, CANCER LETT, V269, P291, DOI 10.1016/j.canlet.2008.04.018; Cornblatt BS, 2007, CARCINOGENESIS, V28, P1485, DOI 10.1093/carcin/bgm049; Danson S, 2004, CANCER TREAT REV, V30, P437, DOI 10.1016/j.ctrv.2004.01.002; Devasagayam TPA, 2003, INDIAN J BIOCHEM BIO, V40, P300; Dimitrova-Shumkovska J, 2010, TOXICOL PATHOL, V38, P957, DOI 10.1177/0192623310379137; Ernster, 1967, METHOD ENZYMOL, V10, P309, DOI [DOI 10.1016/0076-6879(67)10059-1, 10.1016/0076-6879(67)10059-1]; Ganin H, 2013, MEDCHEMCOMM, V4, P175, DOI 10.1039/c2md20196h; Gao J, 2005, TOXICOL SCI, V86, P68, DOI 10.1093/toxsci/kfi176; Gnaiger E., 2010, MITO PHYSL NET, V08, P1; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hanlon N, 2009, MOL NUTR FOOD RES, V53, P836, DOI 10.1002/mnfr.200800292; Harmeet Singh, 2011, European Journal of Medicinal Plants, V1, P162; Her JL, 2013, SENSOR ACTUAT B-CHEM, V182, P396, DOI 10.1016/j.snb.2013.03.026; HUBERMAN E, 1979, P NATL ACAD SCI USA, V76, P862, DOI 10.1073/pnas.76.2.862; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Izzotti A, 1999, CANCER RES, V59, P4285; JIANG ZY, 1992, ANAL BIOCHEM, V202, P384, DOI 10.1016/0003-2697(92)90122-N; Kaur R, 2013, FREE RADICAL BIO MED, V65, P131, DOI 10.1016/j.freeradbiomed.2013.06.016; Keum YS, 2004, MUTAT RES-FUND MOL M, V555, P191, DOI 10.1016/j.mrfmmm.2004.05.024; KONO Y, 1978, ARCH BIOCHEM BIOPHYS, V186, P189, DOI 10.1016/0003-9861(78)90479-4; Kumagai A, 2013, CELL, V153, P1602, DOI 10.1016/j.cell.2013.05.038; Kumar R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090083; MORSE MA, 1987, CANCER LETT, V37, P25, DOI 10.1016/0304-3835(87)90142-X; OMURA T, 1964, J BIOL CHEM, V239, P2370; OMURA T, 1970, J BIOCHEM-TOKYO, V67, P249, DOI 10.1093/oxfordjournals.jbchem.a129248; Putter J., 1974, METHODS ENZYMATIC AN, P685, DOI [DOI 10.1016/B978-0-12-091302-2.50033-5, 10.1016/B978-0-12-091302-2.50033-5]; Ravindra K, 2008, ATMOS ENVIRON, V42, P2895, DOI 10.1016/j.atmosenv.2007.12.010; Rohit Arora, 2014, International Journal of Life Sciences Biotechnology and Pharma Research, V3, P42; Schenkman JB, 2003, PHARMACOL THERAPEUT, V97, P139, DOI 10.1016/S0163-7258(02)00327-3; SCHWARTZ JH, 1963, P NATL ACAD SCI USA, V49, P871, DOI 10.1073/pnas.49.6.871; Strasak AM, 2008, CANCER RES, V68, P3970, DOI 10.1158/0008-5472.CAN-07-6686; Szaefer H, 2014, DRUG CHEM TOXICOL, V37, P472, DOI 10.3109/01480545.2014.893442; SZASZ G, 1976, CLIN CHEM, V22, P2051; Veyrand B, 2013, ENVIRON INT, V54, P11, DOI 10.1016/j.envint.2012.12.011; WONG LK, 1983, APPL ENVIRON MICROB, V46, P1239, DOI 10.1128/AEM.46.5.1239-1242.1983; YANG SK, 1975, P NATL ACAD SCI USA, V72, P2601, DOI 10.1073/pnas.72.7.2601; Yu H, 2005, INT J ENV RES PUB HE, V2, P114; Zhang YS, 2004, MUTAT RES-FUND MOL M, V555, P173, DOI 10.1016/j.mrfmmm.2004.04.017; Zhang YS, 2010, MOL NUTR FOOD RES, V54, P127, DOI 10.1002/mnfr.200900323	52	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112614	10.1371/journal.pone.0112614	http://dx.doi.org/10.1371/journal.pone.0112614			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390337	gold, Green Submitted, Green Published			2022-12-27	WOS:000349144400109
J	Gamble, AL; D'Rozario, AL; Bartlett, DJ; Williams, S; Bin, YS; Grunstein, RR; Marshall, NS				Gamble, Amanda L.; D'Rozario, Angela L.; Bartlett, Delwyn J.; Williams, Shaun; Bin, Yu Sun; Grunstein, Ronald R.; Marshall, Nathaniel S.			Adolescent Sleep Patterns and Night-Time Technology Use: Results of the Australian Broadcasting Corporation's Big Sleep Survey	PLOS ONE			English	Article							AMERICA-POLL; MEDIA USE; CHILDREN; TIME; DURATION; ASSOCIATION; DISORDERS; HEALTH; IMPACT; RISK	Introduction: Electronic devices in the bedroom are broadly linked with poor sleep in adolescents. This study investigated whether there is a dose-response relationship between use of electronic devices (computers, cellphones, televisions and radios) in bed prior to sleep and adolescent sleep patterns. Methods: Adolescents aged 11-17 yrs (n = 1,184; 67.6% female) completed an Australia-wide internet survey that examined sleep patterns, sleepiness, sleep disorders, the presence of electronic devices in the bedroom and frequency of use in bed at night. Results: Over 70% of adolescents reported 2 or more electronic devices in their bedroom at night. Use of devices in bed a few nights per week or more was 46.8% cellphone, 38.5% computer, 23.2% TV, and 15.8% radio. Device use had dose-dependent associations with later sleep onset on weekdays (highest-dose computer adjOR = 3.75: 99% CI = 2.17-6.46; cellphone 2.29: 1.22-4.30) and weekends (computer 3.68: 2.14-6.32; cellphone 3.24: 1.70-6.19; TV 2.32: 1.30-4.14), and later waking on weekdays (computer 2.08: 1.25-3.44; TV 2.31: 1.33-4.02) and weekends (computer 1.99: 1.21-3.26; cellphone 2.33: 1.33-4.08; TV 2.04: 1.18-3.55). Only 'almost every night' computer use (: 2.43: 1.45-4.08) was associated with short weekday sleep duration, and only 'almost every night' cellphone use (2.23: 1.26-3.94) was associated with wake lag (waking later on weekends). Conclusions: Use of computers, cell-phones and televisions at higher doses was associated with delayed sleep/wake schedules and wake lag, potentially impairing health and educational outcomes.	[Gamble, Amanda L.; D'Rozario, Angela L.; Bartlett, Delwyn J.; Williams, Shaun; Bin, Yu Sun; Grunstein, Ronald R.; Marshall, Nathaniel S.] Univ Sydney, NHMRC CIRUS, Sydney, NSW 2006, Australia; [D'Rozario, Angela L.; Bartlett, Delwyn J.; Grunstein, Ronald R.; Marshall, Nathaniel S.] Woolcock Inst Med Res, Sleep & Circadian Res Grp, Sydney, NSW, Australia; [Grunstein, Ronald R.] Royal Prince Alfred Hosp, Dept Sleep & Resp Failure, Sydney, NSW, Australia; [Marshall, Nathaniel S.] Univ Sydney, Sydney Nursing Sch, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; Woolcock Institute of Medical Research; University of Sydney; University of Sydney	Marshall, NS (corresponding author), Univ Sydney, NHMRC CIRUS, Sydney, NSW 2006, Australia.	nathaniel.marshall@sydney.edu.au	D'Rozario, Angela Louise/J-1626-2019; Marshall, Nathaniel S/H-7375-2019; Bin, Yu Sun/A-6944-2015; bin, yu/GQZ-1362-2022	D'Rozario, Angela Louise/0000-0001-8564-796X; Marshall, Nathaniel S/0000-0002-9014-1397; Bin, Yu Sun/0000-0002-4954-2658; 	NHMRC Centre for Integrated Research and Understanding of Sleep (CIRUS) at The University of Sydney [571421]; NHMRC Practitioner Fellowship [1022730]; NHMRC Dora Lush PhD Scholarship [633172]	NHMRC Centre for Integrated Research and Understanding of Sleep (CIRUS) at The University of Sydney; NHMRC Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Dora Lush PhD Scholarship(National Health and Medical Research Council (NHMRC) of Australia)	ABC National Science Week Big Sleep Survey was supported by the NHMRC Centre for Integrated Research and Understanding of Sleep (CIRUS) at The University of Sydney providing personnel and expertise (NHMRC grant # 571421 to Prof Grunstein providing salary support to Drs Gamble, Williams, Marshall and Ms Bin). The Australian Broadcasting Corporation hosts National Science Week and this survey and provided the IT support and advertising to collect these data. Prof Grunstein is supported by an NHMRC Practitioner Fellowship (1022730) and Dr D'Rozario by a NHMRC Dora Lush PhD Scholarship (# 633172). The NHMRC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The ABC did have a role in design data collection but no input into analyses, decision to publish or preparation of the manuscript.	Australian Bureau of Statistics (ABS), 2006, SOC IND AR SEIFA TEC; Cain N, 2010, SLEEP MED, V11, P735, DOI 10.1016/j.sleep.2010.02.006; Calamaro CJ, 2009, PEDIATRICS, V123, pE1005, DOI 10.1542/peds.2008-3641; CARSKADON MA, 1993, SLEEP, V16, P258, DOI 10.1093/sleep/16.3.258; Carskadon MA, 1998, SLEEP, V21, P871, DOI 10.1093/sleep/21.8.871; Carskadon MA, 2011, PEDIATR CLIN N AM, V58, P637, DOI 10.1016/j.pcl.2011.03.003; Carskadon MA, 2011, PROG BRAIN RES, V190, P137, DOI 10.1016/B978-0-444-53817-8.00008-6; Carter PJ, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2712; Chien KL, 2010, SLEEP, V33, P177, DOI 10.1093/sleep/33.2.177; Dahl RE, 2002, J ADOLESCENT HEALTH, V31, P175, DOI 10.1016/S1054-139X(02)00506-2; Fichter MM, 2009, SOC PSYCH PSYCH EPID, V44, P792, DOI 10.1007/s00127-009-0501-y; Fischer FM, 2008, CHRONOBIOL INT, V25, P359, DOI 10.1080/07420520802110639; Foley LS, 2013, PEDIATRICS, V131, P276, DOI 10.1542/peds.2012-1651; Gradisar M, 2013, J CLIN SLEEP MED, V9, P1291, DOI 10.5664/jcsm.3272; Gradisar M, 2011, SLEEP MED, V12, P110, DOI 10.1016/j.sleep.2010.11.008; Higuchi S, 2005, J SLEEP RES, V14, P267, DOI 10.1111/j.1365-2869.2005.00463.x; Jenni OG, 2005, SLEEP, V28, P1446, DOI 10.1093/sleep/28.11.1446; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Li SH, 2007, SLEEP, V30, P361, DOI 10.1093/sleep/30.3.361; Magee L, 2012, SLEEP MED REV, V16, P231, DOI 10.1016/j.smrv.2011.05.005; Mindell JA, 2009, SLEEP MED, V10, P771, DOI 10.1016/j.sleep.2008.07.016; Munezawa T, 2011, SLEEP, V34, P1013, DOI 10.5665/SLEEP.1152; Olds T, 2010, SLEEP MED REV, V14, P371, DOI 10.1016/j.smrv.2009.12.002; Ong SH, 2006, J AFFECT DISORDERS, V96, P1, DOI 10.1016/j.jad.2006.05.025; Owens J.A., 2005, PRINCIPLES PRACTICE, P27; Punamaki RL, 2007, J ADOLESCENCE, V30, P569, DOI 10.1016/j.adolescence.2006.07.004; Sadeh A, 2003, CHILD DEV, V74, P444, DOI 10.1111/1467-8624.7402008; Short MA, 2011, SLEEP, V34, P797, DOI 10.5665/SLEEP.1052; Spiegel K, 2005, J APPL PHYSIOL, V99, P2008, DOI 10.1152/japplphysiol.00660.2005; Tavernier R, 2014, J SLEEP RES, V23, P389, DOI 10.1111/jsr.12132; Van den Bulck J, 2004, SLEEP, V27, P101, DOI 10.1093/sleep/27.1.101; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979	32	78	80	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111700	10.1371/journal.pone.0111700	http://dx.doi.org/10.1371/journal.pone.0111700			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CP	25390034	gold, Green Submitted, Green Published			2022-12-27	WOS:000349144400030
J	Odden, M; Athreya, V; Rattan, S; Linnell, JDC				Odden, Morten; Athreya, Vidya; Rattan, Sandeep; Linnell, John D. C.			Adaptable Neighbours: Movement Patterns of GPS-Collared Leopards in Human Dominated Landscapes in India	PLOS ONE			English	Article							BARDIA NATIONAL-PARK; LARGE CARNIVORES; PANTHERA-PARDUS; CONSERVATION; WILDLIFE	Understanding the nature of the interactions between humans and wildlife is of vital importance for conflict mitigation. We equipped five leopards with GPS-collars in Maharashtra (4) and Himachal Pradesh (1), India, to study movement patterns in human-dominated landscapes outside protected areas. An adult male and an adult female were both translocated 52 km, and exhibited extensive, and directional, post release movements (straight line movements: male = 89 km in 37 days, female = 45 km in 5 months), until they settled in home ranges of 42 km(2) (male) and 65 km(2) (female). The three other leopards, two adult females and a young male were released close to their capture sites and used small home ranges of 8 km(2) (male), 11 km 2 and 15 km(2) (females). Movement patterns were markedly nocturnal, with hourly step lengths averaging 33969.5 m (SE) during night and 60 +/- 4.1 m during day, and night locations were significantly closer to human settlements than day locations. However, more nocturnal movements were observed among those three living in the areas with high human population densities. These visited houses regularly at nighttime (20% of locations,25 m from houses), but rarely during day (<1%). One leopard living in a sparsely populated area avoided human settlements both day and night. The small home ranges of the leopards indicate that anthropogenic food resources may be plentiful although wild prey is absent. The study provides clear insights into the ability of leopards to live and move in landscapes that are extremely modified by human activity.	[Odden, Morten] Hedmark Univ Coll, Fac Appl Ecol & Agr Sci, Koppang, Norway; [Athreya, Vidya] Wildlife Conservat Soc India, Bangalore, Karnataka, India; [Athreya, Vidya] Ctr Wildlife Studies, Bangalore, Karnataka, India; [Rattan, Sandeep] Himachal Pradesh Forest Dept, Wildlife Wing, Shimla, Himachal Prades, India; [Linnell, John D. C.] Norwegian Inst Nat Res, N-7004 Trondheim, Norway	Inland Norway University of Applied Sciences; Norwegian Institute Nature Research	Odden, M (corresponding author), Hedmark Univ Coll, Fac Appl Ecol & Agr Sci, Campus Evenstad, Koppang, Norway.	morten.odden@hihm.no	Linnell, John/V-4177-2019	Linnell, John/0000-0002-8370-5633	Royal Norwegian Embassy; Norwegian Research Council	Royal Norwegian Embassy; Norwegian Research Council(Research Council of NorwayEuropean Commission)	The project was funded by the Royal Norwegian Embassy and the Norwegian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athreya V., 2014, ORYX IN PRESS, DOI [10.1017/S0030605314000106, DOI 10.1017/S0030605314000106]; Athreya V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057872; Athreya V, 2011, CONSERV BIOL, V25, P133, DOI 10.1111/j.1523-1739.2010.01599.x; Balme GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035209; Banerjee K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049457; Belsare A, 2004, CAT NEWS, V41; Boitani Luigi, 2009, P15; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carter NH, 2012, P NATL ACAD SCI USA, V109, P15360, DOI 10.1073/pnas.1210490109; Deka K., 2012, J BOMBAY NATURAL HIS, V109, P153; Downs JA, 2008, J WILDLIFE MANAGE, V72, P1813, DOI 10.2193/2007-454; Fattebert J, 2013, S AFR J WILDL RES, V43, P61, DOI 10.3957/056.043.0108; Ghosal S, 2013, BIODIVERS CONSERV, V22, P2665, DOI 10.1007/s10531-013-0549-6; Hayward MW, 2006, J ZOOL, V270, P298, DOI 10.1111/j.1469-7998.2006.00139.x; Henschel P., 2008, IUCN RED LIST THREAT; Jackson P., 1996, BIOL CONSERVATION; JHALA YV, 1991, CONSERV BIOL, V5, P476, DOI 10.1111/j.1523-1739.1991.tb00354.x; Kolowski JM, 2006, BIOL CONSERV, V128, P529, DOI 10.1016/j.biocon.2005.10.021; Larue MA, 2012, J WILDLIFE MANAGE, V76, P1364, DOI 10.1002/jwmg.396; Linnell JDC, 1997, BIODIVERS CONSERV, V6, P1245, DOI 10.1023/B:BIOC.0000034011.05412.cd; Linnell John D.C., 2009, P72, DOI 10.1002/9781444312034.ch4; Marker LL, 2005, S AFR J WILDL RES, V35, P105; Martins Q, 2013, AFR J ECOL, V51, P571, DOI 10.1111/aje.12068; MOHR CO, 1947, AM MIDL NAT, V37, P223, DOI 10.2307/2421652; Muntifering JR, 2006, ANIM CONSERV, V9, P103, DOI 10.1111/j.1469-1795.2005.00008.x; Odden M, 2005, WILDLIFE BIOL, V11, P145, DOI 10.2981/0909-6396(2005)11[145:SAAPOL]2.0.CO;2; Odden M, 2009, ACTA THERIOL, V54, P23, DOI 10.1007/BF03193134; Perfecto I, 2008, ANN NY ACAD SCI, V1134, P173, DOI 10.1196/annals.1439.011; Powell RA, 2000, METH C CONS, P65; Rogers L.L., 1988, P76; Saberwal V., 2003, BATTLES NATURE SCI P; Simcharoen S, 2008, BIOL CONSERV, V141, P2242, DOI 10.1016/j.biocon.2008.06.015; Singh HS, 2005, CAT NEWS, V42; Stander PE, 1997, AFR J ECOL, V35, P156, DOI 10.1111/j.1365-2028.1997.068-89068.x; Stein AB, 2011, AFR J ECOL, V49, P383, DOI 10.1111/j.1365-2028.2011.01267.x; Woodroffe R., 2005, CONSERV BIOL; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	37	74	79	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112044	10.1371/journal.pone.0112044	http://dx.doi.org/10.1371/journal.pone.0112044			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390067	Green Published, gold, Green Submitted			2022-12-27	WOS:000349144400048
J	Yang, YW; Huang, L; Dong, Y; Zhang, HC; Zhou, W; Ban, JH; Wei, JJ; Liu, Y; Gao, J; Chen, JH				Yang, Yanwei; Huang, Li; Dong, Yan; Zhang, Hongchen; Zhou, Wei; Ban, Jinghao; Wei, Jingjing; Liu, Yan; Gao, Jing; Chen, Jihua			In Vitro Antibacterial Activity of a Novel Resin-Based Pulp Capping Material Containing the Quaternary Ammonium Salt MAE-DB and Portland Cement	PLOS ONE			English	Article							MINERAL TRIOXIDE AGGREGATE; CALCIUM HYDROXIDE; PROROOT MTA; ADHESIVE; BIOCOMPATIBILITY; PHOSPHATE; CARIES; NANOCOMPOSITES; COMPOSITES; MONOMER	Background: Vital pulp preservation in the treatment of deep caries is challenging due to bacterial infection. The objectives of this study were to synthesize a novel, light-cured composite material containing bioactive calcium-silicate (Portland cement, PC) and the antimicrobial quaternary ammonium salt monomer 2-methacryloxylethyl dodecyl methyl ammonium bromide (MAE-DB) and to evaluate its effects on Streptococcus mutans growth in vitro. Methods: The experimental material was prepared from a 2: 1 ratio of PC mixed with a resin of 2-hydroxyethylmethacrylate, bisphenol glycerolate dimethacrylate, and triethylene glycol dimethacrylate (4: 3: 1) containing 5 wt% MAE-DB. Cured resin containing 5% MAE-DB without PC served as the positive control material, and resin without MAE-DB or PC served as the negative control material. Mineral trioxide aggregate (MTA) and calcium hydroxide (Dycal) served as commercial controls. S. mutans biofilm formation on material surfaces and growth in the culture medium were tested according to colony-forming units (CFUs) and metabolic activity after 24 h incubation over freshly prepared samples or samples aged in water for 6 months. Biofilm formation was also assessed by Live/Dead staining and scanning electron microscopy. Results: S. mutans biofilm formation on the experimental material was significantly inhibited, with CFU counts, metabolic activity, viability staining, and morphology similar to those of biofilms on the positive control material. None of the materials affected bacterial growth in solution. Contact-inhibition of biofilm formation was retained by the aged experimental material. Significant biofilm formation was observed on MTA and Dycal. Conclusion: The synthesized material containing HEMA-BisGMA-TEGDMA resin with MAE-DB as the antimicrobial agent and PC to support mineralized tissue formation inhibited S. mutans biofilm formation even after aging in water for 6 months, but had no inhibitory effect on bacteria in solution. Therefore, this material shows promise as a pulp capping material for vital pulp preservation in the treatment of deep caries.	[Yang, Yanwei; Dong, Yan; Zhou, Wei; Ban, Jinghao; Wei, Jingjing; Liu, Yan; Gao, Jing; Chen, Jihua] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, State Key Lab Mil Stomatol, Xian 710032, Peoples R China; [Huang, Li] Fourth Mil Med Univ, Sch Stomatol, Dept Gen Dent & Emergency, State Key Lab Mil Stomatol, Xian 710032, Peoples R China; [Zhang, Hongchen] Fourth Mil Med Univ, Sch Nursing, Dept Clin Nursing, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Huang, L (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Dept Gen Dent & Emergency, State Key Lab Mil Stomatol, Xian 710032, Peoples R China.	519huang@fmmu.edu.cn; jhchen@fmmu.edu.cn	wei, jing/GXA-1455-2022	Chen, Ji-hua/0000-0002-1151-0693	National Natural Science Foundation of China [81200816, 81130078, 81200823]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13051]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This research was financially supported by grants from the National Natural Science Foundation of China (No. 81200816, No. 81130078 and No. 81200823) and by the Program for Changjiang Scholars and Innovative Research Team in University (No. IRT13051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accorinte MDR, 2008, J ENDODONT, V34, P1, DOI 10.1016/j.joen.2007.09.012; Aguilar FG, 2012, J ENDODONT, V38, P367, DOI 10.1016/j.joen.2011.11.002; Al-Hiyasat AS, 2006, J AM DENT ASSOC, V137, P1699, DOI 10.14219/jada.archive.2006.0116; Antonucci JM, 2012, DENT MATER, V28, P219, DOI 10.1016/j.dental.2011.10.004; Asgary S, 2009, J ENDODONT, V35, P243, DOI 10.1016/j.joen.2008.10.026; Ber BS, 2007, J ENDODONT, V33, P1231, DOI 10.1016/j.joen.2007.06.012; Bergenholtz G, 2001, Adv Dent Res, V15, P84; Beyth N, 2006, BIOMATERIALS, V27, P3995, DOI 10.1016/j.biomaterials.2006.03.003; Bjorndal L, 2001, QUINTESSENCE INT, V32, P717; Bjorndal L, 2010, EUR J ORAL SCI, V118, P290, DOI 10.1111/j.1600-0722.2010.00731.x; Borges Álvaro H, 2010, Acta odontol. latinoam., V23, P175; Camilleri J, 2005, INT ENDOD J, V38, P834, DOI 10.1111/j.1365-2591.2005.01028.x; Cheng L, 2012, DENT MATER, V28, P561, DOI 10.1016/j.dental.2012.01.005; Cheng L, 2012, DENT MATER, V28, P573, DOI 10.1016/j.dental.2012.01.006; Cox CF, 1998, AM J DENT, V11, pS55; Dammaschke T, 2010, J ENDODONT, V36, P814, DOI 10.1016/j.joen.2010.02.001; Estrela C, 2000, Braz Dent J, V11, P3; Formosa LM, 2013, DENT MATER, V29, pE11, DOI 10.1016/j.dental.2012.11.006; Gandolfi MG, 2011, DENT MATER, V27, P1055, DOI 10.1016/j.dental.2011.07.007; Gandolfi MG, 2011, DENT MATER, V27, pE134, DOI 10.1016/j.dental.2011.03.011; Hayashi M, 2011, J DENT, V39, P95, DOI 10.1016/j.jdent.2010.10.012; Huang L, 2012, J BIOMED MATER RES B, V100B, P1353, DOI 10.1002/jbm.b.32703; Huang L, 2011, ARCH ORAL BIOL, V56, P367, DOI 10.1016/j.archoralbio.2010.10.011; IMAZATO S, 1994, J DENT RES, V73, P1437, DOI 10.1177/00220345940730080701; Imazato S, 1998, J BIOMED MATER RES, V39, P511, DOI 10.1002/(SICI)1097-4636(19980315)39:4<511::AID-JBM1>3.0.CO;2-M; Kitasako Y, 1999, J DENT, V27, P257, DOI 10.1016/S0300-5712(98)00054-2; Li F, 2009, J DENT RES, V88, P372, DOI 10.1177/0022034509334499; Li F, 2014, DENT MATER, V30, P182, DOI 10.1016/j.dental.2013.11.004; Li F, 2013, DENT MATER, V29, P450, DOI 10.1016/j.dental.2013.01.012; Li F, 2009, J DENT, V37, P289, DOI 10.1016/j.jdent.2008.12.004; Min KS, 2007, J ENDODONT, V33, P163, DOI 10.1016/j.joen.2006.07.022; Miyagak Daniela Cristina, 2006, Braz. oral res., V20, P303, DOI 10.1590/S1806-83242006000400004; Momoi Y, 2012, J DENT, V40, P95, DOI 10.1016/j.jdent.2011.10.011; Namba N, 2009, DENT MATER, V25, P424, DOI 10.1016/j.dental.2008.08.012; Saidon J, 2003, ORAL SURG ORAL MED O, V95, P483, DOI 10.1067/moe.2003.20; Shayegan A, 2009, DENT TRAUMATOL, V25, P413, DOI 10.1111/j.1600-9657.2009.00799.x; Shen QY, 2010, J BIOMED MATER RES B, V94B, P141, DOI 10.1002/jbm.b.31634; Simon S R J, 2011, Adv Dent Res, V23, P340, DOI 10.1177/0022034511405327; Song JS, 2006, ORAL SURG ORAL MED O, V102, P809, DOI 10.1016/j.tripleo.2005.11.034; Torabinejad M, 2010, J ENDODONT, V36, P190, DOI 10.1016/j.joen.2009.09.010; Tran XV, 2012, J DENT RES, V91, P1166, DOI 10.1177/0022034512460833; Tziafas D, 2007, INT ENDOD J, V40, P58, DOI 10.1111/j.1365-2591.2006.01183.x; Xiao YH, 2009, J BIOMED MATER RES B, V90B, P813, DOI 10.1002/jbm.b.31350; Xiao Yu-Hong, 2008, J Oral Sci, V50, P323, DOI 10.2334/josnusd.50.323; Yasuda Yoshiyuki, 2008, J Oral Sci, V50, P309, DOI 10.2334/josnusd.50.309	45	22	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112549	10.1371/journal.pone.0112549	http://dx.doi.org/10.1371/journal.pone.0112549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389975	gold, Green Submitted, Green Published			2022-12-27	WOS:000349144400096
J	do Carmo, AM; Santos, FM; Ortiz-Agostinho, CL; Nishitokukado, I; Frota, CS; Gomes, FU; Leite, AZD; Pannuti, CS; Boas, LSV; Teixeira, MG; Sipahi, AM				do Carmo, Alexandre Medeiros; Santos, Fabiana Maria; Ortiz-Agostinho, Carmen Lucia; Nishitokukado, Ieda; Frota, Cintia S.; Gomes, Flavia Ubeda; de Arruda Leite, Andre Zonetti; Pannuti, Claudio Sergio; Vilas Boas, Lucy Santos; Teixeira, Magaly Gemio; Sipahi, Aytan Miranda			Cytomegalovirus Infection in Inflammatory Bowel Disease Is Not Associated with Worsening of Intestinal Inflammatory Activity	PLOS ONE			English	Article							ULCERATIVE-COLITIS PATIENTS; CROHNS-DISEASE; FECAL CALPROTECTIN; PREVALENCE; THERAPY	Background: Cytomegalovirus is highly prevalent virus and usually occurs in immunocompromised patients. The pathophysiology and treatment of inflammatory bowel disease often induce a state of immunosuppression. Because this, there are still doubts and controversies about the relationship between inflammatory bowel disease and cytomegalovirus. Aim: Evaluate the frequency of cytomegalovirus in patients with inflammatory bowel disease and identify correlations. Methods: Patients with inflammatory bowel disease underwent an interview, review of records and collection of blood and fecal samples. The search for cytomegalovirus was performed by IgG and IgM blood serology, by real-time PCR in the blood and by qualitative PCR in feces. Results were correlated with red blood cell levels, C-reactive protein levels, erythrocyte sedimentation rates and fecal calprotectin levels for each patient. Results: Among the 400 eligible patients, 249 had Crohn's disease, and 151 had ulcerative colitis. In the group of Crohn's disease, 67 of the patients had moderate or severe disease, but 126 patients presented with active disease, based on the evaluation of the fecal calprotectin. In patients with ulcerative colitis, only 21 patients had moderate disease, but 76 patients presented with active disease, based on the evaluation of the fecal calprotectin. A large majority of patients had positive CMV IgG. Overall, 10 patients had positive CMV IgM, and 9 patients had a positive qualitative detection of CMV DNA by PCR in the feces. All 400 patients returned negative results after the quantitative detection of CMV DNA in blood by real-time PCR. Analyzing the 19 patients with active infections, we only found that such an association occurred with the use of combined therapy (anti-TNF-alpha + azathioprine) Conclusion: The findings show that latent cytomegalovirus infections are frequent and active cytomegalovirus infection is rare. We did not find any association between an active infection of CMV and inflammatory bowel disease activity.	[do Carmo, Alexandre Medeiros; Santos, Fabiana Maria; Ortiz-Agostinho, Carmen Lucia; Nishitokukado, Ieda; Frota, Cintia S.; Gomes, Flavia Ubeda; de Arruda Leite, Andre Zonetti; Sipahi, Aytan Miranda] Univ Sao Paulo, Fac Med, Hosp Clin, Dept Gastroenterol, Sao Paulo, Brazil; [Pannuti, Claudio Sergio] Univ Sao Paulo, Fac Med, Inst Trop Med, Sao Paulo, Brazil; [Pannuti, Claudio Sergio] Univ Sao Paulo, Fac Med, Dept Doencas Infecciosas & Parasitarias LIM HC, Sao Paulo, Brazil; [Vilas Boas, Lucy Santos] Univ Sao Paulo, Fac Med LIM HC, Inst Trop Med, Sao Paulo, Brazil; [Vilas Boas, Lucy Santos] Univ Sao Paulo, Fac Med LIM HC, Hosp Clin, Sao Paulo, Brazil; [Teixeira, Magaly Gemio] Univ Sao Paulo, Fac Med, Hosp Clin, Serv Cirurgia Colon Reto & Anus,Dept Cirurgia, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	do Carmo, AM (corresponding author), Univ Sao Paulo, Fac Med, Hosp Clin, Dept Gastroenterol, LIM 07, Sao Paulo, Brazil.	amccirurgia@gmail.com	de Arruda Leite, André Zonetti/W-5660-2019; de Arruda Leite, André Z A Zonetti/G-1341-2014; Sipahi, Aytan Miranda/O-7768-2019	de Arruda Leite, André Zonetti/0000-0002-6494-8234; de Arruda Leite, André Z A Zonetti/0000-0002-6494-8234; Sipahi, Aytan Miranda/0000-0002-9686-1627; Maria dos Santos, Fabiana/0000-0003-1785-7388	FAPESP [2010/18275-8]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This project received funding from FAPESP helping to buy products to experiments (project 2010/18275-8, http://www.fapesp.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankier A T, 1991, DNA Seq, V2, P1, DOI 10.3109/10425179109008433; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Boom R, 2000, J VIROL METHODS, V84, P1, DOI 10.1016/S0166-0934(99)00127-5; CHOU SW, 1991, J INFECT DIS, V163, P1229, DOI 10.1093/infdis/163.6.1229; Criscuoli V, 2004, DIGEST LIVER DIS, V36, P818, DOI 10.1016/j.dld.2004.05.013; Criscuoli V, 2006, WORLD J GASTROENTERO, V12, P4813; Denis MA, 2007, INFLAMM BOWEL DIS, V13, P1100, DOI 10.1002/ibd.20178; Dimitroulia E, 2006, INFLAMM BOWEL DIS, V12, P879, DOI 10.1097/01.mib.0000231576.11678.57; Domenech E, 2008, INFLAMM BOWEL DIS, V14, P1373, DOI 10.1002/ibd.20498; Gisbert JP, 2009, DIGEST LIVER DIS, V41, P56, DOI 10.1016/j.dld.2008.05.008; GOODGAME RW, 1993, ANN INTERN MED, V119, P924, DOI 10.7326/0003-4819-119-9-199311010-00010; Helbling D, 2002, EUR J GASTROEN HEPAT, V14, P1393, DOI 10.1097/00042737-200212000-00018; Kambham N, 2004, AM J SURG PATHOL, V28, P365, DOI 10.1097/00000478-200403000-00009; Kandiel A, 2006, AM J GASTROENTEROL, V101, P2857, DOI 10.1111/j.1572-0241.2006.00869.x; Kim JJ, 2010, DIGEST DIS SCI, V55, P1059, DOI 10.1007/s10620-010-1126-4; Kishore J, 2004, J MED MICROBIOL, V53, P1155, DOI 10.1099/jmm.0.45629-0; Konikoff MR, 2006, INFLAMM BOWEL DIS, V12, P524, DOI 10.1097/00054725-200606000-00013; Lakatos PL, 2009, DIGEST DIS, V27, P215, DOI 10.1159/000228553; Lawlor G, 2010, INFLAMM BOWEL DIS; Leveque N, 2010, J MED VIROL, V82, P1694, DOI 10.1002/jmv.21877; Maconi G, 2005, DIGEST LIVER DIS, V37, P418, DOI 10.1016/j.dld.2005.01.011; Maher MM, 2009, DIGEST DIS SCI, V54, P2456, DOI 10.1007/s10620-008-0639-6; Matsuoka K, 2007, AM J GASTROENTEROL, V102, P331, DOI 10.1111/j.1572-0241.2006.00989.x; Onyeagocha C, 2009, AM J PATHOL, V175, P2034, DOI 10.2353/ajpath.2009.090471; ORVAR K, 1993, DIGEST DIS SCI, V38, P2307, DOI 10.1007/BF01299914; PANNUTI CS, 1985, REV I MED TROP, V27, P105, DOI 10.1590/S0036-46651985000200010; Papadakis KA, 2001, AM J GASTROENTEROL, V96, P2137, DOI 10.1111/j.1572-0241.2001.03949.x; Pickering O, 2009, PEDIATR INFECT DIS J, V28, P556, DOI 10.1097/INF.0b013e3181a39571; Pillet S, 2012, DIGEST LIVER DIS, V44, P541, DOI 10.1016/j.dld.2012.03.018; Rowshani AT, 2005, TRANSPLANTATION, V79, P381, DOI 10.1097/01.TP.0000148239.00384.F0; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; Suassuna J H, 1995, Rev Soc Bras Med Trop, V28, P105, DOI 10.1590/S0037-86821995000200003; TRUELOVE SC, 1955, BRIT MED J, V2, P1041, DOI 10.1136/bmj.2.4947.1041; Vieira Andrea, 2009, BMC Res Notes, V2, P221, DOI 10.1186/1756-0500-2-221; Vilela EG, 2012, WORLD J GASTROENTERO, V18, P872, DOI 10.3748/wjg.v18.i9.872	35	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111574	10.1371/journal.pone.0111574	http://dx.doi.org/10.1371/journal.pone.0111574			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25387236	Green Submitted, Green Published, gold			2022-12-27	WOS:000345250400022
J	Meagher, RK; Dallaire, JA; Campbell, DLM; Ross, M; Moller, SH; Hansen, SW; Diez-Leon, M; Palme, R; Mason, GJ				Meagher, Rebecca K.; Dallaire, Jamie Ahloy; Campbell, Dana L. M.; Ross, Misha; Moller, Steen H.; Hansen, Steffen W.; Diez-Leon, Maria; Palme, Rupert; Mason, Georgia J.			Benefits of a Ball and Chain: Simple Environmental Enrichments Improve Welfare and Reproductive Success in Farmed American Mink (Neovison vison)	PLOS ONE			English	Article							FERRETS MUSTELA-NIGRIPES; STEREOTYPIC BEHAVIOR; QUANTITATIVE ASSESSMENT; INDIVIDUAL-DIFFERENCES; ENRICHED ENVIRONMENTS; ACCESS; STRESS; SELECTION; PERFORMANCE; EXPERIENCE	Can simple enrichments enhance caged mink welfare? Pilot data from 756 sub-adults spanning three colour-types (strains) identified potentially practical enrichments, and suggested beneficial effects on temperament and fur-chewing. Our main experiment started with 2032 Black mink on three farms: from each of 508 families, one juvenile male-female pair was enriched (E) with two balls and a hanging plastic chain or length of hose, while a second pair was left as a non-enriched (NE) control. At 8 months, more than half the subjects were killed for pelts, and 302 new females were recruited (half enriched: 'late E'). Several signs of improved welfare or productivity emerged. Access to enrichment increased play in juveniles. E mink were calmer (less aggressive in temperament tests; quieter when handled; less fearful, if male), and less likely to fur-chew, although other stereotypic behaviours were not reduced. On one farm, E females had lower cortisol (inferred from faecal metabolites). E males tended to copulate for longer. E females also weaned more offspring: about 10% more juveniles per E female, primarily caused by reduced rates of barrenness ('late E' females also giving birth to bigger litters on one farm), effects that our data cautiously suggest were partly mediated by reduced inactivity and changes in temperament. Pelt quality seemed unaffected, but E animals had cleaner cages. In a subsidiary side-study using 368 mink of a second colour-type ('Demis'), similar temperament effects emerged, and while E did not reduce fur-chewing or improve reproductive success in this colour-type, E animals were judged to have better pelts. Overall, simple enrichments were thus beneficial. These findings should encourage welfare improvements on fur farms (which house 60-70 million mink p.a.) and in breeding centres where endangered mustelids (e.g. black-footed ferrets) often reproduce poorly. They should also stimulate future research into more effective practical enrichments.	[Meagher, Rebecca K.; Dallaire, Jamie Ahloy; Campbell, Dana L. M.; Ross, Misha; Diez-Leon, Maria; Mason, Georgia J.] Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada; [Meagher, Rebecca K.] Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC V5Z 1M9, Canada; [Moller, Steen H.; Hansen, Steffen W.] Aarhus Univ, Dept Anim Sci, Aarhus, Denmark; [Palme, Rupert] Univ Vet Med, Dept Biomed Sci Biochem, Vienna, Austria	University of Guelph; University of British Columbia; Aarhus University; University of Veterinary Medicine Vienna	Mason, GJ (corresponding author), Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada.	gmason@uoguelph.ca	Meagher, Rebecca/G-6530-2013; Campbell, Dana/S-6777-2017; Palme, Rupert/A-3499-2008	Meagher, Rebecca/0000-0002-6576-8155; Campbell, Dana/0000-0003-4028-8347; Palme, Rupert/0000-0001-9466-3662; Diez Leon, Maria/0000-0002-0105-7039; Ahloy Dallaire, Jamie/0000-0001-6515-4009; Moller, Steen Henrik/0000-0003-3086-753X	Ontario Ministry of Agriculture, Food and Rural Affairs [200116]	Ontario Ministry of Agriculture, Food and Rural Affairs	This study was supported by the Ontario Ministry of Agriculture, Food and Rural Affairs, project 200116, grant to GJM (http://www.omafra.gov.on.ca/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anna I, 2002, LAB ANIM-UK, V36, P243, DOI 10.1258/002367702320162379; Arranz L, 2010, REJUV RES, V13, P415, DOI 10.1089/rej.2009.0989; Axelsson HMK, 2009, APPL ANIM BEHAV SCI, V121, P222, DOI 10.1016/j.applanim.2009.09.013; Baran SW, 2010, ENRICH REC, V3, P4; Boinski S, 1999, ZOO BIOL, V18, P295, DOI 10.1002/(SICI)1098-2361(1999)18:4<295::AID-ZOO4>3.3.CO;2-X; Booth S, 1998, PURELY POSITIVE TRAI; Branvold HA, 2003, ZOO BIOL, V22, P1, DOI 10.1002/zoo.10066; Bronson E, 2007, J ZOO WILDLIFE MED, V38, P169, DOI 10.1638/1042-7260(2007)038[0169:MOCBFM]2.0.CO;2; Buob M, 2013, APPL ANIM BEHAV SCI, V147, P194, DOI 10.1016/j.applanim.2013.05.004; Campbell DLM, 2013, BEHAV BRAIN RES, V239, P177, DOI 10.1016/j.bbr.2012.11.004; CARLSTEAD K, 1994, ZOO BIOL, V13, P447, DOI 10.1002/zoo.1430130507; Champagne FA, 2007, BEHAV NEUROSCI, V121, P1353, DOI 10.1037/0735-7044.121.6.1353; Cooper JJ, 2000, APPL ANIM BEHAV SCI, V66, P135, DOI 10.1016/S0168-1591(99)00069-6; Dallaire JA, 2012, APPL ANIM BEHAV SCI, V142, P98, DOI 10.1016/j.applanim.2012.09.012; Dallaire JA, 2011, BEHAV BRAIN RES, V224, P213, DOI 10.1016/j.bbr.2011.03.061; Damgaard BM, 2004, APPL ANIM BEHAV SCI, V89, P163, DOI 10.1016/j.applanim.2004.04.010; Damm BI, 2010, APPL ANIM BEHAV SCI, V126, P97, DOI 10.1016/j.applanim.2010.06.009; Dawson L, 2013, APPL ANIM BEHAV SCI, V147, P224, DOI 10.1016/j.applanim.2013.04.001; Diaz-Fleischer F, 2009, J EXP BIOL, V212, P2119, DOI 10.1242/jeb.027342; Diez-Leon M., 2014, THESIS; Diez-Leon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080494; Dukas R, 2003, ANIM BEHAV, V66, P741, DOI 10.1006/anbe.2002.2261; Duncan LM, 2012, APPL ANIM BEHAV SCI, V140, P179, DOI 10.1016/j.applanim.2012.06.003; Dunstone N., 1993, MINK; European Fur Breeders Association, 2013, WELF WELF ASS PROT M, P182; European Medicines Agency, 2011, EN ROADM 2050, P1, DOI DOI 10.2810/52708; Fernandez LT, 2008, ZOO BIOL, V27, P200, DOI 10.1002/zoo.20180; Frigerio D, 2004, GEN COMP ENDOCR, V137, P29, DOI 10.1016/j.ygcen.2004.02.013; Garner JP, 2002, BEHAV BRAIN RES, V136, P83, DOI 10.1016/S0166-4328(02)00111-0; Gaskill BN, 2013, APPL ANIM BEHAV SCI, V143, P110, DOI 10.1016/j.applanim.2012.10.009; Girard I, 2002, J APPL PHYSIOL, V92, P1553, DOI 10.1152/japplphysiol.00465.2001; Gourkow N, 2006, ANIM WELFARE, V15, P371; Grafen A., 2002, MODERN STAT LIFE SCI; Hansen SW, 2007, ANIM WELFARE, V16, P63; Hansen S.W., 1990, Scientifur, V14, P187; Hansen SW, 2006, APPL ANIM BEHAV SCI, V98, P127, DOI 10.1016/j.applanim.2005.08.017; Hansen SW, 1996, APPL ANIM BEHAV SCI, V49, P137, DOI 10.1016/0168-1591(96)01045-3; Hansen SW, 2001, ACTA AGR SCAND A-AN, V51, P93, DOI 10.1080/090647001316923144; Hansen SW, 2008, ANN REP 2007, P13; Hattori S, 2007, BEHAV BRAIN RES, V180, P69, DOI 10.1016/j.bbr.2007.02.036; Held SDE, 2011, ANIM BEHAV, V81, P891, DOI 10.1016/j.anbehav.2011.01.007; Hellstedt P, 2005, J ZOOL, V266, P37, DOI 10.1017/S0952836905006618; Honess PE, 2005, ATLA-ALTERN LAB ANIM, V33, P193, DOI 10.1177/026119290503300308; HUTSON GD, 1990, APPL ANIM BEHAV SCI, V26, P363, DOI 10.1016/0168-1591(90)90035-C; Jeppesen L. L., 2004, Scientifur, V28, P11; Jeppesen L.L., 1990, Scientifur, V14, P179; Jeppesen LL, 2004, APPL ANIM BEHAV SCI, V86, P137, DOI 10.1016/j.applanim.2003.11.011; Jeppesen LL, 2000, APPL ANIM BEHAV SCI, V68, P85, DOI 10.1016/S0168-1591(00)00099-X; Joergensen G., 1985, MINK PRODUCTION; Kiik K, 2013, ZOO BIOL, V32, P387, DOI 10.1002/zoo.21062; Leone EH, 2008, POULTRY SCI, V87, P14, DOI 10.3382/ps.2007-00154; Lumeij JT, 2008, APPL ANIM BEHAV SCI, V111, P85, DOI 10.1016/j.applanim.2007.05.015; Malmkvist J, 2011, STRESS, V14, P312, DOI 10.3109/10253890.2010.547640; Malmkvist J, 2002, ANIM BEHAV, V64, P487, DOI 10.1006/anbe.2002.3058; Malmkvist J, 2013, APPL ANIM BEHAV SCI, V149, P77, DOI 10.1016/j.applanim.2013.10.001; Marashi V, 2003, HORM BEHAV, V43, P281, DOI 10.1016/S0018-506X(03)00002-3; Mason G, 2007, APPL ANIM BEHAV SCI, V102, P163, DOI 10.1016/j.applanim.2006.05.041; Mason GJ, 2004, ANIM WELFARE, V13, pS57; Mason GJ, 2001, NATURE, V410, P35, DOI 10.1038/35065157; Mason GJ., 1991, INDIVIDUAL DIFFERENC; Meagher R, 2012, CAN J ANIM SCI, V92, P131, DOI [10.4141/CJAS2011-107, 10.4141/cjas2011-107]; Meagher RK, 2013, APPL ANIM BEHAV SCI, V144, P138, DOI 10.1016/j.applanim.2013.01.008; Meagher RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049180; Meagher RK, 2011, APPL ANIM BEHAV SCI, V133, P254, DOI 10.1016/j.applanim.2011.05.009; Mellen J.D., 1998, 2 NATURE ENV ENRICHM, P329; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Miller GE, 2007, PSYCHOL BULL, V133, P25, DOI 10.1037/0033-2909.133.1.25; Mills DS., 2010, ENCY APPL ANIMAL BEH, P685; Molla MI, 2011, J APPL ANIM WELF SCI, V14, P85, DOI 10.1080/10888705.2011.551619; Mononen J, 2012, ANIM WELFARE, V21, P363, DOI 10.7120/09627286.21.3.363; Moore D.S., 1993, INTRO PRACTICE STAT; NEWBERRY RC, 1995, APPL ANIM BEHAV SCI, V44, P229, DOI 10.1016/0168-1591(95)00616-Z; NFACC, 2013, CODE PRACTICE CARE H; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; PALME R, 1994, ADVANCES IN STEROID ANALYSIS '93, P111; Palme R, 2013, WIEN TIERARZTL MONAT, V100, P238; Quinn GP, 2002, EXPERIMENTAL DESIGN; Reading RP, 2013, ZOO BIOL, V32, P332, DOI 10.1002/zoo.21054; Rojas IG, 2002, BRAIN BEHAV IMMUN, V16, P74, DOI 10.1006/brbi.2000.0619; Rosenzweig MR, 1996, BEHAV BRAIN RES, V78, P57, DOI 10.1016/0166-4328(95)00216-2; RUSHEN J, 1991, APPL ANIM BEHAV SCI, V28, P381, DOI 10.1016/0168-1591(91)90170-3; Oliveira AFS, 2010, J ETHOL, V28, P1, DOI 10.1007/s10164-009-0167-7; SCHNEIDER RR, 1993, CAN VET J, V34, P159; Scientific Committee on Animal Health and Animal Welfare, 2001, WELF AN KEPT FUR PRO; Sharp J, 2005, CONTEMP TOP LAB ANIM, V44, P32; Shepherdson D., 1994, P167; SUNDQVIST C, 1984, J REPROD FERTIL, V70, P409, DOI 10.1530/jrf.0.0700409; SUNDQVIST C, 1989, J REPROD FERTIL, V85, P413, DOI 10.1530/jrf.0.0850413; Svendsen PM, 2013, APPL ANIM BEHAV SCI, V147, P172, DOI 10.1016/j.applanim.2013.05.011; Svendsen PM, 2007, APPL ANIM BEHAV SCI, V107, P110, DOI 10.1016/j.applanim.2006.09.014; Swaisgood RR, 2005, ZOO BIOL, V24, P499, DOI 10.1002/zoo.20066; Swaisgood RR, 2001, ANIM BEHAV, V61, P447, DOI 10.1006/anbe.2000.1610; Talbot S, 2014, APPL ANIM BEHAV SCI, V151, P94, DOI 10.1016/j.applanim.2013.11.017; Tuyttens FAM, 2014, ANIM BEHAV, V90, P273, DOI 10.1016/j.anbehav.2014.02.007; van Zeeland YRA, 2009, APPL ANIM BEHAV SCI, V121, P75, DOI 10.1016/j.applanim.2009.09.006; Vinke CM, 2005, ANIM WELFARE, V14, P53; Walker MD, 2011, BEHAV BRAIN RES, V224, P207, DOI 10.1016/j.bbr.2011.06.003; Ward S, 2011, WORLD MINK OUTPUT CL; Weiss IC, 2004, BEHAV BRAIN RES, V152, P279, DOI 10.1016/j.bbr.2003.10.015; Whitaker J, 2009, LAB ANIMAL, V38, P24, DOI 10.1038/laban0109-24; Wingfield JC, 2003, J NEUROENDOCRINOL, V15, P711, DOI 10.1046/j.1365-2826.2003.01033.x; Wolf KN, 2000, ZOO BIOL, V19, P517, DOI 10.1002/1098-2361(2000)19:6<517::AID-ZOO4>3.3.CO;2-M	102	16	16	3	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e110589	10.1371/journal.pone.0110589	http://dx.doi.org/10.1371/journal.pone.0110589			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386726	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000345250400011
J	Nolet, C; Poortinga, A; Roosjen, P; Bartholomeus, H; Ruessink, G				Nolet, Corjan; Poortinga, Ate; Roosjen, Peter; Bartholomeus, Harm; Ruessink, Gerben			Measuring and Modeling the Effect of Surface Moisture on the Spectral Reflectance of Coastal Beach Sand	PLOS ONE			English	Article							AEOLIAN SEDIMENT TRANSPORT; WATER-CONTENT; WIND-TUNNEL; SOIL; ENTRAINMENT; PENETRATION; VARIABILITY; LIGHT	Surface moisture is an important supply limiting factor for aeolian sand transport, which is the primary driver of coastal dune development. As such, it is critical to account for the control of surface moisture on available sand for dune building. Optical remote sensing has the potential to measure surface moisture at a high spatio-temporal resolution. It is based on the principle that wet sand appears darker than dry sand: it is less reflective. The goals of this study are (1) to measure and model reflectance under controlled laboratory conditions as function of wavelength (l) and surface moisture (h) over the optical domain of 350-2500 nm, and (2) to explore the implications of our laboratory findings for accurately mapping the distribution of surface moisture under natural conditions. A laboratory spectroscopy experiment was conducted to measure spectral reflectance (1 nm interval) under different surface moisture conditions using beach sand. A non-linear increase of reflectance upon drying was observed over the full range of wavelengths. Two models were developed and tested. The first model is grounded in optics and describes the proportional contribution of scattering and absorption of light by pore water in an unsaturated sand matrix. The second model is grounded in soil physics and links the hydraulic behaviour of pore water in an unsaturated sand matrix to its optical properties. The optical model performed well for volumetric moisture content h v 24% (R-2 > 0.97), but underestimated reflectance for h between 24-30% (R-2 > 0.92), most notable around the 1940 nm water absorption peak. The soil-physical model performed very well (R-2 > 0.99) but is limited to 4% > theta < 24%. Results from a field experiment show that a short-wave infrared terrestrial laser scanner (lambda = 1550 nm) can accurately relate surface moisture to reflectance (standard error 2.6%), demonstrating its potential to derive spatially extensive surface moisture maps of a natural coastal beach.	[Nolet, Corjan; Poortinga, Ate] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [Roosjen, Peter; Bartholomeus, Harm] Wageningen Univ, Lab Geoinformat Sci & Remote Sensing, NL-6700 AP Wageningen, Netherlands; [Ruessink, Gerben] Univ Utrecht, Fac Geosci, Dept Phys Geog, Utrecht, Netherlands	Wageningen University & Research; Wageningen University & Research; Utrecht University	Nolet, C (corresponding author), Wageningen Univ, NL-6700 AP Wageningen, Netherlands.	corjan.nolet@wur.nl	Roosjen, Peter/F-5487-2016	Roosjen, Peter/0000-0001-6029-1047; Ruessink, Gerben/0000-0001-9526-6087; Poortinga, Ate/0000-0001-9647-2317	NatureCoast, project of technology foundation STW; Netherlands Organisation for Scientific Research (NWO); NWO through Vici project [13709]	NatureCoast, project of technology foundation STW; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO through Vici project	CN was funded by NatureCoast, project of technology foundation STW, applied science division of the Netherlands Organisation for Scientific Research (NWO). GR acknowledges additional funding by NWO through Vici project 13709. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angstrom A., 1925, GEOGR ANN, V7, P323; [Anonymous], 1998, ENV SOIL PHYS FUNDAM; Atherton RJ, 2001, J COASTAL RES, V17, P482; Bauer BO, 2009, GEOMORPHOLOGY, V105, P106, DOI 10.1016/j.geomorph.2008.02.016; Belly P.Y., 1964, SAND MOVEMENT WIND; BISAL F, 1966, SOIL SCI, V102, P143, DOI 10.1097/00010694-196609000-00001; Bochev-van der Burgh LM, 2011, COAST ENG, V58, P927, DOI 10.1016/j.coastaleng.2011.05.013; Bohren C. F., 2008, ABSORPTION SCATTERIN, DOI DOI 10.1002/9783527618156; BOWERS S. A., 1965, SOIL SCI, V100, P130, DOI 10.1097/00010694-196508000-00009; Ciani A, 2005, EUR J SOIL SCI, V56, P561, DOI 10.1111/j.1365-2389.2005.00688.x; Cornelis WM, 2003, SEDIMENTOLOGY, V50, P771, DOI 10.1046/j.1365-3091.2003.00577.x; Darke I, 2008, J COASTAL RES, V24, P1200, DOI 10.2112/00-000.1; Darke I, 2009, J COASTAL RES, V25, P248, DOI 10.2112/07-0905.1; Davidson-Arnott RGD, 2009, GEOMORPHOLOGY, V105, P117, DOI 10.1016/j.geomorph.2008.02.018; Davidson-Arnott RGD, 2005, GEOMORPHOLOGY, V68, P115, DOI 10.1016/j.geomorph.2004.04.008; de Vries S, 2014, AEOLIAN RES, V12, P75, DOI 10.1016/j.aeolia.2013.11.005; Delgado-Fernandez I, 2009, J COASTAL RES, V25; Edwards BL, 2012, J COASTAL RES; Edwards BL, 2013, EARTH SURF PROC LAND, V38, P192, DOI 10.1002/esp.3319; Elachi C., 2006, INTRO PHYS TECHNIQUE, V28; Ellis JT, 2012, AEOLIAN RES, V3, P379, DOI 10.1016/j.aeolia.2011.06.001; Hapke B., 2012, THEORY REFLECTANCE E; Hecht E., 2002, OPTICS; Hugenholtz CH, 2009, GEOMORPHOLOGY, V105, P158, DOI 10.1016/j.geomorph.2007.12.017; Huisman CE, 2011, CONT SHELF RES, V31, P1728, DOI 10.1016/j.csr.2011.07.013; IDSO SB, 1975, J APPL METEOROL, V14, P109, DOI 10.1175/1520-0450(1975)014<0109:TDOBSA>2.0.CO;2; Keijsers JG, 2014, MITIGATION ADAPTATIO, P1; Keijsers JG, 2014, J COASTAL RES; Keijsers JGS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091115; Knadel M, 2014, SOIL SCI SOC AM J, V78, P422, DOI 10.2136/sssaj2012.0401; Langston G, 2003, P CAN COAST C 2003, P15; LEKNER J, 1988, APPL OPTICS, V27, P1278, DOI 10.1364/AO.27.001278; Leu D. J., 1977, Remote Sensing of Environment, V6, P169, DOI 10.1016/0034-4257(77)90002-5; Liu WD, 2002, REMOTE SENS ENVIRON, V81, P238, DOI 10.1016/S0034-4257(01)00347-9; Lobell DB, 2002, SOIL SCI SOC AM J, V66, P722, DOI 10.2136/sssaj2002.0722; MCKENNANEUMAN C, 1989, CAN J SOIL SCI, V69, P79, DOI 10.4141/cjss89-008; Namikas SL, 2010, GEOMORPHOLOGY, V114, P303, DOI 10.1016/j.geomorph.2009.07.011; Namikas S. L., 1995, DESERT AEOLIAN PROCE, P269, DOI [10.1007/978-94-009-0067-7_13, DOI 10.1007/978-94-009-0067-7_13]; Neuman CM, 2006, EARTH SURF PROC LAND, V31, P303, DOI 10.1002/esp.1245; Nield JM, 2014, AEOLIAN RES, V12, P9, DOI 10.1016/j.aeolia.2013.10.006; Nield JM, 2011, EARTH SURF PROC LAND, V36, P513, DOI 10.1002/esp.2071; Nield JM, 2011, EARTH SURF PROC LAND, V36, P273, DOI 10.1002/esp.2102; Philpot W, 2010, P ASD IEEE GRS ART S, VII; Poortinga A, 2014, PEERJ, V2, DOI 10.7717/peerj.454; Poortinga A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074007; Poortinga A, 2011, AEOLIAN RES, V3, P81, DOI 10.1016/j.aeolia.2011.05.003; Pope RM, 1997, APPL OPTICS, V36, P8710, DOI 10.1364/AO.36.008710; R Core Team, 2012, R LANG ENV STAT COMP; Roosjen PPJ, 2012, SENSORS-BASEL, V12, P17358, DOI 10.3390/s121217358; Ruessink G, 2014, GEOPH RES ABSTR, V16; Segelstein D.J., 1981, COMPLEX REFRACTIVE I; SHUCHMAN RA, 1981, REMOTE SENS ENVIRON, V11, P295, DOI 10.1016/0034-4257(81)90027-4; SKIDMORE EL, 1975, SOIL SCI SOC AM J, V39, P238, DOI 10.2136/sssaj1975.03615995003900020009x; Solomon S., 2007, PHYS SCI BASIS WORKI; Stive MJF, 2013, J COASTAL RES, V29, P1001, DOI 10.2112/JCOASTRES-D-13-00070.1; TESTER M, 1987, PLANT CELL ENVIRON, V10, P281, DOI 10.1111/j.1365-3040.1987.tb01607.x; van Slobbe E, 2013, NAT HAZARDS, V66, P1461, DOI 10.1007/s11069-013-0612-3; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Wesseling JG, 2008, TRANSPORT POROUS MED, V71, P289, DOI 10.1007/s11242-007-9126-3; Wiggs GFS, 2004, GEOMORPHOLOGY, V59, P13, DOI 10.1016/j.geomorph.2003.09.002; Wosten J, 2001, WATER RETENTION PERM; WOSTEN JHM, 1988, SOIL SCI SOC AM J, V52, P1762, DOI 10.2136/sssaj1988.03615995005200060045x; Yang YQ, 2005, J COASTAL RES, V21, P447, DOI 10.2112/03-0111.1	63	33	35	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112151	10.1371/journal.pone.0112151	http://dx.doi.org/10.1371/journal.pone.0112151			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383709	gold, Green Published, Green Submitted			2022-12-27	WOS:000344816700035
J	Saverino, D; Pesce, G; Antola, P; Porcelli, B; Brusca, I; Villalta, D; Tampoia, M; Tozzoli, R; Tonutti, E; Alessio, MG; Bagnasco, M; Bizzaro, N				Saverino, Daniele; Pesce, Giampaola; Antola, Princey; Porcelli, Brunetta; Brusca, Ignazio; Villalta, Danilo; Tampoia, Marilina; Tozzoli, Renato; Tonutti, Elio; Alessio, Maria Grazia; Bagnasco, Marcello; Bizzaro, Nicola			High Levels of Soluble Ctla-4 Are Present in Anti-Mitochondrial Antibody Positive, but Not in Antibody Negative Patients with Primary Biliary Cirrhosis	PLOS ONE			English	Article							T-CELLS; FORM; AUTOIMMUNITY; EXPRESSION; MOLECULES; DISEASES; SERUM; CD28	Primary biliary cirrhosis (PBC) is a chronic autoimmune cholestatic liver disease frequently characterized by anti-mitochondrial autoantibodies (AMA). A minority of patients are AMA-negative. Cytotoxic-T-Lymphocyte-Antigen-4 (CTLA-4) is a surface molecule expressed on activated T-cells delivering a critical negative immunoregulatory signal. A soluble form of CTLA-4 (sCTLA-4) has been detected at high concentrations in several autoimmune diseases, and its possible functional meaning has been suggested. We aimed to evaluate sCTLA-4 concentration in sera of patients with PBC and to correlate it to immunological abnormalities associated with the disease. Blood samples were collected from 82 PBC-patients diagnosed according to international criteria (44 AMA-positive/MIT3-positive and 38 AMA-negative-MIT3-negative), and 65 controls. sCTLA-4 levels were evaluated by ELISA and Western blot. Increased sCTLA-4 concentrations were found in all AMA-positive PBC-patients, but in none of the AMA-negative ones, nor in normal controls or in controls with unrelated liver diseases. sCTLA-4 presence was associated with autoantibodies against MIT3, but not with nuclear autoantibodies (sp100, gp210). This is the first study to demonstrate that levels of sCTLA-4 are elevated in sera of PBC patients. However, they are clearly restricted to patients with AMA positivity, suggesting an immunological difference with respect to AMA-negative ones.	[Saverino, Daniele] Univ Genoa, Sect Human Anat, Dept Expt Med, Genoa, Italy; [Pesce, Giampaola; Antola, Princey; Bagnasco, Marcello] Univ Genoa, Dept Internal Med, Autoimmun Unit, I-16126 Genoa, Italy; [Porcelli, Brunetta] Univ Siena, Dept Internal Med, I-53100 Siena, Italy; [Brusca, Ignazio] Buccheri La Ferla Hosp, Dept Clin Pathol, Palermo, Italy; [Villalta, Danilo] S Maria degli Angeli Hosp, Pordenone, Italy; [Tampoia, Marilina] Univ Hosp, Clin Pathol Lab, Bari, Italy; [Tozzoli, Renato] S Maria degli Angeli Hosp, Dept Lab Med, Pordenone, Italy; [Tonutti, Elio] S Maria della Misericordia Hosp, Immunopathol & Allergol Unit, Pordenone, Italy; [Alessio, Maria Grazia] Riuniti Hosp, Dept Lab Med, Biochem Lab, Bergamo, Italy; [Bizzaro, Nicola] San Antonio Hosp, Clin Pathol Lab, Udine, Italy	University of Genoa; University of Genoa; University of Siena; Universita degli Studi di Bari Aldo Moro; Hospital Santa Maria della Misericordia; Ospedali Riuniti di Bergamo	Saverino, D (corresponding author), Univ Genoa, Sect Human Anat, Dept Expt Med, Genoa, Italy.	daniele.saverino@unige.it	Tozzoli, Renato/AAG-4067-2020; Alessio, Maria Grazia/AAW-3849-2021; Saverino, Daniele/I-4741-2014; Tampoia, Marilina/P-1811-2015; porcelli, brunetta/S-8189-2018	porcelli, brunetta/0000-0002-7447-9136; Pesce, Giampaola/0000-0002-6294-9110; Brusca, Ignazio/0000-0001-6243-7732; Tampoia, Marilina/0000-0001-9067-8808	University of Genova, Italy [PRA2012]	University of Genova, Italy	This work was funded by University of Genova, Italy (PRA2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernuzzi F, 2010, J AUTOIMMUN, V35, P176, DOI 10.1016/j.jaut.2010.06.004; Berry A, 2008, J NEGAT RESULTS BIOM, V7, DOI 10.1186/1477-5751-7-8; Bizzaro N, 2012, CLIN REV ALLERG IMMU, V42, P288, DOI 10.1007/s12016-010-8234-y; Bogdanos D, 2008, J HEPATOL, V49, P466, DOI 10.1016/j.jhep.2008.05.022; Bogdanos DP, 2011, CLIN CHIM ACTA, V412, P502, DOI 10.1016/j.cca.2010.12.019; Chen RR, 2011, J DIGEST DIS, V12, P428, DOI 10.1111/j.1751-2980.2011.00537.x; Courvalin JC, 1977, SEMINAR LIVER DIS, V17, P79; Cutolo M, 2013, AUTOIMMUN REV, V12, P758, DOI 10.1016/j.autrev.2013.01.001; Dhirapong A, 2013, HEPATOLOGY, V57, P708, DOI 10.1002/hep.26067; Duarte-Rey C, 2012, AUTOIMMUN REV, V11, P898, DOI 10.1016/j.autrev.2012.03.005; Gershwin ME, 2005, HEPATOLOGY, V42, P1194, DOI 10.1002/hep.20907; Gleicher N, 2007, J AUTOIMMUN, V28, P1, DOI 10.1016/j.jaut.2006.12.004; HARPER K, 1991, J IMMUNOL, V147, P1037; Hirschfield GM, 2011, ISR MED ASSOC J, V13, P55; Hohenester S, 2009, SEMIN IMMUNOPATHOL, V31, P283, DOI 10.1007/s00281-009-0164-5; Hudson M, 2008, J AUTOIMMUN, V31, P156, DOI 10.1016/j.jaut.2008.05.002; Invernizzi P, 2010, DIGEST LIVER DIS, V42, P401, DOI 10.1016/j.dld.2010.02.014; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; Karandikar NJ, 1996, J EXP MED, V184, P783, DOI 10.1084/jem.184.2.783; Kumagi T, 2008, CLIN LIVER DIS, V12, P243, DOI 10.1016/j.cld.2008.02.014; Liu HY, 2010, J AUTOIMMUN, V35, P436, DOI 10.1016/j.jaut.2010.09.005; Longhi MS, 2004, J HEPATOL, V41, P31, DOI 10.1016/j.jhep.2004.03.008; Magistrelli G, 1999, EUR J IMMUNOL, V29, P3596, DOI 10.1002/(SICI)1521-4141(199911)29:11<3596::AID-IMMU3596>3.0.CO;2-Y; Milkiewicz P, 2008, CLIN LIVER DIS, V12, P461, DOI 10.1016/j.cld.2008.02.015; Oaks MK, 2000, J IMMUNOL, V164, P5015, DOI 10.4049/jimmunol.164.10.5015; Pares A, 2006, GASTROENTEROLOGY, V130, P715, DOI 10.1053/j.gastro.2005.12.029; Riccio AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037980; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; Sato S, 2004, RHEUMATOLOGY, V43, P1261, DOI 10.1093/rheumatology/keh303; Saverino D, 2007, CLIN IMMUNOL, V123, P190, DOI 10.1016/j.clim.2007.01.003; Saverino D, 2010, AUTOIMMUN HIGHLIGHTS, V1, P73, DOI 10.1007/s13317-010-0011-7; Selmi C, 2008, J HEPATOL, V49, P451, DOI 10.1016/j.jhep.2008.06.006; Simone R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/215763; Simone R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044654; Simone R, 2009, INT IMMUNOL, V21, P1037, DOI 10.1093/intimm/dxp069; Smyk D, 2011, AUTOIMMUN DIS, V2011, DOI 10.4061/2011/189585; Smyk DS, 2012, AUTOIMMUN HIGHLIGHTS, V3, P1, DOI 10.1007/s13317-011-0023-y; Wang XB, 2002, J NEUROIMMUNOL, V130, P224, DOI 10.1016/S0165-5728(02)00228-X; Wong CK, 2005, RHEUMATOLOGY, V44, P989, DOI 10.1093/rheumatology/keh663	39	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112509	10.1371/journal.pone.0112509	http://dx.doi.org/10.1371/journal.pone.0112509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383768	Green Submitted, Green Published, gold			2022-12-27	WOS:000344816700072
J	Xu, Y; Zhang, JX; Wang, J				Xu, Yu; Zhang, Jixiang; Wang, Jun			The Efficacy and Safety of Selective H-1-Antihistamine versus Leukotriene Receptor Antagonist for Seasonal Allergic Rhinitis: A Meta-Analysis	PLOS ONE			English	Article							DOUBLE-BLIND; MONTELUKAST; LORATADINE; SYMPTOMS; COMBINATION; HISTAMINE; LEVOCETIRIZINE; DESLORATADINE; DRUGS	Background: Both selective H-1-antihistamine (SAH) and leukotriene receptor antagonist (LTRA) have been shown to be effective in treating patients with seasonal allergic rhinitis (SAR), but it is still uncertain which treatment option is optimal. This meta-analysis was aimed to compare the efficacy and safety of SAH and LTRA for SAR. Materials and Methods: PubMed, EMBASE and the Cochrane Library were searched for all eligible studies that compared the efficacy and safety of SAH and LTRA for SAR up to September 7, 2014. The pooled mean difference (MD), odd ratios (ORs) and 95% confidence intervals (95% CIs) were calculated using a fixed- or random-effects model. Results: Nine studies with 5781 SAR patients were included. The results showed that SAH is superior to LTRA in terms of the daytime eye symptoms score (DESS) and composite symptoms score (CSS) for SAR (MD = 0.06, 95% CI, 0.03 to 0.10, P = 0.000, I-2 = 99%; MD = 0.03, 95% CI, 0.01 to 0.05, P = 0.010, I-2 = 98%), whereas LTRA overmatched SAH with respect to the night-time symptoms score (NSS) (MD = -0.04, 95% CI, -0.05 to -0.02, P = 0.000, I-2 = 97%). Additionally, the results of subgroup analysis indicated that the dose, duration and gender of the patients might impact the comparisons of the effects of SAH and LTRA on their efficacy for SAR. Conclusion: This meta-analysis suggested that SAH and LTRA have similar effects and safety for SAR, but SAH is more appropriate for daytime nasal symptoms (congestion, rhinorrhea, pruritus and sneezing), while LTRA is better suited for nighttime symptoms (difficulty going to sleep, nighttime awakenings, and nasal congestion on awakening), respectively. Meanwhile, the dose, duration and gender of patients may influence the anti-SAR effects of SAH and LTRA.	[Xu, Yu] Wuhan Univ, Renmin Hosp, Dept Otolaryngol, Wuhan 430060, Hubei Province, Peoples R China; [Zhang, Jixiang; Wang, Jun] Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430060, Hubei Province, Peoples R China	Wuhan University; Wuhan University	Xu, Y (corresponding author), Wuhan Univ, Renmin Hosp, Dept Otolaryngol, Wuhan 430060, Hubei Province, Peoples R China.	xy37138@163.com						Baena-Cagnani CE, 2003, INT ARCH ALLERGY IMM, V130, P307, DOI 10.1159/000070218; Bozek A, 2013, AM J RHINOL ALLERGY, V27, pE140, DOI 10.2500/ajra.2013.27.3920; Castillo J, 2014, EXPERT OPIN INV DRUG, V23, P823, DOI 10.1517/13543784.2014.907271; Ciebiada M, 2006, ANN ALLERG ASTHMA IM, V97, P664, DOI 10.1016/S1081-1206(10)61098-8; Cobanoglu B, 2013, CURR ALLERGY ASTHM R, V13, P203, DOI 10.1007/s11882-013-0341-4; Dranitsaris G, 2014, J EVAL CLIN PRACT, V20, P225, DOI 10.1111/jep.12112; Jacobs RL, 2011, EXPERT REV CLIN IMMU, V7, P735, DOI [10.1586/eci.11.70, 10.1586/ECI.11.70]; Kanaoka Y, 2014, ALLERGY ASTHMA IMMUN, V6, P288, DOI 10.4168/aair.2014.6.4.288; Kurowski M, 2004, ALLERGY, V59, P280, DOI 10.1046/j.1398-9995.2003.00416.x; Lagos Jaime A, 2007, Ther Clin Risk Manag, V3, P327, DOI 10.2147/tcrm.2007.3.2.327; Leung AKC, 2013, RECENT PATENTS INFLA, V7, P187, DOI 10.2174/1872213X113079990022; Lu S, 2009, J ASTHMA, V46, P878, DOI 10.3109/02770900903104540; Marazziti D, 2013, CNS SPECTRUMS, V18, P118, DOI 10.1017/S1092852912001010; Meltzer EO, 2013, ALLERGY ASTHMA PROC, V34, P301, DOI 10.2500/aap.2013.34.3676; Meltzer EO, 2009, J ALLERGY CLIN IMMUN, V124, pS43, DOI 10.1016/j.jaci.2009.05.013; Meltzer EO, 2000, J ALLERGY CLIN IMMUN, V105, P917, DOI 10.1067/mai.2000.106040; Michele TM, 2000, J ALLERGY CLIN IMMUN, V105, pS387, DOI 10.1016/S0091-6749(00)91557-4; Mygind N, 2014, CHEM IMMUNOL ALLERGY, V100, P62, DOI 10.1159/000358505; Nathan RA, 2003, ANN ALLERG ASTHMA IM, V90, P182, DOI 10.1016/S1081-1206(10)62138-2; Nayak AS, 2002, ANN ALLERG ASTHMA IM, V88, P592, DOI 10.1016/S1081-1206(10)61891-1; O'Mahony L, 2011, J ALLERGY CLIN IMMUN, V128, P1153, DOI 10.1016/j.jaci.2011.06.051; Patel P, 2008, ANN ALLERG ASTHMA IM, V101, P287, DOI 10.1016/S1081-1206(10)60494-2; Philip G, 2002, CLIN EXP ALLERGY, V32, P1020, DOI 10.1046/j.1365-2222.2002.01422.x; Platt M, 2014, INT FORUM ALLERGY RH, V4, pS35, DOI 10.1002/alr.21381; Santos CB, 2008, ALLERGY ASTHMA PROC, V29, P140, DOI 10.2500/aap.2008.29.3097; Shakouri AA, 2013, ALLERGY ASTHMA PROC, V34, P488, DOI 10.2500/aap.2013.34.3699; Shirasaki H, 2013, ALLERGOL INT, V62, P223, DOI 10.2332/allergolint.12-OA-0490; Simons FER, 2011, J ALLERGY CLIN IMMUN, V128, P1139, DOI 10.1016/j.jaci.2011.09.005; Simons FER, 2004, NEW ENGL J MED, V351, P2203, DOI 10.1056/NEJMra033121; Singh RK, 2013, J ASTHMA, V50, P922, DOI 10.3109/02770903.2013.823447; Spoletini Ilaria, 2012, Handb Exp Pharmacol, P91, DOI 10.1007/978-3-642-30726-3_5; van Adelsberg J, 2003, ALLERGY, V58, P1268, DOI 10.1046/j.1398-9995.2003.00261.x; van Adelsberg J, 2003, ANN ALLERG ASTHMA IM, V90, P214, DOI 10.1016/S1081-1206(10)62144-8; Van Hoecke H, 2007, DRUGS, V67, P2717, DOI 10.2165/00003495-200767180-00006; Wan GH, 2013, PEDIATR RES, V74, P584, DOI 10.1038/pr.2013.142; Wang K, 2014, LANCET RESP MED, V2, P35, DOI 10.1016/S2213-2600(13)70245-5	36	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112815	10.1371/journal.pone.0112815	http://dx.doi.org/10.1371/journal.pone.0112815			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383622	Green Published, Green Submitted, gold			2022-12-27	WOS:000344816700097
J	Seelenfreund, E; Robinson, WA; Amato, CM; Tan, AC; Kim, J; Robinson, SE				Seelenfreund, Eric; Robinson, William A.; Amato, Carol M.; Tan, Aik-Choon; Kim, Jihye; Robinson, Steven E.			Long Term Storage of Dry versus Frozen RNA for Next Generation Molecular Studies	PLOS ONE			English	Article							SEQ; TOPHAT; ACIDS; GENE	The standard method for the storage and preservation of RNA has been at ultra-low temperatures. However, reliance on liquid nitrogen and freezers for storage of RNA has multiple downsides. Recently new techniques have been developed for storing RNA at room temperature utilizing desiccation and are reported to be an effective alternative for preserving RNA integrity. In this study we compared frozen RNA samples stored for up to one year to those which had been desiccated using RNAstable (Biomatrica, Inc., San Diego, CA) and stored at room temperature. RNA samples were placed in aliquots and stored after desiccation or frozen (at -80 degrees C), and were analyzed for RNA Integrity Number (RIN), and by qPCR, and RNA sequencing. Our study shows that RNAstable is able to preserve desiccated RNA samples at room temperature for up to one year, and that RNA preserved by desiccation is comparable to cryopreserved RNA for downstream analyses including real-time-PCR and RNA sequencing.	[Seelenfreund, Eric; Robinson, William A.; Amato, Carol M.; Tan, Aik-Choon; Kim, Jihye; Robinson, Steven E.] Univ Colorado, Dept Med Oncol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Robinson, SE (corresponding author), Univ Colorado, Dept Med Oncol, Anschutz Med Campus, Aurora, CO 80045 USA.	steven.robinson@ucdenver.edu	Tan, Aik Choon/A-3135-2011	Tan, Aik Choon/0000-0003-2955-8369; Robinson, William/0000-0003-1875-9691	Moore Family Fund; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER	Moore Family Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by The Moore Family Fund. The funder had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Biomatrica, 2009, RNASTABLE HDB; CBS News Staff, 2012, FREEZ MALF THAWS 150; Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Hernandez GE, 2009, BIOTECHNIQUES, V47, P667, DOI 10.2144/000113209; Keysar SB, 2013, MOL ONCOL, V7, P776, DOI 10.1016/j.molonc.2013.03.004; Kuntzman G, 2012, NY DAILY NEWS   1030; Lou JJ, 2014, CLIN BIOCHEM, V47, P267, DOI 10.1016/j.clinbiochem.2013.12.011; Mareninov S, 2013, J NEURO-ONCOL, V113, P365, DOI 10.1007/s11060-013-1135-1; Mathay C, 2012, BIOPRESERV BIOBANK, V10, P532, DOI 10.1089/bio.2012.0030; Oivanen M, 1998, CHEM REV, V98, P961, DOI 10.1021/cr960425x; Stevens DS, 2012, J VIROL METHODS, V182, P104, DOI 10.1016/j.jviromet.2012.03.006; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Ware KE, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.4	18	25	29	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e111827	10.1371/journal.pone.0111827	http://dx.doi.org/10.1371/journal.pone.0111827			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25380187	gold, Green Submitted, Green Published			2022-12-27	WOS:000344863100043
J	Strijbis, K; Yilmaz, OH; Dougan, SK; Esteban, A; Grone, A; Kumamoto, CA; Ploegh, HL				Strijbis, Karin; Yilmaz, Oemer H.; Dougan, Stephanie K.; Esteban, Alexandre; Groene, Andrea; Kumamoto, Carol A.; Ploegh, Hidde L.			Intestinal Colonization by Candida albicans Alters Inflammatory Responses in Bruton's Tyrosine Kinase-Deficient Mice	PLOS ONE			English	Article							INDUCED COLITIS; CELL DEVELOPMENT; BOWEL DISEASES; DECTIN-1; MICROBIOTA; DISTINCT; LINEAGE; FUNGI; YEAST	The commensal yeast Candida albicans is part of the human intestinal microflora and is considered a "pathobiont", a resident microbe with pathogenic potential yet harmless under normal conditions. The aim of this study was to investigate the effect of C. albicans on inflammation of the intestinal tract and the role of Bruton's tyrosine kinase (Btk). Btk is an enzyme that modulates downstream signaling of multiple receptors involved in innate and adaptive immunity, including the major anti-fungal receptor Dectin-1. Colitis was induced in wild type and Btk-/- mice by treatment with dextran sodium sulfate (DSS) and the gastrointestinal tract of selected treatment groups were then colonized with C. albicans. Colonization by C. albicans neither dampened nor exacerbated inflammation in wild type mice, but colon length and spleen weight were improved in Btk-deficient mice colonized with C. albicans. Neutrophil infiltration was comparable between wild type and Btk-/- mice, but the knockout mice displayed severely reduced numbers of macrophages in the colon during both DSS and DSS/Candida treatment. Smaller numbers and reduced responsiveness of Btk-/- macrophages might partially explain the improved colon length of Btk-/- mice as a result of Candida colonization. Surprisingly, DSS/Candida-treated Btk-/- animals had higher levels of certain pro-inflammatory cytokines and levels of the anti-inflammatory cytokine TGF-beta were reduced compared to wild type. A clustering and correlation analysis showed that for wild type animals, spleen TGF-beta and colon IL-10 and for Btk-/- spleen and colon levels of IL-17A best correlated with the inflammatory parameters. We conclude that in Btk-/- immunocompromised animals, colonization of the gastrointestinal tract by the commensal yeast C. albicans alters inflammatory symptoms associated with colitis.	[Strijbis, Karin; Yilmaz, Oemer H.; Dougan, Stephanie K.; Esteban, Alexandre; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Groene, Andrea] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands; [Kumamoto, Carol A.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Utrecht University; Tufts University	Strijbis, K (corresponding author), Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands.	K.Strijbis@uu.nl	Esteban, Alexandre/H-5629-2015	Esteban, Alexandre/0000-0002-7448-4314; Strijbis, Karin/0000-0001-9167-7137	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG045144, K99AG045144] Funding Source: NIH RePORTER; NIA NIH HHS [K99 AG045144, R00 AG045144] Funding Source: Medline; NIGMS NIH HHS [R01 GM100518] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brown DH, 1999, LICHENOLOGIST, V31, P1; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Downward JRE, 2013, SCI REP-UK, V3, DOI 10.1038/srep02191; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Gladiator A, 2013, J IMMUNOL, V190, P521, DOI 10.4049/jimmunol.1202924; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Gow NAR, 2012, CURR OPIN MICROBIOL, V15, P406, DOI 10.1016/j.mib.2012.04.005; Hamad I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040888; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Heinsbroek SEM, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-33; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Honda F, 2012, NAT IMMUNOL, V13, P369, DOI 10.1038/ni.2234; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Jawhara S, 2008, J INFECT DIS, V197, P972, DOI 10.1086/528990; Jawhara S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040648; Jawhara S, 2012, J BIOL CHEM, V287, P11313, DOI 10.1074/jbc.M111.329300; Jongstra-Bilen J, 2008, J IMMUNOL, V181, P288, DOI 10.4049/jimmunol.181.1.288; Katayama M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062231; KERNER JD, 1995, IMMUNITY, V3, P301, DOI 10.1016/1074-7613(95)90115-9; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Koh AY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040035; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Li Q., 2013, J CLIN GASTROENTEROL, V00, P000; Mangla A, 2004, BLOOD, V104, P1191, DOI 10.1182/blood-2004-01-0207; Mason KL, 2012, INFECT IMMUN, V80, P3371, DOI 10.1128/IAI.00449-12; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Miranda LN, 2009, J HOSP INFECT, V72, P9, DOI 10.1016/j.jhin.2009.02.009; Monteleone I, 2012, CURR MOL MED, V12, P592, DOI 10.2174/156652412800620066; Mukhopadhyay S, 1999, J IMMUNOL, V163, P1786; Nucci M, 2001, CLIN INFECT DIS, V33, P1959, DOI 10.1086/323759; Olszak T, 2014, NATURE; Ott SJ, 2008, SCAND J GASTROENTERO, V43, P831, DOI 10.1080/00365520801935434; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pierce JV, 2012, MBIO, V3, DOI 10.1128/mBio.00117-12; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schulze J, 2009, DTSCH ARZTEBL INT, V106, P837, DOI 10.3238/arztebl.2009.0837; Seow CH, 2009, AM J GASTROENTEROL, V104, P1426, DOI 10.1038/ajg.2009.79; Shulzhenko N, 2011, NAT MED, V17, P1585, DOI 10.1038/nm.2505; Strijbis K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003446; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Vautier S, 2012, INFECT IMMUN, V80, P4216, DOI 10.1128/IAI.00559-12; Wheeler RT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000227; White SJ, 2007, PLOS PATHOG, V3, P1866, DOI 10.1371/journal.ppat.0030184	48	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2014	9	11							e112472	10.1371/journal.pone.0112472	http://dx.doi.org/10.1371/journal.pone.0112472			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3WF	25379804	Green Published, gold			2022-12-27	WOS:000344863100104
J	Dey, P; Mall, N; Chattopadhyay, A; Chakraborty, M; Maiti, MK				Dey, Prabuddha; Mall, Nikunj; Chattopadhyay, Atrayee; Chakraborty, Monami; Maiti, Mrinal K.			Enhancement of Lipid Productivity in Oleaginous Colletotrichum Fungus through Genetic Transformation Using the Yeast CtDGAT2b Gene under Model-Optimized Growth Condition	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; SEED OIL CONTENT; EXPRESSION; TUMEFACIENS; BIODIESEL; BIOSYNTHESIS; INCREASE	Oleaginous fungi are of special interest among microorganisms for the production of lipid feedstocks as they can be cultured on a variety of substrates, particularly waste lingocellulosic materials, and few fungal strains are reported to accumulate inherently higher neutral lipid than bacteria or microalgae. Previously, we have characterized an endophytic filamentous fungus Colletotrichum sp. DM06 that can produce total lipid ranging from 34% to 49% of its dry cell weight (DCW) upon growing with various carbon sources and nutrient-stress conditions. In the present study, we report on the genetic transformation of this fungal strain with the CtDGAT2b gene, which encodes for a catalytically efficient isozyme of type-2 diacylglycerol acyltransferase (DGAT) from oleaginous yeast Candida troplicalis SY005. Besides the increase in size of lipid bodies, total lipid titer by the transformed Colletotrichum (lipid content similar to 73% DCW) was found to be similar to 1.7-fold more than the wild type (lipid content similar to 38% DCW) due to functional activity of the CtDGAT2b transgene when grown under standard condition of growth without imposition of any nutrient-stress. Analysis of lipid fractionation revealed that the neutral lipid titer in transformants increased up to 1.8-, 1.6- and 1.5-fold compared to the wild type when grown under standard, nitrogen stress and phosphorus stress conditions, respectively. Lipid titer of transformed cells was further increased to 1.7-fold following model-based optimization of culture conditions. Taken together, similar to 2.9-fold higher lipid titer was achieved in Colletotrichum fungus due to overexpression of a rate-limiting crucial enzyme of lipid biosynthesis coupled with prediction-based bioprocess optimization.	[Dey, Prabuddha; Chakraborty, Monami; Maiti, Mrinal K.] Indian Inst Technol, Adv Technol Dev Ctr, Adv Lab Plant Genet Engn, Kharagpur 721302, W Bengal, India; [Mall, Nikunj; Chattopadhyay, Atrayee; Maiti, Mrinal K.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur	Maiti, MK (corresponding author), Indian Inst Technol, Adv Technol Dev Ctr, Adv Lab Plant Genet Engn, Kharagpur 721302, W Bengal, India.	maitimk@hijli.iitkgp.ernet.in			Institute Scheme for Innovative Research and Development (ISIRD); Sponsored Research and Industrial Consultancy (SRIC); Indian Institute of Technology (IIT)-Kharagpur	Institute Scheme for Innovative Research and Development (ISIRD); Sponsored Research and Industrial Consultancy (SRIC); Indian Institute of Technology (IIT)-Kharagpur	Grant support from Institute Scheme for Innovative Research and Development (ISIRD), Sponsored Research and Industrial Consultancy (SRIC), Indian Institute of Technology (IIT)-Kharagpur is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageitos JM, 2011, APPL MICROBIOL BIOT, V90, P1219, DOI 10.1007/s00253-011-3200-z; Beopoulos A, 2009, PROG LIPID RES, V48, P375, DOI 10.1016/j.plipres.2009.08.005; Betts MF, 2007, FUNGAL GENET BIOL, V44, P1035, DOI 10.1016/j.fgb.2007.05.001; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bouvier-Nave P, 2000, EUR J BIOCHEM, V267, P85, DOI 10.1046/j.1432-1327.2000.00961.x; BUNDOCK P, 1995, EMBO J, V14, P3206, DOI 10.1002/j.1460-2075.1995.tb07323.x; Chen JQ, 1999, J AGR BIOTECH, V7, P316; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Courchesne NMD, 2009, J BIOTECHNOL, V141, P31, DOI 10.1016/j.jbiotec.2009.02.018; Davis MS, 2000, J BIOL CHEM, V275, P28593, DOI 10.1074/jbc.M004756200; de Groot MJA, 1998, NAT BIOTECHNOL, V16, P839, DOI 10.1038/nbt0998-839; Dey P, 2017, PLOS ONE, V12, DOI [10.1371/journal.pone.0094472, 10.1371/journal.pone.0187146]; Dey P, 2013, J APPL MICROBIOL, V114, P1357, DOI 10.1111/jam.12133; Dey P, 2011, BIORESOURCE TECHNOL, V102, P5815, DOI 10.1016/j.biortech.2011.02.064; Dunahay TG, 1996, APPL BIOCHEM BIOTECH, V57-8, P223, DOI 10.1007/BF02941703; Fakas S, 2009, BIOMASS BIOENERG, V33, P573, DOI 10.1016/j.biombioe.2008.09.006; Gatenby CM, 2003, J APPL PHYCOL, V15, P1, DOI 10.1023/A:1022929423011; Guo Y, 2010, BIORESOURCE TECHNOL, V101, P8784, DOI 10.1016/j.biortech.2010.06.072; Jako C, 2001, PLANT PHYSIOL, V126, P861, DOI 10.1104/pp.126.2.861; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kimura K, 2004, J MICROBIOL METH, V56, P331, DOI 10.1016/j.mimet.2003.10.018; Li Q, 2008, APPL MICROBIOL BIOT, V80, P749, DOI 10.1007/s00253-008-1625-9; Liang MH, 2013, PROG LIPID RES, V52, P395, DOI 10.1016/j.plipres.2013.05.002; Meng X, 2009, RENEW ENERG, V34, P1, DOI 10.1016/j.renene.2008.04.014; Mullins ED, 2001, CELL MOL LIFE SCI, V58, P2043, DOI 10.1007/PL00000835; NAGANUMA T, 1985, J GEN APPL MICROBIOL, V31, P29, DOI 10.2323/jgam.31.29; Oakes J, 2011, PLANT PHYSIOL, V155, P1146, DOI 10.1104/pp.110.167676; Pal MP, 2009, J IND MICROBIOL BIOT, V36, P747, DOI 10.1007/s10295-009-0547-6; Papanikolaou S, 2004, BIORESOURCE TECHNOL, V95, P287, DOI 10.1016/j.biortech.2004.02.016; Rangasamy D, 2000, PLANT PHYSIOL, V122, P1231, DOI 10.1104/pp.122.4.1231; Ratledge C, 2002, BIOCHEM SOC T, V30, P1047, DOI 10.1042/bst0301047; Rho HS, 2001, MOL CELLS, V12, P407; Rogers CW, 2004, FEMS MICROBIOL LETT, V241, P207, DOI 10.1016/j.femsle.2004.10.022; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Tai M, 2013, METAB ENG, V15, P1, DOI 10.1016/j.ymben.2012.08.007; Takahara Hiroyuki, 2004, Journal of General Plant Pathology, V70, P93, DOI 10.1007/s10327-003-0099-y; Walker TL, 2005, PLANT CELL REP, V24, P629, DOI 10.1007/s00299-005-0004-6; Weld RJ, 2006, J MICROBIOL METH, V65, P202, DOI 10.1016/j.mimet.2005.07.010; Wu SG, 2011, BIORESOURCE TECHNOL, V102, P1803, DOI 10.1016/j.biortech.2010.09.033; Wu SG, 2010, BIORESOURCE TECHNOL, V101, P6124, DOI 10.1016/j.biortech.2010.02.111; Zhang Y, 2007, MICROBIOL-SGM, V153, P2013, DOI 10.1099/mic.0.2006/002683-0; Zheng P, 2008, NAT GENET, V40, P367, DOI 10.1038/ng.85; Zou JT, 1997, PLANT CELL, V9, P909, DOI 10.1105/tpc.9.6.909	43	8	8	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2014	9	11							e111253	10.1371/journal.pone.0111253	http://dx.doi.org/10.1371/journal.pone.0111253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS6XM	25375973	Green Published, gold, Green Submitted			2022-12-27	WOS:000344402600033
J	Yu, J; Yu, B; He, J; Zheng, P; Mao, XB; Han, GQ; Chen, DW				Yu, Jie; Yu, Bing; He, Jun; Zheng, Ping; Mao, Xiangbing; Han, Guoquan; Chen, Daiwen			Chronic Glucocorticoid Exposure-Induced Epididymal Adiposity Is Associated with Mitochondrial Dysfunction in White Adipose Tissue of Male C57BL/6J Mice	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; GROWTH-FACTOR 21; METABOLIC SYNDROME; CUSHINGS-SYNDROME; HUMAN ADIPOCYTES; PRIMARY SITE; LIPOLYSIS; CORTICOSTERONE; BIOGENESIS; ROSIGLITAZONE	Prolonged and excessive glucocorticoids (GC) exposure resulted from Cushing's syndrome or GC therapy develops central obesity. Moreover, mitochondria are crucial in adipose energy homeostasis. Thus, we tested the hypothesis that mitochondrial dysfunction may contribute to chronic GC exposure-induced epididymal adiposity in the present study. A total of thirty-six 5-week-old male C57BL/6J mice (similar to 20 g) were administrated with 100 mu g/ml corticosterone (CORT) or vehicle through drinking water for 4 weeks. Chronic CORT exposure mildly decreased body weight without altering food and water intake in mice. The epididymal fat accumulation was increased, but adipocyte size was decreased by CORT. CORT also increased plasma CORT, insulin, leptin, and fibroblast growth factor 21 concentrations as measured by RIA or ELISA. Interestingly, CORT increased plasma levels of triacylglycerols and nonesterified fatty acids, and up-regulated the expression of both lipolytic and lipogenic genes as determined by real-time RT-PCR. Furthermore, CORT impaired mitochondrial biogenesis and oxidative function in epididymal WAT. The reactive oxygen species production was increased and the activities of anti-oxidative enzymes were reduced by CORT treatment as well. Taken together, these findings reveal that chronic CORT administration-induced epididymal adiposity is, at least in part, associated with mitochondrial dysfunction in mouse epididymal white adipose tissue.	[Yu, Jie; Yu, Bing; He, Jun; Zheng, Ping; Mao, Xiangbing; Han, Guoquan; Chen, Daiwen] Sichuan Agr Univ, Inst Anim Nutr, Chengdu 611130, Peoples R China; [Yu, Jie; Yu, Bing; He, Jun; Zheng, Ping; Mao, Xiangbing; Chen, Daiwen] Sichuan Agr Univ, Key Lab Anim Dis Resistance Nutr, China Minist Educ, Chengdu 611130, Peoples R China; [Han, Guoquan] Sichuan Agr Univ, Coll Food Sci, Yaan 625014, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University	Chen, DW (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Chengdu 611130, Peoples R China.	dwchen@sicau.edu.cn		Yu, Jiaojun/0000-0001-9400-5408	Sichuan Department of Education [13ZA0261]; Program for Changjiang Scholars and Innovative Research Team in University from Ministry of Education of China [IRT0555-5]	Sichuan Department of Education; Program for Changjiang Scholars and Innovative Research Team in University from Ministry of Education of China(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by Key Project (13ZA0261) from Sichuan Department of Education (JY) and Program for Changjiang Scholars and Innovative Research Team in University (IRT0555-5) from Ministry of Education of China (DC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany M, 2013, NUTR RES, V33, P1, DOI 10.1016/j.nutres.2012.11.013; Anagnostis P, 2009, J CLIN ENDOCR METAB, V94, P2692, DOI 10.1210/jc.2009-0370; Arnaldi G, 2003, J CLIN ENDOCR METAB, V88, P5593, DOI 10.1210/jc.2003-030871; BERDANIER CD, 1989, FASEB J, V3, P2179, DOI 10.1096/fasebj.3.10.2666232; Buttgereit F, 2005, LANCET, V365, P801; Campbell JE, 2011, AM J PHYSIOL-CELL PH, V300, pC198, DOI 10.1152/ajpcell.00045.2010; Cassano AE, 2012, COMPARATIVE MED, V62, P348; D'Antona G, 2010, CELL METAB, V12, P362, DOI 10.1016/j.cmet.2010.08.016; Davies NA, 2013, J ENDOCRINOL; DEMONACOS C, 1995, J STEROID BIOCHEM, V55, P43, DOI 10.1016/0960-0760(95)00159-W; DIVERTIE GD, 1991, DIABETES, V40, P1228, DOI 10.2337/diabetes.40.10.1228; Djurhuus CB, 2002, AM J PHYSIOL-ENDOC M, V283, pE172, DOI 10.1152/ajpendo.00544.2001; Galitzky J, 2013, CELL METAB, V18, P3, DOI 10.1016/j.cmet.2013.06.008; Gathercole LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026223; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hassan-Smith Z, 2014, LANCET, V383, P53; Kaaman M, 2007, DIABETOLOGIA, V50, P2526, DOI 10.1007/s00125-007-0818-6; Karatsoreos IN, 2010, ENDOCRINOLOGY, V151, P2117, DOI 10.1210/en.2009-1436; Lee MJ, 2012, AM J PHYSIOL-ENDOC M, V303, pE1126, DOI 10.1152/ajpendo.00228.2012; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Liu JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034835; Liu Y, 2008, PHYSIOL GENOMICS, V32, P343, DOI 10.1152/physiolgenomics.00067.2007; Lu RH, 2010, MOL BIOL REP, V37, P2173, DOI 10.1007/s11033-009-9695-z; Lundgren M, 2008, HORM METAB RES, V40, P854, DOI 10.1055/s-0028-1087168; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; MAYOSMITH W, 1989, RADIOLOGY, V170, P515, DOI 10.1148/radiology.170.2.2911678; Minami I, 2006, INTERNAL MED, V45, P1231, DOI 10.2169/internalmedicine.45.1809; Murphy MP, 2013, CELL METAB, V18, P145, DOI 10.1016/j.cmet.2013.07.006; Murray F, 2008, EUR J PHARMACOL, V583, P115, DOI 10.1016/j.ejphar.2008.01.014; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Yuji OA, 2007, EXP MOL PATHOL, V83, P73, DOI 10.1016/j.yexmp.2007.02.007; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027; Pezaro C, 2013, BRIT J CANCER, V109, P325, DOI 10.1038/bjc.2013.340; Rees SL, 2004, HORM BEHAV, V46, P411, DOI 10.1016/j.yhbeh.2004.03.010; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Schuff KG, 2003, PRIMARY CARE, V30, P791, DOI 10.1016/S0095-4543(03)00088-5; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; SLAVIN BG, 1994, J LIPID RES, V35, P1535; Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015; Stewart PM, 2005, CLIN MED, V5, P142, DOI 10.7861/clinmedicine.5-2-142; Stewart PM, 2003, EUR J ENDOCRINOL, V149, P163, DOI 10.1530/eje.0.1490163; Tang VM, 2013, HORM METAB RES, V45, P709, DOI 10.1055/s-0033-1345119; Tedesco L, 2008, DIABETES, V57, P2028, DOI 10.2337/db07-1623; Tsiriyotis C, 1997, BIOCHEM BIOPH RES CO, V235, P349, DOI 10.1006/bbrc.1997.6787; Wang Minghan, 2005, Nutr Metab (Lond), V2, P3, DOI 10.1186/1743-7075-2-3; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Xu C, 2009, MOL ENDOCRINOL, V23, P1161, DOI 10.1210/me.2008-0464; Yu J, 2012, BRIT J NUTR, V107, P461, DOI 10.1017/S0007114511003205; Yu J, 2012, ENDOCRINOLOGY, V153, P750, DOI 10.1210/en.2011-1591	51	43	46	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112628	10.1371/journal.pone.0112628	http://dx.doi.org/10.1371/journal.pone.0112628			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25551379	gold, Green Published, Green Submitted			2022-12-27	WOS:000349144400113
